Citrus Sinensis ID: 004268
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 764 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.930 | 0.680 | 0.434 | 1e-160 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.913 | 0.623 | 0.420 | 1e-148 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.901 | 0.625 | 0.386 | 1e-130 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.888 | 0.543 | 0.388 | 1e-121 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.887 | 0.603 | 0.389 | 1e-118 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.883 | 0.612 | 0.395 | 1e-118 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.888 | 0.595 | 0.390 | 1e-117 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.890 | 0.543 | 0.364 | 1e-116 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.897 | 0.604 | 0.368 | 1e-113 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.874 | 0.691 | 0.352 | 1e-112 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 565 bits (1457), Expect = e-160, Method: Compositional matrix adjust.
Identities = 326/751 (43%), Positives = 447/751 (59%), Gaps = 40/751 (5%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
NN TG S +F N+ ++ LSG +P EIG ++ L+ L L N LTG IPS
Sbjct: 248 NNLTGKIPS--SFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPST 305
Query: 63 IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122
+G + L VL L N+L G+IP E+G + ++DL +S N L G +P FG L L+ L L
Sbjct: 306 LGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFL 365
Query: 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPST 182
+ N+L G IP I N T LT L L N +G LP + L++L LD+NH GP+P +
Sbjct: 366 RDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKS 425
Query: 183 LYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHL 242
L L + N G +++ G L+ + L+ NN G + + L L
Sbjct: 426 LRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFIL 485
Query: 243 SHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPT 302
S+N + G IPP I N+T L LDLSSN+++G LP + N+ ++ L LNGN L G IP
Sbjct: 486 SNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSG 545
Query: 303 IGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDL 362
I LTNL YL+L NR SS IPP L N +L + LS N L +IP + L + LDL
Sbjct: 546 IRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDL 605
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLI---VSENNLE--LENS 417
S N ++G I SQ + N+ +DLS NNLSG IP S + + L VS NNL+ + ++
Sbjct: 606 SYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDN 665
Query: 418 TSSENAPPPQATLFKGNKG-----------------------KQRKIVIRLVTIILAMVA 454
+ NAPP F+GNK K R ++I ++ I+ A
Sbjct: 666 AAFRNAPP---DAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIG--A 720
Query: 455 FVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKY 514
+ + GI R++ K+ +T + G SI+++DG++ ++E+I+AT +F KY
Sbjct: 721 IIILSVCAGIFICFRKRTKQIEEHT-DSESGGETLSIFSFDGKVRYQEIIKATGEFDPKY 779
Query: 515 CIGTGGYGSVYRAQLSSGKLVALKKLHR---SETEEPAFLESFQTEARLLSQIRHRNIVK 571
IGTGG+G VY+A+L + ++A+KKL+ S P+ + F E R L++IRHRN+VK
Sbjct: 780 LIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 838
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
L+GFC H + FL+YEYMERGSL VL ND EA +LDW KR+N+VK +AHALSY+H+D
Sbjct: 839 LFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRS 898
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVT 691
P+IVHRDISS NILL + EA ++DFG A+LL PDSSN + V GTYGY+APELAY M VT
Sbjct: 899 PAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVT 958
Query: 692 EKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722
EKCDVYSFGV+ LEV+ G HP DL+S+LSSS
Sbjct: 959 EKCDVYSFGVLTLEVIKGEHPGDLVSTLSSS 989
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1355), Expect = e-148, Method: Compositional matrix adjust.
Identities = 331/788 (42%), Positives = 442/788 (56%), Gaps = 90/788 (11%)
Query: 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRL 79
NL ++ L+G +P ++G + + L LS+N LTG IPS +G L L +L L N L
Sbjct: 295 NLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYL 354
Query: 80 TGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT 139
TG IP E+G++ ++DL L+NN L GSIP FGNLK+L L L N L G+IP +GN+
Sbjct: 355 TGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNME 414
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL------- 192
++ LDLS N+L+G +P GN L+SL+L NHLSG IP + + + L TL
Sbjct: 415 SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNF 474
Query: 193 --------CLG---------YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGY-- 233
C G YN L GP+ K + + K+L R GN TG I G
Sbjct: 475 TGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYP 534
Query: 234 -LNLLDELH---------------------LSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
LN +D H +S+N + G IP I N+T L+ LDLS+N L
Sbjct: 535 DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331
G LP +GNL L+ L LNGN L G +P + +LTNL L+L N SS IP +
Sbjct: 595 FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654
Query: 332 QLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391
+L ++ LS N GSIP + L QLDLS N ++G IPSQL + ++ +DLS NNL
Sbjct: 655 KLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNL 713
Query: 392 SGVIPASVRRIPKLI---VSENNLELENSTSSENAPPPQATLFK--------------GN 434
SG+IP + + L +S N LE P P F+ N
Sbjct: 714 SGLIPTTFEGMIALTNVDISNNKLE---------GPLPDTPTFRKATADALEENIGLCSN 764
Query: 435 KGKQRKIVIR----------LVTIILAMVAFVFAIL-IFGILFVHRRKDKKFNPNTREMT 483
KQR R LV IL + V IL I F + + +K
Sbjct: 765 IPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDP 824
Query: 484 EGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRS 543
E SI++ DG+ ++++IE+T +F + IGTGGY VYRA L ++A+K+LH +
Sbjct: 825 ETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDT 883
Query: 544 ETEE---PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN 600
EE P + F E + L++IRHRN+VKL+GFC H + FLIYEYME+GSL +L N
Sbjct: 884 IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943
Query: 601 DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660
D EA L WTKR+N+VK +AHALSY+H+D IVHRDISS NILL+++ A ++DFG A
Sbjct: 944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003
Query: 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720
+LL DSSN + V GTYGY+APE AYTM VTEKCDVYSFGV+ LE+++G HP DL+SSLS
Sbjct: 1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS 1063
Query: 721 SSSGRKIS 728
SS G +S
Sbjct: 1064 SSPGEALS 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 465 bits (1196), Expect = e-130, Method: Compositional matrix adjust.
Identities = 299/774 (38%), Positives = 419/774 (54%), Gaps = 85/774 (10%)
Query: 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRL 79
NL +W LSG +P +G +S+LE L L N TG IP EIG L+++K L L N+L
Sbjct: 236 NLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQL 295
Query: 80 TGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT 139
TG IP EIG+L D +++ S N L G IP EFG++ +L L L N L G IP +G LT
Sbjct: 296 TGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELT 355
Query: 140 NLTYLDLSLNQLSGRLPQE------------------------VGNLKNLKSLFLDNNHL 175
L LDLS+N+L+G +PQE +G N L + N L
Sbjct: 356 LLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSL 415
Query: 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP------- 228
SGPIP+ L L LG NKL G + +++ K+L +L L N LTGS+P
Sbjct: 416 SGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQ 475
Query: 229 -----------------STIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
+ +G L L+ L L++N G IPP IGNLT ++ ++SSNQL
Sbjct: 476 NLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQL 535
Query: 272 SGLLPREVGN------------------------LKYLASLSLNGNILIGPIPPTIGYLT 307
+G +P+E+G+ L YL L L+ N L G IP + G LT
Sbjct: 536 TGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLT 595
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQL-LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNF 366
L L LG N LS +IP EL + L ++L +SHN+LSG+IP +GNL L L+ N
Sbjct: 596 RLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNK 655
Query: 367 INGTIPSQLGKIPNISAVDLSKNNLSGVIP--ASVRRIPKLIVSENNLELENSTSSENAP 424
++G IP+ +G + ++ ++S NNL G +P A +R+ + N+ L NS S P
Sbjct: 656 LSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNH-GLCNSQRSHCQP 714
Query: 425 PPQATLFKGN---KGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTRE 481
+ K N G QR+ +++TI ++ VF I G+ + +R++ F +
Sbjct: 715 LVPHSDSKLNWLINGSQRQ---KILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQ 771
Query: 482 MTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLH 541
+ + G T++ +++AT +F +G G G+VY+A++S G+++A+KKL+
Sbjct: 772 TKPDVMDSYYFPKKG-FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN 830
Query: 542 RSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND 601
S E + SF+ E L +IRHRNIVKLYGFC H L+YEYM +GSL L+
Sbjct: 831 -SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRG 889
Query: 602 VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661
+ LDW R I A L YLH+DC+P IVHRDI SNNILL+ +A V DFGLA+
Sbjct: 890 EKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAK 949
Query: 662 LLHPD-SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
L+ S + + V G+YGYIAPE AYTM VTEKCD+YSFGVV LE++ G P
Sbjct: 950 LIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQ 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 301/774 (38%), Positives = 412/774 (53%), Gaps = 95/774 (12%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G + I L+ L+ LVL HN+L G++P EI AL +L+VL L NR +G IP EIG+
Sbjct: 396 LEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNC 455
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
L +++ N G IP G LK+L+ L L+ N+L G +P+S+GN L LDL+ NQ
Sbjct: 456 TSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQ 515
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK----- 205
LSG +P G LK L+ L L NN L G +P +L L L + L +N+L G +
Sbjct: 516 LSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSS 575
Query: 206 ------------------EVGNMKNLDRLHLNGNNLTGSIPSTIGY---LNLLD------ 238
E+GN +NLDRL L N LTG IP T+G L+LLD
Sbjct: 576 SYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNAL 635
Query: 239 ---------------ELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
+ L++N L GPIPP +G L+ L L LSSNQ LP E+ N
Sbjct: 636 TGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCT 695
Query: 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSL 343
L LSL+GN L G IP IG L L LNL N+ S S+P + S+L L LS NSL
Sbjct: 696 KLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSL 755
Query: 344 SGSIPSEIGNLIFFRQ-LDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV--- 399
+G IP EIG L + LDLS N G IPS +G + + +DLS N L+G +P SV
Sbjct: 756 TGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDM 815
Query: 400 RRIPKLIVSENNLELENSTSSENAPPPQATLFKGNKG----------------KQRKIVI 443
+ + L VS NNL + P A F GN G KQ+ +
Sbjct: 816 KSLGYLNVSFNNLGGKLKKQFSRWP---ADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSA 872
Query: 444 RLVTIILAMVAF-VFAILIFGI-LFVHRRKD--KKFNPNTREMTEGANE--------FSI 491
R V II A+ A ++I I LF +R D KK + T ++ F
Sbjct: 873 RSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN 932
Query: 492 WNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFL 551
I +E+++EAT + ++ IG+GG G VY+A+L +G+ VA+KK+ + +
Sbjct: 933 GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD--DLMSN 990
Query: 552 ESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMFLIYEYMERGSLFCVLRNDVEAVE--- 606
+SF E + L +IRHR++VKL G+C LIYEYM+ GS++ L D +E
Sbjct: 991 KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050
Query: 607 --LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL- 663
LDW R+ I +A + YLH+DC P IVHRDI S+N+LL+SN+EA + DFGLA++L
Sbjct: 1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110
Query: 664 ---HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
++ + T +YGYIAPE AY++ TEK DVYS G+V +E++ G PTD
Sbjct: 1111 ENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 283/727 (38%), Positives = 400/727 (55%), Gaps = 49/727 (6%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L+G +P E+G LSK+ ++ S N L+G IP E+ +S L++L L N+LTG IP+E+ L
Sbjct: 313 LNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKL 372
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
R+L L+LS N L G IP F NL + QL+L N L G+IP +G + L +D S NQ
Sbjct: 373 RNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQ 432
Query: 151 LSGRLPQEV-----------------GNL-------KNLKSLFLDNNHLSGPIPSTLYHL 186
LSG++P + GN+ K+L L + N L+G P+ L L
Sbjct: 433 LSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKL 492
Query: 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246
L+ + L N+ GP+ E+G + L RLHL N + ++P+ I L+ L ++S N
Sbjct: 493 VNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNS 552
Query: 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
L GPIP I N L LDLS N G LP E+G+L L L L+ N G IP TIG L
Sbjct: 553 LTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNL 612
Query: 307 TNLTYLNLGYNRLSSSIPPELMNCSQL-LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
T+LT L +G N S SIPP+L S L + + LS+N SG IP EIGNL L L+ N
Sbjct: 613 THLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNN 672
Query: 366 FINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL--------ELENS 417
++G IP+ + ++ + S NNL+G +P + +I + + + L L +
Sbjct: 673 HLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHT--QIFQNMTLTSFLGNKGLCGGHLRSC 730
Query: 418 TSSENAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNP 477
S ++ P ++L G+ + R I+I I + + ++ F R + P
Sbjct: 731 DPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHF-----LRNPVEPTAP 785
Query: 478 NTREMTEGANEFSIWNY-DGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVA 536
+ E I+ R T ++++EAT+ FH Y +G G G+VY+A + SGK +A
Sbjct: 786 YVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIA 845
Query: 537 LKKLHRSETEEPAFLES----FQTEARLLSQIRHRNIVKLYGFCLH--NKCMFLIYEYME 590
+KKL + + F+ E L +IRHRNIV+LY FC H + L+YEYM
Sbjct: 846 VKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMS 905
Query: 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650
RGSL +L ++ +DW R I A L+YLH+DCKP I+HRDI SNNIL++ N
Sbjct: 906 RGSLGELLHGG-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENF 964
Query: 651 EAFVADFGLARLLH-PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
EA V DFGLA+++ P S + + V G+YGYIAPE AYTM VTEKCD+YSFGVV LE+L G
Sbjct: 965 EAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTG 1024
Query: 710 SHPTDLL 716
P L
Sbjct: 1025 KAPVQPL 1031
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1095), Expect = e-118, Method: Compositional matrix adjust.
Identities = 284/718 (39%), Positives = 398/718 (55%), Gaps = 43/718 (5%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L+G +P EIG LS ++ S N+LTG IP E+G + L++L L N+LTGTIP E+ +L
Sbjct: 301 LNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTL 360
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
++L L+LS N L G IPL F L+ L L+L N L G IP +G ++L LD+S N
Sbjct: 361 KNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNH 420
Query: 151 LSGRLPQEV-----------------GNL-------KNLKSLFLDNNHLSGPIPSTLYHL 186
LSGR+P + GN+ K L L L N+L G PS L
Sbjct: 421 LSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQ 480
Query: 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246
+ + LG N+ G + +EVGN L RL L N TG +P IG L+ L L++S N+
Sbjct: 481 VNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNK 540
Query: 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
L G +P I N L LD+ N SG LP EVG+L L L L+ N L G IP +G L
Sbjct: 541 LTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNL 600
Query: 307 TNLTYLNLGYNRLSSSIPPELMNCSQL-LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
+ LT L +G N + SIP EL + + L + L LS+N L+G IP E+ NL+ L L+ N
Sbjct: 601 SRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNN 660
Query: 366 FINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP--KLIVSEN--NLELENSTSSE 421
++G IPS + ++ + S N+L+G IP +R I I +E L ++
Sbjct: 661 NLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQ 719
Query: 422 NAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTRE 481
P Q+T G G R +++ I A++ V +LI I+++ RR + + ++
Sbjct: 720 PFAPSQST---GKPGGMRSS--KIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQD 774
Query: 482 MTEGANEFSIW--NYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKK 539
I+ +G TF++++ AT++F + +G G G+VY+A L +G +A+KK
Sbjct: 775 GQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKK 833
Query: 540 LHRSET--EEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCV 597
L + SF+ E L IRHRNIVKL+GFC H L+YEYM +GSL +
Sbjct: 834 LASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEI 893
Query: 598 LRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657
L + + LDW+KR I A L+YLH+DCKP I HRDI SNNILL+ EA V DF
Sbjct: 894 LHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 951
Query: 658 GLARLLH-PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
GLA+++ P S + + + G+YGYIAPE AYTM VTEK D+YS+GVV LE+L G P
Sbjct: 952 GLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQ 1009
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1090), Expect = e-117, Method: Compositional matrix adjust.
Identities = 288/737 (39%), Positives = 393/737 (53%), Gaps = 58/737 (7%)
Query: 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT 80
LV ++ LSG +P EIG L+KLE+L L NSL G IP EIG S LK++DLS N L+
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 81 GTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTN 140
G+IPS IG L L + +S+N +GSIP N L QL+L N++ GLIPS +G LT
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTK 395
Query: 141 LTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200
LT NQL G +P + + +L++L L N L+G IPS L+ L L L L N L
Sbjct: 396 LTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLS 455
Query: 201 GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
G + +E+GN +L RL L N +TG IPS IG L ++ L S NRL G +P IG+ +
Sbjct: 456 GFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSE 515
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L +DLS+N L G LP V +L L L ++ N G IP ++G L +L L L N S
Sbjct: 516 LQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFS 575
Query: 321 SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR-QLDLSRNFINGTIPSQLGKIP 379
SIP L CS L L L N LSG IPSE+G++ L+LS N + G IPS++ +
Sbjct: 576 GSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLN 635
Query: 380 NISAVDLSKNNLSGVIP--ASVRRIPKLIVSEN------------------NLELENSTS 419
+S +DLS N L G + A++ + L +S N +LE
Sbjct: 636 KLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695
Query: 420 SENAPPPQATLFKGN-------KGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKD 472
S T KGN + RK+ + L +I V ++I G + V R +
Sbjct: 696 SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTV----VLMILGAVAVIRARR 751
Query: 473 KKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKY-----CIGTGGYGSVYRA 527
N E+ E Y + T + + + D I+ IG G G VYRA
Sbjct: 752 NIDNERDSELGE--------TYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRA 803
Query: 528 QLSSGKLVALKKL--------HRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579
+ +G+++A+KKL H +T+ +SF E + L IRH+NIV+ G C +
Sbjct: 804 DVDNGEVIAVKKLWPAMVNGGHDEKTKN--VRDSFSAEVKTLGTIRHKNIVRFLGCCWNR 861
Query: 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639
L+Y+YM GSL +L ++ LDW R I+ A L+YLH+DC P IVHRDI
Sbjct: 862 NTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDI 920
Query: 640 SSNNILLNSNLEAFVADFGLARLLHPDSSNRT--LVVGTYGYIAPELAYTMAVTEKCDVY 697
+NNIL+ + E ++ADFGLA+L+ R V G+YGYIAPE Y+M +TEK DVY
Sbjct: 921 KANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVY 980
Query: 698 SFGVVALEVLMGSHPTD 714
S+GVV LEVL G P D
Sbjct: 981 SYGVVVLEVLTGKQPID 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 281/771 (36%), Positives = 407/771 (52%), Gaps = 91/771 (11%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G + S I L+ L++ L HN+L G++P EIG L +L+++ L NR +G +P EIG+
Sbjct: 397 LEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNC 456
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
L +++ N L+G IP G LKDL +L L+ N+L G IP+S+GN +T +DL+ NQ
Sbjct: 457 TRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQ 516
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK----- 205
LSG +P G L L+ + NN L G +P +L +L L + NK G ++
Sbjct: 517 LSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSS 576
Query: 206 ------------------EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL 247
E+G NLDRL L N TG IP T G ++ L L +S N L
Sbjct: 577 SYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSL 636
Query: 248 DGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307
G IP +G L +DL++N LSG++P +G L L L L+ N +G +P I LT
Sbjct: 637 SGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLT 696
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367
N+ L L N L+ SIP E+ N L L L N LSG +PS IG L +L LSRN +
Sbjct: 697 NILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNAL 756
Query: 368 NGTIPSQLGKIPNI-SAVDLSKNNLSGVIPASVRRIPKL---------IVSE-------- 409
G IP ++G++ ++ SA+DLS NN +G IP+++ +PKL +V E
Sbjct: 757 TGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDM 816
Query: 410 ----------NNLELENSTSSENAPPPQATLFKGNKG---------------KQRKIVIR 444
NNLE + QA F GN G QR + +
Sbjct: 817 KSLGYLNLSYNNLE---GKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPK 873
Query: 445 LVTIILA---MVAFVFAILIFGILFVHRRKD--KKFNPNTREMTEG-----ANEFSIWNY 494
V II A + A +L+ ILF + D KK + A FS
Sbjct: 874 TVVIISAISSLAAIALMVLVI-ILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGA 932
Query: 495 DGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESF 554
I +++++EAT + ++ IG+GG G VY+A+L +G+ +A+KK+ + + +SF
Sbjct: 933 KSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKD--DLMSNKSF 990
Query: 555 QTEARLLSQIRHRNIVKLYGFC--LHNKCMFLIYEYMERGSLFCVL---RNDVEAVELDW 609
E + L IRHR++VKL G+C + LIYEYM GS++ L N + L W
Sbjct: 991 NREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGW 1050
Query: 610 TKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL----HP 665
R+ I +A + YLHYDC P IVHRDI S+N+LL+SN+EA + DFGLA++L
Sbjct: 1051 ETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDT 1110
Query: 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716
++ + T+ G+YGYIAPE AY++ TEK DVYS G+V +E++ G PT+ +
Sbjct: 1111 NTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM 1161
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1055), Expect = e-113, Method: Compositional matrix adjust.
Identities = 278/754 (36%), Positives = 395/754 (52%), Gaps = 68/754 (9%)
Query: 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT 80
L + ++ T+LSG +P E+G S+L L L N L+G +P E+G L L+ + L N L
Sbjct: 253 LQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLH 312
Query: 81 GTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTN 140
G IP EIG ++ L ++LS N +G+IP FGNL +L +L L N + G IPS + N T
Sbjct: 313 GPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTK 372
Query: 141 LTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200
L + NQ+SG +P E+G LK L N L G IP L L L L N L
Sbjct: 373 LVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLT 432
Query: 201 GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
G + + ++NL +L L N ++G IP IG L L L +NR+ G IP IG L N
Sbjct: 433 GSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQN 492
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L LDLS N LSG +P E+ N + L L+L+ N L G +P ++ LT L L++ N L+
Sbjct: 493 LSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLT 552
Query: 321 SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380
IP L + L L+LS NS +G IPS +G+ + LDLS N I+GTIP +L I +
Sbjct: 553 GKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQD 612
Query: 381 IS-AVDLSKNNLSGVIP---ASVRRIPKLIVSENNLE--------LENSTS---SEN--- 422
+ A++LS N+L G IP +++ R+ L +S N L LEN S S N
Sbjct: 613 LDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFS 672
Query: 423 APPPQATLFK--------GNKG------------------KQRKIVIRLVTIILAMVAFV 456
P + +F+ GN G QR + + I + ++ V
Sbjct: 673 GYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISV 732
Query: 457 FAIL-IFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYC 515
A+L + G+L V R K + N E E ++W + F+++ E H+ C
Sbjct: 733 TAVLAVLGVLAVIRAKQMIRDDNDSETGE-----NLWTWQ-FTPFQKLNFTVE--HVLKC 784
Query: 516 ------IGTGGYGSVYRAQLSSGKLVALKKLH-------RSETEEPAFLESFQTEARLLS 562
IG G G VY+A++ + +++A+KKL +T+ +SF E + L
Sbjct: 785 LVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLG 844
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
IRH+NIV+ G C + L+Y+YM GSL +L L W R I+ A
Sbjct: 845 SIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQG 904
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT--LVVGTYGYI 680
L+YLH+DC P IVHRDI +NNIL+ + E ++ DFGLA+L+ R+ + G+YGYI
Sbjct: 905 LAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYI 964
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
APE Y+M +TEK DVYS+GVV LEVL G P D
Sbjct: 965 APEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID 998
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1048), Expect = e-112, Method: Compositional matrix adjust.
Identities = 276/784 (35%), Positives = 400/784 (51%), Gaps = 116/784 (14%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G + IG L L+ + L N L G+IP EIG + L LDLS N L G IP I L
Sbjct: 83 LGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDIPFSISKL 142
Query: 91 RDLLDLNLSNNILNGSIPL---EFGNLKDLD----------------------------- 118
+ L LNL NN L G +P + NLK LD
Sbjct: 143 KQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNM 202
Query: 119 ----------------QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNL 162
++GN L G IP SIGN T+ LD+S NQ++G +P +G L
Sbjct: 203 LTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFL 262
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
+ + +L L N L+G IP + + LA L L N+LVGP+ +GN+ +L+L+GN
Sbjct: 263 Q-VATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNM 321
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282
LTG IPS +G ++ L L L+ N+L G IPP +G L L L+L++N+L G +P + +
Sbjct: 322 LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSC 381
Query: 283 KYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
L +++GN+L G IP L +LTYLNL N IP EL + L L LS N+
Sbjct: 382 AALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNN 441
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV--- 399
SGSIP +G+L L+LSRN ++G +P++ G + +I +D+S N LSGVIP +
Sbjct: 442 FSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQL 501
Query: 400 --------------RRIPK----------LIVSENNLE---------------------- 413
+IP L VS NNL
Sbjct: 502 QNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPY 561
Query: 414 -LENSTSSENAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKD 472
N S P P++ +F ++G IV+ ++T++ + V+ + +
Sbjct: 562 LCGNWVGSICGPLPKSRVF--SRGALICIVLGVITLLCMIFLAVYKSM----------QQ 609
Query: 473 KKFNPNTREMTEGANEFSIWNYDGRI-TFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSS 531
KK + + EG + I + D I TF++++ TE+ + K+ IG G +VY+ L S
Sbjct: 610 KKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKS 669
Query: 532 GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591
+ +A+K+L+ + P L F+TE + IRHRNIV L+G+ L L Y+YME
Sbjct: 670 SRPIAIKRLY---NQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMEN 726
Query: 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651
GSL+ +L ++ V+LDW R+ I A L+YLH+DC P I+HRDI S+NILL+ N E
Sbjct: 727 GSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFE 786
Query: 652 AFVADFGLARLLHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGS 710
A ++DFG+A+ + ++ T V+GT GYI PE A T + EK D+YSFG+V LE+L G
Sbjct: 787 AHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGK 846
Query: 711 HPTD 714
D
Sbjct: 847 KAVD 850
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 764 | ||||||
| 225452751 | 878 | PREDICTED: probable leucine-rich repeat | 0.948 | 0.825 | 0.506 | 0.0 | |
| 224065673 | 964 | predicted protein [Populus trichocarpa] | 0.941 | 0.745 | 0.467 | 0.0 | |
| 224110038 | 964 | predicted protein [Populus trichocarpa] | 0.941 | 0.745 | 0.467 | 0.0 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.922 | 0.806 | 0.504 | 1e-180 | |
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.914 | 0.805 | 0.506 | 1e-180 | |
| 224108669 | 811 | predicted protein [Populus trichocarpa] | 0.913 | 0.860 | 0.489 | 1e-177 | |
| 224093626 | 1039 | predicted protein [Populus trichocarpa] | 0.930 | 0.684 | 0.478 | 1e-177 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.857 | 0.798 | 0.475 | 1e-176 | |
| 224110020 | 1048 | predicted protein [Populus trichocarpa] | 0.916 | 0.667 | 0.475 | 1e-176 | |
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.876 | 0.849 | 0.497 | 1e-171 |
| >gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/732 (50%), Positives = 493/732 (67%), Gaps = 7/732 (0%)
Query: 8 AELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALS 67
ELS+L F+ FP+LV + L+G +P +IG L++L L L N+LTG +P + L+
Sbjct: 83 GELSKLEFSSFPSLVELFLSDCGLNGSIPHQIGTLTQLIILYLPLNNLTGELPLSLANLT 142
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
+L+ L L NRL G+IP EIG +++L+ L +N L G IP FGNL +L L L N++
Sbjct: 143 QLEYLSLHSNRLHGSIPPEIGKMKNLIYFILHDNNLTGVIPSSFGNLTNLTYLYLGSNQI 202
Query: 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLN 187
G IP IG + NL +L LS N L G +P E+G L+NL LFLD N+L+ IPS+ +L
Sbjct: 203 SGFIPPQIGKMKNLEFLSLSYNGLHGSIPPEIGKLQNLNYLFLDYNNLTSVIPSSFGNLT 262
Query: 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL 247
L L L N++ G + ++G +KNL+ L L+ N L G IP IG L L L+L +N L
Sbjct: 263 NLTYLYLDSNQISGFIPPQIGKIKNLELLELSYNGLHGPIPLEIGKLKNLKILNLGYNNL 322
Query: 248 DGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307
G IP + GNLTNL L L NQ+SG +P E+G +K L +L N L G IP + G LT
Sbjct: 323 IGVIPSSFGNLTNLTYLTLGGNQISGFIPPEIGKMKNLIFFNLGYNSLTGVIPSSFGNLT 382
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367
+LT L L N+++ SIPPE+ LL L L+ N +SG IP EI NL LD+S N I
Sbjct: 383 HLTSLILRGNQINGSIPPEIGYLLDLLYLDLNTNQISGFIPEEILNLKKLGHLDISNNLI 442
Query: 368 NGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRR--IPKLIVSENNLELENSTSSENAPP 425
+G IPS+LG + +LS+NN+SG IP S+ +S N LE + ST+ A
Sbjct: 443 SGKIPSELGNLKEAIYFNLSRNNISGTIPLSISNNMWTLFDLSHNQLEGQ-STAPLEAFD 501
Query: 426 PQATLFKGNKG---KQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREM 482
L G KG +++ I L+ I + ++ + G LF ++ K P T ++
Sbjct: 502 HNKGLCDGIKGLSHCKKRHQIILIIAISLSATLLLSVAVLGFLFRKQKIRKNQLPKTTKV 561
Query: 483 TEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHR 542
G + FSIW+YDG I ++++I+ATEDF IKYCIGTGGYGSVYRAQL SGK+VALKKLH
Sbjct: 562 KNG-DLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHG 620
Query: 543 SETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDV 602
E ++P +L+SF+ E ++LS+I+HRNIVKL+GFCLHNKCMFL+Y+YME+GSL+C+LR++V
Sbjct: 621 WERDDPTYLKSFENEVQMLSRIQHRNIVKLHGFCLHNKCMFLVYKYMEKGSLYCMLRDEV 680
Query: 603 EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662
E V+LDW KRVN+VK +A+ALSY+H+D I+HRDISSNNILL+S LEAFVADFG ARL
Sbjct: 681 EVVQLDWIKRVNVVKGIANALSYMHHDSTLPIIHRDISSNNILLDSKLEAFVADFGTARL 740
Query: 663 LHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722
L PDSSN+TL+ GTYGYIAPELAYTM VTEKCDVYSFG+VALE +MG HP DL++SLS+S
Sbjct: 741 LDPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGMVALETIMGKHPGDLVTSLSAS 800
Query: 723 SGRKISQNPRLD 734
S + I+ LD
Sbjct: 801 STQNITLKDVLD 812
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065673|ref|XP_002301914.1| predicted protein [Populus trichocarpa] gi|222843640|gb|EEE81187.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/812 (46%), Positives = 508/812 (62%), Gaps = 93/812 (11%)
Query: 6 TGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGA 65
G + ++NF+CF NLV + LSG +P +I L +L L LS N+L G +PS +G
Sbjct: 89 VGNKFGKMNFSCFSNLVRLHLANHELSGSIPPQISILPQLRYLNLSSNNLAGELPSSLGN 148
Query: 66 LSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125
LSRL LD S N LT +IP E+G+L++L+ L+LS+NI +G IP +L++L L + N
Sbjct: 149 LSRLVELDFSSNNLTNSIPPELGNLKNLVTLSLSDNIFSGPIPSALCHLENLRHLFMDHN 208
Query: 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ------------------------EVGN 161
L+G +P IGN+ NL LD+S N L+G +P+ E+GN
Sbjct: 209 SLEGALPREIGNMKNLEILDVSYNTLNGPIPRTMGSLAKLRSLILSRNAINESIPLEIGN 268
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L NL+ L L +N L G IPST+ L L +L L N + G + ++GN+ NL+ L L N
Sbjct: 269 LTNLEDLNLCSNILVGSIPSTMGLLPNLISLFLCENHIQGSIPLKIGNLTNLEYLVLGSN 328
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281
L GSIPST G+L+ L + +S N+++GPIP IGNLTNL L+L N+++GL+P +GN
Sbjct: 329 ILGGSIPSTSGFLSNLIFVDISSNQINGPIPLEIGNLTNLQYLNLDGNKITGLIPFSLGN 388
Query: 282 LK-----YLASLSLNGNI-------------------LIGPIPPTIGYLTNLTYLNLGYN 317
L+ YL+ +NG+I + G IP T+G LT+L +L+L N
Sbjct: 389 LRNLTTLYLSHNQINGSIPLEIQNLTKLEELYLYSNNISGSIPTTMGRLTSLRFLSLYDN 448
Query: 318 RLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGK 377
+++ SIP E+ N ++L L L N++SGSIP+ +G+L R+L+LSRN +NG I S L
Sbjct: 449 QINGSIPLEIQNLTKLEELYLYSNNISGSIPTIMGSL---RKLNLSRNQMNGPISSSLKN 505
Query: 378 IPNISAVDLSKNNLSGVIPASVRRIPKLI---VSENNLELENSTSSENAPPP-------- 426
N++ +DLS NNLS IP ++ + L S NNL + N PP
Sbjct: 506 CNNLTLLDLSCNNLSEEIPYNLYNLTSLQKANFSYNNL---SGPVPLNLKPPFDFYFTCD 562
Query: 427 --------------QATLFKGNK-----------GKQRKIVIRLVTIILAMVAFVFAILI 461
+AT F+GN+ + +I + I L + A +L
Sbjct: 563 LLLHGHITNDSATFKATAFEGNRYLHPDFSNCSLPSKTNRMIHSIKIFLPITAISLCLLC 622
Query: 462 FGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGY 521
G ++ R K + P + + + FSIWNYDGRI +E++I ATE+F ++YCIGTGGY
Sbjct: 623 LGCCYLSRCKATQPEPTS---LKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGTGGY 679
Query: 522 GSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581
G+VYRAQL SGKLVALKKLHR E EEPAF +S + E LL+QIRHR+IVKLYGFCLH +C
Sbjct: 680 GNVYRAQLPSGKLVALKKLHRREAEEPAFDKSLKNEVELLTQIRHRSIVKLYGFCLHQRC 739
Query: 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641
MFL+YEYME+GSLFC LRNDV AVEL W KR +I+K +AHALSYLH+DC P IVHRDISS
Sbjct: 740 MFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVHRDISS 799
Query: 642 NNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGV 701
+N+LLNS ++FVADFG+ARLL PDSSN T++ GTYGYIAPELAYTM VTEKCDVYSFG
Sbjct: 800 SNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGA 859
Query: 702 VALEVLMGSHPTDLLSSLSSSSGRKISQNPRL 733
VALE LMG HP D+LSS + + K +PRL
Sbjct: 860 VALETLMGRHPGDILSSSARAITLKEVLDPRL 891
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110038|ref|XP_002333164.1| predicted protein [Populus trichocarpa] gi|222835017|gb|EEE73466.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/812 (46%), Positives = 507/812 (62%), Gaps = 93/812 (11%)
Query: 6 TGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGA 65
G + ++NF+CF NLV + LSG +P +I L +L L LS N+L G +PS +G
Sbjct: 89 VGNKFGKMNFSCFSNLVRLHLANHELSGSIPPQISILPQLRYLNLSSNNLAGELPSSLGN 148
Query: 66 LSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125
LSRL LD S N LT +IP E+G+L++L+ L+LS+NI +G IP +L++L L + N
Sbjct: 149 LSRLVELDFSSNNLTNSIPPELGNLKNLVTLSLSDNIFSGPIPSALCHLENLRHLFMDHN 208
Query: 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ------------------------EVGN 161
L+G +P IGN+ NL LD+S N L+G +P+ E+GN
Sbjct: 209 SLEGALPREIGNMKNLEILDVSYNTLNGPIPRTMGSLAKLRSLILSRNAIDGSIPLEIGN 268
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L NL+ L L +N L G IPST+ L L +L L N + G + ++GN+ NL+ L L N
Sbjct: 269 LTNLEDLNLCSNILVGSIPSTMGLLPNLISLFLCENHIQGSIPLKIGNLTNLEYLVLGSN 328
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281
L GSIPST G+L+ L + +S N+++GPIP IGNLTNL L+L N+++GL+P +GN
Sbjct: 329 ILGGSIPSTSGFLSNLIFVDISSNQINGPIPLEIGNLTNLQYLNLDGNKITGLIPFSLGN 388
Query: 282 LK-----YLASLSLNGNI-------------------LIGPIPPTIGYLTNLTYLNLGYN 317
L+ YL+ +NG+I + G IP T+G LT+L +L+L N
Sbjct: 389 LRNLTTLYLSHNQINGSIPLEIQNLTKLEELYLYSNNISGSIPTTMGRLTSLRFLSLYDN 448
Query: 318 RLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGK 377
+++ SIP E+ N ++L L L N++SGSIP+ +G+L R+L+LSRN +NG I S L
Sbjct: 449 QINGSIPLEIQNLTKLEELYLYSNNISGSIPTIMGSL---RELNLSRNQMNGPISSSLKN 505
Query: 378 IPNISAVDLSKNNLSGVIPASVRRIPKLI---VSENNLELENSTSSENAPPP-------- 426
N++ +DLS NNLS IP ++ + L S NNL + N PP
Sbjct: 506 CNNLTLLDLSCNNLSEEIPYNLYNLTSLQKANFSYNNL---SGPVPLNLKPPFDFYFTCD 562
Query: 427 --------------QATLFKGNKGKQRKI-----------VIRLVTIILAMVAFVFAILI 461
+AT F+GNK + +I + I L + +L
Sbjct: 563 LLLHGHITNDSATFKATAFEGNKDLHPDLSNCSLPSKTNRMIHSIKIFLPISTISLCLLC 622
Query: 462 FGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGY 521
G ++ R K + P + + + FSIWNYDGRI +E++I ATE+F ++YCIG+GGY
Sbjct: 623 LGCCYLSRCKATQPEPTS---LKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGSGGY 679
Query: 522 GSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581
GSVYRAQL SGKLVALKKLH E EEPAF +SF+ E LL+QIRHR+IVKLYGFCLH +C
Sbjct: 680 GSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIRHRSIVKLYGFCLHQRC 739
Query: 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641
MFL+YEYME+GSLFC LRNDV AVEL W KR +I+K +AHALSYLH+DC P IVHRDISS
Sbjct: 740 MFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVHRDISS 799
Query: 642 NNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGV 701
+N+LLNS ++FVADFG+ARLL PDSSN T++ GTYGYIAPELAYTM VTEKCDVYSFG
Sbjct: 800 SNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGA 859
Query: 702 VALEVLMGSHPTDLLSSLSSSSGRKISQNPRL 733
VALE LMG HP D+LSS + + K +PRL
Sbjct: 860 VALETLMGRHPGDILSSSARAITLKEVLDPRL 891
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = e-180, Method: Compositional matrix adjust.
Identities = 366/725 (50%), Positives = 474/725 (65%), Gaps = 20/725 (2%)
Query: 25 RIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN-RLTGTI 83
RI L G +P +G L+ L L L+ N + G IPSEIG L L LDLSYN L+G I
Sbjct: 89 RISDCGLDGELPVSLGNLTLLVYLSLNFNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAI 148
Query: 84 PSEIGSLRDLLDLNLSNNI-LNGSIPLEFGNLKDLDQLRLQGNK-LDGLIPSSIGNLTNL 141
PS +G L++L+ L+LS+ L G+IP G LK+L L L N L G+IPSS+GNLTNL
Sbjct: 149 PSSLGYLKNLIHLDLSHCYSLYGAIPSSLGYLKNLIHLDLSHNSDLYGVIPSSLGNLTNL 208
Query: 142 TYLDLSLNQLSGRLPQEVGNLKNLKSLFLD-NNHLSGPIPSTLYHLNQLATLCLGYNKLV 200
YL L+ N+++G +P E+GNLKNL L L N +LSG IPS++ +L L L LG N L
Sbjct: 209 VYLSLNFNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLS 268
Query: 201 GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
+ +G++ NL+ L+LN N + GSIPS IG L L +L LSHN L G IP ++GNL N
Sbjct: 269 SVIPSSLGSLTNLEYLYLNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLIN 328
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L L NQ+ GL+P GNL L L L N + G IPP I L NL +L L +N L+
Sbjct: 329 LTYFHLIDNQIQGLIPLSFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLT 388
Query: 321 SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380
I P L L + N + G IPS+IGNL LDLS N I+G IPSQL + +
Sbjct: 389 GVI-PSLGYLIHLNVFNIRRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKS 447
Query: 381 ISAVDLSKNNLSGVIPA---SVRRIPKLIVSENNLELENSTSSENAPPPQATLFKGNKG- 436
+ +++LS N LSG IP + + + S N+ E + PP+ +F NKG
Sbjct: 448 LESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHNDFEGHIPHELQFVYPPR--VFGHNKGL 505
Query: 437 -------KQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEF 489
K + + II + + GIL + R+ + N T+ + F
Sbjct: 506 CGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRR--NQTKATSTKNGDIF 563
Query: 490 SIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPA 549
S+WNYDG+I +E++IEATEDF IKYCIGTGGYGSVY+AQL +G +VALKKLH E +E
Sbjct: 564 SVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAT 623
Query: 550 FLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDW 609
+L+SFQ E ++LS+I+HRNI+KL+G+CLH +CMFLIY+YMERGSL+CVL N+VEA+ELDW
Sbjct: 624 YLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDW 683
Query: 610 TKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669
KRVN++KS+ HAL Y+H+D P I+HRD+SSNNILL+ L+AF++DFG ARLLHPDSSN
Sbjct: 684 IKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSN 743
Query: 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQ 729
+TL+ GTYGYIAPELAYTMAVTEKCDVYSFGVVALE +MG HP +L + LSSSS + I
Sbjct: 744 QTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIML 803
Query: 730 NPRLD 734
LD
Sbjct: 804 TDILD 808
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1645), Expect = e-180, Method: Compositional matrix adjust.
Identities = 364/719 (50%), Positives = 472/719 (65%), Gaps = 20/719 (2%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN-RLTGTIPSEIGS 89
L G +P +G L+ L L L+ N + G IPSEIG L L LDLSYN L+G IPS +G
Sbjct: 89 LDGELPVSLGNLTLLVYLSLNFNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSLGY 148
Query: 90 LRDLLDLNLSNNI-LNGSIPLEFGNLKDLDQLRLQGNK-LDGLIPSSIGNLTNLTYLDLS 147
L++L+ L+LS+ L G+IP G LK+L L L N L G+IPSS+GNLTNL YL L+
Sbjct: 149 LKNLIHLDLSHCYSLYGAIPSSLGYLKNLIHLDLSHNSDLYGVIPSSLGNLTNLVYLSLN 208
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLD-NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206
N+++G +P E+GNLKNL L L N +LSG IPS++ +L L L LG N L +
Sbjct: 209 FNRINGSIPSEIGNLKNLIHLDLSYNYYLSGAIPSSIGYLKNLIHLDLGSNSLSSVIPSS 268
Query: 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDL 266
+G++ NL+ L+LN N + GSIPS IG L L +L LSHN L G IP ++GNL NL L
Sbjct: 269 LGSLTNLEYLYLNFNRINGSIPSEIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHL 328
Query: 267 SSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE 326
NQ+ GL+P GNL L L L N + G IPP I L NL +L L +N L+ I P
Sbjct: 329 IDNQIQGLIPLSFGNLTNLTHLYLRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVI-PS 387
Query: 327 LMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDL 386
L L + N + G IPS+IGNL LDLS N I+G IPSQL + ++ +++L
Sbjct: 388 LGYLIHLNVFNIRRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNL 447
Query: 387 SKNNLSGVIPA---SVRRIPKLIVSENNLELENSTSSENAPPPQATLFKGNKG------- 436
S N LSG IP + + + S N+ E + PP+ +F NKG
Sbjct: 448 SHNKLSGHIPPLSIYIHKGSSIDFSHNDFEGHIPHELQFVYPPR--VFGHNKGLCGEREG 505
Query: 437 -KQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYD 495
K + + II + + GIL + R+ + N T+ + FS+WNYD
Sbjct: 506 LPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRR--NQTKATSTKNGDIFSVWNYD 563
Query: 496 GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQ 555
G+I +E++IEATEDF IKYCIGTGGYGSVY+AQL +G +VALKKLH E +E +L+SFQ
Sbjct: 564 GKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQ 623
Query: 556 TEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI 615
E ++LS+I+HRNI+KL+G+CLH +CMFLIY+YMERGSL+CVL N+VEA+ELDW KRVN+
Sbjct: 624 NEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNV 683
Query: 616 VKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG 675
+KS+ HAL Y+H+D P I+HRD+SSNNILL+ L+AF++DFG ARLLHPDSSN+TL+ G
Sbjct: 684 IKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAG 743
Query: 676 TYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLD 734
TYGYIAPELAYTMAVTEKCDVYSFGVVALE +MG HP +L + LSSSS + I LD
Sbjct: 744 TYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFTLLSSSSAQNIMLTDILD 802
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108669|ref|XP_002333361.1| predicted protein [Populus trichocarpa] gi|222836312|gb|EEE74733.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1623), Expect = e-177, Method: Compositional matrix adjust.
Identities = 361/738 (48%), Positives = 478/738 (64%), Gaps = 40/738 (5%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G +P EIG + LE L +S+N+LTG IP +G+L++L+ L N++ G IP EIG+L
Sbjct: 6 LEGALPREIGNMRNLESLDVSYNTLTGPIPRTMGSLAKLRSLIFRENKINGPIPLEIGNL 65
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS--- 147
+L L+L +NIL GSIP G L +L L L N+++G IP IGNLTNL YLDL
Sbjct: 66 TNLEYLDLCSNILVGSIPSTLGLLPNLSTLVLYDNQINGSIPLKIGNLTNLQYLDLGSNI 125
Query: 148 ---------------------LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL 186
NQ+ G +P ++GNL NL+ L LD N ++G IP +L +L
Sbjct: 126 LGGSIPSTSSLLSNLILLDLSYNQIKGSIPLKIGNLTNLQYLNLDGNKITGLIPFSLGNL 185
Query: 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246
L +L L +N++ G + E+ N+ NL L+L+ NN++GSIP+ IG L L L LSHN+
Sbjct: 186 INLRSLSLSHNQINGSIPLEIQNLTNLKGLYLSSNNISGSIPTVIGRLTNLRSLSLSHNQ 245
Query: 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
++G IP I NLTNL L LSSN +SG +P +G L L L ++ N + GPIP I L
Sbjct: 246 INGSIPLEIQNLTNLKGLYLSSNNISGSIPTVIGRLTSLRFLFISDNQINGPIPLEIQKL 305
Query: 307 TNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNF 366
TNL L L N + SIP ++ + L L LS+N ++G IPS + LDLS N
Sbjct: 306 TNLEVLYLRSNNIRGSIPIKMYRLTSLRLLFLSNNQINGPIPSSLKYCNNLTSLDLSFNN 365
Query: 367 INGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPP 426
++ IPS+L +P++ V+ S NNLSG +P ++ P +L L ++++
Sbjct: 366 LSEEIPSKLYDLPSLQYVNFSYNNLSGPVPLNLPP-PFDFYLTCDLPLHGQITNDSVTF- 423
Query: 427 QATLFKGNKGKQRKI-----------VIRLVTIILAMVAFVFAILIFGILFVHRRKDKKF 475
+AT F+GNK + +I + I L + +L G ++ R K +
Sbjct: 424 KATAFEGNKDLHPDLSNCTLPSKTNRMIHSIKIFLPISTISLCLLCLGCCYLSRCKATQP 483
Query: 476 NPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLV 535
P + + + FSIWNYDGRI +E++I ATE+F ++YCIG+GGYGSVYRAQL SGKLV
Sbjct: 484 EPTS---LKNGDLFSIWNYDGRIAYEDIIAATENFDLRYCIGSGGYGSVYRAQLPSGKLV 540
Query: 536 ALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF 595
ALKKLH E EEPAF +SF+ E LL+QIRHR+IV+LYGFCLH +CMFL+YEYME+GSLF
Sbjct: 541 ALKKLHHREAEEPAFDKSFKNEVELLTQIRHRSIVRLYGFCLHQRCMFLVYEYMEKGSLF 600
Query: 596 CVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655
C LRNDVEAVEL W KR +I+K +AHALSYLH++C P IVHRDISS+N+LLNS ++FVA
Sbjct: 601 CALRNDVEAVELKWMKRAHIIKDIAHALSYLHHECNPPIVHRDISSSNVLLNSESKSFVA 660
Query: 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715
DFG+ARLL PDSSN T++ GTYGYIAPELAYTM VTEKCDVYSFGVVALE LMG HP D+
Sbjct: 661 DFGVARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETLMGKHPGDI 720
Query: 716 LSSLSSSSGRKISQNPRL 733
LSS + + K +PRL
Sbjct: 721 LSSSARAMTLKEVLDPRL 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093626|ref|XP_002334827.1| predicted protein [Populus trichocarpa] gi|222875006|gb|EEF12137.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-177, Method: Compositional matrix adjust.
Identities = 383/800 (47%), Positives = 494/800 (61%), Gaps = 89/800 (11%)
Query: 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRL 79
NLVT + SG +PS + L L L + HN L G +P EIG + L+ LD+SYN L
Sbjct: 170 NLVTLSLSYNRFSGPIPSALCHLDNLTHLHMDHNILEGALPREIGNMKNLESLDVSYNTL 229
Query: 80 TGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT 139
G IP + SL L L S N +NG I LE GNL +L+ L L N++ GLIPS++G L
Sbjct: 230 YGPIPRTLXSLAKLRSLIFSENQINGCIXLEIGNLTNLEDLDLSHNQITGLIPSTLGLLP 289
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL 199
NL +LDL NQ++G +P +GNL+NL +LFL +N ++G IP + +L L L L N +
Sbjct: 290 NLIFLDLFYNQITGLIPFSLGNLRNLTTLFLSHNQINGSIPLEIQNLTNLEELYLSSNSI 349
Query: 200 VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT 259
G + +G + NL L L+ N +TG IPST+G L L L L +N++ G IP ++GNL
Sbjct: 350 SGSIPSTLGLLSNLILLDLSHNQITGLIPSTLGLLPNLIRLDLFYNQITGLIPFSLGNLR 409
Query: 260 NLIALDLSSNQLSGLLPREVGNLK-----YLASLSLNGNI-------------------L 295
NL AL LS NQ++G +P E+ NL YL+S S++G+I +
Sbjct: 410 NLTALFLSHNQINGSIPLEIQNLTNLEELYLSSNSISGSIPSTLGLLPNLILLDLSDNQI 469
Query: 296 IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLI 355
G IP T+G L NL L+L YN+++ IP L N L L LSHN ++GSIP EI NL
Sbjct: 470 TGLIPSTLGLLPNLIRLDLFYNQITGLIPFSLGNLRNLTTLFLSHNQINGSIPLEIQNLT 529
Query: 356 FFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRI-PKLIVSENN--- 411
+L LS N I+G+IPS LG +PN+ +DLS N ++G+IP S+ RI P L +S N
Sbjct: 530 NLEELYLSSNSISGSIPSTLGLLPNLILLDLSDNQITGLIPFSIVRIWPTLFLSHNQING 589
Query: 412 ---LELENSTSSE---------NAPPP------------------------QATLFKGNK 435
LE++N T+ E + P P +AT F+GNK
Sbjct: 590 SIPLEIQNLTNLEELNFSYNNFSGPVPLALRSPFNFYFTCDFVRGQNSTSFEATAFEGNK 649
Query: 436 G----------------------KQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDK 473
+ +I + I L + +L+ G + R K
Sbjct: 650 DLHPNFSYCSSFYDPPSKTYLLPSKDNRMIHSIKIFLPITTISLCLLVLGCCSLSRCKAT 709
Query: 474 KFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGK 533
+ P G + FSIWNYDGRI +E++I ATE+F ++YCIGTGGYGSVYRAQL SGK
Sbjct: 710 Q--PEATSSKNG-DLFSIWNYDGRIAYEDIIAATENFDLRYCIGTGGYGSVYRAQLPSGK 766
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
LVALKKLHR E EEPAF +SF+ E LL+QIRHR+IVKLYGFCLH +CMFL+YEYME+GS
Sbjct: 767 LVALKKLHRREAEEPAFDKSFKNEVELLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGS 826
Query: 594 LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653
LFC LRNDV AVEL W KR +I+K +AHALSYLH++C P IVHRDISS+N+LLNS ++F
Sbjct: 827 LFCALRNDVGAVELKWMKRAHIIKDIAHALSYLHHECNPPIVHRDISSSNVLLNSESKSF 886
Query: 654 VADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPT 713
VADFG+ARLL PDSSN T++ GTYGYIAPELAYTM VTEKCDVYSFGVVALE LMG HP
Sbjct: 887 VADFGVARLLDPDSSNNTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETLMGRHPG 946
Query: 714 DLLSSLSSSSGRKISQNPRL 733
D+LSS + + K +PRL
Sbjct: 947 DILSSSARAITLKEVLDPRL 966
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1614), Expect = e-176, Method: Compositional matrix adjust.
Identities = 351/738 (47%), Positives = 475/738 (64%), Gaps = 83/738 (11%)
Query: 8 AELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALS 67
ELS+L F+ FP+L+ + + + GR+P EIG L+KL L +S + G +P +G L+
Sbjct: 89 VELSKLKFSSFPSLLHLYVSHSSIYGRIPDEIGMLTKLTYLRISECDVYGELPVSLGNLT 148
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
L+ LDL+YN L+G IPS +G L++L+ L+LS N +G L
Sbjct: 149 LLEELDLAYNNLSGVIPSSLGYLKNLIHLDLSFN---------YG--------------L 185
Query: 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLN 187
G+IP S+G L NL YLDLS+N+++G +P ++GNLKNL L+L +N LSG IPS L +L+
Sbjct: 186 SGVIPPSLGYLKNLKYLDLSINEINGSIPSQIGNLKNLTHLYLVSNSLSGVIPSPLANLS 245
Query: 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL 247
L L L +N++ G + E+GN+KNL +L L+ N+L G+IPS++G+L L LHL +N++
Sbjct: 246 NLEYLFLNFNRINGSIPSEIGNLKNLVQLCLSHNSLIGAIPSSLGHLTNLTYLHLFNNQI 305
Query: 248 DGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307
G IP + G+LTNL L L NQ++G +P + NLK L L L+ N L G IP ++GYL
Sbjct: 306 QGGIPLSFGHLTNLTDLYLCYNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLI 365
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367
+L N+ N++S IP + N + L L LS N + G IPS++ NL L+LS N +
Sbjct: 366 HLHEFNISGNQISGQIPSSIGNLNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKL 425
Query: 368 NGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPPQ 427
+G+IP+ L ++DLS N+L G IP EL++ S +
Sbjct: 426 SGSIPTLLIYDHIRPSLDLSYNDLEGHIP---------------FELQSKFSQGS----- 465
Query: 428 ATLFKGNKG-----------KQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFN 476
F NKG K+ R++T R+ K
Sbjct: 466 ---FDNNKGLCGDIKGLPHCKEEYKTTRIIT---------------------RKIQTKEI 501
Query: 477 PNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVA 536
P T+ + FS+WNYDG+I +E++I+ATEDF IKYCIGTGGYGSVY+AQL +G +VA
Sbjct: 502 P-----TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVA 556
Query: 537 LKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFC 596
LKKLH ET+E +L+SFQ E ++LS+IRHRNIVKL G+CLH +CMFLIY YM RGSL+C
Sbjct: 557 LKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYC 616
Query: 597 VLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656
VL N+VEA+ELDW KRVN+VKS+ HA+ Y+H+DC P I+HRDISSNNILL+S L+AF++D
Sbjct: 617 VLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSD 676
Query: 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716
FG +RLLHPDSSN+TL+ GTYGYIAPELAYTM VTEKCDVYSFGVVALE +MG HP +L
Sbjct: 677 FGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELF 736
Query: 717 SSLSSSSGRKISQNPRLD 734
+ LSSSS + I LD
Sbjct: 737 TLLSSSSTQNIMLTDMLD 754
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110020|ref|XP_002333160.1| predicted protein [Populus trichocarpa] gi|222835013|gb|EEE73462.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 624 bits (1609), Expect = e-176, Method: Compositional matrix adjust.
Identities = 366/769 (47%), Positives = 478/769 (62%), Gaps = 69/769 (8%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G +P EIG + LE L +S+N+L G IP +G L++L+ L N++ G+IP EI +L
Sbjct: 210 LEGALPREIGNMRNLEILDVSYNTLNGPIPRTLGRLAKLRSLIFHVNKINGSIPFEIRNL 269
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTY------- 143
+L L+LS+NIL GSIP G L +L+ + L GN+++G IP IGNLTNL Y
Sbjct: 270 TNLEYLDLSSNILGGSIPSTLGLLSNLNFVDLLGNQINGPIPLKIGNLTNLQYLHLGGNK 329
Query: 144 -----------------LDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPST---- 182
LDLS NQ++G +P E+ NL NLK L+L +N +SG IPST
Sbjct: 330 ITGFIPFSLGNLKSLTMLDLSHNQINGSIPLEIQNLTNLKELYLSSNSISGSIPSTLGLL 389
Query: 183 --------------------LYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
L +L L L L +N++ G E N+ NL L+L+ N+
Sbjct: 390 SNLISLDLSDNQITGLIPFLLGNLTSLIILDLSHNQINGSTPLETQNLTNLKELYLSSNS 449
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282
++GSIPST+G L+ L L LS N++ G IP +GNLT+LI LDLS NQ++G P E NL
Sbjct: 450 ISGSIPSTLGLLSNLISLDLSDNQITGLIPFLLGNLTSLIILDLSHNQINGSTPLETQNL 509
Query: 283 KYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
L L L+ N + G IP T+G L+NLT+L+L N+++ IP L N + L L LSHN
Sbjct: 510 TNLKELYLSSNSISGSIPSTLGLLSNLTFLDLSNNQITGLIPFLLDNLTNLTTLYLSHNQ 569
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRI 402
++GSIPS + LDLS N ++ IPS+L + ++ V+ S NNLSG + +
Sbjct: 570 INGSIPSSLKYCNNLAYLDLSFNNLSEEIPSELYDLDSLQYVNFSYNNLSGSVSLP---L 626
Query: 403 PKLIVSENNLELENSTSSENAPPPQATLFKGNK----------------GKQRKIVIRLV 446
P + + + ++ +AT F+GNK K + +
Sbjct: 627 PPPFNFHFTCDFVHGQINNDSATLKATAFEGNKDLHPDFSRCPSIYPPPSKTYLLPSKDS 686
Query: 447 TIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANE--FSIWNYDGRITFEEMI 504
II ++ F+ I L + E T N FSIWNYDGRI +E++I
Sbjct: 687 RIIHSIKIFLPITTISLCLLCLGCYLSRCKATEPETTSSKNGDLFSIWNYDGRIAYEDII 746
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI 564
ATE+F ++YCIGTGGYGSVYRAQL SGKLVALKKLHR E EEPAF +SF+ E LL+QI
Sbjct: 747 AATENFDLRYCIGTGGYGSVYRAQLPSGKLVALKKLHRREAEEPAFDKSFKNEVELLTQI 806
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
RHR+IVKLYGFCLH +CMFL+YEYME+GSLFC LRNDV AVEL W KR +I++ +AHALS
Sbjct: 807 RHRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIEDIAHALS 866
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YLH++C P IVHRDISS+N+LLNS ++FVADFG+ARLL PDSSN T++ GTYGYIAPEL
Sbjct: 867 YLHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPEL 926
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL 733
AYTM VTEKCDVYSFGVVALE LMG HP D+LSS + + K +PRL
Sbjct: 927 AYTMVVTEKCDVYSFGVVALETLMGRHPGDILSSSAQAITLKEVLDPRL 975
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-171, Method: Compositional matrix adjust.
Identities = 348/700 (49%), Positives = 453/700 (64%), Gaps = 30/700 (4%)
Query: 59 IPSEIGALSRLKV--------LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
I ++ LS+LK L++S++ + G IP EIG L L L +S ++G +P+
Sbjct: 30 IDGKMVELSKLKFSSFPSLLHLNVSHSSIYGRIPDEIGMLTKLTYLRISECDVHGELPVS 89
Query: 111 FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ-LSGRLPQEVGNLKNLKSLF 169
GNL L++L L N L G+IPSS+G L NL +LDLS N LSG +P +G LKNLK L
Sbjct: 90 LGNLTLLEELDLAYNNLSGVIPSSLGYLKNLIHLDLSFNYGLSGVIPSSLGYLKNLKYLD 149
Query: 170 LDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPS 229
L N ++G IP + +L L L L N L G + + N+ NL+ L LN N + GSIPS
Sbjct: 150 LSINEINGSIPYQIGNLKNLTHLYLVSNSLSGVIPSSLANLSNLEYLFLNFNRINGSIPS 209
Query: 230 TIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLS 289
IG L L +L SHN L G IPP++G+LTNL L L +NQ+ G +P G+L L L+
Sbjct: 210 EIGNLKNLVQLCFSHNSLIGTIPPSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTKLTDLN 269
Query: 290 LNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPS 349
L N + G IPP I L NL +L L +N L+ IP L L +S N ++G IPS
Sbjct: 270 LCDNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPS 329
Query: 350 EIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV---RRIPKLI 406
IGNL +LDLS N I+G IPSQ+ + ++ ++LS N LSG IP + P L
Sbjct: 330 TIGNLNNLTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLD 389
Query: 407 VSENNLELENSTSSENAPPPQATLFKGNKG-----------KQRKIVIRLVTIILAMVAF 455
+S N +LE E F NKG K+ R++ I L+ F
Sbjct: 390 LSHN--DLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLF 447
Query: 456 VFAILIFGILFVHRRKDKKFNPNTREM-TEGANEFSIWNYDGRITFEEMIEATEDFHIKY 514
+F + + G L + R+ K T+E+ T+ + FS+WNYDG+I +E++I+ATEDF IKY
Sbjct: 448 LFFV-VLGFLLLSRKTRKI---QTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKY 503
Query: 515 CIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
CIGTGGYGSVY+AQL +G +VALKKLH E +E +L+SFQ E ++LS+IRHRNIVKL G
Sbjct: 504 CIGTGGYGSVYKAQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQG 563
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+CLH +CMFLIY YM RGSL+CVL N+VEA+ELDW KRVN+VKS+ HA+ Y+H+DC P I
Sbjct: 564 YCLHKRCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPI 623
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDISSNNILL+S L+AF++DFG ARLLHPDSSN+TL+ GTYGYIAPELAYTM VTEKC
Sbjct: 624 IHRDISSNNILLDSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKC 683
Query: 695 DVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLD 734
DVYSFGVVALE +MG HP +L + LSSSS + I LD
Sbjct: 684 DVYSFGVVALETMMGKHPGELFTLLSSSSTQNIMLTNILD 723
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 764 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.897 | 0.656 | 0.364 | 1e-109 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.937 | 0.639 | 0.355 | 5.1e-106 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.884 | 0.613 | 0.362 | 4.1e-104 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.879 | 0.609 | 0.357 | 1.7e-98 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.887 | 0.603 | 0.354 | 2.9e-96 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.907 | 0.717 | 0.344 | 1.2e-95 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.917 | 0.559 | 0.330 | 3.8e-94 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.506 | 0.396 | 0.341 | 4.5e-94 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.891 | 0.624 | 0.336 | 1.1e-92 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.874 | 0.612 | 0.343 | 3.9e-92 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
Identities = 256/702 (36%), Positives = 366/702 (52%)
Query: 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT 80
L T + L+G +PS +G + L L L N L G IP E+G + + L++S N+LT
Sbjct: 288 LDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLT 347
Query: 81 GTIPSEXXXXXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSI---GN 137
G +P P N +L L+L N G +P +I G
Sbjct: 348 GPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGK 407
Query: 138 LTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197
L NLT D N G +P+ + + K+L + N SG I L + L N
Sbjct: 408 LENLTLDD---NHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNN 464
Query: 198 KLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257
G ++ + L L+ N++TG+IP I + L +L LS NR+ G +P +I N
Sbjct: 465 NFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISN 524
Query: 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXX 317
+ + L L+ N+LSG +P + L L L L+ N IPPT+
Sbjct: 525 INRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRN 584
Query: 318 RLSSSIPPELMNCXXXXXXXXXXXXXXXXIPSEIGNLIFFRQLDLSRNFINGTIPSQLGK 377
L +IP L I S+ +L +LDLS N ++G IP
Sbjct: 585 DLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKD 644
Query: 378 IPNISAVDLSKNNLSGVIP--ASVRRIPKLIVSENNLELENSTSSENAPPPQATLFKGNK 435
+ ++ VD+S NNL G IP A+ R P E N +L S ++ P +
Sbjct: 645 MLALTHVDVSHNNLQGPIPDNAAFRNAPP-DAFEGNKDLCGSVNTTQGLKPCSITSSKKS 703
Query: 436 GKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYD 495
K R ++I ++ I+ A + + GI R++ K+ +T + G SI+++D
Sbjct: 704 HKDRNLIIYILVPIIG--AIIILSVCAGIFICFRKRTKQIEEHT-DSESGGETLSIFSFD 760
Query: 496 GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHR---SETEEPAFLE 552
G++ ++E+I+AT +F KY IGTGG+G VY+A+L + ++A+KKL+ S P+ +
Sbjct: 761 GKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQ 819
Query: 553 SFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
F E R L++IRHRN+VKL+GFC H + FL+YEYMERGSL VL ND EA +LDW KR
Sbjct: 820 EFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKR 879
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFGLARLLHPDSSNRTL 672
+N+VK +AHALSY+H+D P+IVHRD EA ++DFG A+LL PDSSN +
Sbjct: 880 INVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSA 939
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
V GTYGY+APELAY M VTEKCDVYSFGV+ LEV+ G HP D
Sbjct: 940 VAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGD 981
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 5.1e-106, P = 5.1e-106
Identities = 260/732 (35%), Positives = 371/732 (50%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N TG +L +++ ++ L+G +PS G L L L L N LTG IP
Sbjct: 351 ENYLTGVIPPELGN--MESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQ 408
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEXXXXXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLR 121
E+G + + LDLS N+LTG++P P N L L
Sbjct: 409 ELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLI 468
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL-KSLFLDNNHLSGPIP 180
L N G P ++ L + L N L G +P+ + + K+L ++ FL N +G I
Sbjct: 469 LDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNK-FTGDIF 527
Query: 181 STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDEL 240
L + +NK G ++ L L ++ NN+TG+IP+ I + L EL
Sbjct: 528 EAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVEL 587
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP 300
LS N L G +P IGNLTNL L L+ NQLSG +P + L L SL L+ N IP
Sbjct: 588 DLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIP 647
Query: 301 PTIXXXXXXXXXXXXXXRLSSSIPPELMNCXXXXXXXXXXXXXXXXIPSEIGNLIFFRQL 360
T + SIP L IPS++ +L +L
Sbjct: 648 QTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKL 706
Query: 361 DLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVR-RIPKLIVSENNLELENSTS 419
DLS N ++G IP+ + ++ VD+S N L G +P + R E N+ L ++
Sbjct: 707 DLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIP 766
Query: 420 SENAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNT 479
+ P + K K K +V+ ++ IL ++ + +I + R++ + NT
Sbjct: 767 KQRLKPCRE--LKKPK-KNGNLVVWILVPILGVLV-ILSICANTFTYCIRKRKLQNGRNT 822
Query: 480 REMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKK 539
T G N SI++ DG+ ++++IE+T +F + IGTGGY VYRA L ++A+K+
Sbjct: 823 DPET-GEN-MSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKR 879
Query: 540 LHRSETEE---PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFC 596
LH + EE P + F E + L++IRHRN+VKL+GFC H + FLIYEYME+GSL
Sbjct: 880 LHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNK 939
Query: 597 VLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVAD 656
+L ND EA L WTKR+N+VK +AHALSY+H+D IVHRD A ++D
Sbjct: 940 LLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISD 999
Query: 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDXX 716
FG A+LL DSSN + V GTYGY+APE AYTM VTEKCDVYSFGV+ LE+++G HP D
Sbjct: 1000 FGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLV 1059
Query: 717 XXXXXXXGRKIS 728
G +S
Sbjct: 1060 SSLSSSPGEALS 1071
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
Identities = 250/689 (36%), Positives = 356/689 (51%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEXXXX 90
L+G +P E G + L+ L L N L G IP E+G L+ L+ LDLS NRL GTIP E
Sbjct: 319 LTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFL 378
Query: 91 XXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
P G + L + N L G IP+ L L L N+
Sbjct: 379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNK 438
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
LSG +P+++ K+L L L +N L+G +P L++L L L L N L G ++ ++G +
Sbjct: 439 LSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKL 498
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
KNL+RL L NN TG IP IG L + ++S N+L G IP +G+ + LDLS N+
Sbjct: 499 KNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNK 558
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXXRLSSSIPPELMNC 330
SG + +E+G L YL L L+ N L G IP + LS +IP EL
Sbjct: 559 FSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKL 618
Query: 331 XXXXXXXXXXXXXXX-XIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389
IP +GNL L L+ N ++G IP+ +G + ++ ++S N
Sbjct: 619 TSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNN 678
Query: 390 NLSGVIP--ASVRRIPKLIVSENNLELENSTSSENAPPPQATLFKGN---KGKQRKIVIR 444
NL G +P A +R+ + N+ L NS S P + K N G QR+ +
Sbjct: 679 NLVGTVPDTAVFQRMDSSNFAGNH-GLCNSQRSHCQPLVPHSDSKLNWLINGSQRQ---K 734
Query: 445 LVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMI 504
++TI ++ VF I G+ + +R++ F + + + G T++ ++
Sbjct: 735 ILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKG-FTYQGLV 793
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI 564
+AT +F +G G G+VY+A++S G+++A+KKL+ S E + SF+ E L +I
Sbjct: 794 DATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKI 852
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
RHRNIVKLYGFC H L+YEYM +GSL L+ + LDW R I A L
Sbjct: 853 RHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLC 912
Query: 625 YLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFGLARLLHPD-SSNRTLVVGTYGYIAPE 683
YLH+DC+P IVHRD +A V DFGLA+L+ S + + V G+YGYIAPE
Sbjct: 913 YLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPE 972
Query: 684 LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
AYTM VTEKCD+YSFGVV LE++ G P
Sbjct: 973 YAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 248/693 (35%), Positives = 343/693 (49%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEXXXX 90
L+G +P E+G + LE L L N LTG IP E+ L L LDLS N LTG IP
Sbjct: 325 LTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYL 384
Query: 91 XXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
P + G DL L + N L G IPS + +N+ L+L N
Sbjct: 385 RGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNN 444
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
LSG +P + K L L L N+L G PS L + + LG N+ G + +EVGN
Sbjct: 445 LSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNC 504
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
L RL L N TG +P IG L+ L L++S N+L G +P I N L LD+ N
Sbjct: 505 SALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNN 564
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXXRLSSSIPPELMNC 330
SG LP EVG+L L L L+ N L G IP + + SIP EL +
Sbjct: 565 FSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSL 624
Query: 331 XXXXXXXXXXXXXXXX-IPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389
IP E+ NL+ L L+ N ++G IPS + ++ + S N
Sbjct: 625 TGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYN 684
Query: 390 NLSGVIPASVRRIP-KLIVSENNL---ELENSTSSENAPPPQATLFKGNKGKQRKIVIRL 445
+L+G IP +R I + L L ++ P Q+T G G R ++
Sbjct: 685 SLTGPIPL-LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQST---GKPGGMRSS--KI 738
Query: 446 VTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIW--NYDGRITFEEM 503
+ I A++ V +LI I+++ RR + + ++ I+ +G TF+++
Sbjct: 739 IAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDL 797
Query: 504 IEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKL---HRSETEEPAFLESFQTEARL 560
+ AT++F + +G G G+VY+A L +G +A+KKL H SF+ E
Sbjct: 798 VAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVD-NSFRAEILT 856
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
L IRHRNIVKL+GFC H L+YEYM +GSL +L + + LDW+KR I A
Sbjct: 857 LGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP--SCNLDWSKRFKIALGAA 914
Query: 621 HALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFGLARLLH-PDSSNRTLVVGTYGY 679
L+YLH+DCKP I HRD EA V DFGLA+++ P S + + + G+YGY
Sbjct: 915 QGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGY 974
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
IAPE AYTM VTEK D+YS+GVV LE+L G P
Sbjct: 975 IAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
Identities = 247/697 (35%), Positives = 344/697 (49%)
Query: 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEXXX 89
LLSG +P E+ +S+L L L N LTG IP+E+ L L LDLS N LTG IP
Sbjct: 336 LLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQN 395
Query: 90 XXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLN 149
P G L + N+L G IP I +NL L+L N
Sbjct: 396 LTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSN 455
Query: 150 QLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGN 209
++ G +P V K+L L + N L+G P+ L L L+ + L N+ GP+ E+G
Sbjct: 456 RIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGT 515
Query: 210 MKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSN 269
+ L RLHL N + ++P+ I L+ L ++S N L GPIP I N L LDLS N
Sbjct: 516 CQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRN 575
Query: 270 QLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXXRLSSSIPPEL-M 328
G LP E+G+L L L L+ N G IP TI S SIPP+L +
Sbjct: 576 SFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGL 635
Query: 329 NCXXXXXXXXXXXXXXXXIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
IP EIGNL L L+ N ++G IP+ + ++ + S
Sbjct: 636 LSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSY 695
Query: 389 NNLSGVIP-ASVRRIPKLIVSENNLEL----ENSTSSENAPPPQATLFKGNKGKQRKIVI 443
NNL+G +P + + L N L S ++ P + K ++ +I+I
Sbjct: 696 NNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIII 755
Query: 444 RLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDG-RITFEE 502
+ ++I + + AI++ F+ R + P + E I+ R T ++
Sbjct: 756 IVSSVIGGISLLLIAIVVH---FL-RNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKD 811
Query: 503 MIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSE----TEEPAFLESFQTEA 558
++EAT+ FH Y +G G G+VY+A + SGK +A+KKL + SF+ E
Sbjct: 812 ILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEI 871
Query: 559 RLLSQIRHRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIV 616
L +IRHRNIV+LY FC H + L+YEYM RGSL +L ++ +DW R I
Sbjct: 872 LTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWPTRFAIA 930
Query: 617 KSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFGLARLLH-PDSSNRTLVVG 675
A L+YLH+DCKP I+HRD EA V DFGLA+++ P S + + V G
Sbjct: 931 LGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAG 990
Query: 676 TYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+YGYIAPE AYTM VTEKCD+YSFGVV LE+L G P
Sbjct: 991 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 1.2e-95, P = 1.2e-95
Identities = 248/719 (34%), Positives = 362/719 (50%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N TG + L T PNL + G L+G + + L+ L L N LTG + S
Sbjct: 152 NNQLTGPVPATL--TQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSS 209
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEXXXXXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLR 121
++ L+ L D+ N LTGTIP P G L+ + L
Sbjct: 210 DMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQ-VATLS 268
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
LQGN+L G IP IG + L LDLS N+L G +P +GNL L+L N L+GPIPS
Sbjct: 269 LQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPS 328
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241
L ++++L+ L L NKLVG + E+G ++ L L+L N L G IPS I L++ +
Sbjct: 329 ELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFN 388
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
+ N L G IP NL +L L+LSSN G +P E+G++ L L L+GN G IP
Sbjct: 389 VHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPL 448
Query: 302 TIXXXXXXXXXXXXXXRLSSSIPPELMNCXXXXXXXXXXXXXXXXIPSEIGNLIFFRQLD 361
T+ LS +P E N IP+E+G L L
Sbjct: 449 TLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLI 508
Query: 362 LSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV---RRIPKLIVSENNLELENST 418
L+ N ++G IP QL + +++S NNLSG++P R P V L N
Sbjct: 509 LNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYL-CGNWV 567
Query: 419 SSENAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRR-KDKKFNP 477
S P P++ +F ++G L+ I+L ++ + +IF L V++ + KK
Sbjct: 568 GSICGPLPKSRVF--SRGA-------LICIVLGVITLL--CMIF--LAVYKSMQQKKILQ 614
Query: 478 NTREMTEGANEFSIWNYDGRI-TFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVA 536
+ + EG + I + D I TF++++ TE+ + K+ IG G +VY+ L S + +A
Sbjct: 615 GSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIA 674
Query: 537 LKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFC 596
+K+L+ + P L F+TE + IRHRNIV L+G+ L L Y+YME GSL+
Sbjct: 675 IKRLYN---QYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWD 731
Query: 597 VLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVAD 656
+L ++ V+LDW R+ I A L+YLH+DC P I+HRD EA ++D
Sbjct: 732 LLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSD 791
Query: 657 FGLARLLHPDSSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
FG+A+ + ++ T V+GT GYI PE A T + EK D+YSFG+V LE+L G D
Sbjct: 792 FGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVD 850
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
Identities = 241/730 (33%), Positives = 363/730 (49%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N F+G ++ C L +G LSG +PS IG L L +L L N L G IP+
Sbjct: 442 ENRFSGEMPVEIG-NC-TRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPA 499
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEXXXXXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLR 121
+G ++ V+DL+ N+L+G+IPS P NLK+L ++
Sbjct: 500 SLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRIN 559
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
NK +G I G+ + L++ D++ N G +P E+G NL L L N +G IP
Sbjct: 560 FSSNKFNGSISPLCGSSSYLSF-DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPR 618
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241
T +++L+ L + N L G + E+G K L + LN N L+G IP+ +G L LL EL
Sbjct: 619 TFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELK 678
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
LS N+ G +P I +LTN++ L L N L+G +P+E+GNL+ L +L+L N L GP+P
Sbjct: 679 LSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPS 738
Query: 302 TIXXXXXXXXXXXXXXRLSSSIPPELMNCXXXXXXXXXXXXXXXX-IPSEIGNLIFFRQL 360
TI L+ IP E+ IPS I L L
Sbjct: 739 TIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESL 798
Query: 361 DLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSS 420
DLS N + G +P Q+G + ++ ++LS NNL G + R + N L S S
Sbjct: 799 DLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRW-QADAFVGNAGLCGSPLS 857
Query: 421 ENAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKD--KKFNPN 478
K + K V+ +++ I ++ A +L+ ILF + D KK
Sbjct: 858 HCNRAGS----KNQRSLSPKTVV-IISAISSLAAIALMVLVI-ILFFKQNHDLFKKVRGG 911
Query: 479 TREMTEGANE-----FSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGK 533
+ ++ FS I +++++EAT + ++ IG+GG G VY+A+L +G+
Sbjct: 912 NSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGE 971
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMFLIYEYMER 591
+A+KK+ + + +SF E + L IRHR++VKL G+C LIYEYM
Sbjct: 972 TIAVKKILWKD--DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMAN 1029
Query: 592 GSLFCVLR---NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXX 648
GS++ L N + L W R+ I +A + YLHYDC P IVHRD
Sbjct: 1030 GSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDS 1089
Query: 649 XXEAFVADFGLARLL----HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVAL 704
EA + DFGLA++L ++ + T+ G+YGYIAPE AY++ TEK DVYS G+V +
Sbjct: 1090 NIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1149
Query: 705 EVLMGSHPTD 714
E++ G PT+
Sbjct: 1150 EIVTGKMPTE 1159
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 4.5e-94, Sum P(2) = 4.5e-94
Identities = 134/392 (34%), Positives = 200/392 (51%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEXXXX 90
LSG +P I L +LE+L+L +N L G IPS + + LK+LDL+ N+L+G IP
Sbjct: 128 LSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWN 187
Query: 91 XXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
+ L L ++ N L G IP +IGN T LDLS NQ
Sbjct: 188 EVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQ 247
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
L+G +P ++G L+ + +L L N LSG IPS + + LA L L N L G + +GN+
Sbjct: 248 LTGEIPFDIGFLQ-VATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNL 306
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
++L+L+ N LTGSIP +G ++ L L L+ N L G IPP +G LT+L L++++N
Sbjct: 307 TFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANND 366
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXXRLSSSIPPELMNC 330
L G +P + + L SL+++GN G IP + IP EL
Sbjct: 367 LEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRI 426
Query: 331 XXXXXXXXXXXXXXXXIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390
IPS +G+L +++LSRN I G +P G + +I +DLS N+
Sbjct: 427 GNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNND 486
Query: 391 LSGVIPASVRRIPKLIVSENNLELENSTSSEN 422
+SG IP + ++ +I+ L LEN+ + N
Sbjct: 487 ISGPIPEELNQLQNIIL----LRLENNNLTGN 514
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
Identities = 244/725 (33%), Positives = 362/725 (49%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
N T NL ++ +SG +P +G L KL+ L+L N+L G+IP+E+G L ++D
Sbjct: 263 NCTELQNLYLYQ---NSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVD 319
Query: 74 LSYNRLTGTIPSEXXXXXXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPS 133
LS N LTG IP P E N L L + N++ G IP
Sbjct: 320 LSENLLTGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPP 379
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
IG LT+LT NQL+G +P+ + + L+++ L N+LSG IP+ ++ + L L
Sbjct: 380 LIGKLTSLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLL 439
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
L N L G + ++GN NL RL LNGN L G+IP+ IG L L+ + +S NRL G IPP
Sbjct: 440 LLSNYLSGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPP 499
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNL-KYLASLSLNGNILIGPIPPTIXXXXXXXXX 312
I T+L +DL SN L+G LP G L K L + L+ N L G +P I
Sbjct: 500 EISGCTSLEFVDLHSNGLTGGLP---GTLPKSLQFIDLSDNSLTGSLPTGIGSLTELTKL 556
Query: 313 XXXXXRLSSSIPPELMNCXXXXXXXXXXXXXXXXIPSEIGNLIFFR-QLDLSRNFINGTI 371
R S IP E+ +C IP+E+G + L+LS N G I
Sbjct: 557 NLAKNRFSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEI 616
Query: 372 PSQLGKIPNISAVDLSKNNLSGVIP--ASVRRIPKLIVSENNL--ELENSTSSENAPPPQ 427
PS+ + N+ +D+S N L+G + A ++ + L +S N EL N+ P
Sbjct: 617 PSRFSSLTNLGTLDVSHNKLAGNLNVLADLQNLVSLNISFNEFSGELPNTLFFRKLP--- 673
Query: 428 ATLFKGNKG------KQRKIVIRLVTII-LAMVAFVFAILIFGILFVHRR-KDKKFNPNT 479
++ + NKG + I R + + + M V A ++ ++ V+ K ++
Sbjct: 674 LSVLESNKGLFISTRPENGIQTRHRSAVKVTMSILVAASVVLVLMAVYTLVKAQRITGKQ 733
Query: 480 REMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKK 539
E+ + + + Y ++ F + + ++ IGTG G VYR + SG+ +A+KK
Sbjct: 734 EEL----DSWEVTLYQ-KLDFS-IDDIVKNLTSANVIGTGSSGVVYRVTIPSGETLAVKK 787
Query: 540 LHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR 599
+ E +F +E L IRHRNI++L G+C + L Y+Y+ GSL +L
Sbjct: 788 MWSKEENR-----AFNSEINTLGSIRHRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLH 842
Query: 600 NDVEAVE-LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFG 658
+ DW R ++V +AHAL+YLH+DC P I+H D E+++ADFG
Sbjct: 843 GAGKGSGGADWEARYDVVLGVAHALAYLHHDCLPPILHGDVKAMNVLLGSRFESYLADFG 902
Query: 659 LARLLHP------DSS---NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
LA+++ DSS NR + G+YGY+APE A +TEK DVYS+GVV LEVL G
Sbjct: 903 LAKIVSGEGVTDGDSSKLSNRPPLAGSYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTG 962
Query: 710 SHPTD 714
HP D
Sbjct: 963 KHPLD 967
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
Identities = 244/711 (34%), Positives = 349/711 (49%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEXXXX 90
+SG +P+ IG L KL+ L+L N+L G+IP+E+G L ++D S N LTGTIP
Sbjct: 274 ISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLLTGTIPRSFGKL 333
Query: 91 XXXXXXXXXXXXXXXXXPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
P E N L L + N + G IPS + NL +LT N+
Sbjct: 334 ENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLRSLTMFFAWQNK 393
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
L+G +PQ + + L+++ L N LSG IP ++ L L L L N L G + ++GN
Sbjct: 394 LTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNC 453
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
NL RL LNGN L GSIPS IG L L+ + +S NRL G IPP I +L LDL +N
Sbjct: 454 TNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCESLEFLDLHTNS 513
Query: 271 LSGLLPREVGNL--KYLASLSLNGNILIGPIPPTIXXXXXXXXXXXXXXRLSSSIPPELM 328
LSG L +G K L + + N L +PP I RLS IP E+
Sbjct: 514 LSGSL---LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRLSGEIPREIS 570
Query: 329 NCXXXXXXXXXXXXXXXXIPSEIGNLIFFR-QLDLSRNFINGTIPSQLGKIPNISAVDLS 387
C IP E+G + L+LS N G IPS+ + N+ +D+S
Sbjct: 571 TCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDLKNLGVLDVS 630
Query: 388 KNNLSGVIPA--SVRRIPKLIVSENNL--ELENSTSSENAPPPQAT----LFKGNKGKQR 439
N L+G + ++ + L +S N+ +L N+ P L+ N R
Sbjct: 631 HNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGLYISNAISTR 690
Query: 440 -------KIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIW 492
V+RL +IL +V V ++ L R K+ + E + + +
Sbjct: 691 PDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQL------LGEEIDSWEVT 744
Query: 493 NYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLE 552
Y ++ F + + ++ IGTG G VYR + SG+ +A+KK+ E E AF
Sbjct: 745 LYQ-KLDFS-IDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKE-ESGAF-- 799
Query: 553 SFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
+E + L IRHRNIV+L G+C + L Y+Y+ GSL L + +DW R
Sbjct: 800 --NSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGGCVDWEAR 857
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDXXXXXXXXXXXXEAFVADFGLARLL--HPDS--- 667
++V +AHAL+YLH+DC P+I+H D E ++ADFGLAR + +P++
Sbjct: 858 YDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISGYPNTGID 917
Query: 668 ----SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
+NR + G+YGY+APE A +TEK DVYS+GVV LEVL G HP D
Sbjct: 918 LAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLD 968
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pg.C_LG_II000073 | hypothetical protein (964 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 764 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-104 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-74 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-67 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-31 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 342 bits (879), Expect = e-104
Identities = 251/771 (32%), Positives = 373/771 (48%), Gaps = 79/771 (10%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
+ NN E+ + F +L + G +L G++P+ + L+ LE L L+ N L G+IP
Sbjct: 147 LSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205
Query: 61 SEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120
E+G + LK + L YN L+G IP EIG L L L+L N L G IP GNLK+L L
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP 180
L NKL G IP SI +L L LDLS N LSG +P+ V L+NL+ L L +N+ +G IP
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 181 STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDEL 240
L L +L L L NK G + K +G NL L L+ NNLTG IP + L +L
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP 300
L N L+G IP ++G +L + L N SG LP E L + L ++ N L G I
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445
Query: 301 PTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQL 360
+ +L L+L N+ + P+ +L NL LS N SG++P ++G+L QL
Sbjct: 446 SRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 361 DLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP---KLIVSENNLELENS 417
LS N ++G IP +L + ++DLS N LSG IPAS +P +L +S+N L E
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564
Query: 418 TS------------SEN----APPP-------QATLFKGNKG--------------KQRK 440
+ S N + P A+ GN + RK
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK 624
Query: 441 IVIRLVTIILAMVAFVFAILI-FGILFVHRRKDKKFNPNTREMTEGANEFSIWN---YDG 496
I + AF+ L+ FG +F+ R N E+ NE W +D
Sbjct: 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGR-------NNLELKRVENEDGTWELQFFDS 677
Query: 497 R----ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFL 551
+ IT +++ + ++ ++ I G G+ Y+ + + +G +K+++ + + +
Sbjct: 678 KVSKSITINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734
Query: 552 ESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK 611
+++H NIVKL G C K +LI+EY+E +L VLRN L W +
Sbjct: 735 ADM-------GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWER 781
Query: 612 RVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
R I +A AL +LH C P++V ++S I+++ E + L LL D T
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----T 836
Query: 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722
+ Y+APE T +TEK D+Y FG++ +E+L G P D + S
Sbjct: 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 4e-74
Identities = 153/385 (39%), Positives = 216/385 (56%), Gaps = 6/385 (1%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
+G +P G++ LE L LS+N L+G IP++IG+ S LKVLDL N L G IP+ + +L
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187
Query: 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
L L L++N L G IP E G +K L + L N L G IP IG LT+L +LDL N
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
L+G +P +GNLKNL+ LFL N LSGPIP +++ L +L +L L N L G + + V +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
+NL+ LHL NN TG IP + L L L L N+ G IP +G NL LDLS+N
Sbjct: 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNC 330
L+G +P + + L L L N L G IP ++G +L + L N S +P E
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 331 SQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390
+ L +S+N+L G I S ++ + L L+RN G +P G + +DLS+N
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQ 486
Query: 391 LSGVIPASVRRIPKLI---VSENNL 412
SG +P + + +L+ +SEN L
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKL 511
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 5e-67
Identities = 156/401 (38%), Positives = 221/401 (55%), Gaps = 30/401 (7%)
Query: 16 TCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALS-RLKVLDL 74
+V+ + G +SG++ S I L ++ + LS+N L+G IP +I S L+ L+L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 75 SYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSS 134
S N TG+IP GS+ +L L+LSNN+L+G IP + G+ L L L GN L G IP+S
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 135 IGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCL 194
+ NLT+L +L L+ NQL G++P+E+G +K+LK ++L N+LSG IP
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP-------------- 229
Query: 195 GYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPT 254
E+G + +L+ L L NNLTG IPS++G L L L L N+L GPIPP+
Sbjct: 230 ----------YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
Query: 255 IGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314
I +L LI+LDLS N LSG +P V L+ L L L N G IP + L L L L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 315 GYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQ 374
N+ S IP L + L L LS N+L+G IP + + +L L N + G IP
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
Query: 375 LGKIPNISAVDLSKNNLSGVIPASVRRIPK---LIVSENNL 412
LG ++ V L N+ SG +P+ ++P L +S NNL
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 10/204 (4%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ I +G G +G VY A+ +GKLVA+K + + + ++ E E ++L +++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
IV+LY ++L+ EY E G LF +L+ + D + ++ + AL YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLH- 114
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM 688
IVHRD+ NILL+ + +ADFGLAR L P T VGT Y+APE+
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGK 171
Query: 689 AVTEKCDVYSFGVVALEVLMGSHP 712
+ D++S GV+ E+L G P
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 9e-48
Identities = 72/193 (37%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G+VY A+ +GK VA+K + + ++ LE E +L ++ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
++L+ EY E GSL +L+ +L + + I+ + L YLH I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH-SNG--I 113
Query: 635 VHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAYTMAVTE 692
+HRD+ NILL+S N + +ADFGL++LL D S +VGT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 693 KCDVYSFGVVALE 705
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 72/205 (35%), Positives = 107/205 (52%), Gaps = 9/205 (4%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ + +G+G +G+VY+A+ +GK+VA+K L + E+ ++ + E R+L ++ H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
IV+L ++L+ EY E G LF L L + I + L YLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH- 115
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAYT 687
I+HRD+ NILL+ N +ADFGLA+ L SS+ T VGT Y+APE L
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
K DV+S GV+ E+L G P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 516 IGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G G +G VY+ L + VA+K L +EE E F EA ++ ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
+L G C + ++++ EYM G L LR E + L + + +A + YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-SK 121
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----APELA 685
VHRD+++ N L+ NL ++DFGL+R ++ D R G + APE
Sbjct: 122 N--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPESL 176
Query: 686 YTMAVTEKCDVYSFGVV 702
T K DV+SFGV+
Sbjct: 177 KDGKFTSKSDVWSFGVL 193
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 516 IGTGGYGSVYRAQLSSGK-----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G G +G VY+ L VA+K L +E+ +E F EAR++ ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
KL G C + + ++ EYM G L LR EL + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLE--S 121
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV-GTYGYIAPELAYTMA 689
K +HRD+++ N L+ NL ++DFGL+R L+ D + ++APE
Sbjct: 122 KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 690 VTEKCDVYSFGVVALEVL-MGSHP 712
T K DV+SFGV+ E+ +G P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 516 IGTGGYGSVYRAQLSSGK-----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G G +G VY+ +L VA+K L +E+ +E F EAR++ ++ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
KL G C + ++++ EYME G L LR +L + ++ +A + YL
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE-SK 121
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV-GTYGYIAPELAYTMA 689
+HRD+++ N L+ NL ++DFGL+R L+ D R ++APE
Sbjct: 122 N--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 690 VTEKCDVYSFGVVALEVL-MGSHP 712
T K DV+SFGV+ E+ +G P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 515 CIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G +GSVY A +G+L+A+K + + LE+ + E R+LS ++H NIV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 574 GFCLHN-KCMFLIY-EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
G K I+ EY+ GSL +L+ + ++ + + L+YLH +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKY--TRQILEGLAYLHSNG- 121
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLH--PDSSNRTLVVGTYGYIAPELAYTMA 689
IVHRDI NIL++S+ +ADFG A+ L V GT ++APE+
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 690 VTEKCDVYSFGVVALEVLMGSHP 712
D++S G +E+ G P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 509 DFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
F I IG GG+G VY+A +GK VA+K + E+ E E ++L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHP 57
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIVK YG L ++++ E+ GSL +L++ + + + K + L YLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--VCKELLKGLEYLH 115
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
I+HRDI + NILL S+ E + DFGL+ L D+ R +VGT ++APE+
Sbjct: 116 ---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVING 171
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
K D++S G+ A+E+ G P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 516 IGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G VY+ +L VA+K L +EE + F EAR++ ++ H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRN------DVEAVELDWTKRVNIVKSMAHALSY 625
L G C + ++L+ EYME G L LR E L ++ +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI----- 680
L VHRD+++ N L+ +L ++DFGL+R ++ D R T G +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWM 174
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
APE T K DV+SFGV+ E+ +G+ P
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLH-RSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
IG G G VY+A ++GK VA+KK+ R + +E E ++ +H NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-----NEILIMKDCKHPNIVDYY 81
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
L ++++ EYM+ GSL ++ N V E + + + + L YLH
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE---PQIAYVCREVLQGLEYLH---SQ 135
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+++HRDI S+NILL+ + +ADFG A L + S R VVGT ++APE+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 693 KCDVYSFGVVALEVLMGSHP 712
K D++S G++ +E+ G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D +G G G VY+ + +GK+ ALKK+H + F + E + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV--NIVKSMAHALS 624
+VK YG + ++ EYM+ GSL D+ + V I + + L
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSL-----ADLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YLH I+HRDI +N+L+NS E +ADFG++++L VGT Y++PE
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER 171
Query: 685 ----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+Y+ A D++S G+ LE +G P
Sbjct: 172 IQGESYSYA----ADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 20/211 (9%)
Query: 509 DFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ + IG G +G VY+ L +G VA+K++ E + L+S E LL ++H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLKHP 59
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN------DVEAVELDWTKRVNIVKSMAH 621
NIVK G + +++I EY E GSL +++ + AV V +
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---------YVYQVLQ 110
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L+YLH + ++HRDI + NIL + +ADFG+A L+ S + VVGT ++A
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ + D++S G +E+L G+ P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ I IG G +G VY + S GKL LK++ S E ++ E ++L ++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE-------LDWTKRVNIVKSMA 620
NI+K Y + ++ EY + G L ++ + + LDW V +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL--- 114
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
AL YLH I+HRDI NI L SN + DFG++++L VVGT Y+
Sbjct: 115 -ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+PEL K D++S G V E+ HP
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (318), Expect = 1e-31
Identities = 74/226 (32%), Positives = 115/226 (50%), Gaps = 16/226 (7%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-R 567
+ I +G G +G VY A+ KLVALK L + + +E F E ++L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIVKLY F ++L+ EY++ GSL +L+ L ++ + I+ + AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFV-ADFGLARLLHPDSSNRTL------VVGTYGYI 680
I+HRDI NILL+ + DFGLA+LL S ++ VGT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 681 APELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS 723
APE+ + + D++S G+ E+L G P + + S++S
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 81/239 (33%), Positives = 120/239 (50%), Gaps = 14/239 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
E F + CIG G +G VY+A + ++VA+K + E E+ +E Q E + LSQ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRS 58
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
I K YG L +++I EY GS +L+ +LD T I++ + L YL
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYL 114
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H + K +HRDI + NILL+ + +ADFG++ L S R VGT ++APE+
Sbjct: 115 HEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-RKISQNPRLDLQCNAYLKNF 744
EK D++S G+ A+E+ G P LS L I +N L+ N + K F
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP---LSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLH-RSETE-EPAFLESFQTEARLLSQIR 565
D+ + IG G +G+V + + S GK++ K++ + TE E L S E +L +++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS---EVNILRELK 57
Query: 566 HRNIVKLYGFCL--HNKCMFLIYEYMERGSLFCVLRN---DVEAVELD--WTKRVNIVKS 618
H NIV+ Y + N+ ++++ EY E G L +++ + + +E + W I+
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQ 113
Query: 619 MAHALSYLHY--DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT 676
+ AL H D +++HRD+ NI L++N + DFGLA++L DSS VGT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y++PE M+ EK D++S G + E+ S P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+A+ +G+LVALKK+ R E E+ F + E +LL ++RH NIV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 575 FCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+++++EYM+ L +L + K +K + L YLH +
Sbjct: 66 IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC--YMKQLLEGLQYLHSN--- 119
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLVVGTYGYIAPEL-----AY 686
I+HRDI +NIL+N++ +ADFGLAR +S T V T Y PEL Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179
Query: 687 TMAVTEKCDVYSFGVVALEVLMG 709
V D++S G + E+ +G
Sbjct: 180 GPEV----DMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G G +G V + +GKL A+K L + + + +E TE +LS+I H IVKL Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
F K ++L+ EY G LF L + + + AL YLH
Sbjct: 61 AFQTEEK-LYLVLEYAPGGELFSHLSK-EGRFSEERARF--YAAEIVLALEYLH---SLG 113
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMA 689
I++RD+ NILL+++ + DFGLA+ L + S GT Y+APE+ Y A
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 690 VTEKCDVYSFGVVALEVLMGSHP 712
V D +S GV+ E+L G P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT----EARLLSQI 564
+ +G G YG VY+A+ +G++VALKK+ R + EE E + E LL ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEE----EGIPSTALREISLLKEL 55
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
+H NIVKL + ++L++EY + L L + + K I+ + L+
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLA 112
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
Y H I+HRD+ NIL+N + +ADFGLAR T V T Y APE+
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 685 -----AYTMAVTEKCDVYSFGVVALEVLMGS 710
Y+ AV D++S G + E++ G
Sbjct: 170 LLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 74/206 (35%), Positives = 109/206 (52%), Gaps = 29/206 (14%)
Query: 516 IGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
IG G +G V R +L GK VA+K L +++ F TEA ++ Q H NI++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
L G ++ + +I EYME GSL LR + + + V +++ +A + YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYL---SE 124
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY----GYI-----AP 682
+ VHRD+++ NIL+NSNL V+DFGL+R L + S TY G I AP
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL--EDSE-----ATYTTKGGKIPIRWTAP 177
Query: 683 E-LAYTMAVTEKCDVYSFGVVALEVL 707
E +AY T DV+SFG+V EV+
Sbjct: 178 EAIAYR-KFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G VY A L +G+L+A+K++ R + +P ++ E ++L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVL---RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
+H + +++ EY G+L +L R E V + + L+YLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGLAYLH---S 117
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-------VGTYGYIAPEL 684
IVHRDI NI L+ N + DFG A L +N T + GT Y+APE+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 685 AYTMAVTEK---CDVYSFGVVALEVLMGSHP 712
D++S G V LE+ G P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 74/242 (30%), Positives = 123/242 (50%), Gaps = 34/242 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + IG+G YG VY+A+ +++G+LVA+K + ++ E Q E +L + RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRH 59
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSL---FCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
NIV +G L ++++ EY GSL + V R + +++ + R + L
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGL 114
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
+YLH K +HRDI NILL + + +ADFG++ L + R +GT ++APE
Sbjct: 115 AYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171
Query: 684 LAYTMAV------TEKCDVYSFGVVALEV------LMGSHPTDLLSSLSSSSGRKISQNP 731
+A AV KCD+++ G+ A+E+ + HP L +S S+ P
Sbjct: 172 VA---AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----FPPP 224
Query: 732 RL 733
+L
Sbjct: 225 KL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 21/258 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+D+ + IG G VY A L + + VA+K++ + ++ + E + +SQ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+VK Y + ++L+ Y+ GSL ++++ LD ++K + L YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN----RTLVVGTYGYIAP 682
H +HRDI + NILL + +ADFG++ L R VGT ++AP
Sbjct: 119 H---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 683 E-LAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYL 741
E + K D++SFG+ A+E+ G+ P + QN L+ A
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LTLQNDPPSLETGADY 233
Query: 742 KNFSQGNHRWENLLFKKF 759
K +S+ F+K
Sbjct: 234 KKYSK--------SFRKM 243
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 75/212 (35%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 512 IKYCIGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
I+ IG G +G V R +L GK VA+K L TE+ F +EA ++ Q H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHALSYL 626
NI+ L G ++ + +I E+ME G+L LR ND + + V +++ +A + YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYL 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----A 681
+ + VHRD+++ NIL+NSNL V+DFGL+R L D+S+ T G I A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
PE T DV+S+G+V EV+ G P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ + IG G +G V G+ VA+K L T AFL EA +++ +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLA----EASVMTTLRHP 60
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
N+V+L G L ++++ EYM +GSL LR+ AV + +++ + + YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--GYIAPELA 685
+ + VHRD+++ N+L++ +L A V+DFGLA+ +++ G + APE
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171
Query: 686 YTMAVTEKCDVYSFGVVALEV 706
+ K DV+SFG++ E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK------LVALKKLHRSETEEPAFLESFQTEARLL 561
+ +K +G G +G V+ + + LVA+K L ET + F+ EA LL
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAELL 62
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-----------NDVEAVELDWT 610
+ +H NIVK YG C +++EYME G L LR D EL +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 611 KRVNIVKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667
+ + I +A + YL H+ VHRD+++ N L+ +L + DFG++R ++ +
Sbjct: 123 QLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--T 174
Query: 668 SNRTLVVGT----YGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
++ V G ++ PE T + DV+SFGVV E+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
E F I +G G YGSVY+A +G++VA+K + EE L+ E +L Q
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEED--LQEIIKEISILKQCDS 57
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND-VEAVELDWTKRVN------IVKSM 619
IVK YG N ++++ EY GS+ +D ++ K + I+
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSV-----SDIMKITN----KTLTEEEIAAILYQT 108
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
L YLH +HRDI + NILLN +A +ADFG++ L + R V+GT +
Sbjct: 109 LKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFW 165
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+APE+ + K D++S G+ A+E+ G P
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 63/202 (31%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E+F ++ +G+G +G V+ + VA+K L + + + FQ E + L ++RH+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHK 62
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+++ L+ C + +++I E ME+GSL LR+ E L +++ +A ++YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE 121
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD---SSNRTLVVGTYGYIAPEL 684
+ + +HRD+++ NIL+ +L VADFGLARL+ D SS++ + Y + APE
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEA 175
Query: 685 AYTMAVTEKCDVYSFGVVALEV 706
A + K DV+SFG++ E+
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 76/212 (35%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 516 IGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
IG G +G V+R L G+ VA+K L TE+ + F +EA ++ Q H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
L G K +I EYME G+L LR +D E + V +++ +A + YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL---S 124
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG---------YIA 681
+ VHRD+++ NIL+NSNLE V+DFGL+R+L D GTY + A
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE------GTYTTSGGKIPIRWTA 178
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
PE T DV+SFG+V EV+ G P
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 71/207 (34%), Positives = 112/207 (54%), Gaps = 24/207 (11%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH---RNIVK 571
IG G YG+VYR + +G++VALK ++ ++ + Q E LLSQ+R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD--VSDIQREVALLSQLRQSQPPNITK 66
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
YG L +++I EY E GS+ R ++A + I++ + AL Y+H K
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV----RTLMKAGPIAEKYISVIIREVLVALKYIH---K 119
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVT 691
++HRDI + NIL+ + + DFG+A LL+ +SS R+ VGT ++APE+ +T
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV-----IT 174
Query: 692 E------KCDVYSFGVVALEVLMGSHP 712
E K D++S G+ E+ G+ P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 509 DFHIKYCIGTGGYGSVYRA------QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
DF I IG G +G V++ ++ + K + L K++R E EE EAR+L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLA 54
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVL---RNDVEAVELDWTKRVNIVKSM 619
++ I++ Y L + ++ EY E G L +L R + W + I+
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-- 112
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
L++LH I+HRDI S N+ L++ + D G+A+LL +++ +VGT Y
Sbjct: 113 --GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
++PEL EK DV++ GVV E G HP D
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
I G YG V+ A+ S+G + A+K + +++ ++ TE +LSQ + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
K ++L+ EY+ G L +L N V +++ D + + + AL YLH I
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVAR--IYIAEIVLALEYLH---SNGI 114
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARL--------LHPDSSNRTLVVGTYGYIAPELAY 686
+HRD+ +NIL++SN + DFGL+++ L+ D +VGT YIAPE+
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
++ D +S G + E L+G P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+A+ +G++VA+KK+ E ++ E +LL ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
H ++L++E+M+ L+ ++++ L + + + + L++ H I
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-TEK 693
+HRD+ N+L+N+ +ADFGLAR T V T Y APEL +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 694 CDVYSFGVVALEVLMGS 710
D++S G + E+L
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ + VA+K L AFL+ EA+++ ++RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHD 61
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY C + ++++ EYM +GSL L++ E +L + V++ +A ++YL
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD-----SSNRTLVVGTYGYIAP 682
+ +HRD+++ NIL+ NL +ADFGLARL+ D + + T AP
Sbjct: 121 ---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----AP 173
Query: 683 ELAYTMAVTEKCDVYSFGVVALEV 706
E A T K DV+SFG++ E+
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V++A+ +G+ VALKK+ E E + L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
H L+ EYM L VLR++ + K ++ + ++Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGI 120
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLVVGTYGYIAPEL-----AYTM 688
+HRD+ N+L++++ +ADFGLARL + + V T Y APEL Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 689 AVTEKCDVYSFGVVALEVLMGS 710
V D+++ G + E+L GS
Sbjct: 181 GV----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG V + + ++G++VA+KK SE +E ++ E ++L Q+RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE-DVKKTALREVKVLRQLRHENIVNLKE 67
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
++L++EY+ER +L +L + D + + + A++Y H +I
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHNI 121
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLH-PDSSNRTLVVGTYGYIAPEL-----AYTM 688
+HRDI NIL++ + + DFG AR L +S T V T Y APEL Y
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 689 AVTEKCDVYSFGVVALEVLMG 709
V DV++ G + E+L G
Sbjct: 182 PV----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G+G +G V+ + VA+K + E F+E EA+++ ++ H N+V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C + +F++ EYM G L LR + +W +++ + A+ YL + +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---YGYIAPELAYTMAVTE 692
HRD+++ N L+ + V+DFGLAR + D T GT + PE+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 693 KCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRKISQNPRLD 734
K DV+SFGV+ EV G P + S +S +S RL
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGYRLY 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSS-GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
D +K+ +G G YG VY VA+K L E+ +E F EA ++ +I+H
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
N+V+L G C ++I E+M G+L LR + E++ + + ++ A+ YL
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---YGYIAPE- 683
K + +HRD+++ N L+ N VADFGL+RL+ D+ T G + APE
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPES 176
Query: 684 LAYTMAVTEKCDVYSFGVVALEV 706
LAY + K DV++FGV+ E+
Sbjct: 177 LAYN-KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V++ + K+VA+K + E E+ +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L + +++I EY+ GS +L E LD T+ I++ + L YLH + K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 122
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI + N+LL+ + E +ADFG+A L R VGT ++APE+ A K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G+ A+E+ G P
Sbjct: 183 DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRS----ETEEPAFLESFQTEARLLS 562
+DF IG G + +V A+ + K A+K L + E + + E +L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK----YVKIEKEVLT 56
Query: 563 QI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
++ H I+KLY + ++ + EY G L +R +++ T+ +
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTR--FYAAEILL 113
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN------------ 669
AL YLH I+HRD+ NILL+ ++ + DFG A++L P+SS
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 670 --------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
VGT Y++PEL + D+++ G + ++L G P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 55/193 (28%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V+ ++ VA+K L + T +P + F EA+++ ++RH +++LY
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C + ++++ E M+ GSL L+ L + +++ +A ++YL + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKC 694
HRD+++ N+L+ N VADFGLAR++ D R + APE A + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 695 DVYSFGVVALEVL 707
DV+SFG++ E++
Sbjct: 186 DVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 510 FHIKYCIGTGGYGSVYRAQLSSGKLV-ALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
F + IG G +G V Q K + A+K +++ + E + + E R+L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 569 IVKL-YGFCLHNKCMFLIYEYMERGSL-FCVLRNDV---EAVELDWTKRVNIVKSMAHAL 623
+V L Y F + M+L+ + + G L + + + E V+ + + AL
Sbjct: 62 LVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
YLH I+HRDI +NILL+ + DF +A + PD + T GT GY+APE
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPE 169
Query: 684 L----AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722
+ Y++AV D +S GV A E L G P S
Sbjct: 170 VLCRQGYSVAV----DWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+ T F + IG G YG VY+A+ +G+LVA+K + E EE E + E +L +
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRK 58
Query: 564 I-RHRNIVKLYG-------FCLHNKCMFLIYEYMERGS---LFCVLRNDVEAVELDWTKR 612
H NI YG ++ ++L+ E GS L LR + ++ +W
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
I++ L+YLH + ++HRDI NILL N E + DFG++ L R
Sbjct: 118 --ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 673 VVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+GT ++APE+ + + DV+S G+ A+E+ G P
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 516 IGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G G +G VY+ +L S VA+K L E EP + F+ EA L+S ++H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSL--FCVLR---NDVEAVE--------LDWTKRVNIV 616
V L G C + +++EY+ G L F V +DV A LD + ++I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 617 KSMAHALSYL--HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-----SN 669
+A + YL H+ VHRD+++ N L+ L ++DFGL+R ++ S
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
L V ++ PE T + D++SFGVV E+
Sbjct: 186 SLLPV---RWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 512 IKYCIGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
I+ IG G +G V +L GK VA+K L TE+ F +EA ++ Q H
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHALSYL 626
NI+ L G +K + ++ EYME GSL LR +D + + + V +++ +A + YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKYL 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG---TYGYIAPE 683
VHRD+++ NIL+NSNL V+DFGL+R+L D G + APE
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 684 LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
T DV+S+G+V EV+ G P
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 23/219 (10%)
Query: 516 IGTGGYGSVY--RAQLSSGKLVALKKLH-------RSETEEPAFLESFQTEARLL-SQIR 565
+G+G +G VY R + + L+ALK+++ + + E + +E ++ Q+R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSL---FCVLRNDVEAVELDWTKRV-NIVKSMAH 621
H NIV+ Y L N ++++ + +E L F L+ + +R+ NI M
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
AL YLH + + IVHRD++ NNI+L + + + DFGLA+ P+S T VVGT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSC 181
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP---TDLLS 717
PE+ EK DV++FG + ++ P T++LS
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V++ + ++VA+K + E E+ +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L +++I EY+ GS +LR A D + ++K + L YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI + N+LL+ + +ADFG+A L R VGT ++APE+ A K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G+ A+E+ G P
Sbjct: 183 DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
IG G +G VY+ L VA+K T P F EA +L Q H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C+ + ++++ E + GSL LR + L K + + A + YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT----YGYIAPELAYTMAVT 691
HRD+++ N L+ N ++DFG++R + T+ G + APE T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 692 EKCDVYSFGVVALEVL-MGSHP 712
+ DV+S+G++ E +G P
Sbjct: 174 SESDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 24/198 (12%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEE--PAFLESFQTEARLLSQIR---HRNI 569
IG G YG+VY+A+ L++G+ VALKK+ +EE P S E LL Q+ H NI
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL---STLREIALLKQLESFEHPNI 63
Query: 570 VKLYGFCL-----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
V+L C + L++E++++ L L + T + ++++ + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLLRGVD 121
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE- 683
+LH IVHRD+ NIL+ S+ + +ADFGLAR+ + + T VV T Y APE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEV 177
Query: 684 -LAYTMAVTEKCDVYSFG 700
L + A D++S G
Sbjct: 178 LLQSSYATP--VDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 69/198 (34%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VYRA+ +SG++VALKK+ R + E S E LL +RH NIV+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 575 FCL--HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+ H +FL+ EY E+ L +L N K ++ + L YLH +
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK--CLMLQLLRGLQYLHENF-- 128
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-T 691
I+HRD+ +N+LL +ADFGLAR + T V T Y APEL T
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 692 EKCDVYSFGVVALEVLMG 709
D+++ G + E+L
Sbjct: 188 TAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 62/222 (27%), Positives = 111/222 (50%), Gaps = 17/222 (7%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+GTG +G V + VA+K + E F+E EA+++ ++ H +V+LYG
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C + ++++ EYM G L LR + + ++ + + K + ++YL +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---YGYIAPELAYTMAVTE 692
HRD+++ N L++ V+DFGL+R + D T VG+ + PE+ +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 693 KCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRKISQNPRL 733
K DV++FGV+ EV +G P + + +S + K+SQ RL
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGLRL 220
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 10/200 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ + VA+K L AFL+ EA+++ ++RH
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY + + ++++ EYM +GSL L+ ++ L + V++ +A ++Y+
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 119
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAY 686
+ + VHRD+ + NIL+ NL VADFGLARL+ + + R + APE A
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 687 TMAVTEKCDVYSFGVVALEV 706
T K DV+SFG++ E+
Sbjct: 177 YGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 61/213 (28%), Positives = 112/213 (52%), Gaps = 16/213 (7%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V+ ++ VA+K L AFLE EA L+ ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLVRLYAV 69
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
+ +++I EYM +GSL L++D E ++ K ++ +A ++Y+ + + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTMAVTEKC 694
HRD+ + N+L++ +L +ADFGLAR++ + + R + APE + T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 695 DVYSFGVVALEVLM-------GSHPTDLLSSLS 720
DV+SFG++ E++ G +D++S+L
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF +GTG +G V + SGK ALK L +++ + +E E R+L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK--RVNIVKSMAHALS 624
+V LYG + ++L+ EY+ G LF LR + +V AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVL----ALE 115
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYGYIAPE 683
YLH IV+RD+ N+LL+S+ + DFG A+ + RT + GT Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168
Query: 684 L----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ Y AV D ++ G++ E+L G P
Sbjct: 169 IILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 19/210 (9%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLH------RSETEEPAFLESFQTEARLLSQIRHRN 568
IG+G +GSVY SSG+L+A+K++ S+ + + L++ E LL +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
IV+ G L + + EY+ GS+ +L N+ A E + N V+ + L+YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR--NFVRQILKGLNYLH- 123
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS------SNRTLVVGTYGYIAP 682
I+HRDI NIL+++ ++DFG+++ L +S R + G+ ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ + T K D++S G + +E+L G HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 40/211 (18%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKL---HRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G Y VY+A +G++VA+KK+ R E ++ + + E +LL +++H NI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH---------- 621
L H + L++E+ME D+E V K +IV + A
Sbjct: 67 LLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYMLMTLR 113
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L YLH I+HRD+ NN+L+ S+ +ADFGLAR + T V T Y A
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRA 170
Query: 682 PEL-----AYTMAVTEKCDVYSFGVVALEVL 707
PEL Y + V D++S G + E+L
Sbjct: 171 PELLFGARHYGVGV----DMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 42/255 (16%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSS------GKLVALKKLHRSETEEPAFLESFQTEARLL 561
D +K+ +G G +G V+ A+ + LVA+K L E E A + FQ EA LL
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQD-FQREAELL 61
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN------------DVEAVELDW 609
+ ++H++IV+ YG C + + +++EYM G L LR+ DV +L
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 610 TKRVNIVKSMAHALSY---LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666
+ + I +A + Y LH+ VHRD+++ N L+ L + DFG++R ++
Sbjct: 122 GQMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 667 S----SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721
RT++ ++ PE T + D++SFGVV E+ G P LS+ +
Sbjct: 176 DYYRVGGRTML--PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
Query: 722 ----SSGRKISQNPR 732
+ GR++ + PR
Sbjct: 234 IECITQGREL-ERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 43/225 (19%)
Query: 510 FHIKYCIGTGGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ I+ CIG G YG VY+A+ GK A+KK + + +S E LL +++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 567 RNIVKLYGFCLHN--KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV----NIVKSMA 620
N+V L L + K ++L+++Y E L+ +++ + KRV ++VKS+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQ------AKRVSIPPSMVKSLL 114
Query: 621 ----HALSYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLH-----PDS 667
+ + YLH ++HRD+ NIL+ + D GLARL +
Sbjct: 115 WQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 668 SNRTLVVGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVL 707
+ VV T Y APEL YT A+ D+++ G + E+L
Sbjct: 172 LDP--VVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V+ + VA+K L +FLE EA+++ ++RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA- 68
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
+ + ++++ EYM +GSL L+ D E L V++ +A ++Y+ + + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYI 124
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTMAVTEKC 694
HRD+ S NIL+ L +ADFGLARL+ + + R + APE A T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 695 DVYSFGVVALEVL 707
DV+SFG++ E++
Sbjct: 185 DVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G VY+ + ++VA+K + E E+ +E Q E +LSQ I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L +++I EY+ GS +L+ L+ T I++ + L YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERK--- 122
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI + N+LL+ + +ADFG+A L R VGT ++APE+ A K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 695 DVYSFGVVALEVLMGSHP-TDL 715
D++S G+ A+E+ G P +DL
Sbjct: 183 DIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G G+VY A +++G+ VA+K+++ + + E E ++ + +H NIV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L ++++ EY+ GSL V V +D + + + AL +LH + +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDV----VTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI S+NILL + + DFG + P+ S R+ +VGT ++APE+ A K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 516 IGTGGYGSVYRA----QLSSGKL-VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G+G +G+VY+ + K+ VA+K L E P + EA +++ + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHVV 72
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKSMAHALSYL 626
+L G CL + + LI + M G L +RN + + L+W V I K M SYL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYL 125
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--GYIAPEL 684
+ +VHRD+++ N+L+ + + DFGLA+LL D G ++A E
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 685 AYTMAVTEKCDVYSFGVVALEVL-MGSHPTD 714
T K DV+S+GV E++ G+ P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G G V + +GK++A+K + E A + E +L + IV YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYG 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+N + + EYM+ GSL +L+ + ++ + ++ L+YLH K I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--I 122
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE----LAYTMAV 690
+HRD+ +NIL+NS + + DFG++ L +S +T VGT Y+APE Y++
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF-VGTSSYMAPERIQGNDYSV-- 178
Query: 691 TEKCDVYSFGVVALEVLMGSHP 712
K D++S G+ +E+ G P
Sbjct: 179 --KSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G V ++ S + ALK + + E E +E +L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
K ++++ EY G L+ +LR + D + + A YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLH---NRGI 114
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMAV 690
++RD+ N+LL+SN + DFG A+ L T GT Y+APE+ Y +V
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-CGTPEYVAPEIILNKGYDFSV 173
Query: 691 TEKCDVYSFGVVALEVLMGSHP 712
D +S G++ E+L G P
Sbjct: 174 ----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 21/209 (10%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKL---HRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+GTG + S Y+A+ + +G L+A+K++ + +E+ +E+ + E RL++++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRND---VEAVELDWTKRVNIVKSMAHALSYLHY 628
+ G + L E+M GS+ +L EAV +++T+++ LSYLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121
Query: 629 DCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTL----VVGTYGYIAPE 683
+ I+HRD+ N+L++S + +ADFG A L + ++GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 684 LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ CDV+S G V +E+ P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 516 IGTGGYGSV----YRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +GSV Y + VA+K L + A + F EA +++Q+ H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY-LHYDC 630
L G C M L+ E G L L+ E D +K +AH ++ + Y
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSD-------LKELAHQVAMGMAYLE 112
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG-----YIAPELA 685
VHRD+++ N+LL + +A ++DFG++R L S T G + APE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECI 170
Query: 686 YTMAVTEKCDVYSFGVVALEVL 707
+ K DV+S+GV E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 10/193 (5%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V+ + VA+K L + AFL EA L+ Q++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
+ + +++I EYME GSL L+ E ++L K +++ +A ++++ + + +
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTMAVTEKC 694
HRD+ + NIL++ L +ADFGLARL+ + + R + APE T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 695 DVYSFGVVALEVL 707
DV+SFG++ E++
Sbjct: 185 DVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKK--LHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG G G V A S+G+ VA+KK L + + E F E ++ +H NIV++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHPNIVEM 81
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y L ++++ E++E G+L + V ++ + + ++ ALS+LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQ 134
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
++HRDI S++ILL S+ ++DFG + + R +VGT ++APE+ +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 693 KCDVYSFGVVALEVLMGSHP 712
+ D++S G++ +E++ G P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G VY+AQ L A K + E LE F E +LS+ +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK--IIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
+ ++++ E+ + G+L ++ ++E L + + + M AL++LH ++
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM-LELERG-LTEPQIRYVCRQMLEALNFLH---SHKVI 125
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE--- 692
HRD+ + NILL + + +ADFG++ R +GT ++APE+ +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 693 --KCDVYSFGVVALEVLMGSHP 712
K D++S G+ +E+ P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKK--LHRSE--TEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G YG+VY + G+L+A+K+ L S E + E Q E LL ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHVNIVQ 66
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
G CL + + + E++ GS+ +L E + K K + ++YLH +C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT------LVVGTYGYIAPELA 685
+VHRDI NN++L N + DFG AR L + T + GT ++APE+
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS--SSGRKISQNPRLD 734
K D++S G E+ G P + L++ G PRL
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 28/208 (13%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY- 573
IG G YG VY+A+ +G+LVALKK+ R + E+ F + E ++L Q+ HRNIV L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 574 ---------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
F +L++EYM+ L +L + + V + +K + L+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLN 130
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN-RTLVVGTYGYIAPE 683
Y H K + +HRDI +NILLN+ + +ADFGLARL + + S T V T Y PE
Sbjct: 131 YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187
Query: 684 L-----AYTMAVTEKCDVYSFGVVALEV 706
L Y A+ DV+S G + E+
Sbjct: 188 LLLGEERYGPAI----DVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G+G +G V+ + + VA+K ++ E F+E EA+++ ++ H +V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C K ++++ E+ME G L LR + D +++ + + + YL + S +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFI 122
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPD----SSNRTLVVGTYGYIAPELAYTMAVT 691
HRD+++ N L++S V+DFG+ R + D SS V + PE+ +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSKYS 179
Query: 692 EKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGRKISQNPRL 733
K DV+SFGV+ EV G P + S+ IS+ RL
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV--EMISRGFRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E + +G G +G V+ + VA+K L AFL+ EA+++ ++RH
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V LY + + ++++ E+M +GSL L+ + L + V++ +A ++Y+
Sbjct: 62 KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAY 686
+ + +HRD+ + NIL+ NL +ADFGLARL+ + + R + APE A
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176
Query: 687 TMAVTEKCDVYSFGVVALEVL 707
T K DV+SFG++ E++
Sbjct: 177 YGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG V++ + +G++VA+KK SE ++P + E R+L Q++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ + L++EY + ++ L + V K+ I+ A+++ H K +
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCH---KHNC 121
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYTMA 689
+HRD+ NIL+ + + DFG AR+L + T V T Y APEL Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181
Query: 690 VTEKCDVYSFGVVALEVLMG 709
V DV++ G V E+L G
Sbjct: 182 V----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 35/209 (16%)
Query: 515 CIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EARLLSQI-RHR 567
+G G +GSVY A+ +G+LVA+KK+ + S++ E + L ++ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKK-------FYSWEECMNLREVKSLRKLNEHP 58
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIVKL N ++ ++EYME G+L+ ++++ + + +I+ + L+++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIH 116
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR---TLVVGTYGYIAPEL 684
K HRD+ N+L++ +ADFGLAR + +R T V T Y APE+
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR----SRPPYTDYVSTRWYRAPEI 169
Query: 685 -----AYTMAVTEKCDVYSFGVVALEVLM 708
+Y+ V D+++ G + E+
Sbjct: 170 LLRSTSYSSPV----DIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 72/241 (29%), Positives = 118/241 (48%), Gaps = 33/241 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF + IG+G YG VY+A+ +++G+L A+K + E+ A + Q E ++ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV---QQEIIMMKDCKH 65
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE--LDWTKRVNIVKSMAHALS 624
NIV +G L +++ E+ GSL D+ V L ++ + + L
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSL-----QDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YLH K +HRDI NILL N +ADFG++ + + R +GT ++APE+
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 685 AYTMAVTEK------CDVYSFGVVALEV------LMGSHPTDLLSSLSSSSGRKISQNPR 732
A AV K CD+++ G+ A+E+ + HP L ++ S+ Q P+
Sbjct: 178 A---AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----FQPPK 230
Query: 733 L 733
L
Sbjct: 231 L 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 20/235 (8%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G+VY A S + ++VA+KK+ S + + E + L Q++H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 575 FCLHNKCMFLIYEYM--ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
L +L+ EY L V + ++ VE+ I L+YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHNM- 142
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+HRDI + NILL + +ADFG A P +S VGT ++APE+ M +
Sbjct: 143 --IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEGQ 196
Query: 693 ---KCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNF 744
K DV+S G+ +E+ P L + + S+ I+QN LQ N + +F
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 508 EDFHIKYC--IGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARL 560
E H+K+ +G G +G V + ++G+ VA+K L+ S E F+ E +
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEI 59
Query: 561 LSQIRHRNIVKLYGFC--LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
L + H NIVK G C + + LI EY+ GSL L+ +++ + +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQ 117
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS------SNRTL 672
+ + YL +HRD+++ NIL+ S ++DFGLA++L D
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
+ Y APE T + DV+SFGV E+
Sbjct: 175 PIFWY---APECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 68/238 (28%), Positives = 117/238 (49%), Gaps = 27/238 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D+ + +G+G YG VY+A+ L +G+L A+K + ++ + + Q E ++ + +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLI---QQEIFMVKECKH 65
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE--LDWTKRVNIVKSMAHALS 624
NIV +G L + +++ EY GSL D+ V L + + + L+
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSL-----QDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YLH K +HRDI NILL N + +ADFG+A + + R +GT ++APE+
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 685 AYTM---AVTEKCDVYSFGVVALEV------LMGSHPTDLLSSLSSSSGRKISQNPRL 733
A + CD+++ G+ A+E+ + HP L +S S+ Q P+L
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN----FQPPKL 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 29/220 (13%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHR 567
F + +G G YG VY+ + + +G+L A+K + +E EE E + E +L + HR
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73
Query: 568 NIVKLYGFCL------HNKCMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMA 620
NI YG + H+ ++L+ E+ GS+ +++N A++ DW I + +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
L++LH ++HRDI N+LL N E + DFG++ L R +GT ++
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188
Query: 681 APELAYTMAVTE--------KCDVYSFGVVALEVLMGSHP 712
APE+ +A E + D++S G+ A+E+ G+ P
Sbjct: 189 APEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
IG+G +G V+ + VA+K + E E F EA+++ ++ H +V+LYG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C + L++E+ME G L LR + + + + + ++YL ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---YGYIAPELAYTMAVTE 692
HRD+++ N L+ N V+DFG+ R + D T GT + +PE+ +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 693 KCDVYSFGVVALEV 706
K DV+SFGV+ EV
Sbjct: 181 KSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 58/198 (29%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G G+V+ A +++G+ VA+K+++ + + E E ++ ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L +F++ EY+ GSL V V +D + + + AL +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDV----VTETCMDEAQIAAVCRECLQALEFLHAN---QV 136
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI S+N+LL + + DFG + P+ S R+ +VGT ++APE+ A K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 71/231 (30%), Positives = 115/231 (49%), Gaps = 38/231 (16%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ---LSSGK---LVALKKLHRSETEEP--AFLESFQTEARL 560
D +K +G G +G V+ A+ LS K LVA+K L ++P A + FQ EA L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-----KDPTLAARKDFQREAEL 60
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAV------------EL 607
L+ ++H +IVK YG C + +++EYM+ G L LR + +A+ EL
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667
++ ++I +A + YL VHRD+++ N L+ +NL + DFG++R ++
Sbjct: 121 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 668 SNRTLVVGTYG-----YIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
R VG + ++ PE T + DV+SFGV+ E+ G P
Sbjct: 178 YYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 508 EDFHIKYC--IGTGGYGSVYRA-----QLSSGKLVALKKLHRSETEEPAFLESFQTEARL 560
E+ H+K+ +G G +GSV Q ++G++VA+KKL S E L F+ E +
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEI 58
Query: 561 LSQIRHRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV----- 613
L ++H NIVK G C + + L+ EY+ GSL L+ E ++ +++
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYAS 115
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673
I K M + L Y VHRD+++ NIL+ S + DFGL ++L D
Sbjct: 116 QICKGMEY-LGSKRY------VHRDLATRNILVESENRVKIGDFGLTKVLPQDKE--YYK 166
Query: 674 VGTYG-----YIAPELAYTMAVTEKCDVYSFGVVALEV 706
V G + APE + DV+SFGVV E+
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G G+VY A +++G+ VA+K+++ + + E E ++ + ++ NIV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L ++++ EY+ GSL V V +D + + + AL +LH + +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDV----VTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI S+NILL + + DFG + P+ S R+ +VGT ++APE+ A K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G++A+E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 54/193 (27%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V+ A + VA+K + AFL EA ++ ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVKLHA- 68
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
+ + +++I E+M +GSL L++D E + K ++ +A ++++ + + +
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 124
Query: 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTMAVTEKC 694
HRD+ + NIL++++L +ADFGLAR++ + + R + APE + T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 695 DVYSFGVVALEVL 707
DV+SFG++ +E++
Sbjct: 185 DVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 508 EDFHIKYCIGTGGYGSV----YRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
++ + IG G +G V YR G VA+K + T + +F EA +++Q
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQ-----AFLAEASVMTQ 55
Query: 564 IRHRNIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+RH N+V+L G + K ++++ EYM +GSL LR+ +V L + + A
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 114
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
+ YL + + VHRD+++ N+L++ + A V+DFGL + L V + AP
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAP 168
Query: 683 ELAYTMAVTEKCDVYSFGVVALEV 706
E + K DV+SFG++ E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+D +GTG +G V+ + S ALK + E + E R+L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH----- 621
I++L+ + ++++ EY+ G LF LRN + R + S
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFS--NSTGLFYASE 109
Query: 622 ---ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV-GTY 677
AL YLH IV+RD+ NILL+ + DFG A+ L +RT + GT
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTP 162
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+APE+ + + D ++ G++ E+L+G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 72/238 (30%), Positives = 111/238 (46%), Gaps = 22/238 (9%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G+VY A+ + ++VA+KK+ S + + E R L Q+RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 575 FCLHNKCMFLIYEYMERGS---LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
L +L+ EY GS + V + ++ VE+ I L+YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEI-----AAICHGALQGLAYLHSHER 136
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM--- 688
+HRDI + NILL +ADFG A L+ P +S VGT ++APE+ M
Sbjct: 137 ---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEG 189
Query: 689 AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQ 746
K DV+S G+ +E+ P L + + S+ I+QN L N + F
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G G+VY A +++G+ VA+++++ + + E E ++ + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L ++++ EY+ GSL V V +D + + + AL +LH + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDV----VTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRDI S+NILL + + DFG + P+ S R+ +VGT ++APE+ A K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 695 DVYSFGVVALEVLMGSHP 712
D++S G++A+E++ G P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALK--KLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG G G V A + SG+ VA+K L + + E F E ++ +H+N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y L + ++++ E+++ G+L + V L+ + + +S+ AL YLH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLH---SQ 136
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
++HRDI S++ILL + ++DFG + D R +VGT ++APE+
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 693 KCDVYSFGVVALEVLMGSHP 712
+ D++S G++ +E++ G P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 70/246 (28%), Positives = 117/246 (47%), Gaps = 34/246 (13%)
Query: 512 IKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+K +G G +G V+ A+ LVA+K L + + F EA LL+ ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAV---------ELDWTKRVNI 615
H +IVK YG C+ + +++EYM+ G L LR + +AV EL ++ ++I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 616 VKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG 675
+ +A + YL VHRD+++ N L+ NL + DFG++R ++ R VG
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---VG 179
Query: 676 TYG-----YIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSS---LSSSSGRK 726
+ ++ PE T + DV+S GVV E+ G P LS+ + + +
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239
Query: 727 ISQNPR 732
+ Q PR
Sbjct: 240 VLQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 516 IGTGGYGSVYRAQL------SSGKL-VALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+G+G +G VY SG + VA+K L + T++ E F EA L+S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKE-FLKEAHLMSNFNHPN 60
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKSMAHALS 624
IVKL G CL N+ ++I E ME G L LR+ L + ++I +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAF-----VADFGLARLLHPDSSNRTLVVGTYG- 678
YL + +HRD+++ N L++ + DFGLAR ++ R G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 679 -YIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSL 719
++APE T + DV+SFGV+ E+L +G P L++
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 61/195 (31%), Positives = 107/195 (54%), Gaps = 20/195 (10%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
IG G +G+V + + + G+ VA+K + + + AFLE E +++++ H+N+V+L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQAFLE----ETAVMTKLHHKNLVRLLGV 67
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY---LHYDCKP 632
LHN ++++ E M +G+L LR A+ V++++ + +L + Y
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLESK 119
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+VHRD+++ NIL++ + A V+DFGLAR+ N L V + APE +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFSS 176
Query: 693 KCDVYSFGVVALEVL 707
K DV+S+GV+ EV
Sbjct: 177 KSDVWSYGVLLWEVF 191
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 516 IGTGGYGSVYRAQL--SSGKL--VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G V R + S GK+ VA+K L + + ++ F EA ++ + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEA---VELDWTKRVNIVKSMAHALSYLHY 628
LYG L + M ++ E GSL LR D + V I M YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE- 114
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL------HPDSSNRTLVVGTYGYIAP 682
+HRD+++ NILL S+ + + DFGL R L + + + + + AP
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAP 169
Query: 683 ELAYTMAVTEKCDVYSFGVVALEV 706
E T + DV+ FGV E+
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 40/231 (17%)
Query: 506 ATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKL--HRSETEEPAFLESFQTEARLLS 562
D+ I +G G +G VY+A Q+ +G++VALKK+ H E+ F + E ++L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILK 62
Query: 563 QIRHRNIVKL------YGFCLHNK--CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN 614
+++H N+V L K ++++ YM+ L +L N +V+L ++
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKC 119
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN----- 669
+ + ++YLH + I+HRDI + NIL+++ +ADFGLAR N
Sbjct: 120 YMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 670 ------RTLVVGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVLMG 709
T +V T Y PEL YT AV D++ G V E+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKK--LHRSETEEPAFLESFQTEARLLSQIR 565
D IK IG G G V A + SSGKLVA+KK L + + E F E ++ +
Sbjct: 23 DNFIK--IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQ 75
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H N+V++Y L ++++ E++E G+L + V ++ + + ++ ALS
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH ++HRDI S++ILL + ++DFG + + R +VGT ++APEL
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D++S G++ +E++ G P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 71/238 (29%), Positives = 115/238 (48%), Gaps = 23/238 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G+VY A+ + + ++VA+KK+ S + + E + L +I+H N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 575 FCLHNKCMFLIYEYM--ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
L +L+ EY L V + ++ VE+ I L+YLH
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLH---SH 144
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+++HRDI + NILL + +ADFG A + P +S VGT ++APE+ M +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200
Query: 693 ---KCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNA---YLKNF 744
K DV+S G+ +E+ P L + + S+ I+QN LQ N Y +NF
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 3e-18
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 46/218 (21%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQT---------EARLLSQIR 565
IG+G YG V A +G+ VA+KK+ F E +LL +R
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV----------FDDLIDAKRILREIKLLRHLR 57
Query: 566 HRNIVKLYGFCLHNKCM-----FLIYEYMERGSLFCVLRNDVEAVELDWTKRVN-IVKSM 619
H NI+ L +++ E ME L V+++ + + + +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTD----DHIQYFLYQI 112
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV---VGT 676
L YLH +++HRD+ +NIL+NSN + + DFGLAR + PD + + V T
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 677 YGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
Y APEL YT A+ D++S G + E+L
Sbjct: 170 RWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKLY 573
I G +GSVY A+ S+G A+K L +S+ + + + E ++ Q + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 574 GFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+ +K ++L+ EY+ G +++ + + DW K + + + LH
Sbjct: 64 -YSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR--- 116
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLAR--LLHPDSSNRTLVVGTYGYIAPELAYTMAV 690
I+HRDI N+L++ + DFGL+R L + VGT Y+APE +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGD 170
Query: 691 TEKCDVYSFGVVALEVLMGSHP 712
+ D +S G V E L G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 8/194 (4%)
Query: 516 IGTGGYGS--VYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G +G +YR + LV K+++ + E ++ E +LS ++H NI+ Y
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDA-LNEIVILSLLQHPNIIAYY 65
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ + + + EY G+L+ + + + + + + A+SY+H K
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
I+HRDI + NI L + DFG++++L + S VVGT Y++PEL + K
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 694 CDVYSFGVVALEVL 707
D+++ G V E+L
Sbjct: 182 SDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG+G G+VY+ +G+L ALK ++ + E E +L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
HN + ++ E+M+ GSL D E D +++ LS + Y + I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIAD-EQFLADVARQI---------LSGIAYLHRRHI 189
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHP--DSSNRTLVVGTYGYIAPE-----LAYT 687
VHRDI +N+L+NS +ADFG++R+L D N + VGT Y++PE L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHG 247
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
D++S GV LE +G P
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG V + + +G++VA+KK SE ++ + + E R+L Q+RH N+V L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE--LDWTKRVNIVKSMAHALSYLHYDCKP 632
K ++L++E+++ L +D+E LD ++ + + + + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYT 687
+I+HRDI NIL++ + + DFG AR L T V T Y APEL Y
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 688 MAVTEKCDVYSFGVVALEVLMG 709
AV D+++ G + E+L G
Sbjct: 180 RAV----DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 7e-18
Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 31/252 (12%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHR 567
F + +G G YG VY+ + + +G+L A+K + + EE E + E +L + HR
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63
Query: 568 NIVKLYGFCLH------NKCMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMA 620
NI YG + + ++L+ E+ GS+ +++N ++ +W I + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
LS+LH + ++HRDI N+LL N E + DFG++ L R +GT ++
Sbjct: 122 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178
Query: 681 APELAYTMAVTE--------KCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPR 732
APE+ +A E K D++S G+ A+E+ G+ P L + I +NP
Sbjct: 179 APEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPP--LCDMHPMRALFLIPRNPA 233
Query: 733 LDLQCNAYLKNF 744
L+ + K F
Sbjct: 234 PRLKSKKWSKKF 245
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 66/238 (27%), Positives = 112/238 (47%), Gaps = 23/238 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G+VY A+ + + ++VA+KK+ S + + E R L ++RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 575 FCLHNKCMFLIYEYM--ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
L +L+ EY L V + ++ VE+ + L+YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 134
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+++HRD+ + NILL+ + DFG A ++ P + VGT ++APE+ M +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 693 ---KCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNA---YLKNF 744
K DV+S G+ +E + L + + S+ I+QN LQ Y +NF
Sbjct: 191 YDGKVDVWSLGITCIE--LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
ED + CIG G +G VY+ S + VA+K P+ E F EA ++ Q
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC--KNCTSPSVREKFLQEAYIMRQ 63
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVK---SMA 620
H +IVKL G N ++++ E G L L+ V +++ ++
Sbjct: 64 FDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLS 117
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--G 678
AL+YL VHRDI++ N+L++S + DFGL+R L D S G
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK 173
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLM 708
++APE T DV+ FGV E+LM
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+A+ +G++VALKK+ R +TE + E LL ++ H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS----MAHALSYLHYDC 630
++L++E++ + L+ ++A L + ++KS + L++ H
Sbjct: 67 VIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIP-LPLIKSYLFQLLQGLAFCH--- 117
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA----- 685
++HRD+ N+L+N+ +ADFGLAR T V T Y APE+
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 686 YTMAVTEKCDVYSFGVVALEVL 707
Y+ AV D++S G + E++
Sbjct: 178 YSTAV----DIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 515 CIGTGGYGSVYRA-QLSSGKLVALKKLH--RSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G VY + +G+ +A+K++ E + + + E +LL ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRND---VEAVELDWTKRVNIVKSMAHALSYLHY 628
YG ++ + + EYM GS+ L+ E V +T+++ + YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHS 122
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTYGYIAPELA 685
+ IVHRDI NIL +S + DFG ++ L S+ T V GT +++PE+
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
K DV+S G +E+L P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALK--KLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G+G +GSVY L G A+K L ++ + E LLS+++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
G +++ E + GSL +L+ + + + L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLH---DR 121
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYT 687
+ VHRDI NIL+++N +ADFG+A+ + S ++ G+ ++APE+ Y
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGGYG 180
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
+A D++S G LE+ G P
Sbjct: 181 LAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V+ +L + VA+K ET P F EAR+L Q H NIV+L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
C + ++++ E ++ G LR E L + + +V++ A + YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPD--SSNRTLVVGTYGYIAPELAYTMAVTE 692
+HRD+++ N L+ ++DFG++R +S + + APE +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 693 KCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRK-ISQNPRL 733
+ DV+SFG++ E +G+ P ++LS+ R+ I Q RL
Sbjct: 176 ESDVWSFGILLWEAFSLGAVP---YANLSNQQTREAIEQGVRL 215
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 5/201 (2%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+F I+ IG G + VY+A L G++VALKK+ E + + E LL Q+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALS 624
H N++K + N + ++ E + G L ++++ + L + + + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
++H I+HRDI N+ + + + D GL R ++ +VGT Y++PE
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 685 AYTMAVTEKCDVYSFGVVALE 705
+ K D++S G + E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 73/219 (33%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSSG----KLVALKKLHRSETEEPA-FLESFQTEARLLSQ 563
+F + +GTG YG V+ + SG KL A+K L ++ + A E +TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 564 IRHRN-IVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMA 620
IR +V L Y F K + LI +Y+ G LF L E + V I +
Sbjct: 61 IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYGY 679
AL +LH K I++RDI NILL+SN + DFGL++ H D R GT Y
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 680 IAPEL------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+AP++ + AV D +S GV+ E+L G+ P
Sbjct: 173 MAPDIVRGGDGGHDKAV----DWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY- 573
+G+G YGSV A +G+ VA+KKL R E F + E LL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 574 -------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV---ELDWTKRVNIVKSMAHAL 623
G + +L+ YM + D++ + L K +V M L
Sbjct: 82 VFTSAVSGDEFQD--FYLVMPYM---------QTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
Y+H I+HRD+ N+ +N + E + DFGLAR H D+ VV T Y APE
Sbjct: 131 KYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV-TRWYRAPE 184
Query: 684 LAYT-MAVTEKCDVYSFGVVALEVLMG 709
+ M + D++S G + E+L G
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 67/245 (27%), Positives = 104/245 (42%), Gaps = 24/245 (9%)
Query: 516 IGTGGYGSVYRAQLSSGKLV-ALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G GSV + +L + ++ ALK + P + E + + IVK YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 575 FCLHNK-CMFLI-YEYMERGSLFCVLRNDVEAVELDWTKRV--NIVKSMAHALSYLHYDC 630
L I EY E GSL + + V+ ++V I +S+ LSYLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKVLGKIAESVLKGLSYLH--- 122
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV 690
I+HRDI +NILL + + DFG++ L +S GT Y+APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAPERIQGKPY 180
Query: 691 TEKCDVYSFGVVALEVLMGSHP-----------TDLLSSLSSSSGRKISQNPRLDLQCNA 739
+ DV+S G+ LEV P +LLS + + ++ P ++ +
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 740 YLKNF 744
K+F
Sbjct: 241 EFKDF 245
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
DF + +G G YGSVY+ + LS + ALK++ + ++ E R+L+ + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 568 NIVKLY-GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALSY 625
NI+ F NK + ++ EY G L + + +L + + I + L
Sbjct: 60 NIISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH + I+HRD+ S NILL +N + D G++++L + + +GT Y+APE+
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QIGTPHYMAPEVW 173
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K D++S G + E+ + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKK--LHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG G G V A + +GK VA+KK L + + E F E ++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y L ++++ E++E G+L + V ++ + + S+ ALSYLH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGAL----TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQ 137
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
++HRDI S++ILL S+ ++DFG + + R +VGT ++APE+ +
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 693 KCDVYSFGVVALEVLMGSHP 712
+ D++S G++ +E++ G P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 73/231 (31%), Positives = 109/231 (47%), Gaps = 59/231 (25%)
Query: 510 FHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEAR-------LL 561
+ I +G G YG V++A + ++VALKK+ AF T+A+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF------DAF--RNATDAQRTFREIMFL 60
Query: 562 SQIR-HRNIVKLYGF--CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
++ H NIVKL ++K ++L++EYME D+ AV R NI++
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME---------TDLHAV-----IRANILED 106
Query: 619 MAH---------ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669
+ AL Y+H +++HRD+ +NILLNS+ +ADFGLAR L N
Sbjct: 107 VHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 670 R-----TLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGS 710
T V T Y APE+ YT V D++S G + E+L+G
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
LVA+K L ++ E F E ++LS++ NI +L G C + + +I EYME G
Sbjct: 48 LVAVKVLRPDASDNA--REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 594 LFCVLRNDVEAVELDWTKRVNIVKSMAHALSY--------LHYDCKPSIVHRDISSNNIL 645
L L+ + V N L Y + Y + VHRD+++ N L
Sbjct: 106 LNQFLQ---KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162
Query: 646 LNSNLEAFVADFGLARLLHPDSSNRTLVVGT----YGYIAPELAYTMAVTEKCDVYSFGV 701
+ N +ADFG++R L+ SS+ V G ++A E T K DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSRNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 702 VALEVLM 708
E+L
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 39/92 (42%), Positives = 56/92 (60%)
Query: 213 LDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272
+D L L+ L G IP+ I L L ++LS N + G IPP++G++T+L LDLS N +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIG 304
G +P +G L L L+LNGN L G +P +G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-17
Identities = 47/111 (42%), Positives = 62/111 (55%), Gaps = 3/111 (2%)
Query: 72 LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI 131
L L L G IP++I LR L +NLS N + G+IP G++ L+ L L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 132 PSSIGNLTNLTYLDLSLNQLSGRLPQEVGN--LKNLKSLFLDNNHLSGPIP 180
P S+G LT+L L+L+ N LSGR+P +G L F DN L G IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 67/237 (28%), Positives = 108/237 (45%), Gaps = 17/237 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I IG G +G V ++ ++G++ A+K L++ E + A F+ E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 567 RNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA-HALS 624
R I L Y F ++L+ +Y G L +L + + D + +A ++
Sbjct: 61 RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-VGTYGYIAPE 683
L Y VHRDI +N+LL+ N +ADFG L D + ++ V VGT YI+PE
Sbjct: 120 QLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 684 LAYTMA-----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDL 735
+ M +CD +S GV E+L G P SL + G+ ++
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKEHFQF 229
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-17
Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 44/224 (19%)
Query: 516 IGTGGYGSVYRAQ---LSSGK---LVALKKLHRSETEEPAFLE---SFQTEARLLSQIRH 566
IG G +G V++A+ L + +VA+K L +E A + FQ EA L+++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQREAALMAEFDH 67
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------------DVEAVEL 607
NIVKL G C K M L++EYM G L LR+ + + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD- 666
T+++ I K +A ++YL + VHRD+++ N L+ N+ +ADFGL+R ++
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 667 ----SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
S N + + ++ PE + T + DV+++GVV E+
Sbjct: 185 YYKASENDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARL--LSQIRHRNIVKL 572
IG G YG+VY+A+ SG VALK + E+ L + + A L L H NIV+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 573 YGFCLHNKC-----MFLIYEYMERGSLFCVLRNDVEAVE---LDWTKRVNIVKSMAHALS 624
C ++ + L++E++++ LR ++ V L ++++ L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-----LRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
+LH +C IVHRD+ NIL+ S + +ADFGLAR+ + T VV T Y APE+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEV 178
Query: 685 AYTMAVTEKCDVYSFGVVALEVL 707
D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 39/221 (17%)
Query: 510 FHIKYCIGTGGYGSVYRAQLSSG------KLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+ I IG G +G +Y A+ S K + L K+ E E + + E LL++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE------ASKKEVILLAK 55
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEY-----------MERGSLFCVLRNDVEAVELDWTKR 612
++H NIV + N +F++ EY +RG LF E L W +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS------EDQILSWFVQ 109
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPDSSNRT 671
+++ L ++H D K I+HRDI S NI L+ N + A + DFG+AR L+
Sbjct: 110 ISL------GLKHIH-DRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160
Query: 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
VGT Y++PE+ K D++S G V E+ HP
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 32/265 (12%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G VY+AQ ++A K+ +++EE LE + E +L+ H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMAHALSYLHYD 629
+ ++++ E+ G+ V+AV L+ + + + K AL+YLH
Sbjct: 71 FYYENNLWILIEFCAGGA--------VDAVMLELERPLTEPQIRVVCKQTLEALNYLH-- 120
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA 689
+ I+HRD+ + NIL + + +ADFG++ R +GT ++APE+
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 690 VTE-----KCDVYSFGVVALEVLMGS------HPTDLLSSLSSSSGRKISQNPRLDLQCN 738
+ K DV+S G+ +E+ +P +L ++ S ++Q R +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 739 AYLKNFSQGN--HRWENLLFKKFPY 761
+LK + N RW + P+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+A+ +G++VALKK+ R ETE+ + E LL ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS----MAHALSYLHYDC 630
++L++E+++ L+ +++ L ++KS + ++Y H
Sbjct: 66 VVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCH--- 116
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----A 685
++HRD+ N+L++ +ADFGLAR T V T Y APE+
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 686 YTMAVTEKCDVYSFGVVALEVLM 708
Y+ V D++S G + E++
Sbjct: 177 YSTPV----DIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKL---HRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G V+ + + KLV +K++ ++ E + Q E ++L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER----LAAQNECQVLKLLSHPNIIE 63
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
Y L +K + ++ EY G+L ++ ++ LD ++ + AL ++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVH---T 119
Query: 632 PSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV 690
I+HRD+ + NILL+ + + DFG++++L S T VVGT YI+PEL
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 691 TEKCDVYSFGVVALEVL 707
+K D+++ G V E+
Sbjct: 179 NQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 516 IGTGGYGSVYRAQLSSG------KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G G +G V+ A+ LV +K L +T++ F+ E + ++ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE------LDWTKRVNIVKSMAHAL 623
V+L G C + ++I EY + G L LR E L ++V + +A +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS---NRTLVVGTYGYI 680
+L VHRD+++ N L++S E V+ L++ ++ L+ ++
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWL 185
Query: 681 APELAYTMAVTEKCDVYSFGVVALEV 706
APE + K DV+SFGV+ EV
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 66/245 (26%), Positives = 115/245 (46%), Gaps = 32/245 (13%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G VY+A+ +G L A K + EE LE + E +L+ H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVEIEILATCNHPYIVKLLG 76
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMAHALSYLHY 628
+ ++++ E+ G+ V+A+ L+ + + I + M AL YLH
Sbjct: 77 AFYWDGKLWIMIEFCPGGA--------VDAIMLELDRGLTEPQIQVICRQMLEALQYLH- 127
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY-- 686
I+HRD+ + N+LL + + +ADFG++ R +GT ++APE+
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 687 TMAVTE---KCDVYSFGVVALEVLMGS------HPTDLLSSLSSSSGRKISQNPRLDLQC 737
TM T K D++S G+ +E+ +P +L ++ S +SQ + ++
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 738 NAYLK 742
+LK
Sbjct: 246 RDFLK 250
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+A+ + + +ALKK+ R E E+ + E LL +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHALSYLHYDCKPS 633
K ++L++EY++ L+ +++ D+ K ++K+ + L + Y
Sbjct: 69 VVHSEKRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 634 IVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYT 687
++HRD+ N+L++ A +ADFGLAR T V T Y APE+ Y+
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 688 MAVTEKCDVYSFGVVALEVL 707
V D++S G + E++
Sbjct: 183 TPV----DIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 56/214 (26%), Positives = 112/214 (52%), Gaps = 28/214 (13%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLH-------RSETEEPAFLESFQTEARLLSQIRHR 567
IG G YG VY A +++G+++A+K++ R ++ + +++ ++E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA----HAL 623
NIV+ GF + + + EY+ GS+ LR E +V+ L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL---LHPDSSNRTLVVGTYGYI 680
+YLH I+HRD+ ++N+L++++ ++DFG+++ ++ + N ++ G+ ++
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM-QGSVFWM 177
Query: 681 APEL--AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
APE+ +Y+ + K D++S G V LE+ G P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+++ I G YG VYRA+ +G++VALKKL + E E+ F + E +L +++H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63
Query: 567 RNIVKL----YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI--VKSMA 620
NIV + G L ++++ EY+E +D++++ + VK +
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYVE---------HDLKSLMETMKQPFLQSEVKCLM 112
Query: 621 H----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT 676
+++LH I+HRD+ ++N+LLN+ + DFGLAR T +V T
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT 169
Query: 677 YGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
Y APEL Y+ A+ D++S G + E+L
Sbjct: 170 LWYRAPELLLGAKEYSTAI----DMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-16
Identities = 90/246 (36%), Positives = 128/246 (52%), Gaps = 11/246 (4%)
Query: 72 LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI 131
LDL+ NRL I SE+ L +L L+L NN + PL +L +L L NK+ +
Sbjct: 98 LDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155
Query: 132 PSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLAT 191
PS + NL NL LDLS N LS LP+ + NL NL +L L N +S +P + L+ L
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213
Query: 192 LCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251
L L N ++ + + N+KNL L L+ N L +P +IG L+ L+ L LS+N++
Sbjct: 214 LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--S 269
Query: 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTY 311
++G+LTNL LDLS N LS LP L L L N+L+ + + L
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLN 326
Query: 312 LNLGYN 317
N+ N
Sbjct: 327 NNILSN 332
|
Length = 394 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 36/225 (16%)
Query: 516 IGTGGYGSVYRAQL--------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RH 566
+G G +G V A+ VA+K L TE+ L +E ++ I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKH 80
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------------NDVEAVELDWTKRV 613
+NI+ L G C + +++I EY +G+L LR V ++ + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-----PDSS 668
+ +A + YL +HRD+++ N+L+ N +ADFGLAR ++ ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
N L V ++APE + T + DV+SFGV+ E+ +G P
Sbjct: 198 NGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-16
Identities = 36/82 (43%), Positives = 52/82 (63%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90
L G +P++I L L+ + LS NS+ G IP +G+++ L+VLDLSYN G+IP +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 91 RDLLDLNLSNNILNGSIPLEFG 112
L LNL+ N L+G +P G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 41/230 (17%)
Query: 516 IGTGGYGSVYRAQ------LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G G +G V +A + VA+K L E + L +E LL Q+ H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLR-----------------------NDVEAVE 606
+KLYG C + + LI EY + GSL LR D A+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 607 LDWTKRVNIVKSMAHALSY-LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+ + S A +S + Y + +VHRD+++ N+L+ + ++DFGL+R ++
Sbjct: 126 ------MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 666 DSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ S R+ ++A E + T + DV+SFGV+ E++ +G +P
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 7e-16
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 516 IGTGGYGSV-YRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G+G YG+V +G VA+KKL+R E F + E RLL ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 575 FCLHNKCM------FLIYEYM--ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ + +L+ +M + G L + + ++ +V M L Y+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I+HRD+ N+ +N + E + DFGLAR DS VV T Y APE+
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV-TRWYRAPEVIL 188
Query: 687 T-MAVTEKCDVYSFGVVALEVLMG 709
M T+ D++S G + E+L G
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-16
Identities = 37/88 (42%), Positives = 54/88 (61%)
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
L L N L G IP + L+ L + L GN + G IP S+G++T+L LDLS N +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTL 183
P+ +G L +L+ L L+ N LSG +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 71/263 (26%), Positives = 109/263 (41%), Gaps = 55/263 (20%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF IG G +G V Q +G + A+KKL +SE E + + E +L++ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVL-RNDV---EAVELDWTKRVNIVKSMAHA 622
+VKLY ++LI EY+ G + +L + D E + + + S+ H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI-HK 119
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH------------------ 664
L Y +HRDI +N+LL++ ++DFGL L
Sbjct: 120 LGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 665 -------PDSSNRTL-------------VVGTYGYIAPELAYTMAVTEKCDVYSFGVVAL 704
P SS R VGT YIAPE+ ++CD +S GV+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 705 EVLMGSHPTDLLSSLSSSSGRKI 727
E+L+G P S + RKI
Sbjct: 231 EMLVGYPP--FCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/150 (33%), Positives = 83/150 (55%), Gaps = 14/150 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG+V++A+ + ++VALK++ R + ++ S E LL +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 575 FCLHNKCMFLIYEYMERG--SLFCVLRNDVEAVELDWTKRVNIVKS-MAHALSYLHYDCK 631
+K + L++EY ++ F D++ IVKS M L L +
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCHS 117
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLAR 661
+++HRD+ N+L+N N E +ADFGLAR
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 38/252 (15%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF + IG G +G V+ + +G++ A+K L +S+ + + + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
IVKLY + ++L+ EYM G L +L + + + + + AL +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARF--YIAELVLALDSV 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA-------------------------R 661
H K +HRDI +NIL++++ +ADFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 662 LLHPDSSNRT----LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717
+ D R VGT YIAPE+ +CD +S GV+ E+L G P S
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP--FYS 232
Query: 718 SLSSSSGRKISQ 729
+ KI
Sbjct: 233 DTLQETYNKIIN 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG VY+ + +G++VA+KK+ R E+EE + E LL +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC-KPS 633
+ ++LI+E+ L L+ ++++ +VKS + + C
Sbjct: 67 VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYTM 688
++HRD+ N+L+++ +ADFGLAR T V T Y APE+ Y+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 689 AVTEKCDVYSFGVVALEV 706
V D++S G + E+
Sbjct: 182 PV----DIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYR---AQLSSGKL---VALKKLHRSET--EEPAFLESFQTEAR 559
E + +G G +G VY + G+ VA+K ++ + + E FL EA
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN----EAS 61
Query: 560 LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR----NDVEAVELD---WTKR 612
++ + ++V+L G + ++ E M +G L LR L K
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD-----S 667
+ + +A ++YL VHRD+++ N ++ +L + DFG+ R ++
Sbjct: 122 IQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
L V ++APE T K DV+SFGVV E+ + P
Sbjct: 179 GKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF +K +G G +G V + ++G + A+K + +S + F+ E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 567 RNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA-HALS 624
I +L Y F ++L+ EY G L +L + + D + +A H++
Sbjct: 61 PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS-NRTLVVGTYGYIAPE 683
+ Y VHRDI N+L++ +ADFG A L + N L VGT YIAPE
Sbjct: 120 QMGY------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 684 LAYTMAVTEK------CDVYSFGVVALEVLMGSHP 712
+ TM K CD +S GV+A E++ G P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 71/247 (28%), Positives = 113/247 (45%), Gaps = 22/247 (8%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYR-AQLSSGKLVALKKLHRSETEEPAFLESFQT 556
+ E + + T+ + I IG G YG VY+ G L A+K L + E +
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEA 67
Query: 557 EARLLSQI-RHRNIVKLYG-FCLHNKC----MFLIYEYMERGSLFCVLRNDVEAVE-LDW 609
E +L + H N+VK YG F +K ++L+ E GS+ +++ + + LD
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 610 TKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669
I+ L +LH + I+HRD+ NNILL + + DFG++ L
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 670 RTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG 724
R VGT ++APE+ Y + +CDV+S G+ A+E+ G P L +
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP--LFDMHPVKTL 242
Query: 725 RKISQNP 731
KI +NP
Sbjct: 243 FKIPRNP 249
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
DF + +GTG +G V A+ +G+ A+K L + E + ++ E +L ++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH-----A 622
IV + ++ + E++ G LF LR + N V H A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLA 130
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV-GTYGYIA 681
YLH I++RD+ N+LL++ V DFG A+ + +RT + GT Y+A
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLA 183
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ + + D ++ GV+ E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 71/254 (27%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQT---------EARLLSQIR 565
+G+G YG V A + +G+ VA+KKL R FQ+ E RLL +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRP----------FQSAIHAKRTYRELRLLKHMD 72
Query: 566 HRNIVKLYG-FC----LHN-KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN----- 614
H N++ L F L + + ++L+ M L +++ ++++
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK----------CQKLSDDHIQ 121
Query: 615 -IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673
+V + L Y+H I+HRD+ +NI +N + E + DFGLAR T
Sbjct: 122 FLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGY 175
Query: 674 VGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVL---------------------MGSH 711
V T Y APE+ M + D++S G + E+L +G+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 712 PTDLLSSLSSSSGR 725
+LL +SS S R
Sbjct: 236 DEELLQKISSESAR 249
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 14/196 (7%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G +G V++ L VA+K +E F +EAR+L Q H NIVKL G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635
C + ++++ E + G LR + EL + V A ++YL + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 636 HRDISSNNILLNSNLEAFVADFGLARL----LHPDSSNRTLVVGTYGYIAPELAYTMAVT 691
HRD+++ N L+ N ++DFG++R ++ S + + + + APE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYS 172
Query: 692 EKCDVYSFGVVALEVL 707
+ DV+S+G++ E
Sbjct: 173 SESDVWSYGILLWETF 188
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 36/225 (16%)
Query: 516 IGTGGYGSVYRAQL--------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RH 566
+G G +G V RA+ VA+K L + T++ L +E L+ I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD--LADLISEMELMKLIGKH 77
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN----------DVEAV---ELDWTKRV 613
+NI+ L G C +++I EY +G+L LR D+ V +L + V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-----PDSS 668
+ +A + YL +HRD+++ N+L+ + +ADFGLAR +H +S
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
N L V ++APE + T + DV+SFG++ E+ +G P
Sbjct: 195 NGRLPV---KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 516 IGTGGYGSVYRAQLSSGKL---VALKKLH-----RSETEEPAFLESFQTEARLLSQIRHR 567
+G G +GSV QL+ VA+K + RSE +E F +EA + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHP 60
Query: 568 NIVKLYGFCLHNK------CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
N+++L G CL +I +M+ G L L + +VK M
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--GY 679
S + Y S +HRD+++ N +LN N+ VADFGL++ ++ R + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEV 706
IA E T K DV+SFGV E+
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 46/223 (20%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
DF I +G GGYG V+ A+ +G++VALK++ +S + + TE +L+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 568 NIVKL-YGFCLHNKCMFLIYEYMERG---SLFC---VLRND---------VEAVELDWTK 611
+VKL Y F ++L EY+ G +L VL D EAV
Sbjct: 62 WLVKLLYAFQDDEY-LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV------ 114
Query: 612 RVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR--LLHPDSSN 669
H L Y+H D KP N L++++ + DFGL++ + + +S
Sbjct: 115 ------DALHELGYIHRDLKPE---------NFLIDASGHIKLTDFGLSKGIVTYANS-- 157
Query: 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
VVG+ Y+APE+ D +S G + E L G P
Sbjct: 158 ---VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-15
Identities = 40/106 (37%), Positives = 63/106 (59%), Gaps = 3/106 (2%)
Query: 263 ALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322
L L + L G +P ++ L++L S++L+GN + G IPP++G +T+L L+L YN + S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 323 IPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
IP L + L L L+ NSLSG +P+ +G + R S NF +
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA---SFNFTD 524
|
Length = 623 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 54/296 (18%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I IG G +G V ++ + ++ A+K L++ E + A F+ E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 567 RNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA-HALS 624
+ I L Y F N ++L+ +Y G L +L + + D + +A H++
Sbjct: 61 QWITTLHYAFQDENY-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-VGTYGYIAPE 683
LHY VHRDI +N+LL+ N +ADFG ++ D + ++ V VGT YI+PE
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 684 LAYTM-----AVTEKCDVYSFGVVALEVLMGSHP-------------------------- 712
+ M +CD +S GV E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 713 -------TDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQGNHRWENLLFKKFPY 761
DL+ L S R++ QN D + +A+ + WEN+ + PY
Sbjct: 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID-----WENIRNLEAPY 284
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG VY A+ LS+ +A+K++ ++ ++ E L S ++HRNIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLG 72
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRN------DVEAVELDWTKRVNIVKSMAHALSYLHY 628
N + E + GSL +LR+ D E + +TK++ L YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLH- 125
Query: 629 DCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLL---HPDSSNRTLVVGTYGYIAPEL 684
IVHRDI +N+L+N+ ++DFG ++ L +P + T GT Y+APE+
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEV 180
Query: 685 ------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y D++S G +E+ G P
Sbjct: 181 IDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+++ +G G +G Q ++S + A+K++ ++ +E + EA LL++++H
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHP 58
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND-----VEAVELDWTKRVNIVKSMAHA 622
NIV + ++++ EY + G L ++ E L W M
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLG 112
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
+ ++H + ++HRDI S NI L N + + DFG ARLL + VGT Y+ P
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ M K D++S G + E+ HP
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 42/224 (18%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ IG G YG V A +G VA+KK+ S E F + E ++L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKH 62
Query: 567 RNIVKLY------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------ 614
NI+ + F N ++++ E ME L+ +++ T+ ++
Sbjct: 63 ENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIK----------TQHLSNDHIQY 110
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR---T 671
+ + L Y+H +++HRD+ +N+LLN+N + + DFGLAR+ P+ + T
Sbjct: 111 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 672 LVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGS 710
V T Y APE+ YT A+ D++S G + E+L
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YGSVY+ +G +A+K++ R E +E F E +L + IV YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKF-NQIIMELDILHKAVSPYIVDFYG 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+++ EYM+ GSL + V + I ++ L +L + +I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE----------L 684
+HRD+ N+L+N N + + DFG++ L + +G Y+APE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNP 182
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
YT+ + DV+S G+ LE+ +G +P
Sbjct: 183 TYTV----QSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 20/182 (10%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V++A+ + ++VALKK+ E E+ F + E ++L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 575 FC-----LHNKC---MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
C +N+ +L++E+ E L +L N L K+V M L+ L
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV-----MKMLLNGL 132
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH---PDSSNR-TLVVGTYGYIAP 682
+Y + I+HRD+ + NIL+ + +ADFGLAR NR T V T Y P
Sbjct: 133 YYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 683 EL 684
EL
Sbjct: 193 EL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 8e-15
Identities = 66/239 (27%), Positives = 106/239 (44%), Gaps = 21/239 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSG-KLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF I IG G +G V +L + K+ A+K L++ E + A F+ E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK----RVNIVKSMAHA 622
+ I L+ ++L+ +Y G L +L + + D + + I H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG-LARLLHPDSSNRTLVVGTYGYIA 681
L Y VHRDI +NIL++ N +ADFG +L+ + ++ VGT YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 682 PELAYTMA-----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDL 735
PE+ M +CD +S GV E+L G P SL + G+ ++ R
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQF 229
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-15
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG GG G VY A + VALKK+ +E P + F EA++ + + H IV +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-- 632
C ++ Y+E +L +L++ + L +K + S+ LS H C
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIE 127
Query: 633 -----SIVHRDISSNNILLNSNLEAFVADFGLARLLHPD---------------SSNRTL 672
++HRD+ +NILL E + D+G A + S+ T+
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 673 ---VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKIS 728
+VGT Y+APE + +E D+Y+ GV+ ++L S P GRKIS
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP------YRRKKGRKIS 240
|
Length = 932 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 509 DFHIKYCIGTGGYGSVY----RAQLSSGKLVALKKLHRSETEEPA-FLESFQTEARLLSQ 563
+F + +GTG YG V+ +GKL A+K L ++ + A E +TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 564 IRHRN-IVKL-YGFCLHNKCMFLIYEYMERGSLFCVL----RNDVEAVELDWTKRVNIVK 617
+R +V L Y F K + LI +Y+ G LF L V + +
Sbjct: 61 VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEVRV-------YIA 112
Query: 618 SMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGT 676
+ AL +LH + I++RDI NILL+S + DFGL++ + R GT
Sbjct: 113 EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 677 YGYIAPEL------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+APE+ + AV D +S GV+ E+L G+ P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 516 IGTGGYGSVYRAQ---LSSGKL---VALKKL----HRSETEEPAFLESFQTEARLLSQI- 564
+G G +G V A LS VA+K L H SE E + +E +++S +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE------ALMSELKIMSHLG 96
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
H NIV L G C + +I EY G L LR E+ L ++ +A ++
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMA 155
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS-----NRTLVVGTYGY 679
+L + +HRD+++ N+LL + DFGLAR + DS+ N L V +
Sbjct: 156 FLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KW 209
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+APE + T + DV+S+G++ E+ +GS+P
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 516 IGTGGYGSVYRAQ--LSSGKLVALKKLHRSETEEPAFLESFQTEA--RLLSQIRHRNIVK 571
IG G YG V++A+ + G+ VALK++ EE L + + A R L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 572 LYGFCLHNKC-----MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
L+ C ++ + L++E++++ + + V + K +++ + L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H +VHRD+ NIL+ S+ + +ADFGLAR ++ T VV T Y APE+
Sbjct: 127 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLL 182
Query: 687 TMAVTEKCDVYSFGVVALEVL 707
+ D++S G + E+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 38/89 (42%), Positives = 52/89 (58%)
Query: 48 LVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSI 107
L L + L G IP++I L L+ ++LS N + G IP +GS+ L L+LS N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 108 PLEFGNLKDLDQLRLQGNKLDGLIPSSIG 136
P G L L L L GN L G +P+++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED +G G GSV + + + +G ++A K +H + + + E +++ + R
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRS 62
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
IV YG L+ + + E+M+ GSL + + + ++ + I ++ L+YL
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGK--IAVAVVEGLTYL 119
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+ I+HRDI +NIL+NS + + DFG++ L +S T V GT Y++PE
Sbjct: 120 YN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYMSPERIQ 175
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
T K DV+S G+ +E+ +G P
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+DF +G G G V + L+ +KL E + PA E ++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSP 59
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV--NIVKSMAHA--- 622
IV YG + + + E+M+ GSL VL+ R+ NI+ ++ A
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------AGRIPENILGKISIAVLR 110
Query: 623 -LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L+YL K I+HRD+ +NIL+NS E + DFG++ L +N VGT Y++
Sbjct: 111 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMS 166
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE T + D++S G+ +E+ +G +P
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLH--RSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G G +G VY + +G+ +A K++ E + + + E +LL ++H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 573 YGFCLHN---KCMFLIYEYMERGSLFCVLRND---VEAVELDWTKRVNIVKSMAHALSYL 626
YG CL + K + + EYM GS+ L+ E+V +T+++ +SYL
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYL 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT---LVVGTYGYIAPE 683
H + IVHRDI NIL +S + DFG ++ L + T V GT +++PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 684 LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K DV+S G +E+L P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 516 IGTGGYGSVYRAQ---LSSGK-----LVALKKLHRSETEEPAFLESFQTEARLLSQI-RH 566
+G G +G V A+ L K VA+K L TE+ L +E ++ I +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKH 83
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSL-------------FCVLRNDVEAVELDWTKRV 613
+NI+ L G C + +++I EY +G+L +C V +L + V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-----PDSS 668
+ +A + YL +HRD+++ N+L+ + +ADFGLAR +H ++
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
N L V ++APE + T + DV+SFGV+ E+ +G P
Sbjct: 201 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 8/205 (3%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+DF +G G G V + Q L+ +KL E + PA E ++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
IV YG + + + E+M+ GSL VL+ + + + + +V+I ++ L+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILGKVSI--AVLRGLAYLR 120
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
K I+HRD+ +NIL+NS E + DFG++ L +N VGT Y++PE
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQG 176
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D++S G+ +E+ +G +P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 516 IGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G G +G VY VA+K L S +E+ F EA ++S+ H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEALIMSKFNHQNI 71
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLR----NDVEAVELDWTKRVNIVKSMAHALSY 625
V+L G F++ E M G L LR L + + +A Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 626 L---HYDCKPSIVHRDISSNNILLNS---NLEAFVADFGLARLLHPDS----SNRTLVVG 675
L H+ +HRDI++ N LL A +ADFG+AR ++ S R ++
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-- 183
Query: 676 TYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
++ PE T K DV+SFGV+ E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 516 IGTGGYGSVYRAQ----LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G V+ + +G+L A+K L ++ + + + + E +L+++ H IVK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 572 L-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVK----SMAHALSYL 626
L Y F K ++LI +++ G LF L +V E D VK +A AL +L
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED-------VKFYLAELALALDHL 114
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I++RD+ NILL+ + DFGL++ GT Y+APE+
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
T+ D +SFGV+ E+L GS P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL--VALKKLHRSETEEPAFLESFQTEARLLSQIR 565
EDF+ +GTG +G V A + VA+K+ +S+ + ++ +E ++L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR------NDVEAVELDWTKRVNIVKSM 619
H V LYG ++L+ E++ G F LR NDV + ++ ++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF---YAAQIVLIFEY 146
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+L +IV+RD+ N+LL+ + + DFG A+++ D+ TL GT Y
Sbjct: 147 LQSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTL-CGTPEY 194
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
IAPE+ + + D ++ G+ E+L+G P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 516 IGTGGYG-SVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G ++ GK +K+++ S+ ES + E +LS ++H NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQE 66
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRND-----VEAVELDWTKRVNIVKSMAHALSYLHYD 629
N ++++ +Y E G L+ + E LDW V I ++ H +D
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLALKHV-----HD 119
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA 689
K I+HRDI S NI L + + DFG+AR+L+ +GT Y++PE+
Sbjct: 120 RK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 690 VTEKCDVYSFGVVALEVLMGSH 711
K D+++ G V E+ H
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 18/198 (9%)
Query: 516 IGTGGYGSVYRA---QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G+G +G+V + S K VA+K L +++ +PA + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
G C M L+ E E G L L+ + E + T+ V+ V SM + YL +
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQV-SMG--MKYLE---ET 114
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG-----YIAPELAYT 687
+ VHRD+++ N+LL + A ++DFGL++ L D + T+G + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNY 172
Query: 688 MAVTEKCDVYSFGVVALE 705
+ K DV+SFGV+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKL---HRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G YG V + + GK +KKL + S E A + EA+LLSQ++H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA----EQEAQLLSQLKHPNIVA 63
Query: 572 LYGFCLHNKCM-FLIYEYMERGSLFCVLRND-----VEAVELDWTKRVNIVKSMAHALSY 625
+ +++ + E G L+ L+ E ++W ++ A AL Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQY 117
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH + I+HRD+ + N+ L V D G+AR+L + ++GT Y++PEL
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSH 711
K DV++ G E+ H
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 43/257 (16%)
Query: 509 DFHIKY----CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
D +Y IG+G YG V A SGK VA+KK+ + + P + E ++L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA-FDVPTLAKRTLRELKILRH 60
Query: 564 IRHRNIVKLYGFCL----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSM 619
+H NI+ + K ++++ + ME L ++ +D + + + + + +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRY--FLYQL 116
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR----TLVVG 675
L Y+H ++HRD+ +N+L+N + E + DFG+AR L + T V
Sbjct: 117 LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 676 TYGYIAPELAYTM-AVTEKCDVYSFGVVALEVL---------------------MGSHPT 713
T Y APEL ++ T D++S G + E+L +GS
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233
Query: 714 DLLSSLSSSSGRKISQN 730
++L+ + S RK QN
Sbjct: 234 EVLNRIGSDRVRKYIQN 250
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSSG----KLVALKKLHRSETEEPA-FLESFQTEARLLSQ 563
+F + +GTG YG V+ + +G KL A+K L ++ + A +E +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 564 IRHRN-IVKL-YGFCLHNKCMFLIYEYMERGSLFCVL--RNDVEAVELDWTKRVNIVKSM 619
+R +V L Y F K + LI +Y+ G +F L R++ E+ R +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEV----RF-YSGEI 114
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYG 678
AL +LH K IV+RDI NILL+S + DFGL++ + RT GT
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 679 YIAPELAYTMAVTEKC-DVYSFGVVALEVLMGSHPTDL 715
Y+APE+ K D +S G++ E+L G+ P L
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 516 IGTGGYGSVYRAQL--SSGKLV--ALKKLHR-SETEEPAFLESFQTEARLLSQIRHRNIV 570
IG G +G VY L S G+ + A+K L+R ++ EE +E F E ++ H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE---VEQFLKEGIIMKDFSHPNVL 59
Query: 571 KLYGFCLHNKCMFLI-YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSM-------AHA 622
L G CL ++ L+ YM+ G L +R++ VK + A
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKG 110
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS----SNRTLVVGTYG 678
+ YL VHRD+++ N +L+ + VADFGLAR ++ N T
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVL 707
++A E T T K DV+SFGV+ E++
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 25/224 (11%)
Query: 503 MIEATEDFHIKYCIGTGGYGSVYRA-QLSSGKLV----ALKKLHRSETEEPAFLESFQTE 557
+++ TE +K +G+G +G+VY+ + G+ V A+K L +ET P F E
Sbjct: 3 ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDE 59
Query: 558 ARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRV 613
A +++ + H ++V+L G CL + + L+ + M G L + + + L+W V
Sbjct: 60 ALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--V 116
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673
I K M YL + +VHRD+++ N+L+ S + DFGLARLL D
Sbjct: 117 QIAKGMM----YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 674 VGTY--GYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHPTD 714
G ++A E + T + DV+S+GV E++ G P D
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 516 IGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRN 568
+G G +G V +A+ + VA+K L TE+ L +E ++ I +H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKN 77
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-----------NDVEAVELDWTKR--VNI 615
I+ L G C ++++ EY G+L LR +D E T++ V+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 616 VKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG 675
+A + +L +HRD+++ N+L+ + +ADFGLAR +H R G
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 676 --TYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
++APE + T + DV+SFGV+ E+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 516 IGTGGYGSVY----RAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G+VY + ++ +L LK++ E +++ Q EA+LLS++ H IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV----NIVKSMAHALSYLH 627
+ L +I EY E L C L EL T + + + L +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLE------ELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
Y + I+HRD+ + NI L +NL + DFG++RLL T GT Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 688 MAVTEKCDVYSFGVVALEVLMGSH 711
K D++S G + E+ +H
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 71/237 (29%), Positives = 110/237 (46%), Gaps = 42/237 (17%)
Query: 510 FHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ I+ IG G YG V A +G+ VA+KK++ E + E +LL +RH +
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60
Query: 569 IVKLYGFCL-----HNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVN--IVKSMA 620
IV++ L K +++++E ME L V++ ND D T + + +
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLL 113
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTY 677
AL Y+H ++ HRD+ NIL N++ + + DFGLAR+ D+ V T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 678 GYIAPELA------YTMAVTEKCDVYSFGVVALEVLMGS---------HPTDLLSSL 719
Y APEL YT A+ D++S G + EVL G H DL++ L
Sbjct: 171 WYRAPELCGSFFSKYTPAI----DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQI 564
ED + IG G +G V RA + L A+K L +E F E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKL 59
Query: 565 -RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELD------------WTK 611
H NI+ L G C + +++ EY G+L LR +E D T
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTS 118
Query: 612 RVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
+ +++ + + + Y + +HRD+++ N+L+ NL + +ADFGL+R
Sbjct: 119 Q-QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEV 171
Query: 672 LVVGTYG-----YIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
V T G ++A E T K DV+SFGV+ E++ +G P
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 516 IGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G +G +Y+ L +LVA+K L + P FQ EA L++++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 571 KLYGFCLHNKCMFLIYEYMERGSL--FCVLRNDVEAV------------ELDWTKRVNIV 616
L G + + +++EY+ +G L F ++R+ V LD ++I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 617 KSMAHALSYL--HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR---- 670
+A + YL H+ VH+D+++ NIL+ L ++D GL+R ++ R
Sbjct: 131 IQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
+L+ ++ PE + D++SFGVV E+
Sbjct: 186 SLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 516 IGTGGYGSVYRAQL----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +GSV AQL S + VA+K L +++ + +E F EA + + H N++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 572 LYGFCLHNKCM------FLIYEYMERGSLFCVL---RNDVEAVELDWTKRVNIVKSMAHA 622
L G L ++ +I +M+ G L L R E L V + +A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--GYI 680
+ YL + +HRD+++ N +LN N+ VADFGL++ ++ R ++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVL 707
A E T DV++FGV E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 531 SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY--GFCLHNKCMFLIYEY 588
+G VA+K L EE F+ E L +++ H NIV L G +F ++EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 589 MERGSLFCVLRND--VEAVELDWTKRV--NIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644
+ +L VL D + A E T R+ ++ ++A A H IVHRD+ NI
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLMLQVLDALACA----H---NQGIVHRDLKPQNI 110
Query: 645 LLN-SNLE--AFVADFGLARLLHPDS--------SNRTLVVGTYGYIAPELAYTMAVTEK 693
+++ + + A V DFG+ LL P + T V+GT Y APE VT
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 694 CDVYSFGVVALEVLMG 709
D+Y++G++ LE L G
Sbjct: 170 SDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 5/206 (2%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+F I+ IG G + VYRA L G VALKK+ + + E LL Q+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALSYL 626
N++K Y + + + ++ E + G L ++++ + L K V + AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H ++HRDI N+ + + + D GL R ++ +VGT Y++PE +
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
K D++S G + E+ P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQI- 564
D + IG G +G V +A++ L A+K++ +++ F E +L ++
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------DVEAVELDWTK 611
H NI+ L G C H ++L EY G+L LR + A L +
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 612 RVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
++ +A + YL + +HRD+++ NIL+ N A +ADFGL+R
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEV 176
Query: 672 LVVGTYG-----YIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
V T G ++A E T DV+S+GV+ E++ +G P
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 516 IGTGGYGSVYRAQLS-----SGKLVALK--KLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+G G +GSV QLS K VA+K KL E +E F +EA + H N
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPN 62
Query: 569 IVKLYGFCLHNKCM------FLIYEYMERGSLFCVL---RNDVEAVELDWTKRVNIVKSM 619
++KL G C + +I +M+ G L L R +L + + +
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY-- 677
A + YL + +HRD+++ N +L ++ VADFGL++ ++ R +
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+IA E T K DV++FGV E+ G P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 65/241 (26%), Positives = 117/241 (48%), Gaps = 21/241 (8%)
Query: 503 MIEATEDFHIKYCIGTGGYGSVYRA-QLSSGK----LVALKKLHRSETEEPAFLESFQTE 557
+++ TE IK +G+G +G+VY+ + G+ VA+K+L E P + E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDE 59
Query: 558 ARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVK 617
A +++ + + ++ +L G CL + LI + M G L +R + + + +N
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCV 116
Query: 618 SMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY 677
+A ++YL + +VHRD+++ N+L+ + + DFGLA+LL D G
Sbjct: 117 QIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 678 --GYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLSSSS----GRKISQN 730
++A E T + DV+S+GV E++ GS P D + + SS G ++ Q
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 233
Query: 731 P 731
P
Sbjct: 234 P 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSET---EEPAFLESFQTEARL 560
EDF + IG G +G V QL SS ++ A+K L + E + AF F E +
Sbjct: 43 EDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDI 96
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-DVEAVELDWTKRVNIVKSM 619
++ IV+L+ +K ++++ EYM G L ++ N D+ W + +
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFY--TAEV 151
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYG 678
AL +H +HRD+ +N+LL+ + +ADFG + + R VGT
Sbjct: 152 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208
Query: 679 YIAPELAYTMAVT----EKCDVYSFGVVALEVLMGSHP 712
YI+PE+ + +CD +S GV E+L+G P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 516 IGTGGYGSVYRAQL--------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RH 566
+G G +G V A+ + VA+K L T++ L +E ++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKH 77
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------DVEAVELDWTKRV 613
+NI+ L G C + ++++ EY +G+L LR + +L + V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-----PDSS 668
+ +A + YL +HRD+++ N+L+ + +ADFGLAR +H ++
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
N L V ++APE + T + DV+SFGV+ E+ +G P
Sbjct: 195 NGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 42/226 (18%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSE-----TEEPAFLES----FQT--EARLLSQ 563
+G G YG V +A +GK+VA+KK+ E T++ + F T E +++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
I+H NI+ L + + L+ + M L V+ + E ++ I+ + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQILNGL 132
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR-----LLHPDSSNR-------- 670
+ LH K +HRD+S NI +NS +ADFGLAR S
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 671 -TLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGS 710
T V T Y APEL Y A D++S G + E+L G
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFA----VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G GG+G V Q+ ++GKL A KKL++ ++ E E R+L+++ R IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 574 GFCLHNKCMFLIYEYMERGSL-FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
F + L+ M G L + + D E + + L +LH +
Sbjct: 61 AFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTM 688
I++RD+ N+LL+++ ++D GLA L S GT G++APEL Y
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 689 AVTEKCDVYSFGVVALEVLMGSHP 712
+V D ++ GV E++ P
Sbjct: 177 SV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
F + +G G YG V + + + ++VA+KK SE E E+ E ++L ++ N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV-KETTLRELKMLRTLKQEN 61
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
IV+L ++L++EY+E+ ++ +L V + + + + + A+ + H
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR--SYIYQLIKAIHWCH- 117
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYT 687
K IVHRDI N+L++ N + DFG AR L S +N T V T Y +PEL
Sbjct: 118 --KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 688 MAVTEKCDVYSFGVVALEV 706
+ D++S G + E+
Sbjct: 176 APYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 512 IKYCIGTGGYGSVYRA--QLSSGK--LVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
I+ +GTG +G + R +L S + VA+ L +++ F EA L Q H
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHS 66
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIV+L G M ++ EYM G+L LR +L + + ++ +A + YL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYL- 123
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFG-----LARLLHPDSSNRTLVVGTYGYIAP 682
+ VH+ ++++ +L+NS+L ++ F + ++ S ++ V+ + AP
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAP 177
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
E + DV+SFG+V EV+ G P
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 66/251 (26%), Positives = 115/251 (45%), Gaps = 26/251 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + IG G +G V + SS K+ A+K L + E + + F E +++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+V+L+ +K ++++ EYM G L ++ N V W K + AL +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYT--AEVVLALDAI 158
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR------LLHPDSSNRTLVVGTYGYI 680
H ++HRD+ +N+LL+ + +ADFG ++ D++ VGT YI
Sbjct: 159 H---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----VGTPDYI 210
Query: 681 APELAYTMA----VTEKCDVYSFGVVALEVLMGSHP---TDLLSSLSSSSGRKISQNPRL 733
+PE+ + +CD +S GV E+L+G P L+ + S K S N
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270
Query: 734 DLQCNAYLKNF 744
D++ + + KN
Sbjct: 271 DVEISKHAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 516 IGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVK 571
IG G +G V +A++ L A+K++ +++ F E +L ++ H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELD------------WTKRVNIVKSM 619
L G C H ++L EY G+L LR +E D + + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQ-QLLHFA 118
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG- 678
A + Y + +HRD+++ NIL+ N A +ADFGL+R V T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172
Query: 679 ----YIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
++A E T DV+S+GV+ E++ +G P
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 30/224 (13%)
Query: 516 IGTGGYGSVYRAQLSSGKLVA---LKKLHRSET--EEPAFLESFQTEARLLSQIRHRNIV 570
IG G +G V + G A +K+L S T E+ FL+ Q ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQP----YRELNHPNVL 58
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH----ALSYL 626
+ G C+ + L+ E+ G L LR++ V K V ++ MA L +L
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT---LVVGTYGYIAPE 683
H + +H D++ N L ++L + D+GLA +P+ T V ++APE
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPE 172
Query: 684 LA-------YTMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSL 719
L T+K +++S GV E+ P LS
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 36/249 (14%)
Query: 510 FHIKYC-----IGTGGYGSV--YR---AQLSSGKLVALKKLHRSETEEPAFLESFQTEAR 559
FH +Y +G G +G V Y A +G++VA+K L R ++ E
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEIN 58
Query: 560 LLSQIRHRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIV 616
+L + H NIVK G C K + LI EY+ GSL L ++ + +L +
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFA 113
Query: 617 KSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT 676
+ + ++YLH +HRD+++ N+LL+++ + DFGLA+ + V
Sbjct: 114 QQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVRE 168
Query: 677 YG-----YIAPELAYTMAVTEKCDVYSFGVVALEVLMG-----SHPTDLLSSLSSSSGRK 726
G + A E + DV+SFGV E+L S P + G +
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG-Q 227
Query: 727 ISQNPRLDL 735
++ ++L
Sbjct: 228 MTVVRLIEL 236
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 21/228 (9%)
Query: 516 IGTGGYGSVYRA--QLSSGKL-VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G+G +G V + ++ ++ VA+K L E + + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVL--KNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 573 YGFCLHNKCMFLIYEYMERGSL--FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
G C M L+ E G L F + D V N+V+ M + Y
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-------NVVELMHQVSMGMKYLE 112
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS---NRTLVVGTYGYIAPELAYT 687
+ VHRD+++ N+LL + A ++DFGL++ L D S R+ + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 688 MAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRKISQNPRLD 734
+ + DV+S+G+ E G P + S I Q RLD
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS--FIEQGKRLD 218
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIRHRNIVKLY 573
+G G +G V+ A+L + + A+K L + +E E R+LS H + LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +F + EY+ G L +++ + D + + L +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKG 116
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
IV+RD+ +NILL+++ +ADFG+ + + GT YIAPE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 694 CDVYSFGVVALEVLMGSHP 712
D +SFGV+ E+L+G P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
LVA+K L R++ + A F E +++S++++ NI++L G C+ + + +I EYME G
Sbjct: 46 LVAVKML-RADVTKTA-RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 594 LFCVL-RNDVE-----AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647
L L + ++E A + N++ S + Y + VHRD+++ N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 648 SNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALE 705
++ +ADFG++R L+ R V ++A E T DV++FGV E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 706 V--LMGSHPTDLLS---------SLSSSSGRKI--SQNP 731
+ L P LLS + GR+I SQ P
Sbjct: 224 MFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTP 262
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 5/206 (2%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+F I+ IG G + VYRA L K VALKK+ E + + E LL Q+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALSYL 626
N++K + + + ++ E + G L +++ + L + V + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H ++HRDI N+ + + + D GL R ++ +VGT Y++PE +
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
K D++S G + E+ P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 26/206 (12%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLH-RSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G Y +VY+ + ++G++VALK++H +E P+ + E L+ +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS---TAIREISLMKELKHENIVRLH 64
Query: 574 GFCLH--NKCMFLIYEYMERG-SLFCVLRNDVEAVELDWTKRVNIVKSMAHAL----SYL 626
+H NK M L++EYM++ + A++ N VKS + L ++
Sbjct: 65 D-VIHTENKLM-LVFEYMDKDLKKYMDTHGVRGALDP------NTVKSFTYQLLKGIAFC 116
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-PDSSNRTLVVGTYGYIAPE-L 684
H + ++HRD+ N+L+N E +ADFGLAR P ++ VV T Y AP+ L
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGS 710
+ + D++S G + E++ G
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/217 (26%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 516 IGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G +G VY+ L + VA+K L + E E F+ EA + S+++H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSL--FCVLR---NDVEAVELDWTKR--------VNIV 616
V L G + + +I+ Y L F V+R +DV + + D T + V+IV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 617 KSMAHALSYL--HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674
+A + +L H+ +VH+D+++ N+L+ L ++D GL R ++ +++ ++
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVY--AADYYKLM 183
Query: 675 GT----YGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
G +++PE + D++S+GVV EV
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 62/241 (25%), Positives = 114/241 (47%), Gaps = 21/241 (8%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLH--RSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G G +G VY +G+ +A+K++ E + + + E +LL + H IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 573 YGFCLHN---KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD 629
YG CL + + + + E+M GS+ L++ A+ + T++ + + +SYLH +
Sbjct: 70 YG-CLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKYT--RQILEGVSYLHSN 125
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP---DSSNRTLVVGTYGYIAPELAY 686
IVHRDI NIL +S + DFG ++ L + V GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKIS---QNPRLDLQCNAYLKN 743
K D++S G +E+L P ++++ KI+ NP L + + ++
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF--KIATQPTNPVLPPHVSDHCRD 240
Query: 744 F 744
F
Sbjct: 241 F 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKL--HRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G G +G VY +G+ +A+K++ E + + + E +LL +RH IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 573 YGFCLHN---KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD 629
YG CL + K + + EYM GS+ L+ A+ + T+R + + +SYLH +
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYT--RQILQGVSYLHSN 125
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT---LVVGTYGYIAPELAY 686
IVHRDI NIL +S + DFG ++ + + T V GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
K DV+S +E+L P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 19/152 (12%)
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
+ N +KLY K LI +Y++ G LF +L+ + + K I++ + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVK--KIIRQLVEALND 124
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLE-AFVADFGLARLLHPDSSNRTLVVGTYGYIAPE- 683
LH K +I+H DI N+L + + ++ D+GL +++ S GT Y +PE
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEK 177
Query: 684 ---LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y ++ D ++ GV+ E+L G HP
Sbjct: 178 IKGHNYDVSF----DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G GG+G V Q+ ++GK+ A KKL + ++ + E ++L ++ R IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 574 GFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
F K + L+ M G L + N E + + + L +LH +
Sbjct: 61 AF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QR 114
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
IV+RD+ N+LL+ + ++D GLA L GT GY+APE+
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D ++ G E++ G P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 65/158 (41%), Positives = 87/158 (55%), Gaps = 6/158 (3%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
PS + L L+ L LS N L+ +P + LS L LDLS N+++ +P EI L L +
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
L+LSNN + + NLK+L L L NKL +P SIGNL+NL LDLS NQ+S +
Sbjct: 214 LDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-SI 270
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+G+L NL+ L L N LS +P L L L
Sbjct: 271 S-SLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 516 IGTGGYGSVYRAQL----SSGKLVALKKLHRSETEEPAFLESFQTEAR--LLSQIRHRNI 569
+G GGYG V++ + +GK+ A+K L ++ ++ T+A +L ++H I
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILEAVKHPFI 62
Query: 570 VKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
V L Y F K ++LI EY+ G LF L E + ++ T + + ++ AL +LH
Sbjct: 63 VDLIYAFQTGGK-LYLILEYLSGGELFMHLER--EGIFMEDTACFYLSE-ISLALEHLH- 117
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLAR-LLHPDSSNRTLVVGTYGYIAPELAYT 687
+ I++RD+ NILL++ + DFGL + +H + T GT Y+APE+
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPEILMR 174
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
+ D +S G + ++L G+ P
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 496 GRITFEEMIEAT--EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLE 552
G +T + D IG+G G VY+ + +G ++A+K++ R+ +E
Sbjct: 1 GYLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----- 55
Query: 553 SFQTEARLLSQIR-----HR--NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV 605
R+L + H IVK YG+ + + +F+ E M + L
Sbjct: 56 ---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLL------ 104
Query: 606 ELDWTKRVN----------IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655
KR+ + ++ AL YL K ++HRD+ +NILL+++ +
Sbjct: 105 -----KRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLC 157
Query: 656 DFGLA-RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK----CDVYSFGVVALEVLMGS 710
DFG++ RL+ DS +T G Y+APE K DV+S G+ +E+ G
Sbjct: 158 DFGISGRLV--DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 711 HP 712
P
Sbjct: 216 FP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G Y +VY+ + +GKLVALK + E E F + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKHANIVLLHD 70
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ + L++EY+ L + + + K + + LSY+H + I
Sbjct: 71 IIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLSYIH---QRYI 124
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKC 694
+HRD+ N+L++ E +ADFGLAR S + V T Y P++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 695 -DVYSFGVVALEVLMG 709
D++ G + +E++ G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 50/242 (20%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
F +G G G V+ +L +GKL ALK L + E + ++ TE +L+ + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH----AL 623
+ LY + L+ +Y G LF +L+ + + A AL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEVARFYAAEVLLAL 116
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP------------------ 665
YLH IV+RD+ NILL+ + ++DF L++
Sbjct: 117 EYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 666 -DSSNRTLV----------VGTYGYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMGS 710
+ T VGT YIAPE+ + AV D ++ G++ E+L G+
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGT 229
Query: 711 HP 712
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G Y +V++ + + LVALK++ R E EE A + + E LL ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 575 FCLHNKCMFLIYEYMER---------GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
+C+ L++EY++ G+L + + +L LSY
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------------LRGLSY 118
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-L 684
H K I+HRD+ N+L+N E +ADFGLAR + + V T Y P+ L
Sbjct: 119 CH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMG 709
+ + D++ G + E+ G
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 8/205 (3%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+DF +G G G V++ L+ +KL E + PA E ++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSP 63
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
IV YG + + + E+M+ GSL VL+ E +V+I ++ L+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSI--AVIKGLTYLR 120
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
K I+HRD+ +NIL+NS E + DFG++ L +N VGT Y++PE
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQG 176
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D++S G+ +E+ +G +P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-12
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 24/113 (21%)
Query: 168 LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227
L LDN L G IP+ + L ++L ++L+GN++ G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKL------------------------RHLQSINLSGNSIRGNI 458
Query: 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG 280
P ++G + L+ L LS+N +G IP ++G LT+L L+L+ N LSG +P +G
Sbjct: 459 PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + IG G +G V + S+ K+ A+K L + E + + F E +++
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-DV-EAVELDWTKRVNIVKSMAHALS 624
+V+L+ ++ ++++ EYM G L ++ N DV E +T V + H++
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYGYIAPE 683
++H D KP +N+LL+ + +ADFG ++ + R VGT YI+PE
Sbjct: 163 FIHRDVKP---------DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 684 LAYTMA----VTEKCDVYSFGVVALEVLMGSHP 712
+ + +CD +S GV E+L+G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 32/257 (12%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQT 556
I F+ + ++ + I IG G YG V++ +G A+K L + E +
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEA 63
Query: 557 EARLLSQIR-HRNIVKLYGFCLHNKC-----MFLIYEYMERGSLFCVLRNDVEAVELDWT 610
E +L + H N+VK YG ++L+ E GS+ D+ L
Sbjct: 64 EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLKRG 118
Query: 611 KRVN--IVKSMAH----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664
+R+ I+ + H L +LH + +HRD+ NNILL + + DFG++ L
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175
Query: 665 PDSSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719
R VGT ++APE+ +CDV+S G+ A+E+ G P L +
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
Query: 720 SSSSGRKISQNPRLDLQ 736
+ KI +NP L
Sbjct: 236 RALF--KIPRNPPPTLH 250
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 519 GGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH 578
G YG +++ ++ L L K HR+ + ESF A ++SQ+ H+++V YG C+
Sbjct: 20 GDYGELHKTEVL---LKVLDKSHRN------YSESFFEAASMMSQLSHKHLVLNYGVCVC 70
Query: 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRD 638
++ EY++ GSL L+ + + + W ++ + K +A AL +L + H +
Sbjct: 71 GDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE---DKGLTHGN 125
Query: 639 ISSNNILLNSNLEAFVADFGLARLLHPDSS----NRTLVVGTYGYIAPE-LAYTMAVTEK 693
+ + N+LL + + +L P S + +++ ++ PE + ++
Sbjct: 126 VCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLA 185
Query: 694 CDVYSFGVVALEVLMG-SHPTDLLSS 718
D +SFG E+ G P L S
Sbjct: 186 ADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG+G G V A G VA+KKL R + +++ E LL + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 575 FCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
K + +L+ E M+ C V +ELD + ++ M + +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDAN--LC----QVIHMELDHERMSYLLYQMLCGIKHLH- 140
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM 688
I+HRD+ +NI++ S+ + DFGLAR + VV Y Y APE+ M
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGM 197
Query: 689 AVTEKCDVYSFGVVALEVLMGS 710
E D++S G + E++ GS
Sbjct: 198 GYKENVDIWSVGCIMGELVKGS 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 516 IGTGGYGSVYR-AQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK--- 571
IG G +G V+ GK VALKK+ + F+ E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 572 -----LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
++++ E M+ ++ + + D K + + L YL
Sbjct: 67 ILQPPHIDPFEE---IYVVTELMQSDLHKIIVSP--QPLSSDHVKV--FLYQILRGLKYL 119
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS-NRTLVVGTYGYIAPELA 685
H I+HRDI N+L+NSN + DFGLAR+ PD S + T V T Y APE+
Sbjct: 120 H---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 686 -----YTMAVTEKCDVYSFGVVALEVL 707
YT AV D++S G + E+L
Sbjct: 177 MGSRHYTSAV----DIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G G +G V + +SGK A+K L + + TE+R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
F ++ F++ EY+ G LF L + E D T+ + AL YLH
Sbjct: 63 SFQTKDRLCFVM-EYVNGGELFFHLSRERVFSE-DRTRFYG--AEIVSALDYLH---SGK 115
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
IV+RD+ N++L+ + + DFGL + D++ GT Y+APE+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 694 CDVYSFGVVALEVLMGSHP 712
D + GVV E++ G P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 73/268 (27%), Positives = 113/268 (42%), Gaps = 56/268 (20%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDFH IG G +G V Q +GK+ A+K L +SE + L + E +L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+V LY + ++LI E++ G L +L + D T R + + + A+ +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVT-RFYMAECVL-AIEAV 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA-------------RLLHPDSS----- 668
H K +HRDI +NIL++ ++DFGL+ +LL S+
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 669 -------------------------NRTLV----VGTYGYIAPELAYTMAVTEKCDVYSF 699
NR L+ VGT YIAPE+ ++CD +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 700 GVVALEVLMGSHPTDLLSSLSSSSGRKI 727
G + E L+G P S S + RKI
Sbjct: 235 GAIMFECLIGWPP--FCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573
+G G +G V A+L + +L A+K L + + +E TE R+L+ +H + +L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 574 GFCLHNKC-MFLIYEYMERGSL-FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
C K +F + EY+ G L F + R+ D + + L +LH +
Sbjct: 63 S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLH---E 114
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELAYTMAV 690
I++RD+ +N+LL+S +ADFG+ + + + T GT YIAPE+
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPY 173
Query: 691 TEKCDVYSFGVVALEVLMGSHPTD 714
D ++ GV+ E+L G P +
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLY 573
+G G +G V A+L SG+L A+K L + + +E TE R+LS R H + +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 574 GFCLHN-KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
C +F + E++ G L ++ ++ D + + AL +LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLH---DK 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
I++RD+ +N+LL+ +ADFG+ + + + GT YIAPE+ M
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D ++ GV+ E+L G P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 35/249 (14%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G+G YGSV A +G VA+KKL R +++ E RLL ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 575 FCLHNKCMFLIYE-YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ + + Y+ + L N V+ +L ++ + L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 140
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTE 692
I+HRD+ +N+ +N + E + DFGLAR H D T V T Y APE+ M +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQ 197
Query: 693 KCDVYSFGVVALEV---------------------LMGSHPTDLLSSLSSSSGR----KI 727
D++S G + E+ L+G+ +LL +SS S R +
Sbjct: 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 257
Query: 728 SQNPRLDLQ 736
+Q P+++
Sbjct: 258 TQMPKMNFA 266
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 515 CIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAF---LESFQT--EARLLSQIRHRN 568
IG G YG V A+ S + + VA+KK+ AF +++ +T E +LL + H N
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIAN------AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 569 IVKLYGFCLHN-----KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
++ + ++++YE M+ L ++R+ + + D + + + L
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSS-QTLSDDHCQY--FLYQLLRGL 121
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
Y+H +++HRD+ +N+LLN+N + + DFGLAR T V T Y APE
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 684 L-----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
L YT A+ DV+S G + E L+G P
Sbjct: 179 LLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-11
Identities = 32/88 (36%), Positives = 53/88 (60%)
Query: 312 LNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTI 371
L L L IP ++ L ++ LS NS+ G+IP +G++ LDLS N NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 372 PSQLGKIPNISAVDLSKNNLSGVIPASV 399
P LG++ ++ ++L+ N+LSG +PA++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 516 IGTGGYGSVYRA----QLSSGKL-VALKKLHRSETEEPAFLESFQ--TEARL-LSQIRHR 567
+G+G +G+V++ + S K+ VA+K + ++ + ++FQ T+ L + + H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKSMAHAL 623
IV+L G C + L+ + GSL +R ++++ L+W V I K M
Sbjct: 70 YIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM---- 122
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD------SSNRTLVVGTY 677
YL +VHR++++ NILL S+ +ADFG+A LL+PD S ++T +
Sbjct: 123 YYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI---- 175
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
++A E T + DV+S+GV E++ G+ P
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 40/217 (18%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN-IVKLY 573
IG G YG VY+A+ ++GKLVALKK R E +E + E LL + IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 574 GFCLHN-------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR-------VNIVKSM 619
+ + ++L++EY++ +D++ +D R +KS
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYLD---------SDLKKF-MDSNGRGPGRPLPAKTIKSF 115
Query: 620 AHALSYLHYDC-KPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTY 677
+ L C K ++HRD+ N+L++ +AD GL R + T + T
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175
Query: 678 GYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
Y APE+ Y+ V D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLL---SQIRHRNIVK 571
+G G +G V A+ +G+L A+K L + + +ES E R+ + RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 572 LYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
L+ C + + + EY G L + DV + V + L YLH
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV----FSEPRAVFYAACVVLGLQYLH--- 118
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPEL----A 685
+ IV+RD+ +N+LL++ +ADFGL + + T GT ++APE+ +
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-CGTPEFLAPEVLTETS 177
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
YT AV D + GV+ E+L+G P
Sbjct: 178 YTRAV----DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
LVA+K L R + + A F E ++LS+++ NI++L G C+ + +I EYME G
Sbjct: 48 LVAVKIL-RPDANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 594 LFCVLRNDVEAVELDWTKRVNIVKSMAH---ALSY-------------LHYDCKPSIVHR 637
L L + D + N AH A+SY + Y + VHR
Sbjct: 106 LNQFLSSH---HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162
Query: 638 DISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPELAYTMAVTEKCD 695
D+++ N L+ NL +ADFG++R L+ R V ++A E T D
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASD 222
Query: 696 VYSFGVVALEVLM 708
V++FGV E+LM
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 43/211 (20%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V A+ +G+ VA+KK+ + P + E +LL +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISL-- 74
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAV-ELDWTKRVNIVKS--------------M 619
+F D+ V EL T ++ S +
Sbjct: 75 -----------------SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
L Y+H +VHRD+ +NIL+N N + + DFGLAR T V T Y
Sbjct: 118 LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYY 171
Query: 680 IAPELAYT-MAVTEKCDVYSFGVVALEVLMG 709
APE+ T + D++S G + E+L G
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+D + +G G G+VY+A L + +++A+K + T E + +E +L +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58
Query: 567 RNIVKLYG-FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
I+ YG F + N+ + + E+M+ GSL V R E V I ++ L+Y
Sbjct: 59 PYIIGFYGAFFVENR-ISICTEFMDGGSL-DVYRKIPEHV------LGRIAVAVVKGLTY 110
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
L + K I+HRD+ +N+L+N+ + + DFG++ L +S VGT Y+APE
Sbjct: 111 L-WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERI 165
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
DV+S G+ +E+ +G P
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 15/184 (8%)
Query: 534 LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
LVA+K L R + + A F E +++S+++ NI++L C+ + + +I EYME G
Sbjct: 48 LVAVKML-REDANKNA-RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 594 L---FCVLR-----NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNIL 645
L + V + ++ + + +A + YL + VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 646 LNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPELAYTMAVTEKCDVYSFGVVA 703
+ N +ADFG++R L+ R V +++ E T DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
Query: 704 LEVL 707
E+L
Sbjct: 223 WEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 31/89 (34%), Positives = 52/89 (58%)
Query: 144 LDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203
L L L G +P ++ L++L+S+ L N + G IP +L + L L L YN G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
+ +G + +L L+LNGN+L+G +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 8/208 (3%)
Query: 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
DF+ +G G +G V A+ + +L A+K L + + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 568 NIVKLYGFCLHN-KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ C ++ + EY+ G L ++ + + + V ++ L +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFL 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H + I++RD+ +N++L+S +ADFG+ + D GT YIAPE+
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTD 714
+ D +++GV+ E+L G P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 516 IGTGGYGSVYRA-QLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G+G +G+VY+ + G+ VA+K L E P + EA +++ + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKSMAHALSYL 626
+L G CL + L+ + M G L +R + + + L+W V I K M SYL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYL 125
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY--GYIAPEL 684
+ +VHRD+++ N+L+ S + DFGLARLL D + G ++A E
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 685 AYTMAVTEKCDVYSFGVVALEVL-MGSHPTD 714
T + DV+S+GV E++ G+ P D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 516 IGTGGYGSVY--RAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G Y +VY R++L+ LVALK++ R E EE A + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI--VK----SMAHALSYLH 627
K + L++EY+++ D++ D +N+ VK + L+Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK---------DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAY 686
+ ++HRD+ N+L+N E +ADFGLAR + + V T Y P+ L
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 687 TMAVTEKCDVYSFGVVALEVLMG 709
+ + + D++ G + E+ G
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G V Q+ ++GK+ A KKL + ++ E ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ L+ M G L + + EA + + V + L LH + I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLH-PDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
V+RD+ NILL+ + ++D GLA +H P+ VGT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 694 CDVYSFGVVALEVLMGSHP 712
D ++ G + E++ G P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 17/151 (11%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G Y +VY+ + +G+LVALK++ R E EE A + + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV----NIVKSMAHALSYLHYDC 630
K + L++EY++ D++ +D N+ + L L Y
Sbjct: 71 IIHTKKTLTLVFEYLDT---------DLKQY-MDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLAR 661
+ ++HRD+ N+L++ E +ADFGLAR
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 52/246 (21%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF IG G +G V Q +G + A+K L +++ E + + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 567 RNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVL-RNDV---EAVELDWTKRVNIVKSMAH 621
+VK++ + +K ++LI E++ G + +L + D E + + V + S+ H
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-H 118
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA-------------RLLHPDSS 668
L + +HRDI +N+LL+S ++DFGL L H S
Sbjct: 119 QLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 669 NRTL----------------------VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
+ T VGT YIAPE+ + CD +S GV+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 707 LMGSHP 712
L+G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKL- 572
IG G +G V A+ GK A+K L + + E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y F K ++ + +++ G LF L+ + E + +A AL YLH
Sbjct: 63 YSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SI 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+IV+RD+ NILL+S + DFGL + S T GT Y+APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G G +G V + ++G+ A+K L + + TE R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHALSYLHYDCKP 632
F H++ F++ EY G LF L + E R + + AL YLH +
Sbjct: 63 SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLH--SEK 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
++V+RD+ N++L+ + + DFGL + D + GT Y+APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D + GVV E++ G P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G V Q+ ++GK+ A KKL + ++ E R+L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 575 FCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ K + L+ M G L + N + D + + + L L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
IV+RD+ NILL+ ++D GLA + P+ VGT GY+APE+ T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 694 CDVYSFGVVALEVLMGSHP 712
D + G + E++ G P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKL- 572
IG G +G V A+ + K A+K L + + + +E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+ F +K ++ + +Y+ G LF L+ E L+ R +A AL YLH
Sbjct: 63 FSFQTADK-LYFVLDYINGGELFYHLQR--ERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELAYTMAVT 691
+IV+RD+ NILL+S + DFGL + + + + T GT Y+APE+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF-CGTPEYLAPEVLHKQPYD 174
Query: 692 EKCDVYSFGVVALEVLMGSHP 712
D + G V E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 50/245 (20%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF IG G +G V Q +G + A+K L +++ E + + E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVL-RNDV---EAVELDWTKRVNIVKSMAHA 622
+VK++ + ++LI E++ G + +L + D EA + + V + ++ H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA-------------RLLHPDSSN 669
L + +HRDI +N+LL++ ++DFGL L H S+
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 670 -------------------RTL---VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
R L VGT YIAPE+ + CD +S GV+ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 708 MGSHP 712
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 516 IGTGGYGSVY--RAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G Y +V+ R++L+ LVALK++ R E EE A + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI--VK----SMAHALSYLH 627
+K + L++EY+++ D++ D +++ VK + L+Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDK---------DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAY 686
+ ++HRD+ N+L+N E +ADFGLAR + + V T Y P+ L
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 687 TMAVTEKCDVYSFGVVALEVLMG 709
+ + + D++ G + E+ G
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 45/220 (20%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ----IRHRN-- 568
IG G +G+V + SG ++A+K++ RS +E + + RLL +R +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDE-------KEQKRLLMDLDVVMRSSDCP 63
Query: 569 -IVKLYGFCLHNK----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA--- 620
IVK YG CM L+ +++ + E I+ +A
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-------EILGKIAVAT 116
Query: 621 -HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
AL+YL + K I+HRD+ +NILL+ N + DFG++ L DS +T G Y
Sbjct: 117 VKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPY 173
Query: 680 IAPEL-------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+APE Y + + DV+S G+ EV G P
Sbjct: 174 MAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G G +G V + ++G+ A+K L + + TE+R+L RH + L Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
F H++ F++ EY G LF L R V E IV AL YLH
Sbjct: 63 AFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVS----ALEYLH---SR 114
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+V+RDI N++L+ + + DFGL + D + GT Y+APE+
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D + GVV E++ G P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 8/226 (3%)
Query: 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT-NLIALD 265
+ N+ L L LN N L +I S + L L L L +N + IPP IG L NL LD
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELD 146
Query: 266 LSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPP 325
LS N++ LP + NL L +L L+ N + +P + L+NL L+L N++S +PP
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFN-DLSDLPKLLSNLSNLNNLDLSGNKISD-LPP 203
Query: 326 ELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVD 385
E+ S L L LS+NS+ + S + NL L+LS N + +P +G + N+ +D
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261
Query: 386 LSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPPQATLF 431
LS N +S + + + N L
Sbjct: 262 LSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQ--TEAR-------LLSQIR 565
IG+G G V A +G+ VA+KKL R FQ T A+ L+ +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRP----------FQNVTHAKRAYRELVLMKLVN 73
Query: 566 HRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSM 619
H+NI+ L K + +L+ E M+ +L V++ ++LD + ++ M
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MDLDHERMSYLLYQM 127
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+ +LH I+HRD+ +NI++ S+ + DFGLAR VV Y Y
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-Y 183
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGS 710
APE+ M E D++S G + E++ G+
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 516 IGTGGYGSVYRAQLSS-GKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKL- 572
IG G +G V A+ S G A+K L + + E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y F K ++ + +Y+ G LF L+ + +E + +A A+ YLH
Sbjct: 63 YSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLH---SL 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELAYTMAVT 691
+I++RD+ NILL+S + DFGL + + P+ + T GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF-CGTPEYLAPEVLRKEPYD 174
Query: 692 EKCDVYSFGVVALEVLMGSHP 712
D + G V E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 22/201 (10%)
Query: 516 IGTGGYGSV---YRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG+G G V Y A L VA+KKL R + +++ E L+ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 573 YGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
K + +L+ E M+ C V +ELD + ++ M + +L
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDAN--LC----QVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I+HRD+ +NI++ S+ + DFGLAR VV Y Y APE+
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 191
Query: 687 TMAVTEKCDVYSFGVVALEVL 707
M E D++S G + E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIRHRNIVKLY 573
+G G +G V A+L + + A+K L + E +E E R+L+ H + L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +F + EY+ G L ++ + D + + L +LH K
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLH---KKG 116
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
I++RD+ +N+LL+ + +ADFG+ + + GT YIAPE+ E
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 694 CDVYSFGVVALEVLMGSHP 712
D +SFGV+ E+L+G P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 20/230 (8%)
Query: 523 SVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-- 580
S+Y+ + K V ++ + ++ + E + L +I NI+K+YGF +
Sbjct: 35 SIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 581 --CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH-YDCKPSIVHR 637
+ LI EY RG L VL + +L + ++++ L L+ Y KP ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 638 DISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM--AVTEKCD 695
+++S + L+ N + + GL ++L V Y + ++ + T K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 696 VYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNP--RLDLQCNAYLKN 743
+YS GVV E+ G P + L++ I++N +L L C +K
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTT-KEIYDLIINKNNSLKLPLDCPLEIKC 253
|
Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 506 ATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI 564
AT +++ +G G Y +VY+ +G+LVALK + +TEE + + EA LL +
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIR-EASLLKGL 60
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKSMAH 621
+H NIV L+ + + ++EYM D+ + + N+ M
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMH---------TDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L L Y I+HRD+ N+L++ E +ADFGLAR S + V T Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 682 PELAYTMAVTE---KCDVYSFGVVALEVLMGS 710
P++ + T+ D++ G + +E+L G
Sbjct: 172 PDV--LLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQT--EARLLSQIRHRNIVKL 572
+G+G YGSV A + VA+KKL R + + + +T E RLL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ---SLIHARRTYRELRLLKHMKHENVIGL 79
Query: 573 YGFCLHNKCMFLIYE-YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
+ E Y+ + L N V+ +L ++ + L Y+H
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---S 136
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAV 690
I+HRD+ +N+ +N + E + DFGLAR T V T Y APE+ M
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 691 TEKCDVYSFGVVALEVLMG 709
+ D++S G + E+L G
Sbjct: 194 NQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 556 TEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVL--RNDVEAVELDWTKRV 613
TEA +L I H +I++L G +NK LI + L+C L + ++ ++ +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDI-----L 185
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673
I +S+ A+ YLH + I+HRDI + NI +N + + DFG A P N
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKY 240
Query: 674 VGTYGYIA---PELAYTMAVTEKCDVYSFGVVALEVLMG 709
G G IA PEL D++S G+V E+
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 516 IGTGGYGSV---YRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG+G G V Y A L + VA+KKL R + +++ E L+ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 573 YGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
K + +++ E M+ C V +ELD + ++ M + +L
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDAN--LC----QVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I+HRD+ +NI++ S+ + DFGLAR VV Y Y APE+
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 198
Query: 687 TMAVTEKCDVYSFGVVALEVLMG 709
M E D++S G + E++ G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573
IG G Y V +L + ++ A+K + + + ++ QTE + Q H +V L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELD---WTKRVNIVKSMAHALSYLHYDC 630
+F + EY+ G L ++ + E ++ +++ AL+YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLH--- 113
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELAYTMA 689
+ I++RD+ +N+LL+S + D+G+ + L P + + GT YIAPE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGED 172
Query: 690 VTEKCDVYSFGVVALEVLMGSHPTDLLSS 718
D ++ GV+ E++ G P D++ S
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGS 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 516 IGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
+G G +G V + ++G+ VA+K L + + E +L + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 69
Query: 571 KLYGFCLHN--KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR--VNIVKSMAHALSYL 626
K G C + + LI E++ GSL L + + L + V I K M + L
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY-LGSR 128
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTYGYIAPE 683
Y VHRD+++ N+L+ S + + DFGL + + D T+ + + APE
Sbjct: 129 QY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 684 LAYTMAVTEKCDVYSFGVVALEVL 707
DV+SFGV E+L
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 10/209 (4%)
Query: 509 DFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIRH 566
DF+ +G G +G V A + + +L A+K L + + +E E R+L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ +L+ ++ + EY+ G L ++ + E V +A L +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFL 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELA 685
H I++RD+ +N++L++ +ADFG+ + + + RT GT YIAPE+
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEII 173
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
+ D ++FGV+ E+L G P D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ--IRHR----- 567
+G G YG V + + + +G ++A+K++ A + S Q + RLL I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVNS-QEQKRLLMDLDISMRSVDCP 60
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV------NIVKSMAH 621
V YG +++ E M+ SL + D + I S+
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDT-SLDKFYKK-----VYDKGLTIPEDILGKIAVSIVK 114
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
AL YLH K S++HRD+ +N+L+N N + + DFG++ L DS +T+ G Y+A
Sbjct: 115 ALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMA 171
Query: 682 PEL--------AYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
PE Y + K DV+S G+ +E+ G P D
Sbjct: 172 PERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 11/218 (5%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
IG G +G V + + + ++ ALK + ++ + + E +L+Q+ IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
F K ++L+ ++ G LF L+ + D ++ + AL LH K +
Sbjct: 61 SFQSPEK-LYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLH---KFN 113
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
+++RD+ NILL+ + DFGL +L D GT Y+APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 694 CDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNP 731
D ++ GV+ E+L G P + RKI Q P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP--FYDENVNEMYRKILQEP 209
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G VY+ + + ++ A+K L + E + E +L + + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 575 --FCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMAHALSYLHYDC 630
F ++L+ +YM G LF L+ + E R + + AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHLH--- 113
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAYTMA 689
K IV+RD+ NILL++ + DFGL++ D+ GT Y+APE L
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 690 VTEKCDVYSFGVVALEVLMGSHP 712
T+ D +S GV+ E+ G P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKL--HRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
IG G + V +AQ +GK A+K + H E+ L Q RL H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---HPNILRL 63
Query: 573 YGFCLHNK--CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALSYLHYD 629
K + L++E M+ +L+ +++ + KRV + + + +L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH-- 117
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA 689
+ I HRDI NIL+ ++ +ADFG R ++ T + T Y APE T
Sbjct: 118 -RNGIFHRDIKPENILIKDDILK-LADFGSCRGIY-SKPPYTEYISTRWYRAPECLLTDG 174
Query: 690 V-TEKCDVYSFGVVALEVL 707
K D+++ G V E+L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 34/227 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKK------LHRSETEEPAFLESFQTEARL 560
EDF I G YG+VY + + + A+KK + R++ ++ F+E +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQ-VFVER-----DI 54
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
L+ + +V ++ + + ++ EY+E G +L+N + A+ +D R+ +++
Sbjct: 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVD-MARMYFAETVL 112
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-----------LHPDSSN 669
AL YLH IVHRD+ +N+L+ S + DFGL+++ H +
Sbjct: 113 -ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 670 RTL----VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
R V GT YIAPE+ + D ++ G++ E L+G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRS---ETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G G +G V + ++GK A+K L + +E A TE+R+L RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT---LTESRVLQNTRHPFLTA 59
Query: 572 L-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK--RVNIVKSMAHALSYLHY 628
L Y F H++ F++ EY G LF L + E D + IV AL YLH
Sbjct: 60 LKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE-DRARFYGAEIVS----ALGYLH- 112
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA--- 685
C +V+RD+ N++L+ + + DFGL + D + GT Y+APE+
Sbjct: 113 SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 686 -YTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y AV D + GVV E++ G P
Sbjct: 171 DYGRAV----DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G V Q+ ++GK+ A KKL + ++ + + E +L ++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 575 FCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +K + L+ M G L + N V L+ + ++ + + +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
IV+RD+ N+LL+ ++D GLA L D T GT GY+APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 694 CDVYSFGVVALEVLMGSHP 712
D ++ G E++ G P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 516 IGTGGYGSVYRAQLSSGKL-------VALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+G G +G VY ++ G + VA+K ++ + + F EA ++ + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCHH 70
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLR--------NDVEAVELDWTKRVNIVKSMA 620
+V+L G + +I E M RG L LR N V+A K + + +A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP-SLKKMIQMAGEIA 129
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG-- 678
++YL+ + VHRD+++ N ++ + + DFG+ R ++ R G G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---GGKGLL 183
Query: 679 ---YIAPELAYTMAVTEKCDVYSFGVVALEV 706
+++PE T DV+SFGVV E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 34/208 (16%)
Query: 519 GGYGSVYRAQLSSGK-------LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
G +G ++ L K V K H SE + L E+ LL + H+NI+
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL----QESCLLYGLSHQNILP 72
Query: 572 LYGFC--LHNKCMFLIYEYMERGSLFCVLRNDVEAVE-----LDWTKRVNIVKSMAHALS 624
+ C F++Y YM G+L L+ L + V++ +A +S
Sbjct: 73 ILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP-------DSSNRTLVVGTY 677
YLH K ++H+DI++ N +++ L+ + D L+R L P D+ NR +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV----- 183
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALE 705
++A E + DV+SFGV+ E
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 535 VALKKLHRSETE-EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593
V LK L S + AF E+ A ++ Q+ H++IV LYG C+ + ++ E++E G
Sbjct: 35 VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 594 LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653
L + + + W + + K +A ALSYL +VH ++ + NILL E
Sbjct: 91 LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAR--EGI 143
Query: 654 VADFG-LARLLHPDSS----NRTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEV 706
+ G +L P +R V +IAPE + + ++ D +SFG E+
Sbjct: 144 DGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIRHRNIVKLY 573
+G G +G V A+L G+ A+K L + +E E R+L+ + + LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +F + E++ G L ++ + D + + L +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLH---SKG 116
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
I++RD+ +N++L+ + +ADFG+ + + + GT YIAPE+ + T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 694 CDVYSFGVVALEVLMGSHP 712
D +SFGV+ E+L+G P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 494 YDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE-EPAFLE 552
YDGR+ E E ED G + + V LK L S + AF E
Sbjct: 12 YDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELR------VVLKVLDPSHRDIALAFFE 65
Query: 553 SFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
+ A L+SQ+ H ++ ++G C+ ++ E++E G L LR + V + W +
Sbjct: 66 T----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA-------RLLHP 665
+ + + +A ALSYL ++VH ++ + NILL A GLA +L P
Sbjct: 120 ITVAQQLASALSYLE---DKNLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDP 168
Query: 666 DSS----NRTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEV 706
S +R V +IAPE + +++ D +SFG LE+
Sbjct: 169 GVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKL- 572
IG G +G V A+ + GK A+K L + + + E LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
Y F +K F++ +Y+ G LF L+ + E + +A AL YLH
Sbjct: 63 YSFQTADKLYFVL-DYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLH---SL 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+I++RD+ NILL+S + DFGL + S + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 33/166 (19%)
Query: 556 TEARLLSQIRHRNIVKLYGFCLH---NK---CMFL------IYEYMERGSLFCVLRNDVE 603
E +L I HR I+ L +H K CM + ++ Y++R
Sbjct: 135 REIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFTYVDRSG---------- 180
Query: 604 AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
L + + I + + AL+YLH I+HRD+ + NI L+ A + DFG A L
Sbjct: 181 --PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 664 --HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707
HPD+ GT +PEL K D++S G+V E+
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 58/243 (23%), Positives = 101/243 (41%), Gaps = 54/243 (22%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G V ++ + L A+K L +++ + E +L++ + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 575 FCLHNK-CMFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+ +K ++ + +Y+ G + +L R + +L R I + + A+ +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH---KM 120
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLA---RLLH----------------------PDS 667
+HRDI +NIL++ + + DFGL R H +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 668 SNRTL------------------VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
L +VGT YIAPE+ T+ CD +S GV+ E+L+G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 710 SHP 712
P
Sbjct: 241 QPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLY 573
+G G +G V A+L + ++ A+K L + + ++ TE R+L+ H + L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 574 GFCLHNKCMFLIYEYMERGSL-FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+F + EY+ G L F + R + + D + + AL +LH +
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+++RD+ +NILL++ +ADFG+ + + T GT YIAPE+ +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 693 KCDVYSFGVVALEVLMGSHP 712
D ++ GV+ E++ G P
Sbjct: 176 SVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG+G V Q+ ++GK+ A K+L + ++ E ++L ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 575 FCLHNKCMFLIYEYMERGSL-FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ L+ M G L F + E + + + + L LH + +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--RALFYAAEILCGLEDLH---REN 122
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
V+RD+ NILL+ ++D GLA + P+ + VGT GY+APE+ T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 694 CDVYSFGVVALEVLMGSHP 712
D + G + E++ G P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 557 EARLLSQIRHRNIVKLYGFCLHNK--CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN 614
EA LL + H +++++ + CM L + L+ L + +D + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPID--QALI 161
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR--LLHPDSSNRTL 672
I K + L YLH I+HRD+ + NI +N + + D G A+ ++ P
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--- 215
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722
+ GT APE+ K D++S G+V E+L ++P+ + S+
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
E+F I I G +G VY + ++ KL A+K + +++ + Q E L+ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV-----ELDWTKRVNIVKSMAH 621
IV LY ++L+ EY+ G DV+++ D V + +A
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGG--------DVKSLLHIYGYFDEEMAVKYISEVAL 115
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662
AL YLH + I+HRD+ +N+L+++ + DFGL+++
Sbjct: 116 ALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 516 IGTGGYGSVYRAQLSSG-KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G Y V +L ++ A+K + + + ++ QTE + Q +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 575 FCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
C +FL+ EY+ G L ++ + E + AL++LH +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE---EHARFYAAEICIALNFLH---ERG 116
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPELAYTMAVTE 692
I++RD+ +N+LL+++ + D+G+ + L P + T GT YIAPE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF-CGTPNYIAPEILRGEEYGF 175
Query: 693 KCDVYSFGVVALEVLMGSHPTDLLS 717
D ++ GV+ E++ G P D+++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G G G V+ A S K VA+KK+ ++ P ++ E +++ ++ H NIVK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKV 67
Query: 573 Y--------------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
Y G ++++ EYME L N +E L +
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQ 122
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNR---TLVV 674
+ L Y+H +++HRD+ N+ +N+ +L + DFGLAR++ P S++ + +
Sbjct: 123 LLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179
Query: 675 GTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVLMG 709
T Y +P L YT A+ D+++ G + E+L G
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 24/63 (38%), Positives = 41/63 (65%)
Query: 28 GTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI 87
G + G +P +G+++ LE L LS+NS G IP +G L+ L++L+L+ N L+G +P+ +
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
Query: 88 GSL 90
G
Sbjct: 511 GGR 513
|
Length = 623 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-Y 573
+G GG+G V Q+ ++GK+ A KKL + ++ E ++L ++ R +V L Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 574 GF------CLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
+ CL M F IY G D + V +
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPG--------------FDEERAVFYAAEITC 113
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L LH + IV+RD+ NILL+ ++D GLA + P+ VGT GY+A
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMA 169
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ T D + G + E++ G P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 57/231 (24%)
Query: 510 FHIKYCIGTGGYG---SVYRAQLSSGKLVALKKLHRSETEEPAFLESFQT-----EARLL 561
+ + +G G YG S A+ S + VA+KK+ F + E +LL
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN------VFSKKILAKRALRELKLL 55
Query: 562 SQIR-HRNIVKLYGFCLHNKCMF-LIYEYME--RGSLFCVLRNDVEAVELDWTKRVNIVK 617
R H+NI LY + F +Y Y E L ++R+ +
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTD----------- 104
Query: 618 SMAH----------ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD- 666
AH L Y+H +++HRD+ N+L+N++ E + DFGLAR +
Sbjct: 105 --AHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
Query: 667 ---SSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
+ T V T Y APE+ +YT A+ DV+S G + E+L
Sbjct: 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 8/208 (3%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
DF+ +G G +G V A+ + +L A+K L + + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 568 NIVKLYGFCLHN-KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ C ++ + EY+ G L ++ + V +A L +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I++RD+ +N++L+S +ADFG+ + D GT YIAPE+
Sbjct: 118 H---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTD 714
+ D ++FGV+ E+L G P +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 56/246 (22%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V A ++ + L A+K L + + + + E +L++ + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 575 FCLHNKCMFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
++ + +Y+ G + +L R +V L R I + + A+ +H K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVH---KMG 121
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLA---RLLH----------------------PDSS 668
+HRDI +NIL++ + + DFGL R H D S
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 669 N-------RTL---------------VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
N +TL +VGT YIAPE+ T+ CD +S GV+ E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 707 LMGSHP 712
L+G P
Sbjct: 242 LVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 27/70 (38%), Positives = 41/70 (58%)
Query: 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395
L L + L G IP++I L + ++LS N I G IP LG I ++ +DLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 396 PASVRRIPKL 405
P S+ ++ L
Sbjct: 483 PESLGQLTSL 492
|
Length = 623 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 37/112 (33%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 535 VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594
V LK L + AF E+ A L+SQ+ H+++VKLYG C+ ++ + ++ EY++ G L
Sbjct: 33 VVLKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87
Query: 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL 646
L + V L W ++++ K +A AL YL +VH ++ NIL+
Sbjct: 88 DVFLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 520 GYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL------- 572
G S + + +L+A K ++ + LE+ E L ++ H NI+K+
Sbjct: 181 GVNSTNQGKPKCERLIA--KRVKAGSRAAIQLEN---EILALGRLNHENILKIEEILRSE 235
Query: 573 -YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631
+ + K F +Y +M + D + L R I+K + A+ Y+H
Sbjct: 236 ANTYMITQKYDFDLYSFMYDEAF------DWKDRPLLKQTR-AIMKQLLCAVEYIH---D 285
Query: 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYGYIAPELAYTMAV 690
++HRDI NI LN + + + DFG A + VGT +PE+
Sbjct: 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
Query: 691 TEKCDVYSFGVVALEVL 707
E D++S G++ L++L
Sbjct: 346 CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 510 FHIKYC-IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
F + C +G G YG VY+A+ GK K+ + E S E LL +++H N
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 569 IVKLYG-FCLH-NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY- 625
++ L F H ++ ++L+++Y E L+ +++ K + + +SM +L Y
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIK--FHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 626 ----LHYDCKPSIVHRDISSNNILL----NSNLEAFVADFGLARL----LHPDSSNRTLV 673
+HY ++HRD+ NIL+ +AD G ARL L P + +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 674 VGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVL 707
V T+ Y APEL YT A+ D+++ G + E+L
Sbjct: 177 V-TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 515 CIGTGGYGSVYRAQLSSGKLVALKK--LHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
C + + + + LVA+KK L E+ L Q E Q++H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLL---QQEIITSRQLQHPNILPY 64
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
+ + ++++ M GS +L+ L I+K + +AL Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIH---SK 120
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHP--DSSNRTLVVGTYG--------YIAP 682
+HR + +++ILL+ + + ++ R R VV + +++P
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 683 ELAYT--MAVTEKCDVYSFGVVALEVLMGSHP 712
E+ EK D+YS G+ A E+ G P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 516 IGTGGYGSVYRAQLSSG---KLVALKKLHRSET--EEPAFLESFQTEARLLSQIRHRNIV 570
IG G +G V +++SG V +K+L S + E+ FLE EA+ ++H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH--ALSYLHY 628
+ G C L+ E+ G L LR+ +A + T ++ MA AL LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHL 116
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD----SSNRTLVVGTYGYIAPEL 684
K + +H D++ N LL ++L + D+GL+ + + + ++ V +IAPEL
Sbjct: 117 H-KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPEL 173
Query: 685 A-------YTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ T++ +V+S GV E+ +GS P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 37/222 (16%)
Query: 510 FHIKYC-IGTGGYGSVYRAQLSSG---KLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
F + C +G G YG VY+A+ G + ALK++ E S E LL +++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELK 56
Query: 566 HRNIVKLYG-FCLH-NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H N++ L F H ++ ++L+++Y E L+ +++ K V + + M +L
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIK--FHRASKANKKPVQLPRGMVKSL 113
Query: 624 SY-----LHYDCKPSIVHRDISSNNILL----NSNLEAFVADFGLARL----LHPDSSNR 670
Y +HY ++HRD+ NIL+ +AD G ARL L P +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 671 TLVVGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVL 707
+VV T+ Y APEL YT A+ D+++ G + E+L
Sbjct: 174 PVVV-TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH---PDSSNRTLVVGTYGYIAP 682
+H+ ++HRDI S NILL SN + DFG +++ D RT GT Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAP 214
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
E+ ++K D++S GV+ E+L P D
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 14/151 (9%)
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
N+V L+ + + +FL+ ++ E G L+ + + E + KR M AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE-ECVKR--WAAEMVVALDALH 102
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
+ IV RD++ NNILL+ + F + + Y APE+
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV---ENMYCAPEVGGI 156
Query: 688 MAVTEKCDVYSFGVVALEVLMG-----SHPT 713
TE CD +S G + E+L G HP+
Sbjct: 157 SEETEACDWWSLGAILFELLTGKTLVECHPS 187
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/246 (23%), Positives = 102/246 (41%), Gaps = 56/246 (22%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V A ++ + L A+K L + + + + E +L++ + +V+LY
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 575 FCLHNKCMFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
++ + +Y+ G + +L R + +L R I + + A+ +H K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAE-LTCAVESVH---KMG 121
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLA---RLLHP----------------------DSS 668
+HRDI +NIL++ + + DFGL R H D +
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 669 N-------------------RTL---VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEV 706
N R L +VGT YIAPE+ T+ CD +S GV+ E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 707 LMGSHP 712
L+G P
Sbjct: 242 LVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLH--PDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+HRD+++ NILL+ N + DFGLAR ++ PD + ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 693 KCDVYSFGVVALEVL-MGSHP 712
+ DV+SFGV+ E+ +G+ P
Sbjct: 256 QSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLH--PDSSNRTLVVGTYGYIAPELAYTMAVTE 692
+HRD+++ NILL+ N + DFGLAR ++ PD + ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 693 KCDVYSFGVVALEVL-MGSHP 712
+ DV+SFGV+ E+ +G+ P
Sbjct: 261 QSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 59/263 (22%), Positives = 101/263 (38%), Gaps = 68/263 (25%)
Query: 516 IGTGGYGSVYRA------QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRN 568
+G G +G V +A + +S + VA+K L T + ++ TE ++L I H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLN 72
Query: 569 IVKLYGFCLHNKC-MFLIYEYME--------RGSLFCVLRNDVEAVELDWTKRVNIVK-- 617
+V L G C + +I EY + R C ++ K+ K
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 618 --------------------------------------SMAHALSY-------LHYDCKP 632
++ +SY + +
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLH--PDSSNRTLVVGTYGYIAPELAYTMAV 690
+HRD+++ NILL+ N + DFGLAR ++ PD + ++APE +
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 691 TEKCDVYSFGVVALEVL-MGSHP 712
T + DV+SFGV+ E+ +G+ P
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 27/246 (10%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN---IVK 571
IG GG+G VY + + +GK+ A+K L + + E +LS + + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 572 L-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
+ Y F +K F I + M G L L E + + L ++H
Sbjct: 62 MSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAE---MRFYAAEIILGLEHMH--- 114
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLA---RLLHPDSSNRTLVVGTYGYIAPE-LAY 686
+V+RD+ NILL+ + ++D GLA P +S VGT+GY+APE L
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQK 169
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK--ISQNPRLD----LQCNAY 740
+A D +S G + ++L G P + + ++ L + +
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229
Query: 741 LKNFSQ 746
L+ Q
Sbjct: 230 LEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 14/131 (10%)
Query: 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647
Y+++ +L D + LD ++ +A +S+L + +HRD+++ NILL
Sbjct: 194 YIDQDVTSEILEED--ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLT 248
Query: 648 SNLEAFVADFGLARLLHPDSS-----NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV 702
+ DFGLAR + DS+ N L V ++APE + T + DV+S+G++
Sbjct: 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIL 305
Query: 703 ALEVL-MGSHP 712
E+ +GS P
Sbjct: 306 LWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN----IV 570
IG GG+G VY + + +GK+ A+K L + + E +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWT-KRVNIVKSMAHALSYLHYD 629
Y F +K F I + M G L L E + I+ + H +
Sbjct: 62 MTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--- 117
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAYTM 688
+V+RD+ NILL+ + ++D GLA + + VGT+GY+APE L
Sbjct: 118 ----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGT 171
Query: 689 AVTEKCDVYSFGVVALEVLMGSHP 712
A D +S G + ++L G P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 56/232 (24%), Positives = 106/232 (45%), Gaps = 45/232 (19%)
Query: 516 IGTGGYGSVY-----RAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
IG G +G V+ R Q K ++ + L E + E ++ +++H+NI
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ------LVIEVNVMRELKHKNI 74
Query: 570 VKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVEL----DWTKRVNIVKSMAHAL 623
V+ L+ N+ ++++ E+ + G L RN + ++ + V+I + + HAL
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLS---RNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 624 SYLH-YDCKPS---IVHRDISSNNILLNSNLE-----------------AFVADFGLARL 662
+Y H P+ ++HRD+ NI L++ + A + DFGL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 663 LHPDSSNRTLVVGTYGYIAPELAY--TMAVTEKCDVYSFGVVALEVLMGSHP 712
+ +S + VGT Y +PEL T + +K D+++ G + E+ G P
Sbjct: 192 IGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573
IG G Y V +L + ++ A+K + + + ++ QTE + H +V L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 574 GFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELD---WTKRVNIVKSMAHALSYLHYD 629
C + +F + E++ G L ++ + E ++ +++ AL++LH
Sbjct: 63 S-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLH-- 113
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPEL---- 684
+ I++RD+ +N+LL++ + D+G+ + + P + T GT YIAPE+
Sbjct: 114 -ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-CGTPNYIAPEILRGE 171
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718
Y +V D ++ GV+ E++ G P D++
Sbjct: 172 DYGFSV----DWWALGVLMFEMMAGRSPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 516 IGTGGYGSVYRA---QLSSGKL---VALKKLHRSET--EEPAFLESFQTEARLLSQIRHR 567
+G G +G VY + G+ VA+K ++ S + E FL EA ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL----NEASVMKGFTCH 69
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------NDVEAVELDWTKRVNIVKSMA 620
++V+L G + ++ E M G L LR N+ + + + +A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG-- 678
++YL+ VHRD+++ N ++ + + DFG+ R ++ R G G
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK---GGKGLL 183
Query: 679 ---YIAPELAYTMAVTEKCDVYSFGVVALEV 706
++APE T D++SFGVV E+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 25/63 (39%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
NLK LD L N+L + + L NL LDLS N L+ P+ L +L+SL L
Sbjct: 1 NLKSLD---LSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 173 NHL 175
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLL 334
+ NL L SL LN N L I + LTNLT L+L N ++ P + S L
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 335 NLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394
L LS N + S+PS + NL + LDLS N ++ +P L + N++ +DLS N +S
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 395 IPASVRRIPKL--IVSENNLELENSTSSEN 422
+P + + L + NN +E +S N
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSSLSN 230
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 9/84 (10%)
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSS-----NRTLVVGTYGYIAPELAYTMA 689
+HRD+++ N+LL A + DFGLAR + DS+ N L V ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 690 VTEKCDVYSFGVVALEVL-MGSHP 712
T + DV+S+G++ E+ +G P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 27/152 (17%), Positives = 52/152 (34%), Gaps = 18/152 (11%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV--KLY 573
+ G VY V LK E + E +L + + + K+
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGA-----DREREVAILQLLARKGLPVPKVL 59
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +L+ E++E E+ ++ +I + +A L+ LH
Sbjct: 60 ASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+ H D+ NIL++ + D+ A P
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 78/266 (29%), Positives = 118/266 (44%), Gaps = 45/266 (16%)
Query: 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT---GSIPSTIGYLNLLDELHLSH 244
Q+ TL L N+L GN+K L + N N LT ++P TI E+ LS
Sbjct: 200 QITTLILDNNELKSLPENLQGNIKTL---YANSNQLTSIPATLPDTI------QEMELSI 250
Query: 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGL---LPREVGNLKYLASLSLNGNILIGPIPP 301
NR+ +P + + L +LDL N++S L LP E L+YL+ + L +P
Sbjct: 251 NRIT-ELPERLP--SALQSLDLFHNKISCLPENLPEE---LRYLSVYDNSIRTLPAHLPS 304
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361
I T+L + L ++PP L N + SL S+P E+ LD
Sbjct: 305 GI---THLNVQSNSLTALPETLPPGLKTLEAGENAL---TSLPASLPPELQV------LD 352
Query: 362 LSRNFINGTIPSQLGKIPNISAVDLSKN---NLSGVIPASVRRIPKLIVSENNL-ELENS 417
+S+N I +P L P I+ +D+S+N NL +PA+++ + S NNL L S
Sbjct: 353 VSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLPAALQ---IMQASRNNLVRLPES 406
Query: 418 TSS--ENAPPPQATLFKGNKGKQRKI 441
P P + + N +R I
Sbjct: 407 LPHFRGEGPQPTRIIVEYNPFSERTI 432
|
Length = 754 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 23/60 (38%), Positives = 26/60 (43%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
NL L L+ N LT L L L LS N L P L +L +LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 516 IGTGGYGSVYRAQL---SSGKLVALKKLHRSET--EEPAFLESFQTEARLLSQIRHRNIV 570
IG G +G V +++ + V +K+L + + E+ FL+ R+L +H NI+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDP-YRIL---QHPNIL 58
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRN------DVEAVELDWTKRVNIVKSMAHALS 624
+ G C+ L++EY E G L L + + + L + +A ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVT 113
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659
++H K + +H D++ N L S+L V D+G+
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 92/366 (25%), Positives = 149/366 (40%), Gaps = 56/366 (15%)
Query: 38 EIGALS---KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94
EI LS LE L LS S +PS I L++L+ LD+S +P+ I +L+ L
Sbjct: 649 EIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707
Query: 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGR 154
LNLS S P N+ LD L ++ PS++ L NL L L S +
Sbjct: 708 RLNLSGCSRLKSFPDISTNISWLD---LDETAIEE-FPSNL-RLENLDELILC-EMKSEK 761
Query: 155 LPQEVGNLK--------NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206
L + V L +L LFL + +PS++ +L++L L + T
Sbjct: 762 LWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLE--HLEIENCINLETLP 819
Query: 207 VG-NMKNLDRLHLNGNNLTGSIP---STIGYLNL----LDELHLSHNRLDGPIPPTIGNL 258
G N+++L+ L L+G + + P + I LNL ++E+ + +
Sbjct: 820 TGINLESLESLDLSGCSRLRTFPDISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGC 879
Query: 259 TNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNR 318
NL + L+ ++L L + + L S NG P + T+ +++
Sbjct: 880 NNLQRVSLNISKLKHLETVDFSDCGALTEASWNG------SPSEVAMATDNI-----HSK 928
Query: 319 LSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN-----FINGTIPS 373
L S++ +NC L +L + F+QL LS F + T +
Sbjct: 929 LPSTVCINFINC-----FNLDQEAL-------LQQQSIFKQLILSGEEVPSYFTHRTTGA 976
Query: 374 QLGKIP 379
L IP
Sbjct: 977 SLTNIP 982
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 31/203 (15%)
Query: 557 EARLLSQIRHRNIVKLYGFCLHN----KCMFL------IYEYMERGSLFCVLRNDVEAVE 606
EARLL ++ H ++ L + C+ L +Y Y+
Sbjct: 210 EARLLRRLSHPAVLALLD--VRVVGGLTCLVLPKYRSDLYTYLGA-----------RLRP 256
Query: 607 LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666
L + + + + A+ Y+H I+HRDI + N+L+N + + DFG A
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 667 SSNRTL--VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG 724
S + GT APE+ T D++S G+V E + H L S+
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV--HTASLFSASRGDER 371
Query: 725 RKI-SQNPRLDLQCNAYLKNFSQ 746
R +Q R+ Q ++ F Q
Sbjct: 372 RPYDAQILRIIRQAQVHVDEFPQ 394
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 26/60 (43%), Positives = 28/60 (46%)
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
LK LDLS NRLT L +L L+LS N L P F L L L L GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 12/191 (6%)
Query: 526 RAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585
R K+VA K + ++ + A+ S E L+ H IVK + + + LI
Sbjct: 88 RGSDPKEKVVA-KFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 586 YEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644
EY G L ++ + E + + + + AL +H ++HRD+ S NI
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANI 200
Query: 645 LLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTYGYIAPELAYTMAVTEKCDVYSFGV 701
L + DFG ++ + DS + + GT Y+APEL ++K D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 702 VALEVLMGSHP 712
+ E+L P
Sbjct: 260 ILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 25/58 (43%), Positives = 28/58 (48%)
Query: 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
L+ L LS+N LT L LKVLDLS N LT P L L L+LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 38/213 (17%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL-- 572
IG G +G VY A + + + VA+KK+ ++P + E ++ + H NI+ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNR---ELLIMKNLNHINIIFLKD 126
Query: 573 --YGFCL--HNKCMFL----------IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
Y C + K +FL +++YM+ + RN+ A+ L K +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA-----RNN-HALPLFLVKLYSY--Q 178
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTY 677
+ AL+Y+H I HRD+ N+L++ N + DFG A+ L + + + +
Sbjct: 179 LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 678 GYIAPELAY-TMAVTEKCDVYSFGVVALEVLMG 709
Y APEL T D++S G + E+++G
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 2/75 (2%)
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTE 692
VHRD+++ N+LL + DFGLAR + DS+ ++ ++APE + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 693 KCDVYSFGVVALEVL 707
DV+S+G++ E+
Sbjct: 319 LSDVWSYGILLWEIF 333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTE 692
VHRD+++ N+L+ + DFGLAR + DS+ ++ ++APE + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 693 KCDVYSFGVVALEVL-MGSHP 712
DV+SFG++ E+ +G P
Sbjct: 321 LSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 24/57 (42%), Positives = 28/57 (49%)
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
L L LS+NRL L NL LDLS N L+ + P L L SL L+GN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 516 IGTGGYGSVYRA------QLSSGKLVALKKLH-RSETEEPAFLESFQTEARLLSQI-RHR 567
+G G +G V A + + VA+K L + T+E E+ +E ++LS + +H+
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE---REALMSELKILSHLGQHK 102
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEA 604
NIV L G C H + +I EY G L LR E
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 28/99 (28%), Positives = 39/99 (39%), Gaps = 13/99 (13%)
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L L +HR S NILL + + G P+ S Y ++A
Sbjct: 26 CLGALRE------LHRQAKSGNILLTWDG--LLKLDGSVAFKTPEQSR----PDPY-FMA 72
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720
PE+ + TEK D+YS G+ E L P + LS
Sbjct: 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS 111
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 30/108 (27%), Positives = 53/108 (49%), Gaps = 20/108 (18%)
Query: 557 EARLLSQIRHRNIVK---LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV 613
EAR+L++ R V +Y N ++ EY+E G L L++ + R
Sbjct: 49 EARILAKAR-EAGVPVPIVYDVDPDN--GLIVMEYIE-GEL---LKDAL------EEARP 95
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661
++++ + + LH K IVH D++++NI+L+ F+ DFGL
Sbjct: 96 DLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 29/109 (26%), Positives = 54/109 (49%), Gaps = 20/109 (18%)
Query: 556 TEARLLSQIRHRNIVK---LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
EARLLS+ R + V +Y N ++ EY+E G L++ +E
Sbjct: 46 NEARLLSRAR-KAGVNTPVVYDVDPDN--KTIVMEYIE-GKP---LKDVIE------EGN 92
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661
+++ + + LH K IVH D++++NI++ + + ++ DFGL +
Sbjct: 93 DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVRDD-KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 764 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.31 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.31 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.31 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.31 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.29 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.02 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.0 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.91 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.85 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-83 Score=769.49 Aligned_cols=678 Identities=34% Similarity=0.547 Sum_probs=475.1
Q ss_pred cccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCC
Q 004268 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRD 92 (764)
Q Consensus 13 ~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 92 (764)
..|..+++|+.|++++|.+.+.+|..+..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..++.+++
T Consensus 158 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 237 (968)
T PLN00113 158 NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237 (968)
T ss_pred hHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCC
Confidence 34677788888888888888788888888888888888888887777878888888888888888887777777888888
Q ss_pred CCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc
Q 004268 93 LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 93 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 172 (764)
|++|+|++|.+++..|..|.++++|++|+|++|.+.+..|..+.++++|++|+|++|.+.+..|..+.++++|+.|++++
T Consensus 238 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~ 317 (968)
T PLN00113 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317 (968)
T ss_pred CCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC
Confidence 88888888887777777777777888888887777777777777777777777777777766777777777777777777
Q ss_pred CCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCcccc--------------------
Q 004268 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG-------------------- 232 (764)
Q Consensus 173 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-------------------- 232 (764)
|.+++..+..+..+++|+.|++++|.+....+..+..+++|+.|++++|++++..|..+.
T Consensus 318 n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p 397 (968)
T PLN00113 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397 (968)
T ss_pred CccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCC
Confidence 777766666667777777777777776655555666666666666666666555444444
Q ss_pred ----CCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCc
Q 004268 233 ----YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTN 308 (764)
Q Consensus 233 ----~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 308 (764)
.+++|+.|++++|.+++..|..|..+++|+.|++++|.+.+..+..+..+++|+.|++++|++.+..|..+ ..++
T Consensus 398 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~ 476 (968)
T PLN00113 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKR 476 (968)
T ss_pred HHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-cccc
Confidence 44455555555555554555555555555555555555555555555555566666666666555555443 3467
Q ss_pred cceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCC
Q 004268 309 LTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388 (764)
Q Consensus 309 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 388 (764)
|+.|++++|++++..|..+.++++|++|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.||+++
T Consensus 477 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (968)
T PLN00113 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556 (968)
T ss_pred ceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCC
Confidence 77778888888777788888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CccccccCCcc---ccCccccccCCCCCCCCCCCCC-----------CC----CCCCcccccCCCCccceEEEeeehhhh
Q 004268 389 NNLSGVIPASV---RRIPKLIVSENNLELENSTSSE-----------NA----PPPQATLFKGNKGKQRKIVIRLVTIIL 450 (764)
Q Consensus 389 N~l~~~~~~~~---~~~~~~~~~~n~~~~~~~~~~~-----------~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~ 450 (764)
|++++.+|..+ ..+..+++++|++.+.-+.... ++ .++.....+......+..++.++++++
T Consensus 557 N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~ 636 (968)
T PLN00113 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTL 636 (968)
T ss_pred CcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHH
Confidence 88888888654 4577778888887532211100 00 000000000001111222222222222
Q ss_pred HHHHHHHHHHHHHHHHHhhhccCCCCCCccccccCCCccccc--cCCCccCHHHHHHHhhcCCcceeeeecCceeEEEEE
Q 004268 451 AMVAFVFAILIFGILFVHRRKDKKFNPNTREMTEGANEFSIW--NYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ 528 (764)
Q Consensus 451 ~~v~~~~~~li~~~~~~~rrr~k~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~ 528 (764)
++ ++++++++++++++++|+..+... .+...+..+...+ .....+++ .+....|...+.||+|+||.||+|+
T Consensus 637 ~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ig~G~~g~Vy~~~ 710 (968)
T PLN00113 637 GA-FLVLALVAFGFVFIRGRNNLELKR--VENEDGTWELQFFDSKVSKSITI---NDILSSLKEENVISRGKKGASYKGK 710 (968)
T ss_pred HH-HHHHHHHHHHHHHHHhhhcccccc--cccccccccccccccccchhhhH---HHHHhhCCcccEEccCCCeeEEEEE
Confidence 22 222233333333333332211111 1111111010000 00111223 3345668888899999999999998
Q ss_pred E-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCcccccc
Q 004268 529 L-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVEL 607 (764)
Q Consensus 529 ~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 607 (764)
. .+++.||+|++....... ..|++.+++++||||+++++++.+.+..|+||||+++|+|.++++ .+
T Consensus 711 ~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l 777 (968)
T PLN00113 711 SIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NL 777 (968)
T ss_pred ECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cC
Confidence 6 478999999986543221 246888999999999999999999999999999999999999996 27
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccccccccccccc
Q 004268 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687 (764)
Q Consensus 608 ~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 687 (764)
+|..+.+++.|+++|++|||..++.+|+||||||+||+++.++..++. ||.+...... ....+++.|+|||++.+
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRET 852 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccC
Confidence 889999999999999999997667799999999999999998888875 6655433211 22367899999999999
Q ss_pred CCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 688 MAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 688 ~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
..++.++||||+||++|||+||+.||+.
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=460.32 Aligned_cols=401 Identities=37% Similarity=0.574 Sum_probs=312.1
Q ss_pred ccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCC
Q 004268 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93 (764)
Q Consensus 14 ~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 93 (764)
.|.++++|+.|++++|.+++.+|..+..+++|++|+|++|++++..|..+..+++|++|+|++|.+++..|..|+.+++|
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 262 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNL 262 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCC
Confidence 45566667777777776666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccC
Q 004268 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNN 173 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 173 (764)
++|+|++|.+.+..|..+.++++|++|+|++|.+.+..|..+.++++|+.|++++|.+.+..|..+.++++|+.|++++|
T Consensus 263 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n 342 (968)
T PLN00113 263 QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342 (968)
T ss_pred CEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCC
Confidence 66666666666555666666666666666666666555555666666666666666665555555555555555555555
Q ss_pred CCCCCCCCccccCCCccEEEecC------------------------ccCcCCcccccCCccccceeeccCcccccccCc
Q 004268 174 HLSGPIPSTLYHLNQLATLCLGY------------------------NKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPS 229 (764)
Q Consensus 174 ~i~~~~~~~~~~l~~L~~L~l~~------------------------n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 229 (764)
.+++..+..+..+++|+.|++++ |.+....+..+..+++|+.|++++|++++..|.
T Consensus 343 ~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~ 422 (968)
T PLN00113 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422 (968)
T ss_pred CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECCh
Confidence 55544444455555555555554 444444555677788999999999999988999
Q ss_pred cccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCcc
Q 004268 230 TIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL 309 (764)
Q Consensus 230 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 309 (764)
.+..++.|+.|++++|.+.+..+..+..+++|+.|+|++|.+.+..|..+ ..++|+.|++++|++.+..|..+..+++|
T Consensus 423 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L 501 (968)
T PLN00113 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSEL 501 (968)
T ss_pred hHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhcc
Confidence 99999999999999999999999889999999999999999988777665 46899999999999999999999999999
Q ss_pred ceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCC
Q 004268 310 TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389 (764)
Q Consensus 310 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 389 (764)
+.|+|++|++++..|..+..+++|++|+|++|.+++.+|..+.++++|+.|||++|++++.+|..+.++++|+.+++++|
T Consensus 502 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N 581 (968)
T PLN00113 502 MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581 (968)
T ss_pred CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--ccccCccccccCCCCCCC
Q 004268 390 NLSGVIPA--SVRRIPKLIVSENNLELE 415 (764)
Q Consensus 390 ~l~~~~~~--~~~~~~~~~~~~n~~~~~ 415 (764)
++.+.+|. .+..+....+.+|+.-|.
T Consensus 582 ~l~~~~p~~~~~~~~~~~~~~~n~~lc~ 609 (968)
T PLN00113 582 HLHGSLPSTGAFLAINASAVAGNIDLCG 609 (968)
T ss_pred cceeeCCCcchhcccChhhhcCCccccC
Confidence 99998885 455667777788875554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=365.82 Aligned_cols=235 Identities=28% Similarity=0.462 Sum_probs=198.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
...+|.+.+.||+|+||+||+|+++ ++..||||.+.+... .....+.+..|+.+++.++|||||++++++..++..|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 3578999999999999999999865 789999999987764 34446788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC------CCEEEeeec
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN------LEAFVADFG 658 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfg 658 (764)
|||||+||+|.+|+++ .+.+++..++.++.||+.|+++|| +++||||||||.|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999984 347999999999999999999999 9999999999999999854 468999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--CCc----CCCCCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--GRK----ISQNPR 732 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--~~~----~~~~~~ 732 (764)
+|+...+ .....+.+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+..+..+-.. ++. ...+..
T Consensus 161 fAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 161 FARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 9998873 444566899999999999999999999999999999999999999999666533211 111 111222
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.+++..+++.+
T Consensus 240 ~s~~~~~Ll~~ll~~~ 255 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRN 255 (429)
T ss_pred ccCchhhhhhHHHhcC
Confidence 4556667777777765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.20 Aligned_cols=240 Identities=27% Similarity=0.424 Sum_probs=213.6
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||.++. ++++.+|+|++++.........+....|..++.+++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 57899999999999999999974 47999999999988777666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+.||.|...++ ..+.+++..++-++..|+.||.||| ++||||||+||+|||+|.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998 4557999999999999999999999 99999999999999999999999999999997655
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCC-CcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPR-LDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~ 741 (764)
.+.....++||+.|||||++.+.+|+.++|+||+|+++|||++|.+||.+.+.... .........|. ++....+++
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 55566668999999999999999999999999999999999999999998775332 23333344555 899999999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
+.+++++++-|
T Consensus 258 ~~LL~rdp~~R 268 (357)
T KOG0598|consen 258 KKLLKRDPRQR 268 (357)
T ss_pred HHHhccCHHHh
Confidence 99999884443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=361.67 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=207.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-EEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-CMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 585 (764)
.+.+..+.||+|..|+||+++++ +++.+|+|++.. ..++...+++.+|+++++.++||+||++||+|..++ ...|+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 34455678999999999999876 789999999943 334566789999999999999999999999999999 59999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||++|+|..++.. .+++++....+++.++++||.|||. +++||||||||+|||+...|+|||||||.+..+..
T Consensus 157 mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999999983 4679999999999999999999994 37999999999999999999999999999988754
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc-----ccccccCCcCCCCCCC-----cH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS-----SLSSSSGRKISQNPRL-----DL 735 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~-----~~~~~~~~~~~~~~~~-----~~ 735 (764)
. ....++||..|||||.+.+..|+.++||||||+.++|+.+|++||.... ..+........++|.+ ++
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 4 4566899999999999999999999999999999999999999998641 1222223344445554 45
Q ss_pred HHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 736 QCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 736 ~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
+.+.|+..|++++ .||-..++...||
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 6999999999999 4555666666665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=383.72 Aligned_cols=402 Identities=23% Similarity=0.247 Sum_probs=339.8
Q ss_pred ccccccccCCCeeEEEeCCCCccccCCccccCC--CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCccc
Q 004268 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGAL--SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI 87 (764)
Q Consensus 10 ~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 87 (764)
.+.-+=.|-.+.+.|++++++++...-..+..+ +.-+.||+|+|.+..+.+..|.++++|+.++|.+|.++ .+|...
T Consensus 43 ~~~cpa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~ 121 (873)
T KOG4194|consen 43 LSECPATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG 121 (873)
T ss_pred cccCCCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence 333344455678889999998875444444433 34567999999999888888899999999999999998 677766
Q ss_pred CCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCe
Q 004268 88 GSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKS 167 (764)
Q Consensus 88 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 167 (764)
+...+|+.|+|.+|.|+++..+.++.++.|+.|||+.|.|+.+....|..-.++++|+|++|.|+.+...+|.++.+|..
T Consensus 122 ~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~t 201 (873)
T KOG4194|consen 122 HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLT 201 (873)
T ss_pred ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchhee
Confidence 66677999999999999888888888999999999999999888888888888999999999999888889999999999
Q ss_pred eecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcc
Q 004268 168 LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL 247 (764)
Q Consensus 168 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 247 (764)
|.|++|+|+.+++..|..+++|+.|+|..|+|.-+.--.|.++++|+.|.|..|.+......+|..+..+++|+|+.|++
T Consensus 202 lkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l 281 (873)
T KOG4194|consen 202 LKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRL 281 (873)
T ss_pred eecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchh
Confidence 99999999988888888899999999999998866677888999999999999999888888899999999999999999
Q ss_pred cCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhh
Q 004268 248 DGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPEL 327 (764)
Q Consensus 248 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 327 (764)
.....+++.+++.|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+...++.|..+..|+.|+|++|.|+...-..|
T Consensus 282 ~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af 361 (873)
T KOG4194|consen 282 QAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF 361 (873)
T ss_pred hhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence 88888888899999999999999988888888889999999999999998888888889999999999999987777788
Q ss_pred hcccccceeeccccccccCCc---hhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccc--cC
Q 004268 328 MNCSQLLNLVLSHNSLSGSIP---SEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVR--RI 402 (764)
Q Consensus 328 ~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~ 402 (764)
..+++|++|||++|.|+..+. ..|.+|++|+.|+|.+|+|..+...+|.++++|++|||.+|.+..+-|..|. .+
T Consensus 362 ~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L 441 (873)
T KOG4194|consen 362 VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL 441 (873)
T ss_pred HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchh
Confidence 889999999999999875544 3577889999999999999877778899999999999999999888888775 55
Q ss_pred ccccccCCCC
Q 004268 403 PKLIVSENNL 412 (764)
Q Consensus 403 ~~~~~~~n~~ 412 (764)
+++.+....+
T Consensus 442 k~Lv~nSssf 451 (873)
T KOG4194|consen 442 KELVMNSSSF 451 (873)
T ss_pred hhhhhcccce
Confidence 6666555544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=374.19 Aligned_cols=235 Identities=26% Similarity=0.469 Sum_probs=216.9
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+|...+.||+|||+.+|+++. .+|+.||+|++.+.....+...+.+.+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999986 789999999999988777777899999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|+|+.++|..+++ ...++++.+++.+++||+.|+.||| +++|+|||||..|+|++++.+|||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998 3457999999999999999999999 999999999999999999999999999999999888
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc---ccccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL---SSSSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.....+.+|||.|.|||++....++..+||||+||++|-|++|++||+..+-. ..........+..++.++.++|.+
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 78888899999999999999999999999999999999999999999976432 234445555667889999999999
Q ss_pred hhccc
Q 004268 744 FSQGN 748 (764)
Q Consensus 744 ~l~~~ 748 (764)
+|+.+
T Consensus 252 lL~~~ 256 (592)
T KOG0575|consen 252 LLRPN 256 (592)
T ss_pred HhcCC
Confidence 99988
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=348.26 Aligned_cols=245 Identities=26% Similarity=0.347 Sum_probs=212.3
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEee-EEeeCCE-EE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG-FCLHNKC-MF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~~ 583 (764)
...|++.+.||+|+||+||+++ ..+|..||.|.+.-. ..+....+....|+.++++++|||||++++ .+.+++. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4678899999999999999996 568999999999843 344555688899999999999999999999 4545444 89
Q ss_pred EEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
||||+|++|+|..+++... ....+++..+++++.|++.||..+|+.- .. |+||||||.||+++.+|.|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999999997543 3346899999999999999999999421 44 999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCC-----cH
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL-----DL 735 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~-----~~ 735 (764)
+............+|||.||+||.+.+.+|+++|||||+||++|||+.-++||.+..-.+.+.+......|++ +.
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 9988777777788999999999999999999999999999999999999999999876666666666666555 46
Q ss_pred HHHHHHhhhhccchhhHH
Q 004268 736 QCNAYLKNFSQGNHRWEN 753 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~~ 753 (764)
+...++..|+..++.||.
T Consensus 256 ~l~~li~~ci~vd~~~RP 273 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRP 273 (375)
T ss_pred HHHHHHHHHccCCcccCC
Confidence 889999999999988886
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=337.77 Aligned_cols=233 Identities=27% Similarity=0.414 Sum_probs=212.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|+..+.+|.|+||.|.+++.+ +|..+|+|++.+...-.-.+.+....|..+++.+.||+++++++.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467889999999999999999865 7899999999988877777788899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||.|..+++ ..+++++..++.++.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999998 5667999999999999999999999 99999999999999999999999999999998643
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
..-+.||||.|+|||+++..+|..++|.|||||++|||+.|.+||.+..+... +.......++-++.+..++++
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK 273 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence 24568999999999999999999999999999999999999999987776433 344556667778999999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
++++.+
T Consensus 274 ~LL~vD 279 (355)
T KOG0616|consen 274 KLLQVD 279 (355)
T ss_pred HHHhhh
Confidence 999988
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=376.02 Aligned_cols=375 Identities=24% Similarity=0.235 Sum_probs=346.7
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
++-++|++++|.+....+..|.++++|+++++.+|.++ .+|..-....+|+.|+|.+|.|+++..+.+..++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 46778999999999998999999999999999999999 67766667778999999999999888899999999999999
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 178 (764)
|.|.|+.+....|..-.++++|+|++|+|+.+..+.|.++.+|..|.|++|+++.+++..|+++++|+.|+|..|+|.-+
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99999988888899889999999999999999999999999999999999999999999999999999999999999966
Q ss_pred CCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCC
Q 004268 179 IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNL 258 (764)
Q Consensus 179 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 258 (764)
...+|.++++|+.|.|..|.|..+..++|..+.++++|+|+.|+++.....++-+++.|+.|+||+|.|..+.+++..-.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 67889999999999999999999999999999999999999999998888899999999999999999998888888889
Q ss_pred CCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCC---Chhhhcccccce
Q 004268 259 TNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI---PPELMNCSQLLN 335 (764)
Q Consensus 259 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~---~~~~~~l~~L~~ 335 (764)
++|+.|+|++|+|....+..|..+..|++|+|++|.+..+...+|..+.+|++|||++|.|+..+ ...|.++++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 99999999999999999999999999999999999999888888999999999999999998643 346788999999
Q ss_pred eeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcccccc
Q 004268 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395 (764)
Q Consensus 336 L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 395 (764)
|.|.+|+|..+.-..|.++..|+.|||.+|.|..+.|++|..+ .|++|.+..-.+-|.+
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEec
Confidence 9999999997777899999999999999999999999999999 9999988777665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=350.38 Aligned_cols=236 Identities=27% Similarity=0.377 Sum_probs=198.5
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHH----HHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPA----FLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
..+.|.+.+.+|+|+||.|-+|. .++|+.||||++.+....... ....+++|+++|++++||+||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45778899999999999999996 568999999999876654411 2244689999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC---CCEEEeee
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN---LEAFVADF 657 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Df 657 (764)
..|+||||++||+|.+.+-. ...+.+...+.+++|++.|+.||| ++||+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999873 445777778899999999999999 9999999999999999765 77999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCC--C-ccchHHHHHHHHHHHHhCCCCCCcccccc----cccCCc----
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV--T-EKCDVYSFGVVALEVLMGSHPTDLLSSLS----SSSGRK---- 726 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~-~~~DiwslG~il~~lltg~~Pf~~~~~~~----~~~~~~---- 726 (764)
|+|+..+ ......+.|||+.|.|||++.+..+ + .+.|+||+||++|-+++|.+||.+..... +.....
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 9999876 5566777999999999999987754 3 37899999999999999999998765432 111111
Q ss_pred CCCCCCCcHHHHHHHhhhhccc
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.....+++....++|++|+..+
T Consensus 403 p~~w~~Iseea~dlI~~mL~Vd 424 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVD 424 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeC
Confidence 1224457889999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=352.88 Aligned_cols=239 Identities=25% Similarity=0.413 Sum_probs=213.4
Q ss_pred HHHhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCE
Q 004268 504 IEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 504 ~~~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 581 (764)
.....+|.+.+.||.|+|++|++|+ ..+++.||||++.+.....+.-.+.+.+|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4456889999999999999999996 458999999999877666555567788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
+|+|+||+++|+|.++++ ..+.+++..++.++.+|+.||+||| ++|||||||||+|||+|++|++||.|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998 4567999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCC-------------ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc---ccccCC
Q 004268 662 LLHPDSSN-------------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL---SSSSGR 725 (764)
Q Consensus 662 ~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~---~~~~~~ 725 (764)
.+.+.... ...++||..|.+||++.....++++|+|||||++|+|+.|++||.+..+. ..+...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 87542111 14479999999999999999999999999999999999999999988773 345566
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
....++.++....+++++++..+
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~d 325 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRD 325 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccC
Confidence 77778899999999999999887
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.05 Aligned_cols=234 Identities=26% Similarity=0.372 Sum_probs=200.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|+....+|+|+||.||+++++ +|+.||||++..++. ++...+-..+|++++++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56888899999999999999865 899999999987654 3455677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||+.. +.+-+.+ ....++...++++++|++.|+.|+| ++++|||||||+||+|+.+|.+||||||+|+....+
T Consensus 81 E~~dhT-vL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDHT-VLHELER--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecchH-HHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 999874 4444543 3445888999999999999999999 999999999999999999999999999999999877
Q ss_pred CCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---------------------
Q 004268 667 SSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG--------------------- 724 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~--------------------- 724 (764)
+...+..+.|.+|+|||.+.| .+|+...||||+||++.||++|.+-|.+.++.++...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 788888999999999999887 6899999999999999999999999988776332111
Q ss_pred ---Cc----------CCCCCCCcHHHHHHHhhhhccc
Q 004268 725 ---RK----------ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 ---~~----------~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.. ....|.++...-++++.|++.+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD 271 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCC
Confidence 00 1114455667789999999877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.11 Aligned_cols=233 Identities=28% Similarity=0.436 Sum_probs=208.8
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|.+.+.||+|+||+||+|+.+ +.+.||+|.+.+....+. ..+.+.+|+++++.++||||+.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57889999999999999999754 789999999988766543 3678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+.| +|..++. ....++++.++.++.+++.||.||| +.+|.|||+||.||+++..|.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99987 9999998 4557999999999999999999999 999999999999999999999999999999998876
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc---ccccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL---SSSSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
....+...|||.|||||++.++.|+..+|+||+||++||+++|++||-..+-. +.+.......++..+..+..+++.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 66667788999999999999999999999999999999999999999755432 334445555566788999999999
Q ss_pred hhccc
Q 004268 744 FSQGN 748 (764)
Q Consensus 744 ~l~~~ 748 (764)
+++++
T Consensus 234 LL~kd 238 (808)
T KOG0597|consen 234 LLIKD 238 (808)
T ss_pred HhhcC
Confidence 99988
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=352.57 Aligned_cols=236 Identities=32% Similarity=0.545 Sum_probs=198.3
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-EEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-CMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~ 586 (764)
....+.+.+|+|+||+||+|.+.....||+|++......... .+.|.+|+.++++++|||||+++|++.+.. ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 344555569999999999999984444999999887766554 689999999999999999999999999988 799999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCCCCCeeecCCC-CEEEeeeccccccC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS-IVHRDISSNNILLNSNL-EAFVADFGLARLLH 664 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~ 664 (764)
||+++|+|..++... ....+++..+..|+.||++|++||| +.+ ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999854 4567999999999999999999999 888 99999999999999997 99999999998776
Q ss_pred CCCCCceecccccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC-cCCCCCC----CcHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAY--TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR-KISQNPR----LDLQC 737 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~-~~~~~~~----~~~~~ 737 (764)
......+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+.......... .....|. .+..+
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 4433444478999999999999 569999999999999999999999999998873332221 1222233 56677
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
..+++.||+.+
T Consensus 276 ~~l~~~CW~~d 286 (362)
T KOG0192|consen 276 SSLMERCWLVD 286 (362)
T ss_pred HHHHHHhCCCC
Confidence 78888888766
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.73 Aligned_cols=234 Identities=26% Similarity=0.404 Sum_probs=204.4
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+++.||+|+||.||+|+. .+|..+|+|++++.........+.+..|-.+|...++|.||+++-.|++...+|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 57899999999999999999974 48999999999998888777889999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||++..++. ....+++..++.++.+++-|++.+| +.|+|||||||+|+|||..|++||+|||++.....
T Consensus 220 MEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999998 5567999999999999999999999 99999999999999999999999999999854311
Q ss_pred -----------------------CCC-----Cc-------------------eecccccccccccccccCCCCccchHHH
Q 004268 666 -----------------------DSS-----NR-------------------TLVVGTYGYIAPELAYTMAVTEKCDVYS 698 (764)
Q Consensus 666 -----------------------~~~-----~~-------------------~~~~g~~~y~aPE~~~~~~~~~~~Diws 698 (764)
... .. ...+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 00 0147999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCcHHHHHHHhhhhc
Q 004268 699 FGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 699 lG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
||||+|||+.|.+||...++.+...+ -........+.++.++|.+|+.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc
Confidence 99999999999999998877443222 2333344567899999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=343.79 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=217.7
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...|+....||+|+.|.||.|. ..+++.||||.+........ +-+..|+.+|+..+|+|||.+++.|...+..|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4578888899999999999996 55889999999987766543 6788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||+|.+.+.. ..+++.+++.|++++++||+||| .+||+|||||.+||+++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999964 34899999999999999999999 99999999999999999999999999999999987
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~~ 739 (764)
....+...+|||+|||||++....|+++.||||||++++||+-|++||-...+...... -....+..++...++
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 77778889999999999999999999999999999999999999999986665443332 234456668999999
Q ss_pred HHhhhhccc--hhhHHHhhhcCCC
Q 004268 740 YLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 740 ~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
|+.+||+.+ .+|-+..+...||
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChh
Confidence 999999988 6776777777776
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.40 Aligned_cols=235 Identities=23% Similarity=0.371 Sum_probs=209.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+-|++.+.+|.|+.|.|-.|++ .+|+.+|||++.+.....+.....+.+|+-+|+.+.||||+++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46688999999999999999975 58999999999887544444557889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
.||++||-|++++. ..+++++.+++++++||+.|+.|+| ..+|+|||+||+|+++|..+.+||+|||+|... .
T Consensus 91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE-V 163 (786)
T ss_pred EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc-c
Confidence 99999999999997 5567999999999999999999999 899999999999999999999999999999764 3
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccc---cccccCCcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSS---LSSSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 741 (764)
++....+.||+|.|.|||++.|.+| +.++||||+|||+|.|+||+.||++..- ...........+..++.++++++
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 5555677899999999999999999 5799999999999999999999996554 22344556677788999999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
.+|++.+
T Consensus 244 r~ml~VD 250 (786)
T KOG0588|consen 244 RRMLDVD 250 (786)
T ss_pred HHHhccC
Confidence 9999988
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.56 Aligned_cols=239 Identities=24% Similarity=0.400 Sum_probs=214.2
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|.+.+.+|+|.||.|-+|. +..|+.||||.+.++...++...-.+.+|++||+.++||||+.+|++|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4689999999999999999996 578999999999999988888888999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||..+|.|.+|+. +.+.+++.+++.+++||+.|+.|+| +++++|||+|.+||++|.++++||+|||++-.+.
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999998 5567999999999999999999999 9999999999999999999999999999998775
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccc--CCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--GRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 742 (764)
.....++++|++-|.+||++.|.+| ++..|-|||||++|.++.|..||++.+...... .......|..+.....+|+
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIR 284 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIR 284 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHH
Confidence 4455677899999999999999998 688999999999999999999999988743322 2333446677888999999
Q ss_pred hhhccchhhH
Q 004268 743 NFSQGNHRWE 752 (764)
Q Consensus 743 ~~l~~~~~~~ 752 (764)
.|+..++.-|
T Consensus 285 wmLmVNP~RR 294 (668)
T KOG0611|consen 285 WMLMVNPERR 294 (668)
T ss_pred HHHhcCcccc
Confidence 9999884433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.36 Aligned_cols=237 Identities=24% Similarity=0.401 Sum_probs=203.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCC-c-HHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETE-E-PAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 581 (764)
..++|.+.+.||+|+||+|+.|.+ .+++.||+|++.+.... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 467899999999999999999964 47899999977664221 1 123467779999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeeeccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLA 660 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~ 660 (764)
+|+||||+.||+|.+++.. ..++.+..++.+++|++.|++|+| ++||+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999984 457888999999999999999999 9999999999999999999 99999999999
Q ss_pred cccCCCCCCceecccccccccccccccCC-CC-ccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCC-c
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMA-VT-EKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRL-D 734 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~-~ 734 (764)
...........+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++..... .........+..+ +
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S 248 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLS 248 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCC
Confidence 88743445566789999999999999988 85 78999999999999999999999855322 2333444455556 9
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
.++..++.+|++.+
T Consensus 249 ~~~~~Li~~mL~~~ 262 (370)
T KOG0583|consen 249 PEARSLIEKMLVPD 262 (370)
T ss_pred HHHHHHHHHHcCCC
Confidence 99999999999988
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=306.28 Aligned_cols=237 Identities=30% Similarity=0.469 Sum_probs=211.7
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|.+.+.+|+|.||.||.|+ .+++-.||+|++.++........+++.+|+++.+.++||||.++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 36789999999999999999997 45788999999988776666666889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
++||...|.+...++.. ...++++.....++.|++.|+.|+| .++|+||||||+|++++..+.+|++|||.+....
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999854 3456888999999999999999999 9999999999999999999999999999997543
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 741 (764)
...+.+.+||..|.|||+..+..++...|+|++|++.||++.|.+||+.....+ ...+.....++.++..+.++|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 555677899999999999999999999999999999999999999999776432 234456666788999999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
..|+..+
T Consensus 254 ~~ll~~~ 260 (281)
T KOG0580|consen 254 SRLLVKN 260 (281)
T ss_pred HHHhccC
Confidence 9999876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=332.67 Aligned_cols=245 Identities=30% Similarity=0.429 Sum_probs=215.1
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...|+..+.||+|+||.||+|. ..+++.||+|++......++ .+.+++|+.++.+++++||.++|+.+..+..+|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3567778999999999999997 45899999999988776554 48899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||.||++.+.++. ...+++..+.-++++++.|+.|+| .++.+|||||+.||++..+|.+|++|||.+.....
T Consensus 90 Mey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999999973 334477888889999999999999 99999999999999999999999999999998877
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCC----cHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL----DLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 741 (764)
......+++||+.|||||++.+..|+.|+||||||++.+||.+|.+||...++...........+|.+ +...++|+
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 77777889999999999999999999999999999999999999999999999877777666666665 56789999
Q ss_pred hhhhccc--hhhHHHhhhcC
Q 004268 742 KNFSQGN--HRWENLLFKKF 759 (764)
Q Consensus 742 ~~~l~~~--~~~~~~~~~~~ 759 (764)
..|++++ .|+.+..+.+.
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHhhcCcccCcCHHHHhhh
Confidence 9999988 34434444433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=341.27 Aligned_cols=236 Identities=23% Similarity=0.385 Sum_probs=210.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|.+.+.+|+|+||.|++|..+ +++.+|||++++...-..+..+..+.|.+++... +||+++.++.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999865 7889999999998877777788999999999888 5999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
.||||+.||++..+. ....+++..++-++..|+.||.||| ++|||+||||.+||++|.+|++||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999944443 3456999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 740 (764)
--.+....+++|||.|+|||++.+..|+.+.|+|||||++|||+.|+.||.+.++.+ .+.......+..++.+...+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence 545556678999999999999999999999999999999999999999999877643 34444555566689999999
Q ss_pred Hhhhhccc
Q 004268 741 LKNFSQGN 748 (764)
Q Consensus 741 ~~~~l~~~ 748 (764)
++.++.++
T Consensus 599 l~~ll~k~ 606 (694)
T KOG0694|consen 599 MRRLLRKN 606 (694)
T ss_pred HHHHhccC
Confidence 99999988
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.77 Aligned_cols=240 Identities=24% Similarity=0.402 Sum_probs=204.1
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|++.+.||.|..++||+|+ ...+..||||++........ .+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 5789999999999999999997 55789999999987766544 68899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|+||.+|++.++++..... .+++..+..|.+++++||.||| ++|.||||||+.||||+++|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999865433 4899999999999999999999 99999999999999999999999999999877755
Q ss_pred CCCCc----eecccccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCC--------
Q 004268 666 DSSNR----TLVVGTYGYIAPELAY--TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNP-------- 731 (764)
Q Consensus 666 ~~~~~----~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~-------- 731 (764)
.+... ...+|+++|||||++. ..+|+.|+||||||++..|+.+|..||....+.++.......++|
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 44333 3458999999999954 347999999999999999999999999988876544333333333
Q ss_pred -----CCcHHHHHHHhhhhccchhhH
Q 004268 732 -----RLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 732 -----~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..+....+++..|+++++..|
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kR 284 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKR 284 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccC
Confidence 345567788888888774444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.67 Aligned_cols=235 Identities=27% Similarity=0.484 Sum_probs=203.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+.++..+.||+|.||+||.|.++....||+|.+....... +.|.+|+++|++++|++||++++++..++.+||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45567788899999999999999877799999998765443 67889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||+.|+|.++++.. ....+...+...++.||++|++||+ ++++|||||.++||||+++..+||+|||+|+....+
T Consensus 281 E~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999863 4566888999999999999999999 999999999999999999999999999999965433
Q ss_pred CCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHH
Q 004268 667 SSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 740 (764)
.... ....-...|.|||.+....++.|||||||||+||||+| |+.||.+.+..+. .....+..++.-|...-++
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 3221 22233568999999999999999999999999999998 9999998887443 4556777777778888999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
++.||..++
T Consensus 437 M~~CW~~~P 445 (468)
T KOG0197|consen 437 MKSCWHEDP 445 (468)
T ss_pred HHHHhhCCc
Confidence 999997663
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.65 Aligned_cols=206 Identities=28% Similarity=0.435 Sum_probs=184.5
Q ss_pred hcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+|...+.+|+|.||.||+|+ .++|+.||||++......+. ......+|++.++.++||||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 578888999999999999996 56899999999987754432 2356679999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++. +|+..++. ....++..+++.++.++++|++||| ++.|.||||||.|++++++|.+||+|||+|+.+.++
T Consensus 81 Efm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99985 99999975 4456899999999999999999999 999999999999999999999999999999999887
Q ss_pred CCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 004268 667 SSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~ 720 (764)
....+..+-|.+|+|||.+.|. .|+...|+||.||++.||+-|.+-|.+.++.+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 7777777889999999988876 68999999999999999999999998877643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.76 Aligned_cols=219 Identities=42% Similarity=0.731 Sum_probs=193.6
Q ss_pred CCCccCHHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEe
Q 004268 494 YDGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573 (764)
Q Consensus 494 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 573 (764)
....++++++..+++.|.-...||+|+||.||+|...+|+.||||++....... ..+|..|++++.+++|||+++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 345689999999999999999999999999999999988999999887655432 25699999999999999999999
Q ss_pred eEEeeCC-EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCE
Q 004268 574 GFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 574 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 652 (764)
|||.+.+ ..++|+|||++|+|.+.+...... .++|.++.+|+.++|+||+|||+.+...||||||||+|||+|++.++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999998 599999999999999999865433 78999999999999999999998777789999999999999999999
Q ss_pred EEeeeccccccCCCCCCceec-ccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 653 FVADFGLARLLHPDSSNRTLV-VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999999996654312222222 7999999999999999999999999999999999999888754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=315.60 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=205.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|.-|+||+|+.+ ++..+|+|++.+.......-..+++.|.+|++.++||.++.+|+.|+.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 456788899999999999999866 5689999999988877777778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||+||+|....+++ ....+++..++.++..++-||+||| -.|||.|||||+||||.++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999998876 5567999999999999999999999 88999999999999999999999999998754311
Q ss_pred ---------------------------------CCC-----------------------CceecccccccccccccccCC
Q 004268 666 ---------------------------------DSS-----------------------NRTLVVGTYGYIAPELAYTMA 689 (764)
Q Consensus 666 ---------------------------------~~~-----------------------~~~~~~g~~~y~aPE~~~~~~ 689 (764)
... ....++||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 011257899999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 690 VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 690 ~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.+.++|+|+|||++|||+.|..||.+....+-. ........+.++..+.++|++++.++
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999988764322 22334445567799999999999887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.55 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=202.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC--EEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 583 (764)
..+|...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.++++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 355777889999999999999754 59999999987663222 577899999999999999999999754444 699
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeeccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARL 662 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~ 662 (764)
+.|||+++|+|.+++.+... .+++..++.+.+||++||+||| ++|||||||||+|||++. ++.+||+|||.+..
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999986532 6999999999999999999999 999999999999999999 79999999999987
Q ss_pred cCC---CCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc-ccccc----cc-CCcCCCCCC
Q 004268 663 LHP---DSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLL-SSLSS----SS-GRKISQNPR 732 (764)
Q Consensus 663 ~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~-~~~~~----~~-~~~~~~~~~ 732 (764)
... .........||+.|||||++..+ ...+++||||+||++.||+||+.||... ..... .. ...-..+..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ 247 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS 247 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence 653 11223347899999999999953 3446999999999999999999999973 22111 11 112233555
Q ss_pred CcHHHHHHHhhhhccc--hhhHHHhhhcCCCC
Q 004268 733 LDLQCNAYLKNFSQGN--HRWENLLFKKFPYQ 762 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~--~~~~~~~~~~~p~~ 762 (764)
++.+..+|+.+|++++ ++|-...+-..||-
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 7889999999999988 67767777777764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.02 Aligned_cols=238 Identities=26% Similarity=0.397 Sum_probs=194.3
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH-----------HHHHHHHHHHHHHHhcCCCceeeE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP-----------AFLESFQTEARLLSQIRHRNIVKL 572 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~ 572 (764)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+...... ...+.+.+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 35689999999999999999999854 799999999976543221 113578999999999999999999
Q ss_pred eeEEeeC--CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 573 YGFCLHN--KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 573 ~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
+++..+. +.+|+|+|||..|.+...-. ....+++.++++++++++.||+||| .+|||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence 9998764 56999999999887654322 3334899999999999999999999 88999999999999999999
Q ss_pred CEEEeeeccccccCCC-----CCCceecccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 004268 651 EAFVADFGLARLLHPD-----SSNRTLVVGTYGYIAPELAYTMA----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS 721 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~ 721 (764)
+|||+|||.+...... .......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999999765322 11123368999999999987732 35789999999999999999999987665332
Q ss_pred -----ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 722 -----SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 -----~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.........+.+.....++|++|++++
T Consensus 328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~Kd 359 (576)
T KOG0585|consen 328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKD 359 (576)
T ss_pred HHHHhcCcccCCCcccccHHHHHHHHHHhhcC
Confidence 223445556667889999999999988
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.24 Aligned_cols=207 Identities=31% Similarity=0.501 Sum_probs=181.6
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 582 (764)
..+.|+.++.||+|.||.||+|+ ..+|+.||+|++...... +....-..+|+.++++++||||+++.+...+. +.+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 35667778899999999999997 558999999999765533 33456678999999999999999999998876 689
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+|+|||+. +|.-++.. ....+++.+++.++.|++.||+|+| ++||.|||||.+|||||.+|.+||+|||+|+.
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999986 88888763 3456999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCC-ceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 663 LHPDSSN-RTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 663 ~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
+...... .+..+-|.+|+|||.+.|. .|+++.|+||+|||+.||++|++.|.+.+++
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 7655433 5667889999999998877 6999999999999999999999999987764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.47 Aligned_cols=207 Identities=26% Similarity=0.397 Sum_probs=182.5
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCC-EE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNK-CM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~ 582 (764)
..++|++++.+|.|+||+||+|+ ..+|..||||++++.....++. .=.||++.+++++ ||||+++.+++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 56899999999999999999997 4589999999998876654332 2359999999998 999999999999888 89
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+|||||+. +|.++++.+ ...+++..++.|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+|+.
T Consensus 86 ~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence 999999986 999999864 567999999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCCceecccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS 721 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~ 721 (764)
+... ...+..+.|.+|+|||++. ..-|+.+.|+||+||+++|+.+-++-|.+.++.++
T Consensus 160 v~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 160 VRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred cccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 7643 3456678999999999764 55789999999999999999999999988876443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=307.10 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=213.4
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
-|.+++++|+|+||.||+|.++ +|+.||||.+..... .+++.+|+.++++++.|+||++||.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3667888999999999999754 899999999865443 4788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
||..|+..++++. ...++++.++..+++.-+.||+||| ...-||||||+.||++..+|.+||+|||.|.......
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999999985 3456999999999999999999999 7788999999999999999999999999998876665
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCC------cHHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL------DLQCNAYL 741 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 741 (764)
..+.+.+|||.|||||++....|+.++||||+|++..||.-|++||.++++.....-.-...+|.+ +...++++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 666778999999999999999999999999999999999999999999999877776666666654 45779999
Q ss_pred hhhhccchhhH--HHhhhcCCC
Q 004268 742 KNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 742 ~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+.|+-+.+.-| +..+.+.||
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhh
Confidence 99999885555 555666665
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.67 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=199.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-C-CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-S-GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||.||+|.++ + +..||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 567999999999999999999754 3 36899999875543333445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999974 345889999999999999999999 9999999999999999999999999999998654
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 741 (764)
.. .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+... .........++.++..+.+++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 32 234578999999999999899999999999999999999999998766532 112223334566788999999
Q ss_pred hhhhccchhh
Q 004268 742 KNFSQGNHRW 751 (764)
Q Consensus 742 ~~~l~~~~~~ 751 (764)
++|++.+..-
T Consensus 260 ~~~l~~dp~~ 269 (340)
T PTZ00426 260 KKLLSHDLTK 269 (340)
T ss_pred HHHcccCHHH
Confidence 9999987433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.22 Aligned_cols=233 Identities=23% Similarity=0.295 Sum_probs=195.5
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
+.||+|+||.||+|+.+ +|+.||+|++.............+.+|++++++++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999754 78999999997654433444567789999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCcee
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 672 (764)
+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 99999873 346889999999999999999999 999999999999999999999999999998764333333445
Q ss_pred cccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 673 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..|++.|+|||++.+..++.++||||+||++|||++|+.||...+.... ........+..++..+.+++++|++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 6799999999999999999999999999999999999999976543221 1122333455678999999999999874
Q ss_pred hhH
Q 004268 750 RWE 752 (764)
Q Consensus 750 ~~~ 752 (764)
.-|
T Consensus 235 ~~R 237 (323)
T cd05571 235 KQR 237 (323)
T ss_pred HHc
Confidence 433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.88 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=199.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46899999999999999999865 78999999987654333344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999974 345888999999999999999999 999999999999999999999999999999765432
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ........+...+..+.+++++
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence 2235689999999999999999999999999999999999999987654221 1122233344568899999999
Q ss_pred hhccchhhH
Q 004268 744 FSQGNHRWE 752 (764)
Q Consensus 744 ~l~~~~~~~ 752 (764)
|++.++.-|
T Consensus 232 ~l~~dp~~R 240 (291)
T cd05612 232 LLVVDRTRR 240 (291)
T ss_pred HcCCCHHHc
Confidence 999885443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.39 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=200.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|+++ +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 477999999999999999999865 7899999998765433334457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999874 345788899999999999999999 99999999999999999999999999999986643
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ........+..++..+.++++
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 2 2235789999999999999999999999999999999999999986654221 111222334447888999999
Q ss_pred hhhccchhhH
Q 004268 743 NFSQGNHRWE 752 (764)
Q Consensus 743 ~~l~~~~~~~ 752 (764)
+|++.++.-|
T Consensus 248 ~~L~~dP~~R 257 (329)
T PTZ00263 248 GLLQTDHTKR 257 (329)
T ss_pred HHhhcCHHHc
Confidence 9999885444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=293.10 Aligned_cols=235 Identities=22% Similarity=0.356 Sum_probs=200.2
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..+.|++.+.||+|.|+.||++. ..+|+.+|+|++........ ..+.+.+|++|.+.++||||+++.+.+......|+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45778899999999999999996 45899999998876555443 35789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~ 661 (764)
|+|+|.|++|..-+-. ..-+++..+..+++||++||.|+| .+||||||+||+|+++- ....+||+|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999998655432 134788889999999999999999 99999999999999995 34568999999999
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-------cccCCcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-------SSSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-------~~~~~~~~~~~~~~ 734 (764)
... ++.....++|||.|||||++...+|+..+||||.||++|-++.|.+||-+.+..+ ......-.+.+.++
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 887 5555566899999999999999999999999999999999999999998855422 12223333567789
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
+...+++.+|+..+
T Consensus 241 ~~Ak~LvrrML~~d 254 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVN 254 (355)
T ss_pred HHHHHHHHHHhccC
Confidence 99999999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.65 Aligned_cols=231 Identities=23% Similarity=0.332 Sum_probs=194.6
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|+||.||+|... +++.||+|++.............+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 6889999998764433334456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecc
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 674 (764)
.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 999974 345889999999999999999999 99999999999999999999999999999976443333334467
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 675 g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
|++.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ........+..++..+.+++++|++.++.-
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 89999999999999999999999999999999999999986543221 112223345567889999999999988555
Q ss_pred H
Q 004268 752 E 752 (764)
Q Consensus 752 ~ 752 (764)
|
T Consensus 235 R 235 (312)
T cd05585 235 R 235 (312)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=315.29 Aligned_cols=239 Identities=23% Similarity=0.304 Sum_probs=197.4
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|+..+.||+|+||+||+|.. .+|+.||+|.+.............+.+|++++++++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999975 5799999999876544333334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|..++... ....+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998887543 2335889999999999999999999 9999999999999999999999999999998754322
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 740 (764)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ ...........++....++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 235 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI 235 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 22335789999999999999999999999999999999999999986543111 1111223345578899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++||+.++.-|
T Consensus 236 i~~~l~~~P~~R 247 (285)
T cd05631 236 CRMLLTKNPKER 247 (285)
T ss_pred HHHHhhcCHHHh
Confidence 999999875444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=322.16 Aligned_cols=233 Identities=23% Similarity=0.299 Sum_probs=194.9
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
+.||+|+||.||+|+.. +|+.||+|++.............+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999754 78999999997654333344567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCcee
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 672 (764)
+|..++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 99988863 345889999999999999999999 899999999999999999999999999998764333333344
Q ss_pred cccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 673 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........+..++..+.+++++|++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 5789999999999999999999999999999999999999976654221 1122233445678899999999999885
Q ss_pred hhH
Q 004268 750 RWE 752 (764)
Q Consensus 750 ~~~ 752 (764)
.-|
T Consensus 235 ~~R 237 (323)
T cd05595 235 KQR 237 (323)
T ss_pred HHh
Confidence 444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.51 Aligned_cols=233 Identities=24% Similarity=0.373 Sum_probs=193.2
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+.++++++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999754 78999999997654433444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.+ ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999974 346889999999999999999999 999999999999999999999999999998754321
Q ss_pred CC-----------------------------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 004268 667 SS-----------------------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSH 711 (764)
Q Consensus 667 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~ 711 (764)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123479999999999999999999999999999999999999
Q ss_pred CCCcccccccccC-------CcCCCCCCCcHHHHHHHhhhhc
Q 004268 712 PTDLLSSLSSSSG-------RKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 712 Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
||.+......... ........++..+.+++.+++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 276 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC
Confidence 9987654321111 1122223467889999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=316.87 Aligned_cols=230 Identities=30% Similarity=0.469 Sum_probs=195.1
Q ss_pred CCccCHHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEee
Q 004268 495 DGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 495 ~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
...+.|+++.+ .+-+|+|+.|.||+|+.. ++.||||++... -..+++-+++|+||||+.+.|
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~el----------kETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhh----------hhhhHHHHHhccCcceeeEee
Confidence 34566666533 355999999999999987 889999987532 236788999999999999999
Q ss_pred EEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEE
Q 004268 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 575 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
+|.....++||||||..|.|..+++ ....+.......|..+||.|+.||| .+.|||||||.-||||+.+..|||
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEe
Confidence 9999999999999999999999998 4456788889999999999999999 899999999999999999999999
Q ss_pred eeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc-----CCC
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK-----ISQ 729 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~-----~~~ 729 (764)
+|||-++..... ...-.++||..|||||++...+.+.|+|||||||+||||+||..||.+.+...++...- ...
T Consensus 254 sDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 254 SDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred ccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC
Confidence 999999876544 33445789999999999999999999999999999999999999999998877665432 222
Q ss_pred CCCCcHHHHHHHhhhhccch
Q 004268 730 NPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~ 749 (764)
+..-+..+.-++++||+...
T Consensus 333 PstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred cccCchHHHHHHHHHHhcCC
Confidence 33345666778888888663
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=298.66 Aligned_cols=208 Identities=28% Similarity=0.373 Sum_probs=182.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 582 (764)
..+.|+.+..|++|+||.||+|+++ +++.||+|+++..... ..+--...+|+.++.+++|||||.+-.+.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3567888899999999999999754 8899999999766532 22233457999999999999999999987654 569
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+|||||+. +|..++..- ..++...+++.++.|+++|++||| .+.|+|||+||+|+++...|.+||+|||+|+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence 999999986 999999753 357899999999999999999999 99999999999999999999999999999999
Q ss_pred cCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~ 720 (764)
++.+....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.++.+
T Consensus 227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 98887777888899999999988876 68999999999999999999999998877643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.88 Aligned_cols=233 Identities=24% Similarity=0.295 Sum_probs=195.5
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
+.||+|+||.||+|+.. +++.||+|++.............+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999754 78999999997654444444577889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCcee
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 672 (764)
+|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 99988863 345889999999999999999999 999999999999999999999999999998764333333344
Q ss_pred cccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 673 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........+..++..+.+++++|++.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 5789999999999999999999999999999999999999976554221 1222333455678899999999999884
Q ss_pred hhH
Q 004268 750 RWE 752 (764)
Q Consensus 750 ~~~ 752 (764)
.-|
T Consensus 235 ~~R 237 (328)
T cd05593 235 NKR 237 (328)
T ss_pred HHc
Confidence 433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.32 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=196.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-CceeeEeeEEeeCCEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 586 (764)
+|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999755 678999999876543333345677889999999976 56889999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999999873 345788999999999999999999 899999999999999999999999999998754333
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
........|++.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.... ........+..++..+.+++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 3334456789999999999999999999999999999999999999986654221 1122233345678899999999
Q ss_pred hhccchhh
Q 004268 744 FSQGNHRW 751 (764)
Q Consensus 744 ~l~~~~~~ 751 (764)
|++.++.-
T Consensus 235 ~l~~~P~~ 242 (324)
T cd05587 235 LLTKHPAK 242 (324)
T ss_pred HhhcCHHH
Confidence 99987443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.43 Aligned_cols=236 Identities=23% Similarity=0.351 Sum_probs=195.3
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHH---HhcCCCceeeEeeEEeeCCEEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLL---SQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999754 7899999999765433333346677777665 456799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|...+.. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988753 35899999999999999999999 99999999999999999999999999999876443
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
.........|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+. ........+..++..+.++++
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 233 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 33334456789999999999999999999999999999999999999987654221 112223345567889999999
Q ss_pred hhhccchhhH
Q 004268 743 NFSQGNHRWE 752 (764)
Q Consensus 743 ~~l~~~~~~~ 752 (764)
+|++.++.-|
T Consensus 234 ~~L~~dP~~R 243 (324)
T cd05589 234 RLLRRNPERR 243 (324)
T ss_pred HHhhcCHhHc
Confidence 9999874444
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.00 Aligned_cols=232 Identities=23% Similarity=0.353 Sum_probs=192.2
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|++.+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999975 4789999999976554444456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|.+++.+ ...+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999874 345888999999999999999999 8999999999999999999999999999875331100
Q ss_pred -----------------------------------------------CCceecccccccccccccccCCCCccchHHHHH
Q 004268 668 -----------------------------------------------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFG 700 (764)
Q Consensus 668 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 700 (764)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 701 VVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 701 ~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
|++|||++|+.||.......... .........++.++.+++++++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999998665422111 11222233578899999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.48 Aligned_cols=235 Identities=26% Similarity=0.404 Sum_probs=209.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+.........+.+.+|+.+|+++. ||||+.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4578999999999999999999866 69999999998877765545678999999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC----CCEEEeeecc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN----LEAFVADFGL 659 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~ 659 (764)
+|||++.||.|.+.+... .+++..+..++.|++.|++|+| +.||+|||+||+|+++... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999754 3899999999999999999999 8999999999999999733 5799999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-------ccccCCcCCCCCC
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-------SSSSGRKISQNPR 732 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-------~~~~~~~~~~~~~ 732 (764)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.. ...........+.
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 998876 55667789999999999999999999999999999999999999999988742 2223345566777
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.++++.++..+
T Consensus 265 is~~akd~i~~ll~~d 280 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFD 280 (382)
T ss_pred cCHHHHHHHHHhcccC
Confidence 8999999999999987
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.80 Aligned_cols=236 Identities=22% Similarity=0.332 Sum_probs=196.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|.+++..+ .||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4888999999999999999765 6789999998765433333345667788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998863 345888999999999999999999 899999999999999999999999999999765433
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
........|++.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.... ........+..++..+.+++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 3333456789999999999999999999999999999999999999987654221 1122233345678899999999
Q ss_pred hhccchh
Q 004268 744 FSQGNHR 750 (764)
Q Consensus 744 ~l~~~~~ 750 (764)
|++.++.
T Consensus 235 ~l~~~p~ 241 (323)
T cd05616 235 LMTKHPG 241 (323)
T ss_pred HcccCHH
Confidence 9998743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.53 Aligned_cols=239 Identities=28% Similarity=0.466 Sum_probs=192.9
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
+++....++..+.+.||+|.||+||+|+|. ..||||++.......+ ..+.|+.|+..+++-+|.||+-+.||+..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 455555667788899999999999999985 3699999987766544 7899999999999999999999999999888
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
. .||+.+|+|.+|..+++-. ...++..+.+.|++||++|+.||| .++|||||+|..||++.+++.|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 7 9999999999999999753 346888999999999999999999 999999999999999999999999999998
Q ss_pred cccCC--CCCCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCCCCC
Q 004268 661 RLLHP--DSSNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKISQNP 731 (764)
Q Consensus 661 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~~~~ 731 (764)
..-.. .........|...|||||+++.+ +|++++||||||+++|||+||..||.......+.. .....+..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 65432 12222335678899999998754 68999999999999999999999999433322222 22223333
Q ss_pred CC----cHHHHHHHhhhhccc
Q 004268 732 RL----DLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~----~~~~~~~~~~~l~~~ 748 (764)
.. +....+++..||..+
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~ 636 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFD 636 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcC
Confidence 33 335556666677655
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.20 Aligned_cols=233 Identities=27% Similarity=0.410 Sum_probs=193.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999865 78999999997654333444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999874 345899999999999999999999 999999999999999999999999999998754321
Q ss_pred CC--------------------------------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHh
Q 004268 667 SS--------------------------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM 708 (764)
Q Consensus 667 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt 708 (764)
.. .....+||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012368999999999999999999999999999999999
Q ss_pred CCCCCCccccccccc-------CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 709 GSHPTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 709 g~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
|..||...+...... .........++..+.++++.|+.
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 999998765432111 11122233468899999999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.39 Aligned_cols=233 Identities=21% Similarity=0.361 Sum_probs=193.9
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999754 7899999999875544444456788999999998 799999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|..++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 999988863 346899999999999999999999 99999999999999999999999999999875433333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccCCcCCCCCCCcHHHHH
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------------SSSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~ 739 (764)
...|++.|+|||++.+..++.++|+||+||++|+|++|+.||+...... .........+..++..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5678999999999999999999999999999999999999997433211 0111222334567888999
Q ss_pred HHhhhhccchhhH
Q 004268 740 YLKNFSQGNHRWE 752 (764)
Q Consensus 740 ~~~~~l~~~~~~~ 752 (764)
++++|++.++.-|
T Consensus 235 li~~~L~~dP~~R 247 (329)
T cd05588 235 VLKGFLNKDPKER 247 (329)
T ss_pred HHHHHhccCHHHc
Confidence 9999999874444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.74 Aligned_cols=233 Identities=22% Similarity=0.297 Sum_probs=194.2
Q ss_pred eeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 514 YCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
+.||+|+||.||+|.. .+|+.||+|++.............+..|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999975 478999999997654433344567788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
+|..++.. ...+++..+..++.||+.||+||| + +||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99988863 345889999999999999999999 7 7999999999999999999999999999876433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||........ ........+..++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 45799999999999999999999999999999999999999976554221 112223334567889999999999988
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (325)
T cd05594 235 PKQR 238 (325)
T ss_pred HHHh
Confidence 4444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.56 Aligned_cols=233 Identities=27% Similarity=0.404 Sum_probs=192.2
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46899999999999999999754 78999999987644333444577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999873 345888999999999999999999 999999999999999999999999999998633210
Q ss_pred CC-----------------------------------------------CceecccccccccccccccCCCCccchHHHH
Q 004268 667 SS-----------------------------------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSF 699 (764)
Q Consensus 667 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 699 (764)
.. .....+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccccc-------cCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 700 GVVALEVLMGSHPTDLLSSLSSS-------SGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 700 G~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
||++|||++|..||......+.. ..........++..+.+++++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999999999765542211 111112223467899999999996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.31 Aligned_cols=232 Identities=25% Similarity=0.349 Sum_probs=195.0
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|.+. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999865 68999999997654333334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999973 345888999999999999999999 89999999999999999999999999999976543
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----c-CC--cCC----CCCCCcH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----S-GR--KIS----QNPRLDL 735 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~-~~--~~~----~~~~~~~ 735 (764)
......|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.. . .. ... ....++.
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 223457899999999999999999999999999999999999999865542210 0 00 001 1124578
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
.+.+++++|++..
T Consensus 232 ~~~~li~~~l~~~ 244 (333)
T cd05600 232 EAWDLITKLINDP 244 (333)
T ss_pred HHHHHHHHHhhCh
Confidence 9999999999755
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.94 Aligned_cols=240 Identities=21% Similarity=0.360 Sum_probs=208.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+-|.+.+.||+|.|+.|-+|++ -+|..||||++.+...+.. ....+.+|++.|+.++|||||++|++......+|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 56788899999999999999974 4899999999988776543 346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 664 (764)
.|.-++|+|++|+.++ ...+.+.-+++++.||+.|+.|+| +..+||||+||+||.+- .-|-|||.|||++-.+.
T Consensus 96 LELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999754 334888999999999999999999 88999999999999775 67899999999998876
Q ss_pred CCCCCceecccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVT-EKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 740 (764)
+ +...++.+|+..|.|||++.|..|+ ++.||||||||+|.+++|++||+...+.+- +..-....+..++.+|.++
T Consensus 171 P-G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 171 P-GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred C-cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 4 4455678999999999999999996 688999999999999999999998776543 3344455566789999999
Q ss_pred HhhhhccchhhHH
Q 004268 741 LKNFSQGNHRWEN 753 (764)
Q Consensus 741 ~~~~l~~~~~~~~ 753 (764)
|+.|+.++++-|+
T Consensus 250 I~sMLvRdPkkRA 262 (864)
T KOG4717|consen 250 IQSMLVRDPKKRA 262 (864)
T ss_pred HHHHHhcCchhhc
Confidence 9999999866553
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.78 Aligned_cols=232 Identities=23% Similarity=0.367 Sum_probs=191.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999754 788999999876544444455788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|.+++.+. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998742 45788999999999999999999 8999999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCceecccccccccccccccCCCCccchHHHHH
Q 004268 668 -----------------------------------------------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFG 700 (764)
Q Consensus 668 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 700 (764)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 701 VVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 701 ~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
|++|||++|+.||.+.+...... .........++....+++.+++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 288 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR 288 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc
Confidence 99999999999998765432111 11222234578888998888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.48 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=210.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE-EEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC-MFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~l 584 (764)
.++|..++.+|+|+||.++.++++ +++.+++|.+......++. .+...+|+.++++++|||||.+.+.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 367899999999999999999765 7889999999877766554 3477899999999999999999999999888 999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||+||+||++.+.+.+.. ...++++++..|+.|++.|+.||| +++|.|||||+.|||++.++.|||+|||+|+.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999998653 567999999999999999999999 8999999999999999999999999999999998
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCCCCCCCcHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 740 (764)
+........+||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...... ......+...+.+...+
T Consensus 158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 77766777899999999999999999999999999999999999999999877643322 22334444567888999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
++.+++.+++-|
T Consensus 238 v~~~l~~~P~~R 249 (426)
T KOG0589|consen 238 VKSMLRKNPEHR 249 (426)
T ss_pred HHHHhhcCCccC
Confidence 999998874443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.48 Aligned_cols=233 Identities=23% Similarity=0.364 Sum_probs=190.7
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+.. +++.||+|++...........+....|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999864 6889999998764433333345556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 999998873 346889999999999999999999 89999999999999999999999999999976543333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..... .......+..++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 567899999999999999999999999999999999999999876542211 11222234456888999999999988
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (316)
T cd05592 235 PTKR 238 (316)
T ss_pred HHHc
Confidence 5444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.56 Aligned_cols=233 Identities=26% Similarity=0.384 Sum_probs=193.3
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|+.+ +++.||+|++...........+.+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 6889999998764333333346677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 999998874 345889999999999999999999 99999999999999999999999999999876433333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........+..++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 56789999999999999999999999999999999999999987654322 112223334557889999999999987
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (320)
T cd05590 235 PTMR 238 (320)
T ss_pred HHHC
Confidence 5444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.11 Aligned_cols=235 Identities=24% Similarity=0.372 Sum_probs=193.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999865 688999999865433333334667899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|.+++... .+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||.+....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998632 4788899999999999999999 9999999999999999999999999999998764
Q ss_pred CCCC-CceecccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCC
Q 004268 665 PDSS-NRTLVVGTYGYIAPELAYTMA----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPR 732 (764)
Q Consensus 665 ~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~ 732 (764)
.... ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...+...... .........
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 3322 223457999999999987643 7889999999999999999999998665321111 111222234
Q ss_pred CcHHHHHHHhhhhcc
Q 004268 733 LDLQCNAYLKNFSQG 747 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~ 747 (764)
++..+.++++.+++.
T Consensus 274 ~s~~~~~li~~~L~~ 288 (370)
T cd05621 274 ISKHAKNLICAFLTD 288 (370)
T ss_pred CCHHHHHHHHHHccC
Confidence 688899999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.33 Aligned_cols=231 Identities=25% Similarity=0.391 Sum_probs=192.0
Q ss_pred eeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 514 YCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
+.||+|+||.||+|+. .+++.||+|++...... .......+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 36789999998754321 122235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999874 345778889999999999999999 89999999999999999999999999999875443333
Q ss_pred CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhh
Q 004268 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFS 745 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 745 (764)
......|++.|+|||++.+..++.++||||+||++|+|++|+.||........ ........++.++..+.+++++|+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 33445789999999999998999999999999999999999999987654221 112233345667889999999999
Q ss_pred ccchh
Q 004268 746 QGNHR 750 (764)
Q Consensus 746 ~~~~~ 750 (764)
+.++.
T Consensus 236 ~~~p~ 240 (323)
T cd05584 236 KRNPS 240 (323)
T ss_pred ccCHh
Confidence 98733
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.96 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=193.4
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999765 6889999998765433333446677889988876 799999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 999988863 345888999999999999999999 89999999999999999999999999999876543333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||......... .......+..++..+.++++.|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence 567899999999999999999999999999999999999999876543221 12222334457889999999999987
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 p~~R 238 (321)
T cd05591 235 PNKR 238 (321)
T ss_pred HHHc
Confidence 5444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.10 Aligned_cols=207 Identities=28% Similarity=0.389 Sum_probs=179.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc-eeeEeeEEeeCC----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN-IVKLYGFCLHNK---- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~---- 580 (764)
...|..+++||+|+||+||+|+. .+|+.||+|++...... +..-....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45577778899999999999974 48999999999876543 112256679999999999999 999999998877
Q ss_pred --EEEEEEEecCCCCHHHHHhcCccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 581 --CMFLIYEYMERGSLFCVLRNDVEA-VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 581 --~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..++|+||++. +|..++...... ..++...++.+++||+.|++||| ++||+||||||.||+|+++|.+||+||
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 89999999975 999999864322 34667889999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|+|+...-+....+..++|.+|+|||++.+. .|+...||||+|||++||+++++-|.+.++
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 9999877565656677899999999998887 789999999999999999999999988765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.00 Aligned_cols=233 Identities=23% Similarity=0.354 Sum_probs=191.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+|++.+.||+|+||.||+|+.. +++.||+|++.............+.+|++++++++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999754 78999999987543333333467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999974 345788889999999999999999 999999999999999999999999999997532100
Q ss_pred -------------------------------------------CCCceecccccccccccccccCCCCccchHHHHHHHH
Q 004268 667 -------------------------------------------SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVA 703 (764)
Q Consensus 667 -------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il 703 (764)
.......+||+.|+|||++.+..++.++||||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0001124689999999999999999999999999999
Q ss_pred HHHHhCCCCCCccccccccc-------CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 704 LEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 704 ~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
|+|++|+.||.+....+... .........++..+.+++.+|+.
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~ 284 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC 284 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc
Confidence 99999999998765432111 11222334578888999988763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.56 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=194.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3578999999999999999999765 789999999865433332334567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998642 4788889999999999999999 8999999999999999999999999999998764
Q ss_pred CCCC-CceecccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cCCcCCCCCC
Q 004268 665 PDSS-NRTLVVGTYGYIAPELAYTM----AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------SGRKISQNPR 732 (764)
Q Consensus 665 ~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~~~~ 732 (764)
.... ......|++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..... ........+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 3322 22345789999999998654 3788999999999999999999999876542111 1112233345
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.++++.|++.+
T Consensus 274 ~s~~~~~li~~~L~~~ 289 (370)
T cd05596 274 ISKQAKDLICAFLTDR 289 (370)
T ss_pred CCHHHHHHHHHHccCh
Confidence 7899999999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.02 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=200.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCC-CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeE-Eee-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSG-KLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGF-CLH----- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~-~~~----- 578 (764)
..++++.+.|.+|||+.||.|+...+ ..||+|++... ++...+.+.+|+++|+.|+ |||||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45788899999999999999986655 99999998765 4456789999999999996 9999999993 221
Q ss_pred -CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 579 -NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 579 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
...+++.||||+||.|-+++..+. ...+++.++.+|+.|+++|+++||+. +..|||||||-+||||+.+|..|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 135889999999999999998653 33499999999999999999999965 667999999999999999999999999
Q ss_pred ccccccCCCCCCce---------eccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-C
Q 004268 658 GLARLLHPDSSNRT---------LVVGTYGYIAPELA---YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-G 724 (764)
Q Consensus 658 g~~~~~~~~~~~~~---------~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-~ 724 (764)
|.++.......... ...-|+.|+|||++ .+.+.++|+|||||||+||.|+...+||++-....+.. .
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~ 270 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN 270 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence 99986543331111 13468999999976 57789999999999999999999999999887766654 4
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
..+...|+.+....++|+.||+.+..-
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~ 297 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDE 297 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCccc
Confidence 566667899999999999999877433
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.30 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=193.1
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 6889999999876544444456788899988877 899999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 999988863 346889999999999999999999 89999999999999999999999999999876433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccCCcCCCCCCCcHHHHH
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------------SSSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~ 739 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||....... .........+..++..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 5678999999999999999999999999999999999999996432211 0112223334557888999
Q ss_pred HHhhhhccchhhH
Q 004268 740 YLKNFSQGNHRWE 752 (764)
Q Consensus 740 ~~~~~l~~~~~~~ 752 (764)
++++|++.++.-|
T Consensus 235 ll~~~L~~dP~~R 247 (329)
T cd05618 235 VLKSFLNKDPKER 247 (329)
T ss_pred HHHHHhcCCHHHc
Confidence 9999999884444
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.52 Aligned_cols=233 Identities=27% Similarity=0.361 Sum_probs=187.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----E
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-----C 581 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 581 (764)
-.|...+.+|+|+||.||+|... +++.||||+...+.... .+|.++|+.++|||||++.-+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 45777899999999999999754 67999999987655432 37999999999999999998886432 3
Q ss_pred EEEEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeeecc
Q 004268 582 MFLIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGL 659 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~ 659 (764)
..+|||||+. +|..+++.. .....++...++-+.+||++||+||| +.||+||||||.|+++|.+ |.+||||||+
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 5689999986 888888732 12446788889999999999999999 8999999999999999965 9999999999
Q ss_pred ccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------- 723 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------- 723 (764)
|+........ .....|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|.+.+..++..
T Consensus 173 AK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 173 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9998765554 456789999999998876 68999999999999999999999998865421100
Q ss_pred --------------CCcC---CCCCCCcHHHHHHHhhhhccchhhH
Q 004268 724 --------------GRKI---SQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 724 --------------~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.... ......+++.-+++.+++++.+.-|
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 0000 1234567888999999998885444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.71 Aligned_cols=237 Identities=28% Similarity=0.456 Sum_probs=198.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
..+....+.||+|+||.||+|+.. +...||||.++..... ..+++|++|++++..++|||||+++|+|..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 445666788999999999999632 4557999999876543 34689999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc-----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE-----------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
.+++|+|||..|||.++|+.... ..+++..+...|+.|||.|++||- ++.+|||||..+|++|.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence 99999999999999999974321 234888999999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCce--ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc---
Q 004268 650 LEAFVADFGLARLLHPDSSNRT--LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS--- 723 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~--- 723 (764)
..|||+|||+++.+-..++... ...-..+|||||.+..+.|+.+|||||+||++||+++ |+.||.+.+..++..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999987644333221 1234679999999999999999999999999999997 999999998865543
Q ss_pred -CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 -GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
++....+..=|...-.++.+||+.+
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~ 745 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNEN 745 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcC
Confidence 2334444445778888999998766
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.54 Aligned_cols=203 Identities=27% Similarity=0.388 Sum_probs=173.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||.|+||+||+|..+ +++.||+|++........ ...+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc--chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 367999999999999999999755 789999999875433221 25677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ +|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||.+.....
T Consensus 82 ~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999985 898888642 234788899999999999999999 99999999999999999999999999999976543
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........+++.|+|||++.+ ..++.++||||+||++|+|+||++||.+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3333344578999999998865 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.51 Aligned_cols=232 Identities=23% Similarity=0.327 Sum_probs=192.0
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|+||+||+|.+. +++.||+|++...........+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999754 7899999998765444333446778899999999999999999999999999999999999999
Q ss_pred HHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceec
Q 004268 595 FCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673 (764)
Q Consensus 595 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 673 (764)
..++.... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 88875322 3346899999999999999999999 9999999999999999999999999999998765443333445
Q ss_pred ccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 674 VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 674 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
.|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ........++.++..+.+++.+|++
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999986533110 1111222345578899999999998
Q ss_pred cchh
Q 004268 747 GNHR 750 (764)
Q Consensus 747 ~~~~ 750 (764)
.++.
T Consensus 238 ~~P~ 241 (280)
T cd05608 238 KDPE 241 (280)
T ss_pred CCHH
Confidence 8733
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=314.89 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=194.8
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 586 (764)
+|++.+.||+|+||+||+|+.. +|+.||+|++...........+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3678899999999999999754 78999999987644333333466778889988885 578889999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999999873 345889999999999999999999 899999999999999999999999999998765433
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
........|++.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ........+..++..+.+++++
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 3333445689999999999999999999999999999999999999987654221 1122233345678899999999
Q ss_pred hhccch
Q 004268 744 FSQGNH 749 (764)
Q Consensus 744 ~l~~~~ 749 (764)
|++.++
T Consensus 235 ~l~~~p 240 (323)
T cd05615 235 LMTKHP 240 (323)
T ss_pred HcccCH
Confidence 998773
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.29 Aligned_cols=236 Identities=24% Similarity=0.312 Sum_probs=209.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|...+.+|+|.||.|.+++. .+++.+|+|++++...........-..|-++++..+||.+..+.-.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999974 48999999999988776666667778999999999999999999899999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+.||.|.-.+.+ ...+++...+.+...|+.||.||| +++||.||+|.+|.|+|.+|++||.|||+++.--.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988874 446888999999999999999999 99999999999999999999999999999987655
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 742 (764)
.+....+++|||.|.|||++....|+.+.|.|.+||++|||++|+.||...+... .+.......+..++++...++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 6666678999999999999999999999999999999999999999998766532 2334455667778999999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
.++.++
T Consensus 401 GLL~kd 406 (516)
T KOG0690|consen 401 GLLKKD 406 (516)
T ss_pred HHhhcC
Confidence 999766
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.35 Aligned_cols=233 Identities=26% Similarity=0.408 Sum_probs=197.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999865 79999999997654333334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ..+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999743 56889999999999999999999 899999999999999999999999999999876543
Q ss_pred C-----------------------------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 S-----------------------------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
. .......|++.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 12233578999999999999999999999999999999999999998765
Q ss_pred ccccc-------cCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 718 SLSSS-------SGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 718 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
..... ........+.++..+.++++.|+.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~ 270 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC 270 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence 42211 111222333468899999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.24 Aligned_cols=232 Identities=25% Similarity=0.374 Sum_probs=190.6
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHH-HHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|... +|+.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999865 78999999987644332222344555554 56788999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 999999874 346888999999999999999999 89999999999999999999999999999876433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+. .........+.++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 46789999999999999999999999999999999999999986543221 122334456678999999999999987
Q ss_pred hhh
Q 004268 749 HRW 751 (764)
Q Consensus 749 ~~~ 751 (764)
..-
T Consensus 235 p~~ 237 (323)
T cd05575 235 RTK 237 (323)
T ss_pred HHh
Confidence 333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.60 Aligned_cols=233 Identities=22% Similarity=0.340 Sum_probs=190.6
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+++ +|+.||+|++...........+....|.+++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999865 7889999998764322222235567788887765 899999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+...........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 999998873 345888999999999999999999 99999999999999999999999999999875433333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..... .......+..++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence 567899999999999999999999999999999999999999866542211 11122223446889999999999988
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (316)
T cd05620 235 PTRR 238 (316)
T ss_pred HHHc
Confidence 5555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.82 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=192.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|... +++.||+|++.............+.+|+.++..++||+|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999754 78999999997544333444577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.+ ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999999873 345889999999999999999999 999999999999999999999999999998754221
Q ss_pred CC-----------------------------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 004268 667 SS-----------------------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSH 711 (764)
Q Consensus 667 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~ 711 (764)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113468999999999999999999999999999999999999
Q ss_pred CCCccccccccc-------CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 712 PTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 712 Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
||...+...... .........++..+.+++.+++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 276 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT 276 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc
Confidence 998765432211 11112223467889999988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.14 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=203.2
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhc-CCCceeeEe
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQI-RHRNIVKLY 573 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~hpniv~~~ 573 (764)
.+-....+.|.-.+.+|+|..++|-++. ..+|+.+|+|++...... ..+..+.-.+|+.+++++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 3445567889999999999999999986 458899999998654322 233456678999999999 799999999
Q ss_pred eEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 574 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
++++.+..+++|+|.|+.|.|.+++. ....+++...++|++|+..|++||| .++|||||+||+||+++++.++|
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence 99999999999999999999999998 5567999999999999999999999 99999999999999999999999
Q ss_pred EeeeccccccCCCCCCceecccccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCccccc-------c
Q 004268 654 VADFGLARLLHPDSSNRTLVVGTYGYIAPELAY------TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-------S 720 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-------~ 720 (764)
|+|||+|+.+.+ +......+|||+|.|||.+. ..+|+...|+||+||++|.++.|.+||---.+. +
T Consensus 164 isDFGFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 164 ISDFGFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred EeccceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 999999998864 44456689999999999874 336788999999999999999999998544331 1
Q ss_pred cccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 721 SSSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+...++....+++.+|++.+
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVd 270 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVD 270 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeC
Confidence 2233344556667889999999999988
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=294.05 Aligned_cols=208 Identities=28% Similarity=0.415 Sum_probs=178.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-----
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----- 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 578 (764)
+...+|...+.||+|+||.|+.|..+ +|+.||||++..... .....++..+|+++++.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 44567777899999999999999754 899999999975443 33446788899999999999999999998865
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
-+.+|+|+|+|+ .+|...++. ...++...+..+++|+++||+|+| +.+|+|||+||+|++++.+..+||+|||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHc---CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence 346999999995 599999973 345899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCC--CCCceecccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 004268 659 LARLLHPD--SSNRTLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720 (764)
Q Consensus 659 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~ 720 (764)
+|+..... ....+..+.|.+|+|||+.. ...|+.+.||||+|||+.||++|++-|.+.+..+
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 99987542 33446678899999999764 5589999999999999999999999999887643
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.65 Aligned_cols=237 Identities=22% Similarity=0.357 Sum_probs=195.6
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.....++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3344689999999999999999999865 788999999865443333334667899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||+++|+|.+++... .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999998642 4788889999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCC-CceecccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cCCcCCC
Q 004268 662 LLHPDSS-NRTLVVGTYGYIAPELAYTMA----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------SGRKISQ 729 (764)
Q Consensus 662 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~ 729 (764)
....... ......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||...+..... .......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 7643322 223457999999999987543 788999999999999999999999876542111 1112233
Q ss_pred CCCCcHHHHHHHhhhhc
Q 004268 730 NPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~ 746 (764)
.+.++..+.+++..|++
T Consensus 271 ~~~~s~~~~~li~~~L~ 287 (371)
T cd05622 271 DNDISKEAKNLICAFLT 287 (371)
T ss_pred cCCCCHHHHHHHHHHcC
Confidence 44678899999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.92 Aligned_cols=233 Identities=24% Similarity=0.351 Sum_probs=193.4
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|... +++.||+|++...........+.+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999765 6889999999765433333346677899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 999988873 346899999999999999999999 99999999999999999999999999999875433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........+..++..+.+++++|++.+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence 45789999999999999999999999999999999999999986654221 112223334557889999999999988
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (318)
T cd05570 235 PEKR 238 (318)
T ss_pred HHHc
Confidence 4444
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.03 Aligned_cols=232 Identities=25% Similarity=0.357 Sum_probs=190.9
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHH-HHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|+.. +|+.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35899999999999754 78999999987654333333345555655 46778999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999988863 346889999999999999999999 89999999999999999999999999999876433333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+..+. .........+..+..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence 56789999999999999999999999999999999999999986654221 122333445678889999999999987
Q ss_pred hhh
Q 004268 749 HRW 751 (764)
Q Consensus 749 ~~~ 751 (764)
..-
T Consensus 235 p~~ 237 (325)
T cd05604 235 RQR 237 (325)
T ss_pred HHh
Confidence 333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.69 Aligned_cols=233 Identities=22% Similarity=0.357 Sum_probs=193.4
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999754 6889999999876544444557788999999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|..++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 999988863 345899999999999999999999 89999999999999999999999999999875433333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc----------cccCCcCCCCCCCcHHHHHHH
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS----------SSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~ 741 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||+...... .........+..++..+.+++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5679999999999999999999999999999999999999997543211 011122233445788899999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
++|++.++.-|
T Consensus 235 ~~~L~~dP~~R 245 (327)
T cd05617 235 KGFLNKDPKER 245 (327)
T ss_pred HHHhccCHHHc
Confidence 99998874433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.10 Aligned_cols=233 Identities=23% Similarity=0.320 Sum_probs=189.6
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHH-HHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||.||+|+.. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 68899999987644333333345555554 67888999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|...+.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 999988863 345788899999999999999999 89999999999999999999999999999875433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........++..+..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 46789999999999999999999999999999999999999986653211 112223344567788999999999988
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
..-|
T Consensus 235 p~~R 238 (321)
T cd05603 235 QRRR 238 (321)
T ss_pred Hhhc
Confidence 4443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.54 Aligned_cols=230 Identities=24% Similarity=0.351 Sum_probs=188.4
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHH-HHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEA-RLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|++. +++.||+|++.............+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 6788999998754332222223444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 999999874 345778889999999999999999 99999999999999999999999999999976443333344
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|++||......+. .........+.++..+.+++++|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence 56799999999999999999999999999999999999999986554321 122233445678899999999999987
Q ss_pred h
Q 004268 749 H 749 (764)
Q Consensus 749 ~ 749 (764)
.
T Consensus 235 p 235 (325)
T cd05602 235 R 235 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.46 Aligned_cols=203 Identities=27% Similarity=0.391 Sum_probs=173.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.. +++.||+|++........ ...+.+|+++++.++||||+++++++.++...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 478999999999999999999865 789999999875543322 24567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++ +++.+++... ...+++..++.++.|++.||+||| ++||+||||||+||++++++.+||+|||.+.....
T Consensus 82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 5777777542 345788999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 33333445688999999988654 57889999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.14 Aligned_cols=233 Identities=24% Similarity=0.366 Sum_probs=189.3
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||+|+||+||+|+.. +++.||+|++...........+....|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999865 6889999998764322222235566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 999999873 345788999999999999999999 99999999999999999999999999999875433333334
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...|++.|+|||++.+..++.++||||+||++|+|++|+.||...+...... ......+..++..+.+++.+|++.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence 4678999999999999999999999999999999999999998665422111 1112223446788999999999887
Q ss_pred hhhH
Q 004268 749 HRWE 752 (764)
Q Consensus 749 ~~~~ 752 (764)
+.-|
T Consensus 235 P~~R 238 (316)
T cd05619 235 PERR 238 (316)
T ss_pred Hhhc
Confidence 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.08 Aligned_cols=238 Identities=23% Similarity=0.307 Sum_probs=196.1
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|++.+.||+|+||+||++... +++.||+|++.............+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999754 789999999876544333333567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|..++... ....+++..+..++.|++.|+.||| +.|++||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888643 2345899999999999999999999 8999999999999999999999999999997654222
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 740 (764)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.+...... .........+.++..+.++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI 235 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence 22334789999999999988999999999999999999999999986543211 1111222344578889999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
++.|++.++.-
T Consensus 236 i~~~l~~~P~~ 246 (285)
T cd05605 236 CRQLLTKDPGF 246 (285)
T ss_pred HHHHccCCHHH
Confidence 99999987333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.86 Aligned_cols=235 Identities=26% Similarity=0.362 Sum_probs=191.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|..+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999854 68999999987543333334466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.+. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999999642 345888999999999999999999 999999999999999999999999999998765433
Q ss_pred CCC-ceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccc---c-c----CCcCCCCCC
Q 004268 667 SSN-RTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---S-S----GRKISQNPR 732 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~-~----~~~~~~~~~ 732 (764)
... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+. . . .......+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence 222 223468999999999863 4578899999999999999999999986543211 0 0 011112234
Q ss_pred CcHHHHHHHhhhhcc
Q 004268 733 LDLQCNAYLKNFSQG 747 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~ 747 (764)
++..+.+++++|+..
T Consensus 236 ~~~~~~~li~~ll~~ 250 (331)
T cd05597 236 VSEEAKDLIRRLICS 250 (331)
T ss_pred CCHHHHHHHHHHccC
Confidence 688999999998853
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=330.21 Aligned_cols=242 Identities=24% Similarity=0.371 Sum_probs=197.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|.+. +|+.||+|++.......+...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999765 68999999997655555555678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCcc--------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 587 EYMERGSLFCVLRNDVE--------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
||++|++|.+++..... ....++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123566778899999999999999 8999999999999999999999999999
Q ss_pred cccccCCCC------------------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 004268 659 LARLLHPDS------------------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS 720 (764)
Q Consensus 659 ~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~ 720 (764)
.+....... ......+||+.|+|||++.+..++.++||||+||++|+|+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652111 01122468999999999999999999999999999999999999998654322
Q ss_pred cccCCc------CCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 721 SSSGRK------ISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 721 ~~~~~~------~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
...... ......++....+++.+|++.++.-|
T Consensus 239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR 276 (932)
T PRK13184 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276 (932)
T ss_pred hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhC
Confidence 211111 11223467788899999998774433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=302.91 Aligned_cols=207 Identities=30% Similarity=0.460 Sum_probs=180.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.....++++||+|.||.|.++....+..||+|+++....... ...|.+|+++|.+++||||++++++|..++.+++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~--r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA--RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH--HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 456778899999999999999988789999999988776543 488999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||++|+|.+++.++.... .......+|+.||+.|++||. +.++||||+.++|++++.++++||+|||+++..-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998763222 455566789999999999999 889999999999999999999999999999865433
Q ss_pred CCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCccccc
Q 004268 667 SSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM--GSHPTDLLSSL 719 (764)
Q Consensus 667 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--g~~Pf~~~~~~ 719 (764)
.... ...+-..+|||||.+.-++++.++|+|+||+++||+++ ...||...++.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 3221 23455789999999999999999999999999999865 88999988763
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.96 Aligned_cols=237 Identities=25% Similarity=0.365 Sum_probs=192.5
Q ss_pred cCCcceeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
+|++.+.||+|+||.||+|+. .+++.||+|++.+.... .....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999965 36889999998653322 223346678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999863 345888999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCC-CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCC
Q 004268 663 LHPDSS-NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRL 733 (764)
Q Consensus 663 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~ 733 (764)
...... ......|++.|+|||++.+. .++.++||||+||++|+|+||+.||........ ........++.+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 543222 22345789999999998875 478899999999999999999999975432111 111122234457
Q ss_pred cHHHHHHHhhhhccchhh
Q 004268 734 DLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~ 751 (764)
+..+.+++++|++.++.-
T Consensus 235 ~~~~~~li~~~l~~dp~~ 252 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKK 252 (332)
T ss_pred CHHHHHHHHHHcCCCHHH
Confidence 889999999999987333
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.09 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=190.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+.+|+++++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46899999999999999999963 24568999998754322 2346788999999999 899999999988764
Q ss_pred -CEEEEEEEecCCCCHHHHHhcCcc-------------------------------------------------------
Q 004268 580 -KCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------- 603 (764)
Q Consensus 580 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 603 (764)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 458999999999999999874311
Q ss_pred ----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC--Cceeccccc
Q 004268 604 ----AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTY 677 (764)
Q Consensus 604 ----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~ 677 (764)
...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....... ......++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124778888999999999999999 89999999999999999999999999999976532221 112234567
Q ss_pred ccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 678 ~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.|+|||++.+..++.++||||+||++|||++ |..||.+...... ........+...+..+.+++.+|++.++.-
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999997 9999987543211 111112223456778999999999877433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.38 Aligned_cols=203 Identities=29% Similarity=0.403 Sum_probs=174.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|+++ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 47999999999999999999865 68899999987654322 23467789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++++.+..+.. ....+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9999877765543 2345888999999999999999999 899999999999999999999999999999876432
Q ss_pred CC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.. ......|++.|+|||++.+..++.++||||+||++|+|++|++||.+.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 21 2233568999999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.82 Aligned_cols=234 Identities=26% Similarity=0.377 Sum_probs=195.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|... +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999754 78999999998655433444577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.+. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999753 246889999999999999999999 999999999999999999999999999999876433
Q ss_pred CCC-ceecccccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCC
Q 004268 667 SSN-RTLVVGTYGYIAPELAY------TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPR 732 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 732 (764)
... .....|++.|+|||++. +..++.++||||+||++|+|++|+.||........ .........+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 222 22346899999999986 45678899999999999999999999976543221 11122233456
Q ss_pred CcHHHHHHHhhhhc
Q 004268 733 LDLQCNAYLKNFSQ 746 (764)
Q Consensus 733 ~~~~~~~~~~~~l~ 746 (764)
++..+.++++.|++
T Consensus 236 ~~~~~~~li~~ll~ 249 (330)
T cd05601 236 VSSDFLDLIQSLLC 249 (330)
T ss_pred CCHHHHHHHHHHcc
Confidence 78899999999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=275.34 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=197.6
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.+|+|||+-||.++ ..+++.||+|++.....+ ..+..++|++..++++||||++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 5799999999999999999997 568999999999876633 357889999999999999999999876543 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccc-cccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCCEEEeee
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEA-VELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..|++++|+..|+|.+.+++.... ..+++.++..|+.+|++||++|| +.. ++||||||.||++.+++.+++.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence 499999999999999999765433 36999999999999999999999 666 999999999999999999999999
Q ss_pred ccccccCCCCCCc---------eeccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCccccc------
Q 004268 658 GLARLLHPDSSNR---------TLVVGTYGYIAPELAYT---MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL------ 719 (764)
Q Consensus 658 g~~~~~~~~~~~~---------~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~------ 719 (764)
|+++...-.-... .....|..|+|||.+.- ...+.++|||||||++|.|+.|..||+...+.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9998654221111 11346889999998763 35688999999999999999999999866542
Q ss_pred cccc-CCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 720 SSSS-GRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 720 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.... ....+..++.+....++++.|++.++.-|
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qR 287 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQR 287 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccC
Confidence 1222 34555666789999999999999884433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.30 Aligned_cols=239 Identities=26% Similarity=0.413 Sum_probs=196.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECC--C--CE-EEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS--G--KL-VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++..+.+.||+|+||.||+|..+. + .. ||+|..............++.+|+++|++++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4455566899999999999997542 2 23 89999887555556678999999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
+++|||+|.||+|.++++.... .++..+...++.+.+.||+||| +++++||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999986432 5889999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc-----CCcCCCCCCCcH
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS-----GRKISQNPRLDL 735 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~-----~~~~~~~~~~~~ 735 (764)
.............-...|+|||.+....|++++|||||||++||+++ |..||.+....+... ......+..-+.
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~ 390 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK 390 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence 64311111111224578999999999999999999999999999998 899999887643322 233444445567
Q ss_pred HHHHHHhhhhccchh
Q 004268 736 QCNAYLKNFSQGNHR 750 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~ 750 (764)
.....+++|+..+..
T Consensus 391 ~~~~~~~~c~~~~p~ 405 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPE 405 (474)
T ss_pred HHHHHHHHhccCChh
Confidence 788888888887743
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=332.77 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=210.1
Q ss_pred HHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 502 EMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 502 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
++.-..++|.+++.||+|+||.|..++++ +++.||+|++.+-..-......-|..|-.+|..-+.+-|++++-+|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33344678999999999999999999865 78999999998744332333467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
++|+|||||+||+|..++... ..+++..++.++..|+-||+.+| +.|+|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence 999999999999999999743 36999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCC-ceecccccccccccccc----c-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----c--cCCcC
Q 004268 661 RLLHPDSSN-RTLVVGTYGYIAPELAY----T-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-----S--SGRKI 727 (764)
Q Consensus 661 ~~~~~~~~~-~~~~~g~~~y~aPE~~~----~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-----~--~~~~~ 727 (764)
..+..++.. ....+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...+-.+- . .....
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 988755543 34578999999999875 2 4689999999999999999999999976543211 1 11233
Q ss_pred CCCCCCcHHHHHHHhhhhccc--------------hhhHHHhhhcCCCCCC
Q 004268 728 SQNPRLDLQCNAYLKNFSQGN--------------HRWENLLFKKFPYQNL 764 (764)
Q Consensus 728 ~~~~~~~~~~~~~~~~~l~~~--------------~~~~~~~~~~~p~~r~ 764 (764)
++...+|....++|+.++..- |+| |..++|.+|
T Consensus 303 P~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpF----F~g~~W~~i 349 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPF----FEGIDWDNI 349 (1317)
T ss_pred CcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCcc----ccCCChhhh
Confidence 344668999999999999743 444 777777654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.72 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=192.2
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+++.. +++.||+|++.............+.+|..+++.++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 78899999987543333333456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.+. ...+++..+..++.|++.||+|+| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999742 235788999999999999999999 999999999999999999999999999999776433
Q ss_pred CCC-ceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-----CcC---CCCCC
Q 004268 667 SSN-RTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-----RKI---SQNPR 732 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-----~~~---~~~~~ 732 (764)
... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+.... ... .....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence 222 223568999999999876 4678899999999999999999999986553221111 011 11233
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.+++.+|+...
T Consensus 236 ~~~~~~~li~~ll~~~ 251 (331)
T cd05624 236 VSEEAKDLIQRLICSR 251 (331)
T ss_pred CCHHHHHHHHHHccCc
Confidence 5788999999988743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.66 Aligned_cols=232 Identities=26% Similarity=0.363 Sum_probs=193.3
Q ss_pred eeeeecCceeEEEEEE----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 514 YCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
+.||+|+||.||+++. .+|+.||+|++....... .....+..|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999964 368899999987543321 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 669 (764)
++++|.+++.+ ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999999863 345899999999999999999999 899999999999999999999999999999765444333
Q ss_pred ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 670 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.... ........+..++..+.++++.|++
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 3446789999999999998899999999999999999999999987654221 1122233345678899999999999
Q ss_pred cchhhH
Q 004268 747 GNHRWE 752 (764)
Q Consensus 747 ~~~~~~ 752 (764)
.++.-|
T Consensus 235 ~~P~~R 240 (318)
T cd05582 235 RNPANR 240 (318)
T ss_pred cCHhHc
Confidence 884443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.11 Aligned_cols=348 Identities=30% Similarity=0.438 Sum_probs=228.1
Q ss_pred ccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCc-ccCCcccCCCCCCC
Q 004268 16 TCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT-GTIPSEIGSLRDLL 94 (764)
Q Consensus 16 ~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~ 94 (764)
+.|++++.|.|.+..+. .+|+.++.|.+|++|.++||++. .+-..++.++.|+.+++..|++. +-+|..+-.+..|.
T Consensus 29 ~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt 106 (1255)
T KOG0444|consen 29 EQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLT 106 (1255)
T ss_pred HHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccce
Confidence 35567777777777775 67777777777777777777776 34445667777777777777765 23555566667777
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 174 (764)
.||||+|+++ ..|..+...+++-.|+||+|+|..++...|.+++.|-.||||+|++..+ |.-...+..|++|.|++|.
T Consensus 107 ~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 107 ILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred eeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCCh
Confidence 7777777776 5566666666666666666666666666666666666666666666633 3345555666666666665
Q ss_pred CCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccc-cccCccccCCCCCCEEEccCCcccCCCCc
Q 004268 175 LSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT-GSIPSTIGYLNLLDELHLSHNRLDGPIPP 253 (764)
Q Consensus 175 i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 253 (764)
+... ....+-.|++|+.|++++.+=+ ..+|..+..+.+|..+|+|+|.+. +.|.
T Consensus 185 L~hf------------------------QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe 239 (1255)
T KOG0444|consen 185 LNHF------------------------QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE 239 (1255)
T ss_pred hhHH------------------------HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence 5432 2223334555555666554433 245556666667777777777776 6667
Q ss_pred CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCcc-CCChhhhcccc
Q 004268 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS-SIPPELMNCSQ 332 (764)
Q Consensus 254 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~ 332 (764)
++..+++|+.|+||+|+|+. ..-......+|++|+||.|+++ ..|.+++.+++|+.|++.+|+++- -+|..++.+.+
T Consensus 240 cly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ 317 (1255)
T ss_pred HHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence 77777777777777777763 3334445566777777777776 566777777777777777777652 35667777777
Q ss_pred cceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccC
Q 004268 333 LLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 333 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 396 (764)
|+.+..++|.+. ..|..++.+..|+.|.|+.|++- ++|+++.-++.|+.||+..|+=-..+|
T Consensus 318 Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 318 LEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 777777777776 67777777777777777777776 667777777777777777776443333
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.77 Aligned_cols=200 Identities=29% Similarity=0.400 Sum_probs=176.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|++. ++..||+|.+..... +...+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999865 788999998875432 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++++|.+++.. ...+++..+..++.|++.|+.||| ++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999974 335888999999999999999999 64 69999999999999999999999999987653
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
.. ......|++.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 223356899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.44 Aligned_cols=235 Identities=31% Similarity=0.464 Sum_probs=199.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-C---CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-S---GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
....+.+.||.|.||.|++|+.+ . ...||||.++....+ .+...|..|+.||-+++||||+++.|+......++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34567789999999999999865 2 346999999876654 34588999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
||+|||++|+|..+++.+ .+++.+.+...+++.|+.|++||- +.++|||||.++||||+.+..+|++|||+++..
T Consensus 707 IiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999864 467999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCCCc-eeccc--ccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcH
Q 004268 664 HPDSSNR-TLVVG--TYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDL 735 (764)
Q Consensus 664 ~~~~~~~-~~~~g--~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~ 735 (764)
.++.... +...| ..+|.|||.+.-..++.+|||||+|+++||.++ |..||=+.+..+... ......+..=|.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 5544222 22223 468999999999999999999999999999875 999988777755433 344444555578
Q ss_pred HHHHHHhhhhccch
Q 004268 736 QCNAYLKNFSQGNH 749 (764)
Q Consensus 736 ~~~~~~~~~l~~~~ 749 (764)
.+..++..||++++
T Consensus 862 aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDR 875 (996)
T ss_pred HHHHHHHHHHHHHh
Confidence 88999999999883
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.40 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=211.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
....|.+.+.||+|.|+.|..|++. ++..||+|.+.+.........+ +.+|+++|+.++|||||+++.+......+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3578999999999999999999754 8999999999988776655444 8899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+.+|.+++++.+ .++..+..++.++.|+..|++|+| +++|||||||++||+++.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999984 345666888999999999999999 9999999999999999999999999999999886
Q ss_pred CCCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 740 (764)
........+|++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++..-.... .......+-.++.+|.++
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 4445566899999999999999987 58999999999999999999999976543222 223444455678999999
Q ss_pred Hhhhhccc------------hhhHHHhhhc
Q 004268 741 LKNFSQGN------------HRWENLLFKK 758 (764)
Q Consensus 741 ~~~~l~~~------------~~~~~~~~~~ 758 (764)
+++++-.+ ++|+...+.+
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99997655 7888766655
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.82 Aligned_cols=193 Identities=35% Similarity=0.581 Sum_probs=164.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc--CCCceeeEeeEEeeCC----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI--RHRNIVKLYGFCLHNK---- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~---- 580 (764)
....+..+.||+|.||.||+|+.. ++.||||++.... .+.++.|.+|++.. +|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 455666788999999999999987 6999999996433 37788898888876 7999999999876655
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC------CCCcEEcCCCCCCeeecCCCCEEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC------KPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
.+++|++|.+.|+|.+|++.+ .++|....+++..+++||+|||+.. +.+|+|||||.+||||..+++..|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 799999999999999999754 5899999999999999999999653 667999999999999999999999
Q ss_pred eeeccccccCCCCCC--ceecccccccccccccccCC-CC-----ccchHHHHHHHHHHHHhCC
Q 004268 655 ADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMA-VT-----EKCDVYSFGVVALEVLMGS 710 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~-~~-----~~~DiwslG~il~~lltg~ 710 (764)
+|||+|..+.+.... ....+||.+|||||++.+.. +. .+.||||+|.++|||+++-
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 999999988654322 22368999999999988762 22 2689999999999999764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.80 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=191.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|+..+.||+|+||+||+|.+. +++.||+|++..... ....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 355677889999999999999755 789999999865432 33457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.... ...+..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||++.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999886432 2456778889999999999999 89999999999999999999999999999987654
Q ss_pred CCCCceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCC
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRL 733 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~ 733 (764)
.........|+..|+|||++.. ...+.++|||||||++|||++|+.||......+. ............
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 3333344578999999998743 2345689999999999999999999973322110 011122234456
Q ss_pred cHHHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 734 DLQCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
+..+.++++.||+.+ .|+-.....+.||
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 789999999999887 3333333444444
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.50 Aligned_cols=235 Identities=27% Similarity=0.359 Sum_probs=190.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+++.+ +++.||+|++.+...........+..|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999865 67889999986533333333456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.+. ...+++..++.++.||+.|++||| ++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999742 335888999999999999999999 999999999999999999999999999998765333
Q ss_pred CCC-ceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------Cc-CCCCCC
Q 004268 667 SSN-RTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RK-ISQNPR 732 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~-~~~~~~ 732 (764)
... .....|++.|+|||++. ...++.++||||+||++|||++|+.||...+..+.... .. ......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 222 22357899999999986 34678899999999999999999999986654221111 01 111234
Q ss_pred CcHHHHHHHhhhhcc
Q 004268 733 LDLQCNAYLKNFSQG 747 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~ 747 (764)
++..+.+++++|+..
T Consensus 236 ~s~~~~~li~~ll~~ 250 (332)
T cd05623 236 VSEDAKDLIRRLICS 250 (332)
T ss_pred CCHHHHHHHHHHccC
Confidence 688999999998854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.24 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=210.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|.++..+|.|+||.||+|..+ ++-..|.|++.... .+..+.+.-|++|+..++||+|+++++.|...+.+||+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 355778888999999999999765 44455667775433 33468899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
.|||.||....++-. -...+.+.++.-+++|++.||.||| +++|||||+|+.||+++-+|.++|+|||.+.....
T Consensus 108 iEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 999999999888764 3446899999999999999999999 99999999999999999999999999999977655
Q ss_pred CCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCC------c
Q 004268 666 DSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL------D 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~------~ 734 (764)
.......++|||+|||||+.. ..+|++++||||||+++.||..+.+|.+...+..+..+.....+|.+ +
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 555566789999999999864 56899999999999999999999999999999887777666666654 5
Q ss_pred HHHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 735 LQCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 735 ~~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
....++++.|+.++ .+|.+-.+.+.||
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 57899999999988 5666666666665
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=321.74 Aligned_cols=326 Identities=33% Similarity=0.429 Sum_probs=249.9
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcc-cCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTG-RIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 95 (764)
.+.+|++|.++.|+++ .+...+..++.|+.+++.+|++.. -+|..+-.+..|++||||+|+++ ..|..+..-+++..
T Consensus 53 ~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iV 130 (1255)
T KOG0444|consen 53 RLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIV 130 (1255)
T ss_pred HHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEE
Confidence 3447999999999997 677889999999999999999972 35667778999999999999999 78999999999999
Q ss_pred EecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 96 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
|+||+|+|.+|....|.+|..|-.||||+|++..+ |.-+..+.+|++|+|++|.+...--.-+..+++|+.|++++.+-
T Consensus 131 LNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR 209 (1255)
T KOG0444|consen 131 LNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR 209 (1255)
T ss_pred EEcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence 99999999988888999999999999999999965 55678899999999999999755445566778888888887764
Q ss_pred C-CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcC
Q 004268 176 S-GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPT 254 (764)
Q Consensus 176 ~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 254 (764)
+ ...|..+..+.+|..+| +|.|.+. ..|+++-.+.+|+.|+||+|+|+ .+...
T Consensus 210 Tl~N~Ptsld~l~NL~dvD------------------------lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~ 263 (1255)
T KOG0444|consen 210 TLDNIPTSLDDLHNLRDVD------------------------LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMT 263 (1255)
T ss_pred hhhcCCCchhhhhhhhhcc------------------------ccccCCC-cchHHHhhhhhhheeccCcCcee-eeecc
Confidence 4 12334444444444444 4444444 44555555555555555555555 22233
Q ss_pred CcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccC-CCCCCCCCCCccceEEccCCcCccCCChhhhccccc
Q 004268 255 IGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG-PIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333 (764)
Q Consensus 255 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 333 (764)
.+...+|+.|+||.|+++ ..|.++..++.|+.|.+.+|+++- -+|+.++.+.+|+.+..++|.+. .+|+.++.|..|
T Consensus 264 ~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL 341 (1255)
T KOG0444|consen 264 EGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL 341 (1255)
T ss_pred HHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH
Confidence 344455666666666665 455566666666666666666542 36778888999999999999998 889999999999
Q ss_pred ceeeccccccccCCchhcccccccceeecccccccCCCCCC
Q 004268 334 LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQ 374 (764)
Q Consensus 334 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 374 (764)
+.|.|++|++. .+|+.+--++.|+.|||..|+--..+|..
T Consensus 342 ~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP 381 (1255)
T KOG0444|consen 342 QKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP 381 (1255)
T ss_pred HHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence 99999999988 78888888999999999999866455543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.53 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=210.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|+.-+.||+|+||.||-++. .+|+.+|.|++.+........-.....|..++++++.++||.+--+|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 34577778899999999999975 48999999998776655444345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+..|.||+|.-.+.... ...+++..++.++.+|+.||++|| +.+||.||+||+||++|+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999998887553 356999999999999999999999 99999999999999999999999999999998864
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~ 738 (764)
.. .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||..-..... ..........+++.++.
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak 418 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK 418 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence 43 34446999999999999999999999999999999999999999975543211 11223334567889999
Q ss_pred HHHhhhhccchhh-------------HHHhhhcCCCCCC
Q 004268 739 AYLKNFSQGNHRW-------------ENLLFKKFPYQNL 764 (764)
Q Consensus 739 ~~~~~~l~~~~~~-------------~~~~~~~~p~~r~ 764 (764)
.+.+.+++++..- .-..|++.+|+|+
T Consensus 419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 9999999988111 1223777777774
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.81 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=201.4
Q ss_pred eeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCC
Q 004268 515 CIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 593 (764)
.+|+|.||+||.|++. +...+|||.+...... ..+-+..|+.+.++++|.|||+++|.+.+++++-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5899999999999855 5678999998765443 34678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEeeeccccccCCCCCCcee
Q 004268 594 LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGLARLLHPDSSNRTL 672 (764)
Q Consensus 594 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 672 (764)
|.++++.......-.+..+..+.+||++||.||| +..|||||||-+||+|. -.|.+||+|||-+++...-.....+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999986444434478888899999999999999 89999999999999996 6799999999999998777777778
Q ss_pred cccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCccccccc--c----cCCcCCCCCCCcHHHHHHHhhh
Q 004268 673 VVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS--S----SGRKISQNPRLDLQCNAYLKNF 744 (764)
Q Consensus 673 ~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~ 744 (764)
+.||..|||||++..+ +|+.++|||||||++.||.||++||........ - .+..-..+..++..++.||.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 8999999999999866 588999999999999999999999987765321 1 1223333445678999999999
Q ss_pred hccchhhH--HHhhhcCCC
Q 004268 745 SQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 745 l~~~~~~~--~~~~~~~p~ 761 (764)
...+.+-| +..+..+||
T Consensus 816 Fepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred cCCCcccCccHHHhccCcc
Confidence 98875444 444556665
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.65 Aligned_cols=231 Identities=25% Similarity=0.355 Sum_probs=185.9
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
||+|+||+||+|+.. +++.||+|++................|..++... +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 7899999998754433333334555677777665 699999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|..++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 999998873 346889999999999999999999 89999999999999999999999999999876443333344
Q ss_pred ecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 672 LVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
...|++.|+|||++.+. .++.++||||+||++|+|++|+.||......... ..........++..+.+++++|++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence 56799999999998765 4789999999999999999999999765432211 111111223468899999999999
Q ss_pred cchhhH
Q 004268 747 GNHRWE 752 (764)
Q Consensus 747 ~~~~~~ 752 (764)
.++.-|
T Consensus 235 ~~P~~R 240 (330)
T cd05586 235 RNPQHR 240 (330)
T ss_pred CCHHHC
Confidence 874443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.95 Aligned_cols=228 Identities=21% Similarity=0.319 Sum_probs=188.8
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCEEEEEEEec
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKCMFLIYEYM 589 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~ 589 (764)
..||+|++|.||+|.. +|+.||+|.+...........+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999988 489999999987665555556788899999999999999999999877 45689999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
++|+|.+++... ..+++.....++.|++.|+.|+| + .+++||||||+||++++++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999743 45888999999999999999999 6 489999999999999999999999999997654321
Q ss_pred Cceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCcCCCCCCCcHHHHHHH
Q 004268 669 NRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 741 (764)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. .......+...+..+.+++
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 255 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence 23467899999999876 67899999999999999999999999876543211 1112222235678899999
Q ss_pred hhhhccchhh
Q 004268 742 KNFSQGNHRW 751 (764)
Q Consensus 742 ~~~l~~~~~~ 751 (764)
.+||+.++.-
T Consensus 256 ~~cl~~dp~~ 265 (283)
T PHA02988 256 EACTSHDSIK 265 (283)
T ss_pred HHHhcCCccc
Confidence 9999877433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.80 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=197.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++.+.+..+|.|+.|.||+++.+ +|...|||.+.+....++ .+++...+.++... ++|+||+.+|+|..+..+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 345566677999999999999855 789999999988766543 47888888887766 58999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
.||.|.. ....++++ ...++++.-+-++...++.||.||.+ .+||+|||+||+||++|+.|++|+||||.+.++.
T Consensus 169 cMelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee
Confidence 9999854 55666654 34468888889999999999999986 5599999999999999999999999999998875
Q ss_pred CCCCCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccc-cccccCCcCCCCCC------Cc
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSS-LSSSSGRKISQNPR------LD 734 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~-~~~~~~~~~~~~~~------~~ 734 (764)
.. ...+...|-+.|||||.+... .|+.++||||||++++|+.||++||.+... .+...+.....+|. ++
T Consensus 244 dS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 244 DS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred cc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 33 233446789999999998754 688899999999999999999999998543 23322222223332 67
Q ss_pred HHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 735 LQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.+..++.+.|++++|+-| -..+-+.||
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 889999999999997766 334455555
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.80 Aligned_cols=201 Identities=31% Similarity=0.442 Sum_probs=169.0
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----CEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----KCM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 582 (764)
+|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|++++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5889999999999999999754 78999999987543222 2235688999999999999999999987543 348
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+||||++ ++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999996 689888863 345889999999999999999999 99999999999999999999999999999976
Q ss_pred cCCCCC---Cceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 663 LHPDSS---NRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 663 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
...... ......|++.|+|||++.+ ..++.++||||+||++|+|++|++||.+..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 532221 1133578999999999876 578999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.78 Aligned_cols=199 Identities=24% Similarity=0.418 Sum_probs=175.9
Q ss_pred hcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-C-----CceeeEeeEEeeCC
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-H-----RNIVKLYGFCLHNK 580 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~ 580 (764)
.+|.+.+.||+|+||.|.+|. .++++.||||+++... .+..+...|+.++..++ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 489999999999999999996 5589999999997654 34577789999999996 4 48999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC--CCCEEEeeec
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--NLEAFVADFG 658 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg 658 (764)
+.|||+|.++ .+|.++++.+ ....++...++.++.||+.||.+|| +.||||+||||+|||+.+ ...|||+|||
T Consensus 262 HlciVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999996 4999999976 3445999999999999999999999 999999999999999974 3479999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
+|+.....- ...+++..|+|||++.|.+|+.+.||||||||++||++|.+-|.+.++
T Consensus 337 SSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 998754322 257899999999999999999999999999999999999988887654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.66 Aligned_cols=238 Identities=25% Similarity=0.372 Sum_probs=190.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-----------------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCce
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-----------------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 569 (764)
.++|++.+.||+|+||.||+|.+++ +..||+|.+..... ......+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999997532 33699999875432 2335678999999999999999
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCc----------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDV----------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 633 (764)
+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+||| ++|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLN 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCC
Confidence 999999999999999999999999999986421 1124677889999999999999999 899
Q ss_pred cEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh--C
Q 004268 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM--G 709 (764)
Q Consensus 634 iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--g 709 (764)
|+||||||+||+++.++.+||+|||.++........ .....++..|+|||++.+..++.++||||+|+++|+|++ |
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999765432211 122345778999999998899999999999999999986 6
Q ss_pred CCCCCcccccccc-----------cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 710 SHPTDLLSSLSSS-----------SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 710 ~~Pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..||...+..... .......++..+..+.+++.+|++.++
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCc
Confidence 7888765542211 111122345567889999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=293.64 Aligned_cols=230 Identities=22% Similarity=0.300 Sum_probs=186.4
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|+||+||+++.+ +|+.||+|.+.............+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999754 7999999998754433222234556799999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecc
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 674 (764)
..++... ....+++..+..++.|++.|++||| ++||+||||||+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 9888643 2334788999999999999999999 9999999999999999999999999999987764322 223356
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc----c---ccC-CcCCCCCCCcHHHHHHHhhhhc
Q 004268 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS----S---SSG-RKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 675 g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~----~---~~~-~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
|+..|+|||++.+..++.++||||+||++|+|++|+.||....... . ... ........++.+..++++.|++
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence 8899999999999899999999999999999999999997543210 0 000 1111123568899999999998
Q ss_pred cchh
Q 004268 747 GNHR 750 (764)
Q Consensus 747 ~~~~ 750 (764)
.++.
T Consensus 236 ~~P~ 239 (277)
T cd05607 236 KKPE 239 (277)
T ss_pred cCHh
Confidence 8733
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.13 Aligned_cols=235 Identities=24% Similarity=0.357 Sum_probs=189.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+.+.||+|+||+||+|+.+ +++.||+|.+........ ...+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 367999999999999999999765 788999999875443322 24567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ ++.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 83 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999985 788877642 234788899999999999999999 89999999999999999999999999999976543
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------------------
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------------- 723 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------------- 723 (764)
.........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...+..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 3333334567899999998865 467899999999999999999999997654311000
Q ss_pred ---CC---------cCCCCCCCcHHHHHHHhhhhccch
Q 004268 724 ---GR---------KISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 724 ---~~---------~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.. .....+.++....+++++|++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 274 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYES 274 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCCh
Confidence 00 011224567888999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.69 Aligned_cols=235 Identities=22% Similarity=0.232 Sum_probs=193.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC-C-CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-S-GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..|.+.+.||+|++|.||+|... + ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 45999999999999999999654 4 6788888764432 23346678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++|+|.+++... .....+++..+..++.|++.||+|+| ++||+||||||+||+++.++.+||+|||++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999888642 23346888999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCCCCCCCcHHHH
Q 004268 665 PDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~ 738 (764)
.... .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||......+... ......+..++..+.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 3221 1234568999999999999999999999999999999999999998665422111 111122345678899
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
+++..|++.+
T Consensus 301 ~li~~~L~~d 310 (478)
T PTZ00267 301 ALLDPLLSKN 310 (478)
T ss_pred HHHHHHhccC
Confidence 9999999877
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=294.37 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=195.8
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|+..+.||+|+||+||+|... +++.||+|.+.............+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999754 789999999876554444444567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ....+++..+..++.|++.||.||| ++||+||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999988643 2335889999999999999999999 8999999999999999999999999999987654222
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-------cccCCcCCCCCCCcHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-------SSSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 740 (764)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... .............+....++
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 2223478999999999999999999999999999999999999998643211 00111122334567888999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++|++.++.-|
T Consensus 236 i~~~l~~~p~~R 247 (285)
T cd05630 236 CKMLLCKDPKER 247 (285)
T ss_pred HHHHhhcCHHHc
Confidence 999999885444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=300.96 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=175.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999865 788899998865432 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++++|.+++.. ...+++..+..++.|++.|+.||| +. +|+||||||+||++++++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999974 335788899999999999999999 64 79999999999999999999999999987653
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
.. ......|+..|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22 123346889999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=285.24 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=171.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc--CCCceeeEeeEEeeCC---
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI--RHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~--- 580 (764)
..++.++.+.||+|.||+||+|+++ |+.||||++...+. +...+|.++++.. +|+||+.+++.-..+.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4578899999999999999999998 99999999976442 5677899998876 9999999998865543
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCeeecCCCCEEE
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD-----CKPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
.+|+|++|.+.|+|.+|+.+. .++.....+++..++.||++||.+ .+..|+|||||..||||..++...|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 489999999999999999753 588899999999999999999943 3678999999999999999999999
Q ss_pred eeeccccccCCCCC----CceecccccccccccccccCC----C--CccchHHHHHHHHHHHHhC----------CCCCC
Q 004268 655 ADFGLARLLHPDSS----NRTLVVGTYGYIAPELAYTMA----V--TEKCDVYSFGVVALEVLMG----------SHPTD 714 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~----~--~~~~DiwslG~il~~lltg----------~~Pf~ 714 (764)
+|+|+|........ .....+||.+|||||++...- + -..+||||||.++||+.-+ +.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999988755422 234578999999999986542 1 1368999999999999742 67888
Q ss_pred ccccccc
Q 004268 715 LLSSLSS 721 (764)
Q Consensus 715 ~~~~~~~ 721 (764)
+.-+.+.
T Consensus 438 d~Vp~DP 444 (513)
T KOG2052|consen 438 DVVPSDP 444 (513)
T ss_pred cCCCCCC
Confidence 7765444
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=304.30 Aligned_cols=231 Identities=28% Similarity=0.382 Sum_probs=191.8
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
..|.-.+.||.|+||.||-|++ .+...||||++.-......+-...+.+|++.+++++|||++.+.|+|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4466677899999999999974 478899999998777666666788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||-| +-.+++.- ...++.+..+..|..+.++||+||| +.+.||||||+.||++++.|.|||+|||+|....+.
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99975 66777653 2345788899999999999999999 999999999999999999999999999999877544
Q ss_pred CCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCC-----cHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRL-----DLQCN 738 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~~~ 738 (764)
..++|||+|||||++. .+.|+-++||||||++..|+.-+++|+-................|.+ +..+.
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 3479999999999874 56899999999999999999999999876666544444444444444 33455
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
.|+..|+++.
T Consensus 256 ~Fvd~CLqKi 265 (948)
T KOG0577|consen 256 NFVDSCLQKI 265 (948)
T ss_pred HHHHHHHhhC
Confidence 6666666544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.36 Aligned_cols=204 Identities=28% Similarity=0.413 Sum_probs=169.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC--CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEe-----
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS--SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCL----- 577 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~----- 577 (764)
++|++.+.||+|+||+||+|+.. +++.||+|.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 47999999999999999999753 468899998875443321 124456777777766 6999999999885
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
.....++||||++ ++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2456899999997 5898888643 2335889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|.+...... .......|++.|+|||++.+..++.++||||+||++|+|++|++||.+...
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 999765433 223345789999999999988999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=273.59 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=193.2
Q ss_pred CHHHHHHHhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEE
Q 004268 499 TFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFC 576 (764)
Q Consensus 499 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 576 (764)
.++++.+.++ +.+|+|+|+.|--+. .++|..||||++.+.... ...++.+|++++.++ .|+||++++++|
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 3555555544 459999999999885 678999999999876433 347889999999999 599999999999
Q ss_pred eeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEE
Q 004268 577 LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAF 653 (764)
Q Consensus 577 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~k 653 (764)
+++..+|+|||-|.||+|...+++ ...+++.++.++..+|+.||.||| .+||.|||+||+||+-.+.. -||
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence 999999999999999999999874 446899999999999999999999 99999999999999997544 479
Q ss_pred EeeeccccccCCCC-------CCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCccccc--
Q 004268 654 VADFGLARLLHPDS-------SNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-- 719 (764)
Q Consensus 654 l~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-- 719 (764)
||||.++.-+.... ....+.+|+..|||||++. ...|+.++|.|||||++|-|+.|.+||.+.=..
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99999887653221 1223468999999999763 235789999999999999999999999765321
Q ss_pred ----------------ccccCCc----CCCCCCCcHHHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 720 ----------------SSSSGRK----ISQNPRLDLQCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 720 ----------------~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
+.+.... ..+...++.+..+++.+++.++ ++..+..+...||
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 1111111 1123336778888888888766 3333444444444
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.62 Aligned_cols=193 Identities=27% Similarity=0.342 Sum_probs=167.9
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||+|+||.||+|.+ .+++.||+|.... +.+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 35799999999999999999975 4789999996432 4567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+|++. ++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 162 ~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99996 688888763 345788999999999999999999 89999999999999999999999999999975432
Q ss_pred C-CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 666 D-SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 666 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
. ........||+.|+|||++.+..++.++||||+||++|+|++|+.||-.
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 2 1222345799999999999999999999999999999999999988643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=313.92 Aligned_cols=239 Identities=23% Similarity=0.286 Sum_probs=196.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK---- 580 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 580 (764)
..++|++.+.||+|+||+||+|+. .+|+.||+|++...... ......+.+|+.++..++|++++++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457999999999999999999975 47999999998765443 333567889999999999999999988765432
Q ss_pred ----EEEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 581 ----CMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 581 ----~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
.+++||||+++|+|.+++.... ....+++..+..++.|++.||+|+| ++||+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 3789999999999999986432 2346889999999999999999999 9999999999999999999999999
Q ss_pred eeccccccCCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----ccCCcCCC
Q 004268 656 DFGLARLLHPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----SSGRKISQ 729 (764)
Q Consensus 656 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----~~~~~~~~ 729 (764)
|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999997654321 222345789999999999999999999999999999999999999986554221 11122234
Q ss_pred CCCCcHHHHHHHhhhhccc
Q 004268 730 NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~ 748 (764)
++.++..+.++++.|++.+
T Consensus 266 ~~~~~~~l~~li~~~L~~d 284 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSD 284 (496)
T ss_pred CCCCCHHHHHHHHHHcccC
Confidence 5567889999999999877
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.41 Aligned_cols=236 Identities=21% Similarity=0.287 Sum_probs=194.6
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|+..+.||+|+||+||+|.+. +++.||+|.+.............+.+|++++++++|++|+++.+++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999754 789999999876544433334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|..++... ....+++..+..++.|++.||.||| ++||+||||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888643 2345899999999999999999999 9999999999999999999999999999987654222
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 740 (764)
......|+..|+|||++.+..++.++|+||+|+++|+|++|+.||........ .........+.++....++
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence 22335789999999999999999999999999999999999999986543210 0111122345577888999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+..|++.++
T Consensus 236 i~~~l~~~P 244 (285)
T cd05632 236 CKMLLTKDP 244 (285)
T ss_pred HHHHccCCH
Confidence 999998774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.11 Aligned_cols=235 Identities=28% Similarity=0.411 Sum_probs=199.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999765 68999999987655444445577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ..+++..+..++.|++.||+||| ++|++||||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998743 46889999999999999999999 899999999999999999999999999999876433
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHhh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.... ........+...+..+.+++++
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence 2334688999999999888889999999999999999999999986653221 1122233345568899999999
Q ss_pred hhccchhh
Q 004268 744 FSQGNHRW 751 (764)
Q Consensus 744 ~l~~~~~~ 751 (764)
|++.++.-
T Consensus 232 ~l~~~p~~ 239 (290)
T cd05580 232 LLQVDLTK 239 (290)
T ss_pred HccCCHHH
Confidence 99887443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.63 Aligned_cols=199 Identities=23% Similarity=0.363 Sum_probs=164.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 467999999999999999999764 78999999885432 2335799999999999999999876432
Q ss_pred --CEEEEEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEe
Q 004268 580 --KCMFLIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVA 655 (764)
Q Consensus 580 --~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~ 655 (764)
..+++||||+++ ++.+++... .....+++..++.++.||+.||+||| ++||+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 247799999985 676666421 23456889999999999999999999 99999999999999999654 79999
Q ss_pred eeccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|||+|+....... .....|++.|+|||++.+. .++.++||||+||++|+|++|.+||.+..
T Consensus 214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987643322 2335789999999998764 68999999999999999999999998754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=289.92 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=191.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||.||+|.++ .+..||+|.+...... .....+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999643 4568999998765432 3346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++|+|.+++... ...+++..+..++.|++.|++||| ++|++||||||+||+++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998743 346889999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 663 LHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 663 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
....... .....++..|+|||.+.+..++.++||||+||++||+++ |+.||......+.. .......++..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNL 236 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 4222111 111234578999999999999999999999999999775 99999876543211 11122334456788
Q ss_pred HHHHHhhhhccchh
Q 004268 737 CNAYLKNFSQGNHR 750 (764)
Q Consensus 737 ~~~~~~~~l~~~~~ 750 (764)
..+++.+||+.++.
T Consensus 237 ~~~li~~c~~~~p~ 250 (266)
T cd05064 237 LHQLMLDCWQKERG 250 (266)
T ss_pred HHHHHHHHcCCCch
Confidence 89999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=304.71 Aligned_cols=240 Identities=27% Similarity=0.404 Sum_probs=191.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+.+|+++++.+ +||||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 4568999999999999999998642 3457999999765433 2346788999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCcc-------------------------------------------------------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------- 603 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 603 (764)
.+..++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998854211
Q ss_pred ------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC--
Q 004268 604 ------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN-- 669 (764)
Q Consensus 604 ------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 669 (764)
..++++..+.+++.||+.||+||| ++||+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 124778889999999999999999 899999999999999999999999999999765432211
Q ss_pred ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc-----cCCcCCCCCCCcHHHHHHHhh
Q 004268 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-----SGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 670 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.....++..|+|||++.+..++.++||||+||++|+|++ |+.||......... .......+...+....++++.
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 350 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM 350 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence 112234567999999998899999999999999999997 99999865432111 111222333457889999999
Q ss_pred hhccchh
Q 004268 744 FSQGNHR 750 (764)
Q Consensus 744 ~l~~~~~ 750 (764)
|++.++.
T Consensus 351 cl~~dp~ 357 (374)
T cd05106 351 CWNLEPT 357 (374)
T ss_pred HcCCChh
Confidence 9987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=294.32 Aligned_cols=229 Identities=26% Similarity=0.384 Sum_probs=195.8
Q ss_pred ceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 513 KYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.+.+|+|.||+||-|++ ++|+.||||++.+....... ...++.|+.|++.+.||.||.+...|+..+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 46799999999999974 58999999999887766543 27889999999999999999999999999999999999987
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEeeeccccccCCCCC
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~ 668 (764)
.-|+.++.. +.+++++...+.++.||+.||.||| .++|+|+|+||+||++.+ -.++||||||+|+.++.. .
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s 721 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S 721 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence 666666653 5678999999999999999999999 899999999999999964 357999999999988643 4
Q ss_pred CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---CcCCCC--CCCcHHHHHHHhh
Q 004268 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RKISQN--PRLDLQCNAYLKN 743 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~ 743 (764)
.+...+|||.|.|||+++.+.|...-|+||+|||+|--+.|..||....+...+.+ ...... ..++....++|.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 45567999999999999999999999999999999999999999987776543322 222222 3368899999999
Q ss_pred hhccc
Q 004268 744 FSQGN 748 (764)
Q Consensus 744 ~l~~~ 748 (764)
+++..
T Consensus 802 LLqVk 806 (888)
T KOG4236|consen 802 LLQVK 806 (888)
T ss_pred HHHHH
Confidence 99966
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=303.78 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=192.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||.||+|.+ .++..||+|++...... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 356899999999999999999953 24668999998754432 2246788999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCcc-------------------------------------------------------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------- 603 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 603 (764)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864211
Q ss_pred -----------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 604 -----------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 604 -----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124678889999999999999999 899999999999999999999999999999865432
Q ss_pred CCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----cc-CCcCCCCCCCcHHHH
Q 004268 667 SSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SS-GRKISQNPRLDLQCN 738 (764)
Q Consensus 667 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~-~~~~~~~~~~~~~~~ 738 (764)
... .....++..|+|||++.+..++.++||||+||++|+|++ |..||........ .. ......+...+..+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY 347 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence 211 112234567999999999999999999999999999998 8999976543211 11 111222334577899
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++..|++.++.-|
T Consensus 348 ~li~~cl~~dP~~R 361 (375)
T cd05104 348 DIMKSCWDADPLKR 361 (375)
T ss_pred HHHHHHccCChhHC
Confidence 99999998774433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.64 Aligned_cols=237 Identities=27% Similarity=0.386 Sum_probs=197.3
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|.+.+.||+|++|.||+|..+ +++.|++|.+...... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 4788899999999999999764 7899999998654433 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ....+++..+..++.|++.|+.||| ++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999999753 2346889999999999999999999 8999999999999999999999999999998765444
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCcCCC-CCCCcHHHHHHHhh
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRKISQ-NPRLDLQCNAYLKN 743 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~ 743 (764)
.......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||.......... ...... ....+..+.+++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 33344568899999999999999999999999999999999999998665422111 111111 22467889999999
Q ss_pred hhccchh
Q 004268 744 FSQGNHR 750 (764)
Q Consensus 744 ~l~~~~~ 750 (764)
|++.++.
T Consensus 236 ~l~~~p~ 242 (256)
T cd08529 236 CLTKDYR 242 (256)
T ss_pred HccCCcc
Confidence 9986633
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.72 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=196.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|+||.||+++.. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++.+.+++..|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5888999999999999999765 7899999998654322 234778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|++++++.+++... ....+++..+..++.|++.|+.||| ++|++|+||||+||++++++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999988643 2345788999999999999999999 9999999999999999999999999999998765444
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHhh
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+..... .......+..++....+++++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 3334457889999999999989999999999999999999999999865532211 111222234467788999999
Q ss_pred hhccchhhH
Q 004268 744 FSQGNHRWE 752 (764)
Q Consensus 744 ~l~~~~~~~ 752 (764)
|++.++.-|
T Consensus 235 ~l~~~P~~R 243 (255)
T cd08219 235 MFKRNPRSR 243 (255)
T ss_pred HHhCCcccC
Confidence 998764433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.84 Aligned_cols=239 Identities=28% Similarity=0.446 Sum_probs=197.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
....+..+.||+|+||.||+|... .|. .||+|.+.+.... .....|.+|..+|+.++||||++++|++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345666788999999999999644 343 4888888765544 34589999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV----EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
..+|++|||++|+|..++++.+ ....++..+...++.|||+|++||+ ++++|||||.++|+|++....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999998642 1446889999999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCCc-eec-ccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCC
Q 004268 657 FGLARLLHPDSSNR-TLV-VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQ 729 (764)
Q Consensus 657 fg~~~~~~~~~~~~-~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~ 729 (764)
||+|+.+-...... ... .-...|||||.+..+.++.|+|||||||++||++| |..||...+..+.. ...+..+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 99999654332222 111 23468999999999999999999999999999998 99999988875432 2335556
Q ss_pred CCCCcHHHHHHHhhhhccchh
Q 004268 730 NPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~ 750 (764)
++.-+...-+++++||+-++.
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe 946 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPE 946 (1025)
T ss_pred CCCCChHHHHHHHHHccCChh
Confidence 666677778999999987643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.20 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=200.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
...+|++.+.||+|++|.||+|.. .+++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 357899999999999999999985 479999999987544332 3667899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||.+....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999999863 24788899999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc------CCCCCCCcHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK------ISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~ 738 (764)
..........+++.|+|||...+..++.++|+||+|+++|++++|+.||...+......... ...+..++....
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 44433344578889999999999889999999999999999999999997655432211111 112334567788
Q ss_pred HHHhhhhccch--hhHHHhhhcCCC
Q 004268 739 AYLKNFSQGNH--RWENLLFKKFPY 761 (764)
Q Consensus 739 ~~~~~~l~~~~--~~~~~~~~~~p~ 761 (764)
+++.+|++.++ ++......+.||
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCch
Confidence 99999998762 333333444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=289.84 Aligned_cols=204 Identities=26% Similarity=0.365 Sum_probs=173.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4888999999999999999864 78999999986543322 223667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|++ +++.+++........+++..+..++.|++.||+||| ++|++||||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 998 588888875444456899999999999999999999 8999999999999999999999999999997654333
Q ss_pred CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.......+++.|+|||++.+. .++.++||||+|+++|+|+||++||.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 333334568899999987654 46889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.96 Aligned_cols=232 Identities=26% Similarity=0.418 Sum_probs=194.9
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||+|++|.||+|.. .+++.|++|.+....... .+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 46899999999999999999975 478999999987654432 36788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ..+++.++..++.|++.|++||| +.||+||||||+||+++.++.+||+|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999863 24788899999999999999999 89999999999999999999999999999886644
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~~ 739 (764)
.........+++.|+|||.+.+..++.++||||+||++|+|++|+.||........... .....+..++....+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 33333345788999999999988899999999999999999999999976654221110 111223456778899
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++.+|++.+
T Consensus 249 li~~~l~~~ 257 (296)
T cd06654 249 FLNRCLDMD 257 (296)
T ss_pred HHHHHCcCC
Confidence 999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.49 Aligned_cols=202 Identities=33% Similarity=0.480 Sum_probs=176.0
Q ss_pred cCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC------E
Q 004268 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK------C 581 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~ 581 (764)
-|...+.+|+|+||.||+|+ ..+|+.||||.+.......+ .++..+|++++++++|||||+++++-++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34556779999999999998 45899999999987664443 478899999999999999999999765543 5
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCC--CEEEeee
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNL--EAFVADF 657 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~Df 657 (764)
..+|||||.||+|+..+++-.....+++.+...++.++..||.||| ++|||||||||.||++- .+| ..||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 7899999999999999997777778999999999999999999999 89999999999999985 223 4699999
Q ss_pred ccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
|.|+..+.+. .....+||..|.+||++.. +.|+..+|.||+||++|+..||..||.-.
T Consensus 169 G~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 169 GAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999886544 5677899999999999984 78899999999999999999999998643
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=285.50 Aligned_cols=237 Identities=25% Similarity=0.413 Sum_probs=192.4
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 46799999999999999999985 478899999986543322 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.|++||| ++||+||||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 999999999998863 345788999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---Cc-----CCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RK-----ISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~-----~~~~~~~~ 734 (764)
.........++..|+|||.+. ...++.++|+||+||++|+|++|+.||........... .. ......++
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence 333333456888999999874 34578899999999999999999999975543321111 00 11122356
Q ss_pred HHHHHHHhhhhccchhhH
Q 004268 735 LQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~ 752 (764)
..+.+++++|++.++.-|
T Consensus 239 ~~~~~li~~~l~~~P~~R 256 (267)
T cd06646 239 STFHNFVKISLTKNPKKR 256 (267)
T ss_pred HHHHHHHHHHhhCChhhC
Confidence 788899999997764433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.63 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=193.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|... +++.||+|.+.............+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999754 78999999887655445555677889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++.... ....+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2334788999999999999999999 89999999999999999999999999999887654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc--ccccCCcC-CC----CCCCcHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL--SSSSGRKI-SQ----NPRLDLQCN 738 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~--~~~~~~~~-~~----~~~~~~~~~ 738 (764)
.........+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ........ .. ....+....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 333333456888999999999888999999999999999999999999644321 11011011 11 123456788
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
+++.+|++.+
T Consensus 239 ~li~~cl~~~ 248 (267)
T cd08228 239 ELVSMCIYPD 248 (267)
T ss_pred HHHHHHCCCC
Confidence 8888888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=286.01 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=188.8
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|.+ .+++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 3688899999999999999975 4789999999865432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++++++..+. .+++..+..++.|++.|++||| +.||+|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999986553 3677888999999999999999 999999999999999999999999999999765432
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------------cCCcCCCCCCCc
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------------SGRKISQNPRLD 734 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------------~~~~~~~~~~~~ 734 (764)
......++..|+|||++.+..++.++|+||+|+++|+|++|+.||......... ...........+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 223357899999999999999999999999999999999999999754321110 000111123467
Q ss_pred HHHHHHHhhhhccchh
Q 004268 735 LQCNAYLKNFSQGNHR 750 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~ 750 (764)
..+.+++.+|++.++.
T Consensus 227 ~~~~~li~~~l~~~P~ 242 (279)
T cd06619 227 EKFVHFITQCMRKQPK 242 (279)
T ss_pred HHHHHHHHHHhhCChh
Confidence 7899999999987733
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=284.38 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=196.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|... +|+.||+|.+...........+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999866 89999999987655444444678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|..++.... ....+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986432 2345789999999999999999999 89999999999999999999999999999876644
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc--cc---ccCCcC-CCC-CCCcHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL--SS---SSGRKI-SQN-PRLDLQCN 738 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~--~~---~~~~~~-~~~-~~~~~~~~ 738 (764)
.........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... +. ...... ..+ +..+....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 333333456888999999999989999999999999999999999999654321 00 001111 111 24566888
Q ss_pred HHHhhhhccch
Q 004268 739 AYLKNFSQGNH 749 (764)
Q Consensus 739 ~~~~~~l~~~~ 749 (764)
+++.+|++.++
T Consensus 239 ~~i~~cl~~~p 249 (267)
T cd08224 239 DLVSRCINPDP 249 (267)
T ss_pred HHHHHHcCCCc
Confidence 99999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=284.30 Aligned_cols=236 Identities=24% Similarity=0.347 Sum_probs=203.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
..+|.++..||+|+||.|.+|..+ +.+.+|||+++++........+--..|-+++..- +-|.+++++.+|+.-+.+|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 467889999999999999999755 6778999999887655444345556677777766 57899999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+.||+|.-.++ ..+.+.+..+..++..|+-||-+|| ++||+.||+|.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999998887 4456778889999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 741 (764)
-++....+++|||.|+|||++.-.+|+.++|+||+||++|||+.|++||++.++.+ .+.......+..++.+...+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 55555667899999999999999999999999999999999999999999988743 344556666777899999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
+.++.+.
T Consensus 582 kg~ltK~ 588 (683)
T KOG0696|consen 582 KGLLTKH 588 (683)
T ss_pred HHHhhcC
Confidence 9999866
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=287.05 Aligned_cols=234 Identities=26% Similarity=0.401 Sum_probs=192.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|++.+.||.|+||.||+|+.. +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 467999999999999999999865 68999999986543 33457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++++++..++.+. ...+++..+..++.|++.|++||| ++|++||||||+||+++.++.++|+|||.+.....
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999998887542 235889999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~ 734 (764)
.........++..|+|||++. ...++.++|+||+||++|+|++|+.||...+...... ......+..++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence 333334456788999999885 3456889999999999999999999998655322111 11222344567
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 243 ~~~~~li~~~l~~~ 256 (292)
T cd06644 243 MEFRDFLKTALDKH 256 (292)
T ss_pred HHHHHHHHHHhcCC
Confidence 78999999999866
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=284.42 Aligned_cols=236 Identities=24% Similarity=0.407 Sum_probs=192.7
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
++|++.+.||+|+||.||+|+++++..+|+|.+...... .+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 568889999999999999999888889999988654433 2567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|.+++... ...+++..+..++.|++.||+||| ++|++||||+|+||++++++.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999999998743 235888999999999999999999 8999999999999999999999999999987653222
Q ss_pred CCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHHH
Q 004268 668 SNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 741 (764)
... ....++..|+|||++.+..++.++|+||+|+++|+|++ |+.||...+..+... ......+...+..+.+++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM 234 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 111 12234568999999998899999999999999999999 999998765432211 111222333567889999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
++|++.++.-|
T Consensus 235 ~~c~~~~p~~R 245 (256)
T cd05114 235 YSCWHEKPEGR 245 (256)
T ss_pred HHHccCCcccC
Confidence 99998765443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.12 Aligned_cols=234 Identities=26% Similarity=0.455 Sum_probs=193.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|.||+|...++..||+|.+...... .+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 5789999999999999999999888889999987654322 367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.|++||| ++|++||||||+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999998754 3345788899999999999999999 899999999999999999999999999999876432
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 740 (764)
... .....++..|+|||++.+..++.++||||+|+++|+|++ |+.||.......... ..........+..+.++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 211 122345668999999998889999999999999999998 999997654322111 11222334567899999
Q ss_pred Hhhhhccc
Q 004268 741 LKNFSQGN 748 (764)
Q Consensus 741 ~~~~l~~~ 748 (764)
+.+|+..+
T Consensus 237 i~~~l~~~ 244 (261)
T cd05072 237 MKTCWKEK 244 (261)
T ss_pred HHHHccCC
Confidence 99999766
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.56 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=172.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|..+ +++.||+|.+........ ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 467999999999999999999765 788999999865443222 24567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++ ++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+.....
T Consensus 83 ~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 83 FEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred Eeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99997 5888888643 335788999999999999999999 99999999999999999999999999999976543
Q ss_pred CCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........+++.|+|||++.+. .++.++||||+|+++|+|+||++||...+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33333334678899999987654 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.43 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=212.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCC-EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGK-LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+++.+..+|-|+||.|-+++.+..+ .+|+|++++...-+..+.+.+..|-.+|..++.|+||++|..|.+++++|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 455667778999999999999866333 4899999888877777788999999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||-|-||.+...++ ..+.++...++.++..+++|++||| ++|||.||+||+|.+++.+|.+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999998 4567888999999999999999999 99999999999999999999999999999999875
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----ccCCcCC-CCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----SSGRKIS-QNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----~~~~~~~-~~~~~~~~~~~~ 740 (764)
.. ..-+++|||.|.|||++.....+.++|.||||+++||+++|++||.+.++... ....... .+..++....++
T Consensus 573 g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 43 34558999999999999999999999999999999999999999999887532 2333333 345578888888
Q ss_pred Hhhhhccc-----------------hhhHHHhhhcCCCCCC
Q 004268 741 LKNFSQGN-----------------HRWENLLFKKFPYQNL 764 (764)
Q Consensus 741 ~~~~l~~~-----------------~~~~~~~~~~~p~~r~ 764 (764)
++++...+ |+| |....|++|
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~W----f~gfdwegl 688 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRW----FEGFDWEGL 688 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhh----hhcCChhhh
Confidence 88887755 777 666666653
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=282.87 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=194.4
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCc--HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEE--PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
+.|.+.+.||+|++|.||.|.. .+++.||+|.+....... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 478999999987543322 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|+||+++++|.+++.. ...+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+....
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999874 335788999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcCCCCCCCcHH
Q 004268 665 PDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKISQNPRLDLQ 736 (764)
Q Consensus 665 ~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~ 736 (764)
...... ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...+...... ......+...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHH
Confidence 322111 23457789999999999999999999999999999999999997654432111 1122233456788
Q ss_pred HHHHHhhhhccchh
Q 004268 737 CNAYLKNFSQGNHR 750 (764)
Q Consensus 737 ~~~~~~~~l~~~~~ 750 (764)
+.+++++|++.++.
T Consensus 236 ~~~li~~~l~~~p~ 249 (263)
T cd06625 236 ARNFLRRTFVENAK 249 (263)
T ss_pred HHHHHHHHhhcCcc
Confidence 89999999987633
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=287.27 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=197.8
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
-|++.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3678889999999999999865 57788999885433 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|++++++..++.+ ....+++..+..++.|++.||+||| +.|++||||||+||+++.++.+|++|||.+.......
T Consensus 83 ~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999999888763 2345889999999999999999999 8999999999999999999999999999987654333
Q ss_pred CCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHH
Q 004268 668 SNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQ 736 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~ 736 (764)
.......++..|+|||++. +..++.++||||+||++|+|++|+.||...+...... ......+...+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 3334456889999999874 4457889999999999999999999998765432111 1122234456789
Q ss_pred HHHHHhhhhccc--hhhHHHhhhcCCCC
Q 004268 737 CNAYLKNFSQGN--HRWENLLFKKFPYQ 762 (764)
Q Consensus 737 ~~~~~~~~l~~~--~~~~~~~~~~~p~~ 762 (764)
+.+++++|++.+ .|+........||-
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 999999999876 34444445555553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=283.38 Aligned_cols=235 Identities=24% Similarity=0.431 Sum_probs=193.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|.||+|...+++.||+|.+...... .+.+.+|++++++++||||+++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 4679999999999999999998877889999998764432 256889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.... ...+++..+..++.|++.|+.||| ++|++||||||+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999997542 345889999999999999999999 899999999999999999999999999999876532
Q ss_pred CCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
.... .....+..|+|||+..+..++.++||||+|+++|+|++ |+.||.+....... ........+..+..+.++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2111 11122457999999999899999999999999999999 99999876543211 111222344567888999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+.+|++.++
T Consensus 237 i~~~l~~~P 245 (261)
T cd05068 237 MLDCWKEDP 245 (261)
T ss_pred HHHHhhcCc
Confidence 999997663
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=288.06 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=196.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 585 (764)
...|++.+.||+||.+.||++...+.+.||+|++.....+ ......+..|+..+.++ .|.+|+++++|-..++.+|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4679999999999999999999888889999988765544 34468899999999999 599999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+-+ .+|..+++..... .+.-.++.+..|++.|+.++| .+||||.||||.|+++- .|.+||+|||.|..+..
T Consensus 439 mE~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eeccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99875 5999999864322 232367889999999999999 99999999999999985 56999999999998876
Q ss_pred CCCC--ceecccccccccccccccCC-----------CCccchHHHHHHHHHHHHhCCCCCCccccc-c---ccc-CCcC
Q 004268 666 DSSN--RTLVVGTYGYIAPELAYTMA-----------VTEKCDVYSFGVVALEVLMGSHPTDLLSSL-S---SSS-GRKI 727 (764)
Q Consensus 666 ~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~---~~~-~~~~ 727 (764)
+... ....+||..|||||.+.... .+.++||||+|||+|+|+.|++||...... . ... -...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 5433 34468999999999875432 467899999999999999999999876531 1 111 1122
Q ss_pred CCCCCCcH--HHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 728 SQNPRLDL--QCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 728 ~~~~~~~~--~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
...|.++. ++.+++|.|+.++ .||.=..+...||
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 23344433 3799999999988 6776555555555
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.40 Aligned_cols=245 Identities=30% Similarity=0.470 Sum_probs=196.9
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
|++.+.||+|+||+||+|+.. +++.||+|.+......... .....+|+.++++++||||+++++++.+....++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 778999999999999999866 5678999999877654332 23345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
+++++|.+++. ....+++..+..++.|+++||++|| ++|++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 99999999997 3456899999999999999999999 88999999999999999999999999999976433334
Q ss_pred Cceecccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCccc---cccccc---C----CcCCCCCCCcHHH
Q 004268 669 NRTLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVLMGSHPTDLLS---SLSSSS---G----RKISQNPRLDLQC 737 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltg~~Pf~~~~---~~~~~~---~----~~~~~~~~~~~~~ 737 (764)
......++..|+|||++. +..++.++||||+|+++|+|++|..||.... ...... . .........+..+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 444567899999999998 8889999999999999999999999999762 111110 0 1111112224788
Q ss_pred HHHHhhhhccchhhH--HHhhhcCCC
Q 004268 738 NAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 738 ~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.+++++|++.++.-| .....+.||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCC
Confidence 999999998774333 444444443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.96 Aligned_cols=202 Identities=30% Similarity=0.376 Sum_probs=171.1
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC---
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 580 (764)
...++|++.+.||+|+||.||+|... +|+.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 35689999999999999999999754 7899999998755332 233467789999999999999999999986543
Q ss_pred ---EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 581 ---CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 581 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..|+||||+++ ++...+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence 47999999976 56555542 3778889999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|.++..... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999764322 22233578999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.65 Aligned_cols=234 Identities=24% Similarity=0.421 Sum_probs=191.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|+||.|+.+.+..||+|.+...... .+.+.+|+.++++++||||+++++++......+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 3578999999999999999998877778999988754432 256889999999999999999999999988999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+.+++|.+++... ...+++..+..++.||+.|++||| ++|++|+||||+||++++++.+||+|||.++.....
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999999998743 225889999999999999999999 999999999999999999999999999998765432
Q ss_pred CCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHH
Q 004268 667 SSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 740 (764)
.... ....++..|+|||...+..++.++||||+|+++|+|++ |..||......+. ............+..+.++
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 2111 11234567999999998889999999999999999998 9999986554211 1111222233457788999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+..||+.++
T Consensus 234 i~~cl~~~p 242 (256)
T cd05113 234 MYSCWHEKA 242 (256)
T ss_pred HHHHcCCCc
Confidence 999997663
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.79 Aligned_cols=241 Identities=22% Similarity=0.367 Sum_probs=192.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||.||+|.+. .+..||+|++...... ...+.+.+|+++++++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 678999999999999999999742 2347999999754332 23467899999999996 99999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc--------------------------------------------------------
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE-------------------------------------------------------- 603 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 603 (764)
+..|+||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999998864210
Q ss_pred -------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee
Q 004268 604 -------------------------------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL 646 (764)
Q Consensus 604 -------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 646 (764)
...+++..+..++.|++.|++||| ++||+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence 123677888999999999999999 8999999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc--
Q 004268 647 NSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS-- 721 (764)
Q Consensus 647 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~-- 721 (764)
++++.+||+|||+++....... ......++..|+|||++.+..++.++||||+||++|+|++ |..||........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999976543221 1122346778999999999999999999999999999997 9999976432111
Q ss_pred ---ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 722 ---SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 722 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
............+..+.+++.+|++.++.-|
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 384 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKR 384 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHC
Confidence 1111223344567889999999998774433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=284.96 Aligned_cols=236 Identities=27% Similarity=0.410 Sum_probs=191.9
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45788899999999999999975 47899999998654322 235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++|+|||.+.....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999999999863 346889999999999999999999 89999999999999999999999999999876644
Q ss_pred CCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------CcCCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG--------RKISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~ 734 (764)
.........|+..|+|||++. ...++.++|+||+||++|+|++|+.||........... ........++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 333334457899999999874 45688899999999999999999999865543221110 0111122456
Q ss_pred HHHHHHHhhhhccchhh
Q 004268 735 LQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~ 751 (764)
..+.+++++|+..++.-
T Consensus 239 ~~~~~li~~~l~~~P~~ 255 (267)
T cd06645 239 NSFHHFVKMALTKNPKK 255 (267)
T ss_pred HHHHHHHHHHccCCchh
Confidence 78889999999766433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.52 Aligned_cols=236 Identities=26% Similarity=0.447 Sum_probs=191.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN---- 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~---- 579 (764)
..+.|++.+.||+|+||.||+|... +++.||+|.+...... ...+..|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4577889999999999999999754 6889999998654432 25678899999998 799999999998753
Q ss_pred --CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 580 --KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 580 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
...|++|||+++++|.+++... ....+++..+..++.|++.|++||| +++|+||||+|+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence 4689999999999999998753 2345889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKI 727 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~ 727 (764)
|++..............|+..|+|||++. +..++.++||||+||++|+|++|+.||.......... ....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence 99987644333344567899999999886 3457889999999999999999999997655422211 1111
Q ss_pred CCCCCCcHHHHHHHhhhhccch
Q 004268 728 SQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 728 ~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
......+..+.+++.+|+..++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNH 257 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCCh
Confidence 2233457789999999998663
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=273.38 Aligned_cols=236 Identities=22% Similarity=0.372 Sum_probs=207.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|.+...||+|+|+.|..+++ ++.+.+|+|++++.-..+.+..+-++.|-.++.+- +||.+|.++.+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 57899999999999999999985 47889999999887777666667788888888887 69999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|.||++||+|.-.+++ ...++++.++.+...|.-||.||| ++|||.||+|.+||++|..|++|+.|+|+++..-
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999877773 446899999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----------cccCCcCCCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-----------SSSGRKISQNPRL 733 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-----------~~~~~~~~~~~~~ 733 (764)
.++....+++|||.|.|||++++..|+...|.||+||+++||+.|+.||+...... ....+++..+..+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 66677778999999999999999999999999999999999999999998654321 2233555566667
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+......++.+++++
T Consensus 483 svkas~vlkgflnkd 497 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKD 497 (593)
T ss_pred ehhhHHHHHHhhcCC
Confidence 888889999998776
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=288.20 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=194.6
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-C-----CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-G-----KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||.||+|.... + ..||+|.+..... ......+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 3578999999999999999997542 2 5799998865432 334567899999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
..+++|||+++++|.+++..... ...+++..+..++.|++.||+||| ++|++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEc
Confidence 99999999999999999975321 145788899999999999999999 89999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc--
Q 004268 648 SNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-- 722 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-- 722 (764)
+++.++|+|||++........ ......+++.|+|||.+.+..++.++||||+||++|||++ |..||.+....+..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999976533221 1223356788999999988899999999999999999998 99999875543221
Q ss_pred --cCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 723 --SGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 723 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.......+...+..+.++++.|++.+..-
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~ 269 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPAR 269 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhh
Confidence 11222234456889999999999877443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=286.56 Aligned_cols=232 Identities=31% Similarity=0.463 Sum_probs=194.8
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||.|++|.||+|... +++.||+|.+...... .....+.+|+++++.++||||+++++++.++...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46888999999999999999755 7889999998755422 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... .+++..+..++.|++.|+.||| +++++||||+|+||++++++.++|+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998743 6889999999999999999999 899999999999999999999999999999887654
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCC----CC-CcHHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQN----PR-LDLQCNAYL 741 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~ 741 (764)
........+++.|+|||.+.+..++.++||||+|+++|+|+||+.||...+............. .. .+..+.+++
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 3334445788899999999998899999999999999999999999986654322111111111 12 677899999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
.+|+..+
T Consensus 232 ~~~l~~~ 238 (274)
T cd06609 232 SLCLNKD 238 (274)
T ss_pred HHHhhCC
Confidence 9999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=284.00 Aligned_cols=236 Identities=25% Similarity=0.401 Sum_probs=194.6
Q ss_pred cCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC---cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE---EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
+|++.+.||+|+||+||+|...+++.+|+|.+...... .....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58889999999999999998888999999988754322 233446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|.+++.+. ..+++..+..++.|++.|++||| +.|++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999743 35788999999999999999999 89999999999999999999999999999876532
Q ss_pred CC------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCC
Q 004268 666 DS------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRL 733 (764)
Q Consensus 666 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~ 733 (764)
.. .......++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCC
Confidence 11 11123457889999999999899999999999999999999999998655432111 1111233446
Q ss_pred cHHHHHHHhhhhccchh
Q 004268 734 DLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~ 750 (764)
+..+.+++++|++.++.
T Consensus 235 ~~~~~~~i~~~l~~~p~ 251 (265)
T cd06631 235 SAAAIDFVTSCLTRDQH 251 (265)
T ss_pred CHHHHHHHHHHhcCCcc
Confidence 78899999999987633
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.68 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=190.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 582 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|.+...... ......+..|+.++++++||||++++++|.+ ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4678999999999999999999865 6778999988755433 2335778899999999999999999998854 4579
Q ss_pred EEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcC----CCCcEEcCCCCCCeeecC---------
Q 004268 583 FLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDC----KPSIVHRDISSNNILLNS--------- 648 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~----~~~iiH~Dlkp~NIll~~--------- 648 (764)
|+||||+++++|.+++.... ....+++..++.|+.||+.||+|||... .++||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999987432 2346899999999999999999999321 145999999999999964
Q ss_pred --------CCCEEEeeeccccccCCCCCCceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 649 --------NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 649 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.+.+||+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|+||+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3358999999998664322 2234578999999999864 4588999999999999999999999976544
Q ss_pred ccccc----CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 719 LSSSS----GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 719 ~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
..... .......+..+..+.++++.||+.+
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCC
Confidence 22111 1111122345788999999999877
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.98 Aligned_cols=202 Identities=28% Similarity=0.375 Sum_probs=170.6
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----EE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-----CM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 582 (764)
+|++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478889999999999999985 47999999998654322 223467889999999999999999999998776 78
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+||||+. ++|...+. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 57877775 3346889999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCC-CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 663 LHPDS-SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 663 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
..... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 54322 122334678899999998875 478999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=282.64 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=199.1
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc------HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE------PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
+|.+...||+|++|.||+|... +++.||+|.+....... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999754 68899999886654332 2234678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.+++|||+++++|.+++.. ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999974 345788899999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCC------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCCCCC
Q 004268 662 LLHPDS------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKISQNP 731 (764)
Q Consensus 662 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~~~~ 731 (764)
...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... ......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS 234 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCc
Confidence 764221 11123457889999999998889999999999999999999999998765432211 11122334
Q ss_pred CCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 732 RLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
..+..+.+++++|++.++..| .....+.||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 567889999999998775444 333444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=282.43 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=199.0
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CCEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NKCMFLIY 586 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~ 586 (764)
+|++.+.||+|++|.||++..+ +++.||+|.+...... ....+.+.+|++++++++|||++++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5889999999999999999754 6789999998654433 2234678899999999999999999998764 45689999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++.++..++.|++.|+++|| +.|++||||+|+||+++.++.++|+|||.+......
T Consensus 80 e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998753 2345899999999999999999999 999999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CC-cCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GR-KISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~ 742 (764)
........+++.|+|||+..+..++.++|+||+|+++|+|++|+.||...+...... .. ........+..+.+++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 333444568899999999999999999999999999999999999998655322111 11 11223456789999999
Q ss_pred hhhccchhhH--HHhhhcCCC
Q 004268 743 NFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 743 ~~l~~~~~~~--~~~~~~~p~ 761 (764)
+|++.++.-| .......||
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred HHhccCcccCCCHHHHhcCCC
Confidence 9998773333 333444444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.11 Aligned_cols=237 Identities=27% Similarity=0.444 Sum_probs=193.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 456889999999999999999753 3578999998755432 23478899999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc-----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV-----------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
..++||||+++++|.+++.... ....+++..+..++.|++.|+.||| ++|++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCC
Confidence 9999999999999999997532 1234788899999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc---
Q 004268 650 LEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS--- 723 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~--- 723 (764)
+.+||+|||.+........ ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||......+...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999976532221 1122345678999999999999999999999999999998 999997655432111
Q ss_pred -CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 -GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
..........+..+.+++.+|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~ 264 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRD 264 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 1122223456789999999999866
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.74 Aligned_cols=238 Identities=27% Similarity=0.459 Sum_probs=197.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...+|++.+.||.|++|.||+|...+++.+|+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 35679999999999999999999887999999998765432 236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ....+++..+..++.|++.|+.||| ++|++||||+|+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999999754 3345889999999999999999999 89999999999999999999999999999987644
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
.........++..|+|||.+.+..++.++||||+|+++|+|++ |+.||......+.. .......+...+....++
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 3322223345678999999988899999999999999999998 89999876542211 111223345567888999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+.+|++.++.
T Consensus 237 i~~~l~~~p~ 246 (261)
T cd05148 237 MLECWAAEPE 246 (261)
T ss_pred HHHHcCCCch
Confidence 9999976643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=286.65 Aligned_cols=232 Identities=26% Similarity=0.433 Sum_probs=195.6
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||.|++|.||+|.. .+++.|++|.+....... .+.+.+|+++++.++|||++++++++...+..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 35799999999999999999975 578999999986544332 36788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|..++.. ..+++.++..++.|++.|++||| ++|++||||+|+||+++.++.+||+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999998863 24789999999999999999999 99999999999999999999999999999887654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~ 739 (764)
.........++..|+|||.+.+..++.++||||+||++|+|++|+.||...+...... .........++....+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 4333334568889999999998889999999999999999999999998765422111 1112234456788999
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++++|+..+
T Consensus 248 li~~~l~~d 256 (296)
T cd06655 248 FLNRCLEMD 256 (296)
T ss_pred HHHHHhhcC
Confidence 999999877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=289.84 Aligned_cols=202 Identities=31% Similarity=0.423 Sum_probs=166.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEee-----C
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCLH-----N 579 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~ 579 (764)
+|++.+.||+|+||+||+|... +++.||+|.+........ ....+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5889999999999999999765 789999998875432221 113455677777665 69999999998764 3
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...+++|||+++ ++.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence 458999999985 888888643 2345899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
+....... ......++..|+|||++.+..++.++||||+||++|+|++|++||....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 97664322 2233567899999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.30 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=201.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||.|++|+||+|... ++..+|+|++....... ..+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 46899999999999999999754 68899999986544333 3578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|++++++|.++++.......+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999975433356899999999999999999999 999999999999999999999999999998876543
Q ss_pred CCC----ceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCC---------CCC
Q 004268 667 SSN----RTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQ---------NPR 732 (764)
Q Consensus 667 ~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~---------~~~ 732 (764)
... .....++..|+|||++... .++.++|+||+|+++|+|++|+.||................ ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 322 1334688899999998777 78999999999999999999999998765432211111111 125
Q ss_pred CcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 733 LDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
++..+.+++.+|++.++..| .....+.||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 67788999999998875544 333444444
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.57 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=200.5
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999865 689999999987655544556889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|..++... ..+++..+..++.|+++||.||| +.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999743 46889999999999999999999 8899999999999999999999999999987764332
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc--c----cccCCcCCCCCCCcHHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL--S----SSSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~ 741 (764)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... . .........++..+..+.+++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence 223356788999999999888999999999999999999999999876531 1 111122334455788999999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
.+|++.++.-|
T Consensus 234 ~~~l~~~p~~R 244 (258)
T cd05578 234 NKLLERDPQKR 244 (258)
T ss_pred HHHccCChhHc
Confidence 99998874444
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.55 Aligned_cols=244 Identities=29% Similarity=0.459 Sum_probs=204.2
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..-+++-...||.|.||.||-|. ..+|...|+|.+...... ....+.+.+|..++..++|||+|+++|+-.+.+..+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34577778899999999999996 568999999988776655 4445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
.||||++|+|.+.++. ..-.++.....+..|++.|++||| ++|||||||||+||+++.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999973 334666777888999999999999 9999999999999999999999999999999886
Q ss_pred CCCCC----ceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCccccc-----ccccCCcCCCCCC
Q 004268 665 PDSSN----RTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-----SSSSGRKISQNPR 732 (764)
Q Consensus 665 ~~~~~----~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-----~~~~~~~~~~~~~ 732 (764)
..... .....||+.|||||++.+. +...++||||+||++.||+||+.||...+.. .+...+.-..+.+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence 54322 2346899999999999765 3567899999999999999999999887752 2233334444555
Q ss_pred CcHHHHHHHhhhhccc--hhhHHHhh
Q 004268 733 LDLQCNAYLKNFSQGN--HRWENLLF 756 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~--~~~~~~~~ 756 (764)
++....+|+.+|++.+ .+|...+.
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 7889999999999988 66766443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=284.34 Aligned_cols=239 Identities=21% Similarity=0.293 Sum_probs=196.1
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|.. .+++.||+|.+...........+.+.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5688899999999999999985 489999999887655444455578889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++.... ....+++..+..++.|++.|++||| ++|++|+||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345889999999999999999999 99999999999999999999999999999877654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc--ccccCCcC---C--CCCCCcHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL--SSSSGRKI---S--QNPRLDLQCN 738 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~--~~~~~~~~---~--~~~~~~~~~~ 738 (764)
.........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.... ........ . .....+..+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 333333456888999999999889999999999999999999999999754331 11111111 1 1123567889
Q ss_pred HHHhhhhccch
Q 004268 739 AYLKNFSQGNH 749 (764)
Q Consensus 739 ~~~~~~l~~~~ 749 (764)
+++.+|++.++
T Consensus 239 ~li~~~l~~~p 249 (267)
T cd08229 239 QLVNMCINPDP 249 (267)
T ss_pred HHHHHhcCCCc
Confidence 99999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=295.18 Aligned_cols=202 Identities=27% Similarity=0.346 Sum_probs=171.5
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC----
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN---- 579 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 579 (764)
...++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 35689999999999999999999754 7899999998765433 23346778899999999999999999988643
Q ss_pred --CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 580 --KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 580 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
...++||||+++ ++...+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 66666642 3788889999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+++...... ......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 164 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 164 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998654322 2233578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=283.04 Aligned_cols=238 Identities=28% Similarity=0.448 Sum_probs=196.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.+|.|++|.||+|... +++.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 367999999999999999999764 6789999998765433 347888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ...+++..+..++.|++.|++||| +.|++|+||+|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999999998742 245889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------CcCCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG--------RKISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~ 734 (764)
.........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+....... ......+..+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 33333445688899999998877 789999999999999999999999987653221111 1111233456
Q ss_pred HHHHHHHhhhhccchhhH
Q 004268 735 LQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~ 752 (764)
..+.+++++|+..++.-|
T Consensus 234 ~~~~~li~~~l~~~p~~R 251 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKR 251 (262)
T ss_pred HHHHHHHHHHcCCChhhC
Confidence 788899999998764433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=281.92 Aligned_cols=235 Identities=26% Similarity=0.454 Sum_probs=192.9
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||.||+|..++++.||+|.+...... .+.+.+|+.++++++||||+++++++. .+..+++|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 5789999999999999999999888999999998765543 257889999999999999999999874 45689999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.||+||| +.|++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998653 2346888999999999999999999 899999999999999999999999999999766422
Q ss_pred CC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
.. ......++..|+|||++.+..++.++||||+|+++|++++ |+.||.+.+..+.. ...........+....++
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 21 1122345678999999998889999999999999999999 99999866542211 111222334467789999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+++|++.++.
T Consensus 236 i~~~l~~~p~ 245 (260)
T cd05067 236 MRLCWKEKPE 245 (260)
T ss_pred HHHHccCChh
Confidence 9999987643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=286.92 Aligned_cols=234 Identities=26% Similarity=0.411 Sum_probs=194.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||.|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999864 68999999986432 33346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ...+++..++.++.|++.|+.||| +.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 81 IEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 9999999999998642 235889999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------cCCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------KISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------~~~~~~~~~ 734 (764)
.........+++.|+|||.+. +..++.++|+||+|+++|+|++|+.||...+........ ....+...+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (280)
T cd06611 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS 235 (280)
T ss_pred cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence 433344457899999999875 345678999999999999999999999876543211111 122234567
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.++++.|++.+
T Consensus 236 ~~~~~li~~~l~~~ 249 (280)
T cd06611 236 SSFNDFLKSCLVKD 249 (280)
T ss_pred HHHHHHHHHHhccC
Confidence 88999999999877
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.51 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|+||+|... +++.||+|.+...........+.+..|+++++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999765 58999999998766554445678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+.+++|.+++... ....+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998743 3346899999999999999999999 899999999999999999999999999998754322
Q ss_pred CC-----------------------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 SS-----------------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.. ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 0112357889999999999889999999999999999999999998665
Q ss_pred ccccc-----cCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 718 SLSSS-----SGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 718 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..... ..........++..+.+++++|+..++.-|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHC
Confidence 42211 111112222368899999999998774433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.28 Aligned_cols=388 Identities=31% Similarity=0.480 Sum_probs=313.8
Q ss_pred cccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCC
Q 004268 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRD 92 (764)
Q Consensus 13 ~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 92 (764)
....+++-+++|.+..|.++ ..|++++.+..+..|+.++|+++ .+|..+..+.+|+.|++++|++. ..++.++.+..
T Consensus 62 ~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~ 138 (565)
T KOG0472|consen 62 EDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLD 138 (565)
T ss_pred HhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhh
Confidence 34567788999999999997 78999999999999999999998 78888999999999999999998 67788889999
Q ss_pred CCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc
Q 004268 93 LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 93 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 172 (764)
|+.|+..+|+++ ..|+++..+.+|..|++.+|++...+|..+. ++.|++||+.+|-+. ..|..++++.+|+.|+|.+
T Consensus 139 l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~ 215 (565)
T KOG0472|consen 139 LEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRR 215 (565)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhh
Confidence 999999999998 5667788889999999999999987776666 899999999999998 5677899999999999999
Q ss_pred CCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCC
Q 004268 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252 (764)
Q Consensus 173 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 252 (764)
|.|... | .|.++..|++|+++.|+|..++....++++++..|||.+|+++ ..|+.+..+.+|+.||+|+|.|+ ..|
T Consensus 216 Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp 291 (565)
T KOG0472|consen 216 NKIRFL-P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLP 291 (565)
T ss_pred cccccC-C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCC
Confidence 999844 4 7889999999999999999888888889999999999999998 67888888999999999999999 566
Q ss_pred cCCcCCCCCCeEEccCCcccCCC--------------------------------------Ccccc---CCCC-------
Q 004268 253 PTIGNLTNLIALDLSSNQLSGLL--------------------------------------PREVG---NLKY------- 284 (764)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~l~~~~--------------------------------------~~~~~---~l~~------- 284 (764)
-.++++ .|+.|-+.+|.+..+- +..|. .+.+
T Consensus 292 ~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s 370 (565)
T KOG0472|consen 292 YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVS 370 (565)
T ss_pred cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccc
Confidence 678888 8888888888875110 00000 0001
Q ss_pred -------------------CCeEeccCccccC-----------------------CCCCCCCCCCccceEEccCCcCccC
Q 004268 285 -------------------LASLSLNGNILIG-----------------------PIPPTIGYLTNLTYLNLGYNRLSSS 322 (764)
Q Consensus 285 -------------------L~~L~l~~n~l~~-----------------------~~~~~~~~l~~L~~L~ls~N~l~~~ 322 (764)
.+..+++.|++.. .+|..++.+++|..|+|++|.+. .
T Consensus 371 ~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~ 449 (565)
T KOG0472|consen 371 DKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-D 449 (565)
T ss_pred ccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-h
Confidence 3455666676642 23334566777888888888777 6
Q ss_pred CChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCC--ccc
Q 004268 323 IPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA--SVR 400 (764)
Q Consensus 323 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~ 400 (764)
+|..++.+..|+.|++|.|++. .+|...-.+..|+.+-.++|++..+.++.+.++.+|+.|||.+|.+..++|. -..
T Consensus 450 LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~Lgnmt 528 (565)
T KOG0472|consen 450 LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMT 528 (565)
T ss_pred cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhcccc
Confidence 7777777777888888888877 6777776677777777777777777777788889999999999999877764 456
Q ss_pred cCccccccCCCCC
Q 004268 401 RIPKLIVSENNLE 413 (764)
Q Consensus 401 ~~~~~~~~~n~~~ 413 (764)
.+..+.+.+|++.
T Consensus 529 nL~hLeL~gNpfr 541 (565)
T KOG0472|consen 529 NLRHLELDGNPFR 541 (565)
T ss_pred ceeEEEecCCccC
Confidence 8888888888873
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=281.45 Aligned_cols=234 Identities=25% Similarity=0.418 Sum_probs=191.2
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.+|++.+.||+|++|.||+|++++++.+|+|.+....... ..+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 4688899999999999999988777889999986544332 467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ...+++..+..++.|++.|++||| ++|++||||||+||++++++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999999998743 236889999999999999999999 8999999999999999999999999999987654221
Q ss_pred CCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHHH
Q 004268 668 SNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 741 (764)
... ....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||+..+..+.. .......+...+....+++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 111 11123457999999999999999999999999999999 89999866543211 1112233444688899999
Q ss_pred hhhhccchh
Q 004268 742 KNFSQGNHR 750 (764)
Q Consensus 742 ~~~l~~~~~ 750 (764)
.+|+..+..
T Consensus 235 ~~cl~~~p~ 243 (256)
T cd05059 235 YSCWHEKPE 243 (256)
T ss_pred HHHhcCChh
Confidence 999976643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=282.38 Aligned_cols=234 Identities=27% Similarity=0.440 Sum_probs=190.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|+||+|.+.++..||+|++...... .+.+.+|++++++++||||+++++.+.. ...++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 4679999999999999999998776678999998754432 2568899999999999999999998754 5579999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.||+|+| ++|++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999753 2335788999999999999999999 899999999999999999999999999999766433
Q ss_pred CCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHH
Q 004268 667 SSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 740 (764)
.... ....++..|+|||+..+..++.++||||+|+++|+|+| |+.||.......... .......+..+....++
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 2211 12345678999999988899999999999999999999 899998665422111 11122244567888999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+++|++.++
T Consensus 236 i~~~l~~~p 244 (262)
T cd05071 236 MCQCWRKEP 244 (262)
T ss_pred HHHHccCCc
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=290.71 Aligned_cols=234 Identities=25% Similarity=0.430 Sum_probs=188.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..+|++.+.||+|+||.||+|.+. +++ .||+|++..... ....+++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 357999999999999999999753 343 489999864332 33346788999999999999999999998765 4
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++++||+++|+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999999753 335788889999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCCce--ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCc
Q 004268 662 LLHPDSSNRT--LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~ 734 (764)
.......... ...++..|+|||++.+..++.++||||||+++|||++ |+.||++...... .........+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 237 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence 7654332211 1234568999999999999999999999999999997 9999987654221 1112223344567
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++.+|++.+
T Consensus 238 ~~~~~li~~cl~~~ 251 (316)
T cd05108 238 IDVYMIMVKCWMID 251 (316)
T ss_pred HHHHHHHHHHccCC
Confidence 78999999999877
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.64 Aligned_cols=239 Identities=30% Similarity=0.406 Sum_probs=194.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.++ +...||+|.+..... ......+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 367899999999999999999764 245799998865443 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
+++|||+++++|.+++... ...+++..+..++.|++.|++||| ++||+||||||+||++++++.++|+|||.+..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 9999999999999999753 236889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCce--ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcH
Q 004268 663 LHPDSSNRT--LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~ 735 (764)
......... ...++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......... ..........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPS 235 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 752222111 1234568999999998899999999999999999998 999997654322111 112223345678
Q ss_pred HHHHHHhhhhccchhhH
Q 004268 736 QCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~ 752 (764)
.+.+++.+|++.++..|
T Consensus 236 ~l~~li~~cl~~~p~~R 252 (266)
T cd05033 236 ALYQLMLDCWQKDRNER 252 (266)
T ss_pred HHHHHHHHHcCCCcccC
Confidence 99999999998774443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.53 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=191.5
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
..++|++.+.||+|++|.||+|.+. ++..||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3578999999999999999998643 356799998865332 22346788999999999999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCE
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE-------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 652 (764)
...++||||+++++|.++++.... ....++..+..++.|++.|++||| +.|++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence 999999999999999999864321 223577888999999999999999 8999999999999999999999
Q ss_pred EEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CC
Q 004268 653 FVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GR 725 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~ 725 (764)
+|+|||.+.......... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+........ ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654322111 12244678999999998899999999999999999999 789998665432111 11
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
........+..+.+++.+|++.++.-
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKM 264 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 12223445778899999999876433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.91 Aligned_cols=199 Identities=29% Similarity=0.391 Sum_probs=173.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36899999999999999999755 688899998865432 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++... ..+++..+..++.|++.||+||| + .+++||||||+||++++++.+||+|||.+.....
T Consensus 79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 999999999999743 45888999999999999999999 6 5899999999999999999999999999876532
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
. ......++..|+|||+..+..++.++|+||+|+++|+|++|+.||...
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 123357889999999998888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.49 Aligned_cols=234 Identities=26% Similarity=0.440 Sum_probs=190.9
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|.||+|...++..||+|.+...... .+.+.+|+.++++++||+++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 4689999999999999999998888889999998765443 2568899999999999999999998754 5588999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.|++||| ++|++||||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999998743 2345789999999999999999999 899999999999999999999999999999765432
Q ss_pred CCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccC----CcCCCCCCCcHHHHHH
Q 004268 667 SSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG----RKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 740 (764)
.... ....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+.... .........+....++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2111 12234567999999988889999999999999999999 9999976554321111 1222234467788999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+++|++.++
T Consensus 236 i~~~l~~~p 244 (260)
T cd05070 236 MLQCWKKDP 244 (260)
T ss_pred HHHHcccCc
Confidence 999998663
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=279.62 Aligned_cols=233 Identities=30% Similarity=0.459 Sum_probs=196.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|++|.||+|... +++.|++|.+..... .+.+.+|++++++++||||+++++++.+....|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 367999999999999999999866 488999999865432 47889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|.+++... ...+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999998642 345889999999999999999999 88999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------cCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------KISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~~ 739 (764)
.........++..|+|||++.+..++.++||||+|+++|+|++|+.||............ .....+.++..+.+
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 433334456788999999999999999999999999999999999999876543222111 11223345678899
Q ss_pred HHhhhhccch
Q 004268 740 YLKNFSQGNH 749 (764)
Q Consensus 740 ~~~~~l~~~~ 749 (764)
++++|++.++
T Consensus 232 ~i~~~l~~~P 241 (256)
T cd06612 232 FVKKCLVKDP 241 (256)
T ss_pred HHHHHHhcCh
Confidence 9999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=284.66 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=199.8
Q ss_pred cCHHHHHHHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeE
Q 004268 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGF 575 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 575 (764)
.+..+.....+.|++.+.+|+|+||.||+|.. .+++.||+|.+..... ....+..|+.+++++ +||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 34555555678999999999999999999976 4788999998865432 235678899999998 69999999998
Q ss_pred Eee------CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 576 CLH------NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 576 ~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
+.. ....|++|||+++++|.+++... ....+++..+..++.|++.|++||| +.|++|+||+|+||+++++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 853 46789999999999999998743 2345788889999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG 724 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~ 724 (764)
+.++|+|||.+..............|+..|+|||.+. +..++.++|+||+||++|+|++|..||....+......
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 9999999999876543333334457889999999875 34678899999999999999999999976654322221
Q ss_pred CcCC-----CCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 725 RKIS-----QNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 725 ~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.... .....+....+++.+|++.++.-| .....+.||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 1111 122357788999999998774443 333444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.55 Aligned_cols=201 Identities=27% Similarity=0.360 Sum_probs=170.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN----- 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 579 (764)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4689999999999999999999754 7889999998764432 22346778999999999999999999987543
Q ss_pred -CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 580 -KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 580 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
...|+||||+++ ++...+.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 67776642 3778889999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
+++...... ......++..|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 997654322 2234578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.24 Aligned_cols=233 Identities=27% Similarity=0.420 Sum_probs=193.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...|+..+.||.|+||.||+|.+. +++.||+|.+...... ...+.+.+|++++++++||||+++++++.++...++|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356788899999999999999865 6889999988754332 3347888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ..+++..+..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999999863 34788899999999999999999 89999999999999999999999999999977654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCC----CCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKIS----QNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 741 (764)
.........++..|+|||++.+..++.++|+||+|+++|+|++|+.||............... .....+..+.+++
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHH
Confidence 333333456788999999999888999999999999999999999999876543322221111 1223567888999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 234 ~~~l~~~ 240 (277)
T cd06640 234 DACLNKD 240 (277)
T ss_pred HHHcccC
Confidence 9999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=278.68 Aligned_cols=233 Identities=24% Similarity=0.386 Sum_probs=188.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCC--CCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSE--TEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 582 (764)
.+|++.+.||+|+||.||.|... +++.||+|.+.... .......+.+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999754 68999999875432 22233457888999999999999999999988763 568
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
+++|||+++++|.+++... ..+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998743 34788889999999999999999 89999999999999999999999999999876
Q ss_pred cCCCC---CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-----CcCCCCCCCc
Q 004268 663 LHPDS---SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-----RKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~ 734 (764)
..... .......++..|+|||++.+..++.++||||+|+++|+|++|+.||........... .....++.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVS 235 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhC
Confidence 53211 112234578899999999988899999999999999999999999986544322111 1111233456
Q ss_pred HHHHHHHhhhhc
Q 004268 735 LQCNAYLKNFSQ 746 (764)
Q Consensus 735 ~~~~~~~~~~l~ 746 (764)
..+.+++.+|+.
T Consensus 236 ~~~~~~i~~~l~ 247 (265)
T cd06652 236 DHCRDFLKRIFV 247 (265)
T ss_pred HHHHHHHHHHhc
Confidence 788899988884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.59 Aligned_cols=235 Identities=23% Similarity=0.354 Sum_probs=191.0
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||+|... +++.||+|.+..... +.....+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36889999999999999999865 789999998865432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|..++........+++..+..++.|++.|+.|||. +.||+||||||+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999998754333468999999999999999999992 259999999999999999999999999998765322
Q ss_pred CCCceecccccccccccccccCC------CCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCC
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMA------VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRL 733 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~ 733 (764)
......+++.|+|||.+.+.. ++.++|+||+||++|+|++|+.||........ ........++..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 222346788999999986543 47899999999999999999999975433211 111112234457
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|++.+
T Consensus 235 ~~~~~~li~~~l~~~ 249 (286)
T cd06622 235 SDDAQDFVAKCLNKI 249 (286)
T ss_pred CHHHHHHHHHHcccC
Confidence 788999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=277.13 Aligned_cols=235 Identities=23% Similarity=0.344 Sum_probs=195.9
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|+||.||.++. .+++.+++|.+....... ...+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 588999999999999999974 478999999986554332 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++.... ...+++..+..++.|++.|+.||| +.|++||||+|+||++++++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999997542 346889999999999999999999 8899999999999999999999999999998765444
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHhh
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.......+++.|+|||...+..++.++|+||+|+++|+|++|..||......+.. ........+..+..+.+++.+
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 3334457899999999999888999999999999999999999999865442211 111112234467889999999
Q ss_pred hhccc
Q 004268 744 FSQGN 748 (764)
Q Consensus 744 ~l~~~ 748 (764)
|+..+
T Consensus 236 ~l~~~ 240 (256)
T cd08221 236 LLQQD 240 (256)
T ss_pred HcccC
Confidence 99765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=284.70 Aligned_cols=235 Identities=34% Similarity=0.516 Sum_probs=188.1
Q ss_pred cceeeeecCceeEEEEEEC-----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLS-----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.+.||.|.||.||+|.+. .+..|+||.+.... .....+.+.+|++.+++++||||+++++++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeecccccccccccccccccccccccccccccc
Confidence 5678999999999999765 35689999995532 2333588999999999999999999999999888899999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++... ....+++..+..|+.||+.||+||| +++++|+||+++||++++++.+||+|||.+......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999999854 2456899999999999999999999 889999999999999999999999999999876322
Q ss_pred CCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHH
Q 004268 667 SSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 667 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 739 (764)
... .........|+|||.+.+..++.++||||||+++||+++ |+.||.+....+. ............+..+.+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHH
Confidence 111 122346778999999999889999999999999999999 7899987655321 122233345557889999
Q ss_pred HHhhhhccchhhH
Q 004268 740 YLKNFSQGNHRWE 752 (764)
Q Consensus 740 ~~~~~l~~~~~~~ 752 (764)
+++.||..++.-|
T Consensus 237 li~~C~~~~p~~R 249 (259)
T PF07714_consen 237 LIQQCWSHDPEKR 249 (259)
T ss_dssp HHHHHT-SSGGGS
T ss_pred HHHHHcCCChhhC
Confidence 9999999875544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.59 Aligned_cols=239 Identities=23% Similarity=0.310 Sum_probs=194.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||.||++... +++.|++|.+...........+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999865 68899999987655433444567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.. ...+++..+..++.|++.|++||| ++|++||||||+||+++.++.+|++|||.++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999974 345888999999999999999999 899999999999999999999999999988642110
Q ss_pred CC---------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---C---
Q 004268 667 SS---------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---R--- 725 (764)
Q Consensus 667 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~--- 725 (764)
.. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 00 01123567889999999888899999999999999999999999986543221111 1
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.....+..+..+.+++++|++.++.-|
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R 261 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLER 261 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhc
Confidence 111122467889999999998885444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.87 Aligned_cols=237 Identities=24% Similarity=0.392 Sum_probs=190.6
Q ss_pred hcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.+|++.+.||+|+||.||+|.. .+++.|++|.+..... ......+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 5788899999999999999974 2567899999875432 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCcc--------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 583 FLIYEYMERGSLFCVLRNDVE--------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
|+||||+++++|.+++..... ...+++..+..++.|++.||+||| ++|++||||||+||++++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence 999999999999999853211 234788889999999999999999 899999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc---
Q 004268 649 NLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS--- 722 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~--- 722 (764)
++.+||+|||+++....... ......++..|+|||++.+..++.++||||+|+++|||++ |..||.+.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999986543221 1122345678999999988889999999999999999998 99999765432211
Q ss_pred -cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 723 -SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 723 -~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
...........+....+++..|++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGP 267 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCc
Confidence 111222334467788889999987663
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.60 Aligned_cols=232 Identities=24% Similarity=0.399 Sum_probs=186.4
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++||||+++++++......++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 35899999999999764 789999998764432 333467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc--
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-- 670 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 670 (764)
+|.+++... ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+..........
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999998642 335789999999999999999999 9999999999999999999999999999987643221111
Q ss_pred eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHhhhh
Q 004268 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLKNFS 745 (764)
Q Consensus 671 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l 745 (764)
.....+..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ............+....+++++|+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 11123457999999999899999999999999999997 9999976554211 111222334455788899999999
Q ss_pred ccchhhH
Q 004268 746 QGNHRWE 752 (764)
Q Consensus 746 ~~~~~~~ 752 (764)
+.++.-|
T Consensus 234 ~~~p~~R 240 (252)
T cd05084 234 EYDPGQR 240 (252)
T ss_pred CCChhhC
Confidence 8774433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=297.49 Aligned_cols=196 Identities=24% Similarity=0.326 Sum_probs=169.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
..+|.+.+.||+|+||.||+|... .++.||+|.+... +...+|++++++++||||+++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 467999999999999999999643 4678999987643 23457999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|||++. +++.+++. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.++|+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999996 58888884 3456899999999999999999999 899999999999999999999999999999765
Q ss_pred CCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 664 HPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 664 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 433221 223578999999999999999999999999999999999999997543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=285.89 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=193.2
Q ss_pred cCHHHHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeE
Q 004268 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGF 575 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 575 (764)
+.++.+....++|++.+.||+|+||.||+|... +++.+|+|++...... ...+..|+.+++.+ +||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 334555567899999999999999999999754 6889999987643322 25677899999999 69999999998
Q ss_pred Ee-----eCCEEEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 576 CL-----HNKCMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 576 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
+. .++..++||||+++++|.+++.... ....+++..+..++.|++.|+.||| +.+++||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence 74 3457899999999999999876321 2345788999999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG 724 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~ 724 (764)
+.+||+|||.+..............|++.|+|||++.. ..++.++||||+||++|+|++|+.||...........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 99999999999876543333344568999999998753 4578899999999999999999999987654322111
Q ss_pred Cc------CCCCCCCcHHHHHHHhhhhccc
Q 004268 725 RK------ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 ~~------~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.. ...+...+..+.+++.+|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd06638 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKD 270 (286)
T ss_pred ccccCCCcccCCCCcCHHHHHHHHHHccCC
Confidence 11 1112224667899999999766
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=280.81 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=191.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|.+.+.||+|++|.||+|..+ .++.||+|.+..... ..+.+.+|++++++++||||+++++++..++..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 356888999999999999999754 688999999864322 236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ....+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999998753 2345788999999999999999999 89999999999999999999999999999977643
Q ss_pred CCCCc-eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHH
Q 004268 666 DSSNR-TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 739 (764)
..... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+. ........+...+....+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 22111 11223567999999999999999999999999999998 9999976543221 111223334556789999
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++++|++.+
T Consensus 237 li~~cl~~~ 245 (263)
T cd05052 237 LMRACWQWN 245 (263)
T ss_pred HHHHHccCC
Confidence 999999866
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=269.02 Aligned_cols=230 Identities=26% Similarity=0.382 Sum_probs=188.5
Q ss_pred HhhcCCcc-eeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee----
Q 004268 506 ATEDFHIK-YCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH---- 578 (764)
Q Consensus 506 ~~~~y~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---- 578 (764)
.+++|++. +.||-|-.|.|..+.+ .+++.+|+|++... ...++|++..-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 46677775 4689999999999964 48999999998643 4556888877666 69999999998754
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEe
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVA 655 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~ 655 (764)
...+.+|||.|+||.|++.++.+ ....+++.++..|+.||+.|+.||| +.+|+||||||+|+|.. .+..+||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 46789999999999999999865 4556999999999999999999999 99999999999999997 45678999
Q ss_pred eeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------C--
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG--------R-- 725 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~--------~-- 725 (764)
|||+|+.-... ....+.+-||.|.|||++....|+..+|+||+||++|-|++|.+||-..+....... +
T Consensus 207 DfGFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 207 DFGFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 99999876532 334556889999999999999999999999999999999999999987765332211 1
Q ss_pred -cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 -KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 -~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
-......++....++|+.++..+
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~ 309 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTE 309 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCC
Confidence 11122336778899999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.38 Aligned_cols=237 Identities=27% Similarity=0.457 Sum_probs=191.6
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
..+|.+.+.||+|+||.||++.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 36788999999999999999964 234568999886543 233467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV----------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
..++||||+++++|.+++.... ....+++..+..++.|++.||+||| ++|++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 9999999999999999987432 1234899999999999999999999 89999999999999999999
Q ss_pred CEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc---c-
Q 004268 651 EAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS---S- 723 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~---~- 723 (764)
.+||+|||.+......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. .
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999999999765432211 122334678999999999899999999999999999998 99999866542211 1
Q ss_pred CCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 724 GRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..........+....+++.+|++.++
T Consensus 238 ~~~~~~~~~~~~~l~~li~~~l~~~p 263 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLGCWQREP 263 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCCh
Confidence 11122233467889999999998773
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.80 Aligned_cols=196 Identities=27% Similarity=0.442 Sum_probs=161.0
Q ss_pred ceeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEEEEEE
Q 004268 513 KYCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMFLIYE 587 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 587 (764)
.+.||+|+||+||+|+.. +++.||+|.+...... ..+.+|++++++++||||+++++++.. +...+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999754 5678999998754432 456789999999999999999998854 456899999
Q ss_pred ecCCCCHHHHHhcCc------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee----cCCCCEEEeee
Q 004268 588 YMERGSLFCVLRNDV------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL----NSNLEAFVADF 657 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Df 657 (764)
|+.+ ++.+++.... ....+++..++.++.||+.||+||| ++||+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9865 8887775321 1235889999999999999999999 9999999999999999 45678999999
Q ss_pred ccccccCCCCC---CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDSS---NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99987643221 12345789999999998774 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.27 Aligned_cols=238 Identities=25% Similarity=0.396 Sum_probs=188.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+.... .......+.+|++++.++ +||||+++++++..++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 467899999999999999999864 454 45777765432 223346788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 583 FLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
|+||||+++++|.+++..... ...+++..+..++.|++.|++||| ++|++||||||+||+++++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCC
Confidence 999999999999999974321 235788999999999999999999 9999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccC----
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG---- 724 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~---- 724 (764)
+.+||+|||++....... ......++..|+|||.+.+..++.++||||+||++|+|+| |..||......+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 999999999986432111 1111234567999999988889999999999999999998 9999976543221111
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.....+...+....+++.+|++.++.
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~ 265 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPY 265 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChh
Confidence 11122233577889999999988733
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.91 Aligned_cols=203 Identities=29% Similarity=0.419 Sum_probs=174.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|..+ +++.||+|++....... ...+.+.+|++++++++|||++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46899999999999999999865 68999999886543221 22356789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++++++..+... ...+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||.+......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99999888877653 335899999999999999999999 899999999999999999999999999999876544
Q ss_pred CCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 SSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
........++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 333334567889999999876 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.38 Aligned_cols=202 Identities=28% Similarity=0.391 Sum_probs=170.7
Q ss_pred HHHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC---
Q 004268 504 IEATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--- 579 (764)
Q Consensus 504 ~~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 579 (764)
.+..++|++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34568999999999999999999975 47889999998754322 22345677899999999999999999987543
Q ss_pred ---CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 580 ---KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 580 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
...|++++++ +++|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3478999988 6789888752 35889999999999999999999 89999999999999999999999999
Q ss_pred eccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
||++...... .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..
T Consensus 162 fg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 162 FGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999865432 233578999999999877 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=279.61 Aligned_cols=230 Identities=23% Similarity=0.277 Sum_probs=181.3
Q ss_pred eeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHh---cCCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 515 CIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQ---IRHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
.||+|+||.||+|... +++.||+|.+...............+|..+++. .+||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3799999999999764 689999999876544322222334445444443 479999999999999999999999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 670 (764)
+++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++++.++|+|||.+....... .
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 9999998873 345899999999999999999999 8999999999999999999999999999987553322 2
Q ss_pred eecccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcHHHHHHHhh
Q 004268 671 TLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 671 ~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 743 (764)
....|+..|+|||... +..++.++||||+||++|+|++|..||......... .......++.++..+.+++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence 2346899999999886 456889999999999999999999999755432111 111222344578899999999
Q ss_pred hhccchhhH
Q 004268 744 FSQGNHRWE 752 (764)
Q Consensus 744 ~l~~~~~~~ 752 (764)
|++.+..-|
T Consensus 233 ~l~~~p~~R 241 (279)
T cd05633 233 LLQRDVSKR 241 (279)
T ss_pred HhcCCHHHh
Confidence 999884443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=277.71 Aligned_cols=235 Identities=26% Similarity=0.436 Sum_probs=189.9
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|.+.+.||+|++|.||+|....+..+|+|.+...... .+.+.+|++++++++||+++++++++.. +..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 3679999999999999999998877778999988654432 2567889999999999999999998754 5688999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.||+||| +.|++|+||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999753 2335788999999999999999999 899999999999999999999999999999765432
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 740 (764)
... .....++..|+|||...+..++.++||||+|+++|+|++ |+.||.+....+... ..........+..+.++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 211 112345678999999988889999999999999999999 999998765432111 11122234467889999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+++|+..++.
T Consensus 236 i~~~l~~~p~ 245 (260)
T cd05069 236 MKLCWKKDPD 245 (260)
T ss_pred HHHHccCCcc
Confidence 9999976633
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=279.17 Aligned_cols=235 Identities=28% Similarity=0.494 Sum_probs=194.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|.||+|..++++.||+|.+...... .+.+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 5789999999999999999998887889999998765433 267889999999999999999999999989999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.|+.||| ++|++|+||+|+||++++++.+|++|||.+......
T Consensus 81 e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999753 2345889999999999999999999 899999999999999999999999999998766432
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 740 (764)
... ......+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+........ ......+...+..+.++
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111 111234568999999998889999999999999999998 999997655422111 11223344457788999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+.+|++.++
T Consensus 237 i~~~l~~~p 245 (261)
T cd05034 237 MLQCWDKDP 245 (261)
T ss_pred HHHHcccCc
Confidence 999997763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.65 Aligned_cols=200 Identities=19% Similarity=0.310 Sum_probs=166.9
Q ss_pred cceeeeec--CceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 512 IKYCIGTG--GYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 512 ~~~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
+.+.||+| ++++||++.. .+|+.||+|.+...... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46779999 6789999975 47999999998765433 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
+++++|.+++... ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999998643 2234889999999999999999999 89999999999999999999999999987544321111
Q ss_pred -------Cceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 669 -------NRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 669 -------~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
......++..|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1122346778999999876 46889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=284.72 Aligned_cols=232 Identities=28% Similarity=0.419 Sum_probs=192.0
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.|+..+.||+|+||.||+|.+. +++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45777788999999999999754 6889999988654332 23468899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++.. ..+++..+..++.|++.|+.||| ++|++|+||+|+||++++++.++++|||.+......
T Consensus 82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999999998853 35788999999999999999999 899999999999999999999999999999776543
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC----cCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR----KISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 742 (764)
........++..|+|||++.+..++.++|+||+|+++|+|++|+.||............ ........+..+.+++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 33333346788999999999989999999999999999999999999765443221111 11122345678899999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
.|++.+
T Consensus 235 ~~l~~~ 240 (277)
T cd06642 235 ACLNKD 240 (277)
T ss_pred HHccCC
Confidence 999876
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=275.84 Aligned_cols=230 Identities=24% Similarity=0.385 Sum_probs=187.6
Q ss_pred eeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 515 CIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
.||+|+||.||+|...+++.||+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 5899999999999888889999999875442 23335788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc-eec
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLV 673 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 673 (764)
.+++... ...+++..+..++.|++.|+.|+| ++|++||||+|+||++++++.+||+|||.+.......... ...
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 80 LSFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9998643 235789999999999999999999 8999999999999999999999999999987543222111 122
Q ss_pred ccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 674 VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 674 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.++..|+|||++.+..++.++||||+|+++|++++ |..||........ ............+..+.+++++|+..+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 34567999999998889999999999999999998 9999976654221 111122334557889999999999766
Q ss_pred hhh
Q 004268 749 HRW 751 (764)
Q Consensus 749 ~~~ 751 (764)
+.-
T Consensus 235 p~~ 237 (250)
T cd05085 235 PEN 237 (250)
T ss_pred ccc
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=285.75 Aligned_cols=234 Identities=22% Similarity=0.362 Sum_probs=198.9
Q ss_pred hcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
..|..++.||-|+||+|.+++ ..+...||+|.+.+.+.-.......++.|..|+..-+.+-||++|-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457777889999999999996 4567789999998877766666778899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC--
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH-- 664 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~-- 664 (764)
+|++||++..++- ..+-+.+.-++.++..+..|+++.| ..|+|||||||+|||||.+|++||.|||+++-+.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999886 3445888889999999999999999 9999999999999999999999999999986431
Q ss_pred -------CCCCC---------------------------------ceecccccccccccccccCCCCccchHHHHHHHHH
Q 004268 665 -------PDSSN---------------------------------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVAL 704 (764)
Q Consensus 665 -------~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~ 704 (764)
..... ....+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 01147999999999999999999999999999999
Q ss_pred HHHhCCCCCCcccccccccCC-------cCCCCCCCcHHHHHHHhhhhcc
Q 004268 705 EVLMGSHPTDLLSSLSSSSGR-------KISQNPRLDLQCNAYLKNFSQG 747 (764)
Q Consensus 705 ~lltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~ 747 (764)
||+.|++||...++.+.+.+. .+.....++.+|.++|.++...
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~s 912 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCS 912 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcC
Confidence 999999999988775544332 3444566899999999988753
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=284.29 Aligned_cols=235 Identities=26% Similarity=0.420 Sum_probs=187.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
++|++.+.||+|+||.||+|..+ ++. .+++|.+..... ....+.+.+|+++++++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 67999999999999999999764 333 478887764322 22346788999999999 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 584 LIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
++|||+++++|.+++.... ....+++..+..++.|++.|++||| ++||+||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence 9999999999999996432 1134788999999999999999999 89999999999999999999
Q ss_pred CEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCC
Q 004268 651 EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGR 725 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~ 725 (764)
.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|+|++ |..||......+.. ...
T Consensus 157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999864321111 111223457999999998889999999999999999997 99999766542211 111
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
....+...+..+.+++.+|++.+
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~ 258 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDR 258 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCC
Confidence 22233457788999999999877
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.37 Aligned_cols=239 Identities=26% Similarity=0.396 Sum_probs=188.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee-
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~- 578 (764)
.++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 468999999999999999999532 3578999998754332 2346778899999999 89999999998765
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCcc-------------------------------------------------------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------- 603 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 603 (764)
+..++++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4568899999999999999864211
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccc
Q 004268 604 ---AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYG 678 (764)
Q Consensus 604 ---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~ 678 (764)
...+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||++..+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125788999999999999999999 899999999999999999999999999999876432211 122345678
Q ss_pred cccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 679 y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
|+|||++.+..++.++||||+||++|+|++ |..||.+....+. ............+....+++.+|++.+..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999998 9999976432111 11112222334567888999999887633
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=299.05 Aligned_cols=362 Identities=30% Similarity=0.440 Sum_probs=278.4
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
.++.++.|+++.|.+. .+|++++.+-.++.|+..+|+++ ..|.++..+.+|..|++.+|+++...|..+. ++.|++|
T Consensus 112 s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~l 188 (565)
T KOG0472|consen 112 SLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHL 188 (565)
T ss_pred hhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhc
Confidence 3457888888888886 77888888888888888888887 5677777888888888888888854444444 8888888
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
|...|.++ ..|..++++.+|..|+|.+|+|..++ .|.+|..|.+|+++.|+|+.++.....++++|..|+|+.|+++
T Consensus 189 d~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 189 DCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred ccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc
Confidence 88888887 55667788888888888888888653 7888888888888888887555555668888888888888887
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccC----------------------------
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP---------------------------- 228 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---------------------------- 228 (764)
..|+.+.-+.+|+.||+|+|.|+.+ +..++++ +|+.|-+.+|.+..+-.
T Consensus 266 -e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~ 342 (565)
T KOG0472|consen 266 -EVPDEICLLRSLERLDLSNNDISSL-PYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEG 342 (565)
T ss_pred -cCchHHHHhhhhhhhcccCCccccC-Ccccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcc
Confidence 4566677788888888888888865 3456777 78888888887642100
Q ss_pred ----------ccc---cCCCCCCE--------------------------EEccCCcccCCCCcCCcCCCCC-CeEEccC
Q 004268 229 ----------STI---GYLNLLDE--------------------------LHLSHNRLDGPIPPTIGNLTNL-IALDLSS 268 (764)
Q Consensus 229 ----------~~~---~~l~~L~~--------------------------L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~ 268 (764)
..| ....+.+. .+++.|++. ..|..+..+..+ ..+.+++
T Consensus 343 ~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsn 421 (565)
T KOG0472|consen 343 GTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSN 421 (565)
T ss_pred cccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhc
Confidence 000 01122333 445555554 344444433333 3445555
Q ss_pred CcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCc
Q 004268 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIP 348 (764)
Q Consensus 269 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 348 (764)
|.++ .+|..++.+++|..|+|++|.+. ..|..++.+..|+.|++|.|++. ..|..+..+..|+.+-.++|++..+.+
T Consensus 422 n~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~ 498 (565)
T KOG0472|consen 422 NKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDP 498 (565)
T ss_pred Cccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccCh
Confidence 5555 56777889999999999999987 56777888889999999999999 889999988889999899999998888
Q ss_pred hhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccc
Q 004268 349 SEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392 (764)
Q Consensus 349 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 392 (764)
..+.+|.+|..|||.+|.+. .+|..++++.+|++|+++||++.
T Consensus 499 ~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 499 SGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 88999999999999999999 78889999999999999999999
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=276.28 Aligned_cols=235 Identities=23% Similarity=0.344 Sum_probs=194.1
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|+||.||.+.. .+|+.||+|.+....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 588999999999999999975 478999999987543322 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ....+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999988643 2235788999999999999999999 8999999999999999999999999999997765433
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHhh
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||......+. ............+....+++++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 333334678899999999988899999999999999999999999975443211 1111122334567889999999
Q ss_pred hhccc
Q 004268 744 FSQGN 748 (764)
Q Consensus 744 ~l~~~ 748 (764)
|++.+
T Consensus 236 ~l~~~ 240 (256)
T cd08218 236 LFKRN 240 (256)
T ss_pred HhhCC
Confidence 99766
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=277.32 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=194.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC--cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE--EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
+|+..+.||+|++|.||+|... +++.|++|.+...... ..+..+.+.+|+++++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999865 7899999998654422 233457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|.+++... ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999999743 35788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccccccccC-----CcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-----RKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 739 (764)
.. ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||........... ......+.++....+
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 32 223456788999999987776 89999999999999999999999976654222111 111223456788899
Q ss_pred HHhhhhccchh
Q 004268 740 YLKNFSQGNHR 750 (764)
Q Consensus 740 ~~~~~l~~~~~ 750 (764)
++++|++.++.
T Consensus 234 li~~~l~~~p~ 244 (258)
T cd06632 234 FILKCLQRDPS 244 (258)
T ss_pred HHHHHhhcCcc
Confidence 99999986633
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.09 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=196.0
Q ss_pred cceeeeecCceeEEEEEEC-CCCEEEEEEccCC-CCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC--EEEEEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRS-ETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMFLIYE 587 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 587 (764)
....||+|+|-+||+|.+. +|..||--.++.. ....++..+++..|+++++.|+||||+++|+++.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999654 6777774332221 1233455689999999999999999999999988754 4889999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEeeeccccccCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 666 (764)
.+..|+|+.|.++ ...++...++.|++||++||.|||+. ...|||||||-+||||+ ..|.|||+|+|+|+.....
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 45688899999999999999999976 78999999999999998 4689999999999987543
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc-----CCCCCCC-cHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK-----ISQNPRL-DLQCNAY 740 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~ 740 (764)
. ....+|||.|||||+.. ..|+...||||||+++.||+|+.+||........+.+.. -....++ +++.+++
T Consensus 200 ~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f 276 (632)
T KOG0584|consen 200 H--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF 276 (632)
T ss_pred c--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence 2 33479999999999987 789999999999999999999999999887754443322 2222233 6789999
Q ss_pred Hhhhhccc-hhhHHHhhhcCCC
Q 004268 741 LKNFSQGN-HRWENLLFKKFPY 761 (764)
Q Consensus 741 ~~~~l~~~-~~~~~~~~~~~p~ 761 (764)
|.+|+... .+.....+.++||
T Consensus 277 IekCl~~~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 277 IEKCLATKSERLSAKELLKDPF 298 (632)
T ss_pred HHHHhcCchhccCHHHHhhChh
Confidence 99999864 5555666666665
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=280.87 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=193.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||.||+|..+ ++..||+|.+...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 468999999999999999999754 2468999998654322 23467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE-------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
..++||||+++++|.+++..... ...+++..+..++.|++.||.||| ++|++||||||+||++++++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence 99999999999999999864321 223678889999999999999999 99999999999999999999999
Q ss_pred EeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||.++....... ......++..|+|||.+.+..++.++||||+||++|++++ |..||.+.+..... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 999999876543321 1223346778999999988889999999999999999998 99999765532211 1122
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhh
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
...+...+..+.+++++|++.++.-
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKM 264 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhh
Confidence 2334456788899999999877443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=276.41 Aligned_cols=228 Identities=26% Similarity=0.411 Sum_probs=184.3
Q ss_pred eeeecCceeEEEEEE---CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.||+|+||.||+|.+ .+++.||+|++..... .....+.+..|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999964 3678899998865433 34455788999999999999999999998754 567899999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc-
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR- 670 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 670 (764)
++|.+++... ..+++..+..++.|++.|++|+| ++||+||||||+||++++++.+||+|||.+..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999999742 35889999999999999999999 8999999999999999999999999999998764332211
Q ss_pred --eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHhh
Q 004268 671 --TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 671 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
....++..|+|||.+.+..++.++|+||+|+++|||++ |+.||......+. ........++..+..+.++++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL 233 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 11233578999999988889999999999999999998 9999986544211 1111223345578899999999
Q ss_pred hhccchh
Q 004268 744 FSQGNHR 750 (764)
Q Consensus 744 ~l~~~~~ 750 (764)
|++.+..
T Consensus 234 ~~~~~p~ 240 (257)
T cd05116 234 CWTYGVD 240 (257)
T ss_pred HhccCch
Confidence 9987633
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=278.11 Aligned_cols=230 Identities=26% Similarity=0.399 Sum_probs=192.5
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||.|++|.||+|... +++.||+|++...........+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999865 6899999999876655445567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecc
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 674 (764)
.+++.+. ..+++..+..++.|++.||+|+| ++|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 9999743 34788999999999999999999 8999999999999999999999999999998765332 223346
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc--ccccc---c--CCcCCCCCCCcHHHHHHHhhhhcc
Q 004268 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS--SLSSS---S--GRKISQNPRLDLQCNAYLKNFSQG 747 (764)
Q Consensus 675 g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~--~~~~~---~--~~~~~~~~~~~~~~~~~~~~~l~~ 747 (764)
++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... ..... . ......++..+..+.+++++|++.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 7889999999988889999999999999999999999998665 21111 1 222333444578999999999987
Q ss_pred chhhH
Q 004268 748 NHRWE 752 (764)
Q Consensus 748 ~~~~~ 752 (764)
++.-|
T Consensus 234 ~p~~R 238 (262)
T cd05572 234 NPEER 238 (262)
T ss_pred ChhhC
Confidence 74444
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=282.72 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=174.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|.++ +++.||+|.+....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46889999999999999999865 68999999987654432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++++++..+... ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988877653 234889999999999999999999 899999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 SSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
........++..|+|||++.+. .++.++||||+|+++|+|++|++||....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 3333445678899999988753 46789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=281.39 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=193.9
Q ss_pred HHHHHHHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 500 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
+.++....++|++.+.||+|+||.||+|.. .+++.+|+|.+...... ...+.+|+.+++++ +|||++++++++.
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344555678999999999999999999976 47889999998654322 25677899999999 8999999999987
Q ss_pred eC-----CEEEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC
Q 004268 578 HN-----KCMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651 (764)
Q Consensus 578 ~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 651 (764)
.. +..++||||+++++|.++++... ....+++..++.++.|++.||+||| ++|++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 53 35899999999999999886422 2345889999999999999999999 899999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceecccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC-
Q 004268 652 AFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-----AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR- 725 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~- 725 (764)
+||+|||.+..............++..|+|||++... .++.++||||+||++|+|++|+.||............
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999999998765433333345678899999987643 3678999999999999999999999876543221111
Q ss_pred -----cCCCCCCCcHHHHHHHhhhhccchh
Q 004268 726 -----KISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 726 -----~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
........+..+.+++.+|++.+..
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 276 (291)
T cd06639 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFE 276 (291)
T ss_pred cCCCCCCCcccccCHHHHHHHHHHhhcChh
Confidence 1122334566789999999987633
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=282.04 Aligned_cols=236 Identities=29% Similarity=0.453 Sum_probs=191.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|.+.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 356888999999999999999642 355688888764432 22367889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
..++||||+++++|.+++.... ....+++..++.++.||+.|++||| ++|++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEc
Confidence 9999999999999999997432 1234789999999999999999999 99999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc--
Q 004268 648 SNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-- 722 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-- 722 (764)
.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||+|+++|+|+| |+.||......+..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999976543221 1122346788999999999999999999999999999999 99999765542211
Q ss_pred --cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 --SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 --~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...........+..+.+++.+|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~ 265 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQRE 265 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccC
Confidence 11111223345778999999999877
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=276.32 Aligned_cols=233 Identities=27% Similarity=0.444 Sum_probs=196.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|... +++.|++|++...... ...+.+.+|++.+++++|||++++++++...+..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888999999999999999865 6999999998765442 33578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++... ..+++..+..++.|+++|++||| + .|++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999743 56889999999999999999999 8 9999999999999999999999999999987754
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc---cc---c-ccCCcCCCCCC-CcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS---LS---S-SSGRKISQNPR-LDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~---~~---~-~~~~~~~~~~~-~~~~~ 737 (764)
.........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+ . ........... .+..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 44433345678899999999998999999999999999999999999987741 00 0 11111222333 67889
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
.+++++|+..+
T Consensus 233 ~~li~~~l~~~ 243 (264)
T cd06623 233 RDFISACLQKD 243 (264)
T ss_pred HHHHHHHccCC
Confidence 99999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=275.70 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=203.0
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCc----HHHHHHHHHHHHHHHhcCCCceeeEeeEEe-eC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEE----PAFLESFQTEARLLSQIRHRNIVKLYGFCL-HN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~ 579 (764)
..++|-+.+.+|+|+|+.||+|- ....+.||+|+-.....+. +.+.+...+|.+|.+.++||-||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 35789999999999999999995 5578899999876544433 335567889999999999999999999986 45
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVAD 656 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~D 656 (764)
+.+|-|+|||+|.+|.-|++.. ..+++.+++.|+.||+.||.||... +..|||-|+||.||++. ..|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 6799999999999999999843 4588999999999999999999965 78999999999999995 458899999
Q ss_pred eccccccCCCCCCc-------eecccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcccccc-----
Q 004268 657 FGLARLLHPDSSNR-------TLVVGTYGYIAPELAYTM----AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS----- 720 (764)
Q Consensus 657 fg~~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~----- 720 (764)
||+++.++.+.... .-..||.+|.+||.+.-+ ..+.|.||||+|||+|+.+.|+.||.......
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 99999987554432 235799999999976533 45789999999999999999999997543311
Q ss_pred ----cccCCcCCCCCCCcHHHHHHHhhhhccc--hhhHHHhhhcCCCC
Q 004268 721 ----SSSGRKISQNPRLDLQCNAYLKNFSQGN--HRWENLLFKKFPYQ 762 (764)
Q Consensus 721 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~p~~ 762 (764)
..........|.++.+..+||++|+.+- .+..-..+...||-
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 1223455566778999999999999965 33333345555553
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=276.23 Aligned_cols=235 Identities=25% Similarity=0.370 Sum_probs=191.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCC--CCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSE--TEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 582 (764)
.+|++.+.||+|++|.||+|... +++.||+|.+.... .........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46899999999999999999754 78999999875432 12234456888999999999999999999998764 468
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++++||+++++|.+++.. ...+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999873 234788899999999999999999 89999999999999999999999999999986
Q ss_pred cCCC---CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC-----cCCCCCCCc
Q 004268 663 LHPD---SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR-----KISQNPRLD 734 (764)
Q Consensus 663 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~ 734 (764)
.... ........++..|+|||.+.+..++.++|+||+|+++|++++|+.||............ ....++.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~ 235 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccC
Confidence 5321 11122346788999999999888999999999999999999999999876543322211 122244567
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++..
T Consensus 236 ~~~~~~i~~~l~~~ 249 (264)
T cd06653 236 DACRDFLKQIFVEE 249 (264)
T ss_pred HHHHHHHHHHhcCc
Confidence 88999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=274.69 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=197.8
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|... +++.|++|.+...... ....+.+..|++++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 5889999999999999999754 7899999998766543 4456889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++.. ...+++..+..++.|++.|++||| +.|++|+||+|+||++++++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999874 234788899999999999999999 8999999999999999999999999999998765433
Q ss_pred CCce----ecccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCccccccc-----ccC--CcCCCCCCC
Q 004268 668 SNRT----LVVGTYGYIAPELAYTMA---VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-----SSG--RKISQNPRL 733 (764)
Q Consensus 668 ~~~~----~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-----~~~--~~~~~~~~~ 733 (764)
.... ...++..|+|||++.+.. ++.++||||+|+++|++++|+.||........ ... ........+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL 233 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence 2211 245788999999988776 88999999999999999999999976532111 011 111122234
Q ss_pred cHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 734 DLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+....+++++|++.++.-| .......||
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 7788999999998764332 333444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.70 Aligned_cols=230 Identities=25% Similarity=0.410 Sum_probs=189.3
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|.....||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3444466999999999999754 688999998864332 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++.. ..+++..+..++.||+.|++||| ++||+||||||+||++++++.++|+|||.+.......
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998853 24788999999999999999999 8999999999999999999999999999987654433
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 741 (764)
.......++..|+|||...+..++.++|+||+|+++|||++|+.||.......... ..........+..+.+++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 33344578899999999988889999999999999999999999998655432111 111122334577888999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
..|+..+
T Consensus 253 ~~~l~~~ 259 (292)
T cd06658 253 DLMLVRE 259 (292)
T ss_pred HHHccCC
Confidence 9998876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=279.31 Aligned_cols=229 Identities=22% Similarity=0.301 Sum_probs=187.7
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|+||+||+|... +|+.||+|.+.............+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 7899999998754433223335667899999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecc
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 674 (764)
.+++.... ...+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 99987542 235889999999999999999999 899999999999999999999999999998765432 2223346
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-------cccCCcCCCCCCCcHHHHHHHhhhhcc
Q 004268 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-------SSSGRKISQNPRLDLQCNAYLKNFSQG 747 (764)
Q Consensus 675 g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 747 (764)
++..|+|||+..+..++.++|+||+|+++|+|++|+.||....... .........++..+..+.+++++|++.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence 7889999999988889999999999999999999999997654311 111122233445688999999999987
Q ss_pred ch
Q 004268 748 NH 749 (764)
Q Consensus 748 ~~ 749 (764)
++
T Consensus 236 ~p 237 (277)
T cd05577 236 DP 237 (277)
T ss_pred Ch
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=276.38 Aligned_cols=238 Identities=24% Similarity=0.360 Sum_probs=187.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.......||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34444568999999999999754 678899998865432 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++.........++..+..++.|++.|++||| ++||+||||||+||+++. ++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999975322222377888899999999999999 899999999999999986 67999999999876643
Q ss_pred CCCCceecccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMA--VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~ 737 (764)
.........+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||.......... ......+..++..+
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 333333346788999999986643 7889999999999999999999997654321111 11112233467788
Q ss_pred HHHHhhhhccchhh
Q 004268 738 NAYLKNFSQGNHRW 751 (764)
Q Consensus 738 ~~~~~~~l~~~~~~ 751 (764)
.+++++|++.++.-
T Consensus 242 ~~li~~~l~~~p~~ 255 (268)
T cd06624 242 KNFILRCFEPDPDK 255 (268)
T ss_pred HHHHHHHcCCCchh
Confidence 99999999876333
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=277.67 Aligned_cols=236 Identities=30% Similarity=0.428 Sum_probs=190.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-C---CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-S---GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||.||+|... + +..+|+|.+..... ....+.+.+|+.++++++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 467899999999999999999753 2 33799998865432 23346889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++.++..++.|++.|++||| ++|++||||||+||+++.++.++++|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 9999999999999999753 245788999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCCce---ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCc
Q 004268 663 LHPDSSNRT---LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~ 734 (764)
......... ...++..|+|||.+.+..++.++|+||+|+++|++++ |..||......+. ............+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence 643322111 1123467999999998899999999999999999886 9999976653221 1111222334457
Q ss_pred HHHHHHHhhhhccch
Q 004268 735 LQCNAYLKNFSQGNH 749 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~ 749 (764)
..+.+++.+|++.+.
T Consensus 236 ~~~~~li~~~l~~~p 250 (267)
T cd05066 236 AALHQLMLDCWQKDR 250 (267)
T ss_pred HHHHHHHHHHcccCc
Confidence 788999999998663
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=301.59 Aligned_cols=199 Identities=20% Similarity=0.320 Sum_probs=164.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC------CceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH------RNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||+||+|.+. +++.||||++..... .......|+++++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999754 688999999864321 22455678888877754 458889998876
Q ss_pred C-CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCC------
Q 004268 579 N-KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNL------ 650 (764)
Q Consensus 579 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~------ 650 (764)
. ..+++|||++ +++|.+++.+ ...+++..+..++.||+.||+||| + .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccc
Confidence 4 5689999988 5688888763 346889999999999999999999 7 5999999999999998765
Q ss_pred ----------CEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 651 ----------EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 651 ----------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.+||+|||.+.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999886432 223346789999999999999999999999999999999999999986543
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=279.18 Aligned_cols=238 Identities=26% Similarity=0.359 Sum_probs=189.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|++|.||+|.+. .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 467999999999999999999764 3568899987654332 22366889999999999999999999999988
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE----AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~k 653 (764)
..++||||+++++|.+++..... ...+++..+..++.||+.|++||| +++++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence 99999999999999999875421 235889999999999999999999 89999999999999998654 599
Q ss_pred EeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||.++........ ......+..|+|||++.+..++.++||||+||++|+|++ |+.||......+.. ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999999876322111 111233567999999999999999999999999999997 99999865532211 1112
Q ss_pred CCCCCCCcHHHHHHHhhhhccch
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
...++..+....+++.+|++.+.
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCc
Confidence 23345567888999999997653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=274.66 Aligned_cols=226 Identities=23% Similarity=0.388 Sum_probs=182.0
Q ss_pred eeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 516 IGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 516 ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 899999999999653 355799998865432 3345778999999999999999999998864 5689999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc--
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-- 670 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 670 (764)
+|.+++... ...+++..+..++.|++.|++||| ++|++||||||+||+++.++.+||+|||.+..........
T Consensus 80 ~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999998642 346889999999999999999999 8999999999999999999999999999997654332211
Q ss_pred -eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHhhh
Q 004268 671 -TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLKNF 744 (764)
Q Consensus 671 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 744 (764)
....++..|+|||.+.+..++.++||||||+++|++++ |..||......+.. .......++..+.+..+++.+|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 11223568999999988889999999999999999996 99999876543221 1122233445578899999999
Q ss_pred hccch
Q 004268 745 SQGNH 749 (764)
Q Consensus 745 l~~~~ 749 (764)
|..+.
T Consensus 235 ~~~~~ 239 (257)
T cd05115 235 WIYKW 239 (257)
T ss_pred cCCCh
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=283.02 Aligned_cols=234 Identities=27% Similarity=0.396 Sum_probs=194.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC---CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS---SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.+..+..+.||.|.||.||+|... .|+ .||||..+.....+. .+.|..|+.+|+.++||||++++|++.+. .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 344566678999999999999532 233 588888766554433 58899999999999999999999999875 5
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|||||.++.|.|..|++.+ ...++......++.||+.||+||| ++.+|||||..+||++.+...|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhh
Confidence 89999999999999999864 456888999999999999999999 9999999999999999999999999999999
Q ss_pred ccCCCCCCcee-cccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccCCcCCCCCCCcHHH--
Q 004268 662 LLHPDSSNRTL-VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGRKISQNPRLDLQC-- 737 (764)
Q Consensus 662 ~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 737 (764)
.+..+...... ..-...|||||.+.-..++.++|||.|||++||++. |..||.+....+.....+...+.+.|+.|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp 619 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPP 619 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCCh
Confidence 98765543322 233668999999999999999999999999999986 99999999988777666666655555544
Q ss_pred --HHHHhhhhccc
Q 004268 738 --NAYLKNFSQGN 748 (764)
Q Consensus 738 --~~~~~~~l~~~ 748 (764)
--++.+||.++
T Consensus 620 ~LYslmskcWaye 632 (974)
T KOG4257|consen 620 ALYSLMSKCWAYE 632 (974)
T ss_pred HHHHHHHHHhccC
Confidence 45677777776
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=279.49 Aligned_cols=203 Identities=27% Similarity=0.351 Sum_probs=170.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.. .+++.||+|.+........ ...+.+|+++++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 47899999999999999999975 4789999999876543321 24567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+. +++.+++... ...+++..+..++.|++.||+||| +.||+|+||||+||+++.++.+||+|||.++....
T Consensus 82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 5776666432 234778888999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||+...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 33333334578899999998764 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=281.04 Aligned_cols=232 Identities=27% Similarity=0.415 Sum_probs=193.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 47899999999999999999975 47889999998643322 236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|.+++.+. .+++..+..++.|++.|+.||| ++|++||||+|+||+++.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999998642 4778899999999999999999 99999999999999999999999999999876654
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------cCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------KISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~~ 739 (764)
.........+++.|+|||.+.+..++.++|+||+|+++|++++|+.||............ .......++..+.+
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 444344456888999999998888999999999999999999999999866543221111 11122335678899
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++.+|++.+
T Consensus 248 li~~~l~~~ 256 (293)
T cd06647 248 FLNRCLEMD 256 (293)
T ss_pred HHHHHccCC
Confidence 999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.91 Aligned_cols=234 Identities=25% Similarity=0.422 Sum_probs=196.3
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
..+..+.||+|+||+||+|.+ ..|+ +||+|++...... ....++..|+-.|.+++|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 344567899999999999964 3343 6899988765544 33488999999999999999999999998766 88
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|++|++.|+|.++++.+ ...+.......|..||++|+.||| .+++|||||.++||||.+-..+|+.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999864 445777889999999999999999 999999999999999999999999999999988
Q ss_pred CCCCCCceecc--cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVV--GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
.++........ -.+.|||-|.+....|+.++|||||||++||++| |..||+++...++. ...+..++|.=+.+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTID 928 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHH
Confidence 76655443333 3578999999999999999999999999999998 99999998865442 33446667777888
Q ss_pred HHHHHhhhhccchh
Q 004268 737 CNAYLKNFSQGNHR 750 (764)
Q Consensus 737 ~~~~~~~~l~~~~~ 750 (764)
.-..+-+||..++.
T Consensus 929 Vy~~mvkCwmid~~ 942 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDAD 942 (1177)
T ss_pred HHHHHHHHhccCcc
Confidence 88889999987743
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=278.55 Aligned_cols=231 Identities=30% Similarity=0.470 Sum_probs=191.2
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC---CCceeeEeeEEeeCCEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR---HRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l 584 (764)
.|++.+.||+|+||.||+|.+ .+++.||+|.+...... ...+.+.+|++++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477888999999999999985 47899999998654332 22467889999999996 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.++++.. .+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998642 5889999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCC-----CCcHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNP-----RLDLQCN 738 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~-----~~~~~~~ 738 (764)
..........|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.................+ ..+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLR 232 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHH
Confidence 544334445788899999988654 5688999999999999999999999876553322221111111 2567899
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
+++..|++.+
T Consensus 233 ~~i~~~l~~~ 242 (277)
T cd06917 233 EFVAACLDEE 242 (277)
T ss_pred HHHHHHcCCC
Confidence 9999999876
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=281.34 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=191.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999999643 2458999987654322 2235678899999999999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCE
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE-------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 652 (764)
...++||||+++|+|.++++.... ....+...+..++.|++.||.||| ++||+||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence 999999999999999999974221 233566788899999999999999 9999999999999999999999
Q ss_pred EEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CC
Q 004268 653 FVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GR 725 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~ 725 (764)
+|+|||.++......... ....++..|+|||.+.+..++.++|+||+||++|||++ |..||.+....+... ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987653322111 12234678999999998899999999999999999998 899998655432211 11
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
........+....+++..|++.++.-|
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 112233456789999999998874333
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=280.46 Aligned_cols=238 Identities=27% Similarity=0.477 Sum_probs=191.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
..+|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 467888999999999999999632 45678999876433 233468899999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
..+++|||+++++|.+++..... ...+++..+..++.|++.|++||| ++|++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcC
Confidence 99999999999999999875321 134788999999999999999999 999999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc---
Q 004268 649 NLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS--- 722 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~--- 722 (764)
++.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999876532221 1112234678999999999999999999999999999998 99999765542211
Q ss_pred -cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 723 -SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 723 -~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.......+...+....+++.+|++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~ 266 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQ 266 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChh
Confidence 1122233445678899999999976643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=276.71 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=196.7
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCC---cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETE---EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
+|+..+.||+|++|.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999975 57899999998754422 22345788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeecccccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLARLL 663 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~ 663 (764)
||||+++++|.+++.+ ...+++..+..++.|++.||.||| ++|++|+||+|+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999874 345788999999999999999999 89999999999999998776 5999999999876
Q ss_pred CCCCCC----ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------CCcCCCCC
Q 004268 664 HPDSSN----RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------GRKISQNP 731 (764)
Q Consensus 664 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------~~~~~~~~ 731 (764)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... ......++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCch
Confidence 543211 123467889999999988889999999999999999999999997544321110 11122233
Q ss_pred CCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 732 RLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.++.++.+++.+|++.++.-| .......||
T Consensus 235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 235 HLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred hhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 467888999999998764333 333444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=289.90 Aligned_cols=241 Identities=24% Similarity=0.399 Sum_probs=192.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEe
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCL 577 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~ 577 (764)
...++|.+.+.||+|+||.||+|.+. .++.||+|++....... ..+.+.+|++++.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34567888999999999999999753 34689999997654332 2357889999999997 999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc------------------------------------------------------
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------ 603 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 603 (764)
..+..++||||+++|+|.+++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999964321
Q ss_pred -----------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 004268 604 -----------------------------------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSN 642 (764)
Q Consensus 604 -----------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~ 642 (764)
...+++..+..++.|++.||+||| ++|++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 123567788899999999999999 899999999999
Q ss_pred CeeecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccc
Q 004268 643 NILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSL 719 (764)
Q Consensus 643 NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~ 719 (764)
||++++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||+|+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999976532211 1122356788999999998889999999999999999998 89999765432
Q ss_pred ccc-----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 720 SSS-----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 720 ~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
+.. .......++..+..+.+++++|+..+..
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~ 384 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFE 384 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 211 1111223445678899999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=282.98 Aligned_cols=238 Identities=25% Similarity=0.393 Sum_probs=190.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+..... ......+.+|+++++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 467999999999999999999642 235799999875432 22346788899999999 7999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
..+..|+||||+++++|.+++..... ...+++..+..++.|++.||+||| ++|++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence 99999999999999999999975321 134788999999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+||+|||.+.......... ....+++.|+|||++.+..++.++||||+||++|+|++ |..||......+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 99999999999999987654322111 11223568999999999899999999999999999998 8999976554221
Q ss_pred c----cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 722 S----SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 722 ~----~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
. .......+...+....+++++|+..++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCh
Confidence 1 111222334467888999999998663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.02 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=219.7
Q ss_pred CHHHHHHHhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEE
Q 004268 499 TFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFC 576 (764)
Q Consensus 499 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 576 (764)
.++.+....+.|.+.+.||.|.+|.||+++ .++++.+|+|+.......+ +++..|.++++.. .|||++.++++|
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344444557789999999999999999997 4578999999987766654 6778899999988 699999999988
Q ss_pred ee-----CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC
Q 004268 577 LH-----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651 (764)
Q Consensus 577 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 651 (764)
.. ++.+|+|||||.+|+..++++... ..++.|..+..|++.++.|+.+|| ...++|||||-.||+++.++.
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCc
Confidence 64 467999999999999999998764 678999999999999999999999 889999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceecccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc
Q 004268 652 AFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-----AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK 726 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~ 726 (764)
||++|||.+...........+.+||+.|||||++.-. .|+.++|+||||++..||.-|.+|+.+..+......+-
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip 241 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 241 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC
Confidence 9999999999988777778889999999999998643 46789999999999999999999999999988877777
Q ss_pred CCCCCCC------cHHHHHHHhhhhccchhhH--HHhhhcCCCC
Q 004268 727 ISQNPRL------DLQCNAYLKNFSQGNHRWE--NLLFKKFPYQ 762 (764)
Q Consensus 727 ~~~~~~~------~~~~~~~~~~~l~~~~~~~--~~~~~~~p~~ 762 (764)
..++|++ +.+.+++|..|+.++..-| -..+.+.||+
T Consensus 242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 7777766 4578999999999884433 3335566665
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=275.31 Aligned_cols=206 Identities=27% Similarity=0.409 Sum_probs=174.3
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCC--cHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETE--EPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~ 582 (764)
..|++.+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999975 46899999988654322 23345678899999999999999999998875 3678
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++++||+++++|.+++.. ...+++..+..++.|++.||+||| +.||+||||+|+||+++.++.+||+|||.+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999999874 234788899999999999999999 89999999999999999999999999999876
Q ss_pred cCCCC---CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 663 LHPDS---SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 663 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
..... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~ 215 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence 53211 1122345788999999999988999999999999999999999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=279.96 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=171.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|++|.||+|..+ +++.||+|.+........ ...+.+|++++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 468999999999999999999865 789999999875433221 24566899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ +|.+++... ...+++..++.++.|++.||.||| ++||+||||||+||++++++.+||+|||.++....
T Consensus 82 ~e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999985 899888643 236788999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2222223356788999998875 457899999999999999999999997554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=275.93 Aligned_cols=232 Identities=29% Similarity=0.457 Sum_probs=193.2
Q ss_pred eeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 514 YCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
+.||+|+||.||+|.... +..|++|.+....... ..+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 368999999999997653 7899999987665443 3578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcc------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 590 ERGSLFCVLRNDVE------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 590 ~~~~L~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
++++|.+++..... ...+++..+..++.|++.|++||| ++|++||||+|+||++++++.+||+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999975311 356899999999999999999999 999999999999999999999999999999877
Q ss_pred CCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 664 HPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
.... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||......... .......++..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE 235 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChH
Confidence 5432 12233456889999999998889999999999999999999 69999877542211 12233445566889
Q ss_pred HHHHHhhhhccchh
Q 004268 737 CNAYLKNFSQGNHR 750 (764)
Q Consensus 737 ~~~~~~~~l~~~~~ 750 (764)
+.+++..|++.++.
T Consensus 236 ~~~li~~~l~~~p~ 249 (262)
T cd00192 236 LYELMLSCWQLDPE 249 (262)
T ss_pred HHHHHHHHccCCcc
Confidence 99999999987633
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=280.58 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=189.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-----------------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCce
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-----------------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 569 (764)
.++|++.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+++++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 367999999999999999998532 234689998875432 2334678899999999999999
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCcc--------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVE--------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 641 (764)
+++++++...+..+++|||+++++|.+++..... ...+++..+..++.|++.|++||| ++|++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCh
Confidence 9999999999999999999999999999875321 124677889999999999999999 89999999999
Q ss_pred CCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCccc
Q 004268 642 NNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM--GSHPTDLLS 717 (764)
Q Consensus 642 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--g~~Pf~~~~ 717 (764)
+||++++++.++|+|||.+......... .....++..|+|||+..+..++.++||||+||++|||++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999765432211 112234678999999888889999999999999999998 789997654
Q ss_pred cccccc-----------CCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 718 SLSSSS-----------GRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 718 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..+... ......++..+....+++..|++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 322110 11122334456788899999997653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=275.74 Aligned_cols=234 Identities=25% Similarity=0.434 Sum_probs=191.6
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|++++++++|+||+++++.+.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 578999999999999999999877788899998865432 23678899999999999999999999887 7789999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... .....++..+..++.|++.||.||| +.|++||||+|+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 80 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999754 2345788899999999999999999 889999999999999999999999999998765432
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
... .....++..|+|||++.+..++.++|+||+|+++|++++ |+.||...+..... ...........+....++
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 211 112334577999999998889999999999999999998 99999876542211 111222344567889999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+.+|++.++
T Consensus 236 i~~~l~~~p 244 (260)
T cd05073 236 MMRCWKNRP 244 (260)
T ss_pred HHHHcccCc
Confidence 999997663
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-32 Score=276.90 Aligned_cols=232 Identities=29% Similarity=0.432 Sum_probs=192.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+-|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 45778899999999999999754 7889999987654332 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|..++.. ..+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.++++|||.+......
T Consensus 82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999999863 35789999999999999999999 999999999999999999999999999998766443
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----CcCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG----RKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 742 (764)
........++..|+|||.+.+..++.++|+||+||++|+|++|..||........... .........+..+.+++.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence 3333345678899999999888889999999999999999999999986554221111 111123346788999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
.|++.+
T Consensus 235 ~~l~~~ 240 (277)
T cd06641 235 ACLNKE 240 (277)
T ss_pred HHccCC
Confidence 999866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=272.80 Aligned_cols=244 Identities=23% Similarity=0.367 Sum_probs=193.4
Q ss_pred HHHHHHHhhcCCcceee--eecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeE
Q 004268 500 FEEMIEATEDFHIKYCI--GTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGF 575 (764)
Q Consensus 500 ~~~~~~~~~~y~~~~~i--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 575 (764)
..+.....+.|.+.+.+ |+|+||.||++.. .+++.+|+|.+....... .|......+ +||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEE
Confidence 34455566788888777 9999999999975 478899999986543221 122222222 79999999999
Q ss_pred EeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEE
Q 004268 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFV 654 (764)
Q Consensus 576 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl 654 (764)
+...+..++||||+++++|.+++... ..+++..+..++.|+++|+.||| +.|++||||+|+||+++.++ .++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence 99999999999999999999999743 36899999999999999999999 89999999999999999888 9999
Q ss_pred eeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcC
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKI 727 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~ 727 (764)
+|||.+...... ....++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ......
T Consensus 152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T PHA03390 152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227 (267)
T ss_pred ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC
Confidence 999998765422 224678899999999999999999999999999999999999985433211 111222
Q ss_pred CCCCCCcHHHHHHHhhhhccchhhHH---HhhhcCCC
Q 004268 728 SQNPRLDLQCNAYLKNFSQGNHRWEN---LLFKKFPY 761 (764)
Q Consensus 728 ~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~p~ 761 (764)
...+..+..+.+++.+|++.++..|. ....+.||
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 23335788999999999998866662 44555555
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.85 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=168.9
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|... +|+.||+|.+....... .....+.+|++++++++||||+++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 5888999999999999999865 78999999987543221 223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++ ++.+++... ...+++..++.++.||++||.||| ++|++||||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9975 787777532 345899999999999999999999 8999999999999999999999999999998665433
Q ss_pred CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCC
Q 004268 668 SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
.......++..|+|||++.+. .++.++||||+||++|+|+||..||.
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 333345678899999988765 46899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=278.80 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=195.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCC---
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~--- 580 (764)
..++|++.+.||+|++|.||+|..+ +++.+++|++...... .+.+.+|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4689999999999999999999864 6789999998754432 36788999999999 7999999999987644
Q ss_pred ---EEEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 581 ---CMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 581 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
..++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.|++|+||+|+||++++++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999886432 2356889999999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCCceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------ 725 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------ 725 (764)
||.+..............++..|+|||++.. ..++.++||||+|+++|+|++|+.||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9999776544333444568899999998754 34678999999999999999999999765432211111
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
........+..+.+++++|+..++.-| .....+.||
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 111122255688999999998764433 333444444
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=278.09 Aligned_cols=234 Identities=25% Similarity=0.423 Sum_probs=188.1
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..+|++.+.||+|+||+||+|.+ .+++ .||+|++..... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 46788999999999999999974 3454 489998865433 23346788999999999999999999998754 4
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++++||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 77999999999999998742 345889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCc
Q 004268 662 LLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~ 734 (764)
......... ....++..|+|||...+..++.++||||+||++|||++ |..||+....... .........+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICT 237 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCC
Confidence 764322211 11234678999999998899999999999999999998 9999986543211 1112223344567
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
....+++.+|++.+
T Consensus 238 ~~~~~li~~~l~~d 251 (279)
T cd05109 238 IDVYMIMVKCWMID 251 (279)
T ss_pred HHHHHHHHHHcCCC
Confidence 88899999999877
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=273.78 Aligned_cols=231 Identities=26% Similarity=0.403 Sum_probs=187.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEe-eCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCL-HNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv 585 (764)
..+|++.+.||+|++|.||+|... |+.||+|.+..... .+.+.+|+.++++++||+++++++++. .+...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 467999999999999999999775 88899998864322 367889999999999999999999764 45678999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.++++.. ....+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999998753 2334788999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 740 (764)
.. ....++..|+|||++.+..++.++||||+|+++|+|++ |+.||........ .........+..+....++
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 22 12334568999999998899999999999999999997 9999975443211 1111222334567888999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+++|++.+..
T Consensus 232 i~~~l~~~p~ 241 (256)
T cd05082 232 MKQCWHLDAA 241 (256)
T ss_pred HHHHhcCChh
Confidence 9999986633
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=274.69 Aligned_cols=230 Identities=26% Similarity=0.420 Sum_probs=187.4
Q ss_pred eeeeecCceeEEEEEECC--C--CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 514 YCIGTGGYGSVYRAQLSS--G--KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 358999999999997542 3 36899998776553 445789999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 669 (764)
++++|.+++..... ..+++..+..++.|++.||+||| ++|++||||+|+||+++.++.+||+|||.+.........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999975432 46899999999999999999999 999999999999999999999999999999876542221
Q ss_pred ---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc-----cCCcCCCCCCCcHHHHHH
Q 004268 670 ---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 670 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 740 (764)
.....++..|+|||.+.+..++.++||||+|+++|+|++ |+.||...+..+.. ...........+..+.++
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 112346778999999998899999999999999999998 99999765443211 111222234467888999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+.+|++.++.
T Consensus 234 i~~~l~~~p~ 243 (257)
T cd05040 234 MLQCWAHNPA 243 (257)
T ss_pred HHHHCCCCcc
Confidence 9999976633
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=280.59 Aligned_cols=239 Identities=25% Similarity=0.381 Sum_probs=192.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|.+.+.||+|+||.||+|.. .++..||+|.+..... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 46799999999999999999963 1355799998875433 23346789999999999 799999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
+..+++|||+++++|.++++... ...+++.++..++.|++.|++||| ++|++|+||||+||+++.++.++++|||.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999997432 233799999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc-----cCCcCCCCC
Q 004268 660 ARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-----SGRKISQNP 731 (764)
Q Consensus 660 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-----~~~~~~~~~ 731 (764)
+......... .....++..|+|||.+.+..++.++||||+||++|+|++ |..||......... .........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 9765432211 112345678999999999999999999999999999998 99999765432110 111122233
Q ss_pred CCcHHHHHHHhhhhccchhh
Q 004268 732 RLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~~~~ 751 (764)
..+..+.+++++|++.++.-
T Consensus 268 ~~~~~~~~li~~cl~~~p~~ 287 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLK 287 (302)
T ss_pred CCCHHHHHHHHHHcCCCchh
Confidence 46788999999999866433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=280.92 Aligned_cols=238 Identities=22% Similarity=0.304 Sum_probs=190.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.+|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 45788899999999999999753 357899999875432 2334678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 582 MFLIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
.++++||+++++|.+++.... ....+++..+..++.|++.||+|+| ++||+||||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence 999999999999999985321 1234788889999999999999999 899999999999999999
Q ss_pred CCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccC-
Q 004268 649 NLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG- 724 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~- 724 (764)
++.+||+|||.++........ .....+++.|+|||.+.+..++.++||||+|+++|||++ |..||.+....+....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998765432211 122345678999999988889999999999999999998 8899987654322111
Q ss_pred ---CcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 725 ---RKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 725 ---~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.....+...+..+.+++.+|++.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 268 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPS 268 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 11122344677889999999987733
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=281.92 Aligned_cols=194 Identities=27% Similarity=0.450 Sum_probs=159.6
Q ss_pred eeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEEEEEEe
Q 004268 514 YCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMFLIYEY 588 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~ 588 (764)
..||+|+||+||+|+.+ +++.||+|.+...... ..+.+|++++++++||||+++++++.. +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 57999999999999854 4578999988654432 457789999999999999999998854 5678999999
Q ss_pred cCCCCHHHHHhcC------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee----cCCCCEEEeeec
Q 004268 589 MERGSLFCVLRND------VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL----NSNLEAFVADFG 658 (764)
Q Consensus 589 ~~~~~L~~~l~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg 658 (764)
+++ ++.+++... .....+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 875 777776421 12235888999999999999999999 8999999999999999 466799999999
Q ss_pred cccccCCCCC---CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 659 LARLLHPDSS---NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 659 ~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
+++....... ......+++.|+|||++.+. .++.++||||+||++|+|+||++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9987643322 12335688999999998764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=264.43 Aligned_cols=209 Identities=28% Similarity=0.386 Sum_probs=175.3
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC---C--CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS---S--GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH- 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 578 (764)
+....|+..+.||+|.||.||+|..+ + .+.+|+|+++...... .......+|+.+++.++||||+.+..++..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 45678999999999999999999432 2 2378999997764322 223667899999999999999999998877
Q ss_pred CCEEEEEEEecCCCCHHHHHhc--CccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC----CCE
Q 004268 579 NKCMFLIYEYMERGSLFCVLRN--DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN----LEA 652 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~ 652 (764)
+..+|+++||.+. +|.++++- ......++...++.|+.||+.|++||| +.-|+|||+||.||||..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCee
Confidence 7889999999986 88888863 233456899999999999999999999 9999999999999999876 999
Q ss_pred EEeeeccccccCCCCCC---ceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 653 FVADFGLARLLHPDSSN---RTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
||+|||+++.+..+-.. ....+-|.+|+|||.+.|. .|+++.||||+|||+.||+|-++-|.+...
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 99999999988654332 2335679999999998877 589999999999999999999998887654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=282.26 Aligned_cols=239 Identities=25% Similarity=0.406 Sum_probs=190.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|.+.+.||+|+||.||+|+.. ....||+|.+..... ......+..|+++++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 478899999999999999999642 245789998875433 23346788999999999 6999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+.+..+++|||+++++|.+++..... ...+++..+..++.|++.||.||| ++|++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence 99999999999999999999965321 234788999999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
++++++.+||+|||.++......... ....++..|+|||++.+..++.++||||+|+++|+|++ |..||......+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998664322111 11223467999999998899999999999999999999 8999976543221
Q ss_pred c----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 722 S----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 722 ~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
. .......+...+....+++.+|++.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 278 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRECWHAVPT 278 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 1 1111223345577888999999987633
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=272.38 Aligned_cols=232 Identities=25% Similarity=0.439 Sum_probs=193.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|++|.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 467899999999999999999876 88999999876543 3478889999999999999999999999989999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.|+.||| ++|++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999999999753 2235899999999999999999999 999999999999999999999999999999876322
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 741 (764)
.. ....+..|+|||.+.+..++.++||||+|+++|++++ |+.||......... .......+...+..+.+++
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 11 2234567999999988889999999999999999997 99999766432211 1112223445678899999
Q ss_pred hhhhccchh
Q 004268 742 KNFSQGNHR 750 (764)
Q Consensus 742 ~~~l~~~~~ 750 (764)
++|++.++.
T Consensus 233 ~~~l~~~p~ 241 (256)
T cd05039 233 KDCWELDPA 241 (256)
T ss_pred HHHhccChh
Confidence 999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=277.64 Aligned_cols=234 Identities=24% Similarity=0.356 Sum_probs=184.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||+||+|.+. +++ .|++|.+.... ......++..|+..+++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 357888999999999999999754 454 47777765322 22334677888889999999999999998754 45
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++++||+++|+|.+++... ...+++..+..++.||+.||+||| ++|++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 78899999999999999742 345889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc---cc-CCcCCCCCCCc
Q 004268 662 LLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS---SS-GRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~---~~-~~~~~~~~~~~ 734 (764)
....... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.+...... .. ......+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICT 237 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCC
Confidence 6543221 1122346678999999998899999999999999999998 9999987654321 11 11122222345
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
....+++..|+..+
T Consensus 238 ~~~~~li~~c~~~~ 251 (279)
T cd05111 238 IDVYMVMVKCWMID 251 (279)
T ss_pred HHHHHHHHHHcCCC
Confidence 67788899999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=281.01 Aligned_cols=227 Identities=25% Similarity=0.421 Sum_probs=188.1
Q ss_pred cceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 512 IKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
....||+|+||.||+|... +++.||+|.+....... .+.+.+|+.+++.++||||+++++++..++..+++|||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3446999999999999754 78999999986543322 3667899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 670 (764)
+++|..++.. ..+++..+..++.|++.||+||| +.|++||||+|+||+++.++.+||+|||.+..........
T Consensus 102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 9999988753 34788999999999999999999 8999999999999999999999999999987655443333
Q ss_pred eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHHHHhhh
Q 004268 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNAYLKNF 744 (764)
Q Consensus 671 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 744 (764)
....++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..........+....+++.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 44578899999999998899999999999999999999999997554322111 111222334677889999999
Q ss_pred hccc
Q 004268 745 SQGN 748 (764)
Q Consensus 745 l~~~ 748 (764)
++.+
T Consensus 255 l~~~ 258 (297)
T cd06659 255 LTRE 258 (297)
T ss_pred hcCC
Confidence 9876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=275.83 Aligned_cols=227 Identities=23% Similarity=0.279 Sum_probs=179.6
Q ss_pred eeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHH---HHHhcCCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 515 CIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR---LLSQIRHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
.||+|+||.||+|... +++.||+|.+.............+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999754 68999999987654332221122333433 4444579999999999999999999999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 670 (764)
+++|..++.. ...+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+....... .
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 9999998863 346899999999999999999999 8999999999999999999999999999987654322 2
Q ss_pred eecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcHHHHHHHhh
Q 004268 671 TLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 671 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 743 (764)
....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||......... .......+...+..+.+++++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence 234689999999998754 6899999999999999999999999866322111 111122233467899999999
Q ss_pred hhccch
Q 004268 744 FSQGNH 749 (764)
Q Consensus 744 ~l~~~~ 749 (764)
|+..+.
T Consensus 233 ~l~~~p 238 (278)
T cd05606 233 LLQRDV 238 (278)
T ss_pred HhhcCH
Confidence 999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=278.32 Aligned_cols=239 Identities=21% Similarity=0.333 Sum_probs=192.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 580 (764)
.++|++.+.||+|+||.||+|.+.. +..|++|.+.... .....+.+.+|+.++++++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 5789999999999999999998654 6889999886433 33345778899999999999999999998766 56
Q ss_pred EEEEEEEecCCCCHHHHHhcCccc-----cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEA-----VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
..++++||+++++|.+++...... ..+++..+..++.|++.||+||| +++++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998754222 45889999999999999999999 8999999999999999999999999
Q ss_pred eeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCC
Q 004268 656 DFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKIS 728 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~ 728 (764)
|||+++.+....... ....++..|+|||++.+..++.++||||+|+++|++++ |+.||......+... .....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999998654322111 12245667999999998899999999999999999999 999998765432211 11222
Q ss_pred CCCCCcHHHHHHHhhhhccchh
Q 004268 729 QNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.....+..+.+++++|+..++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~ 261 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPE 261 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChh
Confidence 3344577889999999987633
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=280.52 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=192.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-----------------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCce
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-----------------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 569 (764)
.++|++.+.||+|+||.||+|.... +..||+|.+...... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999986542 246899988755433 345788999999999999999
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCc--------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDV--------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 641 (764)
+++++++..++..+++||++++++|.+++.... ....+++..+..++.|++.||+||| ++|++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccch
Confidence 999999999999999999999999999987532 1125889999999999999999999 89999999999
Q ss_pred CCeeecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCccc
Q 004268 642 NNILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM--GSHPTDLLS 717 (764)
Q Consensus 642 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--g~~Pf~~~~ 717 (764)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999876533221 1122345678999999988889999999999999999998 788887654
Q ss_pred ccccc-----------cCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 718 SLSSS-----------SGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 718 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..... .......++..+..+.+++..|++.++.-|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 284 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcC
Confidence 32210 111122234456789999999998774443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=277.28 Aligned_cols=232 Identities=25% Similarity=0.367 Sum_probs=184.0
Q ss_pred hcC-CcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--
Q 004268 508 EDF-HIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-- 579 (764)
Q Consensus 508 ~~y-~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 579 (764)
++| ++.+.||+|+||+||++.. .+++.||+|.+...... ...+.+.+|++++++++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 8899999999999988642 36788999998765332 2346788999999999999999999987653
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...+++|||+++++|.+++... .+++..+..++.|++.|++||| ++||+||||||+||++++++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccc
Confidence 4689999999999999998642 4899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----cc--------
Q 004268 660 ARLLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-----SS-------- 723 (764)
Q Consensus 660 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-----~~-------- 723 (764)
+......... .....++..|+|||...+..++.++||||+|+++|+|+||..||........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 9876432211 1122456679999999888899999999999999999999999865432100 00
Q ss_pred ------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 ------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
......+...+..+.+++++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 264 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETE 264 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 0111113345678899999999866
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=279.79 Aligned_cols=239 Identities=25% Similarity=0.366 Sum_probs=190.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECC---------------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS---------------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 571 (764)
.++|++.+.||+|+||.||+|+... ...||+|.+..... ......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 4689999999999999999986532 23589999875432 233467889999999999999999
Q ss_pred EeeEEeeCCEEEEEEEecCCCCHHHHHhcCcc---------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCC
Q 004268 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVE---------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSN 642 (764)
Q Consensus 572 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~ 642 (764)
+++++...+..++||||+++++|.+++..... ...+++..+..++.|++.|++||| ++|++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChh
Confidence 99999999999999999999999999864211 124678889999999999999999 899999999999
Q ss_pred CeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCcccc
Q 004268 643 NILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM--GSHPTDLLSS 718 (764)
Q Consensus 643 NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt--g~~Pf~~~~~ 718 (764)
||++++++.+||+|||.+......... .....++..|+|||+..+..++.++||||||+++|+|++ |..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999999765332211 122334678999999998889999999999999999988 7788876543
Q ss_pred cccc-----------cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 719 LSSS-----------SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 719 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.... ........+..+....+++.+|++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 2210 1112233555678999999999987733
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=279.07 Aligned_cols=236 Identities=25% Similarity=0.403 Sum_probs=188.7
Q ss_pred cCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4788899999999999999643 2356888888654332 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCc---------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 004268 583 FLIYEYMERGSLFCVLRNDV---------------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 641 (764)
++++||+.+++|.+++.... ....+++..+..++.|++.|++||| ++|++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence 99999999999999986421 1134788899999999999999999 89999999999
Q ss_pred CCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 004268 642 NNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSS 718 (764)
Q Consensus 642 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~ 718 (764)
+||++++++.+||+|||.++........ .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999765332211 122345678999999988889999999999999999998 9999986654
Q ss_pred cccc----cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 719 LSSS----SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 719 ~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.... ...........+..+.+++..|++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P 270 (290)
T cd05045 236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEP 270 (290)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 2211 111222334467789999999997663
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=278.07 Aligned_cols=203 Identities=26% Similarity=0.406 Sum_probs=173.3
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|++|.||+|... +|+.||+|.+....... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4888999999999999999865 68999999987654332 13566789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++ ++.+++........+++..+..++.|++.||+||| +.|++||||+|+||++++++.++++|||.+.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 88888865444456899999999999999999999 8899999999999999999999999999997654333
Q ss_pred CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||.+.+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 223334568899999987664 56889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=249.67 Aligned_cols=224 Identities=24% Similarity=0.363 Sum_probs=177.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..+.......||+|++|.|-+.++ ++|...|+|.+...-... .+++..+|+.+..+. .+|++|.+||...+....|
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 345555667799999999988875 489999999997765543 347778888876665 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 584 LIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
+.||.|+. +|..+.++- .....+++.-+-+|+..+..||.|||+ +..++|||+||+||+++.+|+||+||||.+..
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999974 776655421 245568999999999999999999996 56999999999999999999999999999977
Q ss_pred cCCCCCCceecccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCcc-cccccccCCcCCCCCCCcH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTM----AVTEKCDVYSFGVVALEVLMGSHPTDLL-SSLSSSSGRKISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~il~~lltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~ 735 (764)
.... -..+...|-..|||||.+..+ .|+.++||||||++++||.++++||+.- ++.....+......|.++.
T Consensus 199 L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 199 LVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred ehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 6432 222334677889999987643 7899999999999999999999999743 3344444445555555543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=280.42 Aligned_cols=238 Identities=24% Similarity=0.398 Sum_probs=191.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFC 576 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 576 (764)
..++|++.+.||+|+||.||+|+.. ++..||+|.+..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 3678899999999999999999631 345799998865432 23346788999999999 899999999999
Q ss_pred eeCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 004268 577 LHNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNN 643 (764)
Q Consensus 577 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 643 (764)
......+++|||+++++|.+++..... ...+++..+..++.||+.||.||| ++|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence 999999999999999999999975321 235788889999999999999999 8999999999999
Q ss_pred eeecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 004268 644 ILLNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLS 720 (764)
Q Consensus 644 Ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~ 720 (764)
|++++++.+||+|||.++......... ....+++.|+|||++.+..++.++||||+|+++|+|++ |..||......+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 999999999999999998764332211 12345678999999998889999999999999999998 889997654432
Q ss_pred ccc----CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 721 SSS----GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 721 ~~~----~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
... ......+...+....+++++|+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 279 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAI 279 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccC
Confidence 211 1122233456788899999999766
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=281.28 Aligned_cols=240 Identities=25% Similarity=0.402 Sum_probs=193.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||.||+|... ....+|+|.+...... .....+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3567999999999999999999753 2367999988754332 2346788999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcC-------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCee
Q 004268 579 NKCMFLIYEYMERGSLFCVLRND-------------VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNIL 645 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 645 (764)
++..+++|||+++++|..++++. .....+++..+..++.|++.|++||| ++||+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 99999999999999999999642 12346889999999999999999999 899999999999999
Q ss_pred ecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 004268 646 LNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS 722 (764)
Q Consensus 646 l~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~ 722 (764)
+++++.+||+|||.++......... ....++..|+|||+..+..++.++||||+||++|++++ |..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999998764332111 11234567999999998899999999999999999997 99999865532211
Q ss_pred ----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 723 ----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 723 ----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.......+...+....+++.+|++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 276 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS 276 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence 1112223445577889999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.58 Aligned_cols=192 Identities=24% Similarity=0.334 Sum_probs=165.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|.+.+.||+|+||.||+|.+. +++.||+|.... ..+.+|++++++++||||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 347999999999999999999765 688999996321 3456899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||++. ++|..++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99996 6888887642 236899999999999999999999 89999999999999999999999999999976543
Q ss_pred CCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 004268 666 DSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPT 713 (764)
Q Consensus 666 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf 713 (764)
... ......||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 221 122356899999999999999999999999999999999987654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=274.83 Aligned_cols=238 Identities=24% Similarity=0.376 Sum_probs=189.2
Q ss_pred CCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE----
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC---- 581 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---- 581 (764)
|++.+.||+|+||.||+|... .+..||+|.+...... ....+.+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 577889999999999999754 2468999998764433 3335678999999999999999999998866543
Q ss_pred --EEEEEEecCCCCHHHHHhcCc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 582 --MFLIYEYMERGSLFCVLRNDV---EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 582 --~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
.+++|||+++++|..++.... ....+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999885321 2235889999999999999999999 89999999999999999999999999
Q ss_pred eccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCC
Q 004268 657 FGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQ 729 (764)
Q Consensus 657 fg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~ 729 (764)
||.++......... ....++..|+|||.+.+..++.++||||+|+++|||++ |..||.+....+.. .......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998764332211 11234668999999988899999999999999999999 99999876543221 1122233
Q ss_pred CCCCcHHHHHHHhhhhccchhh
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
+...+....+++.+|++.++.-
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~ 258 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKD 258 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhh
Confidence 4456778899999999866433
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=276.48 Aligned_cols=243 Identities=24% Similarity=0.404 Sum_probs=195.0
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|...+.||+|++|.||+|.. .+++.|++|++...... ..+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567899999999999975 47889999988643322 23567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++.. ..+++..+..++.|++.|++||| ++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999874 35788999999999999999999 8999999999999999999999999999887654333
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 741 (764)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||.......... ..........+..+.+++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 33334568899999999998889999999999999999999999997654322111 111112233678899999
Q ss_pred hhhhccc--hhhHHHhhhcCCC
Q 004268 742 KNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 742 ~~~l~~~--~~~~~~~~~~~p~ 761 (764)
.+|++.+ .++........||
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred HHHcccChhhCcCHHHHccCcc
Confidence 9999877 3333333444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=275.13 Aligned_cols=235 Identities=30% Similarity=0.454 Sum_probs=189.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CC---CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SG---KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
.+|++.+.||+|+||.||+|... ++ ..||+|.+.... .....+.+..|+.+++.++||||+++++++.++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 56889999999999999999754 33 369999986543 2334578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++++|.+++... ...+++.++..++.|++.|++||| ++|++||||||+||+++.++.+|++|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999998743 345889999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCCce---ecc--cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCC
Q 004268 664 HPDSSNRT---LVV--GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRL 733 (764)
Q Consensus 664 ~~~~~~~~---~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~ 733 (764)
........ ... .+..|+|||.+.+..++.++||||+|+++||+++ |..||......+... .......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 236 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccC
Confidence 43221111 111 1357999999999999999999999999999886 999997655432111 1122334456
Q ss_pred cHHHHHHHhhhhccch
Q 004268 734 DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~ 749 (764)
+..+.+++..|++.+.
T Consensus 237 ~~~~~~li~~~l~~~p 252 (269)
T cd05065 237 PTALHQLMLDCWQKDR 252 (269)
T ss_pred CHHHHHHHHHHcCCCh
Confidence 7788999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=277.92 Aligned_cols=232 Identities=25% Similarity=0.354 Sum_probs=191.2
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... ...+.+.+|++++++++||||+++++++...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36788889999999999999865 7899999998765433 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++.... ..+++..+..++.|++.|++|+| + .|++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999997532 56888999999999999999999 8 8999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-----ccccCCcCCCCCC-----CcH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-----SSSSGRKISQNPR-----LDL 735 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-----~~~~~~~~~~~~~-----~~~ 735 (764)
.... ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ...........+. ++.
T Consensus 154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06605 154 SLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231 (265)
T ss_pred HHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 2221 256788999999999999999999999999999999999999765310 1000011111111 577
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
.+.+++.+|+..+
T Consensus 232 ~~~~li~~~l~~~ 244 (265)
T cd06605 232 DFQDFVNLCLIKD 244 (265)
T ss_pred HHHHHHHHHcCCC
Confidence 8899999999866
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=271.67 Aligned_cols=236 Identities=24% Similarity=0.412 Sum_probs=192.1
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.+|++.+.||+|++|.||+|.+..++.+|+|.+....... ..+.+|++++++++||+++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 5788899999999999999987778899999987554432 567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999999998742 235788999999999999999999 8999999999999999999999999999987653321
Q ss_pred CC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHHH
Q 004268 668 SN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 741 (764)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++ |+.||.......... ......+...+..+.+++
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM 234 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 11 112234568999999998899999999999999999998 999997554322111 111122333578899999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
.+|++.++..|
T Consensus 235 ~~~l~~~p~~R 245 (256)
T cd05112 235 QHCWKERPEDR 245 (256)
T ss_pred HHHcccChhhC
Confidence 99998764444
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.76 Aligned_cols=192 Identities=23% Similarity=0.334 Sum_probs=164.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999865 6788999975432 23468999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||++. ++|.+++.. ....+++..+..|+.||+.||.||| ++||+||||||+||+++.++.+||+|||.++...
T Consensus 135 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999996 588888764 2346889999999999999999999 8999999999999999999999999999997533
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPT 713 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf 713 (764)
.. .......|+..|+|||++.+..++.++||||+||++|||+++..|+
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 2223456899999999999999999999999999999999855443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=278.13 Aligned_cols=202 Identities=29% Similarity=0.419 Sum_probs=174.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+.+|++++++++||||+++++++..++..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36899999999999999999865 6889999988754432 233477889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++++.+..+... ...+++..+..++.|++.|++||| +.|++||||+|+||++++++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99998777666542 345889999999999999999999 899999999999999999999999999999876544
Q ss_pred CC-CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
.. ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 22345678899999999888 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=273.42 Aligned_cols=240 Identities=27% Similarity=0.416 Sum_probs=194.7
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 585 (764)
+|++.+.+|.|++|.||+|.. .+++.||+|.+...... ....+.+..|++++++++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 488899999999999999975 47889999998765433 3335778899999999999999999997754 4568999
Q ss_pred EEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 586 YEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDC--KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|||+++++|.+++.... ....+++..++.++.|++.|++|||..+ +.+++|+||+|+||+++.++.+||+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999986432 2456889999999999999999999443 56899999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCCCCCCCcHHHH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKISQNPRLDLQCN 738 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~ 738 (764)
............+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+...... ..........+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 7544432344578999999999999889999999999999999999999998764321111 111122345678899
Q ss_pred HHHhhhhccch
Q 004268 739 AYLKNFSQGNH 749 (764)
Q Consensus 739 ~~~~~~l~~~~ 749 (764)
++++.|++.++
T Consensus 240 ~l~~~~l~~~p 250 (265)
T cd08217 240 EVIKSMLNVDP 250 (265)
T ss_pred HHHHHHccCCc
Confidence 99999998663
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=272.74 Aligned_cols=238 Identities=23% Similarity=0.366 Sum_probs=190.9
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC-------cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE-------EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
+|.+.+.||.|++|.||+|... +|+.||+|.+...... .....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999754 7899999987543211 1223456888999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++||||+++++|.+++++. ..+++..+..++.|++.|+.||| ++|++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999743 46888999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC--CceecccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCc----C
Q 004268 661 RLLHPDSS--NRTLVVGTYGYIAPELAYTMA--VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRK----I 727 (764)
Q Consensus 661 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~----~ 727 (764)
........ ......++..|+|||.+.... ++.++|+||+|+++|++++|..||.......... ... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 76542211 122345788999999987654 7889999999999999999999997544321110 001 1
Q ss_pred CCCCCCcHHHHHHHhhhhccchhhH
Q 004268 728 SQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 728 ~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
...+.++..+.+++++|++.++..|
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~R 260 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNR 260 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhC
Confidence 1123457889999999998775544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=279.55 Aligned_cols=238 Identities=28% Similarity=0.433 Sum_probs=190.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.++++++||||+++++++.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467899999999999999999753 467899999875433 233467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc-------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV-------------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 641 (764)
..+++|||+++++|.+++.... ....+++..+..++.|++.||+||| ++|++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence 9999999999999999996421 1234778889999999999999999 89999999999
Q ss_pred CCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 004268 642 NNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSS 718 (764)
Q Consensus 642 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~ 718 (764)
+||++++++.++|+|||.+......... ......+..|+|||.+.+..++.++||||+||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998765322211 112234567999999998899999999999999999997 8889976544
Q ss_pred ccccc----CCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 719 LSSSS----GRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 719 ~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.+... ......+...+..+.+++.+|++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 273 (288)
T cd05050 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLP 273 (288)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 32211 11112234567889999999997653
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=276.15 Aligned_cols=234 Identities=23% Similarity=0.379 Sum_probs=186.6
Q ss_pred hcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--C
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--K 580 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~ 580 (764)
.-|++.+.||+|+||.||.|.. .+++.||+|.+..... ....+.+.+|+++++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4478899999999999999963 3578899999865432 33346789999999999999999999998775 5
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++||||+++++|.+++.+. ...+++..+..++.|++.||+|+| ++|++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 689999999999999998643 235789999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------------
Q 004268 661 RLLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---------------- 721 (764)
Q Consensus 661 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---------------- 721 (764)
+........ .....++..|+|||++.+..++.++||||+|+++|+|++++.|+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876433221 1234566789999999888899999999999999999998876532211000
Q ss_pred ---ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 722 ---SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
............+....+++.+|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQ 266 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCC
Confidence 001112224456788899999999766
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=277.76 Aligned_cols=204 Identities=29% Similarity=0.397 Sum_probs=174.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC--cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE--EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
+|++.+.||+|++|.||+|... +++.||+|.+...... .......+..|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888899999999999999864 7899999999765543 122345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+ +++|.+++.... ..+++..+..++.||++||+||| ++|++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999997432 36899999999999999999999 99999999999999999999999999999987755
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.........++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 4333334456788999998865 4578899999999999999999888875443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.46 Aligned_cols=203 Identities=27% Similarity=0.398 Sum_probs=172.1
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|++.+.||.|++|.||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4788999999999999999764 78999999886544322 223578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+. ++|..++... ....+++..+..++.|++.|++||| ++|++||||+|+||++++++.+||+|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 5888888643 3346889999999999999999999 8999999999999999999999999999987664433
Q ss_pred CCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 SNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.......++..|+|||++.+.. ++.++||||+|+++|+|+||+.||...+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 3333345688999999887654 5889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.14 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=185.5
Q ss_pred CCcceeeeecCceeEEEEEECC-CC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------C
Q 004268 510 FHIKYCIGTGGYGSVYRAQLSS-GK--LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------K 580 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 580 (764)
|.+.+.||+|+||.||+|+... +. .||+|.+...... ....+.+.+|+++++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999998653 33 6899988765332 33357788999999999999999999976432 2
Q ss_pred EEEEEEEecCCCCHHHHHhcCc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV---EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..+++|||+++|+|..++.... ....+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCC
Confidence 4789999999999998874221 2234789999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCC
Q 004268 658 GLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQN 730 (764)
Q Consensus 658 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~ 730 (764)
|.+......... .....+++.|+|||...+..++.++||||+|+++|+|++ |+.||......... ........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999876433211 122345678999999999999999999999999999999 89999865542211 11122334
Q ss_pred CCCcHHHHHHHhhhhccch
Q 004268 731 PRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~ 749 (764)
+..+..+.+++++|++.++
T Consensus 237 ~~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred CCCCHHHHHHHHHHcCCCc
Confidence 5567888999999998663
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=270.68 Aligned_cols=227 Identities=25% Similarity=0.383 Sum_probs=183.6
Q ss_pred eeeeecCceeEEEEEEC-C---CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 514 YCIGTGGYGSVYRAQLS-S---GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
+.||+|+||.||+|... . +..||+|.+...... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36899999999999643 2 368999998766543 33467889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 669 (764)
++++|.+++... ..+++..+..++.|++.|++||| .+|++||||||+||+++.++.+||+|||.++........
T Consensus 78 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999999743 26889999999999999999999 899999999999999999999999999999876433322
Q ss_pred ce---ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHH
Q 004268 670 RT---LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 670 ~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 741 (764)
.. ...++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+..+. ........+...+....+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 231 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIM 231 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence 11 1123457999999999899999999999999999998 9999987654221 11122334455678889999
Q ss_pred hhhhccch
Q 004268 742 KNFSQGNH 749 (764)
Q Consensus 742 ~~~l~~~~ 749 (764)
.+|++.++
T Consensus 232 ~~cl~~~p 239 (257)
T cd05060 232 LSCWKYRP 239 (257)
T ss_pred HHHhcCCh
Confidence 99998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=275.33 Aligned_cols=234 Identities=22% Similarity=0.381 Sum_probs=183.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHH-HHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARL-LSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
++|++.+.||+|+||.||+|.++ +|+.||+|.+........ ...+..|... ++..+||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 36889999999999999999865 799999999876543322 2345556664 5667899999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
|||++ ++|.+++... .....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||.+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99997 5888777542 23356899999999999999999999 76 9999999999999999999999999999765
Q ss_pred CCCCCCceeccccccccccccccc----CCCCccchHHHHHHHHHHHHhCCCCCCccccc-cc---ccCC--cCCCCCCC
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYT----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-SS---SSGR--KISQNPRL 733 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~~---~~~~--~~~~~~~~ 733 (764)
.... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...... +. .... .......+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 4322 2233467889999998865 45688999999999999999999999753221 11 0111 11112346
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|+..+
T Consensus 234 ~~~l~~li~~~l~~~ 248 (283)
T cd06617 234 SPEFQDFVNKCLKKN 248 (283)
T ss_pred CHHHHHHHHHHccCC
Confidence 788999999999877
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=269.66 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=193.8
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|.. .+++.+|+|.+....... ...+.+.+|++++++++|||++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 588999999999999999975 478899999987654332 335788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeeeccccccCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPD 666 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 666 (764)
|+++++|.+++... ....+++..+..++.|++.|++||| ++|++|+||+|+||+++++ +.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999999753 2335788999999999999999999 8999999999999999855 46799999999876433
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 742 (764)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+..... ...........+..+.+++.
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 234 (256)
T cd08220 156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234 (256)
T ss_pred cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence 22 22356788999999999888999999999999999999999999865432111 11112223446888999999
Q ss_pred hhhccchh
Q 004268 743 NFSQGNHR 750 (764)
Q Consensus 743 ~~l~~~~~ 750 (764)
+|++.++.
T Consensus 235 ~~l~~~p~ 242 (256)
T cd08220 235 SMLNLDPS 242 (256)
T ss_pred HHccCChh
Confidence 99986633
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=273.13 Aligned_cols=234 Identities=26% Similarity=0.437 Sum_probs=190.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..+|++.+.||+|+||.||+|..+ +|+ .||+|....... ......+.+|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 467899999999999999999754 333 589998765543 3345778899999999999999999999887 77
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++|+|.+++... ...+++..+..++.|++.|++||| ++|++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 89999999999999999753 334889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCCce--ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 662 LLHPDSSNRT--LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
.......... ...++..|+|||.+....++.++|+||+|+++||+++ |+.||++....+.. .......++..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICT 237 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence 7653322111 1123567999999988889999999999999999998 99999876543211 122233344456
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++.+|+..+
T Consensus 238 ~~~~~~~~~~l~~~ 251 (279)
T cd05057 238 IDVYMVLVKCWMID 251 (279)
T ss_pred HHHHHHHHHHcCCC
Confidence 78899999999877
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=276.88 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=192.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|++|+||+|... +++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467889999999999999999754 688999998865432 23357889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|..++.. ...+++..+..++.+++.|+.|||. ..|++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998874 3458899999999999999999993 25899999999999999999999999999865432
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----------cccCCcCCC-----
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-----------SSSGRKISQ----- 729 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-----------~~~~~~~~~----- 729 (764)
.. .....++..|+|||++.+..++.++|+||+||++|++++|+.||....... .........
T Consensus 157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd06620 157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234 (284)
T ss_pred hc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence 21 223568899999999988899999999999999999999999998654310 000000011
Q ss_pred CCCCcHHHHHHHhhhhccchhhH
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
....+..+.+++++|++.++.-|
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R 257 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTER 257 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccC
Confidence 11256778899999998774433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=272.48 Aligned_cols=236 Identities=31% Similarity=0.445 Sum_probs=188.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC---EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
..+|+..+.||+|++|.||+|..+ +++ .+|+|.+..... ....+.+..|++++++++|||++++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 357888999999999999999764 333 799998865432 22346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||++++++.+|++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 82 MIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 9999999999999998642 346889999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCCCce---ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCc
Q 004268 663 LHPDSSNRT---LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~ 734 (764)
......... ....+..|+|||++.+..++.++||||+|+++|+|++ |+.||......+... ..........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 236 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 643222111 1123457999999998889999999999999999997 999997654422111 11222233457
Q ss_pred HHHHHHHhhhhccch
Q 004268 735 LQCNAYLKNFSQGNH 749 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~ 749 (764)
..+.+++.+|++.++
T Consensus 237 ~~~~~li~~c~~~~p 251 (268)
T cd05063 237 SAVYQLMLQCWQQDR 251 (268)
T ss_pred HHHHHHHHHHcCCCc
Confidence 788999999997653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=236.66 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=176.3
Q ss_pred cCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|.-.++||+|.||+||+|+ +.+++.||+|.+.....++ ..-....+|+-+++.++|.|||++++....++...+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 56667889999999999998 4578999999987766543 223567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
||+. +|..+... -.+.++.+.++.++.|+++|+.++| ++++.|||+||.|.+|..+|+.|++|||+++.++-+.
T Consensus 82 ~cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9975 88888764 4567899999999999999999999 9999999999999999999999999999999887665
Q ss_pred CCceecccccccccccccccCC-CCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 004268 668 SNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLM-GSHPTDLLSS 718 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~llt-g~~Pf~~~~~ 718 (764)
......+-|.+|++|.++.|.. |+...|+||.||++.|+.. |++-|.+.+-
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 5555667899999999998875 7889999999999999986 7777876543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=271.14 Aligned_cols=229 Identities=22% Similarity=0.306 Sum_probs=183.2
Q ss_pred eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHH-HhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 514 YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLL-SQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
+.||.|++|.||+|... +++.||+|.+.............+..|..++ ...+|||++++++++..++..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999754 6899999998765433222233445555544 445899999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|.+++.. ...+++..+..++.|++.||.||| +.|++||||+|+||++++++.++|+|||.+..... ..
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 999999974 335788999999999999999999 89999999999999999999999999999875432 22
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---C----CcCCCCCCCcHHHHHHHhhh
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---G----RKISQNPRLDLQCNAYLKNF 744 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~ 744 (764)
...++..|+|||...+..++.++||||+|+++|+|++|..||.......... . ......+..+..+.+++++|
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 3467889999999988888999999999999999999999997654422110 0 11112234688999999999
Q ss_pred hccchhhH
Q 004268 745 SQGNHRWE 752 (764)
Q Consensus 745 l~~~~~~~ 752 (764)
++.++.-|
T Consensus 232 l~~~p~~R 239 (260)
T cd05611 232 LCMDPAKR 239 (260)
T ss_pred ccCCHHHc
Confidence 99874444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=271.60 Aligned_cols=231 Identities=26% Similarity=0.430 Sum_probs=188.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||.||++.. +++.||+|.+..... .+.+.+|+.++++++|||++++++++..+ ..+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 36799999999999999999975 588899999865322 26788999999999999999999998765 479999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.|+.||| ++|++||||||+||+++.++.+||+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 999999999999754 2335788999999999999999999 899999999999999999999999999998764322
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 741 (764)
. .....+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+. ............+....+++
T Consensus 154 ~---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 V---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred C---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 1 12234568999999998899999999999999999997 9999986654221 11122233445678889999
Q ss_pred hhhhccchhh
Q 004268 742 KNFSQGNHRW 751 (764)
Q Consensus 742 ~~~l~~~~~~ 751 (764)
++|++.+..-
T Consensus 231 ~~~l~~~p~~ 240 (254)
T cd05083 231 TSCWETEPKK 240 (254)
T ss_pred HHHcCCChhh
Confidence 9999877433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=271.19 Aligned_cols=237 Identities=25% Similarity=0.385 Sum_probs=194.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|... +|..||+|.+....... ...+.+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5888999999999999999765 68899999986643222 223677899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeeccccccCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLARLLHPD 666 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 666 (764)
|+++++|.+++... ....+++..+..++.|++.|+.||| +.+++|+||+|+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999998753 2335789999999999999999999 89999999999999999875 4699999999876544
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 742 (764)
........|++.|+|||+..+..++.++|+||+|+++|+|++|+.||......+.. ........+..+..+.++++
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 33333456888999999998888999999999999999999999999865432111 11122234556789999999
Q ss_pred hhhccchh
Q 004268 743 NFSQGNHR 750 (764)
Q Consensus 743 ~~l~~~~~ 750 (764)
+|++.++.
T Consensus 236 ~~l~~~p~ 243 (257)
T cd08225 236 QLFKVSPR 243 (257)
T ss_pred HHhccChh
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=277.25 Aligned_cols=238 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 585 (764)
++|.+.+.||+|++|.||+|... +++.||+|++...........+.+.+|.+++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46899999999999999999765 79999999987655444444577889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||++++++|.+++.+. ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999743 36899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCC--------------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---c
Q 004268 666 DSS--------------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---S 722 (764)
Q Consensus 666 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~ 722 (764)
... ......++..|+|||+..+..++.++|+||+|+++|++++|+.||...+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 221 12234578899999999888899999999999999999999999987654221 1
Q ss_pred cCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 723 SGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.......++.++..+.+++++|++.++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred HhcCCCCCCccCHHHHHHHHHHhcCCHhh
Confidence 12333445567889999999999877433
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=286.13 Aligned_cols=234 Identities=25% Similarity=0.411 Sum_probs=193.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC--CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS--SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
++.+..+.||+|.||.|++|.|. +|+ .||||.+....... ....|.+|+.+|.+++|||++++||+..+ ....
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 44566678999999999999765 344 68999997665443 46899999999999999999999999988 6688
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|||.++.|+|.+.++. .....+.......++.||+.|+.||. ++++||||+..+|+++-....|||+|||+.+..
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999987 45667888999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCCCcee---cccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccC----CcCCCCCCCcH
Q 004268 664 HPDSSNRTL---VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG----RKISQNPRLDL 735 (764)
Q Consensus 664 ~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~----~~~~~~~~~~~ 735 (764)
......... ..-...|+|||.+....++.++|||+|||++|||+| |+.||-+.....+... .....++.-+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 654443311 123568999999999999999999999999999998 8999998877443332 23333333466
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
..-+++++||.-+
T Consensus 343 dIY~imk~cWah~ 355 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHN 355 (1039)
T ss_pred HHHHHHHHhccCC
Confidence 7788888888755
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=276.52 Aligned_cols=238 Identities=28% Similarity=0.423 Sum_probs=197.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..+.|++.+.+|+|++|.||+|.++ +++.|++|++..... ..+.+.+|+++++.++|+|++++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888899999999999999866 789999999876543 24678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
++||+++++|.+++.... ..+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999998532 36899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~ 738 (764)
..........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... .......+.++..+.
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 43333334457889999999998889999999999999999999999998655421111 111112223677899
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
++++.|++.+...|
T Consensus 248 ~li~~~l~~~p~~R 261 (286)
T cd06614 248 DFLNKCLVKDPEKR 261 (286)
T ss_pred HHHHHHhccChhhC
Confidence 99999999884444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=276.45 Aligned_cols=204 Identities=27% Similarity=0.380 Sum_probs=173.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 583 (764)
.++|++.+.||.|++|.||+|..+ +++.||+|.+...... ......+.+|+.++++++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 467999999999999999999865 6889999998755433 22234567899999999999999999998877 8899
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++ +|.+++... ...+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.+||+|||.+...
T Consensus 83 lv~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999985 898888643 235899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
...........+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5443333345678899999988765 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-31 Score=266.50 Aligned_cols=236 Identities=27% Similarity=0.431 Sum_probs=199.0
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|++++++++|||++++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5888999999999999999755 6889999999776543 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++... ..+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998743 46899999999999999999999 9999999999999999999999999999998776544
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHhh
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLKN 743 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 743 (764)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||........ .........+.++..+.+++.+
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 433445688899999999888889999999999999999999999976554211 1122223344567889999999
Q ss_pred hhccchhh
Q 004268 744 FSQGNHRW 751 (764)
Q Consensus 744 ~l~~~~~~ 751 (764)
|++.+..-
T Consensus 234 ~l~~~p~~ 241 (254)
T cd06627 234 CFQKDPNL 241 (254)
T ss_pred HHhCChhh
Confidence 99876433
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=276.72 Aligned_cols=232 Identities=27% Similarity=0.362 Sum_probs=188.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||+|++|+||+|... +++.||+|.+...........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 466899999999999999999764 7899999998765544444456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ ++.+++... ...+++..+..++.|++.||.||| +.||+||||+|+||++++++.++|+|||.+.....
T Consensus 94 ~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 676666532 235889999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc-----CCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK-----ISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~ 737 (764)
. ....++..|+|||++. ...++.++||||+|+++|+|++|+.||............. .......+..+
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 2 2346788999999874 4568889999999999999999999997655422111111 11122346678
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
.+++.+|+..+
T Consensus 244 ~~li~~~l~~~ 254 (307)
T cd06607 244 RNFVDSCLQKI 254 (307)
T ss_pred HHHHHHHhcCC
Confidence 99999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=277.17 Aligned_cols=237 Identities=24% Similarity=0.294 Sum_probs=186.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCE----
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKC---- 581 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~---- 581 (764)
++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46899999999999999999865 78999999886543221 12356788999999995 6999999999887665
Q ss_pred -EEEEEEecCCCCHHHHHhcCcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeee
Q 004268 582 -MFLIYEYMERGSLFCVLRNDVE--AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADF 657 (764)
Q Consensus 582 -~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Df 657 (764)
.|+||||+++ ++.+++..... ...+++..+..++.||+.||.||| ++||+||||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 78888764322 245799999999999999999999 899999999999999998 899999999
Q ss_pred ccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------C--
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----------G-- 724 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----------~-- 724 (764)
|.+..............+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.+...... .
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999866433332333456888999998765 457899999999999999999999997654321100 0
Q ss_pred -------------------CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 -------------------RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 -------------------~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
......+.++..+.+++++|++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 279 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCCh
Confidence 0001124577888999999998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=274.04 Aligned_cols=202 Identities=30% Similarity=0.420 Sum_probs=174.0
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|++|.||+|... +|+.||+|++....... ...+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5889999999999999999864 78999999987654322 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+ +++|.+++... ...+++..++.++.||+.||+||| ++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 99999998643 245899999999999999999999 8999999999999999999999999999998765432
Q ss_pred C-CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 S-NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
. ......++..|+|||.+.+. .++.++||||+|+++|+|++|++||.+..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 1 12335688899999988654 46889999999999999999998886543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=274.05 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=191.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+..... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 67889999999999999999753 346799998765432 2345788999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccc------cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEA------VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
.++||||+++++|.+++...... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999754322 25899999999999999999999 8999999999999999999999999
Q ss_pred eeccccccCCCC-CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc-----CCcCC
Q 004268 656 DFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS-----GRKIS 728 (764)
Q Consensus 656 Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~-----~~~~~ 728 (764)
|||.+....... .......++..|+|||.+.+..++.++||||+|+++|++++ |..||.......... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 999986543221 11222355778999999988889999999999999999998 889997654422111 11122
Q ss_pred CCCCCcHHHHHHHhhhhccch
Q 004268 729 QNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.....+....+++.+|++.++
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p 260 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNP 260 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCc
Confidence 344567889999999997663
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=282.16 Aligned_cols=241 Identities=24% Similarity=0.371 Sum_probs=186.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999963 35788999998754432 2346788999999999 689999999987654
Q ss_pred -CEEEEEEEecCCCCHHHHHhcCcc-------------------------------------------------------
Q 004268 580 -KCMFLIYEYMERGSLFCVLRNDVE------------------------------------------------------- 603 (764)
Q Consensus 580 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 603 (764)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 568899999999999999864210
Q ss_pred ---------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC--Ccee
Q 004268 604 ---------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS--NRTL 672 (764)
Q Consensus 604 ---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 672 (764)
...+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 123677888999999999999999 99999999999999999999999999999976532221 1112
Q ss_pred cccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc-----ccCCcCCCCCCCcHHHHHHHhhhhc
Q 004268 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 673 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
..++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ........+...+....+++..|++
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 234667999999999899999999999999999996 9999976543111 0111112223356678888888887
Q ss_pred cchhhH
Q 004268 747 GNHRWE 752 (764)
Q Consensus 747 ~~~~~~ 752 (764)
.++..|
T Consensus 321 ~~p~~R 326 (343)
T cd05103 321 GEPSQR 326 (343)
T ss_pred CChhhC
Confidence 664443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=281.79 Aligned_cols=237 Identities=24% Similarity=0.394 Sum_probs=189.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
..+|++.+.||+|+||.||+|+.. .+..||+|.+..... ....+.+.+|+++++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 457999999999999999999642 123689998875332 23347888999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
..+..+++|||+++++|.+++.+.. ....+++..+..++.|++.||+||| ++|++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence 9999999999999999999997532 1234788889999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
++++++.+||+|||.++......... ....++..|+|||++.+..++.++||||+|+++|+|++ |..||.+....+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999997654322111 11233567999999999999999999999999999998 8999976653222
Q ss_pred cc----CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 722 SS----GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 ~~----~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.. ..........+....+++.+|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 276 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRECWHAV 276 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 11 1222233445778889999999866
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=267.92 Aligned_cols=229 Identities=25% Similarity=0.384 Sum_probs=186.1
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCC
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGS 593 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 593 (764)
+.||.|++|.||+|....++.||+|.+...... ...+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 368999999999998766999999988765443 334788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc--e
Q 004268 594 LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR--T 671 (764)
Q Consensus 594 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--~ 671 (764)
|.+++... ...+++..+..++.+++.|++||| ++|++||||+|+||+++.++.+||+|||.+.......... .
T Consensus 79 l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99998643 235788999999999999999999 8999999999999999999999999999997654211111 1
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHHHhhhhc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~ 746 (764)
....+..|+|||.+.+..++.++|+||+|+++|+|+| |..||.......... ......+...+....+++++|+.
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 1223567999999988899999999999999999999 899997665322111 11222334567889999999997
Q ss_pred cch
Q 004268 747 GNH 749 (764)
Q Consensus 747 ~~~ 749 (764)
.+.
T Consensus 234 ~~p 236 (251)
T cd05041 234 YDP 236 (251)
T ss_pred cCh
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=273.49 Aligned_cols=234 Identities=27% Similarity=0.413 Sum_probs=185.0
Q ss_pred hcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CC
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NK 580 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~ 580 (764)
.+|++.+.||+|+||+||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5789999999999999999963 368899999986543 2334678899999999999999999998654 34
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++|++||||||+||++++++.+||+|||.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 689999999999999998642 235789999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 004268 661 RLLHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS--------------- 722 (764)
Q Consensus 661 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~--------------- 722 (764)
.......... ....++..|+|||+..+..++.++||||+|+++|||++|..|+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8764332211 1122345699999999889999999999999999999998776533221000
Q ss_pred -----cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 723 -----SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 723 -----~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
...........+..+.+++.+|++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 267 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCCh
Confidence 001112234456788999999997663
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=273.20 Aligned_cols=238 Identities=26% Similarity=0.382 Sum_probs=190.3
Q ss_pred cCCcceeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
.|++.+.||.|+||.||+|.. .+|+.||+|.+...... .....+.+.+|+++++++ +||+|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 36899999998754322 122346778899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.|++||||+|+||+++.++.+||+|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999874 345788999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCC-CceecccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCC
Q 004268 663 LHPDSS-NRTLVVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPR 732 (764)
Q Consensus 663 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~ 732 (764)
...... ......|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ ........+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence 543221 12234678899999998753 467899999999999999999999974322111 01111222344
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
.+....+++++|++.++..|
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R 254 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKR 254 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHh
Confidence 67788999999999875544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=266.86 Aligned_cols=244 Identities=31% Similarity=0.476 Sum_probs=199.1
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.|++.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+++++.++||+++++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4788899999999999999865 788999999976554 234788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++++|.+++.... ..+++..+..++.|++.|+++|| ++|++||||+|+||++++++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999987532 46899999999999999999999 8999999999999999999999999999998765443
Q ss_pred CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcHHHHHHH
Q 004268 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 741 (764)
. .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..... ...........+....+++
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHH
Confidence 2 33456888999999999888999999999999999999999999866332111 0111111222377889999
Q ss_pred hhhhccchhhH--HHhhhcCCC
Q 004268 742 KNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 742 ~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+.|++.+..-| .....+.||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99998773333 333444443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=271.52 Aligned_cols=234 Identities=28% Similarity=0.419 Sum_probs=188.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||.||+|.+.+ ...||+|....... ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 3568899999999999999997542 34689998865443 2334688899999999999999999998876 457
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++.+. ...+++..+..++.|++.|++||| +.|++||||||+||+++.++.+||+|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeee
Confidence 8999999999999999753 235789999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 663 LHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 663 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
....... .....++..|+|||.+.+..++.++||||+|+++|++++ |..||......+.. .......++..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 5433211 112234567999999988889999999999999999986 99999876543211 11223345567889
Q ss_pred HHHHHhhhhccc
Q 004268 737 CNAYLKNFSQGN 748 (764)
Q Consensus 737 ~~~~~~~~l~~~ 748 (764)
+.+++++|+..+
T Consensus 237 ~~~li~~~l~~~ 248 (270)
T cd05056 237 LYSLMTKCWAYD 248 (270)
T ss_pred HHHHHHHHcCCC
Confidence 999999999766
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=270.13 Aligned_cols=226 Identities=23% Similarity=0.294 Sum_probs=176.9
Q ss_pred eeeeecCceeEEEEEECC-------------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 514 YCIGTGGYGSVYRAQLSS-------------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
+.||+|+||.||+|...+ ...|++|.+.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 358999999999997432 2258888876543 223467888999999999999999999999998
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC-------EE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE-------AF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~k 653 (764)
..++||||+++++|..++... ...+++..+..++.||+.|++||| ++||+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999999888642 345888999999999999999999 999999999999999986654 89
Q ss_pred EeeeccccccCCCCCCceecccccccccccccc-cCCCCccchHHHHHHHHHHHH-hCCCCCCccccccccc--CCcCCC
Q 004268 654 VADFGLARLLHPDSSNRTLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLSSSS--GRKISQ 729 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll-tg~~Pf~~~~~~~~~~--~~~~~~ 729 (764)
++|||.+...... ....++..|+|||.+. +..++.++||||+||++|+|+ +|..||......+... ......
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 228 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML 228 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccC
Confidence 9999998755322 2245778899999886 466889999999999999997 6899987654322111 111122
Q ss_pred CCCCcHHHHHHHhhhhccchhh
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
....+..+.+++.+||+.++.-
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~ 250 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQ 250 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhh
Confidence 2334567889999999866443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=274.62 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=169.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|++|+||+|..+ +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 57999999999999999999865 78999999986543322 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 665 (764)
||+++ ++.+++... .....++..+..++.||+.||+||| ++|++||||+|+||+++. ++.+||+|||.+.....
T Consensus 81 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ecccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 99964 787777543 2234678888899999999999999 899999999999999985 56799999999976543
Q ss_pred CCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.........+++.|+|||++.+. .++.++||||+|+++|+|+||++||...+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33323334678899999988664 57889999999999999999999997543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=278.95 Aligned_cols=240 Identities=27% Similarity=0.414 Sum_probs=203.5
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
++++-...+.++.+++|.|.||.||.|.|+ -.-.||||.++.+..+ .++|.+|+.+|+.++|||+|+++|+|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 445445567788899999999999999876 3567999998765544 48899999999999999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
..+|||+|||..|+|.+|+++. ....++.-....++.||..|++||. .+++|||||.++|++|.++..||++|||+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999864 4445777778899999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCCce-ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCC
Q 004268 660 ARLLHPDSSNRT-LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRL 733 (764)
Q Consensus 660 ~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~ 733 (764)
++.+..+..... ...-...|.|||.+.-..++.|+|||+|||++||+.| |-.||.+++-... .....+..+..-
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC 491 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC 491 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC
Confidence 999865433211 1122568999999998899999999999999999998 8999998876432 345667777778
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
++..-+++..||+-.
T Consensus 492 PpkVYeLMraCW~Ws 506 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWS 506 (1157)
T ss_pred CHHHHHHHHHHhcCC
Confidence 888999999999843
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=270.09 Aligned_cols=230 Identities=26% Similarity=0.421 Sum_probs=180.1
Q ss_pred eeeecCceeEEEEEEC-CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 515 CIGTGGYGSVYRAQLS-SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
.||+|+||.||+|..+ ++. .+++|.+..... ....+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 5899999999999865 444 468888764332 22346788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 591 RGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 591 ~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
+++|.+++.... ....+++..+..++.|++.|++||| ++|++||||||+||++++++.+|++||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCC
Confidence 999999987432 1224788999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPR 732 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~ 732 (764)
|++....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.. ..........
T Consensus 157 gl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 157 GLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred CCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 9985332111 1111233567999999988889999999999999999997 99999765432111 1112223334
Q ss_pred CcHHHHHHHhhhhccchh
Q 004268 733 LDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~ 750 (764)
.+....+++.+|+..++.
T Consensus 236 ~~~~~~~li~~~l~~~p~ 253 (270)
T cd05047 236 CDDEVYDLMRQCWREKPY 253 (270)
T ss_pred CCHHHHHHHHHHcccChh
Confidence 567888999999976633
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=267.58 Aligned_cols=237 Identities=28% Similarity=0.460 Sum_probs=191.8
Q ss_pred CCcceeeeecCceeEEEEEECC-----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLSS-----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
+++.+.||.|+||.||+|.... +..||+|++....... ..+.+..|+++++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3567889999999999997653 3889999986554332 34788899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
+|||+++++|.+++..... ..+++..+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+....
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999999874321 12899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCCce-ecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHH
Q 004268 665 PDSSNRT-LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~ 738 (764)
....... ...+++.|+|||.+.+..++.++|+||+|+++|+|++ |++||........ ............+....
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY 234 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 4322111 1236788999999988889999999999999999998 8999976443211 12222333445678889
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++++|++.++.-|
T Consensus 235 ~~i~~~l~~~p~~R 248 (258)
T smart00219 235 KLMLQCWAEDPEDR 248 (258)
T ss_pred HHHHHHCcCChhhC
Confidence 99999998764433
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=271.69 Aligned_cols=236 Identities=25% Similarity=0.330 Sum_probs=188.9
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
|++.+.||.|++|.||+|... +|+.||+|++....... ...+.+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999754 79999999987543222 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
++ ++|.+++.... ...+++..+..++.|++.||+||| +++++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 96 58999886432 235899999999999999999999 89999999999999999999999999999976543332
Q ss_pred CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc------------------------
Q 004268 669 NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------------------------ 723 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------------------------ 723 (764)
......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||...+......
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 22334568899999987664 56889999999999999999999997554311000
Q ss_pred --------CCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 724 --------GRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 724 --------~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.......+.++..+.+++.+|++.++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 270 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhh
Confidence 0001123556788999999999877433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=273.54 Aligned_cols=226 Identities=26% Similarity=0.427 Sum_probs=187.1
Q ss_pred ceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 513 KYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
...||+|++|.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 35699999999999976 4789999998754332 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
++|.+++.. ..+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||.+...........
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 999998753 24788999999999999999999 89999999999999999999999999999876644333333
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcHHHHHHHhhhh
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDLQCNAYLKNFS 745 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l 745 (764)
...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ ...........++..+.+++.+|+
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 45688999999999888889999999999999999999999976543211 111122223456788899999999
Q ss_pred ccc
Q 004268 746 QGN 748 (764)
Q Consensus 746 ~~~ 748 (764)
+.+
T Consensus 255 ~~~ 257 (292)
T cd06657 255 VRD 257 (292)
T ss_pred hCC
Confidence 876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=270.61 Aligned_cols=226 Identities=25% Similarity=0.327 Sum_probs=174.2
Q ss_pred eeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.||+|+||.||+|... ++..+|+|.+...... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 5899999999999754 3467999988665432 2235788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC-
Q 004268 592 GSLFCVLRNDVE--AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS- 668 (764)
Q Consensus 592 ~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 668 (764)
|+|.+++..... ....++..+..++.|++.|++||| ++|++||||||+||+++.++.+||+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999874322 234567778889999999999999 89999999999999999999999999999875432221
Q ss_pred -CceecccccccccccccccC-------CCCccchHHHHHHHHHHHHh-CCCCCCccccccccc-----CCcCCCCC---
Q 004268 669 -NRTLVVGTYGYIAPELAYTM-------AVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS-----GRKISQNP--- 731 (764)
Q Consensus 669 -~~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~-----~~~~~~~~--- 731 (764)
......++..|+|||++.+. .++.++|+||+|+++|||++ |+.||......+... .......+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 11224567889999988643 35789999999999999996 999997654422111 01111111
Q ss_pred -CCcHHHHHHHhhhh
Q 004268 732 -RLDLQCNAYLKNFS 745 (764)
Q Consensus 732 -~~~~~~~~~~~~~l 745 (764)
..+..+.++++.|+
T Consensus 237 ~~~~~~~~~l~~~c~ 251 (269)
T cd05087 237 LPLSDRWYEVMQFCW 251 (269)
T ss_pred CCCChHHHHHHHHHh
Confidence 24556777777776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.87 Aligned_cols=234 Identities=26% Similarity=0.351 Sum_probs=187.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMFL 584 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 584 (764)
++|...+.||.|++|.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++.. .+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 36888999999999999999864 6889999998754432 334778899999999999999999998865 346899
Q ss_pred EEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 585 IYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
||||+++++|.+++.... ....+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998875321 2345788999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc-----ccccc------CCcCCCC--
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS-----LSSSS------GRKISQN-- 730 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~-----~~~~~------~~~~~~~-- 730 (764)
..... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .+... .......
T Consensus 156 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 42221 234578899999999999999999999999999999999999986632 00000 0000011
Q ss_pred --CCCcHHHHHHHhhhhccc
Q 004268 731 --PRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 731 --~~~~~~~~~~~~~~l~~~ 748 (764)
...+..+.+++.+|++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~ 253 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKD 253 (287)
T ss_pred CCCchHHHHHHHHHHHcCCC
Confidence 123567889999999877
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=264.53 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=201.1
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv 585 (764)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4788899999999999999865 7899999998765543 34457889999999999999999999999988 899999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
+||+++++|.+++... ..+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999999743 27899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----ccc-CCcCCCCCCCcHHH
Q 004268 666 DSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-----SSS-GRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-----~~~-~~~~~~~~~~~~~~ 737 (764)
... ......++..|+|||...+..++.++||||+|+++|+|++|..||....... ... ......+...+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence 432 1334568889999999998889999999999999999999999998765211 111 12222334457889
Q ss_pred HHHHhhhhccchhhH--HHhhhcCCC
Q 004268 738 NAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 738 ~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.+++.+|++.+..-| ...+-..||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 999999998763322 333444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=266.40 Aligned_cols=240 Identities=27% Similarity=0.383 Sum_probs=199.2
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|++|.||++... +++.||+|.+.............+..|++++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 6899999998876655544567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecc
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 674 (764)
.+++... ..+++..+..++.|++.|+.|+| +.+++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 9999743 35889999999999999999999 89999999999999999999999999999987654333334456
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 675 g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
++..|+|||...+..++.++|+||+|+++|++++|+.||...+... .........+...+..+.+++++|++.++.-
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 7889999999988888999999999999999999999997665321 1112233445556889999999999887544
Q ss_pred H--H---HhhhcCCC
Q 004268 752 E--N---LLFKKFPY 761 (764)
Q Consensus 752 ~--~---~~~~~~p~ 761 (764)
| . ......||
T Consensus 235 R~~~~~~~~l~~~~~ 249 (250)
T cd05123 235 RLGSGGAEEIKAHPF 249 (250)
T ss_pred CCCcccHHHHHhCCC
Confidence 4 2 34555554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=277.82 Aligned_cols=206 Identities=28% Similarity=0.454 Sum_probs=170.6
Q ss_pred cCCcceeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCMF 583 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 583 (764)
+|++.+.||+|++|.||+|..+ +++.||+|.+...........+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5888999999999999999764 4789999999874422222336678899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHHhcCc--cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC----CCCEEEeee
Q 004268 584 LIYEYMERGSLFCVLRNDV--EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS----NLEAFVADF 657 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Df 657 (764)
+||||+++ ++.+++.... ....+++..+..++.|++.|++||| ++||+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6766664322 2236889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCC---CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDSS---NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|.+........ ......++..|+|||++.+. .++.++||||+|+++|+|++|++||.+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987643322 12234678899999987764 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=266.48 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=202.5
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||.|++|.||++... +++.|++|.+...... ....+.+.+|+++++.++|||++++.+.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 5888999999999999999765 6899999998765443 2335778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 588 YMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|+++++|.+++.+.. ....+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999997532 1356899999999999999999999 889999999999999999999999999999876544
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 742 (764)
........+++.|+|||...+..++.++|+||+|+++|+|++|+.||......... .......+...+..+.++++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 43334457888999999999888999999999999999999999999766432211 11112223356788999999
Q ss_pred hhhccchhhH--HHhhhcCCC
Q 004268 743 NFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 743 ~~l~~~~~~~--~~~~~~~p~ 761 (764)
+|+..++.-| ....-..||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCC
Confidence 9998764333 333444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=259.68 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=191.1
Q ss_pred CcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEe
Q 004268 511 HIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 511 ~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
+-...||.|+||+|++-.++ +|+..|||.+...... ..++++..|.+...+- +.||||++||+...++.-|+.||.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 33456999999999999755 8999999999876653 3357888888865554 799999999999999999999999
Q ss_pred cCCCCHHHHHhc--CccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 589 MERGSLFCVLRN--DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 589 ~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|+- ++..+.+. ......+++.-+..|....+.||.||.. ...|||||+||+||+++..|.+||||||.+......
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 974 66544432 1234568888888999999999999986 459999999999999999999999999999776422
Q ss_pred CCCceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCccccc-ccccCCcCCCCCC---------Cc
Q 004268 667 SSNRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-SSSSGRKISQNPR---------LD 734 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~~~~~~~~~~~~~---------~~ 734 (764)
...+...|-..|||||.+.. ..|+.+|||||||+++||+.||..||..-+.. ++.......++|. .+
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 23344578889999998864 36899999999999999999999999866542 2223333334433 45
Q ss_pred HHHHHHHhhhhccchhhH--HHhhhcCCCCC
Q 004268 735 LQCNAYLKNFSQGNHRWE--NLLFKKFPYQN 763 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~--~~~~~~~p~~r 763 (764)
.....++.-|+.++..-| -..+++.||=|
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 567889999998873333 34467777654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=270.30 Aligned_cols=231 Identities=27% Similarity=0.396 Sum_probs=190.3
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||.|++|.||+|... +|+.|++|.+...........+.+.+|++++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999876 5999999998766554445567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC------
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS------ 668 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------ 668 (764)
.+++.+. ..+++..+..++.|++.||+||| +.|++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999743 36899999999999999999999 89999999999999999999999999999876543311
Q ss_pred --CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCC--CCcHHHHHHH
Q 004268 669 --NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNP--RLDLQCNAYL 741 (764)
Q Consensus 669 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~ 741 (764)
......++..|+|||...+..++.++|+||+|+++|++++|+.||......... .......+. .++..+.+++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 223346788999999998888999999999999999999999999765542211 111111122 2378999999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
++|++.++.-|
T Consensus 235 ~~~l~~~p~~R 245 (265)
T cd05579 235 SKLLVPDPEKR 245 (265)
T ss_pred HHHhcCCHhhc
Confidence 99998774433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=268.23 Aligned_cols=199 Identities=26% Similarity=0.388 Sum_probs=161.4
Q ss_pred eeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.||+|+||+||+|... ....+|+|.+..... ......+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 5899999999999643 345688887754332 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCC
Q 004268 592 GSLFCVLRNDVE--AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669 (764)
Q Consensus 592 ~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 669 (764)
|+|.+++..... ....++..+..++.||+.|++||| ++||+||||||+||++++++.+||+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999975422 223467788899999999999999 899999999999999999999999999998654322111
Q ss_pred --ceeccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 004268 670 --RTLVVGTYGYIAPELAYT-------MAVTEKCDVYSFGVVALEVLM-GSHPTDLLSS 718 (764)
Q Consensus 670 --~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~ 718 (764)
.....++..|+|||+... ..++.++||||+||++|+|++ |..||.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 122345678999998643 356789999999999999999 8899986654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=274.23 Aligned_cols=206 Identities=33% Similarity=0.434 Sum_probs=171.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~ 582 (764)
..++|++.+.||+|+||.||+|..+ +|+.||+|.+....... .....+.+|+.++++++||||+++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999864 78999999987543322 1123456899999999999999999998765 568
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++ +|.+++... ...+++..+..++.|++.|++||| +.|++||||||+||++++++.+||+|||.+..
T Consensus 84 ~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999999975 788888643 245889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
............++..|+|||++.+ ..++.++||||+|+++|+|++|++||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6544333333455788999999865 4578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=270.58 Aligned_cols=229 Identities=29% Similarity=0.444 Sum_probs=182.9
Q ss_pred eeeecCceeEEEEEECC-------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 515 CIGTGGYGSVYRAQLSS-------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
.||+|+||.||+|+..+ ++.+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 58999999999997542 257899988654322 224678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-----CEEEeeec
Q 004268 588 YMERGSLFCVLRNDV----EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-----EAFVADFG 658 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfg 658 (764)
|+++++|.+++.... ....+++.++..++.|++.|++||| +.+++|+||+|+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999996432 1234788999999999999999999 89999999999999999877 89999999
Q ss_pred cccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCC
Q 004268 659 LARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNP 731 (764)
Q Consensus 659 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~ 731 (764)
++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence 98765322111 112345678999999999999999999999999999998 999997654432211 12223344
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
..+..+.+++.+|++.+
T Consensus 237 ~~~~~~~~li~~~l~~~ 253 (269)
T cd05044 237 NCPDKIYQLMTNCWAQD 253 (269)
T ss_pred cchHHHHHHHHHHcCCC
Confidence 56788889999998765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=273.74 Aligned_cols=234 Identities=25% Similarity=0.423 Sum_probs=185.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 457888899999999999999753 454 478888765433 23335788999999999999999999998754 4
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++++||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence 67899999999999998743 335788899999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCc
Q 004268 662 LLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~ 734 (764)
........ .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.+...... .........+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 237 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 76432221 112345678999999999999999999999999999997 9999976543211 1112222334456
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
....+++..|+..+
T Consensus 238 ~~~~~li~~c~~~~ 251 (303)
T cd05110 238 IDVYMVMVKCWMID 251 (303)
T ss_pred HHHHHHHHHHcCCC
Confidence 78899999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=269.01 Aligned_cols=238 Identities=26% Similarity=0.422 Sum_probs=190.1
Q ss_pred cCCcceeeeecCceeEEEEEECC--CCEEEEEEccCCCC-------CcHHHHHHHHHHHHHHHh-cCCCceeeEeeEEee
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSS--GKLVALKKLHRSET-------EEPAFLESFQTEARLLSQ-IRHRNIVKLYGFCLH 578 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~ 578 (764)
.|++.+.||+|+||.||+|.... ++.+|+|.+..... ........+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998653 78899998764321 223334567788888865 699999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEee
Q 004268 579 NKCMFLIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
++..+++|||+++++|.+++... .....+++..++.++.|++.|+.||| + .|++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887532 13346888999999999999999999 5 6899999999999999999999999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCc-CC-CCC
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRK-IS-QNP 731 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~-~~-~~~ 731 (764)
||.+....... ......++..|+|||...+..++.++|+||+|+++|+|++|+.||.......... ... .. ...
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 99998765433 3334568889999999998889999999999999999999999997654321111 111 11 112
Q ss_pred CCcHHHHHHHhhhhccchh
Q 004268 732 RLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~~~ 750 (764)
..+..+.+++++|++.++.
T Consensus 237 ~~~~~l~~li~~cl~~~p~ 255 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAE 255 (269)
T ss_pred cCCHHHHHHHHHHCCCCCc
Confidence 4578899999999977643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=277.03 Aligned_cols=201 Identities=28% Similarity=0.382 Sum_probs=170.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN----- 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 579 (764)
..++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 5688999999999999999999754 7999999998654332 22345677899999999999999999988643
Q ss_pred -CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 580 -KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 580 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
...|+||||+++ ++.+.+... ++...+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999975 788777532 788899999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.+........ .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...+
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 164 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred cceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9987643322 233467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=277.45 Aligned_cols=200 Identities=28% Similarity=0.451 Sum_probs=167.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|++|.||+|.+ .+|+.||+|++..... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 47899999999999999999975 4789999999864322 22346678899999999999999999987654 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++++||+++ ++..++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence 58999999975 78777753 35889999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCC---ceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 661 RLLHPDSSN---RTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 661 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
......... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 765432221 123467889999998654 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=267.90 Aligned_cols=232 Identities=27% Similarity=0.404 Sum_probs=178.2
Q ss_pred eeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEe-eCCEEEEEEEe
Q 004268 514 YCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCL-HNKCMFLIYEY 588 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~ 588 (764)
+.||+|+||.||+|.+. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 35899999999999743 24579999875432 2233467889999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
+.+++|.+++... ....++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||.++.......
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9999999999743 234567778899999999999999 89999999999999999999999999999976532211
Q ss_pred ----CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHH
Q 004268 669 ----NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNA 739 (764)
Q Consensus 669 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~ 739 (764)
......++..|+|||...+..++.++||||+|+++|||++ |.+||......+... ..........+..+.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 1112345678999999988899999999999999999999 566776544322111 1111222335678889
Q ss_pred HHhhhhccchhhH
Q 004268 740 YLKNFSQGNHRWE 752 (764)
Q Consensus 740 ~~~~~l~~~~~~~ 752 (764)
++..|++.++.-|
T Consensus 234 li~~cl~~~p~~R 246 (262)
T cd05058 234 VMLSCWHPKPEMR 246 (262)
T ss_pred HHHHHcCCChhhC
Confidence 9999998764433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=269.07 Aligned_cols=226 Identities=23% Similarity=0.299 Sum_probs=175.6
Q ss_pred eeeecCceeEEEEEEC-------------------------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCce
Q 004268 515 CIGTGGYGSVYRAQLS-------------------------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 569 (764)
.||+|+||.||+|... ....|++|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 5899999999998632 113588888864322 234677889999999999999
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
+++++++.+....++||||+++++|..++... ...+++..+..++.|++.||+||| ++||+||||||+||++++.
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 99999999999999999999999999998642 345788999999999999999999 9999999999999999754
Q ss_pred C-------CEEEeeeccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHH-hCCCCCCcccccc
Q 004268 650 L-------EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLS 720 (764)
Q Consensus 650 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll-tg~~Pf~~~~~~~ 720 (764)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3 4799999988654322 12356788999998865 56899999999999999994 7999998665432
Q ss_pred ccc--CCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 721 SSS--GRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 721 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
... ......+......+.+++++|++.++.-|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 230 KERFYEKKHRLPEPSCKELATLISQCLTYEPTQR 263 (274)
T ss_pred HHHHHHhccCCCCCCChHHHHHHHHHcccChhhC
Confidence 111 11122233345678899999998664433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.61 Aligned_cols=202 Identities=27% Similarity=0.373 Sum_probs=170.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|.+.+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 46899999999999999999975 478999999987543222 2235677899999999999999999987654 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+|+||+. ++|.+++.. ...+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4899999996 588888863 346899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
..............++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 876543333334567889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=266.19 Aligned_cols=234 Identities=24% Similarity=0.347 Sum_probs=193.7
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|++.+.||+|++|.||++... +++.+|+|.+....... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5888999999999999999754 78899999987654332 334677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 588 YMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|+++++|.+++.+.. ....+++..+..++.|++.|++||| +.|++|+||+|+||++++++.+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999986422 1345888999999999999999999 999999999999999999999999999999876543
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----CcCCCCCCCcHHHHHHHh
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG----RKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 742 (764)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||...+....... .........+.++.++++
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 22234678899999999999999999999999999999999999987654322111 111222345778899999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|+..+
T Consensus 235 ~~l~~~ 240 (256)
T cd08530 235 SMLQVK 240 (256)
T ss_pred HHcCCC
Confidence 999765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=269.93 Aligned_cols=231 Identities=26% Similarity=0.366 Sum_probs=188.0
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
..|...+.||+|+||.||+|... ++..||+|.+...........+.+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44778889999999999999854 78899999987655444455577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+.+ ++.+.+... ...+++..+..++.|++.|+.||| ++||+||||+|+||+++.++.++|+|||.+......
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 777776532 345889999999999999999999 899999999999999999999999999998754322
Q ss_pred CCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-----CcCCCCCCCcHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-----RKISQNPRLDLQCN 738 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~ 738 (764)
....++..|+|||.+. +..++.++||||+||++|+|++|+.||........... .........+..+.
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence 2346788999999874 45688999999999999999999999976543221111 11122334567889
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
+++.+|++.+
T Consensus 255 ~li~~~l~~~ 264 (317)
T cd06635 255 NFVDSCLQKI 264 (317)
T ss_pred HHHHHHccCC
Confidence 9999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=267.73 Aligned_cols=235 Identities=27% Similarity=0.361 Sum_probs=189.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.|...+.||+|++|+||+|... +++.|++|++...........+.+.+|+++++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 33677788999999999999754 78899999987665555555567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+. +++.+++... ...+++..+..++.|++.|+.||| ++|++|+||+|+||+++.++.+||+|||.+.....
T Consensus 101 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 101 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred ecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 9996 4777777532 345889999999999999999999 89999999999999999999999999999864322
Q ss_pred CCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-----CcCCCCCCCcHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-----RKISQNPRLDLQCN 738 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~ 738 (764)
.....|+..|+|||++. +..++.++||||+|+++|+|++|..||........... ......+..+....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHH
Confidence 22346788999999974 45688899999999999999999999976553221111 11112234566789
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++.+|++.++..|
T Consensus 251 ~li~~~l~~~P~~R 264 (313)
T cd06633 251 GFVDYCLQKIPQER 264 (313)
T ss_pred HHHHHHccCChhhC
Confidence 99999998774333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=289.27 Aligned_cols=204 Identities=21% Similarity=0.315 Sum_probs=161.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC--CCCEEEEEE--------------ccCCCCCcHHHHHHHHHHHHHHHhcCCCc
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS--SGKLVALKK--------------LHRSETEEPAFLESFQTEARLLSQIRHRN 568 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 568 (764)
...++|++.+.||+|+||+||+|..+ .+..++.|. +.+...........+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999998643 222222221 11111112233466889999999999999
Q ss_pred eeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCcc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee
Q 004268 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVE--AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL 646 (764)
Q Consensus 569 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 646 (764)
|+++++++...+..|+|++++.+ ++..++..... ........++.++.||+.||+||| ++||+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 99999999999999999999964 67776643211 122345677889999999999999 8999999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 004268 647 NSNLEAFVADFGLARLLHPDSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712 (764)
Q Consensus 647 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P 712 (764)
+.++.+||+|||++..+..... ......|+..|+|||++.+..++.++||||+||++|||++|..|
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987653322 22235789999999999999999999999999999999998754
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.57 Aligned_cols=222 Identities=25% Similarity=0.355 Sum_probs=175.7
Q ss_pred eeeeecCceeEEEEEECC-C----------CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 514 YCIGTGGYGSVYRAQLSS-G----------KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
+.||+|+||.||+|.+.. + ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 358999999999997653 3 24777876544322 3778899999999999999999999888 778
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-------CEEEe
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-------EAFVA 655 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~ 655 (764)
++||||+++++|.+++.... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999999997532 25788999999999999999999 89999999999999999887 79999
Q ss_pred eeccccccCCCCCCceecccccccccccccccC--CCCccchHHHHHHHHHHHHh-CCCCCCcccccccccCC--cCCCC
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGR--KISQN 730 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~~--~~~~~ 730 (764)
|||.+..... .....++..|+|||++.+. .++.++||||+|+++|+|++ |..||...+........ .....
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 226 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCC
Confidence 9999986543 2223567789999998876 78999999999999999999 68888776432211111 11111
Q ss_pred CCCcHHHHHHHhhhhccch
Q 004268 731 PRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~ 749 (764)
......+.+++++|++.++
T Consensus 227 ~~~~~~~~~li~~~l~~~p 245 (259)
T cd05037 227 MPDCAELANLINQCWTYDP 245 (259)
T ss_pred CCCchHHHHHHHHHhccCh
Confidence 1223688899999997663
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.77 Aligned_cols=234 Identities=26% Similarity=0.405 Sum_probs=187.1
Q ss_pred hcCCcceeeeecCceeEEEEEEC-----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CC
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NK 580 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~ 580 (764)
+.|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56888899999999999999743 4789999998765543 345789999999999999999999999887 55
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 799999999999999999753 235889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 004268 661 RLLHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS--------------- 722 (764)
Q Consensus 661 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~--------------- 722 (764)
.......... ....++..|+|||...+..++.++||||+|+++|+|++|+.||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8765322211 1123456799999998889999999999999999999999998754322110
Q ss_pred ----cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 ----SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ----~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...........+....+++.+|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAE 266 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence 00111112334567778888888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.39 Aligned_cols=235 Identities=24% Similarity=0.320 Sum_probs=183.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv 585 (764)
++|+..+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35666778999999999999754 6899999998765433 33467889999999996 99999999999999999999
Q ss_pred EEecCCCCHHHHHhc--CccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 586 YEYMERGSLFCVLRN--DVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|||+.. ++.++... ......+++..+..++.|++.||+||| + .|++||||||+||+++.++.+||+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 999874 55443321 112346889999999999999999999 5 4999999999999999999999999999976
Q ss_pred cCCCCCCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccccc-cccCC--------cCCCC
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-SSSGR--------KISQN 730 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-~~~~~--------~~~~~ 730 (764)
...... .....++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ..... .....
T Consensus 158 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 158 LVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred hccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 543222 2234678899999998776 68899999999999999999999997654211 10000 01112
Q ss_pred CCCcHHHHHHHhhhhccch
Q 004268 731 PRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~ 749 (764)
..++..+.++++.|++.++
T Consensus 237 ~~~~~~l~~li~~~l~~~p 255 (288)
T cd06616 237 REFSPSFVNFINLCLIKDE 255 (288)
T ss_pred CccCHHHHHHHHHHccCCh
Confidence 2367788999999998773
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.06 Aligned_cols=226 Identities=21% Similarity=0.301 Sum_probs=170.9
Q ss_pred eeeecCceeEEEEEECCC---CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGYGSVYRAQLSSG---KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.||+|+||.||+|+..++ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999975433 3466676654332 22347889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC--C
Q 004268 592 GSLFCVLRNDVE-AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS--S 668 (764)
Q Consensus 592 ~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 668 (764)
|+|.+++.+... ....++..+..++.||+.||+||| +++++||||||+||+++.++.+||+|||.+....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999975322 234666778899999999999999 8999999999999999999999999999986432111 1
Q ss_pred Cceeccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----C-C----cCCCCC
Q 004268 669 NRTLVVGTYGYIAPELAYT-------MAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----G-R----KISQNP 731 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~-~----~~~~~~ 731 (764)
......++..|+|||+... ..++.++||||+|+++|||++ |..||......+... . . ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1223467889999998753 245789999999999999997 577887655422111 0 0 011122
Q ss_pred CCcHHHHHHHhhhh
Q 004268 732 RLDLQCNAYLKNFS 745 (764)
Q Consensus 732 ~~~~~~~~~~~~~l 745 (764)
..+..+.++++.|+
T Consensus 237 ~~~~~~~~l~~~c~ 250 (268)
T cd05086 237 PYSERWYEVLQFCW 250 (268)
T ss_pred CCcHHHHHHHHHHh
Confidence 34566777777776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=268.50 Aligned_cols=227 Identities=21% Similarity=0.366 Sum_probs=178.5
Q ss_pred eeeeecCceeEEEEEEC-C-------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 514 YCIGTGGYGSVYRAQLS-S-------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
+.||+|+||.||+|... . ...||+|.+.... ....+.+..|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 35899999999999753 2 2347888775432 23346788899999999999999999999998999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC--------EEEeee
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE--------AFVADF 657 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Df 657 (764)
|||+++|+|.+++... ...+++..+..++.||+.|++||| ++||+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999753 235788899999999999999999 999999999999999987665 699999
Q ss_pred ccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhC-CCCCCcccccccc--cCCcCCCCCCC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSSS--SGRKISQNPRL 733 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~~--~~~~~~~~~~~ 733 (764)
|.+...... ....++..|+|||++.+. .++.++||||+|+++|+|++| ..||...+..... .......++..
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPK 228 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCC
Confidence 998655322 234678899999998874 578999999999999999998 5777655443211 11122233345
Q ss_pred cHHHHHHHhhhhccchhhH
Q 004268 734 DLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~~ 752 (764)
+....+++++|++.++.-|
T Consensus 229 ~~~~~~li~~~l~~~p~~R 247 (258)
T cd05078 229 WTELANLINQCMDYEPDFR 247 (258)
T ss_pred cHHHHHHHHHHhccChhhC
Confidence 5788999999998774444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=267.64 Aligned_cols=235 Identities=20% Similarity=0.244 Sum_probs=169.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHH--------HHHHHHHHHHHHhcCCCceeeEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAF--------LESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
.++|++.+.||+|+||+||+|...+ +..+|+|+........... ......+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998653 4566666543322111000 011122334455668999999999
Q ss_pred EEeeCC----EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 575 FCLHNK----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 575 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.|++||| +++|+||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 766543 35778887754 66666653 223567888999999999999999 89999999999999999999
Q ss_pred CEEEeeeccccccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--
Q 004268 651 EAFVADFGLARLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-- 721 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-- 721 (764)
.++|+|||+|+....... ......||+.|+|||+..+..++.++||||+||++|||++|+.||.+......
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 11234689999999999999999999999999999999999999987743111
Q ss_pred ---------ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 722 ---------SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.........+..+..+.++++.|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLS 279 (294)
T ss_pred HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCC
Confidence 001111123344667788888888655
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=264.65 Aligned_cols=238 Identities=26% Similarity=0.391 Sum_probs=186.9
Q ss_pred CCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
|++.+.||+|+||.||+|.+. +++.||+|.+....... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999643 46889999987654333 33577889999999999999999999886532
Q ss_pred -EEEEEEEecCCCCHHHHHhcCc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDV---EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
..++++||+.+++|..++.... ....+++..+..++.|++.|++||| ++||+||||||+||++++++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 3578899999999988874321 2235788899999999999999999 89999999999999999999999999
Q ss_pred eccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCC
Q 004268 657 FGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQ 729 (764)
Q Consensus 657 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~ 729 (764)
||.++....... ......+++.|++||...+..++.++||||+|+++|+|++ |++||......+. ........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 999986543221 1112344678999999998889999999999999999999 8999986654221 11122223
Q ss_pred CCCCcHHHHHHHhhhhccchhh
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.+..+..+.+++.+|++.++.-
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~ 258 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKC 258 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhh
Confidence 3456788999999999876433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.16 Aligned_cols=203 Identities=27% Similarity=0.401 Sum_probs=170.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 581 (764)
.++|++.+.||+|++|.||+|... +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 478999999999999999999754 7999999998764332 2234677789999999999999999998753 356
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+||| ++|++||||||+||++++++.+||+|||.+.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999996 589888863 334899999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCC----ceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 662 LLHPDSSN----RTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 662 ~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
........ .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 65432211 123467889999998765 468899999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.08 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=164.0
Q ss_pred eeeec--CceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTG--GYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.||+| +||+||+|++. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45666 99999999864 79999999987654433 3457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc-
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR- 670 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 670 (764)
+++.+++.+.. ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987542 335888999999999999999999 8999999999999999999999999998654332211111
Q ss_pred ------eecccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 671 ------TLVVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 671 ------~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
....++..|+|||++.+. .++.++||||+||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 112345679999998764 47889999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=273.32 Aligned_cols=206 Identities=29% Similarity=0.358 Sum_probs=169.5
Q ss_pred HhhcCCc-ceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHH-----------HHHHHHHHHHHHHhcCCCceeeE
Q 004268 506 ATEDFHI-KYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPA-----------FLESFQTEARLLSQIRHRNIVKL 572 (764)
Q Consensus 506 ~~~~y~~-~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~ 572 (764)
..++|.. .+.||.|+||+||+|... +++.||+|++......... ....+.+|++++++++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3567764 467999999999999754 7899999998654332210 01246789999999999999999
Q ss_pred eeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCE
Q 004268 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 573 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 652 (764)
++++...+..++||||++ ++|.+++.. ...+++..+..++.|++.||+||| ++|++||||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 999999999999999997 589888863 345888999999999999999999 8999999999999999999999
Q ss_pred EEeeeccccccCCC--------------CCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 653 FVADFGLARLLHPD--------------SSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 653 kl~Dfg~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
+|+|||.+...... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765411 1111223467889999998765 46889999999999999999999997654
Q ss_pred c
Q 004268 718 S 718 (764)
Q Consensus 718 ~ 718 (764)
.
T Consensus 239 ~ 239 (335)
T PTZ00024 239 E 239 (335)
T ss_pred H
Confidence 3
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=267.21 Aligned_cols=206 Identities=34% Similarity=0.501 Sum_probs=170.4
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC---
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 580 (764)
...++|++.+.||+|++|.||+|..+ +|+.||+|.+....... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 35688999999999999999999865 68899999987543221 12356678999999999999999999887654
Q ss_pred -------EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 581 -------CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 581 -------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
..++|+||+++ ++...+... ...+++..+..++.|++.||+||| +.||+||||+|+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEE
Confidence 79999999986 677776542 346899999999999999999999 89999999999999999999999
Q ss_pred EeeeccccccCCCCC-CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 654 VADFGLARLLHPDSS-NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+|||.+........ ......++..|+|||.+.+. .++.++||||+||++|+|++|++||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987643332 11223457789999987654 56889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=266.58 Aligned_cols=238 Identities=25% Similarity=0.388 Sum_probs=190.4
Q ss_pred cCCcceeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
+|++.+.||+|++|.||+|.. .+++.||+|.+...... .....+.+.+|+++++++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999964 35788999998754322 122346678999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++.. ...+++..+..++.|+++||+||| +.|++||||+|+||+++.++.++|+|||.+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999863 345788999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCC-ceecccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCcccccc-------cccCCcCCCCCC
Q 004268 663 LHPDSSN-RTLVVGTYGYIAPELAYTMA--VTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-------SSSGRKISQNPR 732 (764)
Q Consensus 663 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-------~~~~~~~~~~~~ 732 (764)
....... .....++..|+|||...+.. ++.++|+||+|+++|+|++|..||....... .........+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence 5433221 22345788999999987665 7889999999999999999999996432211 011122233444
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
++..+.+++++|++.+..-|
T Consensus 235 ~~~~l~~li~~~l~~~p~~R 254 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKR 254 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhc
Confidence 67889999999998875444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.52 Aligned_cols=198 Identities=25% Similarity=0.327 Sum_probs=164.7
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeC--CEEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHN--KCMFLI 585 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv 585 (764)
|++.+.||+|++|.||+|... +++.||+|.+......... ....+|+.+++++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678899999999999999754 7899999998765433221 23457888898885 99999999999987 889999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ ++.+.+... ...+++..+..++.|++.||+||| +.|++||||+|+||+++. +.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 999975 777777642 245899999999999999999999 899999999999999999 9999999999987643
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
... .....++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+
T Consensus 152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 322 223457889999997644 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=257.23 Aligned_cols=225 Identities=22% Similarity=0.244 Sum_probs=179.8
Q ss_pred cCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHH
Q 004268 519 GGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCV 597 (764)
Q Consensus 519 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 597 (764)
|.+|.||+|++. +++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999754 789999999875431 22444555556799999999999999999999999999999999
Q ss_pred HhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccc
Q 004268 598 LRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY 677 (764)
Q Consensus 598 l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 677 (764)
+.+. ..+++..+..++.|++.||+|+| ++||+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 76 l~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 146 (237)
T cd05576 76 ISKF---LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVEN 146 (237)
T ss_pred HHHh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCc
Confidence 8643 35889999999999999999999 8999999999999999999999999999876654321 2234567
Q ss_pred ccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHHHHhhhhccchhhHH----
Q 004268 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQGNHRWEN---- 753 (764)
Q Consensus 678 ~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---- 753 (764)
.|+|||...+..++.++|+||+|+++|+|++|+.||...... .........++.++..+.+++.+|++.++.-|.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 899999998888999999999999999999999998643321 111122233455788899999999988855442
Q ss_pred ---HhhhcCCC
Q 004268 754 ---LLFKKFPY 761 (764)
Q Consensus 754 ---~~~~~~p~ 761 (764)
..+...||
T Consensus 226 ~~~~~~~~h~~ 236 (237)
T cd05576 226 AGVEDIKSHPF 236 (237)
T ss_pred cchHHHHcCCC
Confidence 44555555
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=273.56 Aligned_cols=201 Identities=29% Similarity=0.431 Sum_probs=170.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC---
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 580 (764)
...++|++.+.||+|++|.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3567899999999999999999974 4799999999865432 2333467889999999999999999999887653
Q ss_pred ---EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 581 ---CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 581 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..++||||+ +++|..++.. ..+++..+..++.|++.|++||| +.||+||||||+||+++.++.++++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 468999998 6789888753 35889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.+..
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999765432 223457889999998876 457889999999999999999999997554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=274.17 Aligned_cols=225 Identities=24% Similarity=0.345 Sum_probs=185.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
+.+.|.+...+|.|+|+.|-.+.. .+++..++|++.+.... ..+|+.++... +||||+++.+.+.++...|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 357788888899999999999864 47889999999876332 23677776666 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee-cCCCCEEEeeeccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL-NSNLEAFVADFGLARL 662 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfg~~~~ 662 (764)
+|||.+.|+-+.+.+... .... ..+..|+++|+.|+.||| ++||||||+||+|||+ ++.++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 999999999777776532 2223 677889999999999999 8999999999999999 5899999999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCC---CCCcHHHHH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQN---PRLDLQCNA 739 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~ 739 (764)
..+. ....+-|..|.|||+....+|++++|+||||++||+|++|+.||..-... ......+... ..+|....+
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s~~vS~~AKd 541 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFSECVSDEAKD 541 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccccccCHHHHH
Confidence 6544 22345688999999999999999999999999999999999999855443 1222222222 568999999
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++++|++.+
T Consensus 542 Ll~~LL~~d 550 (612)
T KOG0603|consen 542 LLQQLLQVD 550 (612)
T ss_pred HHHHhccCC
Confidence 999999988
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=268.44 Aligned_cols=232 Identities=26% Similarity=0.379 Sum_probs=187.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...|+..+.||+|++|.||+|+.. +++.||+|.+...........+.+.+|+++++.++|||++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777888999999999999864 6889999998754443444456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+. +++.+.+... ...+++..+..++.|++.|+.||| ++|++||||+|+||+++.++.++|+|||.+.....
T Consensus 94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 5777776532 235788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcCCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~ 737 (764)
. ....+++.|+|||.+. ...++.++||||+||++|+|++|..||.......... ..........+..+
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence 2 2346788999999874 3467889999999999999999999987654322111 11111233467788
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
.+++++|++.+
T Consensus 244 ~~li~~cl~~~ 254 (308)
T cd06634 244 RNFVDSCLQKI 254 (308)
T ss_pred HHHHHHHhhCC
Confidence 99999999866
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=267.87 Aligned_cols=206 Identities=27% Similarity=0.441 Sum_probs=169.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC---
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--- 580 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 580 (764)
+..++|++.+.||+|++|.||+|... +++.||+|.+....... .....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 34678999999999999999999765 78999999886543222 11245568999999999999999999886643
Q ss_pred -----EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 581 -----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 581 -----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
..++||||+.+ ++.+++... ...+++..+..++.|++.||+||| ++|++|+||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEEC
Confidence 45999999975 787777642 235899999999999999999999 8899999999999999999999999
Q ss_pred eeccccccCCCCCC----ceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 656 DFGLARLLHPDSSN----RTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 656 Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|||.+......... .....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999766432211 1234567889999987665 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=272.14 Aligned_cols=203 Identities=33% Similarity=0.462 Sum_probs=169.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC--CE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN--KC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~ 581 (764)
..++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4678999999999999999999865 68899999886533222 2235677899999999 999999999988653 46
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++ +|..++... .+++..+..++.|++.||+||| ++||+||||+|+||+++.++.+||+|||.+.
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 8999999984 898888642 5788888999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCC-----Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 662 LLHPDSS-----NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 662 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
....... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 6643321 2233568889999998765 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.73 Aligned_cols=201 Identities=30% Similarity=0.420 Sum_probs=173.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----EE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-----CM 582 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~ 582 (764)
+|++.+.||.|++|.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999865 589999999876442 2233467889999999999999999999988775 78
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|++|||+++ +|.+++.+. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.++|+|||.+..
T Consensus 80 ~lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 999999984 888888642 36899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCC---CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 663 LHPDS---SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 663 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
..... .......++..|+|||++.+. .++.++|+||+|+++|+|++|++||.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 65443 122334678899999999888 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=264.02 Aligned_cols=201 Identities=31% Similarity=0.445 Sum_probs=169.1
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEeeCCE----
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCLHNKC---- 581 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~---- 581 (764)
|++.+.||+|++|.||+|.++ +++.||+|.+....... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999876 58999999997554432 2234566788877776 59999999999988776
Q ss_pred -EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 582 -MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 582 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
.+++|||+.+ ++.+++.... ...+++..+..++.|++.||.||| +.|++|+||+|+||++++++.+||+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 7888886432 235899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
........ .....++..|+|||++.+..++.++|+||+|+++|+|++|++||.+..
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 77643322 223357889999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.37 Aligned_cols=202 Identities=28% Similarity=0.422 Sum_probs=173.6
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
|++.+.||+|++|.||+|... +++.+++|.+...... +.....+.+|++++++++||+|+++++++..+...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677889999999999999764 7889999998765433 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
+++ ++.+++... ...+++..+..++.|++.|+.||| +.||+|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 985 888887642 246899999999999999999999 89999999999999999999999999999987755432
Q ss_pred CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 669 NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||...+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23334678899999998877 789999999999999999999999976543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=270.04 Aligned_cols=204 Identities=24% Similarity=0.354 Sum_probs=175.8
Q ss_pred HHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHH-----HHHHHHHHHHHhcC---CCceeeEee
Q 004268 504 IEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFL-----ESFQTEARLLSQIR---HRNIVKLYG 574 (764)
Q Consensus 504 ~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---hpniv~~~~ 574 (764)
......|+..+.+|.|+||.|+.|.++ ....|++|.+.+.+.-...+. -.+-.|+.||.+++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344567999999999999999999766 566899999987664432222 23567999999996 999999999
Q ss_pred EEeeCCEEEEEEEecC-CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 575 FCLHNKCMFLIYEYME-RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 575 ~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
+|++++.+|++||... |.+|++++. ....+++.++..|++|++.|+++|| +.||||||||-+||.++.+|-+|
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 9999999999999764 459999997 4557899999999999999999999 99999999999999999999999
Q ss_pred EeeeccccccCCCCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCc
Q 004268 654 VADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
|+|||.|..... .....++||..|.|||++.|..| +..-||||+|+++|.++....||..
T Consensus 711 lidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999987643 33456899999999999999988 5678999999999999999999863
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=269.19 Aligned_cols=205 Identities=28% Similarity=0.401 Sum_probs=170.7
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
.++....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34556779999999999999999999974 47899999998754322 22246678899999999999999999987643
Q ss_pred ------CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 580 ------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 580 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
...+++++++ +++|.+++.. ..+++..+..++.|++.|++||| ++||+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 3467888877 6789888753 24889999999999999999999 89999999999999999999999
Q ss_pred EeeeccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 654 VADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+|||.+..... ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....
T Consensus 161 l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 161 ILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred Eecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876432 2223467889999998866 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=263.86 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=191.6
Q ss_pred cCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC--cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE--EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
+|.+.+.||+|+||.||++... .+..+++|+.+..... .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999754 3455556655432211 111224567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
+||+++++|..++.... ....+++..+..++.|++.|+.||| ++|++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998886421 3346899999999999999999999 899999999999999975 579999999987765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC----cCCCCCCCcHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR----KISQNPRLDLQCNAY 740 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 740 (764)
..........+++.|+|||...+..++.++|+||+|+++|+|++|..||............ ....+...+..+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 4433334456788999999998888899999999999999999999999755442221111 111233456788999
Q ss_pred HhhhhccchhhH--HHhhhcCCC
Q 004268 741 LKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 741 ~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+++|++.++.-| .......||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCC
Confidence 999998764333 333444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=291.69 Aligned_cols=200 Identities=30% Similarity=0.510 Sum_probs=165.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-----
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----- 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 578 (764)
+...+|...+.+|+||||.||+++.+ +|+.||||++.... .......+.+|+..+.+++|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 45667788889999999999999977 89999999998876 33445778899999999999999999853300
Q ss_pred --------------------------------------------------C-----------------------------
Q 004268 579 --------------------------------------------------N----------------------------- 579 (764)
Q Consensus 579 --------------------------------------------------~----------------------------- 579 (764)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHH
Q 004268 580 -----------------------------------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624 (764)
Q Consensus 580 -----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~ 624 (764)
-.+||-||||+..++.++++++.... .....++++++|+.||+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 13588899999988888887543211 45778999999999999
Q ss_pred HHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC------------------CCCCCceecccccccccccccc
Q 004268 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH------------------PDSSNRTLVVGTYGYIAPELAY 686 (764)
Q Consensus 625 ~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~~ 686 (764)
|+| ++|||||||||.||++++++.|||+|||+|+... ......+..+||.-|+|||++.
T Consensus 712 YIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999 9999999999999999999999999999998721 1112345678999999999988
Q ss_pred cCC---CCccchHHHHHHHHHHHHhCCCCCC
Q 004268 687 TMA---VTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 687 ~~~---~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
+.. |+.|+|+||+||+++||+. ||.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~ 816 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFG 816 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCC
Confidence 765 9999999999999999985 565
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=264.24 Aligned_cols=236 Identities=22% Similarity=0.358 Sum_probs=184.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|++|.||+|.+. +++.||+|.+....... ....+.+|+.++.+. .||||+++++++.+....|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 467899999999999999999876 58999999987654332 235566777766666 59999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|||+.+ ++..+.... ...+++..+..++.|++.|++||| + .||+||||+|+||++++++.+||+|||.+...
T Consensus 92 v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 92 CMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9999864 777776542 236888999999999999999999 6 59999999999999999999999999998765
Q ss_pred CCCCCCceecccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCccccc-cc---ccC---CcCCCCCC
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMA----VTEKCDVYSFGVVALEVLMGSHPTDLLSSL-SS---SSG---RKISQNPR 732 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~~---~~~---~~~~~~~~ 732 (764)
..... .....++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||...... +. ... ........
T Consensus 166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCC
Confidence 43222 22335778999999987654 788999999999999999999999753221 10 011 11111223
Q ss_pred CcHHHHHHHhhhhccchhh
Q 004268 733 LDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~ 751 (764)
.+..+.+++++|+..++.-
T Consensus 245 ~~~~l~~li~~~l~~~p~~ 263 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRK 263 (296)
T ss_pred CCHHHHHHHHHHccCChhh
Confidence 5778999999999877333
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=268.48 Aligned_cols=199 Identities=21% Similarity=0.286 Sum_probs=162.2
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCC
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERG 592 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 592 (764)
.+.+|.|+++.||++.. +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..+++|||++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 33344444444444433 6999999998765322 234578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC----
Q 004268 593 SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS---- 668 (764)
Q Consensus 593 ~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 668 (764)
++.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999754 2335788999999999999999999 89999999999999999999999999998875532211
Q ss_pred ---CceecccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 669 ---NRTLVVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 669 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
......++..|+|||++.+. .++.++|+||+||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11223567789999998763 57899999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=267.28 Aligned_cols=202 Identities=28% Similarity=0.417 Sum_probs=169.5
Q ss_pred HHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CCE
Q 004268 504 IEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NKC 581 (764)
Q Consensus 504 ~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 581 (764)
....++|++.+.||.|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++.+++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 346789999999999999999999754 89999999886543222 223667789999999999999999998865 557
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++++||+. ++|..+++. ..+++..+..++.|++.||+||| ++||+||||+|+||++++++.++|+|||.+.
T Consensus 85 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehhc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 899999984 588888753 24778888899999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
..... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322 223456889999998766 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=288.64 Aligned_cols=149 Identities=28% Similarity=0.452 Sum_probs=135.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++.............+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999865 7899999999876655555567889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
|||+.+++|.+++.. ...+++..++.++.||+.||+||| .+||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999874 335788899999999999999999 8899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=264.57 Aligned_cols=201 Identities=30% Similarity=0.413 Sum_probs=172.2
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+..|++++++++|||++++++++.+.+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567788999999999999865 699999999886542 222346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
++ ++|.+++.+.. ..+++..+..++.|++.||+||| +.||+||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 48999997532 46899999999999999999999 89999999999999999999999999999987654433
Q ss_pred CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 669 NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
......++..|+|||.+.+. .++.++||||+|+++|++++|++||....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 33334567789999998776 78999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=264.33 Aligned_cols=201 Identities=33% Similarity=0.499 Sum_probs=170.5
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEEEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCMFLIY 586 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~ 586 (764)
|++.+.||+|++|.||+|... +++.+|+|.+.... ........+.+|++++++++|||++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999865 58899999998764 2223346678999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++ +|.+++... ...+++..+..++.|++.|++||| ++|++|+||+|+||++++++.+||+|||.+......
T Consensus 80 e~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99985 888887643 246889999999999999999999 899999999999999999999999999999876543
Q ss_pred CC-Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 667 SS-NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||+...
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223456788999998765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=270.11 Aligned_cols=200 Identities=27% Similarity=0.398 Sum_probs=165.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
..+|++.+.||.|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 478999999999999999999754 7899999998665442 246788999999999999999999876543
Q ss_pred --------CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCC
Q 004268 580 --------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNL 650 (764)
Q Consensus 580 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~ 650 (764)
...++||||++ ++|.+++.. ..+++..++.++.||+.|+.||| +.||+||||||+||+++ +++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence 35799999997 488888753 35888999999999999999999 89999999999999997 456
Q ss_pred CEEEeeeccccccCCCCCC---ceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 651 EAFVADFGLARLLHPDSSN---RTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.+|++|||.+......... .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||....
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7899999999765322111 122357889999997654 567889999999999999999999997553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=267.41 Aligned_cols=205 Identities=29% Similarity=0.450 Sum_probs=167.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
.++|++.+.||+|++|.||+|..+ +++.||+|++......+. ....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 578999999999999999999855 789999998865443221 124567899999999999999999987543
Q ss_pred --CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 580 --KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 580 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
..+++||||+.+ ++...+.. ....+++..+..++.|+++||+||| ++|++||||||+||++++++.++|+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence 347999999975 67666653 2346899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCC-----------ceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDSSN-----------RTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|.+......... .....+++.|+|||.+.+. .++.++||||+|+++|+|++|++||.+...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999765432211 1123567889999987654 578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=268.08 Aligned_cols=198 Identities=31% Similarity=0.448 Sum_probs=166.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
..+|.+.+.||+|++|.||+|... +|+.||+|++....... .....+.+|+++++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 578999999999999999999854 78999999987643222 2235678999999999999999999998754
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
..+++|+||+.. ++..+.. ..+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 346999999964 6766642 24788999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
+...... .....++..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765322 223467889999999876 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=263.08 Aligned_cols=200 Identities=27% Similarity=0.417 Sum_probs=168.5
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 587 (764)
|++.+.||+|++|+||+|... +++.|++|.+........ .....+|+..+++++ |||++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 678899999999999999865 588999999876543221 134457899999998 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+ ++++.+++.... ...+++..+..++.|++.||.||| ++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 778988887432 346899999999999999999999 8999999999999999999999999999998664322
Q ss_pred CCceecccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 SNRTLVVGTYGYIAPELAY-TMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
. .....++..|+|||++. +..++.++|+||+|+++|+|++|++||....
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 154 P-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred C-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 2 22346788999999875 4457899999999999999999999996554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=265.53 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=165.2
Q ss_pred cCCcceeeeecCceeEEEEEEC-C--CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC----C
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLS-S--GKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN----K 580 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~----~ 580 (764)
+|++.+.||+|+||.||+|+.. + +..||+|.+...... ....+.+.+|+++++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 5888999999999999999865 4 779999998653322 22246678899999999 599999999875432 4
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++++|++. ++|.+++.. ...+++..++.++.||+.||+||| ++|++||||||+||++++++.+||+|||.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5789999986 589888863 345889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC----Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 661 RLLHPDSS----NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 661 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
........ ......|+..|+|||...+ ..++.++|+||+|+++|+|++|++||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 86543221 1223468899999998765 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=270.22 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=169.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE---
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC--- 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 581 (764)
..++|++.+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4678999999999999999999865 6889999988654322 2334667789999999999999999998766554
Q ss_pred ---EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 582 ---MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 582 ---~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
.++|+||+ +++|.+++.. ..+++..+..++.|++.|++||| +.||+||||+|+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699988863 35899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.+...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865432 233467889999998765 367889999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-32 Score=292.70 Aligned_cols=377 Identities=32% Similarity=0.424 Sum_probs=267.6
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecC
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 99 (764)
.|+.|+|++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+...+.+|++|.|.+|++. ..|..+..+.+|++|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 3889999999886 77888899999999999999998 56788888999999999999988 688889999999999999
Q ss_pred CCcccccCCccCcCCCCCCEEEccCC-------------------cCcccCCccccCCCCcCEEecccCcccccCCcccc
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGN-------------------KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n-------------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 160 (764)
.|.+. ..|..+..+..++++..++| .+.+..+..+..+.+ .|+|.+|.+. + ..+.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls 196 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLS 196 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhh
Confidence 99887 34444444444444444433 333333333333333 3677777665 2 1233
Q ss_pred CCCCCCeeecccCCCCCCC------------------CCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcc
Q 004268 161 NLKNLKSLFLDNNHLSGPI------------------PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222 (764)
Q Consensus 161 ~l~~L~~L~L~~n~i~~~~------------------~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 222 (764)
.+.+|+.|+...|++..+. ...-....+|+.+++++|+++.++ +....+.+|+.+...+|.
T Consensus 197 ~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNR 275 (1081)
T ss_pred hccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcch-HHHHhcccceEecccchh
Confidence 4444444444444433110 001112345677777777777665 666777777777777777
Q ss_pred cccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCcccc----------------------
Q 004268 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG---------------------- 280 (764)
Q Consensus 223 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---------------------- 280 (764)
++ ..|..+....+|+.|++..|.++ -+|.....++.|++|+|..|+|...++..|.
T Consensus 276 l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~ 353 (1081)
T KOG0618|consen 276 LV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSY 353 (1081)
T ss_pred HH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccc
Confidence 75 45555555666666666666666 4444566677777777777777633222111
Q ss_pred ---CCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhccccccc
Q 004268 281 ---NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF 357 (764)
Q Consensus 281 ---~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 357 (764)
.++.|+.|.+.+|.+++..-..+.++++|+.|+|++|+|.......+.++..|++|+||||+++ .+|..+..+..|
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L 432 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL 432 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence 2334777888888888766667888899999999999999666667889999999999999999 788999999999
Q ss_pred ceeecccccccCCCCCCCCCCCccceecCCCCcccc-ccCCc--cccCccccccCCC
Q 004268 358 RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSG-VIPAS--VRRIPKLIVSENN 411 (764)
Q Consensus 358 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~-~~~~~--~~~~~~~~~~~n~ 411 (764)
++|...+|+|. ..| .+..++.|+.+|+|.|.|+- .+|.. ++.++.+++++|.
T Consensus 433 ~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 433 HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred HHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 99999999998 666 78899999999999999983 33432 2689999999997
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=253.50 Aligned_cols=202 Identities=23% Similarity=0.376 Sum_probs=173.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CC----ceeeEeeEEe
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HR----NIVKLYGFCL 577 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp----niv~~~~~~~ 577 (764)
...++|.++..+|+|.||.|..+.+ ..+..||+|+++... .+.+...-|+++++++. .| -++++.+||.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3478999999999999999999964 467899999987543 34577788999999993 23 3788889999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---------
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--------- 648 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------- 648 (764)
..++.+||+|.+ |.++.+++..+ ...+++...++.+++|+++++++|| +.+++|.|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEecc
Confidence 999999999988 45999999865 4557999999999999999999999 999999999999999842
Q ss_pred -----------CCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 649 -----------NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 649 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
+..|+++|||.|+... ......+.|..|+|||++.+-+++.++||||+|||++|++||..-|..-+
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3458999999998643 23356789999999999999999999999999999999999999998665
Q ss_pred c
Q 004268 718 S 718 (764)
Q Consensus 718 ~ 718 (764)
.
T Consensus 314 n 314 (415)
T KOG0671|consen 314 N 314 (415)
T ss_pred c
Confidence 3
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-32 Score=262.33 Aligned_cols=364 Identities=23% Similarity=0.235 Sum_probs=179.3
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccC-CcCcccCCcccCCCCCCCEEec
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSY-NRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L 98 (764)
+.+.++|..|.|+.+.+.+|+.+++|++||||+|+|+.+.|++|.++.+|.+|-+-+ |+|+.+..++|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 444445555555444444444555555555555555444444554444444433333 4444444444444445555544
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCccc------------ccCCccccCCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS------------GRLPQEVGNLKNLK 166 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------~~~~~~~~~l~~L~ 166 (764)
.-|++.-+..++|..+++|..|.+-+|.+..+....|..+.+++.+.+..|.+. ...+..+++.....
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 444444444444444555544555555444444444444444444444444410 11122223333222
Q ss_pred eeecccCCCCCCCCCccccC-CCc-cEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccC
Q 004268 167 SLFLDNNHLSGPIPSTLYHL-NQL-ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244 (764)
Q Consensus 167 ~L~L~~n~i~~~~~~~~~~l-~~L-~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 244 (764)
...+.++++..+....|... ..+ ..+....+.....+...|+.+++|++|+|++|+++.+-+.+|.....+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 22233332222222111111 001 1112222222223344456666666666666666666666666666666666666
Q ss_pred CcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccC----------------CCCCCCCCCCc
Q 004268 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG----------------PIPPTIGYLTN 308 (764)
Q Consensus 245 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------~~~~~~~~l~~ 308 (764)
|+|..+....|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.- .....-+....
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 66665555556666666666666666665566666666666666665554310 00000111223
Q ss_pred cceEEccCCcCcc------------------------------------CCChhhhcccccceeeccccccccCCchhcc
Q 004268 309 LTYLNLGYNRLSS------------------------------------SIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352 (764)
Q Consensus 309 L~~L~ls~N~l~~------------------------------------~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 352 (764)
++.+.++++.+.+ .+|..+. ..-++|++.+|.++ .+|..
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~-- 462 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE-- 462 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH--
Confidence 4444444433321 2222221 13466788888887 55655
Q ss_pred cccccceeecccccccCCCCCCCCCCCccceecCCCC
Q 004268 353 NLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389 (764)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 389 (764)
.+.+| .+|+++|+|.......|.++.+|.+|-+++|
T Consensus 463 ~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 55667 7888888887666777888888887777765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=239.86 Aligned_cols=205 Identities=27% Similarity=0.449 Sum_probs=168.8
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 578 (764)
...|.-..+||+|.||.||+|+. ++|+.||+|++.-.. +.+.+-....+|++++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 46677778899999999999974 478889998764322 122223556799999999999999999887643
Q ss_pred -CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 579 -NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 579 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
...+|+|+.+|+. +|.-++.. ...+++..++.+++.++..||.|+| +..|+|||+||+|++|+.+|.+||+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence 3458999999985 88888864 3356889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDS----SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|+++.+.... ...+..+-|.+|++||.+.|. .|+++.|||+.||++.||.||.+-|++.+.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 9997654221 223445679999999988765 789999999999999999999999988765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=274.11 Aligned_cols=237 Identities=27% Similarity=0.429 Sum_probs=190.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----C----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----S----GKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++..+.+.+|+|.||.||+|... . ...||||..+..... ...+.+..|+++|+.+ +||||+.++|++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 444566679999999999999532 1 457999999877665 3458899999999999 6999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCc-----------cc--cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDV-----------EA--VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
..+..++|+||+..|+|.++++... .. ..++..+...++.||+.|++||+ ++++||||+.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhE
Confidence 9999999999999999999998654 01 23888999999999999999999 99999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCCc-eecc--cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccc-c
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSNR-TLVV--GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSS-L 719 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~-~ 719 (764)
++.++..+||+|||+|+......... .... -...|||||.+....|+.++||||+|+++||++| |..||.+... .
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~ 529 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE 529 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence 99999999999999999765443332 1112 2456999999999999999999999999999998 9999997441 1
Q ss_pred c----cccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 720 S----SSSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 720 ~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
+ .........+..-+.+.-++++.||..+
T Consensus 530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~ 562 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNAD 562 (609)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCC
Confidence 1 1122333333334667778889999655
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-31 Score=285.29 Aligned_cols=358 Identities=30% Similarity=0.353 Sum_probs=237.1
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
+++|+.|.++.|-+. .+|.+...+.+|++|.|.+|.+. ..|..+..+++|++||+++|+.. ..|..+..+..+..+.
T Consensus 67 l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~ 143 (1081)
T KOG0618|consen 67 LSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELA 143 (1081)
T ss_pred HHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHh
Confidence 346777888888776 67777777788888888887777 67777778888888888887776 3444444444333333
Q ss_pred cCCC-------------------cccccCCccCcCCCCCCEEEccCCcCcccCCccccCCC-------------------
Q 004268 98 LSNN-------------------ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT------------------- 139 (764)
Q Consensus 98 L~~n-------------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~------------------- 139 (764)
.++| .+.+..+.....+.. .|+|..|.+..+ .+.+++
T Consensus 144 ~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g 218 (1081)
T KOG0618|consen 144 ASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISG 218 (1081)
T ss_pred hhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecC
Confidence 3333 222222222222222 355555555421 222222
Q ss_pred -CcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeec
Q 004268 140 -NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL 218 (764)
Q Consensus 140 -~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L 218 (764)
+|+.|+.++|.+....+. .--.+|+++++++|+++.+. +.+..+.+|+.|...+|.+..+.. ....+++|+.|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~lp~-ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVALPL-RISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHhhHH-HHhhhhhHHHHHh
Confidence 333333333333311111 11135666666666666443 666666666666666666654332 3334555555555
Q ss_pred cCcccccccCccccCCCCCCEEEccCCcccCCCCc-----------------------CC--cCCCCCCeEEccCCcccC
Q 004268 219 NGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-----------------------TI--GNLTNLIALDLSSNQLSG 273 (764)
Q Consensus 219 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----------------------~~--~~l~~L~~L~L~~n~l~~ 273 (764)
..|.+. -+|.....+++|+.|+|..|+|...++. .+ ..++.|+.|++.+|.+++
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 555555 2333444455555555555555422211 11 124568999999999998
Q ss_pred CCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhccc
Q 004268 274 LLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGN 353 (764)
Q Consensus 274 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 353 (764)
.....+.++++|+.|+|++|++.......+.+++.|+.|+||+|+++ .+|..+..+..|+.|...+|+|. ..| .+..
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~ 450 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQ 450 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhh
Confidence 77778999999999999999998777778899999999999999999 78899999999999999999999 777 8999
Q ss_pred ccccceeecccccccCC-CCCCCCCCCccceecCCCCccc
Q 004268 354 LIFFRQLDLSRNFINGT-IPSQLGKIPNISAVDLSKNNLS 392 (764)
Q Consensus 354 l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~ 392 (764)
++.|+.+|+|.|+++.. +|....+ |+|++|||+||.-.
T Consensus 451 l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 451 LPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRL 489 (1081)
T ss_pred cCcceEEecccchhhhhhhhhhCCC-cccceeeccCCccc
Confidence 99999999999999754 3443333 89999999999843
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=238.69 Aligned_cols=239 Identities=19% Similarity=0.279 Sum_probs=191.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 578 (764)
....+++....+-+|.||.||+|.+. +.+.|.+|.++.... +-+...+..|.-++..+.|||+..+.+++.+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33456777788999999999999654 234567777655443 3345778899999999999999999998754
Q ss_pred -CCEEEEEEEecCCCCHHHHHh-----cCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCE
Q 004268 579 -NKCMFLIYEYMERGSLFCVLR-----NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 579 -~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~ 652 (764)
....+++++++.-|+|..+++ .......++..+...++.|++.|++||| ++||||.||.++|.+||+..+|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence 556889999999999999998 3333445777888999999999999999 9999999999999999999999
Q ss_pred EEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCC
Q 004268 653 FVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGR 725 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~ 725 (764)
||+|=.+++...+.+... ...-....||+||.+....|+.++|+|||||++|||+| |+.||.++++.++. ...
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 999999999876654432 11234668999999999999999999999999999998 99999999987654 334
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...++-.-|.+.-..+.-||...
T Consensus 516 RlaQP~NCPDeLf~vMacCWall 538 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALL 538 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcC
Confidence 55555555666666777776655
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-29 Score=225.08 Aligned_cols=191 Identities=23% Similarity=0.409 Sum_probs=165.0
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeC--CEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHN--KCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~ 582 (764)
.++|++.+++|+|.|++||.|. ..+.+.++||+++... .+.+.+|+.+++.++ ||||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4689999999999999999996 4578899999987543 378999999999996 99999999998775 457
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeecccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLAR 661 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~ 661 (764)
.+++||+.+.+...+.. .++...++.++.+++.||.|+| +.||.|||+||.|||||. .-..+|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 89999999887776654 3677888999999999999999 999999999999999994 5679999999999
Q ss_pred ccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCC
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPT 713 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf 713 (764)
++.+... ....+.+..|.-||.+... .|+..-|+||+||++..|++.+.||
T Consensus 182 FYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 182 FYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred hcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 8875443 4456778899999987655 5788999999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=255.21 Aligned_cols=252 Identities=17% Similarity=0.236 Sum_probs=177.1
Q ss_pred hhcCCcceeeeecCceeEEEEEE-----------------CCCCEEEEEEccCCCCCcHH-----------HHHHHHHHH
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-----------------SSGKLVALKKLHRSETEEPA-----------FLESFQTEA 558 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~ 558 (764)
.++|.+.++||+|+||+||+|.. ..++.||||.+......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999953 24568999998653321100 012234577
Q ss_pred HHHHhcCCCce-----eeEeeEEee--------CCEEEEEEEecCCCCHHHHHhcCcc---------------------c
Q 004268 559 RLLSQIRHRNI-----VKLYGFCLH--------NKCMFLIYEYMERGSLFCVLRNDVE---------------------A 604 (764)
Q Consensus 559 ~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~ 604 (764)
.++.+++|.++ +++++++.. .+..|+||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 667776643 3568999999999999998864211 1
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc-eeccccccccccc
Q 004268 605 VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLVVGTYGYIAPE 683 (764)
Q Consensus 605 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g~~~y~aPE 683 (764)
...++..++.++.|++.||.|+| +.+|+||||||+||+++.++.+||+|||++.......... ....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 23466778899999999999999 8999999999999999999999999999997654322111 1223478999999
Q ss_pred ccccCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCcccccccc----------------cC
Q 004268 684 LAYTMA--------------------V--TEKCDVYSFGVVALEVLMGSH-PTDLLSSLSSS----------------SG 724 (764)
Q Consensus 684 ~~~~~~--------------------~--~~~~DiwslG~il~~lltg~~-Pf~~~~~~~~~----------------~~ 724 (764)
.+.... + ..+.|+||+||++|+|++|.. ||......... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875432 1 124799999999999999986 77643221110 11
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccch-----hhHHHhhhcCCC
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNH-----RWENLLFKKFPY 761 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~p~ 761 (764)
.........+....+++++++..+. |+-...-...||
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 1222334567889999999998642 444444445554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-30 Score=253.23 Aligned_cols=386 Identities=21% Similarity=0.249 Sum_probs=267.9
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCC-
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN- 100 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~- 100 (764)
...+..+.+++ .+|..+-. ...+++|..|+|+.+.+.+|+.+++|+.||||+|.|+.+-|++|.++++|..|-+-+
T Consensus 49 ~~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred ceEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 45677777776 67777654 778899999999988889999999999999999999988899999999888877766
Q ss_pred CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC----
Q 004268 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS---- 176 (764)
Q Consensus 101 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~---- 176 (764)
|+|+.+..++|.+|..|+.|.+.-|++..+..++|..+++|..|.+.+|.+..+....|..+.+++.+++..|..-
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 8999888889999999999999999999888889999999999999999998777778999999999999988732
Q ss_pred --------CCCCCccccCCCccEEEecCccCcCCcccccCCc-cccc-eeeccCcccccccCccccCCCCCCEEEccCCc
Q 004268 177 --------GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM-KNLD-RLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246 (764)
Q Consensus 177 --------~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l-~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 246 (764)
...+..++...-..-..+.++++..+.+..|... ..+. .+....+....-+..+|+.+++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 1122223333333334445555555555544432 1221 22222223333344568888888888888888
Q ss_pred ccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccC----
Q 004268 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS---- 322 (764)
Q Consensus 247 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~---- 322 (764)
|+.+.+.+|.+...++.|.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+--.
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 8888888888888888888888888877777888888888888888888888888888888888888887765410
Q ss_pred -CChhh-----------hcccccceeeccccccccC---Cchhccc---------cccc-ceeecccccccCCCCCCCCC
Q 004268 323 -IPPEL-----------MNCSQLLNLVLSHNSLSGS---IPSEIGN---------LIFF-RQLDLSRNFINGTIPSQLGK 377 (764)
Q Consensus 323 -~~~~~-----------~~l~~L~~L~ls~N~l~~~---~~~~~~~---------l~~L-~~L~l~~N~l~~~~~~~~~~ 377 (764)
+.+++ ..-..++.+.++++.+... .|++... .+-+ ++...|++.+. .+|..+.
T Consensus 366 wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP- 443 (498)
T KOG4237|consen 366 WLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP- 443 (498)
T ss_pred HHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC-
Confidence 00111 1112456666766665421 1111111 1111 12222333333 2222211
Q ss_pred CCccceecCCCCccccccCCccccCccccccCCCCCC
Q 004268 378 IPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLEL 414 (764)
Q Consensus 378 l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~~~ 414 (764)
..-+++++.+|.++.+....+..+ .+++++|++..
T Consensus 444 -~d~telyl~gn~~~~vp~~~~~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 444 -VDVTELYLDGNAITSVPDELLRSL-LLDLSNNRISS 478 (498)
T ss_pred -chhHHHhcccchhcccCHHHHhhh-hcccccCceeh
Confidence 134567788888886665666666 77788887753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=235.63 Aligned_cols=200 Identities=31% Similarity=0.381 Sum_probs=166.2
Q ss_pred CcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----EEEE
Q 004268 511 HIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-----CMFL 584 (764)
Q Consensus 511 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~l 584 (764)
+-.+.||-|+||.||.+.+ ++|+.||+|++..... .-...+++.+|.+++..++|.|+...+++..-.. ..|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3456799999999999964 4899999999865432 2334578889999999999999999888765443 3678
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
++|.|.. +|..++- ....++.+.++-+.+||++||+||| +.+|.||||||.|.++.++-..||||||+++...
T Consensus 135 ~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence 8888864 7777765 4556888999999999999999999 9999999999999999999999999999998765
Q ss_pred CCC-CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 665 PDS-SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 665 ~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.+. ...+..+-|..|+|||++.|. .|+.+.||||+||++.|++.++.-|....+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 433 234445678999999999876 589999999999999999999998876554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=248.36 Aligned_cols=212 Identities=22% Similarity=0.260 Sum_probs=181.6
Q ss_pred cCHHHHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC------CCcee
Q 004268 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR------HRNIV 570 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv 570 (764)
+.+.-.+....+|.+....|+|-|++|.+|.+. .|..||||++...+.. .+.-.+|++++++|. --|++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 333344456789999999999999999999754 6889999999876544 356678999999995 24889
Q ss_pred eEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-
Q 004268 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN- 649 (764)
Q Consensus 571 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~- 649 (764)
+++..|...+++|+|+|.... +|.++++.......+....++.++.|+.-||..|- ..||+|.||||.||||.+.
T Consensus 498 rl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence 999999999999999998864 99999998877778999999999999999999999 8899999999999999854
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
..+||||||.|....... .+.+.-+..|.|||++.|.+|++..|+||+||++||++||+..|.+.+.-
T Consensus 574 ~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 567999999998765332 33345577899999999999999999999999999999999999987753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=235.72 Aligned_cols=221 Identities=31% Similarity=0.499 Sum_probs=182.1
Q ss_pred CceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHH
Q 004268 520 GYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVL 598 (764)
Q Consensus 520 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 598 (764)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|++++++++++......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999876 589999999976654432 478899999999999999999999999999999999999999999998
Q ss_pred hcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecccccc
Q 004268 599 RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG 678 (764)
Q Consensus 599 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 678 (764)
... ..+++..+..++.+++.++.+|| +.+++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 79 ~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKR---GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred Hhc---cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 743 22788999999999999999999 8899999999999999999999999999998765432 2334567889
Q ss_pred cccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCC---CcHHHHHHHhhhhccch
Q 004268 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPR---LDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 679 y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~~~l~~~~ 749 (764)
|+|||...+..++.++||||+|+++|++++|..||......... .......... ++..+.+++.+|+..++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCc
Confidence 99999998888999999999999999999999999763221111 1111111111 77889999999998663
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=231.48 Aligned_cols=201 Identities=30% Similarity=0.392 Sum_probs=172.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
..+|.-.+.+|.|.- .|..|.+. .+++||+|+....... ....++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 467888888999988 56666433 7999999998776433 334578889999999999999999999987554
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.+|+|||+|.. +|...+. .+++-..+..+..|++.|+.|+| +.||+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence 48999999974 8888876 34777889999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
|+..... -..+..+.+..|+|||++.+..+.+.+||||+||++.||++|+.-|.+.+..
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i 223 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI 223 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH
Confidence 9876544 3456678899999999999999999999999999999999999999877654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=229.81 Aligned_cols=199 Identities=38% Similarity=0.584 Sum_probs=172.4
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
|.+.+.||.|++|.||+|... +++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 567889999999999999876 4899999999765543 2357888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC-
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS- 667 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 667 (764)
+++++|.+++..... .+++..+..++.+++.++.++| +.+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999974321 1788999999999999999999 8899999999999999999999999999998765432
Q ss_pred CCceeccccccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 668 SNRTLVVGTYGYIAPELA-YTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
.......++..|++||.. ....++.++|+|++|+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334678889999998 666778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=254.12 Aligned_cols=237 Identities=26% Similarity=0.425 Sum_probs=202.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.....+|+|.||.||+|++. +++..|+|+++....++ ..-+++|+-+++.++||||+.+++.+......|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 467999999999999999999754 89999999998766554 36778999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||.+|+|++.-+ ..+++++.++..+++..+++++||| +.|-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999876 5667999999999999999999999 99999999999999999999999999999988876
Q ss_pred CCCCceeccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------CCcCCCCCCCc
Q 004268 666 DSSNRTLVVGTYGYIAPELA---YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------GRKISQNPRLD 734 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~ 734 (764)
.-.....+.||+.|||||+. ..+.|...+||||+|+...|+---++|--+..+..... --...+..+.+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 66666778999999999975 45678999999999999999998888866666533221 12233444557
Q ss_pred HHHHHHHhhhhccchhhH
Q 004268 735 LQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~ 752 (764)
+..++|+|.++.++..-|
T Consensus 245 ~~fh~fvK~altknpKkR 262 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKR 262 (829)
T ss_pred HHHHHHHHHHhcCCCccC
Confidence 788999999998885444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=257.60 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=142.5
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-C----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeE-----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-S----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF----- 575 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~----- 575 (764)
..++|.+.+.||+|+||.||+|.+. + +..||+|++...... +....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3578999999999999999999865 4 789999987643221 111111 1111122222222211
Q ss_pred -EeeCCEEEEEEEecCCCCHHHHHhcCccc-----------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEc
Q 004268 576 -CLHNKCMFLIYEYMERGSLFCVLRNDVEA-----------------VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHR 637 (764)
Q Consensus 576 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~ 637 (764)
.......++|+||+++++|.+++...... .......+..++.|++.||+||| ++||+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence 24556799999999999999988643110 01123446689999999999999 8999999
Q ss_pred CCCCCCeeecC-CCCEEEeeeccccccCCCC-CCceecccccccccccccccC----------------------CCCcc
Q 004268 638 DISSNNILLNS-NLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELAYTM----------------------AVTEK 693 (764)
Q Consensus 638 Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~ 693 (764)
||||+|||++. ++.+||+|||+|+...... .......+++.|+|||.+... .++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 6899999999998654322 223446789999999965322 23446
Q ss_pred chHHHHHHHHHHHHhCCCCCCc
Q 004268 694 CDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 694 ~DiwslG~il~~lltg~~Pf~~ 715 (764)
+||||+||++|||+++..|++.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch
Confidence 7999999999999998887653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-28 Score=227.80 Aligned_cols=200 Identities=24% Similarity=0.407 Sum_probs=163.5
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEee-EEeeCCE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYG-FCLHNKC 581 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~-~~~~~~~ 581 (764)
...+.|.+.+.+|+|.||.+-+|+++ +...+++|.+...... .+.|.+|...--.| .|.||+.-|+ .|+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 35678999999999999999999866 6778999998876654 47788888766566 4899998776 5778889
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCCCEEEeeecc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNLEAFVADFGL 659 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~ 659 (764)
+++++||++.|+|.+-+.. ..+.+....+++.|++.|+.|+| ++++||||||.+||+|- +...||+||||.
T Consensus 97 YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999999988753 34778888999999999999999 99999999999999994 445899999999
Q ss_pred ccccCCCCCCceecccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTM-----AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
++..+.... ....+..|.|||..... ...+.+|+|.||+++|..+||.+||+....
T Consensus 170 t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 170 TRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred ccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 976543222 23346679999976432 357789999999999999999999984443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-28 Score=256.64 Aligned_cols=229 Identities=27% Similarity=0.372 Sum_probs=179.5
Q ss_pred ceeeeecCce-eEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 513 KYCIGTGGYG-SVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 513 ~~~ig~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
.+.+|.|+.| .||+|... |+.||||.+.... .+..++|+..++.- +||||+++++.-.++.+.||+.|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3457899887 57889876 8999999886543 36778999999998 69999999999999999999999997
Q ss_pred CCCHHHHHhcCccccc-cCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---C--CCEEEeeeccccccC
Q 004268 591 RGSLFCVLRNDVEAVE-LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---N--LEAFVADFGLARLLH 664 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfg~~~~~~ 664 (764)
. +|.+++........ ......+.+..|++.||++|| +.+||||||||.||+|+. + ..++|+|||+++...
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999986311111 111445778999999999999 889999999999999975 3 468999999999886
Q ss_pred CCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccccccccCCcCCC----CCCCcHH
Q 004268 665 PDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSSSSGRKISQ----NPRLDLQ 736 (764)
Q Consensus 665 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~~~~~~~~~----~~~~~~~ 736 (764)
..... .....||.+|+|||++....-+.++||||+||++|+.++| .+||.+....+......... .+..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence 54332 3446799999999999998888899999999999999986 99999776643332222222 2222237
Q ss_pred HHHHHhhhhccchhhH
Q 004268 737 CNAYLKNFSQGNHRWE 752 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~~ 752 (764)
..++|.+|+..++..|
T Consensus 743 A~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLR 758 (903)
T ss_pred HHHHHHHhcCCCcccC
Confidence 8999999998874433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=234.02 Aligned_cols=132 Identities=25% Similarity=0.492 Sum_probs=112.1
Q ss_pred hcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-----C---CceeeEeeEEee
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-----H---RNIVKLYGFCLH 578 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~~~~~~~~ 578 (764)
.+|.+.++||-|.|++||+|. .+..+.||+|+.+... .+.+....|++++++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 799999999999999999996 4578899999987543 34577889999999994 2 479999999975
Q ss_pred ----CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 579 ----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 579 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
+.++++|+|+. |.+|..++... ....++...+++|++||+.||.|||..| ||||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45799999999 45787887654 3445899999999999999999999876 999999999999983
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=264.82 Aligned_cols=341 Identities=24% Similarity=0.279 Sum_probs=200.1
Q ss_pred cccccccccCCCeeEEEeCCCC------ccccCCccccCCC-CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcc
Q 004268 9 ELSQLNFTCFPNLVTFRIWGTL------LSGRMPSEIGALS-KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG 81 (764)
Q Consensus 9 ~~~~~~~~~~~~l~~L~l~~~~------~~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~ 81 (764)
.++...|.++++|+.|.+..+. +...+|..+..++ +|+.|++.++.++ ..|..| ...+|+.|+|++|++.
T Consensus 548 ~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~- 624 (1153)
T PLN03210 548 HIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE- 624 (1153)
T ss_pred eecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-
Confidence 4556667888888888876543 3334566666653 5888888888776 456566 3577888888888877
Q ss_pred cCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccC
Q 004268 82 TIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161 (764)
Q Consensus 82 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 161 (764)
.++..+..+++|++|+|++|......| .+..+++|++|+|++|......|..+.++++|+.|++++|..-...|..+ +
T Consensus 625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~ 702 (1153)
T PLN03210 625 KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-N 702 (1153)
T ss_pred ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-C
Confidence 466667778888888887765332444 36777888888888776544566777778888888888764322344433 6
Q ss_pred CCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccc-------ccCccccCC
Q 004268 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG-------SIPSTIGYL 234 (764)
Q Consensus 162 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-------~~~~~~~~l 234 (764)
+++|+.|++++|......+. ...+|+.|++++|.+..++.. + .+++|++|++.++.... ..+..+...
T Consensus 703 l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~lP~~-~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 703 LKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEEFPSN-L-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred CCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCcccccccc-c-cccccccccccccchhhccccccccchhhhhcc
Confidence 77788888877754322222 235677777777777654332 1 45666666666533211 111112223
Q ss_pred CCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEc
Q 004268 235 NLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314 (764)
Q Consensus 235 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 314 (764)
++|+.|+|++|.....+|..++++++|+.|+|++|..-+..|... ++++|+.|++++|......|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 456666666655444555556666666666666553222333333 4555666666655433232221 245555556
Q ss_pred cCCcCccCCChhhhcccccceeecccc-ccccCCchhcccccccceeecccc
Q 004268 315 GYNRLSSSIPPELMNCSQLLNLVLSHN-SLSGSIPSEIGNLIFFRQLDLSRN 365 (764)
Q Consensus 315 s~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~l~~N 365 (764)
++|.++ .+|..+..+++|+.|+|++| +++ .+|..+..+++|+.|++++|
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 555555 44555555555555555553 333 34444555555555555555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=260.36 Aligned_cols=342 Identities=22% Similarity=0.259 Sum_probs=259.0
Q ss_pred cCCccccCCCCCcEEEcCCCcC------cccCCccccCC-CCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCccccc
Q 004268 34 RMPSEIGALSKLEKLVLSHNSL------TGRIPSEIGAL-SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGS 106 (764)
Q Consensus 34 ~~~~~~~~l~~L~~L~Ls~n~i------~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 106 (764)
..+.+|..+++|+.|.+.++.. ....|..|..+ .+|+.|++.++.++ .+|..| ...+|++|+|++|.+. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 4456788999999999976643 23456667665 46999999999988 567777 4689999999999998 4
Q ss_pred CCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccC
Q 004268 107 IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL 186 (764)
Q Consensus 107 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 186 (764)
.+..+..+++|+.|+|++|......| .+..+++|++|+|++|......|..+.++++|+.|++++|..-...|..+ .+
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 56677889999999999875433344 47889999999999987555678889999999999999874332344333 78
Q ss_pred CCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCccc-------CCCCcCCcCCC
Q 004268 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD-------GPIPPTIGNLT 259 (764)
Q Consensus 187 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~ 259 (764)
++|+.|++++|......+. ..++|++|++++|.+.. .|..+ .+++|+.|++.++... ...+..+...+
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~ 778 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP 778 (1153)
T ss_pred CCCCEEeCCCCCCcccccc---ccCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence 8999999999864332222 24688999999999874 44443 5788888888774432 11222233457
Q ss_pred CCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecc
Q 004268 260 NLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLS 339 (764)
Q Consensus 260 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls 339 (764)
+|+.|+|++|......|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|......|.. ..+|++|+|+
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 89999999998776788889999999999999986555666655 6889999999998654455542 3578999999
Q ss_pred ccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCc
Q 004268 340 HNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390 (764)
Q Consensus 340 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 390 (764)
+|.++ .+|..+..+++|+.|+|++|+--..+|.....+++|+.++++++.
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 99998 678889999999999999854333577778888999999988774
|
syringae 6; Provisional |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=213.19 Aligned_cols=243 Identities=20% Similarity=0.304 Sum_probs=205.1
Q ss_pred hhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.-.|++.++||+|+||.++.|. .-+++.||||.-...... .++..|.+.++.| ..++|+.+|-+...+.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 4579999999999999999996 557999999987654433 5678899999999 57999999988888888899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-----CCEEEeeecc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-----LEAFVADFGL 659 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg~ 659 (764)
|+|.. |.+|+++..- -...++..++..+|.|++.-++|+| ++..|.|||||+|+||... ..+.++|||+
T Consensus 102 VidLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 99988 5688888763 2346899999999999999999999 9999999999999999743 4578999999
Q ss_pred ccccCCCCCCc-------eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCC
Q 004268 660 ARLLHPDSSNR-------TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKIS 728 (764)
Q Consensus 660 ~~~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~ 728 (764)
|+.+.++.... ....||.+||+-....|.+.+.+.|+=|+|.++++++-|..||.++...... ......
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 99886554322 2357999999999999999999999999999999999999999998764322 223444
Q ss_pred CCCCCcHHHHHHHhhhhccchhhHHHhhhcCC
Q 004268 729 QNPRLDLQCNAYLKNFSQGNHRWENLLFKKFP 760 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~p 760 (764)
+...+...|..++.++.++.++.|++.|.+.|
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 56667889999999999999999999999888
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=205.48 Aligned_cols=244 Identities=18% Similarity=0.302 Sum_probs=199.1
Q ss_pred HhhcCCcceeeeecCceeEEEEE-ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-CceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 583 (764)
..+.|++++.||+|+||.+|.|. ..+|..||||+-...... .++..|.++++.+++ ..|+.+..++.+..+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 45789999999999999999996 668999999987665543 567789999999964 78888889999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~ 660 (764)
+||+.. |.+|++...- -...++..++...+-|++.-++|+| .+++|||||||+|++.. ....+.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccch
Confidence 999988 5688888753 2335888999999999999999999 99999999999999996 3457889999999
Q ss_pred cccCCCCCC-------ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc----CCC
Q 004268 661 RLLHPDSSN-------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK----ISQ 729 (764)
Q Consensus 661 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~----~~~ 729 (764)
+.+.+.... .....||.+|.+-....+.+.+.+.|+-|+|.++.++--|..||+++.......+.+ ...
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 987543322 223578999999998888888999999999999999999999999988754433322 223
Q ss_pred CCCCcHHHHHHHhhhhccchhhHHHhhhcCC
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRWENLLFKKFP 760 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~p 760 (764)
...+...|..++.++.....+.|.+-|.+.|
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 3444567788888887777777777777776
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=207.30 Aligned_cols=184 Identities=39% Similarity=0.656 Sum_probs=160.2
Q ss_pred eeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCH
Q 004268 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSL 594 (764)
Q Consensus 516 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 594 (764)
||+|++|.||++... +++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999865 48999999998665432 246788999999999999999999999999999999999999999
Q ss_pred HHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeeccccccCCCCCCceec
Q 004268 595 FCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNRTLV 673 (764)
Q Consensus 595 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 673 (764)
.+++.... ..+++..+..++.++++++++|| ++|++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99987431 45888999999999999999999 889999999999999999 8999999999998765443223335
Q ss_pred ccccccccccccccC-CCCccchHHHHHHHHHHH
Q 004268 674 VGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEV 706 (764)
Q Consensus 674 ~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l 706 (764)
.+...|++||..... .++.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 678899999998877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=220.46 Aligned_cols=198 Identities=29% Similarity=0.441 Sum_probs=166.9
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
+....+.|..+++||.|.|++||+|... ..+.||+|.+...... .++..|++++..+ .+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3345678999999999999999999532 4778999999776654 6788999999999 5899999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEee
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVAD 656 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 656 (764)
.++...+|+||++.....++.. .++...+..+++.++.||+++| ..|||||||||.|++.+ ..+.-.|+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence 9999999999999998888876 3667889999999999999999 99999999999999998 456788999
Q ss_pred eccccccCC----------------C--CC----------------C----------ceecccccccccccccccCC-CC
Q 004268 657 FGLARLLHP----------------D--SS----------------N----------RTLVVGTYGYIAPELAYTMA-VT 691 (764)
Q Consensus 657 fg~~~~~~~----------------~--~~----------------~----------~~~~~g~~~y~aPE~~~~~~-~~ 691 (764)
||+|...+. . +. . .....||++|+|||++...+ .+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 999872210 0 00 0 01146999999999987664 57
Q ss_pred ccchHHHHHHHHHHHHhCCCCCC
Q 004268 692 EKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 692 ~~~DiwslG~il~~lltg~~Pf~ 714 (764)
++.||||.||++..++++++||-
T Consensus 257 taiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred Cccceeeccceeehhhccccccc
Confidence 89999999999999999999984
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=236.27 Aligned_cols=264 Identities=27% Similarity=0.300 Sum_probs=130.4
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
.-..|+|+.|.++ .+|..+. ++|+.|++++|+++. +|. .+++|++|+|++|+|+.+ |.. .++|+.|+|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 3445666666665 3444443 256666666666652 332 134555666666655533 221 2455555555
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCc
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~ 203 (764)
+|.+..++ .. ..+|+.|+|++|+++.++ . ..++|+.|+|++|+++.+.. .
T Consensus 271 ~N~L~~Lp-~l---p~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~L~~Lp~-l--------------------- 320 (788)
T PRK15387 271 SNPLTHLP-AL---PSGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQLASLPA-L--------------------- 320 (788)
T ss_pred CCchhhhh-hc---hhhcCEEECcCCcccccc-c---cccccceeECCCCccccCCC-C---------------------
Confidence 55555432 11 134555555555555332 1 12445555555555543211 1
Q ss_pred ccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCC
Q 004268 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283 (764)
Q Consensus 204 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 283 (764)
..+|+.|++++|+++++ |. ...+|+.|+|++|+|+. +|.. ..+|+.|++++|+|..+ |.. ..
T Consensus 321 ------p~~L~~L~Ls~N~L~~L-P~---lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~ 382 (788)
T PRK15387 321 ------PSELCKLWAYNNQLTSL-PT---LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL---PS 382 (788)
T ss_pred ------cccccccccccCccccc-cc---cccccceEecCCCccCC-CCCC---CcccceehhhccccccC-ccc---cc
Confidence 12334444444444421 11 11245555555555553 2221 13455555555555532 221 23
Q ss_pred CCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecc
Q 004268 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLS 363 (764)
Q Consensus 284 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~ 363 (764)
+|+.|++++|++.. +|.. .++|+.|++++|+|+. +|.. ..+|+.|++++|+|+ .+|..+.++.+|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 45666666666653 2221 2456666666666663 3432 234566666676666 556666666666777777
Q ss_pred cccccCCCCCCC
Q 004268 364 RNFINGTIPSQL 375 (764)
Q Consensus 364 ~N~l~~~~~~~~ 375 (764)
+|++++..+..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 777665554443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=237.99 Aligned_cols=267 Identities=27% Similarity=0.284 Sum_probs=188.0
Q ss_pred CCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecc
Q 004268 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD 171 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 171 (764)
+-..|+|++|.++. .|..+. ++|+.|++.+|+++.++. .+++|++|+|++|+|+.+ |.. .++|+.|+++
T Consensus 202 ~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 202 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 34455666666653 333333 256666666666664422 135666666666666644 221 2466677777
Q ss_pred cCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC
Q 004268 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251 (764)
Q Consensus 172 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 251 (764)
+|.++.+.. -..+|+.|++++|+++.++. .+++|+.|++++|+++++ |.. ..+|+.|++++|.++. +
T Consensus 271 ~N~L~~Lp~----lp~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchhhhhh----chhhcCEEECcCCccccccc----cccccceeECCCCccccC-CCC---cccccccccccCcccc-c
Confidence 776664321 12456677777777775543 246799999999999864 332 3468899999999985 3
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccc
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 331 (764)
|. + ..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|.. +|.. +.+|+.|+|++|+|+. +|.. .+
T Consensus 338 P~-l--p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s 402 (788)
T PRK15387 338 PT-L--PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PS 402 (788)
T ss_pred cc-c--ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---cc
Confidence 43 2 25899999999999964 332 3578899999999985 4543 3689999999999994 5543 36
Q ss_pred ccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccC
Q 004268 332 QLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRI 402 (764)
Q Consensus 332 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~ 402 (764)
+|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+..+
T Consensus 403 ~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 403 ELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred CCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 8999999999999 466543 46889999999998 778889999999999999999998887766443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=213.77 Aligned_cols=167 Identities=21% Similarity=0.223 Sum_probs=130.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC--CCCEEEEEEccCCCC--CcHHHHHHHHHHHHHHHhcCCCceee-EeeEEeeC
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS--SGKLVALKKLHRSET--EEPAFLESFQTEARLLSQIRHRNIVK-LYGFCLHN 579 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~ 579 (764)
....+|.+.+.||+|+||+||+|+++ +++.||||++..... ......+.+.+|++++++++|+++++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34688999999999999999999764 577789998753321 12334567999999999999999985 4432
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCCeeecCCCCEEEeeec
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI-SSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg 658 (764)
+..|+||||++|++|... . .. . ...++.|+++||+|+| ++||+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---cc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 1 11 1 1467899999999999 999999999 9999999999999999999
Q ss_pred cccccCCCCCC--------ceecccccccccccccccC
Q 004268 659 LARLLHPDSSN--------RTLVVGTYGYIAPELAYTM 688 (764)
Q Consensus 659 ~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~ 688 (764)
+|+........ .....++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99876543211 1235678889999987644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=217.75 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=168.0
Q ss_pred cCCcceeeeecCceeEEEEEECCC--CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC----CceeeEeeEE-eeCCE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSG--KLVALKKLHRSETEEPAFLESFQTEARLLSQIRH----RNIVKLYGFC-LHNKC 581 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~ 581 (764)
+|.+.+.||+|+||.||.|..... ..+|+|.......... ..+..|..++..+.. ++++++++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 899999999999999999986543 4788888766433321 257788888888862 6999999999 57888
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-----CCEEEee
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-----LEAFVAD 656 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~D 656 (764)
.|+||+.+ |.+|.++..... ...++..++..++.|++.+|+++| +.|++||||||+|+++... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99999988 669999886553 567999999999999999999999 9999999999999999854 4689999
Q ss_pred ecccc--ccCCCC--------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 657 FGLAR--LLHPDS--------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 657 fg~~~--~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
||+++ .+.... .......||..|+++.+..+.+.+.+.|+||++.++.++..|..||.....
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99998 322111 112235699999999999999999999999999999999999999977664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=192.56 Aligned_cols=193 Identities=14% Similarity=0.184 Sum_probs=149.2
Q ss_pred CccccccCCCccCHHHHHH--HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHH------HHHHH
Q 004268 487 NEFSIWNYDGRITFEEMIE--ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLES------FQTEA 558 (764)
Q Consensus 487 ~~~~~~~~~~~~~~~~~~~--~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~ 558 (764)
.++.++-++....|.++.+ ..++|++.+.+|.|+||.||.+.. +++.+|+|.+.......+..... +.+|+
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea 86 (232)
T PRK10359 8 KGYTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLI 86 (232)
T ss_pred cceEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHH
Confidence 3455666666766766543 367899999999999999999866 57789999998776665554444 57999
Q ss_pred HHHHhcCCCceeeEeeEEeeC--------CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC
Q 004268 559 RLLSQIRHRNIVKLYGFCLHN--------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630 (764)
Q Consensus 559 ~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 630 (764)
+.+.++.||+|+.+.+++... +..+++|||++|.+|.++.. .+. ....+++.++..+|
T Consensus 87 ~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH--- 152 (232)
T PRK10359 87 VQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH--- 152 (232)
T ss_pred HHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---
Confidence 999999999999999886643 35889999999999987742 222 24669999999999
Q ss_pred CCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHH
Q 004268 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL 707 (764)
Q Consensus 631 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 707 (764)
+.|++|||++|+||+++++| ++++|||.......... . ........++.++|+||+|+++..+.
T Consensus 153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a-~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA-K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh-H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999999999999988 99999998865422111 0 11334445677899999999887653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=235.06 Aligned_cols=178 Identities=17% Similarity=0.173 Sum_probs=124.7
Q ss_pred cCC-CceeeEeeEE-------eeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 004268 564 IRH-RNIVKLYGFC-------LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635 (764)
Q Consensus 564 l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 635 (764)
++| +||.++++++ .....++.++|++ +++|.+++... ...+++.++..++.||++||+||| ++||+
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 345 5777777776 2334577888987 45999999642 345899999999999999999999 99999
Q ss_pred EcCCCCCCeeecCCC-------------------CEEEeeeccccccCCCC----------------CCceecccccccc
Q 004268 636 HRDISSNNILLNSNL-------------------EAFVADFGLARLLHPDS----------------SNRTLVVGTYGYI 680 (764)
Q Consensus 636 H~Dlkp~NIll~~~~-------------------~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~y~ 680 (764)
||||||+|||++..+ .+|++|||+++...... .......||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 45555666554321100 0011135788899
Q ss_pred cccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCC---CcHHHHHHHhhhhccc
Q 004268 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPR---LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 681 aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~ 748 (764)
|||++.+..++.++|||||||++|||++|.+|+.............. .++. -.....+++..|++.+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV-LPPQILLNWPKEASFCLWLLHPE 252 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999999875432111111111 1111 1234556777777766
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=217.77 Aligned_cols=223 Identities=26% Similarity=0.348 Sum_probs=111.6
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
+...|+++++.++ .+|..+. ++|+.|+|++|.|+.+. ..+. ++|++|++++|+++.++ ..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP-~~l~--~nL~~L~Ls~N~LtsLP-~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLP-ENLQ--GNIKTLYANSNQLTSIP-ATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCC-hhhc--cCCCEEECCCCccccCC-hhhh--ccccEEECc
Confidence 4566777777766 3454443 46677777777776433 3222 36777777777766543 2222 356677777
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 227 (764)
+|++..+ |..+. .+|+.|++++|+++.+ |..+. ++|+.|++++|+++.++... .++|+.|++++|.++.+
T Consensus 250 ~N~L~~L-P~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~~l---p~sL~~L~Ls~N~Lt~L- 319 (754)
T PRK15370 250 INRITEL-PERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTLPAHL---PSGITHLNVQSNSLTAL- 319 (754)
T ss_pred CCccCcC-ChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccCcccc---hhhHHHHHhcCCccccC-
Confidence 7776633 33332 3566666666666643 22221 35666666666665443211 13455555666555532
Q ss_pred CccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCC
Q 004268 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307 (764)
Q Consensus 228 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 307 (764)
|..+ .++|+.|++++|.++. +|..+. ++|+.|+|++|+++. .|..+. ++|+.|++++|++..+ |..+. .
T Consensus 320 P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~--~ 388 (754)
T PRK15370 320 PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNL-PENLP--A 388 (754)
T ss_pred Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCC-CHhHH--H
Confidence 2211 1345555555555553 233222 355555555555542 222221 3445555555544422 22221 2
Q ss_pred ccceEEccCCcCc
Q 004268 308 NLTYLNLGYNRLS 320 (764)
Q Consensus 308 ~L~~L~ls~N~l~ 320 (764)
.|+.|++++|+++
T Consensus 389 sL~~LdLs~N~L~ 401 (754)
T PRK15370 389 ALQIMQASRNNLV 401 (754)
T ss_pred HHHHHhhccCCcc
Confidence 3444455555444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=183.47 Aligned_cols=143 Identities=20% Similarity=0.209 Sum_probs=109.7
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHH-----------------------HHHHHHHHHHHHHhcCCCce
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPA-----------------------FLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hpni 569 (764)
.+.||+|++|.||+|...+|+.||+|++......... .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999999764321100 01233459999999987776
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcCCCCCCeeecC
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL-HYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~Dlkp~NIll~~ 648 (764)
.....+... ..++||||++++++..... ....++...+..++.|++.+|.++ | +.||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence 443332222 2389999999887765432 223578899999999999999999 7 78999999999999998
Q ss_pred CCCEEEeeeccccccC
Q 004268 649 NLEAFVADFGLARLLH 664 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~ 664 (764)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-21 Score=217.11 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=152.7
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
+...|+++++.++. +|..+. +.|+.|+|++|+|+. +|..+. .+|++|+|++|.++.+ |..+. ++|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEECc
Confidence 35566666666663 444333 356666666666663 444333 4666777776666633 33332 356677777
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCc
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~ 203 (764)
+|.+..+ |..+. ++|+.|+|++|+++.+ |..+. ++|+.|++++|+++.+.. .+ .++|+.|++++|++..++
T Consensus 250 ~N~L~~L-P~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~-~l--p~sL~~L~Ls~N~Lt~LP 320 (754)
T PRK15370 250 INRITEL-PERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTLPA-HL--PSGITHLNVQSNSLTALP 320 (754)
T ss_pred CCccCcC-ChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccCcc-cc--hhhHHHHHhcCCccccCC
Confidence 7776644 33332 3567777777777643 33332 467777777777764332 22 135777777777777544
Q ss_pred ccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCC
Q 004268 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283 (764)
Q Consensus 204 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 283 (764)
... .++|+.|++++|.++. +|..+ .++|+.|++++|+++ .+|..+. ++|+.|+|++|.+..+ |..+. .
T Consensus 321 ~~l---~~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~--~ 388 (754)
T PRK15370 321 ETL---PPGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNL-PENLP--A 388 (754)
T ss_pred ccc---cccceeccccCCcccc-CChhh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCC-CHhHH--H
Confidence 322 2578888888888875 34433 268888999998888 4555443 6899999999998854 43443 3
Q ss_pred CCCeEeccCccccCCCCCC----CCCCCccceEEccCCcCc
Q 004268 284 YLASLSLNGNILIGPIPPT----IGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 284 ~L~~L~l~~n~l~~~~~~~----~~~l~~L~~L~ls~N~l~ 320 (764)
+|+.|++++|++.. +|.. ...++++..|+|.+|.++
T Consensus 389 sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 389 ALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred HHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence 68889999999874 3433 233466777777777776
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-20 Score=196.36 Aligned_cols=203 Identities=35% Similarity=0.548 Sum_probs=174.7
Q ss_pred CCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCC-ceeeEeeEEeeCCEEEEEEEe
Q 004268 510 FHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR-NIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 588 (764)
|.+.+.+|.|+||.||++... ..+++|.+.............+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778889999999999999876 88999999877766544568899999999999988 799999999888888999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeeccccccCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLARLLHPDS 667 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~ 667 (764)
+.++++.+++........+.......++.|++.++.|+| +.|++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977763221125888999999999999999999 89999999999999999888 79999999998654333
Q ss_pred C------Cceeccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 668 S------NRTLVVGTYGYIAPELAYT---MAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 668 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2355789999999999987 578889999999999999999999987665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=219.00 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=162.2
Q ss_pred cceeeeecCceeEEEEEEC-CCCEEEEEEccC---CCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLS-SGKLVALKKLHR---SETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
....+|.|++|.|+.+... ..+..+.|.+.. .......+...+..|+-+-..+.|||++.....+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3567899999988877533 344455554431 222333344447788888889999999888887777776666699
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
||++ +|...+.+. ..+...++..++.|+..|++|+| +.||.|||+|++|++++.+|.+||+|||.+....-+.
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 999999743 45777888899999999999999 9999999999999999999999999999998765433
Q ss_pred C----CceecccccccccccccccCCCCc-cchHHHHHHHHHHHHhCCCCCCccccccc
Q 004268 668 S----NRTLVVGTYGYIAPELAYTMAVTE-KCDVYSFGVVALEVLMGSHPTDLLSSLSS 721 (764)
Q Consensus 668 ~----~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~~lltg~~Pf~~~~~~~~ 721 (764)
. .....+|+..|+|||++.+.+|++ ..||||.|++++.|.+|+.||......+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 3 234578999999999999999976 58999999999999999999986655433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=173.48 Aligned_cols=188 Identities=13% Similarity=0.090 Sum_probs=140.6
Q ss_pred CcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-HHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEEEEe
Q 004268 511 HIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-AFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 511 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
.+...+++|+||+||.+.. .+.+++.+.+........ .+...+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998866 578888777765443221 11235889999999995 5889999886 346899999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC-CCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI-SSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
+.|.+|...... ....++.|++.+++++| ++||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654321 11347889999999999 999999999 7999999999999999999998654433
Q ss_pred CC-----c--------eecccccccccccccccC-CCC-ccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 668 SN-----R--------TLVVGTYGYIAPELAYTM-AVT-EKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 668 ~~-----~--------~~~~g~~~y~aPE~~~~~-~~~-~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
.. . .....++.|++|+...-. ..+ .+.+.++.|.-+|.++||..|+-+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 21 0 012356777778754322 233 5678899999999999999986533
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-22 Score=206.92 Aligned_cols=223 Identities=26% Similarity=0.384 Sum_probs=184.3
Q ss_pred eeecCceeEEEEE----ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEEEEecC
Q 004268 516 IGTGGYGSVYRAQ----LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 516 ig~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
+|.|+||.|+.++ ...|.-+|+|+..+........ .....|..++..++ ||.++++.-.++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6899999999874 3357788998887655443222 25567888888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 670 (764)
+|.+...+. ....+.+.....+...++-|++++| +.|++|||+|++||+++.+|++++.|||.++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999988876 3445677788889999999999999 99999999999999999999999999999987643322
Q ss_pred eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 671 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.+||..|||||++. ....++|.||+|+++++|+||..||.. +....+.+.....+..++...+.++..+..++..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRILKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 28999999999988 567889999999999999999999997 3334444556666777888889999888888866
Q ss_pred hH
Q 004268 751 WE 752 (764)
Q Consensus 751 ~~ 752 (764)
||
T Consensus 228 nr 229 (612)
T KOG0603|consen 228 NR 229 (612)
T ss_pred HH
Confidence 65
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=176.14 Aligned_cols=142 Identities=22% Similarity=0.290 Sum_probs=111.6
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-----------------------HHHHHHHHHHHHHHhcCCCce
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-----------------------AFLESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~hpni 569 (764)
.+.||+|++|.||+|...+|+.||+|++........ ........|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999877899999999886532110 012234689999999999987
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHHH-HhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeec
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFCV-LRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLN 647 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~ 647 (764)
.....+.... .++||||++|+++... +. ...++...+..++.|++.++.++| + +||+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE
Confidence 5444433332 4899999998855433 32 234677889999999999999999 7 8999999999999998
Q ss_pred CCCCEEEeeeccccccC
Q 004268 648 SNLEAFVADFGLARLLH 664 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~ 664 (764)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-21 Score=176.54 Aligned_cols=231 Identities=20% Similarity=0.327 Sum_probs=182.4
Q ss_pred cCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
...+.-+|.....|+.|+|+++ |..+++|++...... .+....|..|.-.++-+.||||..+++.|.......++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3445556888999999999998 667777777554433 22346788888899999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe--eeccccccCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA--DFGLARLLHPD 666 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~--Dfg~~~~~~~~ 666 (764)
|+.|+|...+++. .....+..++.+++.++++|++|||+. +.=|----+....|+||++.+.+|. |--++..
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999865 445578889999999999999999965 3344445789999999999887763 3322211
Q ss_pred CCCceecccccccccccccccCCCC---ccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcCCCCCCCcHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVT---EKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKISQNPRLDLQCN 738 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~~ 738 (764)
.....-+|.|++||.++..+-+ .++|+|||++++||+.|+..||.+.++.+-.. ......+|.++...+
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 1123457899999999877654 47999999999999999999999998865433 345566888999999
Q ss_pred HHHhhhhccchh
Q 004268 739 AYLKNFSQGNHR 750 (764)
Q Consensus 739 ~~~~~~l~~~~~ 750 (764)
.+++-|+..++-
T Consensus 420 klm~icmnedpg 431 (448)
T KOG0195|consen 420 KLMNICMNEDPG 431 (448)
T ss_pred HHHHHHhcCCCC
Confidence 999999987643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=182.77 Aligned_cols=234 Identities=18% Similarity=0.237 Sum_probs=152.2
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC----------CceeeEeeEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH----------RNIVKLYGFC 576 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv~~~~~~ 576 (764)
..+...+.||.|+++.||.+.+. +++.+|+|++...........+.+++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34556778999999999999876 689999999877665555556777777755544322 1222222221
Q ss_pred ---------eeC---CE-----EEEEEEecCCCCHHHHHhc---Cc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 004268 577 ---------LHN---KC-----MFLIYEYMERGSLFCVLRN---DV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635 (764)
Q Consensus 577 ---------~~~---~~-----~~lv~e~~~~~~L~~~l~~---~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 635 (764)
... .. .+++|+-+. ++|.+++.. .. ............+..|+++.+++|| +.|++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence 111 12 367888885 588877642 11 1112333344566789999999999 99999
Q ss_pred EcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccccccccccccc--------CCCCccchHHHHHHHHHHHH
Q 004268 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT--------MAVTEKCDVYSFGVVALEVL 707 (764)
Q Consensus 636 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll 707 (764)
|+||+|+|++++.+|.++|+||+.....+... .....+..|.|||.... ..++.+.|.|++|+++|.+.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999999887654221 11344578999997643 24688999999999999999
Q ss_pred hCCCCCCccccccccc-CCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 708 MGSHPTDLLSSLSSSS-GRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 708 tg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
+|..||+......... ....+. .+|...+.+|+.+++.+++
T Consensus 245 C~~lPf~~~~~~~~~~~~f~~C~--~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEWDFSRCR--DMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HSS-STCCCGGGSTSGGGGTTSS-----HHHHHHHHHHT-SSGG
T ss_pred HccCCCCCCCccccccccchhcC--CcCHHHHHHHHHHccCCcc
Confidence 9999999776543332 222222 8899999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=178.67 Aligned_cols=139 Identities=22% Similarity=0.187 Sum_probs=107.9
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
|+|.++++.. ...+++..++.++.|++.||+||| +++ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888998742 345899999999999999999999 666 999999999999999 99987664322
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----CcCC-------CCCCCcH--HHH
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG----RKIS-------QNPRLDL--QCN 738 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~----~~~~-------~~~~~~~--~~~ 738 (764)
..|++.|+|||++.+..++.++||||+||++|||+||+.||........... .... ....++. .+.
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 2578999999999999999999999999999999999999976543221110 0000 0111222 578
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
++++.|++.+
T Consensus 143 ~~i~~cl~~~ 152 (176)
T smart00750 143 DFMRVCASRL 152 (176)
T ss_pred HHHHHHHhcc
Confidence 8888888776
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=202.62 Aligned_cols=228 Identities=24% Similarity=0.285 Sum_probs=175.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC---CCceeeEeeEEeeCCE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR---HRNIVKLYGFCLHNKC 581 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~ 581 (764)
.-.+.|.|.+.+|+|+||+||+|...+|+.||+|+-+.....+-.... +++.+|+ -+.|..+..++...+.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCCc
Confidence 345789999999999999999998777999999998776665422222 2333333 2455666666667777
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-------CCCCEEE
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-------SNLEAFV 654 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl 654 (764)
-++|+||.+.|+|.+++. ....+++.-+..+..|++..++.|| ..+||||||||+|.|+. +.--++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999997 4556889999999999999999999 89999999999999995 2345899
Q ss_pred eeeccccccC--CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCC
Q 004268 655 ADFGLARLLH--PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPR 732 (764)
Q Consensus 655 ~Dfg~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~ 732 (764)
+|||.+..+. +++......++|-.+-.+|+..|..+++++|.|.++.+++-|++|++-= .............++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----~~~g~~~~~~~~~~R 918 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----VKNGSSWMVKTNFPR 918 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----hcCCcceeccccchh
Confidence 9999998775 3333455678899999999999999999999999999999999998753 111111111111223
Q ss_pred C--cHHHHHHHhhhhccc
Q 004268 733 L--DLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~--~~~~~~~~~~~l~~~ 748 (764)
. ...|.++...+|..+
T Consensus 919 y~~~~~W~~~F~~lLN~~ 936 (974)
T KOG1166|consen 919 YWKRDMWNKFFDLLLNPD 936 (974)
T ss_pred hhhHHHHHHHHHHHhCcC
Confidence 2 347788888887744
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-21 Score=200.47 Aligned_cols=277 Identities=26% Similarity=0.286 Sum_probs=136.8
Q ss_pred EEecCCCcccc-cCCccCcCCCCCCEEEccCCcCccc----CCccccCCCCcCEEecccCcccc------cCCccccCCC
Q 004268 95 DLNLSNNILNG-SIPLEFGNLKDLDQLRLQGNKLDGL----IPSSIGNLTNLTYLDLSLNQLSG------RLPQEVGNLK 163 (764)
Q Consensus 95 ~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~ 163 (764)
.|+|.++.+++ .....|..+.+|+.|++++|.++.. .+..+...++|++|+++++.+.. ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 46677777762 2334456667788888888877432 23345556667777777776652 1223455566
Q ss_pred CCCeeecccCCCCCCCCCccccCCC---ccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCC-CCCCE
Q 004268 164 NLKSLFLDNNHLSGPIPSTLYHLNQ---LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYL-NLLDE 239 (764)
Q Consensus 164 ~L~~L~L~~n~i~~~~~~~~~~l~~---L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~ 239 (764)
+|+.|++++|.+....+..+..+.+ |++|++++|.+...... .....+..+ ++|++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~--------------------~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR--------------------LLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH--------------------HHHHHHHhCCCCceE
Confidence 6666666666665333333333333 55555555554421111 111122223 44444
Q ss_pred EEccCCcccCC----CCcCCcCCCCCCeEEccCCcccCC----CCccccCCCCCCeEeccCccccCCC----CCCCCCCC
Q 004268 240 LHLSHNRLDGP----IPPTIGNLTNLIALDLSSNQLSGL----LPREVGNLKYLASLSLNGNILIGPI----PPTIGYLT 307 (764)
Q Consensus 240 L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~ 307 (764)
|++++|.+++. .+..+..+++|+.|++++|.+++. .+..+..+++|+.|++++|.+.+.. ...+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 44444444411 112333444555555555555421 1112333345555555555543221 12334455
Q ss_pred ccceEEccCCcCccCCChhhhc-----ccccceeecccccccc----CCchhcccccccceeecccccccCC----CCCC
Q 004268 308 NLTYLNLGYNRLSSSIPPELMN-----CSQLLNLVLSHNSLSG----SIPSEIGNLIFFRQLDLSRNFINGT----IPSQ 374 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~ 374 (764)
+|++|++++|.+++.....+.. .+.|++|++++|.+++ .+...+..+++|+.+++++|.++.. ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 6666666666665322222211 2566666666666652 1223344445666666666666533 2223
Q ss_pred CCCC-CccceecCCCCcc
Q 004268 375 LGKI-PNISAVDLSKNNL 391 (764)
Q Consensus 375 ~~~l-~~L~~l~l~~N~l 391 (764)
+... +.|+++++.+|++
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 3333 5666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.77 E-value=9e-21 Score=199.48 Aligned_cols=275 Identities=25% Similarity=0.292 Sum_probs=123.5
Q ss_pred EEeCCCCcc-ccCCccccCCCCCcEEEcCCCcCccc----CCccccCCCCCCEEEccCCcCcc------cCCcccCCCCC
Q 004268 24 FRIWGTLLS-GRMPSEIGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTG------TIPSEIGSLRD 92 (764)
Q Consensus 24 L~l~~~~~~-~~~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~ 92 (764)
|+|.++.++ ......+..+..|++|+++++.++.. ++..+...++|+.|+++++.+.. .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 445555554 23333444555566666666655321 23334445556666666555541 12234445556
Q ss_pred CCEEecCCCcccccCCccCcCCCC---CCEEEccCCcCcc----cCCccccCC-CCcCEEecccCccccc----CCcccc
Q 004268 93 LLDLNLSNNILNGSIPLEFGNLKD---LDQLRLQGNKLDG----LIPSSIGNL-TNLTYLDLSLNQLSGR----LPQEVG 160 (764)
Q Consensus 93 L~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~~~ 160 (764)
|++|+|++|.+....+..|..+.+ |++|++++|++.. .....+..+ ++|++|++++|.+++. ....+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 666666666555333333333333 6666666655542 111223334 5555555555555421 122334
Q ss_pred CCCCCCeeecccCCCCCC----CCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCC
Q 004268 161 NLKNLKSLFLDNNHLSGP----IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL 236 (764)
Q Consensus 161 ~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 236 (764)
.+++|++|++++|.+++. ....+..+++|+.|++++|.+....... ....+..+++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------l~~~~~~~~~ 222 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA--------------------LAETLASLKS 222 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH--------------------HHHHhcccCC
Confidence 445555555555555421 0111223334444444444443221110 1122333444
Q ss_pred CCEEEccCCcccCCCCcCCc-----CCCCCCeEEccCCcccCC----CCccccCCCCCCeEeccCccccCC----CCCCC
Q 004268 237 LDELHLSHNRLDGPIPPTIG-----NLTNLIALDLSSNQLSGL----LPREVGNLKYLASLSLNGNILIGP----IPPTI 303 (764)
Q Consensus 237 L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~ 303 (764)
|+.|++++|.+++.....+. ..+.|+.|++++|.++.. ....+..+++|+.+++++|.+.+. ....+
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 55555555544421111111 124556666666655411 122334445566666666665533 12222
Q ss_pred CCC-CccceEEccCCc
Q 004268 304 GYL-TNLTYLNLGYNR 318 (764)
Q Consensus 304 ~~l-~~L~~L~ls~N~ 318 (764)
... +.|++|++.+|.
T Consensus 303 ~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 303 LEPGNELESLWVKDDS 318 (319)
T ss_pred hhcCCchhhcccCCCC
Confidence 333 566666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-19 Score=198.68 Aligned_cols=231 Identities=23% Similarity=0.289 Sum_probs=166.4
Q ss_pred cCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
+|...+.+|++.|=.|.+|+++.|. |+||++.+.... .-+..++-.+|++ ....+|||++++.-+-..++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7888899999999999999988776 999998766533 2222233334455 556699999999998888888899999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC--C
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH--P 665 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~--~ 665 (764)
|... +|.+.+.. .+-+...+.+.|+.|++.|+..+| ..||+|||||.+||||++-.-+.|+||..-+..- .
T Consensus 102 yvkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9865 88888863 334666778889999999999999 9999999999999999999999999998875432 1
Q ss_pred CCC-Cceec----ccccccccccccccC----------C-CCccchHHHHHHHHHHHHh-CCCCCCcccccccccCC---
Q 004268 666 DSS-NRTLV----VGTYGYIAPELAYTM----------A-VTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGR--- 725 (764)
Q Consensus 666 ~~~-~~~~~----~g~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~~--- 725 (764)
++. ..+.+ ..-..|.|||.+... . .+++.||||+||+++|+++ |++||+-..-.+-....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 111 11112 233479999987542 1 4678999999999999988 78998732211100000
Q ss_pred cCCCCCCC-cHHHHHHHhhhhccc
Q 004268 726 KISQNPRL-DLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~-~~~~~~~~~~~l~~~ 748 (764)
......++ +...++++..|++++
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rd 278 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRD 278 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccC
Confidence 00000111 336678888888776
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=170.33 Aligned_cols=234 Identities=25% Similarity=0.367 Sum_probs=159.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-CC-----------------------------------EEEEEEccCCCCCc--H
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-GK-----------------------------------LVALKKLHRSETEE--P 548 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-~~-----------------------------------~vavK~~~~~~~~~--~ 548 (764)
.++|.+.+.||+|..+.||.|+.++ |. +.|+|.+..-+..+ .
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 4679999999999999999986532 11 23666654332221 1
Q ss_pred HHHHHHHHHH--------------HHHHhc--------CCCceeeEeeEEee---------------------------C
Q 004268 549 AFLESFQTEA--------------RLLSQI--------RHRNIVKLYGFCLH---------------------------N 579 (764)
Q Consensus 549 ~~~~~~~~E~--------------~~l~~l--------~hpniv~~~~~~~~---------------------------~ 579 (764)
...+.+.+|. ...+.+ +|||||++.++|.+ .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 2222333332 111222 59999999987743 2
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCC--CEEEe
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNL--EAFVA 655 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~--~~kl~ 655 (764)
..+|+||..++. +|..++..+ ..+....+-++.|+++|+.||| ++||.|||+|.+||++. +++ ...++
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEc
Confidence 468999999975 899998643 3556677789999999999999 99999999999999994 333 46799
Q ss_pred eeccccccCC------CCCCceecccccccccccccccCCC------CccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 004268 656 DFGLARLLHP------DSSNRTLVVGTYGYIAPELAYTMAV------TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS 723 (764)
Q Consensus 656 Dfg~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~ 723 (764)
|||.+-.-+. .........|...-||||+....+- -.|+|.|+.|.+.||+++...||....+.....
T Consensus 388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~ 467 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT 467 (598)
T ss_pred ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech
Confidence 9998754322 1112223467788999998764321 248999999999999999999998744322211
Q ss_pred -CCcCCCCCC----CcHHHHHHHhhhhccc
Q 004268 724 -GRKISQNPR----LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -~~~~~~~~~----~~~~~~~~~~~~l~~~ 748 (764)
..+..+.|. +++..++++-.+++.+
T Consensus 468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 468 RTYQESQLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred hhhhhhhCCCCcccCChHHHHHHHHHhcCC
Confidence 133334444 4556677777777766
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=160.06 Aligned_cols=135 Identities=16% Similarity=0.178 Sum_probs=103.9
Q ss_pred cceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-----CCCceeeEeeEEeeCC---E-E
Q 004268 512 IKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-----RHRNIVKLYGFCLHNK---C-M 582 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~-~ 582 (764)
-.+.||+|++|.||. .-.++. .+||++...... ..+.+.+|+++++.+ +||||++++++++++. . +
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE-CCCCcC-eEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 356799999999996 223344 479988664332 236789999999999 5799999999998874 3 3
Q ss_pred EEEEEe--cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHH-HHHHhcCCCCcEEcCCCCCCeeecC----CCCEEEe
Q 004268 583 FLIYEY--MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL-SYLHYDCKPSIVHRDISSNNILLNS----NLEAFVA 655 (764)
Q Consensus 583 ~lv~e~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~ 655 (764)
.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+||+++. ++.++|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 478999 5579999999642 24444 35677888777 9999 999999999999999974 3479999
Q ss_pred eeccc
Q 004268 656 DFGLA 660 (764)
Q Consensus 656 Dfg~~ 660 (764)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 94444
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-20 Score=161.63 Aligned_cols=155 Identities=37% Similarity=0.583 Sum_probs=100.9
Q ss_pred CccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeE
Q 004268 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASL 288 (764)
Q Consensus 209 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 288 (764)
.+.+++.|.|++|+++ ..|..++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4555666666666666 34445666666666666666666 45556666666666666666666 566666666666666
Q ss_pred eccCccccC-CCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccc
Q 004268 289 SLNGNILIG-PIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367 (764)
Q Consensus 289 ~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 367 (764)
||.+|.+.. ..|+.|..++.|+-|+|++|.+. .+|+.++.+++|+.|.+.+|.+- ..|..++.++.|++|++.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 666666543 45666666666666666666666 66666666666666666666666 5666666666666666666666
Q ss_pred c
Q 004268 368 N 368 (764)
Q Consensus 368 ~ 368 (764)
+
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 6
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=165.26 Aligned_cols=148 Identities=24% Similarity=0.240 Sum_probs=114.3
Q ss_pred hhcCCcceeeeecCceeEEEEE--ECCCCEEEEEEccCCCCCc-------------------H--HHHHHHHHHHHHHHh
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ--LSSGKLVALKKLHRSETEE-------------------P--AFLESFQTEARLLSQ 563 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~ 563 (764)
..-|.+.+.||+|++|.||+|. ..+|+.||+|++....... . .....+.+|++.+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999997 4689999999987543210 0 012346789999999
Q ss_pred cCC--CceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-cEEcCCC
Q 004268 564 IRH--RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS-IVHRDIS 640 (764)
Q Consensus 564 l~h--pniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-iiH~Dlk 640 (764)
+.+ ..+++++++ ...++||||+++.++...... ........+..++.|++.+++++| +.| |+|||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 975 334555543 234899999999887665421 223555667889999999999999 899 9999999
Q ss_pred CCCeeecCCCCEEEeeeccccccCC
Q 004268 641 SNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 641 p~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|+||+++ ++.++++|||.+.....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999 88999999999876543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-19 Score=156.72 Aligned_cols=161 Identities=30% Similarity=0.520 Sum_probs=147.8
Q ss_pred cCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccce
Q 004268 232 GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTY 311 (764)
Q Consensus 232 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 311 (764)
-.+..++.|.||+|+++ ..|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++. ..|..|+.+|.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34567889999999999 55667899999999999999998 57889999999999999999997 78999999999999
Q ss_pred EEccCCcCcc-CCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCc
Q 004268 312 LNLGYNRLSS-SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390 (764)
Q Consensus 312 L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 390 (764)
|||++|++.. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- ..|..++.+..|++|++.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 9999999975 68999999999999999999999 88999999999999999999998 889999999999999999999
Q ss_pred cccccCC
Q 004268 391 LSGVIPA 397 (764)
Q Consensus 391 l~~~~~~ 397 (764)
++..+|+
T Consensus 185 l~vlppe 191 (264)
T KOG0617|consen 185 LTVLPPE 191 (264)
T ss_pred eeecChh
Confidence 9976664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.9e-18 Score=185.11 Aligned_cols=197 Identities=25% Similarity=0.361 Sum_probs=143.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|..++.|..|+||.||.++++ +.+++|+| +.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--cccccCCccee---------------
Confidence 467889999999999999999877 56678884 433221 1111 33333444443
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|+-...++ ..+.++.+ ++.|++|+| +.||+|||+||+|.+|+.-|++|+.|||+++..-.
T Consensus 136 ------gDc~tllk---~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLK---NIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhcc---cCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 33334443 22233333 278999999 99999999999999999999999999999875421
Q ss_pred CCC---------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------cccC
Q 004268 666 DSS---------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------SSSG 724 (764)
Q Consensus 666 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------~~~~ 724 (764)
... .....+||+.|+|||++..+.|+..+|+|++|+++|+++.|..||.+.++.+ ....
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 100 0122589999999999999999999999999999999999999999885422 1222
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
........++++.++++.++++.+.
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhCh
Confidence 2333366678899999999999773
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=156.83 Aligned_cols=138 Identities=20% Similarity=0.374 Sum_probs=114.7
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-----AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
+.||+|++|.||+|.. .|..|++|+........+ .....+.+|++++..+.|++++....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 578899998765433221 1234678899999999999988777777777788999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
++|++|.+++... .. ....++.+++.++.++| +.|++|||++|+||+++ ++.++++|||.+...
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998632 11 77889999999999999 99999999999999999 789999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=156.50 Aligned_cols=134 Identities=23% Similarity=0.378 Sum_probs=107.7
Q ss_pred eeeecCceeEEEEEECCCCEEEEEEccCCCCCc-----HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 515 CIGTGGYGSVYRAQLSSGKLVALKKLHRSETEE-----PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
.||+|++|.||+|.+ +|+.|++|......... .....++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999986 47889999865433221 112366789999999998887655555555666678999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|++|.+.+.... . .++.+++.++.++| +.|++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 0 68999999999999 99999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.7e-17 Score=155.72 Aligned_cols=143 Identities=20% Similarity=0.193 Sum_probs=111.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-------------------HHHHHHHHHHHHHHhcCC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-------------------AFLESFQTEARLLSQIRH 566 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h 566 (764)
....|.+.+.||+|++|.||+|...+|+.||||++........ ........|..++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 3334888899999999999999888899999998765331100 011236788999999977
Q ss_pred C--ceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 567 R--NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 567 p--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+ .+++.++. ...++||||++|+++...... .....++.+++.++.++| +.||+||||+|+||
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Ni 156 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNI 156 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccE
Confidence 7 45555442 345899999999988765421 234578899999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccC
Q 004268 645 LLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~ 664 (764)
++++++.++|+|||.+....
T Consensus 157 ll~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCCcEEEEECCccccCC
Confidence 99999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.8e-16 Score=173.05 Aligned_cols=143 Identities=23% Similarity=0.334 Sum_probs=114.5
Q ss_pred HHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
.....|...+.||+|+||+||+|.+. ++.+++|+....... .....+++.+|+++++.++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33455677889999999999999875 334444443222111 112235788999999999999999888777777
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...++||||+++++|.+++. ....++.+++.++.+|| +.|++|||+||+||++ +++.++|+|||.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 77899999999999998875 34578999999999999 9999999999999999 677999999999
Q ss_pred cccc
Q 004268 660 ARLL 663 (764)
Q Consensus 660 ~~~~ 663 (764)
++..
T Consensus 474 a~~~ 477 (535)
T PRK09605 474 GKYS 477 (535)
T ss_pred cccC
Confidence 9764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=146.00 Aligned_cols=139 Identities=22% Similarity=0.242 Sum_probs=100.2
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHH---------------------HHHHHHHHHhcCCC--ce
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLES---------------------FQTEARLLSQIRHR--NI 569 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--ni 569 (764)
.+.||+|+||+||+|...+++.||+|++............. ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999987543221111111 13566666666443 35
Q ss_pred eeEeeEEeeCCEEEEEEEecCCCCHHH-HHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeec
Q 004268 570 VKLYGFCLHNKCMFLIYEYMERGSLFC-VLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLN 647 (764)
Q Consensus 570 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~ 647 (764)
++.+++. ..++||||++++.+.. .+... ... ..+..++.+++.++.++| . +||+||||||+||+++
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence 5555432 3589999999954321 11110 011 567789999999999999 7 8999999999999999
Q ss_pred CCCCEEEeeeccccccC
Q 004268 648 SNLEAFVADFGLARLLH 664 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~ 664 (764)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-16 Score=164.46 Aligned_cols=163 Identities=24% Similarity=0.369 Sum_probs=126.7
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.++||.|++|...+|.+++.+.......++.....++.|++.|++| +|.+|+|+||.||+...+.++||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3588999999999999999876667778888999999999999998 5899999999999999999999999999
Q ss_pred ccccCCCC------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccCCcCCCCCC
Q 004268 660 ARLLHPDS------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGRKISQNPR 732 (764)
Q Consensus 660 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~~~~~~~~~ 732 (764)
........ ...+...||..||+||.+.+..|+.++||||||++++|++. =..+|+............+...-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHh
Confidence 98765433 12344679999999999999999999999999999999998 455665554443333333321122
Q ss_pred CcH-HHHHHHhhhhccc
Q 004268 733 LDL-QCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~-~~~~~~~~~l~~~ 748 (764)
... .-..++.+++-..
T Consensus 483 ~d~p~e~~ll~~lls~~ 499 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPS 499 (516)
T ss_pred hcCcHHHHHHHHhcCCC
Confidence 222 2236666666544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=144.02 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=106.4
Q ss_pred eeee-ecCceeEEEEEECCCCEEEEEEccCCCC----------CcHHHHHHHHHHHHHHHhcCCCce--eeEeeEEeeCC
Q 004268 514 YCIG-TGGYGSVYRAQLSSGKLVALKKLHRSET----------EEPAFLESFQTEARLLSQIRHRNI--VKLYGFCLHNK 580 (764)
Q Consensus 514 ~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~~ 580 (764)
..+| .|+.|+||.+... +..+++|.+..... .......++.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4577 8999999999875 78899998854321 011223678899999999988774 67777644322
Q ss_pred ----EEEEEEEecCC-CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 581 ----CMFLIYEYMER-GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 581 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
..++|||+++| .+|.+++... .++.. .+.+++.++.++| ++||+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898887532 34433 3678999999999 9999999999999999998899999
Q ss_pred eecccccc
Q 004268 656 DFGLARLL 663 (764)
Q Consensus 656 Dfg~~~~~ 663 (764)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-14 Score=134.56 Aligned_cols=135 Identities=19% Similarity=0.167 Sum_probs=112.9
Q ss_pred cceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC--CceeeEeeEEeeCCEEEEEEEec
Q 004268 512 IKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH--RNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~ 589 (764)
+.+.+|+|.++.||++... ++.+++|....... ...+.+|+.+++.++| +.+++++++....+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4577999999999999876 47899999865543 2578899999999976 58999999988888899999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
+++.+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98766533 4456677899999999999944335899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-14 Score=151.49 Aligned_cols=184 Identities=29% Similarity=0.454 Sum_probs=140.9
Q ss_pred HHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCc-EEcCC
Q 004268 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI-VHRDI 639 (764)
Q Consensus 561 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-iH~Dl 639 (764)
++.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...++++|+.||+|+|. ..| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 3567899999999999999999999999999999999985 35568888888999999999999994 344 99999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCC--CCCCceecccccccccccccccCC-------CCccchHHHHHHHHHHHHhCC
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHP--DSSNRTLVVGTYGYIAPELAYTMA-------VTEKCDVYSFGVVALEVLMGS 710 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~il~~lltg~ 710 (764)
++.|+++|....+|+.|||+...... .........-..-|.|||.+.+.. .+.++||||+|++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999877642 111112223456799999987642 356799999999999999999
Q ss_pred CCCCccccccc----ccC----CcCCCCCCC------cHHHHHHHhhhhccch
Q 004268 711 HPTDLLSSLSS----SSG----RKISQNPRL------DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 711 ~Pf~~~~~~~~----~~~----~~~~~~~~~------~~~~~~~~~~~l~~~~ 749 (764)
.||+....... ... ......|.+ +.....++++||...+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIP 208 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccCh
Confidence 99987443222 111 111223332 2356677788887653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.6e-15 Score=162.02 Aligned_cols=235 Identities=24% Similarity=0.310 Sum_probs=181.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
...|.+.+.||+|+++.|-.+... ....+|+|.+.... ......+....|..+-+.+. |+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 456788888999999999888643 34566777665544 23334567778888888886 999999999999999999
Q ss_pred EEEEecCCCCHHHHH-hcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeecccc
Q 004268 584 LIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLAR 661 (764)
Q Consensus 584 lv~e~~~~~~L~~~l-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~ 661 (764)
+++++.+++++...+ ... ....+...+..++.|+..++.|+|. ..++.|+|+||+|.+++..+ ..++.|||+|.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999998887 422 2145566677899999999999995 56999999999999999999 99999999998
Q ss_pred ccCC-CCCC--ceeccc-ccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC--------cCC
Q 004268 662 LLHP-DSSN--RTLVVG-TYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR--------KIS 728 (764)
Q Consensus 662 ~~~~-~~~~--~~~~~g-~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~--------~~~ 728 (764)
.+.. .+.. ....+| ++.|+|||...+. ...+..|+||.|+++..+++|..||+........... ...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 8765 2222 234577 9999999998885 4467899999999999999999999877654332111 123
Q ss_pred CCCCCcHHHHHHHhhhhc
Q 004268 729 QNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~ 746 (764)
....++....+.+.+++.
T Consensus 254 ~~~~~~~~~~~~l~k~l~ 271 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILK 271 (601)
T ss_pred ccccCChhhhhccccccc
Confidence 334456666667777764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-12 Score=139.67 Aligned_cols=167 Identities=19% Similarity=0.215 Sum_probs=131.8
Q ss_pred EECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCcccccc
Q 004268 528 QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVEL 607 (764)
Q Consensus 528 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 607 (764)
+..++.+|.|..++.... ...+...+-++.++.++||+|+++++.++..+..|+|+|.+. .|..++.+ +
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence 455788999888876554 234667788899999999999999999999999999999985 78888874 2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccccccccccccc
Q 004268 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687 (764)
Q Consensus 608 ~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 687 (764)
....+...+.||+.||.|||. +.+++|++|....|+|+..|+.||++|..+..............--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 356677789999999999985 559999999999999999999999999998765433322222222334667776544
Q ss_pred CCCCccchHHHHHHHHHHHHhC
Q 004268 688 MAVTEKCDVYSFGVVALEVLMG 709 (764)
Q Consensus 688 ~~~~~~~DiwslG~il~~lltg 709 (764)
.. -..|.|.||+++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 33 345999999999999999
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.4e-15 Score=152.27 Aligned_cols=172 Identities=32% Similarity=0.463 Sum_probs=89.1
Q ss_pred CccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEcc
Q 004268 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLS 267 (764)
Q Consensus 188 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 267 (764)
--...||+.|++..+ +..+..+-.|+.+.|..|.+. .+|.++..+..|+.|+|+.|+++ ..|..++.+ -|+.|-++
T Consensus 76 dt~~aDlsrNR~~el-p~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFSEL-PEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVS 151 (722)
T ss_pred chhhhhccccccccC-chHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEEEe
Confidence 334455555555533 223444445555555555555 44555555555555555555555 344444433 25555555
Q ss_pred CCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCC
Q 004268 268 SNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSI 347 (764)
Q Consensus 268 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 347 (764)
+|+++ ..|..++.+..|..|+.+.|.+. ..|..++.+.+|+.|++..|++. .+|+.+..+ .|..||+|.|+++ .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence 55555 34444555555555555555554 23444555555555555555555 444444433 3555555555555 45
Q ss_pred chhcccccccceeeccccccc
Q 004268 348 PSEIGNLIFFRQLDLSRNFIN 368 (764)
Q Consensus 348 ~~~~~~l~~L~~L~l~~N~l~ 368 (764)
|-.|.+|..|++|-|.+|+++
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred chhhhhhhhheeeeeccCCCC
Confidence 555555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=141.14 Aligned_cols=142 Identities=22% Similarity=0.280 Sum_probs=99.3
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-------------------------------HHHH------HHHH
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-------------------------------AFLE------SFQT 556 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~~~~------~~~~ 556 (764)
+.||+|++|.||+|+.++|+.||||+........- +... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421110 0000 2445
Q ss_pred HHHHHHhcC-----CCce--eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHH-HHHHHHh
Q 004268 557 EARLLSQIR-----HRNI--VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH-ALSYLHY 628 (764)
Q Consensus 557 E~~~l~~l~-----hpni--v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~ 628 (764)
|++.+.+++ ++++ ++++. ......++||||++|+++.++...... .. ....++.+++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~- 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL- 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH-
Confidence 666555552 3332 33332 223457899999999999887642111 11 23346666665 467888
Q ss_pred cCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 629 ~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
..|++|+|+||.||+++.++.++++|||++..+.+
T Consensus 275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.5e-13 Score=151.28 Aligned_cols=107 Identities=31% Similarity=0.490 Sum_probs=85.7
Q ss_pred ccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCC
Q 004268 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 387 (764)
.++.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|||++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37788888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCccccccCCcccc----CccccccCCCCCC
Q 004268 388 KNNLSGVIPASVRR----IPKLIVSENNLEL 414 (764)
Q Consensus 388 ~N~l~~~~~~~~~~----~~~~~~~~n~~~~ 414 (764)
+|+++|.+|..+.. +..+.+.+|+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 88888888876543 2355666666544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.1e-13 Score=142.59 Aligned_cols=194 Identities=39% Similarity=0.474 Sum_probs=80.8
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCC-CcCEEecccCcccccCCccccCCCCCCeeecccC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT-NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNN 173 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 173 (764)
.|.++.|.+. ........++.++.|++.+|.+..+. .....+. +|+.|++++|++..+ +..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~-~~~~~~~~nL~~L~l~~N~i~~l-~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIP-PLIGLLKSNLKELDLSDNKIESL-PSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCc-cccccchhhcccccccccchhhh-hhhhhccccccccccCCc
Confidence 3444444442 11222233344555555555554332 2223232 455555555555422 233444455555555555
Q ss_pred CCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCc
Q 004268 174 HLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253 (764)
Q Consensus 174 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 253 (764)
+++.+.+ ....++.|+.|++++|++..+.. .......|++|.+++|.+. ..+.
T Consensus 174 ~l~~l~~-~~~~~~~L~~L~ls~N~i~~l~~-------------------------~~~~~~~L~~l~~~~N~~~-~~~~ 226 (394)
T COG4886 174 DLSDLPK-LLSNLSNLNNLDLSGNKISDLPP-------------------------EIELLSALEELDLSNNSII-ELLS 226 (394)
T ss_pred hhhhhhh-hhhhhhhhhheeccCCccccCch-------------------------hhhhhhhhhhhhhcCCcce-ecch
Confidence 5443221 11133444444444444443322 1122223444444444222 1223
Q ss_pred CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCcc
Q 004268 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321 (764)
Q Consensus 254 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 321 (764)
.+..+.++..|.+.+|++.. .+..+..+++++.|++++|.++.... ++.+.+|+.|++++|.+..
T Consensus 227 ~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 227 SLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred hhhhcccccccccCCceeee-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence 34444444444444444432 13344444445555555555543322 4444555555555555543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.1e-13 Score=143.01 Aligned_cols=261 Identities=35% Similarity=0.420 Sum_probs=159.0
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCC-CCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLR-DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
.|+++.|.+. ........++.++.|++.+|.++ .++.....+. +|+.|++++|.+.. .+..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCc
Confidence 5777777774 23334555677888888888877 4555555553 78888888888873 3345677788888888888
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 205 (764)
++..+. .....+++|+.|++++|+++.+ |........|++|.+++|++. ..+..+..+.++..|.+++|++... ..
T Consensus 174 ~l~~l~-~~~~~~~~L~~L~ls~N~i~~l-~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~ 249 (394)
T COG4886 174 DLSDLP-KLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE 249 (394)
T ss_pred hhhhhh-hhhhhhhhhhheeccCCccccC-chhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence 887553 3333667788888888888744 333344455888888888533 2345567777777777777777643 44
Q ss_pred ccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCC
Q 004268 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285 (764)
Q Consensus 206 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 285 (764)
.+..+++++.|++++|.++.+.. +..+.+++.|++++|.+....+....... +...... +.+. ..+..+.....+
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~-~~~~~~~-~~~~-~~~~~~~~~~~~ 324 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLL-LLELLLN-LLLT-LKALELKLNSIL 324 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccch-hHHhhhh-hhhh-cccccccccccc
Confidence 56677778888888888875444 77778888888888888766554433221 1111111 2222 111222222333
Q ss_pred CeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 286 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
....+..+... ..+..+.....+..++...+...
T Consensus 325 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 358 (394)
T COG4886 325 LNNNILSNGET-SSPEALSILESLNNLWTLDNALD 358 (394)
T ss_pred ccccccccccc-ccchhhcccccccCceecccccc
Confidence 33344444433 33334444455555655555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-13 Score=149.74 Aligned_cols=246 Identities=28% Similarity=0.322 Sum_probs=117.3
Q ss_pred CCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEe
Q 004268 66 LSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLD 145 (764)
Q Consensus 66 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 145 (764)
+..++.+.+..|.|.. ....+..+.+|+.|+|.+|.|..+.. .+..+++|+.|+|++|.|+.+ ..+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhhe
Confidence 3444444455555542 22334444555555555555543322 133444555555555555443 2334444455555
Q ss_pred cccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccc
Q 004268 146 LSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 146 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
+++|.|+.+ ..+..+++|+.+++++|++..+... . ...+.+++.+++.+|.+..
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~-----------------------~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND-----------------------E-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhh-----------------------h-hhhccchHHHhccCCchhc
Confidence 555554432 2333344444444444444432220 1 2444555555555555542
Q ss_pred ccCccccCCCCCCEEEccCCcccCCCCcCCcCCCC--CCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCC
Q 004268 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN--LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303 (764)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 303 (764)
+ ..+..+..+..+++..|.+..+. .+..+.. |+.+++++|++.. .+..+..+..+..|++.+|++... ..+
T Consensus 201 i--~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~ 273 (414)
T KOG0531|consen 201 I--EGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGL 273 (414)
T ss_pred c--cchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccc
Confidence 2 22333333444455555555331 1222222 5666666666652 224455666666666666666533 334
Q ss_pred CCCCccceEEccCCcCccC---CChh-hhcccccceeeccccccccCCc
Q 004268 304 GYLTNLTYLNLGYNRLSSS---IPPE-LMNCSQLLNLVLSHNSLSGSIP 348 (764)
Q Consensus 304 ~~l~~L~~L~ls~N~l~~~---~~~~-~~~l~~L~~L~ls~N~l~~~~~ 348 (764)
...+.+..+.+..|.+... .... ....++++.+.+..|.+....+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 4555666666666665521 1111 3455667777777777765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.5e-11 Score=115.63 Aligned_cols=140 Identities=18% Similarity=0.194 Sum_probs=101.3
Q ss_pred ceeeeecCceeEEEEEECC-------CCEEEEEEccCCCCC----------c---------HHHHHHH----HHHHHHHH
Q 004268 513 KYCIGTGGYGSVYRAQLSS-------GKLVALKKLHRSETE----------E---------PAFLESF----QTEARLLS 562 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~~----~~E~~~l~ 562 (764)
...||.|--+.||.|...+ +..+|+|+++..... + ....+.+ .+|++.++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999996442 579999988632210 0 1112333 38999999
Q ss_pred hcC--CCceeeEeeEEeeCCEEEEEEEecCCCCHHH-HHhcCccccccCHHHHHHHHHHHHHHHHHH-HhcCCCCcEEcC
Q 004268 563 QIR--HRNIVKLYGFCLHNKCMFLIYEYMERGSLFC-VLRNDVEAVELDWTKRVNIVKSMAHALSYL-HYDCKPSIVHRD 638 (764)
Q Consensus 563 ~l~--hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~D 638 (764)
++. .-.+++.+++ ..-++||||+.+..+.. .++ ...++..+...+..+++.++..+ | +.|+||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 994 3567777765 34579999998754322 222 12344556677889999999998 8 88999999
Q ss_pred CCCCCeeecCCCCEEEeeeccccccC
Q 004268 639 ISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 639 lkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
+++.||+++ ++.++++|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-12 Score=140.92 Aligned_cols=148 Identities=20% Similarity=0.218 Sum_probs=95.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-CCEEEEEEccCCCCCc-------------------------------HHHHHH-
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-GKLVALKKLHRSETEE-------------------------------PAFLES- 553 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-------------------------------~~~~~~- 553 (764)
...|.. +.+|+|++|.||+|+.++ |+.||||+..+..... .+..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455766 789999999999999876 9999999997542110 011222
Q ss_pred -----HHHHHHHHHhcC----CCceeeEeeEEee-CCEEEEEEEecCCCCHHHHH--hcCc-cccccCHHHHHHHHHHHH
Q 004268 554 -----FQTEARLLSQIR----HRNIVKLYGFCLH-NKCMFLIYEYMERGSLFCVL--RNDV-EAVELDWTKRVNIVKSMA 620 (764)
Q Consensus 554 -----~~~E~~~l~~l~----hpniv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~-~~~~l~~~~~~~i~~qi~ 620 (764)
+.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- .... ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 334444444442 3332333233222 44578999999999997742 2111 01122333333334443
Q ss_pred HHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeeeccccccCC
Q 004268 621 HALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADFGLARLLHP 665 (764)
Q Consensus 621 ~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~~ 665 (764)
. ..|++|+|+||.||+++.++ .++++|||++....+
T Consensus 277 ------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 56999999999999999887 999999999987643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.4e-13 Score=121.24 Aligned_cols=124 Identities=31% Similarity=0.372 Sum_probs=35.7
Q ss_pred CCCCCCeEEccCCcccCCCCcccc-CCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhh-hcccccc
Q 004268 257 NLTNLIALDLSSNQLSGLLPREVG-NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPEL-MNCSQLL 334 (764)
Q Consensus 257 ~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~ 334 (764)
+..+++.|+|.+|.|..+ +.++ .+.+|+.|++++|.|..+ +.+..+++|+.|++++|+|+. +.+.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 344566666666666533 2343 355666666666666544 345566666666666666663 33333 3466666
Q ss_pred eeeccccccccCCc-hhcccccccceeecccccccCCCC---CCCCCCCccceec
Q 004268 335 NLVLSHNSLSGSIP-SEIGNLIFFRQLDLSRNFINGTIP---SQLGKIPNISAVD 385 (764)
Q Consensus 335 ~L~ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~ 385 (764)
+|+|++|+|.+... ..+..+++|+.|+|.+|+++.... ..+..+|+|+.||
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 67777666654221 344556666666666666652211 1234455555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-13 Score=147.59 Aligned_cols=240 Identities=29% Similarity=0.333 Sum_probs=159.4
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
++++.++...+.+...--. ...+..++.+.+..|.|.. .-..+..+++|+.|++.+|+|.. +...+..+++|++|+|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDL 125 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheec
Confidence 3455555555544322111 1466778888899999984 44568889999999999999994 4444888999999999
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCC-ccccCCCCCCeeecccCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP-QEVGNLKNLKSLFLDNNHLSG 177 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~ 177 (764)
++|.|+.+. .+..++.|+.|++++|.|+.+ ..+..+++|+.+++++|++..+.+ . ...+.+|+.+.+..|.+..
T Consensus 126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred ccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 999999664 456778899999999999976 567779999999999999986654 2 5788999999999999874
Q ss_pred CCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcC
Q 004268 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257 (764)
Q Consensus 178 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 257 (764)
+ ..+..+..+..+++..|.+..+..-....+.+|+.+++++|.+... +..+..+..+..|++++|++... ..+..
T Consensus 201 i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~ 275 (414)
T KOG0531|consen 201 I--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLER 275 (414)
T ss_pred c--cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--ccccc
Confidence 4 3355556666667788877744321111111266666666666522 13333444444555555544422 12333
Q ss_pred CCCCCeEEccCCcc
Q 004268 258 LTNLIALDLSSNQL 271 (764)
Q Consensus 258 l~~L~~L~L~~n~l 271 (764)
.+.+..+.+..|.+
T Consensus 276 ~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 276 LPKLSELWLNDNKL 289 (414)
T ss_pred cchHHHhccCcchh
Confidence 33444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-12 Score=121.06 Aligned_cols=105 Identities=30% Similarity=0.384 Sum_probs=22.1
Q ss_pred CCCEEEccCCcCcccCCcccC-CCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEec
Q 004268 68 RLKVLDLSYNRLTGTIPSEIG-SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDL 146 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 146 (764)
.+++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.+. .+..+++|++|++++|+|+.+.+.....+++|++|+|
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 444455555554422 1232 2444455555555544331 2444445555555555554432211123444555555
Q ss_pred ccCcccccCC-ccccCCCCCCeeecccCCCC
Q 004268 147 SLNQLSGRLP-QEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 147 ~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~ 176 (764)
++|+|..... ..++.+++|+.|+|.+|.++
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 5554443211 22334444444444444443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.7e-13 Score=126.72 Aligned_cols=132 Identities=26% Similarity=0.317 Sum_probs=85.1
Q ss_pred CCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeec
Q 004268 259 TNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVL 338 (764)
Q Consensus 259 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l 338 (764)
.-|+.||||+|.|+. ..+...-.|.++.|++|+|.|..+ +.+..+++|+.||||+|.++ ....+-..+.+++.|.|
T Consensus 284 q~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 345566666666652 333444556666666666666543 23566677777777777776 33445556667777777
Q ss_pred cccccccCCchhcccccccceeecccccccCCC-CCCCCCCCccceecCCCCccccccC
Q 004268 339 SHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTI-PSQLGKIPNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 339 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~ 396 (764)
++|.|.+ -+.+..+.+|..||+++|+|.... ...++++|-|..+.|.+|++.+.+.
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 7777752 234666677777777777776432 2567888889999999999886554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-14 Score=138.26 Aligned_cols=248 Identities=23% Similarity=0.279 Sum_probs=139.4
Q ss_pred ccccCCCCCcEEEcCCCcCcc----cCCccccCCCCCCEEEccCC---cCcccCC-------cccCCCCCCCEEecCCCc
Q 004268 37 SEIGALSKLEKLVLSHNSLTG----RIPSEIGALSRLKVLDLSYN---RLTGTIP-------SEIGSLRDLLDLNLSNNI 102 (764)
Q Consensus 37 ~~~~~l~~L~~L~Ls~n~i~~----~~~~~~~~l~~L~~L~L~~n---~i~~~~~-------~~~~~l~~L~~L~L~~n~ 102 (764)
+.+..+..++.|+||+|.+.. .+...+...++|+..++++= +....+| .++.++++|++||||+|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 345667788888888888873 24445666778888888763 2222233 455667789999999998
Q ss_pred ccccCCcc----CcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCC
Q 004268 103 LNGSIPLE----FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178 (764)
Q Consensus 103 l~~~~~~~----~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 178 (764)
+....+.. +.++..|++|.|.+|.+.-.....++. .|.+|. .|+. ...-+.|+.+...+|++..-
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccccc
Confidence 87444333 456778888888888886332222221 122211 1110 11123455555555544321
Q ss_pred C----CCccccCCCccEEEecCccCcCC----cccccCCccccceeeccCcccccc----cCccccCCCCCCEEEccCCc
Q 004268 179 I----PSTLYHLNQLATLCLGYNKLVGP----VTKEVGNMKNLDRLHLNGNNLTGS----IPSTIGYLNLLDELHLSHNR 246 (764)
Q Consensus 179 ~----~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~ 246 (764)
. ...|...+.|+.+.++.|.|..- ....|..+++|+.|+|.+|.++.. ....++.+++|++|++++|.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 1 12233444555555555554421 123355566666666666666522 23345556667777777776
Q ss_pred ccCCCCcCC-----cCCCCCCeEEccCCcccCC----CCccccCCCCCCeEeccCccc
Q 004268 247 LDGPIPPTI-----GNLTNLIALDLSSNQLSGL----LPREVGNLKYLASLSLNGNIL 295 (764)
Q Consensus 247 l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l 295 (764)
++.....+| ...++|+.|.|.+|.|+.. ........+.|+.|+|++|++
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 664433322 2356777777777777522 222344567788888888877
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-13 Score=135.12 Aligned_cols=207 Identities=23% Similarity=0.191 Sum_probs=111.7
Q ss_pred CCccEEEecCccCcCCcc-cccCCccccceeeccCcccccccC--ccccCCCCCCEEEccCCcccCCCCc-CCcCCCCCC
Q 004268 187 NQLATLCLGYNKLVGPVT-KEVGNMKNLDRLHLNGNNLTGSIP--STIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLI 262 (764)
Q Consensus 187 ~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~ 262 (764)
.+|+...|.+..+..... +....+++++.|+|++|-+..+.+ .....+++|+.|+|+.|++...... .-..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 344444444444432221 233445556666666655553221 2234556666666666665422111 111345667
Q ss_pred eEEccCCcccCCCC-ccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCC-Chhhhcccccceeeccc
Q 004268 263 ALDLSSNQLSGLLP-REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI-PPELMNCSQLLNLVLSH 340 (764)
Q Consensus 263 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~ls~ 340 (764)
.|.|+.|.++.... ..+..+|+|+.|+|.+|...........-+..|+.|+|++|++.+.. ......++.|+.|+++.
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 77777777653221 22445667777777777432232333444566777777777665321 13455667777777777
Q ss_pred cccccCC-chh-----cccccccceeecccccccCCCC-CCCCCCCccceecCCCCcccc
Q 004268 341 NSLSGSI-PSE-----IGNLIFFRQLDLSRNFINGTIP-SQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 341 N~l~~~~-~~~-----~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~ 393 (764)
|.+..+. |+. ...+++|+.|+++.|+|..... ..+..+++|+.|....|+|+.
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 7766432 111 2455677888888888753322 445666777777777777773
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-11 Score=116.73 Aligned_cols=128 Identities=21% Similarity=0.225 Sum_probs=95.9
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc-eeeEeeEEeeCCEEEEEEEecCC
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN-IVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.+.++.|.++.||+++.. ++.|++|........ ...+.+|+++++.+.+.+ +++++.+... ..++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCC
Confidence 356889999999999876 788999997654321 134568999999886444 4556655432 34799999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS-----IVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
.++... . .....++.+++++++.|| +.+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~-~----------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE-D----------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc-c----------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 876543 0 111245789999999999 666 49999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.3e-14 Score=136.22 Aligned_cols=200 Identities=22% Similarity=0.252 Sum_probs=111.0
Q ss_pred cccCCCCcCEEecccCcccccCCcc----ccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCC
Q 004268 134 SIGNLTNLTYLDLSLNQLSGRLPQE----VGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGN 209 (764)
Q Consensus 134 ~~~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~ 209 (764)
++.++++|+.||||+|-+..-.+.. ++++++|++|.|.+|.+.......++. .|..|. .|+ ....
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~ 155 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAAS 155 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCC
Confidence 4555667888888888775433333 345678888888888775322211111 011111 010 1122
Q ss_pred ccccceeeccCcccccc----cCccccCCCCCCEEEccCCcccCC----CCcCCcCCCCCCeEEccCCcccCC----CCc
Q 004268 210 MKNLDRLHLNGNNLTGS----IPSTIGYLNLLDELHLSHNRLDGP----IPPTIGNLTNLIALDLSSNQLSGL----LPR 277 (764)
Q Consensus 210 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~ 277 (764)
.+.|+.+...+|++... ....|...+.|+++.++.|.|... ...+|..+++|+.|||.+|-++.. ...
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 34555555555555421 222344555666666666665422 123455667777777777766532 334
Q ss_pred cccCCCCCCeEeccCccccCCCCCCC-----CCCCccceEEccCCcCccC----CChhhhcccccceeeccccccc
Q 004268 278 EVGNLKYLASLSLNGNILIGPIPPTI-----GYLTNLTYLNLGYNRLSSS----IPPELMNCSQLLNLVLSHNSLS 344 (764)
Q Consensus 278 ~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~ 344 (764)
.++.+++|++|++++|.+.......| ...|+|+.|.|.+|.|+.. +.......+.|..|+|++|++.
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 56666777777777777654422222 2357778888888877741 2233455677888888888873
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-13 Score=141.31 Aligned_cols=193 Identities=32% Similarity=0.492 Sum_probs=99.3
Q ss_pred EEEccCCcCcccCCcccc-CCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCc
Q 004268 119 QLRLQGNKLDGLIPSSIG-NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197 (764)
Q Consensus 119 ~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 197 (764)
+|.|++-+++..+-+++. .+.--...||+.|++. ..|..++.+..|+.+.|..|.+. ..+..+..+..|..|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 344555555543333322 2333345567777776 45556666666777777777666 44555566666666666666
Q ss_pred cCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCc
Q 004268 198 KLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPR 277 (764)
Q Consensus 198 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 277 (764)
++..++.. +..+ -|+.|-+++|+++ ..|..++..+.|..||.+.|.+. ..|..++++.+|+.|.+..|++.. .|.
T Consensus 132 qlS~lp~~-lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~ 206 (722)
T KOG0532|consen 132 QLSHLPDG-LCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPE 206 (722)
T ss_pred hhhcCChh-hhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCH
Confidence 66543322 2222 2555555555555 34444444555555555555555 334445555555555555555542 333
Q ss_pred cccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 278 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
.+..++ |..||++.|++. .+|-.|..|..|++|-|.+|.++
T Consensus 207 El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 207 ELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 333333 555555555554 34445555555555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7e-13 Score=126.16 Aligned_cols=200 Identities=25% Similarity=0.255 Sum_probs=133.0
Q ss_pred CCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccC-cccccccCccccCCCCCCEE
Q 004268 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNG-NNLTGSIPSTIGYLNLLDEL 240 (764)
Q Consensus 162 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L 240 (764)
+.+|..+.++.+.-..+. +....-+.|.++.+.+..+... ..+-.+..+..+.-+. .-.++.........+.|++|
T Consensus 213 f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Ltel 289 (490)
T KOG1259|consen 213 FRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADTWQELTEL 289 (490)
T ss_pred hhhhheeeeeccchhhee-ceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecchHhhhhhc
Confidence 345555555554333211 1223335677777766655432 1222222332222221 11122222233344678899
Q ss_pred EccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 241 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
|||+|.|+ .+..+..-.|.++.|++|+|.|..+ +.+..+++|+.||||+|.++. ..++-..+-+.+.|.|++|.|.
T Consensus 290 DLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La~N~iE 365 (490)
T KOG1259|consen 290 DLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLAQNKIE 365 (490)
T ss_pred cccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehhhhhHh
Confidence 99999998 4556777789999999999999744 348889999999999999874 4455567888999999999998
Q ss_pred cCCChhhhcccccceeeccccccccC-CchhcccccccceeecccccccCC
Q 004268 321 SSIPPELMNCSQLLNLVLSHNSLSGS-IPSEIGNLIFFRQLDLSRNFINGT 370 (764)
Q Consensus 321 ~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~ 370 (764)
+. ..+..+-+|..||+++|+|... ....+++++-|+.+.|-+|++.+.
T Consensus 366 ~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 366 TL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 43 5678888999999999999742 224678899999999999999843
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.7e-13 Score=134.16 Aligned_cols=134 Identities=25% Similarity=0.302 Sum_probs=53.8
Q ss_pred CCCCCeeecccCCCCCC-CCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccC-ccccCCCCCCE
Q 004268 162 LKNLKSLFLDNNHLSGP-IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP-STIGYLNLLDE 239 (764)
Q Consensus 162 l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~ 239 (764)
++.|+.|.|++|.++.- ....+..+++|+.|+|+.|....+......-+..|++|+|++|++-.... .....++.|+.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 34445555555544410 11122334444444444443222222233334445555555554442110 12334444555
Q ss_pred EEccCCcccCCC-CcC-----CcCCCCCCeEEccCCcccCC-CCccccCCCCCCeEeccCccc
Q 004268 240 LHLSHNRLDGPI-PPT-----IGNLTNLIALDLSSNQLSGL-LPREVGNLKYLASLSLNGNIL 295 (764)
Q Consensus 240 L~L~~n~l~~~~-~~~-----~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l 295 (764)
|+++.|.+.++- |+. ...+++|++|++..|+|.+. ..+.+..+++|+.|.+..|.+
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l 338 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL 338 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccc
Confidence 555555444331 111 12344555555555555321 112233334444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.7e-11 Score=106.54 Aligned_cols=134 Identities=24% Similarity=0.386 Sum_probs=103.4
Q ss_pred eeeecCceeEEEEEECCCCEEEEEEccCCCCCcHH-----HHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEec
Q 004268 515 CIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPA-----FLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
.+++|+-+.+|.+.+. |..+++|.-.++....++ ..++..+|++++.+++--.|...+-+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 555777754444333322 2356678999999997656655555666777778999999
Q ss_pred CCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 590 ERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 590 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|..|.+++... ...++..+-..+.-|| ..||+|+|+.++||++.+++ +.++|||++..-
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888643 1346778888889999 99999999999999998764 999999999743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.3e-11 Score=130.41 Aligned_cols=239 Identities=24% Similarity=0.215 Sum_probs=176.2
Q ss_pred hhcCCcceeeee--cCceeEEEEEE---CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGT--GGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 580 (764)
...+.+.+.+|. |.+|.||.+.. .++..+|+|.-+...... ....+=.+|+...+.+ .|++.++.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccccCC
Confidence 456777888999 99999999965 378889998744333211 1113334677777777 5999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHH----HHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEe
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH----ALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVA 655 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~ 655 (764)
..++-+|.+. .++..+... ....++...++.+..+..+ |+.++| +.+++|-|+||.||+...+ ...+++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecC
Confidence 9999999996 578777763 2233677778888888888 999999 9999999999999999988 889999
Q ss_pred eeccccccCCCCCCcee-----cccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc--cccccccCC--c
Q 004268 656 DFGLARLLHPDSSNRTL-----VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL--SSLSSSSGR--K 726 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~-----~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~--~~~~~~~~~--~ 726 (764)
|||....+....-.... ..|...|++||...+ -++.++|+|++|.++.+..+|..++..- ......... .
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 99999888655422222 267788999998765 5678999999999999999988776543 222222221 1
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhhHH
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRWEN 753 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~~~ 753 (764)
.......+......+..+++.+.+|+-
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~ 371 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRL 371 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhh
Confidence 112223344555588888888877763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.4e-10 Score=103.66 Aligned_cols=147 Identities=20% Similarity=0.257 Sum_probs=109.4
Q ss_pred cceeeeecCceeEEEEEECCCCEEEEEEccCCCCCc-----HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEE-----PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
....+-+|+-+.|+++.+. |+..+||.-....... .-..++..+|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4677899999999999886 8887877544433332 223466789999999987555554444555666667999
Q ss_pred EecCC-CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEEEeeeccccc
Q 004268 587 EYMER-GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAFVADFGLARL 662 (764)
Q Consensus 587 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~~~ 662 (764)
||++| .++.+++......... ......++.+|-+.+.-|| ..++||||+..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~-d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESE-DEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCccc-chhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4788888754333322 2333678999999999999 99999999999999997554 347999999865
Q ss_pred c
Q 004268 663 L 663 (764)
Q Consensus 663 ~ 663 (764)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-11 Score=137.46 Aligned_cols=113 Identities=35% Similarity=0.511 Sum_probs=104.4
Q ss_pred CCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecc
Q 004268 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLS 363 (764)
Q Consensus 284 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~ 363 (764)
.++.|+|++|.+.+..|..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCC-CccceecCCCCccccccC
Q 004268 364 RNFINGTIPSQLGKI-PNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 364 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 396 (764)
+|++++.+|..+..+ .++..+++++|+..|..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999888664 467789999998776544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.2e-10 Score=109.39 Aligned_cols=143 Identities=22% Similarity=0.278 Sum_probs=107.9
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC--CceeeEeeEEeeCC---EEEEEEEe
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH--RNIVKLYGFCLHNK---CMFLIYEY 588 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~---~~~lv~e~ 588 (764)
+.++.|..+.||++...+|+.+++|......... ....+..|+++++.+++ ..+++++.+..... ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~--~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP--SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc--ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 5689999999999987767899999986544321 12567899999999965 44677887766542 57899999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC-------------------------------------- 630 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 630 (764)
++|.++...+.. ..++..+...++.++++++.+||...
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999877665421 23566666777788888888887321
Q ss_pred ---------------CCCcEEcCCCCCCeeecC--CCCEEEeeeccccc
Q 004268 631 ---------------KPSIVHRDISSNNILLNS--NLEAFVADFGLARL 662 (764)
Q Consensus 631 ---------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 662 (764)
...++|+|++|.||+++. ++.+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1e-10 Score=134.75 Aligned_cols=129 Identities=27% Similarity=0.365 Sum_probs=74.2
Q ss_pred CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCc--CcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEE
Q 004268 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNR--LTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 120 (764)
...+...+-+|.+.. .+.. ...+.|++|-+..|. +.....+.|..++.|+.|||++|.=.+..|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~-~~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEH-IAGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhh-ccCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 455666666666652 2222 222356666666664 443444446666666666666665555666666666666666
Q ss_pred EccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC
Q 004268 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 121 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 174 (764)
+|+++.++. .|..+.+|..|.+||+..+.-....+.....+++|++|.+..-.
T Consensus 601 ~L~~t~I~~-LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGISH-LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCccc-cchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 666666663 45566666666666666655443445555556666666665443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-10 Score=122.65 Aligned_cols=233 Identities=21% Similarity=0.192 Sum_probs=162.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEE--CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL--SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
...+|..+..||.|.|+.|+.+.. .++..|++|............ ..-..|+.+...+ .|.++++++..+......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 456788899999999999999853 367889999887655443322 2224566666666 589999988888777778
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeeecccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLAR 661 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg~~~ 661 (764)
|+--||+++++...... ...-+++...+++..|++.++.++| ++.++|+|++|+||++..+ +..+++|||.++
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 89999999998765552 3334677888899999999999999 9999999999999999876 777899999987
Q ss_pred ccCCCCCCceecccccccc--cccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHH
Q 004268 662 LLHPDSSNRTLVVGTYGYI--APELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (764)
.+.-. .....+.-++. +|+......+-.++|++|+|..+.+..+|..--.................+....+.+.
T Consensus 416 ~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 416 RLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQV 492 (524)
T ss_pred cccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhh
Confidence 53211 11122333344 55555666788899999999999999998754332222222222223333333344455
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
..+-.+..+
T Consensus 493 ~~kv~~~~~ 501 (524)
T KOG0601|consen 493 LLKVMINPD 501 (524)
T ss_pred hhhhhcCCc
Confidence 555554443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-09 Score=100.88 Aligned_cols=129 Identities=26% Similarity=0.346 Sum_probs=86.0
Q ss_pred eEEEEEECCCCEEEEEEccCCCCC-----------------------cHHHHHHHHHHHHHHHhcCCC--ceeeEeeEEe
Q 004268 523 SVYRAQLSSGKLVALKKLHRSETE-----------------------EPAFLESFQTEARLLSQIRHR--NIVKLYGFCL 577 (764)
Q Consensus 523 ~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~ 577 (764)
.||.|...+|..+|+|+....... .........+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998888999999988643211 112235678999999999754 577777553
Q ss_pred eCCEEEEEEEecC--CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHH-HHhcCCCCcEEcCCCCCCeeecCCCCEEE
Q 004268 578 HNKCMFLIYEYME--RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY-LHYDCKPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 578 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
. -++||||++ |..+..+.... ++......++.+++..+.. +| ..|++|||+.+.||+++++ .+.+
T Consensus 80 -~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 -R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp -T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred -C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence 2 369999999 65665544321 1133455677788885555 58 8899999999999999887 9999
Q ss_pred eeeccccccC
Q 004268 655 ADFGLARLLH 664 (764)
Q Consensus 655 ~Dfg~~~~~~ 664 (764)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-11 Score=135.21 Aligned_cols=210 Identities=22% Similarity=0.253 Sum_probs=150.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..+.+.+.+.+-+|.++.++.+.-. .|...++|+......-.....+....+-.+.-...+|.+++..-.+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456667778889999999988633 454444444332221111112333344444444456776665555555667899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
+++|..++++...++.. +..+..-++.....+.++.++|| ...+.|+|++|.|.++..++..++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999998743 34555666777888999999999 7779999999999999999999999998432211
Q ss_pred CC---------------------C----------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 004268 665 PD---------------------S----------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPT 713 (764)
Q Consensus 665 ~~---------------------~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf 713 (764)
.- . .......+|+.|.+||...+......+|+|+.|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 0012246899999999999999999999999999999999999999
Q ss_pred Cccccccc
Q 004268 714 DLLSSLSS 721 (764)
Q Consensus 714 ~~~~~~~~ 721 (764)
........
T Consensus 1036 na~tpq~~ 1043 (1205)
T KOG0606|consen 1036 NAETPQQI 1043 (1205)
T ss_pred CCcchhhh
Confidence 98776543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-10 Score=86.83 Aligned_cols=59 Identities=46% Similarity=0.657 Sum_probs=27.0
Q ss_pred CCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCc
Q 004268 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 150 (764)
+|++|++++|+++.+.+.+|.++++|++|++++|.++.+.+++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444444444444444444444444444444444444443
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-10 Score=131.52 Aligned_cols=274 Identities=27% Similarity=0.317 Sum_probs=173.6
Q ss_pred CCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCc--ccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcC
Q 004268 65 ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI--LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT 142 (764)
Q Consensus 65 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 142 (764)
.....+...+-+|.+. .++.... +++|++|-+.+|. +..+..+.|..++.|+.|||++|.-.+..|..++.|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3467788888888887 4444443 3589999999996 6656666688899999999998876667888999999999
Q ss_pred EEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccC--cCCcccccCCccccceeeccC
Q 004268 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL--VGPVTKEVGNMKNLDRLHLNG 220 (764)
Q Consensus 143 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i--~~~~~~~~~~l~~L~~L~L~~ 220 (764)
+|+|++..++ ..|..+.++..|.+|++..+.-....++....+.+|++|.+..... .......+..+.+|+.+....
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9999999998 6788899999999999998876555577777899999998876642 222333445555666655543
Q ss_pred cccccccCccccCCCCCC----EEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC------CCCCCeEec
Q 004268 221 NNLTGSIPSTIGYLNLLD----ELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN------LKYLASLSL 290 (764)
Q Consensus 221 n~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~------l~~L~~L~l 290 (764)
.... ....+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+..+....+.. ++++..+..
T Consensus 678 ~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~ 754 (889)
T KOG4658|consen 678 SSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSI 754 (889)
T ss_pred chhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHh
Confidence 3321 111122222222 3333232322 34456777788888888888876443322221 122222222
Q ss_pred cCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecccccccc
Q 004268 291 NGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSG 345 (764)
Q Consensus 291 ~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 345 (764)
.++... ..+.+....++|+.|++.++.....+.+....+..++++-+..+.+.+
T Consensus 755 ~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 755 LNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred hccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 222211 122233345677777777776665555555555666655555555543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.1e-10 Score=85.25 Aligned_cols=61 Identities=46% Similarity=0.611 Sum_probs=47.8
Q ss_pred CCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 115 KDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
++|++|++++|+++.++++.|.++++|++|++++|.++.+.+.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888877777788888888888888888777777788888888888877764
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.3e-09 Score=105.15 Aligned_cols=195 Identities=15% Similarity=0.220 Sum_probs=135.2
Q ss_pred cceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeE------EeeC-CEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGF------CLHN-KCMF 583 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~------~~~~-~~~~ 583 (764)
....+|+|+.+.+|-.-. -+..+.|++....... .- +.++.+... .||-+-.=+.| ..+. ...-
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~-----~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAA-----QA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchH-----HH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 456799999999997521 1123567776654431 11 223333333 56654331221 1122 2366
Q ss_pred EEEEecCCC-CHHHHHh---cCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 584 LIYEYMERG-SLFCVLR---NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 584 lv~e~~~~~-~L~~~l~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
+.|+.+.+. ....+.. ++.......|.-..+.++.++.|.+.|| ..|.+-||+.++|+|+++++.|.|.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 788888765 3333332 2234456889999999999999999999 88999999999999999999999998665
Q ss_pred ccccCCCCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhC-CCCCCcccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMG-SHPTDLLSS 718 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~ 718 (764)
-... ..+......+|.+.|.+||.-. +..-+...|.|.+|+++++++.| ++||.++..
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~ 227 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL 227 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence 4332 3444455678999999999754 44556789999999999999986 999988754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.1e-10 Score=107.19 Aligned_cols=151 Identities=26% Similarity=0.362 Sum_probs=114.0
Q ss_pred HHHhcCCCceeeEeeEEeeCC-----EEEEEEEecCCCCHHHHHhcCcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004268 560 LLSQIRHRNIVKLYGFCLHNK-----CMFLIYEYMERGSLFCVLRNDVE-AVELDWTKRVNIVKSMAHALSYLHYDCKPS 633 (764)
Q Consensus 560 ~l~~l~hpniv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 633 (764)
-+-++-|.|+++++.|+.+.+ ...+++|||..|++..++++... ...+......+|+-||+.||.|||.. +..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344456999999999886644 47889999999999999986432 34577778889999999999999965 889
Q ss_pred cEEcCCCCCCeeecCCCCEEEeeeccccccCCC----CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 004268 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPD----SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709 (764)
Q Consensus 634 iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg 709 (764)
|+|+++.-+-|++..+|-+|++--.-......- ......-.+-++|.|||.-.....+.++|||++|+...+|..|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998887432111110000 0001122456889999986666677789999999999999887
Q ss_pred CC
Q 004268 710 SH 711 (764)
Q Consensus 710 ~~ 711 (764)
..
T Consensus 279 Ei 280 (458)
T KOG1266|consen 279 EI 280 (458)
T ss_pred ee
Confidence 64
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.1e-09 Score=99.87 Aligned_cols=139 Identities=24% Similarity=0.249 Sum_probs=103.7
Q ss_pred CCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC-----------------c--HHHHHHHHHHHHHHHhcCCC--c
Q 004268 510 FHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE-----------------E--PAFLESFQTEARLLSQIRHR--N 568 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~--~~~~~~~~~E~~~l~~l~hp--n 568 (764)
+.+...||-|--+.||.|....|.++|+|.-...... + .......++|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4456789999999999999999999999965432211 0 11234578999999999644 6
Q ss_pred eeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 569 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
|++.+++ +.-.+|||+++|..|...- ++......++..|+.-+.-.- ..|+||||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 7777766 4457999999986654332 133444556666777766666 679999999999999999
Q ss_pred CCCEEEeeecccccc
Q 004268 649 NLEAFVADFGLARLL 663 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~ 663 (764)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-08 Score=98.80 Aligned_cols=143 Identities=20% Similarity=0.147 Sum_probs=100.1
Q ss_pred eeeecCceeEEEEEECCCCEEEEEEccCCCCCc---H-----HHHHHHHHHHHHHHhcCCC--ceeeEeeEEee-----C
Q 004268 515 CIGTGGYGSVYRAQLSSGKLVALKKLHRSETEE---P-----AFLESFQTEARLLSQIRHR--NIVKLYGFCLH-----N 579 (764)
Q Consensus 515 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~-----~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~-----~ 579 (764)
.+-......|+++... |+.|.||......... . .....+.+|.+.+.++..- .+++.+++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3444444456677664 7889999774433110 0 0012477899988888433 33445555543 2
Q ss_pred CEEEEEEEecCCC-CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-------CCC
Q 004268 580 KCMFLIYEYMERG-SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-------NLE 651 (764)
Q Consensus 580 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~~~ 651 (764)
...++|||++++. +|.+++.... ..+.+......++.+++..+.-|| .+||+|+|+++.|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 3478999999986 8988885321 233455677789999999999999 999999999999999975 468
Q ss_pred EEEeeeccccc
Q 004268 652 AFVADFGLARL 662 (764)
Q Consensus 652 ~kl~Dfg~~~~ 662 (764)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998854
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.7e-10 Score=108.80 Aligned_cols=221 Identities=24% Similarity=0.260 Sum_probs=120.3
Q ss_pred CCCEEecCCCcccccCCc-cCc-CCCCCCEEEccCCcCcc--cCCccccCCCCcCEEecccCcccccCCccc-cCCCCCC
Q 004268 92 DLLDLNLSNNILNGSIPL-EFG-NLKDLDQLRLQGNKLDG--LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLK 166 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~-~~~-~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~ 166 (764)
-++-|.|.++.|..+... .|+ ..+.+++|||.+|.|+. .+...+.++|.|+.|+|+.|++...+ ..+ ..+.+|+
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~lp~p~~nl~ 124 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KSLPLPLKNLR 124 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-ccCcccccceE
Confidence 344555555555533221 122 24566777777777762 22334556777777777777776322 223 3456777
Q ss_pred eeecccCCCCC-CCCCccccCCCccEEEecCccCcCCc--ccccCCc-cccceeeccCcccccc--cCccccCCCCCCEE
Q 004268 167 SLFLDNNHLSG-PIPSTLYHLNQLATLCLGYNKLVGPV--TKEVGNM-KNLDRLHLNGNNLTGS--IPSTIGYLNLLDEL 240 (764)
Q Consensus 167 ~L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~n~i~~~~--~~~~~~l-~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L 240 (764)
.|-|.+..+.. .....+..++.+++|++|.|.++.+. .+..... +.+++|++..|..... ....-+-++++..+
T Consensus 125 ~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv 204 (418)
T KOG2982|consen 125 VLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSV 204 (418)
T ss_pred EEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhe
Confidence 77777766652 22234556677777777777544321 1122211 3455555555543311 01112334667777
Q ss_pred EccCCcccCCC-CcCCcCCCCCCeEEccCCcccCC-CCccccCCCCCCeEeccCccccCCCCCC------CCCCCccceE
Q 004268 241 HLSHNRLDGPI-PPTIGNLTNLIALDLSSNQLSGL-LPREVGNLKYLASLSLNGNILIGPIPPT------IGYLTNLTYL 312 (764)
Q Consensus 241 ~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L 312 (764)
.+..|.+.... ...+..++.+..|+|+.|+|... ..+++.++++|..|.+++|.+.+..... ++.+++++.|
T Consensus 205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vL 284 (418)
T KOG2982|consen 205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVL 284 (418)
T ss_pred eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEe
Confidence 77777665432 23455566777788888887532 3456777777888888877776433221 3445555555
Q ss_pred E
Q 004268 313 N 313 (764)
Q Consensus 313 ~ 313 (764)
+
T Consensus 285 N 285 (418)
T KOG2982|consen 285 N 285 (418)
T ss_pred c
Confidence 4
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.1e-11 Score=128.13 Aligned_cols=127 Identities=29% Similarity=0.367 Sum_probs=62.9
Q ss_pred CCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCCh-hhhcccccceeec
Q 004268 260 NLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPP-ELMNCSQLLNLVL 338 (764)
Q Consensus 260 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~l 338 (764)
.|...+.++|.+. .....+.-++.|+.|+|++|++... ..+..++.|++|||++|.++ .+|. ...++. |..|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 3445555555554 3334455555555555555555543 24555555555555555555 2222 222232 555555
Q ss_pred cccccccCCchhcccccccceeecccccccCCCC-CCCCCCCccceecCCCCcccc
Q 004268 339 SHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP-SQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 339 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~ 393 (764)
++|.++.. ..+.+|.+|+.|||++|-|.+.-. ..++.+..|+.|+|.||++.+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 55555522 234555555555555555543211 223444555556666666553
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.5e-11 Score=124.52 Aligned_cols=127 Identities=31% Similarity=0.334 Sum_probs=78.9
Q ss_pred ccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEecc
Q 004268 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291 (764)
Q Consensus 212 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 291 (764)
.|...+.+.|.+. .....+.-++.|+.|+|++|++... +.+..++.|++|||++|.+....--...++. |..|.+.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4556666666666 4455566666777777777777644 3566777777777777777643322233343 6777777
Q ss_pred CccccCCCCCCCCCCCccceEEccCCcCccC-CChhhhcccccceeeccccccc
Q 004268 292 GNILIGPIPPTIGYLTNLTYLNLGYNRLSSS-IPPELMNCSQLLNLVLSHNSLS 344 (764)
Q Consensus 292 ~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~ 344 (764)
+|.++.. -.+.++.+|+.||+++|-|.+. .-..++.+..|+.|+|.||++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7766543 3456667777777777766642 1233456666777777777765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=88.53 Aligned_cols=142 Identities=15% Similarity=0.084 Sum_probs=102.1
Q ss_pred eeecCceeEEEEEECCCCEEEEEEccCCCCCc---HHHHHHHHHHHHHHHhcCC--CceeeEeeEEee----CCEEEEEE
Q 004268 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEE---PAFLESFQTEARLLSQIRH--RNIVKLYGFCLH----NKCMFLIY 586 (764)
Q Consensus 516 ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~----~~~~~lv~ 586 (764)
-|+||.+-|++.... |+.+-+|.-...-... +--...|.+|...++++.. -.+++...+... .-..++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367888999998776 5578888654111110 1123678899999999842 225555522212 12368999
Q ss_pred EecCC-CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC--EEEeeeccccc
Q 004268 587 EYMER-GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE--AFVADFGLARL 662 (764)
Q Consensus 587 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~ 662 (764)
|-+++ .+|.+++... ...+.+......+..+++.++.-|| +.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97765 3888888643 2334577777899999999999999 999999999999999986666 99999988764
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-09 Score=104.08 Aligned_cols=216 Identities=23% Similarity=0.189 Sum_probs=118.7
Q ss_pred ccCCccccCCCCCcEEEcCCCcCcccCC-ccc-cCCCCCCEEEccCCcCc--ccCCcccCCCCCCCEEecCCCcccccCC
Q 004268 33 GRMPSEIGALSKLEKLVLSHNSLTGRIP-SEI-GALSRLKVLDLSYNRLT--GTIPSEIGSLRDLLDLNLSNNILNGSIP 108 (764)
Q Consensus 33 ~~~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~-~~l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 108 (764)
|..+-.+..++-++.|.+.++.|..+.. ..| ...+.++.|||.+|.|+ +.+...+.++|.|+.|+|+.|++...+.
T Consensus 35 g~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~ 114 (418)
T KOG2982|consen 35 GLSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK 114 (418)
T ss_pred ccceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc
Confidence 3444445555667777777777763311 122 24678888899999887 3445667788889999999998874332
Q ss_pred ccCcCCCCCCEEEccCCcCccc-CCccccCCCCcCEEecccCcccc--cCCccccCC-CCCCeeecccCCCCC--CCCCc
Q 004268 109 LEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSG--RLPQEVGNL-KNLKSLFLDNNHLSG--PIPST 182 (764)
Q Consensus 109 ~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l-~~L~~L~L~~n~i~~--~~~~~ 182 (764)
..=..+.+|+.|.|.+..+..- ....+..+|.+++|++|.|.+.. +..+..... +.+++|++..|.... .....
T Consensus 115 ~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l 194 (418)
T KOG2982|consen 115 SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKL 194 (418)
T ss_pred cCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhH
Confidence 2213567888888888888632 23346677888888888885432 222222222 245555554443210 00001
Q ss_pred cccCCCccEEEecCccCcCCc-ccccCCccccceeeccCccccccc-CccccCCCCCCEEEccCCccc
Q 004268 183 LYHLNQLATLCLGYNKLVGPV-TKEVGNMKNLDRLHLNGNNLTGSI-PSTIGYLNLLDELHLSHNRLD 248 (764)
Q Consensus 183 ~~~l~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~ 248 (764)
-.-.+++..+-+..|.+.+.. ...+..++.+.-|+|+.|++.... -+.+..+++|..|.+++|.+.
T Consensus 195 ~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 195 SRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred HhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 122345555555555554332 223344445555555555554221 123444444555555544444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.2e-07 Score=88.91 Aligned_cols=106 Identities=23% Similarity=0.322 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHhcC--CCceeeEeeEEeeCC----EEEEEEEecCCC-CHHHHHhcCccccccCHHHHHHHHHHHHHHHH
Q 004268 552 ESFQTEARLLSQIR--HRNIVKLYGFCLHNK----CMFLIYEYMERG-SLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624 (764)
Q Consensus 552 ~~~~~E~~~l~~l~--hpniv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~ 624 (764)
....+|.+.+..+. .=.+++.+++.+... ..++|+|++++. +|.+++.... ..+......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence 46778888888874 334566677666532 358999999985 7999887422 1455667889999999999
Q ss_pred HHHhcCCCCcEEcCCCCCCeeecCCC---CEEEeeecccccc
Q 004268 625 YLHYDCKPSIVHRDISSNNILLNSNL---EAFVADFGLARLL 663 (764)
Q Consensus 625 ~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~ 663 (764)
-|| .+||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999 99999999999999999877 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.7e-07 Score=94.02 Aligned_cols=169 Identities=17% Similarity=0.311 Sum_probs=126.8
Q ss_pred CceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCEEEEEEEecCCC-C
Q 004268 520 GYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKCMFLIYEYMERG-S 593 (764)
Q Consensus 520 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~~~~~-~ 593 (764)
...+.|++.. .+|..|++|+++....... .....-+++++++.|+|||++.+++.. +...++|++|+++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 4468899964 4899999999955443332 223355888999999999999998863 45689999999875 6
Q ss_pred HHHHHhcCc------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 594 LFCVLRNDV------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 594 L~~~l~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
|.++--... .....++..+|.++.|+..||.++| +.|..-+-+.|.+|+++.+.+++|...|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEeccccee
Confidence 655442111 2234678899999999999999999 9999999999999999999999998877765
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSH 711 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~ 711 (764)
....+.. |.+.+ -.+-|.=.||.++..|.||..
T Consensus 442 vl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 5543320 11111 135699999999999999954
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-09 Score=90.89 Aligned_cols=135 Identities=27% Similarity=0.193 Sum_probs=84.3
Q ss_pred CCCeEEccCCcccCCCCcc---ccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccccee
Q 004268 260 NLIALDLSSNQLSGLLPRE---VGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336 (764)
Q Consensus 260 ~L~~L~L~~n~l~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L 336 (764)
.+-.++|++|++.. .++. +.....|+..+|++|.+.+..+..-...+.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 28 E~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred HhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 34556777776652 2222 334455666677777776544444445567777888888887 567777778888888
Q ss_pred eccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCc
Q 004268 337 VLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS 398 (764)
Q Consensus 337 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 398 (764)
+++.|++. ..|..+..+.+|-.||..+|.+..+... +-.-...-.+++.++++.+..+.-
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccccCccc
Confidence 88888877 6666666777777778777777633333 322223333455666776655543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.5e-07 Score=85.84 Aligned_cols=158 Identities=22% Similarity=0.260 Sum_probs=107.0
Q ss_pred cCHHHHHHHhhcCCcceee---eecCceeEEEEEECCCCEEEEEEccCCCCCcHH---------------------HHHH
Q 004268 498 ITFEEMIEATEDFHIKYCI---GTGGYGSVYRAQLSSGKLVALKKLHRSETEEPA---------------------FLES 553 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~~~i---g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~~ 553 (764)
.+.+.+.....+..+.... ++|.-+.||+|...++..+|+|++......-.. ...-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4566777777777776654 457778999998888999999998754322111 0112
Q ss_pred HHHHHHHHHhcC--CCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 004268 554 FQTEARLLSQIR--HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK 631 (764)
Q Consensus 554 ~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~ 631 (764)
..+|+.-|+++. +-.+++.+++.. -.+||||+..... -.-.....++....+..+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 356777777773 444555555543 3699999965411 0000011122333577788888888888872 3
Q ss_pred CCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 632 PSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 632 ~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
.|+||+||+.-|||+. ++.+.++|||.|.....
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 7999999999999999 88999999999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 764 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-31 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-08 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-31 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-10 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-10 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-09 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 4e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 8e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 4fmz_A | 347 | Crystal Structure Of An Internalin (Inlf) From List | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 5e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 3e-06 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 4e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 2e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 7e-04 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 764 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-128 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-121 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-120 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-118 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-112 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-110 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-99 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-39 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-84 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 5e-81 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-79 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-08 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-82 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-73 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 7e-82 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-78 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-77 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-76 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-73 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-64 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-48 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-35 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-12 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-76 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-73 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-67 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-67 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-51 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-46 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-08 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-08 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-60 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-56 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-67 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-65 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-62 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-60 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-29 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-66 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-63 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-62 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-47 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-61 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-60 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-59 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-57 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-53 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-46 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-22 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-59 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-54 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-54 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-53 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-55 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-52 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-55 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-53 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-53 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 7e-53 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-53 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 7e-47 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-07 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-52 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-52 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-51 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-51 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-50 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-49 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-48 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 4e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-50 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-46 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-45 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-49 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 6e-48 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-44 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-38 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-46 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-44 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-41 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-45 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-40 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-45 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-45 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-41 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-27 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-45 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-44 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-20 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-09 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-44 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-42 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-42 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-38 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-36 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-40 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-40 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-36 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-25 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-38 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-38 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-38 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-38 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-38 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-12 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-37 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-37 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 9e-34 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-26 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-05 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-36 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-36 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-36 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-36 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-36 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 4e-35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-08 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-36 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 9e-36 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-35 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-35 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-35 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-32 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-35 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-33 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-25 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-35 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-35 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-34 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-34 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-34 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-34 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-34 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-34 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-34 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-34 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-34 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-34 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 9e-34 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-33 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-33 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-33 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-33 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-28 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-23 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-33 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-33 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-33 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-33 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 9e-33 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-32 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-32 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-32 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-32 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-32 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-32 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-26 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-32 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 6e-32 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-32 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-29 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-31 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-31 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-31 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-31 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-31 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-31 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-31 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-31 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-31 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 7e-31 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 8e-31 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-31 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-30 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-25 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-20 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 9e-31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-31 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-30 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-30 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-30 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-30 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-30 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-30 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-30 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-30 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-30 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-30 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-30 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-29 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-29 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-29 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-29 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-29 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-29 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-29 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-29 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-29 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-29 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-29 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-29 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-28 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-24 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-21 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-28 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-28 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-28 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-28 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-28 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-28 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-28 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-27 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-27 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-27 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-27 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-27 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-27 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-26 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-26 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-26 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-26 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-26 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-26 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-26 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-26 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-26 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-26 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-23 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-26 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-25 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-25 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-25 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-21 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-16 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-25 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-25 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-25 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-25 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-25 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-20 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-16 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 9e-25 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-24 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-24 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-06 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-24 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-24 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-24 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-23 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-23 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-22 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-09 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-23 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-23 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 8e-23 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-23 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-22 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-22 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-22 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-20 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-20 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-19 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-17 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-14 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-20 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-20 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-20 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-20 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-20 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-19 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-19 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-11 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-18 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-18 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-18 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 6e-18 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-17 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-17 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-17 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-17 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-17 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-15 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 6e-17 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 9e-17 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-16 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-16 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-16 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-15 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 8e-15 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-09 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-15 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-06 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-14 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-12 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 8e-12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-11 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-10 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 8e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 2e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 5e-10 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-04 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 7e-10 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-10 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 3e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 6e-09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 6e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-08 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-07 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-07 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-128
Identities = 143/441 (32%), Positives = 212/441 (48%), Gaps = 30/441 (6%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N FTG L+ C L + G G +P G+ S LE L LS N+ +G +P
Sbjct: 278 ENKFTGEIPDFLSGAC-DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 62 E-IGALSRLKVLDLSYNRLTGTIPSEIGSLR-DLLDLNLSNNILNGSIPLEFGN--LKDL 117
+ + + LKVLDLS+N +G +P + +L LL L+LS+N +G I L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177
+L LQ N G IP ++ N + L L LS N LSG +P +G+L L+ L L N L G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456
Query: 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLL 237
IP L ++ L TL L +N L G + + N NL+ + L+ N LTG IP IG L L
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516
Query: 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLAS---------- 287
L LS+N G IP +G+ +LI LDL++N +G +P + +
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576
Query: 288 ------------LSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
+ N G + L+ N+ P N ++
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395
L +S+N LSG IP EIG++ + L+L N I+G+IP ++G + ++ +DLS N L G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 396 PASVRRIPKLI---VSENNLE 413
P ++ + L +S NNL
Sbjct: 697 PQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-121
Identities = 129/400 (32%), Positives = 193/400 (48%), Gaps = 10/400 (2%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALS-KLEKLVLSHNSLTGRIP 60
NNF+G EL L + SG +P + LS L L LS N+ +G I
Sbjct: 327 SNNFSG-ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 61 SEIG--ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLD 118
+ + L+ L L N TG IP + + +L+ L+LS N L+G+IP G+L L
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR 445
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178
L+L N L+G IP + + L L L N L+G +P + N NL + L NN L+G
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505
Query: 179 IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLD 238
IP + L LA L L N G + E+G+ ++L L LN N G+IP+ + +
Sbjct: 506 IPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK- 564
Query: 239 ELHLSHNRLDGPIPPTIGNLTNLIALDLSSN--QLSGLLPREVGNLKYLASLSLNGNILI 296
++ N + G I N + N + G+ ++ L ++ +
Sbjct: 565 ---IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 297 GPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIF 356
G PT ++ +L++ YN LS IP E+ + L L L HN +SGSIP E+G+L
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 357 FRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396
LDLS N ++G IP + + ++ +DLS NNLSG IP
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-120
Identities = 138/424 (32%), Positives = 200/424 (47%), Gaps = 16/424 (3%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
N +G ++ + NL + S +P +G S L+ L +S N L+G
Sbjct: 187 GNKISG----DVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQL 120
I + LK+L++S N+ G IP L+ L L+L+ N G IP G L L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPI 179
L GN G +P G+ + L L LS N SG LP + ++ LK L L N SG +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 180 PSTLYHL-NQLATLCLGYNKLVGPVTKEVGN--MKNLDRLHLNGNNLTGSIPSTIGYLNL 236
P +L +L L TL L N GP+ + L L+L N TG IP T+ +
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI 296
L LHLS N L G IP ++G+L+ L L L N L G +P+E+ +K L +L L+ N L
Sbjct: 420 LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479
Query: 297 GPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIF 356
G IP + TNL +++L NRL+ IP + L L LS+NS SG+IP+E+G+
Sbjct: 480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539
Query: 357 FRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
LDL+ N NGTIP+ + K ++ N ++G ++ L
Sbjct: 540 LIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 417 STSS 420
Sbjct: 596 FQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-118
Identities = 138/426 (32%), Positives = 207/426 (48%), Gaps = 22/426 (5%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPS--EIGALSKLEKLVLSHNSLTGRI 59
+++ G+ F C +L + + LSG + + +G+ S L+ L +S N+L
Sbjct: 86 NSHINGSVSG---FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142
Query: 60 PSEIGA-LSRLKVLDLSYNRLTGTIPSEI---GSLRDLLDLNLSNNILNGSIPLEFGNLK 115
G L+ L+VLDLS N ++G +L L +S N ++G + +
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCV 200
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175
+L+ L + N IP +G+ + L +LD+S N+LSG + + LK L + +N
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYL 234
GPIP L L L L NK G + + G L L L+GN+ G++P G
Sbjct: 260 VGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 235 NLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKY-LASLSLNG 292
+LL+ L LS N G +P T+ + L LDLS N+ SG LP + NL L +L L+
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 293 NILIGPIPPTIG--YLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSE 350
N GPI P + L L L N + IPP L NCS+L++L LS N LSG+IPS
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 351 IGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV--- 407
+G+L R L L N + G IP +L + + + L N+L+G IP+ + L
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497
Query: 408 SENNLE 413
S N L
Sbjct: 498 SNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-112
Identities = 122/399 (30%), Positives = 182/399 (45%), Gaps = 20/399 (5%)
Query: 29 TLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPS--E 86
+ + S + +L+ LE L LS++ + G + + L LDLS N L+G + +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 87 IGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSI---GNLTNLT 142
+GS L LN+S+N L+ + L L+ L L N + G L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202
+L +S N++SG + V NL+ L + +N+ S IP L + L L + NKL G
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238
Query: 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNL 261
++ + L L+++ N G IP L L L L+ N+ G IP + G L
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTL 296
Query: 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLS 320
LDLS N G +P G+ L SL+L+ N G +P T+ + L L+L +N S
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 321 SSIPPELMNCS-QLLNLVLSHNSLSGSIPSEIGNLIFF--RQLDLSRNFINGTIPSQLGK 377
+P L N S LL L LS N+ SG I + ++L L N G IP L
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 378 IPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
+ ++ LS N LSG IP+S+ + KL N LE
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-110
Identities = 129/387 (33%), Positives = 183/387 (47%), Gaps = 11/387 (2%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIG--ALSKLEKLVLSHNSLTGRI 59
N F+G EL + +L+T + SG + + + L++L L +N TG+I
Sbjct: 352 FNEFSG-ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 60 PSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119
P + S L L LS+N L+GTIPS +GSL L DL L N+L G IP E +K L+
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
L L N L G IPS + N TNL ++ LS N+L+G +P+ +G L+NL L L NN SG I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE 239
P+ L L L L N G + + + N + G I + E
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKE 586
Query: 240 LHLSHN--RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG 297
H + N G + L+ +++S G N + L ++ N+L G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 298 PIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF 357
IP IG + L LNLG+N +S SIP E+ + L L LS N L G IP + L
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 358 RQLDLSRNFINGTIPS--QLGKIPNIS 382
++DLS N ++G IP Q P
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAK 733
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = 2e-99
Identities = 113/388 (29%), Positives = 168/388 (43%), Gaps = 23/388 (5%)
Query: 43 SKLEKLVLSHNSLT---GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99
K+ + LS L + S + +L+ L+ L LS + + G++ L L+LS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 100 NNILNGSIP--LEFGNLKDLDQLRLQGNKLDGLIPSSIG-NLTNLTYLDLSLNQLSGRLP 156
N L+G + G+ L L + N LD S G L +L LDLS N +SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 157 QEV---GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNL 213
LK L + N +SG + + L L + N + +G+ L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSG 273
L ++GN L+G I L L++S N+ GPIPP L +L L L+ N+ +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 274 LLPREV-GNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCS 331
+P + G L L L+GN G +PP G + L L L N S +P + L+
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 332 QLLNLVLSHNSLSGSIPSEIGNLIFF-RQLDLSRNFINGTIPSQLGKIP--NISAVDLSK 388
L L LS N SG +P + NL LDLS N +G I L + P + + L
Sbjct: 344 GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN 403
Query: 389 NNLSGVIPASVRRIPKLIV---SENNLE 413
N +G IP ++ +L+ S N L
Sbjct: 404 NGFTGKIPPTLSNCSELVSLHLSFNYLS 431
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 7e-63
Identities = 79/290 (27%), Positives = 122/290 (42%), Gaps = 19/290 (6%)
Query: 137 NLTNLTYLDLSLNQLS---GRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+T +DLS L+ + + +L L+SLFL N+H++G + L +L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106
Query: 194 LGYNKLVG--PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGY-LNLLDELHLSHNRLDGP 250
L N L G +G+ L L+++ N L + G LN L+ L LS N + G
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 251 IPPTI---GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307
L L +S N++SG + V L L ++ N I P +G +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCS 223
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367
L +L++ N+LS + C++L L +S N G IP L + L L+ N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 368 NGTIPSQL-GKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
G IP L G ++ +DLS N+ G +P L S NN
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-51
Identities = 76/309 (24%), Positives = 127/309 (41%), Gaps = 51/309 (16%)
Query: 150 QLSGRLPQEVGNLKNLKSLFLDNNHLS--------------------------------- 176
S L +E+ L + K + D N L
Sbjct: 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNV 64
Query: 177 --GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPS--TIG 232
+ S+L L L +L L + + G V+ +L L L+ N+L+G + + ++G
Sbjct: 65 GFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 233 YLNLLDELHLSHNRLDGPIP-PTIGNLTNLIALDLSSNQLSGLLPREV---GNLKYLASL 288
+ L L++S N LD P L +L LDLS+N +SG L L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 289 SLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIP 348
+++GN + G + + NL +L++ N S+ I P L +CS L +L +S N LSG
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFS 240
Query: 349 SEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV----RRIPK 404
I + L++S N G IP + ++ + L++N +G IP + +
Sbjct: 241 RAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTG 298
Query: 405 LIVSENNLE 413
L +S N+
Sbjct: 299 LDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-39
Identities = 59/179 (32%), Positives = 82/179 (45%), Gaps = 2/179 (1%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
N G + G ++ LS ++ G
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
Query: 61 SEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120
+ LD+SYN L+G IP EIGS+ L LNL +N ++GSIP E G+L+ L+ L
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL-KSLFLDNNHLSGP 178
L NKLDG IP ++ LT LT +DLS N LSG +P+ G + + FL+N L G
Sbjct: 686 DLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 7e-89
Identities = 72/446 (16%), Positives = 160/446 (35%), Gaps = 44/446 (9%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
++ + F +L+ I + K ++ N++T +
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA 201
Query: 63 IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122
+ L++L+ + + E N + L++ NLKDL + +
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQL--------SGRLPQEVGNLKNLKSLFLDNNH 174
+P+ + L + ++++ N+ + + + ++ +++ N+
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 175 L-SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGY 233
L + P+ ++L + +L L YN+L G + G+ L L+L N +T + G+
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 234 LNLLDELHLSHNRLDG-PIPPTIGNLTNLIALDLSSNQLSGL-------LPREVGNLKYL 285
++ L +HN+L P +++ + A+D S N++ + L +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS-------SIPPELMNCSQLLNLVL 338
+S++L+ N + + L+ +NL N L+ N L ++ L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 339 SHNSLSGSIPSEI--GNLIFFRQLDLSRNFINGTIPSQLGKIPNISA------VDLSKNN 390
N L+ + + L + +DLS N + P+Q + D N
Sbjct: 496 RFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553
Query: 391 LSGVIPASVRRIPKLIV---SENNLE 413
P + P L N++
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIR 579
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 3e-84
Identities = 75/433 (17%), Positives = 158/433 (36%), Gaps = 42/433 (9%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
+ L+KL + + ++ E + Y + T + +L+DL D
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTD 253
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL--------IPSSIGNLTNLTYLDLS 147
+ + N +P L ++ + + N+ + + + +
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 148 LNQL-SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206
N L + + + +K L L N L G +P+ +LA+L L YN++
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANF 372
Query: 207 VGNMKNLDRLHLNGNNLTGSIPST--IGYLNLLDELHLSHNRLDG-------PIPPTIGN 257
G + ++ L N L IP+ ++++ + S+N + P+ PT
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL-------IGPIPPTIGYLTNLT 310
N+ +++LS+NQ+S L+S++L GN+L + LT
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 311 YLNLGYNRLSSSIPPELM--NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQL------DL 362
++L +N+L+ + + L+ + LS+NS S P++ N + D
Sbjct: 492 SIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSEN 422
N P + P+++ + + N++ V I L + +N + +
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDLSYVCP 609
Query: 423 APPPQATLFKGNK 435
+ +K
Sbjct: 610 YIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 5e-81
Identities = 73/404 (18%), Positives = 134/404 (33%), Gaps = 37/404 (9%)
Query: 38 EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG----TIPSEIGSLRDL 93
+ + ++ L L +GR+P IG L+ L+VL L + P I +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 94 LDLNLSNNILNGSIP--LEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
+ + DL + + + I S T + N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
+ + + V L L+ ++ N+ + Y + + N+K
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLK 249
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL--------DGPIPPTIGNLTNLIA 263
+L + + +P+ + L + ++++ NR D +
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 264 LDLSSNQLSGL-LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322
+ + N L + + +K L L N L G P G L LNL YN++ +
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQI-TE 367
Query: 323 IPPELM-NCSQLLNLVLSHNSLSGSIPS--EIGNLIFFRQLDLSRNFING-------TIP 372
IP Q+ NL +HN L IP+ + ++ +D S N I +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 373 SQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
K N+S+++LS N +S L N L
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 4e-79
Identities = 69/404 (17%), Positives = 146/404 (36%), Gaps = 48/404 (11%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT--------GRIPSEIGALSRL 69
+L ++ ++P+ + AL +++ + ++ N + ++ ++
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 70 KVLDLSYNRL-TGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
+++ + YN L T + + + ++ L L N L G +P FG+ L L L N++
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQ--EVGNLKNLKSLFLDNNHLSG-------PI 179
+ + G + L + N+L +P + ++ + ++ N + P+
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG-------SIPSTIG 232
T + ++++ L N++ + L ++L GN LT
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 233 YLNLLDELHLSHNRLDGPIPPTI--GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSL 290
LL + L N+L + L L+ +DLS N S P + N L +
Sbjct: 486 NTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGI 543
Query: 291 N------GNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
GN + P I +LT L +G N + + ++ + L + N
Sbjct: 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT--PNISVLDIKDNPNI 600
Query: 345 GSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
S + I L + + I A+D+ +
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYD--------KTQDIRGCDALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 1e-75
Identities = 63/408 (15%), Positives = 135/408 (33%), Gaps = 37/408 (9%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGAL--SRLKVLDLSYNRLTGTIPSEIGSLRDL 93
P I A E+ S L ++ + +I
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSG 153
+ +N + + L L Q + + N Y Q
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYK 239
Query: 154 RLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVT--------K 205
+ NLK+L + + N +P+ L L ++ + + N+ +
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 206 EVGNMKNLDRLHLNGNNL-TGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIAL 264
+ + + +++ NNL T + +++ + L L +N+L+G P G+ L +L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASL 358
Query: 265 DLSSNQLSGLLPREVGNLKYLASLSLNGNILIG-PIPPTIGYLTNLTYLNLGYNRLSS-- 321
+L+ NQ++ + G + + +LS N L P ++ ++ ++ YN + S
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 322 -----SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFING------- 369
+ P + ++ LS+N +S ++L N +
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 370 TIPSQLGKIPNISAVDLSKNNLSGVIPA-SVRRIPKLIV---SENNLE 413
++++DL N L+ + +P L+ S N+
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS 526
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-63
Identities = 55/349 (15%), Positives = 120/349 (34%), Gaps = 34/349 (9%)
Query: 2 DNNFTGAELSQLNFTCFP------NLVTFRIWGT-LLSGRMPSEIGALSKLEKLVLSHNS 54
N E + ++ + I L + + + + + KL L +N
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341
Query: 55 LTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG-SIPLEFGN 113
L G G+ +L L+L+YN++T + G + +L+ ++N L + +
Sbjct: 342 LEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400
Query: 114 LKDLDQLRLQGNKLDGL-------IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLK 166
+ + + N++ + + + N++ ++LS NQ+S + L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 167 SLFLDNNHLSG-------PIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHL 218
S+ L N L+ + L ++ L +NKL + L + L
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDL 520
Query: 219 NGNNLTGSIPSTIG------YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272
+ N+ + P+ + ++ NR P I +L L + SN +
Sbjct: 521 SYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
Query: 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
+ ++ ++ L + N I + L Y++
Sbjct: 580 K-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-57
Identities = 46/337 (13%), Positives = 112/337 (33%), Gaps = 25/337 (7%)
Query: 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSG- 153
+ N ++ + + + L L+G G +P +IG LT L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 154 ---RLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLN--QLATLCLGYNKLVGPVTKEVG 208
P+ + + + H + L C+ + + K
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
++ NN+T + + L L + ++ ++ N
Sbjct: 181 ITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEY 234
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS------- 321
Q + NLK L + + + +P + L + +N+ NR S
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 322 -SIPPELMNCSQLLNLVLSHNSL-SGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIP 379
+ ++ + + +N+L + + + + + L+ N + G +P+ G
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEI 353
Query: 380 NISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
+++++L+ N ++ + ++ + N L+
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 20/162 (12%), Positives = 41/162 (25%), Gaps = 32/162 (19%)
Query: 263 ALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322
AL+ + G + N + L + G ++ +T L+L S
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQ----PGVSLNSNGRVTGLSLEGFGASGR 96
Query: 323 IPPELMNCSQLLNLVLSHNSLSG----SIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKI 378
+P + ++L L L + P I + Q R
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM------------- 143
Query: 379 PNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSS 420
+ R + ++ + + S
Sbjct: 144 -----------HYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-86
Identities = 86/303 (28%), Positives = 120/303 (39%), Gaps = 31/303 (10%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGT--IPSEIGSLRDLLDLNLSN-NILNGS 106
+ + G + R+ LDLS L IPS + +L L L + N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 107 IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLK 166
IP L L L + + G IP + + L LD S N LSG LP + +L NL
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 167 SLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR-LHLNGNNLTG 225
+ D N +SG IP G+ L + ++ N LTG
Sbjct: 153 GITFDGNRISGAIPD------------------------SYGSFSKLFTSMTISRNRLTG 188
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285
IP T LN L + LS N L+G G+ N + L+ N L+ L +VG K L
Sbjct: 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL 246
Query: 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSG 345
L L N + G +P + L L LN+ +N L IP N + ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLC 305
Query: 346 SIP 348
P
Sbjct: 306 GSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 6e-86
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 31/300 (10%)
Query: 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG--LIPSSIGNLTNLTYLDLS-LNQL 151
+ N G + ++ L L G L IPSS+ NL L +L + +N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
G +P + L L L++ + ++SG IP L +K
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL------------------------SQIK 125
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLI-ALDLSSNQ 270
L L + N L+G++P +I L L + NR+ G IP + G+ + L ++ +S N+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNC 330
L+G +P NL LA + L+ N+L G G N ++L N L+ + ++
Sbjct: 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLS 243
Query: 331 SQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390
L L L +N + G++P + L F L++S N + G IP G + + N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-82
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 33/288 (11%)
Query: 20 NLVTFRIWGTLLSGRM--PSEIGALSKLEKLVLSH-NSLTGRIPSEIGALSRLKVLDLSY 76
+ + G L PS + L L L + N+L G IP I L++L L +++
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 77 NRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIG 136
++G IP + ++ L+ L+ S N L+G++P +L +L + GN++ G IP S G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 137 NLTNL-TYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLG 195
+ + L T + +S N+L+G++P NL NL + L N L G
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF------------ 217
Query: 196 YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255
G+ KN ++HL N+L + +G L+ L L +NR+ G +P +
Sbjct: 218 ------------GSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 256 GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI--GPIPP 301
L L +L++S N L G +P+ GNL+ + N + P+P
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 1e-73
Identities = 81/294 (27%), Positives = 127/294 (43%), Gaps = 37/294 (12%)
Query: 131 IPSSIGNLTNL----TYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG--PIPSTLY 184
I +GN T L D G L + +L L +L PIPS
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS--- 70
Query: 185 HLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL-NGNNLTGSIPSTIGYLNLLDELHLS 243
+ N+ L+ L++ NNL G IP I L L L+++
Sbjct: 71 ---------------------SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109
Query: 244 HNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303
H + G IP + + L+ LD S N LSG LP + +L L ++ +GN + G IP +
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 304 GYLTNL-TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDL 362
G + L T + + NRL+ IPP N + L + LS N L G G+ +++ L
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLI---VSENNLE 413
++N + + +G N++ +DL N + G +P + ++ L VS NNL
Sbjct: 229 AKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 7e-82
Identities = 91/221 (41%), Positives = 128/221 (57%), Gaps = 4/221 (1%)
Query: 497 RITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQT 556
R + E+ A+++F K +G GG+G VY+ +L+ G LVA+K+L E FQT
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQT 76
Query: 557 EARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE-LDWTKRVNI 615
E ++S HRN+++L GFC+ L+Y YM GS+ LR E+ LDW KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 616 VKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN-RTLVV 674
A L+YLH C P I+HRD+ + NILL+ EA V DFGLA+L+ ++ T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715
GT G+IAPE T +EK DV+ +GV+ LE++ G DL
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-78
Identities = 91/443 (20%), Positives = 164/443 (37%), Gaps = 30/443 (6%)
Query: 4 NFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEI 63
+ + +L+Q+ N+ + L + S+L L + N+++ P
Sbjct: 10 DCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 64 GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123
L LKVL+L +N L+ +L +L+L +N + F K+L L L
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129
Query: 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN--LKSLFLDNNHLSGPIPS 181
N L + L NL L LS N++ +E+ N LK L L +N + P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVG---NMKNLDRLHLNGNNLTGSIPSTIGYLNL-- 236
+ + +L L L +L +T+++ ++ L L+ + L+ + +T L
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI 296
L L LS+N L+ + L L L N + L + L + L+L +
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 297 GPI---------PPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSI 347
I + +L L +LN+ N + L L LS++ S
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL-- 367
Query: 348 PSEIGNLIFF-------RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV- 399
+ N F L+L++N I+ + ++ +DL N + +
Sbjct: 368 -RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 400 ---RRIPKLIVSENNLELENSTS 419
I ++ +S N S
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-77
Identities = 91/445 (20%), Positives = 152/445 (34%), Gaps = 35/445 (7%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIG---ALSKLEKLVLSHNSLTGR 58
N S F L + L + ++ A + + L LS++ L+
Sbjct: 180 SNQIKE--FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 59 IPSEIGAL--SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKD 116
+ L + L +LDLSYN L L L L N + L +
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 117 LDQLRLQGN---------KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKS 167
+ L L+ + L + S L L +L++ N + G L NLK
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357
Query: 168 LFLDNNHLS--GPIPSTLYHL--NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
L L N+ S T L + L L L NK+ + + +L+ L L N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 224 TGSIP-STIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL--LPREVG 280
+ L + E++LS+N+ + + +L L L L + P
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 281 NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS--------SIPPELMNCSQ 332
L+ L L L+ N + + L L L+L +N L+ L S
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 333 LLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
L L L N +L + +DL N +N S ++ +++L KN ++
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 393 GVIPASVRRIPK----LIVSENNLE 413
V + L + N +
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-76
Identities = 96/455 (21%), Positives = 162/455 (35%), Gaps = 32/455 (7%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
N + +L+ +L + + P A+ +L L L++ L + +
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
Query: 63 IG---ALSRLKVLDLSYNRLTGTIPSEIGSLRD--LLDLNLSNNILNGSIPLEFGNLKDL 117
+ A + ++ L LS ++L+ T + L+ L L+LS N LN F L L
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDL---------SLNQLSGRLPQEVGNLKNLKSL 168
+ L+ N + L S+ L N+ YL+L SL L LK L+ L
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 169 FLDNNHLSGPIPSTLYHLNQLATLCLGYNKL----VGPVTKEVGNMKNLDRLHLNGNNLT 224
+++N + G + L L L L + + T L L+L N ++
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS 394
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
+L L+ L L N + + L N+ + LS N+ L +
Sbjct: 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVP 454
Query: 284 YLASLSLNGNIL--IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L L L L + P L NLT L+L N +++ L +L L L HN
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514
Query: 342 SLS--------GSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSG 393
+L+ G + L L+L N + + + +DL NNL+
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574
Query: 394 VIPASVRRIPKLIV---SENNLELENSTSSENAPP 425
+ + L +N + A
Sbjct: 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 9e-73
Identities = 83/372 (22%), Positives = 139/372 (37%), Gaps = 22/372 (5%)
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
+V D S+ +LT +P ++ ++ LNL++N L F L L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLN 187
L P L L L+L N+LS + NL L L +N + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL--LDELHLSHN 245
L TL L +N L ++NL L L+ N + + L +L LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG---NLKYLASLSLNGNILIGPIPPT 302
++ P + L L L++ QL L ++ + +LSL+ + L T
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 303 IGYL--TNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQL 360
L TNLT L+L YN L+ QL L +N++ + L R L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 361 DLSRNF---------INGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---S 408
+L R+F + + + +++ N++ G+ + L S
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 409 ENNLELENSTSS 420
+ L T+
Sbjct: 362 NSFTSLRTLTNE 373
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-64
Identities = 89/416 (21%), Positives = 143/416 (34%), Gaps = 34/416 (8%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHN-------- 53
NN + +F P L F + + + L + L L +
Sbjct: 257 YNNLNV--VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 54 -SLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGS--IPLE 110
SL L L+ L++ N + G + L +L L+LSN+ +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 111 FGNL--KDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKS 167
F +L L L L NK+ + + L +L LDL LN++ L + L+N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 168 LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL--VGPVTKEVGNMKNLDRLHLNGNNLTG 225
++L N ++ + L L L L V ++NL L L+ NN+
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 226 SIPSTIGYLNLLDELHLSHNRL--------DGPIPPTIGNLTNLIALDLSSNQLSGLLPR 277
+ L L+ L L HN L G + L++L L+L SN +
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM-NCSQLLNL 336
+L L + L N L +L LNL N ++S L L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 337 VLSHNSLSGSIPS-----EIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387
+ N + S N +LS +++ T P G + D S
Sbjct: 615 DMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF--PVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-48
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 13/284 (4%)
Query: 139 TNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198
+ D S +L+ ++P ++ N+ L L +N L + +QL +L +G+N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 199 LVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNL 258
+ + + L L+L N L+ T + L ELHL N +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 259 TNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL--TNLTYLNLGY 316
NLI LDLS N LS L+ L L L+ N + + ++L L L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG---NLIFFRQLDLSRNFINGTIPS 373
N++ P +L L L++ L S+ ++ R L LS + ++ T +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 374 QLG--KIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNL 412
K N++ +DLS NNL+ V S +P+L NN+
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-35
Identities = 59/285 (20%), Positives = 92/285 (32%), Gaps = 39/285 (13%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTG--RI 59
N EL+ + N+ + + + L++L+L +L
Sbjct: 414 LNEIGQ-ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS 472
Query: 60 PSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN--------GSIPLEF 111
PS L L +LDLS N + + L L L+L +N L G
Sbjct: 473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532
Query: 112 GNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD 171
L L L L+ N D + +L L +DL LN L+ N +LKSL L
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
Query: 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI 231
N ++ +NL L + N + S
Sbjct: 593 KNLITSVEKKVFGP-----------------------AFRNLTELDMRFNPFDCTCESIA 629
Query: 232 GYLNLLDELHLSHNRLDGPI----PPTIGNLTNLIALDLSSNQLS 272
++N ++E H + L PP + D SS + S
Sbjct: 630 WFVNWINETHTNIPELSSHYLCNTPPHYHGF-PVRLFDTSSCKDS 673
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-12
Identities = 21/110 (19%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 307 TNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNF 366
+ + + +L + +P +L + + L L+HN L + LD+ N
Sbjct: 4 VSHEVADCSHLKL-TQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 367 INGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
I+ P K+P + ++L N LS + + L N+++
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-76
Identities = 87/251 (34%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 473 KKFNPNTREMTEGANEFSIWNYDGR-ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSS 531
K++ T + + + + ++ + ++ EAT +F K+ IG G +G VY+ L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 532 GKLVALKKLHRS----ETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587
G VALK+ E F+TE LS RH ++V L GFC M LIY+
Sbjct: 63 GAKVALKRRTPESSQGIEE-------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 588 YMERGSLFCVL-RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL 646
YME G+L L +D+ + + W +R+ I A L YLH +I+HRD+ S NILL
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILL 172
Query: 647 NSNLEAFVADFGLARLLHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVA 703
+ N + DFG+++ + T+V GT GYI PE +TEK DVYSFGVV
Sbjct: 173 DENFVPKITDFGISKKG-TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 704 LEVLMGSHPTD 714
EVL
Sbjct: 232 FEVLCARSAIV 242
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 1e-73
Identities = 76/448 (16%), Positives = 159/448 (35%), Gaps = 46/448 (10%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
+ ++ L +L+ I + + K ++ N +T I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-IS 441
Query: 61 SEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120
I L++L+++ + + T + D D N + L + NLKDL +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDV 496
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSG---------RLPQEVGNLKNLKSLFLD 171
L +P + +L L L+++ N+ RL + ++ ++
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG 556
Query: 172 NNHLSG-PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPST 230
N+L P ++L + +L L +NK+ + G L L L+ N + IP
Sbjct: 557 YNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPED 613
Query: 231 IGY-LNLLDELHLSHNRLDG-PIPPTIGNLTNLIALDLSSNQLSGLLPR-----EVGNLK 283
+ ++ L SHN+L P ++ + ++D S N++ +
Sbjct: 614 FCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673
Query: 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS-------SIPPELMNCSQLLNL 336
++++L+ N + + ++ + L N ++S N L +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733
Query: 337 VLSHNSLSGSIPSEI--GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK------ 388
L N L+ S+ + L + +D+S N + + P+Q + A +
Sbjct: 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEG 791
Query: 389 NNLSGVIPASVRRIPKLIV---SENNLE 413
N + P + P LI N++
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDIR 819
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-67
Identities = 62/394 (15%), Positives = 126/394 (31%), Gaps = 38/394 (9%)
Query: 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG-------- 81
L L + L + ++P + L L+ L+++ NR
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 82 -TIPSEIGSLRDLLDLNLSNNILNG-SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT 139
+ + + + + N L + L L NK+ L + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNV 595
Query: 140 NLTYLDLSLNQLSGRLPQEVG-NLKNLKSLFLDNNHLSG-PIPSTLYHLNQLATLCLGYN 197
LT L L NQ+ +P++ ++ L +N L P + + ++ YN
Sbjct: 596 KLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 198 KLVG-----PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD---- 248
K+ + + N + L+ N + + + + LS+N +
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE 714
Query: 249 ---GPIPPTIGNLTNLIALDLSSNQLSGLLPR-EVGNLKYLASLSLNGNILIGPIPPTIG 304
P N L +DL N+L+ L L YL+++ ++ N P
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 305 YLTNLTYLNLGY------NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR 358
+ L + + NR+ P + C L+ L + N + + ++ +
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQL--Y 830
Query: 359 QLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
LD++ N + + L +
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-67
Identities = 70/403 (17%), Positives = 126/403 (31%), Gaps = 37/403 (9%)
Query: 38 EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97
++ ++ L L+ GR+P IG L+ LKVL + T +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 98 LSNNILNGSIPLEFG----NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL--NQL 151
+ + F L D L+ N+ + P + +L + N++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
+ + + + L L+ ++ N+ + + Y K N+K
Sbjct: 438 TF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLK 491
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP---------IPPTIGNLTNLI 262
+L + L +P + L L L+++ NR + +
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551
Query: 263 ALDLSSNQLSGL-LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
+ N L + + L L N + G LT L L YN++
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQI-E 608
Query: 322 SIPPELM-NCSQLLNLVLSHNSLSGSIPS--EIGNLIFFRQLDLSRNFINGTIPSQLGKI 378
IP + Q+ L SHN L IP+ ++ +D S N I + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 379 P-----NISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
N S V LS N + + S N +
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-64
Identities = 64/386 (16%), Positives = 134/386 (34%), Gaps = 40/386 (10%)
Query: 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTG---------RIPSEIGA 65
++ +L ++ ++P + L +L+ L ++ N R+ +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
Query: 66 LSRLKVLDLSYNRLTGTIPS-EIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124
++++ + YN L S + + L L+ +N + + FG L L+L
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDY 604
Query: 125 NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ--EVGNLKNLKSLFLDNNHLSGPIPST 182
N+++ + + L S N+L +P ++ + S+ N + +
Sbjct: 605 NQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 183 LYHLN-----QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT-------GSIPST 230
++ +T+ L YN++ T+ + + L+ N +T
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 231 IGYLNLLDELHLSHNRLDGPIPPTI--GNLTNLIALDLSSNQLSGLLPREVGNLKYLASL 288
LL + L N+L + L L +D+S N S P + N L +
Sbjct: 724 YKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAF 781
Query: 289 SL------NGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
+ GN ++ P I +L L +G N + + +L QL L ++ N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYILDIADNP 838
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFIN 368
+ + I L +
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-51
Identities = 60/373 (16%), Positives = 114/373 (30%), Gaps = 62/373 (16%)
Query: 2 DNNFTGAELSQLNFTCFP-------NLVTFRIWGTLLSGRMPS-EIGALSKLEKLVLSHN 53
N A + ++T + F + L S + + KL L HN
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 54 SLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS-LRDLLDLNLSNNILNGSIP--LE 110
+ G +L L L YN++ IP + + + L S+N L IP
Sbjct: 584 KVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFN 639
Query: 111 FGNLKDLDQLRLQGNKLDGLIPS-----SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
++ + + NK+ + N + + LS N++ + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 166 KSLFLDNNHLS-------GPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLH 217
++ L NN ++ P + L T+ L +NKL + L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759
Query: 218 LNGNNLTGSIPSTIG------YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
++ N + S P+ + + NR+ P I +LI L + SN +
Sbjct: 760 VSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331
+ + L L++ N S +
Sbjct: 819 RK-------------------------VDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851
Query: 332 QLLNLVLSHNSLS 344
+ VL ++
Sbjct: 852 EAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-46
Identities = 54/390 (13%), Positives = 110/390 (28%), Gaps = 26/390 (6%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
L+K + + I + + LD R + + + N +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELD 309
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161
+ ++ N + L L G G +P +IG LT L L + +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 162 LKNLKSLFLDNNHLSGPIP----STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLH 217
+ + LN L N+ + + +L
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 218 LNG-NNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
+ N I I L L ++ +++ + + +
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEE 484
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS---------SIPPEL 327
NLK L + L + +P + L L LN+ NR S + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 328 MNCSQLLNLVLSHNSLSGSIPS-EIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDL 386
++ + +N+L S + ++ LD N + G ++ + L
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKL 602
Query: 387 SKNNLSGVIPASVRRIPKLIV---SENNLE 413
N + + ++ S N L+
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKLK 632
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 19/173 (10%), Positives = 47/173 (27%), Gaps = 1/173 (0%)
Query: 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYN 317
LT + + + + + +L + N N +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELD 309
Query: 318 RLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGK 377
+L N ++ L L+ G +P IG L + L + + +
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 378 IPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPPQATL 430
+ K+ + + + + L+ + + E P + +
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 12/81 (14%), Positives = 32/81 (39%), Gaps = 7/81 (8%)
Query: 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT----GTIPSE 86
+ + P+ I L +L + N + + ++ +L +LD++ N ++
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 87 IGSLRDLLDLNLSNNILNGSI 107
I + +L + + +I
Sbjct: 851 IEAGMYVLLYDKTQDIRGCDA 871
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-67
Identities = 80/424 (18%), Positives = 147/424 (34%), Gaps = 17/424 (4%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
N + F+ NL + + + +L+ LVL+ N L +
Sbjct: 43 NVLP--TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA 100
Query: 63 IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122
+ LK L ++ + + + L L L +N ++ + + L L
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDF 160
Query: 123 QGNKLDGLIPSSIGNLTNLT--YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP 180
Q N + L + +L T L+L+ N ++G + + +SL I
Sbjct: 161 QNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIF 219
Query: 181 STLYH--LNQLATLCLGYNKL--VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL 236
L + + L + P E +++ ++L + +T +
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI 296
L EL L+ L +P + L+ L L LS+N+ L N L LS+ GN
Sbjct: 280 LQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
Query: 297 GPIPP-TIGYLTNLTYLNLGYNRLSSS--IPPELMNCSQLLNLVLSHNSLSGSIPSEIGN 353
+ + L NL L+L ++ + +S +L N S L +L LS+N
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398
Query: 354 LIFFRQLDLSRNFINGTIP-SQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SE 409
LDL+ + S + + ++LS + L +P L
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 410 NNLE 413
N+
Sbjct: 459 NHFP 462
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-64
Identities = 72/384 (18%), Positives = 128/384 (33%), Gaps = 14/384 (3%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
+ E L S N L + L L LDL+ ++ S L L L+ N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161
L K L L + + + N L L L N +S +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLA--TLCLGYNKLVGPVTKEVGNMKNLDRLHLN 219
+ LK L NN + + L Q +L L N + G + + L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 220 GNNLTGSIPSTIGYLNL--LDELHLSHNRLDGPIPPTIGNL--TNLIALDLSSNQLSGLL 275
G I + + L + P L ++ +++L + +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
L L L + +P + L+ L L L N+ + N L +
Sbjct: 271 SNTFHCFSGLQELDLTAT-HLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 336 LVLSHNSLSGSIPSE-IGNLIFFRQLDLSRNFIN--GTIPSQLGKIPNISAVDLSKNNLS 392
L + N+ + + + NL R+LDLS + I QL + ++ +++LS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 393 GVIPASVRRIPKLIV---SENNLE 413
+ + + P+L + + L+
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLK 413
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-64
Identities = 84/428 (19%), Positives = 155/428 (36%), Gaps = 21/428 (4%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVL--SHNSLTGRI 59
N+ + +L L + ++ +L + L L + N + G I
Sbjct: 138 SNHISSIKLP--KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-I 194
Query: 60 PSEIGALSRLKVLDLSYNRLTGTIPSEIG--SLRDLLDLNLSNNILNGSIPLEFGNLKDL 117
+ + L+ + I + +++ L + P F L ++
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 118 D--QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175
+ LQ + + ++ + L LDL+ LS LP + L LK L L N
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGS--IPSTIG 232
+ + L L + N + N++NL L L+ +++ S +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLN 291
L+ L L+LS+N L LDL+ +L + NL L L+L+
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 292 GNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI---PPELMNCSQLLNLVLSHNSLSGSIP 348
++L L L +LNL N L +L LVLS LS
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493
Query: 349 SEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKL--- 405
+L +DLS N + + L + I ++L+ N++S ++P+ + + +
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTI 552
Query: 406 IVSENNLE 413
+ +N L+
Sbjct: 553 NLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 9e-64
Identities = 76/399 (19%), Positives = 141/399 (35%), Gaps = 11/399 (2%)
Query: 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRL 69
L+++ T + +L + L L L L+ + + RL
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
L L+ N L + + + L L ++ + N K L+ L L N +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD--NNHLSGPIPSTLYHLN 187
+ L LD N + +++ +L+ +L L+ N ++G I +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSA 202
Query: 188 QLATLCLGYNKLVGPVTKEVGN--MKNLDRLHLNGNNLTGSIPSTIGYLNLLD--ELHLS 243
+L G + + + K + N +++L + P+ L + ++L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 244 HNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303
+ T + L LDL++ LS LP + L L L L+ N +
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 304 GYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSL--SGSIPSEIGNLIFFRQL 360
+LT+L++ N + L N L L LSH+ + S ++ NL + L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 361 DLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV 399
+LS N + P + +DL+ L S
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-63
Identities = 76/370 (20%), Positives = 131/370 (35%), Gaps = 13/370 (3%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIG--ALSRLKVLDLSYNRLTGTIPSEIGSLRD 92
+ + + L I + + L + P+ L +
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 93 --LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150
+ +NL + F L +L L L +PS + L+ L L LS N+
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS-TLYHLNQLATLCLGYNKL--VGPVTKEV 207
N +L L + N + + L +L L L L ++ + ++
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 208 GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDL 266
N+ +L L+L+ N L+ L L+ RL + NL L L+L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 267 SSNQLSGLLPREVGNLKYLASLSLNGNILIGPI---PPTIGYLTNLTYLNLGYNRLSSSI 323
S + L + L L L+L GN ++ L L L L + LSS
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 324 PPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISA 383
+ + ++ LSHN L+ S + +L L+L+ N I+ +PS L +
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRT 551
Query: 384 VDLSKNNLSG 393
++L +N L
Sbjct: 552 INLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 6e-60
Identities = 92/400 (23%), Positives = 144/400 (36%), Gaps = 15/400 (3%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSK--LEKLVLSHNSLTGRI 59
L + +L P+ L + +E + L +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 60 PSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119
+ S L+ LDL+ L+ +PS + L L L LS N + N L
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 120 LRLQGNKLDGLIPS-SIGNLTNLTYLDLSLNQL--SGRLPQEVGNLKNLKSLFLDNNHLS 176
L ++GN + + + NL NL LDLS + + S ++ NL +L+SL L N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLN 235
QL L L + +L + N+ L L+L+ + L S L
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449
Query: 236 LLDELHLSHNRLDGPI---PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
L L+L N ++ L L L LS LS + +LK + + L+
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
Query: 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352
N L + +L + YLNL N +S +P L SQ + L N L +
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT----CS 564
Query: 353 NLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
N+ F + + T + P + V LS LS
Sbjct: 565 NIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-56
Identities = 63/335 (18%), Positives = 112/335 (33%), Gaps = 11/335 (3%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
K + L IP + L S N+L F L +L L L ++
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
+ + + L L L+ N L + K LK LF +S L++ L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLD--ELHLSHNRL 247
+L LG N + + + L L N + + L L+L+ N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 248 DGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN--LKYLASLSLNGNILIGPIPPTIGY 305
G I P + +L+ Q ++ + + N ++ L + P
Sbjct: 192 AG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 306 L--TNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLS 363
L ++ +NL + + S L L L+ LS +PS + L ++L LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 364 RNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS 398
N P+++ + + N +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 3e-67
Identities = 92/455 (20%), Positives = 148/455 (32%), Gaps = 48/455 (10%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLE----KLVLSHNSLTG 57
N +L + F+ NL + + +++ L ++ L LS N +
Sbjct: 133 HNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 58 RIPSEIGALSRLKVLDLSYNRLTGTIPSE-IGSLRDLLDLNLSNNILNGSIPLE------ 110
I RL L L N + + I L L L LE
Sbjct: 192 -IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 111 FGNLKDLDQLRLQGNKLD---GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKS 167
L +L + LD I LTN++ L + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308
Query: 168 LFLDNNHLS-------------------GPIPSTLYHLNQLATLCLGYNKL--VGPVTKE 206
L L N G + L L L L N L G ++
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALD 265
+L L L+ N + + S L L+ L H+ L ++ +L NLI LD
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 266 LSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIP 324
+S L L L + GN P L NLT+L+L +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 325 PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIP-NISA 383
+ S L L +SHN+ L + LD S N I + +L P +++
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 384 VDLSKNNLSGVIPAS-----VRRIPKLIVSENNLE 413
++L++N+ + ++ +L+V +E
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 9e-65
Identities = 87/433 (20%), Positives = 136/433 (31%), Gaps = 40/433 (9%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN 77
+ + L + +L+ L LS + +LS L L L+ N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 78 RLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIG 136
+ L L L L G+LK L +L + N + +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLK----SLFLDNNHLSGPIPSTLYHLNQLATL 192
NLTNL +LDLS N++ ++ L + SL L N ++ P + L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205
Query: 193 CLGYNKLVGPVTKEV-GNMKNLDRLHL------NGNNLTGSIPSTIGYLNLLDELHLSHN 245
L N V K + L+ L N NL S + L L
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 246 RLD---GPIPPTIGNLTNLIALDLSSNQLSGLLP-----------------REVGNLKYL 285
LD I LTN+ + L S + + + LK
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS--SSIPPELMNCSQLLNLVLSHNSL 343
+ L G + L +L +L+L N LS + L L LS N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 344 SGSIPSEIGNLIFFRQLDLSRNFINGTIP-SQLGKIPNISAVDLSKNNLSGVIPASVRRI 402
+ S L LD + + S + N+ +D+S + +
Sbjct: 386 IT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 403 PKLIV---SENNL 412
L V + N+
Sbjct: 445 SSLEVLKMAGNSF 457
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-62
Identities = 86/403 (21%), Positives = 141/403 (34%), Gaps = 25/403 (6%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRM---PSEIGALSKLEKLVLSHNSLT- 56
+ NNF + + L R+ + AL L L + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 57 -----GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEF 111
I L+ + L + L L N L+
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 112 GNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS--GRLPQEVGNLKNLKSLF 169
+LK L +G S +L +L +LDLS N LS G Q +LK L
Sbjct: 325 KSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 170 LDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIP 228
L N + + S L QL L ++ L V +++NL L ++ + +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 229 STIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLAS 287
L+ L+ L ++ N P L NL LDLS QL L P +L L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 288 LSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNC-SQLLNLVLSHNSLSGS 346
L+++ N L +L L+ N + +S EL + S L L L+ N + +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 347 IPSE--IGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387
+ + + RQL + + PS +P + +++++
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-60
Identities = 79/384 (20%), Positives = 134/384 (34%), Gaps = 31/384 (8%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109
+ +IP + K LDLS+N L S +L L+LS +
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 110 EFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLF 169
+ +L L L L GN + L + L++L L L+ +G+LK LK L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 170 LDNNHL-SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLD----RLHLNGNNLT 224
+ +N + S +P +L L L L NK+ ++ + + L L+ N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPT-IGNLTNLIALDLSSNQLSG---LLPREVG 280
P + L +L L +N + T I L L L + L +
Sbjct: 191 FIQPGAFKEIRLH-KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 281 NLKYLASLSLNGN------ILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLL 334
L+ L +L++ + I LTN++ +L +
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ 307
Query: 335 NLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS-- 392
+L L + ++ +L L+ G +P++ +DLS+N LS
Sbjct: 308 HLELVNCKFGQFPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 393 GVIPASVRRIPKLIV---SENNLE 413
G S L S N +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 38/176 (21%), Positives = 68/176 (38%), Gaps = 4/176 (2%)
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
IP + + LDLS N L L + L L L+ +
Sbjct: 14 CMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361
L++L+ L L N + S S L LV +L+ IG+L ++L+
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 362 LSRNFINGT-IPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
++ N I +P + N+ +DLS N + + +R + ++ + +L+L
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-66
Identities = 77/229 (33%), Positives = 117/229 (51%), Gaps = 18/229 (7%)
Query: 497 RITFEEMIEATEDFHIKYC------IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAF 550
+F E+ T +F + +G GG+G VY+ ++ VA+KKL
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 551 LES-FQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDW 609
L+ F E +++++ +H N+V+L GF + L+Y YM GSL L L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 610 TKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-- 667
R I + A+ +++LH + +HRDI S NILL+ A ++DFGLAR +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 668 --SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
++R +VGT Y+APE A +T K D+YSFGVV LE++ G D
Sbjct: 190 VMTSR--IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-65
Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 27/235 (11%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTE 557
+ E + + + G +G V++AQL + VA+K + + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS----WQNEYE 68
Query: 558 ARLLSQIRHRNIVKLYGFCLH----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV 613
L ++H NI++ G + ++LI + E+GSL L+ +V + W +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELC 124
Query: 614 NIVKSMAHALSYLHYD-------CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666
+I ++MA L+YLH D KP+I HRDI S N+LL +NL A +ADFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 667 SS--NRTLVVGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
S + VGT Y+APE+ + + D+Y+ G+V E+ D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-64
Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 3/205 (1%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
D +IK IG G +G+V+RA+ G VA+K L + + F E ++ ++RH
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHP 94
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIV G + ++ EY+ RGSL+ +L +LD +R+++ +A ++YLH
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT 687
+ P IVHR++ S N+L++ V DFGL+RL + GT ++APE+
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
EK DVYSFGV+ E+ P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-63
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 12/229 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ ++ +G G +G V +A+ K VA+K++ + ++F E R LS++ H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE-----SESERKAFIVELRQLSRVNHP 61
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIVKLYG CL+ C+ + EY E GSL+ VL ++ + ++YLH
Sbjct: 62 NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+++HRD+ N+LL + + DFG A + ++ T G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDL 735
+EKCDV+S+G++ EV+ P D + + + R L
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 94/356 (26%), Positives = 152/356 (42%), Gaps = 25/356 (7%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
L++ + VL S+T + L + L ++ ++ I L +L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYL 71
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
NL+ N + PL NL L L + NK+ S++ NLTNL L L+ + +S
Sbjct: 72 NLNGNQITDISPL--SNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--I 125
Query: 157 QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRL 216
+ NL + SL L NH S L ++ L L + +K+ + N+ +L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSL 182
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
LN N + P + L L N++ P + N+T L +L + +N+++ L P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336
+ NL L L + N + + LT L LN+G N++S L N SQL +L
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 337 VLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
L++N L IG L L LS+N I P L + + + D + +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-53
Identities = 79/348 (22%), Positives = 151/348 (43%), Gaps = 28/348 (8%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
L + P L + + L + + E L+ + +L + G K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ I LTNL YL+L+ NQ++ + NL L +L++ N ++ S L +L
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 189 LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD 248
L L L + + + N+ + L+L N+ S S + + L+ L ++ +++
Sbjct: 112 LRELYLNEDNISDI--SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 249 GPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTN 308
P I NLT+L +L L+ NQ+ + P + +L L + N + P + +T
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222
Query: 309 LTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
L L +G N+++ P L N SQL L + N +S + + +L + L++ N I
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI- 277
Query: 369 GTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
+ S L + ++++ L+ N L + + L S+N++
Sbjct: 278 -SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 69/282 (24%), Positives = 132/282 (46%), Gaps = 19/282 (6%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
+ L I ++ S + L+ L +L L+ ++++ S + L+++ L+
Sbjct: 83 PLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L N + S + ++ L L ++ + + P NL DL L L N+++ + P
Sbjct: 139 LGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP- 194
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ +LT+L Y +NQ++ V N+ L SL + NN ++ P L +L+QL L
Sbjct: 195 -LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
+G N++ V ++ L L++ N ++ S + L+ L+ L L++N+L
Sbjct: 250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL 295
IG LTNL L LS N ++ + P + +L + S ++
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-61
Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 23/251 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSS-GKLVALKKLHR----SETEEPAFLESFQTEARLLS 562
+ + IG GG+G V++ +L +VA+K L ETE + FQ E ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+ H NIVKLYG + M + E++ G L+ L + +A + W+ ++ ++ +A
Sbjct: 79 NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAF-----VADFGLARLLHPDSSNRTLVVGTY 677
+ Y+ + P IVHRD+ S NI L S E VADFGL++ + ++G +
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNF 190
Query: 678 GYIAPEL--AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKI-SQNPRLD 734
++APE A + TEK D YSF ++ +L G P D S I + R
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 735 L--QCNAYLKN 743
+ C L+N
Sbjct: 251 IPEDCPPRLRN 261
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-60
Identities = 109/410 (26%), Positives = 178/410 (43%), Gaps = 32/410 (7%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
T + + T ++ L ++ L + + L+ L ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
S N+LT P + +L L+D+ ++NN + PL NL +L L L N++ + P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITDIDP- 129
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ NLTNL L+LS N +S + L +L+ L N L +L L L
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLD 183
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
+ NK+ + + NL+ L N ++ P +G L LDEL L+ N+L
Sbjct: 184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
T+ +LTNL LDL++NQ+S L P + L L L L N + P + LT LT L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPS 373
L N+L P + N L L L N++S P + +L ++L N + + S
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVS 347
Query: 374 QLGKIPNISAVDLSKNNLSGVIP-ASVRRIPKLIVSENNLELENSTSSEN 422
L + NI+ + N +S + P A++ RI +L +++ N
Sbjct: 348 SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-59
Identities = 110/412 (26%), Positives = 184/412 (44%), Gaps = 33/412 (8%)
Query: 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVL 72
++ T + T + + + L+ L ++ S+N LT P + L++L +
Sbjct: 40 VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 95
Query: 73 DLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP 132
++ N++ P + +L +L L L NN + PL NL +L++L L N + +
Sbjct: 96 LMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDI-- 149
Query: 133 SSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192
S++ LT+L L NQ++ P + NL L+ L + +N +S S L L L +L
Sbjct: 150 SALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 204
Query: 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252
N++ +G + NLD L LNGN L T+ L L +L L++N++ P
Sbjct: 205 IATNNQISDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
Query: 253 PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYL 312
+ LT L L L +NQ+S + P + L L +L LN N L P I L NLTYL
Sbjct: 261 --LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 313 NLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP 372
L +N +S P + + ++L L +N +S S + NL L N I+ P
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
Query: 373 SQLGKIPNISAVDLSKNNLSGVIPASVR--RIPKLIVSENNLELENSTSSEN 422
L + I+ + L+ + IP + + + +T S+
Sbjct: 371 --LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDG 420
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-57
Identities = 95/382 (24%), Positives = 161/382 (42%), Gaps = 31/382 (8%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
LV + ++ + + L+ L L L +N +T + L+ L L+
Sbjct: 85 PLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLE 140
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
LS N ++ S + L L L+ N + + NL L++L + NK+ + S
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDI--S 193
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ LTNL L + NQ+S +G L NL L L+ N L TL L L L
Sbjct: 194 VLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 249
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
L N++ + + L L L N ++ P + L L L L+ N+L+ P
Sbjct: 250 LANNQISNL--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP- 304
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
I NL NL L L N +S + P V +L L L N + ++ LTN+ +L+
Sbjct: 305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTI-P 372
G+N++S P L N +++ L L+ + + + + N+ + +N I P
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANV---SIPNTVKNVTGALIAP 414
Query: 373 SQLGKIPNISAVDLSKNNLSGV 394
+ + + + D++ N S
Sbjct: 415 ATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-53
Identities = 97/370 (26%), Positives = 164/370 (44%), Gaps = 29/370 (7%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
L ++ ++ +I + AL+ L +T T+ L + L
Sbjct: 3 LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--G 57
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164
L +L Q+ N+L + P + NLT L + ++ NQ++ + NL N
Sbjct: 58 IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTN 113
Query: 165 LKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224
L L L NN ++ P L +L L L L N + + + +L +L N +T
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVT 168
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284
P + L L+ L +S N++ + LTNL +L ++NQ+S + P +G L
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L LSLNGN L T+ LTNLT L+L N++S+ P L ++L L L N +S
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 345 GSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP-ASVRRIP 403
P + L L+L+ N + P + + N++ + L NN+S + P +S+ ++
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQ 334
Query: 404 KLIVSENNLE 413
+L N +
Sbjct: 335 RLFFYNNKVS 344
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-46
Identities = 78/313 (24%), Positives = 135/313 (43%), Gaps = 21/313 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
+ L+ LE+L +S N ++ S + L+ L+ L + N+++ P +G L +L +
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
L+L+ N L I +L +L L L N++ L P + LT LT L L NQ+S
Sbjct: 226 LSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-- 279
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR 215
+ L L +L L+ N L P + +L L L L +N + V ++ L R
Sbjct: 280 ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQR 335
Query: 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL 275
L N ++ S++ L ++ L HN++ P + NLT + L L+ +
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
N+ ++ LI P TI + T ++ +N L S SQ +
Sbjct: 392 VNYKANVSIPNTVKNVTGALIAPA--TISDGGSYTEPDITWN-LPSYTNEVSYTFSQPVT 448
Query: 336 LVLSHNSLSGSIP 348
+ + SG++
Sbjct: 449 IGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-22
Identities = 41/215 (19%), Positives = 75/215 (34%), Gaps = 13/215 (6%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
+ L ++ +S S + L+ L L L+ N L S I L L L
Sbjct: 260 PLSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLT 315
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L +N ++ P + SL L L NN ++ NL +++ L N++ L P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 370
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ NLT +T L L+ + N+ ++ L P+T+
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPD 427
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228
+ +N + + +G++
Sbjct: 428 ITWNLPSYT-NEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-59
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPA-FLESFQTEARLLSQIRH 566
+ ++ IG GG+G VYRA G VA+K E+ + +E+ + EA+L + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
NI+ L G CL + L+ E+ G L VL + VN +A ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAF--------VADFGLARLLHPDSSNRTLVVGTYG 678
H + I+HRD+ S+NIL+ +E + DFGLAR H + + G Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYA 179
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
++APE+ ++ DV+S+GV+ E+L G P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 65/241 (26%), Positives = 116/241 (48%), Gaps = 23/241 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D +G G +G + +G+++ +K+L R + E +F E +++ + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEH 66
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N++K G +K + I EY++ G+L ++++ + W++RV+ K +A ++YL
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL--------------HPDSSNRTL 672
H +I+HRD++S+N L+ N VADFGLARL+ PD R
Sbjct: 125 H---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPR 732
VVG ++APE+ + EK DV+SFG+V E++ + + G +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 733 L 733
Sbjct: 242 R 242
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-56
Identities = 82/431 (19%), Positives = 139/431 (32%), Gaps = 30/431 (6%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKL----EKLVLSHNSLTG 57
N +L F+ NLV + + +++ L + L +S N +
Sbjct: 137 HNFIHSCKLPAY-FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195
Query: 58 RIPSEIGALSRLKVLDLSYNRLTGTIPSE-IGSLRDLLDLNLSNNILNGSIPLE------ 110
I + +L L L N + I + +L L L LE
Sbjct: 196 -IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 111 FGNLKDL--DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168
L D+ D+ RL L N++ + L+ + ++V +SL
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSL 312
Query: 169 FLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228
+ L L L +L L NK K + +L L L+ N L+ S
Sbjct: 313 SIIRCQLKQFPTLDLPFLK---SLTLTMNKGSISFKK--VALPSLSYLDLSRNALSFSGC 367
Query: 229 STIGYLNL--LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYL 285
+ L L L LS N + L L LD + L + +L+ L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLS 344
L ++ LT+L L + N + N + L L LS L
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 345 GSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPK 404
L + L++S N + S ++ ++S +D S N +
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS 546
Query: 405 L---IVSENNL 412
L ++ N++
Sbjct: 547 LAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 7e-55
Identities = 80/370 (21%), Positives = 125/370 (33%), Gaps = 21/370 (5%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSE-IGALSRLKVLDLSYNRLTGTI------PSEIG 88
+ KL +L L N + I + L+ L V L PS +
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 89 SLRDL--LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDL 146
L D+ + L+ ++F L ++ + L G + L + L +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSI 314
Query: 147 SLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL--VGPVT 204
QL +L LKSL L N S I L L+ L L N L G +
Sbjct: 315 IRCQLKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCS 369
Query: 205 KEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIA 263
+L L L+ N + + L L L H+ L +L L+
Sbjct: 370 YSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSS 322
LD+S L L +L + GN TNLT+L+L +L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 323 IPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNIS 382
+L L +SHN+L S L LD S N I + +++
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548
Query: 383 AVDLSKNNLS 392
+L+ N+++
Sbjct: 549 FFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-54
Identities = 89/440 (20%), Positives = 150/440 (34%), Gaps = 46/440 (10%)
Query: 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDL 74
+ +L + G + P L+ LE LV L IG L LK L++
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 75 SYNRLTG-TIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ----LRLQGNKLDG 129
++N + +P+ +L +L+ ++LS N + + L++ Q L + N +D
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSL------FLDNNHLSGPIPST 182
I L L L N S + + NL L F D +L PS
Sbjct: 196 -IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 183 LYHLNQLATLCL--GYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL---- 236
+ L + Y + + N+ + L G ++ + +
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLS 313
Query: 237 ----------------LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG 280
L L L+ N+ I L +L LDLS N LS
Sbjct: 314 IIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS 371
Query: 281 NLKY--LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLV 337
+L L L L+ N I + L L +L+ ++ L ++ +LL L
Sbjct: 372 DLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430
Query: 338 LSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQ-LGKIPNISAVDLSKNNLSGVIP 396
+S+ + L L ++ N S N++ +DLSK L +
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 397 ASVRRIPKLIV---SENNLE 413
+ +L + S NNL
Sbjct: 491 GVFDTLHRLQLLNMSHNNLL 510
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-54
Identities = 78/388 (20%), Positives = 140/388 (36%), Gaps = 30/388 (7%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109
L+ ++P +I S K +DLS+N L + +L L+LS +
Sbjct: 18 CMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 110 EFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLF 169
+ L L L L GN + P S LT+L L +L+ +G L LK L
Sbjct: 75 AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134
Query: 170 LDNNHLSG-PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLD----RLHLNGNNLT 224
+ +N + +P+ +L L + L YN + ++ ++ L ++ N +
Sbjct: 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPT-IGNLTNLIALDLSSNQLSGLLPREVGNLK 283
+ L EL L N I T + NL L L + E+
Sbjct: 195 FIQDQAFQGIKLH-ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253
Query: 284 YLASL--------SLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
+ L L L N++ ++L + ++ + +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQS 311
Query: 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395
L + L ++ L + L L+ N G+I + +P++S +DLS+N LS
Sbjct: 312 LSIIRCQLKQFPTLDLPFL---KSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSG 366
Query: 396 PASVRRIP-----KLIVSENNLELENST 418
S + L +S N + ++
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAIIMSAN 394
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-53
Identities = 82/434 (18%), Positives = 138/434 (31%), Gaps = 43/434 (9%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN 77
+ + L S+L+ L LS + L L L L+ N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 78 RLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIG 136
+ P L L +L L G L L +L + N + +P+
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLK----SLFLDNNHLSGPIPSTLYHLNQLATL 192
NLTNL ++DLS N + ++ L+ SL + N + I + +L L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209
Query: 193 CLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLD--------ELHLS 243
L N + K N+ L L I ++++ E L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 244 HNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPR-------------------EVGNLKY 284
+ L N+ A+ L+ + L +L +
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP--PELMNCSQLLNLVLSHNS 342
L SL+L N I L +L+YL+L N LS S + + L +L LS N
Sbjct: 330 LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTIP-SQLGKIPNISAVDLSKNNLSGVIPASVRR 401
+ + L + LD + + S + + +D+S N
Sbjct: 388 AI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446
Query: 402 IPKLIV---SENNL 412
+ L + N+
Sbjct: 447 LTSLNTLKMAGNSF 460
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-49
Identities = 72/356 (20%), Positives = 124/356 (34%), Gaps = 20/356 (5%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLV--------LSH 52
+ NF + + + L R+ EI S +E L L++
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 53 NSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFG 112
+ + L+ + + L+ + ++ L++ L
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPTL 325
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS--GRLPQEVGNLKNLKSLFL 170
+L L L L NK I L +L+YLDLS N LS G +L+ L L
Sbjct: 326 DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 171 DNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPS 229
N + + L +L L ++ L +++ L L ++ N
Sbjct: 384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 230 TIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASL 288
L L+ L ++ N N TNL LDLS QL + L L L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 289 SLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
+++ N L+ L +L+ L+ +NR+ +S L L++NS++
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-55
Identities = 57/313 (18%), Positives = 102/313 (32%), Gaps = 24/313 (7%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRD- 92
+ LS+ ++ + + + ++ + L +
Sbjct: 24 ALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 93 -LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
+ L L + L P + L L + + L L P ++ L L L+ N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPL 139
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
LP + +L L+ L + +P L + E +
Sbjct: 140 R-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS---------------GEHQGLV 183
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
NL L L + S+P++I L L L + ++ L + P I +L L LDL
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331
P G L L L + +P I LT L L+L S +P +
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 332 QLLNLVLSHNSLS 344
+++ + +
Sbjct: 302 ANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 59/333 (17%), Positives = 110/333 (33%), Gaps = 27/333 (8%)
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121
S + L + + + + + + N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIET 62
Query: 122 LQGNKLDGLIPSSIGNLT--NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
G L + + T L+L L + P + L +L+ + +D L +
Sbjct: 63 RTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-L 119
Query: 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE 239
P T+ L TL L N L + + ++ L L + +P + +
Sbjct: 120 PDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDA--- 175
Query: 240 LHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI 299
L NL +L L + L P + NL+ L SL + + L +
Sbjct: 176 ------------SGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSA-L 221
Query: 300 PPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQ 359
P I +L L L+L + PP + L L+L S ++P +I L +
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 360 LDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
LDL +PS + ++P + + + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 54/303 (17%), Positives = 97/303 (32%), Gaps = 27/303 (8%)
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164
GS + + L QG+ + D + + R N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 165 LKSLFLDNNHLSGPIPSTLYHLNQ--LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
+ L L Q L L L + + +L + ++
Sbjct: 58 PQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282
L +P T+ L+ L L+ N L +P +I +L L L + + LP + +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 283 KYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
L NL L L + + S +P + N L +L + ++
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP 217
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRI 402
LS ++ I +L +LDL P G + + L + +P + R+
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 403 PKL 405
+L
Sbjct: 277 TQL 279
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 29/114 (25%), Positives = 45/114 (39%), Gaps = 3/114 (2%)
Query: 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLS-YNR 78
NL + +I + LS + I L KLE+L L + P G + LK L L +
Sbjct: 207 NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 79 LTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP 132
L T+P +I L L L+L + +P L + + + L
Sbjct: 266 LL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 7e-55
Identities = 38/210 (18%), Positives = 80/210 (38%), Gaps = 14/210 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ + + G +++ + G + +K L + F E L H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHP 67
Query: 568 NIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
N++ + G C LI +M GSL+ VL +D ++ V MA +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL- 684
LH +P I ++S +++++ ++ A ++ + + ++APE
Sbjct: 127 LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEAL 180
Query: 685 --AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
D++SF V+ E++ P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D + C+G G YG V+R G+ VA+K S +E ++ +TE +RH
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIF--SSRDEKSWF--RETELYNTVMLRH 61
Query: 567 RNIVKLYGFCLHNKC----MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
NI+ + ++ ++LI Y E GSL+ L+ LD + IV S+A
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASG 117
Query: 623 LSYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS----NRTLV 673
L++LH + KP+I HRD+ S NIL+ N + +AD GLA + ++
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 674 VGTYGYIAPEL------AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719
VGT Y+APE+ ++ D+++FG+V EV ++
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-53
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 39/240 (16%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTE 557
E ++ + IG G YG+VY+ L + VA+K + ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN------RQNFINE 55
Query: 558 AR--LLSQIRHRNIVKLYGFCLHNKC-----MFLIYEYMERGSLFCVLRNDVEAVELDWT 610
+ + H NI + L+ EY GSL L DW
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 611 KRVNIVKSMAHALSYLHYD------CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664
+ S+ L+YLH + KP+I HRD++S N+L+ ++ ++DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 665 PDSSNR--------TLVVGTYGYIAPE-------LAYTMAVTEKCDVYSFGVVALEVLMG 709
+ R VGT Y+APE L + ++ D+Y+ G++ E+ M
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-53
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ + IG G YG V+ + G+ VA+K +E +TE +RH
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS----WFRETEIYQTVLMRHE 91
Query: 568 NIVKLYGFCLHNKC----MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
NI+ + ++LI +Y E GSL+ L++ LD + + S L
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGL 147
Query: 624 SYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV----V 674
+LH + KP+I HRD+ S NIL+ N +AD GLA D++ + V
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 675 GTYGYIAPE-LAYTMAV-----TEKCDVYSFGVVALEVLMGSHPTDLLSSL 719
GT Y+ PE L ++ D+YSFG++ EV ++
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 9e-53
Identities = 66/405 (16%), Positives = 135/405 (33%), Gaps = 23/405 (5%)
Query: 39 IGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98
++ + ++ +SL + S + +K LDLS N L+ +++ L LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQE 158
S+N+L ++ +L L L L N + + ++ L + N +S R+
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS-- 115
Query: 159 VGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLH 217
+ K+++L NN ++ +++ L L N++ + + L+ L+
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 218 LNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPR 277
L N + + + L L LS N+L + P + + + L +N+L + +
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEK 231
Query: 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV 337
+ + L L GN + N + + C+
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 338 LSHNSLSGSIPSEIGNLIFFRQLDLSRNFING----TIPSQLGKIPNISAVDLSKNNLSG 393
LI ++ + + G + + +D K
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 394 VIPASVRRIPKLIV---SENNLELENSTSSENAPPPQATLFKGNK 435
VI R I + L+ + S TL +
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG 395
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-47
Identities = 66/432 (15%), Positives = 125/432 (28%), Gaps = 22/432 (5%)
Query: 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDL 74
N+ + G LS +++ +KLE L LS N L ++ +LS L+ LDL
Sbjct: 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDL 87
Query: 75 SYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSS 134
+ N + E+ + L+ +NN ++ + + + L NK+ L
Sbjct: 88 NNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLD 139
Query: 135 IGNLTNLTYLDLSLNQLSG-RLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
G + + YLDL LN++ + + L+ L L N + + + +L TL
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLD 197
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
L NKL + E + + + L N L I + + L+ L N
Sbjct: 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
N ++ + L + P L L
Sbjct: 256 DF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKE 314
Query: 314 LGYNRLS----SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFING 369
+ E N ++ + I L+ + ++
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDE 374
Query: 370 TIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPPQAT 429
+ + + + + L + Q
Sbjct: 375 QVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPL-QLLRAIVKRYEEMYVEQQSVQNN 432
Query: 430 LFKGNKGKQRKI 441
+ Q K
Sbjct: 433 AIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 7e-47
Identities = 56/349 (16%), Positives = 115/349 (32%), Gaps = 16/349 (4%)
Query: 83 IPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT 142
I + ++++ L ++ + ++ +L L GN L + + + T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202
L+LS N L ++ +L L++L L+NN++ L + TL N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI--- 111
Query: 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIGNLTNL 261
+ ++L N +T G + + L L N +D + L
Sbjct: 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
L+L N + + + L +L L+ N + + P +T+++L N+L
Sbjct: 172 EHLNLQYNFIYDVKGQV--VFAKLKTLDLSSN-KLAFMGPEFQSAAGVTWISLRNNKL-V 227
Query: 322 SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNI 381
I L L + L N R +++ + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 382 SAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENSTSSENAPPPQATL 430
+ + R+ L E+ L + +E +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-45
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 16/308 (5%)
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
+I N ++ + L + S + N+ LDLS N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225
+ L L +N L + L L+ L TL L N + +E+ +++ LH NN++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL-LPREVGNLKY 284
+ + ++L++N++ G + + LDL N++ + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L L+L N + + + L L+L N+L + + PE + + + + L +N L
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 345 GSIPSEIGNLIFFRQLDLSRNFIN-GTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP 403
I + DL N + GT+ K + V +P
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 404 KLIVSENN 411
L
Sbjct: 287 TLGHYGAY 294
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-35
Identities = 55/364 (15%), Positives = 110/364 (30%), Gaps = 16/364 (4%)
Query: 38 EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG-TIPSEIGSLRDLLDL 96
+ + L++N +T + G SR++ LDL N + S L L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
NL N + + + L L L NKL + + +T++ L N+L +
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 157 QEVGNLKNLKSLFLDNNHLS-GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR 215
+ + +NL+ L N G + ++ T+ K + +E
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE--ECTVPTL 288
Query: 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG----PIPPTIGNLTNLIALDLSSNQL 271
H L L + G + N +D Q
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL-TYLNLGYNRLSSSIPPELMNC 330
++ + + +L L + L L ++ E +
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
Query: 331 SQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP--SQLGKIPNISAVDLSK 388
QLL ++ + + R D+ ++ ++L K+ + + L+
Sbjct: 409 LQLLRAIVKRYEEM-YVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALAS 467
Query: 389 NNLS 392
N +
Sbjct: 468 ANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 17/149 (11%), Positives = 40/149 (26%), Gaps = 9/149 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLT-------GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIG 88
+L L ++L R+ E +R + +D + I
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+ + L L+ + +LD Q L + + L L +
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIEL-QHATEEQSPLQLLRAIV 416
Query: 149 NQLSGRL-PQEVGNLKNLKSLFLDNNHLS 176
+ Q+ ++ + + +
Sbjct: 417 KRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-52
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E I IG G +G VY + G+ VA++ + + L++F+ E Q RH
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHE 89
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
N+V G C+ + +I + +L+ V+R+ + LD K I + + + YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-----TLVVGTYGYIAP 682
I+H+D+ S N+ + N + + DFGL + + R + G ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 683 EL---------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ + ++ DV++ G + E+ P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ IG+G +G+VY+ + G VA+K L P L++F+ E +L + RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWH-GD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NI+ G+ + ++ ++ E SL+ L + + K ++I + A + YLH
Sbjct: 81 NILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH 137
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH--PDSSNRTLVVGTYGYIAPEL- 684
SI+HRD+ SNNI L+ + + DFGLA S + G+ ++APE+
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 685 --AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ + + DVY+FG+V E++ G P
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ IG G +G V+R + G+ VA+K S EE ++ + E +RH
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF--SSREERSWF--REAEIYQTVMLRHE 96
Query: 568 NIVKLYGFCLHNK----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
NI+ + ++L+ +Y E GSLF L + + + S A L
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGL 152
Query: 624 SYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV----V 674
++LH + KP+I HRD+ S NIL+ N +AD GLA + + V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 675 GTYGYIAPEL------AYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
GT Y+APE+ ++ D+Y+ G+V E+
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 55/331 (16%), Positives = 118/331 (35%), Gaps = 21/331 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
++ + ++ +SL + S + +K LDLS N L+ +++ L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
LNLS+N+L + +L L L L N + + ++ L + N +S R+
Sbjct: 63 LNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RV 114
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLD 214
+ K+++L NN ++ +++ L L N++ + + L+
Sbjct: 115 S--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 215 RLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL 274
L+L N + + + L L LS N+L + P + + + L +N+L
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL- 228
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLL 334
+ + + + L L GN + N + + C+ +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT--V 285
Query: 335 NLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
+ + + R + L +
Sbjct: 286 PTLGHYGAYCCEDLPA---PFADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 16/308 (5%)
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
+I N ++ + L + S + N+ LDLS N LS ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225
+ L L +N L + L L+ L TL L N + +E+ +++ LH NN++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL-LPREVGNLKY 284
+ + ++L++N++ G + + LDL N++ + +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L L+L N + + + L L+L N+L + + PE + + + + L +N L
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 345 GSIPSEIGNLIFFRQLDLSRNFIN-GTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP 403
I + DL N + GT+ K + V +P
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 404 KLIVSENN 411
L
Sbjct: 287 TLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 52/287 (18%), Positives = 102/287 (35%), Gaps = 16/287 (5%)
Query: 83 IPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT 142
I + ++++ L ++ + ++ +L L GN L + + + T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202
L+LS N L ++ +L L++L L+NN++ L + TL N +
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI--- 111
Query: 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIGNLTNL 261
+ ++L N +T G + + L L N +D + L
Sbjct: 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
L+L N + + + L +L L+ N L + P +T+++L N+L
Sbjct: 172 EHLNLQYNFIYDVKGQV--VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-V 227
Query: 322 SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
I L L + L N R +++ +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 43/239 (17%), Positives = 89/239 (37%), Gaps = 22/239 (9%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93
++ +LS L L L++N + E+ ++ L + N ++ + +
Sbjct: 71 YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGK 122
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLS 152
++ L+NN + L+ G + L L+ N++D + + L +L+L N +
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 153 GRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKN 212
+ +V LK+L L +N L+ + + + L NKLV + K + +N
Sbjct: 183 -DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQN 238
Query: 213 LDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
L+ L GN + ++ + LT + + L
Sbjct: 239 LEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK--------KLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 29/139 (20%), Positives = 55/139 (39%), Gaps = 7/139 (5%)
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLL 334
+ N + + L + N+ L+L N LS +L ++L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 335 NLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394
L LS N L ++ +L R LDL+ N++ +L P+I + + NN+S V
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 395 IPASVRRIPKLIVSENNLE 413
+ + + ++ N +
Sbjct: 115 SCSRGQGKKNIYLANNKIT 133
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 9e-50
Identities = 68/331 (20%), Positives = 138/331 (41%), Gaps = 26/331 (7%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L+ + + ++++ ++P+ + + ++++L+L+ ++ I + + L +
Sbjct: 44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101
Query: 100 NNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQE 158
N + +P F N+ L L L+ N L L N LT L +S N L R+ +
Sbjct: 102 FNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 159 V-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLH 217
+L++L L +N L+ + +L + L + YN L + ++ L
Sbjct: 160 TFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELD 211
Query: 218 LNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPR 277
+ N++ + + L L L HN L + N L+ +DLS N+L ++
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH 266
Query: 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV 337
++ L L ++ N + + + L L+L +N L + +L NL
Sbjct: 267 PFVKMQRLERLYISNN-RLVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLY 324
Query: 338 LSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
L HNS+ ++ + + L LS N +
Sbjct: 325 LDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 63/356 (17%), Positives = 127/356 (35%), Gaps = 17/356 (4%)
Query: 59 IPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLD 118
I S + + + E +L + + N+ + + + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178
L L +++ + + + L + N + P N+ L L L+ N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 179 IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLD 238
++ +L TL + N L +L L L+ N LT + + + L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLF 189
Query: 239 ELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGP 298
++S+N L T+ + LD S N ++ + L L L N L
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD- 240
Query: 299 IPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF 357
+ L ++L YN L I + +L L +S+N L ++ +
Sbjct: 241 -TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297
Query: 358 RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ LDLS N + + + + + L N++ + ++ + L +S N+ +
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-45
Identities = 71/345 (20%), Positives = 125/345 (36%), Gaps = 24/345 (6%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
+ T N + + + + + ++E L L+ + I +
Sbjct: 29 DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTY 87
Query: 63 I-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQ 119
++ L + +N + +P + ++ L L L N L+ S+P F N L
Sbjct: 88 AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 145
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
L + N L+ + + T+L L LS N+L+ + + + +L + N L
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL---- 198
Query: 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE 239
STL + L +N + L L L NNLT + L E
Sbjct: 199 -STLAIPIAVEELDASHNSI---NVVRGPVNVELTILKLQHNNLT-DTAWLLN-YPGLVE 252
Query: 240 LHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI 299
+ LS+N L+ + + L L +S+N+L L + L L L+ N + +
Sbjct: 253 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN-HLLHV 310
Query: 300 PPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L L L +N + ++ L NL LSHN
Sbjct: 311 ERNQPQFDRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWD 352
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-49
Identities = 94/372 (25%), Positives = 148/372 (39%), Gaps = 52/372 (13%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
LE LV S NSLT +P +L L V + + L+ P L L +SNN
Sbjct: 90 PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNN 141
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161
L +P E N L + + N L L +L ++ NQL LP E+ N
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLKKLPDL----PPSLEFIAAGNNQLE-ELP-ELQN 193
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L L +++ DNN L +P L ++ G N L E+ N+ L ++ + N
Sbjct: 194 LPFLTAIYADNNSLKK-LPD---LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNN 247
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281
L ++P L+ L++ N L +P +LT L + + LS L P
Sbjct: 248 LLK-TLPDLPP---SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN---- 298
Query: 282 LKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L L+ + N I + +L LN+ N+L +P +L L+ S N
Sbjct: 299 ---LYYLNASSN-EIRSLCDL---PPSLEELNVSNNKLIE-LPALP---PRLERLIASFN 347
Query: 342 SLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRR 401
L+ +P NL +QL + N + P + + L N+ +P +
Sbjct: 348 HLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPELPQN 397
Query: 402 IPKLIVSENNLE 413
+ +L V N L
Sbjct: 398 LKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-48
Identities = 82/379 (21%), Positives = 142/379 (37%), Gaps = 54/379 (14%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
P + + L++ + ++LT +P E + +++ P G R++
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
L + + +L L L L P +L + L S N L+ L
Sbjct: 63 SRLRDCLDRQ-----------AHELELNNLGLSSL-PELPPHLES---LVASCNSLT-EL 106
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLD 214
P+ +LK+L + LS P L L + N+L P E+ N L
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKLP---ELQNSSFLK 156
Query: 215 RLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL 274
+ ++ N+L +P L + +N+L+ P + NL L A+ +N L
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK- 209
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLL 334
LP +L+ S+ NIL P + L LT + N L ++P L
Sbjct: 210 LPDLPLSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNNLL-KTLPDLP---PSLE 260
Query: 335 NLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394
L + N L+ +P +L LD+S N + + PN+ ++ S N +
Sbjct: 261 ALNVRDNYLT-DLPELPQSL---TFLDVSENIFS-GLSE---LPPNLYYLNASSNEIR-S 311
Query: 395 IPASVRRIPKLIVSENNLE 413
+ + +L VS N L
Sbjct: 312 LCDLPPSLEELNVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-44
Identities = 90/424 (21%), Positives = 150/424 (35%), Gaps = 71/424 (16%)
Query: 10 LSQLNFTCFP----NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS---- 61
L+ L + P +L + L+ +P +L L + +L+ P
Sbjct: 78 LNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYL 136
Query: 62 -----------EIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
E+ S LK++D+ N L +P SL + NN L +P E
Sbjct: 137 GVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELP-E 190
Query: 111 FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFL 170
NL L + N L L +L + N L LP E+ NL L +++
Sbjct: 191 LQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYA 244
Query: 171 DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPST 230
DNN L +P L L + N L + + ++ LD + L+ P+
Sbjct: 245 DNNLLKT-LPD---LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN- 298
Query: 231 IGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSL 290
L L+ S N + + +L L ++S+N+L L P L+ L
Sbjct: 299 ------LYYLNASSNEIRS-LCDLPPSLEEL---NVSNNKLIEL-PALPPRLERL---IA 344
Query: 291 NGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSE 350
+ N L +P NL L++ YN L P + L NS +P
Sbjct: 345 SFNHLAE-VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDL-----RMNSHLAEVPEL 394
Query: 351 IGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKL--IVS 408
NL +QL + N + P + ++ ++ + + KL V
Sbjct: 395 PQNL---KQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVF 447
Query: 409 ENNL 412
E++
Sbjct: 448 EHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 65/345 (18%), Positives = 116/345 (33%), Gaps = 53/345 (15%)
Query: 38 EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97
E+ S L+ + + +NSL ++P L+ + N+L +P E+ +L L +
Sbjct: 148 ELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIY 201
Query: 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ 157
NN L +P +L+ + N L+ + NL LT + N L LP
Sbjct: 202 ADNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254
Query: 158 EVGNLKNLKSLFLDNNHLSGPIPSTLYHLN--------------QLATLCLGYNKLVGPV 203
+L+ L L +P +L L+ L L N++
Sbjct: 255 LPPSLEALNVRDNYLTDLP-ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI---- 309
Query: 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIA 263
+L+ L+++ N L +P+ L L S N L +P NL L
Sbjct: 310 RSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPELPQNLKQL-- 362
Query: 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI 323
+ N L P +++ L N + +P NL L++ N L
Sbjct: 363 -HVEYNPLREF-PDIPESVE-----DLRMNSHLAEVPELPQ---NLKQLHVETNPLRE-F 411
Query: 324 PPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
P + +L ++ + + +
Sbjct: 412 PDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 58/299 (19%), Positives = 103/299 (34%), Gaps = 45/299 (15%)
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
I + T L + L+ +P E N+K+ + + P ++
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
A L + L LN L+ S+P +L L S N L
Sbjct: 61 AVSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT- 104
Query: 250 PIPPTIGNLTNLIALDLSSNQLSGLLPR---------------EVGNLKYLASLSLNGNI 294
+P +L +L+ + + LS L P E+ N +L + ++ N
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNN- 163
Query: 295 LIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNL 354
+ +P +L ++ G N+L PEL N L + +NSL +P +L
Sbjct: 164 SLKKLPDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK-KLPDLPLSL 217
Query: 355 IFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ N + +L +P ++ + N L +P + L V +N L
Sbjct: 218 ---ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 36/191 (18%), Positives = 73/191 (38%), Gaps = 21/191 (10%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSR 68
++S+ F+ L + S + S LE+L +S+N L +P+ R
Sbjct: 283 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---R 338
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
L+ L S+N L +P +L+ L++ N L P +++DL + L
Sbjct: 339 LERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR----MNSHLA 389
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ NL L + N L P ++++L+ +++ + P ++
Sbjct: 390 EVPEL----PQNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDK 441
Query: 189 LATLCLGYNKL 199
L ++
Sbjct: 442 LEDDVFEHHHH 452
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-46
Identities = 68/330 (20%), Positives = 137/330 (41%), Gaps = 24/330 (7%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L+ + + ++++ ++P+ + + ++++L+L+ ++ I + + L +
Sbjct: 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107
Query: 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV 159
N + P F N+ L L L+ N L L N LT L +S N L R+ +
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
Query: 160 -GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL 218
+L++L L +N L+ + +L + L + YN L + ++ L
Sbjct: 167 FQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLL-----STLAIPIAVEELDA 218
Query: 219 NGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPRE 278
+ N++ + + L L L HN L + N L+ +DLS N+L ++
Sbjct: 219 SHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 279 VGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVL 338
++ L L ++ N + + + L L+L +N L + +L NL L
Sbjct: 274 FVKMQRLERLYISNN-RLVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYL 331
Query: 339 SHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
HNS+ ++ + + L LS N +
Sbjct: 332 DHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-44
Identities = 82/392 (20%), Positives = 145/392 (36%), Gaps = 25/392 (6%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDL 93
+ S + + + + E L+ K++ + + +P+ + S R +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 94 LDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152
LNL++ + I F + +L + N + L P N+ LT L L N LS
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 153 GRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
LP+ + N L +L + NN+L T L L L N+L ++ +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THVDLSLIP 192
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
+L +++ N L+ T+ ++EL SHN ++ + L L L N L
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNL 244
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331
+ + N L + L+ N L + + L L + NRL ++
Sbjct: 245 TDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIP 301
Query: 332 QLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391
L L LSHN L + L L N I T+ L + + LS N+
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 357
Query: 392 SGV-IPASVRRIPKLIVSENNLELENSTSSEN 422
+ A R + + V + + + E+
Sbjct: 358 DCNSLRALFRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 3e-42
Identities = 70/335 (20%), Positives = 123/335 (36%), Gaps = 24/335 (7%)
Query: 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEI-GALSRLKV 71
N + + + + + ++E L L+ + I + ++
Sbjct: 45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQK 103
Query: 72 LDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDG 129
L + +N + +P + ++ L L L N L+ S+P F N L L + N L+
Sbjct: 104 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER 161
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
+ + T+L L LS N+L+ + + + +L + N L STL +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAV 213
Query: 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
L +N + L L L NNLT + L E+ LS+N L+
Sbjct: 214 EELDASHNSI---NVVRGPVNVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEK 268
Query: 250 PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL 309
+ + L L +S+N+L L + L L L+ N + + L
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN-HLLHVERNQPQFDRL 326
Query: 310 TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L L +N + ++ L NL LSHN
Sbjct: 327 ENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 62/351 (17%), Positives = 120/351 (34%), Gaps = 29/351 (8%)
Query: 82 TIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNL 141
I S + D+++ + E L + + + + + L + + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 142 TYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200
L+L+ Q+ + ++ L++ N + P ++ L L L N L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 201 GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP------- 253
N L L ++ NNL T L L LS NRL +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPSLF 195
Query: 254 ----------TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303
T+ + LD S N ++ + L L L N L +
Sbjct: 196 HANVSYNLLSTLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD--TAWL 250
Query: 304 GYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDL 362
L ++L YN L I + +L L +S+N L ++ + + LDL
Sbjct: 251 LNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
S N + + + + + L N++ + ++ + L +S N+ +
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 358
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-45
Identities = 86/435 (19%), Positives = 146/435 (33%), Gaps = 45/435 (10%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
N L +F FP L + + +LS L L+L+ N +
Sbjct: 38 NPLR--HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 63 IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN-GSIPLEFGNLKDLDQLR 121
LS L+ L L IG L+ L +LN+++N++ +P F NL +L+ L
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 122 LQGNKLDGLIPSSIGNLTNLTY----LDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177
L NK+ + + + L + LDLSLN ++ + L L L NN S
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSL 214
Query: 178 PIPSTLYH-LNQLATLCL------GYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGS---I 227
+ T L L L L + + NL L I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGN--------------------LTNLIALDLS 267
L + L ++ + N L +L L +
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 268 SNQLSGLLPREVGNLKYLASLSLNGNIL--IGPIPPTIGYLTNLTYLNLGYNRLSSSIPP 325
SN+ +L L L L+ N L G + T+L YL+L +N + ++
Sbjct: 334 SNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSS 390
Query: 326 ELMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAV 384
+ QL +L H++L + +L LD+S + ++ +
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 385 DLSKNNLSGVIPASV 399
++ N+ +
Sbjct: 451 KMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-44
Identities = 88/411 (21%), Positives = 142/411 (34%), Gaps = 44/411 (10%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
+ L LS N L + L+VLDLS + SL L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL-SGRLPQEVGN 161
+ F L L +L L L IG+L L L+++ N + S +LP+ N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQL----ATLCLGYNKLVGPVTKEVGNMKNLDRLH 217
L NL+ L L +N + + L L+Q+ +L L N + + L +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 218 LNGNNLTGSIPSTI-------GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
L N + ++ T L+ + L+ + L NL +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 271 LSGLLPREVG---NLKYLASLSLNGNIL--IGPIPPTIG-----------------YLTN 308
L L + L ++S SL + + G L +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 309 LTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS--GSIPSEIGNLIFFRQLDLSRNF 366
L L N+ ++ ++ L L LS N LS G + LDLS N
Sbjct: 327 LKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 367 INGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPK----LIVSENNLE 413
+ T+ S + + +D +NL + SV + L +S +
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-42
Identities = 86/433 (19%), Positives = 156/433 (36%), Gaps = 38/433 (8%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT-GRIPSEIGALS 67
L+ F+ +L T L+ IG L L++L ++HN + ++P L+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDL----LDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123
L+ LDLS N++ +++ L + L L+LS N +N I L +L L+
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 124 GNKLDGLIPS-SIGNLTNLTYLDLSLNQLSGR---LPQEVGNLKNLKSLFLDNNHLSG-- 177
N + I L L L L + + L+ L +L ++ L+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 178 ----PIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
I L +++ L + ++L+ ++ ++
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 233 YLNL----------------LDELHLSHNRLD--GPIPPTIGNLTNLIALDLSSNQLSGL 274
L L+ L LS N L G + T+L LDLS N + +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM 388
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333
L+ L L + L ++ L NL YL++ + + S L
Sbjct: 389 -SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 334 LNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
L ++ NS + +I L LDLS+ + P+ + ++ ++++ N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 393 GVIPASVRRIPKL 405
V R+ L
Sbjct: 508 SVPDGIFDRLTSL 520
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-42
Identities = 80/400 (20%), Positives = 138/400 (34%), Gaps = 41/400 (10%)
Query: 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKV----LDLSYNRLTGTIPS 85
+ S ++P L+ LE L LS N + +++ L ++ + LDLS N + I
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 86 EIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQG------NKLDGLIPSSIGNL 138
L L L NN + ++ L L+ RL L+ S++ L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 139 TNLTYLDLSLNQLSGRLPQEVG---NLKNLKSLFLDNNHLS----GPIPSTLYHLN---- 187
NLT + L L L + L N+ S L + + HL
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
Query: 188 -----------QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT--GSIPSTIGYL 234
L L NK ++ ++ +L+ L L+ N L+ G +
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 235 NLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGN 293
L L LS N + + L L LD + L + V +L+ L L ++
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 294 ILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEIG 352
L++L L + N + P+ L L LS L P+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 353 NLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
+L + L+++ N + ++ ++ + L N
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-40
Identities = 83/404 (20%), Positives = 139/404 (34%), Gaps = 48/404 (11%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109
+ +IP + K LDLS+N L S +L L+LS +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 110 EFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLF 169
+ +L L L L GN + L + L++L L L+ +G+LK LK L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 170 LDNNHL-SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLD----RLHLNGNNLT 224
+ +N + S +P +L L L L NK+ ++ + + L L+ N +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPT-IGNLTNLIALDL------SSNQLSGLLPR 277
I L +L L +N + T I L L L + L
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 278 EVGNLKYLASLSLNGNIL---IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS--- 331
+ L L L + I LTN++ +L + + N
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYNFGWQH 308
Query: 332 -----------------QLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN--GTIP 372
L L + N + SE+ +L LDLSRN ++ G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCS 366
Query: 373 SQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
++ +DLS N + + ++ + +L +NL+
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 74/333 (22%), Positives = 109/333 (32%), Gaps = 21/333 (6%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRM---PSEIGALSKLEKLVLSHNSLTG 57
+ NNF + + L R+ + AL L L + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 58 ------RIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEF 111
I L+ + L + + L L N
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKFGQ---FPT 321
Query: 112 GNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS--GRLPQEVGNLKNLKSLF 169
LK L +L NK +L +L +LDLS N LS G Q +LK L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 170 LDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIP 228
L N + + S L QL L ++ L +++NL L ++ + +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 229 STIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLAS 287
L+ L+ L ++ N P I L NL LDLS QL L P +L L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 288 LSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L++ N L LT+L + L N
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-29
Identities = 56/233 (24%), Positives = 87/233 (37%), Gaps = 9/233 (3%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGA---LSKLEKLVLSHNSLT--GRIPSEI 63
EL F FP L + + + L LE L LS N L+ G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 64 GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRL 122
+ LK LDLS+N + T+ S L L L+ ++ L F +L++L L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPS 181
L++L L ++ N ++ L+NL L L L P+
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYL 234
L+ L L + N+L + +L ++ L+ N S P I YL
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-IDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 40/186 (21%), Positives = 74/186 (39%), Gaps = 5/186 (2%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
N + + +L + + M S L +LE L H++L
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 62 EI-GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQ 119
+ +L L LD+S+ L L L ++ N + + F L++L
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGP 178
L L +L+ L P++ +L++L L+++ NQL +P + L +L+ ++L N
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 533
Query: 179 IPSTLY 184
P Y
Sbjct: 534 CPRIDY 539
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 38/177 (21%), Positives = 68/177 (38%), Gaps = 4/177 (2%)
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP 300
IP + + LDLS N L L + L L L+ +
Sbjct: 13 QCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 301 PTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQL 360
L++L+ L L N + S S L LV +L+ IG+L ++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 361 DLSRNFIN-GTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
+++ N I +P + N+ +DLS N + + +R + ++ + +L+L
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-45
Identities = 81/419 (19%), Positives = 147/419 (35%), Gaps = 18/419 (4%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
N T + + NL + + ++ +L LE L LS N L+ S
Sbjct: 36 NKIT--YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW 93
Query: 63 IGALSRLKVLDLSYNRLTG-TIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQL 120
G LS LK L+L N + S +L +L L + N I F L L++L
Sbjct: 94 FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP 180
++ L S+ ++ ++ +L L L++ + L L +++ L L + +L+
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 181 STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDEL 240
S L + + + + + L R L + + L
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLG 267
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP 300
+ + D + L + L L L+ + +++ + +
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 301 PTIGYLTNLTYLNLGYNRLSSSIPPE---LMNCSQLLNLVLSHNSLSGSIPSEIG---NL 354
+L +L +L+L N + L LVLS N L S+ L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTL 386
Query: 355 IFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
LD+SRN + +P + ++LS + V + + L VS NNL+
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-43
Identities = 80/401 (19%), Positives = 143/401 (35%), Gaps = 31/401 (7%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSN 100
+ ++ L LS N +T ++ A + L+VL L +R+ TI + SL L L+LS+
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEV 159
N L+ FG L L L L GN L + S NLTNL L + + + +
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 160 -GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL 218
L +L L + L +L + + L L ++ + + ++ L L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 219 NGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP----------IPPTIGNLTNLIALDLSS 268
NL S + + + R + I L+ + D +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 269 NQLSGLLPREVGNLKYLAS--------LSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
N L P E + L L + L + L + + + +++
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 321 SSIPPELMNCSQLLNLVLSHNSLSGSI---PSEIGNLIFFRQLDLSRNFIN--GTIPSQL 375
+ L L LS N + + G + L LS+N + L
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 376 GKIPNISAVDLSKNNLSGVIPASVRRIPKLIV---SENNLE 413
+ N++++D+S+N +P S + K+ S +
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-39
Identities = 77/429 (17%), Positives = 149/429 (34%), Gaps = 37/429 (8%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSG-RMPSEIGALSKLEKLVLSHNSLTGRIP 60
DN+ + LS F +L + G + S L+ L+ L + + I
Sbjct: 83 DNHLS--SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 61 SE-IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119
L+ L L++ L + S+RD+ L L + + + L +
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS--- 176
L L+ L S + + + + S + L L L+ + +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 177 ---------------GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
+ L + L ++ ++ + R+ + +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPT---IGNLTNLIALDLSSNQLSGL--LP 276
+ S +L L+ L LS N + G +L L LS N L +
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336
+ LK L SL ++ N P+P + + + +LNL + + + ++L++
Sbjct: 381 EILLTLKNLTSLDISRN-TFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIPQTLEVLDV 438
Query: 337 VLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396
S+N+L S + L ++L +SRN + T+P P + + +S+N L V
Sbjct: 439 --SNNNLD-SFSLFLPRL---QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPD 490
Query: 397 ASVRRIPKL 405
R+ L
Sbjct: 491 GIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-38
Identities = 59/355 (16%), Positives = 128/355 (36%), Gaps = 25/355 (7%)
Query: 65 ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124
+ V D T +IPS + + L+LS N + + +L L L+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 125 NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG-PIPST 182
++++ + + +L +L +LDLS N LS L G L +LK L L N + S
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 183 LYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241
+L L TL +G + + + + +L+ L + +L ++ + + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL------ 295
L + + L+++ L+L L+ + + + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 296 ----IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPEL--------MNCSQLLNLVLSHNSL 343
+ + I L+ + + + N L P E + + L + L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 344 SGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS 398
+ + L +++ + + + S + ++ +DLS+N + +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-36
Identities = 71/388 (18%), Positives = 126/388 (32%), Gaps = 33/388 (8%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
+ N T +E+ +++F +L I L + ++ + L L + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 61 SEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ- 119
LS ++ L+L L S + + + F L L +
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 120 ---------LRLQGNKLDGLIPSSIG--------NLTNLTYLDLSLNQLSGRLPQEVGNL 162
N L PS + L + L L L
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE---VGNMKNLDRLHLN 219
+ +K + ++N+ + S HL L L L N +V K G +L L L+
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 220 GNNLT--GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPR 277
N+L + L L L +S N P+P + + L+LSS + +
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKT- 427
Query: 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV 337
+ L L ++ N + +L L L + N+L + P+ LL +
Sbjct: 428 --CIPQTLEVLDVSNN-NLDSFSL---FLPRLQELYISRNKLKT--LPDASLFPVLLVMK 479
Query: 338 LSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
+S N L L +++ L N
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 50/245 (20%), Positives = 88/245 (35%), Gaps = 17/245 (6%)
Query: 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGA-LSR 68
+S+L + I L + + L K++++ + ++ + +P L
Sbjct: 277 VSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKS 335
Query: 69 LKVLDLSYNRLTGTI---PSEIGSLRDLLDLNLSNNILN--GSIPLEFGNLKDLDQLRLQ 123
L+ LDLS N + + G+ L L LS N L LK+L L +
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395
Query: 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTL 183
N +P S + +L+LS + + + L+ L + NN+L
Sbjct: 396 RNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDS-FSL-- 448
Query: 184 YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLS 243
L +L L + NKL + L + ++ N L L L ++ L
Sbjct: 449 -FLPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 244 HNRLD 248
N D
Sbjct: 506 TNPWD 510
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-45
Identities = 75/335 (22%), Positives = 132/335 (39%), Gaps = 15/335 (4%)
Query: 16 TCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLS 75
C +P I ++ L L N + E + L+ L+L+
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 76 YNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPS 133
N ++ + +L +L L L +N L IPL F L +L +L + NK+ L+
Sbjct: 65 ENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDY 122
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192
+L NL L++ N L + L +L+ L L+ +L+ L HL+ L L
Sbjct: 123 MFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVL 181
Query: 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252
L + + + L L ++ ++ Y L L ++H L +P
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VP 240
Query: 253 P-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLT 310
+ +L L L+LS N +S + + L L + L G + + P L L
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG-QLAVVEPYAFRGLNYLR 299
Query: 311 YLNLGYNRLSSSIPPELM-NCSQLLNLVLSHNSLS 344
LN+ N+L +++ + + L L+L N L+
Sbjct: 300 VLNVSGNQL-TTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-41
Identities = 79/352 (22%), Positives = 140/352 (39%), Gaps = 36/352 (10%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
++ + + R +P I + L+L N + EF + L++L L N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYH 185
+ + P + NL NL L L N+L +P V L NL L + N + +
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
L L +L +G N LV + + +L++L L NLT SIP
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIP----------------- 168
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305
+ +L LI L L ++ + L L L ++ + + P Y
Sbjct: 169 ------TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 306 LTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLS 363
NLT L++ + L++ +P + + L L LS+N +S +I + L+ +++ L
Sbjct: 223 GLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLV 280
Query: 364 RNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP---ASVRRIPKLIVSENNL 412
+ P + + +++S N L+ + SV + LI+ N L
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 50/297 (16%), Positives = 98/297 (32%), Gaps = 30/297 (10%)
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
+ + +P I T LDL N++ E + +L+ L L+ N +S
Sbjct: 16 VLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE 239
P +L L TL L N+L + NL +L ++ N + + L L
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132
Query: 240 LHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI 299
L + N L L +L L L L+ +
Sbjct: 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE---------------------- 170
Query: 300 PPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQ 359
+ +L L L L + +++ +L L +SH ++ +
Sbjct: 171 --ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 360 LDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKL---IVSENNLE 413
L ++ + + + + ++LS N +S + + + + +L + L
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 30/177 (16%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
N + +F L I M L L ++H +LT +P
Sbjct: 185 HLNIN--AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 62 E-IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120
+ L L+ L+LSYN ++ TI + L L ++
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSM-----------------------LHELLRLQEI 277
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLS 176
+L G +L + P + L L L++S NQL+ L + V ++ NL++L LD+N L+
Sbjct: 278 QLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-45
Identities = 89/372 (23%), Positives = 138/372 (37%), Gaps = 55/372 (14%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
+ L + + LT +P + + + L + N LT ++P+ LR L +S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNL--------------TNLTYLDLS 147
L S+P+ L +L L L PS + L L L +S
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV 207
NQL+ LP L L NN L+ +P + L L + N+L +
Sbjct: 150 DNQLA-SLPALPSELCKLW---AYNNQLTS-LPMLP---SGLQELSVSDNQLAS-LPTLP 200
Query: 208 GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLS 267
+ L + N LT S+P+ L EL +S NRL +P L L +S
Sbjct: 201 SELYKLWAYN---NRLT-SLPALPSGLK---ELIVSGNRLTS-LPVLPSELKEL---MVS 249
Query: 268 SNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS---SIP 324
N+L+ L P L SLS+ N + +P ++ +L++ T +NL N LS
Sbjct: 250 GNRLTSL-PMLPSGLL---SLSVYRN-QLTRLPESLIHLSSETTVNLEGNPLSERTLQAL 304
Query: 325 PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP----SQLGKIPN 380
E+ + ++ + S P E L L P G+ N
Sbjct: 305 REITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDN 364
Query: 381 ISAVDLSKNNLS 392
A L + LS
Sbjct: 365 ADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-44
Identities = 77/347 (22%), Positives = 129/347 (37%), Gaps = 68/347 (19%)
Query: 66 LSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125
+ VL++ + LT T+P + + + L + +N L S+P L+ L+ + GN
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYH 185
+L L P L L+ L L L L++ N L+ +P
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLTS-LPVLP-- 140
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
L L ++ N L S+P+ L +L +N
Sbjct: 141 -------------------------PGLQELSVSDNQLA-SLPALPSELC---KLWAYNN 171
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305
+L +P L L +S NQL+ L P L L + + + +P
Sbjct: 172 QLTS-LPMLPSGLQEL---SVSDNQLASL-PTLPSELYKLWAYNNR----LTSLPALPS- 221
Query: 306 LTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
L L + NRL+S +P S+L L++S N L+ S+P L L + RN
Sbjct: 222 --GLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLPSGL---LSLSVYRN 271
Query: 366 FINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL 412
+ +P L + + + V+L N LS ++R I +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 24/181 (13%)
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
N L++ + L +P + ++ L + N L+ LP L+ +L ++G
Sbjct: 38 LNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPELR---TLEVSG 90
Query: 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352
N L +P L L+ + L + S L L + N L+ S+P
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPP 141
Query: 353 NLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL 412
L ++L +S N + ++P+ + + N L+ +P + +L VS+N L
Sbjct: 142 GL---QELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELSVSDNQL 193
Query: 413 E 413
Sbjct: 194 A 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 25/158 (15%), Positives = 48/158 (30%), Gaps = 11/158 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
P L L + N LT R+P + LS ++L N L+ + +
Sbjct: 257 PMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPG 312
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL-SGR 154
+ + + + L D L+P+ G + + +
Sbjct: 313 YSGPIIRFDMAGASAPRETRALHLAA-----ADWLVPAREGEPAPADRWHMFGQEDNADA 367
Query: 155 LPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192
+ L ++ F+ + I S L L + L
Sbjct: 368 FSLFLDRLSETEN-FIKDAGFKAQISSWLAQLAEDEAL 404
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-42
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKL---HRSETEEPAFLESFQTEARLLSQ 563
E + IG G +G + G+ +K++ S E E + E +L+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLAN 79
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDV-----EAVELDWTKRVNIVKS 618
++H NIV+ N ++++ +Y E G LF + E LDW +
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ 133
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG 678
+ AL ++H I+HRDI S NI L + + DFG+AR+L+ +GT
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y++PE+ K D+++ G V E+ H
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 515 CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
IG G + +VY+ + VA +L + + + + F+ EA +L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 574 GFCL----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD 629
KC+ L+ E M G+L L+ + + + + L +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 630 CKPSIVHRDISSNNILLNSNL-EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM 688
P I+HRD+ +NI + + D GLA L +S V+GT ++APE+ Y
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-YEE 204
Query: 689 AVTEKCDVYSFGVVALEVLMGSHP 712
E DVY+FG+ LE+ +P
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP 228
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 5/207 (2%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+F I+ IG G + VYRA L G VALKK+ + + E LL Q+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAHALSY 625
N++K Y + + + ++ E + G L ++++ + L + V + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
+H ++HRDI N+ + + + D GL R ++ +VGT Y++PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K D++S G + E+ P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-41
Identities = 86/389 (22%), Positives = 138/389 (35%), Gaps = 32/389 (8%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109
+LT ++P L+ + L LS+N + S L L L L + +I
Sbjct: 11 YRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 110 E-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQE--VGNLKNLK 166
E F NL +L L L +K+ L P + L +L L L LS + ++ NLK L
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 167 SLFLDNNHLSG-PIPSTLYHLNQLATLCLGYNKL--VGPVTKEVGNMKNLDRLHLNGNNL 223
L L N + + + LN L ++ N++ V E K L L N+L
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186
Query: 224 TGSIPSTIGYLN------LLDELHLSHNRLDGPIPPTIGN------------LTNLIALD 265
+ G +L+ L +S N I N +++
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246
Query: 266 LSSNQLSGLLPREVGNLK--YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI 323
+ + L + L L+ + L +L LNL YN+++
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 324 PPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISA 383
L L LS+N L S L +DL +N I + +
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 384 VDLSKNNLSGVIPASVRRIPKLIVSENNL 412
+DL N L+ + + IP + +S N L
Sbjct: 367 LDLRDNALTTI--HFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 91/437 (20%), Positives = 151/437 (34%), Gaps = 62/437 (14%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSK------LEKLVLSHNSLT 56
N +L L F + L R+ + G LE L +S N T
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217
Query: 57 GRIPS------------EIGALSRLKVLDLSYNRLTGTIPSEIGSLRD--LLDLNLSNNI 102
I + + ++ + + L + L+LS+
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNL 162
+ F LKDL L L NK++ + + L NL L+LS N L L
Sbjct: 278 VFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL 337
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
+ + L NH++ T L +L TL L N L + + ++ + L+GN
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNK 392
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIGNLTNLIALDLSSNQLSGLLPREV-G 280
L ++P NL+ LS NRL+ I + + +L L L+ N+ S +
Sbjct: 393 LV-TLPKINLTANLIH---LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448
Query: 281 NLKYLASLSLNGNILIGPIPPTI-----GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
L L L N+L + L++L L L +N L+S P + + L
Sbjct: 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395
L L+ N L+ + + N+ +D+S+N L
Sbjct: 509 LSLNSNRLT-----VLSHNDLP---------------------ANLEILDISRNQLLAPN 542
Query: 396 PASVRRIPKLIVSENNL 412
P + L ++ N
Sbjct: 543 PDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-36
Identities = 83/336 (24%), Positives = 132/336 (39%), Gaps = 22/336 (6%)
Query: 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
A S + L LSH + L LKVL+L+YN++ L +L LNLS
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160
N+L F L + + LQ N + + + L L LDL N L+ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIH 378
Query: 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLN 219
+ ++ +FL N L +P N + L N+L + + + +L L LN
Sbjct: 379 FIPSIPDIFLSGNKLVT-LPKINLTAN---LIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 220 GNNLTG-SIPSTIGYLNLLDELHLSHNRLDGPIPPTI-----GNLTNLIALDLSSNQLSG 273
N + S T L++L L N L + L++L L L+ N L+
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
Query: 274 LLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333
L P +L L LSLN N L + NL L++ N+L + P ++ S L
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLTV-LSHND-LPANLEILDISRNQLLAPNPDVFVSLSVL 552
Query: 334 LNLVLSHNSLSGSIP-SEIGNLIFFRQLDLSRNFIN 368
++HN S N + + ++ +
Sbjct: 553 D---ITHNKFICECELSTFINWLNHTNVTIAGPPAD 585
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG G VY A+ ++VALK + + + +P F Q EAR +++ ++V ++
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
F + +++ + L +LR L + V IV+ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAH---AAGA 155
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYGYIAPELAYTMAVTEK 693
HRD+ NIL++++ A++ DFG+A + + VGT Y+APE T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 694 CDVYSFGVVALEVLMGSHP 712
D+Y+ V E L GS P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 80/307 (26%), Positives = 126/307 (41%), Gaps = 20/307 (6%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
L+V+ S L +P ++ D L+L NN + +F NLK+L L L NK+
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ P + L L L LS NQL LP+++ K L+ L + N ++ S LNQ
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQ 146
Query: 189 LATLCLGYNKL-VGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246
+ + LG N L + MK L + + N+T +IP G L ELHL N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203
Query: 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
+ ++ L NL L LS N +S + + N +L L LN N L+ +P +
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADH 262
Query: 307 TNLTYLNLGYNRLSS------SIPPELMNCSQLLNLVLSHNSLS-GSIPSEI-GNLIFFR 358
+ + L N +S+ P + + L N + I +
Sbjct: 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 322
Query: 359 QLDLSRN 365
+ L
Sbjct: 323 AVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 17/284 (5%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
L L +N +T + L L L L N+++ P L L L LS N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL-SGRLPQEV-GNL 162
+P + K L +LR+ N++ + S L + ++L N L S + +
Sbjct: 114 -ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
K L + + + +++ IP L L L L NK+ + + NL +L L+ N+
Sbjct: 171 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL------LP 276
++ ++ L ELHL++N+L +P + + + + L +N +S + P
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286
Query: 277 REVGNLKYLASLSLNGN-ILIGPIPP-TIGYLTNLTYLNLGYNR 318
+ +SL N + I P T + + LG +
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 23/280 (8%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N T E+ +F NL T + +S P L KLE+L LS N L +P
Sbjct: 61 NNKIT--EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNN-ILNGSIPLE-FGNLKDLD 118
L+ L + N +T + + L ++ + L N + + I F +K L
Sbjct: 118 --KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG 177
+R+ + IP G +LT L L N+++ ++ L NL L L N +S
Sbjct: 175 YIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230
Query: 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG------SIPSTI 231
+L + L L L NKLV V + + K + ++L+ NN++ P
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 289
Query: 232 GYLNLLDELHLSHNRL-DGPIPP-TIGNLTNLIALDLSSN 269
+ L N + I P T + A+ L +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 41/302 (13%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175
L ++ L+ +P + + LDL N+++ + NLKNL +L L NN +
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLN 235
S P L +L L L N+L K L L ++ N +T S LN
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK---ELPEKMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 236 LLDELHLSHNRL-DGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
+ + L N L I + L + ++ ++ + G L L L+GN
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGN 202
Query: 294 ILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEI 351
I + ++ L NL L L +N +S+ + L N L L L++N L
Sbjct: 203 -KITKVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV------- 253
Query: 352 GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENN 411
+P L I V L NN+S I ++ P + +
Sbjct: 254 ------------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKAS 294
Query: 412 LE 413
Sbjct: 295 YS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 28/242 (11%)
Query: 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT-GRIPSEI-GALS 67
L +L L R+ ++ S L+++ + L N L I + +
Sbjct: 112 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNK 126
+L + ++ +T TIP G L +L+L N + + L +L +L L N
Sbjct: 172 KLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL 186
+ + S+ N +L L L+ N+L ++P + + K ++ ++L NN++S I S +
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA-IGSNDFCP 285
Query: 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI--PSTIGYLNLLDELHLSH 244
T + + L N + PST + + + L +
Sbjct: 286 PGYNT-----------------KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 245 NR 246
+
Sbjct: 329 YK 330
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 7/216 (3%)
Query: 503 MIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
M ED+ + Y IGTG YG + + S GK++ K+L E + +E LL
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59
Query: 562 SQIRHRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKS 618
+++H NIV+ Y + N ++++ EY E G L V+ + + + V ++
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 619 MAHALSYLHY--DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT 676
+ AL H D +++HRD+ N+ L+ + DFGLAR+L+ D+S VGT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y++PE M+ EK D++S G + E+ P
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 73/376 (19%), Positives = 132/376 (35%), Gaps = 39/376 (10%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
+ I L+ L KL+ + N++T ++ + L L N+LT + + L L L
Sbjct: 58 TGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
N N L L+ L L N L + + + T LT LD LN+ +L
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD 165
Query: 157 QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRL 216
V L +L N ++ + L L N + ++ L L
Sbjct: 166 --VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI---TKLDLNQNIQLTFL 217
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
+ N LT I + L L S N L + + L+ L L L +
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI-- 269
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336
++ + L G I + + + T L L+ ++ +L +L+ L
Sbjct: 270 -DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYL 323
Query: 337 VLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396
L++ L+ + + + + L I S +GKIP ++ ++ +
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPK 378
Query: 397 ASVRRIPKLIVSENNL 412
++ I +L
Sbjct: 379 ETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-38
Identities = 73/371 (19%), Positives = 133/371 (35%), Gaps = 36/371 (9%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
V + + L+ L LD + +T + I L L L ++N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNL 162
+ L+ +L L NKL L + LT LTYL+ N+L+ +V
Sbjct: 76 ITT---LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
L L N L+ + H QL L NK + + +V L L + N
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282
+T + + LL+ L+ N + + L LD SSN+L+ + +V L
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 283 KYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
L + N + + + L+ LT L+ L +L + +QL+
Sbjct: 233 TQLTYFDCSVN-PLTELDVST--LSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCR 286
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRI 402
+ ++ + LD I + L + P + + L+ L+ + + ++
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTELDVSHNTKL 341
Query: 403 PKLIVSENNLE 413
L +++
Sbjct: 342 KSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 65/368 (17%), Positives = 126/368 (34%), Gaps = 36/368 (9%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSR 68
+L+ L+ T L L+ ++ L L + N+LT ++ ++
Sbjct: 96 KLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQ 149
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
L LD N+ + + L L+ S N + L+ K L++L N +
Sbjct: 150 LTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT 204
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
L + LT+LD S N+L+ + V L L N L+ S L++
Sbjct: 205 KL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVS---TLSK 255
Query: 189 LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD 248
L TL L+ ++ + L G + + + L L +
Sbjct: 256 LTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
Query: 249 GPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTN 308
+ + L+ L L++ +L+ L +V + L SLS + ++G +
Sbjct: 311 -ELD--LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQDF--SSVGKIPA 362
Query: 309 LTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSG---SIPSEIGNLIFFRQLDLSRN 365
L + + L N S + + G +I G + ++
Sbjct: 363 LNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWE 422
Query: 366 FINGTIPS 373
++ P+
Sbjct: 423 NLSTDNPA 430
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 8/199 (4%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G GG +VY A+ VA+K + E+ L+ F+ E SQ+ H+NIV +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ C +L+ EY+E +L + L +N + + + H I
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYGYIAPELAYTMAVTEK 693
VHRDI NIL++SN + DFG+A+ L S +T V+GT Y +PE A A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 694 CDVYSFGVVALEVLMGSHP 712
D+YS G+V E+L+G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
DF IG+GG+G V++A+ GK +K++ + E + E + L+++ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 567 RNIVKLYGF----------------CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWT 610
NIV G KC+F+ E+ ++G+L + +LD
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKV 122
Query: 611 KRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670
+ + + + + Y+H +++RD+ +NI L + + DFGL L D
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
GT Y++PE + ++ D+Y+ G++ E+L
Sbjct: 180 R-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL-VALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED + IG G +G V+ +L + VA+K + + F EAR+L Q H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARILKQYSH 171
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
NIV+L G C + ++++ E ++ G LR + + + + +V A + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYL 229
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----A 681
+HRD+++ N L+ ++DFG++R + G + A
Sbjct: 230 E---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS---GGLRQVPVKWTA 283
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE + + DV+SFG++ E G+ P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 30/226 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
DF C+G GG+G V+ A+ A+K++ E E E + L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEH 62
Query: 567 RNIVKLYGFCLHNKCM------------FLIYEYMERGSLFCVLRNDVEAVELDWTKRVN 614
IV+ + L ++ + + +L + E + + ++
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH---------- 664
I +A A+ +LH ++HRD+ +NI + V DFGL +
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 665 --PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM 708
P + T VGT Y++PE + + + K D++S G++ E+L
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 64/308 (20%), Positives = 113/308 (36%), Gaps = 23/308 (7%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
L+V+ S L +P EI D L+L NN ++ +F L+ L L L NK+
Sbjct: 35 LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ + L L L +S N L +P + +L L + +N + L
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 189 LATLCLGYNKL-VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL 247
+ + +G N L + L+ L ++ LT IP L+ELHL HN++
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 248 DGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
I + + L L L NQ+ + + L L L L+ N + +P + L
Sbjct: 206 QA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN-KLSRVPAGLPDL 263
Query: 307 TNLTYLNLGYNRLSSSIPPE-------LMNCSQLLNLVLSHNSLS-GSIPSEI-GNLIFF 357
L + L N + + + + + + L +N + + +
Sbjct: 264 KLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322
Query: 358 RQLDLSRN 365
+
Sbjct: 323 LAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 18/284 (6%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
L L +N ++ + L L L L N+++ LR L L +S N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL-SGRLPQEVGNLK 163
IP L +LR+ N++ + L N+ +++ N L + +
Sbjct: 116 -EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNN 222
L L + L+G IP L L L L +NK+ + E L RL L N
Sbjct: 173 KLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP------ 276
+ ++ +L L ELHL +N+L +P + +L L + L +N ++ +
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 277 REVGNLKYLASLSLNGN-ILIGPIPP-TIGYLTNLTYLNLGYNR 318
Y +SL N + + P T +T+ + G +
Sbjct: 288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 44/233 (18%), Positives = 82/233 (35%), Gaps = 27/233 (11%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSY 76
+LV RI + L + + + N L +L L +S
Sbjct: 122 PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 77 NRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSI 135
+LT IP L +L+L +N + +I LE L +L L N++ + S+
Sbjct: 182 AKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237
Query: 136 GNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLG 195
L L L L N+LS R+P + +LK L+ ++L N+++ + +
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGV----- 291
Query: 196 YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI--PSTIGYLNLLDELHLSHNR 246
+ + L N + P+T + + + +
Sbjct: 292 -------------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 36/204 (17%), Positives = 73/204 (35%), Gaps = 33/204 (16%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
+L + + L ++P I L L +N + L +L AL L +N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNC 330
S + + L+ L L ++ N + IPP ++L L + NR+ +P
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKN-HLVEIPP--NLPSSLVELRIHDNRIRK-VPKGVFSGL 146
Query: 331 SQLLNLVLSHNSL-SGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389
+ + + N L + F L L+ + +S+
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGA-----FDGLKLNY-------------------LRISEA 182
Query: 390 NLSGVIPASVRRIPKLIVSENNLE 413
L+G+ + +L + N ++
Sbjct: 183 KLTGIPKDLPETLNELHLDHNKIQ 206
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 26/247 (10%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
E F IG G +G V++ + K+VA+K + E E+ +E Q E +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCD 78
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
+ K YG L + +++I EY+ GS +L LD T+ I++ + L Y
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDY 134
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH +HRDI + N+LL+ + E +ADFG+A L R VGT ++APE+
Sbjct: 135 LH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGS------HPTDLLSSLSSSSGRKISQN--PRLDLQC 737
A K D++S G+ A+E+ G HP +L I +N P L+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--------FLIPKNNPPTLEGNY 243
Query: 738 NAYLKNF 744
+ LK F
Sbjct: 244 SKPLKEF 250
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-37
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 12/255 (4%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
++ K+V + L+ +P I S + L+L N + L L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 103 LNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-G 160
+ I + F L L+ L L N L + + L+ L L L N + +P
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 161 NLKNLKSLFL-DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLN 219
+ +L L L + L L L L LG + + + L+ L ++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLEELEMS 226
Query: 220 GNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPRE 278
GN+ P + L+ L +L + ++++ I L +L+ L+L+ N LS L
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 279 VGNLKYLASLSLNGN 293
L+YL L L+ N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 8/253 (3%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
++ + + L+ +P I + LNL N + F +L L+ L+L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYH 185
+ + + L +L L+L N L+ +P L L+ L+L NN +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 186 LNQLATLCLG-YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244
+ L L LG KL + NL L+L N+ +P + L L+EL +S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIG 304
N P + L++L L + ++Q+S + L L L+L N L
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 305 YLTNLTYLNLGYN 317
L L L+L +N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 61/257 (23%), Positives = 99/257 (38%), Gaps = 14/257 (5%)
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL 199
+ + + LS +PQ + N + L L N++ T HL+ L L LG N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 200 VGPVTKEVGNMKNLDRLHLNGNNLTGSIPS-TIGYLNLLDELHLSHNRLDGPIPPTI-GN 257
+ +L+ L L N LT IPS YL+ L EL L +N ++ IP
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNR 169
Query: 258 LTNLIALDLSS-NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
+ +L+ LDL +L + L L L+L + P + L L L +
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSG 227
Query: 317 NRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSE-IGNLIFFRQLDLSRNFINGTIPSQ 374
N I P S L L + ++ +S I L +L+L+ N ++
Sbjct: 228 NHF-PEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 375 LGKIPNISAVDLSKNNL 391
+ + + L N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 11/226 (4%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+NN + F +L ++ + L+ L L L N LT IPS
Sbjct: 84 ENNIQ--MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPS 140
Query: 62 EI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLD 118
LS+L+ L L N + +IPS + L+ L+L I F L +L
Sbjct: 141 GAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG 177
L L + + ++ L L L++S N + L +LK L++ N+ +S
Sbjct: 200 YLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+ L L L L +N L ++ L LHL+ N
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 10/197 (5%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
++ L+ +P I + L+L N + T +L +L L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 272 SGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPE-LMN 329
+ L L +L L N + IP YL+ L L L N + S IP
Sbjct: 112 RQIEVGAFNGLASLNTLELFDN-WLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNR 169
Query: 330 CSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
L+ L L I L + L+L I +P+ L + + +++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 389 NNLSGVIPASVRRIPKL 405
N+ + P S + L
Sbjct: 228 NHFPEIRPGSFHGLSSL 244
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 10/132 (7%)
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
+ + L +P I +N YLNL N + + L L L NS+
Sbjct: 56 FSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 345 GSIPSEI-GNLIFFRQLDLSRNFINGTIPSQ-LGKIPNISAVDLSKNNLSGVIPASVRRI 402
I L L+L N++ IPS + + + L N + + + R+
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 403 PKLIV---SENN 411
P L+ E
Sbjct: 171 PSLMRLDLGELK 182
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 51/221 (23%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH- 566
+ I IG+GG V++ ++ A+K ++ E + L+S++ E L++++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 86
Query: 567 -RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
I++LY + + ++ ++++ E L L+ +D +R + K+M A+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 142
Query: 626 LHYDCKPSIVHRDISSNNILL-NSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAP 682
+H + IVH D+ N L+ + L+ + DFG+A + PD+++ + VGT Y+ P
Sbjct: 143 IH---QHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 683 EL-----------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E ++ K DV+S G + + G P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
DF +G G +G V +A+ + A+KK+ +E + + +E LL+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60
Query: 566 HRNIVKLYGFCLHN-------------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
H+ +V+ Y L +F+ EY E G+L+ ++ ++ + D R
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD------ 666
+ + + ALSY+H I+HRD+ NI ++ + + DFGLA+ +H
Sbjct: 121 --LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 667 --------SSNRTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEVLMG 709
S N T +GT Y+A E L T EK D+YS G++ E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY- 573
+G GG V+ A+ L + VA+K L +P+F F+ EA+ + + H IV +Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 574 -GF--CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
G +++ EY++ +L ++ + + + ++ AL++ H
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH--- 133
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT---LVVGTYGYIAPELAYT 687
+ I+HRD+ NI++++ V DFG+AR + ++ T V+GT Y++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 688 MAVTEKCDVYSFGVVALEVLMGSHP 712
+V + DVYS G V EVL G P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF I +G G +G+VY A+ S ++ALK L +++ E+ + E + S +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMA 620
NI++LYG+ ++LI EY G+++ L+ + + + +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---------LSKFDEQRTATYITELA 119
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+ALSY H ++HRDI N+LL S E +ADFG + +H SS RT + GT Y+
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYL 174
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ EK D++S GV+ E L+G P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 515 CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G YG VY LS+ +A+K++ ++ + E L ++H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYL 85
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
G N + + E + GSL +LR+ ++ + K + L YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 634 IVHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE--LAYTMAV 690
IVHRDI +N+L+N+ + ++DFG ++ L + GT Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 691 TEKCDVYSFGVVALEVLMGSHP 712
+ D++S G +E+ G P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ IG+G +G V+ + VA+K + E F+E EA ++ ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHP 63
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL- 626
+V+LYG CL + L+ E+ME G L LR + + + ++YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE 121
Query: 627 --HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---A 681
+HRD+++ N L+ N V+DFG+ R + D + GT + +
Sbjct: 122 EACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS--TGTKFPVKWAS 173
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE+ + K DV+SFGV+ EV G P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-36
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 510 FHIKYCIGTGGYGSVYRA--QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ +K CI GG G +Y A + +G+ V LK L S + E + L+++ H
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139
Query: 568 NIVKLYGFCLH-----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+IV+++ F H + +++ EY+ SL + +L + + + + A
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPA 194
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
LSYLH +V+ D+ NI+L + + D G ++ + GT G+ AP
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQAP 246
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ T T D+Y+ G + +
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-36
Identities = 71/358 (19%), Positives = 139/358 (38%), Gaps = 39/358 (10%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGA-LSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L L+ L + + I + LS L +L L YN+ + + L +L L L+
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLT 111
Query: 100 NNILNGS-IPLE-FGNLKDLDQLRLQGNKLDGLIPSSI-GNLTNLTYLDLSLNQLS---- 152
L+G+ + F L L+ L L+ N + + P+S N+ LDL+ N++
Sbjct: 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
Query: 153 ------GRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206
+ L ++ ++ L + + TL L N + K
Sbjct: 172 EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231
Query: 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNL---------------LDELHLSHNRLDGPI 251
+ ++ + + ++ S+ G+ N + LS +++ +
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-L 290
Query: 252 PPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNL 309
++ + T+L L L+ N+++ + L +L L+L+ N +G I + L L
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN-FLGSIDSRMFENLDKL 349
Query: 310 TYLNLGYNRLSSSIPPEL-MNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRN 365
L+L YN + ++ + + L L L N L S+P I L +++ L N
Sbjct: 350 EVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 75/377 (19%), Positives = 128/377 (33%), Gaps = 41/377 (10%)
Query: 51 SHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
+ L ++P + + +DLS N + + L+DL L + I
Sbjct: 18 INRGLH-QVPEL---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 111 -FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL-SGRLPQEV-GNLKNLKS 167
F L L L+L N+ L + L NL L L+ L L L +L+
Sbjct: 74 TFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
Query: 168 LFLDNNHLSGPIPSTL-YHLNQLATLCLGYNKL----------VGPVTKEVGNMKNLDRL 216
L L +N++ P++ ++ + L L +NK+ + + ++
Sbjct: 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIAL------------ 264
+N L + L LS N + + +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 265 -DLSSNQLSGLLPREVGNLKY--LASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLS 320
L+ + + L+ + I + ++ + T+L L L N +
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS-KIFALLKSVFSHFTDLEQLTLAQNEI- 311
Query: 321 SSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQL-GK 377
+ I + LL L LS N L SI S + NL LDLS N I + Q
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLG 369
Query: 378 IPNISAVDLSKNNLSGV 394
+PN+ + L N L V
Sbjct: 370 LPNLKELALDTNQLKSV 386
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 76/377 (20%), Positives = 137/377 (36%), Gaps = 43/377 (11%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGA-LSKLEKLVLSHNSLTGRIP 60
N+ EL++ +F+ +L ++ + + LS L L L +N ++
Sbjct: 39 LNSIA--ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLE 95
Query: 61 SEI-GALSRLKVLDLSYNRLTGT-IPSEI-GSLRDLLDLNLSNNILNGSIPLE--FGNLK 115
+ L+ L+VL L+ L G + L L L L +N + I F N++
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMR 154
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLT--NLTYLDLSLNQLSGRLPQEVG--------NLKNL 165
L L NK+ + + N + T L LS L +G ++
Sbjct: 155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 166 KSLFLDNNHLSGPIPSTLYHL-------------NQLATLCLGYNKLVGPVTKEVGNMK- 211
+L L N + + + G+ P ++
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274
Query: 212 -NLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSS 268
+ L+ + + ++ ++ + L++L L+ N ++ I LT+L+ L+LS
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPE- 326
N L + R NL L L L+ N I + + L NL L L N+L S+P
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYN-HIRALGDQSFLGLPNLKELALDTNQL-KSVPDGI 390
Query: 327 LMNCSQLLNLVLSHNSL 343
+ L + L N
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 45/177 (25%), Positives = 68/177 (38%), Gaps = 22/177 (12%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
++ G+ NF N + + ++ LS + + +
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEAS--------------GVKTCDLSKSKIF-ALL 291
Query: 61 SEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDL 117
+ + L+ L L+ N + I L LL LNLS N L GSI F NL L
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKL 349
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNN 173
+ L L N + L S L NL L L NQL +P + L +L+ ++L N
Sbjct: 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L+ L KL LS N L I S + L +L+VLDLSYN + + + L +L +L L
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379
Query: 100 NNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
N L S+P F L L ++ L N D
Sbjct: 380 TNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 51/221 (23%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH- 566
+ I IG+GG V++ ++ A+K ++ E + L+S++ E L++++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 67
Query: 567 -RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
I++LY + + ++ ++++ E L L+ +D +R + K+M A+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 123
Query: 626 LHYDCKPSIVHRDISSNNILL-NSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAP 682
+H + IVH D+ N L+ + L+ + DFG+A + PD+++ + VGT Y+ P
Sbjct: 124 IH---QHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 683 EL-----------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E ++ K DV+S G + + G P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-36
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+D +GTG +G V + VA+K + E F+E EA+++ + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHE 79
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL- 626
+V+LYG C + +F+I EYM G L LR + + + K + A+ YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137
Query: 627 --HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---A 681
+ +HRD+++ N L+N V+DFGL+R + D + VG+ +
Sbjct: 138 SKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSP 189
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE+ + K D+++FGV+ E+ G P
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-35
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHR 567
F K +G G G++ + + VA+K++ E +LL + H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHP 78
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLF-CVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+++ + + ++ E +L V + D + L+ + +++ L++L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 627 HYDCKPSIVHRDISSNNILL-----NSNLEAFVADFGLARLLHPDSS---NRTLVVGTYG 678
H +IVHRD+ +NIL+ + ++A ++DFGL + L R+ V GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 679 YIAPEL---AYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+IAPE+ T D++S G V V+ GSHP
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 28/261 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF +G G G V++ SG ++A K +H +PA E ++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMA 620
IV YG + + + E+M+ GSL VL+ R+ + ++
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVI 141
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
L+YL K I+HRD+ +NIL+NS E + DFG++ L S VGT Y+
Sbjct: 142 KGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYM 197
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP------TDLLSSLSSSSGRKISQNPRLD 734
+PE + + D++S G+ +E+ +G +P +L ++ P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 735 LQCNAYLKNFSQGNHRWENLL 755
L F + +
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIF 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E+ + +G+G +G V + VA+K + E F + EA+ + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL- 626
+VK YG C ++++ EY+ G L LR+ L+ ++ + + + +++L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 627 --HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---A 681
+ +HRD+++ N L++ +L V+DFG+ R + D + VGT + A
Sbjct: 122 SHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSA 173
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE+ + + K DV++FG++ EV G P
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 26/242 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + +G GG+ V + L G ALK++ E ++ E Q EA + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNH 85
Query: 567 RNIVKLYGFCL----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV-NIVKSMAH 621
NI++L +CL +L+ + +RG+L+ + + ++ ++ +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT---------L 672
L +H HRD+ NILL + + D G
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 673 VVGTYGYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKIS 728
T Y APEL ++ + + E+ DV+S G V ++ G P D++ S +
Sbjct: 203 QRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 729 QN 730
Sbjct: 262 NQ 263
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 502 EMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESF-QTEAR 559
E E + +G G +G V+R + +G A+KK+ LE F E
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELV 102
Query: 560 LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND---VEAVELDWTKRVNIV 616
+ + IV LYG + + E +E GSL +++ E L +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL------YYL 156
Query: 617 KSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPDSSNRTL--- 672
L YLH I+H D+ ++N+LL+S+ A + DFG A L PD ++L
Sbjct: 157 GQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 673 --VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ GT ++APE+ K D++S + L +L G HP
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 507 TEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ + IG G G+VY A +++G+ VA+++++ + + E E ++ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
+ NIV L ++++ EY+ GSL V+ +D + + + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEF 131
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH ++HRDI S+NILL + + DFG + P+ S R+ +VGT ++APE+
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
A K D++S G++A+E++ G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
IG G G V A+ SG+ VA+K + + + E E ++ +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQ 100
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H N+V++Y L + ++++ E+++ G+L ++ V L+ + + +++ AL+Y
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAY 156
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH ++HRDI S++ILL + ++DFG + D R +VGT ++APE+
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ D++S G++ +E++ G P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-35
Identities = 59/341 (17%), Positives = 114/341 (33%), Gaps = 34/341 (9%)
Query: 29 TLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIG 88
+ S K + N + + +++ L L+ L+ ++P +
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP 79
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+ L ++ N L S+P +L+ LD N+L L P +L +L D+
Sbjct: 80 P--QITVLEITQNAL-ISLPELPASLEYLD---ACDNRLSTL-PELPASLKHL---DVDN 129
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG 208
NQL+ LP+ L+ + DNN L+ +P L L + N+L T
Sbjct: 130 NQLT-MLPELPALLE---YINADNNQLTM-LPELP---TSLEVLSVRNNQL----TFLPE 177
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE----LHLSHNRLDGPIPPTIGNLTNLIAL 264
++L+ L ++ N L S+P+ + +E NR+ IP I +L +
Sbjct: 178 LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235
Query: 265 DLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP 324
L N LS + + + + + +
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQ 293
Query: 325 PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
++ N+ S + + + + R R
Sbjct: 294 SDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFRE 333
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 61/338 (18%), Positives = 118/338 (34%), Gaps = 35/338 (10%)
Query: 82 TIPSEIGSLRDLLDLNLSNNILN--GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT 139
+I I + L + N I + + N+ L+ + +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL 199
+ L L+ LS LP + + L + N L +P L L N+L
Sbjct: 60 QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELP---ASLEYLDACDNRL 112
Query: 200 VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT 259
+ + ++K+LD ++ N LT +P LL+ ++ +N+L +P +L
Sbjct: 113 ST-LPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELPTSLE 163
Query: 260 NLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLT----YLNLG 315
L + +NQL+ L P +L+ +L ++ N+L +P + +
Sbjct: 164 VL---SVRNNQLTFL-PELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215
Query: 316 YNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQL 375
NR++ IP +++ ++L N LS I + Q D I ++
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT--AQPDYHGPRIYFSMSDGQ 272
Query: 376 GKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ D + V +I E +
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHAN 310
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-35
Identities = 61/255 (23%), Positives = 110/255 (43%), Gaps = 12/255 (4%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
++ K++ +L +P I + ++L+L N++ + LR L L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 103 LNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-G 160
+ +I + F L +L+ L L N+L + + L+ L L L N + +P
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 161 NLKNLKSLFL-DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLN 219
+ +L+ L L + LS L+ L L L L + + LD L L+
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLS 215
Query: 220 GNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPRE 278
GN+L+ P + L L +L + +++ I NL +L+ ++L+ N L+ L
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 279 VGNLKYLASLSLNGN 293
L +L + L+ N
Sbjct: 275 FTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 8/253 (3%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
++ + L +P I + LNL N + F +L+ L+ L+L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYH 185
+ + + L NL L+L N+L+ +P L LK L+L NN +
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 186 LNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244
+ L L LG K + +++ + NL L+L NL IP + L LDEL LS
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIG 304
N L P + L +L L + +Q+ + NL+ L ++L N L
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 305 YLTNLTYLNLGYN 317
L +L ++L +N
Sbjct: 277 PLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 60/257 (23%), Positives = 97/257 (37%), Gaps = 14/257 (5%)
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL 199
+ + L +P + N + L L N + ++ HL L L L N +
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 200 VGPVTKEVGNMKNLDRLHLNGNNLTGSIPS-TIGYLNLLDELHLSHNRLDGPIPP-TIGN 257
+ NL+ L L N LT +IP+ YL+ L EL L +N ++ IP
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNR 158
Query: 258 LTNLIALDLSS-NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
+ +L LDL +LS + L L L+L L P + L L L+L
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSG 216
Query: 317 NRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSE-IGNLIFFRQLDLSRNFINGTIPSQ 374
N LS+ I P L L + + + I NL +++L+ N +
Sbjct: 217 NHLSA-IRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 375 LGKIPNISAVDLSKNNL 391
+ ++ + L N
Sbjct: 275 FTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 10/245 (4%)
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+ +L +P + L L N++ ++++L+ L L+ N++
Sbjct: 44 QFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 224 TGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNL 282
L L+ L L NRL IP L+ L L L +N + + +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 283 KYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L L L + I L+NL YLNL L P L +L L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGN 217
Query: 342 SLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVR 400
LS +I L+ ++L + ++ I + + ++ ++L+ NNL+ +
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 401 RIPKL 405
+ L
Sbjct: 277 PLHHL 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 11/226 (4%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N + +F +L ++ + L+ L L L N LT IP+
Sbjct: 73 ENQIQ--IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPN 129
Query: 62 EI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLD 118
LS+LK L L N + +IPS + L L+L I F L +L
Sbjct: 130 GAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG 177
L L L + ++ L L LDLS N LS + L +L+ L++ + +
Sbjct: 189 YLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+ +L L + L +N L + +L+R+HL+ N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ +G GG+ + + ++ A K + +S +P E E + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMA 620
+++V +GF N +F++ E R SL + + K + ++ +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---------KALTEPEARYYLRQIV 151
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
YLH + ++HRD+ N+ LN +LE + DFGLA + D + ++ GT YI
Sbjct: 152 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 208
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
APE+ + + DV+S G + +L+G P
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALK--KLHRSETEEPAFLESFQTEARLLSQI 564
+D+ ++ IG+G V A + VA+K L + +T ++ E + +SQ
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQC 70
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-----DVEAVELDWTKRVNIVKSM 619
H NIV Y + ++L+ + + GS+ ++++ + ++ LD + I++ +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL-----HPDSSNRTLVV 674
L YLH K +HRD+ + NILL + +ADFG++ L + R V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 675 GTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGS------HPTDLLSSLSSSS 723
GT ++APE+ Y K D++SFG+ A+E+ G+ P +L
Sbjct: 188 GTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPMKVL------- 236
Query: 724 GRKISQN--PRLDLQCNAY--LKNFSQGNHRWENLLFKKF 759
QN P L+ LK + + F+K
Sbjct: 237 -MLTLQNDPPSLETGVQDKEMLKKYGK--------SFRKM 267
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-35
Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH- 566
+ I IG+GG V++ ++ A+K ++ E + L+S++ E L++++
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQH 114
Query: 567 -RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
I++LY + + ++ ++++ E L L+ +D +R + K+M A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 170
Query: 626 LHYDCKPSIVHRDISSNNILL-NSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAP 682
+H + IVH D+ N L+ + L+ + DFG+A + PD+++ VG Y+ P
Sbjct: 171 IH---QHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 683 EL-----------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E ++ K DV+S G + + G P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 71/218 (32%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
HI+ IG+G G V +L VA+K L TE F +EA ++ Q
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H NI++L G + ++ EYME GSL LR + + V +++ + +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGM 164
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
YL Y VHRD+++ N+L++SNL V+DFGL+R+L D T G I
Sbjct: 165 RYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKI 216
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
APE + DV+SFGVV EVL G P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
E + I +G G +G VY+A+ +G L A K + EE LE + E +L+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCD 74
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H IVKL G H+ ++++ E+ G++ ++ + + + + M AL++
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNF 132
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH I+HRD+ + N+L+ + +ADFG++ R +GT ++APE+
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 686 YTMAVTE-----KCDVYSFGVVALEVLMGSHP 712
+ + K D++S G+ +E+ P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D +K+ +G G YG VY VA+K L E FL+ EA ++ +I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 275
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G C ++I E+M G+L LR E+ + + ++ A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 334
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS-SNRTLVVGTYGYIAPELA 685
K + +HR++++ N L+ N VADFGL+RL+ D+ + + APE
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 686 YTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ K DV++FGV+ E+ G P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ +G GG+ + + ++ A K + +S +P E E + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMA 620
+++V +GF N +F++ E R SL + + K + ++ +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---------KALTEPEARYYLRQIV 125
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
YLH + ++HRD+ N+ LN +LE + DFGLA + D + ++ GT YI
Sbjct: 126 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
APE+ + + DV+S G + +L+G P
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+ I +G G +G V +L VA+K L TE+ F EA ++ Q
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H NI++L G +K + ++ EYME GSL LR + + V +++ +A +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
YL Y VHRD+++ NIL+NSNL V+DFGL R+L D G I
Sbjct: 161 KYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 681 ---APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+PE T DV+S+G+V EV+ G P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 516 IGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G+G +G+V + K+ VA+K L ++E +PA + EA ++ Q+ + IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL---HYD 629
G C L+ E E G L L+ + + + +V ++ + YL ++
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---YGYIAPELAY 686
VHRD+++ N+LL + A ++DFGL++ L D + + APE
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 687 TMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ K DV+SFGV+ E G P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL-VALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D +K+ +G G YG VY L VA+K L E FL+ EA ++ +I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 68
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G C ++I E+M G+L LR E+ + + ++ A+ YL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 127
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----A 681
K + +HRD+++ N L+ N VADFGL+RL+ D T A
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 180
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE + K DV++FGV+ E+ G P
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 48/213 (22%), Positives = 72/213 (33%), Gaps = 23/213 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ F +G G YG V++ + G+L A+K+ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDV----EAVELDWTKRVNIVKSMAHA 622
V+L ++L E SL EA + + A
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLR------DTLLA 169
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
L++LH +VH D+ NI L + DFGL L + G Y+AP
Sbjct: 170 LAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAP 225
Query: 683 EL---AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
EL +Y DV+S G+ LEV
Sbjct: 226 ELLQGSY----GTAADVFSLGLTILEVACNMEL 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E + +G G +G V+ + VA+K L + AFL EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQ 68
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY +++I EYME GSL L+ ++L K +++ +A ++++
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----AP 682
+ + +HRD+ + NIL++ L +ADFGLARL+ + AP
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR----EGAKFPIKWTAP 179
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
E T K DV+SFG++ E++ G P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL-----VALKKLHRSETEEPAFLESFQTEARLLS 562
+F +G+G +G+VY+ VA+K+L R T A E EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMA 72
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+ + ++ +L G CL + LI + M G L +R + + +N +A
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129
Query: 623 LSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
++YL VHRD+++ N+L+ + + DFGLA+LL + G
Sbjct: 130 MNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGK 180
Query: 680 I-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ A E T + DV+S+GV E++ GS P
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I +G G +G+VY A+ + ++ALK L +S+ E+ + E + S +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSMA 620
NI+++Y + K ++L+ E+ RG L+ L+ R + ++ +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---------GRFDEQRSATFMEELA 124
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
AL Y H + ++HRDI N+L+ E +ADFG + +H S R + GT Y+
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYL 179
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ EK D++ GV+ E L+G P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 6/206 (2%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF + +G G + VYRA+ + +G VA+K + + + ++ Q E ++ Q++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+I++LY + + ++L+ E G + L+N V+ + + + + + YL
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYL 128
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H I+HRD++ +N+LL N+ +ADFGLA L + GT YI+PE+A
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
A + DV+S G + +L+G P
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 512 IKYCIGTGGYGSVYRAQLSSGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+G G +GSV + K VA+K L + + E EA+++ Q+ +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPY 71
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL-- 626
IV+L G C + + L+ E G L L + E+ + ++ ++ + YL
Sbjct: 72 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 627 -HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---AP 682
++ VHRD+++ N+LL + A ++DFGL++ L D S T + AP
Sbjct: 129 KNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
E + + DV+S+GV E L G P
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 20/216 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL----VALKKLHRSETEEPAFLESFQTEARLLSQ 563
+D + +G G +G V R + + VA+K L +P ++ F E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
+ HRN+++LYG L M ++ E GSL LR +A +
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGM 134
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT---Y 677
YL + +HRD+++ N+LL + + DFGL R L + + + +
Sbjct: 135 GYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ APE T + D + FGV E+ G P
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 74/217 (34%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK-----LVALKKLHRSETEEPAFLESFQTEARLLS 562
+ IG G +G VY+ L + VA+K L TE+ F EA ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
Q H NI++L G K M +I EYME G+L LR E + V +++ +A
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 159
Query: 623 LSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+ YL +Y VHRD+++ NIL+NSNL V+DFGL+R+L D G
Sbjct: 160 MKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 680 I---APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
I APE T DV+SFG+V EV+ G P
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
E F + +G G YGSVY+A +G++VA+K++ E L+ E ++ Q
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESD--LQEIIKEISIMQQCD 82
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
++VK YG N ++++ EY GS+ ++R + + D I++S L Y
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEY 140
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH +HRDI + NILLN+ A +ADFG+A L + R V+GT ++APE+
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ D++S G+ A+E+ G P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 46/231 (19%), Positives = 89/231 (38%), Gaps = 46/231 (19%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL--------SSGKLVALKKLHRSETEEPAFLESFQTEAR 559
ED +G G + +++ V LK L ++ ESF A
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 560 LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSM 619
++S++ H+++V YG C+ L+ E+++ GSL L+ + + + W ++ + K +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 620 AHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAF--------VADFGLARLLHPDSS 668
A A+ +L +H ++ + NILL + ++D G++ + P
Sbjct: 123 AAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD- 175
Query: 669 NRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
PE + + D +SFG E+ G P
Sbjct: 176 --------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 33/227 (14%), Positives = 67/227 (29%), Gaps = 27/227 (11%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ------LSSGKLVALKKLHRSETEEPAFLESFQTEARL 560
++ ++ + +G G + VY A + + LK + E
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMER 120
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE--LDWTKRVNIVKS 618
L +K Y L L+ E G+L + E + ++
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-----------VADFGLARLLHPDS 667
M + + +H I+H DI +N +L + + D G + +
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 668 SNRTL--VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
T G+ E+ + D + +L G++
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + +G G +V+R + +G L A+K + P ++ E +L ++ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66
Query: 567 RNIVKLYGF--CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
+NIVKL+ + LI E+ GSL+ VL A L ++ + +++ + ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSNRTLVVGTYGYI 680
+L + IVHR+I NI+ + + DFG AR L D +L GT Y+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYL 182
Query: 681 APEL--------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
P++ + D++S GV GS P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 28/277 (10%), Positives = 67/277 (24%), Gaps = 41/277 (14%)
Query: 490 SIWNYDGRITFEEMI-EATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEE 547
++W + T + ++ + + + G V+ + + ALK
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 548 PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM------------------------- 582
+ LE +++ + +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 583 -FLIYEYMERGSLFCVL----RNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHR 637
L+ L + V + + + + L +VH
Sbjct: 163 YLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218
Query: 638 DISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL--AYTMAVTEKCD 695
+ +N+ + + + D + Y E A T T +
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 696 VYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPR 732
+ G+ V P L++ S ++ S
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/258 (23%), Positives = 98/258 (37%), Gaps = 13/258 (5%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD- 128
+ + LT ++P+ I L L +N L F L L +L L N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 129 -GLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG-PIPSTLYHL 186
G S T+L YLDLS N + + L+ L+ L +++L S L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 187 NQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSH 244
L L + + + + +L+ L + GN+ + I L L L LS
Sbjct: 126 RNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI- 303
+L+ P +L++L L++S N L L L L + N I
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN-HIMTSKKQEL 243
Query: 304 -GYLTNLTYLNLGYNRLS 320
+ ++L +LNL N +
Sbjct: 244 QHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 57/240 (23%), Positives = 91/240 (37%), Gaps = 10/240 (4%)
Query: 40 GALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLT--GTIPSEIGSLRDLLDLN 97
G S +L L N L L++L L LS N L+ G L L+
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSI-GNLTNLTYLDLSLNQLSGRLP 156
LS N + ++ F L+ L+ L Q + L + S+ +L NL YLD+S
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142
Query: 157 QEV-GNLKNLKSLFL-DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLD 214
+ L +L+ L + N+ +P L L L L +L ++ +L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202
Query: 215 RLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI--GNLTNLIALDLSSNQLS 272
L+++ NN LN L L S N + ++L L+L+ N +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 51/260 (19%), Positives = 87/260 (33%), Gaps = 34/260 (13%)
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL 199
+ T + + L+ +P + + L L++N L L QL L L N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 200 --VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIG 256
G ++ +L L L+ N + ++ S L L+ L H+ L
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
+L NLI LD+S I G L++L L +
Sbjct: 124 SLRNLIYLDISHTHTR----------------VAFNGIFNG--------LSSLEVLKMAG 159
Query: 317 NRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQ 374
N + P+ L L LS L + +L + L++S N
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218
Query: 375 LGKIPNISAVDLSKNNLSGV 394
+ ++ +D S N++
Sbjct: 219 YKCLNSLQVLDYSLNHIMTS 238
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 8/203 (3%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
N + + +L + + M S L +LE L H++L
Sbjct: 61 SNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 119
Query: 62 EI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLD 118
+ +L L LD+S+ + I L L L ++ N + + F L++L
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178
Query: 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG 177
L L +L+ L P++ +L++L L++S N L L +L+ L NH+
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMT 237
Query: 178 PIPSTLYHL-NQLATLCLGYNKL 199
L H + LA L L N
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDF 260
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ + VA+K L AFL+ EA+++ ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY ++++ EYM +GSL L+ + L + V++ +A ++Y+
Sbjct: 240 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD----SSNRTLVVGTYGYIAPE 683
+ + VHRD+ + NIL+ NL VADFGLARL+ + + + APE
Sbjct: 298 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPE 351
Query: 684 LAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
A T K DV+SFG++ E+ G P
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 21/213 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+G G +G V + ++G+ VA+K L + + E +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILR 78
Query: 563 QIRHRNIVKLYGFCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
+ H NIVK G C + + LI E++ GSL L + +++ +++ +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQIC 136
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+ YL VHRD+++ N+L+ S + + DFGL + + D V
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDRDS 191
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM 708
APE DV+SFGV E+L
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-33
Identities = 41/220 (18%), Positives = 88/220 (40%), Gaps = 21/220 (9%)
Query: 507 TEDFHIKYCIGTG--GYGSVYRAQ-LSSGKLVALKK--LHRSETEEPAFLESFQTEARLL 561
+ + IG G +V A+ +G+ V +++ L E + Q E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM---VTFLQGELHVS 80
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
H NIV + + ++++ +M GS ++ ++ I++ +
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLK 139
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-------V 674
AL Y+H VHR + +++IL++ + + +++ + + +V V
Sbjct: 140 ALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 675 GTYGYIAPELAYTMAV--TEKCDVYSFGVVALEVLMGSHP 712
+++PE+ K D+YS G+ A E+ G P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 4e-33
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ +K +GTGG+G V R +G+ VA+K+ + + + E + E +++ ++ H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHP 72
Query: 568 NIVKLY------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
N+V N L EY E G L L L ++ ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGTYG 678
AL YLH + I+HRD+ NI+L + + D G A+ L V GT
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQ 188
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+APEL T D +SFG +A E + G P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ + VA+K L AFL+ EA+++ ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY ++++ EYM +GSL L+ + L + V++ +A ++Y+
Sbjct: 323 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-----AP 682
+ + VHRD+ + NIL+ NL VADFGLARL+ + AP
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWTAP 433
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
E A T K DV+SFG++ E+ G P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ + IG G +G V G VA+K + T + AFL EA +++Q+RH
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-AFLA----EASVMTQLRHS 74
Query: 568 NIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G + K ++++ EYM +GSL LR+ L + + A+ YL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+ VHRD+++ N+L++ + A V+DFGL + L V + APE
Sbjct: 134 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 187
Query: 687 TMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ K DV+SFG++ E+ G P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ + IG G +G V G VA+K + T + AFL EA +++Q+RH
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-AFLA----EASVMTQLRHS 246
Query: 568 NIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G + K ++++ EYM +GSL LR+ L + + A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+ VHRD+++ N+L++ + A V+DFGL + L V + APE
Sbjct: 306 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 359
Query: 687 TMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ K DV+SFG++ E+ G P
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-33
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 15/209 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ A + VA+K + AFL EA ++ ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+VKL+ +++I E+M +GSL L++D E + K ++ +A ++++
Sbjct: 244 KLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---APEL 684
+ + +HRD+ + NIL++++L +ADFGLAR++ + T G I APE
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEA 356
Query: 685 AYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ T K DV+SFG++ +E++ G P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 23/231 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+G G +GSV + ++G++VA+KKL + TEE L F+ E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH--LRDFEREIEILK 97
Query: 563 QIRHRNIVKLYGFCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
++H NIVK G C + LI EY+ GSL L+ E +D K + +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQIC 155
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+ YL +HRD+++ NIL+ + + DFGL ++L D V G
Sbjct: 156 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGES 210
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGR 725
APE + DV+SFGVV E+ + G
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 14/213 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIR 565
ED IG G YGSV + SG+++A+K++ T + + + ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRSSD 79
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV--NIVKSMAHAL 623
IV+ YG ++ E M S + ++ + + I + AL
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
++L + K I+HRDI +NILL+ + + DFG++ L DS +T G Y+APE
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 195
Query: 684 ----LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
A + DV+S G+ E+ G P
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 23/218 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+G G +GSV + ++G LVA+K+L S ++ FQ E ++L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILK 79
Query: 563 QIRHRNIVKLYGFCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
+ IVK G + L+ EY+ G L L+ LD ++ + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQIC 137
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+ YL VHRD+++ NIL+ S +ADFGLA+LL D VV G
Sbjct: 138 KGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQS 192
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
APE + + DV+SFGVV E+
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 23/231 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+G G +GSV + ++G++VA+KKL + TEE L F+ E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH--LRDFEREIEILK 66
Query: 563 QIRHRNIVKLYGFCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
++H NIVK G C + LI EY+ GSL L+ E +D K + +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQIC 124
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+ YL +HRD+++ NIL+ + + DFGL ++L D V G
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGES 179
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGR 725
APE + DV+SFGVV E+ + G
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + +G G +V+R + +G L A+K + P ++ E +L ++ H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66
Query: 567 RNIVKLYGF--CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
+NIVKL+ + LI E+ GSL+ VL A L ++ + +++ + ++
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSNRTLVVGTYGYI 680
+L + IVHR+I NI+ + + DFG AR L D +L GT Y+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL-YGTEEYL 182
Query: 681 APEL--------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
P++ + D++S GV GS P
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK-----LVALKKLHRSETEEPAFLESFQTEARLLS 562
+F +G+G +G+VY+ VA+K+L R T A E EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMA 72
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+ + ++ +L G CL + LI + M G L +R + + +N +A
Sbjct: 73 SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129
Query: 623 LSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
++YL VHRD+++ N+L+ + + DFGLA+LL + G
Sbjct: 130 MNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGK 180
Query: 680 I-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ A E T + DV+S+GV E++ GS P
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
T F +Y G G +G V +G+ A+K + + + ++ ES E +LL
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
Q+ H NI+KLY F +L+ E G LF + + E+D I++ +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLS 137
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGTYG 678
++Y+H K IVHRD+ N+LL S + + DFGL+ + +GT
Sbjct: 138 GITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KIGTAY 193
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 194 YIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ F IG G +G+VY A+ + + ++VA+KK+ S + + E R L ++R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H N ++ G L +L+ EY GS +L + ++ + L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH +++HRD+ + NILL+ + DFG A ++ + VGT ++APE+
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222
Query: 686 YTMAVTE---KCDVYSFGVVALEVLMGSHP 712
M + K DV+S G+ +E+ P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 33/225 (14%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI- 564
F + +G G YG VY+ + + +G+L A+K + + EE E + E +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYS 78
Query: 565 RHRNIVKLYG------FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN---- 614
HRNI YG + ++L+ E+ GS+ D+ ++ +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-----TDL--IKNTKGNTLKEEWI 131
Query: 615 --IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
I + + LS+LH + ++HRDI N+LL N E + DFG++ L R
Sbjct: 132 AYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 673 VVGTYGYIAPELAYTMAVTE-----KCDVYSFGVVALEVLMGSHP 712
+GT ++APE+ + K D++S G+ A+E+ G+ P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 77/388 (19%), Positives = 141/388 (36%), Gaps = 31/388 (7%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94
+P ++ K L +S N ++ S+I +LS+L++L +S+NR+ S ++L
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSG 153
L+LS+N L I +L L L N D L I GN++ L +L LS L
Sbjct: 73 YLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129
Query: 154 RLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNL 213
+ +L K L + L T L + ++
Sbjct: 130 SSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187
Query: 214 DRLHLNGNNLTG-----------SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNL---T 259
+L +N+ SI + + L L L++ I L T
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 260 NLIALDLSSNQLSGLLPREVG-----NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314
+ +S+ +L G L +LK L+ + ++ P +N+ N
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 315 GYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQ 374
+ S L+L S+N L+ ++ G+L L L N + +
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366
Query: 375 LG---KIPNISAVDLSKNNLSGVIPASV 399
++ ++ +D+S+N++S
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-31
Identities = 75/387 (19%), Positives = 138/387 (35%), Gaps = 28/387 (7%)
Query: 42 LSKLEKLVLSHNSLTG-RIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
L+ L LS N+ I E G +S+LK L LS L + I L L +
Sbjct: 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL----- 155
+ L+D + L I +++ T +L L+ + L
Sbjct: 149 E--TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 156 ------PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL---NQLATLCLGYNKLVGPVTKE 206
++ L +L L+N + + L + + KL G +
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 207 VG-----NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNL 261
++K L + + + ++ + + + ++
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL--IGPIPPTIGYLTNLTYLNLGYNRL 319
+ LD S+N L+ + G+L L +L L N L + I + +L L++ N +
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 320 SSSIPPEL-MNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKI 378
S LL+L +S N L+ +I + I + LDL N I +IP Q+ K+
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI--KVLDLHSNKIK-SIPKQVVKL 443
Query: 379 PNISAVDLSKNNLSGVIPASVRRIPKL 405
+ ++++ N L V R+ L
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSL 470
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 57/302 (18%), Positives = 111/302 (36%), Gaps = 21/302 (6%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
ELS + N ++ + + +++ KL L L++ T
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLS-------ILAKLQTNPKLSNLTLNNIETTWNSFIR 239
Query: 63 IGAL---SRLKVLDLSYNRLTGTIPSEIG-----SLRDLLDLNLSNNILNGSIPLEFGNL 114
I L + + +S +L G + SL+ L + +++ +
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 115 KDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174
+++ + + ++ +LD S N L+ + + G+L L++L L N
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 175 LS--GPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTI 231
L I + L L + N + K K+L L+++ N LT +I +
Sbjct: 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 232 GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291
+ L L N++ IP + L L L+++SNQL + L L + L+
Sbjct: 420 --PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476
Query: 292 GN 293
N
Sbjct: 477 TN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 67/393 (17%), Positives = 129/393 (32%), Gaps = 36/393 (9%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRM-PSEIGALSKLEKLVLSHNSLTGRIPSEIGALS 67
L + + +L ++ L + L L T + I +S
Sbjct: 126 HLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
V +L + + + S + L N ++ L +R+
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV- 244
Query: 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG-----NLKNLKSLFLDNNHLSGPIPST 182
T + Y +S +L G+L +LK L + ++ P
Sbjct: 245 ---------WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 183 LYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHL 242
+ + + + L + N LT ++ G+L L+ L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 243 SHNRLDGPIPPTIG---NLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGNILIGP 298
N+L + + +L LD+S N +S + K L SL+++ NIL
Sbjct: 356 QMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 299 IPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFF 357
I + + L+L N++ S IP +++ L L ++ N L S+P I L
Sbjct: 415 IFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSL 470
Query: 358 RQLDLSRN----------FINGTIPSQLGKIPN 380
+++ L N +++ + K
Sbjct: 471 QKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 503
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 34/235 (14%)
Query: 501 EEMIEATEDFHIKY---------CIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEE 547
E+++A + I IG G +G VY L A+K L+R
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 548 PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVE 606
+ F TE ++ H N++ L G CL ++ ++ YM+ G L +RN E
Sbjct: 69 E--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHN 124
Query: 607 LDWTKRVNIVKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
+ +A + YL + VHRD+++ N +L+ VADFGLAR +
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 664 HPDSSNRTLVVGTYGYI-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ T + A E T T K DV+SFGV+ E++ G+ P
Sbjct: 179 YDKEYYSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-32
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 516 IGTGGYGSVYRAQLSSGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G G +GSV + K VA+K L + + E EA+++ Q+ + IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL---HYD 629
G C + + L+ E G L L E E+ + ++ ++ + YL ++
Sbjct: 402 IGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 630 CKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI---APELAY 686
VHR++++ N+LL + A ++DFGL++ L D S T + APE
Sbjct: 458 -----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 687 TMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ + DV+S+GV E L G P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 41/229 (17%), Positives = 82/229 (35%), Gaps = 31/229 (13%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI- 564
T +FH IG+G +GSV++ G + A+K+ + ++ E + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLG 68
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHAL 623
+H ++V+ + + M + EY GSL + N + +++ + L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFV-------------------ADFGLARLLH 664
Y+H S+VH DI +NI ++ D G +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 665 PDSSNRTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
S+ + G ++A E L K D+++ + +
Sbjct: 185 ---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 59/229 (25%), Positives = 83/229 (36%), Gaps = 6/229 (2%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
L +P I + L N ++ F ++L L L N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYH 185
L + ++ L L LDLS N + L L +L LD L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
L L L L N L ++ NL L L+GN ++ L+ LD L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 246 RLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
R+ + P +L L+ L L +N LS L + L+ L L LN N
Sbjct: 188 RVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/218 (25%), Positives = 83/218 (38%), Gaps = 11/218 (5%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+P I + L N++S +NL L+L +N L+ + L L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 191 TLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLD 248
L L N + V + L LHL+ L + + L L L+L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 249 GPIPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYL 306
+P +L NL L L N++S + R L L L L+ N + + P L
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN-RVAHVHPHAFRDL 200
Query: 307 TNLTYLNLGYNRLSSSIPPELM-NCSQLLNLVLSHNSL 343
L L L N L S++P E + L L L+ N
Sbjct: 201 GRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 60/216 (27%), Positives = 87/216 (40%), Gaps = 9/216 (4%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRD 92
+P I + +++ L N ++ + A L +L L N L I + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 93 LLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
L L+LS+N S+ F L L L L L L P L L YL L N L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 152 SGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM 210
LP + +L NL LFL N +S L+ L L L N++ ++
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 211 KNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHN 245
L L+L NNL+ ++P+ L L L L+ N
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 59/210 (28%), Positives = 84/210 (40%), Gaps = 7/210 (3%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSY 76
+ G +S + A L L L N L RI + L+ L+ LDLS
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89
Query: 77 NRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSS 134
N ++ L L L+L L + F L L L LQ N L L +
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 135 IGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+L NLT+L L N++S +P+ L +L L L N ++ P L +L TL
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
L N L T+ + ++ L L LN N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 7/198 (3%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSN-Q 270
R+ L+GN ++ ++ L L L N L L L LDLS N Q
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPE-LM 328
L + P L L +L L+ + + P + L L YL L N L + +P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRC-GLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFR 150
Query: 329 NCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387
+ L +L L N +S S+P L +L L +N + P + + + L
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 388 KNNLSGVIPASVRRIPKL 405
NNLS + ++ + L
Sbjct: 210 ANNLSALPTEALAPLRAL 227
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 22/96 (22%), Positives = 33/96 (34%), Gaps = 5/96 (5%)
Query: 299 IPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI-GNLIFF 357
+P I + L NR+S C L L L N L+ I + L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 358 RQLDLSRNFINGTIPSQ-LGKIPNISAVDLSKNNLS 392
QLDLS N ++ + + + L + L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIR 565
D +G+G G V++ + +G ++A+K++ RS +E + + +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
IV+ +G + N +F+ E M + R + + + ++ AL Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGK--MTVAIVKALYY 139
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
L ++HRD+ +NILL+ + + DFG++ L D + G Y+APE
Sbjct: 140 LKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERI 196
Query: 686 YTMAVTE-----KCDVYSFGVVALEVLMGSHP 712
T+ + DV+S G+ +E+ G P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 48/221 (21%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIR 565
+D +G G YG V + + + SG+++A+K++ T + + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------IVKSM 619
V YG +++ E M+ SL + +D + + I S+
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKIAVSI 118
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
AL +LH ++HRD+ +N+L+N+ + + DFG++ L D + + G Y
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPY 175
Query: 680 IAPE--------LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+APE Y++ K D++S G+ +E+ + P
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 511 HIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
H IG G +G VY L A+K L+R + F TE ++ H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSH 149
Query: 567 RNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
N++ L G CL ++ ++ YM+ G L +RN E + +A + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKF 207
Query: 626 L---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI-- 680
L + VHRD+++ N +L+ VADFGLAR ++ + T +
Sbjct: 208 LASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV-HNKTGAKLPV 260
Query: 681 ---APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
A E T T K DV+SFGV+ E++ G+ P
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 24/230 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+G G +G V +G++VA+K L + ++ E +L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--RSGWKQEIDILR 88
Query: 563 QIRHRNIVKLYGFCLHNKC--MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
+ H +I+K G C + L+ EY+ GSL L + + + + +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQIC 144
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
++YLH +HRD+++ N+LL+++ + DFGLA+ + V G
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDS 199
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG 724
APE DV+SFGV E+L + G
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
E + CIG G +G V++ S + VA+K ++ E F EA + Q
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQ 72
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H +IVKL G N +++I E G L L+ LD + ++ AL
Sbjct: 73 FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTAL 129
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+YL + VHRDI++ N+L++SN + DFGL+R + + + + G +
Sbjct: 130 AYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKL 179
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
APE T DV+ FGV E+LM G P
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 67/261 (25%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 476 NPNTREMTEGANEFSIWNYD-GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGK- 533
NPN + ++ + IT + G G +G VY Q+S
Sbjct: 9 NPNYCFAGKTSSISDLKEVPRKNITLIRGL------------GHGAFGEVYEGQVSGMPN 56
Query: 534 -----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588
VA+K L +E+ F EA ++S+ H+NIV+ G L + F++ E
Sbjct: 57 DPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114
Query: 589 MERGSLFCVLRN----DVEAVELDWTKRVNIVKSMAHALSYL---HYDCKPSIVHRDISS 641
M G L LR + L +++ + +A YL H+ +HRDI++
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAA 168
Query: 642 NNILLNSNLEAFV---ADFGLARLLHPDSSNRTLVVGTYGYI-----APE-LAYTMAVTE 692
N LL V DFG+AR ++ S R G + PE + T
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAMLPVKWMPPEAFMEGI-FTS 224
Query: 693 KCDVYSFGVVALEVL-MGSHP 712
K D +SFGV+ E+ +G P
Sbjct: 225 KTDTWSFGVLLWEIFSLGYMP 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL-----VALKKLHRSETEEPAFLESFQTEARLLS 562
+ +G+G +G+V++ V +K + + ++ +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIG 70
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKS 618
+ H +IV+L G C + + L+ +Y+ GSL +R A+ L+W V I K
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKG 127
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG 678
M + L VHR++++ N+LL S + VADFG+A LL PD +
Sbjct: 128 MYY-LEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL---YSEA 177
Query: 679 YI-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
A E + T + DV+S+GV E++ G+ P
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-31
Identities = 52/246 (21%), Positives = 99/246 (40%), Gaps = 44/246 (17%)
Query: 501 EEMIEATEDFHIKYC----IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQT 556
+ + +G G G+V G+ VA+K++ F +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALM 57
Query: 557 EARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRNDVEAVELDWTKR- 612
E +LL++ H N+++ Y ++ +++ E +L +N + +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116
Query: 613 -VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-------------NLEAFVADFG 658
+++++ +A +++LH I+HRD+ NIL+++ NL ++DFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 659 LARLLHPDSSNRTL----VVGTYGYIAPEL-------AYTMAVTEKCDVYSFGVVALEVL 707
L + L S+ GT G+ APEL +T D++S G V +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 708 -MGSHP 712
G HP
Sbjct: 234 SKGKHP 239
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
Y G+G YG V + A+K + ++ + E +L
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVL 90
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
+ H NI+KLY F + +L+ E + G LF + + ++ E+D I+K +
Sbjct: 91 KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLS 147
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGTYG 678
++YLH K +IVHRD+ N+LL S + + DFGL+ + + +GT
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-RLGTAY 203
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
YIAPE+ EKCDV+S GV+ +L G P
Sbjct: 204 YIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 65/330 (19%), Positives = 114/330 (34%), Gaps = 48/330 (14%)
Query: 65 ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124
+ R + S L +IPS + + L+LSNN + + +L L L
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 125 NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSG-PIPST 182
N ++ + S +L +L +LDLS N LS L L +L L L N S
Sbjct: 86 NGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144
Query: 183 LYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241
HL +L L +G + ++ + L+ L ++ ++L P ++ + + L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
L + + + +++ L+L L + L++ N I
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTF------HFSELSTGETNSLI------- 251
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361
+ + L + L S LL L S N L S+P I F +L
Sbjct: 252 ---KKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGI-----FDRL- 300
Query: 362 LSRNFINGTIPSQLGKIPNISAVDLSKNNL 391
++ + L N
Sbjct: 301 -----------------TSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 50/258 (19%), Positives = 93/258 (36%), Gaps = 27/258 (10%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L+ LVL+ N + I + +L L+ LDLSYN L+ + S L L LNL
Sbjct: 75 CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132
Query: 100 NNILNGSIPLE--FGNLKDLDQLRLQGN-KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
N ++ F +L L LR+ + LT L L++ + L
Sbjct: 133 GNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYE 190
Query: 157 QEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR 215
+ +++N+ L L + + + + L L L
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD--------------- 235
Query: 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL 275
+ + L+ +++ + ++ L + + ++ L+ L+ S NQL +
Sbjct: 236 -TFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVP 293
Query: 276 PREVGNLKYLASLSLNGN 293
L L + L+ N
Sbjct: 294 DGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 31/193 (16%), Positives = 69/193 (35%), Gaps = 11/193 (5%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
LS L L L N + + L++L++L + I + L L +L +
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV 159
+ L P +++++ L L + L+ + +++ L+L L E+
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 160 --------GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
+++ + + L + L ++ L L N+L +
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301
Query: 212 NLDRLHLNGNNLT 224
+L ++ L+ N
Sbjct: 302 SLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 43/210 (20%), Positives = 86/210 (40%), Gaps = 12/210 (5%)
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
+ +L SIPS + + L LS+NR+ + NL AL L+SN ++ +
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELM--NCSQL 333
+L L L L+ N + + + L++LT+LNL N + + + + ++L
Sbjct: 94 DSFSSLGSLEHLDLSYN-YLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKL 151
Query: 334 LNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392
L + + I + L F +L++ + + P L I N+S + L
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 393 GVIPASVRRIPKLIV---SENNLELENSTS 419
++ V + + +L+ + +
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSE 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
H IG G +G VY + A+K L R + +E+F E L+
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRG 78
Query: 564 IRHRNIVKLYGFCLHNKCM-FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+ H N++ L G L + + ++ YM G L +R+ ++ +A
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARG 136
Query: 623 LSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+ YL + VHRD+++ N +L+ + VADFGLAR + +
Sbjct: 137 MEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ-QHRHAR 189
Query: 680 I-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ A E T T K DV+SFGV+ E+L G+ P
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 28/218 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL----VALKKLHRSETEEPAFLESFQTEARLLSQ 563
ED + +G G +G VY ++ K VA+K + T + E F +EA ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
+ H +IVKL G + ++I E G L L + L V + A+
Sbjct: 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAM 126
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+YL + VHRDI+ NIL+ S + DFGL+R + + + + +
Sbjct: 127 AYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA----SVTRL 176
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+PE T DV+ F V E+L G P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 20/282 (7%)
Query: 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
AL+ K+ +++T L + L +T + L +L+ L L +
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160
N + PL+ NL + +L L GN L + S+I L ++ LDL+ Q++ +
Sbjct: 73 NQITDLAPLK--NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD--VTPLA 126
Query: 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNG 220
L NL+ L+LD N ++ P L L L L +G ++ + N+ L L +
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADD 182
Query: 221 NNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG 280
N ++ I + L L E+HL +N++ P + N +NL + L++ ++
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 281 NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322
NL + I P TI NL +N S
Sbjct: 239 NLVVPNVVKGPSGAPIAPA--TISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/282 (20%), Positives = 117/282 (41%), Gaps = 20/282 (7%)
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+L + + + + + ++ +L + L G + + + L NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG 208
NQ++ + NL + L L N L S + L + TL L ++ +
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD--VTPLA 126
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
+ NL L+L+ N +T +I + L L L + + ++ + P + NL+ L L
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADD 182
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM 328
N++S + P + +L L + L N I + P + +NL + L +++ P
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNN-QISDVSP-LANTSNLFIVTLTNQTITN--QPVFY 236
Query: 329 NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGT 370
N + ++ V+ S + P+ I + + +L+ N +
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 64/251 (25%), Positives = 104/251 (41%), Gaps = 18/251 (7%)
Query: 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNG 220
L N + ++++ T L+ + TL + + V + NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 221 NNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG 280
N +T + + L + EL LS N L I L ++ LDL+S Q++ + P +
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 281 NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSH 340
L L L L+ N I I P + LTNL YL++G ++S P L N S+L L
Sbjct: 127 GLSNLQVLYLDLN-QITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 341 NSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVR 400
N +S I S + +L ++ L N I+ P L N+ V L+ ++
Sbjct: 183 NKIS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 401 RIPKLIVSENN 411
+ V +
Sbjct: 239 NLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 16/237 (6%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
NL+ + ++ + + L+K+ +L LS N L S I L +K LD
Sbjct: 58 GVQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLD 113
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L+ ++T P + L +L L L N + PL L +L L + ++ L +
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDL--T 167
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ NL+ LT L N++S + +L NL + L NN +S P L + + L +
Sbjct: 168 PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP 250
L + N+ + + P+TI +L+ N
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 48/226 (21%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSE--------------TEEPAFLES 553
D+ I + G + + + K ALKK +S + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 554 FQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-----NDVEAVELD 608
F+ E ++++ I++ + G + +++IYEYME S+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 609 WTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668
I+KS+ ++ SY+H + +I HRD+ +NIL++ N ++DFG + + D
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDKK 206
Query: 669 NRTLVVGTYGYIAPELAYTMAVT--EKCDVYSFGVVALEVLMGSHP 712
+ GTY ++ PE + K D++S G+ + P
Sbjct: 207 IKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+ F + +G G +GSV AQL VA+K L +++ + +E F EA + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKE 81
Query: 564 IRHRNIVKLYGFCLHN------KCMFLIYEYMERGSLFCVLRN---DVEAVELDWTKRVN 614
H ++ KL G L + +I +M+ G L L L V
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 615 IVKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
+ +A + YL ++ +HRD+++ N +L ++ VADFGL+R ++ R
Sbjct: 142 FMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR- 194
Query: 672 LVVGTYGYI-----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
G + A E T DV++FGV E++ G P
Sbjct: 195 --QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 498 ITFEEMIEATEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALK-----KLHRSETEE 547
+T ++ + +Y + G+G G V A + + K VA++ K E
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 548 PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAV 605
+ +TE +L ++ H I+K+ F + +++ E ME G LF D V
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF-----DKVVGNK 234
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARL 662
L M A+ YLH + I+HRD+ N+LL+S E + DFG +++
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 663 LHPDSSNRTLVVGTYGYIAPE-LAYTMAV--TEKCDVYSFGVV 702
L S RTL GT Y+APE L D +S GV+
Sbjct: 292 LGETSLMRTL-CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 33/227 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+ +G G +GSV L + VA+K + + + +E F +EA +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92
Query: 564 IRHRNIVKLYGFCLHNK-----CMFLIYEYMERGSLFCVLRN---DVEAVELDWTKRVNI 615
H N+++L G C+ +I +M+ G L L + + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 616 VKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
+ +A + YL ++ +HRD+++ N +L ++ VADFGL++ ++ R
Sbjct: 153 MVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-- 204
Query: 673 VVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
G + A E LA + T K DV++FGV E+ G P
Sbjct: 205 -QGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 35/228 (15%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
E + +G G +G VY VA+K ++ + + F EA ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 82
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------NDVEAVELDWTKRVN 614
+ ++V+L G + +I E M RG L LR N+ +K +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 615 IVKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
+ +A ++YL + VHRD+++ N ++ + + DFG+ R ++ R
Sbjct: 143 MAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR- 195
Query: 672 LVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
G G + +PE L + T DV+SFGVV E+ P
Sbjct: 196 --KGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 504 IEATEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEA 558
+ F +Y I G G +G V + + + A+K ++++ + + E
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREV 72
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
LL ++ H NI+KL+ + +++ E G LF + E D I+K
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD---AARIIKQ 129
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVG 675
+ ++Y+H K +IVHRD+ NILL S + + DFGL+ ++ + +G
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIG 185
Query: 676 TYGYIAPEL---AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
T YIAPE+ Y EKCDV+S GV+ +L G+ P
Sbjct: 186 TAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
F +Y I G G +G V + + + A+K ++++ + + E LL
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELL 75
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSM 619
++ H NI+KL+ + +++ E G LF D ++ I+K +
Sbjct: 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQV 130
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
++Y+H K +IVHRD+ NILL S + + DFGL+ ++ + +GT
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGT 186
Query: 677 YGYIAPEL---AYTMAVTEKCDVYSFGVV 702
YIAPE+ Y EKCDV+S GV+
Sbjct: 187 AYYIAPEVLRGTY----DEKCDVWSAGVI 211
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 507 TEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALK-----KLHRSETEEPAFLESFQTEARL 560
+++ + +G+G G V A + + K VA+K K E + +TE +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKS 618
L ++ H I+K+ F + +++ E ME G LF D V L
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQ 122
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVG 675
M A+ YLH + I+HRD+ N+LL+S E + DFG +++L S RTL G
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CG 178
Query: 676 TYGYIAPE-LAYTMAV--TEKCDVYSFGVV 702
T Y+APE L D +S GV+
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 70/224 (31%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRS----------ETEEPAFL 551
Y G+G YG V + + A+K + +S F
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 552 ESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK 611
E E LL + H NI+KL+ K +L+ E+ E G LF + N + E D
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD--- 147
Query: 612 RVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSS 668
NI+K + + YLH K +IVHRDI NILL + + DFGL+ D
Sbjct: 148 AANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
R +GT YIAPE EKCDV+S GV+ +L G P
Sbjct: 205 LRD-RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 69/264 (26%), Positives = 106/264 (40%), Gaps = 52/264 (19%)
Query: 475 FNPNTREMTEGANEFSIWNYD-GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGK 533
+NPN + ++ + IT + G G +G VY Q+S
Sbjct: 49 YNPNYCFAGKTSSISDLKEVPRKNITLIRGL------------GHGAFGEVYEGQVSGMP 96
Query: 534 ------LVALKKL--HRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585
VA+K L SE +E FL EA ++S+ H+NIV+ G L + F++
Sbjct: 97 NDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQNIVRCIGVSLQSLPRFIL 152
Query: 586 YEYMERGSLFCVLRN----DVEAVELDWTKRVNIVKSMAHALSYL---HYDCKPSIVHRD 638
E M G L LR + L +++ + +A YL H+ +HRD
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRD 206
Query: 639 ISSNNILLNSNLEAFV---ADFGLARLLHPDSSNRTLVVGTYGYI-----APE-LAYTMA 689
I++ N LL V DFG+AR ++ R G + PE +
Sbjct: 207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAMLPVKWMPPEAFMEGI- 262
Query: 690 VTEKCDVYSFGVVALEVL-MGSHP 712
T K D +SFGV+ E+ +G P
Sbjct: 263 FTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 54/274 (19%)
Query: 468 HRRKDKKFNPNTREMTEGANEFSIWNYD-GRITFEEMIEATEDFHIKYCIGTGGYGSVYR 526
K + E + ++ + + I + + G G +G V+
Sbjct: 12 TEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWEL------------GEGAFGKVFL 59
Query: 527 AQLSSGK------LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580
A+ + LVA+K L + +E + FQ EA LL+ ++H++IV+ +G C +
Sbjct: 60 AECHNLLPEQDKMLVAVKAL-KEASESA--RQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 581 CMFLIYEYMERGSLFCVLR------------NDVEAVELDWTKRVNIVKSMAHALSYL-- 626
+ +++EYM G L LR DV L + + + +A + YL
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176
Query: 627 -HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI----- 680
H+ VHRD+++ N L+ L + DFG++R ++ R VG +
Sbjct: 177 LHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTMLPIRWM 227
Query: 681 APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
PE + Y T + DV+SFGVV E+ G P
Sbjct: 228 PPESILYRK-FTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 496 GRITFEEMIEATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESF 554
GR + F K +G+G +G V+ + SSG +K +++ ++ P +E
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQI 67
Query: 555 QTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR-- 612
+ E +L + H NI+K++ M+++ E E G L + K
Sbjct: 68 EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL-----ERIVSAQARGKALS 122
Query: 613 ----VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHP 665
++K M +AL+Y H +VH+D+ NIL + DFGLA L
Sbjct: 123 EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 666 DSSNRTLVVGTYGYIAPEL---AYTMAVTEKCDVYSFGVV 702
D + GT Y+APE+ T KCD++S GVV
Sbjct: 180 DEHSTN-AAGTALYMAPEVFKRDV----TFKCDIWSAGVV 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 507 TEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRS--ETEEPAFLESFQTEARLLSQ 563
+ + + IG G + V R +G+ A+K + + + E + EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRNDVEAVELDWTKRV--NIVKSM 619
++H +IV+L + +++++E+M+ L V R D V +++ V + ++ +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV---YSEAVASHYMRQI 139
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
AL Y H +I+HRD+ + +LL S + + FG+A L VGT
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVV 702
++APE+ + DV+ GV+
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 47/205 (22%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 509 DFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+G G +G V++ + ++G +A K + ++ E + E +++Q+ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRNDV----EAVELDWTKRVNIVKSMAH 621
N+++LY + L+ EY++ G LF + + + + +K +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF--------MKQICE 198
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVVGTYGY 679
+ ++H + I+H D+ NIL + + DFGLAR P + GT +
Sbjct: 199 GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV-NFGTPEF 254
Query: 680 IAPE-LAYTMAVTEKCDVYSFGVVA 703
+APE + Y V+ D++S GV+A
Sbjct: 255 LAPEVVNYD-FVSFPTDMWSVGVIA 278
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 54/259 (20%), Positives = 101/259 (38%), Gaps = 30/259 (11%)
Query: 468 HRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCI----GTGGYGS 523
H K + + + + + + Y I G+G +G
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 524 VYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582
V+R + ++G++ K ++ + + + E +++Q+ H ++ L+ M
Sbjct: 67 VHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 583 FLIYEYMERGSLF--CVLRNDV----EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVH 636
LI E++ G LF + E +N ++ L ++H + SIVH
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEV--------INYMRQACEGLKHMH---EHSIVH 172
Query: 637 RDISSNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAYTMAVTEK 693
DI NI+ + + V DFGLA L+PD + T + APE + V
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIVDRE-PVGFY 230
Query: 694 CDVYSFGVVALEVLMGSHP 712
D+++ GV+ +L G P
Sbjct: 231 TDMWAIGVLGYVLLSGLSP 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK------LVALKKLHRSETEEPAFLESFQTEARLL 561
+G +G VY+ L VA+K L + + E P E F+ EA L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLR 66
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS--- 618
++++H N+V L G ++ + +I+ Y G L L ++ T VKS
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 619 --------------MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664
M + LS H VH+D+++ N+L+ L ++D GL R ++
Sbjct: 127 PPDFVHLVAQIAAGMEY-LSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 665 PDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
+ + APE + Y + D++S+GVV EV G P
Sbjct: 180 AADYYKL---LGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 508 EDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
++ + KY I G G +G V+R + SS K K + T++ + E +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILN 56
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRNDV----EAVELDWTKRVNIV 616
RHRNI+ L+ + + +I+E++ +F E V+ V
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI--------VSYV 108
Query: 617 KSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVV 674
+ AL +LH +I H DI NI+ + + + +FG AR L P + R +
Sbjct: 109 HQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LF 164
Query: 675 GTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y APE + V+ D++S G + +L G +P
Sbjct: 165 TAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINP 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
+ F Y + G G + V R ++G A K ++ + F + + EAR+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARIC 59
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSM 619
+++H NIV+L+ +L+++ + G LF + V + ++ +
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQI 114
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
+++Y H IVHR++ N+LL S + +ADFGLA ++ + GT
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGT 170
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVV 702
GY++PE+ ++ D+++ GV+
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
D + Y + G G +G V A Q + A KK+ + E+ ++ F+ E ++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIM 60
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSM 619
+ H NI++LY N ++L+ E G LF + V + I+K +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDV 115
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
A++Y H K ++ HRD+ N L ++ + DFGLA P RT VGT
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGT 171
Query: 677 YGYIAPEL---AYTMAVTEKCDVYSFGVV 702
Y++P++ Y +CD +S GV+
Sbjct: 172 PYYVSPQVLEGLY----GPECDEWSAGVM 196
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 31/215 (14%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALK---KLHRSETEEPAFLESFQTEA 558
+ Y I G+G + V + + S+G A K K + E + E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRN---DVEAVELDWTKRV 613
+L Q+ H NI+ L+ + + LI E + G LF + + EA
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSN 669
+K + ++YLH I H D+ NI+L + DFGLA +
Sbjct: 121 --IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 670 RTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVA 703
+ + GT ++APE + Y + + D++S GV+
Sbjct: 176 KN-IFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 55/276 (19%), Positives = 109/276 (39%), Gaps = 20/276 (7%)
Query: 93 LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152
+ + + + P + + + L+ + + L ++ + + + +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 153 GRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKN 212
+ Q + L N+ LFL+ N L+ I L +L L L L NK+ + ++K
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTD-I-KPLTNLKNLGWLFLDENKIK--DLSSLKDLKK 110
Query: 213 LDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272
L L L N ++ I + + +L L+ L+L +N++ + LT L L L NQ+S
Sbjct: 111 LKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 166
Query: 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQ 332
++P + L L +L L+ N I + + L NL L L + N
Sbjct: 167 DIVP--LAGLTKLQNLYLSKN-HISDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 333 LLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
+ + SL P I + + + ++ +
Sbjct: 223 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 2e-26
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 20/277 (7%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
+ + + + P + A + +L +T + L + + +N+ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164
S+ L ++ +L L GNKL + + NL NL +L L N++ + +LK
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSSLK--DLKK 110
Query: 165 LKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224
LKSL L++N +S + L HL QL +L LG NK+ + + LD L L N ++
Sbjct: 111 LKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284
I + L L L+LS N + + + L NL L+L S + NL
Sbjct: 167 -DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
++ L P I + N+ ++
Sbjct: 223 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEF 257
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 48/255 (18%), Positives = 102/255 (40%), Gaps = 18/255 (7%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN 77
F + + ++ L+ +++++ +++ + + I L + L L+ N
Sbjct: 20 FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75
Query: 78 RLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGN 137
+LT + +L++L L L N + L+ +LK L L L+ N + + + + +
Sbjct: 76 KLTDI--KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGISDI--NGLVH 129
Query: 138 LTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197
L L L L N+++ + L L +L L++N +S L L +L L L N
Sbjct: 130 LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKN 185
Query: 198 KLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257
+ + + +KNLD L L + L + + + + L P I +
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISD 241
Query: 258 LTNLIALDLSSNQLS 272
+ ++ +
Sbjct: 242 DGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 2e-19
Identities = 54/251 (21%), Positives = 90/251 (35%), Gaps = 16/251 (6%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
I L + KL L+ N LT I + L L L L N++ + S + L+ L L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSL 114
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
+L +N ++ L +L L+ L L NK+ + + + LT L L L NQ+S
Sbjct: 115 SLEHNGISDINGLV--HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--I 168
Query: 157 QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRL 216
+ L L++L+L NH+S L L L L L + + N+ + +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 217 HLNGNNLTG----SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272
+L S N+ L N + + Q
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPL 286
Query: 273 GLLPREVGNLK 283
+ ++
Sbjct: 287 KEVYTVSYDVD 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 87.5 bits (216), Expect = 5e-18
Identities = 53/236 (22%), Positives = 86/236 (36%), Gaps = 19/236 (8%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
PN+ + G L+ P + L L L L N + + S + L +LK L
Sbjct: 60 GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLS 115
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L +N ++ I + L L L L NN + L L LD L L+ N++ +
Sbjct: 116 LEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDI--V 169
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ LT L L LS N +S + + LKNL L L + + +L T+
Sbjct: 170 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
LV P D N+ +P ++ + ++ +
Sbjct: 228 NTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 506 ATEDFHIKY----CIGTGGYGSVYRA-QLSSGKLVALK-----KLHRSETEEPAFLESFQ 555
A ++F+ KY IG G V R ++G A+K S + E+ +
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 556 TEARLLSQIR-HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKR 612
E +L Q+ H +I+ L + MFL+++ M +G LF D E V L +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-----DYLTEKVALSEKET 202
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
+I++S+ A+S+LH +IVHRD+ NILL+ N++ ++DFG + L P R
Sbjct: 203 RSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258
Query: 673 VVGTYGYIAPE-LAYTMAVTEK-----CDVYSFGVV 702
+ GT GY+APE L +M T D+++ GV+
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-29
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQ 563
E + CIG G +G V++ S + VA+K ++ E F EA + Q
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQ 447
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H +IVKL G N +++I E G L L+ LD + ++ AL
Sbjct: 448 FDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTAL 504
Query: 624 SYL---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
+YL + VHRDI++ N+L++SN + DFGL+R + + + + G +
Sbjct: 505 AYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKL 554
Query: 681 -----APELAYTMAVTEKCDVYSFGVVALEVLM-GSHP 712
APE T DV+ FGV E+LM G P
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 58/254 (22%), Positives = 106/254 (41%), Gaps = 18/254 (7%)
Query: 468 HRRKDKKFNPNTREMTEGANEFSIWNYDGRITFEEMI--EATEDFHIKYCI----GTGGY 521
+ R ++ + + +D + + Y I GTG +
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 522 GSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580
G V+R + ++G A K + + E+ + E + +S +RH +V L+ +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDIS 640
M +IYE+M G LF + E ++ + V ++ + L ++H + + VH D+
Sbjct: 228 EMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLK 282
Query: 641 SNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYS 698
NI+ + + DFGL L P S + GT + APE+A V D++S
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 699 FGVVALEVLMGSHP 712
GV++ +L G P
Sbjct: 342 VGVLSYILLSGLSP 355
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 516 IGTGGYGSVYRAQLSSGK------LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G G +G V+ A+ + LVA+K L + T + FQ EA LL+ ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA--RKDFQREAELLTNLQHEHI 79
Query: 570 VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS----------- 618
VK YG C + +++EYM+ G L LR + + K
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 619 ------MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
M + L+ H+ VHRD+++ N L+ +NL + DFG++R ++ R
Sbjct: 140 SQIASGMVY-LASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190
Query: 673 VVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
VG + + PE + Y T + DV+SFGV+ E+ G P
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQP 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 501 EEMIEATEDFHIKY----CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQ 555
E M+ A+ F Y +G G + V R ++G A K ++ + F + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLE 76
Query: 556 TEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRV 613
EAR+ +++H NIV+L+ +L+++ + G LF + V
Sbjct: 77 REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADAS 131
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNR 670
+ ++ + +++Y H IVHR++ N+LL S + +ADFGLA ++ +
Sbjct: 132 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV 702
GT GY++PE+ ++ D+++ GV+
Sbjct: 189 G-FAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 27/202 (13%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALK---KLHRSETEEPAFLESFQTEARLLSQIRHRNIVK 571
+G+G + V + Q +GK A K K S + E + E +L +IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 572 LYGFCLHNKCMFLIYEYMERGSLF--CVLRN---DVEAVELDWTKRVNIVKSMAHALSYL 626
L+ + + LI E + G LF + + EA + +K + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--------LKQILDGVHYL 124
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSNRTLVVGTYGYIAP 682
H I H D+ NI+L + DFG+A + + + + GT ++AP
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAP 180
Query: 683 E-LAYTMAVTEKCDVYSFGVVA 703
E + Y + + D++S GV+
Sbjct: 181 EIVNYE-PLGLEADMWSIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 505 EATEDFHIKY----CIGTGGYGSVYRA-QLSSGKLVALK------KLHRSETEEPAFLES 553
+T F+ Y +G G V R + K A+K S E E+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 554 FQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWT 610
E +L ++ H NI++L N FL+++ M++G LF D E V L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEK 124
Query: 611 KRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670
+ I++++ + LH K +IVHRD+ NILL+ ++ + DFG + L P R
Sbjct: 125 ETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 671 TLVVGTYGYIAPE-LAYTMAV-----TEKCDVYSFGVV 702
V GT Y+APE + +M ++ D++S GV+
Sbjct: 182 E-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 31/215 (14%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALK---KLHRSETEEPAFLESFQTEA 558
+ Y I G+G + V + + S+G A K K + E + E
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRN---DVEAVELDWTKRV 613
+L Q+ H N++ L+ + + LI E + G LF + + EA
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF------ 120
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSN 669
+K + ++YLH I H D+ NI+L + DFGLA +
Sbjct: 121 --IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 670 RTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVA 703
+ + GT ++APE + Y + + D++S GV+
Sbjct: 176 KN-IFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 80/425 (18%), Positives = 150/425 (35%), Gaps = 55/425 (12%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLL 94
P ++ + + L LS NS++ +I LS L+VL LS+NR+ ++ + +DL
Sbjct: 47 PKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSG 153
L++S+N L +I + L L L N D L + GNLT LT+L LS +
Sbjct: 104 YLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR- 159
Query: 154 RLPQEVGNLKNLKSLFLDN--NHLSGPIPSTLYHLN------------------------ 187
+L +L + LD H+ G +L N
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 188 ----QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL-----LD 238
QL+ + L +T + L++ ++ + ++ ++
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 239 ELHLSHNRLDGPIPPTIGN-----LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
L++ + + I L +L+ + + + L+ +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 294 ILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG- 352
++ T+LN N + S+ +L L+L N L +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALM 398
Query: 353 --NLIFFRQLDLSRNFINGTIPSQLGKIP-NISAVDLSKNNL-SGVIPASVRRIPKLIVS 408
N+ LD+S N +N + +I ++LS N L V ++ L +
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLH 458
Query: 409 ENNLE 413
N +
Sbjct: 459 NNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 80/417 (19%), Positives = 144/417 (34%), Gaps = 57/417 (13%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94
+I LS+L L LSHN + + + L+ LD+S+NRL I + L
Sbjct: 69 MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLR 124
Query: 95 DLNLSNNILNGSIPL--EFGNLKDLDQLRLQGNKLDGLIPSSIGNL-TNLTYLDLSLNQL 151
L+LS N + +P+ EFGNL L L L K L + +L + LDL +
Sbjct: 125 HLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183
Query: 152 SGRLPQ--EVGNLKNLKSLFLDNNHLSGPIPSTLYHLN--QLATLCLGYNKLVGPVTKEV 207
G + ++ N L +F N+ S + ++ L QL+ + L +T
Sbjct: 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS 243
Query: 208 GNMKNLDRLHLNGNNLTGSIPSTIGYLNL-----LDELHLSHNRLDGPIPPTIGN----- 257
+ L++ ++ + ++ ++ L++ + + I
Sbjct: 244 ELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA 303
Query: 258 ------------------------LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
+ LS + + + L+ N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 294 ILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGN 353
+ + L L L L N L + + + +L SL+ S+ S +
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLN-SLNSHAYD 421
Query: 354 LIFF-----RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKL 405
L+LS N + G++ L P + +DL N + IP V + L
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL 475
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 55/270 (20%), Positives = 111/270 (41%), Gaps = 14/270 (5%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGAL---SRLKVLDLSYNRLTGTIPSEIG--- 88
SE+ L + L H T + ++ ++ L++ +T I E
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS 300
Query: 89 --SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDL 146
+L+ L+ ++ N + S + +++ L + + + ++ T+L+
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360
Query: 147 SLNQLSGRLPQEVGNLKNLKSLFLDNNHLS--GPIPSTLYHLNQLATLCLGYNKL-VGPV 203
+ N + + Q LK L++L L N L + +++ L TL + N L
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420
Query: 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIA 263
+ +++ L+L+ N LTGS+ + + L L +NR+ IP + +L L
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQE 477
Query: 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
L+++SNQL + L L + L+ N
Sbjct: 478 LNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 54/366 (14%), Positives = 113/366 (30%), Gaps = 46/366 (12%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
++D S LT +P ++ L+LS N ++ + L +L LRL N+
Sbjct: 31 ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL-SGPIPSTLYH 185
+ L +L YLD+S N+L + + +L+ L L N P+ +
Sbjct: 88 IRSLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGN 144
Query: 186 LNQLATLCLGYNKL-VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL-------- 236
L +L L L K + + L L ++ G ++ N
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 237 --------------------LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
L + L+ + L+++ +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 277 REVGNLKY-----LASLSLNGNILIGPIPPTIG-----YLTNLTYLNLGYNRLSSSIPPE 326
V ++ + L++ + I L +L ++ S
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 327 LMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDL 386
+++ +LS + + F L+ ++N ++ + + + L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 387 SKNNLS 392
+N L
Sbjct: 385 QRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 62/359 (17%), Positives = 112/359 (31%), Gaps = 49/359 (13%)
Query: 4 NFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEI--GALSKLEKLVLSHNSLTGR--- 58
+ + T + + S +++ L L LS+ L
Sbjct: 177 DLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ 236
Query: 59 ----IPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL---RDLLDLNLSNNILNGSIPLEF 111
SE+ L + L + T ++ R + LN+ N + I E
Sbjct: 237 RLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREE 296
Query: 112 GN-----LKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLK 166
LK L ++ + + LS++ + +
Sbjct: 297 FTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT 356
Query: 167 SLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL--VGPVTKEVGNMKNLDRLHLNGNNLT 224
L N + + L +L TL L N L V NM +L+ L ++ N+L
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416
Query: 225 -GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
+ T + + L+LS N L G + + + LDL +N++ +
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI--------- 465
Query: 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHN 341
P + +L L LN+ N+L S+P + L + L N
Sbjct: 466 ----------------PKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 5/103 (4%)
Query: 27 WGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSE 86
+L S + L LS N LTG + + ++KVLDL NR+ +IP +
Sbjct: 412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKD 468
Query: 87 IGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
+ L+ L +LN+++N L S+P F L L + L N D
Sbjct: 469 VTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 44/233 (18%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQI 564
D + IG G +G V +A++ L A+K++ +++ F E +L ++
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 82
Query: 565 -RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS----- 618
H NI+ L G C H ++L EY G+L LR N S
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 619 ------------MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666
M + LS + +HRD+++ NIL+ N A +ADFGL+R
Sbjct: 143 QLLHFAADVARGMDY-LSQKQF------IHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 667 SSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
V T G + A E L Y++ T DV+S+GV+ E++ +G P
Sbjct: 191 -GQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 507 TEDFHIKYC----IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
F +Y +G G + V R ++ +G+ A ++ + + + EAR+
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARIC 64
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSM 619
++H NIV+L+ +LI++ + G LF + V + ++ +
Sbjct: 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF-----EDIVAREYYSEADASHCIQQI 119
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
A+ + H + +VHR++ N+LL S L+ +ADFGLA + + GT
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVV 702
GY++PE+ + D+++ GV+
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVI 202
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
+ + + G G VYR Q + K ALK L ++ ++ +TE +L
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVL 102
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSM 619
++ H NI+KL + L+ E + G LF D VE + VK +
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELF-----DRIVEKGYYSERDAADAVKQI 157
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGT 676
A++YLH + IVHRD+ N+L + +ADFGL++++ +T V GT
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGT 213
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVV 702
GY APE+ A + D++S G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALK---KLHRSETEEPAFLESFQTEA 558
E+ Y G+G + V + + S+G A K K + E + E
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRN---DVEAVELDWTKRV 613
+L +I+H N++ L+ + + LI E + G LF + + EA E
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF------ 119
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSN 669
+K + + + YLH I H D+ NI+L + DFGLA + +
Sbjct: 120 --LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 670 RTLVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVA 703
+ + GT ++APE + Y + + D++S GV+
Sbjct: 175 KN-IFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 507 TEDFHIKYCI----GTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
T + + G+G + V+ Q +GKL ALK + +S S + E +L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVL 60
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDW-TKR-------- 612
+I+H NIV L +L+ + + G LF D +R
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF------------DRILERGVYTEKDA 108
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSN 669
+++ + A+ YLH + IVHRD+ N+L + E + DFGL+++
Sbjct: 109 SLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI 163
Query: 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV 702
+ GT GY+APE+ ++ D +S GV+
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 507 TEDFHIKYCI-----GTGGYGSVYRA-QLSSGKLVALK---KLHRSETEEPAFLESFQTE 557
E+F+ Y + G G + V + S+G+ A K K R + E
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR----AEILHE 78
Query: 558 ARLLSQIRHR-NIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLRNDVEAVELDWTKRVN 614
+L + ++ L+ + + LI EY G +F C+ E D +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIR 135
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRT 671
++K + + YLH + +IVH D+ NILL+S + DFG++R + R
Sbjct: 136 LIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 672 LVVGTYGYIAPE-LAYTMAVTEKCDVYSFGVVA 703
++GT Y+APE L Y +T D+++ G++A
Sbjct: 193 -IMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 51/263 (19%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRS--ETEEPAFLESF 554
++E + +H+K IG G YG V A + + + A+K ++++ P +E
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 555 QTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLF------------------- 595
+TE RL+ ++ H NI +LY + + L+ E G L
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 596 ------CVLRNDVEAVELDWTKRV------------NIVKSMAHALSYLHYDCKPSIVHR 637
C N+ R NI++ + AL YLH I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHR 192
Query: 638 DISSNNILLNSNLEAFV--ADFGLARLLHPDSSNR----TLVVGTYGYIAPEL--AYTMA 689
DI N L ++N + DFGL++ + ++ T GT ++APE+ +
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 690 VTEKCDVYSFGVVALEVLMGSHP 712
KCD +S GV+ +LMG+ P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 28/227 (12%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HR 567
++ + GG+ VY AQ + SG+ ALK+L +E E+ + E + ++ H
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHP 86
Query: 568 NIVKLYGFCL-------HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
NIV+ + FL+ + +G L L+ L + I
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV------- 673
A+ ++H KP I+HRD+ N+LL++ + DFG A +
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 674 -----VGTYGYIAPELAYTMA---VTEKCDVYSFGVVALEVLMGSHP 712
T Y PE+ + + EK D+++ G + + HP
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 516 IGTGGYGSVYRAQL------SSGKLVALKKLHR--SETEEPAFLESFQTEARLLSQI-RH 566
+G G +G V A + VA+K L E+ A + E +++S + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----ELKIMSHLGQH 109
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------------ 614
NIV L G C H + +I EY G L LR +E D +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 615 ---IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671
+ + MA L+ + +HRD+++ N+LL + A + DFGLAR + DS+
Sbjct: 170 SSQVAQGMAF-LASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI- 221
Query: 672 LVVGTYGYI-----APELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
V + APE + T + DV+S+G++ E+ +G +P
Sbjct: 222 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 21/203 (10%)
Query: 507 TEDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
T+ + +K IG G Y R ++ A+K + +S+ + + LL +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQ 74
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSMAHAL 623
H NI+ L K ++++ E M+ G L D + + ++ ++ +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELL-----DKILRQKFFSEREASAVLFTITKTV 129
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARLLHPDSSNRTLVVGTYGY 679
YLH +VHRD+ +NIL + DFG A+ L ++ T +
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 680 IAPELAYTMAVTEKCDVYSFGVV 702
+APE+ CD++S GV+
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVL 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 29/234 (12%), Positives = 66/234 (28%), Gaps = 40/234 (17%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEA---RLLSQIRHRNIVK 571
+G + A +G+ + + +E ++ + E RLL I+++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 572 LY--------------------------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV 605
++ + ++ + VL +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 606 E-LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL- 663
+ L R+ + + L+ LH +VH + +I+L+ F+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 664 HPDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHP 712
S A + +T D ++ G+ + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 70/276 (25%), Positives = 107/276 (38%), Gaps = 63/276 (22%)
Query: 476 NPNTREMTEGAN-EFSIWNYD-GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGK 533
NP + M N + Y I + I G G +G V++A+
Sbjct: 25 NPMYQRMPLLLNPKLLSLEYPRNNIEYVRDI------------GEGAFGRVFQARAPGLL 72
Query: 534 ------LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587
+VA+K L + + FQ EA L+++ + NIVKL G C K M L++E
Sbjct: 73 PYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130
Query: 588 YMERGSLFCVLRN-----DVEAVELDWTKRVNIVKSMAHALS----------------YL 626
YM G L LR+ D + R + LS YL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190
Query: 627 ---HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYI--- 680
+ VHRD+++ N L+ N+ +ADFGL+R ++ + I
Sbjct: 191 SERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---ADGNDAIPIR 241
Query: 681 --APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
PE + Y T + DV+++GVV E+ G P
Sbjct: 242 WMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP 276
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG V + + +G++VA+KK ++ + E +LL Q+RH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
C K +L++E+++ ++ L ++ + + + + + + H +I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCH---SHNI 145
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYTMA 689
+HRDI NIL++ + + DFG AR L V T Y APEL Y A
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 690 VTEKCDVYSFGVVALEVLMG 709
V DV++ G + E+ MG
Sbjct: 206 V----DVWAIGCLVTEMFMG 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 34/213 (15%)
Query: 507 TEDFHIKY-------CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEA 558
F+ Y +G G + + S + A+K + + + Q E
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEI 56
Query: 559 RLLSQIR-HRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLR---NDVEAVELDWTKR 612
L H NIVKL+ FL+ E + G LF + ++ EA
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------ 110
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSN 669
I++ + A+S++H +VHRD+ N+L + + DFG ARL PD+
Sbjct: 111 --IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV 702
T Y APEL E CD++S GV+
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL--------SSGKLVALKKLHR--SETEEPAFLESFQTE 557
+ + +G G +G V A+ VA+K L +E + + E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 90
Query: 558 ARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------------NDVE 603
++ I +H+NI+ L G C + +++I EY +G+L LR N V
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 604 AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
++ + V+ +A + YL +HRD+++ N+L+ N +ADFGLAR +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 664 HPDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ + T G + APE L + T + DV+SFGV+ E+ +G P
Sbjct: 208 NNIDYYK---KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 53/244 (21%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKL--HRSETEEPAFLESFQTEAR 559
++ + +G G +G V +A + VA+K L + S +E L E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS----EFN 78
Query: 560 LLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN------------------- 600
+L Q+ H +++KLYG C + + LI EY + GSL LR
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 601 --DVEAVELDWTKRVNIVKSMAHALSYL---HYDCKPSIVHRDISSNNILLNSNLEAFVA 655
+ L ++ ++ + YL VHRD+++ NIL+ + ++
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKIS 192
Query: 656 DFGLARLLHPDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-M 708
DFGL+R ++ + S + G I A E L + T + DV+SFGV+ E++ +
Sbjct: 193 DFGLSRDVYEEDSYV---KRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTL 248
Query: 709 GSHP 712
G +P
Sbjct: 249 GGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/239 (25%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHR--SETEEPAFLESFQTEAR 559
+G G +G V A + VA+K L TE A + E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS----ELK 78
Query: 560 LLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN---- 614
+LS + H NIV L G C +I EY G L LR ++ T
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 615 ---------------IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659
+ K MA L+ + +HRD+++ NILL + DFGL
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAF-LASKNC------IHRDLAARNILLTHGRITKICDFGL 191
Query: 660 ARLLHPDSSNRTLVVGTYGYI-----APELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
AR + DS+ V + APE + T + DV+S+G+ E+ +GS P
Sbjct: 192 ARDIKNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL--------SSGKLVALKKLHR--SETEEPAFLESFQTE 557
+ + +G G +G V A+ VA+K L +E + + E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 136
Query: 558 ARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------------NDVE 603
++ I +H+NI+ L G C + +++I EY +G+L LR N V
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 604 AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
++ + V+ +A + YL +HRD+++ N+L+ N +ADFGLAR +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 664 HPDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ + T G + APE L + T + DV+SFGV+ E+ +G P
Sbjct: 254 NNIDYYK---KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 507 TEDFHIKY-----CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARL 560
+ F Y +G G + V L + + A+K + + E +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEM 63
Query: 561 LSQIR-HRNIVKLYGFCLHNKCMFLIYEYMERGSLF--CVLR---NDVEAVELDWTKRVN 614
L Q + HRN+++L F +L++E M GS+ R N++EA
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------- 115
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRT 671
+V+ +A AL +LH I HRD+ NIL + + DF L + +
Sbjct: 116 VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 672 L-------VVGTYGYIAPELAYTMAVT-----EKCDVYSFGVV 702
+ G+ Y+APE+ + ++CD++S GV+
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHR--SETEEPAFLESFQTEAR 559
+ + +G G +G V A ++ + VA+K L + +E A + E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS----ELK 82
Query: 560 LLSQI-RHRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVK 617
+L I H N+V L G C + +I E+ + G+L LR+ ++ K
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 618 SM-------------AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664
A + +L +HRD+++ NILL+ + DFGLAR ++
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 665 PDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
D + APE + + T + DV+SFGV+ E+ +G+ P
Sbjct: 200 KDPDYV---RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG V++ + +G++VA+KK ++P + E R+L Q++H N+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ + L++EY + ++ L V K +I A+++ H K +
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH---KHNC 123
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYTMA 689
+HRD+ NIL+ + + DFG ARLL S V T Y +PEL Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 690 VTEKCDVYSFGVVALEVLMG 709
V DV++ G V E+L G
Sbjct: 184 V----DVWAIGCVFAELLSG 199
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/278 (20%), Positives = 96/278 (34%), Gaps = 37/278 (13%)
Query: 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG 105
+ + +T IPS++ L +L DL + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 106 SIPLE-FGNLKDLDQLRLQ-GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNL 162
I + F NL L ++R++ N L + P + NL NL YL +S + LP +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 163 KNLKSLFL-DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L + DN ++ ++ L L LN N
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGL-----------------------SFESVILWLNKN 164
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLSGLLPREVG 280
+ S L + +N L+ +P + + + LD+S ++ L +
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRTRIHSLPSYGLE 223
Query: 281 NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNR 318
NLK L + S + PT+ L L +L Y
Sbjct: 224 NLKKLRARSTYNLKKL----PTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 46/253 (18%), Positives = 84/253 (33%), Gaps = 15/253 (5%)
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
+ + IP + ++ +LR KL + + +L +++S N + +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 156 PQEV-GNLKNLKSLFLDN-NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNL 213
+V NL L + ++ N+L P +L L L + + +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 214 DRLHLNGNNLTGSIPSTI--GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS-NQ 270
L + N +I G L L+ N + I + N T L L+LS N
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNN 189
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMN 329
L L L ++ I +P L L + + +P L
Sbjct: 190 LEELPNDVFHGASGPVILDISRT-RIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEK 244
Query: 330 CSQLLNLVLSHNS 342
L+ L++ S
Sbjct: 245 LVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 11/238 (4%)
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+ + + ++ IPS L L KL +L+++ ++ N++
Sbjct: 10 SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 224 TGSIPS-TIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLSGLLPREVGN 281
I + L L E+ + I P NL NL L +S+ + L +
Sbjct: 67 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126
Query: 282 LKYLASLSLNGNILIGPIPPTI--GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLS 339
L + NI I I G L L N + I N +QL L LS
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLS 185
Query: 340 HNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396
N+ +P+++ LD+SR I+ L + + A NL +
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 43/236 (18%), Positives = 84/236 (35%), Gaps = 14/236 (5%)
Query: 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLS- 75
N + R T L LEK+ +S N + I +++ L +L + +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 76 YNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIP-LEFGNLKDLDQLRLQGN-KLDGLIP 132
N L I E +L +L L +SN + +P + + L +Q N + +
Sbjct: 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 133 SSIGNLT-NLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+S L+ L L+ N + + + + DNN+L + +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 191 TLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246
L + ++ + + N+K L +P+ + L L E L++
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 35/207 (16%), Positives = 67/207 (32%), Gaps = 8/207 (3%)
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLS-S 268
+N L L L+++ +S N + I NL L + + +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPEL 327
N L + P NL L L ++ I +P + L++ N +I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNT-GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 328 MN--CSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSR-NFINGTIPSQLGKIPNISAV 384
+ + L L+ N + I + N +L+LS N + +
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 385 DLSKNNLSGVIPASVRRIPKLIVSENN 411
D+S+ + + + + KL
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 50/240 (20%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL--------SSGKLVALKKLHR--SETEEPAFLESFQTE 557
+ + +G G +G V A+ + VA+K L +E + + E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----E 124
Query: 558 ARLLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN-- 614
++ I +H+NI+ L G C + +++I EY +G+L L+ +
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 615 ---------------IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659
+ + M + L+ +HRD+++ N+L+ + +ADFGL
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEY-LASKKC------IHRDLAARNVLVTEDNVMKIADFGL 237
Query: 660 ARLLHPDSSNRTLVVGTYGYI-----APE-LAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
AR +H + T G + APE L + T + DV+SFGV+ E+ +G P
Sbjct: 238 ARDIHHIDYYK---KTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
IG G YG VY+AQ + G+ ALKK+ R E E+ + E +L +++H NIVKLY
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKSMAH----ALSYLHY 628
K + L++E+++ D++ + LD + KS ++Y H
Sbjct: 69 IHTKKRLVLVFEHLD---------QDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL---- 684
++HRD+ N+L+N E +ADFGLAR T + T Y AP++
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 685 -AYTMAVTEKCDVYSFGVVALEVLMG 709
Y+ + D++S G + E++ G
Sbjct: 176 KKYSTTI----DIWSVGCIFAEMVNG 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 30/206 (14%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
+G G YG VY+A+ S G++VALK++ R + E+ + E LL ++ H NIV L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 576 CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKSMAH----ALSYLHY 628
+C+ L++E+ME D++ V LD K + +K + +++ H
Sbjct: 88 IHSERCLTLVFEFME---------KDLKKV-LDENKTGLQDSQIKIYLYQLLRGVAHCH- 136
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL---- 684
+ I+HRD+ N+L+NS+ +ADFGLAR + T V T Y AP++
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 685 -AYTMAVTEKCDVYSFGVVALEVLMG 709
Y+ +V D++S G + E++ G
Sbjct: 195 KKYSTSV----DIWSIGCIFAEMITG 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ F I IG G +G V Q + K+ A+K +++ + E + + E +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 567 RNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVK----SMAH 621
+V L Y F MF++ + + G L L+ +V E VK +
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKE-------ETVKLFICELVM 126
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
AL YL I+HRD+ +NILL+ + + DF +A +L ++ T+ GT Y+A
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-AGTKPYMA 182
Query: 682 PEL-------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ Y+ AV D +S GV A E+L G P
Sbjct: 183 PEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 12/210 (5%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
L L N L L S + L LDLS ++ + +L +L +L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 175 LSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPS--TIG 232
+ L+ L L L +G++K L L++ N + S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNL----IALDLSSNQLSGLLPREVGNLKYLASL 288
L L+ L LS N++ + L + ++LDLS N ++ + P ++ L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKEL 205
Query: 289 SLNGNILIGPIPPTI-GYLTNLTYLNLGYN 317
+L+ N L +P I LT+L + L N
Sbjct: 206 ALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/252 (24%), Positives = 87/252 (34%), Gaps = 50/252 (19%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNIL 103
+ L LS N L + L+VLDLS + TI SL L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 104 NGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GN 161
S+ L F L L +L L L IG+L L L+++ N + E N
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L NL+ L L +N + + L L+Q+ L L L L+ N
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL--------------------SLDLSLN 187
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281
+ I E+ L L L +NQL +
Sbjct: 188 PMN-FIQP-----GAFKEIRLKE-------------------LALDTNQLKSVPDGIFDR 222
Query: 282 LKYLASLSLNGN 293
L L + L+ N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 34/163 (20%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
LS L+KLV +L + + G L LK L++++N +
Sbjct: 99 LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-------------------- 137
Query: 101 NILNGSIPLE--FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTY----LDLSLNQLSGR 154
S L F NL +L+ L L NK+ + + + L + LDLSLN ++
Sbjct: 138 -----SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 155 LPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197
+ LK L LD N L L L + L N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 11/171 (6%)
Query: 251 IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNL 309
IP + + LDLS N L L + L L L+ I I L++L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHL 78
Query: 310 TYLNLGYNRLSSSIPPEL-MNCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFI 367
+ L L N + S+ S L LV +L+ S+ + G+L ++L+++ N I
Sbjct: 79 STLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 368 NGTIPSQ--LGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
+ + N+ +DLS N + + +R + ++ + +L+L
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 25/199 (12%), Positives = 57/199 (28%), Gaps = 36/199 (18%)
Query: 515 CIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLY 573
G ++A + + VAL + L+ + LS+I + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 574 GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
++ E++ GSL V V + ++S+A A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAH---RAG 149
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
+ + + + S + +V+ + +
Sbjct: 150 VALSIDHPSRVRV--------------------SIDGDVVLAYPATMPD-------ANPQ 182
Query: 694 CDVYSFGVVALEVLMGSHP 712
D+ G +L+ P
Sbjct: 183 DDIRGIGASLYALLVNRWP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I IG G + V ++ +G++ A+K +++ + + + F+ E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 567 RNIVKLYGFCLH-NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
R I +L+ F ++L+ EY G L +L E + + + + + A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMAIDS 177
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-VGTYGYIAPEL 684
+H + VHRDI +NILL+ +ADFG L D + R+LV VGT Y++PE+
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 685 -----------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+Y CD ++ GV A E+ G P
Sbjct: 235 LQAVGGGPGTGSYGPE----CDWWALGVFAYEMFYGQTP 269
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 53/236 (22%)
Query: 516 IGTGGYGSVYRAQL------SSGKLVALKKLHR--SETEEPAFLESFQTEARLLSQI-RH 566
+G+G +G V A VA+K L +E A + E ++++Q+ H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSH 108
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN------------ 614
NIV L G C + ++LI+EY G L LR+ E D + N
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 615 ------------IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662
+ K M L + VHRD+++ N+L+ + DFGLAR
Sbjct: 169 LTFEDLLCFAYQVAKGMEF-LEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 663 LHPDSSNRTLVVGTYGYI-----APELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ DS+ V + APE + T K DV+S+G++ E+ +G +P
Sbjct: 222 IMSDSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF I IG G +G V +L ++ K+ A+K L++ E + A F+ E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ I L+ + ++L+ +Y G L +L + + + + + M A+ +
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAIDSV 191
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-VGTYGYIAPELA 685
H + VHRDI +NIL++ N +ADFG L D + ++ V VGT YI+PE+
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 686 YTMAVTEK-----CDVYSFGVVALEVLMGSHP 712
M + CD +S GV E+L G P
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 27/186 (14%), Positives = 64/186 (34%), Gaps = 10/186 (5%)
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+ + L+ L + + + + L + L + L + I N+ L ++
Sbjct: 21 TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG 208
+ + L NL+ L + ++ L L L L + ++ + ++
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
+ ++ + L+ N I + L L L++ + + I + L L S
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 269 NQLSGL 274
+ G
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 33/183 (18%), Positives = 75/183 (40%), Gaps = 7/183 (3%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
S + + + ++ L + L+ +T + I ++ DL ++N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77
Query: 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNL 162
P+ L +L++LR+ G + ++ LT+LT LD+S + + ++ L
Sbjct: 78 ATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
+ S+ L N I L L +L +L + ++ + + + + L++L+
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQT 192
Query: 223 LTG 225
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 25/141 (17%), Positives = 55/141 (39%), Gaps = 5/141 (3%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
+ I ++ L +++ T + I LS L+ L + +T + L L L
Sbjct: 60 TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
++S++ + SI + L ++ + L N I + L L L++ + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG 176
Query: 157 QEVGNLKNLKSLFLDNNHLSG 177
+ + L L+ + + G
Sbjct: 177 --IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-21
Identities = 30/186 (16%), Positives = 71/186 (38%), Gaps = 10/186 (5%)
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
K L ++ T +N L + L++ + + I N+ L +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINN 75
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM 328
+ P + L L L + G + P + LT+LT L++ ++ SI ++
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 329 NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
++ ++ LS+N I + L + L++ + ++ + P ++ +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 389 NNLSGV 394
+ G
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 36/184 (19%), Positives = 68/184 (36%), Gaps = 10/184 (5%)
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
LG + +T+ M +L + L N+T + + I Y + + +L +++
Sbjct: 22 FKAYLNGLLGQSS-TANITEA--QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305
P I L+NL L + ++ + L L L ++ + I I
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 306 LTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
L + ++L YN + I P L +L +L + + + I + QL
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 366 FING 369
I G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 29/140 (20%), Positives = 54/140 (38%), Gaps = 5/140 (3%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
N+ I + + I LS LE+L + +T + L+ L +LD
Sbjct: 61 GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
+S++ +I ++I +L + ++LS N I L +L L +Q + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--R 175
Query: 134 SIGNLTNLTYLDLSLNQLSG 153
I + L L + G
Sbjct: 176 GIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 30/143 (20%), Positives = 60/143 (41%), Gaps = 5/143 (3%)
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
T + +L + L++ ++ L + + L++N P I L+NL L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI-HATNYNP-ISGLSNLERLR 94
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPS 373
+ ++S P L + L L +SH++ SI ++I L +DLS N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 374 QLGKIPNISAVDLSKNNLSGVIP 396
L +P + ++++ + +
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRG 176
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G YG+V++A+ + ++VALK++ R + ++ S E LL +++H+NIV+L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKSMAH----ALSYLH 627
+K + L++E+ + D++ D IVKS L + H
Sbjct: 69 VLHSDKKLTLVFEFCD---------QDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL--- 684
+++HRD+ N+L+N N E +A+FGLAR + V T Y P++
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 685 --AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+ ++ D++S G + E+ P
Sbjct: 176 AKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 121
Query: 574 GFC----LHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKR--VNIVKSMAHALSY 625
KC+ ++ E ++ G LF + + +T+R I+KS+ A+ Y
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELF-----SRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSSNRTLVVGTYGYIAP 682
LH +I HRD+ N+L S + DFG A+ +S T T Y+AP
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP 232
Query: 683 ELAYTMAVTEKCDVYSFGVV 702
E+ + CD++S GV+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVI 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 43/282 (15%), Positives = 87/282 (30%), Gaps = 53/282 (18%)
Query: 477 PNTREMTEGANEF---SIWNYDGRITFEEMI-EATEDFHIKYCIGTGGYGSVYRAQ-LSS 531
+ M A+ S+WN E + E +G + A +
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97
Query: 532 GKLVALKKLHRSETEEPAFLESFQTEA---RLLSQIR----------------------H 566
G+ + + +E ++ + E RLL I+
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 567 RNIVKLYGFCLHNKCM--FLIYEYME--RGSLFCVLRNDVEAVE-LDWTKRVNIVKSMAH 621
+ ++++ + F +Y M+ + VL + + L R+ + +
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L+ LH +VH + +I+L+ F+ F R + + G+
Sbjct: 218 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD----GARVVSSVSRGFEP 270
Query: 682 PELAYTMA-----------VTEKCDVYSFGVVALEVLMGSHP 712
PEL A +T D ++ G+V + P
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 36/214 (16%)
Query: 507 TEDFHIKY-----CIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARL 560
Y +G G G V +G+ ALK L+ S + E
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDH 74
Query: 561 LSQI-RHRNIVKLYGFC----LHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKR- 612
Q +IV + +C+ +I E ME G LF E + +T+R
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-----SRIQERGDQAFTERE 129
Query: 613 -VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLARLLHPDSS 668
I++ + A+ +LH +I HRD+ N+L S + + DFG A+ ++
Sbjct: 130 AAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV 702
T Y+APE+ + CD++S GV+
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG VY+A + + VA+K++ R E EE + E LL +++HRNI++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN--IVKSMAH----ALSYLHY 628
HN + LI+EY E D++ +D V+ ++KS + +++ H
Sbjct: 101 VIHHNHRLHLIFEYAEN---------DLKKY-MDKNPDVSMRVIKSFLYQLINGVNFCH- 149
Query: 629 DCKPSIVHRDISSNNILLNSNLEAF-----VADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
+HRD+ N+LL+ + + + DFGLAR T + T Y PE
Sbjct: 150 --SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
Query: 684 L-----AYTMAVTEKCDVYSFGVVALEVLMG 709
+ Y+ +V D++S + E+LM
Sbjct: 208 ILLGSRHYSTSV----DIWSIACIWAEMLMK 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 18/258 (6%)
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
+ + L+ + + L ++ + + + + + Q + L N+ LFL+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
N L+ P L +L L L L NK+ + ++K L L L N ++ I +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS-DING-LV 131
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
+L L+ L+L +N++ + LT L L L NQ+S ++P + L L +L L+
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352
N I + + L NL L L + N + + SL P I
Sbjct: 188 N-HISDLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIIS 243
Query: 353 NLIFFRQLDLSRNFINGT 370
+ + + ++ + T
Sbjct: 244 DDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 20/276 (7%)
Query: 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGS 106
+ + + + A + +L +T + L + + +N+ +
Sbjct: 6 ETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV 61
Query: 107 IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLK 166
++ L ++ +L L GNKL + + NL NL +L L N++ + +LK LK
Sbjct: 62 QGIQ--YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLK 115
Query: 167 SLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226
SL L++N +S + L HL QL +L LG NK+ + + LD L L N ++
Sbjct: 116 SLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-D 170
Query: 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLA 286
I + L L L+LS N + + + L NL L+L S + NL
Sbjct: 171 IVP-LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 287 SLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322
++ L+ P I + N+ ++ +
Sbjct: 228 TVKNTDGSLVTPE--IISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 50/255 (19%), Positives = 105/255 (41%), Gaps = 21/255 (8%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
L+ +++++ +++ + + I L + L L+ N+LT + +L++L L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWL 95
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
L N + L+ +LK L L L+ N + + + + +L L L L N+++
Sbjct: 96 FLDENKVKDLSSLK--DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--I 149
Query: 157 QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRL 216
+ L L +L L++N +S +P L L +L L L N + + + +KNLD L
Sbjct: 150 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVL 205
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
L + L + + + + L P I + + ++ + LP
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE--IISDDGDYEKPNVKWH-----LP 258
Query: 277 REVGNLKYLASLSLN 291
+ ++ +
Sbjct: 259 EFTNEVSFIFYQPVT 273
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 59/299 (19%), Positives = 106/299 (35%), Gaps = 43/299 (14%)
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
+ + +L ++ + Q L ++ + +N+ +
Sbjct: 9 TVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK--SVQ 62
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241
+ +L + L L NKL K + N+KNL L L+ N + + S++ L L L
Sbjct: 63 GIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118
Query: 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
L HN + I + +L L +L L +N+++ +
Sbjct: 119 LEHNGISD-ING-LVHLPQLESLYLGNNKITDI--------------------------T 150
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361
+ LT L L+L N++S I P L ++L NL LS N +S + + L L+
Sbjct: 151 VLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLE 206
Query: 362 LSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS-VRRIPKLIVSENNLELENSTS 419
L + + + V + +L S K V + E N S
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 50/214 (23%), Positives = 78/214 (36%), Gaps = 12/214 (5%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
PN+ + G L+ + L L L L N + + S + L +LK L
Sbjct: 63 GIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLS 118
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L +N ++ I + L L L L NN + L L LD L L+ N++ +
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDI--V 172
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ LT L L LS N +S + + LKNL L L + + +L T+
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227
LV P + + T +
Sbjct: 231 NTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 58/224 (25%), Positives = 110/224 (49%), Gaps = 37/224 (16%)
Query: 504 IEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEE--PAFLESFQT---E 557
+ ++ F +G G Y +VY+ ++G VALK++ + ++EE P+ T E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPS------TAIRE 53
Query: 558 ARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR---VN 614
L+ +++H NIV+LY + L++E+M+ L+ +++ + T R +N
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-----NDLKKYMDSRTVGNTPRGLELN 108
Query: 615 IVKSMAH----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670
+VK L++ H + I+HRD+ N+L+N + + DFGLAR +
Sbjct: 109 LVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 671 TLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
+ V T Y AP++ Y+ ++ D++S G + E++ G
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITG 205
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + IG G +G V + S+ K+ A+K L + E + + F E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+V+L+ ++ ++++ EYM G L ++ N V W + + AL +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFY--TAEVVLALDAI 184
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV-VGTYGYIAPEL- 684
H +HRD+ +N+LL+ + +ADFG ++ + R VGT YI+PE+
Sbjct: 185 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 685 -------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y CD +S GV E+L+G P
Sbjct: 242 KSQGGDGYYGRE----CDWWSVGVFLYEMLVGDTP 272
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 508 EDFHIKYCIGTGGYGSVYRA-QLSSGKLVALKKLHRSETEE--PAFLESFQT---EARLL 561
E + +G G Y +VY+ + LVALK++ R E EE P T E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPC------TAIREVSLL 54
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKS 618
++H NIV L+ K + L++EY+++ D++ LD + + VK
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK---------DLKQY-LDDCGNIINMHNVKL 104
Query: 619 MAH----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674
L+Y H + ++HRD+ N+L+N E +ADFGLAR + V
Sbjct: 105 FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 675 GTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
T Y P++ Y+ + D++ G + E+ G
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI----DMWGVGCIFYEMATG 197
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/208 (27%), Positives = 79/208 (37%), Gaps = 13/208 (6%)
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY 196
+ + ++ L+ LP ++ K+ L L N L +TL +L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 197 NKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255
+L V G + L L L+ N L S+P L L L +S NRL +P
Sbjct: 65 AELTKLQVD---GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGA 119
Query: 256 -GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLN 313
L L L L N+L L P + L LSL N L +P + L NL L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLL 178
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L N L +IP L L N
Sbjct: 179 LQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 55/178 (30%), Positives = 76/178 (42%), Gaps = 6/178 (3%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
L LS N L + + +RL L+L LT + + G+L L L+LS+N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLK 163
S+PL L L L + N+L L ++ L L L L N+L LP +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L+ L L NN+L+ L L L TL L N L + K L L+GN
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 299 IPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR 358
+PP + + T L+L N L + LM ++L L L L+ + + G L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLG 80
Query: 359 QLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV 399
LDLS N + ++P +P ++ +D+S N L+ +P
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESF-QT---EARLLS 562
+ IG G +G V++A+ +G+ VALKK+ E E+ E F T E ++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEK----EGFPITALREIKILQ 71
Query: 563 QIRHRNIVKLYG--------FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN 614
++H N+V L + ++L++++ E L +L N + L K
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--R 128
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT--- 671
+++ + + L Y+H + I+HRD+ + N+L+ + +ADFGLAR +++
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 672 --LVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
VV T Y PEL Y + D++ G + E+
Sbjct: 186 TNRVV-TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTR 225
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 42/214 (19%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESF-QT---EARLLSQIRHRNIV 570
+G G + +VY+A+ ++ ++VA+KK+ E + +T E +LL ++ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE--AKDGINRTALREIKLLQELSHPNII 75
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV---NIVKSMAH----AL 623
L H + L++++ME D+E + + V + +K+ L
Sbjct: 76 GLLDAFGHKSNISLVFDFMET---------DLEVI-IKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTYGYI 680
YLH + I+HRD+ NN+LL+ N +ADFGLA+ S NR VV T Y
Sbjct: 126 EYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVV-TRWYR 179
Query: 681 APEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
APEL Y + V D+++ G + E+L+
Sbjct: 180 APELLFGARMYGVGV----DMWAVGCILAELLLR 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 512 IKYCIGTGGYGSVYRAQ---LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+G G YG VY+A+ K ALK++ E S E LL +++H N
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRELKHPN 79
Query: 569 IVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN--IVKSMAH--- 621
++ L L ++ ++L+++Y E L+ +++ + ++ +VKS+ +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 622 -ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF----VADFGLARL----LHPDSSNRTL 672
+ YLH ++HRD+ NIL+ +AD G ARL L P + +
Sbjct: 139 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 673 VVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
VV T+ Y APEL YT A+ D+++ G + E+L
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTS 232
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF +G G + +V A+ ++ + A+K L + + + E ++S++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS------MA 620
VKLY ++ ++ Y + G L +R + + +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR---TLVVGTY 677
AL YLH I+HRD+ NILLN ++ + DFG A++L P+S + VGT
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-VGTA 196
Query: 678 GYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y++PEL + + D+++ G + +++ G P
Sbjct: 197 QYVSPELLTEKSACKSS----DLWALGCIIYQLVAGLPP 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 36/211 (17%), Positives = 76/211 (36%), Gaps = 15/211 (7%)
Query: 511 HIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIV 570
I + Q ++ + P+ +++ + R + +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 571 KLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
+++ + + +L + + + ++I +A A+ +LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS------------NRTLVVGTYG 678
++HRD+ +NI + V DFGL + D T VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
Y++PE + + K D++S G++ E+L
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G + V A+ + +G+ VA+K + +++ + L+ E R++ + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFREVRIMKILNHPNIVKLFE 81
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
K ++LI EY G +F L V + + + + + A+ Y H + I
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMAV 690
VHRD+ + N+LL++++ +ADFG + G Y APEL Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQGKKYDGP- 193
Query: 691 TEKCDVYSFGVVALEVLM-GSHPTD 714
+ DV+S GV+ L L+ GS P D
Sbjct: 194 --EVDVWSLGVI-LYTLVSGSLPFD 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 61/180 (33%), Positives = 91/180 (50%), Gaps = 6/180 (3%)
Query: 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNIL 103
+KL L N L+ L++L++L L+ N+L T+P+ I L++L L +++N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 104 NGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GN 161
++P+ F L +L +LRL N+L L P +LT LTYL L N+L LP+ V
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L +LK L L NN L L +L TL L N+L +++ L L L N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
D +L LQ NKL L + LT L L L+ N+L LP + LKNL++L++ +N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 175 LSGPIPSTLY-HLNQLATLCLGYNKLVGPVTK-EVG---NMKNLDRLHLNGNNLTGSIPS 229
L +P ++ L LA L L N+L ++ L L L N L S+P
Sbjct: 97 LQA-LPIGVFDQLVNLAELRLDRNQL----KSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 230 TI-GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASL 288
+ L L EL L +N+L LT L L L +NQL + +L+ L L
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 289 SLNGN 293
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 65/201 (32%), Positives = 81/201 (40%), Gaps = 9/201 (4%)
Query: 51 SHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
S LT IPS I A K LDL N+L+ L L L L++N L ++P
Sbjct: 24 SSKKLT-AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG 79
Query: 111 -FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSL 168
F LK+L+ L + NKL L L NL L L NQL LP V +L L L
Sbjct: 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 169 FLDNNHLSGPIPSTLY-HLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227
L N L +P ++ L L L L N+L + L L L+ N L
Sbjct: 139 SLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197
Query: 228 PSTIGYLNLLDELHLSHNRLD 248
L L L L N D
Sbjct: 198 EGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 8/182 (4%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQ 270
+ +L L N L+ L L L+L+ N+L +P I L NL L ++ N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMN 329
L L L LA L L+ N + +PP + LT LTYL+LGYN L S+P + +
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRN-QLKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFD 154
Query: 330 C-SQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387
+ L L L +N L +P L + L L N + + + + L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 388 KN 389
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 37/133 (27%), Positives = 52/133 (39%), Gaps = 26/133 (19%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
L L +L L N L +P + +L++L L L YN L ++P +
Sbjct: 108 LVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV------------- 152
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160
F L L +LRL N+L + + LT L L L NQL
Sbjct: 153 ----------FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202
Query: 161 NLKNLKSLFLDNN 173
+L+ LK L L N
Sbjct: 203 SLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 235 NLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNI 294
N + + S +L IP I + LDL SN+LS L + L L L LN N
Sbjct: 16 NNKNSVDCSSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72
Query: 295 LIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMNC-SQLLNLVLSHNSLSGSIPSEI- 351
L +P I L NL L + N+L ++P + + L L L N L S+P +
Sbjct: 73 LQT-LPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF 129
Query: 352 GNLIFFRQLDLSRNFINGTIPSQLGKIP--------NISAVDLSKNNLSGVIPASV 399
+L L L N +L +P ++ + L N L +P
Sbjct: 130 DSLTKLTYLSLGYN--------ELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGA 176
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 33/92 (35%), Positives = 44/92 (47%), Gaps = 10/92 (10%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGA---LSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLN 97
L+KL L L +N L +P G L+ LK L L N+L +P L +L L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPK--GVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187
Query: 98 LSNNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
L NN L +P F +L+ L L+LQ N D
Sbjct: 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 46/216 (21%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G +G VY+A+L SG+LVA+KK+ + + + E +++ ++ H NIV+L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCNIVRLRY 114
Query: 575 FCLHN------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-----VKS----M 619
F + + L+ +Y+ V V +++ VK +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYG 678
+L+Y+H I HRDI N+LL+ + + DFG A+ L N + + Y
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 679 YIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
Y APEL YT ++ DV+S G V E+L+G
Sbjct: 222 YRAPELIFGATDYTSSI----DVWSAGCVLAELLLG 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 43/218 (19%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEAR------LLSQIRHRN 568
IG G YG+VY+A+ SG VALK + R + R L H N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 569 IVKLYGFCLHNKC-----MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI----VKSM 619
+V+L C ++ + L++E++++ D+ LD + +K +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ---------DLRTY-LDKAPPPGLPAETIKDL 125
Query: 620 AH----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG 675
L +LH IVHRD+ NIL+ S +ADFGLAR+ + +VV
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV- 181
Query: 676 TYGYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMG 709
T Y APE+ Y V D++S G + E+
Sbjct: 182 TLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRR 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 31/229 (13%)
Query: 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQT--- 556
E+ + ++ I +G YG+V S G VA+K++ + + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNT-VSDGRTVNILSDSFL 72
Query: 557 ------EARLLSQIRHRNIVKLYG-FCLHNKCMF----LIYEYMERGSLFCVLRNDVEAV 605
E RLL+ H NI+ L F + L+ E M L V+ + +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI 131
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+ + + L LH + +VHRD+ NILL N + + DF LAR
Sbjct: 132 SPQHIQ--YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 666 DSSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
D +N+T V Y APEL +T V D++S G V E+
Sbjct: 187 D-ANKTHYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNR 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V + +G VA+K L+R + + + E + L RH +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
F++ EY+ G LF + + ++ + + + + A+ Y H + +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCH---RHMV 132
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMAV 690
VHRD+ N+LL++++ A +ADFGL+ ++ RT G+ Y APE+ Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAGP- 190
Query: 691 TEKCDVYSFGVVALEVLM-GSHPTD 714
+ D++S GV+ L L+ G+ P D
Sbjct: 191 --EVDIWSCGVI-LYALLCGTLPFD 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 55/211 (26%), Positives = 84/211 (39%), Gaps = 23/211 (10%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALK-----KLHRSETEEPAFLESFQTEARLLSQIRHRNI 569
+G+G +G V+ A K V +K K+ E L E +LS++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 570 VKLYGFCLHNKCMFLIYEYMERGS-LFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
+K+ + L+ E G LF + LD I + + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVGYLR- 147
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL---- 684
I+HRDI NI++ + + DFG A L T GT Y APE+
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMGN 204
Query: 685 AYTMAVTEKCDVYSFGVVALEVLM-GSHPTD 714
Y + +++S GV L L+ +P
Sbjct: 205 PYRGP---ELEMWSLGVT-LYTLVFEENPFC 231
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 57/276 (20%), Positives = 91/276 (32%), Gaps = 22/276 (7%)
Query: 40 GALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIP---SEIGSLRDLLDL 96
G S L ++I LK L + R+ I + + L +L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 97 NLSNNILNGSIPLEFGNL--KDLDQLRLQGNKLDGL--IPSSIGNL--TNLTYLDLSLNQ 150
L N + G+ P DL+ L L+ + + L L ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 151 LSGRLPQEVGNLKNLKSLFLDNNHLSGPI-------PSTLYHLNQLATLCLGYNKLVGPV 203
++V L +L L +N G P L LA G G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGPIPPTIGNLTNLI 262
+ L L L+ N+L + + + + L+ L+LS L +P + L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLS 277
Query: 263 ALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGP 298
LDLS N+L L + +LSL GN +
Sbjct: 278 VLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 59/285 (20%), Positives = 88/285 (30%), Gaps = 29/285 (10%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
LK +D + T + SL+ L L + L +L L+ ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 129 GLIPSSIGNLTNLTYLDLSLNQLS-GRLPQEVGNL-----KNLKSLFLDNNHLSGPIPST 182
G P + T L+L +S + L LK L + H
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 183 LYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHL 242
+ L+TL L N +G ++ P L +L +
Sbjct: 169 VRVFPALSTLDLSDNPELGERG-----------------LISALCPLKFPTLQVLALRNA 211
Query: 243 SHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGNILIGPIPP 301
G L LDLS N L L SL+L+ L +P
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK 270
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGS 346
+ L+ L+L YNRL + P Q+ NL L N S
Sbjct: 271 GL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 46/213 (21%), Positives = 67/213 (31%), Gaps = 25/213 (11%)
Query: 31 LSGRMPSEIGALS--KLEKLVLSHNSLTGRIPS----EIGALSRLKVLDLSYNRLTGTIP 84
++G P + + L L L + S R + LKVL ++
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 85 SEIGSLRDLLDLNLSNNILNGSIPLE-------FGNLKDLDQLRLQGNKLDGLIPSSIGN 137
++ L L+LS+N G L F L+ L G+ +
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 138 LTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLS---GPIPSTLYHLNQLATLC 193
L LDLS N L L SL L L +P+ L L+
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLD------ 280
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226
L YN+L + + L L GN S
Sbjct: 281 LSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 52/283 (18%), Positives = 82/283 (28%), Gaps = 50/283 (17%)
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ---EVGNLKNLKSLFLDNNHLS 176
L+ + D + I +L L + ++ R+ V + L+ L L+N ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL 236
G P L +L+ L+L +
Sbjct: 109 GTAPPPL----------------------LEATGPDLNILNLRNVSWATRDAWLAELQQW 146
Query: 237 LD----ELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
L L ++ + L LDLS N G
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG---------------- 190
Query: 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352
++ P L L N G S QL L LSHNSL + +
Sbjct: 191 -LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 353 NLIFF-RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394
+ L+LS + +P L +S +DLS N L
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN 289
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 43/223 (19%), Positives = 75/223 (33%), Gaps = 19/223 (8%)
Query: 210 MKNLDRLHLNGNNLTGSIPSTIGYLNLLD-----ELHLSHNRLDGPIPPTIGNLT--NLI 262
+K+L L G L +L EL L + + G PP + T +L
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 263 ALDLSSNQLSGLLPR----EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNR 318
L+L + + + L LS+ + + L+ L+L N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 319 LSSSIPPELMNC----SQLLNLVLSHN---SLSGSIPSEIGNLIFFRQLDLSRNFINGTI 371
C L L L + + SG + + + LDLS N +
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 372 PSQLGKIP-NISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ P +++++LS L V ++ L +S N L+
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLD 287
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 6/162 (3%)
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L +D ++ + +LK L + I + ++ L L L ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 321 SSIPPELMNCS--QLLNLVLSHNSLSG--SIPSEIGNLIF--FRQLDLSRNFINGTIPSQ 374
+ PP L+ + L L L + S + + +E+ + + L +++ Q
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 375 LGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
+ P +S +DLS N G P + L L N
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-22
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGF 575
IG G +G V++A+L VA+KK+ + + + E +++ ++H N+V L F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLKAF 100
Query: 576 CLHN------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR-----VNIVKS----MA 620
N + L+ EY+ V + K + ++K +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE---------TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYGY 679
+L+Y+H I HRDI N+LL+ + DFG A++L N + + Y Y
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-Y 207
Query: 680 IAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
APEL YT + D++S G V E++ G
Sbjct: 208 RAPELIFGATNYTTNI----DIWSTGCVMAELMQG 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 49/220 (22%)
Query: 516 IGTGGYGSVYRAQ--LSSGKLVALKKLHRSETEEPAFLESFQTEA-------RLLSQIRH 566
IG G YG V++A+ + G+ VALK++ R +T E E R L H
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGE----EGMPLSTIREVAVLRHLETFEH 73
Query: 567 RNIVKLY-----GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI----VK 617
N+V+L+ + L++E++++ D+ LD + +K
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---------DLTTY-LDKVPEPGVPTETIK 123
Query: 618 SMAH----ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLV 673
M L +LH +VHRD+ NIL+ S+ + +ADFGLAR+ + ++V
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 674 VGTYGYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMG 709
V T Y APE+ +Y V D++S G + E+
Sbjct: 181 V-TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRR 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAF----LESF 554
E + + F ++ G G +G+V + +G VA+KK+ ++P F L+
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRNRELQ-- 68
Query: 555 QTEARLLSQIRHRNIVKLYGFCLHNK-------CMFLIYEYMERGSLFCVLRNDVEAVEL 607
+ L+ + H NIV+L + + ++ EY+ +L RN
Sbjct: 69 --IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV- 124
Query: 608 DWTKRVNIVKS----MAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGLARL 662
++K + ++ LH ++ HRDI +N+L+N ++ + DFG A+
Sbjct: 125 --APPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 663 LHPDSSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
L P N + Y Y APEL YT AV D++S G + E+++G
Sbjct: 182 LSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-22
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
F +G GG+G V Q+ ++GK+ A KKL + ++ E ++L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 567 RNIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAV--ELDWTKRVNI-VKSMAHA 622
R +V L + K + L+ M G L + + +A E R +
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCG 298
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
L LH + IV+RD+ NILL+ + ++D GLA + + + VGT GY+AP
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-VGTVGYMAP 354
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ YT + D ++ G + E++ G P
Sbjct: 355 EVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 7e-22
Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 79/279 (28%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
+ + +G G +G V A ++ + VA+K L T + +E ++L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 562 SQI-RHRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRN------------------- 600
I H N+V L G C + +I E+ + G+L LR+
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139
Query: 601 -DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS-------------------------- 633
V A+ +D +R++ + S + S + K
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 634 --------------IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+HRD+++ NILL+ + DFGLAR ++ D
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDAR 256
Query: 680 I-----APELAYTMAVTEKCDVYSFGVVALEVL-MGSHP 712
+ APE + T + DV+SFGV+ E+ +G+ P
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-21
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ F +G GG+G V+ Q+ ++GKL A KKL++ ++ + E ++L+++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 567 RNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHALS 624
R IV L + K + L+ M G + + N E R + + L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
+LH + +I++RD+ N+LL+ + ++D GLA L + GT G++APEL
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 685 ----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y +V D ++ GV E++ P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 35/217 (16%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT---EARLLSQIRHR--NI 569
+G+GG+GSVY +S VA+K + + + L + E LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 570 VKLYGFCLHNKCMFLIYEYME-RGSLF--CVLR---NDVEAVELDWTKRVNIVKSMAHAL 623
++L + LI E E LF R + A R + + A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-------R-SFFWQVLEAV 162
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
+ H ++HRDI NIL++ N E + DFG LL D+ GT Y P
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF-DGTRVYSPP 217
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLM-GSHPTD 714
E Y V+S G++ L ++ G P +
Sbjct: 218 EWIRYHRYHGR---SAAVWSLGIL-LYDMVCGDIPFE 250
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG V A + + VA+K + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+L EY G LF + + + + + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPEL----AYTM 688
HRDI N+LL+ ++DFGLA + ++ R L + GT Y+APEL +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 689 AVTEKCDVYSFGVVALEVLM-GSHPTD 714
DV+S G+V L ++ G P D
Sbjct: 187 E---PVDVWSCGIV-LTAMLAGELPWD 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+F +G G +G V + ++G+ A+K L + + TE R+L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 567 RNIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMAHALS 624
+ L + + + EY G LF L + E R + AL
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 262
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPE 683
YLH + ++V+RD+ N++L+ + + DFGL + + ++ +T GT Y+APE
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPE 319
Query: 684 L----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ Y AV D + GVV E++ G P
Sbjct: 320 VLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V + +G VA+K L+R + + + E + L RH +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+F++ EY+ G LF + + LD + + + + + Y H + +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCH---RHMV 137
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMAV 690
VHRD+ N+LL++++ A +ADFGL+ ++ RT G+ Y APE+ Y
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-CGSPNYAAPEVISGRLYAGP- 195
Query: 691 TEKCDVYSFGVVALEVLM-GSHPTD 714
+ D++S GV+ L L+ G+ P D
Sbjct: 196 --EVDIWSSGVI-LYALLCGTLPFD 217
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 37/219 (16%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT---EARLLSQIR----HR 567
+G GG+G+V+ L+ VA+K + R+ + L T E LL ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGS-LF--CVLR---NDVEAVELDWTKRVNIVKSMAH 621
+++L + + L+ E LF + + + R +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-CFFGQVVA 150
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNRTLVVGTYGYI 680
A+ + H +VHRDI NIL++ A + DFG LL D GT Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF-DGTRVYS 205
Query: 681 APEL----AYTMAVTEKCDVYSFGVVALEVLM-GSHPTD 714
PE Y V+S G++ L ++ G P +
Sbjct: 206 PPEWISRHQYHAL---PATVWSLGIL-LYDMVCGDIPFE 240
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 17/184 (9%)
Query: 51 SHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI--GSLRDLLDLNLSNNILNGSIP 108
S L +P + + +LDLS+N L+ + +E L +L L LS+N LN I
Sbjct: 26 SKQQLP-NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FIS 80
Query: 109 LE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLK 166
E F + +L L L N L L +L L L L N + + + ++ L+
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139
Query: 167 SLFLDNNHLSGPIP----STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR--LHLNG 220
L+L N +S P L +L L L NKL ++ + + L+L+
Sbjct: 140 KLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
Query: 221 NNLT 224
N L
Sbjct: 199 NPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 45 LEKLVLSHNSLTGRIPSEI--GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNN 101
L LSHN+L+ R+ +E L+ L L LS+N L I SE + +L L+LS+N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 102 ILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV- 159
L+ ++ F +L+ L+ L L N + + ++ ++ L L LS NQ+S R P E+
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 160 ---GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCL 194
L L L L +N L + L L L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 44/144 (30%), Positives = 62/144 (43%), Gaps = 15/144 (10%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGA---LSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLN 97
L+ L L+LSHN L I S A + L+ LDLS N L T+ + L+ L L
Sbjct: 63 LTNLHSLLLSHNHLN-FISS--EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLL 118
Query: 98 LSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIP---SSIGNLTNLTYLDLSLNQLSG 153
L NN + + F ++ L +L L N++ L L LDLS N+L
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 154 RLPQEVGNLKNLK--SLFLDNNHL 175
++ L L+L NN L
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 15/187 (8%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI--GNLTNLIALDLSSN 269
+ L + L ++P ++ + L LSHN L + LTNL +L LS N
Sbjct: 19 ASNILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHN 74
Query: 270 QLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPE-L 327
L+ + + L L L+ N + + L L L L N + +
Sbjct: 75 HLNFISSEAFVPVPNLRYLDLSSN-HLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAF 132
Query: 328 MNCSQLLNLVLSHNSLSGSIPSEI----GNLIFFRQLDLSRNFINGTIPSQLGKIPNISA 383
+ +QL L LS N +S P E+ L LDLS N + + L K+P
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 384 VDLSKNN 390
L +N
Sbjct: 192 NGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGNILI 296
+ L S +L +P ++ + LDLS N LS L L L SL L+ N +
Sbjct: 21 NILSCSKQQLPN-VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN-HL 76
Query: 297 GPIPP-TIGYLTNLTYLNLGYNRLSSSIPPE-LMNCSQLLNLVLSHNSLSGSIPSEI-GN 353
I + NL YL+L N L + + + L L+L +N + + +
Sbjct: 77 NFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
Query: 354 LIFFRQLDLSRNFINGTIP----SQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSE 409
+ ++L LS+N I+ P K+P + +DLS N L + ++++P +
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW--VK 191
Query: 410 NNLELEN 416
N L L N
Sbjct: 192 NGLYLHN 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ F +GTG +G V + SG A+K L + + + +E E R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTK--RVNIVKSMAHALS 624
+VKL N ++++ EY+ G +F LR E + IV
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVL----TFE 155
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YLH +++RD+ N+L++ V DFG A+ + TL GT +APE+
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTL-CGTPEALAPEI 209
Query: 685 ----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y AV D ++ GV+ E+ G P
Sbjct: 210 ILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 42/251 (16%), Positives = 89/251 (35%), Gaps = 23/251 (9%)
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
+ ++ + P L N +L ++ + Q+ L +++ DN+++ +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ--SLA 57
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL--LDE 239
+ L L L +N++ + ++ L+ L +N N L + + L
Sbjct: 58 GMQFFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSR 110
Query: 240 LHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI 299
L L +N L + +L NL L + +N+L ++ +G L L L L+GN I
Sbjct: 111 LFLDNNELRDTDS--LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGN-EITNT 165
Query: 300 PPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQ 359
+ L + +++L + + + P I N +
Sbjct: 166 GG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVD 222
Query: 360 LDLSRNFINGT 370
+ T
Sbjct: 223 GCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 48/238 (20%), Positives = 93/238 (39%), Gaps = 17/238 (7%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
L+ K L S+T LS ++ + + + ++ + + +L +L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
+LS+N ++ PL+ +L L++L + N+L L + L+ L L N+L
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--T 121
Query: 157 QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRL 216
+ +LKNL+ L + NN L L L++L L L N++ T + +K ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT--NTGGLTRLKKVNWI 177
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL 274
L G L + + + R P I N + + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY--YISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 45/200 (22%), Positives = 82/200 (41%), Gaps = 17/200 (8%)
Query: 168 LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227
++ P L LG + V+++ + + + + +N+ S+
Sbjct: 2 SIQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL 56
Query: 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLAS 287
+ + + L ELHLSHN++ + P + +LT L L ++ N+L L L
Sbjct: 57 -AGMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSR--- 110
Query: 288 LSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSI 347
L L+ N L + +L NL L++ N+L SI L S+L L L N ++ +
Sbjct: 111 LFLDNNELRDTDS--LIHLKNLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHGNEIT-NT 165
Query: 348 PSEIGNLIFFRQLDLSRNFI 367
+ L +DL+
Sbjct: 166 -GGLTRLKKVNWIDLTGQKC 184
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 28/217 (12%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EA 558
+ + IG+G G V A + VA+KKL R F E
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR------PFQNQTHAKRAYREL 75
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
L+ + H+NI+ L K + +++ E M+ +L V++ +++ + +
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY--- 131
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
++ M + +LH I+HRD+ +NI++ S+ + DFGLAR T
Sbjct: 132 --LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TP 185
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
V T Y APE+ M E D++S G + E++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 41/231 (17%), Positives = 80/231 (34%), Gaps = 31/231 (13%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFL-DNN 173
L+L L + + NL N++ + +S++ +L NL + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 174 HLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPSTI- 231
+L+ P L L L L + L P +V + L + N SIP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 232 -GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSL 290
G N L L +N + N T L A+ L+ N+ L + +
Sbjct: 152 QGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNK----------YLTVIDKDAF 200
Query: 291 NGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
G + + L++ + +++P + + L L+ +
Sbjct: 201 G------------GVYSGPSLLDVSQTSV-TALPSKGL--EHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 45/231 (19%), Positives = 76/231 (32%), Gaps = 36/231 (15%)
Query: 45 LEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNIL 103
+ L L L IPS L + + +S + + S
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHS---------------- 75
Query: 104 NGSIPLEFGNLKDLDQLRLQGNK-LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQE--VG 160
F NL + + ++ + L + P ++ L L +L + L P V
Sbjct: 76 -------FYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 161 NLKNLKSLFL-DNNHLSGPIPSTLYHL-NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL 218
+ L + DN +++ + L N+ TL L N V N LD ++L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYL 186
Query: 219 NGNNLTGSIPSTI--GYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDL 266
N N I G + L +S + +P +L LIA +
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 42/219 (19%), Positives = 78/219 (35%), Gaps = 13/219 (5%)
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+ + + IPS TL L L + N+ N+ R++++ +
Sbjct: 12 QEEDFRVTCKDIQR-IPSLPPSTQ---TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 224 TGSIPSTI-GYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLP-REVG 280
+ S L+ + + + + R I P + L L L + + L +V
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 281 NLKYLASLSLNGNILIGPIPP-TIGYLTNLT-YLNLGYNRLSSSIPPELMNCSQLLNLVL 338
+ L + N + IP L N T L L N +S + N ++L + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYL 186
Query: 339 SHNSLSGSIPSEI--GNLIFFRQLDLSRNFINGTIPSQL 375
+ N I + G LD+S+ + +PS+
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 9e-14
Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 9/158 (5%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSE--IGSLRDLLDLNL 98
LSK+ + + + I + L LK L + L P + S L +
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 99 SNNILNGSIPLE-FGNL-KDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
++N SIP+ F L + L+L N + N T L + L+ N+ +
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 157 QEV--GNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192
++ G L + ++ L HL +L
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 34/139 (24%), Positives = 56/139 (40%), Gaps = 11/139 (7%)
Query: 42 LSKLEKLVLSHNSLTGRIPSE--IGALSRLKVLDLSYNRLTGTIPSEI--GSLRDLLDLN 97
L L+ L + + L P + + +L+++ N +IP G + L L
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSI--GNLTNLTYLDLSLNQLSGRL 155
L NN S+ N LD + L NK +I G + + LD+S ++ L
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 156 PQEVGNLKNLKSLFLDNNH 174
P + L++LK L N
Sbjct: 221 PSKG--LEHLKELIARNTW 237
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 57/265 (21%), Positives = 103/265 (38%), Gaps = 57/265 (21%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT------- 556
+ + IG+G G V A + VA+KKL R FQ
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP----------FQNQTHAKRA 108
Query: 557 --EARLLSQIRHRNIVKLY------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELD 608
E L+ + H+NI+ L + ++L+ E M+ +L V++ +++ +
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMS 167
Query: 609 WTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668
+ ++ M + +LH I+HRD+ +NI++ S+ + DFGLAR
Sbjct: 168 Y-----LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL--------------------- 707
T V T Y APE+ M E D++S G + E++
Sbjct: 220 M-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
Query: 708 MGSHPTDLLSSLSSSSGRKISQNPR 732
+G+ + + L + + P+
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPK 303
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-20
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-- 564
DF + IG GG+G VY + +GK+ A+K L + + E +LS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 565 -RHRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMAH 621
IV + + H + I + M G L L E + +
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIIL 303
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
L ++H +V+RD+ NILL+ + ++D GLA + VGT+GY+A
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-AS-VGTHGYMA 358
Query: 682 PEL-----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ AY + D +S G + ++L G P
Sbjct: 359 PEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G YG V A + + VA+K + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYG 72
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+L EY G LF + + + + + YLH I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGI 126
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPEL----AYTM 688
HRDI N+LL+ ++DFGLA + ++ R L + GT Y+APEL +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 689 AVTEKCDVYSFGVVALEVLM-GSHPTD 714
DV+S G+V L ++ G P D
Sbjct: 187 E---PVDVWSCGIV-LTAMLAGELPWD 209
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EA 558
E + +G+G YG+V A +G VA+KKL+R F E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR------PFQSELFAKRAYREL 75
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
RLL +RH N++ L ++ + +L+ +M L +++++ +L +
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRI 130
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
+V M L Y+H I+HRD+ N+ +N + E + DFGLAR + T
Sbjct: 131 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TG 184
Query: 673 VVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
V T Y APE+ YT V D++S G + E++ G
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTV----DIWSVGCIMAEMITG 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+G G +G V A + + VALK + R ++ + E L +RH +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
+ ++ EY G LF + VE + + + + A+ Y H + I
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCH---RHKI 129
Query: 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTMAV 690
VHRD+ N+LL+ NL +ADFGL+ ++ + +T G+ Y APE+ Y
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKLYAGP- 187
Query: 691 TEKCDVYSFGVVALEVLM-GSHPTD 714
+ DV+S G+V L V++ G P D
Sbjct: 188 --EVDVWSCGIV-LYVMLVGRLPFD 209
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EA 558
E + + +G+G YGSV A SG+ VA+KKL R F E
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR------PFQSEIFAKRAYREL 74
Query: 559 RLLSQIRHRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELDWTKR 612
LL ++H N++ L + +L+ +M+ L ++ K
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSEEKI 128
Query: 613 VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
+V M L Y+H +VHRD+ N+ +N + E + DFGLAR + T
Sbjct: 129 QYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TG 182
Query: 673 VVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
V T Y APE+ Y V D++S G + E+L G
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTG 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I +GTG +G V+ + +G+ A+K L + +E E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVE---------AVELDWTKRVNIVK 617
I++++G + +F+I +Y+E G LF +LR A E+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---------- 115
Query: 618 SMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTY 677
AL YLH I++RD+ NILL+ N + DFG A+ + TL GT
Sbjct: 116 --CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTL-CGTP 167
Query: 678 GYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
YIAPE+ Y ++ D +SFG++ E+L G P
Sbjct: 168 DYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 48/229 (20%), Positives = 87/229 (37%), Gaps = 51/229 (22%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRS-----------------------ETEEPAFL 551
IG G YG V A + A+K L + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 552 ESFQTEARLLSQIRHRNIVKLYG--FCLHNKCMFLIYEYMERGSLFCVLRND----VEAV 605
E E +L ++ H N+VKL + +++++E + +G + V +A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+ + + YLHY I+HRDI +N+L+ + +ADFG++
Sbjct: 141 --------FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 666 DSSNRTLVVGTYGYIAPEL------AYTMAVTEKCDVYSFGVVALEVLM 708
+ + VGT ++APE ++ DV++ GV L +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGK---ALDVWAMGVT-LYCFV 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 46/228 (20%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT------- 556
+ + IG G YG V A + VA+KK+ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-----------FEHQTYCQRT 72
Query: 557 --EARLLSQIRHRNIVKLYGFCL-----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDW 609
E ++L + RH NI+ + K ++++ + ME L ++ L
Sbjct: 73 LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQHLSN 127
Query: 610 TKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN 669
+ + L Y+H +++HRD+ +N+LLN+ + + DFGLAR+ PD +
Sbjct: 128 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 670 R---TLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
T V T Y APE+ YT ++ D++S G + E+L
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSN 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
DF +G G +G V + ++G+ A+K L + + TE+R+L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 567 RNIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHALS 624
+ L + + + EY G LF L + E +R + + AL
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALE 119
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAPE 683
YLH +V+RDI N++L+ + + DFGL + + ++ +T GT Y+APE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPE 175
Query: 684 L----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ Y AV D + GVV E++ G P
Sbjct: 176 VLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 90.6 bits (224), Expect = 5e-19
Identities = 54/286 (18%), Positives = 92/286 (32%), Gaps = 54/286 (18%)
Query: 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
DL +L++ + + + + + L ++ + L +LS+ +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKS 361
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL------------ 199
+ L E+ + K L+ L +N I + L+ L
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420
Query: 200 ---------VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP 250
+ + ++ LHL +LT + + L L+ L LSHNRL
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA- 477
Query: 251 IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLT 310
+PP + L L L S N L + + L L
Sbjct: 478 LPPALAALRCLEVLQASDNALENV--------------------------DGVANLPRLQ 511
Query: 311 YLNLGYNRLSS-SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLI 355
L L NRL + L++C +L+ L L NSL L
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLA 556
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 1e-15
Identities = 36/159 (22%), Positives = 57/159 (35%), Gaps = 7/159 (4%)
Query: 8 AELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALS 67
S L + + + L L+H LT + + L
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLL 463
Query: 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127
+ LDLS+NRL +P + +LR L L S+N L ++ NL L +L L N+L
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
Query: 128 DGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
+ + L L+L N L + L +
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 2e-15
Identities = 43/210 (20%), Positives = 66/210 (31%), Gaps = 28/210 (13%)
Query: 60 PSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119
+ +L +LS + T + SE+ S ++L +L N +I L L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 120 LRLQGNKLDGL---------------------IPSSIGNLTNLTYLDLSLNQLSGRLPQE 158
+ L ++ L L+ L+ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-H 458
Query: 159 VGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL 218
+ L + L L +N L +P L L L L N L V N+ L L L
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLL 515
Query: 219 NGNNLTG-SIPSTIGYLNLLDELHLSHNRL 247
N L + + L L+L N L
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 8e-15
Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 20/171 (11%)
Query: 36 PSEIGALSKLEKL--------VLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI 87
+ S L+ + + + ++VL L++ L T+ +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHL 459
Query: 88 GSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147
L + L+LS+N L ++P L+ L+ L+ N L+ + + NL L L L
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLC 516
Query: 148 LNQLSG-RLPQEVGNLKNLKSLFLDNNHLSGP------IPSTLYHLNQLAT 191
N+L Q + + L L L N L + L ++ + T
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 37/231 (16%), Positives = 74/231 (32%), Gaps = 10/231 (4%)
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
+L + L++ + L ++ ++ + L R L+
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC-RDSATDEQLFRCELSVEKS 361
Query: 224 TGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
T + S + L EL + I + L L+ + S L + +
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL---KAVDPM 417
Query: 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSL 343
A L + + ++ L+L + L+ L + +L LSHN L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRL 475
Query: 344 SGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394
++P + L L S N + + + +P + + L N L
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQS 523
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT------- 556
+ + +G GG G V+ A K VA+KK+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHA 55
Query: 557 --EARLLSQIRHRNIVKLY----------GFCLHNKCMF----LIYEYMERGSLFCVLRN 600
E +++ ++ H NIVK++ + + ++ EYME L N
Sbjct: 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLAN 110
Query: 601 DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGL 659
+E L + + L Y+H +++HRD+ N+ +N+ +L + DFGL
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 660 ARLLHPDSSNR---TLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
AR++ P S++ + + T Y +P L YT A+ D+++ G + E+L G
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTG 221
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSE-TEEPAFLESFQTEARLLSQIRHRNIVKLY 573
+G G YG V + A+K L + + P + + E +LL ++RH+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 574 GFCLH--NKCMFLIYEYMERGS--LFCVLRNDVEAVELDWTKRVNIVKS------MAHAL 623
+ + M+++ EY G + + KR + ++ + L
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE----------KRFPVCQAHGYFCQLIDGL 122
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIA 681
YLH IVH+DI N+LL + ++ G+A LHP +++ T G+ +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 682 PELA-----YTMAVTEKCDVYSFGVVALEVLM-GSHPTD 714
PE+A ++ K D++S GV L + G +P +
Sbjct: 180 PEIANGLDTFSGF---KVDIWSAGVT-LYNITTGLYPFE 214
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 43/233 (18%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 492 WNYD-GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPA 549
W+Y+ + + +D+ + +G G Y V+ A +++ + V +K L + ++
Sbjct: 23 WDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-- 76
Query: 550 FLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF---LIYEYMERGSLFCVLRNDVEAV 605
+ E ++L +R NI+ L + + L++E++ + + +
Sbjct: 77 ----IKREIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNN----TDFKQLYQTL 127
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLH 664
+ + + AL Y H I+HRD+ +N++++ + + + D+GLA H
Sbjct: 128 TDYDIRF--YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 665 PDSSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
P + V + + PEL Y ++ D++S G + ++ P
Sbjct: 183 PGQE-YNVRVASRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 49/239 (20%)
Query: 497 RITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQ 555
RI + + DF +K +G G YG V A +G++VA+KK+ F +
Sbjct: 4 RIVYNI----SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-------PFDKPLF 52
Query: 556 T-----EARLLSQIRHRNIVKLY-----GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV 605
E ++L +H NI+ ++ + +++I E M+ L V+
Sbjct: 53 ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ---- 107
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
L + A+ LH +++HRD+ +N+L+NSN + V DFGLAR++
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 666 DSSNRTLVVGTYG----------YIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
+++ + G Y APE+ Y+ A+ DV+S G + E+ +
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLR 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT------- 556
E E + +G+G YGSV A +G VA+KKL R FQ+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP----------FQSIIHAKRT 75
Query: 557 --EARLLSQIRHRNIVKLY------GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELD 608
E RLL ++H N++ L ++L+ M L N V+ +L
Sbjct: 76 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLT 130
Query: 609 WTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668
++ + L Y+H I+HRD+ +N+ +N + E + DFGLAR +
Sbjct: 131 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTAD 184
Query: 669 NRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
T V T Y APE+ Y V D++S G + E+L G
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTG 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG+G +G + + +LVA+K + R + E+ Q E +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83
Query: 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634
L + +I EY G L+ + A + + + +SY H I
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 635 VHRDISSNNILLNSNLEAF--VADFGLARLLHPDSSNRTLVVGTYGYIAPEL----AYTM 688
HRD+ N LL+ + + DFG ++ S ++ VGT YIAPE+ Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRQEYDG 196
Query: 689 AVTEKCDVYSFGVVALEVLM-GSHPTD 714
DV+S GV L V++ G++P +
Sbjct: 197 K---IADVWSCGVT-LYVMLVGAYPFE 219
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 53/201 (26%)
Query: 516 IGTGGYGSVYRA-QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77
Query: 574 GFC----LHNKCMFLIYEYMERGSLFCVLRND--VEAVELDWTKR--VNIVKSMAHALSY 625
KC+ ++ E ++ G LF + + +T+R I+KS+ A+ Y
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELF-----SRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAF---VADFGLAR-LLHPDSSNRTLVVGTYGYIA 681
LH +I HRD+ N+L S + DFG A+ Y
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----------EKYD--- 176
Query: 682 PELAYTMAVTEKCDVYSFGVV 702
+ CD++S GV+
Sbjct: 177 ----------KSCDMWSLGVI 187
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 508 EDFHIKYCIGTGGYGSVY----RAQLSSGKLVALKKLH------RSETEEPAFLESFQTE 557
F + +G G +G V+ + + +L A+K L R + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-------KME 76
Query: 558 ARLLSQIRHRNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI- 615
+L ++ H IVKL Y F K ++LI +++ G LF L +V E + V
Sbjct: 77 RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----EDVKFY 131
Query: 616 VKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVV 674
+ +A AL +LH I++RD+ NILL+ + DFGL++ + + +
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-C 187
Query: 675 GTYGYIAPEL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
GT Y+APE+ +T + D +SFGV+ E+L G+ P
Sbjct: 188 GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSE-TEEPAFLESFQTEARLLS 562
E F + +G GGYG V++ + ++GK+ A+K L ++ + E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 563 QIRHRNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMA 620
+++H IV L Y F K ++LI EY+ G LF L + +E + ++
Sbjct: 77 EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLAEIS 131
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGY 679
AL +LH + I++RD+ NI+LN + DFGL + +H + T GT Y
Sbjct: 132 MALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CGTIEY 187
Query: 680 IAPEL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+APE+ + AV D +S G + ++L G+ P
Sbjct: 188 MAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 75/257 (29%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EA 558
+++ IK+ IG G YG VY A ++ K VA+KK++R F + E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR------MFEDLIDCKRILREI 76
Query: 559 RLLSQIRHRNIVKLYG-FCLHNKCMF----LIYEYMERGSLFCVLRNDVEAVELDWTKRV 613
+L++++ I++LY + F ++ E + D++ + +
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---------DLKKL-----FKT 122
Query: 614 NIVKSMAH----------ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
I + H +++H + I+HRD+ N LLN + V DFGLAR +
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 664 HPDSSNRTLV----------------------VGTYGYIAPEL-----AYTMAVTEKCDV 696
+ + + V T Y APEL YT ++ D+
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DI 235
Query: 697 YSFGVVALEVLMGSHPT 713
+S G + E+L
Sbjct: 236 WSTGCIFAELLNMLQSH 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 51/239 (21%), Positives = 85/239 (35%), Gaps = 60/239 (25%)
Query: 516 IGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
+GTG +G V SGK ALKK+ ++P + E ++ + H NI+KL
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYK---NRELDIMKVLDHVNIIKLVD 67
Query: 575 F---CLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR----VNIVK---------- 617
+ + + + +N++
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 618 -----------SMAH----------ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-VA 655
M A+ ++H I HRDI N+L+NS +
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 656 DFGLARLLHPDSSNRTLVVGTYGYIAPEL-----AYTMAVTEKCDVYSFGVVALEVLMG 709
DFG A+ L P + + + Y APEL YT ++ D++S G V E+++G
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGCVFGELILG 238
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 51/154 (33%), Positives = 70/154 (45%), Gaps = 4/154 (2%)
Query: 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILN 104
EKL L L + L++L L+L YN+L T+ + + L +L L L+NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 105 GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLK 163
F +L LD+L L GN+L L LT L L L+ NQL +P L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197
NL++L L N L L +L T+ L N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 56/185 (30%), Positives = 75/185 (40%), Gaps = 15/185 (8%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
K +D L ++PS I + + LDL + L F L L L L N+L
Sbjct: 17 KEVDCQGKSLD-SVPSGIPADTEKLDLQ--STGLATLSDATFRGLTKLTWLNLDYNQLQT 73
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
L +LT L L L+ NQL+ LP V +L L L+L N L L +
Sbjct: 74 LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK 132
Query: 189 LATLCLGYNKL----VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLS 243
L L L N+L G K + NL L L+ N L S+P L L + L
Sbjct: 133 LKELRLNTNQLQSIPAGAFDK----LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLF 187
Query: 244 HNRLD 248
N+ D
Sbjct: 188 GNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 64/182 (35%), Positives = 86/182 (47%), Gaps = 32/182 (17%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
D ++L LQ L L ++ LT LT+L+L NQL L V +L L +L L NN
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN- 93
Query: 175 LSGPIPSTLYHLNQLATLCLG-YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-G 232
QLA+L LG ++ L LD+L+L GN L S+PS +
Sbjct: 94 -------------QLASLPLGVFDHLT-----------QLDKLYLGGNQLK-SLPSGVFD 128
Query: 233 YLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291
L L EL L+ N+L IP LTNL L LS+NQL + L L +++L
Sbjct: 129 RLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 292 GN 293
GN
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 45/153 (29%), Positives = 62/153 (40%), Gaps = 6/153 (3%)
Query: 192 LCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGP 250
L L L + L L+L+ N L ++ + + L L L L++N+L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS- 97
Query: 251 IPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTN 308
+P + +LT L L L NQL L L L L LN N L IP LTN
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTN 156
Query: 309 LTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L L+L N+L S +L + L N
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 34/123 (27%), Positives = 53/123 (43%), Gaps = 21/123 (17%)
Query: 287 SLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNC-SQLLNLVLSHNSLSG 345
L L L T LT LT+LNL YN+L ++ + + ++L L L++N L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 346 SIPSEI-GNLIFFRQLDLSRNFINGTIPSQLGKIP--------NISAVDLSKNNLSGVIP 396
S+P + +L +L L N QL +P + + L+ N L IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGN--------QLKSLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
Query: 397 ASV 399
A
Sbjct: 148 AGA 150
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSE-TEEPAFLESFQTEARLLS 562
E+F + +GTG YG V+ + +GKL A+K L ++ ++ E +TE ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 563 QIRHRN-IVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-M 619
IR +V L Y F K + LI +Y+ G LF L E V I +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYG 678
AL +LH K I++RDI NILL+SN + DFGL++ D + R GT
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 679 YIAPEL------AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+AP++ + AV D +S GV+ E+L G+ P
Sbjct: 226 YMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 4/153 (2%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
+D S +L IP I L LN +N F L L ++ NK+
Sbjct: 14 TTVDCSNQKLN-KIPEHIPQYTAELRLN-NNEFTVLEATGIFKKLPQLRKINFSNNKITD 71
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ + + + + L+ N+L + ++ L++LK+L L +N ++ + L+
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS 130
Query: 189 LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
+ L L N++ + +L L+L N
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 31/130 (23%), Positives = 55/130 (42%), Gaps = 5/130 (3%)
Query: 191 TLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
L L N+ T + L +++ + N +T + ++E+ L+ NRL+
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 250 PIPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLT 307
+ + L +L L L SN+++ + L + LSL N I + P L
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN-QITTVAPGAFDTLH 153
Query: 308 NLTYLNLGYN 317
+L+ LNL N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 30/115 (26%), Positives = 52/115 (45%), Gaps = 10/115 (8%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGA---LSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLN 97
L +L K+ S+N +T I GA S + + L+ NRL + ++ L L L
Sbjct: 56 LPQLRKINFSNNKIT-DIEE--GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLM 111
Query: 98 LSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
L +N + + + F L + L L N++ + P + L +L+ L+L N
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 26/134 (19%), Positives = 49/134 (36%), Gaps = 17/134 (12%)
Query: 251 IPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGNILIGPIPPTI-GYLTN 308
IP I L L++N+ + L + L L ++ + N I I +
Sbjct: 26 IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-KITDIEEGAFEGASG 82
Query: 309 LTYLNLGYNRLSSSIPPELM-NCSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNF 366
+ + L NRL ++ ++ L L+L N ++ + ++ L R L L N
Sbjct: 83 VNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN- 139
Query: 367 INGTIPSQLGKIPN 380
Q+ +
Sbjct: 140 -------QITTVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 22/90 (24%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
S + +++L+ N L + ++ L LK L L NR+T + ++ L + L+L
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 100 NNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
+N + ++ F L L L L N +
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 69/261 (26%), Positives = 98/261 (37%), Gaps = 62/261 (23%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
P + A + K L S+T ++ L+ + + + + + ++ I L ++
Sbjct: 14 PDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIK-SVQG-IQYLPNVRY 67
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
L L N L+ I L +L L L GN+L L LTNL L L NQL L
Sbjct: 68 LALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SL 124
Query: 156 PQEVGN-LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLG-YNKLVGPVTKEVGNMKNL 213
P V + L NL L L + NQL +L G ++KL NL
Sbjct: 125 PDGVFDKLTNLTYLNLAH--------------NQLQSLPKGVFDKLT-----------NL 159
Query: 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSG 273
L L+ N L S+P + D LT L L L NQL
Sbjct: 160 TELDLSYNQLQ-SLPEGV-----FD------------------KLTQLKDLRLYQNQLKS 195
Query: 274 LLPREV-GNLKYLASLSLNGN 293
+P V L L + L+ N
Sbjct: 196 -VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS--GPIPSTLYHLNQ 188
P +L ++ + L ++ + +N+ + I +L
Sbjct: 13 FPDDA--FAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ----YLPN 64
Query: 189 LATLCLGYNKLVGPVTKEVG---NMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSH 244
+ L LG NKL ++ + NL L L GN L S+P+ + L L EL L
Sbjct: 65 VRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVE 118
Query: 245 NRLDGPIPPTIGN-LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303
N+L +P + + LTNL L+L+ NQL L L L L L+ N L +P +
Sbjct: 119 NQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPEGV 176
Query: 304 -GYLTNLTYLNLGYNRLSSSIP 324
LT L L L N+L S+P
Sbjct: 177 FDKLTQLKDLRLYQNQL-KSVP 197
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 45/233 (19%), Positives = 86/233 (36%), Gaps = 49/233 (21%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQT-----EA 558
+ + + I++ IGTG YG V A ++VA+KK+ R F + E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR------VFEDLIDCKRILREI 103
Query: 559 RLLSQIRHRNIVKLY-----GFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV 613
+L+++ H ++VK+ ++++ E + D + + R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS---------DFKKL-----FRT 149
Query: 614 NIVKSMAH----------ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663
+ + H + Y+H I+HRD+ N L+N + V DFGLAR +
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVV-----ALEVLMGSH 711
+ + + + L + VV A E+++
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 61/251 (24%)
Query: 496 GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESF 554
GR+ + + +G G YG V+++ +G++VA+KK+ AF S
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD------AFQNST 50
Query: 555 QT-----EARLLSQIR-HRNIVKLYGFCL--HNKCMFLIYEYMERGSLFCVLRNDVEAVE 606
E +L+++ H NIV L +++ ++L+++YME L V+R ++
Sbjct: 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI---- 105
Query: 607 LDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFVADFGLARLLH 664
L+ + +V + + YLH S ++HRD+ +NILLN+ VADFGL+R
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 665 PDSSNRTLV---------------------VGTYGYIAPEL-----AYTMAVTEKCDVYS 698
+ V T Y APE+ YT + D++S
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWS 216
Query: 699 FGVVALEVLMG 709
G + E+L G
Sbjct: 217 LGCILGEILCG 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-R 565
+DF + IG G Y V +L + ++ A+K + + + ++ QTE + Q
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 566 HRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMAHAL 623
H +V L+ C + +F + EY+ G L ++ + E + ++ AL
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLAL 123
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+YLH + I++RD+ +N+LL+S + D+G+ + L P + T GT YIAP
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAP 179
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y +V D ++ GV+ E++ G P
Sbjct: 180 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-R 565
DF+ +G G +G V ++ + +L A+K L + + +E E R+L+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 566 HRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHAL 623
+ +L+ C ++ + EY+ G L ++ E + +A L
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGL 455
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+L I++RD+ +N++L+S +ADFG+ + + + +T GT YIAP
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDYIAP 511
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y +V D ++FGV+ E+L G P
Sbjct: 512 EIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)
Query: 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILN 104
++ L N++ P +L+ +DLS N+++ + + LR L L L N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 105 GSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNL 162
+P F L L L L NK++ L + +L NL L L N+L + + L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 163 KNLKSLFLDNN 173
+ ++++ L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 36/135 (26%), Positives = 59/135 (43%), Gaps = 4/135 (2%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
+ ++RL+ N + + P + L +DLS NQ+S L + L++L SL L N
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 175 LSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGY 233
++ S L L L L NK+ + + ++ NL+ L L N L T
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 234 LNLLDELHLSHNRLD 248
L + +HL+ N
Sbjct: 151 LRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 32/166 (19%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
IP+++ +T + L N + +P K L+ + L NN +S P L
Sbjct: 26 IPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL--- 79
Query: 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLD 248
++L+ L L GN +T +P ++ L L L L+ N+++
Sbjct: 80 ---------------------RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 249 GPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
+ +L NL L L N+L + L+ + ++ L N
Sbjct: 118 C-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 30/157 (19%)
Query: 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG---NMKNLDRLHLNG 220
+ + L+ N + P +L + L N++ +++L+ L L G
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS---ELAPDAFQGLRSLNSLVLYG 89
Query: 221 NNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG 280
N +T +P ++ +G L +L L L++N+++ L
Sbjct: 90 NKIT-ELPKSL---------------FEG--------LFSLQLLLLNANKINCLRVDAFQ 125
Query: 281 NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYN 317
+L L LSL N L T L + ++L N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 31/133 (23%), Positives = 51/133 (38%), Gaps = 6/133 (4%)
Query: 212 NLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSN 269
+ + L N + IP L + LS+N++ + P L +L +L L N
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 270 QLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPELM 328
+++ L L L L LN N I + L NL L+L N+L +
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNAN-KINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 329 NCSQLLNLVLSHN 341
+ + L+ N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L L LVL N +T +P + L L++L L+ N++ + + L +L L+L
Sbjct: 79 LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLY 136
Query: 100 NNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
+N L +I F L+ + + L N
Sbjct: 137 DNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 27/122 (22%), Positives = 50/122 (40%), Gaps = 8/122 (6%)
Query: 288 LSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPEL-MNCSQLLNLVLSHNSLSG 345
+ L N I IPP L ++L N++ S + P+ L +LVL N ++
Sbjct: 37 IRLEQN-TIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 346 SIPSEI-GNLIFFRQLDLSRNFINGTIPSQL-GKIPNISAVDLSKNNLSGVIPASVRRIP 403
+P + L + L L+ N IN + + N++ + L N L + + +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 404 KL 405
+
Sbjct: 153 AI 154
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-R 565
+DF + IG G Y V +L + ++ A++ + + + ++ QTE + Q
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 566 HRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHAL 623
H +V L+ C + +F + EY+ G L ++ + E + + ++ AL
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLAL 166
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+YLH + I++RD+ +N+LL+S + D+G+ + L P + T GT YIAP
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIAP 222
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y +V D ++ GV+ E++ G P
Sbjct: 223 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ-IR 565
DFH IG G +G V A+ + A+K L + + + +E +L + ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 566 HRNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNI-VKSMAHAL 623
H +V L + F +K ++ + +Y+ G LF L+ + +E R +A AL
Sbjct: 98 HPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASAL 152
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
YLH +IV+RD+ NILL+S + DFGL + + +S+ T GT Y+AP
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-CGTPEYLAP 208
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y V D + G V E+L G P
Sbjct: 209 EVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 73/375 (19%), Positives = 131/375 (34%), Gaps = 70/375 (18%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGAL-----SRLKVLDLSYNRLTGT----IPSEIGSLRDL 93
L +L L N L + +++ L L LTG + S + +L L
Sbjct: 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 115
Query: 94 LDLNLSNNILNGS-IPLEFGNLKD----LDQLRLQGNKLD----GLIPSSIGNLTNLTYL 144
+L+LS+N+L + + L L D L++L+L+ L + S + + L
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL 175
Query: 145 DLSLNQLSGRLPQEVG-----NLKNLKSLFLDNNHLS----GPIPSTLYHLNQLATLCLG 195
+S N ++ + + + L++L L++ ++ + + L L LG
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235
Query: 196 YNKLVGPVTKEVGNM-----KNLDRLHLNGNNLT----GSIPSTIGYLNLLDELHLSHNR 246
NKL E+ L L + +T G + + L EL L+ N
Sbjct: 236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295
Query: 247 LDGPIPPTIGNL-----TNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
L + L +L + S + + +S+
Sbjct: 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFT-----AAC-CSHFSSV------------- 336
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPEL-----MNCSQLLNLVLSHNSLS----GSIPSEIG 352
+ L L + NRL + EL S L L L+ +S S+ + +
Sbjct: 337 -LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 353 NLIFFRQLDLSRNFI 367
R+LDLS N +
Sbjct: 396 ANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 79/408 (19%), Positives = 133/408 (32%), Gaps = 85/408 (20%)
Query: 69 LKVLDLSYNRLTGT-----------------------------IPSEIGSLRDLLDLNLS 99
++ LD+ L+ I S + L +LNL
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 100 NNILNGS------IPLEFGNLKDLDQLRLQGNKLD----GLIPSSIGNLTNLTYLDLSLN 149
+N L L+ + K + +L LQ L G++ S++ L L L LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCK-IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 150 QLSGRLPQEVG-----NLKNLKSLFLDNNHLS----GPIPSTLYHLNQLATLCLGYNKLV 200
L Q + L+ L L+ LS P+ S L L + N +
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 201 GPVTKEVG-----NMKNLDRLHLNGNNLT----GSIPSTIGYLNLLDELHLSHNRLDGP- 250
+ + + L+ L L +T + + L EL L N+L
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243
Query: 251 ----IPPTIGNLTNLIALDLSSNQLS----GLLPREVGNLKYLASLSLNGNILIGPIPPT 302
P + + L L + ++ G L R + + L LSL GN L
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303
Query: 303 IG-----YLTNLTYLNLGYNRLSS----SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGN 353
+ L L + ++ L LL L +S+N L + E+
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363
Query: 354 LIFF-----RQLDLSRNFIN----GTIPSQLGKIPNISAVDLSKNNLS 392
+ R L L+ ++ ++ + L ++ +DLS N L
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 70/348 (20%), Positives = 121/348 (34%), Gaps = 66/348 (18%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGAL-----SRLKVLDLSYNRLTGTIPSEIGSL----RDL 93
L++L LS N L + RL+ L L Y L+ + S+ D
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDF 172
Query: 94 LDLNLSNNILNGS-IPLEFGNLKD----LDQLRLQGNKL--DGL--IPSSIGNLTNLTYL 144
+L +SNN +N + + + LKD L+ L+L+ + D + + + +L L
Sbjct: 173 KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 145 DLSLNQLSGRLPQEVGN-----LKNLKSLFLDNNHLSGP----IPSTLYHLNQLATLCLG 195
L N+L E+ L++L++ ++ + L L L L
Sbjct: 233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292
Query: 196 YNKLVGPVTKEVGNM-----KNLDRLHLNGNNLTG----SIPSTIGYLNLLDELHLSHNR 246
N+L + + L+ L + + T S + L EL +S+NR
Sbjct: 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352
Query: 247 LDGPIPPTIG-----NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301
L+ + + L L L+ +S + LA+ +L N
Sbjct: 353 LEDAGVRELCQGLGQPGSVLRVLWLADCDVS-----DSS-CSSLAA-TLLAN-------- 397
Query: 302 TIGYLTNLTYLNLGYNRLSSSIPPEL-----MNCSQLLNLVLSHNSLS 344
+L L+L N L + +L L LVL S
Sbjct: 398 -----HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 60/295 (20%), Positives = 99/295 (33%), Gaps = 41/295 (13%)
Query: 139 TNLTYLDLSLNQLS-GRLPQEVGNLKNLKSLFLDNNHLS----GPIPSTLYHLNQLATLC 193
++ LD+ +LS R + + L+ + + LD+ L+ I S L LA L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 194 LGYNKLVGPVTKEVGNM-----KNLDRLHLNGNNLT----GSIPSTIGYLNLLDELHLSH 244
L N+L V + +L L LT G + ST+ L L ELHLS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 245 NRLDGPIPPTIG-----NLTNLIALDLSSNQLS----GLLPREVGNLKYLASLSLNGNIL 295
N L + L L L LS L + L+++ N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 296 IGP----IPPTIGYLT-NLTYLNLGYNRLS----SSIPPELMNCSQLLNLVLSHNSLSGS 346
+ + L L L ++ + + + + L L L N L
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 347 IPSEIGNLI-----FFRQLDLSRNFIN----GTIPSQLGKIPNISAVDLSKNNLS 392
+E+ + R L + I G + L ++ + L+ N L
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ-IR 565
EDF + +G G +G V+ A+ + + A+K L + +E E R+LS
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 566 HRNIVKL-YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHAL 623
H + + F +F + EY+ G L +++ + R + + L
Sbjct: 77 HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEIILGL 131
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+LH IV+RD+ +NILL+ + +ADFG+ + + D+ T GT YIAP
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAP 187
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y +V D +SFGV+ E+L+G P
Sbjct: 188 EILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-R 565
++F +G G +G V A++ +G L A+K L + + +E TE R+LS
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 566 HRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHAL 623
H + +L+ C +F + E++ G L ++ E R + + AL
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISAL 137
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+LH I++RD+ +N+LL+ +ADFG+ + + + T GT YIAP
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-CGTPDYIAP 193
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y AV D ++ GV+ E+L G P
Sbjct: 194 EILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 5/118 (4%)
Query: 59 IPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDL 117
+P+ I + ++L L N++T P SL +L +L L +N L ++P+ F +L L
Sbjct: 34 VPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175
L L N+L L + L +L L + N+L+ LP+ + L +L L LD N L
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 45/141 (31%), Positives = 63/141 (44%), Gaps = 7/141 (4%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDL 93
+P+ I + + L L N +T P +L LK L L N+L +P + SL L
Sbjct: 34 VPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 94 LDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152
L+L N L +P F L L +L + NKL +P I LT+LT+L L NQL
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
Query: 153 GRLPQEVGNLKNLKSLFLDNN 173
L +L +L N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 50/165 (30%), Positives = 67/165 (40%), Gaps = 31/165 (18%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+P+ I TN L L NQ++ P +L NLK L+L + NQL
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGS--------------NQLG 77
Query: 191 TLCLG-YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLD 248
L +G ++ L L L L N LT +PS + L L EL + N+L
Sbjct: 78 ALPVGVFDSLT-----------QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT 125
Query: 249 GPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
+P I LT+L L L NQL + L L L GN
Sbjct: 126 E-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 39/109 (35%), Positives = 55/109 (50%), Gaps = 3/109 (2%)
Query: 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLS 272
L+L+ N +T P L L EL+L N+L +P + +LT L LDL +NQL+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
Query: 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321
L L +L L + N L +P I LT+LT+L L N+L S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKS 149
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-R 565
DF+ +G G +G V ++ + +L A+K L + + +E E R+L+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 566 HRNIVKLYGFCLHNKC-MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS-MAHAL 623
+ +L+ C ++ + EY+ G L ++ E + +A L
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGL 134
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL-LHPDSSNRTLVVGTYGYIAP 682
+L I++RD+ +N++L+S +ADFG+ + + + +T GT YIAP
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-CGTPDYIAP 190
Query: 683 EL----AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ Y +V D ++FGV+ E+L G P
Sbjct: 191 EIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 45/223 (20%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--------- 565
+G G + +V+ A+ + + VA+K + R + + E+ + E +LL ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIV-RGD---KVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 566 --HRNIVKLYG-FCLHNKC---MFLIYEYMERGSLFCVL-RNDVEAVELDWTKRVNIVKS 618
+I+KL F + +++E + +L ++ + + + L + K+ I K
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF------VADFGLARLLHPDSSNRTL 672
+ L Y+H C I+H DI N+L+ +AD G A +N
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 194
Query: 673 VVGTYGYIAPE----LAYTMAVTEKCDVYSFGVVALEVLMGSH 711
+ T Y +PE + D++S + E++ G
Sbjct: 195 SIQTREYRSPEVLLGAPWGCG----ADIWSTACLIFELITGDF 233
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 59/343 (17%), Positives = 101/343 (29%), Gaps = 75/343 (21%)
Query: 45 LEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTGT----IPSEIGSLRDLLDL 96
+E L +++T + + + +K + LS N + + I S +DL
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
S+ L+ L+ ++ L + LS N
Sbjct: 66 EFSDIFTGRVKDEIPEALR--------------LLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 157 QEVGNL----KNLKSLFLDNNHLS-------------GPIPSTLYHLNQLATLCLGYNKL 199
+ + + L+ L+L NN L + + L ++ G N+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 200 VGPVTKEVGNM----KNLDRLHLNGNNLT-----GSIPSTIGYLNLLDELHLSHNRL--D 248
KE + L + + N + + + Y L L L N
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 249 G--PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
G + + + NL L L+ LS G + + S N
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKLEN------------- 273
Query: 307 TNLTYLNLGYNRLSSSIPPEL-----MNCSQLLNLVLSHNSLS 344
L L L YN + L LL L L+ N S
Sbjct: 274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 47/327 (14%), Positives = 91/327 (27%), Gaps = 65/327 (19%)
Query: 91 RDLLDLNLSNNILNG----SIPLEFGNLKDLDQLRLQGNKL--DG--LIPSSIGNLTNLT 142
+ +L + + S+ + ++ L GN + + + +I + +L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKL--- 199
+ S + L+ L L L T+ L N
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH--------------TVRLSDNAFGPT 109
Query: 200 -VGPVTKEVGNMKNLDRLHLNGNNLT-------------GSIPSTIGYLNLLDELHLSHN 245
P+ + L+ L+L+ N L ++ L + N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 246 RLDGP----IPPTIGNLTNLIALDLSSNQL-----SGLLPREVGNLKYLASLSLNGNILI 296
RL+ T + L + + N + LL + + L L L N
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN-TF 228
Query: 297 GP-----IPPTIGYLTNLTYLNLGYNRLSS----SIPPELMNCS--QLLNLVLSHNSLSG 345
+ + NL L L LS+ ++ L L L +N +
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 346 SIPSEIG-----NLIFFRQLDLSRNFI 367
+ + L+L+ N
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 50/284 (17%), Positives = 79/284 (27%), Gaps = 63/284 (22%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGA-----------LSRLKVLDLSYNRLTGTIPSEIGSL- 90
LE S TGR+ EI +L + LS N T +
Sbjct: 60 KDLEIAEFSDIF-TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 91 ---RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147
L L L NN L ++ + + N L +
Sbjct: 119 SKHTPLEHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 148 LNQLSGR----LPQEVGNLKNLKSLFLDNNHL-----SGPIPSTLYHLNQLATLCLGYNK 198
N+L + + + L ++ + N + + L + +L L L N
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 199 L----VGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPT 254
+ + + NL L LN L+ G ++D N
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKLEN--------- 273
Query: 255 IGNLTNLIALDLSSNQLS-----GLLPREVGNLKYLASLSLNGN 293
L L L N++ L + L L LNGN
Sbjct: 274 ----IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 41/215 (19%), Positives = 69/215 (32%), Gaps = 53/215 (24%)
Query: 43 SKLEKLVLSHNSLT-------------GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS 89
+ LE L L +N L + + L+ + NRL E
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 90 LRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL-----DGLIPSSIGNLTNLTYL 144
F + + L +++ N + + L+ + L L
Sbjct: 182 T--------------------FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL 221
Query: 145 DLSLNQLSGR----LPQEVGNLKNLKSLFLDNNHLSGP----IPSTLYHLN--QLATLCL 194
DL N + L + + NL+ L L++ LS + L L TL L
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281
Query: 195 GYNKLVGPVTKEVG-----NMKNLDRLHLNGNNLT 224
YN++ + + M +L L LNGN +
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/154 (19%), Positives = 57/154 (37%), Gaps = 24/154 (15%)
Query: 43 SKLEKLVLSHNSLTGR-----IPSEIGALSRLKVLDLSYNRLTGT----IPSEIGSLRDL 93
L + + N + + + LKVLDL N T + + S +L
Sbjct: 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 246
Query: 94 LDLNLSNNIL--NGSIP----LEFGNLKDLDQLRLQGNKLD-----GLIPSSIGNLTNLT 142
+L L++ +L G+ L LRLQ N+++ L + +L
Sbjct: 247 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 306
Query: 143 YLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176
+L+L+ N+ S +E + ++ +F
Sbjct: 307 FLELNGNRFS----EEDDVVDEIREVFSTRGRGE 336
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 28/171 (16%), Positives = 54/171 (31%), Gaps = 24/171 (14%)
Query: 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLT----- 80
L + + L ++ N L + L + + N +
Sbjct: 146 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE 205
Query: 81 GTIPSEIGSLRDLLDLNLSNNIL--NGSIPL--EFGNLKDLDQLRLQGNKLDG----LIP 132
+ + ++L L+L +N GS L + +L +L L L +
Sbjct: 206 HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV 265
Query: 133 SSIGNLTN--LTYLDLSLNQLSGRLPQEVG-----NLKNLKSLFLDNNHLS 176
+ L N L L L N++ + + + +L L L+ N S
Sbjct: 266 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 8/142 (5%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDL 93
+P+ I A + L L NSL L+ L L L N+L ++P+ + L L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 94 LDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152
LNLS N L S+P F L L +L L N+L L LT L L L NQL
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 153 GRLPQEV-GNLKNLKSLFLDNN 173
+P V L +L+ ++L +N
Sbjct: 138 -SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 7/151 (4%)
Query: 73 DLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP 132
+ T ++P+ I + LDL N L F L L QL L GNKL L
Sbjct: 13 ECYSQGRT-SVPTGIPAQTTYLDLE--TNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69
Query: 133 SSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLY-HLNQLA 190
LT+LTYL+LS NQL LP V L LK L L+ N L +P ++ L QL
Sbjct: 70 GVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLK 127
Query: 191 TLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L L N+L + +L + L+ N
Sbjct: 128 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 5/113 (4%)
Query: 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN-LTNLIALDLSSNQLS 272
L L N+L L L +L+L N+L +P + N LT+L L+LS+NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIP 324
L L L L+LN N L +P + LT L L L N+L S+P
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL-KSVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 39/125 (31%), Positives = 54/125 (43%), Gaps = 7/125 (5%)
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285
S+P+ I L L N L LT+L L L N+L L L L
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 286 ASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMN-CSQLLNLVLSHNSL 343
L+L+ N L +P + LT L L L N+L S+P + + +QL +L L N L
Sbjct: 79 TYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 344 SGSIP 348
S+P
Sbjct: 137 K-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 42/129 (32%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 192 LCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGP 250
L L N L + +L +L+L GN L S+P+ + L L L+LS N+L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 251 IPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI-GYLTN 308
+P + LT L L L++NQL L L L L L N L +P + LT+
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTS 149
Query: 309 LTYLNLGYN 317
L Y+ L N
Sbjct: 150 LQYIWLHDN 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 23/210 (10%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR- 567
+ + IG G +G V +A + VALK + R+E F E R+L +R +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNE---KRFHRQAAEEIRILEHLRKQD 154
Query: 568 -----NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAH 621
N++ + + + +E + +L+ +++ N + L ++ S+
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQ 211
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF--VADFGLARLLHPDSSNRTLVVGTYGY 679
L LH K I+H D+ NILL + V DFG + H T + + Y
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSRF-Y 265
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMG 709
APE+ D++S G + E+L G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR- 567
+ I IG G +G V +A + VA+K + +++ AFL Q E RLL +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNK---KAFLNQAQIEVRLLELMNKHD 111
Query: 568 -----NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAH 621
IV L + + L++E + +L+ +LR + V L+ T++ + M
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCT 168
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF--VADFGLARLLHPDSSNRTLVVGTYGY 679
AL +L + SI+H D+ NILL + + + DFG + L + + Y
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRF-Y 224
Query: 680 IAPE----LAYTMAVTEKCDVYSFGVVALEVLMG 709
+PE + Y +A D++S G + +E+ G
Sbjct: 225 RSPEVLLGMPYDLA----IDMWSLGCILVEMHTG 254
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 39/130 (30%), Positives = 57/130 (43%), Gaps = 8/130 (6%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
V+ S L +P I L L+ N +P E N K L + L N++
Sbjct: 13 TVVRCSNKGLK-VLPKGIPRDVTELYLD-GNQF--TLVPKELSNYKHLTLIDLSNNRIST 68
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLY-HLN 187
L S N+T L L LS N+L +P LK+L+ L L N +S +P + L+
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLS 126
Query: 188 QLATLCLGYN 197
L+ L +G N
Sbjct: 127 ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 34/129 (26%), Positives = 51/129 (39%), Gaps = 27/129 (20%)
Query: 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG 105
+L L N T +P E+ L ++DLS NR++ LSN
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS----------------TLSNQS--- 73
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKN 164
F N+ L L L N+L + P + L +L L L N +S +P+ +L
Sbjct: 74 -----FSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSA 127
Query: 165 LKSLFLDNN 173
L L + N
Sbjct: 128 LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLA 286
IP + EL+L N+ +P + N +L +DLS+N++S L + N+ L
Sbjct: 29 IPRDV------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 287 SLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIP 324
+L L+ N L IPP L +L L+L N + S +P
Sbjct: 82 TLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDI-SVVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 32/132 (24%), Positives = 47/132 (35%), Gaps = 33/132 (25%)
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG---NMKNLDRLHLNGNN 222
L+LD N + +P L + L + L N++ T NM L L L+ N
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS---TLSNQSFSNMTQLLTLILSYNR 89
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GN 281
L IP DG L +L L L N +S +P +
Sbjct: 90 LR-CIPPRT---------------FDG--------LKSLRLLSLHGNDISV-VPEGAFND 124
Query: 282 LKYLASLSLNGN 293
L L+ L++ N
Sbjct: 125 LSALSHLAIGAN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 38/129 (29%), Positives = 62/129 (48%), Gaps = 4/129 (3%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
+D + L IP +I L LN N + S FG L L +L L+ N+L G
Sbjct: 11 TTVDCTGRGLK-EIPRDIPLHTTELLLN-DNELGRISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+ P++ +++ L L N++ + ++ L LK+L L +N +S +P + HLN
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 189 LATLCLGYN 197
L +L L N
Sbjct: 128 LTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 6/91 (6%)
Query: 238 DELHLSHNRLDGPIPPT--IGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL 295
EL L+ N L I G L +L+ L+L NQL+G+ P ++ L L N +
Sbjct: 32 TELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 296 IGPIPPTI-GYLTNLTYLNLGYNRLSSSIPP 325
I + L L LNL N++ S + P
Sbjct: 91 -KEISNKMFLGLHQLKTLNLYDNQI-SCVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 26/103 (25%), Positives = 41/103 (39%), Gaps = 12/103 (11%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
IP I + T L L+ N+L + G L +L L L N L+G P+ + +
Sbjct: 23 IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 190 ATLCLGYNKL----VGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228
L LG NK+ + L L+L N ++ +
Sbjct: 81 QELQLGENKIKEISNKMFLG----LHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEI-GALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLS 99
L L KL L N LT I S ++ L L N++ I +++ L L LNL
Sbjct: 53 LPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110
Query: 100 NNILNGSIPLE-FGNLKDLDQLRLQGNKLD 128
+N ++ + F +L L L L N +
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASNPFN 139
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 4e-12
Identities = 33/260 (12%), Positives = 71/260 (27%), Gaps = 63/260 (24%)
Query: 498 ITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLH-----RSETEEPAFLE 552
+ F + TE IG G +G V++ VA+K + E
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 553 SFQTEARLLSQI---------RHRNIVKLYGFCLH------------------------- 578
E + ++ R + L
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 579 -----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS 633
+ +F++ E+ G +R + +I+ + +L+
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEA--SLR 182
Query: 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEK 693
HRD+ N+LL + ++ + + G + YT++ E+
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLN---------GKSSTIPSCGLQVSIIDYTLSRLER 233
Query: 694 --CDVYSFGVVALEVLMGSH 711
V+ + ++ G
Sbjct: 234 DGIVVFCDVSMDEDLFTGDG 253
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-12
Identities = 36/117 (30%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 59 IPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDL 117
+P+ I + L+L N+L L L L+LS N + S+P F L L
Sbjct: 22 VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNN 173
L L NKL L LT L L L NQL +P + L +L+ ++L N
Sbjct: 79 TILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 35/108 (32%), Positives = 49/108 (45%), Gaps = 4/108 (3%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
+L L+ NKL L LT LT L LS NQ+ LP V L L L+L N
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENK 87
Query: 175 LSGPIPSTLY-HLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN 221
L +P+ ++ L QL L L N+L + +L ++ L+ N
Sbjct: 88 LQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 179 IPST---LY-HLNQLATLCLG-YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-G 232
IPS+ L N+L +L G ++KL L +L L+ N + S+P +
Sbjct: 26 IPSSATRLELESNKLQSLPHGVFDKLT-----------QLTKLSLSQNQIQ-SLPDGVFD 73
Query: 233 YLNLLDELHLSHNRLDGPIPPTI-GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291
L L L+L N+L +P + LT L L L +NQL + L L + L+
Sbjct: 74 KLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 132
Query: 292 GN 293
N
Sbjct: 133 TN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 31/96 (32%), Positives = 38/96 (39%), Gaps = 8/96 (8%)
Query: 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLA 286
IPS+ L L N+L LT L L LS NQ+ L L L
Sbjct: 26 IPSS------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 287 SLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSS 321
L L+ N L +P + LT L L L N+L S
Sbjct: 80 ILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKS 114
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 21/100 (21%), Positives = 36/100 (36%), Gaps = 2/100 (2%)
Query: 77 NRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDGLIPSSI 135
+ +L +L + N + L L +L L + + L + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 136 GNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175
L+ L+LS N L L + +L+ L L N L
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
+ NLT L + Q L L L++L + + L P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224
+ L L +N L ++ + +L L L+GN L
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 209 NMKNLDRLHLNGNNLTGSIPS-TIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDL 266
+NL L++ + + L L L + + L + P L L+L
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNL 87
Query: 267 SSNQLSGLLPREVGNLKYLASLSLNGN 293
S N L L + V L L L L+GN
Sbjct: 88 SFNALESLSWKTVQGLS-LQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 7e-09
Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 3/105 (2%)
Query: 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGL 274
L + + L EL++ + + + + L L L + + L +
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRL 319
P L+ L+L+ N L + +L L L N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 2/102 (1%)
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS-TLYHLNQLATLCLGYNKLVGPVTKE 206
+ + +NL L+++N + L L +L L + + L
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD 248
L RL+L+ N L T+ L+L EL LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQ-ELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSE-IGALSRLKVLDLSYNRLTGTIPSEIGS-LRDL 93
+ L +L + + + + L L+ L + + L + + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
LNLS N L L L +L L GN L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 4/93 (4%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSE-IGALSKLEKLVLSHNSLTGRIPSEI-GALSRLKV 71
+ NL I + + L +L L + + L + + RL
Sbjct: 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSR 84
Query: 72 LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILN 104
L+LS+N L ++ + L +L LS N L+
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 18/99 (18%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSE-IGNLIFFRQLDLSRNFINGTIPSQL 375
+ L L L + + + + L R L + ++ + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 376 GKIPNISAVDLSKNNLSGVIPASVR--RIPKLIVSENNL 412
P +S ++LS N L + +V+ + +L++S N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 53/274 (19%), Positives = 98/274 (35%), Gaps = 83/274 (30%)
Query: 508 EDFHIKYCI----GTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLS 562
+ F+ +Y + G G + +V+ + + K VA+K + +S + E+ E RLL
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSA---EHYTETALDEIRLLK 88
Query: 563 QIR--------HRNIVKLYG-FCLHNK-----CMFLIYEYMERGSLFCVL-RNDVEAVEL 607
+R +V+L F + CM ++E + L + +++ + + L
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGLPL 145
Query: 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-------------------- 647
K+ I++ + L YLH C+ I+H DI NILL+
Sbjct: 146 PCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 648 -----------------------------SNLEAFVADFGLARLLHPDSSNRTLVVGTYG 678
L+ +AD G A + T + T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQ 258
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y + E+ D++S +A E+ G +
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 5/103 (4%)
Query: 72 LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI 131
++ RL ++P+ I + D L L+NN + P F +L +L QL NKL +
Sbjct: 17 VNCQNIRLA-SVPAGIPT--DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73
Query: 132 PSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNN 173
LT LT LDL+ N L +P+ NLK+L ++L NN
Sbjct: 74 TGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
D +L L N++ L P +L NL L + N+L+ +P V L L L L++NH
Sbjct: 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92
Query: 175 L 175
L
Sbjct: 93 L 93
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 16/98 (16%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLY-HLNQ 188
+P+ I T+ L L+ NQ++ +L V +L NL+ L+ ++N L+ IP+ ++ L Q
Sbjct: 27 VPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQ 82
Query: 189 LATLCLGYNKLVGPVTKEV-----GNMKNLDRLHLNGN 221
L L L N L K + N+K+L ++L N
Sbjct: 83 LTQLDLNDNHL-----KSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLL 94
P+ I + ++L L++N +T P L L+ L + N+LT IP+ + L L
Sbjct: 28 PAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLT 84
Query: 95 DLNLSNNILNGSIPL-EFGNLKDLDQLRLQGN 125
L+L++N L SIP F NLK L + L N
Sbjct: 85 QLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 5/103 (4%)
Query: 72 LDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI 131
+D S L ++P+ I + L L +N + P F L L +L L N+L L
Sbjct: 14 VDCSGKSLA-SVPTGIPT--TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLP 70
Query: 132 PSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNN 173
LT LT L L+ NQL +P+ NLK+L ++L NN
Sbjct: 71 AGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNH 174
L L N++ L P LT LT LDL NQL+ LP V L L L L++N
Sbjct: 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89
Query: 175 L 175
L
Sbjct: 90 L 90
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 16/98 (16%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEV-GNLKNLKSLFLDNNHLSGPIPSTLY-HLNQ 188
+P+ I T L L NQ++ +L V L L L LDNN L+ +P+ ++ L Q
Sbjct: 24 VPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQ 79
Query: 189 LATLCLGYNKLVGPVTKEV-----GNMKNLDRLHLNGN 221
L L L N+L K + N+K+L + L N
Sbjct: 80 LTQLSLNDNQL-----KSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLL 94
P+ I + + L L N +T P L++L LDL N+LT +P+ + L L
Sbjct: 25 PTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLT 81
Query: 95 DLNLSNNILNGSIPLE-FGNLKDLDQLRLQGN 125
L+L++N L SIP F NLK L + L N
Sbjct: 82 QLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 27/128 (21%), Positives = 53/128 (41%), Gaps = 12/128 (9%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109
L+ + ++ R + LDL ++ I + +L ++ S+N + L
Sbjct: 4 LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KL 57
Query: 110 E-FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV---GNLKNL 165
+ F L+ L L + N++ + L +LT L L+ N L ++ +LK+L
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSL 115
Query: 166 KSLFLDNN 173
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 10/137 (7%)
Query: 71 VLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL 130
++ L+ + ++ + +L+L + I L D + N++ L
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP-IPSTLYHLNQL 189
L L L ++ N++ L +L L L NN L L L L
Sbjct: 58 --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 190 ATLCLGYNKLVGPVTKE 206
LC+ N PVT +
Sbjct: 116 TYLCILRN----PVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
L + + + S N + ++ L RLK L ++ NR+ +L DL +L L+N
Sbjct: 40 TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 101 N-ILNGSIPLEFGNLKDLDQLRLQGN---KLDGLIPSSIGNLTNLTYLD 145
N ++ +LK L L + N I + + LD
Sbjct: 98 NSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 12/114 (10%)
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN---LTNLIALD 265
N L L G + I + L+ D + S N + + L L L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLKTLL 70
Query: 266 LSSNQLSGLLPREVGNLKYLASLSLNGNIL--IGPIPPTIGYLTNLTYLNLGYN 317
+++N++ + L L L L N L +G + P + L +LTYL + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 23/115 (20%), Positives = 37/115 (32%), Gaps = 14/115 (12%)
Query: 257 NLTNLIALDLSSNQLS---GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
N LDL ++ L L ++ + N I + L L L
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGA----TLDQFDAIDFSDN-EIRKLD-GFPLLRRLKTLL 70
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF---RQLDLSRN 365
+ NR+ L L+L++NSL ++ L L + RN
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 20/116 (17%), Positives = 38/116 (32%), Gaps = 8/116 (6%)
Query: 133 SSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192
+ N LDL ++ + L ++ +N + + L +L TL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLN---LLDELHLSHN 245
+ N++ + +L L L N+L + L L L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 14/87 (16%), Positives = 30/87 (34%), Gaps = 3/87 (3%)
Query: 306 LTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
L+L ++ I Q + S N + + L + L ++ N
Sbjct: 18 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74
Query: 366 FINGTIPSQLGKIPNISAVDLSKNNLS 392
I +P+++ + L+ N+L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 51/368 (13%), Positives = 106/368 (28%), Gaps = 53/368 (14%)
Query: 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRL 69
L LN +C + V+F L++ L+ L L+ ++ + + +L
Sbjct: 186 LVSLNISCLASEVSFSALERLVTR--------CPNLKSLKLNRAVPLEKLATLLQRAPQL 237
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
+ L + + + K+L L + +
Sbjct: 238 EELGTGGYT------------------AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA 279
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGR-LPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
+P+ + LT L+LS + L + + L+ L++ + +
Sbjct: 280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKD 339
Query: 189 LATLCLGYNKLVGP----------VTKEVGNMKNLDRLHLNGNNLTGSIPSTIG-YLNLL 237
L L + ++ + L+ + +T + TI +
Sbjct: 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399
Query: 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG 297
L P T+ L + + K L LSL+G +
Sbjct: 400 TRFRLCIIEPKAPDYLTLEPLDIGFGAIVE-------------HCKDLRRLSLSGLLTDK 446
Query: 298 PIPPTIGYLTNLTYLNLGYNRLS-SSIPPELMNCSQLLNLVLSHNSLSG-SIPSEIGNLI 355
Y + L++ + S + L C L L + ++ + L
Sbjct: 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE 506
Query: 356 FFRQLDLS 363
R L +S
Sbjct: 507 TMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 45/296 (15%), Positives = 91/296 (30%), Gaps = 50/296 (16%)
Query: 88 GSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147
R + + + ++ F ++ ++ L+P G +S
Sbjct: 42 RWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMS 101
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV 207
+ L+ + L ++ L +A
Sbjct: 102 ------------SSYTWLEEIRLKRMVVTDD------CLELIAKSF-------------- 129
Query: 208 GNMKNLDRLHLNG-NNLTGSIPSTIG-YLNLLDELHLSHNRLDGPIPPTIG----NLTNL 261
KN L L+ + + I L EL L + +D + T+L
Sbjct: 130 ---KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186
Query: 262 IALDLS--SNQLSGL-LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY-- 316
++L++S ++++S L R V L SL LN + + + + L L G
Sbjct: 187 VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYT 246
Query: 317 ----NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368
+ S + L C +L L +++ +P+ L+LS +
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 47/233 (20%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR- 567
F + +G G +G V Q + + K A+K + R+ + S + EA +L +I++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNI---KKYTRSAKIEADILKKIQNDD 92
Query: 568 ----NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHA 622
NIVK +G ++ M LI+E + SL+ ++ N+ ++ K + A
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKL--YCIEILKA 149
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT------ 676
L+YL + H D+ NILL+
Sbjct: 150 LNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 677 ----------YGYI------APE----LAYTMAVTEKCDVYSFGVVALEVLMG 709
I APE L + ++ D++SFG V E+ G
Sbjct: 207 GCATFKSDYHGSIINTRQYRAPEVILNLGWDVS----SDMWSFGCVLAELYTG 255
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 62/369 (16%), Positives = 111/369 (30%), Gaps = 70/369 (18%)
Query: 50 LSHNSLTGRIPSEIGAL----SRLKVLDLSYNRLTGTIPSEIGS-LRD----LLDLNLSN 100
+++ + + + LDLS N L E+ + + LNLS
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 101 NIL--NGSIPLEFG---NLKDLDQLRLQGNKLD-----GLIPSSIGNLTNLTYLDLSLNQ 150
N L S L ++ L L GN L L+ + +T LDL N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 151 LSGRLPQEVGNL-----KNLKSLFLDNNHLSGP----IPSTLYHLN-QLATLCLGYNKLV 200
S + E ++ SL L N L + L + + +L L N L
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 201 GPVTKEVGNM-----KNLDRLHLNGNNLTGSIPSTIGYL-----NLLDELHLSHNRLDGP 250
E+ ++ L L+ N L + + Y+ N + L+L N L GP
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 251 ----IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306
+ +L +L + L + + + + K L + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQ---CKALGAA--------------FPNI 283
Query: 307 TNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF--------- 357
+ ++ + S + N + L+ SL
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE 343
Query: 358 -RQLDLSRN 365
R+ +
Sbjct: 344 LRESIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 55/324 (16%), Positives = 99/324 (30%), Gaps = 67/324 (20%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGAL-----SRLKVLDLSYNRLTGTIPSEIGSL-----RD 92
+ + L LS NSL + E+ + + + L+LS N L+ E+
Sbjct: 51 ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 93 LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152
+ L+L N + ++T L+L N L
Sbjct: 111 ITVLDLGWN-------------------DFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151
Query: 153 GRLPQEVGNL-----KNLKSLFLDNNHLSGP----IPSTLYHLNQ-LATLCLGYNKLVGP 202
+ E+ + N+ SL L N+L+ + L + + +L L N L
Sbjct: 152 IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK 211
Query: 203 VTKEVG-----NMKNLDRLHLNGNNLTGSIPSTIGYL----NLLDELHLSHNRLDGP--- 250
E+ ++ L+L N L G + L L ++L ++ +
Sbjct: 212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271
Query: 251 ----IPPTIGNLTNLIALDLSSNQ--------LSGLLPREVGNLKYLASLSLNGNILIGP 298
+ N+ +I +D + + +S L+ G SL I
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVP-SLLNQCLIFAQK 330
Query: 299 IPPTIGYLTN---LTYLNLGYNRL 319
I L L L
Sbjct: 331 HQTNIEDLNIPDELRESIQTCKPL 354
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (142), Expect = 2e-09
Identities = 31/187 (16%), Positives = 58/187 (31%), Gaps = 24/187 (12%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIG------ALSKLEKLVLSHNSLTGRIPSEIGALS 67
N F + + S I L + L T +
Sbjct: 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRP 193
Query: 68 RLKVLDLSYNRLTGTIPSEIGS-----LRDL-LDLNLSNNILNGSIP-----LEFGNLKD 116
LK L++ L ++ +I L L L + + + +G + +
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253
Query: 117 LDQLRLQGNKLDGLIPSSIGN---LTNLTYLDLSLNQLSGR----LPQEVGNLKNLKSLF 169
L L + + ++ L L +D+S L+ L V +K+LK +
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313
Query: 170 LDNNHLS 176
+ N+LS
Sbjct: 314 MKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 1e-05
Identities = 23/147 (15%), Positives = 49/147 (33%), Gaps = 19/147 (12%)
Query: 41 ALSKLEKLVLSHNSLTGRIPSEIGA--LSRLKVLDLSYNRLTGTIPSEIGSLRDLLD--- 95
L+ L + L + +I L L+ L L ++ R L
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 96 ------LNLSNNILNGSIP---LEFGNLKDLDQLRLQGNKL--DGL--IPSSIGNLTNLT 142
L + + + LE L L+ + + L +G + + + +L
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 143 YLDLSLNQLSGRLPQEVGN-LKNLKSL 168
++++ N LS + +E+ L +
Sbjct: 311 FINMKYNYLSDEMKKELQKSLPMKIDV 337
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 3e-04
Identities = 22/162 (13%), Positives = 55/162 (33%), Gaps = 18/162 (11%)
Query: 234 LNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVG--NLKYLASLSL- 290
L+ + L+ + + NL +L++ S L + ++ +L L L L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 291 ------NGNILIGPIPPTI--GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV---LS 339
+ + P NL +L + + + + L L +S
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 340 HNSLSGS----IPSEIGNLIFFRQLDLSRNFINGTIPSQLGK 377
L+ + + + + +++ N+++ + +L K
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 31/197 (15%), Positives = 65/197 (32%), Gaps = 26/197 (13%)
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG 208
+ ++ + + + + LF + S + L+ + L K
Sbjct: 125 SDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ-VDLSPVLDAMPLLNNLKIKGTN 183
Query: 209 NMK-------NLDRLHLNGNNLTGSIPSTIGYLNL--LDELHLSHNRLDGPIPPTIGNLT 259
N+ NL L + L S+ I +L L++L L D +
Sbjct: 184 NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243
Query: 260 ---------NLIALDLSSNQLSGLLPR---EVGNLKYLASLSLNGNIL----IGPIPPTI 303
NL L + + ++ E L L ++ ++ +L + +
Sbjct: 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV 303
Query: 304 GYLTNLTYLNLGYNRLS 320
+ +L ++N+ YN LS
Sbjct: 304 DKIKHLKFINMKYNYLS 320
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 62/355 (17%), Positives = 114/355 (32%), Gaps = 39/355 (10%)
Query: 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGR--IPSEIGALSRLKVL 72
F NL F MP + L KL S G +P ++++ L
Sbjct: 239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKL 298
Query: 73 DLSYNRL-TGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI 131
DL Y L T + I +L L N I + + + K L +LR++ + +
Sbjct: 299 DLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGM 358
Query: 132 PSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS----GPIPSTLYHLN 187
G ++ L L+ + L+ + + + ++ I + L +L
Sbjct: 359 EDEEGLVS-----QRGLIALA-------QGCQELEYMAVYVSDITNESLESIGTYLKNLC 406
Query: 188 QLATLCLGYNKLVGPVTKEVG------NMKNLDRLHLNGN--NLTGSIPSTIG-YLNLLD 238
+ L + + + + G K L R LT S IG Y +
Sbjct: 407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVR 466
Query: 239 ELHLSHNRL-DGPIPPTIGNLTNLIALDLSSNQLSGL-LPREVGNLKYLASLSLNG-NIL 295
+ L + D + NL L++ S + V L L L + G
Sbjct: 467 WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
Query: 296 IGPIPPTIGYLT--NLTYLNLGYNRLSS--SIPPELMNCSQLLNLVLSHNSLSGS 346
+ N+ + + E+ + + + L++ SL+G
Sbjct: 527 MTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI----LAYYSLAGQ 577
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 51/366 (13%), Positives = 107/366 (29%), Gaps = 41/366 (11%)
Query: 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGA------------LSRL 69
VT + T R+ L L+ ++ IP G L +L
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114
Query: 70 KVLDLSYNRLTGTIPSEIGSLR--DLLDLNLSN--NILNGSIPLEFGNLKDLDQLRLQGN 125
K + ++ + R DL L L + + + + L ++ +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174
Query: 126 KLDGLIPSSIG----NLTNLTYLDLSLNQLSG----RLPQEVGNLKNLKSLFLDNNHLSG 177
+ + T+L L+ + + + L N ++L S+ + + +
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234
Query: 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG--SIPSTIGYLN 235
+ L C G + ++ N+ +L G + G +P +
Sbjct: 235 LV-GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAA 293
Query: 236 LLDELHLSHNRLDGP-IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNI 294
+ +L L + L+ I NL L+ + L K L L +
Sbjct: 294 QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA 353
Query: 295 LIGPIPPTIGYLT------------NLTYLNLGYNRLS-SSIPPELMNCSQLLNLVLSHN 341
+ G ++ L Y+ + + ++ S+ L + L
Sbjct: 354 DEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLL 413
Query: 342 SLSGSI 347
I
Sbjct: 414 DREERI 419
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 35/146 (23%), Positives = 58/146 (39%), Gaps = 16/146 (10%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93
+M + + L + L LS N++ +I S + + L++L L N + I + L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLS 152
+L +S N + +E L +L L + NK+ + L L L L+ N L
Sbjct: 96 EELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
Query: 153 GRLPQE----------VGNLKNLKSL 168
+ V L NLK L
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 39/192 (20%), Positives = 67/192 (34%), Gaps = 36/192 (18%)
Query: 138 LTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYN 197
+ T + ++ R + ++ L + + +TL L L L N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTN 58
Query: 198 KLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR---LDGPIPPT 254
+ + M+NL L L N + I + + L+EL +S+N+ L G
Sbjct: 59 NI--EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG----- 110
Query: 255 IGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314
I L NL L +S+N+++ G + LA+L L L L
Sbjct: 111 IEKLVNLRVLYMSNNKIT-----NWGEIDKLAAL------------------DKLEDLLL 147
Query: 315 GYNRLSSSIPPE 326
N L +
Sbjct: 148 AGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 32/168 (19%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 109 LEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168
+ + ++ L ++ + +++ L +L LS N + ++ + ++NL+ L
Sbjct: 20 VVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75
Query: 169 FLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG-SI 227
L N + I + + L L + YN++ + + NL L+++ N +T
Sbjct: 76 SLGRNLIKK-IENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 228 PSTIGYLNLLDELHLSHNRLDGPIPPT----------IGNLTNLIALD 265
+ L+ L++L L+ N L + L NL LD
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 31/152 (20%)
Query: 239 ELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGP 298
ELH ++ + T+ L L LS+N + ++ +L
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSL---------------- 66
Query: 299 IPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR 358
+ NL L+LG N + I L L +S+N ++ S+ S I L+ R
Sbjct: 67 -----SGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR 118
Query: 359 QLDLSRNFING-TIPSQLGKIPNISAVDLSKN 389
L +S N I +L + + + L+ N
Sbjct: 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 50/232 (21%), Positives = 88/232 (37%), Gaps = 49/232 (21%)
Query: 510 FHIKYCIGTGGYGSVYRA--QLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ I +G G +G V VALK + R+ + E+ + E +L +I+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV---GKYREAARLEINVLKKIKEK 76
Query: 568 ------NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMA 620
V + + + M + +E + + + F L+ N+ + L + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRH--MAYQLC 133
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA-------------------DFGLAR 661
HAL +LH + + H D+ NIL ++ + DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 662 LLHPDSSNRTLVVGTYGYIAPE----LAYTMAVTEKCDVYSFGVVALEVLMG 709
D + T +V T Y PE L + CDV+S G + E G
Sbjct: 191 F---DHEHHTTIVATRHYRPPEVILELGWAQP----CDVWSIGCILFEYYRG 235
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 14/235 (5%)
Query: 37 SEIGALSKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
+E + +++ + LS++ + + + S+L+ L L RL+ I + + +L+
Sbjct: 87 AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 146
Query: 96 LNLSN--NILNGSIPLEFGNLKDLDQLRLQGNKL---DGLIPSSIGNLTNLTYLDLS--L 148
LNLS ++ + LD+L L + + +T L+LS
Sbjct: 147 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206
Query: 149 NQLSGR-LPQEVGNLKNLKSLFL-DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVT-K 205
L L V NL L L D+ L + LN L L L + P T
Sbjct: 207 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 266
Query: 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
E+G + L L + G G++ L L +++ SH PTIGN N
Sbjct: 267 ELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL-QINCSHFTTIA--RPTIGNKKN 318
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 51/239 (21%), Positives = 80/239 (33%), Gaps = 12/239 (5%)
Query: 60 PSEIGALSRLKVLDLSYNR-LTGTIPSEIGSLRDLLDLNLSN-NILNGSIPLEFGNLKDL 117
P G L V+ R +E S + ++LSN I ++ L
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLS-LNQLSGR-LPQEVGNLKNLKSLFLDNNHL 175
L L+G +L I +++ +NL L+LS + S L + + L L L
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180
Query: 176 ---SGPIPSTLYHLNQLATLCL-GYNKLVG--PVTKEVGNMKNLDRLHLNG-NNLTGSIP 228
+ + + L L GY K + ++ V NL L L+ L
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 240
Query: 229 STIGYLNLLDELHLSH-NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLA 286
LN L L LS + +G + L L + G L L +L
Sbjct: 241 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 33/199 (16%), Positives = 73/199 (36%), Gaps = 13/199 (6%)
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRL--DGPIPPTIGNLTNLIALDLSS 268
L L L G L+ I +T+ + L L+LS + + + + + L L+LS
Sbjct: 118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177
Query: 269 ------NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY-NRLSS 321
+ + + L N+ + + NL +L+L L +
Sbjct: 178 CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 237
Query: 322 SIPPELMNCSQLLNLVLSH-NSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380
E + L +L LS + E+G + + L + +GT+ +P+
Sbjct: 238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH 297
Query: 381 ISAVDLSKNNLSGVIPASV 399
+ ++ ++ + + ++
Sbjct: 298 L---QINCSHFTTIARPTI 313
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 45/232 (19%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 510 FHIKYCIGTGGYGSVYRAQ--LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ I +G G +G V + G+ VA+K + ++ + E+ ++E ++L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV---DRYCEAARSEIQVLEHLNTT 71
Query: 568 ------NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMA 620
V++ + H+ + +++E + S + ++ N LD ++ + +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRK--MAYQIC 128
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA-------------------DFGLAR 661
++++LH + H D+ NIL + DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 662 LLHPDSSNRTLVVGTYGYIAPE----LAYTMAVTEKCDVYSFGVVALEVLMG 709
D + + +V T Y APE L ++ CDV+S G + +E +G
Sbjct: 186 Y---DDEHHSTLVSTRHYRAPEVILALGWSQP----CDVWSIGCILIEYYLG 230
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 29/120 (24%), Positives = 46/120 (38%), Gaps = 8/120 (6%)
Query: 89 SLRDLLDLNLSNN-ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147
+ D+ +L L N+ G + ++L+ L L + +++ L L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP-IPSTLYHLNQLATLCLGYNKLVGPVTKE 206
N++SG L NL L L N + L L L +L L VT
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVTNL 128
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 33 GRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRD 92
G++ +LE L + LT I + + L++LK L+LS NR++G + +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 93 LLDLNLSNN-ILNGSIPLEFGNLKDLDQLRLQGN---KLDGLIPSSIGNLTNLTYLD 145
L LNLS N I + S L++L L L L+ + L LTYLD
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 4/111 (3%)
Query: 41 ALSKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99
S +++LVL ++ G++ L+ L LT +I + + L L L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLN 149
+N ++G + + +L L L GNK+ L + L NL LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 4/111 (3%)
Query: 185 HLNQLATLCLGYNKLVGPVTKEVG-NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLS 243
+ + L L ++ + + + L+ L LT SI + + LN L +L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 244 HNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREV-GNLKYLASLSLNGN 293
NR+ G + NL L+LS N++ L E L+ L SL L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 26/113 (23%), Positives = 42/113 (37%), Gaps = 8/113 (7%)
Query: 257 NLTNLIALDLSSNQLSGLLPREVG-NLKYLASLSLNGNIL--IGPIPPTIGYLTNLTYLN 313
+++ L L +++ + + + L LS L I +P L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSG-SIPSEIGNLIFFRQLDLSRN 365
L NR+S + C L +L LS N + S + L + LDL
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-08
Identities = 33/120 (27%), Positives = 45/120 (37%), Gaps = 8/120 (6%)
Query: 89 SLRDLLDLNLSNNILN-GSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147
+ + +L L N N G I +L+ L L L + S++ L L L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP-IPSTLYHLNQLATLCLGYNKLVGPVTKE 206
N++ G L L NL L L N L L L L +L L VT
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC----EVTNL 135
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 36/111 (32%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 39 IGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98
LE L L + L + + + L +LK L+LS NR+ G + L +L LNL
Sbjct: 45 TAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 99 SNNILNGSIPLE-FGNLKDLDQLRLQGN---KLDGLIPSSIGNLTNLTYLD 145
S N L LE L+ L L L L+ S L LTYLD
Sbjct: 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 41 ALSKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99
+ + +LVL + G+I L+ L L L ++ + + L L L LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLS 152
N + G + + L +L L L GNKL + + L L LDL +++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 6/115 (5%)
Query: 161 NLKNLKSLFLDNNHLS-GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLN 219
++ L LDN + G I L L L L+ + + L +L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 220 GNNLTGSIPSTIGYLNLLDELHLSHNRLDGP--IPPTIGNLTNLIALDLSSNQLS 272
N + G + L L L+LS N+L + P + L L +LDL + +++
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 30/137 (21%), Positives = 40/137 (29%), Gaps = 32/137 (23%)
Query: 233 YLNLLDELHLSHNRLD-GPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291
+ EL L + + + G I NL L L + L V NL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKL------ 70
Query: 292 GNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI 351
L L L NR+ + L +L LS N L S +
Sbjct: 71 ---------------PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTL 113
Query: 352 GNLIFF---RQLDLSRN 365
L + LDL
Sbjct: 114 EPLKKLECLKSLDLFNC 130
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 32/162 (19%), Positives = 69/162 (42%), Gaps = 26/162 (16%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-R 567
+ + IG+G +G +Y +++G+ VA+K +T+ P E+++ ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHP----QLHIESKIYKMMQGGV 65
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSL-----FCVLRNDVEAVELDWTKRVNIVKSMAHA 622
I + ++ E + SL FC + ++ V + + M
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTV-------LLLADQMISR 117
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEA---FVADFGLAR 661
+ Y+H + +HRD+ +N L+ + ++ DFGLA+
Sbjct: 118 IEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 33/164 (20%), Positives = 63/164 (38%), Gaps = 28/164 (17%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-R 567
F + IG G +G + + L + + VA+K ++ P E R Q+
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAP----QLHLEYRFYKQLGSGD 65
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSL-----FCVLRNDVEAVELDWTKRVNIVKSMAHA 622
I ++Y F K ++ E + SL C ++ V + I +
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTV-------LMIAIQLISR 117
Query: 623 LSYLHYDCKPSIVHRDISSNNILL-----NSNLEAFVADFGLAR 661
+ Y+H ++++RD+ N L+ + + DF LA+
Sbjct: 118 MEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 30/165 (18%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-R 567
+ + IG G +G ++ L + + VA+K R ++ P + E R +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAP----QLRDEYRTYKLLAGCT 66
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSL-----FCVLRNDVEAVELDWTKRVNIVKSMAHA 622
I +Y F L+ + + SL C + V+ V K M
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTV-------AMAAKQMLAR 118
Query: 623 LSYLHYDCKPSIVHRDISSNNILL------NSNLEAFVADFGLAR 661
+ +H S+V+RDI +N L+ N+N+ +V DFG+ +
Sbjct: 119 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 2e-06
Identities = 54/394 (13%), Positives = 123/394 (31%), Gaps = 109/394 (27%)
Query: 399 VRRIPKLIVSENNLELENSTSSENAPPPQATLFKGNKGKQRKIVIRLVTIILAM-VAFVF 457
V+ +PK I+S E+++ S++A LF KQ ++V + V +L + F+
Sbjct: 38 VQDMPKSILS--KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLM 95
Query: 458 AILIFGILFVHRRKDKKFNPNTREMTEGANEFSIWNYDGR------ITFEEMIEA----- 506
+ + + + ++ + TR E + ++N D + ++ +
Sbjct: 96 SPI--------KTEQRQPSMMTRMYIEQRDR--LYN-DNQVFAKYNVSRLQPYLKLRQAL 144
Query: 507 TEDFHIKYCI--GTGGYGSVYRAQLSSGK--LVALKKLHRSETEEPAF--------LESF 554
E K + G G SGK + + S + L++
Sbjct: 145 LELRPAKNVLIDGVLG----------SGKTWVAL--DVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 555 QTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVN 614
+ +L L + + R ++ + +++ +R+
Sbjct: 193 NSPETVLEM-------------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLL 238
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVV 674
K + L +V ++ + AF + + L+
Sbjct: 239 KSKPYENCL----------LVLLNVQNAKAW-----NAF--NLSC----------KILL- 270
Query: 675 GTYGYIAPELAYTMAVTEKCDVYSFGVVALE-VLMGSHPTDLLSSLSSSSGRKISQNPRL 733
T + VT+ + ++L+ M P ++ S L + PR
Sbjct: 271 -TTRFKQ--------VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 734 DLQCN--------AYLKNFSQGNHRWENLLFKKF 759
L N +++ W+++ K
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 4e-06
Identities = 76/389 (19%), Positives = 112/389 (28%), Gaps = 149/389 (38%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWG--TLLSGRMPSEIGALSKLEKLVLSHNSLTGR 58
+ N + N +C L+T R LS + I L +LT
Sbjct: 250 LLNVQNAKAWNAFNLSC-KILLTTRFKQVTDFLSAATTTHI-------SLDHHSMTLT-- 299
Query: 59 IPSEIGALSRLKVLDLSYNRL----TGTIP---SEIG-SLRDLLDLNLSNNILNGSIPLE 110
P E+ +L LK LD L T P S I S+RD L +N
Sbjct: 300 -PDEVKSLL-LKYLDCRPQDLPREVLTTNPRRLSIIAESIRD--GLATWDNWK------- 348
Query: 111 FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNL-KNLKSLF 169
+ +KL +I + SLN L P E + L S+F
Sbjct: 349 ----------HVNCDKLTTII-------------ESSLNVLE---PAEYRKMFDRL-SVF 381
Query: 170 LDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHL---NGNNLTGS 226
+ H IP+ L L + ++ V + L + L T S
Sbjct: 382 PPSAH----IPT--------ILLSLIWFDVIKSDVMVV--VNKLHKYSLVEKQPKESTIS 427
Query: 227 IPSTIGYLNL---LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
IPS YL L L+ + H + +D
Sbjct: 428 IPS--IYLELKVKLENEYALHRSI----------------VD-----------------H 452
Query: 284 YLASLSLNGNILIGPIPPTI-GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNS 342
Y + + + IPP + Y Y ++G+ H
Sbjct: 453 YNIPKTFDSD---DLIPPYLDQYF----YSHIGH-----------------------H-- 480
Query: 343 LSGSIPSEIGNLIFFRQLDLSRNFINGTI 371
L E L FR + L F+ I
Sbjct: 481 LKNIEHPERMTL--FRMVFLDFRFLEQKI 507
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 87/622 (13%), Positives = 170/622 (27%), Gaps = 165/622 (26%)
Query: 165 LKSLF----LDNNHLSGPIPSTLYHLNQLATLCL----GYNKLVGPVTKEVGNMKNL-DR 215
KS+ +D+ +S S L TL K V V + N K L
Sbjct: 42 PKSILSKEEIDHIIMSKDAVSGTLRL--FWTLLSKQEEMVQKFVEEVLRI--NYKFLMSP 97
Query: 216 LHLNGNNLTGSIPS--TIGYLNLLDELHLSHNRLDG---PIPPTIGNLTNLIALDLSSNQ 270
+ PS T Y+ D L+ + L + L+L +
Sbjct: 98 IKTEQRQ-----PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAK 151
Query: 271 ---LSGLLPREVGNLK-YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE 326
+ G+L G+ K ++A + + I + +LNL ++
Sbjct: 152 NVLIDGVL----GSGKTWVALDVCLSYKVQCKMDFKI-F-----WLNLKNCNSPETVLEM 201
Query: 327 LMN-CSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQL--------GK 377
L Q+ S + S +I I ++ Q +L R + + L K
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSI----QAELRRLLKSKPYENCLLVLLNVQNAK 257
Query: 378 IPNISAVDL-------SKN-NLSGVIPASVRRIPKLIVSENNLELENSTS--------SE 421
+A +L ++ ++ + A+ L L + S
Sbjct: 258 A--WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 422 NAPPPQATLFKGNKGKQRKIVIRLVTIILAMVAFVFAILIFGILFVHRRKDKKFNPNTRE 481
P + N + I
Sbjct: 316 QDLPREVL--TTNP---------------------RRLSIIA----------------ES 336
Query: 482 MTEGANEFSIWNYDGRITFEEMIEATEDFHIKYCIGTGGYGSVYR--------AQLSSGK 533
+ +G + W + +IE++ + + Y ++ A + +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLN-----VLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 534 LVAL-KKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG------------FCLHNK 580
L + + +S+ + L+ + + + + + LH
Sbjct: 392 LSLIWFDVIKSDVMV--VVNKLHK-YSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 581 CMFLIYEYMERGSLFCVLRNDVEAVELD--WTKRVNIVKSMAHALSYLH-YDCKPSIVHR 637
++ Y + +D+ LD + + + H + + R
Sbjct: 449 ---IVDHYNIPKTFDS---DDLIPPYLDQYF----------YSHIGH-HLKNIEHP--ER 489
Query: 638 DISSNNILLNSN-LEAFVADFGLARLLHPDSSNRTLVVGTY-GYIAP-ELAYTMAVTEKC 694
+ L+ LE + A N + Y YI + Y V
Sbjct: 490 MTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV---N 546
Query: 695 DVYSFGVVALEVLMGSHPTDLL 716
+ F E L+ S TDLL
Sbjct: 547 AILDFLPKIEENLICSKYTDLL 568
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALK-----KLHRSET----EEPAFLESFQTEARLLSQIRH 566
IG GG+G +Y A ++S + V K+ S+ E F + ++ IR
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 567 RN-----IVKLYGFCLHNKCM----FLIYEYMERGSLFCVLRNDVEAVELDWTKR----- 612
R + K +G LH+K F+I M+R +D++ + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDR------FGSDLQKI-YEANAKRFSRK 152
Query: 613 --VNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661
+ + + L Y+H VH DI ++N+LL N + + ++ D+GLA
Sbjct: 153 TVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/162 (21%), Positives = 71/162 (43%), Gaps = 26/162 (16%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HR 567
F + IG+G +G +Y + + + VA+K + +T+ P E+++ ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHP----QLLYESKIYRILQGGT 63
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSL-----FCVLRNDVEAVELDWTKRVNIVKSMAHA 622
I + F + L+ + + SL FC + ++ V + + M +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV-------LMLADQMINR 115
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEA---FVADFGLAR 661
+ ++H S +HRDI +N L+ A ++ DFGLA+
Sbjct: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 50/313 (15%), Positives = 94/313 (30%), Gaps = 65/313 (20%)
Query: 65 ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124
LS L+ L+L+ R+T P + + +L S LD++ L
Sbjct: 70 VLSSLRQLNLAGVRMT---PVKCTVVAAVL---GSGR-------------HALDEVNLAS 110
Query: 125 NKLDG-----LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG-----NLKNLKSLFLDNNH 174
+LD L+P L L LN L +++ + + +L L NN
Sbjct: 111 CQLDPAGLRTLLPV----FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNP 166
Query: 175 LSGP----IPSTLYHLNQLATLCLGYNKL----VGPVTKEVGNMKNLDRLHLNGNNLTGS 226
L+ + L + L L + L + + ++ + L L++ N +
Sbjct: 167 LTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
Query: 227 ----IPSTIGYLNLLDELHLSHNRLD-------GPIPPTIGNLTNLIALDLSSNQLSGLL 275
+ L+ LHL N L + ++ +S
Sbjct: 227 AALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS--- 283
Query: 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS----SSIPPELMNCS 331
L+ + N N + L +L +R + L
Sbjct: 284 ---EYWSVILSEVQRNLNSW---DRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEG 337
Query: 332 QLLNLVLSHNSLS 344
++ L+ S
Sbjct: 338 EVRALLEQLGSSG 350
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 29/178 (16%), Positives = 55/178 (30%), Gaps = 50/178 (28%)
Query: 516 IGTGGYGSVYRAQ---------LSSGKLVALK--KLHRSETEEPAFLESFQTEARL---- 560
G +Y A + +LK E F + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 561 -LSQIRHRNIVKLYGFCLH-NKCMFLI-----------YEYMERG--SLFCVLRNDVEAV 605
L I GF +H +K FL+ + + S VL+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ------ 163
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA--FVADFGLAR 661
+ + AL +LH + VH ++++ NI ++ ++ +A +G A
Sbjct: 164 ---------VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 39/171 (22%), Positives = 66/171 (38%), Gaps = 39/171 (22%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALK--KLHRSETE----EPAFLESFQ-----TEARLLSQ 563
IG+GG+G +Y A + + A K+ E E F + + Q
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 564 IRHRNIVKLYGFCLH----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR------V 613
+ + I YG L F++ MER L D++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV---MER------LGIDLQKI-SGQNGTFKKSTVL 154
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661
+ M L Y+H + VH DI + N+LL N + + ++AD+GL+
Sbjct: 155 QLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 764 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.85 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.83 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.79 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.69 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.51 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.49 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.61 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.38 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.09 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.14 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.94 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.77 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.96 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.87 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.67 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.89 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.31 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 85.23 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 81.8 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=476.68 Aligned_cols=398 Identities=37% Similarity=0.530 Sum_probs=330.3
Q ss_pred cCCCeeEEEeCCCCccccCCccccCC-CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcc-cCCCCCCC
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGAL-SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSE-IGSLRDLL 94 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~ 94 (764)
.+++|+.|++++|.+++.+|..+... ++|++|+|++|++++..|..|..+++|++|+|++|.+++.+|.. |..+++|+
T Consensus 267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~ 346 (768)
T 3rgz_A 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346 (768)
T ss_dssp CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCC
T ss_pred ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCC
Confidence 45556666666666666666666554 67777777777776666667777777777777777776555544 66777777
Q ss_pred EEecCCCcccccCCccCcCCC-CCCEEEccCCcCcccCCccccC--CCCcCEEecccCcccccCCccccCCCCCCeeecc
Q 004268 95 DLNLSNNILNGSIPLEFGNLK-DLDQLRLQGNKLDGLIPSSIGN--LTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD 171 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 171 (764)
+|+|++|.+++..|..+..++ +|++|++++|.+.+..+..+.. +++|++|++++|++++..|..|.++++|+.|+++
T Consensus 347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 426 (768)
T 3rgz_A 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426 (768)
T ss_dssp EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECC
T ss_pred EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECc
Confidence 777777777666666666665 6777777777776655666555 6788888888888888888889999999999999
Q ss_pred cCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC
Q 004268 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251 (764)
Q Consensus 172 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 251 (764)
+|.+++..+..+..+++|+.|++++|.+....+..+..+++|++|++++|++++..|..+..+++|+.|+|++|++.+..
T Consensus 427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 506 (768)
T 3rgz_A 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506 (768)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence 99998888888999999999999999998888888889999999999999999888999999999999999999999889
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCC------------------------------
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP------------------------------ 301 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------------ 301 (764)
|..++.+++|+.|+|++|++.+..|..+..+++|+.|++++|.+.+.+|.
T Consensus 507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (768)
T 3rgz_A 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 586 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTT
T ss_pred ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccc
Confidence 99999999999999999999988899999999999999999988765553
Q ss_pred ----------------------------------------CCCCCCccceEEccCCcCccCCChhhhcccccceeecccc
Q 004268 302 ----------------------------------------TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341 (764)
Q Consensus 302 ----------------------------------------~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N 341 (764)
.+..+++|++|+|++|++++.+|..+.++++|+.|+|++|
T Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N 666 (768)
T 3rgz_A 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666 (768)
T ss_dssp CCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCC
Confidence 2444678999999999999999999999999999999999
Q ss_pred ccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCC--ccccCccccccCCCCCC
Q 004268 342 SLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA--SVRRIPKLIVSENNLEL 414 (764)
Q Consensus 342 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~~~~~~~~~n~~~~ 414 (764)
++++.+|..+.++++|+.|||++|++++.+|..+..+++|+.||+++|+++|.+|. .+..++...+.+|+.-|
T Consensus 667 ~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEE
T ss_pred ccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhc
Confidence 99999999999999999999999999999999999999999999999999999996 57788888888887544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=416.78 Aligned_cols=235 Identities=23% Similarity=0.364 Sum_probs=204.4
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|++. +|+.||+|++.+.........+.+.+|++++++++||||+++++++++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999864 79999999997543322223478899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||+||+|.+++++ ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999973 456999999999999999999999 899999999999999999999999999999887543
Q ss_pred C--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 667 S--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 667 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
. ......+||+.|||||++.+..|+.++||||+||++|+|+||++||.+.+..+. ........+..++.++.+++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 2 234557899999999999999999999999999999999999999987654322 12233344567899999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 266 ~~lL~~d 272 (311)
T 4aw0_A 266 EKLLVLD 272 (311)
T ss_dssp HHHSCSS
T ss_pred HHHccCC
Confidence 9999988
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=466.92 Aligned_cols=399 Identities=35% Similarity=0.571 Sum_probs=314.8
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCC-CCC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL-RDL 93 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L 93 (764)
|..+++|+.|++++|.+++.+|..+..+++|++|+|++|.+++..|.. .+++|++|+|++|++++.+|..+..+ ++|
T Consensus 219 l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L 296 (768)
T 3rgz_A 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTL 296 (768)
T ss_dssp CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTC
T ss_pred cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcC
Confidence 778888888888888888888888888888888888888877655533 55566666666666655555555443 556
Q ss_pred CEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCc-cccCCCCcCEEecccCcccccC-----------------
Q 004268 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS-SIGNLTNLTYLDLSLNQLSGRL----------------- 155 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~----------------- 155 (764)
++|+|++|.+++..|..|.++++|++|+|++|.+.+..|. .|.++++|++|+|++|++++..
T Consensus 297 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls 376 (768)
T 3rgz_A 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376 (768)
T ss_dssp SEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECC
T ss_pred CEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEcc
Confidence 6666666655555555555555555555555555533332 2555555555555555554333
Q ss_pred --------CccccC--CCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccc
Q 004268 156 --------PQEVGN--LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 156 --------~~~~~~--l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
+..+.. +++|++|++++|.+++..+..+..+++|+.|++++|++.+..+..+..+++|++|++++|.+++
T Consensus 377 ~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 456 (768)
T 3rgz_A 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456 (768)
T ss_dssp SSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccC
Confidence 334433 5667777777777776777888888999999999999888888888899999999999999998
Q ss_pred ccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCC
Q 004268 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305 (764)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 305 (764)
..|..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++.+..|..+..+++|+.|++++|++.+..|..+..
T Consensus 457 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 536 (768)
T 3rgz_A 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGG
T ss_pred cCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcC
Confidence 88889999999999999999999888989999999999999999999889999999999999999999999888999999
Q ss_pred CCccceEEccCCcCccCCChhhh---------------------------------------------------------
Q 004268 306 LTNLTYLNLGYNRLSSSIPPELM--------------------------------------------------------- 328 (764)
Q Consensus 306 l~~L~~L~ls~N~l~~~~~~~~~--------------------------------------------------------- 328 (764)
+++|++|++++|++++.+|..+.
T Consensus 537 l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 616 (768)
T 3rgz_A 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616 (768)
T ss_dssp CTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTT
T ss_pred CCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccc
Confidence 99999999999998876665442
Q ss_pred -------------cccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcccccc
Q 004268 329 -------------NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395 (764)
Q Consensus 329 -------------~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 395 (764)
.+++|+.|+|++|++++.+|..+.+++.|+.|+|++|++++.+|..+.++++|+.|||++|+++|.+
T Consensus 617 ~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~i 696 (768)
T 3rgz_A 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696 (768)
T ss_dssp SCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECC
T ss_pred cceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcC
Confidence 3467889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccc---cCccccccCCCCCCC
Q 004268 396 PASVR---RIPKLIVSENNLELE 415 (764)
Q Consensus 396 ~~~~~---~~~~~~~~~n~~~~~ 415 (764)
|..+. .+..+++++|++.+.
T Consensus 697 p~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 697 PQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp CGGGGGCCCCSEEECCSSEEEEE
T ss_pred ChHHhCCCCCCEEECcCCccccc
Confidence 98664 677889999988643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=415.82 Aligned_cols=237 Identities=22% Similarity=0.342 Sum_probs=199.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++....... ...+.+.+|++++++++|||||++++++.+++.+|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999865 79999999998765443 3467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||+||+|.+++... ....+++..++.|+.||+.||+||| ++|||||||||+|||++++|.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999999743 3445789999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----CcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG----RKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 741 (764)
........+||+.|||||++.+..|+.++||||+||++|||+||++||.+.+..+.... ........++.++.+++
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 33333456899999999999999999999999999999999999999987765332211 12233456789999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++||+.+
T Consensus 258 ~~~L~~d 264 (350)
T 4b9d_A 258 SQLFKRN 264 (350)
T ss_dssp HHHTCSS
T ss_pred HHHccCC
Confidence 9999988
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=410.23 Aligned_cols=231 Identities=25% Similarity=0.415 Sum_probs=202.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.|++.+.||+|+||+||+|+++ +|+.||||++....... .+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999865 79999999997654433 256789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||+||+|.+++.. ..+++..++.++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999964 35899999999999999999999 899999999999999999999999999999987666
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCCcHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 740 (764)
.......+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+..+.... ......+.++..+.++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 5566678999999999999999999999999999999999999999987665332111 1222334578899999
Q ss_pred Hhhhhccc
Q 004268 741 LKNFSQGN 748 (764)
Q Consensus 741 ~~~~l~~~ 748 (764)
+++||+.+
T Consensus 304 i~~~L~~d 311 (346)
T 4fih_A 304 LDRLLVRD 311 (346)
T ss_dssp HHHHSCSS
T ss_pred HHHHcCCC
Confidence 99999988
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=455.33 Aligned_cols=408 Identities=24% Similarity=0.227 Sum_probs=304.7
Q ss_pred CcccccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcC-cccCCccccCCCCCCEEEccCCcCcccCC
Q 004268 6 TGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSL-TGRIPSEIGALSRLKVLDLSYNRLTGTIP 84 (764)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i-~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 84 (764)
.+..+.+.+- -.++++.|+|++|.+++..|..|..+++|++|+|++|.. ..+.|.+|.++++|++|+|++|.|++..|
T Consensus 12 s~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 12 RFCNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp SCCCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred cCCCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 3444555554 456788888888888888888888888888888888844 34457888888888888888888888788
Q ss_pred cccCCCCCCCEEecCCCcccccCCc--cCcCCCCCCEEEccCCcCcccCC-ccccCCCCcCEEecccCcccccCCccccC
Q 004268 85 SEIGSLRDLLDLNLSNNILNGSIPL--EFGNLKDLDQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161 (764)
Q Consensus 85 ~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 161 (764)
.+|.++++|++|+|++|.+++..+. .|.++++|++|+|++|.+.++.+ ..|.++++|++|+|++|.++++.+..|..
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 8888888888888888888864444 38888888888888888887654 46888888888888888887766666554
Q ss_pred C--CC------------------------------CCeeecccCCCCCCCCCccc-------------------------
Q 004268 162 L--KN------------------------------LKSLFLDNNHLSGPIPSTLY------------------------- 184 (764)
Q Consensus 162 l--~~------------------------------L~~L~L~~n~i~~~~~~~~~------------------------- 184 (764)
+ ++ |+.|++++|.+++..+..+.
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~ 250 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence 4 44 55555555544332222211
Q ss_pred -----------c--CCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC
Q 004268 185 -----------H--LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251 (764)
Q Consensus 185 -----------~--l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 251 (764)
. .++|+.|++++|.+..+.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++..
T Consensus 251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 330 (844)
T 3j0a_A 251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330 (844)
T ss_dssp SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence 1 156777888888777777777888888888888888888888888888888888888888888777
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCC------------------C------------
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP------------------P------------ 301 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------~------------ 301 (764)
+..|..+++|+.|+|++|.+..+.+..|.++++|+.|+|++|.+++... .
T Consensus 331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~ 410 (844)
T 3j0a_A 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE 410 (844)
T ss_dssp SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCS
T ss_pred HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeeccc
Confidence 8888888888888888888887777788888888888888887764211 0
Q ss_pred ----------CCCCCCccceEEccCCcCccC------------------------------CChhhhcccccceeecccc
Q 004268 302 ----------TIGYLTNLTYLNLGYNRLSSS------------------------------IPPELMNCSQLLNLVLSHN 341 (764)
Q Consensus 302 ----------~~~~l~~L~~L~ls~N~l~~~------------------------------~~~~~~~l~~L~~L~ls~N 341 (764)
.+..+++|++|+|++|++++. .+..|.++++|+.|+|++|
T Consensus 411 N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N 490 (844)
T 3j0a_A 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490 (844)
T ss_dssp CCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHH
T ss_pred CccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCC
Confidence 012455666666666665532 1233556677777777777
Q ss_pred ccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCccccccCCCCCCCC
Q 004268 342 SLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416 (764)
Q Consensus 342 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~~~~~ 416 (764)
++++..|..|.++++|+.|+|++|+|++..+..+. ++|+.|++++|++++..|..+..+..+++++|++.|..
T Consensus 491 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 491 YLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp HHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSS
T ss_pred cccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccc
Confidence 77777777777788888888888888776666665 77888888888888888888888999999999987743
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=437.18 Aligned_cols=400 Identities=20% Similarity=0.175 Sum_probs=226.6
Q ss_pred ccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCC
Q 004268 12 QLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLR 91 (764)
Q Consensus 12 ~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 91 (764)
...|..+++|++|++++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..++
T Consensus 50 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~ 129 (606)
T 3t6q_A 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK 129 (606)
T ss_dssp TTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCT
T ss_pred hhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCC
Confidence 44566667777777777777666666777777777777777777666666677777777777777777655556666777
Q ss_pred CCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcC--EEecccCcccccCCccccCC-------
Q 004268 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT--YLDLSLNQLSGRLPQEVGNL------- 162 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~~~~~~l------- 162 (764)
+|++|+|++|.++++....+.++++|++|++++|.++++.+..|..+++|+ .|++++|.++++.+..|...
T Consensus 130 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l 209 (606)
T 3t6q_A 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNF 209 (606)
T ss_dssp TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEEC
T ss_pred cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccccccc
Confidence 777777777777655444455566777777777776666666666666666 55666665554443322110
Q ss_pred --------------------------------------------CCCCeeecccCCCCCCCCCccccCCCccEEEecCcc
Q 004268 163 --------------------------------------------KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 163 --------------------------------------------~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
.+|+.|++++|.++++.+..|..+++|++|++++|.
T Consensus 210 ~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 289 (606)
T 3t6q_A 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289 (606)
T ss_dssp TTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSC
T ss_pred CCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCc
Confidence 023333333333333333334444555555555555
Q ss_pred CcCCcccccCCccccceeeccCcccccccCcc-------------------------ccCCCCCCEEEccCCcccCCC--
Q 004268 199 LVGPVTKEVGNMKNLDRLHLNGNNLTGSIPST-------------------------IGYLNLLDELHLSHNRLDGPI-- 251 (764)
Q Consensus 199 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~n~l~~~~-- 251 (764)
++.++ ..+..+++|++|++++|.+++..+.. +..+++|++|++++|.+.+..
T Consensus 290 l~~lp-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 368 (606)
T 3t6q_A 290 LSELP-SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368 (606)
T ss_dssp CSCCC-SSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEES
T ss_pred cCCCC-hhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCc
Confidence 44332 23444445555555555444444444 444455555555555554333
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCC-CCCCCCccceEEccCCcCccCCChhhhcc
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTYLNLGYNRLSSSIPPELMNC 330 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 330 (764)
+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|++.+..+. .+..+++|++|++++|.+++..|..+..+
T Consensus 369 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 448 (606)
T 3t6q_A 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGL 448 (606)
T ss_dssp TTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTC
T ss_pred chhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCC
Confidence 44455555555555555555555555555555555555555555544332 25555666666666666655555555556
Q ss_pred cccceeeccccccccC---CchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCc--cc
Q 004268 331 SQLLNLVLSHNSLSGS---IPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP--KL 405 (764)
Q Consensus 331 ~~L~~L~ls~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~--~~ 405 (764)
++|++|++++|++++. .+..+..+++|+.|+|++|++++..|..|.++++|+.|++++|++++..|..+..++ .+
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~L 528 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL 528 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSCEE
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccccEE
Confidence 6666666666665541 223455566666666666666655566666666666666666666665555544333 34
Q ss_pred cccCCCC
Q 004268 406 IVSENNL 412 (764)
Q Consensus 406 ~~~~n~~ 412 (764)
++++|.+
T Consensus 529 ~L~~N~l 535 (606)
T 3t6q_A 529 NLASNHI 535 (606)
T ss_dssp ECCSSCC
T ss_pred ECcCCcc
Confidence 4455554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=438.20 Aligned_cols=404 Identities=22% Similarity=0.236 Sum_probs=346.0
Q ss_pred ccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCC
Q 004268 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS 89 (764)
Q Consensus 10 ~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 89 (764)
+....|..+++|++|++++|.+++..|..|+.+++|++|++++|.++++.+..|..+++|++|+|++|++++.....+..
T Consensus 72 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 151 (606)
T 3t6q_A 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151 (606)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC
T ss_pred eChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccC
Confidence 44567899999999999999999888999999999999999999999877788999999999999999998655455566
Q ss_pred CCCCCEEecCCCcccccCCccCcCCCCCC--EEEccCCcCcccCC-----------------------------------
Q 004268 90 LRDLLDLNLSNNILNGSIPLEFGNLKDLD--QLRLQGNKLDGLIP----------------------------------- 132 (764)
Q Consensus 90 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~n~l~~~~~----------------------------------- 132 (764)
+++|++|+|++|.++++.+..|..+++|+ +|++++|.+.++.+
T Consensus 152 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~ 231 (606)
T 3t6q_A 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231 (606)
T ss_dssp CTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEE
T ss_pred CcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhhee
Confidence 88999999999988877777777777777 66666666654443
Q ss_pred ----------------------------------------ccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc
Q 004268 133 ----------------------------------------SSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 133 ----------------------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 172 (764)
..|.++++|++|++++|+++ ..|..+.++++|++|++++
T Consensus 232 ~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~ 310 (606)
T 3t6q_A 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310 (606)
T ss_dssp CCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTT
T ss_pred chhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECcc
Confidence 34566677788888888777 4455677778888888888
Q ss_pred CCCCCCCCCccccCCCccEEEecCccCc-CCcccccCCccccceeeccCccccccc--CccccCCCCCCEEEccCCcccC
Q 004268 173 NHLSGPIPSTLYHLNQLATLCLGYNKLV-GPVTKEVGNMKNLDRLHLNGNNLTGSI--PSTIGYLNLLDELHLSHNRLDG 249 (764)
Q Consensus 173 n~i~~~~~~~~~~l~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~ 249 (764)
|.++++.+..+..+++|++|++++|.+. .+....+..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+
T Consensus 311 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 390 (606)
T 3t6q_A 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390 (606)
T ss_dssp CCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEE
T ss_pred CCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCc
Confidence 8877766777778888888888888776 345556888999999999999998766 7789999999999999999998
Q ss_pred CCCcCCcCCCCCCeEEccCCcccCCCCc-cccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccC---CCh
Q 004268 250 PIPPTIGNLTNLIALDLSSNQLSGLLPR-EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS---IPP 325 (764)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~---~~~ 325 (764)
..+..|..+++|+.|++++|.+.+..+. .+..+++|+.|++++|.+.+..|..+..+++|++|++++|++++. .+.
T Consensus 391 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 470 (606)
T 3t6q_A 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470 (606)
T ss_dssp ECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSC
T ss_pred CCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccch
Confidence 8999999999999999999999876554 489999999999999999998999999999999999999999862 346
Q ss_pred hhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCcc---ccC
Q 004268 326 ELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV---RRI 402 (764)
Q Consensus 326 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~---~~~ 402 (764)
.+..+++|++|++++|++++..|..|..+++|+.|+|++|++++..|..|..+++| .|++++|++++..|..+ +.+
T Consensus 471 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L 549 (606)
T 3t6q_A 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549 (606)
T ss_dssp GGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTS
T ss_pred hhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCC
Confidence 78999999999999999999989999999999999999999999999999999999 99999999999888754 578
Q ss_pred ccccccCCCCCCC
Q 004268 403 PKLIVSENNLELE 415 (764)
Q Consensus 403 ~~~~~~~n~~~~~ 415 (764)
..+++++|++.|.
T Consensus 550 ~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 550 RTINLRQNPLDCT 562 (606)
T ss_dssp SEEECTTCCEECS
T ss_pred CEEeCCCCCcccc
Confidence 8999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=395.09 Aligned_cols=234 Identities=25% Similarity=0.367 Sum_probs=185.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +|+.||+|++.+.........+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999864 7999999999876655555567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+ +|+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 5799999874 346999999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
. ......+||+.|+|||++.+..| +.++||||+||++|+|+||+.||.+.+.... ........+..++..+.+++
T Consensus 165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 243 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 3 23345789999999999998886 5799999999999999999999987654221 12223334556899999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 244 ~~~L~~d 250 (275)
T 3hyh_A 244 KRMLIVN 250 (275)
T ss_dssp HHHSCSS
T ss_pred HHHccCC
Confidence 9999988
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=412.45 Aligned_cols=232 Identities=25% Similarity=0.416 Sum_probs=204.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|++.+.||+|+||+||+|+++ +|+.||||++....... .+.+.+|++++++++|||||++++++.+++.+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 357999999999999999999865 79999999997655443 25688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||+||+|.++++. ..+++.+++.|+.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 999999999999963 35899999999999999999999 89999999999999999999999999999998766
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~ 739 (764)
........+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+..+... .........++..+.+
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG 379 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHH
Confidence 6566667899999999999999999999999999999999999999998766533211 1123344568899999
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++++||+.+
T Consensus 380 li~~~L~~d 388 (423)
T 4fie_A 380 FLDRLLVRD 388 (423)
T ss_dssp HHHHHSCSS
T ss_pred HHHHHcCCC
Confidence 999999988
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=436.42 Aligned_cols=409 Identities=20% Similarity=0.121 Sum_probs=272.5
Q ss_pred CcccccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCc
Q 004268 6 TGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPS 85 (764)
Q Consensus 6 ~~~~~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 85 (764)
+|..+...+-.-.++++.|++++|.+++..+..|..+++|++|+|++|.++++.|.+|.++++|++|+|++|.+++..|.
T Consensus 19 ~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~ 98 (606)
T 3vq2_A 19 MDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98 (606)
T ss_dssp TTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT
T ss_pred cCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh
Confidence 34444444433345678888888888777777777888888888888888777777777788888888888887776677
Q ss_pred ccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCccc-CCccccCCCCcCEEecccCcccccCCccccCCCC
Q 004268 86 EIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164 (764)
Q Consensus 86 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 164 (764)
+|+++++|++|+|++|.++++.+..|+++++|++|++++|.+.++ .|..|.++++|++|+|++|+++++.+..|..+++
T Consensus 99 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 178 (606)
T 3vq2_A 99 SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178 (606)
T ss_dssp SSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHH
T ss_pred hcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhc
Confidence 788888888888888887766667777788888888888877753 3677777788888888887777766665554443
Q ss_pred CC----eeecccCCCCCCCCCcc---------------------------------------------------------
Q 004268 165 LK----SLFLDNNHLSGPIPSTL--------------------------------------------------------- 183 (764)
Q Consensus 165 L~----~L~L~~n~i~~~~~~~~--------------------------------------------------------- 183 (764)
|+ +|++++|.++.+.+..+
T Consensus 179 L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l 258 (606)
T 3vq2_A 179 NPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258 (606)
T ss_dssp CTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTG
T ss_pred cccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhh
Confidence 32 45555554443332222
Q ss_pred ---------------------------------------------ccCCCccEEEecCccCcCCc---------------
Q 004268 184 ---------------------------------------------YHLNQLATLCLGYNKLVGPV--------------- 203 (764)
Q Consensus 184 ---------------------------------------------~~l~~L~~L~l~~n~i~~~~--------------- 203 (764)
..+++|+.|++++|.+..++
T Consensus 259 ~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n 338 (606)
T 3vq2_A 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMN 338 (606)
T ss_dssp GGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESC
T ss_pred hhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCC
Confidence 22233334444444332221
Q ss_pred ----ccccCCccccceeeccCccccccc--CccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCC-
Q 004268 204 ----TKEVGNMKNLDRLHLNGNNLTGSI--PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP- 276 (764)
Q Consensus 204 ----~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~- 276 (764)
...+..+++|++|++++|.+++.. +..+..+++|+.|++++|.+.+ .|..+..+++|+.|++++|.+.+..+
T Consensus 339 ~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~ 417 (606)
T 3vq2_A 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417 (606)
T ss_dssp SSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTT
T ss_pred cCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccCh
Confidence 112334555666666666665442 5566666777777777777664 34566777777777777777766655
Q ss_pred ccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCcc-CCChhhhcccccceeeccccccccCCchhccccc
Q 004268 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS-SIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLI 355 (764)
Q Consensus 277 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 355 (764)
..+..+++|+.|++++|.+.+..|..+..+++|++|++++|++++ ..|..+..+++|++|+|++|++++..|..+.+++
T Consensus 418 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 497 (606)
T 3vq2_A 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497 (606)
T ss_dssp TTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc
Confidence 567777777777777777777677777777777777777777775 3566677777777777777777776677777777
Q ss_pred ccceeecccccccCCCCCCCCCCCccceecCCCCccccccCC--ccc-cCccccccCCCCCCC
Q 004268 356 FFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA--SVR-RIPKLIVSENNLELE 415 (764)
Q Consensus 356 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~-~~~~~~~~~n~~~~~ 415 (764)
+|+.|+|++|++++..|..|..+++|+.|++++|+++..++. .++ .+..+++++|++.|.
T Consensus 498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 777777777777776677777777777777777777744433 112 356677777777553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=403.62 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=196.9
Q ss_pred hcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
++|++.+.||+|+||+||+|+.. +++.||+|++.+....... ..++.+|++++++++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 67999999999999999999752 5789999999764432211 246778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+|||||+||+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999974 446999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 740 (764)
..........+||+.|||||++.+..|+.++||||+||++|||+||++||.+.+..+. ........+..++.++.++
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 5544455567899999999999999999999999999999999999999987665332 1223344456689999999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++||+.++.-|
T Consensus 257 i~~~L~~dP~~R 268 (304)
T 3ubd_A 257 LRMLFKRNPANR 268 (304)
T ss_dssp HHHHTCSSGGGS
T ss_pred HHHHcccCHHHC
Confidence 999999884443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=396.05 Aligned_cols=231 Identities=23% Similarity=0.274 Sum_probs=195.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|++.+.||+|+||+||+|+++ +|+.||||++...... .+|+.++++++|||||++++++.+++.+|+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457888999999999999999865 7999999999765432 3699999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~ 664 (764)
||||+||+|.+++++ ...+++..++.++.||+.||+||| ++|||||||||+|||++.+| .+||+|||+|+...
T Consensus 129 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 999999999999973 346999999999999999999999 99999999999999999887 69999999998775
Q ss_pred CCCCC-----ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------cCCCCCCC
Q 004268 665 PDSSN-----RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------KISQNPRL 733 (764)
Q Consensus 665 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------~~~~~~~~ 733 (764)
..... ....+||+.|||||++.+..|+.++||||+||++|||+||++||.+.+........ ....++.+
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence 43221 12357999999999999999999999999999999999999999876653322111 11235678
Q ss_pred cHHHHHHHhhhhccchhh
Q 004268 734 DLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~ 751 (764)
+..+.+++++||+.++.-
T Consensus 283 s~~~~~li~~~L~~dP~~ 300 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVH 300 (336)
T ss_dssp CHHHHHHHHHHTCSSGGG
T ss_pred CHHHHHHHHHHccCCHhH
Confidence 899999999999988433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=384.48 Aligned_cols=230 Identities=25% Similarity=0.404 Sum_probs=191.0
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKCMFL 584 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~l 584 (764)
|++.+.||+|+||+||+|.+. +++.||+|++....... ...+.+.+|++++++++|||||++++++.+ ++.+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 367788999999999999865 78999999997655433 345789999999999999999999999865 356899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecC-CCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNS-NLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~ 661 (764)
|||||+||+|.+++.+ ...+++..++.|+.||+.||+||| ++| ||||||||+|||+++ ++.+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999999974 456899999999999999999999 778 999999999999984 7999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----C-CcCCCCCCCcH
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----G-RKISQNPRLDL 735 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~-~~~~~~~~~~~ 735 (764)
... .......+||+.|||||++.+ .|+.++||||+||++|||+||++||.+........ . .........++
T Consensus 181 ~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 181 LKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred eCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 643 234456789999999999875 69999999999999999999999997654422111 1 11112334567
Q ss_pred HHHHHHhhhhccch
Q 004268 736 QCNAYLKNFSQGNH 749 (764)
Q Consensus 736 ~~~~~~~~~l~~~~ 749 (764)
++.+++++||+.++
T Consensus 258 ~~~~li~~~L~~dP 271 (290)
T 3fpq_A 258 EVKEIIEGCIRQNK 271 (290)
T ss_dssp HHHHHHHHHSCSSG
T ss_pred HHHHHHHHHccCCh
Confidence 89999999999883
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=427.83 Aligned_cols=196 Identities=21% Similarity=0.229 Sum_probs=132.8
Q ss_pred cccccccCccccCCCCCCEEEccCCcccCCCC-cCCcCCCCCCeEEccCCcccC--------------------------
Q 004268 221 NNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP-PTIGNLTNLIALDLSSNQLSG-------------------------- 273 (764)
Q Consensus 221 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~-------------------------- 273 (764)
|+++++.+..|..+++|+.|+|++|.+.+..+ ..|.++++|+.|++++|++.+
T Consensus 391 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 470 (680)
T 1ziw_A 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470 (680)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTT
T ss_pred CCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccc
Confidence 33444444555555556666666665543222 345555555555555554433
Q ss_pred CCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCC--------hhhhcccccceeecccccccc
Q 004268 274 LLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP--------PELMNCSQLLNLVLSHNSLSG 345 (764)
Q Consensus 274 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~ls~N~l~~ 345 (764)
..|..|.++++|+.|++++|+++++.+..+..+++|++|+|++|++++..+ ..|.++++|+.|+|++|+++.
T Consensus 471 ~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 550 (680)
T 1ziw_A 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550 (680)
T ss_dssp CSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCC
T ss_pred cCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCC
Confidence 345666777777777777777777766777777777888888777774321 236777788888888888875
Q ss_pred CCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCC----ccccCccccccCCCCCCCC
Q 004268 346 SIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA----SVRRIPKLIVSENNLELEN 416 (764)
Q Consensus 346 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~----~~~~~~~~~~~~n~~~~~~ 416 (764)
..+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++++..|. .++.+..+++++|++.|..
T Consensus 551 i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 5555678888888888888888877777778888888888888888877665 3467788888888887654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=426.15 Aligned_cols=404 Identities=24% Similarity=0.247 Sum_probs=292.1
Q ss_pred ccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCC
Q 004268 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS 89 (764)
Q Consensus 10 ~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 89 (764)
++...|..+++|++|++++|.+++..|..|..+++|++|+|++|.++++.+.+|.++++|++|+|++|++++..+..|+.
T Consensus 40 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 119 (680)
T 1ziw_A 40 LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119 (680)
T ss_dssp CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTT
T ss_pred cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccc
Confidence 34455777788888888888888777777888888888888888887666667888888888888888887666677888
Q ss_pred CCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCcccc--CCCCcCEEecccCcccccCCc----------
Q 004268 90 LRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIG--NLTNLTYLDLSLNQLSGRLPQ---------- 157 (764)
Q Consensus 90 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~~~---------- 157 (764)
+++|++|+|++|.+++..+..|.++++|++|++++|.++++.+..+. .+++|++|++++|.++++.+.
T Consensus 120 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 199 (680)
T 1ziw_A 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFG 199 (680)
T ss_dssp CTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECE
T ss_pred cCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhh
Confidence 88888888888888777777777777777777777777665554432 234455555554444433322
Q ss_pred -----------------------------------------cccCCC--CCCeeecccCCCCCCCCCccccCCCccEEEe
Q 004268 158 -----------------------------------------EVGNLK--NLKSLFLDNNHLSGPIPSTLYHLNQLATLCL 194 (764)
Q Consensus 158 -----------------------------------------~~~~l~--~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 194 (764)
.|.+++ +|+.|++++|.++++.+..|..+++|++|++
T Consensus 200 L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (680)
T 1ziw_A 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279 (680)
T ss_dssp EECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred hhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeC
Confidence 222222 2666666666666555566666666666666
Q ss_pred cCccCcCCccc---------------------------------ccCCccccceeeccCcccccccCccccCCCCCCEEE
Q 004268 195 GYNKLVGPVTK---------------------------------EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241 (764)
Q Consensus 195 ~~n~i~~~~~~---------------------------------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 241 (764)
++|.+..+.+. .|..+++|++|++++|.+++..+..|..+++|++|+
T Consensus 280 ~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 359 (680)
T 1ziw_A 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359 (680)
T ss_dssp CSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEE
T ss_pred CCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEE
Confidence 66655433221 455567777777778888777666666666555555
Q ss_pred c----------------------------cCCcccCCCCcCCcCCCCCCeEEccCCcccCCC-CccccCCCCCCeEeccC
Q 004268 242 L----------------------------SHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL-PREVGNLKYLASLSLNG 292 (764)
Q Consensus 242 L----------------------------~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~ 292 (764)
+ ++|.++++.+.+|..+++|+.|+|++|.+.+.. +..|.++++|+.|++++
T Consensus 360 Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~ 439 (680)
T 1ziw_A 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439 (680)
T ss_dssp CTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCS
T ss_pred CCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCC
Confidence 5 555666667788999999999999999997644 47899999999999999
Q ss_pred ccccCCCCCCCCCCCccceEEccCCcCc--cCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCC
Q 004268 293 NILIGPIPPTIGYLTNLTYLNLGYNRLS--SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGT 370 (764)
Q Consensus 293 n~l~~~~~~~~~~l~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 370 (764)
|++.+..+..|..+++|+.|++++|.++ +..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++.
T Consensus 440 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~ 519 (680)
T 1ziw_A 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL 519 (680)
T ss_dssp CSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGG
T ss_pred CCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcccc
Confidence 9998888888888888888888888876 35677788888888888888888877777788888888888888888754
Q ss_pred CC--------CCCCCCCccceecCCCCccccccCCcc---ccCccccccCCCCC
Q 004268 371 IP--------SQLGKIPNISAVDLSKNNLSGVIPASV---RRIPKLIVSENNLE 413 (764)
Q Consensus 371 ~~--------~~~~~l~~L~~l~l~~N~l~~~~~~~~---~~~~~~~~~~n~~~ 413 (764)
.+ ..|.++++|+.|++++|+++...+..| +.+..+++++|.+.
T Consensus 520 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 573 (680)
T 1ziw_A 520 WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573 (680)
T ss_dssp GSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred chhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCC
Confidence 22 236777888888888888886555444 46677778888775
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=389.04 Aligned_cols=238 Identities=28% Similarity=0.459 Sum_probs=199.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|.+.+.||+|+||+||+|++. +++.||||++.... ....+++.+|++++++++|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 367889999999999999999753 47789999997542 344578999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV----------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
..|+|||||++|+|.++++... ....+++.++..|+.||+.||+||| +++||||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCC
Confidence 9999999999999999997532 2346999999999999999999999 89999999999999999999
Q ss_pred CEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----c
Q 004268 651 EAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----S 723 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~ 723 (764)
.+||+|||+|+......... ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.. .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999998764332221 22468999999999999999999999999999999998 99999987653321 1
Q ss_pred CCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 724 GRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
......++..+..+.+++.+||+.++.
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~ 272 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPH 272 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChh
Confidence 223344556788999999999998843
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=429.89 Aligned_cols=392 Identities=21% Similarity=0.299 Sum_probs=349.8
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcC-------------------------------------------
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSL------------------------------------------- 55 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i------------------------------------------- 55 (764)
-.++.|+|+++++.|.+|++++.+++|++|+|++|.+
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~ 160 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHH
Confidence 3699999999999999999999999999999999843
Q ss_pred -----------------------------------cccCCccccCCCCCCEEEccCCcCccc-----------------C
Q 004268 56 -----------------------------------TGRIPSEIGALSRLKVLDLSYNRLTGT-----------------I 83 (764)
Q Consensus 56 -----------------------------------~~~~~~~~~~l~~L~~L~L~~n~i~~~-----------------~ 83 (764)
++ +|..|.++++|++|+|++|.+++. +
T Consensus 161 ~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~i 239 (636)
T 4eco_A 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239 (636)
T ss_dssp HHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccC
Confidence 34 678899999999999999999975 8
Q ss_pred CcccC--CCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCc-Ccc-cCCccccCC------CCcCEEecccCcccc
Q 004268 84 PSEIG--SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK-LDG-LIPSSIGNL------TNLTYLDLSLNQLSG 153 (764)
Q Consensus 84 ~~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~l~~ 153 (764)
|..++ .+++|++|+|++|.+.+..|..|.++++|++|+|++|+ +++ ..|..+..+ ++|++|+|++|+++
T Consensus 240 p~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~- 318 (636)
T 4eco_A 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK- 318 (636)
T ss_dssp TSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-
T ss_pred chhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-
Confidence 99999 99999999999999999999999999999999999998 987 677777776 99999999999999
Q ss_pred cCCc--cccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccc-cceeeccCcccccccCcc
Q 004268 154 RLPQ--EVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKN-LDRLHLNGNNLTGSIPST 230 (764)
Q Consensus 154 ~~~~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~ 230 (764)
..|. .|.++++|++|++++|.+++..+ .+..+++|+.|++++|++..+ +..+..+++ |++|++++|.++ ..|..
T Consensus 319 ~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~l-p~~l~~l~~~L~~L~Ls~N~l~-~lp~~ 395 (636)
T 4eco_A 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI-PANFCGFTEQVENLSFAHNKLK-YIPNI 395 (636)
T ss_dssp SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEEC-CTTSEEECTTCCEEECCSSCCS-SCCSC
T ss_pred ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccc-cHhhhhhcccCcEEEccCCcCc-ccchh
Confidence 5666 89999999999999999996566 899999999999999999954 455888999 999999999999 66777
Q ss_pred ccCCC--CCCEEEccCCcccCCCCcCCc-------CCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCC
Q 004268 231 IGYLN--LLDELHLSHNRLDGPIPPTIG-------NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP 301 (764)
Q Consensus 231 ~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 301 (764)
+..++ +|+.|++++|.+.+..|..+. .+++|+.|+|++|.++.+.+..+..+++|+.|+|++|++..+.+.
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~ 475 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSS
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHH
Confidence 77654 899999999999998888888 888999999999999977777788899999999999999955555
Q ss_pred CCCCCC-------ccceEEccCCcCccCCChhhh--cccccceeeccccccccCCchhcccccccceeec------cccc
Q 004268 302 TIGYLT-------NLTYLNLGYNRLSSSIPPELM--NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDL------SRNF 366 (764)
Q Consensus 302 ~~~~l~-------~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l------~~N~ 366 (764)
.+.... +|++|+|++|+++ .+|..+. .+++|++|+|++|++++ +|..+..+++|+.|+| ++|+
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~ 553 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCB
T ss_pred HhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCc
Confidence 554443 9999999999999 6778786 99999999999999996 8889999999999999 5688
Q ss_pred ccCCCCCCCCCCCccceecCCCCccccccCCccccCccccccCCCCCCCCC
Q 004268 367 INGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELENS 417 (764)
Q Consensus 367 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~~~~~~ 417 (764)
+.+.+|..+..+++|+.|++++|+++.++....+.+..+++++|++.+-+.
T Consensus 554 l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 554 TLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCCTTCCEEECCSCTTCEEEC
T ss_pred ccccChHHHhcCCCCCEEECCCCcCCccCHhHhCcCCEEECcCCCCccccH
Confidence 888999999999999999999999965544466899999999999976543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=425.06 Aligned_cols=386 Identities=23% Similarity=0.221 Sum_probs=329.6
Q ss_pred ccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCC
Q 004268 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS 89 (764)
Q Consensus 10 ~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 89 (764)
+....|.++++|++|++++|.+++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|+.
T Consensus 47 ~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 126 (606)
T 3vq2_A 47 LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126 (606)
T ss_dssp ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTT
T ss_pred eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCC
Confidence 44557899999999999999999988999999999999999999999888999999999999999999999777788999
Q ss_pred CCCCCEEecCCCccccc-CCccCcCCCCCCEEEccCCcCcccCCccccCCCCcC----EEecccCcccccCCcc------
Q 004268 90 LRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT----YLDLSLNQLSGRLPQE------ 158 (764)
Q Consensus 90 l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~------ 158 (764)
+++|++|+|++|.++++ .|..|+++++|++|++++|+++++.+..|..+++|+ +|++++|.++.+.+..
T Consensus 127 l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L 206 (606)
T 3vq2_A 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKL 206 (606)
T ss_dssp CTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEE
T ss_pred CCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCcee
Confidence 99999999999999864 488899999999999999999988877776655443 4555555554333322
Q ss_pred --------------------------------------------------------------------------------
Q 004268 159 -------------------------------------------------------------------------------- 158 (764)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (764)
T Consensus 207 ~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~ 286 (606)
T 3vq2_A 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286 (606)
T ss_dssp EEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTT
T ss_pred eeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCC
Confidence
Q ss_pred ----------------ccCCCCCCeeecccCCCCCCC-------------------CCccccCCCccEEEecCccCcCCc
Q 004268 159 ----------------VGNLKNLKSLFLDNNHLSGPI-------------------PSTLYHLNQLATLCLGYNKLVGPV 203 (764)
Q Consensus 159 ----------------~~~l~~L~~L~L~~n~i~~~~-------------------~~~~~~l~~L~~L~l~~n~i~~~~ 203 (764)
+..+++|++|++++|.+..+. ...+..+++|+.|++++|.+....
T Consensus 287 L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~ 366 (606)
T 3vq2_A 287 VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366 (606)
T ss_dssp CSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEE
T ss_pred CCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCc
Confidence 333345555666665553222 113446677788888888877653
Q ss_pred --ccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCC-cCCcCCCCCCeEEccCCcccCCCCcccc
Q 004268 204 --TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP-PTIGNLTNLIALDLSSNQLSGLLPREVG 280 (764)
Q Consensus 204 --~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 280 (764)
+..+..+++|++|++++|.+++ .+..+..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|.+.+..+..+.
T Consensus 367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 445 (606)
T 3vq2_A 367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445 (606)
T ss_dssp ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence 5678889999999999999996 45889999999999999999998877 6899999999999999999988999999
Q ss_pred CCCCCCeEeccCccccC-CCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccce
Q 004268 281 NLKYLASLSLNGNILIG-PIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQ 359 (764)
Q Consensus 281 ~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~ 359 (764)
++++|+.|++++|.+.+ ..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++|+.
T Consensus 446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 525 (606)
T 3vq2_A 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525 (606)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence 99999999999999987 47889999999999999999999888999999999999999999999988999999999999
Q ss_pred eecccccccCCCCCCCCCCC-ccceecCCCCccccccCC
Q 004268 360 LDLSRNFINGTIPSQLGKIP-NISAVDLSKNNLSGVIPA 397 (764)
Q Consensus 360 L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~ 397 (764)
|+|++|+++ .+|..+..++ +|+.|++++|++.|..+.
T Consensus 526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999 5666688887 599999999999987764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=387.15 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=200.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
..++++.+.||+|+||+||+|.+. +++.||||++....... ..++|.+|+.++++++|||||+++|++.+++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--HHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 356788899999999999999752 56789999997654332 2478999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
..++|||||++|+|.+++.... ....+++.++..|+.||+.||+||| +++||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence 9999999999999999996432 1345899999999999999999999 89999999999999999
Q ss_pred CCCCEEEeeeccccccCCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc--
Q 004268 648 SNLEAFVADFGLARLLHPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-- 722 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-- 722 (764)
+++.+||+|||+|+...... ...+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998764322 22334678999999999999999999999999999999998 89999987653322
Q ss_pred --cCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 723 --SGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 723 --~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.......++..+..+.+++.+||+.++.-|
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 122233455678889999999999885544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=388.50 Aligned_cols=238 Identities=27% Similarity=0.467 Sum_probs=194.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|.+.+.||+|+||+||+|+++ +++.||||++... .....+.|.+|++++++++|||||++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 356788899999999999999764 4788999999753 2344578999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
..|+|||||++|+|.++++... ...++++.++..|+.||+.||+||| +++||||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECC
Confidence 9999999999999999997542 2346899999999999999999999 889999999999999999
Q ss_pred CCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc---
Q 004268 649 NLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS--- 722 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~--- 722 (764)
++.+||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+..
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987643322 2234578999999999999999999999999999999999 99999887653321
Q ss_pred -cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 723 -SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 723 -~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.......++..+..+.+++++||+.++.
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~ 302 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQ 302 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTT
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChh
Confidence 2233444556788999999999998743
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=418.49 Aligned_cols=395 Identities=21% Similarity=0.184 Sum_probs=294.2
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
.++++.|++++|.+++..+.+|..+++|++|+|++|+++++.+..|.++++|++|+|++|+++...+.+|.++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 34688888888888877777888888888888888888877777888888888888888888877777888888888888
Q ss_pred cCCCcccccCCccCcCCCCCCEEEccCCcCccc-CCccccCCCCcCEEecccCcccccCCccccCCCCC----Ceeeccc
Q 004268 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL----KSLFLDN 172 (764)
Q Consensus 98 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~ 172 (764)
|++|.++.+.+..|+++++|++|++++|.+.++ .|..|.++++|++|++++|+++++.+..|..+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 888888876666788888888888888888764 47778888888888888888887777777777776 6777777
Q ss_pred CCCCCCCCCcc---------------------------------------------------------------------
Q 004268 173 NHLSGPIPSTL--------------------------------------------------------------------- 183 (764)
Q Consensus 173 n~i~~~~~~~~--------------------------------------------------------------------- 183 (764)
|.++.+.+..+
T Consensus 187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 77665544433
Q ss_pred ------------ccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccc-------------------c
Q 004268 184 ------------YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTI-------------------G 232 (764)
Q Consensus 184 ------------~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-------------------~ 232 (764)
..+++|+.|++++|.+..++ ..+..+ +|++|++++|.+.......+ .
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~-~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~ 344 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSCC-BCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhhh-hhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccc
Confidence 33455556666655555432 223333 45555555554442211111 3
Q ss_pred CCCCCCEEEccCCcccCCC--CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCC-CCCCCCCcc
Q 004268 233 YLNLLDELHLSHNRLDGPI--PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP-PTIGYLTNL 309 (764)
Q Consensus 233 ~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L 309 (764)
.+++|+.|++++|.+++.. +..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+.+..+ ..+..+++|
T Consensus 345 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 423 (570)
T 2z63_A 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423 (570)
T ss_dssp BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC
T ss_pred cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC
Confidence 4566777777777766443 45566777788888888877755444 7888888888888888877655 467888888
Q ss_pred ceEEccCCcCccCCChhhhcccccceeeccccccc-cCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCC
Q 004268 310 TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS-GSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388 (764)
Q Consensus 310 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 388 (764)
++|++++|.+++..|..+.++++|++|++++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|+.|++++
T Consensus 424 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 88888888888778888888888888888888887 46778888888888899988888888888888888888899988
Q ss_pred CccccccCCcc---ccCccccccCCCCCCC
Q 004268 389 NNLSGVIPASV---RRIPKLIVSENNLELE 415 (764)
Q Consensus 389 N~l~~~~~~~~---~~~~~~~~~~n~~~~~ 415 (764)
|++++..|..+ +.+..+++++|++.|.
T Consensus 504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 88888777654 4667778888888654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=380.67 Aligned_cols=235 Identities=25% Similarity=0.434 Sum_probs=190.4
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+++++.+.||+|+||+||+|+++ ..||||+++.... .....+.|.+|++++++++|||||++++++.+ +..|+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 467889999999999999999875 3699999875543 34456889999999999999999999998865 4589999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
|||++|+|.+++... ...+++.++..|+.||+.||+||| +++||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999743 346899999999999999999999 889999999999999999999999999999876432
Q ss_pred C--CCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCc----CCCCCC
Q 004268 667 S--SNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRK----ISQNPR 732 (764)
Q Consensus 667 ~--~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~----~~~~~~ 732 (764)
. ......+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..... .... ....+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 2 223456899999999998643 5899999999999999999999999876542211 1111 122345
Q ss_pred CcHHHHHHHhhhhccchh
Q 004268 733 LDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~ 750 (764)
.+..+.+++.+||+.++.
T Consensus 266 ~~~~l~~li~~cl~~dP~ 283 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKE 283 (307)
T ss_dssp SCHHHHHHHHHHTCSSST
T ss_pred chHHHHHHHHHHcCCCHh
Confidence 678899999999998843
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=430.19 Aligned_cols=382 Identities=22% Similarity=0.216 Sum_probs=307.4
Q ss_pred cccccccCCCeeEEEeCCCCccccC-CccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcc--c
Q 004268 11 SQLNFTCFPNLVTFRIWGTLLSGRM-PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSE--I 87 (764)
Q Consensus 11 ~~~~~~~~~~l~~L~l~~~~~~~~~-~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~ 87 (764)
....|..+++|+.|++++|...+.+ |..|..+++|++|+|++|.+++..|+.|.++++|++|+|++|.+++..+.. |
T Consensus 40 ~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 119 (844)
T 3j0a_A 40 TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119 (844)
T ss_dssp CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCC
T ss_pred ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccc
Confidence 3456778888888888888554444 677888888888888888888777888888888888888888887644443 7
Q ss_pred CCCCCCCEEecCCCcccccCC-ccCcCCCCCCEEEccCCcCcccCCccccCC--CC------------------------
Q 004268 88 GSLRDLLDLNLSNNILNGSIP-LEFGNLKDLDQLRLQGNKLDGLIPSSIGNL--TN------------------------ 140 (764)
Q Consensus 88 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~------------------------ 140 (764)
..+++|++|+|++|.+++..+ ..|+++++|++|+|++|.++++.+..|..+ ++
T Consensus 120 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 199 (844)
T 3j0a_A 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199 (844)
T ss_dssp SSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC
T ss_pred cccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCC
Confidence 788888888888888876654 467888888888888888776665555433 22
Q ss_pred ------cCEEecccCcccccCCccc------------------------------------cC--CCCCCeeecccCCCC
Q 004268 141 ------LTYLDLSLNQLSGRLPQEV------------------------------------GN--LKNLKSLFLDNNHLS 176 (764)
Q Consensus 141 ------L~~L~L~~n~l~~~~~~~~------------------------------------~~--l~~L~~L~L~~n~i~ 176 (764)
|++|+|++|.+++..+..+ .+ .++|+.|++++|.++
T Consensus 200 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~ 279 (844)
T 3j0a_A 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279 (844)
T ss_dssp TTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCC
T ss_pred ccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCccc
Confidence 6777777776543333222 22 268999999999999
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCc
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 256 (764)
++.+..|..+++|+.|+|++|++..+.+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|.+..+.+..|.
T Consensus 280 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 359 (844)
T 3j0a_A 280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359 (844)
T ss_dssp EECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSC
T ss_pred ccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhc
Confidence 88899999999999999999999998889999999999999999999988899999999999999999999988888999
Q ss_pred CCCCCCeEEccCCcccCCCC----------------------------------------ccccCCCCCCeEeccCcccc
Q 004268 257 NLTNLIALDLSSNQLSGLLP----------------------------------------REVGNLKYLASLSLNGNILI 296 (764)
Q Consensus 257 ~l~~L~~L~L~~n~l~~~~~----------------------------------------~~~~~l~~L~~L~l~~n~l~ 296 (764)
.+++|+.|+|++|.++++.. ..+.++++|+.|+|++|++.
T Consensus 360 ~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~ 439 (844)
T 3j0a_A 360 FLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439 (844)
T ss_dssp SCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred CCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence 99999999999998874321 01225666777777776665
Q ss_pred CC------------------------------CCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccC
Q 004268 297 GP------------------------------IPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGS 346 (764)
Q Consensus 297 ~~------------------------------~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 346 (764)
+. .+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.
T Consensus 440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l 519 (844)
T 3j0a_A 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519 (844)
T ss_dssp CCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSC
T ss_pred ccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCcc
Confidence 32 224477889999999999999988888899999999999999999987
Q ss_pred CchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCC
Q 004268 347 IPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA 397 (764)
Q Consensus 347 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 397 (764)
.+..+. ++|+.|||++|++++..|..|. +|+.+++++|++.|.++-
T Consensus 520 ~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 520 SHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECEL 565 (844)
T ss_dssp CCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSC
T ss_pred Chhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCccccccc
Confidence 777666 8999999999999999888764 788999999999987663
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=413.84 Aligned_cols=385 Identities=22% Similarity=0.242 Sum_probs=339.8
Q ss_pred ccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCC
Q 004268 10 LSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS 89 (764)
Q Consensus 10 ~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 89 (764)
+....|.++++|++|++++|.+++..+..|..+++|++|+|++|.++++.+..|.++++|++|++++|+++...+..|+.
T Consensus 43 ~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~ 122 (570)
T 2z63_A 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122 (570)
T ss_dssp ECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTT
T ss_pred cChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccc
Confidence 34457999999999999999999988899999999999999999999888899999999999999999999766668999
Q ss_pred CCCCCEEecCCCccccc-CCccCcCCCCCCEEEccCCcCcccCCccccCCCCc----CEEecccCcccccCCc-------
Q 004268 90 LRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNL----TYLDLSLNQLSGRLPQ------- 157 (764)
Q Consensus 90 l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~~~------- 157 (764)
+++|++|+|++|.++++ .|..|+++++|++|++++|+++++.+..|..+++| +.|++++|.++++.+.
T Consensus 123 l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L 202 (570)
T 2z63_A 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202 (570)
T ss_dssp CTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEE
T ss_pred cccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcc
Confidence 99999999999999874 58899999999999999999998888888888888 7888888877655443
Q ss_pred --------------------------------------------------------------------------cccCCC
Q 004268 158 --------------------------------------------------------------------------EVGNLK 163 (764)
Q Consensus 158 --------------------------------------------------------------------------~~~~l~ 163 (764)
.|..++
T Consensus 203 ~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~ 282 (570)
T 2z63_A 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282 (570)
T ss_dssp EEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGT
T ss_pred eeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcC
Confidence 344567
Q ss_pred CCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccccc-------------------CCccccceeeccCcccc
Q 004268 164 NLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-------------------GNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 164 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~-------------------~~l~~L~~L~L~~n~l~ 224 (764)
+|++|++++|.++. .+..+..+ +|++|++++|.+..++...+ ..+++|++|++++|.++
T Consensus 283 ~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~ 360 (570)
T 2z63_A 283 NVSSFSLVSVTIER-VKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360 (570)
T ss_dssp TCSEEEEESCEECS-CCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCB
T ss_pred cccEEEecCccchh-hhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccC
Confidence 89999999998884 45566666 78888888887775544322 56788999999999998
Q ss_pred ccc--CccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCC-ccccCCCCCCeEeccCccccCCCCC
Q 004268 225 GSI--PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP-REVGNLKYLASLSLNGNILIGPIPP 301 (764)
Q Consensus 225 ~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~ 301 (764)
+.. +..+..+++|+.|++++|.+.+..+. +..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|.+.+..|.
T Consensus 361 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 439 (570)
T 2z63_A 361 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439 (570)
T ss_dssp EEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTT
T ss_pred ccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchh
Confidence 654 67788999999999999999966554 9999999999999999987755 5789999999999999999999999
Q ss_pred CCCCCCccceEEccCCcCc-cCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCc
Q 004268 302 TIGYLTNLTYLNLGYNRLS-SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380 (764)
Q Consensus 302 ~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 380 (764)
.+..+++|++|++++|+++ +..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+..|..+++
T Consensus 440 ~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 519 (570)
T 2z63_A 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519 (570)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccC
Confidence 9999999999999999998 468889999999999999999999888999999999999999999999998899999999
Q ss_pred cceecCCCCccccccCC
Q 004268 381 ISAVDLSKNNLSGVIPA 397 (764)
Q Consensus 381 L~~l~l~~N~l~~~~~~ 397 (764)
|+.|++++|+++|.+|.
T Consensus 520 L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 520 LQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CCEEECCSSCBCCCTTT
T ss_pred CcEEEecCCcccCCCcc
Confidence 99999999999998875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=379.17 Aligned_cols=234 Identities=22% Similarity=0.362 Sum_probs=182.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... +...+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999865 799999999976543 334578899999999999999999999987544
Q ss_pred -------EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 581 -------CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 581 -------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
..|+|||||++|+|.+++.........++..++.|+.||+.||+||| ++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence 37999999999999999986655556677788999999999999999 89999999999999999999999
Q ss_pred EeeeccccccCCCCC------------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-c
Q 004268 654 VADFGLARLLHPDSS------------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-S 720 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~ 720 (764)
|+|||+|+....... ..+..+||+.|||||++.+..|+.++||||+||++|||++ ||....+. .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 1233579999999999999999999999999999999996 88754321 1
Q ss_pred cccCCcCCCCCC----CcHHHHHHHhhhhccc
Q 004268 721 SSSGRKISQNPR----LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 721 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~~ 748 (764)
..........|. .++...+++++||+.+
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~d 267 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS 267 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSS
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 111111112222 2345678999999988
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=420.38 Aligned_cols=388 Identities=19% Similarity=0.280 Sum_probs=335.9
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEc-CCCcCccc---------------------------------------
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVL-SHNSLTGR--------------------------------------- 58 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~L-s~n~i~~~--------------------------------------- 58 (764)
..++.|+|++|++.|.+|+.++.+++|++|+| ++|.+++.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 77754332
Q ss_pred -------------------------------------CCccccCCCCCCEEEccCCcCcc-----------------cCC
Q 004268 59 -------------------------------------IPSEIGALSRLKVLDLSYNRLTG-----------------TIP 84 (764)
Q Consensus 59 -------------------------------------~~~~~~~l~~L~~L~L~~n~i~~-----------------~~~ 84 (764)
+|..|.++++|++|+|++|++++ .+|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 67889999999999999999997 388
Q ss_pred cccC--CCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCc-Ccc-cCCccccCC-------CCcCEEecccCcccc
Q 004268 85 SEIG--SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK-LDG-LIPSSIGNL-------TNLTYLDLSLNQLSG 153 (764)
Q Consensus 85 ~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l-------~~L~~L~L~~n~l~~ 153 (764)
..++ .+++|++|+|++|.+.+..|..|.++++|++|+|++|+ +++ ..|..+.++ ++|++|+|++|+++
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~- 561 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-
Confidence 8877 99999999999999998999999999999999999998 887 566655555 49999999999999
Q ss_pred cCCc--cccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccc-cceeeccCcccccccCcc
Q 004268 154 RLPQ--EVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKN-LDRLHLNGNNLTGSIPST 230 (764)
Q Consensus 154 ~~~~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~ 230 (764)
..|. .|.++++|+.|+|++|.++ ..| .|..+++|+.|+|++|++.. .+..+..+++ |+.|+|++|.++ .+|..
T Consensus 562 ~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~-lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~ 637 (876)
T 4ecn_A 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637 (876)
T ss_dssp BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSC-CCTTSCEECTTCCEEECCSSCCC-SCCSC
T ss_pred ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcccc-chHHHhhccccCCEEECcCCCCC-cCchh
Confidence 5666 8999999999999999999 455 89999999999999999994 4556888998 999999999999 56777
Q ss_pred ccCCCC--CCEEEccCCcccCCCCcCC---c--CCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCC
Q 004268 231 IGYLNL--LDELHLSHNRLDGPIPPTI---G--NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303 (764)
Q Consensus 231 ~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 303 (764)
+..++. |+.|+|++|.+.+.+|... . .+++|+.|+|++|.+..+.+..+..+++|+.|+|++|++..+.+..+
T Consensus 638 ~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~ 717 (876)
T 4ecn_A 638 FNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717 (876)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSS
T ss_pred hhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHh
Confidence 776654 9999999999987655322 2 34589999999999996655556789999999999999985444444
Q ss_pred CCC-------CccceEEccCCcCccCCChhhh--cccccceeeccccccccCCchhcccccccceeeccc------cccc
Q 004268 304 GYL-------TNLTYLNLGYNRLSSSIPPELM--NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSR------NFIN 368 (764)
Q Consensus 304 ~~l-------~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~------N~l~ 368 (764)
... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.
T Consensus 718 ~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~ 795 (876)
T 4ecn_A 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795 (876)
T ss_dssp SCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCC
T ss_pred ccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccccc
Confidence 332 39999999999999 7788887 99999999999999996 788899999999999976 8888
Q ss_pred CCCCCCCCCCCccceecCCCCccccccCCccccCccccccCCCCC
Q 004268 369 GTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413 (764)
Q Consensus 369 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~~ 413 (764)
+.+|..+..+++|+.|+|++|++..+++...+.+..+++++|++.
T Consensus 796 ~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 796 RQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp CCCCTTGGGCSSCCEEECCSSCCCBCCSCCCSSSCEEECCSCTTC
T ss_pred ccChHHHhcCCCCCEEECCCCCCCccCHhhcCCCCEEECCCCCCC
Confidence 899999999999999999999995444445678999999999984
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=416.44 Aligned_cols=358 Identities=20% Similarity=0.280 Sum_probs=318.1
Q ss_pred CccccCCccccCCCCCcEEEcCCCcCccc-----------------CCcccc--CCCCCCEEEccCCcCcccCCcccCCC
Q 004268 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGR-----------------IPSEIG--ALSRLKVLDLSYNRLTGTIPSEIGSL 90 (764)
Q Consensus 30 ~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~-----------------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l 90 (764)
++++ +|+.++.+++|++|+|++|.+++. +|..+. ++++|++|+|++|.+.+.+|..|+.+
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4445 788999999999999999999985 899998 99999999999999999999999999
Q ss_pred CCCCEEecCCCc-ccc-cCCccCcCC------CCCCEEEccCCcCcccCCc--cccCCCCcCEEecccCcccccCCcccc
Q 004268 91 RDLLDLNLSNNI-LNG-SIPLEFGNL------KDLDQLRLQGNKLDGLIPS--SIGNLTNLTYLDLSLNQLSGRLPQEVG 160 (764)
Q Consensus 91 ~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~ 160 (764)
++|++|+|++|. +++ ..|..+..+ ++|++|+|++|+++ ..|. .|.++++|++|+|++|++++..| .|.
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999998 887 677777766 99999999999999 4566 89999999999999999996677 899
Q ss_pred CCCCCCeeecccCCCCCCCCCccccCCC-ccEEEecCccCcCCcccccCCcc--ccceeeccCcccccccCcccc-----
Q 004268 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQ-LATLCLGYNKLVGPVTKEVGNMK--NLDRLHLNGNNLTGSIPSTIG----- 232 (764)
Q Consensus 161 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~l~~n~i~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~----- 232 (764)
++++|++|++++|.++ ..+..+..+++ |++|++++|.+..++ ..+..++ +|++|++++|.+++..|..+.
T Consensus 351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~ 428 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIP-NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428 (636)
T ss_dssp EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCC-SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSS
T ss_pred CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccc-hhhhhcccCccCEEECcCCcCCCcchhhhcccccc
Confidence 9999999999999999 56677999999 999999999999554 4565544 899999999999998888888
Q ss_pred --CCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCC-------CCCeEeccCccccCCCCCCC
Q 004268 233 --YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK-------YLASLSLNGNILIGPIPPTI 303 (764)
Q Consensus 233 --~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~~~ 303 (764)
.+++|+.|+|++|.++.+.+..+..+++|+.|+|++|+++.+.+..+.... +|+.|+|++|+++ .+|..+
T Consensus 429 ~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 507 (636)
T 4eco_A 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDF 507 (636)
T ss_dssp CCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGG
T ss_pred cccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhh
Confidence 788999999999999976666677899999999999999966665665543 9999999999998 566667
Q ss_pred C--CCCccceEEccCCcCccCCChhhhcccccceeec------cccccccCCchhcccccccceeecccccccCCCCCCC
Q 004268 304 G--YLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVL------SHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQL 375 (764)
Q Consensus 304 ~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l------s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 375 (764)
. .+++|++|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|+|++|++. .+|..+
T Consensus 508 ~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~ 585 (636)
T 4eco_A 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI 585 (636)
T ss_dssp STTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCC
T ss_pred hhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhH
Confidence 6 89999999999999996 8899999999999999 568888899999999999999999999995 677766
Q ss_pred CCCCccceecCCCCccccccCC
Q 004268 376 GKIPNISAVDLSKNNLSGVIPA 397 (764)
Q Consensus 376 ~~l~~L~~l~l~~N~l~~~~~~ 397 (764)
. ++|+.|++++|++.+..+.
T Consensus 586 ~--~~L~~L~Ls~N~l~~~~~~ 605 (636)
T 4eco_A 586 T--PNISVLDIKDNPNISIDLS 605 (636)
T ss_dssp C--TTCCEEECCSCTTCEEECT
T ss_pred h--CcCCEEECcCCCCccccHH
Confidence 5 8999999999999875543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=394.57 Aligned_cols=373 Identities=21% Similarity=0.167 Sum_probs=320.1
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcc-cCCcccCCCCCCCEEecC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG-TIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~ 99 (764)
-+.+++.+++++ .+|. + .++|++|+|++|.++++.|..|.++++|++|+|++|.+.+ ..+..|.++++|++|+|+
T Consensus 12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 446788888886 5565 3 3789999999999998888889999999999999998863 446788999999999999
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcCcccCCc--cccCCCCcCEEecccCcccccCCcc-ccCCCCCCeeecccCCCC
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS--SIGNLTNLTYLDLSLNQLSGRLPQE-VGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~ 176 (764)
+|.++++.+..|.++++|++|+|++|.+++..+. .|.++++|++|+|++|+++++.|.. |.++++|++|++++|.++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 9999888888999999999999999999864333 4888999999999999998876765 788999999999999998
Q ss_pred CCCCCccccC--CCccEEEecCccCcCCcccc--------cCCccccceeeccCcccccccCccccCC---CCCCEEEcc
Q 004268 177 GPIPSTLYHL--NQLATLCLGYNKLVGPVTKE--------VGNMKNLDRLHLNGNNLTGSIPSTIGYL---NLLDELHLS 243 (764)
Q Consensus 177 ~~~~~~~~~l--~~L~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~ 243 (764)
++.+..+..+ .+|+.|++++|.+..+.... +..+++|++|++++|.+++..+..+... ++|+.|+++
T Consensus 168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~ 247 (455)
T 3v47_A 168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247 (455)
T ss_dssp CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence 8888877776 68899999999988765543 3356889999999999987777766544 789999999
Q ss_pred CCcccCC----------CCcCCcC--CCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccce
Q 004268 244 HNRLDGP----------IPPTIGN--LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTY 311 (764)
Q Consensus 244 ~n~l~~~----------~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 311 (764)
+|.+.+. .+..+.. .++|+.|++++|.+.+..+..+..+++|+.|++++|++.+..+..+..+++|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 327 (455)
T 3v47_A 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327 (455)
T ss_dssp TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence 8865432 2222332 368999999999999999999999999999999999999988999999999999
Q ss_pred EEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcc
Q 004268 312 LNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391 (764)
Q Consensus 312 L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 391 (764)
|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++
T Consensus 328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 407 (455)
T 3v47_A 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407 (455)
T ss_dssp EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence 99999999988889999999999999999999988899999999999999999999988888899999999999999999
Q ss_pred ccccCC
Q 004268 392 SGVIPA 397 (764)
Q Consensus 392 ~~~~~~ 397 (764)
+|.+|.
T Consensus 408 ~~~~~~ 413 (455)
T 3v47_A 408 DCSCPR 413 (455)
T ss_dssp CCCTTT
T ss_pred ccCCCc
Confidence 998884
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=381.76 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=202.7
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-CceeeEe
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNIVKLY 573 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~ 573 (764)
.+++...++|++.+.||+|+||+||+|.+. +++.||||++...... ...+.+.+|++++++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344445689999999999999999999754 2358999999765443 334789999999999975 8999999
Q ss_pred eEEeeC-CEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 004268 574 GFCLHN-KCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639 (764)
Q Consensus 574 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 639 (764)
++|.+. +.+++|||||++|+|.++++.... ...+++.++..++.||+.||+||| +++||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence 998764 568999999999999999975322 234899999999999999999999 899999999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLL 716 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~ 716 (764)
||+|||+++++.+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 234578999999999999999999999999999999998 99999876
Q ss_pred ccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 717 SSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 717 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..... ........+...+..+.+++.+||+.++.-|
T Consensus 292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~R 332 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 332 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHC
Confidence 54221 1122334455578899999999999884443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=405.94 Aligned_cols=387 Identities=21% Similarity=0.228 Sum_probs=292.5
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
+++|++|++++|.+++..|..|..+++|++|+|++|+++++.|++|..+++|++|+|++|++++..+..|+.+++|++|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 46899999999999988899999999999999999999988889999999999999999999977777799999999999
Q ss_pred cCCCccccc-CCccCcCCCCCCEEEccCCc-CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 98 LSNNILNGS-IPLEFGNLKDLDQLRLQGNK-LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 98 L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
|++|.++++ .+..|.++++|++|++++|. +..+++..|.++++|++|++++|.+++..+..+.++++|++|+++.|.+
T Consensus 105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 999999864 45689999999999999998 6666667899999999999999999988888888877777777777766
Q ss_pred CCCCCCccccCCCccEEEecCccCcCCcc---cccCC-------------------------------------------
Q 004268 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVT---KEVGN------------------------------------------- 209 (764)
Q Consensus 176 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~---~~~~~------------------------------------------- 209 (764)
..+....+..+++|+.|++++|++..... .....
T Consensus 185 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~ 264 (549)
T 2z81_A 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264 (549)
T ss_dssp TTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEE
T ss_pred cccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccc
Confidence 54333333456666666666666654310 00011
Q ss_pred --------------------------------------------ccccceeeccCcccccccCccccCCCCCCEEEccCC
Q 004268 210 --------------------------------------------MKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245 (764)
Q Consensus 210 --------------------------------------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 245 (764)
.++|++|++++|.++.+....+..+++|+.|++++|
T Consensus 265 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N 344 (549)
T 2z81_A 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344 (549)
T ss_dssp CCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSS
T ss_pred ccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCC
Confidence 124555555555555322222356778888888888
Q ss_pred cccCCC---CcCCcCCCCCCeEEccCCcccCCCC--ccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 246 RLDGPI---PPTIGNLTNLIALDLSSNQLSGLLP--REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 246 ~l~~~~---~~~~~~l~~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
.+.+.. +..++.+++|+.|+|++|++++..+ ..+..+++|+.|++++|+++ .+|..+..+++|++|++++|+++
T Consensus 345 ~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~ 423 (549)
T 2z81_A 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423 (549)
T ss_dssp CCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred ccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence 887544 2346677888888888888875432 45777888888888888887 45667777888888888888887
Q ss_pred cCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCcc-
Q 004268 321 SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASV- 399 (764)
Q Consensus 321 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~- 399 (764)
.+|..+ .++|+.|+|++|++++.. ..+++|+.|+|++|+|+ .+|. ...+++|+.|++++|++++.+|..+
T Consensus 424 -~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~ 494 (549)
T 2z81_A 424 -VVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD 494 (549)
T ss_dssp -CCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred -cccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence 334333 257888888888887542 46788888888888888 4554 4568888888899888888887654
Q ss_pred --ccCccccccCCCCCC
Q 004268 400 --RRIPKLIVSENNLEL 414 (764)
Q Consensus 400 --~~~~~~~~~~n~~~~ 414 (764)
+.+..+++++|++.|
T Consensus 495 ~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 495 RLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp GCTTCCEEECCSSCBCC
T ss_pred cCcccCEEEecCCCccC
Confidence 466778888888743
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=401.30 Aligned_cols=235 Identities=23% Similarity=0.309 Sum_probs=195.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC---cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE---EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.... ..........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999865 7999999999653321 122222233445666777999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+||||++||+|..++.+ ...+++..++.++.||+.||+||| ++|||||||||+|||++.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999974 456999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~ 735 (764)
.... .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.+...... ........+..++.
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 6533 2345689999999999964 5799999999999999999999999986543211 12233444667899
Q ss_pred HHHHHHhhhhccch
Q 004268 736 QCNAYLKNFSQGNH 749 (764)
Q Consensus 736 ~~~~~~~~~l~~~~ 749 (764)
.+.++++.|++.++
T Consensus 420 ~a~dLI~~lL~~dP 433 (689)
T 3v5w_A 420 ELRSLLEGLLQRDV 433 (689)
T ss_dssp HHHHHHHHHTCSCG
T ss_pred HHHHHHHHHccCCH
Confidence 99999999999873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=410.69 Aligned_cols=368 Identities=20% Similarity=0.246 Sum_probs=313.5
Q ss_pred CCccccCCCCCcEEEcCCCcCcc-----------------cCCcccc--CCCCCCEEEccCCcCcccCCcccCCCCCCCE
Q 004268 35 MPSEIGALSKLEKLVLSHNSLTG-----------------RIPSEIG--ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95 (764)
Q Consensus 35 ~~~~~~~l~~L~~L~Ls~n~i~~-----------------~~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 95 (764)
+|..++.+++|++|+|++|++++ .+|+.+. ++++|++|+|++|.+.+.+|..|..+++|++
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 78899999999999999999998 3788877 9999999999999999999999999999999
Q ss_pred EecCCCc-ccc-cCCccCc-------CCCCCCEEEccCCcCcccCCc--cccCCCCcCEEecccCcccccCCccccCCCC
Q 004268 96 LNLSNNI-LNG-SIPLEFG-------NLKDLDQLRLQGNKLDGLIPS--SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164 (764)
Q Consensus 96 L~L~~n~-l~~-~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 164 (764)
|+|++|+ +++ ..|..+. .+++|++|+|++|.++. .|. .|.++++|++|+|++|+++ ..| .|.++++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~-ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB-CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc-cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 9999998 886 5665444 45699999999999994 566 8999999999999999999 555 8999999
Q ss_pred CCeeecccCCCCCCCCCccccCCC-ccEEEecCccCcCCcccccCCcc--ccceeeccCcccccccCccc---c--CCCC
Q 004268 165 LKSLFLDNNHLSGPIPSTLYHLNQ-LATLCLGYNKLVGPVTKEVGNMK--NLDRLHLNGNNLTGSIPSTI---G--YLNL 236 (764)
Q Consensus 165 L~~L~L~~n~i~~~~~~~~~~l~~-L~~L~l~~n~i~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~---~--~l~~ 236 (764)
|+.|+|++|.++ ..+..+..+++ |+.|+|++|.+..+ +..+..++ +|+.|++++|.+++.+|... . .+++
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l-p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~ 674 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI-PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC-CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCC
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcC-chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCC
Confidence 999999999999 56677999999 99999999999955 45666654 49999999999987655432 2 3458
Q ss_pred CCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCC-------CCCCeEeccCccccCCCCCCCC--CCC
Q 004268 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL-------KYLASLSLNGNILIGPIPPTIG--YLT 307 (764)
Q Consensus 237 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-------~~L~~L~l~~n~l~~~~~~~~~--~l~ 307 (764)
|+.|+|++|.++.+.+..+..+++|+.|+|++|+++.+.+..+... ++|+.|+|++|++. .+|..+. .++
T Consensus 675 L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~ 753 (876)
T 4ecn_A 675 ASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753 (876)
T ss_dssp EEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCT
T ss_pred cCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCC
Confidence 9999999999995554455689999999999999996555555433 39999999999998 5677776 899
Q ss_pred ccceEEccCCcCccCCChhhhcccccceeeccc------cccccCCchhcccccccceeecccccccCCCCCCCCCCCcc
Q 004268 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSH------NSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNI 381 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 381 (764)
+|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..+.++++|+.|+|++|++ +.+|..+. ++|
T Consensus 754 ~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L 829 (876)
T 4ecn_A 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQL 829 (876)
T ss_dssp TCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSS
T ss_pred CcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCC
Confidence 99999999999996 788899999999999976 888889999999999999999999999 57777765 699
Q ss_pred ceecCCCCccccccCCccc---cCccccccCCCC
Q 004268 382 SAVDLSKNNLSGVIPASVR---RIPKLIVSENNL 412 (764)
Q Consensus 382 ~~l~l~~N~l~~~~~~~~~---~~~~~~~~~n~~ 412 (764)
+.|||++|++....+..+. ......+..|+.
T Consensus 830 ~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863 (876)
T ss_dssp CEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred CEEECCCCCCCccChHHccccccchheeecCCCc
Confidence 9999999999977766553 333445555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=393.81 Aligned_cols=378 Identities=23% Similarity=0.257 Sum_probs=250.5
Q ss_pred cccccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcc
Q 004268 7 GAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSE 86 (764)
Q Consensus 7 ~~~~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 86 (764)
+..+...+..-.++|+.|++++|.+++..|..|..+++|++|+|++|+++++.|+.|.++++|++|+|++|+|+. +|..
T Consensus 9 ~n~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~ 87 (520)
T 2z7x_B 9 KNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH 87 (520)
T ss_dssp TSCCSSCCCSCCTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC
T ss_pred CCCcccccccccccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc
Confidence 333443333333789999999999998888899999999999999999998888999999999999999999984 5544
Q ss_pred cCCCCCCCEEecCCCccccc-CCccCcCCCCCCEEEccCCcCcccCCccccCCCCc--CEEecccCcc--cccCCccccC
Q 004268 87 IGSLRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNL--TYLDLSLNQL--SGRLPQEVGN 161 (764)
Q Consensus 87 ~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~ 161 (764)
.+++|++|+|++|.++++ .|..|+++++|++|++++|.+.+ ..|..+++| ++|++++|.+ .+..|..+..
T Consensus 88 --~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 88 --PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp --CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred --ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccc
Confidence 789999999999999874 57889999999999999999876 457777777 9999999988 5555555544
Q ss_pred --------------------------CCCCCeeecccC------------------------------------------
Q 004268 162 --------------------------LKNLKSLFLDNN------------------------------------------ 173 (764)
Q Consensus 162 --------------------------l~~L~~L~L~~n------------------------------------------ 173 (764)
+++|+.|++++|
T Consensus 163 l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~ 242 (520)
T 2z7x_B 163 FNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242 (520)
T ss_dssp CCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHH
T ss_pred cccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHH
Confidence 333344444333
Q ss_pred ---------------CCCCCCCCcc-----ccCCCccEEEecCccCcCCcccccCCc---cccceeeccCcccccccCcc
Q 004268 174 ---------------HLSGPIPSTL-----YHLNQLATLCLGYNKLVGPVTKEVGNM---KNLDRLHLNGNNLTGSIPST 230 (764)
Q Consensus 174 ---------------~i~~~~~~~~-----~~l~~L~~L~l~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~ 230 (764)
.+++..+..+ ..+++|+.+++++|.+ .++...+..+ .+|+.|++++|.+.... .
T Consensus 243 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~ 319 (520)
T 2z7x_B 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--C 319 (520)
T ss_dssp HHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--C
T ss_pred HhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--c
Confidence 3332223322 3344444444444443 2221112111 33455555555443221 1
Q ss_pred ccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccC--CCCccccCCCCCCeEeccCccccC-CCCCCCCCCC
Q 004268 231 IGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSG--LLPREVGNLKYLASLSLNGNILIG-PIPPTIGYLT 307 (764)
Q Consensus 231 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~ 307 (764)
+..+++|+.|++++|.+++..|..+..+++|+.|+|++|++++ ..|..+..+++|+.|++++|.+.+ ..+..+..++
T Consensus 320 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~ 399 (520)
T 2z7x_B 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399 (520)
T ss_dssp CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence 2456667777777777776666666677777777777777764 233556667777777777777765 3333466667
Q ss_pred ccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCC
Q 004268 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 387 (764)
+|++|++++|++++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|+|++|+++...+..|..+++|+.|+++
T Consensus 400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECc
Confidence 777777777777655444432 56777777777776 555555567777777777777764443446667777777777
Q ss_pred CCccccccC
Q 004268 388 KNNLSGVIP 396 (764)
Q Consensus 388 ~N~l~~~~~ 396 (764)
+|+++|.++
T Consensus 477 ~N~~~c~c~ 485 (520)
T 2z7x_B 477 TNPWDCSCP 485 (520)
T ss_dssp SSCBCCCHH
T ss_pred CCCCcccCC
Confidence 777766554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=379.80 Aligned_cols=234 Identities=25% Similarity=0.350 Sum_probs=193.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee------C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------N 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 579 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ....+.+.+|++++++++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 368999999999999999999865 8999999999765543 3345778899999999999999999998764 3
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
+.+|+|||||+ |+|.+++.. ...+++..++.++.||+.||+||| ++|||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 57899999996 579999973 457999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCC----CCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC---------
Q 004268 660 ARLLHPD----SSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR--------- 725 (764)
Q Consensus 660 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~--------- 725 (764)
|+..... .......+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+..+.....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876432 2233457899999999998876 4689999999999999999999999876532111000
Q ss_pred ----------------c---------CCCCCCCcHHHHHHHhhhhccc
Q 004268 726 ----------------K---------ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ----------------~---------~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
. ....+.++.++.+++++||+.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 332 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFE 332 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCC
Confidence 0 0012456889999999999988
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=384.19 Aligned_cols=354 Identities=20% Similarity=0.224 Sum_probs=316.0
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCc-ccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
++|+.|++++|.+++..|..|..+++|++|+|++|.+. .+.+..|.++++|++|+|++|++++..|..|..+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 57999999999999999999999999999999999997 45678899999999999999999988899999999999999
Q ss_pred cCCCcccccCC--ccCcCCCCCCEEEccCCcCcccCCcc-ccCCCCcCEEecccCcccccCCccccCC--CCCCeeeccc
Q 004268 98 LSNNILNGSIP--LEFGNLKDLDQLRLQGNKLDGLIPSS-IGNLTNLTYLDLSLNQLSGRLPQEVGNL--KNLKSLFLDN 172 (764)
Q Consensus 98 L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~ 172 (764)
|++|.+++..+ ..|.++++|++|+|++|.+.++.|.. |.++++|++|+|++|+++++.+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 99999986443 44999999999999999999887776 8999999999999999999988888876 7899999999
Q ss_pred CCCCCCCCCc--------cccCCCccEEEecCccCcCCcccccCCc---cccceeeccCcccccc----------cCccc
Q 004268 173 NHLSGPIPST--------LYHLNQLATLCLGYNKLVGPVTKEVGNM---KNLDRLHLNGNNLTGS----------IPSTI 231 (764)
Q Consensus 173 n~i~~~~~~~--------~~~l~~L~~L~l~~n~i~~~~~~~~~~l---~~L~~L~L~~n~l~~~----------~~~~~ 231 (764)
|.+..+.+.. +..+++|++|++++|.+....+..+... ++|+.|++++|.+.+. .+..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 9998765543 3467899999999999987666555443 8999999999865532 12222
Q ss_pred cC--CCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCcc
Q 004268 232 GY--LNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL 309 (764)
Q Consensus 232 ~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 309 (764)
.. .++|+.|++++|.+.+..+..+..+++|+.|+|++|++.+..+..|.++++|+.|++++|++.+..+..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 22 3689999999999999999999999999999999999999889999999999999999999998888899999999
Q ss_pred ceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCC
Q 004268 310 TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP 372 (764)
Q Consensus 310 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 372 (764)
++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999999998889999999999999999999998777788999999999999999997665
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=397.96 Aligned_cols=376 Identities=21% Similarity=0.235 Sum_probs=315.0
Q ss_pred cccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCccc-CCcccCC
Q 004268 11 SQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGT-IPSEIGS 89 (764)
Q Consensus 11 ~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~ 89 (764)
....|.++++|+.|++++|.+++..|..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+++. .+..|+.
T Consensus 42 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 121 (549)
T 2z81_A 42 GHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121 (549)
T ss_dssp CSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTT
T ss_pred ChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhc
Confidence 345789999999999999999999999999999999999999999988888899999999999999999863 5678999
Q ss_pred CCCCCEEecCCCc-ccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCee
Q 004268 90 LRDLLDLNLSNNI-LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168 (764)
Q Consensus 90 l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 168 (764)
+++|++|+|++|. ++.+.+..|.++++|++|++++|.+++..|..+.++++|++|++++|.+..+....+..+++|++|
T Consensus 122 l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L 201 (549)
T 2z81_A 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201 (549)
T ss_dssp CTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEE
T ss_pred cCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEE
Confidence 9999999999998 666666789999999999999999999888888888877777777777764443334556677777
Q ss_pred ecccCCCCCCCC---C----------------------------------------------------------------
Q 004268 169 FLDNNHLSGPIP---S---------------------------------------------------------------- 181 (764)
Q Consensus 169 ~L~~n~i~~~~~---~---------------------------------------------------------------- 181 (764)
++++|.+++... .
T Consensus 202 ~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~ 281 (549)
T 2z81_A 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281 (549)
T ss_dssp EEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCT
T ss_pred EccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhc
Confidence 777776654210 0
Q ss_pred -----------------------ccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccC---ccccCCC
Q 004268 182 -----------------------TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP---STIGYLN 235 (764)
Q Consensus 182 -----------------------~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~ 235 (764)
.+....+|+.|++++|.+..++...+..+++|++|++++|++++..+ ..+..++
T Consensus 282 ~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~ 361 (549)
T 2z81_A 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361 (549)
T ss_dssp TCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSST
T ss_pred ccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccc
Confidence 01112457777788888776666666789999999999999997653 3477889
Q ss_pred CCCEEEccCCcccCCCC--cCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEE
Q 004268 236 LLDELHLSHNRLDGPIP--PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313 (764)
Q Consensus 236 ~L~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 313 (764)
+|+.|+|++|.+++..+ ..+..+++|+.|+|++|+++ ..|..+..+++|+.|++++|++... +..+ .++|++|+
T Consensus 362 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~ 437 (549)
T 2z81_A 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLD 437 (549)
T ss_dssp TCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEE
T ss_pred cCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEE
Confidence 99999999999986532 45889999999999999999 4677889999999999999999854 3333 36899999
Q ss_pred ccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcccc
Q 004268 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 314 ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 393 (764)
|++|++++.. ..+++|++|+|++|+++ .+|. ...+++|+.|+|++|++++..|..|..+++|+.|++++|+++|
T Consensus 438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 511 (549)
T 2z81_A 438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511 (549)
T ss_dssp CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence 9999999642 57899999999999999 5665 4679999999999999999999999999999999999999998
Q ss_pred ccC
Q 004268 394 VIP 396 (764)
Q Consensus 394 ~~~ 396 (764)
.+|
T Consensus 512 ~~~ 514 (549)
T 2z81_A 512 SCP 514 (549)
T ss_dssp CHH
T ss_pred CCc
Confidence 887
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=370.04 Aligned_cols=197 Identities=27% Similarity=0.381 Sum_probs=170.8
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
+..++|++.+.||+|+||+||+|+.+ +++.||+|++...... .++.+|+++++.+ +||||+++++++.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35678999999999999999999753 5788999998765432 5678999999998 699999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeeec
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFG 658 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg 658 (764)
+.+|+||||+++|+|.+++. .+++.+++.++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999985 3889999999999999999999 9999999999999999876 899999999
Q ss_pred cccccCCCCC----------------------------CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhC
Q 004268 659 LARLLHPDSS----------------------------NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMG 709 (764)
Q Consensus 659 ~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg 709 (764)
+|+....... .....+||+.|+|||++.+. .|+.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9976543211 12335799999999999876 589999999999999999999
Q ss_pred CCCCCc
Q 004268 710 SHPTDL 715 (764)
Q Consensus 710 ~~Pf~~ 715 (764)
++||..
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 999953
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=388.35 Aligned_cols=378 Identities=22% Similarity=0.255 Sum_probs=279.8
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCC
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 101 (764)
++|++++|+++ .+|..+. ++|++|+|++|.++++.|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57999999998 6777776 89999999999999888889999999999999999999888999999999999999999
Q ss_pred cccccCCccCcCCCCCCEEEccCCcCccc-CCccccCCCCcCEEecccCcccccCCccccCCCCC--CeeecccCCC--C
Q 004268 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL--KSLFLDNNHL--S 176 (764)
Q Consensus 102 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~i--~ 176 (764)
.++.+... .+++|++|+|++|.++++ .|..|.++++|++|+|++|++++ ..|..+++| +.|++++|.+ .
T Consensus 80 ~l~~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLVKISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCCEEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred ceeecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 99965544 899999999999999975 57899999999999999999985 467778888 9999999998 5
Q ss_pred CCCCCcccc--------------------------CCCccEEEecCcc-------CcCCcccccCC--------------
Q 004268 177 GPIPSTLYH--------------------------LNQLATLCLGYNK-------LVGPVTKEVGN-------------- 209 (764)
Q Consensus 177 ~~~~~~~~~--------------------------l~~L~~L~l~~n~-------i~~~~~~~~~~-------------- 209 (764)
+..+..+.. +++|+.|++++|. +.+..+ .+..
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 455544444 4445555554443 100000 0111
Q ss_pred -------------ccccceeeccCcccccccCccc-----cCCCC--------------------------CCEEEccCC
Q 004268 210 -------------MKNLDRLHLNGNNLTGSIPSTI-----GYLNL--------------------------LDELHLSHN 245 (764)
Q Consensus 210 -------------l~~L~~L~L~~n~l~~~~~~~~-----~~l~~--------------------------L~~L~L~~n 245 (764)
.++|++|++++|.+++..|..+ ..+++ |+.|++++|
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n 312 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESS
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCC
Confidence 1256666666666665555544 44444 555555555
Q ss_pred cccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccC--CCCCCCCCCCccceEEccCCcCccCC
Q 004268 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG--PIPPTIGYLTNLTYLNLGYNRLSSSI 323 (764)
Q Consensus 246 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~ls~N~l~~~~ 323 (764)
.+.... .+..+++|++|++++|.+++..|..+..+++|+.|++++|++.+ ..|..+..+++|++|++++|++++.+
T Consensus 313 ~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l 390 (520)
T 2z7x_B 313 RMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390 (520)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCG
T ss_pred cccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccc
Confidence 554321 12567788888888888877777777888888888888888775 33455777788888888888887634
Q ss_pred Ch-hhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCc---c
Q 004268 324 PP-ELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS---V 399 (764)
Q Consensus 324 ~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~---~ 399 (764)
|. .+..+++|++|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++...+.. +
T Consensus 391 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l 467 (520)
T 2z7x_B 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467 (520)
T ss_dssp GGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccC
Confidence 43 467777888888888888766665553 67888888888887 56665667888888888888888554442 3
Q ss_pred ccCccccccCCCCCC
Q 004268 400 RRIPKLIVSENNLEL 414 (764)
Q Consensus 400 ~~~~~~~~~~n~~~~ 414 (764)
+.+..+++++|++.|
T Consensus 468 ~~L~~L~l~~N~~~c 482 (520)
T 2z7x_B 468 TSLQKIWLHTNPWDC 482 (520)
T ss_dssp TTCCEEECCSSCBCC
T ss_pred CcccEEECcCCCCcc
Confidence 466777788887754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=363.29 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=163.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----EE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----CM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 582 (764)
.++|.+.+.||+|+||+||+|++. |+.||||++...... ......|+..+.+++||||+++++++.+++ .+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 357889999999999999999885 899999998653211 122345566667889999999999998653 58
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
|+|||||++|+|.++++.. .+++..+.+++.|++.||+|||.. ++.+||||||||+|||+++++.+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999999743 589999999999999999999922 1239999999999999999999999999
Q ss_pred ccccccCCCCCC----ceecccccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 658 GLARLLHPDSSN----RTLVVGTYGYIAPELAYTM------AVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 658 g~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
|+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||.+||...
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999876543322 2235799999999998764 4678999999999999999998877543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=388.97 Aligned_cols=361 Identities=23% Similarity=0.258 Sum_probs=215.5
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCC
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 101 (764)
+++++++|++++ +|..+. +++++|+|++|.++++.+..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 455555555552 444332 45555555555555544455555555555555555555555555555555555555555
Q ss_pred cccccCCccCcCCCCCCEEEccCCcCcccC-CccccCCCCcCEEecccCcccccCCccccCCCCC--CeeecccCCC--C
Q 004268 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLI-PSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL--KSLFLDNNHL--S 176 (764)
Q Consensus 102 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~n~i--~ 176 (764)
.++.+... .+++|++|+|++|+++++. |..|.++++|++|+|++|+++.. .+.++++| ++|++++|.+ +
T Consensus 111 ~l~~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQNISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCCEECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCCccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 55533222 4555555555555555432 34555555555555555555432 23333333 5555555555 3
Q ss_pred CCCCCccccCC---------------------------------------------------------------------
Q 004268 177 GPIPSTLYHLN--------------------------------------------------------------------- 187 (764)
Q Consensus 177 ~~~~~~~~~l~--------------------------------------------------------------------- 187 (764)
+..+..+..+.
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~ 264 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHH
Confidence 33333333322
Q ss_pred ------------CccEEEecCccCcCCccccc-----CCcc--------------------------ccceeeccCcccc
Q 004268 188 ------------QLATLCLGYNKLVGPVTKEV-----GNMK--------------------------NLDRLHLNGNNLT 224 (764)
Q Consensus 188 ------------~L~~L~l~~n~i~~~~~~~~-----~~l~--------------------------~L~~L~L~~n~l~ 224 (764)
+|++|++++|.+.+..+..+ ..++ +|++|++++|.+.
T Consensus 265 ~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~ 344 (562)
T 3a79_B 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344 (562)
T ss_dssp HHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCC
T ss_pred HHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcc
Confidence 67777777777763333332 3333 3555566666554
Q ss_pred cccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCC--CccccCCCCCCeEeccCccccC-CCCC
Q 004268 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL--PREVGNLKYLASLSLNGNILIG-PIPP 301 (764)
Q Consensus 225 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~-~~~~ 301 (764)
... ....+++|+.|++++|.+++..|..+..+++|+.|+|++|+++++. +..+.++++|+.|++++|++.+ ..+.
T Consensus 345 ~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 422 (562)
T 3a79_B 345 HMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422 (562)
T ss_dssp CCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSC
T ss_pred ccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChh
Confidence 221 1256677777777777777767777777777788888777777543 3457777777778887777776 3344
Q ss_pred CCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCcc
Q 004268 302 TIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNI 381 (764)
Q Consensus 302 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 381 (764)
.+..+++|++|++++|++++..|..+. ++|++|+|++|+++ .+|..+..+++|+.|+|++|+++...+..|..+++|
T Consensus 423 ~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L 499 (562)
T 3a79_B 423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL 499 (562)
T ss_dssp CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTC
T ss_pred hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCC
Confidence 567777777788877777755444333 57777788887777 555555577777778888877774444447777777
Q ss_pred ceecCCCCccccccC
Q 004268 382 SAVDLSKNNLSGVIP 396 (764)
Q Consensus 382 ~~l~l~~N~l~~~~~ 396 (764)
+.|++++|+++|.+|
T Consensus 500 ~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 500 QYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCEECCSCCBCCCHH
T ss_pred CEEEecCCCcCCCcc
Confidence 777888887776655
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=391.52 Aligned_cols=396 Identities=20% Similarity=0.161 Sum_probs=303.0
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecC
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 99 (764)
+++.|+|++|.|++..+.+|..+++|++|+|++|+|+++.+++|.++++|++|+|++|+|++..+.+|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 79999999999998888999999999999999999998889999999999999999999998777899999999999999
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcCccc-CCccccCCCCcCEEecccCcccccCCccccCCCCCC----eeecccCC
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLK----SLFLDNNH 174 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n~ 174 (764)
+|.++++.+..|+++++|++|+|++|.++.+ .|..+..+++|++|+|++|+++++.+..|..+.+++ .++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 9999988888999999999999999999865 467788999999999999999988777776544332 45555555
Q ss_pred CCCCCCCcc-----------------------------------------------------------------------
Q 004268 175 LSGPIPSTL----------------------------------------------------------------------- 183 (764)
Q Consensus 175 i~~~~~~~~----------------------------------------------------------------------- 183 (764)
++.+.+..+
T Consensus 213 l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~ 292 (635)
T 4g8a_A 213 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 292 (635)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCC
T ss_pred ccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhc
Confidence 442222111
Q ss_pred --------------------------------ccCCCccEEEecCccCcCCcccc-------------------cCCccc
Q 004268 184 --------------------------------YHLNQLATLCLGYNKLVGPVTKE-------------------VGNMKN 212 (764)
Q Consensus 184 --------------------------------~~l~~L~~L~l~~n~i~~~~~~~-------------------~~~l~~ 212 (764)
.....|+.|++.+|.+..+.... ...+++
T Consensus 293 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~ 372 (635)
T 4g8a_A 293 YYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 372 (635)
T ss_dssp SCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTT
T ss_pred ccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccc
Confidence 11122333333333332221111 112344
Q ss_pred cceeeccCccccc--ccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCC-CCccccCCCCCCeEe
Q 004268 213 LDRLHLNGNNLTG--SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL-LPREVGNLKYLASLS 289 (764)
Q Consensus 213 L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 289 (764)
|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.++++.|..... ....|..+.+++.++
T Consensus 373 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 373 LEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp CCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred cccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccc
Confidence 4444444444431 122333344445555555554442 334566778888888887776544 345678888999999
Q ss_pred ccCccccCCCCCCCCCCCccceEEccCCcCc-cCCChhhhcccccceeeccccccccCCchhcccccccceeeccccccc
Q 004268 290 LNGNILIGPIPPTIGYLTNLTYLNLGYNRLS-SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368 (764)
Q Consensus 290 l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 368 (764)
++.|.+....+..+..++.|+.|++++|.+. ...|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 9999998888888889999999999999754 456778889999999999999999888889999999999999999999
Q ss_pred CCCCCCCCCCCccceecCCCCccccccCCccc----cCccccccCCCCCCCC
Q 004268 369 GTIPSQLGKIPNISAVDLSKNNLSGVIPASVR----RIPKLIVSENNLELEN 416 (764)
Q Consensus 369 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~~~~~~~n~~~~~~ 416 (764)
+..+..|.++++|+.||+++|+|++..|..+. .+..+++++|++.|..
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 88888899999999999999999988887653 5677889999987753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=384.53 Aligned_cols=233 Identities=24% Similarity=0.371 Sum_probs=201.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.++ +|+.||+|++..... ...+.+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999865 899999999876432 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC--CCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN--LEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg~~~~~ 663 (764)
||||+||+|.+++.. ....+++.+++.++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999999864 2346899999999999999999999 8999999999999999854 89999999999987
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~ 736 (764)
... ......+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+..+... .......+.++..
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 543 33455689999999999999999999999999999999999999998776532211 1112233568899
Q ss_pred HHHHHhhhhccc
Q 004268 737 CNAYLKNFSQGN 748 (764)
Q Consensus 737 ~~~~~~~~l~~~ 748 (764)
+.+++++||+.+
T Consensus 387 ~~dli~~~L~~d 398 (573)
T 3uto_A 387 GKDFIRKLLLAD 398 (573)
T ss_dssp HHHHHHTTSCSS
T ss_pred HHHHHHHHccCC
Confidence 999999999988
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=380.38 Aligned_cols=361 Identities=22% Similarity=0.239 Sum_probs=295.7
Q ss_pred CCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEE
Q 004268 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120 (764)
Q Consensus 41 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 120 (764)
.+...+++++++|++++ +|..+. ++|++|+|++|.|++..+.+|..+++|++|+|++|.++++.+.+|.++++|++|
T Consensus 29 ~~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 29 SNELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp ----CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 44556899999999995 565554 799999999999998888899999999999999999999999999999999999
Q ss_pred EccCCcCcccCCccccCCCCcCEEecccCcccccC-CccccCCCCCCeeecccCCCCCCCCCccccCCCc--cEEEecCc
Q 004268 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL-PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQL--ATLCLGYN 197 (764)
Q Consensus 121 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L--~~L~l~~n 197 (764)
+|++|+++.+++. .+++|++|+|++|+++++. |..|.++++|++|++++|.++.. .+..+++| +.|++++|
T Consensus 106 ~Ls~N~l~~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n 179 (562)
T 3a79_B 106 DVSHNRLQNISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLV 179 (562)
T ss_dssp ECTTSCCCEECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEES
T ss_pred ECCCCcCCccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecc
Confidence 9999999977554 7999999999999999764 58999999999999999999864 35555555 99999999
Q ss_pred cC--cCCcccccCCcc----------------------------------------------------------------
Q 004268 198 KL--VGPVTKEVGNMK---------------------------------------------------------------- 211 (764)
Q Consensus 198 ~i--~~~~~~~~~~l~---------------------------------------------------------------- 211 (764)
.+ ....+..+..+.
T Consensus 180 ~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259 (562)
T ss_dssp SCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEE
T ss_pred cccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCC
Confidence 98 544444443322
Q ss_pred -----------------ccceeeccCcccccccCccc-----cCC--------------------------CCCCEEEcc
Q 004268 212 -----------------NLDRLHLNGNNLTGSIPSTI-----GYL--------------------------NLLDELHLS 243 (764)
Q Consensus 212 -----------------~L~~L~L~~n~l~~~~~~~~-----~~l--------------------------~~L~~L~L~ 243 (764)
+|++|++++|.+++..|..+ ..+ .+|+.|+++
T Consensus 260 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~ 339 (562)
T 3a79_B 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339 (562)
T ss_dssp EECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEE
T ss_pred cCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEcc
Confidence 67778888888876666554 222 347788888
Q ss_pred CCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCC--CCCCCCCCccceEEccCCcCcc
Q 004268 244 HNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI--PPTIGYLTNLTYLNLGYNRLSS 321 (764)
Q Consensus 244 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ls~N~l~~ 321 (764)
+|.+.... ....+++|++|++++|.+++..+..+.++++|+.|++++|++.+.. |..+..+++|++|++++|++++
T Consensus 340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 88776432 2267899999999999999888999999999999999999998643 4568899999999999999997
Q ss_pred CCC-hhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCc--
Q 004268 322 SIP-PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPAS-- 398 (764)
Q Consensus 322 ~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-- 398 (764)
.+| ..+..+++|++|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++...+..
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 494 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD 494 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence 344 4588899999999999999877666554 68999999999999 56666669999999999999999765543
Q ss_pred -cccCccccccCCCCCCC
Q 004268 399 -VRRIPKLIVSENNLELE 415 (764)
Q Consensus 399 -~~~~~~~~~~~n~~~~~ 415 (764)
++.+..+++++|++.|.
T Consensus 495 ~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 495 RLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp TCTTCCCEECCSCCBCCC
T ss_pred cCCCCCEEEecCCCcCCC
Confidence 35677888999988653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.76 Aligned_cols=348 Identities=30% Similarity=0.450 Sum_probs=308.8
Q ss_pred ccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCE
Q 004268 16 TCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95 (764)
Q Consensus 16 ~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 95 (764)
..+++++.|++.++.++. +| .+..+++|++|+|++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 457899999999999974 45 48899999999999999996654 9999999999999999996544 999999999
Q ss_pred EecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 96 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
|+|++|.++++.+ |.++++|++|++++|.+.++ ..+.++++|++|+++ |.+.... .+.++++|+.|++++|.+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence 9999999997644 89999999999999999976 358999999999997 5565443 489999999999999999
Q ss_pred CCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCC
Q 004268 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255 (764)
Q Consensus 176 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 255 (764)
+++ ..+..+++|++|++++|.+....+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+.+..+ +
T Consensus 190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 261 (466)
T 1o6v_A 190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L 261 (466)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence 865 458999999999999999997655 77899999999999999864 468899999999999999996644 8
Q ss_pred cCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccce
Q 004268 256 GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335 (764)
Q Consensus 256 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~ 335 (764)
..+++|+.|++++|.+++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|++++..| +..+++|++
T Consensus 262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 899999999999999997654 8899999999999999987654 8899999999999999997654 789999999
Q ss_pred eeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccc
Q 004268 336 LVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGV 394 (764)
Q Consensus 336 L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 394 (764)
|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 336 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 336 LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 99999999965 478999999999999999998877 89999999999999999974
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=380.48 Aligned_cols=387 Identities=25% Similarity=0.275 Sum_probs=326.5
Q ss_pred cccccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccC
Q 004268 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIG 88 (764)
Q Consensus 9 ~~~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 88 (764)
+++...|.++++|+.|+|++|.++++.+.+|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+++++.+..|+
T Consensus 66 ~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~ 145 (635)
T 4g8a_A 66 HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 145 (635)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCT
T ss_pred CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhh
Confidence 35667899999999999999999988889999999999999999999988888999999999999999999988778899
Q ss_pred CCCCCCEEecCCCccccc-CCccCcCCCCCCEEEccCCcCcccCCccccCCCCcC----EEecccCcccccCCc------
Q 004268 89 SLRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT----YLDLSLNQLSGRLPQ------ 157 (764)
Q Consensus 89 ~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~------ 157 (764)
.+++|++|+|++|.++.+ .+..+..+++|++|+|++|+++++.+..|..+.+++ .++++.|.++.+.+.
T Consensus 146 ~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~ 225 (635)
T 4g8a_A 146 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 225 (635)
T ss_dssp TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCE
T ss_pred cCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchh
Confidence 999999999999999865 467889999999999999999988887776554433 455555554322111
Q ss_pred --------------------------------------------------------------------------------
Q 004268 158 -------------------------------------------------------------------------------- 157 (764)
Q Consensus 158 -------------------------------------------------------------------------------- 157 (764)
T Consensus 226 ~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~ 305 (635)
T 4g8a_A 226 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCL 305 (635)
T ss_dssp EEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGG
T ss_pred hhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhh
Confidence
Q ss_pred -----------------cccCCCCCCeeecccCCCCCCCCC-------------------ccccCCCccEEEecCccCcC
Q 004268 158 -----------------EVGNLKNLKSLFLDNNHLSGPIPS-------------------TLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 158 -----------------~~~~l~~L~~L~L~~n~i~~~~~~-------------------~~~~l~~L~~L~l~~n~i~~ 201 (764)
.+....+|+.|++.+|.+..+... ....+++|+.|+++.|.+..
T Consensus 306 ~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~ 385 (635)
T 4g8a_A 306 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 385 (635)
T ss_dssp TTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBE
T ss_pred cccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccc
Confidence 112233556666666655433222 22357789999999998864
Q ss_pred C--cccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC-CcCCcCCCCCCeEEccCCcccCCCCcc
Q 004268 202 P--VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI-PPTIGNLTNLIALDLSSNQLSGLLPRE 278 (764)
Q Consensus 202 ~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~ 278 (764)
. .+..+..+.+|+.|++..|.... .+..+..+++|+.++++.|...... ...|..+++++.++++.|.+....+..
T Consensus 386 ~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~ 464 (635)
T 4g8a_A 386 KGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 464 (635)
T ss_dssp EEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred ccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccc
Confidence 3 23445677899999999999884 4556888999999999998876554 456888999999999999999899999
Q ss_pred ccCCCCCCeEeccCccc-cCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhccccccc
Q 004268 279 VGNLKYLASLSLNGNIL-IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFF 357 (764)
Q Consensus 279 ~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 357 (764)
+..+++|+.|++++|.+ ....|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|
T Consensus 465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 544 (635)
T 4g8a_A 465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 544 (635)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence 99999999999999975 44578889999999999999999999999999999999999999999999889999999999
Q ss_pred ceeecccccccCCCCCCCCCC-CccceecCCCCccccccC
Q 004268 358 RQLDLSRNFINGTIPSQLGKI-PNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 358 ~~L~l~~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 396 (764)
+.|||++|+|++..|..|..+ ++|+.|++++|+++|.+.
T Consensus 545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999998 589999999999998765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.03 Aligned_cols=354 Identities=21% Similarity=0.174 Sum_probs=190.8
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCC
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 101 (764)
+.+++++++++ .+|..+. +++++|+|++|+++++.+..|..+++|++|+|++|.|++..|.+|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 34555555554 3444332 35555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCC
Q 004268 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181 (764)
Q Consensus 102 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~ 181 (764)
.++.+.+..|.++++|++|+|++|++..+.+..|.++++|++|+|++|.++.+.+..|.++++|++|+|++|.++.+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--- 167 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI--- 167 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC---
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc---
Confidence 55544444555555555555555555555555555555555555555555555555555555555555555555544
Q ss_pred ccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCC
Q 004268 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNL 261 (764)
Q Consensus 182 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 261 (764)
....+..+++|+.|++++|.+.+..+..|..+++|+.|++++|...+..+.......+|
T Consensus 168 ---------------------~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 168 ---------------------PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp ---------------------CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred ---------------------ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 44444444445555555555444444445555555555555544443333333334456
Q ss_pred CeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecccc
Q 004268 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341 (764)
Q Consensus 262 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N 341 (764)
+.|+|++|.++++.+..|..+++|+.|+|++|.+.+..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 66666666665444445556666666666666665555555666666666666666666555566666666666666666
Q ss_pred ccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCc
Q 004268 342 SLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP 403 (764)
Q Consensus 342 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~ 403 (764)
++++..+..|..+++|+.|+|++|++.+..+..+ -......+++.++...|..|..+...+
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~-~~~~~~~~~~~~~~~~C~~p~~~~g~~ 367 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLW-VFRRRWRLNFNRQQPTCATPEFVQGKE 367 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHH-HHTTTTSSCCTTCCCBEEESGGGTTCB
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccCccchHh-HHhhhhccccCccCceeCCchHHcCCc
Confidence 6665555555666666666666666653322110 011223345566666666665554433
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.22 Aligned_cols=304 Identities=23% Similarity=0.221 Sum_probs=231.3
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
-.++++.|++++|.+++..+..|..+++|++|+|++|.++++.|..|.++++|++|+|++|+++...+..|..+++|++|
T Consensus 30 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 109 (477)
T 2id5_A 30 IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKL 109 (477)
T ss_dssp CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEE
T ss_pred CCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEE
Confidence 34589999999999999999999999999999999999999999999999999999999999997777789999999999
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|++|.++.+.+..|.++++|++|+|++|.+..+.+..|.++++|++|+|++|+++++.+..|.++++|+.|+|++|.++
T Consensus 110 ~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~ 189 (477)
T 2id5_A 110 DISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189 (477)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCC
T ss_pred ECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCc
Confidence 99999999999999999999999999999999999999999999999999999999888888999999999999999998
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCc
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 256 (764)
.+.+..|..+++|+.|++++|......+.......+|++|++++|.++.+.+..+..+++|+.|+|++|.+++..+..|.
T Consensus 190 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (477)
T 2id5_A 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269 (477)
T ss_dssp EECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCT
T ss_pred EeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcc
Confidence 88777888888888888888765543333333334556666666555544434455555555555555555544444555
Q ss_pred CCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 257 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
.+++|+.|+|++|++.++.+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 270 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred ccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555555555555555444444444555555555555444444444444444444444444443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.90 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 478999999999999999999865 7999999999754321122246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|..++.+ ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999999873 346899999999999999999999 89999999999999999999999999999987544
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.... ........+..++..+.++++
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 44445567899999999999999999999999999999999999999986554221 112233345568899999999
Q ss_pred hhhccchh
Q 004268 743 NFSQGNHR 750 (764)
Q Consensus 743 ~~l~~~~~ 750 (764)
+|++.++.
T Consensus 238 ~lL~~dP~ 245 (337)
T 1o6l_A 238 GLLKKDPK 245 (337)
T ss_dssp HHTCSSTT
T ss_pred HHhhcCHH
Confidence 99987743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=352.55 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=203.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|+.+ +++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 578999999999999999999865 6889999999876555444456788999999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|..++.+ ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999974 346899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccCCcCCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------------SSSGRKISQNPR 732 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------------~~~~~~~~~~~~ 732 (764)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........+..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 44445566789999999999999999999999999999999999999997542211 111233344566
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
++..+.+++++|++.++.-|
T Consensus 285 ~s~~~~~li~~lL~~dP~~R 304 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKER 304 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTS
T ss_pred CCHHHHHHHHHHhcCCHhHc
Confidence 89999999999999874433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.46 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=199.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999865 7899999999764332233346788999999998 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++|+|..++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999974 346899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 740 (764)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+. ........+..++..+.++
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 5444445567899999999999999999999999999999999999999987665322 1223334455688999999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++|++.++.-|
T Consensus 255 i~~lL~~dP~~R 266 (353)
T 3txo_A 255 LKSFMTKNPTMR 266 (353)
T ss_dssp HHHHTCSSGGGS
T ss_pred HHHHhhhCHHHc
Confidence 999999874433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.04 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=205.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||.||+|+.+ +++.||+|++...........+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999865 6889999999877666666667889999999998 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|..++.+ ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999973 346899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------------cccCCcCCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------------SSSGRKISQNPR 732 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------------~~~~~~~~~~~~ 732 (764)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........+..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 44444556789999999999999999999999999999999999999997532110 111223334556
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
++..+.+++++|++.++.-|
T Consensus 242 ~s~~~~~li~~lL~~dP~~R 261 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKER 261 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTS
T ss_pred CCHHHHHHHHHHhcCCHhHC
Confidence 88999999999999874433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.26 Aligned_cols=232 Identities=26% Similarity=0.427 Sum_probs=201.9
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+ .+++.||+|++....... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 57899999999999999999985 579999999987655443 26788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999999743 4889999999999999999999 88999999999999999999999999999988766
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~ 739 (764)
.........||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... .......+..++..+.+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 555556678999999999999999999999999999999999999999876543211 11122334557888999
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++++|++.+
T Consensus 249 li~~~l~~d 257 (297)
T 3fxz_A 249 FLNRCLEMD 257 (297)
T ss_dssp HHHHHSCSS
T ss_pred HHHHHccCC
Confidence 999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.75 Aligned_cols=235 Identities=27% Similarity=0.427 Sum_probs=202.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 357899999999999999999986 58999999999765543 3445778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999973 346899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVT-EKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 740 (764)
.. ......+||+.|+|||++.+..++ +++||||+||++|+|++|+.||.+.+..... .......+...+..+.++
T Consensus 166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 43 334456899999999999988875 7999999999999999999999876543221 122333445678999999
Q ss_pred Hhhhhccc
Q 004268 741 LKNFSQGN 748 (764)
Q Consensus 741 ~~~~l~~~ 748 (764)
+++|++.+
T Consensus 245 i~~~L~~d 252 (328)
T 3fe3_A 245 LKRFLVLN 252 (328)
T ss_dssp HHHHCCSS
T ss_pred HHHHCCCC
Confidence 99999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.58 Aligned_cols=242 Identities=26% Similarity=0.355 Sum_probs=198.1
Q ss_pred HHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 502 EMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 502 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
++....++|++.+.||+|+||+||+|+++ +++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33344679999999999999999999876 57899999986532211111234789999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+||||+++|+|.+++.+. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999742 346899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCC-ceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcC
Q 004268 661 RLLHPDSSN-RTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKI 727 (764)
Q Consensus 661 ~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~ 727 (764)
+........ ....+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+..+.... ...
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 876543332 23368999999999987 55789999999999999999999999987654322111 111
Q ss_pred -CCCCCCcHHHHHHHhhhhccc
Q 004268 728 -SQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 728 -~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...+.++..+.+++++|+..+
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~ 324 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSR 324 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCG
T ss_pred CcccccCCHHHHHHHHHHhccc
Confidence 112458999999999999643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.28 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=201.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||.||+|+++ +|+.||+|++...........+.+..|.++++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4689999999999999999999875 7899999999754321111236678899999887 9999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++|+|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999973 346899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 740 (764)
..........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..... .......+..++..+.++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 44444455678999999999999999999999999999999999999999876542211 112223345578999999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+++|++.++.
T Consensus 249 i~~lL~~dp~ 258 (345)
T 1xjd_A 249 LVKLFVREPE 258 (345)
T ss_dssp HHHHSCSSGG
T ss_pred HHHHhcCCHh
Confidence 9999998743
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.32 Aligned_cols=328 Identities=30% Similarity=0.418 Sum_probs=292.0
Q ss_pred ccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCC
Q 004268 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93 (764)
Q Consensus 14 ~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 93 (764)
.|..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|+|++|.+++.. .+..+++|
T Consensus 63 ~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L 136 (466)
T 1o6v_A 63 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID--PLKNLTNL 136 (466)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTC
T ss_pred chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCCh--HHcCCCCC
Confidence 37889999999999999986544 9999999999999999996655 999999999999999999653 39999999
Q ss_pred CEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccC
Q 004268 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNN 173 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 173 (764)
++|+|++|.++.+. .+.++++|++|+++ |.+.... .+.++++|++|++++|.++.+ ..+..+++|++|++++|
T Consensus 137 ~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n 209 (466)
T 1o6v_A 137 NRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNN 209 (466)
T ss_dssp SEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CEEECCCCccCCCh--hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCC
Confidence 99999999998643 58999999999997 5565553 389999999999999999865 45899999999999999
Q ss_pred CCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCc
Q 004268 174 HLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253 (764)
Q Consensus 174 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 253 (764)
.+++..+ +..+++|++|++++|.+..+ ..+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+
T Consensus 210 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~- 282 (466)
T 1o6v_A 210 QISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282 (466)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-
T ss_pred ccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-
Confidence 9987654 78899999999999999975 468889999999999999997655 8899999999999999996644
Q ss_pred CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccc
Q 004268 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333 (764)
Q Consensus 254 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 333 (764)
+..+++|+.|+|++|++.+..+ +..+++|+.|++++|++.+..| +..+++|++|++++|++++. ..+..+++|
T Consensus 283 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L 355 (466)
T 1o6v_A 283 -LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNI 355 (466)
T ss_dssp -GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred -ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCC
Confidence 8899999999999999997654 8899999999999999998765 78999999999999999965 578999999
Q ss_pred ceeeccccccccCCchhcccccccceeecccccccCC
Q 004268 334 LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGT 370 (764)
Q Consensus 334 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 370 (764)
++|++++|++++..| +..+++|+.|++++|++++.
T Consensus 356 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 356 NWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred CEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 999999999998777 89999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=345.99 Aligned_cols=238 Identities=21% Similarity=0.316 Sum_probs=202.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||+||+|+.+ +++.||+|++...........+.+..|.++++.+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999876 5889999998764322222246778999999888 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||++||+|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999973 346899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 740 (764)
..........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+. ........+..++..+.++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 4444445567899999999999999999999999999999999999999987654221 1222333456689999999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
+++|++.++
T Consensus 252 i~~lL~~dP 260 (353)
T 2i0e_A 252 CKGLMTKHP 260 (353)
T ss_dssp HHHHTCSCT
T ss_pred HHHHhhcCH
Confidence 999999773
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.95 Aligned_cols=233 Identities=27% Similarity=0.438 Sum_probs=199.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 478999999999999999999865 7999999998754322222246778999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999974 346899999999999999999999 99999999999999999999999999999987543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.... ........++.++..+.++++
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2 2346799999999999999999999999999999999999999986654221 112233345668899999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 236 ~lL~~d 241 (318)
T 1fot_A 236 RLITRD 241 (318)
T ss_dssp HHTCSC
T ss_pred HHhccC
Confidence 999877
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.40 Aligned_cols=241 Identities=29% Similarity=0.450 Sum_probs=196.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..++|++.+.||+|+||+||+|+.. |+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 4678999999999999999999874 889999998765543 34457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
|||+++++|.+++........+++..+..++.|++.||+||| ++| |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999986544445899999999999999999999 889 999999999999999999999999999865
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCcCCCCCCCcHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRKISQNPRLDLQCN 738 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~ 738 (764)
...........||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... .......+..++..+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 54433344567999999999999999999999999999999999999999876653221 2223344566789999
Q ss_pred HHHhhhhccchhh
Q 004268 739 AYLKNFSQGNHRW 751 (764)
Q Consensus 739 ~~~~~~l~~~~~~ 751 (764)
+++++|++.++.-
T Consensus 270 ~li~~~l~~dP~~ 282 (309)
T 3p86_A 270 AIIEGCWTNEPWK 282 (309)
T ss_dssp HHHHHHTCSSGGG
T ss_pred HHHHHHccCChhh
Confidence 9999999987443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.60 Aligned_cols=344 Identities=20% Similarity=0.214 Sum_probs=249.8
Q ss_pred cccccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCC
Q 004268 11 SQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSL 90 (764)
Q Consensus 11 ~~~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 90 (764)
....|..+++|+.|++++|.+++. | .+..+++|++|+|++|+++++ | +..+++|++|+|++|++++. + ++.+
T Consensus 34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l 105 (457)
T 3bz5_A 34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPL 105 (457)
T ss_dssp SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence 344678889999999999999865 4 789999999999999999975 3 88999999999999999964 3 8899
Q ss_pred CCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeec
Q 004268 91 RDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFL 170 (764)
Q Consensus 91 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 170 (764)
++|++|+|++|.++++ + +..+++|++|++++|+++++ .+.++++|++|++++|+..+.. .+..+++|++|++
T Consensus 106 ~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l 177 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDC 177 (457)
T ss_dssp TTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEEC
Confidence 9999999999999865 3 88999999999999999986 3788999999999999543333 5888999999999
Q ss_pred ccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCC
Q 004268 171 DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP 250 (764)
Q Consensus 171 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 250 (764)
++|+++++. +..+++|+.|++++|+++.+ .+..+++|++|++++|+++++ | +..+++|+.|++++|.+++.
T Consensus 178 s~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~ 248 (457)
T 3bz5_A 178 SFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTEL 248 (457)
T ss_dssp CSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC
T ss_pred CCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCc
Confidence 999998753 78889999999999999876 478889999999999999974 4 78889999999999999977
Q ss_pred CCcCCcCCC-------CCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCC--------CCCCCCccceEEcc
Q 004268 251 IPPTIGNLT-------NLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP--------TIGYLTNLTYLNLG 315 (764)
Q Consensus 251 ~~~~~~~l~-------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L~ls 315 (764)
.+..+..+. +|+.|++++|.+.+..| +..+++|+.|++++|...+.+|. .+..+++|++|+++
T Consensus 249 ~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~ 326 (457)
T 3bz5_A 249 DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLN 326 (457)
T ss_dssp CCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECT
T ss_pred CHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECC
Confidence 554444333 34444444444433332 45667778888877765443332 13344455555555
Q ss_pred CCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcccccc
Q 004268 316 YNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVI 395 (764)
Q Consensus 316 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 395 (764)
+|++++. + +..+++|+.|++++|++++ ++.|..|++++|.+.+. ..+..|..+++++|+++|.+
T Consensus 327 ~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~i 390 (457)
T 3bz5_A 327 NTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAV 390 (457)
T ss_dssp TCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEEC
T ss_pred CCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEc
Confidence 5555542 1 4455555555555555553 12344445555555433 12334455555555555555
Q ss_pred CC
Q 004268 396 PA 397 (764)
Q Consensus 396 ~~ 397 (764)
|.
T Consensus 391 p~ 392 (457)
T 3bz5_A 391 SP 392 (457)
T ss_dssp CT
T ss_pred Ch
Confidence 54
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=352.55 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=197.0
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
...++|++.+.||+|+||+||+|+++ +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999865 68999999986522111111245778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||++||+|.++++. ..+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 146 lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999999864 24889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCC-CceecccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCC
Q 004268 664 HPDSS-NRTLVVGTYGYIAPELAYTMA----VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNP 731 (764)
Q Consensus 664 ~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~ 731 (764)
..... .....+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+.+....... ......+
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 54322 223568999999999998765 78899999999999999999999987654322111 2233345
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
.++..+.++++.|++..
T Consensus 299 ~~s~~~~~li~~lL~~~ 315 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDR 315 (410)
T ss_dssp CCCHHHHHHHHHHSSCG
T ss_pred cccHHHHHHHHHHccCh
Confidence 68999999999999744
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=332.28 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=199.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 578999999999999999999865 7899999999777666667778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999974 346899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------CcCCCCCCCcHH
Q 004268 666 DSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG--------RKISQNPRLDLQ 736 (764)
Q Consensus 666 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~ 736 (764)
... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+......... ......+.++..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 322 22345789999999999999999999999999999999999999987664321111 111234567889
Q ss_pred HHHHHhhhhccch
Q 004268 737 CNAYLKNFSQGNH 749 (764)
Q Consensus 737 ~~~~~~~~l~~~~ 749 (764)
+.+++.+|++.++
T Consensus 244 l~~li~~~l~~dp 256 (294)
T 4eqm_A 244 LSNVILRATEKDK 256 (294)
T ss_dssp HHHHHHHHSCSSG
T ss_pred HHHHHHHHhcCCH
Confidence 9999999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.18 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=194.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHH-HHhcCCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARL-LSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||.||+|+.+ +++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 578999999999999999999865 688999999987655444444566777776 567899999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||++||+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999974 346889999999999999999999 8999999999999999999999999999998754
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+. ........++.++..+.+++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 444445567899999999999999999999999999999999999999987654322 12223344567899999999
Q ss_pred hhhhccch
Q 004268 742 KNFSQGNH 749 (764)
Q Consensus 742 ~~~l~~~~ 749 (764)
++|++.+.
T Consensus 271 ~~lL~~dp 278 (373)
T 2r5t_A 271 EGLLQKDR 278 (373)
T ss_dssp HHHTCSSG
T ss_pred HHHcccCH
Confidence 99999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.05 Aligned_cols=237 Identities=26% Similarity=0.394 Sum_probs=200.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999865 6899999998654322222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+.+|+|..++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999974 446899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCCceeccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT---MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDLQ 736 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~ 736 (764)
. ......+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ........+..++..
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 3 33455689999999999874 4589999999999999999999999975443211 112233445667899
Q ss_pred HHHHHhhhhccchh
Q 004268 737 CNAYLKNFSQGNHR 750 (764)
Q Consensus 737 ~~~~~~~~l~~~~~ 750 (764)
+.+++++|++.++.
T Consensus 247 ~~~li~~lL~~dP~ 260 (384)
T 4fr4_A 247 MVSLLKKLLEPNPD 260 (384)
T ss_dssp HHHHHHHHSCSSGG
T ss_pred HHHHHHHHhcCCHh
Confidence 99999999998733
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.16 Aligned_cols=234 Identities=22% Similarity=0.331 Sum_probs=200.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999865 7999999998654322222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999974 345899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.... ........+..++..+.++++
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2 2346799999999999999999999999999999999999999987654222 112233345568899999999
Q ss_pred hhhccch
Q 004268 743 NFSQGNH 749 (764)
Q Consensus 743 ~~l~~~~ 749 (764)
+|++.++
T Consensus 271 ~lL~~dp 277 (350)
T 1rdq_E 271 NLLQVDL 277 (350)
T ss_dssp HHSCSCT
T ss_pred HHhhcCH
Confidence 9999773
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.59 Aligned_cols=332 Identities=20% Similarity=0.176 Sum_probs=209.4
Q ss_pred CCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEE
Q 004268 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121 (764)
Q Consensus 42 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 121 (764)
+++++.|++++|.++.+.+..|..+++|++|+|++|.++...+..|..+++|++|+|++|.++++.+..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 45666666666666655555566666666666666666655555666666666666666666666666666666666666
Q ss_pred ccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcC
Q 004268 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 122 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
|++|+++.+++..|.++++|++|+|++|+++++.+..|.++++|++|++++|.++.+ .+..+++|+.|++++|.+..
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence 666666665555566666666666666666666566666666666666666666543 13344455555555554432
Q ss_pred CcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC
Q 004268 202 PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281 (764)
Q Consensus 202 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 281 (764)
+ ...++|++|++++|.+..... . ..++|+.|++++|.+++. ..+..
T Consensus 201 ~-----------------------------~~~~~L~~L~l~~n~l~~~~~-~--~~~~L~~L~l~~n~l~~~--~~l~~ 246 (390)
T 3o6n_A 201 L-----------------------------AIPIAVEELDASHNSINVVRG-P--VNVELTILKLQHNNLTDT--AWLLN 246 (390)
T ss_dssp E-----------------------------ECCSSCSEEECCSSCCCEEEC-C--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred c-----------------------------CCCCcceEEECCCCeeeeccc-c--ccccccEEECCCCCCccc--HHHcC
Confidence 1 222345555555555553321 1 135666666666666643 45666
Q ss_pred CCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceee
Q 004268 282 LKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361 (764)
Q Consensus 282 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 361 (764)
+++|+.|++++|.+.+..|..+..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 6677777777777666666666777777777777777763 3445566777777777777777 4566677777888888
Q ss_pred cccccccCCCCCCCCCCCccceecCCCCccccccCC-ccccCccccccCCCCCCC
Q 004268 362 LSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPA-SVRRIPKLIVSENNLELE 415 (764)
Q Consensus 362 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~n~~~~~ 415 (764)
|++|+++... +..+++|+.|++++|++++.... ++..+++..+..+...|.
T Consensus 325 L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~ 376 (390)
T 3o6n_A 325 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 376 (390)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCC
T ss_pred CCCCccceeC---chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceec
Confidence 8888877442 66778888899999998875443 455666666555554443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=351.32 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=196.8
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.....++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3334688999999999999999999875 799999999865332222223457889999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||+++|+|.+++.+. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++++||+|||+++
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999742 236899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCC-ceecccccccccccccc-------cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------Cc
Q 004268 662 LLHPDSSN-RTLVVGTYGYIAPELAY-------TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RK 726 (764)
Q Consensus 662 ~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~ 726 (764)
........ ....+||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+..+.... ..
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 76544332 23458999999999987 35689999999999999999999999987654322111 01
Q ss_pred CC-CCCCCcHHHHHHHhhhhc
Q 004268 727 IS-QNPRLDLQCNAYLKNFSQ 746 (764)
Q Consensus 727 ~~-~~~~~~~~~~~~~~~~l~ 746 (764)
.. ....++..+.+++++|+.
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~ 311 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC 311 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS
T ss_pred CCccccCCCHHHHHHHHHHcC
Confidence 11 124689999999999997
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.52 Aligned_cols=237 Identities=20% Similarity=0.281 Sum_probs=201.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
...++|++.+.||+|+||+||+|... +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 45788999999999999999999764 7899999999776543 333567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~ 660 (764)
+||||+++|+|.+.+.. ...+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999999999874 346899999999999999999999 89999999999999998 4688999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCC
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRL 733 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~ 733 (764)
..............||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+...... .......+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 877655544455789999999999999999999999999999999999999997665422111 1112223467
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|++.+
T Consensus 241 s~~~~~li~~~L~~d 255 (444)
T 3soa_A 241 TPEAKDLINKMLTIN 255 (444)
T ss_dssp CHHHHHHHHHHSCSS
T ss_pred CHHHHHHHHHHcCCC
Confidence 899999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=338.71 Aligned_cols=236 Identities=21% Similarity=0.326 Sum_probs=199.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|++.+.||+|+||+||+|..+ +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999865 799999999976543221 123678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeee
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADF 657 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df 657 (764)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999973 346899999999999999999999 89999999999999998776 7999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCcC----CCC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRKI----SQN 730 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~~----~~~ 730 (764)
|++....... .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+... .... ...
T Consensus 164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9998765432 2344679999999999999999999999999999999999999998765432211 1111 112
Q ss_pred CCCcHHHHHHHhhhhccc
Q 004268 731 PRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~ 748 (764)
+.++..+.+++++|++.+
T Consensus 243 ~~~s~~~~~li~~~L~~d 260 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKE 260 (361)
T ss_dssp TTSCHHHHHHHHHHSCSS
T ss_pred cCCCHHHHHHHHHHCCCC
Confidence 457889999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.45 Aligned_cols=234 Identities=24% Similarity=0.364 Sum_probs=197.2
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+ .+++.||+|++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57899999999999999999986 57999999998653222111235788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+ +|+|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||++++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788888863 346899999999999999999999 88999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccccC---CcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 741 (764)
.. .....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||++......... .....+..++..+.+++
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 32 2344679999999999998876 7899999999999999999999987654332222 22333555789999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 240 ~~~L~~d 246 (336)
T 3h4j_B 240 RRMIVAD 246 (336)
T ss_dssp HTTSCSS
T ss_pred HHHcCCC
Confidence 9999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=335.39 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=192.4
Q ss_pred hhcCCcceeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||.||+|+. .+++.||+|++...... .......+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 57899999999999999999986 47899999999765432 12234567899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999973 345889999999999999999999 8899999999999999999999999999997
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHH
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 738 (764)
.............||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+...... ........++.++..+.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 654443334456799999999999999999999999999999999999999987654221 12223344567889999
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++++|++.++.-|
T Consensus 250 ~li~~~L~~dp~~R 263 (327)
T 3a62_A 250 DLLKKLLKRNAASR 263 (327)
T ss_dssp HHHHHHSCSCGGGS
T ss_pred HHHHHHHhcCHhhc
Confidence 99999999884433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.56 Aligned_cols=206 Identities=28% Similarity=0.437 Sum_probs=177.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..++|++.+.||+|+||+||+|++.+|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 46899999999999999999999888999999999765432 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++ ++.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 98 ~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 788887643 345899999999999999999999 89999999999999999999999999999988765
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.........+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+...
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5444555678999999999876 5689999999999999999999999986554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.20 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=205.0
Q ss_pred CCccCHHHHHHHhhc----------CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHh
Q 004268 495 DGRITFEEMIEATED----------FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563 (764)
Q Consensus 495 ~~~~~~~~~~~~~~~----------y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~ 563 (764)
.+.++++++..+.+. |...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+.++++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~ 98 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRD 98 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTT
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHh
Confidence 345677777766653 777889999999999999876 79999999987655433 3678899999999
Q ss_pred cCCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 004268 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNN 643 (764)
Q Consensus 564 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 643 (764)
++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~N 171 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDS 171 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHH
Confidence 9999999999999999999999999999999999863 35899999999999999999999 8899999999999
Q ss_pred eeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 004268 644 ILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS 723 (764)
Q Consensus 644 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~ 723 (764)
|+++.++.+||+|||++..............||+.|+|||++.+..++.++||||+|+++|+|++|+.||..........
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999999877654444455689999999999999999999999999999999999999998665422211
Q ss_pred C------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 G------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ~------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
. ........++..+.+++++|++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred HHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence 1 111223346788999999999887
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.94 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=204.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|++...........+.+.+|++++++++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 7999999999654332222246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||++||+|..++.... ....+++..++.++.||+.||+||| ++||+||||||+||+++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987542 2346899999999999999999999 8999999999999999999999999999998876
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQC 737 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~ 737 (764)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... ........++.++..+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence 544444456899999999999999999999999999999999999999986542110 1112233456789999
Q ss_pred HHHHhhhhccchhh
Q 004268 738 NAYLKNFSQGNHRW 751 (764)
Q Consensus 738 ~~~~~~~l~~~~~~ 751 (764)
.+++++|++.++.-
T Consensus 421 ~~li~~lL~~dP~~ 434 (543)
T 3c4z_A 421 KDFCEALLQKDPEK 434 (543)
T ss_dssp HHHHHHHSCSSGGG
T ss_pred HHHHHHhccCCHhH
Confidence 99999999987433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.63 Aligned_cols=236 Identities=21% Similarity=0.341 Sum_probs=199.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
...++|++.+.||+|+||.||+|.++ +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34678999999999999999999865 7899999999766543 334577899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC---CCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN---LEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~ 660 (764)
+||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999999873 346899999999999999999999 8999999999999999864 45999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CC----cCCCCCCC
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GR----KISQNPRL 733 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~----~~~~~~~~ 733 (764)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+...... .. .....+.+
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 876533 22344679999999999999999999999999999999999999998665422111 11 11112346
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|++.+
T Consensus 258 ~~~~~~li~~~L~~d 272 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVN 272 (362)
T ss_dssp CHHHHHHHHHHSCSS
T ss_pred CHHHHHHHHHHcCCC
Confidence 889999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.40 Aligned_cols=232 Identities=24% Similarity=0.328 Sum_probs=197.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999865 68899999987543 2236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC--CCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--NLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 663 (764)
|||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||.+...
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999642 346899999999999999999999 899999999999999987 789999999999877
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---C----cCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---R----KISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~----~~~~~~~~~~~ 736 (764)
... .......|++.|+|||++.+..++.++||||+|+++|+|++|..||.+......... . .....+.++..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 543 334456799999999999998899999999999999999999999987654321111 1 11112467889
Q ss_pred HHHHHhhhhccc
Q 004268 737 CNAYLKNFSQGN 748 (764)
Q Consensus 737 ~~~~~~~~l~~~ 748 (764)
+.+++++|++.+
T Consensus 234 ~~~li~~~L~~d 245 (321)
T 1tki_A 234 AMDFVDRLLVKE 245 (321)
T ss_dssp HHHHHHTTSCSS
T ss_pred HHHHHHHHcCCC
Confidence 999999999987
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.75 Aligned_cols=348 Identities=22% Similarity=0.218 Sum_probs=287.9
Q ss_pred CCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccC
Q 004268 28 GTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSI 107 (764)
Q Consensus 28 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 107 (764)
.+...+..+..++.+++|++|++++|.+++. | .+..+++|++|+|++|++++. + ++.+++|++|+|++|.++++
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-
Confidence 3444556667889999999999999999975 5 699999999999999999964 3 89999999999999999975
Q ss_pred CccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCC
Q 004268 108 PLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLN 187 (764)
Q Consensus 108 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 187 (764)
+ |+++++|++|++++|+++++ + +..+++|++|++++|+++++ .+.++++|++|++++|...+.. .+..++
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~ 170 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQT 170 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCT
T ss_pred e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCC
Confidence 2 88999999999999999986 2 89999999999999999975 3889999999999999543333 478899
Q ss_pred CccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEcc
Q 004268 188 QLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLS 267 (764)
Q Consensus 188 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 267 (764)
+|+.|++++|+++.++ +..+++|+.|++++|.+++. .+..+++|+.|++++|+++++ | +..+++|+.|+++
T Consensus 171 ~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 171 QLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCS 241 (457)
T ss_dssp TCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred cCCEEECCCCccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEee
Confidence 9999999999999864 78899999999999999975 388899999999999999974 4 8899999999999
Q ss_pred CCcccCCCCccccCCC-------CCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCCh--------hhhcccc
Q 004268 268 SNQLSGLLPREVGNLK-------YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPP--------ELMNCSQ 332 (764)
Q Consensus 268 ~n~l~~~~~~~~~~l~-------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~--------~~~~l~~ 332 (764)
+|++++..+..+..+. +|+.|++++|.+.+..| ++.+++|+.|++++|...+.+|. .+.++++
T Consensus 242 ~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~ 319 (457)
T 3bz5_A 242 VNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPK 319 (457)
T ss_dssp SSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTT
T ss_pred CCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhccc
Confidence 9999987655554444 45566666665544444 45678999999999986544332 2566788
Q ss_pred cceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCccccccCCCC
Q 004268 333 LLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL 412 (764)
Q Consensus 333 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~ 412 (764)
|++|++++|++++. + +..+++|+.|++++|++++ ++.|..|++++|.++|. ..+..++.++++.|.+
T Consensus 320 L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~--~~~~~l~~l~l~~N~l 386 (457)
T 3bz5_A 320 LVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE--GQTITMPKETLTNNSL 386 (457)
T ss_dssp CCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE--EEEEECCCBCCBTTBE
T ss_pred CCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec--ceeeecCccccccCcE
Confidence 89999999999864 3 8888899999999999885 35677788899999876 3566788899999988
Q ss_pred CCC
Q 004268 413 ELE 415 (764)
Q Consensus 413 ~~~ 415 (764)
.+.
T Consensus 387 ~g~ 389 (457)
T 3bz5_A 387 TIA 389 (457)
T ss_dssp EEE
T ss_pred EEE
Confidence 643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.23 Aligned_cols=241 Identities=22% Similarity=0.290 Sum_probs=201.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.............+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 7999999998654322222236678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||+|.+++... ....+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999754 2334899999999999999999999 88999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCcHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~ 738 (764)
.. .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ........+..++..+.
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~ 417 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence 32 33446899999999999999999999999999999999999999987543111 11122233456889999
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++++|++.++.-|
T Consensus 418 dLI~~lL~~dP~~R 431 (576)
T 2acx_A 418 SLCSQLLCKDPAER 431 (576)
T ss_dssp HHHHHHTCSSGGGS
T ss_pred HHHHHhccCCHHHc
Confidence 99999999874333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.49 Aligned_cols=237 Identities=26% Similarity=0.436 Sum_probs=199.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 478999999999999999999865 7899999988543 334457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999999999752 346899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCCc--------------eecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------
Q 004268 666 DSSNR--------------TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------ 725 (764)
Q Consensus 666 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------ 725 (764)
..... ....||+.|+|||++.+..++.++||||+|+++|+|++|..||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 32211 1457899999999999999999999999999999999999999865443222211
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
....++..+..+.+++++|++.++.-
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~ 266 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEK 266 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred cccCCCCCCHHHHHHHHHHccCChhh
Confidence 11225667888999999999987433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.42 Aligned_cols=311 Identities=21% Similarity=0.188 Sum_probs=243.8
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
.+++++.|++.+|.++...+..+..+++|++|+|++|.++++.+..|..+++|++|+|++|.+++..+..|+.+++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 45899999999999987766678999999999999999998888899999999999999999998888899999999999
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|++|.++.+.+..|.++++|++|++++|.+..+.+..|.++++|++|++++|+++.+ .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999988777889999999999999999999999999999999999999999866 3667899999999999887
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCc
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 256 (764)
. +...++|+.|++++|.+..+... ..++ |+.|++++|.+++. ..+.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~~~~---~~~~------------------------L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVVRGP---VNVE------------------------LTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEEECC---CCSS------------------------CCEEECCSSCCCCC--GGGG
T ss_pred c-----cCCCCcceEEECCCCeeeecccc---cccc------------------------ccEEECCCCCCccc--HHHc
Confidence 4 34456777888887777644221 1234 45555555555432 3455
Q ss_pred CCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccccee
Q 004268 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336 (764)
Q Consensus 257 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L 336 (764)
.+++|+.|+|++|.+.+..+..|..+++|+.|++++|++.+ .+..+..+++|++|+|++|+++ .+|..+..+++|++|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 55666666666666665556666666666666666666654 3344556777777777777777 456667777788888
Q ss_pred eccccccccCCchhcccccccceeecccccccC
Q 004268 337 VLSHNSLSGSIPSEIGNLIFFRQLDLSRNFING 369 (764)
Q Consensus 337 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 369 (764)
+|++|++++. + +..+++|+.|++++|++.+
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 8888887744 2 5667778888888888764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=350.93 Aligned_cols=237 Identities=22% Similarity=0.300 Sum_probs=191.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|... +|+.||+|++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999864 7999999998754333333346778899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++++|..++.. ...+++..+..++.||+.||+||| + +||+||||||+||+++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999873 346899999999999999999999 7 899999999999999999999999999998655
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
.........+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ........+..++..+.+++
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 444445567899999999999999999999999999999999999999986654221 12223334556889999999
Q ss_pred hhhhccch
Q 004268 742 KNFSQGNH 749 (764)
Q Consensus 742 ~~~l~~~~ 749 (764)
++|++.++
T Consensus 381 ~~~L~~dP 388 (446)
T 4ejn_A 381 SGLLKKDP 388 (446)
T ss_dssp HHHTCSST
T ss_pred HHHcccCH
Confidence 99999873
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.18 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=196.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC--cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE--EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++...... .....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3578999999999999999999865 7999999998542210 001136788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC---EEEeeec
Q 004268 583 FLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVADFG 658 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg 658 (764)
|+||||+++++|.+++.... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876432 2335899999999999999999999 899999999999999986554 9999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc--ccCCcCC----CCCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS--SSGRKIS----QNPR 732 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~--~~~~~~~----~~~~ 732 (764)
++..............||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ....... ..+.
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence 998876544444556899999999999999999999999999999999999999986543110 0111111 1245
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.+++++|++.+
T Consensus 259 ~s~~~~~li~~~L~~d 274 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLD 274 (351)
T ss_dssp SCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHCCCC
Confidence 7889999999999977
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.83 Aligned_cols=235 Identities=27% Similarity=0.401 Sum_probs=194.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3578999999999999999999865 89999999986554332 23678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999999999863 345899999999999999999999 8999999999999999999999999999998653
Q ss_pred CCC--CCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcH
Q 004268 665 PDS--SNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDL 735 (764)
Q Consensus 665 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~ 735 (764)
... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......... ..........++.
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 222 22234678999999999988776 77899999999999999999999866543211 1112222345788
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
.+.+++++|++.+
T Consensus 237 ~~~~li~~~L~~d 249 (323)
T 3tki_A 237 APLALLHKILVEN 249 (323)
T ss_dssp HHHHHHHHHSCSS
T ss_pred HHHHHHHHHccCC
Confidence 9999999999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=328.93 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=199.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|++.+.||+|+||.||+|... +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3577999999999999999999865 789999999876543211 123678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeee
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADF 657 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df 657 (764)
.++||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999973 346899999999999999999999 89999999999999999877 8999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---C----cCCCC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---R----KISQN 730 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~----~~~~~ 730 (764)
|.+....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+.... . .....
T Consensus 163 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 163 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 9998765332 23345799999999999999999999999999999999999999976554221110 1 11112
Q ss_pred CCCcHHHHHHHhhhhccchh
Q 004268 731 PRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~~ 750 (764)
+..+..+.++++.|++.++.
T Consensus 242 ~~~~~~~~~li~~~L~~dP~ 261 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPK 261 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGG
T ss_pred ccCCHHHHHHHHHHccCChh
Confidence 45788899999999998833
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.47 Aligned_cols=236 Identities=24% Similarity=0.366 Sum_probs=193.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|.+. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 57999999999999999999865 78999999997655433 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++ ++.+.+.. ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 81 e~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99986 55555543 2346899999999999999999999 889999999999999999999999999999877655
Q ss_pred CCCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCC-Cccccccc-----------------------
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPT-DLLSSLSS----------------------- 721 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf-~~~~~~~~----------------------- 721 (764)
........||+.|+|||++.+.. ++.++||||+||++|+|++|..|| .+.+..+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 55555568899999999988766 799999999999999999988885 33221000
Q ss_pred ---------ccCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 722 ---------SSGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 722 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.........+.++..+.+++++|++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 272 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChh
Confidence 00011122345788999999999998833
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=320.63 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=184.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 357899999999999999999986 4799999999865432222224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999743 346899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCcCCCCCCCcHHHHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 741 (764)
..........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.......... ......+..++..+.+++
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 44433445678999999999999899999999999999999999999998655432221 122233455788999999
Q ss_pred hhhhccchhhH--HHhhhcCCC
Q 004268 742 KNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 742 ~~~l~~~~~~~--~~~~~~~p~ 761 (764)
++|++.++.-| .......||
T Consensus 244 ~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 244 HQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp HHHSCSSGGGSCCHHHHTTSTT
T ss_pred HHHcccCHhhCCCHHHHhcCcc
Confidence 99999884433 333344443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.24 Aligned_cols=235 Identities=27% Similarity=0.353 Sum_probs=190.2
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
++|++.+.||+|+||+||+|+..+|+.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998889999999987554321 123667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++ +|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9986 898888742 345889999999999999999999 8999999999999999999999999999998775444
Q ss_pred CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----------------------
Q 004268 668 SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---------------------- 724 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---------------------- 724 (764)
.......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+....+....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 444456789999999998764 589999999999999999999999986543211000
Q ss_pred ---C-------cCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 ---R-------KISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 ---~-------~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
. .......++..+.+++++|++.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 269 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCc
Confidence 0 001123467888999999998773
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.69 Aligned_cols=234 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 578999999999999999999865 789999999875432 2236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC--CCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--NLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 663 (764)
|||+++++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++. .+.+||+|||++...
T Consensus 127 ~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999998742 345899999999999999999999 899999999999999974 578999999999877
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~ 736 (764)
.... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+........ .........++..
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 280 (387)
T 1kob_A 202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280 (387)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence 5432 3344579999999999999999999999999999999999999998765422111 1112223467899
Q ss_pred HHHHHhhhhccch
Q 004268 737 CNAYLKNFSQGNH 749 (764)
Q Consensus 737 ~~~~~~~~l~~~~ 749 (764)
+.++++.|++.++
T Consensus 281 ~~~li~~~L~~dP 293 (387)
T 1kob_A 281 AKDFIKNLLQKEP 293 (387)
T ss_dssp HHHHHHTTSCSSG
T ss_pred HHHHHHHHcCCCh
Confidence 9999999999883
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.12 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=200.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|++.+.||+|+||+||+|++. ++..||+|++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 478999999999999999999752 35579999997653 334457899999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+.+..|+||||+++|+|.+++..... ...+++..+..++.||+.||+||| ++||+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence 99999999999999999999975421 235789999999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987654322 1223456789999999999999999999999999999999 9999987654322
Q ss_pred cc----CCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 722 SS----GRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 722 ~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.. ......+...+..+.+++++|++.++.-|
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 11 12233445678899999999998874433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.77 Aligned_cols=236 Identities=22% Similarity=0.341 Sum_probs=191.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc-----------------------HHHHHHHHHHHHHHH
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE-----------------------PAFLESFQTEARLLS 562 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 562 (764)
.++|++.+.||+|+||+||+|... +++.||+|++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 578999999999999999999864 78899999987654221 112356889999999
Q ss_pred hcCCCceeeEeeEEee--CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCC
Q 004268 563 QIRHRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDIS 640 (764)
Q Consensus 563 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk 640 (764)
+++||||+++++++.+ .+..++||||+++++|.++.. ...+++..+..++.||+.||+||| ++||+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 9999999999999987 568999999999999987653 346899999999999999999999 8899999999
Q ss_pred CCCeeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 641 SNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA---VTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 641 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+||+++.++.+||+|||++..............||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||.+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987765444444567999999999988765 3778999999999999999999998654
Q ss_pred ccccc-----cCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 718 SLSSS-----SGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 718 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..... ........+.++..+.+++++|++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 281 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNP 281 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCT
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcCh
Confidence 32111 112223345688999999999998773
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.98 Aligned_cols=331 Identities=21% Similarity=0.183 Sum_probs=205.8
Q ss_pred CCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEE
Q 004268 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121 (764)
Q Consensus 42 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 121 (764)
+.+++.|++++|.++.+.+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|.++++.+..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 34556666666666655555555666666666666666655555666666666666666666655555566666666666
Q ss_pred ccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcC
Q 004268 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 122 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
|++|.++.+++..|.++++|++|+|++|.++++.+..|.++++|++|+|++|.++++. +..+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~------------- 193 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPS------------- 193 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTT-------------
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhh-------------
Confidence 6666666555555566666666666666666555555666666666666666555331 333444
Q ss_pred CcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC
Q 004268 202 PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281 (764)
Q Consensus 202 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 281 (764)
|+.|++++|.+++ +....+|+.|++++|.+....+.. .++|+.|+|++|.+++ +..+..
T Consensus 194 -----------L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~ 252 (597)
T 3oja_B 194 -----------LFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLN 252 (597)
T ss_dssp -----------CSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGG
T ss_pred -----------hhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhcc
Confidence 4445555544442 223345566666666555332221 2466777777777664 255667
Q ss_pred CCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceee
Q 004268 282 LKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLD 361 (764)
Q Consensus 282 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 361 (764)
+++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 7777777777777776666677777777777777777774 4555566777888888888877 5666677788888888
Q ss_pred cccccccCCCCCCCCCCCccceecCCCCccccccC-CccccCccccccCCCCCC
Q 004268 362 LSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP-ASVRRIPKLIVSENNLEL 414 (764)
Q Consensus 362 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~~~~~~~~~n~~~~ 414 (764)
|++|++++.. +..+++|+.|++++|+++|... .++..+....+..+...|
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C 381 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 381 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCC
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccC
Confidence 8888887542 6677888999999999987543 345555555554444433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.39 Aligned_cols=206 Identities=24% Similarity=0.385 Sum_probs=164.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|... +|+.||+|++........ .+.+.+|++++++++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 578999999999999999999864 789999999875543221 25678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 586 YEYMERGSLFCVLRNDV---EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|||++ ++|.+++.... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 59998886431 1235889999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
............||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 75444444456789999999998764 689999999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.30 Aligned_cols=236 Identities=25% Similarity=0.407 Sum_probs=193.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----E
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----C 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 581 (764)
.++|++.+.||+|+||+||+|++ .+++.||+|++.............+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999986 578999999998876666666788999999999999999999999987654 3
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 5999999999999999973 346899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCC---CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC-------cCCCCC
Q 004268 662 LLHPDSS---NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR-------KISQNP 731 (764)
Q Consensus 662 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~-------~~~~~~ 731 (764)
....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+.......... .....+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 7643322 123356899999999999999999999999999999999999999876543221111 111134
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
.++..+.+++++|++.+
T Consensus 245 ~~~~~l~~li~~~l~~d 261 (311)
T 3ork_A 245 GLSADLDAVVLKALAKN 261 (311)
T ss_dssp TCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHHHHHHHhcC
Confidence 57889999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.50 Aligned_cols=235 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+.+.||+|+||.||+|++. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 578999999999999999999875 8999999998754322222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999973 446899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||++...... ........+..++..+.+++
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 247 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence 3 23345689999999999998876 6899999999999999999999987654221 11222334455789999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 248 ~~~L~~d 254 (476)
T 2y94_A 248 KHMLQVD 254 (476)
T ss_dssp HHHTCSS
T ss_pred HHHcCCC
Confidence 9999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.86 Aligned_cols=231 Identities=26% Similarity=0.372 Sum_probs=186.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.. +++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 578999999999999999999876 89999999997655443 5678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC--EEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE--AFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~ 663 (764)
|||+++|+|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999999873 346899999999999999999999 899999999999999987665 999999999754
Q ss_pred CCCCCCceecccccccccccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCcccccccc---------cCCcCCCCCCC
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEK-CDVYSFGVVALEVLMGSHPTDLLSSLSSS---------SGRKISQNPRL 733 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~~lltg~~Pf~~~~~~~~~---------~~~~~~~~~~~ 733 (764)
... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+....... ..........+
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 322 22334579999999999988888665 89999999999999999999875542211 11223334457
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|++.+
T Consensus 248 s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 248 SPECCHLISRIFVAD 262 (361)
T ss_dssp CHHHHHHHHHHSCSC
T ss_pred CHHHHHHHHHHccCC
Confidence 899999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.38 Aligned_cols=236 Identities=22% Similarity=0.388 Sum_probs=205.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 578999999999999999999865 6889999999876655566678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998873 346899999999999999999999 88999999999999999999999999999987764
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
.........|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+. ........+..++..+.++++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 44445556789999999999999999999999999999999999999987543221 112223345567889999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 248 ~~l~~~ 253 (294)
T 2rku_A 248 KMLQTD 253 (294)
T ss_dssp HHTCSS
T ss_pred HHcccC
Confidence 999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=329.73 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=198.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK---- 580 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---- 580 (764)
..++|++.+.||+|+||.||+|+++ +|+.||+|++....... ..+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4688999999999999999999876 89999999997654332 3478899999999999999999999886543
Q ss_pred -----------------------------------------------------EEEEEEEecCCCCHHHHHhcCcccccc
Q 004268 581 -----------------------------------------------------CMFLIYEYMERGSLFCVLRNDVEAVEL 607 (764)
Q Consensus 581 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l 607 (764)
..++||||+++++|.+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 389999999999999999876666667
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC------------Cceeccc
Q 004268 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS------------NRTLVVG 675 (764)
Q Consensus 608 ~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~g 675 (764)
++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....... ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 78889999999999999999 89999999999999999999999999999987754321 1233578
Q ss_pred ccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc--CCCCCCCcHHHHHHHhhhhccchhhH-
Q 004268 676 TYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK--ISQNPRLDLQCNAYLKNFSQGNHRWE- 752 (764)
Q Consensus 676 ~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~- 752 (764)
|+.|+|||++.+..++.++||||+|+++|+|++|..|+............. ....+..+....+++++|++.++.-|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999999999999999999999999999999998875433221111111 11112235677889999998874333
Q ss_pred -HHhhhcCCC
Q 004268 753 -NLLFKKFPY 761 (764)
Q Consensus 753 -~~~~~~~p~ 761 (764)
.....+.||
T Consensus 319 s~~~~l~~~~ 328 (332)
T 3qd2_B 319 EATDIIENAI 328 (332)
T ss_dssp CHHHHHHSTT
T ss_pred CHHHHhhchh
Confidence 444444444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=358.36 Aligned_cols=238 Identities=21% Similarity=0.316 Sum_probs=203.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||.||+|+++ +++.||+|++.+.........+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999865 7889999998754322222236678899999888 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++|+|..++.. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999974 346899999999999999999999 899999999999999999999999999999875
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 740 (764)
..........+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+. ........+..++..+.++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 572 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 572 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 5444455567899999999999999999999999999999999999999987655322 2233444556789999999
Q ss_pred Hhhhhccch
Q 004268 741 LKNFSQGNH 749 (764)
Q Consensus 741 ~~~~l~~~~ 749 (764)
++.|++.++
T Consensus 573 i~~lL~~dP 581 (674)
T 3pfq_A 573 CKGLMTKHP 581 (674)
T ss_dssp HHHHSCSSS
T ss_pred HHHHccCCH
Confidence 999999873
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.48 Aligned_cols=207 Identities=18% Similarity=0.308 Sum_probs=181.0
Q ss_pred hhcCCcceeeeec--CceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 507 TEDFHIKYCIGTG--GYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
.++|++.+.||+| +||+||+|+.. +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 5789999999999 99999999876 7999999999765543 345678889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++++|.+++... ....+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999754 2345899999999999999999999 899999999999999999999999999988654
Q ss_pred CCCC-------CCceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 664 HPDS-------SNRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 664 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 2211 11223478999999999987 6789999999999999999999999987554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.72 Aligned_cols=236 Identities=22% Similarity=0.388 Sum_probs=205.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 578999999999999999999865 6889999999876655566678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999999873 346899999999999999999999 88999999999999999999999999999987764
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
.........|++.|+|||++.+..++.++||||+|+++|+|++|+.||......+. ...........++..+.++++
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 44445556799999999999999999999999999999999999999986543221 111223344567889999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 274 ~~l~~d 279 (335)
T 2owb_A 274 KMLQTD 279 (335)
T ss_dssp HHTCSS
T ss_pred HHccCC
Confidence 999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.46 Aligned_cols=232 Identities=25% Similarity=0.340 Sum_probs=181.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|++. +++.||+|++..... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3578999999999999999999876 688999999976432 2667899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~ 661 (764)
||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999999974 345899999999999999999999 889999999999999975 8899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----ccC----CcCCCCCCC
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----SSG----RKISQNPRL 733 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----~~~----~~~~~~~~~ 733 (764)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||........ ... ......+.+
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 76432 223346789999999999999999999999999999999999999976543211 011 111223467
Q ss_pred cHHHHHHHhhhhccch
Q 004268 734 DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~ 749 (764)
+..+.+++++|++.++
T Consensus 279 ~~~~~~li~~~L~~dP 294 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDP 294 (349)
T ss_dssp CHHHHHHHHTTSCSSG
T ss_pred CHHHHHHHHHHccCCh
Confidence 8899999999999883
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.66 Aligned_cols=235 Identities=23% Similarity=0.327 Sum_probs=199.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhcCCCceeeEeeEEee
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP-----AFLESFQTEARLLSQIRHRNIVKLYGFCLH 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 578 (764)
+..++|++.+.||+|+||+||+|.+. +++.||+|++........ ...+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45689999999999999999999854 788999999976543221 112456789999999999999999999999
Q ss_pred CCEEEEEEEecCCC-CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 579 NKCMFLIYEYMERG-SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 579 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
.+..++||||+.+| +|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999777 99999974 346899999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHH
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQ 736 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 736 (764)
|.+....... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||...... .......+..++..
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---VEAAIHPPYLVSKE 250 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---TTTCCCCSSCCCHH
T ss_pred ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---HhhccCCCcccCHH
Confidence 9998765433 2344679999999999988877 78999999999999999999999865442 22333445557899
Q ss_pred HHHHHhhhhccch
Q 004268 737 CNAYLKNFSQGNH 749 (764)
Q Consensus 737 ~~~~~~~~l~~~~ 749 (764)
+.++++.|++.++
T Consensus 251 l~~li~~~L~~dP 263 (335)
T 3dls_A 251 LMSLVSGLLQPVP 263 (335)
T ss_dssp HHHHHHHHTCSSG
T ss_pred HHHHHHHHccCCh
Confidence 9999999999883
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=324.81 Aligned_cols=239 Identities=28% Similarity=0.413 Sum_probs=197.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+. .+..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 468999999999999999999864 344699999976543 33457889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.++++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999642 346899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 663 LHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
........ ....+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....+.. .......+...+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 65432221 22345778999999999999999999999999999999 99999876553221 122334455678
Q ss_pred HHHHHHHhhhhccchhhH
Q 004268 735 LQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~ 752 (764)
..+.+++..|++.++.-|
T Consensus 281 ~~l~~li~~~l~~dp~~R 298 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQR 298 (325)
T ss_dssp HHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHccCChhhC
Confidence 899999999999874433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.22 Aligned_cols=307 Identities=26% Similarity=0.395 Sum_probs=176.7
Q ss_pred ccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCC
Q 004268 39 IGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLD 118 (764)
Q Consensus 39 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 118 (764)
+..+++|++|++++|.++.+ + .+..+++|++|++++|+++... . +..+++|++|+|++|.++.+ ..|.++++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~-~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDIS-P-LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccch-h-hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 44566777777777777643 2 3666777777777777776432 2 66777777777777776643 2466677777
Q ss_pred EEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCcc
Q 004268 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 119 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
+|++++|.+..+.+ +..+++|++|++++|..... ...+..+++|++|++++|.+.++.+ +..+++|++|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 77777777665533 66666777777776644322 2336666666666666666654322 4555555555555555
Q ss_pred CcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCcc
Q 004268 199 LVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPRE 278 (764)
Q Consensus 199 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 278 (764)
+..+.. +..+++|+.|++++ |.+.+..+ +..+++|+.|++++|.+++..+
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~------------------------n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-- 238 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYV------------------------NQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCS------------------------SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred cccccc--ccCCCccceeeccc------------------------CCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence 554332 44444444554444 44443322 4444555555555555543322
Q ss_pred ccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccc
Q 004268 279 VGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR 358 (764)
Q Consensus 279 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~ 358 (764)
+..+++|+.|++++|.+.+. ..+..+++|++|++++|++++. +.+..+++|++|++++|++++..+..+..+++|+
T Consensus 239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 314 (347)
T 4fmz_A 239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence 45555555555555555432 2355556666666666666533 3455666666666666666655566666666666
Q ss_pred eeecccccccCCCCCCCCCCCccceecCCCCccc
Q 004268 359 QLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLS 392 (764)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 392 (764)
.|+|++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 66666666665544 556666666666666654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=314.71 Aligned_cols=237 Identities=22% Similarity=0.394 Sum_probs=200.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|+.+++..||+|++....... +.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 57899999999999999999998888899999997665442 66889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999743 335899999999999999999999 899999999999999999999999999999876433
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||+........ .......+...+..+.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 221 122345678999999999899999999999999999999 99999876653221 122333344568899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
++.|++.++.-|
T Consensus 238 i~~~l~~~p~~R 249 (268)
T 3sxs_A 238 MYSCWHELPEKR 249 (268)
T ss_dssp HHHTTCSSGGGS
T ss_pred HHHHcCCChhhC
Confidence 999999874433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.48 Aligned_cols=230 Identities=24% Similarity=0.365 Sum_probs=171.4
Q ss_pred hhcCCcc---eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCE
Q 004268 507 TEDFHIK---YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~---~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 581 (764)
.++|++. +.||+|+||+||+|.+. +++.||+|++.... ...+.+|+.+++.+. ||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 3455554 78999999999999865 78999999986432 266789999999997 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEEEeeec
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAFVADFG 658 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfg 658 (764)
.|+||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999999999999999974 346899999999999999999999 89999999999999998765 89999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------ccCCcCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----------SSGRKIS 728 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----------~~~~~~~ 728 (764)
.+..............||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .......
T Consensus 155 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp TCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred cceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 998766555555566789999999999999999999999999999999999999986543110 0111111
Q ss_pred C----CCCCcHHHHHHHhhhhccc
Q 004268 729 Q----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ~----~~~~~~~~~~~~~~~l~~~ 748 (764)
. .+.++..+.++++.|++.+
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~d 258 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVD 258 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCC
T ss_pred CCcccccCCCHHHHHHHHHHCCCC
Confidence 1 1246889999999999877
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.05 Aligned_cols=232 Identities=15% Similarity=0.169 Sum_probs=192.3
Q ss_pred hhcCCcceeeeecCceeEEEEE------ECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC---CCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQ------LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR---HRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~ 577 (764)
.++|++.+.||+|+||+||+|. ..+++.||+|++.... ...+.+|+++++.++ |+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 5789999999999999999993 4578999999987543 256778888888886 999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCc--cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-------
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDV--EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS------- 648 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~------- 648 (764)
..+..++||||+++|+|.+++.... ....+++..++.++.||+.||+||| ++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999997422 2346999999999999999999999 999999999999999998
Q ss_pred ----CCCEEEeeeccccccCC--CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 004268 649 ----NLEAFVADFGLARLLHP--DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722 (764)
Q Consensus 649 ----~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~ 722 (764)
++.+||+|||+|+.+.. ........+||+.|+|||++.+..++.++||||+||++|||+||+.||.........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 89999999999976532 222334567999999999999999999999999999999999999999755443222
Q ss_pred cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
... .......+..+.+++..|++.+
T Consensus 295 ~~~-~~~~~~~~~~~~~~~~~~l~~~ 319 (365)
T 3e7e_A 295 PEG-LFRRLPHLDMWNEFFHVMLNIP 319 (365)
T ss_dssp ECS-CCTTCSSHHHHHHHHHHHHCCC
T ss_pred ech-hccccCcHHHHHHHHHHHcCCC
Confidence 111 1222245778888888888866
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.60 Aligned_cols=237 Identities=24% Similarity=0.400 Sum_probs=200.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|.+.+++.||+|++....... +.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 47899999999999999999998889999999998765443 66889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999743 345899999999999999999999 899999999999999999999999999999865432
Q ss_pred C-CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 S-SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
. .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......+.. .......+...+..+.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 239 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence 1 11122456778999999999999999999999999999999 99999876553221 122333445568899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
++.|++.++.-|
T Consensus 240 i~~~l~~~p~~R 251 (269)
T 4hcu_A 240 MNHCWRERPEDR 251 (269)
T ss_dssp HHHHTCSSGGGS
T ss_pred HHHHccCCcccC
Confidence 999998874443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.04 Aligned_cols=328 Identities=25% Similarity=0.265 Sum_probs=158.6
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCC-------------cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcc
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKL-------------EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTG 81 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L-------------~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~ 81 (764)
|..+++|+.|++++|.+++.+|..++.+++| ++|++++|.++++ |.. .++|++|++++|.+++
T Consensus 30 i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~~---~~~L~~L~l~~n~l~~ 105 (454)
T 1jl5_A 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PEL---PPHLESLVASCNSLTE 105 (454)
T ss_dssp ----CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CSC---CTTCSEEECCSSCCSS
T ss_pred HhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CCC---cCCCCEEEccCCcCCc
Confidence 5555566666666666665666655555543 5555555555532 221 2455555555555553
Q ss_pred cCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccC
Q 004268 82 TIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161 (764)
Q Consensus 82 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 161 (764)
+|.. +++|++|++++|.++++.. . .++|++|++++|+++++ | .|.++++|++|++++|+++++ |..
T Consensus 106 -lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~N~l~~l-p~~--- 171 (454)
T 1jl5_A 106 -LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKL-PDL--- 171 (454)
T ss_dssp -CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCC-CCC---
T ss_pred -cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCCCC-c-ccCCCCCCCEEECCCCcCccc-CCC---
Confidence 3322 2455555555555553211 0 14555555555555543 2 355555555555555555532 221
Q ss_pred CCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEE
Q 004268 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELH 241 (764)
Q Consensus 162 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 241 (764)
..+|++|++++|.++++ + .+..+++|+.|++++|++..++. ..++|++|++++|.++. .| .+..+++|+.|+
T Consensus 172 ~~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~ 243 (454)
T 1jl5_A 172 PPSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILEE-LP-ELQNLPFLTTIY 243 (454)
T ss_dssp CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcCCC----CcCcccEEECcCCcCCc-cc-ccCCCCCCCEEE
Confidence 13555555555555542 2 35555555555555555554321 11355555555555552 23 255555555555
Q ss_pred ccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCcc
Q 004268 242 LSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS 321 (764)
Q Consensus 242 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 321 (764)
+++|++++. |.. +++|+.|++++|+++++ |.. .++|+.|++++|++.+.. . ..++|++|++++|++++
T Consensus 244 l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l-~~~---~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~ 311 (454)
T 1jl5_A 244 ADNNLLKTL-PDL---PPSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRS 311 (454)
T ss_dssp CCSSCCSSC-CSC---CTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSE
T ss_pred CCCCcCCcc-ccc---ccccCEEECCCCccccc-Ccc---cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCc
Confidence 555555532 221 24555555555555532 211 245555555555554311 0 01344444444444442
Q ss_pred CCChhhhcc-cccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCcccc
Q 004268 322 SIPPELMNC-SQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 322 ~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 393 (764)
. + .+ ++|++|++++|++++ +|.. +++|+.|++++|+++. +|. .+++|+.|++++|++++
T Consensus 312 i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 312 L-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp E-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS
T ss_pred c-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCc
Confidence 1 1 11 355556666665553 3322 3455566666665553 333 24555566666666555
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.09 Aligned_cols=219 Identities=41% Similarity=0.713 Sum_probs=187.8
Q ss_pred CCccCHHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEee
Q 004268 495 DGRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 495 ~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
...+++.++....++|++.+.||+|+||+||+|+.++++.||+|++........ ...+.+|+++++.++||||+++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEE
Confidence 345788899999999999999999999999999988899999999976543321 136889999999999999999999
Q ss_pred EEeeCCEEEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 575 FCLHNKCMFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 575 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||..+..||+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998643 233589999999999999999999932222999999999999999999999
Q ss_pred EeeeccccccCCCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 654 VADFGLARLLHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
|+|||.+......... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 9999999876533322 2335689999999999998999999999999999999999999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.35 Aligned_cols=234 Identities=30% Similarity=0.487 Sum_probs=196.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 578999999999999999999765 6789999998654333222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999873 345899999999999999999999 99999999999999999999999999999865432
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ........+...+..+.++++
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 2 23345789999999999999999999999999999999999999986654322 122233345557889999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 240 ~~l~~~ 245 (279)
T 3fdn_A 240 RLLKHN 245 (279)
T ss_dssp HHCCSS
T ss_pred HHhccC
Confidence 999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.56 Aligned_cols=231 Identities=21% Similarity=0.318 Sum_probs=193.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
...++|++.+.||+|+||.||+|.++ +++.||+|++...... ..+|++++.++ +||||+++++++.+.+..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 35688999999999999999999865 7889999999765433 24688888888 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC----CCEEEeeec
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN----LEAFVADFG 658 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg 658 (764)
|+||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||++.+. +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999999999999974 346899999999999999999999 8999999999999998533 359999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------c----cCCcCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------S----SGRKIS 728 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~----~~~~~~ 728 (764)
++.............+||+.|+|||++.+..++.++||||+||++|+|++|+.||........ . ......
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 998776555445567889999999999988899999999999999999999999985322110 0 011111
Q ss_pred CCCCCcHHHHHHHhhhhccc
Q 004268 729 QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~ 748 (764)
..+.++..+.+++++|++.+
T Consensus 246 ~~~~~s~~~~~li~~~L~~d 265 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVD 265 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSS
T ss_pred ccccCCHHHHHHHHHHCCCC
Confidence 23568899999999999987
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.30 Aligned_cols=348 Identities=25% Similarity=0.272 Sum_probs=270.6
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCC-------------CEEEccCCcCcccCC
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRL-------------KVLDLSYNRLTGTIP 84 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~~ 84 (764)
...|+.|++++|.+ +.+|++++.+++|++|++++|.+++..|..+..+++| ++|++++|.+++ +|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 47899999999999 7999999999999999999999999999999998865 999999999995 44
Q ss_pred cccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCC
Q 004268 85 SEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164 (764)
Q Consensus 85 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 164 (764)
.. .++|++|+|++|.+++ .|.. +++|++|++++|+++++.. + .++|++|++++|+++++ | .|.++++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~--~--~~~L~~L~L~~n~l~~l-p-~~~~l~~ 154 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD--L--PPLLEYLGVSNNQLEKL-P-ELQNSSF 154 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS--C--CTTCCEEECCSSCCSSC-C-CCTTCTT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC--C--CCCCCEEECcCCCCCCC-c-ccCCCCC
Confidence 42 3789999999999997 4433 4899999999999997532 1 27999999999999974 4 6999999
Q ss_pred CCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccC
Q 004268 165 LKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244 (764)
Q Consensus 165 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 244 (764)
|++|++++|+++++. .. ..+|++|++++|++..+. .+..+++|++|++++|.+++. |.. .++|++|++++
T Consensus 155 L~~L~l~~N~l~~lp-~~---~~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~ 224 (454)
T 1jl5_A 155 LKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKKL-PDL---PLSLESIVAGN 224 (454)
T ss_dssp CCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSSC-CCC---CTTCCEEECCS
T ss_pred CCEEECCCCcCcccC-CC---cccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCcC-CCC---cCcccEEECcC
Confidence 999999999998643 32 359999999999999864 589999999999999999963 332 36899999999
Q ss_pred CcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCC
Q 004268 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP 324 (764)
Q Consensus 245 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 324 (764)
|.++ ..| .++.+++|+.|++++|+++++. . .+++|+.|++++|++.+ +|.. +++|++|++++|++++. |
T Consensus 225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~-~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~ 293 (454)
T 1jl5_A 225 NILE-ELP-ELQNLPFLTTIYADNNLLKTLP-D---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-S 293 (454)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSSCC-S---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-S
T ss_pred CcCC-ccc-ccCCCCCCCEEECCCCcCCccc-c---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-c
Confidence 9999 455 4899999999999999998643 2 24899999999999986 4433 48999999999999963 2
Q ss_pred hhhhcccccceeeccccccccCCchhcccc-cccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCc
Q 004268 325 PELMNCSQLLNLVLSHNSLSGSIPSEIGNL-IFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIP 403 (764)
Q Consensus 325 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~ 403 (764)
. + .++|++|++++|++++. + .+ .+|+.|++++|++++ +|.. +++|+.|++++|.+++. |..+..+.
T Consensus 294 ~-~--~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~l-p~~l~~L~ 360 (454)
T 1jl5_A 294 E-L--PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEV-PELPQNLK 360 (454)
T ss_dssp C-C--CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CCCCTTCC
T ss_pred C-c--CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccc-cchhhhcc
Confidence 1 1 26899999999999852 2 33 589999999999996 5544 58999999999999965 44788999
Q ss_pred cccccCCCCCC
Q 004268 404 KLIVSENNLEL 414 (764)
Q Consensus 404 ~~~~~~n~~~~ 414 (764)
.+++++|++..
T Consensus 361 ~L~L~~N~l~~ 371 (454)
T 1jl5_A 361 QLHVEYNPLRE 371 (454)
T ss_dssp EEECCSSCCSS
T ss_pred EEECCCCCCCc
Confidence 99999999866
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.65 Aligned_cols=235 Identities=28% Similarity=0.384 Sum_probs=190.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999875 699999999876543 334457788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++++++..++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999999988863 345899999999999999999999 89999999999999999999999999999987765
Q ss_pred CCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------------------
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------------- 723 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------------- 723 (764)
.........|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+....+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 4444455678999999999876 568999999999999999999999998765321100
Q ss_pred ---CCcC----------CCCCCCcHHHHHHHhhhhccc
Q 004268 724 ---GRKI----------SQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ---~~~~----------~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.... ...+.++..+.+++++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 272 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCC
Confidence 0000 012467888999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.07 Aligned_cols=232 Identities=23% Similarity=0.374 Sum_probs=196.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.+. ++..||+|++....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 4678999999999999999999865 67899999987654443 3678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~ 661 (764)
||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999999998873 345899999999999999999999 8999999999999999 788999999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---CcCCC----CCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RKISQ----NPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~~~~----~~~~~ 734 (764)
...... ......|++.|+|||++.+. ++.++||||+|+++|+|++|+.||........... ..... ...++
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 765433 33445789999999998765 89999999999999999999999987654322111 11111 12578
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 236 ~~~~~li~~~l~~d 249 (277)
T 3f3z_A 236 PQAESLIRRLLTKS 249 (277)
T ss_dssp HHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHccCC
Confidence 89999999999977
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.37 Aligned_cols=309 Identities=26% Similarity=0.377 Sum_probs=231.8
Q ss_pred cccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCC
Q 004268 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRD 92 (764)
Q Consensus 13 ~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 92 (764)
..++.+++|+.|++++|.++. ++ .+..+++|++|++++|+++++.+ +..+++|++|+|++|.++.. ..|..+++
T Consensus 38 ~~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~ 111 (347)
T 4fmz_A 38 VTQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN 111 (347)
T ss_dssp ECHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred ccchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence 456688999999999999975 44 48999999999999999996544 99999999999999999953 47999999
Q ss_pred CCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc
Q 004268 93 LLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 93 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 172 (764)
|++|+|++|.++.+.+ +..+++|++|++++|...... ..+..+++|++|++++|.+..+.+ +..+++|++|++++
T Consensus 112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~ 186 (347)
T 4fmz_A 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186 (347)
T ss_dssp CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence 9999999999996544 889999999999999655443 448999999999999999986644 88999999999999
Q ss_pred CCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCC
Q 004268 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252 (764)
Q Consensus 173 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 252 (764)
|.++++.+ +..+++|+.|++++|.+..... +..+++|++|++++|.+++..+ +..+++|++|++++|.+++.
T Consensus 187 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-- 258 (347)
T 4fmz_A 187 NQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-- 258 (347)
T ss_dssp SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--
T ss_pred Cccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--
Confidence 99986544 8899999999999999986654 6677778888887777775433 55566666666666665532
Q ss_pred cCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccc
Q 004268 253 PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQ 332 (764)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 332 (764)
..+..+++|+.|++++|.+++ . ..+..+++|++|++++|++++..+..+..+++
T Consensus 259 ~~~~~l~~L~~L~l~~n~l~~------------------------~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~ 312 (347)
T 4fmz_A 259 NAVKDLTKLKMLNVGSNQISD------------------------I--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312 (347)
T ss_dssp GGGTTCTTCCEEECCSSCCCC------------------------C--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTT
T ss_pred hhHhcCCCcCEEEccCCccCC------------------------C--hhhcCCCCCCEEECcCCcCCCcChhHhhcccc
Confidence 234455555555555555543 2 23445556666666666666555555666666
Q ss_pred cceeeccccccccCCchhcccccccceeeccccccc
Q 004268 333 LLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368 (764)
Q Consensus 333 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 368 (764)
|++|++++|++++..| +..+++|+.|++++|+|+
T Consensus 313 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 6666666666664444 556666666666666654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.83 Aligned_cols=204 Identities=26% Similarity=0.407 Sum_probs=177.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC--EEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 583 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++........ .+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 478999999999999999999865 699999999976443332 367789999999999999999999988765 789
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee----cCCCCEEEeeecc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL----NSNLEAFVADFGL 659 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 659 (764)
+||||+++++|.+++........+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986544455999999999999999999999 8999999999999999 7788899999999
Q ss_pred ccccCCCCCCceecccccccccccccc--------cCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAY--------TMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
++....... .....||+.|+|||++. +..++.++||||+||++|+|++|+.||...
T Consensus 163 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 163 ARELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CEECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ceecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 987654332 33457899999999886 567899999999999999999999999743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=327.14 Aligned_cols=243 Identities=35% Similarity=0.513 Sum_probs=198.9
Q ss_pred HHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 502 EMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 502 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
++....++|++.+.||+|+||+||+|.+++++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+.
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 344467899999999999999999999888999999998765433 24778999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVE-AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
.++||||+++++|.+++..... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865322 235899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------------C
Q 004268 661 RLLHPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------G 724 (764)
Q Consensus 661 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------~ 724 (764)
....... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.......... .
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654322 22234568999999999999999999999999999999999999997654322110 0
Q ss_pred C--cC----CCCCCCcHHHHHHHhhhhccchh
Q 004268 725 R--KI----SQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 725 ~--~~----~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
. .. ...+..+..+.+++.+|++.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 298 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcc
Confidence 0 00 11122345677888899887743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.59 Aligned_cols=311 Identities=21% Similarity=0.178 Sum_probs=252.6
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
+++++.|++.+|.+....+..+..+++|++|+|++|.++++.+..|..+++|++|+|++|.|++..+..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 46889999999999987777889999999999999999999999999999999999999999988888999999999999
Q ss_pred cCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCC
Q 004268 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177 (764)
Q Consensus 98 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 177 (764)
|++|.++.+.+..|.++++|++|+|++|.+++++|..|.++++|++|+|++|.++++. +..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 9999999888888999999999999999999999999999999999999999998763 5667899999999998863
Q ss_pred CCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcC
Q 004268 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257 (764)
Q Consensus 178 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 257 (764)
+....+|+.|++++|.+..+... . .++|+.|+|++|.+++. ..+..
T Consensus 207 -----l~~~~~L~~L~ls~n~l~~~~~~------------------------~---~~~L~~L~L~~n~l~~~--~~l~~ 252 (597)
T 3oja_B 207 -----LAIPIAVEELDASHNSINVVRGP------------------------V---NVELTILKLQHNNLTDT--AWLLN 252 (597)
T ss_dssp -----EECCTTCSEEECCSSCCCEEECS------------------------C---CSCCCEEECCSSCCCCC--GGGGG
T ss_pred -----ccCCchhheeeccCCcccccccc------------------------c---CCCCCEEECCCCCCCCC--hhhcc
Confidence 23444566666666655432211 1 13566666666666642 45666
Q ss_pred CCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceee
Q 004268 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV 337 (764)
Q Consensus 258 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 337 (764)
+++|+.|+|++|.+.+..|..|..+++|+.|+|++|.+.+ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~ 330 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence 7777777777777776667777777777777777777765 3455666788888888888888 5677788888888888
Q ss_pred ccccccccCCchhcccccccceeecccccccCC
Q 004268 338 LSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGT 370 (764)
Q Consensus 338 ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 370 (764)
|++|++++.. +..+++|+.|+|++|++.+.
T Consensus 331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence 8888887542 56777888888888888653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=318.36 Aligned_cols=246 Identities=20% Similarity=0.221 Sum_probs=192.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++......... ......|+..+.++ +||||+++++++.+++..++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 478999999999999999999876 7999999998765544333 34445555555555 99999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+ +++|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 56888888643 345899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCc--CCCCCCCcHHHHHHHh
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRK--ISQNPRLDLQCNAYLK 742 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 742 (764)
... ......||+.|+|||++.+ .++.++||||+||++|||++|..||............. ....+.++..+.++++
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 332 2334568999999999876 78999999999999999999977665444322221111 1123457889999999
Q ss_pred hhhccchhhH--HHhhhcCCC
Q 004268 743 NFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 743 ~~l~~~~~~~--~~~~~~~p~ 761 (764)
.|++.++.-| .....+.||
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGG
T ss_pred HHcCCChhhCcCHHHHHhCcc
Confidence 9999873333 344444444
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=321.46 Aligned_cols=236 Identities=21% Similarity=0.323 Sum_probs=198.5
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|++.+.||+|+||.||+|... +|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3578999999999999999999865 789999999876543321 123678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeee
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADF 657 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df 657 (764)
.++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999974 346889999999999999999999 88999999999999999887 7999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---CcCC----CC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RKIS----QN 730 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~~~----~~ 730 (764)
|.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+....+.... .... ..
T Consensus 164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 9998765432 23345789999999999999999999999999999999999999986554222111 1111 12
Q ss_pred CCCcHHHHHHHhhhhccc
Q 004268 731 PRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~ 748 (764)
+..+..+.++++.|++.+
T Consensus 243 ~~~~~~~~~li~~~l~~d 260 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKE 260 (321)
T ss_dssp TTCCHHHHHHHHTTSCSS
T ss_pred cccCHHHHHHHHHHcCCC
Confidence 456788999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.02 Aligned_cols=235 Identities=21% Similarity=0.336 Sum_probs=198.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 3578999999999999999999865 6899999999765543 3345778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC---EEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~~ 661 (764)
||||+++++|.+.+.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999988873 345899999999999999999999 899999999999999986655 9999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cCCcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------SGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~~~~~~ 734 (764)
...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+....... ..........++
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 157 EVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp ECCSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred EcccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 765332 233467899999999999999999999999999999999999999766542211 111222234678
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 236 ~~~~~li~~~l~~d 249 (284)
T 3kk8_A 236 PEAKSLIDSMLTVN 249 (284)
T ss_dssp HHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHcccC
Confidence 89999999999877
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=316.78 Aligned_cols=234 Identities=28% Similarity=0.468 Sum_probs=198.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 578999999999999999999865 6789999998654322222236788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999974 345899999999999999999999 99999999999999999999999999999976543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ........++.++..+.++++
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence 2 23345789999999999999999999999999999999999999986654221 112233345667899999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 245 ~~l~~~ 250 (284)
T 2vgo_A 245 KLLRYH 250 (284)
T ss_dssp HHSCSS
T ss_pred HHhhcC
Confidence 999877
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.19 Aligned_cols=238 Identities=25% Similarity=0.375 Sum_probs=192.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4689999999999999999999865 788999999987666666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 112 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999974 346899999999999999999999 8899999999999999999999999999997664
Q ss_pred CCC-CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcHHH
Q 004268 665 PDS-SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDLQC 737 (764)
Q Consensus 665 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~ 737 (764)
... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ .........+.++..+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 332 222345789999999999999999999999999999999999999987654211 1111223356688899
Q ss_pred HHHHhhhhccch
Q 004268 738 NAYLKNFSQGNH 749 (764)
Q Consensus 738 ~~~~~~~l~~~~ 749 (764)
.+++++|++.++
T Consensus 266 ~~li~~~l~~dP 277 (309)
T 2h34_A 266 DAVIARGMAKNP 277 (309)
T ss_dssp HHHHHHHTCSSG
T ss_pred HHHHHHhccCCH
Confidence 999999998773
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.72 Aligned_cols=232 Identities=26% Similarity=0.378 Sum_probs=196.2
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 46699999999999999999986 57899999999876655555667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+. |++.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 578777753 2346899999999999999999999 88999999999999999999999999999986643
Q ss_pred CCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcCCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~ 737 (764)
. ....||+.|+|||++. +..++.++||||+||++|+|++|+.||.......... ..........+..+
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2 2357899999999984 5678999999999999999999999998665422111 11112234568899
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
.++++.|++.+
T Consensus 283 ~~li~~~l~~d 293 (348)
T 1u5q_A 283 RNFVDSCLQKI 293 (348)
T ss_dssp HHHHHHHTCSS
T ss_pred HHHHHHHcccC
Confidence 99999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.19 Aligned_cols=229 Identities=24% Similarity=0.386 Sum_probs=183.0
Q ss_pred hhcCCcc-eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHh-cCCCceeeEeeEEee----C
Q 004268 507 TEDFHIK-YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQ-IRHRNIVKLYGFCLH----N 579 (764)
Q Consensus 507 ~~~y~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~ 579 (764)
.++|.+. +.||+|+||+||+|.+. +++.||+|++... ..+.+|++++.+ .+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 5678776 68999999999999865 7899999998632 456688888755 489999999999876 5
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVAD 656 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 656 (764)
...|+||||+++|+|.+++... ....+++..++.++.||+.||+||| ++||+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence 6799999999999999999753 2345899999999999999999999 889999999999999997 78999999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------C---C
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------G---R 725 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------~---~ 725 (764)
||+++..... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+........ . .
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 9999876432 22345678999999999999999999999999999999999999998665432110 0 1
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......++..+.++++.|++.+
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~d 309 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTE 309 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSS
T ss_pred CCcccccCCHHHHHHHHHHCCCC
Confidence 11122457889999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.74 Aligned_cols=206 Identities=25% Similarity=0.369 Sum_probs=168.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
...++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 45689999999999999999999754 7899999999765432 233466789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-----CCCCEEEeeec
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-----SNLEAFVADFG 658 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~Dfg 658 (764)
+||||+++ +|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++ ..+.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99999874 345899999999999999999999 89999999999999994 45569999999
Q ss_pred cccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.+..............||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+...
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 998876554445556789999999998875 489999999999999999999999986553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.02 Aligned_cols=247 Identities=20% Similarity=0.309 Sum_probs=202.2
Q ss_pred CccCHHHHHHHhhcCCcc-eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeE
Q 004268 496 GRITFEEMIEATEDFHIK-YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKL 572 (764)
Q Consensus 496 ~~~~~~~~~~~~~~y~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~ 572 (764)
+.+.+.......++|.+. +.||+|+||+||+|... +++.||+|++........ ....+.+|+.+++.+ .||||+++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEE
Confidence 445555666778899998 88999999999999865 799999999876543322 236788999999999 56999999
Q ss_pred eeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---C
Q 004268 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---N 649 (764)
Q Consensus 573 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~ 649 (764)
++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||+||| ++||+||||||+||+++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTB
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCC
Confidence 99999999999999999999999998643 3456899999999999999999999 899999999999999997 7
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------c
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------S 722 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~ 722 (764)
+.+||+|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ .
T Consensus 171 ~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp CCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 899999999998765332 22345789999999999999999999999999999999999999987654221 1
Q ss_pred cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+.++..+.++++.|++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~d 275 (327)
T 3lm5_A 250 VDYSEETFSSVSQLATDFIQSLLVKN 275 (327)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred cccCchhhcccCHHHHHHHHHHcCCC
Confidence 11222334567889999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=314.92 Aligned_cols=237 Identities=24% Similarity=0.414 Sum_probs=197.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|++.+++.||+|++....... +.+.+|++++++++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 57899999999999999999999888899999998665443 66889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999752 345899999999999999999999 899999999999999999999999999999866432
Q ss_pred CC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
.. ......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......... .......+...+..+.++
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 11 1122346778999999999999999999999999999998 99999876553221 122233344568899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
++.|++.++.-|
T Consensus 254 i~~~l~~~p~~R 265 (283)
T 3gen_A 254 MYSCWHEKADER 265 (283)
T ss_dssp HHHTTCSSGGGS
T ss_pred HHHHccCChhHC
Confidence 999998874443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=326.31 Aligned_cols=243 Identities=29% Similarity=0.412 Sum_probs=193.4
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCC--CcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSET--EEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
+.+..++|++.+.||+|+||+||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456899999999999999999999864 788999999865421 1122347889999999999999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCc-------------------------------------cccccCHHHHHHHHHHHHHH
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDV-------------------------------------EAVELDWTKRVNIVKSMAHA 622 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~a 622 (764)
+..++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985211 01224677888999999999
Q ss_pred HHHHHhcCCCCcEEcCCCCCCeeecCCC--CEEEeeeccccccCCCCC----Cceeccccccccccccccc--CCCCccc
Q 004268 623 LSYLHYDCKPSIVHRDISSNNILLNSNL--EAFVADFGLARLLHPDSS----NRTLVVGTYGYIAPELAYT--MAVTEKC 694 (764)
Q Consensus 623 L~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 694 (764)
|+||| ++||+||||||+||+++.++ .+||+|||.+........ ......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999 88999999999999998766 899999999986543221 2244678999999999875 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 695 DVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 695 DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
||||+|+++|+|++|+.||.+....+.... ........++..+.+++++|++.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 999999999999999999987655322111 111122236889999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=325.95 Aligned_cols=228 Identities=22% Similarity=0.355 Sum_probs=187.5
Q ss_pred ceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 513 KYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 568999999999999864 799999999876432 2347889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee--cCCCCEEEeeeccccccCCCCCC
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL--NSNLEAFVADFGLARLLHPDSSN 669 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~ 669 (764)
++|.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||++ +.++.+||+|||+++...... .
T Consensus 171 ~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~ 244 (373)
T 2x4f_A 171 GELFDRIID--ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K 244 (373)
T ss_dssp CEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence 999998864 2345889999999999999999999 8999999999999999 567899999999998765433 2
Q ss_pred ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHHHHHHHh
Q 004268 670 RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 670 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 742 (764)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+... .......+.++..+.++++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 334579999999999999999999999999999999999999998765432111 1111223567899999999
Q ss_pred hhhccch
Q 004268 743 NFSQGNH 749 (764)
Q Consensus 743 ~~l~~~~ 749 (764)
+|++.++
T Consensus 325 ~~L~~dp 331 (373)
T 2x4f_A 325 KLLIKEK 331 (373)
T ss_dssp TTSCSSG
T ss_pred HHcCCCh
Confidence 9999883
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.28 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=198.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 578999999999999999999876 78999999987543 233446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.++++. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999974 2345889999999999999999999 89999999999999999999999999999986532
Q ss_pred CCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHH
Q 004268 666 DSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCN 738 (764)
Q Consensus 666 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~ 738 (764)
.... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....... .......+...+..+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 2111 112235778999999998899999999999999999998 99999876643221 1223333455688899
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++++||+.++.-|
T Consensus 346 ~li~~cl~~dP~~R 359 (377)
T 3cbl_A 346 RLMEQCWAYEPGQR 359 (377)
T ss_dssp HHHHHHTCSSGGGS
T ss_pred HHHHHHcCCCchhC
Confidence 99999998874433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.55 Aligned_cols=233 Identities=25% Similarity=0.351 Sum_probs=184.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|... +++.||+|++....... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 57999999999999999999865 78999999986544221 1124557999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++ +|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred ccccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 99985 888888743 345889999999999999999999 899999999999999999999999999999876544
Q ss_pred CCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------------------
Q 004268 667 SSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---------------------- 723 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---------------------- 723 (764)
........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 444455678999999999876 568999999999999999999999998755321100
Q ss_pred -----------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 -----------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -----------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+.++..+.+++++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 269 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFE 269 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcC
Confidence 0001123457888999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.44 Aligned_cols=205 Identities=29% Similarity=0.437 Sum_probs=166.4
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCC--
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNK-- 580 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~-- 580 (764)
...++|++.+.||+|+||+||+|.+. +|+.||+|++...... ....+.+.+|+.+++++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35689999999999999999999764 7999999998754333 344577889999999997 999999999997544
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+||||++ ++|..+++. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899999998 589988864 35888999999999999999999 899999999999999999999999999999
Q ss_pred cccCCC---------------------CCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 661 RLLHPD---------------------SSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 661 ~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
+..... ....+..+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 111234579999999999887 6789999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=326.89 Aligned_cols=237 Identities=29% Similarity=0.426 Sum_probs=187.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
..+|++.+.||+|+||+||+|+.. ++..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 468999999999999999999754 577899999976542 33457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999743 346899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 663 LHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
........ ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ...........+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 276 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 65332211 12234678999999999999999999999999999998 99999866543221 112233445678
Q ss_pred HHHHHHHhhhhccchh
Q 004268 735 LQCNAYLKNFSQGNHR 750 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~ 750 (764)
..+.+++.+|++.++.
T Consensus 277 ~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 277 AALYQLMLDCWQKDRN 292 (373)
T ss_dssp HHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHhCcChh
Confidence 8999999999998733
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=340.20 Aligned_cols=235 Identities=26% Similarity=0.422 Sum_probs=199.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|... +|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999865 899999999976554333334788999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~ 661 (764)
||||+.+++|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||++ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999873 346899999999999999999999 8999999999999999 467899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~ 734 (764)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+....+.... ........++
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 775433 3344679999999999876 689999999999999999999999987665322111 1122234578
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 256 ~~~~~li~~~L~~d 269 (484)
T 3nyv_A 256 ESAKDLIRKMLTYV 269 (484)
T ss_dssp HHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHCCCC
Confidence 89999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.29 Aligned_cols=237 Identities=27% Similarity=0.396 Sum_probs=198.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|... +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 4688999999999999999999865 78999999987554332 24788899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 9999999999998863 346899999999999999999999 8999999999999999999999999999997653
Q ss_pred CCC--CCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcH
Q 004268 665 PDS--SNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDL 735 (764)
Q Consensus 665 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~ 735 (764)
... .......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||......... ..........++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCH
Confidence 221 12234578999999999988775 77899999999999999999999875542111 1111222345788
Q ss_pred HHHHHHhhhhccchh
Q 004268 736 QCNAYLKNFSQGNHR 750 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~ 750 (764)
.+.++++.|++.++.
T Consensus 237 ~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 237 APLALLHKILVENPS 251 (276)
T ss_dssp HHHHHHHHHSCSSTT
T ss_pred HHHHHHHHHCCCCch
Confidence 999999999998733
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.16 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=196.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||+||+|.+ .+++.||+|++...... ...+.+.+|+++++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 457899999999999999999985 24568999999754322 2347889999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccc--------------------cccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEA--------------------VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRD 638 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~D 638 (764)
.+..++||||+++|+|.+++...... ..+++..+..++.||+.||+||| ++||+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 99999999999999999999754221 23789999999999999999999 89999999
Q ss_pred CCCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 004268 639 ISSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDL 715 (764)
Q Consensus 639 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~ 715 (764)
|||+||+++.++.+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|+| |..||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876543322 223457889999999999999999999999999999998 9999987
Q ss_pred cccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 716 LSSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 716 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
...... ........+...+..+.++++.|++.++.-
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 318 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 318 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchh
Confidence 654221 111233345557889999999999987433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=312.00 Aligned_cols=234 Identities=29% Similarity=0.446 Sum_probs=201.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|++.+.||+|+||+||+|... +++.||+|++........ .+.+.+|+.++++++||||+++++++.+....++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999754 789999999976554332 47889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999863 35899999999999999999999 88999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 741 (764)
.........|++.|+|||++.+..++.++||||+|+++|+|++|+.||......... ...........+..+.+++
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 251 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 251 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHH
Confidence 444445567899999999999999999999999999999999999999876543221 1112223446788999999
Q ss_pred hhhhccch
Q 004268 742 KNFSQGNH 749 (764)
Q Consensus 742 ~~~l~~~~ 749 (764)
+.|++.++
T Consensus 252 ~~~l~~dp 259 (303)
T 3a7i_A 252 EACLNKEP 259 (303)
T ss_dssp HHHCCSSG
T ss_pred HHHcCCCh
Confidence 99999873
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.65 Aligned_cols=237 Identities=28% Similarity=0.418 Sum_probs=191.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|.+.+.||+|+||+||+|... +++.||+|++........ .+.+.+|++++++++||||+++++++.+....++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 3578999999999999999999864 789999999876554332 3778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeeccc
Q 004268 585 IYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLA 660 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~ 660 (764)
||||+++++|.+++.... ....+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999999886421 2356899999999999999999999 8999999999999999 45688999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCc
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLD 734 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~ 734 (764)
....... ......|++.|+|||++. ..++.++||||+|+++|+|++|+.||.+........ .........++
T Consensus 175 ~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 175 ELFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred eecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 7664332 234467899999999876 468999999999999999999999998765422211 11112233468
Q ss_pred HHHHHHHhhhhccch
Q 004268 735 LQCNAYLKNFSQGNH 749 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~ 749 (764)
..+.+++++|++.++
T Consensus 253 ~~~~~li~~~L~~dP 267 (285)
T 3is5_A 253 PQAVDLLKQMLTKDP 267 (285)
T ss_dssp HHHHHHHHHHTCSCT
T ss_pred HHHHHHHHHHccCCh
Confidence 899999999998873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.47 Aligned_cols=234 Identities=17% Similarity=0.190 Sum_probs=185.6
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHH---HHHhcCCCceeeEe-------eE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEAR---LLSQIRHRNIVKLY-------GF 575 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~~~-------~~ 575 (764)
.++|++.+.||+|+||+||+|.+ .+|+.||||++...........+.+.+|++ ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999985 579999999998655444445688899994 55555899999998 66
Q ss_pred EeeCC-----------------EEEEEEEecCCCCHHHHHhcCcc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004268 576 CLHNK-----------------CMFLIYEYMERGSLFCVLRNDVE----AVELDWTKRVNIVKSMAHALSYLHYDCKPSI 634 (764)
Q Consensus 576 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 634 (764)
+.+.+ ..|+||||+ +|+|.+++..... ...+++..+..++.||+.||+||| ++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 65543 288999999 5799999974311 112345788889999999999999 8899
Q ss_pred EEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccC-----------CCCccchHHHHHHHH
Q 004268 635 VHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-----------AVTEKCDVYSFGVVA 703 (764)
Q Consensus 635 iH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~il 703 (764)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999986432 3344567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 704 LEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 704 ~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
|+|++|+.||.+........ ......+.++..+.+++++|++.++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSE-WIFRSCKNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHSSCCC------CCSG-GGGSSCCCCCHHHHHHHHHHTCSSG
T ss_pred HHHHHCCCCCcccccccchh-hhhhhccCCCHHHHHHHHHHcCCCc
Confidence 99999999998766543222 2223346789999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=323.31 Aligned_cols=240 Identities=26% Similarity=0.412 Sum_probs=199.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+.+|++++++++||||+++++++.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 4578999999999999999999864 347899999976543 34457899999999999999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcC
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE---------------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRD 638 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~D 638 (764)
+..++||||+++++|.+++..... ...+++..+..++.||+.||+||| ++||+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 999999999999999999975321 156899999999999999999999 89999999
Q ss_pred CCCCCeeecCCCCEEEeeeccccccCCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 004268 639 ISSNNILLNSNLEAFVADFGLARLLHPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDL 715 (764)
Q Consensus 639 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~ 715 (764)
|||+||+++.++.+||+|||.+....... .......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999998764322 12233567889999999999999999999999999999999 9999987
Q ss_pred ccccccc----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 716 LSSLSSS----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 716 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
....+.. .......+...+..+.++++.|++.++.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 318 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 318 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcc
Confidence 6543221 1122233456788999999999998743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=324.85 Aligned_cols=239 Identities=24% Similarity=0.378 Sum_probs=199.8
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|.+.+.||+|+||+||+|.+. .+..||+|++..... ....+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 578999999999999999999752 235799999976543 34457889999999999 9999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+||| ++||+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 99999999999999999999975431 235899999999999999999999 88999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||+||++|+|++ |..||.+....+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987654322 2223456889999999999999999999999999999999 9999987654222
Q ss_pred c----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 722 S----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 722 ~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
. .......+...+..+.++++.|++.++.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 335 (382)
T 3tt0_A 303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPS 335 (382)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChh
Confidence 1 1223334556788999999999988733
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=326.08 Aligned_cols=239 Identities=26% Similarity=0.356 Sum_probs=197.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 578999999999999999999743 567899999975433 233467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc----cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV----EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~k 653 (764)
..++||||+++|+|.+++.... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999997532 2245899999999999999999999 89999999999999999555 599
Q ss_pred EeeeccccccCCC--CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPD--SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||+++..... ........+|+.|+|||++.+..++.++||||+||++|||++ |..||......+.. ....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999765321 122334567899999999999999999999999999999998 99999876653221 1222
Q ss_pred CCCCCCCcHHHHHHHhhhhccchh
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.......+..+.++++.|++.++.
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~ 328 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPE 328 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCccCCHHHHHHHHHHcCCCHh
Confidence 334556788999999999998733
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.95 Aligned_cols=236 Identities=25% Similarity=0.359 Sum_probs=192.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|+.. +|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3589999999999999999999865 6899999998765433 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||++++++..+.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999999988876 3345899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------------------
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------------------- 724 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------------------- 724 (764)
..........|++.|+|||++.+. .++.++||||+|+++|+|++|+.||.+....+....
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 544444556789999999998875 789999999999999999999999986653211000
Q ss_pred ---------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 725 ---------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 ---------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
......+.++..+.+++++|++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 294 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccC
Confidence 000113457889999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.39 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=201.5
Q ss_pred CHHHHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhc-CCCceee
Q 004268 499 TFEEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQI-RHRNIVK 571 (764)
Q Consensus 499 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~hpniv~ 571 (764)
.+.......++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455667789999999999999999999875 7999999998765422 123346788999999999 7999999
Q ss_pred EeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC
Q 004268 572 LYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651 (764)
Q Consensus 572 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 651 (764)
+++++......++||||+++++|.+++.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999999999999973 346899999999999999999999 889999999999999999999
Q ss_pred EEEeeeccccccCCCCCCceeccccccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-
Q 004268 652 AFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG- 724 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~- 724 (764)
+||+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 239 ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp EEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999998765433 2344679999999998863 3578899999999999999999999976543221110
Q ss_pred --Cc----CCCCCCCcHHHHHHHhhhhccchh
Q 004268 725 --RK----ISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 725 --~~----~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.. .......+..+.+++++|++.++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 349 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPE 349 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence 11 111235677899999999987743
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.66 Aligned_cols=233 Identities=23% Similarity=0.386 Sum_probs=189.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC--CceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH--RNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|...+++.||+|++...... ....+.+.+|++++++++| |||+++++++.++...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4679999999999999999999888999999998765543 3445788999999999986 999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||| +.+++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 567899999974 346889999999999999999999 88999999999999997 5789999999998765
Q ss_pred CCCC--Cceeccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCC
Q 004268 665 PDSS--NRTLVVGTYGYIAPELAYT-----------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGR 725 (764)
Q Consensus 665 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~ 725 (764)
.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4322 1234579999999999865 6788999999999999999999999986433110 1112
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
....+...+..+.++++.|++.+
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~d 261 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRD 261 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSS
T ss_pred ccCCcccCCHHHHHHHHHHcCCC
Confidence 22334445678999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=313.85 Aligned_cols=250 Identities=27% Similarity=0.337 Sum_probs=193.9
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCc--HHHHHHHHHHHHHHHhc---CCCceeeEeeEEeeC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEE--PAFLESFQTEARLLSQI---RHRNIVKLYGFCLHN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~ 579 (764)
..++|++.+.||+|+||+||+|++ .+++.||+|++....... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 479999999986433211 01114556777777776 499999999999875
Q ss_pred C-----EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEE
Q 004268 580 K-----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 580 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
. ..++||||++ ++|.+++... ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 5 5899999997 5999999754 2334899999999999999999999 899999999999999999999999
Q ss_pred eeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC---------
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR--------- 725 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~--------- 725 (764)
+|||.++...... ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+..........
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999998765332 334567899999999999999999999999999999999999999765542111000
Q ss_pred ---------------------cCCCCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 726 ---------------------KISQNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 726 ---------------------~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.....+.++..+.+++++|++.++.-| .....+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 001124567888999999999873332 333444444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.13 Aligned_cols=199 Identities=31% Similarity=0.465 Sum_probs=171.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----EE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----CM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 582 (764)
.++|++.+.||+|+||+||+|++. ++.||+|++..... ......+|+.++++++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 578999999999999999999876 89999999865432 2345567899999999999999999998743 47
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC----------CcEEcCCCCCCeeecCCCCE
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP----------SIVHRDISSNNILLNSNLEA 652 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~----------~iiH~Dlkp~NIll~~~~~~ 652 (764)
++||||+++|+|.++++.. .+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999999743 4899999999999999999999 88 99999999999999999999
Q ss_pred EEeeeccccccCCCCCC--ceecccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 653 FVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTM-----AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
||+|||.++........ .....||+.|+|||++.+. .++.++||||+||++|+|+||+.||.+..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999876543322 2235789999999998873 55678999999999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=334.51 Aligned_cols=200 Identities=28% Similarity=0.350 Sum_probs=169.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+++.+|+++++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999755 789999999976532 334457888999999999999999999999654
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...|+||||+++ ++.+.+.. .+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 468999999986 46666642 3888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
++..... ......+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876533 23345689999999999999999999999999999999999999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.72 Aligned_cols=248 Identities=17% Similarity=0.241 Sum_probs=201.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4688999999999999999999875 799999999986544433 246778999999999 9999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCcc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-------------
Q 004268 584 LIYEYMERGSLFCVLRNDVE-AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN------------- 649 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------------- 649 (764)
+||||+++++|.+++..... ...+++..+..++.||+.||+||| ++||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999975322 245899999999999999999999 8999999999999999844
Q ss_pred ------CCEEEeeeccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 004268 650 ------LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS 722 (764)
Q Consensus 650 ------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~ 722 (764)
..+||+|||.+....... ...|++.|+|||++.+. .+++++||||+|+++|+|++|.+|+.........
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 479999999998765432 23589999999998876 5668999999999999999999887655443222
Q ss_pred cCC-cCCCCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 723 SGR-KISQNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 723 ~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
... ....++.++..+.++++.|++.++.-| .....+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 222 223345678999999999999874333 444455554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.52 Aligned_cols=230 Identities=18% Similarity=0.256 Sum_probs=190.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|.. .+++.||+|++...... +.+.+|+++++++ +||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 46899999999999999999986 57899999998765433 4578999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC-----EEEeeecc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE-----AFVADFGL 659 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~ 659 (764)
||||+ +++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 89999999753 346899999999999999999999 889999999999999998887 99999999
Q ss_pred ccccCCCCCC-------ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------Cc
Q 004268 660 ARLLHPDSSN-------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RK 726 (764)
Q Consensus 660 ~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~ 726 (764)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......... ..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 9876443221 2346799999999999999999999999999999999999999987543221100 00
Q ss_pred CCC-----CCCCcHHHHHHHhhhhccc
Q 004268 727 ISQ-----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 727 ~~~-----~~~~~~~~~~~~~~~l~~~ 748 (764)
... ....+ .+.++++.|++.+
T Consensus 237 ~~~~~~~~~~~~p-~~~~li~~~l~~~ 262 (330)
T 2izr_A 237 RATPIEVLCENFP-EMATYLRYVRRLD 262 (330)
T ss_dssp HHSCHHHHTTTCH-HHHHHHHHHHHCC
T ss_pred ccCCHHHHhccCh-HHHHHHHHHHhCC
Confidence 000 12234 7888888888766
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.05 Aligned_cols=240 Identities=25% Similarity=0.403 Sum_probs=200.1
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 57899999999999999999975 245789999997544 2344578899999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE---------------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 639 (764)
..++||||+++++|.+++..... ...+++..+..++.||+.||+||| ++||+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 99999999999999999975432 234889999999999999999999 889999999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLL 716 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~ 716 (764)
||+||+++.++.+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876443221 223456788999999999899999999999999999999 99999876
Q ss_pred cccccc----cCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 717 SSLSSS----SGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 717 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
...... .......+...+..+.+++++|++.++.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 295 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDK 295 (314)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhh
Confidence 553221 11223345567889999999999877443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=309.28 Aligned_cols=236 Identities=29% Similarity=0.480 Sum_probs=185.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCc-HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEE-PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. ++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999876 8999999987654332 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC---cEEcCCCCCCeeecC--------CCCEEE
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS---IVHRDISSNNILLNS--------NLEAFV 654 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~---iiH~Dlkp~NIll~~--------~~~~kl 654 (764)
|||+++++|.+++.. ..+++..+..++.|++.||+||| ++| |+||||||+||+++. ++.+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999853 35899999999999999999999 778 999999999999985 778999
Q ss_pred eeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCcCCC
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRKISQ 729 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~~~~ 729 (764)
+|||.+........ ....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+....... .......
T Consensus 158 ~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 158 TDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred ccCCcccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99999986643322 2457899999999999999999999999999999999999999876643221 1122333
Q ss_pred CCCCcHHHHHHHhhhhccchhhH
Q 004268 730 NPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 730 ~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
+...+..+.+++++|++.++.-|
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~R 258 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSR 258 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CcccCHHHHHHHHHHhcCCcccC
Confidence 45678899999999998774433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.39 Aligned_cols=242 Identities=24% Similarity=0.387 Sum_probs=184.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-CC---EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-GK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+.. ++ .||+|++....... ...+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 5789999999999999999997653 32 79999997654333 3357889999999999999999999999877655
Q ss_pred ------EEEEEecCCCCHHHHHhcCc---cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 583 ------FLIYEYMERGSLFCVLRNDV---EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 583 ------~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
++||||+++++|.+++.... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 1225899999999999999999999 89999999999999999999999
Q ss_pred EeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||.++....... ......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....+.. ....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 999999987643322 1223456788999999999999999999999999999999 99999876653321 1233
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
....+..+..+.+++++|++.++.-|
T Consensus 258 ~~~~~~~~~~l~~li~~~l~~dp~~R 283 (323)
T 3qup_A 258 LKQPPECMEEVYDLMYQCWSADPKQR 283 (323)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred CCCCCccCHHHHHHHHHHccCChhhC
Confidence 44566788999999999999884433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=326.72 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred HHHHHHHhhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeE
Q 004268 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKL 572 (764)
Q Consensus 500 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~ 572 (764)
..++....++|++.+.||+|+||.||+|++ .+++.||+|++...... ...+.+.+|+++++++ +||||+++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeee
Confidence 344445578999999999999999999973 25678999999765432 3347789999999999 78999999
Q ss_pred eeEEeeCCE-EEEEEEecCCCCHHHHHhcCcc------------------------------------------------
Q 004268 573 YGFCLHNKC-MFLIYEYMERGSLFCVLRNDVE------------------------------------------------ 603 (764)
Q Consensus 573 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------ 603 (764)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887554 8999999999999999975432
Q ss_pred ---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 604 ---------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 604 ---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112889999999999999999999 88999999999999999999999999999987643322
Q ss_pred --CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc-----ccCCcCCCCCCCcHHHHHH
Q 004268 669 --NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS-----SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 669 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 740 (764)
......||+.|+|||++.+..++.++||||+|+++|+|+| |+.||.+...... ........+...+..+.++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2234567889999999999999999999999999999998 9999987653221 1122333445578899999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
+..|++.++.-
T Consensus 329 i~~~l~~dP~~ 339 (359)
T 3vhe_A 329 MLDCWHGEPSQ 339 (359)
T ss_dssp HHHHTCSSGGG
T ss_pred HHHHccCChhh
Confidence 99999877443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.96 Aligned_cols=232 Identities=26% Similarity=0.408 Sum_probs=195.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-EEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK-CMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv 585 (764)
.++|++.+.||+|+||.||+|.+. ++.||||++..... .+.+.+|++++++++||||+++++++.... ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 578999999999999999999886 78999999976542 267889999999999999999999987665 79999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.++++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999753 2234788999999999999999999 89999999999999999999999999999986532
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....+.. .......+...+..+.++
T Consensus 342 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 418 (450)
T 1k9a_A 342 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV 418 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred c---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 2 122356889999999999999999999999999999998 99999876543321 222344456678899999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
+++||+.++.-
T Consensus 419 i~~cl~~dp~~ 429 (450)
T 1k9a_A 419 MKNCWHLDAAT 429 (450)
T ss_dssp HHHHTCSSGGG
T ss_pred HHHHcCCChhH
Confidence 99999987443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.16 Aligned_cols=232 Identities=23% Similarity=0.386 Sum_probs=188.8
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv 585 (764)
.+|++.+.||+|+||+||+|...+++.||||++...... ....+.+.+|++++++++ ||||+++++++...+..|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 569999999999999999999888999999999765543 344678999999999996 59999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|| +.+++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5678999999743 36888899999999999999999 99999999999999995 57999999999987653
Q ss_pred CCC--Cceeccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCc
Q 004268 666 DSS--NRTLVVGTYGYIAPELAYT-----------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRK 726 (764)
Q Consensus 666 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~ 726 (764)
... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ .....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 322 1234579999999999865 3688999999999999999999999986532110 01112
Q ss_pred CCCCCCCcHHHHHHHhhhhccc
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
...+...+..+.++++.|++.+
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~d 308 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRD 308 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSS
T ss_pred CCCCccchHHHHHHHHHHcccC
Confidence 2233445778999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=325.52 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=169.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+++.+|++++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 578999999999999999999865 688999999976533 344457889999999999999999999999776 5
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+||||++ ++|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6999999997 599999973 346899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC----------------------Cceeccccccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 004268 661 RLLHPDSS----------------------NRTLVVGTYGYIAPELA-YTMAVTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 661 ~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
+....... ..+..+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87643321 12456889999999986 56679999999999999999998655543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.21 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CC-----CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SG-----KLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 578 (764)
..++|++.+.||+|+||+||+|.+. ++ +.||+|.+..... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4678999999999999999999864 23 4799999976543 23357889999999999 89999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCcc-----------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVE-----------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+||| ++||+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence 9999999999999999999974321 235789999999999999999999 88999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc--
Q 004268 648 SNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-- 722 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-- 722 (764)
.++.+||+|||++......... .....+++.|+|||++.+..++.++||||+|+++|+|+| |..||.+.......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 9999999999999866433221 223456789999999999999999999999999999998 99999875532211
Q ss_pred ---cCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 723 ---SGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 723 ---~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.......+...+..+.++++.|++.++.-
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 310 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTH 310 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhh
Confidence 11223334556889999999999887443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.03 Aligned_cols=234 Identities=24% Similarity=0.409 Sum_probs=194.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|... +++.||+|++........ ....+.+|++++++++||||+++++++.+....|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 4688999999999999999999865 799999999864322111 13678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~ 661 (764)
||||+++++|.+.+.. ...+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999998863 346899999999999999999999 89999999999999995 45679999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~ 734 (764)
...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+....+.... ........++
T Consensus 173 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 173 CFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred ECCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 765432 2344679999999999876 589999999999999999999999987655322111 1122234578
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 251 ~~~~~li~~~L~~d 264 (486)
T 3mwu_A 251 DDAKDLIRKMLTFH 264 (486)
T ss_dssp HHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHcCCC
Confidence 89999999999977
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=311.25 Aligned_cols=243 Identities=21% Similarity=0.271 Sum_probs=189.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 357899999999999999999986 4799999999987665556667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 585 IYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
||||+++++|.+++.... ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986422 2345889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-----cccC--CcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-----SSSG--RKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-----~~~~--~~~~~~~~~~~~ 736 (764)
...........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+..... .... .........+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 544443445678999999999999999999999999999999999999997543210 0001 111122457889
Q ss_pred HHHHHhhhhccchhh
Q 004268 737 CNAYLKNFSQGNHRW 751 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~ 751 (764)
+.++++.|++.+..-
T Consensus 267 l~~li~~~l~~dp~~ 281 (310)
T 2wqm_A 267 LRQLVNMCINPDPEK 281 (310)
T ss_dssp HHHHHHHHTCSSGGG
T ss_pred HHHHHHHHcCCChhh
Confidence 999999999887433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.12 Aligned_cols=236 Identities=26% Similarity=0.453 Sum_probs=189.7
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee----
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH---- 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---- 578 (764)
...++|++.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 35688999999999999999999864 79999999987654432 6788999999999 79999999999987
Q ss_pred --CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 579 --NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 579 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
.+..++||||+++++|.+++... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEee
Confidence 46799999999999999999754 2346899999999999999999999 88999999999999999999999999
Q ss_pred eccccccCCCCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCc
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRK 726 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~ 726 (764)
||.+..............|++.|+|||++. +..++.++||||+|+++|+|++|+.||.+........ ...
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 999987654433344567899999999987 5678999999999999999999999998765432211 111
Q ss_pred CCCCCCCcHHHHHHHhhhhccc
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+..+.+++++|++.+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~d 274 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKN 274 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSS
T ss_pred cCCccccCHHHHHHHHHHhccC
Confidence 1224557889999999999887
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.21 Aligned_cols=233 Identities=27% Similarity=0.440 Sum_probs=187.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|++. ++.||+|++.... ..+.+.+|++++++++||||+++++++.+. .++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEE
Confidence 468999999999999999999886 7899999986432 237789999999999999999999988743 78999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC-EEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE-AFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++........+++..+..++.|+++||+|||..+.+||+||||||+||+++.++. +||+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999986544456788999999999999999999322289999999999999998886 79999999976543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~ 739 (764)
. .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||........ ...........++..+.+
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 2 2234689999999999999999999999999999999999999986543211 111222334567889999
Q ss_pred HHhhhhccchh
Q 004268 740 YLKNFSQGNHR 750 (764)
Q Consensus 740 ~~~~~l~~~~~ 750 (764)
++++|++.++.
T Consensus 236 li~~~l~~dp~ 246 (307)
T 2eva_A 236 LMTRCWSKDPS 246 (307)
T ss_dssp HHHHHTCSSGG
T ss_pred HHHHHhcCChh
Confidence 99999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=310.80 Aligned_cols=242 Identities=28% Similarity=0.448 Sum_probs=198.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 583 (764)
.++|++.+.||+|+||+||+|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 578999999999999999999865 7899999999765543 3345788999999999999999999998754 67899
Q ss_pred EEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCC-----cEEcCCCCCCeeecCCCCEEEeee
Q 004268 584 LIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPS-----IVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
+||||+++++|.+++.... ....+++..+..++.|++.||+||| ++| |+||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999997432 2334899999999999999999999 777 999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCC
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRL 733 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~ 733 (764)
|.+..............|++.|+|||++.+..++.++||||+|+++|+|++|+.||......... .......+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence 99987654433333457899999999999999999999999999999999999999876542211 11122334467
Q ss_pred cHHHHHHHhhhhccchhhH
Q 004268 734 DLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~~ 752 (764)
+..+.+++++|++.++.-|
T Consensus 241 ~~~l~~li~~~l~~~p~~R 259 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHR 259 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHHHHHHHcCCCcccC
Confidence 8899999999999885444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.82 Aligned_cols=233 Identities=27% Similarity=0.427 Sum_probs=193.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+...... +.+.+|++++++++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH-----HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4678999999999999999999865 6999999999765432 678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++.. ....+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+....
T Consensus 102 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999999863 2346899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHH
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~ 738 (764)
..........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..........+..+.
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 54444445678999999999999999999999999999999999999998765432111 111222334578899
Q ss_pred HHHhhhhccc
Q 004268 739 AYLKNFSQGN 748 (764)
Q Consensus 739 ~~~~~~l~~~ 748 (764)
++++.|++.+
T Consensus 257 ~li~~~l~~d 266 (314)
T 3com_A 257 DFVKQCLVKS 266 (314)
T ss_dssp HHHHHHTCSC
T ss_pred HHHHHHccCC
Confidence 9999999877
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=306.74 Aligned_cols=236 Identities=29% Similarity=0.469 Sum_probs=194.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHH----HHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFL----ESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||+||+|++. +++.||+|++........... +.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999864 799999999976554433222 67889999999999999999999997766
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCC-----EEE
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLE-----AFV 654 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~-----~kl 654 (764)
++||||+++++|.+++... ...+++..+..++.|++.||+||| ++| |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6999999999999888643 346899999999999999999999 889 999999999999988776 999
Q ss_pred eeeccccccCCCCCCceecccccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCC
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPELAY--TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGR 725 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~ 725 (764)
+|||.+..... ......|++.|+|||++. +..++.++||||+|+++|+|++|+.||........ ....
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999975432 334467899999999984 45678999999999999999999999986554221 1112
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
........+..+.++++.|++.++.-|
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~R 274 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKR 274 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhC
Confidence 233445678899999999998774433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=311.77 Aligned_cols=232 Identities=23% Similarity=0.383 Sum_probs=194.4
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|.+.+.||+|+||+||+|+.. +|+.||+|++....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 4678999999999999999999865 79999999997654322 2568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~ 661 (764)
||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999999863 345889999999999999999999 8899999999999999 788999999999997
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~ 734 (764)
.... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.......... .......+.++
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 158 MEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred ecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 5432 22334578999999999999999999999999999999999999998655422110 11112235678
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++.+|++.+
T Consensus 236 ~~~~~li~~~l~~d 249 (304)
T 2jam_A 236 ESAKDFICHLLEKD 249 (304)
T ss_dssp HHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHcCCC
Confidence 89999999999877
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.71 Aligned_cols=235 Identities=21% Similarity=0.345 Sum_probs=194.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|... +++.||+|++........ ...+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 468999999999999999999876 799999999876543211 1247788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeeec
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADFG 658 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg 658 (764)
++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999973 346899999999999999999999 88999999999999998877 89999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCc----CCCCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRK----ISQNP 731 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~----~~~~~ 731 (764)
.+....... ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.+........ ... ....+
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 998765332 2234568999999999999999999999999999999999999998765422111 111 11124
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
..+..+.+++++|++.+
T Consensus 237 ~~~~~~~~li~~~l~~d 253 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKD 253 (283)
T ss_dssp TCCHHHHHHHHTTSCSS
T ss_pred cCCHHHHHHHHHHccCC
Confidence 56788999999999887
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=310.37 Aligned_cols=218 Identities=34% Similarity=0.575 Sum_probs=187.8
Q ss_pred CccCHHHHHHHhhcCCcc------eeeeecCceeEEEEEECCCCEEEEEEccCCCC-CcHHHHHHHHHHHHHHHhcCCCc
Q 004268 496 GRITFEEMIEATEDFHIK------YCIGTGGYGSVYRAQLSSGKLVALKKLHRSET-EEPAFLESFQTEARLLSQIRHRN 568 (764)
Q Consensus 496 ~~~~~~~~~~~~~~y~~~------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpn 568 (764)
..+++.++......|... +.||+|+||+||+|.. +++.||+|++..... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 356788888888887766 8999999999999987 488999999876432 22334578899999999999999
Q ss_pred eeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 569 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
|+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||+||| ++||+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999976544556899999999999999999999 889999999999999999
Q ss_pred CCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 649 NLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
++.+||+|||.+......... .....|++.|+|||++.+ .++.++||||+|+++|+|++|+.||.....
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 999999999999876533222 223468999999998875 488999999999999999999999987554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=331.48 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=160.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|+||+||+|.+. +++.||||++..... .....+++.+|++++++++||||+++++++... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999755 799999999976433 344457889999999999999999999998543 5
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+||||++ ++|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccc
Confidence 6999999985 689999873 456899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC---------------------------Cceeccccccccccccc-ccCCCCccchHHHHHHHHHHHHh----
Q 004268 661 RLLHPDSS---------------------------NRTLVVGTYGYIAPELA-YTMAVTEKCDVYSFGVVALEVLM---- 708 (764)
Q Consensus 661 ~~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~~llt---- 708 (764)
+....... .....+||+.|+|||++ .+..++.++||||+||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87643211 12345789999999976 56679999999999999999999
Q ss_pred -------CCCCCCccc
Q 004268 709 -------GSHPTDLLS 717 (764)
Q Consensus 709 -------g~~Pf~~~~ 717 (764)
|++||.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 677776543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=316.51 Aligned_cols=236 Identities=24% Similarity=0.415 Sum_probs=189.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCE----EEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKL----VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+...... ...+.+.+|++++++++||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 478999999999999999999854 4543 588887644322 22478899999999999999999999998765
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++|+||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 77899999999999999753 346899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 662 LLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
........ .....+|+.|+|||++.+..++.++||||+||++|+|+| |+.||.+....... .......++..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCC
Confidence 76543322 223456789999999999999999999999999999999 99999876553321 122334456678
Q ss_pred HHHHHHHhhhhccchh
Q 004268 735 LQCNAYLKNFSQGNHR 750 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~ 750 (764)
..+.+++..|++.++.
T Consensus 246 ~~~~~li~~~l~~~p~ 261 (327)
T 3poz_A 246 IDVYMIMVKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHTCSCGG
T ss_pred HHHHHHHHHHcCCChh
Confidence 8999999999998843
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.35 Aligned_cols=235 Identities=29% Similarity=0.444 Sum_probs=193.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH----------HHHHHHHHHHHHHHhcCCCceeeEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP----------AFLESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
..++|++.+.||+|+||+||+|... +++.||+|++........ ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999865 688999999976543211 22467889999999999999999999
Q ss_pred EEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---C
Q 004268 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---E 651 (764)
Q Consensus 575 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~ 651 (764)
++.+....|+||||+++|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998863 346899999999999999999999 89999999999999998765 6
Q ss_pred EEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---C---
Q 004268 652 AFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---R--- 725 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~--- 725 (764)
+||+|||++....... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+.... .
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999999998765432 3344679999999999874 689999999999999999999999987665322111 1
Q ss_pred -cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 -KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 -~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.....+.++..+.++++.|++.+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~d 289 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYD 289 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred CCccccCCCCHHHHHHHHHHcCCC
Confidence 11112567899999999999977
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.41 Aligned_cols=238 Identities=24% Similarity=0.329 Sum_probs=187.7
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc--HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE--PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
...++|++.+.||+|+||.||+|.+. +|+.||+|++....... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34688999999999999999999865 68999999997543322 1122467899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++ +|..++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 888888642 345788899999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----------------
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---------------- 724 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---------------- 724 (764)
.............||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+....+....
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 776555445556889999999998764 588999999999999999999999987553211000
Q ss_pred ------CcCC---------CCCCCcHHHHHHHhhhhccc
Q 004268 725 ------RKIS---------QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 ------~~~~---------~~~~~~~~~~~~~~~~l~~~ 748 (764)
.... ..+..+..+.++++.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 279 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 279 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccC
Confidence 0000 01345678999999999977
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.55 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=186.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+. .+..||+|.+..... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 578999999999999999999764 245799999875432 344578899999999999999999999985 4568
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence 8999999999999999743 335889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 663 LHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 663 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
....... .....+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....+.. .......++..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 6433221 223456788999999999999999999999999999997 99999876543321 11223345667889
Q ss_pred HHHHHhhhhccchhhH
Q 004268 737 CNAYLKNFSQGNHRWE 752 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~~ 752 (764)
+.+++++|++.++.-|
T Consensus 246 l~~li~~~l~~~p~~R 261 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRR 261 (281)
T ss_dssp HHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHccCChhhC
Confidence 9999999998874443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.25 Aligned_cols=202 Identities=27% Similarity=0.366 Sum_probs=177.3
Q ss_pred HHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-----CCceeeEeeEEe
Q 004268 504 IEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-----HRNIVKLYGFCL 577 (764)
Q Consensus 504 ~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~ 577 (764)
....++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+..|+++++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 345689999999999999999999864 7899999998642 233467788999999996 999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---------
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--------- 648 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------- 648 (764)
..+..++||||+ +++|.+++... ....+++..+..++.||+.||+||| ++||+||||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccc
Confidence 999999999999 88999999754 2335899999999999999999999 899999999999999975
Q ss_pred ----------------CCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 004268 649 ----------------NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712 (764)
Q Consensus 649 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P 712 (764)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999865432 2345789999999999999999999999999999999999999
Q ss_pred CCccc
Q 004268 713 TDLLS 717 (764)
Q Consensus 713 f~~~~ 717 (764)
|....
T Consensus 259 f~~~~ 263 (360)
T 3llt_A 259 FRTHE 263 (360)
T ss_dssp CCCSS
T ss_pred CCCCc
Confidence 97654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.71 Aligned_cols=233 Identities=21% Similarity=0.340 Sum_probs=186.7
Q ss_pred hhcCCcc-eeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEE
Q 004268 507 TEDFHIK-YCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 507 ~~~y~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 583 (764)
.++|++. +.||+|+||+||+|... +++.||+|++....... .+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4778885 78999999999999854 79999999997654332 36788999999995 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC---EEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfg~~ 660 (764)
+||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999999999974 346899999999999999999999 889999999999999998766 999999998
Q ss_pred cccCCCCC-------Cceeccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------
Q 004268 661 RLLHPDSS-------NRTLVVGTYGYIAPELAYT-----MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------ 722 (764)
Q Consensus 661 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------ 722 (764)
........ ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76542211 1123468999999999875 56889999999999999999999999875432210
Q ss_pred ------------cCCcCCC----CCCCcHHHHHHHhhhhccc
Q 004268 723 ------------SGRKISQ----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ------------~~~~~~~----~~~~~~~~~~~~~~~l~~~ 748 (764)
....... .+.++..+.+++++|++.+
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCC
Confidence 0001111 1356788999999999887
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.51 Aligned_cols=236 Identities=24% Similarity=0.342 Sum_probs=183.3
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhcCCCceeeEeeEEee
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQIRHRNIVKLYGFCLH 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 578 (764)
...++|.+.+.||+|+||+||+|... +++.||+|++...... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34689999999999999999999764 7899999998754321 11122457899999999999999999999754
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---CEEEe
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL---EAFVA 655 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 655 (764)
+..++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence 558999999999999998863 346899999999999999999999 88999999999999997544 59999
Q ss_pred eeccccccCCCCCCceeccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCC
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYT---MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKIS 728 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~ 728 (764)
|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.......... .....
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 99999876533 22344679999999999864 567889999999999999999999998654322111 11111
Q ss_pred ----CCCCCcHHHHHHHhhhhccc
Q 004268 729 ----QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ----~~~~~~~~~~~~~~~~l~~~ 748 (764)
..+.++..+.+++++|++.+
T Consensus 364 ~~~~~~~~~~~~~~~li~~~L~~d 387 (419)
T 3i6u_A 364 FIPEVWAEVSEKALDLVKKLLVVD 387 (419)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CCchhhcccCHHHHHHHHHHccCC
Confidence 12456889999999999877
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.12 Aligned_cols=238 Identities=24% Similarity=0.425 Sum_probs=198.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..++|++.+.||+|+||+||+|.++++..||||++...... .+.+.+|++++++++||||+++++++. .+..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 35789999999999999999999988899999999765433 378899999999999999999999986 5668999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.++++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999743 2335788999999999999999999 88999999999999999999999999999987643
Q ss_pred CCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHH
Q 004268 666 DSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 739 (764)
... ......++..|+|||++.+..++.++||||||+++|||+| |+.||.+.+..+.. .......+...+..+.+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 211 1122345778999999998999999999999999999999 99999876543221 12233445567889999
Q ss_pred HHhhhhccchhhH
Q 004268 740 YLKNFSQGNHRWE 752 (764)
Q Consensus 740 ~~~~~l~~~~~~~ 752 (764)
++++||+.++.-|
T Consensus 417 li~~cl~~dp~~R 429 (454)
T 1qcf_A 417 IMMRCWKNRPEER 429 (454)
T ss_dssp HHHHHTCSSGGGS
T ss_pred HHHHHccCChhHC
Confidence 9999999884433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=334.17 Aligned_cols=234 Identities=26% Similarity=0.399 Sum_probs=191.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|+.. +++.||+|++........ ....+.+|+++++.++||||+++++++.+....|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3578999999999999999999865 789999999876543221 13678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg~~~ 661 (764)
||||+++|+|.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++. ++.+||+|||++.
T Consensus 114 v~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999998863 346899999999999999999999 899999999999999976 4559999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~ 734 (764)
...... ......||+.|+|||++. ..++.++||||+||++|+|++|++||.+....+.... ......+.++
T Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 265 (494)
T 3lij_A 188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265 (494)
T ss_dssp ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSC
T ss_pred ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCC
Confidence 765432 234467999999999986 4699999999999999999999999987665322111 1112234678
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 266 ~~~~~li~~~L~~d 279 (494)
T 3lij_A 266 EGAKDLIKQMLQFD 279 (494)
T ss_dssp HHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHCCCC
Confidence 89999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=307.29 Aligned_cols=236 Identities=25% Similarity=0.391 Sum_probs=198.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||.||+|.+.+++.||+|++....... +.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 47899999999999999999998888999999998765442 67889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|||.+......
T Consensus 83 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999999743 345889999999999999999999 899999999999999999999999999999865432
Q ss_pred C-CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 S-SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
. .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......... .......+...+..+.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 1 11122456788999999998899999999999999999999 99999876542211 112233345568899999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
+++|++.++.-
T Consensus 238 i~~~l~~~p~~ 248 (267)
T 3t9t_A 238 MNHCWRERPED 248 (267)
T ss_dssp HHHHTCSSGGG
T ss_pred HHHHccCChhh
Confidence 99999887443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.68 Aligned_cols=240 Identities=26% Similarity=0.380 Sum_probs=199.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||+||+|.+ .+++.||+|++..... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 57899999999999999999974 3567899999976543 23357889999999999 999999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE---------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||+||| ++||+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 999999999999999999975422 124899999999999999999999 88999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|+| |+.||.+......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9999999999999999876544322 223456789999999999999999999999999999999 9999987653211
Q ss_pred -----ccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 722 -----SSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 722 -----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
............+..+.++++.|++.++.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 291 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchh
Confidence 111223334567889999999999987443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.55 Aligned_cols=239 Identities=24% Similarity=0.398 Sum_probs=197.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|++.+.||+|+||+||+|++. +++.||+|++..... ....+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 578999999999999999999763 567899999976543 33457889999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+.+..++||||+++++|.+++..... ...+++..+..++.||+.||+||| ++||+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 99999999999999999999975432 234889999999999999999999 88999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....+.
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 9999999999999999876543221 222456788999999998899999999999999999999 9999987654221
Q ss_pred c----cCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 722 S----SGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 722 ~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
. ...........+..+.++++.|++.++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 301 (334)
T 2pvf_A 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPS 301 (334)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChh
Confidence 1 1122334556788999999999987743
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.26 Aligned_cols=235 Identities=24% Similarity=0.395 Sum_probs=189.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 578999999999999999999876 7999999998654322222346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999974 345889999999999999999999 88999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
.. ......+++.|+|||++.+..+ +.++||||+|+++|+|++|+.||........ ........+..++..+.+++
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 242 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence 32 2234578999999999988765 6899999999999999999999986543211 11122233455788999999
Q ss_pred hhhhccc
Q 004268 742 KNFSQGN 748 (764)
Q Consensus 742 ~~~l~~~ 748 (764)
++|++.+
T Consensus 243 ~~~l~~~ 249 (276)
T 2h6d_A 243 MHMLQVD 249 (276)
T ss_dssp HHHTCSS
T ss_pred HHHccCC
Confidence 9999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.20 Aligned_cols=238 Identities=25% Similarity=0.387 Sum_probs=192.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-- 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 579 (764)
.++|++.+.||+|+||+||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 57899999999999999999974 368899999987543 33457889999999999999999999998653
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4589999999999999999753 335899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC---CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc----------------
Q 004268 660 ARLLHPDSS---NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---------------- 720 (764)
Q Consensus 660 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---------------- 720 (764)
+........ ......++..|+|||++.+..++.++||||+|+++|+|+||..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987643322 1223456778999999999999999999999999999999999987543210
Q ss_pred ----cccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 721 ----SSSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 721 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.........+...+..+.+++++|++.++.-|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 276 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhC
Confidence 01112333455678899999999998874443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=314.62 Aligned_cols=237 Identities=27% Similarity=0.416 Sum_probs=200.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 4678999999999999999999866 5889999998754432 4778899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....
T Consensus 87 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999754 3345899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHH
Q 004268 665 PDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~ 738 (764)
..... .....+++.|+|||++.+..++.++||||+|+++|+|++ |..||......... .......+...+..+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 242 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence 33321 223456788999999999999999999999999999999 99999876543221 1223344566788999
Q ss_pred HHHhhhhccchh
Q 004268 739 AYLKNFSQGNHR 750 (764)
Q Consensus 739 ~~~~~~l~~~~~ 750 (764)
++++.|++.++.
T Consensus 243 ~li~~~l~~dp~ 254 (288)
T 3kfa_A 243 ELMRACWQWNPS 254 (288)
T ss_dssp HHHHHHTCSSGG
T ss_pred HHHHHHhCCChh
Confidence 999999998733
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.59 Aligned_cols=231 Identities=19% Similarity=0.249 Sum_probs=193.8
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|.. .+++.||+|++...... +.+.+|+++++.+ +|++++++++++.+....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46899999999999999999985 57999999998755433 4577899999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC-----EEEeeecc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE-----AFVADFGL 659 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfg~ 659 (764)
||||+ +++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|||.
T Consensus 84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 89999999743 335899999999999999999999 999999999999999987766 99999999
Q ss_pred ccccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------
Q 004268 660 ARLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------- 723 (764)
Q Consensus 660 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------- 723 (764)
+........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 987654322 1234578999999999999999999999999999999999999998754321110
Q ss_pred --CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 --GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 --~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+.++..+.++++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~d 264 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLA 264 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCC
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCC
Confidence 0011113467889999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=305.62 Aligned_cols=235 Identities=18% Similarity=0.284 Sum_probs=196.9
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--CEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN--KCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l 584 (764)
.++|++.+.||+|+||+||+|+++ ++.||+|++...... ....+.+.+|++++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 578999999999999999999986 889999999876543 33457799999999999999999999999887 77899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
||||+++++|.+++... ....+++..+..++.|++.||+||| ++| |+||||||+||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999853 2335899999999999999999999 888 99999999999999999999999998765
Q ss_pred cCCCCCCceecccccccccccccccCCCCc---cchHHHHHHHHHHHHhCCCCCCcccccccc-----cCCcCCCCCCCc
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTMAVTE---KCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~ 734 (764)
.... ...||+.|+|||++.+..++. ++||||+|+++|+|++|+.||.+....... .......++..+
T Consensus 163 ~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 163 FQSP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGIS 237 (271)
T ss_dssp TSCT-----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCC
T ss_pred eccc-----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCC
Confidence 3322 246799999999998765544 799999999999999999999876553221 122233455678
Q ss_pred HHHHHHHhhhhccchhhH
Q 004268 735 LQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~ 752 (764)
..+.++++.|++.++.-|
T Consensus 238 ~~~~~li~~~l~~~p~~R 255 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKR 255 (271)
T ss_dssp HHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHcCCChhhC
Confidence 899999999998875444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.67 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=194.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE----CCCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSETE-EPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|+. .+++.||+|++...... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999986 37899999998753311 111124567899999999 6999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999974 346899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCC-CCceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cCCcCCCC
Q 004268 661 RLLHPDS-SNRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------SGRKISQN 730 (764)
Q Consensus 661 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~~ 730 (764)
+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......+
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 8654322 22234579999999999886 34789999999999999999999999754432111 11223345
Q ss_pred CCCcHHHHHHHhhhhccchhhH
Q 004268 731 PRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
+.++..+.+++++|++.++.-|
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R 308 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKR 308 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGS
T ss_pred cccCHHHHHHHHHHhhhCHHHh
Confidence 5678899999999999884443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.59 Aligned_cols=230 Identities=27% Similarity=0.355 Sum_probs=187.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+++.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 578999999999999999999864 799999999976543 3445678899999999999999999999997653
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.+|+||||+ +++|.++++. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999864 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------- 723 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------- 723 (764)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 175 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 175 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9875432 334578999999999887 678999999999999999999999998755321100
Q ss_pred -------------------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 -------------------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -------------------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+..+..+.+++++|++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~d 295 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 295 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCC
Confidence 0011123456889999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=308.20 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=193.3
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|.....||+|+||+||+|.+ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 3455566899999999999986 4788999999876543 22477889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeeccccccCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHP 665 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~ 665 (764)
||+++++|.+++.........++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||.+.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999999986544456778899999999999999999 889999999999999987 89999999999987654
Q ss_pred CCCCceecccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMA--VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~ 737 (764)
.........|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||........ ........+..++..+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 433344567899999999987653 78999999999999999999999976543211 1112223345678899
Q ss_pred HHHHhhhhccchh
Q 004268 738 NAYLKNFSQGNHR 750 (764)
Q Consensus 738 ~~~~~~~l~~~~~ 750 (764)
.+++++|++.++.
T Consensus 256 ~~li~~~l~~dp~ 268 (295)
T 2clq_A 256 KAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHHTTCSSTT
T ss_pred HHHHHHHccCChh
Confidence 9999999998733
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.85 Aligned_cols=233 Identities=10% Similarity=0.070 Sum_probs=177.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc--CCCceeeEe-------eEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI--RHRNIVKLY-------GFC 576 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~-------~~~ 576 (764)
...|++.+.||+|+||+||+|.+. +|+.||+|++...........+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356999999999999999999865 7899999999887765666667888886666555 599988855 444
Q ss_pred eeC-----------------CEEEEEEEecCCCCHHHHHhcCccccccCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 004268 577 LHN-----------------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKR------VNIVKSMAHALSYLHYDCKPS 633 (764)
Q Consensus 577 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~~ 633 (764)
... ...|+||||++ ++|.+++.... ..+.+..+ ..++.||+.||+||| ++|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQ---SKG 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence 332 34899999999 79999997532 12344444 567799999999999 899
Q ss_pred cEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCC
Q 004268 634 IVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSH 711 (764)
Q Consensus 634 iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~ 711 (764)
|+||||||+||+++.++.+||+|||+++.... ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986542 2224567799999999987 689999999999999999999999
Q ss_pred CCCcccccccc------------cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 712 PTDLLSSLSSS------------SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 712 Pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
||.+....... ........+.++..+.+++++|++.+
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 340 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence 99877432111 01112223467899999999999877
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.63 Aligned_cols=235 Identities=26% Similarity=0.449 Sum_probs=196.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 5789999999999999999999888889999999765543 2678899999999999999999999874 4589999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||++++++.+||+|||.+......
T Consensus 87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999742 2235899999999999999999999 899999999999999999999999999999876533
Q ss_pred CCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
... .....++..|+|||++.+..++.++||||+|+++|+|++ |+.||.+....+.. ...........+..+.++
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 211 122346778999999998889999999999999999999 99999876542211 112233445678899999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
++.|++.++.
T Consensus 243 i~~~l~~~p~ 252 (279)
T 1qpc_A 243 MRLCWKERPE 252 (279)
T ss_dssp HHHHTCSSGG
T ss_pred HHHHhccChh
Confidence 9999988743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.13 Aligned_cols=236 Identities=27% Similarity=0.438 Sum_probs=193.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|.++.+..||+|++...... .+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 5789999999999999999999887888999999865533 2678899999999999999999999876 6689999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999742 2335889999999999999999999 899999999999999999999999999999876432
Q ss_pred CC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+.. .......++..+..+.++
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 21 1223456788999999999999999999999999999999 99999876543221 122334456678899999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
+++||+.++.-
T Consensus 414 i~~cl~~dP~~ 424 (452)
T 1fmk_A 414 MCQCWRKEPEE 424 (452)
T ss_dssp HHHHTCSSGGG
T ss_pred HHHHccCChhh
Confidence 99999988443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.20 Aligned_cols=235 Identities=24% Similarity=0.367 Sum_probs=192.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 581 (764)
...|++.+.||+|+||+||+|.+. ++..||+|++...... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345888999999999999999764 7889999998765543 3345788999999999999999999998875 456
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeec-CCCCEEEeeec
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLN-SNLEAFVADFG 658 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg 658 (764)
.++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++| |+||||||+||+++ .++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 8999999999999999973 346889999999999999999999 888 99999999999998 78999999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPR 732 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~ 732 (764)
.+..... .......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||........... ........
T Consensus 178 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 178 LATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred Ccccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 9976533 23345678999999998875 589999999999999999999999986544221111 11112333
Q ss_pred CcHHHHHHHhhhhccchhh
Q 004268 733 LDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~ 751 (764)
.+..+.++++.|++.++.-
T Consensus 255 ~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGG
T ss_pred CCHHHHHHHHHHccCChhh
Confidence 4678999999999987433
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=306.58 Aligned_cols=288 Identities=22% Similarity=0.282 Sum_probs=161.1
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
+++.++++++.++ .+|..+. ++|++|+|++|.|++..+..|..+++|++|+|++|.++++.+.+|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666666 3443332 456666666666665555566666666666666666666656666666666666666
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCC--CCCCccccCCCccEEEecCccCcC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG--PIPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
+|+++.+++..+ ++|++|++++|+++.+.+..|.++++|++|++++|.++. ..+..+..+
T Consensus 111 ~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l--------------- 172 (332)
T 2ft3_A 111 KNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL--------------- 172 (332)
T ss_dssp SSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC---------------
T ss_pred CCcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC---------------
Confidence 666664433332 556666666666665555556666666666666665542 333333333
Q ss_pred CcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC
Q 004268 202 PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281 (764)
Q Consensus 202 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 281 (764)
+|++|++++|.++++ |..+. ++|++|++++|.+++..+..|..+++|+.|+|++|++++..+..+..
T Consensus 173 ----------~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 239 (332)
T 2ft3_A 173 ----------KLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239 (332)
T ss_dssp ----------CCSCCBCCSSBCSSC-CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGG
T ss_pred ----------ccCEEECcCCCCCcc-Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhC
Confidence 444444444444432 11111 34555555555555555455555555566666666555555555555
Q ss_pred CCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhc------ccccceeeccccccc--cCCchhccc
Q 004268 282 LKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMN------CSQLLNLVLSHNSLS--GSIPSEIGN 353 (764)
Q Consensus 282 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~------l~~L~~L~ls~N~l~--~~~~~~~~~ 353 (764)
+++|+.|++++|++. .+|..+..+++|++|++++|+++...+..|.. ..+|+.|++++|++. +..|..|..
T Consensus 240 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~ 318 (332)
T 2ft3_A 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318 (332)
T ss_dssp CTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccc
Confidence 566666666666555 34444555666666666666666544444433 245666667776665 456666666
Q ss_pred ccccceeeccccc
Q 004268 354 LIFFRQLDLSRNF 366 (764)
Q Consensus 354 l~~L~~L~l~~N~ 366 (764)
+++|+.|++++|+
T Consensus 319 l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 319 VTDRLAIQFGNYK 331 (332)
T ss_dssp BCCSTTEEC----
T ss_pred cchhhhhhccccc
Confidence 7777777776663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.85 Aligned_cols=289 Identities=21% Similarity=0.245 Sum_probs=189.1
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
+++.++++++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|.++++.|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4556666666665 3333332 456666666666665555556666666666666666665556666666666666666
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCC--CCCCccccCCCccEEEecCccCcC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG--PIPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
+|+++.++...+ ++|++|++++|+++.+.+..|.++++|+.|++++|.++. ..+..+..+++|+.|++++|.+..
T Consensus 109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 666664433222 456666666666665555556666666666666666642 445556666666666666666665
Q ss_pred CcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC
Q 004268 202 PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281 (764)
Q Consensus 202 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 281 (764)
++...+ ++|++|++++|.+++..+..+..+++|+.|+|++|.+++..+..+..+++|+.|+|++|+++ ..|..+..
T Consensus 186 l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 443322 66777777777777766777777777777777777777666667777777888888888777 45566777
Q ss_pred CCCCCeEeccCccccCCCCCCCCC------CCccceEEccCCcCcc--CCChhhhcccccceeeccccc
Q 004268 282 LKYLASLSLNGNILIGPIPPTIGY------LTNLTYLNLGYNRLSS--SIPPELMNCSQLLNLVLSHNS 342 (764)
Q Consensus 282 l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~ls~N~ 342 (764)
+++|+.|++++|++++..+..|.. .+.|+.|++++|.+.. +.|..|..+.+|+.++|++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 777888888888877766666643 3678899999998864 567788889999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.55 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=176.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC--EEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK--CMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 583 (764)
.++|++.+.||+|+||+||+|++. +|+.||+|++........ .+.+.+|++++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 468999999999999999999865 699999999976443322 367789999999999999999999998755 789
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee----cCCCCEEEeeecc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL----NSNLEAFVADFGL 659 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfg~ 659 (764)
+||||+++++|.+++........+++..++.++.||+.||+||| ++||+||||||+||++ +.++.+||+|||.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999986544445899999999999999999999 8999999999999999 7778899999999
Q ss_pred ccccCCCCCCceeccccccccccccccc--------CCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT--------MAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 98765432 2234578999999999865 56788999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.71 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=198.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 578 (764)
...++|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|++++++++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 35688999999999999999999653 477899999975443 2334678899999999999999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCcc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVE-------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 651 (764)
.+..++||||+++++|.+++..... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999874321 135688999999999999999999 889999999999999999999
Q ss_pred EEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cC
Q 004268 652 AFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SG 724 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~ 724 (764)
+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....... ..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 999999999765432211 123456889999999999999999999999999999999 89999876543211 11
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.........+..+.++++.|++.++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp 281 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNP 281 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCc
Confidence 2233455678899999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=333.12 Aligned_cols=237 Identities=27% Similarity=0.406 Sum_probs=199.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|++.+.||+|+||.||+|.++ ++..||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 567999999999999999999876 5889999999765443 36789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.++++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999753 2345889999999999999999999 89999999999999999999999999999987643
Q ss_pred CCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHH
Q 004268 666 DSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 739 (764)
.... .....++..|+|||++.+..++.++|||||||++|||+| |..||.+.+..... .......+...+..+.+
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 2211 122345678999999999899999999999999999999 99999876643221 12233445567889999
Q ss_pred HHhhhhccchhh
Q 004268 740 YLKNFSQGNHRW 751 (764)
Q Consensus 740 ~~~~~l~~~~~~ 751 (764)
+++.||+.++.-
T Consensus 451 li~~cl~~dP~~ 462 (495)
T 1opk_A 451 LMRACWQWNPSD 462 (495)
T ss_dssp HHHHHTCSSGGG
T ss_pred HHHHHcCcChhH
Confidence 999999987443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.63 Aligned_cols=236 Identities=25% Similarity=0.404 Sum_probs=195.6
Q ss_pred hhcCCcce-eeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKY-CIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|.+.+ .||+|+||+||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 46677776 8999999999999753 67889999997653 334457899999999999999999999999 45568
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 85 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999999964 2345899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 663 LHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
....... .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......+.. .......++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 6543221 122356789999999998889999999999999999998 99999876543211 112233456678
Q ss_pred HHHHHHHhhhhccchh
Q 004268 735 LQCNAYLKNFSQGNHR 750 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~ 750 (764)
..+.++++.|++.++.
T Consensus 240 ~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 240 PELYALMSDCWIYKWE 255 (287)
T ss_dssp HHHHHHHHHTTCSSGG
T ss_pred HHHHHHHHHHcCCChh
Confidence 9999999999987743
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=306.44 Aligned_cols=299 Identities=21% Similarity=0.260 Sum_probs=221.7
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 94 (764)
+.|..+++.+++++++++ .+|..+. +++++|++++|.++++.+..|.++++|++|+|++|+|++..|.+|..+++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 105 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105 (332)
T ss_dssp SSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCC
T ss_pred CCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCC
Confidence 444457999999999997 6777664 6999999999999988889999999999999999999988899999999999
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccc--cCCccccCCCCCCeeeccc
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSG--RLPQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~ 172 (764)
+|+|++|.++.+.+..+ ++|++|++++|+++.+.+..|.++++|++|++++|.++. ..+..|..+ +|++|++++
T Consensus 106 ~L~L~~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~ 181 (332)
T 2ft3_A 106 KLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE 181 (332)
T ss_dssp EEECCSSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCS
T ss_pred EEECCCCcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcC
Confidence 99999999995554443 799999999999999988889999999999999999964 678888888 999999999
Q ss_pred CCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCC
Q 004268 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252 (764)
Q Consensus 173 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 252 (764)
|.++.+....+ ++|++|++++|.+..+.+..+..+++|++|++++|.+++..+..+..+++|+.|+|++|.++ .+|
T Consensus 182 n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 257 (332)
T 2ft3_A 182 AKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257 (332)
T ss_dssp SBCSSCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCC
T ss_pred CCCCccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecC
Confidence 99986543322 56666666666666665556666666666666666666555555555556666666666555 344
Q ss_pred cCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc--cCCChhhhcc
Q 004268 253 PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS--SSIPPELMNC 330 (764)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~--~~~~~~~~~l 330 (764)
..+..+++|+.|++++|+++++.+..|.... .....+.|+.|++++|.+. ...|..|..+
T Consensus 258 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~------------------~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l 319 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVG------------------FGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319 (332)
T ss_dssp TTGGGCTTCCEEECCSSCCCBCCTTSSSCSS------------------CCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred hhhhcCccCCEEECCCCCCCccChhHccccc------------------cccccccccceEeecCcccccccCccccccc
Confidence 4455555555555555555544444333211 0011356777788887776 4666777778
Q ss_pred cccceeeccccc
Q 004268 331 SQLLNLVLSHNS 342 (764)
Q Consensus 331 ~~L~~L~ls~N~ 342 (764)
++|+.|++++|+
T Consensus 320 ~~L~~l~l~~n~ 331 (332)
T 2ft3_A 320 TDRLAIQFGNYK 331 (332)
T ss_dssp CCSTTEEC----
T ss_pred chhhhhhccccc
Confidence 888888887774
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.98 Aligned_cols=231 Identities=23% Similarity=0.310 Sum_probs=185.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK------ 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------ 580 (764)
..+|++.+.||+|+||+||+|++..+..||+|++...... ..+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4679999999999999999999877777999988654432 236999999999999999999985533
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEeeecc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGL 659 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~ 659 (764)
..++||||++++.+............+++..++.++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 38899999987544443322223456899999999999999999999 89999999999999999 799999999999
Q ss_pred ccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------------- 724 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------------- 724 (764)
++....... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 987643332 3345789999999998765 589999999999999999999999987653211000
Q ss_pred --------Cc----------CCCCCCCcHHHHHHHhhhhccc
Q 004268 725 --------RK----------ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 --------~~----------~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.. ....+..+..+.+++++|++.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCC
Confidence 00 0113347789999999999988
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.41 Aligned_cols=236 Identities=25% Similarity=0.403 Sum_probs=190.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.+. +++.||+|++....... .+.+.+|+++++.++||||+++++++...+..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4688999999999999999999876 68999999987654332 3678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++++|.+++... ...+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+|||.+....
T Consensus 94 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999988642 345899999999999999999999 8899999999999999999999999999876432
Q ss_pred CCCCCceeccccccccccccc-----ccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELA-----YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRL 733 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~ 733 (764)
..........|++.|+|||++ .+..++.++||||+|+++|+|++|+.||........... .........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence 221122335789999999988 466789999999999999999999999987654322111 112223446
Q ss_pred cHHHHHHHhhhhccch
Q 004268 734 DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~ 749 (764)
+..+.++++.|++.++
T Consensus 249 ~~~l~~li~~~l~~dp 264 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNP 264 (302)
T ss_dssp CHHHHHHHHHHSCSCT
T ss_pred CHHHHHHHHHHcccCh
Confidence 7889999999998873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.64 Aligned_cols=201 Identities=28% Similarity=0.404 Sum_probs=177.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 468999999999999999999865 78999999987653 234457889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++++|.+++.. ...+++..+..++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||.+....
T Consensus 110 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999974 346889999999999999999999 75 99999999999999999999999999997653
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.. ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||....
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 1233578999999999999999999999999999999999999997644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.45 Aligned_cols=205 Identities=26% Similarity=0.430 Sum_probs=173.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 578 (764)
.++|++.+.||+|+||+||+|+. .+|+.||+|++....... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 57899999999999999999986 479999999986654332 112567799999999999999999999887
Q ss_pred -CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 579 -NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 579 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
.+..++||||+++ ++...+... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 777777542 345899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----CCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDS----SNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|.+....... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9998764221 22234578999999999876 4579999999999999999999999987553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=315.46 Aligned_cols=235 Identities=23% Similarity=0.373 Sum_probs=189.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCE----EEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKL----VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+........ .+.+.+|+.++++++||||+++++++.+ +.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--BCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--HHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 468999999999999999999864 4543 78888754432221 2456789999999999999999999864 56
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 88999999999999999753 346888999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 662 LLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
....... ......++..|+|||++.+..++.++||||+|+++|+|++ |+.||.+....... .......+...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence 8754332 2234567889999999999999999999999999999999 99999876543221 122333444567
Q ss_pred HHHHHHHhhhhccch
Q 004268 735 LQCNAYLKNFSQGNH 749 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~ 749 (764)
..+.+++++|++.++
T Consensus 244 ~~~~~li~~~l~~dp 258 (325)
T 3kex_A 244 IDVYMVMVKCWMIDE 258 (325)
T ss_dssp TTTTHHHHHHTCSCT
T ss_pred HHHHHHHHHHcCCCh
Confidence 788999999998773
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=304.73 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=197.5
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC------cHHHHHHHHHHHHHHHhcC-CCceeeEeeEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE------EPAFLESFQTEARLLSQIR-HRNIVKLYGFC 576 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~ 576 (764)
...++|++.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45689999999999999999999865 7899999998765421 1233467889999999995 99999999999
Q ss_pred eeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 577 LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 577 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++|++||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999974 346899999999999999999999 89999999999999999999999999
Q ss_pred eccccccCCCCCCceecccccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAY------TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------- 723 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------- 723 (764)
||.+....... ......+++.|+|||++. ...++.++||||+|+++|+|++|+.||..........
T Consensus 168 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 168 FGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp CTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 99998765432 234457899999999875 4567899999999999999999999997655422111
Q ss_pred CCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 724 GRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.......+.++..+.++++.|++.++.
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~ 273 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQ 273 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred ccCcccccccCHHHHHHHHHHccCCcc
Confidence 111111234678899999999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=310.56 Aligned_cols=239 Identities=22% Similarity=0.358 Sum_probs=194.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC--
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-- 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 579 (764)
.++|++.+.||+|+||.||+|++ .+++.||+|++....... ..+.+.+|++++++++||||+++++++.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 46799999999999999999983 368899999997654332 236788999999999999999999999876
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999642 345899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC---CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 004268 660 ARLLHPDSS---NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL----------------- 719 (764)
Q Consensus 660 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~----------------- 719 (764)
+........ ......++..|+|||++.+..++.++||||+|+++|+|++|..|+......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987754432 123356788899999999999999999999999999999999986533210
Q ss_pred --ccccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 720 --SSSSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 720 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..........++.++..+.+++++|++.++.-|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 287 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCC
Confidence 001122333456678899999999998774443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.32 Aligned_cols=242 Identities=25% Similarity=0.335 Sum_probs=190.1
Q ss_pred HHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC--------cHHHHHHHHHHHHHHHhcCCCceee
Q 004268 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE--------EPAFLESFQTEARLLSQIRHRNIVK 571 (764)
Q Consensus 500 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~ 571 (764)
..++....++|++.+.||+|+||+||+|...+|+.||+|++...... .....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45667778999999999999999999999888999999998654322 2334578899999999999999999
Q ss_pred EeeEEee-----CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee
Q 004268 572 LYGFCLH-----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL 646 (764)
Q Consensus 572 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll 646 (764)
+++++.. ....|+||||++ |++.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 9999854 346899999998 588888764 3346899999999999999999999 8899999999999999
Q ss_pred cCCCCEEEeeeccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---
Q 004268 647 NSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS--- 722 (764)
Q Consensus 647 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~--- 722 (764)
+.++.+||+|||.+...... .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp CTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999755432 22344578999999999877 67899999999999999999999999875421110
Q ss_pred --------------------------------cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 --------------------------------SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 --------------------------------~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+..+..+.+++++|++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 304 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFN 304 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCC
Confidence 00011123456788999999999988
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=322.26 Aligned_cols=232 Identities=24% Similarity=0.319 Sum_probs=186.2
Q ss_pred HHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-----
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----- 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 578 (764)
...++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3467899999999999999999976 58999999998755432 2379999999999999999999844
Q ss_pred ---------------------------------CCEEEEEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHH
Q 004268 579 ---------------------------------NKCMFLIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALS 624 (764)
Q Consensus 579 ---------------------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~ 624 (764)
....++||||+++ +|.+.+... .....+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348999999985 777776532 13456899999999999999999
Q ss_pred HHHhcCCCCcEEcCCCCCCeeec-CCCCEEEeeeccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHH
Q 004268 625 YLHYDCKPSIVHRDISSNNILLN-SNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVV 702 (764)
Q Consensus 625 ~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~i 702 (764)
||| ++||+||||||+||+++ .++.+||+|||.++...... ......+|+.|+|||++.+. .++.++||||+||+
T Consensus 156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999 99999999999999998 68899999999998765433 23345789999999998875 48999999999999
Q ss_pred HHHHHhCCCCCCcccccccccC--------------------------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 703 ALEVLMGSHPTDLLSSLSSSSG--------------------------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 703 l~~lltg~~Pf~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
+|+|++|+.||.+.+..+.... .....+...+..+.+++++|++.+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999987654221100 000123446788999999999988
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=300.96 Aligned_cols=289 Identities=26% Similarity=0.291 Sum_probs=177.0
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
+++.++++++.++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|.++++.|..|.++++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4666666666666 3444443 466666666666666655566666666666666666666666666666666666666
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcC--CcccccCCccccceeeccCccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG--PVTKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
+|+++.+....+ ++|++|++++|.++.+.+..+..+++|+.|++++|.+.. ..+..+..+++|++|++++|.++.
T Consensus 109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 666664433222 566666666666666555566666666666666666643 344556666666666666666664
Q ss_pred ccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCC
Q 004268 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305 (764)
Q Consensus 226 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 305 (764)
+. ..+. ++|++|++++|.+++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|++. .+|..+..
T Consensus 186 l~-~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 IP-QGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp CC-SSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred CC-cccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 32 2221 56666666666666666666666666666666666666655556666666666666666665 44555666
Q ss_pred CCccceEEccCCcCccCCChhhhc------ccccceeecccccccc--CCchhcccccccceeeccccc
Q 004268 306 LTNLTYLNLGYNRLSSSIPPELMN------CSQLLNLVLSHNSLSG--SIPSEIGNLIFFRQLDLSRNF 366 (764)
Q Consensus 306 l~~L~~L~ls~N~l~~~~~~~~~~------l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~ 366 (764)
+++|++|++++|+|++..+..|.. ...|+.|++++|++.. ..|..|..+.+|+.++|++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 666666666666666554444432 2556666666666642 445566666666666666663
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.94 Aligned_cols=201 Identities=28% Similarity=0.363 Sum_probs=166.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 578999999999999999999765 788999999976543 3344577889999999999999999999997665
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
..|+||||+++ +|.+.+.. .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999985 78887752 3788999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus 174 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 174 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 98764322 23346789999999999999999999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=326.24 Aligned_cols=230 Identities=27% Similarity=0.369 Sum_probs=183.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
..+|++.+.||+|+||.||+|++. +|+.||||++...... ..+|++++++++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 457999999999999999999875 6999999998654322 33799999999999999999988542
Q ss_pred CEEEEEEEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-CCEEEeee
Q 004268 580 KCMFLIYEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADF 657 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Df 657 (764)
...++||||+++ ++...+... .....+++..++.++.||+.||+||| ++||+||||||+||+++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccc
Confidence 247799999986 566555421 13456899999999999999999999 9999999999999999955 57899999
Q ss_pred ccccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------------- 723 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------------- 723 (764)
|+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+...
T Consensus 202 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 202 GSAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TTCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99987643332 3345789999999998765 78999999999999999999999998765321100
Q ss_pred ---------CCcCC----------CCCCCcHHHHHHHhhhhccc
Q 004268 724 ---------GRKIS----------QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ---------~~~~~----------~~~~~~~~~~~~~~~~l~~~ 748 (764)
..... ..+..+..+.+++++|++.+
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 324 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCC
Confidence 00000 13456789999999999988
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.45 Aligned_cols=192 Identities=21% Similarity=0.376 Sum_probs=170.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEee--CCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLH--NKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+ .+++.||+|++.... .+.+.+|++++++++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 47899999999999999999975 478999999987433 267889999999997 9999999999988 6679
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeecccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLAR 661 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~ 661 (764)
++||||+++++|.++++ .+++..++.++.|++.||+||| ++||+||||||+||+++.++ .+||+|||.+.
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999999885 3788999999999999999999 89999999999999999776 89999999998
Q ss_pred ccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCC
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
...... ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.
T Consensus 180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 765433 2344578999999999887 678999999999999999999999994
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.26 Aligned_cols=235 Identities=26% Similarity=0.359 Sum_probs=187.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... .......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4678999999999999999999865 6889999998764321 112234678999999999999999999998776
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC---EEEee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVAD 656 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~D 656 (764)
. .++||||+++++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999999873 346899999999999999999999 899999999999999987654 99999
Q ss_pred eccccccCCCCCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CCcCC-
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GRKIS- 728 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~~~~- 728 (764)
||.+...... .......|++.|+|||++. +..++.++||||+|+++|+|++|+.||.......... .....
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence 9999876432 1223457899999999874 5678899999999999999999999998654321111 01111
Q ss_pred ---CCCCCcHHHHHHHhhhhccc
Q 004268 729 ---QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ---~~~~~~~~~~~~~~~~l~~~ 748 (764)
..+.++..+.+++++|++.+
T Consensus 240 ~~~~~~~~~~~~~~li~~~l~~d 262 (322)
T 2ycf_A 240 IPEVWAEVSEKALDLVKKLLVVD 262 (322)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CchhhhhcCHHHHHHHHHHcccC
Confidence 12456888999999999877
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=312.25 Aligned_cols=236 Identities=24% Similarity=0.427 Sum_probs=188.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCE----EEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKL----VALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+........ .+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC--HHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH--HHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 478999999999999999999854 4554 57777755443322 377889999999999999999999998765
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++|+|++.+|+|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 78899999999999999753 345889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCc
Q 004268 662 LLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~ 734 (764)
........ .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....... .......++..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 76433222 223456778999999999999999999999999999999 99999876653321 222344456678
Q ss_pred HHHHHHHhhhhccchh
Q 004268 735 LQCNAYLKNFSQGNHR 750 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~ 750 (764)
..+.++++.|++.++.
T Consensus 246 ~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHcCCChh
Confidence 8999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.84 Aligned_cols=235 Identities=23% Similarity=0.376 Sum_probs=194.5
Q ss_pred hcC-CcceeeeecCceeEEEEEEC-----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--C
Q 004268 508 EDF-HIKYCIGTGGYGSVYRAQLS-----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--N 579 (764)
Q Consensus 508 ~~y-~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 579 (764)
++| ++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+ .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 455 99999999999999988542 68899999997653 23445789999999999999999999999987 4
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...++||||+++++|.+++... .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccc
Confidence 6799999999999999999643 3889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 004268 660 ARLLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL----------------- 719 (764)
Q Consensus 660 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~----------------- 719 (764)
+......... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||......
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 9877543321 22345788899999999989999999999999999999999999754321
Q ss_pred --ccccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 720 --SSSSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 720 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
..............+..+.++++.|++.++.-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 294 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASF 294 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCccc
Confidence 00112233345567889999999999987443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.46 Aligned_cols=237 Identities=25% Similarity=0.426 Sum_probs=192.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEE--EEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLV--ALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||.||+|+.. ++..+ |+|.+...... ...+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 478999999999999999999754 56644 99988653322 2346788999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCc-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 583 FLIYEYMERGSLFCVLRNDV-------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
++||||+++++|.+++.... ....+++..++.++.||+.||+||| ++||+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCC
Confidence 99999999999999997542 2346899999999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccC
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSG 724 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~ 724 (764)
+.+||+|||++...... .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+...... ...
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999999754321 12233456889999999998889999999999999999998 9999987654221 112
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.....+...+..+.+++++|++.++
T Consensus 258 ~~~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 258 YRLEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCh
Confidence 2233455678899999999998873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.30 Aligned_cols=235 Identities=31% Similarity=0.423 Sum_probs=189.3
Q ss_pred hhcCCcceeeeecCceeEEEEEECC-----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS-----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..+|++.+.||+|+||+||+|.... +..||+|++..... ......+.+|++++++++||||+++++++.+.+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 4678889999999999999997542 23599999875443 3334678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999742 346899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCC
Q 004268 662 LLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRL 733 (764)
Q Consensus 662 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~ 733 (764)
........ .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......+.. ...........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence 76533221 122345778999999999999999999999999999999 99999766542211 11223345567
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.+++++|++.+
T Consensus 276 ~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQE 290 (333)
T ss_dssp BHHHHHHHHHHTCSS
T ss_pred CHHHHHHHHHHcCCC
Confidence 889999999999877
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=307.31 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=188.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 4678999999999999999999653 3458999998765443 3345778999999999999999999999887553
Q ss_pred -----EEEEEEecCCCCHHHHHhcC---ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 582 -----MFLIYEYMERGSLFCVLRND---VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 582 -----~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
.++||||+++++|.+++... .....+++..++.++.|++.||.||| ++||+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 59999999999999998532 13356899999999999999999999 99999999999999999999999
Q ss_pred EeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||.+........ ......+++.|+|||++.+..++.++||||+|+++|+|++ |..||.+....... ....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999987643321 1233456889999999999999999999999999999999 99999876553221 1222
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhh
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
...++..+..+.++++.|++.++.-
T Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~ 292 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYSCWRTDPLD 292 (313)
T ss_dssp CCCBTTCCHHHHHHHHHTTCSSGGG
T ss_pred CCCCccccHHHHHHHHHHcCCChhh
Confidence 3345567889999999999877443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.51 Aligned_cols=232 Identities=25% Similarity=0.430 Sum_probs=194.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee------
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------ 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------ 578 (764)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4678999999999999999999876 79999999987543 346689999999999999999998864
Q ss_pred ----------CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC
Q 004268 579 ----------NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS 648 (764)
Q Consensus 579 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~ 648 (764)
....++||||+++++|.+++... ....+++..+..++.|++.||.||| ++||+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence 45589999999999999999753 2346899999999999999999999 889999999999999999
Q ss_pred CCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCC
Q 004268 649 NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKIS 728 (764)
Q Consensus 649 ~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~ 728 (764)
++.+||+|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|..||.......... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-~~~~ 235 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL-RDGI 235 (284)
T ss_dssp TTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHH-HTTC
T ss_pred CCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHh-hccc
Confidence 9999999999998765433 2334578999999999999999999999999999999999999986543321111 1112
Q ss_pred CCCCCcHHHHHHHhhhhccchh
Q 004268 729 QNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.....+..+.+++++|++.++.
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~ 257 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPE 257 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccCCHHHHHHHHHHccCChh
Confidence 3455788999999999988743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=317.55 Aligned_cols=236 Identities=27% Similarity=0.408 Sum_probs=183.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC--CC--CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CCEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS--SG--KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NKCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 582 (764)
..|++.+.||+|+||+||+|.+. ++ ..||+|.+..... ....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 45788899999999999999753 22 3689999875433 2345789999999999999999999998654 5678
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.++++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999999743 345788999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCC----CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCC
Q 004268 663 LHPDSS----NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRL 733 (764)
Q Consensus 663 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~ 733 (764)
...... ......+++.|+|||++.+..++.++||||+|+++|||+| |.+||......+.. .......+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 543221 1123456788999999999999999999999999999999 78889876543321 12233345567
Q ss_pred cHHHHHHHhhhhccchh
Q 004268 734 DLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~ 750 (764)
+..+.+++++||+.++.
T Consensus 322 ~~~l~~li~~cl~~dp~ 338 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAE 338 (373)
T ss_dssp CHHHHHHHHHHTCSSGG
T ss_pred CHHHHHHHHHHcCCChh
Confidence 88999999999998743
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=303.40 Aligned_cols=236 Identities=25% Similarity=0.421 Sum_probs=182.8
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|... ..||+|++...... ....+.+.+|++++++++||||++++++. .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 578999999999999999999864 35999998765543 44467899999999999999999999965 455689999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999643 345899999999999999999999 899999999999999999999999999999765432
Q ss_pred --CCCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------CCcCCCCCC
Q 004268 667 --SSNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---------GRKISQNPR 732 (764)
Q Consensus 667 --~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---------~~~~~~~~~ 732 (764)
........|++.|+|||++. +..++.++||||+|+++|+|++|+.||.......... .........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 12223457899999999986 5678889999999999999999999998755422110 011112345
Q ss_pred CcHHHHHHHhhhhccchhh
Q 004268 733 LDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~ 751 (764)
.+..+.+++++|++.++.-
T Consensus 254 ~~~~l~~li~~~l~~~p~~ 272 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDE 272 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGG
T ss_pred CCHHHHHHHHHHccCChhh
Confidence 6788999999999877443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.39 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=192.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+.. +..||+|.+..... ....+.+.+|++++++++||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 5789999999999999999997542 33699999876543 33457899999999999999999999998754 46
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 8999999999999999742 345889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 663 LHPDSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 663 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
...... ......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......... .......+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 643322 1233456789999999998999999999999999999998 99999765443221 11223344557889
Q ss_pred HHHHHhhhhccchhh
Q 004268 737 CNAYLKNFSQGNHRW 751 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~ 751 (764)
+.+++++|++.++.-
T Consensus 243 l~~li~~~l~~~p~~ 257 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSD 257 (281)
T ss_dssp HHHHHHHHTCSSGGG
T ss_pred HHHHHHHHccCCchh
Confidence 999999999877443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=307.70 Aligned_cols=236 Identities=24% Similarity=0.385 Sum_probs=192.6
Q ss_pred HhhcCCcce-eeeecCceeEEEEEE---CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKY-CIGTGGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~-~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|++.+ .||+|+||+||+|.+ .+++.||+|++...... ....+.+.+|+++++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 357899988 999999999999953 25788999999765432 33457899999999999999999999999 5667
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 8999999999999999974 345889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCCc---eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCC
Q 004268 662 LLHPDSSNR---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRL 733 (764)
Q Consensus 662 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~ 733 (764)
......... ....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||.+....... .......++..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 765433221 22345688999999998889999999999999999999 99999876543221 11223345567
Q ss_pred cHHHHHHHhhhhccch
Q 004268 734 DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~ 749 (764)
+..+.++++.|++.++
T Consensus 246 ~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDV 261 (291)
T ss_dssp CHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHcCCCh
Confidence 8899999999998773
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.80 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=199.1
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEe
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLY 573 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~ 573 (764)
..+....++|++.+.||+|+||+||+|.+ .+++.||+|++..... ....+.+.+|+++++++ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34444568999999999999999999974 3568999999976543 23346789999999999 799999999
Q ss_pred eEEeeCC-EEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 004268 574 GFCLHNK-CMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639 (764)
Q Consensus 574 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 639 (764)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.|++.||+||| ++||+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence 9987754 48999999999999999975432 122788999999999999999999 889999999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLL 716 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~ 716 (764)
||+||+++.++.+||+|||.+......... .....+++.|+|||++.+..++.++||||+|+++|+|+| |+.||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876543322 223467889999999999999999999999999999998 99999875
Q ss_pred ccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchh
Q 004268 717 SSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 717 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
..... ........+...+..+.+++..|++.++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 293 (316)
T 2xir_A 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 293 (316)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChh
Confidence 53211 11122333455788999999999987743
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.98 Aligned_cols=235 Identities=30% Similarity=0.429 Sum_probs=184.5
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHh--cCCCceeeEeeEEee----CC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ--IRHRNIVKLYGFCLH----NK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~ 580 (764)
.++|++.+.||+|+||+||+|++ +++.||+|++.... .+.+.+|.+++.. ++||||+++++++.. ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 57899999999999999999988 58999999986532 2456677777777 799999999998654 35
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
..++||||+++|+|.++++. ..+++..+..++.|++.||+|||.. +++||+||||||+||+++.++.+||+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 68999999999999999953 3589999999999999999999932 15699999999999999999999999
Q ss_pred eeccccccCCCCCC----ceecccccccccccccccC------CCCccchHHHHHHHHHHHHhC----------CCCCCc
Q 004268 656 DFGLARLLHPDSSN----RTLVVGTYGYIAPELAYTM------AVTEKCDVYSFGVVALEVLMG----------SHPTDL 715 (764)
Q Consensus 656 Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~il~~lltg----------~~Pf~~ 715 (764)
|||+++........ .....||+.|+|||++.+. .+++++||||+|+++|||+|| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999766443322 1234789999999999877 455799999999999999999 888865
Q ss_pred cccccccc------CCcCCCCCC---------CcHHHHHHHhhhhccchhhH
Q 004268 716 LSSLSSSS------GRKISQNPR---------LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 716 ~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~~~~~~ 752 (764)
........ .......+. .+..+.+++++|++.++.-|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 43321110 011111122 33568889999998774443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.86 Aligned_cols=232 Identities=26% Similarity=0.361 Sum_probs=191.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 578999999999999999999865 78899999997543 334457889999999999999999999998765 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..|+||||+++ +|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 68999999985 89998864 35899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC---Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC-----------
Q 004268 661 RLLHPDSS---NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR----------- 725 (764)
Q Consensus 661 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~----------- 725 (764)
........ ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87643322 1234578999999998654 45899999999999999999999999876543211100
Q ss_pred -----------------------cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 -----------------------KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 -----------------------~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.....+..+..+.+++++|++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 301 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 301 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCC
Confidence 00112557888999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.78 Aligned_cols=237 Identities=27% Similarity=0.384 Sum_probs=196.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEe--eC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCL--HN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~ 579 (764)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|++++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 47899999999999999999983 368899999987643 334577899999999999999999999886 45
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence 6799999999999999999742 335899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc----------------
Q 004268 660 ARLLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---------------- 720 (764)
Q Consensus 660 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---------------- 720 (764)
+......... .....+++.|+|||++.+..++.++||||+|+++|+|++|+.||.......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876543321 223457888999999999899999999999999999999999986544310
Q ss_pred ---cccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 721 ---SSSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 721 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
..........+..+..+.++++.|++.++.-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 287 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQD 287 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhh
Confidence 0111223345667889999999999987433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.41 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=157.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------ 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------ 579 (764)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 57899999999999999999975 4789999999976543 334457888999999999999999999998654
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...|+|+|++ +++|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5589999999 6799888863 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.
T Consensus 179 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 179 ARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9865432 334678999999999887 6789999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.20 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=192.4
Q ss_pred hhcCCcceeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEe-eCCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCL-HNKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~ 581 (764)
..+|++.+.||+|+||+||+|.+.. +..||+|.+..... ....+.+.+|++++++++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 4679999999999999999997542 23589998876433 344578899999999999999999999854 5567
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||+++++|.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence 8999999999999999974 2345788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCC----CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCC
Q 004268 662 LLHPDS----SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPR 732 (764)
Q Consensus 662 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~ 732 (764)
...... .......+++.|+|||++.+..++.++||||+|+++|+|++ |.+||......+.. .......+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCcc
Confidence 664322 11233467789999999999999999999999999999999 67777765543321 1223333455
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
.+..+.++++.|++.++.-|
T Consensus 257 ~~~~l~~li~~~l~~~p~~R 276 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMR 276 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGS
T ss_pred CCHHHHHHHHHHcCCChhhC
Confidence 78899999999999874433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.54 Aligned_cols=233 Identities=21% Similarity=0.378 Sum_probs=191.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CC-------CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SG-------KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 578 (764)
.++|++.+.||+|+||+||+|.+. ++ ..||+|++...... ..+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 478999999999999999999754 33 47999998654332 24778999999999999999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC-------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE------- 651 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~------- 651 (764)
++..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999999753 334889999999999999999999 899999999999999998877
Q ss_pred -EEEeeeccccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhC-CCCCCcccccccc--cCCc
Q 004268 652 -AFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSSS--SGRK 726 (764)
Q Consensus 652 -~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~~--~~~~ 726 (764)
+||+|||.+..... .....+++.|+|||++.+ ..++.++||||+|+++|+|++| .+||......... ....
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 99999999875432 233568899999999987 6789999999999999999995 5666554432111 1122
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhh
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
...++..+..+.+++++|++.++.-
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~ 259 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDH 259 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGG
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhH
Confidence 3334556788999999999887443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.01 Aligned_cols=232 Identities=26% Similarity=0.405 Sum_probs=188.0
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-CEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-KCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.. |+.||+|++..... .+.+.+|++++++++||||+++++++.+. +..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 578999999999999999999875 88999999975432 36788999999999999999999987554 468999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999999743 2233788999999999999999999 89999999999999999999999999999976543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
. .....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......+.. ...........+..+.++
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 246 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence 2 223457889999999999999999999999999999998 99999876543221 122233455678899999
Q ss_pred Hhhhhccchhh
Q 004268 741 LKNFSQGNHRW 751 (764)
Q Consensus 741 ~~~~l~~~~~~ 751 (764)
+++|++.++.-
T Consensus 247 i~~~l~~~p~~ 257 (278)
T 1byg_A 247 MKNCWHLDAAM 257 (278)
T ss_dssp HHHHTCSSGGG
T ss_pred HHHHhcCChhh
Confidence 99999887443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=319.72 Aligned_cols=236 Identities=19% Similarity=0.270 Sum_probs=183.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECC------CCEEEEEEccCCCCCcHHHH--------HHHHHHHHHHHhcCCCceeeE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS------GKLVALKKLHRSETEEPAFL--------ESFQTEARLLSQIRHRNIVKL 572 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~ 572 (764)
.++|++.+.||+|+||+||+|.+.. ++.||+|++........... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 47899999876542111000 123345556667789999999
Q ss_pred eeEEeeC----CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-
Q 004268 573 YGFCLHN----KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN- 647 (764)
Q Consensus 573 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~- 647 (764)
++++... ...++||||+ +++|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence 9998764 5589999999 89999999752 346899999999999999999999 88999999999999999
Q ss_pred -CCCCEEEeeeccccccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 648 -SNLEAFVADFGLARLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 648 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999977643221 113345999999999999999999999999999999999999999864321
Q ss_pred ccccC--------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 720 SSSSG--------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 720 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
..... .........+..+.++++.|+..+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC
Confidence 11000 000112456788888898888876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=310.95 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=177.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|... +++.||+|++...... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 4678999999999999999999754 7899999998654432 224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC-----ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 585 IYEYMERGSLFCVLRND-----VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
||||+++++|.+++... .....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998631 12345899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCC-----Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------
Q 004268 660 ARLLHPDSS-----NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---------- 723 (764)
Q Consensus 660 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---------- 723 (764)
+........ ......|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 977643221 1233578999999999876 568999999999999999999999998754422110
Q ss_pred ---CCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 724 ---GRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 724 ---~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..........+..+.++++.|++.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCCh
Confidence 01111234567889999999999883
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=317.64 Aligned_cols=236 Identities=25% Similarity=0.400 Sum_probs=195.1
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH--------------HHHHHHHHHHHHHHhcCCCceeeE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP--------------AFLESFQTEARLLSQIRHRNIVKL 572 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~~ 572 (764)
.++|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999988 899999999865432211 112678899999999999999999
Q ss_pred eeEEeeCCEEEEEEEecCCCCHHHH------HhcCccccccCHHHHHHHHHHHHHHHHHHHhcCC-CCcEEcCCCCCCee
Q 004268 573 YGFCLHNKCMFLIYEYMERGSLFCV------LRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCK-PSIVHRDISSNNIL 645 (764)
Q Consensus 573 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~iiH~Dlkp~NIl 645 (764)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||+||| + +||+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 9999999999999999999999998 5432 2456899999999999999999999 7 89999999999999
Q ss_pred ecCCCCEEEeeeccccccCCCCCCceecccccccccccccccC-CCCc-cchHHHHHHHHHHHHhCCCCCCccccccc--
Q 004268 646 LNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTE-KCDVYSFGVVALEVLMGSHPTDLLSSLSS-- 721 (764)
Q Consensus 646 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~il~~lltg~~Pf~~~~~~~~-- 721 (764)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|+|++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876433 33445789999999999887 6666 99999999999999999999986654110
Q ss_pred --ccCCcCCCC-------------------CCCcHHHHHHHhhhhccch
Q 004268 722 --SSGRKISQN-------------------PRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 722 --~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~~ 749 (764)
........+ +.++..+.+++++|++.++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 311 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSG
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCCh
Confidence 011111111 5678899999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.47 Aligned_cols=238 Identities=26% Similarity=0.367 Sum_probs=192.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|++ .+++.||+|.+..... ......+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 57899999999999999999973 3577999999975432 333467889999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCcc----ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVE----AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~k 653 (764)
..++||||+++++|.+++..... ...+++..+..++.|++.||.||| ++||+||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999975422 245889999999999999999999 899999999999999984 44699
Q ss_pred EeeeccccccCCCC--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCc
Q 004268 654 VADFGLARLLHPDS--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~ 726 (764)
|+|||.+....... .......+++.|+|||++.+..++.++||||+|+++|+|+| |+.||........ .....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999997653322 12233567889999999999999999999999999999998 9999986654221 11222
Q ss_pred CCCCCCCcHHHHHHHhhhhccch
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.......+..+.++++.|++.++
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp 286 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQP 286 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCHHHHHHHHHHhcCCh
Confidence 33455678899999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.66 Aligned_cols=238 Identities=24% Similarity=0.384 Sum_probs=186.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+. +++ .||+|++...........+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 478999999999999999999753 333 68999987765544555688999999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999742 345889999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc-----cCCcCCCCCCC
Q 004268 663 LHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-----SGRKISQNPRL 733 (764)
Q Consensus 663 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-----~~~~~~~~~~~ 733 (764)
....... .....++..|+|||++.+..++.++||||+|+++|+|++ |+.||.+....... ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 6543322 123456778999999998889999999999999999999 99999876542211 11223344567
Q ss_pred cHHHHHHHhhhhccchh
Q 004268 734 DLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~ 750 (764)
+..+.++++.|++.++.
T Consensus 251 ~~~l~~li~~~l~~~p~ 267 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPE 267 (291)
T ss_dssp CHHHHHHHHHHTCSSGG
T ss_pred CHHHHHHHHHHccCCcc
Confidence 88999999999998743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.23 Aligned_cols=238 Identities=22% Similarity=0.307 Sum_probs=190.8
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc-HHHHHHHHHHHHHHHhcCCCceeeEeeEEe--eCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE-PAFLESFQTEARLLSQIRHRNIVKLYGFCL--HNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~ 581 (764)
..++|++.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999864 78999999987543211 123477899999999999999999999984 4557
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.++||||++++ +.+++... ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999976 77777643 3456899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCC--CCceecccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCc
Q 004268 662 LLHPDS--SNRTLVVGTYGYIAPELAYTMA--VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~ 734 (764)
...... .......|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||.+...... ........+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG 237 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence 765322 2223456899999999987654 37799999999999999999999987553221 1112233445678
Q ss_pred HHHHHHHhhhhccc
Q 004268 735 LQCNAYLKNFSQGN 748 (764)
Q Consensus 735 ~~~~~~~~~~l~~~ 748 (764)
..+.+++++|++.+
T Consensus 238 ~~l~~li~~~l~~d 251 (305)
T 2wtk_C 238 PPLSDLLKGMLEYE 251 (305)
T ss_dssp HHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHccCC
Confidence 89999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.03 Aligned_cols=236 Identities=22% Similarity=0.317 Sum_probs=176.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEe-------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCL------- 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~------- 577 (764)
..+|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 458999999999999999999864 78999999985543 333467889999999996 999999999983
Q ss_pred -eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeecCCCCEEE
Q 004268 578 -HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 578 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl 654 (764)
.....++||||++ |+|.+++........+++..+..++.||+.||+||| ++| |+||||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEE
Confidence 4456899999997 689888875444556999999999999999999999 888 999999999999999999999
Q ss_pred eeeccccccCCCCCC------------ceeccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 004268 655 ADFGLARLLHPDSSN------------RTLVVGTYGYIAPELA---YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL 719 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~ 719 (764)
+|||.+......... .....|++.|+|||++ .+..++.++||||+|+++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876533221 1134689999999998 5667899999999999999999999999876554
Q ss_pred ccccC-CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 720 SSSSG-RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 720 ~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
..... .........+..+.++++.|++.++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 290 (337)
T 3ll6_A 260 RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNP 290 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSG
T ss_pred HhhcCcccCCcccccchHHHHHHHHHccCCh
Confidence 33322 2233345567789999999999873
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.31 Aligned_cols=237 Identities=27% Similarity=0.437 Sum_probs=197.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..++|++.+.||+|+||+||+|.+..+..||||++...... .+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 35789999999999999999999987888999999865543 2678899999999999999999999876 668999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.++++.. ....+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 9999999999999742 2235889999999999999999999 89999999999999999999999999999986542
Q ss_pred CCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHH
Q 004268 666 DSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNA 739 (764)
Q Consensus 666 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 739 (764)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. ........+..+..+.+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 210 1122346778999999999999999999999999999999 99999876543221 12233345567889999
Q ss_pred HHhhhhccchhh
Q 004268 740 YLKNFSQGNHRW 751 (764)
Q Consensus 740 ~~~~~l~~~~~~ 751 (764)
++++||+.+..-
T Consensus 496 li~~cl~~dP~~ 507 (535)
T 2h8h_A 496 LMCQCWRKEPEE 507 (535)
T ss_dssp HHHHHTCSSGGG
T ss_pred HHHHHcCCChhH
Confidence 999999988433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.76 Aligned_cols=236 Identities=20% Similarity=0.312 Sum_probs=178.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+. .+|+.||+|++....... ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 57899999999999999999986 478999999997654332 2234455555567888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcC-ccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRND-VEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
|||+++ +|.+++... .....+++..++.++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||.+...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 887776532 13456899999999999999999999 77 9999999999999999999999999999876
Q ss_pred CCCCCCceeccccccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCC
Q 004268 664 HPDSSNRTLVVGTYGYIAPELA----YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRL 733 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~ 733 (764)
.... ......|++.|+|||++ .+..++.++||||+|+++|+|++|+.||........ ............
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 5332 22334789999999996 566789999999999999999999999985332111 111122223457
Q ss_pred cHHHHHHHhhhhccc
Q 004268 734 DLQCNAYLKNFSQGN 748 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~ 748 (764)
+..+.++++.|++.+
T Consensus 240 ~~~~~~li~~~l~~~ 254 (290)
T 3fme_A 240 SAEFVDFTSQCLKKN 254 (290)
T ss_dssp CHHHHHHHHHHTCSS
T ss_pred CHHHHHHHHHHhhcC
Confidence 889999999999988
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.18 Aligned_cols=232 Identities=18% Similarity=0.280 Sum_probs=186.1
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEee-EEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG-FCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~~~ 583 (764)
..++|++.+.||+|+||+||+|.+ .+++.||+|++...... +.+.+|+++++.++|++++..+. ++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 468899999999999999999986 57899999987654433 45778999999998877665555 456778899
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~ 660 (764)
+||||+ +++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.+
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 88999998742 345899999999999999999999 8999999999999999 78899999999999
Q ss_pred cccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC------cC
Q 004268 661 RLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR------KI 727 (764)
Q Consensus 661 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~------~~ 727 (764)
........ ......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654322 223457899999999999999999999999999999999999999876543221110 11
Q ss_pred CC-----CCCCcHHHHHHHhhhhccc
Q 004268 728 SQ-----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 728 ~~-----~~~~~~~~~~~~~~~l~~~ 748 (764)
.. ...++..+.++++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcC
Confidence 11 2456888999999999877
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=300.97 Aligned_cols=236 Identities=25% Similarity=0.408 Sum_probs=195.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
...++|++.+.||+|+||+||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 45689999999999999999999875 79999999986544322 12367889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC---CCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN---LEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfg~~ 660 (764)
+||||+++++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.+ +.+||+|||.+
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998863 346899999999999999999999 8899999999999999754 47999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCC
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRL 733 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~ 733 (764)
....... ......+++.|+|||++.+ .++.++||||+|+++|+|++|+.||.+........ .........+
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 172 TCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp GTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred eeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence 8765332 2234568999999999876 48999999999999999999999998765432111 1111223467
Q ss_pred cHHHHHHHhhhhccch
Q 004268 734 DLQCNAYLKNFSQGNH 749 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~ 749 (764)
+..+.++++.|++.++
T Consensus 250 ~~~~~~li~~~l~~dp 265 (287)
T 2wei_A 250 SDDAKDLIRKMLTFHP 265 (287)
T ss_dssp CHHHHHHHHHHTCSSG
T ss_pred CHHHHHHHHHHcccCh
Confidence 8899999999998773
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.36 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=191.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKC 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 581 (764)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 47899999999999999999986 579999999986532 3345788999999999999999999999873 447
Q ss_pred EEEEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
.++||||+++++|.+++.... ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999987422 2346899999999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCCC---------ceecccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCccccccc------c
Q 004268 661 RLLHPDSSN---------RTLVVGTYGYIAPELAYTMA---VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------S 722 (764)
Q Consensus 661 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~ 722 (764)
......... .....|++.|+|||++.+.. ++.++||||+|+++|+|++|+.||........ .
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 765321111 11235689999999987654 68899999999999999999999975322111 1
Q ss_pred cCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 723 SGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
........+..+..+.++++.|++.++.-
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhh
Confidence 12223344567899999999999988443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.01 Aligned_cols=200 Identities=22% Similarity=0.317 Sum_probs=174.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc------CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI------RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~ 579 (764)
..+|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+++++.+ .|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 568999999999999999999765 6899999998653 23346778899988888 477999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC--EEEeee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE--AFVADF 657 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Df 657 (764)
+..++||||+. ++|.+++... ....+++..++.++.||+.||+||| ++||+||||||+||+++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999997 5899988754 2335899999999999999999999 889999999999999999887 999999
Q ss_pred ccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 658 GLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 658 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
|++...... .....||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999765432 2345789999999999999999999999999999999999999986543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.36 Aligned_cols=231 Identities=18% Similarity=0.288 Sum_probs=190.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEee-EEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG-FCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|++ .+++.||+|++...... +.+.+|+++++.++|++++..+. +....+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 57899999999999999999986 57999999998765543 45789999999999877555554 4567788999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~ 661 (764)
||||+ +++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||++ +.++.+||+|||.+.
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 99999 88999999742 345899999999999999999999 8999999999999999 488899999999998
Q ss_pred ccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCC
Q 004268 662 LLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKIS 728 (764)
Q Consensus 662 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~ 728 (764)
....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 7654332 12345789999999999999999999999999999999999999987543221110 0111
Q ss_pred C-----CCCCcHHHHHHHhhhhccc
Q 004268 729 Q-----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ~-----~~~~~~~~~~~~~~~l~~~ 748 (764)
. .+..+..+.++++.|++.+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcC
Confidence 1 2567889999999999877
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=302.00 Aligned_cols=236 Identities=25% Similarity=0.381 Sum_probs=190.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCC---EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE-
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM- 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 582 (764)
-.|.+.+.||+|+||+||+|.+. +++ .||+|.+.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 35667799999999999999743 333 79999987543 334457889999999999999999999999876654
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+.+++|.+++.. ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+..
T Consensus 99 ~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999999975 2345788999999999999999999 88999999999999999999999999999976
Q ss_pred cCCC----CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccccccc----cCCcCCCCCCC
Q 004268 663 LHPD----SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSSS----SGRKISQNPRL 733 (764)
Q Consensus 663 ~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~~----~~~~~~~~~~~ 733 (764)
.... ........+++.|+|||.+.+..++.++||||+|+++|+|++| .+||......... .......+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYC 253 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccc
Confidence 5432 1222335678899999999999999999999999999999995 5556554443221 12233345557
Q ss_pred cHHHHHHHhhhhccchh
Q 004268 734 DLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~ 750 (764)
+..+.++++.|++.++.
T Consensus 254 ~~~l~~li~~~l~~~p~ 270 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPA 270 (298)
T ss_dssp CHHHHHHHHHHTCSSGG
T ss_pred hHHHHHHHHHHccCChh
Confidence 88999999999998733
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=331.20 Aligned_cols=233 Identities=24% Similarity=0.395 Sum_probs=189.1
Q ss_pred hcCCcce-eeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKY-CIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
+++.+.+ .||+|+||.||+|.++ ++..||||++....... ..+.+.+|++++++++||||+++++++.. +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 4455555 7999999999999753 46679999997654332 24788999999999999999999999976 5589
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++|+|.+++... ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999999643 345899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcH
Q 004268 664 HPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDL 735 (764)
Q Consensus 664 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~ 735 (764)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. .......++..+.
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 433221 122345688999999999999999999999999999998 99999876653321 2233344566789
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
.+.++++.||+.+
T Consensus 567 ~l~~li~~cl~~d 579 (613)
T 2ozo_A 567 ELYALMSDCWIYK 579 (613)
T ss_dssp HHHHHHHHTTCSS
T ss_pred HHHHHHHHHcCCC
Confidence 9999999999877
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.78 Aligned_cols=211 Identities=23% Similarity=0.316 Sum_probs=163.2
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN 579 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 579 (764)
.......++|++.+.||+|+||+||+|++. +|+.||+|++....... ....+|++.++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 445667899999999999999999999865 78999999986654332 4556778888999999999999998653
Q ss_pred C-------EEEEEEEecCCCCHHHHHh-cCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CC
Q 004268 580 K-------CMFLIYEYMERGSLFCVLR-NDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NL 650 (764)
Q Consensus 580 ~-------~~~lv~e~~~~~~L~~~l~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~ 650 (764)
+ ..++||||++++ +...+. .......+++..+..++.|++.|+.|||.. ++||+||||||+||+++. ++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 3 388999999874 444332 222445688899999999999999999943 679999999999999996 89
Q ss_pred CEEEeeeccccccCCCCCCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 651 EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
.+||+|||++........ .....||+.|+|||++.+.. ++.++||||+||++|+|++|+.||.+...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp EEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999999999987654332 33457899999999987654 89999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.89 Aligned_cols=239 Identities=27% Similarity=0.383 Sum_probs=184.8
Q ss_pred CHHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc--CCCceeeEeeEE
Q 004268 499 TFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI--RHRNIVKLYGFC 576 (764)
Q Consensus 499 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~ 576 (764)
+........++|++.+.||+|+||+||+|++. ++.||+|++.... .....+|.+++... +||||+++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 33444456789999999999999999999886 8999999985432 13445566666554 899999999999
Q ss_pred eeC----CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC--------CcEEcCCCCCCe
Q 004268 577 LHN----KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP--------SIVHRDISSNNI 644 (764)
Q Consensus 577 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~--------~iiH~Dlkp~NI 644 (764)
... ...++||||+++|+|.++++.. .+++..+..++.|++.||+||| ++ ||+||||||+||
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGE
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHE
Confidence 887 7899999999999999999642 5899999999999999999999 77 999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCC----ceecccccccccccccccCCCCcc------chHHHHHHHHHHHHhC-----
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSN----RTLVVGTYGYIAPELAYTMAVTEK------CDVYSFGVVALEVLMG----- 709 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~DiwslG~il~~lltg----- 709 (764)
+++.++.+||+|||.+......... .....||+.|+|||++.+..++.+ +||||+||++|||+||
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 9999999999999999776433222 123578999999999988776665 9999999999999999
Q ss_pred -----CCCCCcccccccc---------cCCcCCCCC------CCcHHHHHHHhhhhccchhh
Q 004268 710 -----SHPTDLLSSLSSS---------SGRKISQNP------RLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 710 -----~~Pf~~~~~~~~~---------~~~~~~~~~------~~~~~~~~~~~~~l~~~~~~ 751 (764)
+.||......... ........+ ..+..+.+++++|++.++.-
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 315 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315 (337)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred ccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhh
Confidence 6677654322110 001111111 23445778899999877433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.86 Aligned_cols=229 Identities=20% Similarity=0.256 Sum_probs=187.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECC---------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceee------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS---------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVK------ 571 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~------ 571 (764)
.++|++.+.||+|+||+||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999998653 789999998754 35678999999999999887
Q ss_pred ---------EeeEEee-CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCC
Q 004268 572 ---------LYGFCLH-NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISS 641 (764)
Q Consensus 572 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp 641 (764)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.||+.||+||| ++||+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence 5677766 77899999999 89999999853 2356999999999999999999999 88999999999
Q ss_pred CCeeecCCC--CEEEeeeccccccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 004268 642 NNILLNSNL--EAFVADFGLARLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712 (764)
Q Consensus 642 ~NIll~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P 712 (764)
+||+++.++ .+||+|||+++....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999988 999999999987643221 12334789999999999999999999999999999999999999
Q ss_pred CCccccccccc----C------C----cCCCCCCCcHHHHHHHhhhhccc
Q 004268 713 TDLLSSLSSSS----G------R----KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 713 f~~~~~~~~~~----~------~----~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
|.......... . . .......++..+.++++.|++.+
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 98764211000 0 0 00011246889999999999877
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.66 Aligned_cols=229 Identities=28% Similarity=0.395 Sum_probs=187.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE---
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM--- 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--- 582 (764)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 578999999999999999999865 789999999976543 344467888999999999999999999999877654
Q ss_pred ---EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 583 ---FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 583 ---~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
++||||++ ++|.+++.. .+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 588877642 3889999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------------- 724 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------------- 724 (764)
++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 191 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 191 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp C-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9865432 234578999999999887 6789999999999999999999999987543111000
Q ss_pred --------------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 725 --------------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 --------------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
......+..+..+.+++++|++.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 311 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSC
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCC
Confidence 001113456889999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.30 Aligned_cols=202 Identities=27% Similarity=0.440 Sum_probs=157.5
Q ss_pred hhcCCc-ceeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CC
Q 004268 507 TEDFHI-KYCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NK 580 (764)
Q Consensus 507 ~~~y~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~ 580 (764)
.+.|.+ .+.||+|+||+||+|+++ +++.||+|++...... ..+.+|++++++++||||+++++++.. ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 456776 457999999999999865 5789999999765443 567899999999999999999999954 67
Q ss_pred EEEEEEEecCCCCHHHHHhcCc------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee----cCCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL----NSNL 650 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~ 650 (764)
..++||||+++ +|.+++.... ....+++..++.++.||+.||+||| ++||+||||||+||++ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 7877775321 2224899999999999999999999 8999999999999999 6788
Q ss_pred CEEEeeeccccccCCCC---CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 651 EAFVADFGLARLLHPDS---SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.+||+|||+++...... ......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999998765322 222346789999999998874 58999999999999999999999997544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.29 Aligned_cols=235 Identities=19% Similarity=0.214 Sum_probs=183.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHH--------HHHHHHHHHHHHHhcCCCceeeEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPA--------FLESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
.++|++.+.||+|+||+||+|... ++..||+|++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999865 5788999998765432111 0123567888899999999999999
Q ss_pred EEee----CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC
Q 004268 575 FCLH----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL 650 (764)
Q Consensus 575 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~ 650 (764)
++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||+||| ++||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence 9988 77899999999 89999998743 37899999999999999999999 88999999999999999877
Q ss_pred --CEEEeeeccccccCCCC-------CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 004268 651 --EAFVADFGLARLLHPDS-------SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS 721 (764)
Q Consensus 651 --~~kl~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~ 721 (764)
.+||+|||+++.+.... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998764321 112345789999999999999999999999999999999999999965322110
Q ss_pred c----cCCc----------CCCCCCCcHHHHHHHhhhhccc
Q 004268 722 S----SGRK----------ISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 ~----~~~~----------~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
. .... .......+..+.++++.|++.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 309 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLA 309 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCC
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcC
Confidence 0 0000 0011267789999999999877
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.44 Aligned_cols=232 Identities=26% Similarity=0.391 Sum_probs=189.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... .......+.+|++++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 578999999999999999999865 78999999996543 334456788999999999999999999988764 6
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..++||||++ ++|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.+
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 7999999998 589988864 35899999999999999999999 889999999999999999999999999999
Q ss_pred cccCCCCCC----------ceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------
Q 004268 661 RLLHPDSSN----------RTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------ 723 (764)
Q Consensus 661 ~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------ 723 (764)
......... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876432211 122468999999998764 678999999999999999999999998754211000
Q ss_pred --------C---------------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 --------G---------------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 --------~---------------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
. ......+.++..+.+++++|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 0 000112467889999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.94 Aligned_cols=236 Identities=26% Similarity=0.350 Sum_probs=189.8
Q ss_pred HhhcCCcceeeeecCceeEEEEEE--CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEe---
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL--SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCL--- 577 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~--- 577 (764)
..++|++.+.||+|+||+||+|++ .+|+.||+|++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 458899999999999999999987 3688999999865432211 013455777777766 8999999999987
Q ss_pred --eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEe
Q 004268 578 --HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVA 655 (764)
Q Consensus 578 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 655 (764)
.....++||||++ ++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence 5567999999998 5999998754 2335899999999999999999999 8899999999999999999999999
Q ss_pred eeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------------
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------------ 723 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------------ 723 (764)
|||.+...... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+........
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99999765422 22334578999999999999999999999999999999999999998654321100
Q ss_pred ------------------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 ------------------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ------------------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+.++..+.+++++|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC
Confidence 0001123557888999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.22 Aligned_cols=199 Identities=24% Similarity=0.336 Sum_probs=170.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--------CCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--------HRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~ 577 (764)
.++|++.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 578999999999999999999754 7889999998643 234577889999999995 788999999987
Q ss_pred ----eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCC--
Q 004268 578 ----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNL-- 650 (764)
Q Consensus 578 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~-- 650 (764)
.....++||||+. +++.+.+... ....+++..++.++.||+.||+||| ++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence 5567999999995 5666665432 2345899999999999999999999 87 999999999999999775
Q ss_pred -----------------------------------------------CEEEeeeccccccCCCCCCceeccccccccccc
Q 004268 651 -----------------------------------------------EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683 (764)
Q Consensus 651 -----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE 683 (764)
.+||+|||.+...... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876432 23357899999999
Q ss_pred ccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 684 LAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 684 ~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
++.+..++.++||||+||++|+|++|+.||...+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.80 Aligned_cols=234 Identities=23% Similarity=0.380 Sum_probs=188.3
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEeeEEeeCCEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~ 583 (764)
..++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+.+|++++++++ ||||+++++++...+..+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 45789999999999999999999888999999999765443 344578899999999997 599999999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||| +.+++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||++++ +.+||+|||.+...
T Consensus 105 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 567899999974 346889999999999999999999 889999999999999965 89999999999876
Q ss_pred CCCCC--Cceeccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccC
Q 004268 664 HPDSS--NRTLVVGTYGYIAPELAYT-----------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSG 724 (764)
Q Consensus 664 ~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~ 724 (764)
..... ......|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||........ ...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 43322 1234578999999999875 4688899999999999999999999986533110 111
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.....+...+..+.++++.|++.+
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~d 280 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRD 280 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSS
T ss_pred cccCCcccchHHHHHHHHHHccCC
Confidence 122233445788999999999977
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.36 Aligned_cols=230 Identities=23% Similarity=0.344 Sum_probs=164.6
Q ss_pred HhhcCCcce-eeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----C
Q 004268 506 ATEDFHIKY-CIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----N 579 (764)
Q Consensus 506 ~~~~y~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 579 (764)
..++|.+.+ .||+|+||+||+|.+. +++.||+|++.... ....+....++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 468899965 6999999999999866 79999999986421 122223334566799999999999876 4
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVAD 656 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 656 (764)
...++||||+++|+|.+++... ....+++..++.++.|++.||+||| ++||+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 5689999999999999999854 2346899999999999999999999 889999999999999986 45599999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------C----C
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------G----R 725 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~----~ 725 (764)
||.+...... ......+++.|+|||++.+..++.++||||+|+++|+|++|+.||.......... . .
T Consensus 175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999865432 2234578999999999988889999999999999999999999997665432210 0 0
Q ss_pred cCCCCCCCcHHHHHHHhhhhccc
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......++..+.++++.|++.+
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~d 275 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTD 275 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSS
T ss_pred CchhhccCCHHHHHHHHHHCCCC
Confidence 11112457889999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.36 Aligned_cols=235 Identities=23% Similarity=0.297 Sum_probs=169.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHH-HHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||.||+|... +|+.||+|++...... .....+..|+. +++.++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 478999999999999999999875 7899999999765432 22345556665 6677799999999999999999999
Q ss_pred EEEecCCCCHHHHHhcC--ccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRND--VEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
||||+++ +|.+++... .....+++..+..++.|++.||.||| +. ||+||||||+||+++.++.+||+|||.+.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999986 787777531 12456899999999999999999999 77 99999999999999999999999999998
Q ss_pred ccCCCCCCceeccccccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-ccC---CcC-----C
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELA----YTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-SSG---RKI-----S 728 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-~~~---~~~-----~ 728 (764)
...... ......|++.|+|||++ .+..++.++||||+|+++|+|++|+.||........ ... ... .
T Consensus 175 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 175 QLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 764332 22334789999999998 466789999999999999999999999986543211 111 111 1
Q ss_pred CCCCCcHHHHHHHhhhhccc
Q 004268 729 QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ~~~~~~~~~~~~~~~~l~~~ 748 (764)
.....+..+.++++.|++.+
T Consensus 254 ~~~~~~~~l~~li~~~l~~d 273 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKD 273 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSS
T ss_pred ccccCCHHHHHHHHHHhhCC
Confidence 12346889999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.44 Aligned_cols=235 Identities=21% Similarity=0.304 Sum_probs=195.6
Q ss_pred HHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcC--CCceeeEeeEEee
Q 004268 505 EATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIR--HRNIVKLYGFCLH 578 (764)
Q Consensus 505 ~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~ 578 (764)
...++|++.+.||+|+||+||+|.+ .+++.||+|++........ ...+.+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3568899999999999999999975 4789999999876543210 01145668999999996 5999999999999
Q ss_pred CCEEEEEEEecCC-CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCEEEee
Q 004268 579 NKCMFLIYEYMER-GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEAFVAD 656 (764)
Q Consensus 579 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 656 (764)
.+..++|||++.+ ++|.+++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899999874 346889999999999999999999 89999999999999999 789999999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcH
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDL 735 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 735 (764)
||.+...... ......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||...... ..........++.
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 268 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IRGQVFFRQRVSS 268 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHCCCCCSSCCCH
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---hcccccccccCCH
Confidence 9999876532 2334578999999999887766 67899999999999999999999865432 1222334567889
Q ss_pred HHHHHHhhhhccchh
Q 004268 736 QCNAYLKNFSQGNHR 750 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~ 750 (764)
.+.+++++|++.++.
T Consensus 269 ~~~~li~~~l~~dp~ 283 (320)
T 3a99_A 269 ECQHLIRWCLALRPS 283 (320)
T ss_dssp HHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHccCChh
Confidence 999999999998733
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=305.29 Aligned_cols=231 Identities=24% Similarity=0.354 Sum_probs=183.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEe--------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCL-------- 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-------- 577 (764)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 578999999999999999999876 58999999986542 344578899999999999999999999873
Q ss_pred ------eCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCC
Q 004268 578 ------HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNL 650 (764)
Q Consensus 578 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~ 650 (764)
+....++||||++ ++|.+++.. ..+++..++.++.|++.||+||| ++||+||||||+||+++ +++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 4467899999998 599999863 35889999999999999999999 89999999999999997 567
Q ss_pred CEEEeeeccccccCCCC---CCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--
Q 004268 651 EAFVADFGLARLLHPDS---SNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-- 724 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-- 724 (764)
.+||+|||.+....... .......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.........
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998764321 12233467899999998765 6789999999999999999999999987654211100
Q ss_pred -------------------------------CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 725 -------------------------------RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 -------------------------------~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
......+.++..+.+++++|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCC
Confidence 000112457889999999999977
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=296.17 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=187.7
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee------
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------ 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------ 578 (764)
..++|++.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4678999999999999999999864 7999999998542 3345788999999999999999999998765
Q ss_pred -------CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC
Q 004268 579 -------NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE 651 (764)
Q Consensus 579 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~ 651 (764)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+||| ++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence 45689999999999999999753 345788899999999999999999 889999999999999999999
Q ss_pred EEEeeeccccccCCCC--------------CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 652 AFVADFGLARLLHPDS--------------SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 652 ~kl~Dfg~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
+||+|||.+....... .......|++.|+|||++.+. .++.++||||+|+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999998654221 122345689999999998865 68999999999999999998 55432
Q ss_pred cc-cc---cccCC----cCCCCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 717 SS-LS---SSSGR----KISQNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 717 ~~-~~---~~~~~----~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.. .. ..... ........+..+.++++.|++.++.-| .......||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 11 10 01111 111223456678999999999884433 444445555
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.75 Aligned_cols=229 Identities=28% Similarity=0.386 Sum_probs=187.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC---- 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---- 581 (764)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999865 789999999976543 34445788899999999999999999999987653
Q ss_pred --EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 582 --MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 582 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.++||||++ ++|.+++.. .+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 599999998 588777642 3889999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---------------- 722 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---------------- 722 (764)
+...... .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.+..+..
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9765422 234578999999999887 67899999999999999999999999875431100
Q ss_pred ------------------cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 ------------------SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ------------------~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+..+..+.+++++|++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 293 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCC
Confidence 00011223467889999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.53 Aligned_cols=200 Identities=22% Similarity=0.410 Sum_probs=174.0
Q ss_pred hhcCCcceeeeecCceeEEEEEE-C-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCC------ceeeEeeEEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-S-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR------NIVKLYGFCLH 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~ 578 (764)
.++|++.+.||+|+||+||+|.+ . +++.||+|++... ....+.+.+|+++++.++|+ +++++++++.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 57899999999999999999976 3 6889999998643 23457788999999998765 49999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC----------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---------- 648 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---------- 648 (764)
.+..++||||+ +++|.+++... ....+++..+..++.||+.||+||| ++||+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 78999998754 2345889999999999999999999 899999999999999987
Q ss_pred ---------CCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 649 ---------NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 649 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...+.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865432 2345789999999999999999999999999999999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.28 Aligned_cols=227 Identities=25% Similarity=0.400 Sum_probs=185.9
Q ss_pred eeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 514 YCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
+.||+|+||+||+|.+. .++.||||++...... ....+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999542 5678999999765432 2334789999999999999999999999965 45889999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC--
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS-- 668 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 668 (764)
+|+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.......
T Consensus 453 ~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999973 346899999999999999999999 89999999999999999999999999999987654322
Q ss_pred -CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcHHHHHHHh
Q 004268 669 -NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 669 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 742 (764)
......+++.|+|||++.+..++.++||||+||++|||++ |+.||.+....+. ........+...+..+.++++
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1223456788999999999999999999999999999998 9999987765322 122233445567889999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
.||+.+
T Consensus 607 ~cl~~d 612 (635)
T 4fl3_A 607 LCWTYD 612 (635)
T ss_dssp HHTCSS
T ss_pred HHcCCC
Confidence 999877
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=318.97 Aligned_cols=231 Identities=19% Similarity=0.293 Sum_probs=191.2
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-CceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+++++.++| ++++.+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 47899999999999999999986 57999999988765543 457789999999976 667777777888889999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee---cCCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfg~~~ 661 (764)
||||+ +++|.+++... ...+++..++.|+.||+.||+||| ++||+||||||+|||+ +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 88999999742 346899999999999999999999 8999999999999999 688999999999998
Q ss_pred ccCCCCCC-------ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC----------
Q 004268 662 LLHPDSSN-------RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---------- 724 (764)
Q Consensus 662 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---------- 724 (764)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 76543321 1246799999999999999999999999999999999999999987654211100
Q ss_pred -CcCCCCCCCcHHHHHHHhhhhccc
Q 004268 725 -RKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 725 -~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........++..+.++++.|++.+
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLR 259 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCC
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCC
Confidence 001112456788999999999877
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=303.84 Aligned_cols=235 Identities=21% Similarity=0.307 Sum_probs=186.5
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhc----CCCceeeEee
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEP---AFLESFQTEARLLSQI----RHRNIVKLYG 574 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hpniv~~~~ 574 (764)
.....++|++.+.||+|+||.||+|.+ .+++.||+|++........ .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344578899999999999999999976 4789999999976544321 1123456799999999 8999999999
Q ss_pred EEeeCCEEEEEEEe-cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec-CCCCE
Q 004268 575 FCLHNKCMFLIYEY-MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN-SNLEA 652 (764)
Q Consensus 575 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~ 652 (764)
++...+..++|||+ +.+++|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 788999999974 345899999999999999999999 88999999999999999 88999
Q ss_pred EEeeeccccccCCCCCCceecccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCC
Q 004268 653 FVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVT-EKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNP 731 (764)
Q Consensus 653 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~ 731 (764)
||+|||.+...... ......|++.|+|||++.+..+. .++||||+|+++|+|++|+.||....... ........
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 254 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---EAELHFPA 254 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---HTCCCCCT
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---hhccCCcc
Confidence 99999999876532 23345789999999998877664 58999999999999999999998654321 22233456
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
.++..+.+++++|++.+
T Consensus 255 ~~~~~~~~li~~~l~~~ 271 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPK 271 (312)
T ss_dssp TSCHHHHHHHHHHTCSS
T ss_pred cCCHHHHHHHHHHccCC
Confidence 67899999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.50 Aligned_cols=237 Identities=25% Similarity=0.388 Sum_probs=193.3
Q ss_pred hhcCCcceeeeecCceeEEEEEE-----CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-----SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 580 (764)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 56799999999999999999973 368899999987643 233578899999999999999999999987654
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
..++||||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 689999999999999999753 245899999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-----------------
Q 004268 660 ARLLHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL----------------- 719 (764)
Q Consensus 660 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~----------------- 719 (764)
+......... .....++..|+|||++.+..++.++||||+|+++|+|+||..||......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9876543321 12235677899999999888999999999999999999999998743210
Q ss_pred --cc-ccCCcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 720 --SS-SSGRKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 720 --~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.. ........++..+..+.+++++|++.++.-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 306 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhh
Confidence 00 011122335567889999999999877433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.44 Aligned_cols=194 Identities=28% Similarity=0.488 Sum_probs=159.6
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHH--HHhcCCCceeeEeeEEee-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARL--LSQIRHRNIVKLYGFCLH-----N 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~-----~ 579 (764)
.++|++.+.||+|+||+||+|+. +++.||+|++..... ..+..|.++ +..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 57899999999999999999977 589999999864321 334444444 445799999999985542 3
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC---------CcEEcCCCCCCeeecCCC
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP---------SIVHRDISSNNILLNSNL 650 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~---------~iiH~Dlkp~NIll~~~~ 650 (764)
..+++||||+++|+|.+++... ..++..+..++.||+.||+||| ++ ||+||||||+||+++.++
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 3679999999999999999643 3588899999999999999999 88 999999999999999999
Q ss_pred CEEEeeeccccccCCCC--------CCceeccccccccccccccc-------CCCCccchHHHHHHHHHHHHhCCCCCC
Q 004268 651 EAFVADFGLARLLHPDS--------SNRTLVVGTYGYIAPELAYT-------MAVTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 651 ~~kl~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
.+||+|||++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|..||.
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999998764321 11223578999999999887 456779999999999999999977754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.81 Aligned_cols=231 Identities=23% Similarity=0.351 Sum_probs=175.1
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.|.+.+.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..|+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 4566678899999999988777789999999986532 25677999999887 8999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccc----cCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC-------------
Q 004268 587 EYMERGSLFCVLRNDVEAVE----LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN------------- 649 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------------- 649 (764)
||++ |+|.+++........ .++..+..++.||+.||+||| ++||+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 599999975422111 123345789999999999999 8899999999999999754
Q ss_pred CCEEEeeeccccccCCCCCC----ceeccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCccc
Q 004268 650 LEAFVADFGLARLLHPDSSN----RTLVVGTYGYIAPELAYT-------MAVTEKCDVYSFGVVALEVLM-GSHPTDLLS 717 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~llt-g~~Pf~~~~ 717 (764)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++||||+||++|||+| |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999877543221 234579999999999876 568999999999999999999 999997653
Q ss_pred cccccc--C-CcCC-----CCCCCcHHHHHHHhhhhccc
Q 004268 718 SLSSSS--G-RKIS-----QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 718 ~~~~~~--~-~~~~-----~~~~~~~~~~~~~~~~l~~~ 748 (764)
...... . .... ..+.++..+.+++++|++.+
T Consensus 245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (434)
T 2rio_A 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283 (434)
T ss_dssp THHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSS
T ss_pred hhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCC
Confidence 321110 0 0111 11224578899999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.92 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=173.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CC-----ceeeEeeEEee
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HR-----NIVKLYGFCLH 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~~~ 578 (764)
..++|++.+.||+|+||+||+|... +++.||+|++... ......+.+|+++++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 4689999999999999999999865 7889999998743 233467788999988884 44 49999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCCCEEEee
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNLEAFVAD 656 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~D 656 (764)
.+..++||||+++ +|.+++... ....+++..++.++.|++.||.|||.. +.||+||||||+||+++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999975 999998754 234589999999999999999999932 46999999999999995 578899999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
||+++..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876432 2345789999999999999999999999999999999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.45 Aligned_cols=231 Identities=23% Similarity=0.324 Sum_probs=176.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 585 (764)
..+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....|+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 356999999999999997766666799999999876443 2345899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-----CCCEEEeeeccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-----NLEAFVADFGLA 660 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~~ 660 (764)
|||++ |+|.+++.... ....+..+..++.||+.||+||| ++||+||||||+||+++. ...+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99997 59999997532 23444556789999999999999 899999999999999953 336889999999
Q ss_pred cccCCCC---CCceecccccccccccccc---cCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccC------CcC
Q 004268 661 RLLHPDS---SNRTLVVGTYGYIAPELAY---TMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSG------RKI 727 (764)
Q Consensus 661 ~~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~~------~~~ 727 (764)
+...... .......||+.|+|||++. +..++.++||||+||++|+|++ |..||........... ...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence 8765332 2233467999999999987 4567889999999999999999 9999975443211111 111
Q ss_pred CCCCCCcHHHHHHHhhhhccch
Q 004268 728 SQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 728 ~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
......+..+.+++++|++.++
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSG
T ss_pred CccccccHHHHHHHHHHHhCCH
Confidence 1112234567899999999883
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.73 Aligned_cols=377 Identities=21% Similarity=0.159 Sum_probs=255.7
Q ss_pred CCCeeEEEeCCCCccccCCcc-ccCCCCCcEEEcCCCcCccc----CCccccCCCCCCEEEccCCcCcccCCcc-cCCCC
Q 004268 18 FPNLVTFRIWGTLLSGRMPSE-IGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTGTIPSE-IGSLR 91 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~-~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~ 91 (764)
+|+|+.|++++|.++...... +..+++|++|+|++|.+++. ++..+..+++|++|+|++|.++...+.. +..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 467888999998887554333 77788899999999988742 4566777888999999998887543322 23344
Q ss_pred ----CCCEEecCCCcccc----cCCccCcCCCCCCEEEccCCcCcccCCcccc-----CCCCcCEEecccCcccccC---
Q 004268 92 ----DLLDLNLSNNILNG----SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIG-----NLTNLTYLDLSLNQLSGRL--- 155 (764)
Q Consensus 92 ----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~--- 155 (764)
+|++|+|++|.++. ..+..|..+++|++|+|++|.++...+..+. .+++|++|+|++|+++...
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 68899999998884 3467788888899999998888754333322 3567888888888887543
Q ss_pred -CccccCCCCCCeeecccCCCCCCCCCccc-----cCCCccEEEecCccCcCCc----ccccCCccccceeeccCccccc
Q 004268 156 -PQEVGNLKNLKSLFLDNNHLSGPIPSTLY-----HLNQLATLCLGYNKLVGPV----TKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 156 -~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-----~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
+..+..+++|++|++++|.+++.....+. ..++|++|++++|.+.... +..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 45566678888888888887643333332 2558888888888887643 4455667888888888888765
Q ss_pred cc-----CccccCCCCCCEEEccCCcccCC----CCcCCcCCCCCCeEEccCCcccCCCCccccC-----CCCCCeEecc
Q 004268 226 SI-----PSTIGYLNLLDELHLSHNRLDGP----IPPTIGNLTNLIALDLSSNQLSGLLPREVGN-----LKYLASLSLN 291 (764)
Q Consensus 226 ~~-----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-----l~~L~~L~l~ 291 (764)
.. +..+..+++|+.|++++|.+++. .+..+..+++|+.|+|++|.+++..+..+.. .++|+.|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 32 22233567888888888877753 3455666788888888888876443333332 3578888888
Q ss_pred CccccCC----CCCCCCCCCccceEEccCCcCccCCChhhhc-----ccccceeecccccccc----CCchhcccccccc
Q 004268 292 GNILIGP----IPPTIGYLTNLTYLNLGYNRLSSSIPPELMN-----CSQLLNLVLSHNSLSG----SIPSEIGNLIFFR 358 (764)
Q Consensus 292 ~n~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~ 358 (764)
+|.+++. .+..+..+++|++|+|++|++++..+..+.. .++|++|+|++|++++ .++..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 8877654 2334556678888888888777544444433 5678888888888775 5666777777888
Q ss_pred eeecccccccCCCCCC----C-CCCCccceecCCCCccccc
Q 004268 359 QLDLSRNFINGTIPSQ----L-GKIPNISAVDLSKNNLSGV 394 (764)
Q Consensus 359 ~L~l~~N~l~~~~~~~----~-~~l~~L~~l~l~~N~l~~~ 394 (764)
.|+|++|++++..... + ....+|+.|++.++.+...
T Consensus 402 ~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~ 442 (461)
T 1z7x_W 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442 (461)
T ss_dssp EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred EEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHH
Confidence 8888888776431111 1 1123455555555555543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.29 Aligned_cols=204 Identities=30% Similarity=0.422 Sum_probs=175.2
Q ss_pred HhhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee------
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------ 578 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------ 578 (764)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++.... .....+.+.+|++++++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 358899999999999999999976 478999999987643 33445788999999999999999999998765
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCC---EEEe
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVA 655 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~ 655 (764)
.+..++||||+++++|.+++........+++..++.++.|++.||+||| ++||+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 6678999999999999999986555556889999999999999999999 889999999999999997665 9999
Q ss_pred eeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
|||.+....... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999998765433 23446789999999999999999999999999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=324.30 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=193.8
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC 581 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 581 (764)
..++|++.+.||+|+||+||+|.+. .+..||+|.+..... ....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 3578999999999999999999764 245799999865432 3445788999999999999999999999854 56
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||+++|+|.++++.. ...+++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 89999999999999999743 335889999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcH
Q 004268 662 LLHPDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDL 735 (764)
Q Consensus 662 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~ 735 (764)
........ .....+++.|+|||++.+..++.++||||+|+++|||++ |..||.+....+.. .......++..+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 76433221 223456789999999999999999999999999999997 99999876543221 1223334566788
Q ss_pred HHHHHHhhhhccchhhH
Q 004268 736 QCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~ 752 (764)
.+.+++.+|++.++.-|
T Consensus 620 ~l~~li~~~l~~dP~~R 636 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRR 636 (656)
T ss_dssp HHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHcCCChhHC
Confidence 99999999999874433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.02 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=190.4
Q ss_pred ccCHHHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHh--cCCCceeeEee
Q 004268 497 RITFEEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ--IRHRNIVKLYG 574 (764)
Q Consensus 497 ~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~ 574 (764)
..+........++|++.+.||+|+||+||+|.+. ++.||+|++.... ...+.+|.++++. ++||||+++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 3344444556789999999999999999999885 8999999986432 2567789999988 68999999999
Q ss_pred EEeeCC----EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCee
Q 004268 575 FCLHNK----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD-----CKPSIVHRDISSNNIL 645 (764)
Q Consensus 575 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIl 645 (764)
++.... ..++||||+++|+|.+++.+. .+++..+..++.|++.||+|||.. +++||+||||||+||+
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEE
Confidence 998876 799999999999999999642 588999999999999999999932 1469999999999999
Q ss_pred ecCCCCEEEeeeccccccCCCCCC----ceecccccccccccccccCC------CCccchHHHHHHHHHHHHhC------
Q 004268 646 LNSNLEAFVADFGLARLLHPDSSN----RTLVVGTYGYIAPELAYTMA------VTEKCDVYSFGVVALEVLMG------ 709 (764)
Q Consensus 646 l~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~~lltg------ 709 (764)
++.++.+||+|||.+......... .....|++.|+|||++.+.. ++.++||||+|+++|+|+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876543321 23357899999999987762 34689999999999999999
Q ss_pred ----CCCCCccccccccc------CCcCCCCCCC---------cHHHHHHHhhhhccchh
Q 004268 710 ----SHPTDLLSSLSSSS------GRKISQNPRL---------DLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 710 ----~~Pf~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~~~~ 750 (764)
+.||.......... .......+.+ +..+.+++++|++.++.
T Consensus 260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319 (342)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChh
Confidence 78887654321100 0011112222 24667888888887733
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=342.32 Aligned_cols=371 Identities=22% Similarity=0.193 Sum_probs=294.4
Q ss_pred CCCCcEEEcCCCcCcccCCcc-ccCCCCCCEEEccCCcCcc----cCCcccCCCCCCCEEecCCCcccccCCccC-cCCC
Q 004268 42 LSKLEKLVLSHNSLTGRIPSE-IGALSRLKVLDLSYNRLTG----TIPSEIGSLRDLLDLNLSNNILNGSIPLEF-GNLK 115 (764)
Q Consensus 42 l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~ 115 (764)
+++|++|+|++|++++..... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 357899999999998654333 7889999999999999984 346778889999999999999986444333 3455
Q ss_pred ----CCCEEEccCCcCcc----cCCccccCCCCcCEEecccCcccccCCccc-----cCCCCCCeeecccCCCCCCC---
Q 004268 116 ----DLDQLRLQGNKLDG----LIPSSIGNLTNLTYLDLSLNQLSGRLPQEV-----GNLKNLKSLFLDNNHLSGPI--- 179 (764)
Q Consensus 116 ----~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~i~~~~--- 179 (764)
+|++|+|++|.++. ..+..+..+++|++|+|++|.+++..+..+ ...++|++|++++|.+++..
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 79999999999985 347789999999999999999975544433 23678999999999998643
Q ss_pred -CCccccCCCccEEEecCccCcCCcccccC-----CccccceeeccCcccccc----cCccccCCCCCCEEEccCCcccC
Q 004268 180 -PSTLYHLNQLATLCLGYNKLVGPVTKEVG-----NMKNLDRLHLNGNNLTGS----IPSTIGYLNLLDELHLSHNRLDG 249 (764)
Q Consensus 180 -~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~ 249 (764)
+..+..+++|++|++++|.+.......+. ..++|++|++++|.+++. .+..+..+++|++|++++|.+++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 45567789999999999998765444443 356999999999999864 46677889999999999999875
Q ss_pred CC-----CcCCcCCCCCCeEEccCCcccCC----CCccccCCCCCCeEeccCccccCCCCCCCC-----CCCccceEEcc
Q 004268 250 PI-----PPTIGNLTNLIALDLSSNQLSGL----LPREVGNLKYLASLSLNGNILIGPIPPTIG-----YLTNLTYLNLG 315 (764)
Q Consensus 250 ~~-----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~ls 315 (764)
.. +..+..+++|+.|++++|.+++. .+..+..+++|++|++++|.+.+..+..+. ..++|++|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 42 23334689999999999999854 456677899999999999998654333332 23699999999
Q ss_pred CCcCccC----CChhhhcccccceeeccccccccCCchhccc-----ccccceeecccccccC----CCCCCCCCCCccc
Q 004268 316 YNRLSSS----IPPELMNCSQLLNLVLSHNSLSGSIPSEIGN-----LIFFRQLDLSRNFING----TIPSQLGKIPNIS 382 (764)
Q Consensus 316 ~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~ 382 (764)
+|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|+.|+|++|++++ .++..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 9999865 4566778899999999999999766665543 6799999999999986 6788888899999
Q ss_pred eecCCCCccccc--------cCCccccCccccccCCCC
Q 004268 383 AVDLSKNNLSGV--------IPASVRRIPKLIVSENNL 412 (764)
Q Consensus 383 ~l~l~~N~l~~~--------~~~~~~~~~~~~~~~n~~ 412 (764)
.|++++|+++.. +|.....++.+.+.++..
T Consensus 402 ~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~ 439 (461)
T 1z7x_W 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439 (461)
T ss_dssp EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred EEECCCCCCCHHHHHHHHHHhccCCcchhheeeccccc
Confidence 999999999854 444455677776655544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.35 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=171.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CC-CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc------eeeEeeEEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SG-KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN------IVKLYGFCLH 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~ 578 (764)
.++|++.+.||+|+||+||+|... ++ +.||+|++... ....+.+.+|++++++++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 578999999999999999999864 44 68999998643 233477889999999997665 9999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeee------------
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILL------------ 646 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll------------ 646 (764)
.+..++||||+ ++++.+++... ....+++..+..++.||+.||+||| ++||+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 55676776543 2345899999999999999999999 9999999999999999
Q ss_pred -------cCCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 004268 647 -------NSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 647 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~ 718 (764)
+.++.+||+|||.+...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999865432 2345789999999999999999999999999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.04 Aligned_cols=199 Identities=21% Similarity=0.355 Sum_probs=168.9
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-----------CCceeeEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-----------HRNIVKLYG 574 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~ 574 (764)
.++|++.+.||+|+||+||+|.+ .+++.||+|++.... ...+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 47899999999999999999986 478999999986432 23467889999999886 899999999
Q ss_pred EEeeCC----EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeec--
Q 004268 575 FCLHNK----CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLN-- 647 (764)
Q Consensus 575 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~-- 647 (764)
++...+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+||| ++ ||+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence 988654 789999999 88999999753 2345899999999999999999999 87 999999999999995
Q ss_pred ----CCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 648 ----SNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 648 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
..+.+||+|||.+...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999876432 233578999999999999999999999999999999999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.07 Aligned_cols=211 Identities=13% Similarity=0.108 Sum_probs=177.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.+. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 478999999999999999999875 5899999999887766666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++|++|.++++.. ....++..++.|++.||+||| ++||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999632 345678899999999999999 8999999999999999999999998543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CC-cC------CCCCCCcH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GR-KI------SQNPRLDL 735 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~-~~------~~~~~~~~ 735 (764)
|++ .++.++||||+||++|+|+||+.||.+.+...... .. .. ...+.++.
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence 223 36789999999999999999999999776543221 11 11 12356788
Q ss_pred HHHHHHhhhhccchhhH
Q 004268 736 QCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~ 752 (764)
.+.+++.+|++.+..-|
T Consensus 235 ~l~~li~~~l~~dP~~R 251 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR 251 (286)
T ss_dssp HHHHHHHHHHCTTSSCC
T ss_pred HHHHHHHHHcccCCccC
Confidence 99999999998774433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.97 Aligned_cols=234 Identities=21% Similarity=0.311 Sum_probs=172.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|.+. +|+.||+|++....... ...+.+..+..+++.++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 578999999999999999999875 79999999997654332 2234455555678888999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+ ++.+..+... ....+++..+..++.|++.||+||| ++ ||+||||||+||+++.++.+||+|||.+....
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4566555542 2346899999999999999999999 74 99999999999999999999999999997664
Q ss_pred CCCCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-c------ccCCcCCCCCC
Q 004268 665 PDSSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS-S------SSGRKISQNPR 732 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~-~------~~~~~~~~~~~ 732 (764)
... ......+++.|+|||++. +..++.++||||+|+++|+|++|+.||....... . ...........
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 332 223457899999999984 5568899999999999999999999998643211 0 01111222335
Q ss_pred CcHHHHHHHhhhhccc
Q 004268 733 LDLQCNAYLKNFSQGN 748 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~ 748 (764)
++..+.++++.|++.+
T Consensus 256 ~~~~l~~li~~~l~~d 271 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKD 271 (318)
T ss_dssp CCHHHHHHHHHHTCSC
T ss_pred CCHHHHHHHHHHccCC
Confidence 7889999999999877
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=304.73 Aligned_cols=235 Identities=22% Similarity=0.358 Sum_probs=186.8
Q ss_pred HhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
..++|++.+.||+|+||+||+|.... .||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 46789999999999999999998753 49999987644322 1125577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999743 345889999999999999999999 88999999999999998 67999999999875432
Q ss_pred C-----CCCceeccccccccccccccc---------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCc
Q 004268 666 D-----SSNRTLVVGTYGYIAPELAYT---------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRK 726 (764)
Q Consensus 666 ~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~ 726 (764)
. ........|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||.......... ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 1 122233568999999999875 357889999999999999999999998765432111 111
Q ss_pred CCCCCCCcHHHHHHHhhhhccch
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
.......+..+.++++.|++.++
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p 284 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQ 284 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSST
T ss_pred CCCcCCCCHHHHHHHHHHhcCCh
Confidence 11223467889999999998773
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.32 Aligned_cols=229 Identities=16% Similarity=0.178 Sum_probs=178.9
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC-----cHHHHHHHHHHHHHHHhcC---------CCceeeE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE-----EPAFLESFQTEARLLSQIR---------HRNIVKL 572 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hpniv~~ 572 (764)
.++|++.+.||+|+||+||+|++ +|+.||+|++...... .....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 57899999999999999999988 6899999999765432 1222367889999999986 6666666
Q ss_pred eeEE-----------------ee-------------CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHH
Q 004268 573 YGFC-----------------LH-------------NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622 (764)
Q Consensus 573 ~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~a 622 (764)
.+++ .+ .+..|+||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6543 32 6789999999999976666642 357899999999999999
Q ss_pred HHHHHhcCCCCcEEcCCCCCCeeecCCC--------------------CEEEeeeccccccCCCCCCceecccccccccc
Q 004268 623 LSYLHYDCKPSIVHRDISSNNILLNSNL--------------------EAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682 (764)
Q Consensus 623 L~~LH~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aP 682 (764)
|+|||. ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 999993 35999999999999999887 8999999999876532 35799999999
Q ss_pred cccccCCCCccchHHHHHHH-HHHHHhCCCCCCcccc----cccc---cCCcCCC----CCCCcHHHHHHHhhhhccc
Q 004268 683 ELAYTMAVTEKCDVYSFGVV-ALEVLMGSHPTDLLSS----LSSS---SGRKISQ----NPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 683 E~~~~~~~~~~~DiwslG~i-l~~lltg~~Pf~~~~~----~~~~---~~~~~~~----~~~~~~~~~~~~~~~l~~~ 748 (764)
|++.+.. +.++||||+|++ .+++++|..||..... .+.. ....... .+.++..+.+++++|++.+
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 9998776 899999998777 7889999999975311 0000 0111111 2235778999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=325.19 Aligned_cols=223 Identities=23% Similarity=0.325 Sum_probs=183.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCE---
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKC--- 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--- 581 (764)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 478999999999999999999865 68999999987543 23445778999999999999999999999987655
Q ss_pred --EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 582 --MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 582 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.|+||||+++++|.+++.. .+++..+..++.||+.||+||| ++||+||||||+||+++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887753 5899999999999999999999 8999999999999999875 999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHH
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNA 739 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (764)
++..... ....||+.|+|||++.+. ++.++||||+||++|+|++|..||.+....... ........+..+.+
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---EDDPVLKTYDSYGR 299 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---TTCHHHHHCHHHHH
T ss_pred chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---ccccccccCHHHHH
Confidence 9876533 345789999999998765 488999999999999999999998864322111 00011113467889
Q ss_pred HHhhhhccc
Q 004268 740 YLKNFSQGN 748 (764)
Q Consensus 740 ~~~~~l~~~ 748 (764)
++.+|++.+
T Consensus 300 li~~~l~~d 308 (681)
T 2pzi_A 300 LLRRAIDPD 308 (681)
T ss_dssp HHHHHTCSS
T ss_pred HHhhhccCC
Confidence 999999887
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=288.53 Aligned_cols=248 Identities=30% Similarity=0.519 Sum_probs=145.3
Q ss_pred CeeEEEeCCCCccc--cCCccccCCCCCcEEEcCC-CcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 20 NLVTFRIWGTLLSG--RMPSEIGALSKLEKLVLSH-NSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 20 ~l~~L~l~~~~~~~--~~~~~~~~l~~L~~L~Ls~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
+++.|++++|.+++ .+|+.+..+++|++|+|++ |.+++..|..|..+++|++|+|++|++++..|..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45556666665555 5555555555566666653 55555555555555555555555555555555555555555555
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCC-CcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT-NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
+|++|.+++..|..|..+++|++|+|++|++++..|..+..++ +|++|+|++|++++..|..|..++ |+.|++++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 5555555555555555555555555555555544555555554 555555555555545555555444 55555555544
Q ss_pred CCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCC
Q 004268 176 SGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255 (764)
Q Consensus 176 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 255 (764)
....+..+..+++|+.|++++|.+++..+. +..+++|++|+|++|.+++..|..|
T Consensus 210 ------------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 210 ------------------------EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp ------------------------EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ------------------------cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 444444555555555555555555544333 5556666666666666666666666
Q ss_pred cCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCcc
Q 004268 256 GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNI 294 (764)
Q Consensus 256 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 294 (764)
..+++|+.|+|++|++++..|.. ..+++|+.|++++|.
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 66777777777777776555554 666677777777776
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=288.97 Aligned_cols=249 Identities=29% Similarity=0.485 Sum_probs=161.9
Q ss_pred CCCEEEccCCcCcc--cCCccccCCCCcCEEeccc-CcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEE
Q 004268 116 DLDQLRLQGNKLDG--LIPSSIGNLTNLTYLDLSL-NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192 (764)
Q Consensus 116 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 192 (764)
+++.|+|++|.+.+ ..|..|.++++|++|+|++ |.+.+..|..|.++++|++|+|++|.+++.
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-------------- 116 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA-------------- 116 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE--------------
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc--------------
Confidence 45555555555554 4445555555555555553 555444444555555555555555544433
Q ss_pred EecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCC-CCCeEEccCCcc
Q 004268 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT-NLIALDLSSNQL 271 (764)
Q Consensus 193 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l 271 (764)
.+..|..+++|++|++++|.+++..|..+..+++|++|++++|.+++..|..+..++ +|+.|+|++|++
T Consensus 117 ----------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 117 ----------IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ----------CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred ----------CCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 344455555555555555655555566666666666666666666655666666665 677777777777
Q ss_pred cCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhc
Q 004268 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI 351 (764)
Q Consensus 272 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 351 (764)
++..|..+..+. |+.|++++|.+.+..|..+..+++|++|+|++|++++..|. +..+++|++|+|++|++++.+|..+
T Consensus 187 ~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l 264 (313)
T 1ogq_A 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGG
T ss_pred eccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHH
Confidence 666666666665 77777777777766666777777777777777777744433 6667778888888888877777778
Q ss_pred ccccccceeecccccccCCCCCCCCCCCccceecCCCCcc
Q 004268 352 GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391 (764)
Q Consensus 352 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 391 (764)
..+++|+.|+|++|++++.+|.. ..+++|+.+++++|+.
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~ 303 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSE
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCC
Confidence 88888888888888887777765 7778888888888873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=300.92 Aligned_cols=233 Identities=16% Similarity=0.183 Sum_probs=177.0
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-Cce----------------
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNI---------------- 569 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pni---------------- 569 (764)
..|...+.||+|+||+||+|.+ .+|+.||||++...........+.+.+|+.+++.++| ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4588889999999999999985 4799999999885554444445788999999999976 211
Q ss_pred -----eeEeeEEee-----CCEEEEEEEecCCCCHHHHHhc----CccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 004268 570 -----VKLYGFCLH-----NKCMFLIYEYMERGSLFCVLRN----DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIV 635 (764)
Q Consensus 570 -----v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii 635 (764)
..+..++.. ....+++|+++ +++|.++++. ......+++..+..++.||+.||+||| ++||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 111111111 12357777766 5799988842 112445788889999999999999999 89999
Q ss_pred EcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccccccccccccc----------ccCCCCccchHHHHHHHHHH
Q 004268 636 HRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA----------YTMAVTEKCDVYSFGVVALE 705 (764)
Q Consensus 636 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwslG~il~~ 705 (764)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||+||++|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999998765432 334567 999999998 56668899999999999999
Q ss_pred HHhCCCCCCcccccccccCCcCCCCCCCcHHHHHHHhhhhccch
Q 004268 706 VLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 706 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
|++|+.||.......... ......+.++..+.+++++|++.++
T Consensus 310 lltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSE-WIFRSCKNIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp HHHSSCCCCTTGGGSCSG-GGGSSCCCCCHHHHHHHHHHTCSSG
T ss_pred HHHCCCCCCCcchhhhHH-HHHhhcccCCHHHHHHHHHHccCCh
Confidence 999999998766543322 2233445788999999999999873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=280.31 Aligned_cols=209 Identities=23% Similarity=0.395 Sum_probs=169.2
Q ss_pred HhhcCCcc-eeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHH-HhcCCCceeeEeeEEee----
Q 004268 506 ATEDFHIK-YCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLL-SQIRHRNIVKLYGFCLH---- 578 (764)
Q Consensus 506 ~~~~y~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~---- 578 (764)
..++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 35778887 7799999999999986 47899999998642 4567888888 55599999999999887
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEe
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVA 655 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~ 655 (764)
....++||||+++++|.+++... ....+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 67799999999999999999754 2346899999999999999999999 899999999999999997 7899999
Q ss_pred eeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----CC---cCC
Q 004268 656 DFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----GR---KIS 728 (764)
Q Consensus 656 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----~~---~~~ 728 (764)
|||++.... +..++.++||||+||++|+|++|+.||.......... .. ...
T Consensus 163 Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 163 DFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999986532 2346789999999999999999999997665432211 11 111
Q ss_pred CC----CCCcHHHHHHHhhhhccc
Q 004268 729 QN----PRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 729 ~~----~~~~~~~~~~~~~~l~~~ 748 (764)
.+ ..++..+.+++++|++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~d 244 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTE 244 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSS
T ss_pred CCchhcccCCHHHHHHHHHHcccC
Confidence 11 456889999999999877
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=281.28 Aligned_cols=277 Identities=22% Similarity=0.185 Sum_probs=166.0
Q ss_pred CCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEE
Q 004268 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120 (764)
Q Consensus 41 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 120 (764)
.|+.....+++++.++. +|..+. ++|++|+|++|++++..+..|..+++|++|+|++|.++++.+.+|.++++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 34444556666666663 343333 366777777777665555566667777777777777766666666677777777
Q ss_pred EccCCcCcccCCccccCCCCcCEEecccCcccccCC-ccccCCCCCCeeecccC-CCCCCCCCccccCCCccEEEecCcc
Q 004268 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP-QEVGNLKNLKSLFLDNN-HLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 121 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
+|++|+++++++..|.++++|++|+|++|+++.+.+ ..|.++++|++|++++| .++.+.+..+..+++|++|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 777777766655556667777777777777665544 45666677777777766 3555555666666677777777776
Q ss_pred CcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCc---CCCCCCeEEccCCcccCC-
Q 004268 199 LVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG---NLTNLIALDLSSNQLSGL- 274 (764)
Q Consensus 199 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~- 274 (764)
+....+..+..+++|++|++++|.++......+..+++|+.|++++|.+++..+..+. ....++.++|+++.+++.
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~ 265 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHH
T ss_pred cCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcc
Confidence 6666566666667777777777766644444444566677777777776654433322 244566666666665431
Q ss_pred ---CCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 275 ---LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 275 ---~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
.|..+..+++|+.|++++|+++.+.+..|..+++|++|+|++|++.
T Consensus 266 l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 266 LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314 (353)
T ss_dssp HHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCcc
Confidence 2334445555555555555554332222344455555555555444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=275.33 Aligned_cols=78 Identities=31% Similarity=0.277 Sum_probs=34.3
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccC--CccccCCCCCCeeeccc
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL--PQEVGNLKNLKSLFLDN 172 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~ 172 (764)
.++++++.++.+ |..+. ++|++|+|++|+++.+++..|.++++|++|+|++|+++.+. +..+.++++|++|++++
T Consensus 11 ~l~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCSSC-CSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcccC-CCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 445555555422 22221 34555555555555444444455555555555555544221 22333344444444444
Q ss_pred CCC
Q 004268 173 NHL 175 (764)
Q Consensus 173 n~i 175 (764)
|.+
T Consensus 88 n~i 90 (306)
T 2z66_A 88 NGV 90 (306)
T ss_dssp CSE
T ss_pred Ccc
Confidence 443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.24 Aligned_cols=276 Identities=21% Similarity=0.222 Sum_probs=241.1
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
|.....++++++++ .+|..+. ++|++|++++|+++++.+..|.++++|++|+|++|++++..+.+|..+++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 44456899999998 6677665 48999999999999888889999999999999999999888889999999999999
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCC-ccccCCCCcCEEecccC-cccccCCccccCCCCCCeeecccCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLN-QLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
++|.++++.+..|.++++|++|+|++|+++.+++ ..|.++++|++|++++| .+..+.+..|.++++|++|++++|.++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999997777779999999999999999998766 68999999999999999 588788889999999999999999999
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCcccc---CCCCCCEEEccCCcccCC---
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG---YLNLLDELHLSHNRLDGP--- 250 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~--- 250 (764)
+..+..+..+++|++|++++|.+..+....+..+++|++|++++|.+++..+..+. ....++.++|+++.+.+.
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~ 267 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence 88889999999999999999999877766677789999999999999976655443 456788999999988752
Q ss_pred -CCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccC
Q 004268 251 -IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG 297 (764)
Q Consensus 251 -~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 297 (764)
.|..+..+++|+.|+|++|+++.+.+..|..+++|+.|++++|.+..
T Consensus 268 ~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 45678889999999999999997666667999999999999999864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.12 Aligned_cols=279 Identities=22% Similarity=0.218 Sum_probs=155.0
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccC--CccCcCCCCCCEEEcc
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSI--PLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~ 123 (764)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|.++.+. +..+.++++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 35666666665 3333332 45666666666665444444555666666666666555321 3344445555555555
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCC-ccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP-QEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
+|.+..+ +..+.++++|++|++++|+++++.+ ..+.+ +++|++|++++|.+...
T Consensus 87 ~n~i~~l-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~------------------------l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 87 FNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS------------------------LRNLIYLDISHTHTRVA 141 (306)
T ss_dssp SCSEEEE-EEEEETCTTCCEEECTTSEEESSTTTTTTTT------------------------CTTCCEEECTTSCCEEC
T ss_pred CCccccC-hhhcCCCCCCCEEECCCCcccccccchhhhh------------------------ccCCCEEECCCCcCCcc
Confidence 5555532 2334555555555555555543332 33444 44444444444444444
Q ss_pred cccccCCccccceeeccCccccc-ccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccC
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTG-SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 281 (764)
.+..+..+++|++|++++|.+++ ..|..+..+++|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..+..
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 44445555666666666666654 45566666677777777777776666666777777777777777776666666666
Q ss_pred CCCCCeEeccCccccCCCCCCCCCCC-ccceEEccCCcCccCCC--hhhhcccccceeeccccccccCCchhcc
Q 004268 282 LKYLASLSLNGNILIGPIPPTIGYLT-NLTYLNLGYNRLSSSIP--PELMNCSQLLNLVLSHNSLSGSIPSEIG 352 (764)
Q Consensus 282 l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~ls~N~l~~~~~--~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 352 (764)
+++|+.|++++|++.+..+..+..++ +|++|+|++|.++..-. .....+...+.+....+.+....|..+.
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 77777777777777666666666663 67777777777663211 1112233334444444555444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-30 Score=280.57 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=199.8
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
....++.+++.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567777777777 3454444 577788888888877777777788888888888888877777777788888888888
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc-CCCCCCCCCccccCCCccEEEecCccCcCC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN-NHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
+|+++.+++..|.++++|++|+|++|+++.+.+..|.++++|+.|++++ |.+..+.+..|..+++|+.|+|++|++..+
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 8888777777777788888888888888777777777888888888877 455556666777888888888888888765
Q ss_pred cccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCC
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 282 (764)
. .+..+++|++|+|++|.+++..+..|..+++|+.|+|++|.++++.+..|..+++|+.|+|++|+++++.+..|..+
T Consensus 212 ~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 P--NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp C--CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred c--cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 3 47788889999999999998888889999999999999999998888889999999999999999998888888999
Q ss_pred CCCCeEeccCcccc
Q 004268 283 KYLASLSLNGNILI 296 (764)
Q Consensus 283 ~~L~~L~l~~n~l~ 296 (764)
++|+.|+|++|.+.
T Consensus 290 ~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 290 RYLVELHLHHNPWN 303 (452)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEccCCCcC
Confidence 99999999999875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=279.62 Aligned_cols=248 Identities=23% Similarity=0.271 Sum_probs=210.0
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
....++.+++.++ .+|..+. ++++.|+|++|+|+...+..|..+++|++|+|++|.++.+.+.+|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4667888888887 4555554 578888888888887777888888888888888888887777888888888888888
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc-CCCCCCCCCccccCCCccEEEecCccCcCC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN-NHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
+|+++.+.+..|.++++|++|+|++|+++.+.+..|.++++|++|+|++ |.++.+.+..|..+++|++|++++|.++.+
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 8888887777888888888888888888877777888888888888887 456656666788888888888888888865
Q ss_pred cccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCC
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 282 (764)
+ .+..+++|++|+|++|.+++..+..|..+++|+.|+|++|.++++.+..|..+++|+.|+|++|+++++.+..|..+
T Consensus 201 ~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 201 P--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp C--CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred c--ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 4 47888999999999999998888999999999999999999998888999999999999999999998888889999
Q ss_pred CCCCeEeccCcccc
Q 004268 283 KYLASLSLNGNILI 296 (764)
Q Consensus 283 ~~L~~L~l~~n~l~ 296 (764)
++|+.|+|++|.+.
T Consensus 279 ~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 279 HHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEcCCCCcc
Confidence 99999999999875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-30 Score=278.40 Aligned_cols=248 Identities=25% Similarity=0.256 Sum_probs=225.6
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
..+.++.+++.++ .+|..+. ++++.|+|++|.++.+.+..|.++++|++|+|++|.++.+.+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4678999999998 5676665 789999999999998888999999999999999999999988999999999999999
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecC-ccCcCCcccccCCccccceeeccCcccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY-NKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 226 (764)
+|+++.+.+..|.++++|++|+|++|.++.+.+..|..+++|++|++++ |.+..+....|..+++|++|++++|+++.+
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 200 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc
Confidence 9999988888899999999999999999988888999999999999998 566667777899999999999999999854
Q ss_pred cCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCC
Q 004268 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306 (764)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 306 (764)
| .+..+++|+.|+|++|.+++..+..|.++++|+.|+|++|+++++.+..|.++++|+.|+|++|++++..+..+..+
T Consensus 201 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 201 -P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp -C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred -c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 3 47889999999999999998889999999999999999999998889999999999999999999998888889999
Q ss_pred CccceEEccCCcCc
Q 004268 307 TNLTYLNLGYNRLS 320 (764)
Q Consensus 307 ~~L~~L~ls~N~l~ 320 (764)
++|+.|+|++|.+.
T Consensus 279 ~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 279 HHLERIHLHHNPWN 292 (440)
T ss_dssp TTCCEEECCSSCEE
T ss_pred cCCCEEEcCCCCcc
Confidence 99999999999987
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=278.82 Aligned_cols=249 Identities=24% Similarity=0.228 Sum_probs=223.6
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
....++.+++.++ .+|..+. ++|++|+|++|.++++.+..|.++++|++|+|++|.++++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4578899999988 5666554 689999999999998889999999999999999999999988999999999999999
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecC-ccCcCCcccccCCccccceeeccCcccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY-NKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 226 (764)
+|+++.+.+..|.++++|++|+|++|.++.+.+..|..+++|+.|++++ |.+..+....|..+++|++|+|++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999988888899999999999999999988888899999999999998 567767777899999999999999999865
Q ss_pred cCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCC
Q 004268 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306 (764)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 306 (764)
| .+..+++|+.|+|++|.+++..+..|.++++|+.|+|++|+++++.+..|.++++|+.|+|++|++++..+..+..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 3 47888999999999999998888999999999999999999998888899999999999999999998888888999
Q ss_pred CccceEEccCCcCcc
Q 004268 307 TNLTYLNLGYNRLSS 321 (764)
Q Consensus 307 ~~L~~L~ls~N~l~~ 321 (764)
++|+.|+|++|.+.-
T Consensus 290 ~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 290 RYLVELHLHHNPWNC 304 (452)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred cCCCEEEccCCCcCC
Confidence 999999999998873
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-30 Score=262.08 Aligned_cols=223 Identities=27% Similarity=0.322 Sum_probs=106.8
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.++++++.++. +|..+ .++|++|+|++|.|+...+..|..+++|++|+|++|.++++.+..|.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 345555555552 23222 234555555555555444444555555555555555555444445555555555555555
Q ss_pred c-CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcc
Q 004268 126 K-LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVT 204 (764)
Q Consensus 126 ~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 204 (764)
. +..+.+..|.++++|++|+|++|.++++.+..|.++++|++|++++|.+ ..+..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l------------------------~~~~~ 146 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL------------------------QALPD 146 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC------------------------CCCCT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcc------------------------cccCH
Confidence 4 4444444444444444444444444444444444444444444444444 33333
Q ss_pred cccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCC
Q 004268 205 KEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284 (764)
Q Consensus 205 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 284 (764)
..|..+++|++|++++|++++..+..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++
T Consensus 147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 33444444555555555544444444444455555555555554444445555555555555555555444344444444
Q ss_pred CCeEeccCccc
Q 004268 285 LASLSLNGNIL 295 (764)
Q Consensus 285 L~~L~l~~n~l 295 (764)
|+.|++++|.+
T Consensus 227 L~~L~l~~N~~ 237 (285)
T 1ozn_A 227 LQYLRLNDNPW 237 (285)
T ss_dssp CCEEECCSSCE
T ss_pred cCEEeccCCCc
Confidence 44444444444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=261.11 Aligned_cols=237 Identities=25% Similarity=0.215 Sum_probs=114.6
Q ss_pred CCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC-CCCCCCCccccCCCccEEEe
Q 004268 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH-LSGPIPSTLYHLNQLATLCL 194 (764)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l 194 (764)
+|++|+|++|.++.+.+..|.++++|++|+|++|.++++.+..|.++++|++|++++|. ++.+.+..+..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 44444444444444444444444444444444444444444444444444444444443 33333333444444444444
Q ss_pred cCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCC
Q 004268 195 GYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL 274 (764)
Q Consensus 195 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 274 (764)
++|.+..+.+..+..+++|++|++++|.+++..+.. |..+++|+.|+|++|.++++
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------------~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT------------------------FRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT------------------------TTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH------------------------hccCCCccEEECCCCccccc
Confidence 444444333444445555555555555555444444 44444555555555555444
Q ss_pred CCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccc
Q 004268 275 LPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNL 354 (764)
Q Consensus 275 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 354 (764)
.+..|..+++|+.|++++|.+.+..|..+..+++|++|++++|++++..+..+..+++|++|++++|++....+. ..-.
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~ 247 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHH
Confidence 444455555555555555555554455555555566666666665544444455566666666666665532221 1112
Q ss_pred cccceeecccccccCCCCCCCCC
Q 004268 355 IFFRQLDLSRNFINGTIPSQLGK 377 (764)
Q Consensus 355 ~~L~~L~l~~N~l~~~~~~~~~~ 377 (764)
..++.+..+.|.+.+..|..+.+
T Consensus 248 ~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 248 AWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HHHHHCCSEECCCBEEESGGGTT
T ss_pred HHHHhcccccCccccCCchHhCC
Confidence 33445555566666555555433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=274.12 Aligned_cols=267 Identities=24% Similarity=0.218 Sum_probs=146.6
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccC
Q 004268 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124 (764)
Q Consensus 45 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 124 (764)
++.|++++|.++ .+|..+. ++|++|+|++|.|+. +|. .+++|++|+|++|.++.+.. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcC
Confidence 444445444444 2333332 345555555554442 222 23445555555555443222 344555555555
Q ss_pred CcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcc
Q 004268 125 NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVT 204 (764)
Q Consensus 125 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 204 (764)
|+++++++ .+++|+.|++++|+++.+.. . +++|++|+|++|.++++.. .+.+|+.|++++|.++.+.
T Consensus 111 N~l~~l~~----~l~~L~~L~L~~N~l~~lp~-~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~- 177 (622)
T 3g06_A 111 NPLTHLPA----LPSGLCKLWIFGNQLTSLPV-L---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSLP- 177 (622)
T ss_dssp CCCCCCCC----CCTTCCEEECCSSCCSCCCC-C---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCC-
T ss_pred CcCCCCCC----CCCCcCEEECCCCCCCcCCC-C---CCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCCc-
Confidence 55544322 33445555555555543221 1 2455555555555543221 2344555555555555433
Q ss_pred cccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCC
Q 004268 205 KEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284 (764)
Q Consensus 205 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 284 (764)
..+++|+.|++++|.++++.. .+++|+.|++++|.++.+ |. .+++|+.|+|++|.++++. ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~lp----~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSLP----VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCCC----CCCTT
T ss_pred ---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcCC----CCCCc
Confidence 234566666666666664221 235667777777777633 32 2367777777777777532 34567
Q ss_pred CCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhccccc
Q 004268 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLI 355 (764)
Q Consensus 285 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 355 (764)
|+.|++++|+|+.+ |. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..+.
T Consensus 243 L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 243 LKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 77777777777643 33 4567778888888777 5577777777888888888887776666665554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=274.70 Aligned_cols=268 Identities=26% Similarity=0.255 Sum_probs=159.7
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
++++|++++|.++ .+|..+. ++|++|+|++|.++.+.+ .+++|++|+|++|+++++++ .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV----LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCCCC----CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECc
Confidence 5778888888887 5565554 678888888887774433 45777777777777776543 56777777777
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 227 (764)
+|+++++.. .+++|+.|++++|.++.+.. .+++|++|++++|++..++. .+++
T Consensus 110 ~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~----~~~~--------------- 162 (622)
T 3g06_A 110 SNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----LPSE--------------- 162 (622)
T ss_dssp SCCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC----CCTT---------------
T ss_pred CCcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCcCC----ccCC---------------
Confidence 777775433 45667777777777664332 13555555555555554321 2234
Q ss_pred CccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCC
Q 004268 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307 (764)
Q Consensus 228 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 307 (764)
|+.|++++|.++.+ | ..+++|+.|+|++|.++++.. .+++|+.|++++|.+... |. .++
T Consensus 163 ---------L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l-~~---~~~ 221 (622)
T 3g06_A 163 ---------LCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSL-PA---LPS 221 (622)
T ss_dssp ---------CCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC-CC---CCT
T ss_pred ---------CCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCccccc-CC---CCC
Confidence 44455555555432 2 223455555555555553221 124555555555555532 21 135
Q ss_pred ccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCC
Q 004268 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLS 387 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 387 (764)
+|++|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+++
T Consensus 222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 66666666666663 33 33456666666666666 3333 4556677777777776 556667777777777777
Q ss_pred CCccccccCCccccCc
Q 004268 388 KNNLSGVIPASVRRIP 403 (764)
Q Consensus 388 ~N~l~~~~~~~~~~~~ 403 (764)
+|++++..|..+..++
T Consensus 293 ~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 293 GNPLSERTLQALREIT 308 (622)
T ss_dssp SCCCCHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHhcc
Confidence 7777776666555444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=269.42 Aligned_cols=255 Identities=22% Similarity=0.210 Sum_probs=133.5
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCc
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 126 (764)
.++++.+.+.......+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+ |..+++|++|+|++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 44555555544444444445555555555555554444555555555555555555553332 4555555555555555
Q ss_pred CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccc
Q 004268 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206 (764)
Q Consensus 127 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 206 (764)
++++. ..++|++|++++|+++++.+. .+++|++|++++|++..+.+..
T Consensus 92 l~~l~-----~~~~L~~L~l~~n~l~~~~~~---------------------------~~~~L~~L~l~~N~l~~~~~~~ 139 (317)
T 3o53_A 92 VQELL-----VGPSIETLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITMLRDLD 139 (317)
T ss_dssp EEEEE-----ECTTCCEEECCSSCCSEEEEC---------------------------CCSSCEEEECCSSCCCSGGGBC
T ss_pred ccccc-----CCCCcCEEECCCCccCCcCcc---------------------------ccCCCCEEECCCCCCCCccchh
Confidence 54332 124445555555444433222 1234444555555544444444
Q ss_pred cCCccccceeeccCcccccccCccc-cCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCC
Q 004268 207 VGNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285 (764)
Q Consensus 207 ~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 285 (764)
+..+++|++|++++|.+++..+..+ ..+++|++|+|++|.+++.. ....+++|+.|+|++|+++++.+ .+..+++|
T Consensus 140 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L 216 (317)
T 3o53_A 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGV 216 (317)
T ss_dssp TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTC
T ss_pred hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcc
Confidence 5555555555555555555444444 24566666666666665442 22235666666766666664333 35566666
Q ss_pred CeEeccCccccCCCCCCCCCCCccceEEccCCcCc-cCCChhhhcccccceeecc
Q 004268 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS-SSIPPELMNCSQLLNLVLS 339 (764)
Q Consensus 286 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~ls 339 (764)
+.|++++|++.+ +|..+..+++|+.|++++|.++ +..+..+..+++|+.|+++
T Consensus 217 ~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 217 TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp SEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred cEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 666666666653 3444555566666666666665 3444455555555555555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=269.41 Aligned_cols=268 Identities=21% Similarity=0.182 Sum_probs=215.4
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
..+..++++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+ |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 457777888888876666677788899999999999998888899999999999999999986543 899999999999
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 178 (764)
++|.++++. ..++|++|++++|+++++.+.. +++|++|++++|+++++.+..|..+++|++|++++|.++++
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence 999998554 3489999999999999876544 57899999999999988888899999999999999999876
Q ss_pred CCCcc-ccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcC
Q 004268 179 IPSTL-YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257 (764)
Q Consensus 179 ~~~~~-~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 257 (764)
.+..+ ..+++|++|++++|.++.+. ....+++|++|++++|+++++.+ .+..+++|+.|+|++|.++. +|..+..
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l~~~~~~ 235 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF 235 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred cHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-hhhHhhc
Confidence 66665 46888899999998888653 23347888888888888886544 47778888888888888884 4566778
Q ss_pred CCCCCeEEccCCccc-CCCCccccCCCCCCeEeccCc-cccCCCC
Q 004268 258 LTNLIALDLSSNQLS-GLLPREVGNLKYLASLSLNGN-ILIGPIP 300 (764)
Q Consensus 258 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n-~l~~~~~ 300 (764)
+++|+.|++++|++. +..+..+..+++|+.|++++| .+.+..+
T Consensus 236 l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp CTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred CCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 888888888888887 556667777777888877744 3444333
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=287.21 Aligned_cols=187 Identities=18% Similarity=0.093 Sum_probs=133.4
Q ss_pred eeecCceeEEEEE-ECCCCEEEEEEccCCCCC-------cHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEEEEEE
Q 004268 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETE-------EPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 516 ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.+.|+.|.+..++ ...|+.|++|++...... .+...+++.+|+++++++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3455666555553 336889999999765322 233456799999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||++|++|.+++.+. .+++.. +|+.||+.||+|+| ++|||||||||+|||++++|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999843 345544 58999999999999 999999999999999999999999999999887665
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P 712 (764)
.......+||+.|+|||++.+. +..++|+||+|++++++.+|..|
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 5556667899999999998764 66789999999998877655443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-31 Score=304.28 Aligned_cols=379 Identities=14% Similarity=0.096 Sum_probs=208.2
Q ss_pred cccccCCCeeEEEeCCCCc---cccCCcccc------------CCCCCcEEEcCCCcCcccCCccccC-C-CCCCEEEcc
Q 004268 13 LNFTCFPNLVTFRIWGTLL---SGRMPSEIG------------ALSKLEKLVLSHNSLTGRIPSEIGA-L-SRLKVLDLS 75 (764)
Q Consensus 13 ~~~~~~~~l~~L~l~~~~~---~~~~~~~~~------------~l~~L~~L~Ls~n~i~~~~~~~~~~-l-~~L~~L~L~ 75 (764)
..+..+|+|+.|++.+|.. .+.+|..++ .+++|++|+|++|.+++..+..+.. + .+|++|+|+
T Consensus 67 ~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~ 146 (592)
T 3ogk_B 67 RLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD 146 (592)
T ss_dssp HHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEE
T ss_pred HHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECc
Confidence 3455666666666655432 122222222 4566666666666555443333333 2 236666665
Q ss_pred CCc-Ccc-cCCcccCCCCCCCEEecCCCcccccC----CccCcCCCCCCEEEccCCcCcccC----CccccCCCCcCEEe
Q 004268 76 YNR-LTG-TIPSEIGSLRDLLDLNLSNNILNGSI----PLEFGNLKDLDQLRLQGNKLDGLI----PSSIGNLTNLTYLD 145 (764)
Q Consensus 76 ~n~-i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~ 145 (764)
+|. ++. ..+.....+++|++|+|++|.+++.. +..+..+++|++|++++|.++++. +..+.++++|++|+
T Consensus 147 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~ 226 (592)
T 3ogk_B 147 KCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVK 226 (592)
T ss_dssp SCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEe
Confidence 554 110 01122234556666666666554331 112334555666666655554221 22234455566666
Q ss_pred cccCcccccCCccccCCCC---------------------------CCeeecccCCCCCCCCCccccCCCccEEEecCcc
Q 004268 146 LSLNQLSGRLPQEVGNLKN---------------------------LKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 146 L~~n~l~~~~~~~~~~l~~---------------------------L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
|++|.+.+ .+..+.++++ |+.|.++++... ..+..+..+++|++|++++|.
T Consensus 227 L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~ 304 (592)
T 3ogk_B 227 VGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYAL 304 (592)
T ss_dssp CSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCC
T ss_pred ccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCc
Confidence 66555543 2234444444 444444443222 233445566677777777777
Q ss_pred CcCCcc-cccCCccccceeeccCccccc-ccCccccCCCCCCEEEcc-----------CCcccCCCC-cCCcCCCCCCeE
Q 004268 199 LVGPVT-KEVGNMKNLDRLHLNGNNLTG-SIPSTIGYLNLLDELHLS-----------HNRLDGPIP-PTIGNLTNLIAL 264 (764)
Q Consensus 199 i~~~~~-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~-----------~n~l~~~~~-~~~~~l~~L~~L 264 (764)
+..... ..+..+++|++|+++ +.+.+ ..+..+..+++|++|+++ .|.+++... ..+..+++|++|
T Consensus 305 l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L 383 (592)
T 3ogk_B 305 LETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYM 383 (592)
T ss_dssp CCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEE
T ss_pred CCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEE
Confidence 543222 234667777777777 33332 223333556777777777 345543211 123346778888
Q ss_pred EccCCcccCCCCccccC-CCCCCeEecc----CccccCCC-----CCCCCCCCccceEEccCCc--CccCCChhhh-ccc
Q 004268 265 DLSSNQLSGLLPREVGN-LKYLASLSLN----GNILIGPI-----PPTIGYLTNLTYLNLGYNR--LSSSIPPELM-NCS 331 (764)
Q Consensus 265 ~L~~n~l~~~~~~~~~~-l~~L~~L~l~----~n~l~~~~-----~~~~~~l~~L~~L~ls~N~--l~~~~~~~~~-~l~ 331 (764)
+++.|.+++..+..+.. +++|+.|+++ .|.+++.. +..+..+++|++|++++|. +++..+..+. .++
T Consensus 384 ~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~ 463 (592)
T 3ogk_B 384 AVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463 (592)
T ss_dssp EEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCT
T ss_pred EeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCc
Confidence 88777776555555544 7778888885 55565421 1124557788888887543 5544334443 367
Q ss_pred ccceeeccccccccC-CchhcccccccceeecccccccCC-CCCCCCCCCccceecCCCCccccc
Q 004268 332 QLLNLVLSHNSLSGS-IPSEIGNLIFFRQLDLSRNFINGT-IPSQLGKIPNISAVDLSKNNLSGV 394 (764)
Q Consensus 332 ~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~ 394 (764)
+|++|+|++|++++. .+..+.++++|+.|+|++|++++. .+..+..+++|+.|++++|+++..
T Consensus 464 ~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp TCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred cceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 788888888887753 344456778888888888887543 233345677888888888887754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=248.74 Aligned_cols=234 Identities=22% Similarity=0.287 Sum_probs=126.4
Q ss_pred CCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEec
Q 004268 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDL 146 (764)
Q Consensus 67 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 146 (764)
++++.|+|++|.++ .+|..+..+++|++|+|++|.++ ..|..|.++++|++|+|++|.++. .|..|.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~-lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCC-CCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCcccc-CcHHHhcCcCCCEEEC
Confidence 45555666666555 44445555556666666666555 445555555666666666666552 3445556666666666
Q ss_pred ccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccc
Q 004268 147 SLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226 (764)
Q Consensus 147 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 226 (764)
++|++.+..|..+.. . ...+.+..+++|++|++++|.++.+ +..+..+++|++|++++|.+++
T Consensus 158 ~~n~~~~~~p~~~~~------~---------~~~~~~~~l~~L~~L~L~~n~l~~l-p~~l~~l~~L~~L~L~~N~l~~- 220 (328)
T 4fcg_A 158 RACPELTELPEPLAS------T---------DASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSA- 220 (328)
T ss_dssp EEETTCCCCCSCSEE------E---------C-CCCEEESTTCCEEEEEEECCCCC-CGGGGGCTTCCEEEEESSCCCC-
T ss_pred CCCCCccccChhHhh------c---------cchhhhccCCCCCEEECcCCCcCcc-hHhhcCCCCCCEEEccCCCCCc-
Confidence 665554444443332 0 0011233444444444444444422 2234445555555555555553
Q ss_pred cCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCC
Q 004268 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL 306 (764)
Q Consensus 227 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 306 (764)
.|..+..+++|++|+|++|.+.+..|..+..+++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 23345555555555555555555555556666666666666665555555556666666666666666665666666666
Q ss_pred CccceEEccCCcCc
Q 004268 307 TNLTYLNLGYNRLS 320 (764)
Q Consensus 307 ~~L~~L~ls~N~l~ 320 (764)
++|+.+++..|.+.
T Consensus 301 ~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 301 PANCIILVPPHLQA 314 (328)
T ss_dssp CTTCEEECCGGGSC
T ss_pred cCceEEeCCHHHHH
Confidence 66666666655544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=247.69 Aligned_cols=235 Identities=23% Similarity=0.278 Sum_probs=152.2
Q ss_pred CCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEE
Q 004268 114 LKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193 (764)
Q Consensus 114 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 193 (764)
.++++.|+|++|.++.+ |..+..+++|++|+|++|.++ ..|..+.++++|++|+|++|.++ ..+..+..+++|++|+
T Consensus 80 ~~~l~~L~L~~n~l~~l-p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~ 156 (328)
T 4fcg_A 80 QPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156 (328)
T ss_dssp STTCCEEEEESSCCSSC-CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred ccceeEEEccCCCchhc-ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence 35677777777777643 444556777777777777776 45566667777777777777766 3455566666666666
Q ss_pred ecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccC
Q 004268 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSG 273 (764)
Q Consensus 194 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 273 (764)
+++|.+....+..+.. . ..+..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++
T Consensus 157 L~~n~~~~~~p~~~~~------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 157 IRACPELTELPEPLAS------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp EEEETTCCCCCSCSEE------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred CCCCCCccccChhHhh------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 6665544333322211 0 01122445667777777777776 556667777777777777777764
Q ss_pred CCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhccc
Q 004268 274 LLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGN 353 (764)
Q Consensus 274 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 353 (764)
.+..+..+++|+.|++++|.+.+..|..+..+++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+.+|..+.+
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 3445667777777777777776666777777777777777777766666767777777777777777776677777777
Q ss_pred ccccceeeccccccc
Q 004268 354 LIFFRQLDLSRNFIN 368 (764)
Q Consensus 354 l~~L~~L~l~~N~l~ 368 (764)
+++|+.+++..|.+.
T Consensus 300 L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 300 LPANCIILVPPHLQA 314 (328)
T ss_dssp SCTTCEEECCGGGSC
T ss_pred ccCceEEeCCHHHHH
Confidence 777777777666554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-30 Score=297.51 Aligned_cols=389 Identities=15% Similarity=0.101 Sum_probs=260.2
Q ss_pred EEEeCCCCccccCCccccCCCCCcEEEcCCCcCc---ccCCcccc------------CCCCCCEEEccCCcCcccCCccc
Q 004268 23 TFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLT---GRIPSEIG------------ALSRLKVLDLSYNRLTGTIPSEI 87 (764)
Q Consensus 23 ~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~---~~~~~~~~------------~l~~L~~L~L~~n~i~~~~~~~~ 87 (764)
.+.+.++ ....++..+..+++|++|+|+++... +..|..+. .+++|++|+|++|.++...+..+
T Consensus 54 ~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l 132 (592)
T 3ogk_B 54 HVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRL 132 (592)
T ss_dssp EEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHH
Confidence 3444443 23344556778999999999886431 23333333 68999999999999886655555
Q ss_pred CC-CC-CCCEEecCCCc-cccc-CCccCcCCCCCCEEEccCCcCcccC----CccccCCCCcCEEecccCccccc----C
Q 004268 88 GS-LR-DLLDLNLSNNI-LNGS-IPLEFGNLKDLDQLRLQGNKLDGLI----PSSIGNLTNLTYLDLSLNQLSGR----L 155 (764)
Q Consensus 88 ~~-l~-~L~~L~L~~n~-l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~----~ 155 (764)
.. ++ +|++|+|++|. ++.. .+....++++|++|+|++|.+.+.. +..+.++++|++|++++|.++++ .
T Consensus 133 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l 212 (592)
T 3ogk_B 133 AKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDL 212 (592)
T ss_dssp HHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHH
T ss_pred HHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHH
Confidence 55 33 49999999987 2211 1222347899999999999987652 23456789999999999999733 3
Q ss_pred CccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCc--------------------------CCcccccCC
Q 004268 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV--------------------------GPVTKEVGN 209 (764)
Q Consensus 156 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~--------------------------~~~~~~~~~ 209 (764)
+..+.++++|++|++++|.+.+ .+..+..+++|++|+++.+... ...+..+..
T Consensus 213 ~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~ 291 (592)
T 3ogk_B 213 ETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291 (592)
T ss_dssp HHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGG
T ss_pred HHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhh
Confidence 4445688999999999998875 3356667777777777632211 112334455
Q ss_pred ccccceeeccCcccccccC-ccccCCCCCCEEEccCCcccCC-CCcCCcCCCCCCeEEccC-----------CcccCCCC
Q 004268 210 MKNLDRLHLNGNNLTGSIP-STIGYLNLLDELHLSHNRLDGP-IPPTIGNLTNLIALDLSS-----------NQLSGLLP 276 (764)
Q Consensus 210 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~-----------n~l~~~~~ 276 (764)
+++|++|++++|.+++... ..+..+++|+.|+++ +.+.+. .+..+..+++|+.|+|++ |.+++...
T Consensus 292 ~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~ 370 (592)
T 3ogk_B 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370 (592)
T ss_dssp GGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred cCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence 6677777777777653322 234667777777777 333322 222334567788888883 45543222
Q ss_pred -ccccCCCCCCeEeccCccccCCCCCCCCC-CCccceEEcc----CCcCccC-----CChhhhcccccceeecccc--cc
Q 004268 277 -REVGNLKYLASLSLNGNILIGPIPPTIGY-LTNLTYLNLG----YNRLSSS-----IPPELMNCSQLLNLVLSHN--SL 343 (764)
Q Consensus 277 -~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~ls----~N~l~~~-----~~~~~~~l~~L~~L~ls~N--~l 343 (764)
.....+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|++|++++| .+
T Consensus 371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l 450 (592)
T 3ogk_B 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL 450 (592)
T ss_dssp HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGC
T ss_pred HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCc
Confidence 22345788888888777776544444444 7788888886 6677743 2233667888999998743 36
Q ss_pred ccCCchhccc-ccccceeecccccccC-CCCCCCCCCCccceecCCCCcccccc-CC---ccccCccccccCCCCCC
Q 004268 344 SGSIPSEIGN-LIFFRQLDLSRNFING-TIPSQLGKIPNISAVDLSKNNLSGVI-PA---SVRRIPKLIVSENNLEL 414 (764)
Q Consensus 344 ~~~~~~~~~~-l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~-~~---~~~~~~~~~~~~n~~~~ 414 (764)
++..+..+.. +++|+.|+|++|++++ ..+..+..+++|+.|++++|+++... +. .++.++.+++++|++..
T Consensus 451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 6555555543 7889999999999875 33445577899999999999987432 22 35688999999998643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=260.74 Aligned_cols=58 Identities=33% Similarity=0.359 Sum_probs=26.1
Q ss_pred CCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeeccccccc
Q 004268 306 LTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368 (764)
Q Consensus 306 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 368 (764)
+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 344444444444444 3333332 4444444444444433 32 444445555555555444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=261.04 Aligned_cols=154 Identities=25% Similarity=0.232 Sum_probs=76.0
Q ss_pred CCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCC--CCcc--ccCCCCCCeEeccCccccCC---CCCCCCCCC
Q 004268 235 NLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGL--LPRE--VGNLKYLASLSLNGNILIGP---IPPTIGYLT 307 (764)
Q Consensus 235 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--~~~~--~~~l~~L~~L~l~~n~l~~~---~~~~~~~l~ 307 (764)
++|++|+|++|.+.+..+..|+.+++|+.|+|++|++.+. .+.. +..+++|++|++++|++.+. ....+..++
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 228 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence 3444444444444433334444444444444444443321 1111 14444444444444444311 111223445
Q ss_pred ccceEEccCCcCccCCC-hhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecC
Q 004268 308 NLTYLNLGYNRLSSSIP-PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDL 386 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 386 (764)
+|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |. +..+++|+.|++
T Consensus 229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L 303 (312)
T 1wwl_A 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL 303 (312)
T ss_dssp CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence 55556666665554432 33444566666666666666 4454444 5666666666666644 43 666666666666
Q ss_pred CCCcccc
Q 004268 387 SKNNLSG 393 (764)
Q Consensus 387 ~~N~l~~ 393 (764)
++|++++
T Consensus 304 ~~N~l~~ 310 (312)
T 1wwl_A 304 KGNPFLD 310 (312)
T ss_dssp TTCTTTC
T ss_pred cCCCCCC
Confidence 6666653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=266.44 Aligned_cols=234 Identities=22% Similarity=0.227 Sum_probs=119.5
Q ss_pred CCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecc
Q 004268 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD 171 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 171 (764)
+|++|+|++|.++++.+..|.++++|++|+|++|.+++..+ |..+++|++|+|++|.++++.+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 44444444444444434444444444444444444443322 4444444444444444443221 1445555555
Q ss_pred cCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCcccc-CCCCCCEEEccCCcccCC
Q 004268 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG-YLNLLDELHLSHNRLDGP 250 (764)
Q Consensus 172 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~ 250 (764)
+|.++++.+. .+++|+.|+|++|.+..+.+..+..+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 5544433222 234455555555555555555555566666666666666655555554 456666666666666644
Q ss_pred CCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc-cCCChhhhc
Q 004268 251 IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS-SSIPPELMN 329 (764)
Q Consensus 251 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~-~~~~~~~~~ 329 (764)
.+ +..+++|+.|+|++|.++++++ .+..+++|+.|+|++|.+.+ +|..+..+++|+.|++++|.+. +..|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 22 2346666666666666665433 35566666666666666653 3444555556666666666555 333444444
Q ss_pred ccccceeecc
Q 004268 330 CSQLLNLVLS 339 (764)
Q Consensus 330 l~~L~~L~ls 339 (764)
++.|+.|+++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 4444444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=269.25 Aligned_cols=246 Identities=22% Similarity=0.245 Sum_probs=151.1
Q ss_pred CCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEE
Q 004268 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192 (764)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 192 (764)
.+++|++|+|++|.++++.|..|.++++|++|+|++|.+++..+ |.++++|++|+|++|.++++. ..++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 44578888888888887777788888888888888888876554 777777888888777776432 22555555
Q ss_pred EecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCccc
Q 004268 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272 (764)
Q Consensus 193 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 272 (764)
++++|.+..+... .+ ++|+.|+|++|.+++..|..++.+++|+.|+|++|.++
T Consensus 105 ~L~~N~l~~~~~~---~l------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 157 (487)
T 3oja_A 105 HAANNNISRVSCS---RG------------------------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157 (487)
T ss_dssp ECCSSCCCCEEEC---CC------------------------SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC
T ss_pred ECcCCcCCCCCcc---cc------------------------CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC
Confidence 5555555543322 22 34555555555555444445555555555555555555
Q ss_pred CCCCcccc-CCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhc
Q 004268 273 GLLPREVG-NLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI 351 (764)
Q Consensus 273 ~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 351 (764)
+..|..+. .+++|+.|+|++|.+++..+ ...+++|++|+|++|.+++. |..+..+++|+.|+|++|.+++ +|..+
T Consensus 158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 158 TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred CcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhh
Confidence 54444443 45556666666665554422 22456666666666666643 3346666667777777776663 45556
Q ss_pred ccccccceeeccccccc-CCCCCCCCCCCccceecCC-------CCccccccC
Q 004268 352 GNLIFFRQLDLSRNFIN-GTIPSQLGKIPNISAVDLS-------KNNLSGVIP 396 (764)
Q Consensus 352 ~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~-------~N~l~~~~~ 396 (764)
..+++|+.|++++|++. +..|..+..++.|+.++++ .|+..+..+
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCC
Confidence 66666777777777665 4455556666667666665 555554444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-26 Score=233.47 Aligned_cols=204 Identities=25% Similarity=0.269 Sum_probs=91.9
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
+|++|+|++|++++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|.++++.+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 34444444444444333344444444444444444444444444444445555554444444444444444555555555
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCC-CCccccCCCccEEEecCccCcCCcccccCCccccc----eeeccCcc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI-PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLD----RLHLNGNN 222 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~----~L~L~~n~ 222 (764)
+|.++++.+..+.++++|++|++++|.++++. +..+..+++|++|++++|+++.+.+..+..+++|+ +|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 55444444444444455555555555444321 34444444444444444444443333333333333 44444444
Q ss_pred cccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCccc
Q 004268 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272 (764)
Q Consensus 223 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 272 (764)
++++.+..+... +|+.|+|++|.+++..+..|..+++|+.|+|++|++.
T Consensus 189 l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 189 MNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp CCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred ccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 443333322221 3444444444444333333444444444444444443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=234.68 Aligned_cols=224 Identities=25% Similarity=0.262 Sum_probs=186.2
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCC
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 101 (764)
...++.+.+++ .+|..+. +++++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp TEEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 35677777775 5666554 47889999999988877778888889999999999888777778888899999999999
Q ss_pred cccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccC-CccccCCCCCCeeecccCCCCCCCC
Q 004268 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL-PQEVGNLKNLKSLFLDNNHLSGPIP 180 (764)
Q Consensus 102 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~ 180 (764)
.++++.+..|.++++|++|++++|.+.++.+..+.++++|++|+|++|.++++. |..|.++++|++|++++|+++++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 988888888888999999999999988887777888899999999999888653 7788888999999999998887777
Q ss_pred CccccCCCcc----EEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccC
Q 004268 181 STLYHLNQLA----TLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249 (764)
Q Consensus 181 ~~~~~l~~L~----~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 249 (764)
..+..+.+|+ .|++++|.+..+.+..+.. .+|++|++++|++++..+..|..+++|+.|+|++|.+..
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence 7777777776 8899999988776666654 479999999999998777778889999999999998873
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-25 Score=228.68 Aligned_cols=205 Identities=29% Similarity=0.349 Sum_probs=133.4
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
|.++.+.+++++++++ .+|..+. +++++|+|++|+++++.+..|.++++|++|+|++|.++...+..|..+++|++|
T Consensus 14 c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 14 CNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL 90 (270)
T ss_dssp EETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEE
T ss_pred eCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEE
Confidence 3345667777777776 4555443 466777777777776666667777777777777777765555556666777777
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|++|.++.+.+..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|.++.+.+..|.++++|+.|+|++|.++
T Consensus 91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 170 (270)
T 2o6q_A 91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence 77777776666666666677777777777776666666666667777777777666665555666666666666666666
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccc
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 224 (764)
.+.+..|..+++|++|++++|++..+....|..+++|+.|++++|.+.
T Consensus 171 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 655555666666666666666666555555555556666666655554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-25 Score=225.82 Aligned_cols=202 Identities=30% Similarity=0.310 Sum_probs=124.0
Q ss_pred CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 44 KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
+.+.+++++++++. +|..+. ++|++|+|++|+|+...+.+|..+++|++|+|++|.++.+.+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 45667777777763 444443 466777777777765555566667777777777777666666666666666777666
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCc
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~ 203 (764)
+|+++.+++..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|.++.+.+..|..+++|+.|++++|
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n------ 167 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNN------ 167 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS------
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCC------
Confidence 66666666666666666666666666666665555666666666666666665554444455555555555554
Q ss_pred ccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCccc
Q 004268 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272 (764)
Q Consensus 204 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 272 (764)
.++++.+..|..+++|+.|+|++|.++...+..|..+++|+.|+|++|++.
T Consensus 168 ------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 168 ------------------QLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ------------------CCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ------------------cCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 444444444555555555555555555555555666666666666666654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-29 Score=286.79 Aligned_cols=391 Identities=16% Similarity=0.129 Sum_probs=259.8
Q ss_pred ccccccCCCeeEEEeCCCCccc---cCCc------------cccCCCCCcEEEcCCCcCcccCCcccc-CCCCCCEEEcc
Q 004268 12 QLNFTCFPNLVTFRIWGTLLSG---RMPS------------EIGALSKLEKLVLSHNSLTGRIPSEIG-ALSRLKVLDLS 75 (764)
Q Consensus 12 ~~~~~~~~~l~~L~l~~~~~~~---~~~~------------~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~ 75 (764)
...+..+|+|+.|++.+|.... ..|. -...+++|++|+|++|.+++..+..+. .+++|++|+|+
T Consensus 59 ~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~ 138 (594)
T 2p1m_B 59 ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS 138 (594)
T ss_dssp HHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEE
T ss_pred HHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCC
Confidence 3456778899999999886322 1111 134678899999999988866666664 67899999999
Q ss_pred CC-cCccc-CCcccCCCCCCCEEecCCCcccccCCccC----cCCCCCCEEEccCCcCcccCCcc----ccCCCCcCEEe
Q 004268 76 YN-RLTGT-IPSEIGSLRDLLDLNLSNNILNGSIPLEF----GNLKDLDQLRLQGNKLDGLIPSS----IGNLTNLTYLD 145 (764)
Q Consensus 76 ~n-~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~ 145 (764)
+| .++.. .+..+..+++|++|+|++|.+++..+..+ ..+++|++|++++|. ..+.... +.++++|++|+
T Consensus 139 ~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~ 217 (594)
T 2p1m_B 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLK 217 (594)
T ss_dssp SCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEE
T ss_pred CcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEe
Confidence 88 55532 33445578899999999998775444333 366789999999887 2222222 34568899999
Q ss_pred cccC-cccccCCccccCCCCCCeeecccCC--------------------------CCCC----CCCccccCCCccEEEe
Q 004268 146 LSLN-QLSGRLPQEVGNLKNLKSLFLDNNH--------------------------LSGP----IPSTLYHLNQLATLCL 194 (764)
Q Consensus 146 L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~--------------------------i~~~----~~~~~~~l~~L~~L~l 194 (764)
|++| .+.+ .+..+..+++|++|++..+. +... .+..+..+++|++|++
T Consensus 218 L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L 296 (594)
T 2p1m_B 218 LNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296 (594)
T ss_dssp CCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEEC
T ss_pred cCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEc
Confidence 9888 4443 45556667777777655442 1111 1222335788999999
Q ss_pred cCccCcCCcc-cccCCccccceeeccCcccccc-cCccccCCCCCCEEEccC---------CcccCCCCcCCc-CCCCCC
Q 004268 195 GYNKLVGPVT-KEVGNMKNLDRLHLNGNNLTGS-IPSTIGYLNLLDELHLSH---------NRLDGPIPPTIG-NLTNLI 262 (764)
Q Consensus 195 ~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~---------n~l~~~~~~~~~-~l~~L~ 262 (764)
++|.+..... ..+..+++|++|++++| +++. .+.....+++|++|+++. +.+++.....+. .+++|+
T Consensus 297 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~ 375 (594)
T 2p1m_B 297 SYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE 375 (594)
T ss_dssp TTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCC
T ss_pred cCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHH
Confidence 9998663222 23567889999999988 4422 222233578899998843 445432222222 478899
Q ss_pred eEEccCCcccCCCCcccc-CCCCCCeEecc--C----ccccCCCCC-----CCCCCCccceEEccCCcCccCCChhhhc-
Q 004268 263 ALDLSSNQLSGLLPREVG-NLKYLASLSLN--G----NILIGPIPP-----TIGYLTNLTYLNLGYNRLSSSIPPELMN- 329 (764)
Q Consensus 263 ~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~--~----n~l~~~~~~-----~~~~l~~L~~L~ls~N~l~~~~~~~~~~- 329 (764)
.|+++.|.+++.....+. .+++|+.|+++ + |.+++.... .+..+++|+.|+|++ .+++..+..+..
T Consensus 376 ~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~ 454 (594)
T 2p1m_B 376 SVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTY 454 (594)
T ss_dssp EEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHH
T ss_pred HHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHh
Confidence 999988888765555554 58899999998 4 455422111 145678999999987 666555555555
Q ss_pred ccccceeeccccccccCCchhc-ccccccceeecccccccCCCCC-CCCCCCccceecCCCCccccccCCcc-ccCcccc
Q 004268 330 CSQLLNLVLSHNSLSGSIPSEI-GNLIFFRQLDLSRNFINGTIPS-QLGKIPNISAVDLSKNNLSGVIPASV-RRIPKLI 406 (764)
Q Consensus 330 l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~l~l~~N~l~~~~~~~~-~~~~~~~ 406 (764)
+++|++|+|++|.+++..+..+ .++++|+.|+|++|++++.... ....+++|+.|++++|+++......+ ..+|.+.
T Consensus 455 ~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~ 534 (594)
T 2p1m_B 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLN 534 (594)
T ss_dssp CTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEE
T ss_pred chhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCE
Confidence 7889999999999876655555 6688999999999998644333 34558899999999999864322222 3445543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=254.60 Aligned_cols=187 Identities=17% Similarity=0.220 Sum_probs=148.1
Q ss_pred CcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH-----HHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 511 HIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP-----AFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 511 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
...+.||+|+||+||+|.. .++.+++|+......... ...+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 488999998765443322 1245689999999999999999655555566677999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++++|.+++.. +..++.|++.||+||| ++||+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999873 4579999999999999 899999999999999998 999999999988754
Q ss_pred CCCC-------ceeccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 004268 666 DSSN-------RTLVVGTYGYIAPELAYT--MAVTEKCDVYSFGVVALEVLMGSHPTD 714 (764)
Q Consensus 666 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~~lltg~~Pf~ 714 (764)
.... .....||+.|+|||++.. ..|+..+|+|+.++-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3221 134689999999999987 567888999999999999888888875
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=222.14 Aligned_cols=202 Identities=27% Similarity=0.220 Sum_probs=111.3
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 94 (764)
++++++++++++++++++ .+|..+. +++++|+|++|.+++..+..|..+++|++|+|++|.|++..+ ...+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 455566666666666665 3444432 456666666666665555556666666666666666654322 24555666
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 174 (764)
+|+|++|.++ ..|..+.++++|++|+|++|+++++++..|.++++|++|+|++|+++.+.+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 6666666665 334455555666666666666655555555556666666666666555555555555555555555555
Q ss_pred CCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccc
Q 004268 175 LSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223 (764)
Q Consensus 175 i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 223 (764)
++.+.+..|..+++|+.|+|++|++..++.. +..+++|+.|+|++|.+
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~-~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKG-FFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCCCCTT-TTTTCCCSEEECCSCCB
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCccChh-hcccccCCeEEeCCCCc
Confidence 5555544555555555555555555543322 22233444444444444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-25 Score=223.46 Aligned_cols=227 Identities=24% Similarity=0.270 Sum_probs=140.5
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecC
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 99 (764)
++..+++.++.+... ..+..+++|+.|++++|.++.. ..+..+++|++|+|++|.+++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 444455555555433 3344556666666666666532 2356666666666666666632 356666666666666
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCC
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 179 (764)
+|.++++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++++.+..|.++++|+.|++++|.++++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 173 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLP 173 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccC
Confidence 66666665556666666666666666666666666666666666666666666665555666666666666666666665
Q ss_pred CCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCC
Q 004268 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT 259 (764)
Q Consensus 180 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 259 (764)
+..+..+++|++|++++|++..+.+..+..+++|+.|++++|.+.+ .++.|+.|+++.|.+.+.+|..++.++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccC
Confidence 5556666666666666666666666666666666666666666553 234566666666666666666655544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=225.25 Aligned_cols=188 Identities=28% Similarity=0.244 Sum_probs=100.3
Q ss_pred ccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCe
Q 004268 184 YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIA 263 (764)
Q Consensus 184 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 263 (764)
..+++|+.|++++|.+..+ ..+..+++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..|..+++|++
T Consensus 60 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 137 (272)
T 3rfs_A 60 QYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137 (272)
T ss_dssp GGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence 3334444444444443332 13444444455555555444444444455555555555555555444444555555555
Q ss_pred EEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecccccc
Q 004268 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSL 343 (764)
Q Consensus 264 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l 343 (764)
|+|++|.+++..+..|..+++|+.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++
T Consensus 138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 217 (272)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence 55555555555554555555555555555555555555555556666666666666655555555666666666666655
Q ss_pred ccCCchhcccccccceeecccccccCCCCCCCCCCCc
Q 004268 344 SGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380 (764)
Q Consensus 344 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 380 (764)
.+. +++|+.|+++.|.+++.+|..+..++.
T Consensus 218 ~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 218 DCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred ccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 532 334566666666666666666655543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=220.41 Aligned_cols=132 Identities=27% Similarity=0.327 Sum_probs=60.2
Q ss_pred ccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCC
Q 004268 39 IGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLD 118 (764)
Q Consensus 39 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 118 (764)
+..+++++++++++|.++. +|..+. +++++|+|++|.|++..+..|..+++|++|+|++|.++.+.+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 4445555555555555552 232222 3455555555555544444555555555555555555433221 3444444
Q ss_pred EEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 119 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|+|++|+++.+ |..+.++++|++|+|++|+++.+.+..|.++++|++|+|++|+++
T Consensus 81 ~L~Ls~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 137 (290)
T 1p9a_G 81 TLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (290)
T ss_dssp EEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred EEECCCCcCCcC-chhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence 444444444422 233444444444444444444333334444444444444444433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-28 Score=279.04 Aligned_cols=373 Identities=17% Similarity=0.157 Sum_probs=262.3
Q ss_pred ccCCCeeEEEeCCCCccccCCcccc-CCCCCcEEEcCCC-cCccc-CCccccCCCCCCEEEccCCcCcccCCccc----C
Q 004268 16 TCFPNLVTFRIWGTLLSGRMPSEIG-ALSKLEKLVLSHN-SLTGR-IPSEIGALSRLKVLDLSYNRLTGTIPSEI----G 88 (764)
Q Consensus 16 ~~~~~l~~L~l~~~~~~~~~~~~~~-~l~~L~~L~Ls~n-~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~----~ 88 (764)
..+++|+.|++++|.+++..+..+. .+++|++|+|++| .+++. .+..+..+++|++|+|++|.++...+..+ .
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 4678999999999999887777776 6899999999999 66532 34444578999999999999875444333 3
Q ss_pred CCCCCCEEecCCCc--cccc-CCccCcCCCCCCEEEccCC-cCcccCCccccCCCCcCEEecccCc--------------
Q 004268 89 SLRDLLDLNLSNNI--LNGS-IPLEFGNLKDLDQLRLQGN-KLDGLIPSSIGNLTNLTYLDLSLNQ-------------- 150 (764)
Q Consensus 89 ~l~~L~~L~L~~n~--l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~-------------- 150 (764)
.+++|++|+|++|. ++.. ....+..+++|++|+|++| .+.+ .+..+..+++|++|+++.+.
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~ 260 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHH
Confidence 67799999999997 2211 1112345699999999998 4444 55667778888888765542
Q ss_pred ------------cccc----CCccccCCCCCCeeecccCCCCCCC-CCccccCCCccEEEecCccCcCCccc-ccCCccc
Q 004268 151 ------------LSGR----LPQEVGNLKNLKSLFLDNNHLSGPI-PSTLYHLNQLATLCLGYNKLVGPVTK-EVGNMKN 212 (764)
Q Consensus 151 ------------l~~~----~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~-~~~~l~~ 212 (764)
+... .+..+..+++|++|+|++|.+++.. ...+..+++|++|++++| +...... ....+++
T Consensus 261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~ 339 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD 339 (594)
T ss_dssp HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence 1111 2222336789999999999976321 122458899999999998 4422222 2235789
Q ss_pred cceeecc---------CcccccccCcccc-CCCCCCEEEccCCcccCCCCcCCc-CCCCCCeEEcc--C----CcccCCC
Q 004268 213 LDRLHLN---------GNNLTGSIPSTIG-YLNLLDELHLSHNRLDGPIPPTIG-NLTNLIALDLS--S----NQLSGLL 275 (764)
Q Consensus 213 L~~L~L~---------~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~----n~l~~~~ 275 (764)
|++|+++ .+.+++.....+. .+++|+.|.++.|.+++.....+. .+++|+.|+|+ + |.+++..
T Consensus 340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~ 419 (594)
T 2p1m_B 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP 419 (594)
T ss_dssp CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence 9999984 3455543333333 489999999999999865444454 58999999999 4 5665322
Q ss_pred C-----ccccCCCCCCeEeccCccccCCCCCCCCC-CCccceEEccCCcCccCCChhh-hcccccceeeccccccccCCc
Q 004268 276 P-----REVGNLKYLASLSLNGNILIGPIPPTIGY-LTNLTYLNLGYNRLSSSIPPEL-MNCSQLLNLVLSHNSLSGSIP 348 (764)
Q Consensus 276 ~-----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~~~~~ 348 (764)
. ..+..+++|+.|++++ .+++.....+.. +++|++|+|++|.+++..+..+ .++++|++|+|++|++++...
T Consensus 420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~ 498 (594)
T 2p1m_B 420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL 498 (594)
T ss_dssp THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHH
T ss_pred hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHH
Confidence 2 2267789999999987 555433333443 7899999999999986555555 678999999999999975544
Q ss_pred h-hcccccccceeecccccccCCCCCCC-CCCCccceecCCCCcc
Q 004268 349 S-EIGNLIFFRQLDLSRNFINGTIPSQL-GKIPNISAVDLSKNNL 391 (764)
Q Consensus 349 ~-~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l 391 (764)
. ....+++|+.|++++|+++......+ ..+|+++...+..+.-
T Consensus 499 ~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 499 LANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp HHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred HHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 4 34568999999999999853322333 4567776666655543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=216.36 Aligned_cols=196 Identities=18% Similarity=0.182 Sum_probs=95.8
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCc-ccccCCccCcCCCCCCEEEccC-CcCcccCCccccCCCCcCEEe
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI-LNGSIPLEFGNLKDLDQLRLQG-NKLDGLIPSSIGNLTNLTYLD 145 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 145 (764)
+|++|+|++|+|++..+..|..+++|++|+|++|. ++.+.+.+|.++++|++|++++ |+++.+.+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444455555555555555554 5544444555555555555555 555555555555555555555
Q ss_pred cccCcccccCCccccCCCCCC---eeecccC-CCCCCCCCccccCCCcc-EEEecCccCcCCcccccCCccccceeeccC
Q 004268 146 LSLNQLSGRLPQEVGNLKNLK---SLFLDNN-HLSGPIPSTLYHLNQLA-TLCLGYNKLVGPVTKEVGNMKNLDRLHLNG 220 (764)
Q Consensus 146 L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~i~~~~~~~~~~l~~L~-~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 220 (764)
+++|+++++ |. |.++++|+ +|++++| .++.+.+..|..+++|+ .|++++|+++.++...|.. ++|++|++++
T Consensus 112 l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 555555532 22 44444444 5555555 44444444444444444 4444444444433333333 4455555555
Q ss_pred cc-cccccCccccCC-CCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCC
Q 004268 221 NN-LTGSIPSTIGYL-NLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSN 269 (764)
Q Consensus 221 n~-l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 269 (764)
|+ ++.+.+..|..+ ++|+.|++++|.++.+.+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 52 444444444444 4455555555554432222 2344444444443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=215.86 Aligned_cols=205 Identities=18% Similarity=0.170 Sum_probs=180.1
Q ss_pred ccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCc-CcccCCcccCCCCCCCEEecCC-CcccccCC
Q 004268 31 LSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNR-LTGTIPSEIGSLRDLLDLNLSN-NILNGSIP 108 (764)
Q Consensus 31 ~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~ 108 (764)
++ .+|. +. +++++|++++|+++++.+..|.++++|++|+|++|+ ++.+.+.+|..+++|++|+|++ |.++.+.+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 54 5666 43 489999999999998888899999999999999997 8877777899999999999998 99998888
Q ss_pred ccCcCCCCCCEEEccCCcCcccCCccccCCCCcC---EEecccC-cccccCCccccCCCCCC-eeecccCCCCCCCCCcc
Q 004268 109 LEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLT---YLDLSLN-QLSGRLPQEVGNLKNLK-SLFLDNNHLSGPIPSTL 183 (764)
Q Consensus 109 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~L~~n~i~~~~~~~~ 183 (764)
..|.++++|++|++++|++++++ . |..+++|+ +|++++| .++.+.+..|.++++|+ +|++++|.++.+.+..|
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~~lp-~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~ 176 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLKMFP-D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF 176 (239)
T ss_dssp TSEECCTTCCEEEEEEECCCSCC-C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTT
T ss_pred HHhCCCCCCCEEeCCCCCCcccc-c-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhc
Confidence 89999999999999999999854 3 88888888 9999999 99988888899999999 99999999997777677
Q ss_pred ccCCCccEEEecCcc-CcCCcccccCCc-cccceeeccCcccccccCccccCCCCCCEEEccCC
Q 004268 184 YHLNQLATLCLGYNK-LVGPVTKEVGNM-KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245 (764)
Q Consensus 184 ~~l~~L~~L~l~~n~-i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 245 (764)
.. ++|+.|++++|+ ++.+.+..|..+ ++|++|++++|+++.+.+. .+++|+.|+++++
T Consensus 177 ~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 177 NG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 66 899999999995 998888889999 9999999999999965544 5778999998876
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-26 Score=240.45 Aligned_cols=108 Identities=20% Similarity=0.143 Sum_probs=51.4
Q ss_pred EEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCC----ccccCCC-CCCEEEccCCcCcccCCcccCCC-----CCC
Q 004268 24 FRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP----SEIGALS-RLKVLDLSYNRLTGTIPSEIGSL-----RDL 93 (764)
Q Consensus 24 L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l-----~~L 93 (764)
++++.|++++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+|+...+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3445555555555544444445555555555554443 4444454 55555555555554433333332 455
Q ss_pred CEEecCCCcccccCCcc----CcCC-CCCCEEEccCCcCcccC
Q 004268 94 LDLNLSNNILNGSIPLE----FGNL-KDLDQLRLQGNKLDGLI 131 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~~~----~~~l-~~L~~L~L~~n~l~~~~ 131 (764)
++|+|++|.++...+.. +..+ ++|++|+|++|+++...
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 125 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS 125 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence 55555555554333332 2222 44555555555544433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-25 Score=239.65 Aligned_cols=107 Identities=23% Similarity=0.243 Sum_probs=52.9
Q ss_pred EEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCC----cccCCCC-CCCEEecCCCcccccCCccCcCC-----CCC
Q 004268 48 LVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIP----SEIGSLR-DLLDLNLSNNILNGSIPLEFGNL-----KDL 117 (764)
Q Consensus 48 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~L 117 (764)
+++++|.+++.+|..+...++|++|+|++|.++...+ .+|..++ +|++|+|++|.++...+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4555555555555444444445555555555554333 4455555 55555555555554444444332 555
Q ss_pred CEEEccCCcCcccCCcccc----CC-CCcCEEecccCccccc
Q 004268 118 DQLRLQGNKLDGLIPSSIG----NL-TNLTYLDLSLNQLSGR 154 (764)
Q Consensus 118 ~~L~L~~n~l~~~~~~~~~----~l-~~L~~L~L~~n~l~~~ 154 (764)
++|+|++|.++...+..+. .+ ++|++|+|++|++++.
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 124 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK 124 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGS
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcH
Confidence 5555555555544333222 22 4455555555554433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-23 Score=208.44 Aligned_cols=180 Identities=30% Similarity=0.338 Sum_probs=137.1
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
++.+.++++++.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 56677888888776 5565554 47788888888887777777788888888888888887777777777888888888
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 178 (764)
++|.++.+.+..|.++++|++|+|++|+++++++..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++++
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 88888777777777778888888888888777777777777888888888887777666777777777777777777777
Q ss_pred CCCccccCCCccEEEecCccCcC
Q 004268 179 IPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 179 ~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
.+..+..+++|+.|++++|.+..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 66677777777777777777653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=215.79 Aligned_cols=192 Identities=26% Similarity=0.366 Sum_probs=99.4
Q ss_pred CCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEE
Q 004268 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120 (764)
Q Consensus 41 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 120 (764)
.+++|++|++++|.++.. + .+..+++|++|+|++|.++...+ +..+++|++|+|++|.++++ ..|..+++|++|
T Consensus 39 ~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 344555555555555432 2 34455555555555555553222 55555555555555555432 234555555555
Q ss_pred EccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCc
Q 004268 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200 (764)
Q Consensus 121 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~ 200 (764)
+|++|+++++. .+..+++|++|+|++|+++++.+ +.++++|+.|++++|.++++.+ +..+++|+.|++++|.+.
T Consensus 113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 55555555432 25555555555555555554322 5555555555555555554322 455555555555555555
Q ss_pred CCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCccc
Q 004268 201 GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD 248 (764)
Q Consensus 201 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 248 (764)
.+.+ +..+++|++|++++|++++.. .+..+++|+.|+|++|.++
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 4432 555566666666666665443 2555666666666666665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=218.93 Aligned_cols=201 Identities=22% Similarity=0.237 Sum_probs=107.7
Q ss_pred CCCEEecCCCcccccCCccC--cCCCCCCEEEccCCcCcccCC----ccccCCCCcCEEecccCcccccCCccccCCCCC
Q 004268 92 DLLDLNLSNNILNGSIPLEF--GNLKDLDQLRLQGNKLDGLIP----SSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 165 (764)
+|++|+|++|.+++..+..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++.++.+..|.++++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 34444444444444444444 444444444444444443222 222334445555555555544444444455555
Q ss_pred CeeecccCCCCC---C-CCCccccCCCccEEEecCccCcCCccc---ccCCccccceeeccCcccccccCccccCC---C
Q 004268 166 KSLFLDNNHLSG---P-IPSTLYHLNQLATLCLGYNKLVGPVTK---EVGNMKNLDRLHLNGNNLTGSIPSTIGYL---N 235 (764)
Q Consensus 166 ~~L~L~~n~i~~---~-~~~~~~~l~~L~~L~l~~n~i~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~ 235 (764)
++|+|++|++.+ + ....+..+++|++|+|++|+++.+... .+..+++|++|+|++|.+++..|..+..+ +
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 251 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS 251 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence 555555554331 1 011223444555555555555432211 23455666677777777666555555444 5
Q ss_pred CCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccC
Q 004268 236 LLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG 297 (764)
Q Consensus 236 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 297 (764)
+|+.|+|++|.++ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|++++
T Consensus 252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 7777777777777 3444443 6788888888887754 22 5677788888888887753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=216.71 Aligned_cols=208 Identities=26% Similarity=0.437 Sum_probs=129.9
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCc
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 126 (764)
.+.+..+.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|.++++.+ |..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc
Confidence 3445566665432 24567778888888888874 33 57778888888888888875544 7778888888888888
Q ss_pred CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccc
Q 004268 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206 (764)
Q Consensus 127 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 206 (764)
++++ ..+..+++|++|+|++|+++++. .+.++++|++|++++|.++++.+ +..+++|+.|++++|.+..+.+
T Consensus 97 l~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 97 LKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCCc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 7765 35777778888888888877543 37777777777777777765433 5666666666666666654433
Q ss_pred cCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCccc
Q 004268 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272 (764)
Q Consensus 207 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 272 (764)
+..+++|++|++++|.+++..+ +..+++|+.|+|++|.+++.. .+..+++|+.|+|++|+++
T Consensus 169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 5555555555555555553322 444444555555555444332 2444444444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=220.18 Aligned_cols=154 Identities=19% Similarity=0.162 Sum_probs=84.2
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccc-cCCccCcCCCCCCE-EEcc
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG-SIPLEFGNLKDLDQ-LRLQ 123 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~-L~L~ 123 (764)
+.++.++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+ +.+.+|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45666666666 3444442 456666666666665555566666666666666666533 34455666666554 3444
Q ss_pred CCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeeccc-CCCCCCCCCccccCC-CccEEEecCccCcC
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN-NHLSGPIPSTLYHLN-QLATLCLGYNKLVG 201 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~-~L~~L~l~~n~i~~ 201 (764)
+|+++.+.+++|.++++|++|++++|+++.+.+..+....++..|++.+ |.+..+....|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 5666666666666666666666666666655555555555555555533 344444444443332 24444444444443
Q ss_pred C
Q 004268 202 P 202 (764)
Q Consensus 202 ~ 202 (764)
+
T Consensus 169 i 169 (350)
T 4ay9_X 169 I 169 (350)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=217.38 Aligned_cols=241 Identities=17% Similarity=0.151 Sum_probs=197.1
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccC-CcccCCCCCCCE-Eec
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTI-PSEIGSLRDLLD-LNL 98 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~-L~L 98 (764)
-+++++++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|+|.+.+ +.+|.++++|++ +.+
T Consensus 11 ~~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 11 NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TTEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CCEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 367899999998 778776 468999999999999888889999999999999999986544 568999999876 667
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEeccc-CcccccCCccccCCC-CCCeeecccCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL-NQLSGRLPQEVGNLK-NLKSLFLDNNHLS 176 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~L~~n~i~ 176 (764)
++|+++.+.+.+|.++++|++|++++|++..+.+..+....++..|++.+ |++..+.+..|.++. .++.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78999999999999999999999999999998888888888899999966 688888888888875 6899999999999
Q ss_pred CCCCCccccCCCccEEEec-CccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCC-cccCCCCcC
Q 004268 177 GPIPSTLYHLNQLATLCLG-YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN-RLDGPIPPT 254 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~-~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~ 254 (764)
.+.+..|. ..+|++|+++ +|.++.++.+.|..+++|++|++++|+++.+.+..| .+|+.|.+.++ .++ ..| .
T Consensus 168 ~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~-~lP-~ 241 (350)
T 4ay9_X 168 EIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLK-KLP-T 241 (350)
T ss_dssp EECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCC-CCC-C
T ss_pred CCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcC-cCC-C
Confidence 77766664 4689999997 478888888888999999999999999886655444 45555554443 344 444 4
Q ss_pred CcCCCCCCeEEccCCc
Q 004268 255 IGNLTNLIALDLSSNQ 270 (764)
Q Consensus 255 ~~~l~~L~~L~L~~n~ 270 (764)
+..+++|+.++++++.
T Consensus 242 l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 242 LEKLVALMEASLTYPS 257 (350)
T ss_dssp TTTCCSCCEEECSCHH
T ss_pred chhCcChhhCcCCCCc
Confidence 6777778888876653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-23 Score=205.45 Aligned_cols=180 Identities=28% Similarity=0.292 Sum_probs=142.4
Q ss_pred CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEc
Q 004268 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 122 (764)
...++++++++.++ .+|..+. ++|+.|+|++|.+++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35678888888888 4555554 57888888888888777778888888888888888888877777888888888888
Q ss_pred cCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCC
Q 004268 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 123 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
++|+++.+++..|.++++|++|+|++|+++++.+..|.++++|++|+|++|.++++.+..|..+++|++|+|++|++..+
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 88888888777888888888888888888877777778888888888888888877766777777777777777777777
Q ss_pred cccccCCccccceeeccCccccc
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
.+..|..+++|+.|++++|.+..
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCT
T ss_pred CHHHHhCCCCCCEEEeeCCceeC
Confidence 66667777777777777777654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=218.70 Aligned_cols=226 Identities=18% Similarity=0.126 Sum_probs=184.9
Q ss_pred CCeeEEEeCCCCccccCCc---cccCCCCCcEEEcCCCcCcccCCccc--cCCCCCCEEEccCCcCcccCC----cccCC
Q 004268 19 PNLVTFRIWGTLLSGRMPS---EIGALSKLEKLVLSHNSLTGRIPSEI--GALSRLKVLDLSYNRLTGTIP----SEIGS 89 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~---~~~~l~~L~~L~Ls~n~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~ 89 (764)
..++.|.+.++.++...-. .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578899998887532111 12345679999999999998898888 899999999999999996544 44567
Q ss_pred CCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcc---cC-CccccCCCCcCEEecccCcccccCCc---cccCC
Q 004268 90 LRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG---LI-PSSIGNLTNLTYLDLSLNQLSGRLPQ---EVGNL 162 (764)
Q Consensus 90 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~---~~-~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~l 162 (764)
+++|++|+|++|.++++.+..|.++++|++|+|++|++.+ +. +..+..+++|++|+|++|+++.+... .+.++
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 8999999999999998888999999999999999999864 22 23357899999999999999744321 35788
Q ss_pred CCCCeeecccCCCCCCCCCccccC---CCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCE
Q 004268 163 KNLKSLFLDNNHLSGPIPSTLYHL---NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDE 239 (764)
Q Consensus 163 ~~L~~L~L~~n~i~~~~~~~~~~l---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 239 (764)
++|++|+|++|.+++..|..+..+ ++|++|+|++|+++.++...+ ++|++|+|++|+++++ |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999998767666666 699999999999997654432 7999999999999965 33 678899999
Q ss_pred EEccCCcccC
Q 004268 240 LHLSHNRLDG 249 (764)
Q Consensus 240 L~L~~n~l~~ 249 (764)
|+|++|.+++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999974
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-25 Score=240.28 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=136.4
Q ss_pred EccCCcCcccCCcccCCCCCCCEEecCCCcccccCC----ccCcCCCCCCEEEccCCcCc---ccCCccc-------cCC
Q 004268 73 DLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIP----LEFGNLKDLDQLRLQGNKLD---GLIPSSI-------GNL 138 (764)
Q Consensus 73 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~---~~~~~~~-------~~l 138 (764)
.++...+. .++..+..+++|++|+|++|.++...+ ..|..+++|++|+|++|.+. +..|..+ ..+
T Consensus 15 ~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~ 93 (386)
T 2ca6_A 15 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93 (386)
T ss_dssp SCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTC
T ss_pred CCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhC
Confidence 33444444 455677777888888888888875533 33667788888888776444 2223333 455
Q ss_pred CCcCEEecccCcccc----cCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCc----
Q 004268 139 TNLTYLDLSLNQLSG----RLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNM---- 210 (764)
Q Consensus 139 ~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l---- 210 (764)
++|++|+|++|.++. ..+..+.++++|++|+|++|.++...+..+.. .+..+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~l~~l~~~~ 153 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------ALQELAVNK 153 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------HHHHHHHHH
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------HHHHHhhhh
Confidence 666666666666654 23444555566666666666554221111111 11111
Q ss_pred -----cccceeeccCccccc-ccC---ccccCCCCCCEEEccCCcccC-----CCCcCCcCCCCCCeEEccCCccc----
Q 004268 211 -----KNLDRLHLNGNNLTG-SIP---STIGYLNLLDELHLSHNRLDG-----PIPPTIGNLTNLIALDLSSNQLS---- 272 (764)
Q Consensus 211 -----~~L~~L~L~~n~l~~-~~~---~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~n~l~---- 272 (764)
++|++|++++|+++. ..+ ..+..+++|+.|+|++|.++. ..+..+..+++|+.|+|++|.++
T Consensus 154 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~ 233 (386)
T 2ca6_A 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233 (386)
T ss_dssp HHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH
T ss_pred hcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH
Confidence 455555555555541 111 234455566666666665542 12224555666666666666663
Q ss_pred CCCCccccCCCCCCeEeccCccccCC----CCCCC--CCCCccceEEccCCcCcc----CCChhh-hcccccceeecccc
Q 004268 273 GLLPREVGNLKYLASLSLNGNILIGP----IPPTI--GYLTNLTYLNLGYNRLSS----SIPPEL-MNCSQLLNLVLSHN 341 (764)
Q Consensus 273 ~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~--~~l~~L~~L~ls~N~l~~----~~~~~~-~~l~~L~~L~ls~N 341 (764)
...+..+..+++|+.|+|++|.+.+. ++..+ +.+++|++|+|++|.++. .+|..+ .++++|+.|++++|
T Consensus 234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N 313 (386)
T 2ca6_A 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313 (386)
T ss_dssp HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTS
T ss_pred HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCC
Confidence 23444555556666666666655432 22233 225666666666666664 244444 44566666666666
Q ss_pred ccccCC
Q 004268 342 SLSGSI 347 (764)
Q Consensus 342 ~l~~~~ 347 (764)
++++..
T Consensus 314 ~l~~~~ 319 (386)
T 2ca6_A 314 RFSEED 319 (386)
T ss_dssp BSCTTS
T ss_pred cCCcch
Confidence 666444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-25 Score=240.64 Aligned_cols=255 Identities=20% Similarity=0.198 Sum_probs=163.5
Q ss_pred EcCCCcCcccCCccccCCCCCCEEEccCCcCcccC----CcccCCCCCCCEEecCCCccc---ccCCcc-------CcCC
Q 004268 49 VLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTI----PSEIGSLRDLLDLNLSNNILN---GSIPLE-------FGNL 114 (764)
Q Consensus 49 ~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~L~~n~l~---~~~~~~-------~~~l 114 (764)
.++...+. .++..+..+++|++|+|++|.|+... +..|..+++|++|+|++|.+. +..|.. |..+
T Consensus 15 ~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~ 93 (386)
T 2ca6_A 15 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93 (386)
T ss_dssp SCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTC
T ss_pred CCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhC
Confidence 33444444 46677888999999999999998653 345889999999999997554 333433 4789
Q ss_pred CCCCEEEccCCcCcc----cCCccccCCCCcCEEecccCcccccCCccccC----C---------CCCCeeecccCCCCC
Q 004268 115 KDLDQLRLQGNKLDG----LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN----L---------KNLKSLFLDNNHLSG 177 (764)
Q Consensus 115 ~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----l---------~~L~~L~L~~n~i~~ 177 (764)
++|++|+|++|.++. ..+..+..+++|++|+|++|.++...+..+.. + ++|++|+|++|+++.
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 999999999999997 35667889999999999999997554444443 3 777777777777752
Q ss_pred C-CC---CccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCccc----C
Q 004268 178 P-IP---STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD----G 249 (764)
Q Consensus 178 ~-~~---~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~----~ 249 (764)
. .+ ..+..+++|++|++++|.+...... ...+..+..+++|+.|+|++|.++ .
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~-------------------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~ 234 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE-------------------HLLLEGLAYCQELKVLDLQDNTFTHLGSS 234 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH-------------------HHHHTTGGGCTTCCEEECCSSCCHHHHHH
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHH-------------------HHHHHHhhcCCCccEEECcCCCCCcHHHH
Confidence 1 11 2334455555555555554411000 012224445555555555555553 2
Q ss_pred CCCcCCcCCCCCCeEEccCCcccCC----CCcccc--CCCCCCeEeccCccccC----CCCCCC-CCCCccceEEccCCc
Q 004268 250 PIPPTIGNLTNLIALDLSSNQLSGL----LPREVG--NLKYLASLSLNGNILIG----PIPPTI-GYLTNLTYLNLGYNR 318 (764)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~--~l~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~ls~N~ 318 (764)
.++..+..+++|+.|+|++|.+++. .+..+. .+++|+.|+|++|.+.+ .+|..+ ..+++|++|+|++|+
T Consensus 235 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 235 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred HHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 3344555566666666666666543 233342 26667777777776665 244444 446777888888887
Q ss_pred CccCC
Q 004268 319 LSSSI 323 (764)
Q Consensus 319 l~~~~ 323 (764)
+++..
T Consensus 315 l~~~~ 319 (386)
T 2ca6_A 315 FSEED 319 (386)
T ss_dssp SCTTS
T ss_pred CCcch
Confidence 77544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-24 Score=226.79 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=128.2
Q ss_pred CcEEEcCCCcCcccCCccccCC--CCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCccccc-CCccCcCCCCCCEEE
Q 004268 45 LEKLVLSHNSLTGRIPSEIGAL--SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLR 121 (764)
Q Consensus 45 L~~L~Ls~n~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~ 121 (764)
++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.++.. .+..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555666665554 2334444 5566666666665543333 33455566666666555433 344455555555555
Q ss_pred ccCCcCcccCCccccCCCCcCEEecccC-ccccc-CCccccCCCCCCeeecccC-CCCCCCCCccccCCCccEEEecCcc
Q 004268 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLN-QLSGR-LPQEVGNLKNLKSLFLDNN-HLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 122 L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
|++|.+++..+..+..+++|++|+|++| .+++. .+..+.++++|++|++++| .+++..
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~------------------- 185 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH------------------- 185 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH-------------------
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHH-------------------
Confidence 5555555444445555555555555555 34421 2333444555555555555 443210
Q ss_pred CcCCcccccCCcc-ccceeeccCc--ccc-cccCccccCCCCCCEEEccCCc-ccCCCCcCCcCCCCCCeEEccCCc-cc
Q 004268 199 LVGPVTKEVGNMK-NLDRLHLNGN--NLT-GSIPSTIGYLNLLDELHLSHNR-LDGPIPPTIGNLTNLIALDLSSNQ-LS 272 (764)
Q Consensus 199 i~~~~~~~~~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~-l~ 272 (764)
.+..+..++ +|++|++++| .++ +..+..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.
T Consensus 186 ----~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~ 261 (336)
T 2ast_B 186 ----VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 261 (336)
T ss_dssp ----HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred ----HHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCC
Confidence 122233444 4555555555 222 2233344555666666666665 444444555666666666666663 22
Q ss_pred CCCCccccCCCCCCeEeccCccccCCCCCCCCCC-CccceEEccCCcCccCCChhhh
Q 004268 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYL-TNLTYLNLGYNRLSSSIPPELM 328 (764)
Q Consensus 273 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~ 328 (764)
......+..+++|+.|++++| +.. ..+..+ .+|+.|++++|++++..|..+.
T Consensus 262 ~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 262 PETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp GGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred HHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 222224556666666666666 221 233333 2355566677777666555444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-24 Score=226.20 Aligned_cols=198 Identities=18% Similarity=0.219 Sum_probs=151.8
Q ss_pred CeeEEEeCCCCccccCCccccCC--CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCccc-CCcccCCCCCCCEE
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGAL--SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGT-IPSEIGSLRDLLDL 96 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L 96 (764)
.++.|+++++.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.++.. .+..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3788999999876 4667777 8999999999999977665 56789999999999999855 77889999999999
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCC-cCccc-CCccccCCCCcCEEecccC-ccccc-CCccccCCC-CCCeeecc
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGN-KLDGL-IPSSIGNLTNLTYLDLSLN-QLSGR-LPQEVGNLK-NLKSLFLD 171 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~-~L~~L~L~ 171 (764)
+|++|.+++..+..|..+++|++|+|++| .+++. .+..+.++++|++|++++| .+++. .+..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999998778888999999999999999 67752 4566888999999999999 88854 456678888 99999999
Q ss_pred cCC--CC-CCCCCccccCCCccEEEecCcc-CcCCcccccCCccccceeeccCc
Q 004268 172 NNH--LS-GPIPSTLYHLNQLATLCLGYNK-LVGPVTKEVGNMKNLDRLHLNGN 221 (764)
Q Consensus 172 ~n~--i~-~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~l~~L~~L~L~~n 221 (764)
+|. ++ ...+..+..+++|++|++++|. ++......+..+++|++|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 984 43 1222344455566666666555 33333334444455555555544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.9e-23 Score=208.45 Aligned_cols=166 Identities=15% Similarity=0.141 Sum_probs=126.8
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcH---------------HHHHHHHHHHHHHHhcCCC
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEP---------------AFLESFQTEARLLSQIRHR 567 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp 567 (764)
+......|.+.+.||+|+||.||+|.+.+|+.||+|++........ .....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3344556778899999999999999887899999999865332110 134678999999999984
Q ss_pred ceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 568 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
+++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||+||| ++||+||||||+||+++
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 555554433 44699999999999988 431 123469999999999999 89999999999999999
Q ss_pred CCCCEEEeeeccccccCCCCCCceeccccccccccccccc----------CCCCccchHHHH
Q 004268 648 SNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYT----------MAVTEKCDVYSF 699 (764)
Q Consensus 648 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Diwsl 699 (764)
++.+||+|||+|+. +..+.|||.+.+ ..|+..+|+|.+
T Consensus 228 -~~~vkl~DFG~a~~-------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE-------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp -TTEEEECCCTTCEE-------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred -CCcEEEEECCCCeE-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999999999963 335688998654 345555666653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=187.73 Aligned_cols=180 Identities=25% Similarity=0.241 Sum_probs=108.5
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.++++++.++. +|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.++.+.+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 345555555553 23222 235666666666666554555566666666666666666555555666666666666666
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 205 (764)
+++++++..|.++++|++|+|++|+++++.+..|.++++|++|++++|.++++.+..+..+++|+.|++++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~----- 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD----- 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC-----
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee-----
Confidence 666555555666666666666666666555555666666666666666666555555666666666666666544
Q ss_pred ccCCccccceeeccCcccccccCccccCCC
Q 004268 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLN 235 (764)
Q Consensus 206 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 235 (764)
..+++|++|+++.|++++.+|..++.++
T Consensus 162 --~~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 162 --CTCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp --CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred --cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence 2345677777777777776666555443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.9e-21 Score=186.42 Aligned_cols=182 Identities=26% Similarity=0.256 Sum_probs=154.3
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 100 (764)
-+.+++.+++++ .+|..+ .++|++|++++|+++++.+..|..+++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 356788888886 455544 45899999999999987777889999999999999999977777788999999999999
Q ss_pred CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCC
Q 004268 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP 180 (764)
Q Consensus 101 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 180 (764)
|.++++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++++.+..|.++++|+.|++++|.+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~---- 161 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD---- 161 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC----
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee----
Confidence 9999887778899999999999999999888888899999999999999999888878899999999999999775
Q ss_pred CccccCCCccEEEecCccCcCCcccccCCccc
Q 004268 181 STLYHLNQLATLCLGYNKLVGPVTKEVGNMKN 212 (764)
Q Consensus 181 ~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~ 212 (764)
..+++|+.|+++.|++++..+..+..++.
T Consensus 162 ---~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 162 ---CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 34578889999999998777776665544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=206.46 Aligned_cols=283 Identities=16% Similarity=0.114 Sum_probs=172.8
Q ss_pred CCCCcEEEcCCCcCcccCCccccC-CCCCCEEEccCCcCc--ccCCcccCCCCCCCEEecCCCcccccCCccCcC-----
Q 004268 42 LSKLEKLVLSHNSLTGRIPSEIGA-LSRLKVLDLSYNRLT--GTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGN----- 113 (764)
Q Consensus 42 l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----- 113 (764)
+.+++.|.++++ +.......+.. +++|++|||++|+|. ......+ +.+..+.+..|. +.+.+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~ 96 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGV 96 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhccccccc
Confidence 456677777654 21111122333 677888888888777 3222222 234556666653 45567777
Q ss_pred ---CCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccC----CCCCCCCCccccC
Q 004268 114 ---LKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNN----HLSGPIPSTLYHL 186 (764)
Q Consensus 114 ---l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n----~i~~~~~~~~~~l 186 (764)
+++|++|+|.+ .++.+.+.+|.+|++|+.|++++|.+..+.+.+|.++.++..+.+..+ ....+...+|.++
T Consensus 97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~ 175 (329)
T 3sb4_A 97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG 175 (329)
T ss_dssp EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence 88888888887 777777778888888888888888887777888887777777766553 2233555667777
Q ss_pred CCcc-EEEecCccCcCCccccc---CCccccceeeccCcccccccCccc-cCCCCCCEEEccCCcccCCCCcCCcCCCCC
Q 004268 187 NQLA-TLCLGYNKLVGPVTKEV---GNMKNLDRLHLNGNNLTGSIPSTI-GYLNLLDELHLSHNRLDGPIPPTIGNLTNL 261 (764)
Q Consensus 187 ~~L~-~L~l~~n~i~~~~~~~~---~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 261 (764)
..|+ .+.+.... .+....+ ....++..+.+.++-.. .....+ ..+++|+.|+|++|.++.+...+|.++++|
T Consensus 176 ~~L~~~i~~~~~~--~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L 252 (329)
T 3sb4_A 176 EPLETTIQVGAMG--KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL 252 (329)
T ss_dssp CCCEEEEEECTTC--CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred cccceeEEecCCC--cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence 7776 45544322 1111111 12455566665544222 111111 235677777777777776666677777777
Q ss_pred CeEEccCCcccCCCCccccCCCCCC-eEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceee
Q 004268 262 IALDLSSNQLSGLLPREVGNLKYLA-SLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLV 337 (764)
Q Consensus 262 ~~L~L~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 337 (764)
+.|+|.+| +..+...+|.++.+|+ .+++.+ .++.+.+.+|..+++|+.|++++|+++.+.+.+|.++++|+.|+
T Consensus 253 ~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 253 LKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 77777776 6556666677777776 677666 55555556666666666666666666655556666666666655
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-21 Score=194.38 Aligned_cols=187 Identities=24% Similarity=0.331 Sum_probs=114.7
Q ss_pred EEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCc
Q 004268 23 TFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102 (764)
Q Consensus 23 ~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 102 (764)
.+.+.++.+++. ..+..+++|++|++++|.+++. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|.
T Consensus 28 ~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~ 101 (291)
T 1h6t_A 28 KDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK 101 (291)
T ss_dssp HHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhcCCCcccc--cchhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCc
Confidence 334445544432 2234556666666666666643 2 36666666666666666664332 6666666666666666
Q ss_pred ccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCc
Q 004268 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPST 182 (764)
Q Consensus 103 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 182 (764)
++.+ ..+..+++|++|+|++|+++++ ..+..+++|++|++++|+++++ ..+..+++|++|++++|.++++.+
T Consensus 102 l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 102 VKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--
Confidence 6643 2366666666666666666654 3566666666666666666654 456666667777777666665443
Q ss_pred cccCCCccEEEecCccCcCCcccccCCccccceeeccCccccc
Q 004268 183 LYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225 (764)
Q Consensus 183 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 225 (764)
+..+++|+.|++++|.++.+. .+..+++|+.|++++|.++.
T Consensus 174 l~~l~~L~~L~L~~N~i~~l~--~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GTTCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEEEEEEC
T ss_pred hcCCCccCEEECCCCcCCCCh--hhccCCCCCEEECcCCcccC
Confidence 666666777777777666542 36667777777777777664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=208.93 Aligned_cols=194 Identities=22% Similarity=0.233 Sum_probs=91.1
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecC
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 99 (764)
+++.|++++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 55555555555543 343332 44555555555555 233 223455555555555553 333 332 45555555
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCC
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 179 (764)
+|.++++.+ .+++|+.|+|++|.++++++ .+++|++|+|++|+++++++ |. ++|+.|+|++|.|+.+.
T Consensus 129 ~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N~L~~lp 196 (571)
T 3cvr_A 129 NNQLTMLPE----LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTNLLESLP 196 (571)
T ss_dssp SSCCSCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSSCCSSCC
T ss_pred CCcCCCCCC----cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCCCCCchh
Confidence 555543222 34455555555555544322 23445555555555543222 33 44445555544444222
Q ss_pred CCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCC
Q 004268 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNL 258 (764)
Q Consensus 180 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 258 (764)
. +.. +| +...+.|+.|+|++|+++. +|..+..+++|+.|+|++|.+++..|..+..+
T Consensus 197 ~--~~~--~L-----------------~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 197 A--VPV--RN-----------------HHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp C--CC---------------------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred h--HHH--hh-----------------hcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 1 211 22 0111222666777776663 44445556777777777777766555555443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-20 Score=182.64 Aligned_cols=133 Identities=27% Similarity=0.348 Sum_probs=65.8
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
+|++|+|++|+|+...+..|..+++|++|+|++|.++++.+.+|.++++|++|+|++|+++.+++..|.++++|++|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 44444444444444444444444444444554444444444444445555555555555544444444445555555555
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~ 200 (764)
+|+++++.+..|.++++|+.|+|++|.++++.+..|..+++|+.|+|++|.+.
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 55555444444555555555555555555444444555555555555555443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=199.26 Aligned_cols=175 Identities=27% Similarity=0.251 Sum_probs=89.1
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccC-CCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIG-SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
.+++++++++. +|..+. +.++.|+|++|+|++..+..|. .+++|++|+|++|.|+.+.+.+|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45555555552 333332 2355555555555544444444 5555555555555555555555555555555555555
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCcc---ccCCCccEEEecCccCcCC
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTL---YHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~---~~l~~L~~L~l~~n~i~~~ 202 (764)
+|+.+.+..|.++++|++|+|++|+|+.+.+..|.++++|+.|+|++|.++.+....| ..+++|+.|+|++|++..+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 5555555555555555555555555555555555555555555555555554443333 3345555555555555544
Q ss_pred cccccCCccc--cceeeccCcccc
Q 004268 203 VTKEVGNMKN--LDRLHLNGNNLT 224 (764)
Q Consensus 203 ~~~~~~~l~~--L~~L~L~~n~l~ 224 (764)
....+..++. ++.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 4444444443 244555555443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=200.06 Aligned_cols=179 Identities=26% Similarity=0.201 Sum_probs=162.2
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCcccc-CCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIG-ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
.-+++++++++++ .+|..+. ..++.|+|++|+|+++.+..|. ++++|++|+|++|+|+...+.+|..+++|++|+|
T Consensus 19 ~~~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 19 ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp ETTEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 4568999999998 5777664 4699999999999998888898 9999999999999999888889999999999999
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccc---cCCCCCCeeecccCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEV---GNLKNLKSLFLDNNHL 175 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~i 175 (764)
++|.|+.+.+..|.++++|++|+|++|+|..+.+..|.++++|++|+|++|+++.+.+..| ..+++|+.|+|++|+|
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 9999999988899999999999999999999999999999999999999999998877777 5799999999999999
Q ss_pred CCCCCCccccCCC--ccEEEecCccCcC
Q 004268 176 SGPIPSTLYHLNQ--LATLCLGYNKLVG 201 (764)
Q Consensus 176 ~~~~~~~~~~l~~--L~~L~l~~n~i~~ 201 (764)
+.+.+..+..++. ++.|+|++|.+..
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred CccCHHHhhhccHhhcceEEecCCCccC
Confidence 9888788888887 4889999999873
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.7e-20 Score=180.68 Aligned_cols=153 Identities=24% Similarity=0.325 Sum_probs=128.7
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 100 (764)
-+.+++.+++++ .+|..+. +++++|+|++|+|+++.+..|..+++|++|+|++|+|++..|.+|.++++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 357888888887 5666554 6888888888888887777888888888888888888877788888888888888888
Q ss_pred CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 101 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
|.|+.+.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++++.+..|..+++|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 8888777777888888888888888888888888888888888888888888888778888888888888888875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=192.96 Aligned_cols=165 Identities=29% Similarity=0.386 Sum_probs=97.0
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
..+.+..+.+++..+ +..+++|++|++++|.++.. + .+..+++|++|+|++|.++++.+ +.++++|++|+|++|
T Consensus 27 ~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 344555555554322 45566777777777777643 2 36667777777777777765443 666777777777777
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 205 (764)
.++++ ..+..+++|++|+|++|+++++ ..+..+++|+.|++++|.++++ ..+..+++|+.|++++|++..+.+
T Consensus 101 ~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 101 KVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp CCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred cCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 77654 2366666777777777766643 3456666666666666666543 345555555555555555544332
Q ss_pred ccCCccccceeeccCcccc
Q 004268 206 EVGNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 206 ~~~~l~~L~~L~L~~n~l~ 224 (764)
+..+++|++|++++|.++
T Consensus 174 -l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp -GTTCTTCCEEECCSSCCC
T ss_pred -hcCCCccCEEECCCCcCC
Confidence 444444444444444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.4e-20 Score=204.18 Aligned_cols=189 Identities=24% Similarity=0.314 Sum_probs=105.7
Q ss_pred CCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEec
Q 004268 116 DLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLG 195 (764)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 195 (764)
+|+.|+|++|.++++++.. .++|++|+|++|+|+.+ | ..+++|++|+|++|.++++.. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l---~~~L~~L~Ls~N~l~~i-p---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNL---PPQITVLEITQNALISL-P---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSCCCSCC---CTTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCccCHhH---cCCCCEEECcCCCCccc-c---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECC
Confidence 6666666666666543322 25566666666666633 2 234566666666666654322 322 44445555
Q ss_pred CccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCC
Q 004268 196 YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL 275 (764)
Q Consensus 196 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 275 (764)
+|+++.++. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+++++
T Consensus 129 ~N~l~~lp~----------------------------~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l- 175 (571)
T 3cvr_A 129 NNQLTMLPE----------------------------LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFL- 175 (571)
T ss_dssp SSCCSCCCC----------------------------CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-
T ss_pred CCcCCCCCC----------------------------cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCc-
Confidence 444443222 34455555555555553 222 345555555555555542
Q ss_pred CccccCCCCCCeEeccCccccCCCCCCCCCCCcc-------ceEEccCCcCccCCChhhhcccccceeeccccccccCCc
Q 004268 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL-------TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIP 348 (764)
Q Consensus 276 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 348 (764)
|. |. ++|+.|+|++|+|+. +|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|
T Consensus 176 p~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 176 PE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp CC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred ch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 22 33 556666666665552 233 332 44 88888888888 567777778888888888888887777
Q ss_pred hhcccccc
Q 004268 349 SEIGNLIF 356 (764)
Q Consensus 349 ~~~~~l~~ 356 (764)
..+..+..
T Consensus 248 ~~l~~l~~ 255 (571)
T 3cvr_A 248 ESLSQQTA 255 (571)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhc
Confidence 77766543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-20 Score=181.41 Aligned_cols=156 Identities=19% Similarity=0.197 Sum_probs=113.2
Q ss_pred CEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCC-ccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccC
Q 004268 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP-REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316 (764)
Q Consensus 238 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 316 (764)
+.+++++|.++. +|..+. ..++.|+|++|.++++.+ ..|..+++|+.|+|++|+++++.+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 466666666663 333332 345677777777766533 4467777777777777777766666777777777777777
Q ss_pred CcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccC
Q 004268 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 317 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 396 (764)
|++++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|++++|+++|..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776666667777788888888888877777777778888888888888887777788888888888888888876655
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.83 E-value=4.8e-19 Score=189.12 Aligned_cols=265 Identities=11% Similarity=0.092 Sum_probs=130.9
Q ss_pred CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEc
Q 004268 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 122 (764)
..++.+.+.. .++.+...+|.++ +|+.++|.++ ++.+...+|.++ +|+.+.|.+ .++.+...+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4444444443 2333444444443 4555555444 443444444442 355555543 344444445555555555555
Q ss_pred cCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCC
Q 004268 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 123 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
.+|.++.+...+|. +.+|+.+.|..+ ++.+...+|.++++|+.+.+..| +..+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-------------------------l~~I 240 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-------------------------VSTI 240 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-------------------------CCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-------------------------ccCc
Confidence 55555544444444 344555555422 44444445555555555555443 3334
Q ss_pred cccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCccc-----CCCCcCCcCCCCCCeEEccCCcccCCCCc
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLD-----GPIPPTIGNLTNLIALDLSSNQLSGLLPR 277 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 277 (764)
...+|.+ .+|+.+.+. +.++.+...+|..+++|+.+++.+|.+. .+...+|.++++|+.++|. +.+..+...
T Consensus 241 ~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~ 317 (401)
T 4fdw_A 241 GQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQG 317 (401)
T ss_dssp CTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTT
T ss_pred ccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhh
Confidence 4444444 444444442 3334344444555555555555444433 3444556666666666665 335545555
Q ss_pred cccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccc-ccceeeccccccc
Q 004268 278 EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS-QLLNLVLSHNSLS 344 (764)
Q Consensus 278 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~ 344 (764)
+|.++.+|+.+.|..| ++.+...+|..+ +|+.+++++|.+.......|.+++ +++.|++..+.+.
T Consensus 318 aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 318 LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 5666666666666443 444455556665 666666666665554555555553 5566666665543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=208.43 Aligned_cols=188 Identities=23% Similarity=0.344 Sum_probs=95.2
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 100 (764)
+..+.+..+.+...++ +..+++|+.|++++|.++.+ + .+..+++|+.|+|++|+|++..+ +..+++|++|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 4444555555543322 34555666666666666532 2 35556666666666666654332 55556666666666
Q ss_pred CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCC
Q 004268 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP 180 (764)
Q Consensus 101 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 180 (764)
|.++.+ ..|..+++|++|+|++|.+..+ ..+..+++|+.|+|++|.++++ ..+..+++|+.|+|++|.++++.+
T Consensus 97 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 665532 1455555555555555555543 2355555555555555555543 345555555555555555544332
Q ss_pred CccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccc
Q 004268 181 STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 181 ~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 224 (764)
+..+++|+.|+|++|.+..+ ..+..+++|+.|+|++|.+.
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence 44444444444444444432 12334444444444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.6e-19 Score=188.60 Aligned_cols=269 Identities=10% Similarity=0.062 Sum_probs=196.0
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 94 (764)
+..+..++.+.+-.+ ++.+-..+|..+ +|+.+.+..+ ++.+...+|.++ +|+.+.|.+ .++.+...+|.++++|+
T Consensus 109 ~~~~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~ 183 (401)
T 4fdw_A 109 TEILKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLK 183 (401)
T ss_dssp EEECSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCC
T ss_pred EEecCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCC
Confidence 344567777777654 666777788886 7999999887 777888999985 799999997 77778889999999999
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 174 (764)
.++|++|.++.+...+|. ..+|+.+.|..+ +..+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.
T Consensus 184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~ 258 (401)
T 4fdw_A 184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG 258 (401)
T ss_dssp EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred eeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence 999999999999999998 589999999855 88899999999999999999985 67788899998 88999999 455
Q ss_pred CCCCCCCccccCCCccEEEecCccCc-----CCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccC
Q 004268 175 LSGPIPSTLYHLNQLATLCLGYNKLV-----GPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249 (764)
Q Consensus 175 i~~~~~~~~~~l~~L~~L~l~~n~i~-----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 249 (764)
++.+...+|.++++|+.+++.+|.+. .+...+|.++++|+.+.+. +.++ .
T Consensus 259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~------------------------~ 313 (401)
T 4fdw_A 259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR------------------------I 313 (401)
T ss_dssp CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC------------------------E
T ss_pred ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE------------------------E
Confidence 77788888999999999988887665 3444445555555555554 2244 3
Q ss_pred CCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCC-ccceEEccCCcCc
Q 004268 250 PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT-NLTYLNLGYNRLS 320 (764)
Q Consensus 250 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~ls~N~l~ 320 (764)
+...+|.++++|+.++|..| +..+...+|.++ +|+.+++++|.+.......|..++ +++.|++..+.+.
T Consensus 314 I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 314 LGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp ECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 44445555555555555333 443444555555 555555555555544444555543 5566666555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-21 Score=202.16 Aligned_cols=285 Identities=13% Similarity=0.077 Sum_probs=213.7
Q ss_pred cCCCeeEEEeCCCCccccCCccccC-CCCCcEEEcCCCcCc--ccCCccccCCCCCCEEEccCCcCcccCCcccCC----
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGA-LSKLEKLVLSHNSLT--GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGS---- 89 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~-l~~L~~L~Ls~n~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~---- 89 (764)
.+++++.|.+.|+ +....-..+.. +++|+.|||++|+|. ......+.. ++.+.+..|.| .+.+|.+
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~---~~~~~~~~~~I---~~~aF~~~~~~ 95 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPN---GKFYIYMANFV---PAYAFSNVVNG 95 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGG---GCCEEECTTEE---CTTTTEEEETT
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccc---ccccccccccc---CHHHhcccccc
Confidence 4677999999876 32222234444 789999999999998 444333333 56677777744 4577888
Q ss_pred ----CCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCc----ccccCCccccC
Q 004268 90 ----LRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ----LSGRLPQEVGN 161 (764)
Q Consensus 90 ----l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~----l~~~~~~~~~~ 161 (764)
+++|+.|+|++ .++.+.+.+|.++++|++|++++|.+..+.+.+|.++.++..+.+..+. ...+...+|.+
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~ 174 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE 174 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence 99999999999 8888999999999999999999999999999999999989888877643 33455667888
Q ss_pred CCCCC-eeecccCCCCCCCCCcc---ccCCCccEEEecCccCcCCccccc-CCccccceeeccCcccccccCccccCCCC
Q 004268 162 LKNLK-SLFLDNNHLSGPIPSTL---YHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNL 236 (764)
Q Consensus 162 l~~L~-~L~L~~n~i~~~~~~~~---~~l~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 236 (764)
+..|+ .+.+....- +....+ ....++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+...+|..+.+
T Consensus 175 ~~~L~~~i~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~ 251 (329)
T 3sb4_A 175 GEPLETTIQVGAMGK--LEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY 251 (329)
T ss_dssp SCCCEEEEEECTTCC--HHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred ccccceeEEecCCCc--HHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence 88887 555543321 111111 12455666766655221 111122 23688999999988888888888999999
Q ss_pred CCEEEccCCcccCCCCcCCcCCCCCC-eEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEc
Q 004268 237 LDELHLSHNRLDGPIPPTIGNLTNLI-ALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314 (764)
Q Consensus 237 L~~L~L~~n~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 314 (764)
|++|+|++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|.++++|+.++.
T Consensus 252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999999888 7778888899999998 999988 777788888999999999999899888888888999999988864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-20 Score=210.03 Aligned_cols=171 Identities=26% Similarity=0.334 Sum_probs=82.6
Q ss_pred CCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEE
Q 004268 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDEL 240 (764)
Q Consensus 161 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 240 (764)
.+++|+.|++++|.+..+. .+..+++|+.|+|++|.+..+.+ +..+++|+.|+|++|.+++. ..+..+++|+.|
T Consensus 41 ~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEE
Confidence 3444444444444444321 23444444444444444443332 44444444444444444421 134445555555
Q ss_pred EccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 241 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
+|++|.+.+. ..+..+++|+.|+|++|.++++ ..+..+++|+.|+|++|.+.+..| +..+++|+.|+|++|+|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 5555555432 2345555555555555555533 345555555555555555554433 555555555555555555
Q ss_pred cCCChhhhcccccceeecccccccc
Q 004268 321 SSIPPELMNCSQLLNLVLSHNSLSG 345 (764)
Q Consensus 321 ~~~~~~~~~l~~L~~L~ls~N~l~~ 345 (764)
+. ..+..+++|+.|+|++|++++
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcC
Confidence 32 235555555555555555553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-19 Score=177.67 Aligned_cols=151 Identities=23% Similarity=0.252 Sum_probs=87.3
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCC-cccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIP-SEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|.|+++.+.+|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 55555555553 333332 234556666666654432 34555666666666666666555555666666666666666
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLV 200 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~ 200 (764)
+++++.+..|.++++|++|+|++|+++++.+..|.++++|+.|+|++|.++++.+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 666555555666666666666666666555556666666666666666666555555555556666666655554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-19 Score=178.66 Aligned_cols=156 Identities=24% Similarity=0.268 Sum_probs=122.3
Q ss_pred CCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccC
Q 004268 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316 (764)
Q Consensus 237 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 316 (764)
.+.++++++.++. +|..+. ++|+.|+|++|.++++.+..|.++++|+.|+|++|++..+.+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 4567777777763 333333 6778888888888777777778888888888888888766666777888888888888
Q ss_pred CcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccC
Q 004268 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 317 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 396 (764)
|+|+...+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|+++|..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8888666666788888888888888888 667778888888888888888887777788888999999999999887665
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.3e-19 Score=173.89 Aligned_cols=149 Identities=30% Similarity=0.303 Sum_probs=64.9
Q ss_pred EEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCc
Q 004268 23 TFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102 (764)
Q Consensus 23 ~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 102 (764)
.+++++++++ .+|..+. ++|++|+|++|+++++.|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|.
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 3444444443 3333222 344444444444444444444444444444444444443333344444444444444444
Q ss_pred ccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCC
Q 004268 103 LNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHL 175 (764)
Q Consensus 103 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i 175 (764)
++.+.+..|..+++|++|+|++|+++.+ |..+.++++|++|+|++|+++.+.+..|..+++|+.|+|++|.+
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 171 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW 171 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCSC-CTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred CCccChhHhCcchhhCeEeccCCccccc-CcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence 4444444444444444444444444422 33334444444444444444443333444444444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.8e-18 Score=180.88 Aligned_cols=336 Identities=11% Similarity=0.028 Sum_probs=239.3
Q ss_pred CccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCc
Q 004268 30 LLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPL 109 (764)
Q Consensus 30 ~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 109 (764)
.++.+-..+|.+|.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+...
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 35556667788888888888874 466677778888888888888765 55566778888888888777655 4447777
Q ss_pred cCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCc
Q 004268 110 EFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQL 189 (764)
Q Consensus 110 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 189 (764)
+|.++..++.... +.+..+...+|.++++|+.+.+.++.. .+...+|.++.+|+.+.+..| ++.+...+|.++..|
T Consensus 135 aF~~~~~~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 135 AFKGCDFKEITIP--EGVTVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TTTTCCCSEEECC--TTCCEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccccccC--ccccccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 7877754333322 223345567788888888888876543 477778888888888888766 555777778888888
Q ss_pred cEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCC
Q 004268 190 ATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSN 269 (764)
Q Consensus 190 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 269 (764)
+.+.+..+... +.. .+.....|+.+.+..+ ++.+...+|..+..|+.+.+..+... +...+|..+..++.+.+..+
T Consensus 211 ~~i~~~~~~~~-i~~-~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 211 ENMEFPNSLYY-LGD-FALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp CBCCCCTTCCE-ECT-TTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred ceeecCCCceE-eeh-hhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence 87777665433 222 2334467788877644 34466677788888888888777555 66677888888888887776
Q ss_pred cccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCch
Q 004268 270 QLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPS 349 (764)
Q Consensus 270 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~ 349 (764)
.+. ...|.++.+|+.+.+..+ +..+...+|..+.+|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...
T Consensus 287 ~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 360 (394)
T 4fs7_A 287 IVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGAN 360 (394)
T ss_dssp EEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred eec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHH
Confidence 543 356778888888888665 55566677888888888888654 66566778888888888888777 6667777
Q ss_pred hcccccccceeecccccccCCCCCCCCCCCcccee
Q 004268 350 EIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAV 384 (764)
Q Consensus 350 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 384 (764)
.|.++.+|+.+++..+ +. ....+|.+.++|+.+
T Consensus 361 aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 361 AFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred HhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 8888888888888765 33 334567777777764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-18 Score=183.38 Aligned_cols=319 Identities=10% Similarity=0.001 Sum_probs=227.0
Q ss_pred cCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCc
Q 004268 54 SLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133 (764)
Q Consensus 54 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 133 (764)
.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+...
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 456667778888888888888754 66666778888888888888755 56577778888888888776654 5556677
Q ss_pred cccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCcccc
Q 004268 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNL 213 (764)
Q Consensus 134 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 213 (764)
+|.++..++..... .+..+...+|.++++|+.+.+.++. ..+...+|.++.+|+.+.+..+ +..+...+|.++..|
T Consensus 135 aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L 210 (394)
T 4fs7_A 135 AFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL 210 (394)
T ss_dssp TTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred eeecccccccccCc--cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence 77777544433322 2333566778888888888887654 3377778888888888888766 555677778888888
Q ss_pred ceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCc
Q 004268 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293 (764)
Q Consensus 214 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 293 (764)
+.+.+..+... + ...+.....|+.+.+..+. +.+...+|..+.+|+.+.+..+... +....|..+..++.+....+
T Consensus 211 ~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 211 ENMEFPNSLYY-L-GDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp CBCCCCTTCCE-E-CTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred ceeecCCCceE-e-ehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence 88887766543 2 2333345678888776543 3355667778888888888777554 66677888888888877776
Q ss_pred cccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCC
Q 004268 294 ILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPS 373 (764)
Q Consensus 294 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 373 (764)
.+. ...|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++.+....|.++.+|+.+++..| ++.+...
T Consensus 287 ~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~ 360 (394)
T 4fs7_A 287 IVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGAN 360 (394)
T ss_dssp EEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred eec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHH
Confidence 543 246777788888888765 55566677888888888888654 66566777888888888888776 6666777
Q ss_pred CCCCCCccceecCCCC
Q 004268 374 QLGKIPNISAVDLSKN 389 (764)
Q Consensus 374 ~~~~l~~L~~l~l~~N 389 (764)
+|.++++|+.+++..|
T Consensus 361 aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 361 AFQGCINLKKVELPKR 376 (394)
T ss_dssp TBTTCTTCCEEEEEGG
T ss_pred HhhCCCCCCEEEECCC
Confidence 8888888888877544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-19 Score=171.70 Aligned_cols=153 Identities=19% Similarity=0.215 Sum_probs=104.9
Q ss_pred cCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCE
Q 004268 40 GALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119 (764)
Q Consensus 40 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 119 (764)
..+++|++|++++|.++. +| .+..+++|++|++++|.++. +..+..+++|++|+|++|.+++..+..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 556677777777777763 33 46677777777777776652 246677777777777777777666667777777777
Q ss_pred EEccCCcCcccCCccccCCCCcCEEecccCc-ccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCcc
Q 004268 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ-LSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 120 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
|++++|++++..+..+..+++|++|+|++|. ++.+ + .+.++++|++|++++|.++++. .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 7777777776666667777777777777776 6544 2 5777777777777777776543 56777777777777777
Q ss_pred Cc
Q 004268 199 LV 200 (764)
Q Consensus 199 i~ 200 (764)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 65
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=183.26 Aligned_cols=170 Identities=23% Similarity=0.267 Sum_probs=103.4
Q ss_pred CCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEe
Q 004268 18 FPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 97 (764)
+.++..+++.++.+++.. .+..+++|++|++++|.++.+ + .+..+++|++|+|++|+|++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344556666666665432 466666777777777776643 3 56666777777777777664333 66667777777
Q ss_pred cCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCC
Q 004268 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177 (764)
Q Consensus 98 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 177 (764)
|++|.++++.+ +.. ++|++|+|++|+++++ ..+..+++|++|+|++|+++++ ..+..+++|+.|++++|.+++
T Consensus 92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECCCCcCcc
Confidence 77777664432 222 6666666666666654 2466666666666666666654 246666666666666666654
Q ss_pred CCCCccccCCCccEEEecCccCcCC
Q 004268 178 PIPSTLYHLNQLATLCLGYNKLVGP 202 (764)
Q Consensus 178 ~~~~~~~~l~~L~~L~l~~n~i~~~ 202 (764)
+ ..+..+++|+.|++++|.+...
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 4 4455555566666665555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-19 Score=181.75 Aligned_cols=126 Identities=24% Similarity=0.341 Sum_probs=55.4
Q ss_pred ccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCe
Q 004268 184 YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIA 263 (764)
Q Consensus 184 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 263 (764)
..+++|+.|++++|++..+.+ +..+++|++|++++|++++..+ +.. ++|+.|+|++|.+++. ..+..+++|+.
T Consensus 60 ~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~ 132 (263)
T 1xeu_A 60 QFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEI 132 (263)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCE
T ss_pred hhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccE
Confidence 333334444444443333322 3344444444444444443211 111 4444455555544432 23444555555
Q ss_pred EEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCc
Q 004268 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 264 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~ 320 (764)
|+|++|+++++ ..+..+++|+.|++++|++.+. ..+..+++|+.|++++|+++
T Consensus 133 L~Ls~N~i~~~--~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 133 LSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp EECTTSCCCBC--GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred EECCCCcCCCC--hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 55555555433 1344455555555555555443 33444555555555555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=168.20 Aligned_cols=152 Identities=16% Similarity=0.246 Sum_probs=72.6
Q ss_pred ccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCE
Q 004268 16 TCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95 (764)
Q Consensus 16 ~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 95 (764)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34445555555555554 233 34455555555555554432 124445555555555555555444444555555555
Q ss_pred EecCCCcccccCCccCcCCCCCCEEEccCCc-CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCC
Q 004268 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNK-LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 96 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 174 (764)
|+|++|.+++..+..|..+++|++|+|++|. ++.+ + .+..+++|++|++++|+++++. .+.++++|++|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 5555555544444444555555555555554 4433 1 3444555555555555554322 44445555555555554
Q ss_pred C
Q 004268 175 L 175 (764)
Q Consensus 175 i 175 (764)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=165.75 Aligned_cols=156 Identities=21% Similarity=0.231 Sum_probs=77.4
Q ss_pred CCCeEEccCCcccCCCCc-cccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeec
Q 004268 260 NLIALDLSSNQLSGLLPR-EVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVL 338 (764)
Q Consensus 260 ~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l 338 (764)
+|+.|+|++|.++++.+. .|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 445555555555443332 2444555555555555555444445555555555555555555444444555555555555
Q ss_pred cccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCccccccCCCCCCCC
Q 004268 339 SHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416 (764)
Q Consensus 339 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~n~~~~~~ 416 (764)
++|++++..|..+..+++|+.|+|++|++++..+... -...++...+.++...+..|..+...+-..+..+.+.|..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P~~l~~~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCChHHcCCChhhCcHhhcCcCC
Confidence 5555554445555555555555555555543322110 0011222334455555666666666666666666665553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=8.9e-21 Score=211.81 Aligned_cols=187 Identities=27% Similarity=0.277 Sum_probs=99.8
Q ss_pred CCCCcCEEecccCcccccCCccccCCCCCCeeecccCC-------------CCCCCCCccccCCCccEEE-ecCccCcCC
Q 004268 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNH-------------LSGPIPSTLYHLNQLATLC-LGYNKLVGP 202 (764)
Q Consensus 137 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------i~~~~~~~~~~l~~L~~L~-l~~n~i~~~ 202 (764)
.+++|+.|+|++|+++ ..|..+.++++|+.|++++|. +.+..+..+..+++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3445555555555554 334445555555555554332 2223334445555555554 343322
Q ss_pred cccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCC
Q 004268 203 VTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282 (764)
Q Consensus 203 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 282 (764)
..|+.+.+++|.++...+ ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|.|+ ..|..+.++
T Consensus 423 --------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred --------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 234445555555553222 136666666666664 333 666666666666666666 345566666
Q ss_pred CCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCC-ChhhhcccccceeeccccccccC
Q 004268 283 KYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI-PPELMNCSQLLNLVLSHNSLSGS 346 (764)
Q Consensus 283 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~ 346 (764)
++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 666666666666654 33 5555666666666666666443 55566666666666666666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=172.69 Aligned_cols=142 Identities=22% Similarity=0.264 Sum_probs=108.0
Q ss_pred cCCcceeeeecCceeEEEEEE-CCCCE--EEEEEccCCCCC---------------------cHHHHHHHHHHHHHHHhc
Q 004268 509 DFHIKYCIGTGGYGSVYRAQL-SSGKL--VALKKLHRSETE---------------------EPAFLESFQTEARLLSQI 564 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l 564 (764)
-|.+.+.||+|+||.||+|.. .+|+. ||||++...... .......+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999987 67989 999987543211 011224678999999999
Q ss_pred CCCce--eeEeeEEeeCCEEEEEEEecCC-C----CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEc
Q 004268 565 RHRNI--VKLYGFCLHNKCMFLIYEYMER-G----SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHR 637 (764)
Q Consensus 565 ~hpni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~ 637 (764)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.|+.|||. +.||+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence 88753 444443 245899999942 3 66665431 2244667899999999999994 4599999
Q ss_pred CCCCCCeeecCCCCEEEeeeccccccC
Q 004268 638 DISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 638 Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+|||++. .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-20 Score=209.92 Aligned_cols=204 Identities=24% Similarity=0.197 Sum_probs=150.8
Q ss_pred cCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCc-------------ccccCCccccCCCCCCeee-cccCCCCC
Q 004268 112 GNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ-------------LSGRLPQEVGNLKNLKSLF-LDNNHLSG 177 (764)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~l~~L~~L~-L~~n~i~~ 177 (764)
..+++|+.|+|++|+++. .|..++++++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~~-Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHHH-HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHHh-hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 456677777777777763 36667777777777776654 4455667778888888888 666643
Q ss_pred CCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcC
Q 004268 178 PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257 (764)
Q Consensus 178 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 257 (764)
..|..+.+++|.+..+.. ..|+.|+|++|.++++ |. +..+++|+.|+|++|.|+ .+|..|+.
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhc
Confidence 345556677777664432 2478888888888864 44 888888899999988888 66778888
Q ss_pred CCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCC-CCCCCCCCccceEEccCCcCccCCCh---hhhccccc
Q 004268 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPI-PPTIGYLTNLTYLNLGYNRLSSSIPP---ELMNCSQL 333 (764)
Q Consensus 258 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L 333 (764)
+++|+.|+|++|.|+++ | .+..+++|+.|+|++|++++.. |..+..+++|+.|+|++|++++..|. .+..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 88999999999988864 4 7888889999999999988776 88888899999999999998865432 22346677
Q ss_pred ceeec
Q 004268 334 LNLVL 338 (764)
Q Consensus 334 ~~L~l 338 (764)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 77653
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-17 Score=156.72 Aligned_cols=175 Identities=23% Similarity=0.277 Sum_probs=107.5
Q ss_pred ceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCc-CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccC
Q 004268 214 DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292 (764)
Q Consensus 214 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 292 (764)
+.+++++|.++. +|..+. .+|++|++++|.++++.+. .|..+++|++|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 455666666653 233222 2566666666666655543 366677777777777777766666677777777777777
Q ss_pred ccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCC
Q 004268 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP 372 (764)
Q Consensus 293 n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 372 (764)
|++.+..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+.. .-...++...+..+...+..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~-~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch-HHHHHHHHcCCCCCCCCCCCC
Confidence 7777666666777777777777777777666777777777777777777776543311 001123333445555555556
Q ss_pred CCCCCCCccceecCCCCcccccc
Q 004268 373 SQLGKIPNISAVDLSKNNLSGVI 395 (764)
Q Consensus 373 ~~~~~l~~L~~l~l~~N~l~~~~ 395 (764)
..+.+ ....++..+.+++..
T Consensus 167 ~~l~~---~~l~~l~~~~~~C~~ 186 (192)
T 1w8a_A 167 SKVRD---VQIKDLPHSEFKCSS 186 (192)
T ss_dssp TTTTT---SBGGGSCTTTCCCCC
T ss_pred hHHcC---CChhhCcHhhcCcCC
Confidence 55444 345567777776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=195.70 Aligned_cols=141 Identities=29% Similarity=0.346 Sum_probs=69.4
Q ss_pred ccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCC
Q 004268 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283 (764)
Q Consensus 204 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 283 (764)
+..|..++.|+.|+|++|.+. .++..+..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|+ ..|..|.+++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 444555555555555555555 23333335555555555555555 44445555555555555555555 3344555555
Q ss_pred CCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccc-cceeeccccccccCCc
Q 004268 284 YLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQ-LLNLVLSHNSLSGSIP 348 (764)
Q Consensus 284 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~L~ls~N~l~~~~~ 348 (764)
+|+.|+|++|.|. .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 5555555555554 33444555555555555555555444444433221 1234555555554444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=154.68 Aligned_cols=132 Identities=25% Similarity=0.278 Sum_probs=68.1
Q ss_pred CCCcEEEcCCCcCc-ccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEE
Q 004268 43 SKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 121 (764)
++|++|++++|.++ +.+|..+..+++|++|+|++|.|+.. ..+..+++|++|+|++|.+++..+..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 33444445555555555555555533 4455555555555555555544444444455555555
Q ss_pred ccCCcCcccCC-ccccCCCCcCEEecccCcccccCC---ccccCCCCCCeeecccCCCC
Q 004268 122 LQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLSGRLP---QEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 122 L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~n~i~ 176 (764)
|++|.++++.. ..+..+++|++|++++|+++++.+ ..|..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 55555554322 445555555555555555554433 34555555555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-17 Score=152.81 Aligned_cols=135 Identities=27% Similarity=0.249 Sum_probs=89.5
Q ss_pred CCCeeEEEeCCCCcc-ccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 18 FPNLVTFRIWGTLLS-GRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
+++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..|..+++|++|+|++|++++..|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356777777777765 56666666677777777777777654 566667777777777777765566666666777777
Q ss_pred ecCCCcccccCC-ccCcCCCCCCEEEccCCcCcccCC---ccccCCCCcCEEecccCccccc
Q 004268 97 NLSNNILNGSIP-LEFGNLKDLDQLRLQGNKLDGLIP---SSIGNLTNLTYLDLSLNQLSGR 154 (764)
Q Consensus 97 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~n~l~~~ 154 (764)
+|++|.++++.. ..|..+++|++|++++|.++++++ ..|..+++|++|++++|.+..+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 777777765432 556667777777777777766554 4566677777777777766533
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=151.68 Aligned_cols=127 Identities=27% Similarity=0.333 Sum_probs=72.4
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+++.+.+|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 34555555555 2333332 35555666666555 34455555566666666666665555555666666666666666
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|+++.+..|.++++|++|+|++|+++.+.+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666555555666666666666666665555555666666666666666553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=151.56 Aligned_cols=127 Identities=29% Similarity=0.410 Sum_probs=90.8
Q ss_pred eEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCC
Q 004268 22 VTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101 (764)
Q Consensus 22 ~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 101 (764)
+.+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|++|+|++|.|++..+.+|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46777777776 4555443 46777777777776 45567777777777777777777666667777777777777777
Q ss_pred cccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCccc
Q 004268 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 102 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
.|+++.+.+|.++++|++|+|++|.++.+++..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 777777777777777777777777777766666777777777777777765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=192.93 Aligned_cols=163 Identities=23% Similarity=0.201 Sum_probs=123.5
Q ss_pred eeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccc
Q 004268 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL 295 (764)
Q Consensus 216 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 295 (764)
+++..|.+. ..+..+..++.|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ ..|..|.++++|+.|+|++|+|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 345556665 67888999999999999999999 56666779999999999999999 6788899999999999999999
Q ss_pred cCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccc-cceeecccccccCCCCCC
Q 004268 296 IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIF-FRQLDLSRNFINGTIPSQ 374 (764)
Q Consensus 296 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~ 374 (764)
+ .+|..|..+++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 8 66889999999999999999998 67888999999999999999999988888866533 345899999999888765
Q ss_pred CCCCCccceecCCCC
Q 004268 375 LGKIPNISAVDLSKN 389 (764)
Q Consensus 375 ~~~l~~L~~l~l~~N 389 (764)
|+.|++++|
T Consensus 361 ------l~~l~l~~n 369 (727)
T 4b8c_D 361 ------RRFIEINTD 369 (727)
T ss_dssp ---------------
T ss_pred ------cceeEeecc
Confidence 455667777
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.3e-15 Score=160.34 Aligned_cols=330 Identities=8% Similarity=0.067 Sum_probs=157.1
Q ss_pred ccccCCC-CCcEEEcCCCcCcccCCccccCCCCCCEEEccCCc---CcccCCcccCCCCCCCEEecCCCcccccCCccCc
Q 004268 37 SEIGALS-KLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNR---LTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFG 112 (764)
Q Consensus 37 ~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 112 (764)
.+|.+++ .|+.+.+-.+ ++.+...+|.++++|+.+.++.|. ++.+...+|..+.+|+.+.+.++ ++.+...+|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3444443 3555555533 444555556666666666555543 44444455555555555555443 3335555555
Q ss_pred CCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEE
Q 004268 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192 (764)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 192 (764)
++.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. +...+|..+.+++..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 5556666555432 33345555555555665555443 33344555543 34555555443322 444555555555555
Q ss_pred EecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCccc
Q 004268 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272 (764)
Q Consensus 193 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 272 (764)
....+.........+....... .....+.....+..+.+.. .+..+...+|.++.+|+.+.+.++...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~ 278 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGD-----------YALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS 278 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSC-----------EEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE
T ss_pred cccccccccccceeeccccccc-----------ccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce
Confidence 5444433221111111000000 0000011122233333332 223244455666666666666544433
Q ss_pred CCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcc
Q 004268 273 GLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIG 352 (764)
Q Consensus 273 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 352 (764)
+...+|.++.+|+.+.+. +.+..+...+|..+.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++.+....|.
T Consensus 279 -I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~ 354 (394)
T 4gt6_A 279 -IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS 354 (394)
T ss_dssp -ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred -ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence 455556666666666664 3334444455666666666666543 44345556666666666666443 5545555666
Q ss_pred cccccceeecccccccCCCCCCCCCCCccceecCCCCcc
Q 004268 353 NLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391 (764)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 391 (764)
++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 355 ~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 355 NCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 66666666666655431 2344455566666555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-17 Score=149.00 Aligned_cols=128 Identities=25% Similarity=0.283 Sum_probs=70.7
Q ss_pred CCCeeEEEeCCCCcc-ccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 18 FPNLVTFRIWGTLLS-GRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 18 ~~~l~~L~l~~~~~~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
+++++.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 355666666666665 45555555666666666666666543 445555666666666666554455555555555555
Q ss_pred ecCCCcccccC-CccCcCCCCCCEEEccCCcCcccCC---ccccCCCCcCEEecc
Q 004268 97 NLSNNILNGSI-PLEFGNLKDLDQLRLQGNKLDGLIP---SSIGNLTNLTYLDLS 147 (764)
Q Consensus 97 ~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~ 147 (764)
+|++|.++++. +..+..+++|++|++++|.++++++ ..+..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555555431 2445555555555555555554443 345555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=8e-17 Score=167.20 Aligned_cols=140 Identities=12% Similarity=0.155 Sum_probs=102.9
Q ss_pred cCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC---------------cHHH----HHHHHHHHHHHHhcCCCce
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE---------------EPAF----LESFQTEARLLSQIRHRNI 569 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~~----~~~~~~E~~~l~~l~hpni 569 (764)
-|.+.+.||+|++|.||+|...+|+.||||+++..... .... .....+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 39999999999999999999889999999987542110 0000 1123467777777754443
Q ss_pred --eeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec
Q 004268 570 --VKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN 647 (764)
Q Consensus 570 --v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~ 647 (764)
+..+++ .. .++||||++|+++..+.. . .....++.|++.++.++| ++|||||||||.|||++
T Consensus 176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE--ET--TEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCeeeec--cC--ceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 233322 22 369999999988765432 1 234568899999999999 88999999999999998
Q ss_pred CCCC----------EEEeeeccccccC
Q 004268 648 SNLE----------AFVADFGLARLLH 664 (764)
Q Consensus 648 ~~~~----------~kl~Dfg~~~~~~ 664 (764)
+++. +.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 7763 8999999887643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.7e-15 Score=159.15 Aligned_cols=335 Identities=10% Similarity=0.078 Sum_probs=240.7
Q ss_pred cccccccccC-CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCc---CcccCCccccCCCCCCEEEccCCcCcccCC
Q 004268 9 ELSQLNFTCF-PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNS---LTGRIPSEIGALSRLKVLDLSYNRLTGTIP 84 (764)
Q Consensus 9 ~~~~~~~~~~-~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~---i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~ 84 (764)
+|....|.+. ..|+.+.+-.+ ++.+-..+|.+|.+|+.+.++.|. ++.+...+|.++.+|+.+.+..+ ++.+..
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~ 130 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS 130 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence 4566778876 46999999765 777888999999999999998774 77778889999999999998876 555777
Q ss_pred cccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCC
Q 004268 85 SEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKN 164 (764)
Q Consensus 85 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 164 (764)
.+|..+.+|+.+.+..+. ..+...+|..+.+|+.+.+..+ +..+...+|.+ .+|+.+.+..+-.. +...+|.++.+
T Consensus 131 ~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~ 206 (394)
T 4gt6_A 131 EAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFA 206 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred hhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccc
Confidence 899999999999998654 4588899999999999999765 66677788876 67999999876554 78889999999
Q ss_pred CCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccC
Q 004268 165 LKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244 (764)
Q Consensus 165 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 244 (764)
++......+....+....+........- ...+.....+..+.+. +.++.+...+|..+..|+.+.+..
T Consensus 207 l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~ 274 (394)
T 4gt6_A 207 LSTITSDSESYPAIDNVLYEKSANGDYA-----------LIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPD 274 (394)
T ss_dssp CCEEEECCSSSCBSSSCEEEECTTSCEE-----------EEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCT
T ss_pred cceecccccccccccceeeccccccccc-----------ccccccccccceEEcC-CcceEcccceeeecccccEEeccc
Confidence 9999887776653322222221111111 1112223344445554 334446667788888888888876
Q ss_pred CcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCC
Q 004268 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP 324 (764)
Q Consensus 245 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 324 (764)
+... +...+|.++++|+.+.+. +.+..+...+|.++.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ ++.+..
T Consensus 275 ~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~ 350 (394)
T 4gt6_A 275 SVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPE 350 (394)
T ss_dssp TCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCG
T ss_pred ccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhH
Confidence 6554 666788888888888885 4555577778888888888888765 55566678888888888888655 665667
Q ss_pred hhhhcccccceeeccccccccCCchhcccccccceeeccccccc
Q 004268 325 PELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFIN 368 (764)
Q Consensus 325 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 368 (764)
.+|.++.+|+.+++.+|.... ..+.....|+.+.+..|.+.
T Consensus 351 ~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 351 SAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp GGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred hHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 788888899999988886541 45667778888888777653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9e-17 Score=146.94 Aligned_cols=127 Identities=25% Similarity=0.301 Sum_probs=82.9
Q ss_pred CCCcEEEcCCCcCc-ccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEE
Q 004268 43 SKLEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 121 (764)
+++++|++++|.++ +..|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++..|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56677777777776 45566666777777777777777644 5666667777777777777655555566666777777
Q ss_pred ccCCcCcccC-CccccCCCCcCEEecccCcccccCC---ccccCCCCCCeeecc
Q 004268 122 LQGNKLDGLI-PSSIGNLTNLTYLDLSLNQLSGRLP---QEVGNLKNLKSLFLD 171 (764)
Q Consensus 122 L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~ 171 (764)
+++|+++++. +..+..+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777766542 3556666667777777666665544 456666666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=9.8e-16 Score=144.48 Aligned_cols=128 Identities=28% Similarity=0.336 Sum_probs=70.9
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.+++++|+++. +|..+. ++|++|++++|++++..+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|
T Consensus 10 ~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 455555555553 222221 35555555555555444445555555555555555555555555555566666666666
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+++++++..|.++++|++|+|++|+++++.+..|.++++|++|+|++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 665555555555566666666666665555555555666666666666554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-15 Score=143.79 Aligned_cols=129 Identities=26% Similarity=0.252 Sum_probs=72.1
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 100 (764)
.+.+++++++++ .+|..+. ++|++|++++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 345555555554 3333222 4555666666665555555555556666666666665544444555556666666666
Q ss_pred CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCccc
Q 004268 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 101 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
|.++++.+..|..+++|++|+|++|+++++++..|..+++|++|+|++|++.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 6665555555555566666666666665555555555556666666666554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.63 E-value=5.5e-16 Score=145.99 Aligned_cols=132 Identities=21% Similarity=0.197 Sum_probs=56.6
Q ss_pred ccCCCCCcEEEcCCCcCcccCCccccCC-CCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCC
Q 004268 39 IGALSKLEKLVLSHNSLTGRIPSEIGAL-SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDL 117 (764)
Q Consensus 39 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 117 (764)
+..+.+|++|++++|+++.+ +. +..+ ++|++|+|++|.|++. ..|..+++|++|+|++|.++++.+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 33444444444444444422 22 2222 2444444444444432 344444444444444444444433333444444
Q ss_pred CEEEccCCcCcccCC-ccccCCCCcCEEecccCcccccCCc---cccCCCCCCeeecccCC
Q 004268 118 DQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLSGRLPQ---EVGNLKNLKSLFLDNNH 174 (764)
Q Consensus 118 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~n~ 174 (764)
++|+|++|+++.+++ ..+..+++|++|++++|+++.+... .+..+++|+.|+++.|.
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECC
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCC
Confidence 444444444443221 1344444444444444444422111 24444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=6.7e-16 Score=145.39 Aligned_cols=137 Identities=22% Similarity=0.206 Sum_probs=118.0
Q ss_pred cccccCCCeeEEEeCCCCccccCCccccCC-CCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCC
Q 004268 13 LNFTCFPNLVTFRIWGTLLSGRMPSEIGAL-SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLR 91 (764)
Q Consensus 13 ~~~~~~~~l~~L~l~~~~~~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 91 (764)
..|..+++|+.|++++|.++. ++. +..+ ++|++|+|++|.+++. ..|..+++|++|+|++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 457788999999999999984 454 5554 4999999999999976 6899999999999999999976666679999
Q ss_pred CCCEEecCCCcccccCC-ccCcCCCCCCEEEccCCcCcccCCc---cccCCCCcCEEecccCcccc
Q 004268 92 DLLDLNLSNNILNGSIP-LEFGNLKDLDQLRLQGNKLDGLIPS---SIGNLTNLTYLDLSLNQLSG 153 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~L~~n~l~~ 153 (764)
+|++|+|++|.++.+.+ ..+..+++|++|++++|.+..+++. .+..+++|+.||+++|.+..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 99999999999985443 3789999999999999999966443 58999999999999999864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-17 Score=159.67 Aligned_cols=135 Identities=23% Similarity=0.273 Sum_probs=81.4
Q ss_pred cccCCCeeEEEeCCCCccccCCc------cccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPS------EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIG 88 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~------~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~ 88 (764)
|...+.++.+++.++.+++..|. .+..+++|++|+|++|.+++ +| .+..+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44555566666666666555554 66666666666666666664 34 5666666666666666666 3455555
Q ss_pred CCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCC-ccccCCCCcCEEecccCccccc
Q 004268 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLSGR 154 (764)
Q Consensus 89 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~ 154 (764)
.+++|++|+|++|.++++. .+..+++|++|++++|+++.+.+ ..+..+++|++|++++|++.+.
T Consensus 91 ~~~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred cCCcCCEEECcCCcCCcCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 5566666666666666432 45556666666666666664432 3455666666666666666544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=5.2e-17 Score=156.32 Aligned_cols=132 Identities=21% Similarity=0.295 Sum_probs=78.1
Q ss_pred CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccc
Q 004268 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333 (764)
Q Consensus 254 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 333 (764)
.+..+++|+.|+|++|.+++ .| .+..+++|+.|++++|.+. .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 45555666666666666654 23 5556666666666666665 334444555666666666666664 22 46666667
Q ss_pred ceeeccccccccCCc-hhcccccccceeecccccccCCCCCC----------CCCCCccceecCCCCccc
Q 004268 334 LNLVLSHNSLSGSIP-SEIGNLIFFRQLDLSRNFINGTIPSQ----------LGKIPNISAVDLSKNNLS 392 (764)
Q Consensus 334 ~~L~ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~----------~~~l~~L~~l~l~~N~l~ 392 (764)
+.|++++|++++..+ ..+..+++|+.|++++|++.+..|.. +..+++|+.|| +|+++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 777777776664322 35666666666777666665554432 55666666665 55554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=5e-14 Score=131.43 Aligned_cols=104 Identities=31% Similarity=0.339 Sum_probs=58.1
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.|++++|.++. +|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455566665553 333332 45555666666555555555555555555555555555555555555555555555555
Q ss_pred cCcccCCccccCCCCcCEEecccCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
+++++++..|.++++|++|+|++|++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 555555555555555555555555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.6e-12 Score=138.66 Aligned_cols=314 Identities=11% Similarity=0.082 Sum_probs=154.4
Q ss_pred ccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCC
Q 004268 39 IGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLD 118 (764)
Q Consensus 39 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 118 (764)
+....+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ +..+...+|... +|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence 44445555555543 344455555666666666666543 444445555554 4555555433 333555555543 455
Q ss_pred EEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCcc
Q 004268 119 QLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNK 198 (764)
Q Consensus 119 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 198 (764)
.+.+..+ +..+...+|.++ +|+.+.+..+ ++.+...+|.++.+++.+.+..+........... .+.
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-----------~~~ 182 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-----------YNK 182 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-----------EET
T ss_pred cccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccccee-----------ccc
Confidence 5555443 222444444443 3444443332 3334445555555555555444332210000000 000
Q ss_pred CcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCcc
Q 004268 199 LVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPRE 278 (764)
Q Consensus 199 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 278 (764)
. ......+.....+..+.+..+.. ......+.....|+.+.+..+ +..+...+|.++.+|+.+.+..+ +..+...+
T Consensus 183 ~-~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~a 258 (379)
T 4h09_A 183 N-KTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFL 258 (379)
T ss_dssp T-SSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTT
T ss_pred c-cceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccc
Confidence 0 01112233334444444443322 234445555566666666544 23244556666666666666554 44455556
Q ss_pred ccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccc
Q 004268 279 VGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFR 358 (764)
Q Consensus 279 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~ 358 (764)
|.++.+|+.+.+..+ +..+...+|..+++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+
T Consensus 259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 336 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS 336 (379)
T ss_dssp TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence 666666666666443 33344455666666666666666665555556666666666666543 4444455566666666
Q ss_pred eeecccccccCCCCCCCCCC
Q 004268 359 QLDLSRNFINGTIPSQLGKI 378 (764)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l 378 (764)
.+.+..+ ++.+-..+|.+.
T Consensus 337 ~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 337 TISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCCCCTT-CCEECTTTTTTS
T ss_pred EEEECCc-cCEEchhHhhCC
Confidence 6666443 443444555444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=8.7e-14 Score=130.20 Aligned_cols=104 Identities=26% Similarity=0.291 Sum_probs=56.9
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555555 3333332 45555555555555555555555555555555555555554445555555555555555
Q ss_pred cCcccCCccccCCCCcCEEecccCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
+|+++++..|.++++|++|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555555444555555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=7.6e-14 Score=130.18 Aligned_cols=105 Identities=31% Similarity=0.339 Sum_probs=77.5
Q ss_pred CCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEeccc
Q 004268 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148 (764)
Q Consensus 69 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 148 (764)
.++|++++|.++. +|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+++++..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4677888887773 555443 6777778877777777777777777777777777777777777777777777777777
Q ss_pred CcccccCCccccCCCCCCeeecccCCCC
Q 004268 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 149 n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
|+|+++.+..|.++++|+.|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 7777666666777777777777777765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.3e-12 Score=137.57 Aligned_cols=302 Identities=11% Similarity=0.052 Sum_probs=177.0
Q ss_pred cccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCC
Q 004268 15 FTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94 (764)
Q Consensus 15 ~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 94 (764)
|....+|+.+.+.. +++.+-..+|.+|.+|+.++|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|... +|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence 55667899999975 488788889999999999999764 777888999987 6888888765 555667788775 899
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccC------------CccccCC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL------------PQEVGNL 162 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------------~~~~~~l 162 (764)
.+.+.++- ..+...+|.+. +|+.+.+..+ ++.+...+|.++.+++.+.+..+...... ...+...
T Consensus 117 ~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 99998764 44777888775 6888777654 55677888999999999988766543221 1123333
Q ss_pred CCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEc
Q 004268 163 KNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHL 242 (764)
Q Consensus 163 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 242 (764)
..+..+.+..+... +....+....+|+.+.+..+ +..+...+|..+..|+.+.+..+ ++.+...
T Consensus 194 ~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~------------- 257 (379)
T 4h09_A 194 KTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF------------- 257 (379)
T ss_dssp CCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT-------------
T ss_pred ccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc-------------
Confidence 44444444332221 33344444455555544332 23334444444455555554433 3333444
Q ss_pred cCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccC
Q 004268 243 SHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSS 322 (764)
Q Consensus 243 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 322 (764)
+|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+.++.++.+...+|..+.+|+.+.|..+ ++.+
T Consensus 258 -----------aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I 324 (379)
T 4h09_A 258 -----------LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTI 324 (379)
T ss_dssp -----------TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEE
T ss_pred -----------ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEE
Confidence 4444444444444332 33233344444445555555444444444444555555555555433 3334
Q ss_pred CChhhhcccccceeeccccccccCCchhcccc
Q 004268 323 IPPELMNCSQLLNLVLSHNSLSGSIPSEIGNL 354 (764)
Q Consensus 323 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 354 (764)
...+|.++.+|+++.+..+ ++.+...+|.+.
T Consensus 325 ~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 325 QVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred HHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 4445555555555555433 433334444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.2e-13 Score=129.15 Aligned_cols=104 Identities=33% Similarity=0.416 Sum_probs=80.0
Q ss_pred CEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccC
Q 004268 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLN 149 (764)
Q Consensus 70 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 149 (764)
+.+++++|+++ .+|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888887 4555554 67888888888888777777888888888888888888777777777888888888888
Q ss_pred cccccCCccccCCCCCCeeecccCCCC
Q 004268 150 QLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 150 ~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
+|+.+.+..|.++++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 887766666777777777777777765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=7.6e-15 Score=155.07 Aligned_cols=138 Identities=22% Similarity=0.153 Sum_probs=60.1
Q ss_pred CCCCEEecCCCcccccCCccC-cCCCCCCEEEccCCcCcccCCccc-----cCCCCcCEEecccCcccccC----Ccccc
Q 004268 91 RDLLDLNLSNNILNGSIPLEF-GNLKDLDQLRLQGNKLDGLIPSSI-----GNLTNLTYLDLSLNQLSGRL----PQEVG 160 (764)
Q Consensus 91 ~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~----~~~~~ 160 (764)
++|++|+|++|.++......+ ..+++|++|+|++|.++......+ ...++|++|+|++|.++... +.++.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555554442221111 123345555555555543222222 12344555555555554321 12223
Q ss_pred CCCCCCeeecccCCCCCCC----CCccccCCCccEEEecCccCcCCccc----ccCCccccceeeccCcccccccC
Q 004268 161 NLKNLKSLFLDNNHLSGPI----PSTLYHLNQLATLCLGYNKLVGPVTK----EVGNMKNLDRLHLNGNNLTGSIP 228 (764)
Q Consensus 161 ~l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~ 228 (764)
.+++|++|+|++|.|++.. ...+..+++|++|+|++|.|+..... .+...++|++|+|++|.+++...
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~ 256 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGR 256 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHH
Confidence 4455555555555544211 22334445555555555555432221 22234556666666666554333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-14 Score=153.91 Aligned_cols=182 Identities=18% Similarity=0.149 Sum_probs=99.1
Q ss_pred CCCcEEEcCCCcCcccCCccccC-----CCCCCEEEccCCcCcccCCccc-CCCCCCCEEecCCCcccccCCccC-----
Q 004268 43 SKLEKLVLSHNSLTGRIPSEIGA-----LSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIPLEF----- 111 (764)
Q Consensus 43 ~~L~~L~Ls~n~i~~~~~~~~~~-----l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~----- 111 (764)
+.|++|+|++|.++......+.. .++|++|+|++|.|+......+ ..+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45667777777666433222222 2567777777776653222222 234566777777777664333333
Q ss_pred cCCCCCCEEEccCCcCcccC----CccccCCCCcCEEecccCcccccC----CccccCCCCCCeeecccCCCCCCC----
Q 004268 112 GNLKDLDQLRLQGNKLDGLI----PSSIGNLTNLTYLDLSLNQLSGRL----PQEVGNLKNLKSLFLDNNHLSGPI---- 179 (764)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~i~~~~---- 179 (764)
...++|++|+|++|.++... +.++..+++|++|+|++|.|++.. ..++...++|++|+|++|.|++..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 23466777777777765422 223355667777777777776432 344556667777777777776322
Q ss_pred CCccccCCCccEEEecCccCcCCcccccCCc---c--ccceee--ccCcccc
Q 004268 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNM---K--NLDRLH--LNGNNLT 224 (764)
Q Consensus 180 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l---~--~L~~L~--L~~n~l~ 224 (764)
...+..+++|++|+|++|.|.......+..+ . .|+.+. +..+.+.
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 1233455677777777777765444333322 1 155555 5555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.5e-12 Score=127.14 Aligned_cols=148 Identities=14% Similarity=0.085 Sum_probs=115.6
Q ss_pred HHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCE
Q 004268 503 MIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKC 581 (764)
Q Consensus 503 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 581 (764)
+......|++....+.|+.+.||++... ++.+++|......... ...+.+|+++++.+. +..++++++++.+.+.
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 3455678998888998999999999765 7899999986532111 145789999999994 6788999999999999
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC------------------------------- 630 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------- 630 (764)
.|+||||++|.++.+... +......++.++++++..||...
T Consensus 85 ~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999999877632 11223467889999999999510
Q ss_pred -------------------------CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 631 -------------------------KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 631 -------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
..+++|+|++|.||++++++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 15699999999999998765567999998753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-12 Score=131.93 Aligned_cols=102 Identities=24% Similarity=0.239 Sum_probs=52.6
Q ss_pred EEcCCC-cCcccCCccccCCCCCCEEEccC-CcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 48 LVLSHN-SLTGRIPSEIGALSRLKVLDLSY-NRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 48 L~Ls~n-~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
++++++ +++. +|. +..+++|++|+|++ |.|+++.+..|..+++|++|+|++|.|+++.+..|.++++|++|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455554 4542 333 55555555555553 5555444445555555555555555555555555555555555555555
Q ss_pred cCcccCCccccCCCCcCEEecccCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
+|+++++..|..++ |+.|+|++|.+.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 55554444444443 555555555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.4e-12 Score=131.82 Aligned_cols=103 Identities=23% Similarity=0.281 Sum_probs=78.3
Q ss_pred EEEccCC-cCcccCCcccCCCCCCCEEecCC-CcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEeccc
Q 004268 71 VLDLSYN-RLTGTIPSEIGSLRDLLDLNLSN-NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148 (764)
Q Consensus 71 ~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 148 (764)
.++++++ +++ .+|. +..+++|++|+|++ |.|+++.+..|.++++|+.|+|++|+|+++++..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4677777 777 4666 77778888888875 888877777788888888888888888877777788888888888888
Q ss_pred CcccccCCccccCCCCCCeeecccCCCC
Q 004268 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 149 n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
|+|+++.+..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 888776666666655 777777777665
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=117.51 Aligned_cols=139 Identities=17% Similarity=0.113 Sum_probs=101.6
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc--eeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN--IVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~l 584 (764)
...|.+....+.|..+.||++...+|+.+++|....... ..+.+|+++++.+.+.+ +++++++...++..++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 345555443345666999999877788899999765421 45678999999985433 6778998888888999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC---------------------------------- 630 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------- 630 (764)
||||++|.++. ... .. ...++.++++++..||...
T Consensus 93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999998874 211 11 1256778888888888321
Q ss_pred ---------------------CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 631 ---------------------KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 631 ---------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
..+++|+|++|.||++++++.+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.3e-10 Score=117.50 Aligned_cols=144 Identities=18% Similarity=0.267 Sum_probs=107.1
Q ss_pred cceeeeecCceeEEEEEECCCCEEEEEEcc--CCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEeeEEeeC---CEEEE
Q 004268 512 IKYCIGTGGYGSVYRAQLSSGKLVALKKLH--RSETEEPAFLESFQTEARLLSQIR--HRNIVKLYGFCLHN---KCMFL 584 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~l 584 (764)
..+.++.|.++.||++... +..+++|+.. ...... ....+.+|+++++.+. +..+++++.++.+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4567899999999999876 5688888876 332111 1256789999999996 45688999988776 45899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC---------------------------------- 630 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------- 630 (764)
||||++|..+.+. ....++..+...++.+++++|..||...
T Consensus 119 vme~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999999776432 1223667788889999999999999520
Q ss_pred ---------------------CCCcEEcCCCCCCeeecCCCC--EEEeeecccccc
Q 004268 631 ---------------------KPSIVHRDISSNNILLNSNLE--AFVADFGLARLL 663 (764)
Q Consensus 631 ---------------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~ 663 (764)
..+++|||++|.||+++.++. +.++||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997653 689999988653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.2e-10 Score=121.62 Aligned_cols=83 Identities=16% Similarity=0.196 Sum_probs=40.5
Q ss_pred CCCccEEEecCccCcCCccccc---CCccccceeeccCccccccc----CccccCCCCCCEEEccCCcccCCCCcCCcC-
Q 004268 186 LNQLATLCLGYNKLVGPVTKEV---GNMKNLDRLHLNGNNLTGSI----PSTIGYLNLLDELHLSHNRLDGPIPPTIGN- 257 (764)
Q Consensus 186 l~~L~~L~l~~n~i~~~~~~~~---~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~- 257 (764)
+++|+.|+|++|.+.......+ ..+++|++|+|+.|.+++.. +..+..+++|+.|+|++|.|++.....+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 3455555555554432111111 13566666666666665432 222234566777777766665432222322
Q ss_pred CCCCCeEEccCCc
Q 004268 258 LTNLIALDLSSNQ 270 (764)
Q Consensus 258 l~~L~~L~L~~n~ 270 (764)
+ ...++++.++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 2446666665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=1e-10 Score=122.17 Aligned_cols=81 Identities=17% Similarity=0.149 Sum_probs=35.4
Q ss_pred ccCCCeeEEEeCCCCcc---------ccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcc
Q 004268 16 TCFPNLVTFRIWGTLLS---------GRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSE 86 (764)
Q Consensus 16 ~~~~~l~~L~l~~~~~~---------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~ 86 (764)
+.||+|+.|.+.+.... +.++..+..+++|+.|+|++|.-. ..+. +. +++|+.|+|..|.+.......
T Consensus 136 ~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~ 212 (362)
T 2ra8_A 136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVED 212 (362)
T ss_dssp HHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHH
T ss_pred hhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHH
Confidence 34566666666543221 112233445555555555554211 1111 22 455555555555544222222
Q ss_pred cC--CCCCCCEEecC
Q 004268 87 IG--SLRDLLDLNLS 99 (764)
Q Consensus 87 ~~--~l~~L~~L~L~ 99 (764)
+. .+++|++|+|+
T Consensus 213 l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 213 ILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHSBCTTCCEEEEE
T ss_pred HHHccCCCCcEEEEe
Confidence 22 34555555553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=4.2e-10 Score=115.77 Aligned_cols=187 Identities=21% Similarity=0.207 Sum_probs=123.3
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCc--eeeEeeEEeeCC---EEEEEE
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRN--IVKLYGFCLHNK---CMFLIY 586 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~ 586 (764)
.+.++.|....||++. +.+++|+.... .....+.+|+++++.+. +.. +++++....... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3558999999999873 56888886432 23467889999999883 332 456655544333 358899
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD------------------------------------- 629 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------------------------------------- 629 (764)
++++|.++..... ..++..+...++.+++..+..||..
T Consensus 96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 9999988765332 2356677778888888888888841
Q ss_pred ------------------CCCCcEEcCCCCCCeeecC--CCCEEEeeeccccccCCCCCCcee--------------ccc
Q 004268 630 ------------------CKPSIVHRDISSNNILLNS--NLEAFVADFGLARLLHPDSSNRTL--------------VVG 675 (764)
Q Consensus 630 ------------------~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~--------------~~g 675 (764)
....++|+|++|.||++++ ...+.++||+.+....+..+-... ...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 0135899999999999998 456789999998764321100000 000
Q ss_pred cccccc-ccccccCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 004268 676 TYGYIA-PELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDL 715 (764)
Q Consensus 676 ~~~y~a-PE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~ 715 (764)
...... |+..... ....+.|++|.++|.+.+|..||-.
T Consensus 251 ~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 251 HYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 001111 2221111 1236899999999999999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=6e-09 Score=98.17 Aligned_cols=92 Identities=17% Similarity=0.210 Sum_probs=44.8
Q ss_pred ccccCCCCCcEEEcCCC-cCccc----CCccccCCCCCCEEEccCCcCccc----CCcccCCCCCCCEEecCCCccccc-
Q 004268 37 SEIGALSKLEKLVLSHN-SLTGR----IPSEIGALSRLKVLDLSYNRLTGT----IPSEIGSLRDLLDLNLSNNILNGS- 106 (764)
Q Consensus 37 ~~~~~l~~L~~L~Ls~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~- 106 (764)
..+...+.|++|+|++| .+++. +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34455556666666666 55421 223344455566666666655421 223334445555555555555532
Q ss_pred ---CCccCcCCCCCCEEEc--cCCcCc
Q 004268 107 ---IPLEFGNLKDLDQLRL--QGNKLD 128 (764)
Q Consensus 107 ---~~~~~~~l~~L~~L~L--~~n~l~ 128 (764)
...++...++|++|+| ++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 1223344444555555 445544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=9.7e-09 Score=96.71 Aligned_cols=67 Identities=9% Similarity=0.070 Sum_probs=32.2
Q ss_pred cccCCCCCCEEEccCC-cCccc----CCcccCCCCCCCEEecCCCcccccC----CccCcCCCCCCEEEccCCcCc
Q 004268 62 EIGALSRLKVLDLSYN-RLTGT----IPSEIGSLRDLLDLNLSNNILNGSI----PLEFGNLKDLDQLRLQGNKLD 128 (764)
Q Consensus 62 ~~~~l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~ 128 (764)
.+...+.|++|+|++| .|... +...+...++|++|+|++|.|+... ...+...+.|++|+|++|.|.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 3445556666666665 55421 2334444555555555555554321 122233344555555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1e-06 Score=88.69 Aligned_cols=142 Identities=19% Similarity=0.170 Sum_probs=100.9
Q ss_pred hhcCCcceeeeecCce-eEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 507 TEDFHIKYCIGTGGYG-SVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
...|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|.+.++.+. +--++++++++.+.+..|
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 344543 345556655 69988754 5667899986432 2367889999999884 444788999999999999
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC--------------------------------- 630 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------- 630 (764)
+|||+++|.++.+..... ......+..+++..+..||...
T Consensus 97 lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 999999998887665421 1222345666666666666320
Q ss_pred ----------------------CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 631 ----------------------KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 631 ----------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
...++|+|+++.|||+++++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877777999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.9e-06 Score=88.16 Aligned_cols=138 Identities=17% Similarity=0.097 Sum_probs=94.5
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCC---ceeeEeeEEe-eCCEEEEEEEe
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR---NIVKLYGFCL-HNKCMFLIYEY 588 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~ 588 (764)
.+.++.|....||+. |+.+++|+... ......+.+|.++++.+.+. .+++++.+.. ..+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888998999998 56788887422 22346789999999999642 4677777764 45567899999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD--------------------------------------- 629 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------------------------------------- 629 (764)
++|.++....-. .++..+...++.+++..|..||..
T Consensus 95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999887653211 123333444444444444444421
Q ss_pred ------------------CCCCcEEcCCCCCCeeecC---CCCE-EEeeeccccccC
Q 004268 630 ------------------CKPSIVHRDISSNNILLNS---NLEA-FVADFGLARLLH 664 (764)
Q Consensus 630 ------------------~~~~iiH~Dlkp~NIll~~---~~~~-kl~Dfg~~~~~~ 664 (764)
....++|+|++|.||+++. ++.+ .|+||+.+....
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1346799999999999987 4555 799999886543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.38 E-value=2.7e-08 Score=98.31 Aligned_cols=81 Identities=27% Similarity=0.245 Sum_probs=50.3
Q ss_pred CCCCCCCEEecCCCcccccC--CccCcCCCCCCEEEccCCcCcccCCccccCCC--CcCEEecccCcccccCC-------
Q 004268 88 GSLRDLLDLNLSNNILNGSI--PLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLT--NLTYLDLSLNQLSGRLP------- 156 (764)
Q Consensus 88 ~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~------- 156 (764)
..+++|+.|+|++|.|+++. +..+..+++|+.|+|++|+|+++ ..+..+. +|++|+|++|.+.+..+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 44667777777777776532 34455677777777777777755 2333333 77777777777764332
Q ss_pred ccccCCCCCCeeec
Q 004268 157 QEVGNLKNLKSLFL 170 (764)
Q Consensus 157 ~~~~~l~~L~~L~L 170 (764)
..+..+++|+.|+-
T Consensus 245 ~il~~~P~L~~LDg 258 (267)
T 3rw6_A 245 AIRERFPKLLRLDG 258 (267)
T ss_dssp HHHHHCTTCCEESS
T ss_pred HHHHHCcccCeECC
Confidence 23556677777653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=3.3e-08 Score=97.67 Aligned_cols=81 Identities=31% Similarity=0.325 Sum_probs=52.1
Q ss_pred cCCCCCCEEEccCCcCccc--CCcccCCCCCCCEEecCCCcccccC-CccCcCCCCCCEEEccCCcCcccCC-------c
Q 004268 64 GALSRLKVLDLSYNRLTGT--IPSEIGSLRDLLDLNLSNNILNGSI-PLEFGNLKDLDQLRLQGNKLDGLIP-------S 133 (764)
Q Consensus 64 ~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~-------~ 133 (764)
..+++|++|+|++|+|+++ ++..+..+++|+.|+|++|.|+++. ...+..+ +|++|+|++|.+.+-.| .
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHH
Confidence 3566777777777777752 3455566777777777777777541 1223333 77888888887765333 2
Q ss_pred cccCCCCcCEEe
Q 004268 134 SIGNLTNLTYLD 145 (764)
Q Consensus 134 ~~~~l~~L~~L~ 145 (764)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 466778888876
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.14 E-value=5.2e-07 Score=82.39 Aligned_cols=34 Identities=18% Similarity=0.282 Sum_probs=14.3
Q ss_pred CcCEEecccCc-ccccCCccccCCCCCCeeecccC
Q 004268 140 NLTYLDLSLNQ-LSGRLPQEVGNLKNLKSLFLDNN 173 (764)
Q Consensus 140 ~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n 173 (764)
+|++|+|++|. |++..-..+.++++|++|+++++
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c 149 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL 149 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence 34444444442 43332233344444444444444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.7e-06 Score=87.50 Aligned_cols=80 Identities=8% Similarity=0.011 Sum_probs=55.9
Q ss_pred ceee-eecCceeEEEEEEC-------CCCEEEEEEccCCC---CCcHHHHHHHHHHHHHHHhcC-C--CceeeEeeEEee
Q 004268 513 KYCI-GTGGYGSVYRAQLS-------SGKLVALKKLHRSE---TEEPAFLESFQTEARLLSQIR-H--RNIVKLYGFCLH 578 (764)
Q Consensus 513 ~~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~ 578 (764)
.+.+ +.|....+|+.... +++.+++|...... ... ...+.+|+++++.+. + -.+++++.+..+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3567 78888999998654 26789999875432 100 134668888888884 2 357888888766
Q ss_pred C---CEEEEEEEecCCCCHH
Q 004268 579 N---KCMFLIYEYMERGSLF 595 (764)
Q Consensus 579 ~---~~~~lv~e~~~~~~L~ 595 (764)
. +..|+|||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.09 E-value=8.2e-07 Score=81.06 Aligned_cols=84 Identities=13% Similarity=0.136 Sum_probs=42.0
Q ss_pred CCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCc-ccccCCccCcCC----CCCCEEEccCCc-CcccCCccccCCCC
Q 004268 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI-LNGSIPLEFGNL----KDLDQLRLQGNK-LDGLIPSSIGNLTN 140 (764)
Q Consensus 67 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~ 140 (764)
.+|+.|||++|.|+...-..+.++++|++|+|++|. ++...-..+..+ ++|++|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 345566666655554434445555566666665553 443222233332 245566665553 54332233455555
Q ss_pred cCEEecccCc
Q 004268 141 LTYLDLSLNQ 150 (764)
Q Consensus 141 L~~L~L~~n~ 150 (764)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666655553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.6e-05 Score=82.98 Aligned_cols=141 Identities=18% Similarity=0.279 Sum_probs=80.9
Q ss_pred eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEee------EEeeCCEEEEE
Q 004268 514 YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HRNIVKLYG------FCLHNKCMFLI 585 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~------~~~~~~~~~lv 585 (764)
+.++.|..+.||++...+| .+++|+.... . ..+..|.++++.+. .-.+++++. +....+..+++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 3466677889999987644 5899988652 1 33445566666553 113444443 22356778999
Q ss_pred EEecCCCCHH-----------HH---HhcCcc----cc-------ccCHHH-----------------------------
Q 004268 586 YEYMERGSLF-----------CV---LRNDVE----AV-------ELDWTK----------------------------- 611 (764)
Q Consensus 586 ~e~~~~~~L~-----------~~---l~~~~~----~~-------~l~~~~----------------------------- 611 (764)
|+|++|..+. .. ++.... .. ...|..
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986542 01 111000 00 011111
Q ss_pred --HHHHHHHHHHHHHHHHh----------cCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 612 --RVNIVKSMAHALSYLHY----------DCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 612 --~~~i~~qi~~aL~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
...+..++..++++|+. ....+++|||+++.||+++.++.+.++||+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112234445666652 0157899999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.1e-05 Score=83.92 Aligned_cols=78 Identities=10% Similarity=0.077 Sum_probs=50.0
Q ss_pred ceeeeecCceeEEEEEEC-CCCEEEEEEccCCCC-CcH---HHHHHHHHHHHHHHhcCC---CceeeEeeEEeeCCEEEE
Q 004268 513 KYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSET-EEP---AFLESFQTEARLLSQIRH---RNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~~~l 584 (764)
.+.+|.|..+.||++... +++.|++|....... ..+ ...+++..|.++++.+.. ..+++++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 467899999999999754 578999998653221 000 012456789999888732 3456676543 344579
Q ss_pred EEEecCCC
Q 004268 585 IYEYMERG 592 (764)
Q Consensus 585 v~e~~~~~ 592 (764)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00014 Score=73.94 Aligned_cols=75 Identities=21% Similarity=0.232 Sum_probs=60.8
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC---CCceeeEeeEEeeCCEEEEEEEec
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR---HRNIVKLYGFCLHNKCMFLIYEYM 589 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~ 589 (764)
.+.++.|....+|+.... ++.+++|...... ...+..|++.++.+. ...+++++++....+..++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 456899999999999764 7789999875431 367889999998883 367889999988888999999999
Q ss_pred CCCCH
Q 004268 590 ERGSL 594 (764)
Q Consensus 590 ~~~~L 594 (764)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.70 E-value=9.8e-06 Score=75.43 Aligned_cols=65 Identities=12% Similarity=0.191 Sum_probs=30.6
Q ss_pred cCCCCCcEEEcCCC-cCccc----CCccccCCCCCCEEEccCCcCccc----CCcccCCCCCCCEEecCCCccc
Q 004268 40 GALSKLEKLVLSHN-SLTGR----IPSEIGALSRLKVLDLSYNRLTGT----IPSEIGSLRDLLDLNLSNNILN 104 (764)
Q Consensus 40 ~~l~~L~~L~Ls~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~ 104 (764)
..-+.|++|+|++| +|.+. +.+++...+.|+.|+|++|+|... +.+++...+.|++|+|++|.|+
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33445555555553 44421 233344445555555555555421 2233334455555555555554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00021 Score=76.56 Aligned_cols=78 Identities=10% Similarity=0.056 Sum_probs=49.4
Q ss_pred CCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCceeccc--ccccccccccccC---CCCccchHHHHHHHHHH
Q 004268 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVG--TYGYIAPELAYTM---AVTEKCDVYSFGVVALE 705 (764)
Q Consensus 631 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ 705 (764)
...++|||++|.|||++.++ ++++||+.+....+..+ ...... ...|.+|+..... ......++.+.+..+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67999999999999998776 99999999875432111 111111 1346666654311 11223455677888888
Q ss_pred HHhCC
Q 004268 706 VLMGS 710 (764)
Q Consensus 706 lltg~ 710 (764)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00037 Score=70.42 Aligned_cols=79 Identities=18% Similarity=0.209 Sum_probs=57.8
Q ss_pred cCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-C--CceeeEeeEEeeCCEEEEE
Q 004268 509 DFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-H--RNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 509 ~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~~~~~lv 585 (764)
+..-++.+|.|..+.||+.+..+|+.|++|+......... ..+..|++.++.+. . --+++++++. . .++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence 4455677999999999999999999999998765443221 45778999999884 2 2356666543 2 3689
Q ss_pred EEecCCCCH
Q 004268 586 YEYMERGSL 594 (764)
Q Consensus 586 ~e~~~~~~L 594 (764)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.63 E-value=1.2e-05 Score=74.84 Aligned_cols=62 Identities=13% Similarity=0.160 Sum_probs=30.1
Q ss_pred CCCcCEEecccCcccccC----CccccCCCCCCeeecccCCC---CC----CCCCccccCCCccEEEecCccC
Q 004268 138 LTNLTYLDLSLNQLSGRL----PQEVGNLKNLKSLFLDNNHL---SG----PIPSTLYHLNQLATLCLGYNKL 199 (764)
Q Consensus 138 l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~i---~~----~~~~~~~~l~~L~~L~l~~n~i 199 (764)
-+.|++|+|+.|.|.... ..++...+.|++|+|++|.. .. ....++...++|+.|+++.|.+
T Consensus 97 N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 97 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred CCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 345555555555554221 22344445566666654422 21 0122345556666666666554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0009 Score=68.96 Aligned_cols=160 Identities=13% Similarity=0.120 Sum_probs=91.8
Q ss_pred ccCHHHHHHHhhcCCc-----ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC--Cce
Q 004268 497 RITFEEMIEATEDFHI-----KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH--RNI 569 (764)
Q Consensus 497 ~~~~~~~~~~~~~y~~-----~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pni 569 (764)
.++.+.+....+.|.+ ...++ |....||++...+|+.+++|........ ...+..|..+++.+.. -.+
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCee
Confidence 3455666655565543 23466 7788999987767778999998644322 1456678888887732 124
Q ss_pred eeEeeE-----EeeCCEEEEEEEecCCCCHH-----H------H---Hhc---Ccc---ccccCHHHH------------
Q 004268 570 VKLYGF-----CLHNKCMFLIYEYMERGSLF-----C------V---LRN---DVE---AVELDWTKR------------ 612 (764)
Q Consensus 570 v~~~~~-----~~~~~~~~lv~e~~~~~~L~-----~------~---l~~---~~~---~~~l~~~~~------------ 612 (764)
++++.. ....+..+++|++++|..+. . . ++. ... ....++...
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 444442 22356678999999885431 0 0 010 000 011121110
Q ss_pred ----------HHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 613 ----------VNIVKSMAHALSYLHY-DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 613 ----------~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
...+.+++..++..-. .....++|||+++.||+++ + .+.++||+.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1111122222222210 0256789999999999999 4 8999999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=68.00 Aligned_cols=159 Identities=13% Similarity=0.135 Sum_probs=89.7
Q ss_pred cCHHHHHHHhhcCCcc-----eeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCC--cee
Q 004268 498 ITFEEMIEATEDFHIK-----YCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR--NIV 570 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~-----~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv 570 (764)
++.+++.....+|.+. +.++.|....+|++...+| .+++|........ +.+..|.++++.+... .++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~-----~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH-----HHHHHHHHHHHHHHHCCCCCC
Confidence 5566677777777652 3466788889999987655 6889988653211 3455788887777321 134
Q ss_pred eEeeE------EeeCCEEEEEEEecCCCCHHH-----------H---HhcCc---cccc---c---CHHHHHH-------
Q 004268 571 KLYGF------CLHNKCMFLIYEYMERGSLFC-----------V---LRNDV---EAVE---L---DWTKRVN------- 614 (764)
Q Consensus 571 ~~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~~---~~~~---l---~~~~~~~------- 614 (764)
+++.. ....+..+++|+|++|..+.. . ++... .... . .|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 44421 223466789999999865310 0 11000 0000 0 1111000
Q ss_pred -----HHHHHHHHHHHHHhc----CCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 615 -----IVKSMAHALSYLHYD----CKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 615 -----i~~qi~~aL~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
+...+...+++++.. ...+++|+|+++.||++++++.+.++||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133444555421 145899999999999999876568999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00052 Score=70.96 Aligned_cols=142 Identities=20% Similarity=0.193 Sum_probs=75.8
Q ss_pred eeeecCcee-EEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGYGS-VYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.++.|.... +|+....+|+.+++|....... ..+..|+++++.+. .-.+++++.+....+ +++||++.+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 455554444 6677654477888886554321 22345677777663 234667777644444 689999987
Q ss_pred CCHHHHHhcCcc-----------------------ccccCHHHHH-------HH-------------HHHHHHHHHHHH-
Q 004268 592 GSLFCVLRNDVE-----------------------AVELDWTKRV-------NI-------------VKSMAHALSYLH- 627 (764)
Q Consensus 592 ~~L~~~l~~~~~-----------------------~~~l~~~~~~-------~i-------------~~qi~~aL~~LH- 627 (764)
..+.+.+..... ...++..... .+ ...+..+++.+.
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 676544421100 0111111100 00 011112222221
Q ss_pred --hcCCCCcEEcCCCCCCeeecCC----CCEEEeeeccccccC
Q 004268 628 --YDCKPSIVHRDISSNNILLNSN----LEAFVADFGLARLLH 664 (764)
Q Consensus 628 --~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~~~~~~ 664 (764)
......++|||+.+.|||++.+ +.+.++||+.+....
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1125689999999999999874 678999999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00085 Score=70.06 Aligned_cols=141 Identities=18% Similarity=0.238 Sum_probs=83.8
Q ss_pred eeeeecCceeEEEEEEC--------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEE
Q 004268 514 YCIGTGGYGSVYRAQLS--------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l 584 (764)
+.+..|-...+|++... +++.+++|+..... .. ...+.+|.++++.+. +.-.+++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 45777888899999764 35789999864321 11 245568999998883 3334777776654 28
Q ss_pred EEEecCCCCHHH-----------H---H---hcC-cc-cccc--CHHHHHHHHHHHHH-------------------HHH
Q 004268 585 IYEYMERGSLFC-----------V---L---RND-VE-AVEL--DWTKRVNIVKSMAH-------------------ALS 624 (764)
Q Consensus 585 v~e~~~~~~L~~-----------~---l---~~~-~~-~~~l--~~~~~~~i~~qi~~-------------------aL~ 624 (764)
||||++|.++.. + + +.. .. .... -+.++.++..++.. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865421 0 1 000 00 1111 23455555544422 123
Q ss_pred HHH----h-cCCCCcEEcCCCCCCeeecCC----CCEEEeeeccccc
Q 004268 625 YLH----Y-DCKPSIVHRDISSNNILLNSN----LEAFVADFGLARL 662 (764)
Q Consensus 625 ~LH----~-~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg~~~~ 662 (764)
+|. . .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 1 124578999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00093 Score=71.45 Aligned_cols=73 Identities=22% Similarity=0.220 Sum_probs=49.6
Q ss_pred ceeeeecCceeEEEEEECC--------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 513 KYCIGTGGYGSVYRAQLSS--------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
.+.|+.|....+|++...+ ++.+++|+...... .+.+.+|..+++.+. +.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4567888889999998653 57899999844211 134457999888884 3334677776542 2
Q ss_pred EEEEecCCCCH
Q 004268 584 LIYEYMERGSL 594 (764)
Q Consensus 584 lv~e~~~~~~L 594 (764)
+|+||++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 88999987443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00099 Score=67.70 Aligned_cols=139 Identities=12% Similarity=0.072 Sum_probs=75.9
Q ss_pred ceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEEEEEEec-C
Q 004268 513 KYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMFLIYEYM-E 590 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~-~ 590 (764)
.+.++.|....+|++ +.+++|+........ ....+|+.+++.+. +.-.++++++..+ .-++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCC
Confidence 677999999999999 568888876532110 12246787777773 2222566655433 346899999 6
Q ss_pred CCCHHHH---------------H---hcCcc--ccccC-HHHHHHHHHH--------------HHHHH----HHHH-hcC
Q 004268 591 RGSLFCV---------------L---RNDVE--AVELD-WTKRVNIVKS--------------MAHAL----SYLH-YDC 630 (764)
Q Consensus 591 ~~~L~~~---------------l---~~~~~--~~~l~-~~~~~~i~~q--------------i~~aL----~~LH-~~~ 630 (764)
|.++... + +.... ....+ ...+..+..+ +...+ +.+. ...
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 6544210 0 00000 00000 1111111110 11111 1111 012
Q ss_pred CCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 631 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
...++|+|+.|.||+ ..++.+.++||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 446899999999999 56678899999988654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00037 Score=60.55 Aligned_cols=37 Identities=22% Similarity=0.302 Sum_probs=20.6
Q ss_pred cceeecccccccCCCCCCCCCCCccceecCCCCcccc
Q 004268 357 FRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 357 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 393 (764)
|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 4555555555554555555555555555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00094 Score=57.97 Aligned_cols=34 Identities=32% Similarity=0.430 Sum_probs=13.1
Q ss_pred CCEEEccCCcCcccCCccccCCCCcCEEecccCc
Q 004268 117 LDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQ 150 (764)
Q Consensus 117 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 150 (764)
|++|+|++|+|+.+.++.|..+++|+.|+|++|.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP 66 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCC
Confidence 3333333333333333333333333344444433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0051 Score=66.01 Aligned_cols=74 Identities=18% Similarity=0.142 Sum_probs=48.1
Q ss_pred ceeeeecCceeEEEEEECC-CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc-eeeEeeEEeeCCEEEEEEEecC
Q 004268 513 KYCIGTGGYGSVYRAQLSS-GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN-IVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~ 590 (764)
.+.|+.|-...+|++...+ ++.+++|+.......- -...+|..+++.+...+ .+++++.+. +. .||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeC
Confidence 4568888889999998764 4789999875432111 11247899999985433 467777763 32 5999998
Q ss_pred CCCH
Q 004268 591 RGSL 594 (764)
Q Consensus 591 ~~~L 594 (764)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0056 Score=63.19 Aligned_cols=33 Identities=24% Similarity=0.441 Sum_probs=28.9
Q ss_pred CCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 631 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
..+++|+|+.+.||++++++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999887654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0019 Score=67.66 Aligned_cols=74 Identities=16% Similarity=0.103 Sum_probs=44.6
Q ss_pred ceeeeecCceeEEEEEECC---------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEE
Q 004268 513 KYCIGTGGYGSVYRAQLSS---------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 582 (764)
.+.++.|....+|++...+ ++.+++|+....... ......|.++++.+. +.-++++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 3457788888999997653 278999987543211 012357888888874 32255777554 22
Q ss_pred EEEEEecCCCCH
Q 004268 583 FLIYEYMERGSL 594 (764)
Q Consensus 583 ~lv~e~~~~~~L 594 (764)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.04 Score=58.27 Aligned_cols=141 Identities=9% Similarity=0.088 Sum_probs=84.8
Q ss_pred ceeeeecCceeEEEEEECC--------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 513 KYCIGTGGYGSVYRAQLSS--------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
.+.+..|-...+|++...+ ++.+++|+.......- -...+|.++++.+. +.-.+++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 4557778889999997653 6889999875432110 12347888888883 333566765432 2 6
Q ss_pred EEEEecCCCCHHH-------H-------Hh---c-Cc---------cccccCHHHHHHHHHHHH----------------
Q 004268 584 LIYEYMERGSLFC-------V-------LR---N-DV---------EAVELDWTKRVNIVKSMA---------------- 620 (764)
Q Consensus 584 lv~e~~~~~~L~~-------~-------l~---~-~~---------~~~~l~~~~~~~i~~qi~---------------- 620 (764)
.||||++|.++.. . +. . .. ...+..+.++.++..++-
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8899999865311 0 00 0 00 001112344444443322
Q ss_pred ---HHHHHHH---------------------hcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 621 ---HALSYLH---------------------YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 621 ---~aL~~LH---------------------~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
..+.+|. ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223322 111356899999999999 8888999999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.04 E-value=0.1 Score=48.66 Aligned_cols=124 Identities=15% Similarity=0.097 Sum_probs=80.4
Q ss_pred CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCce
Q 004268 592 GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT 671 (764)
Q Consensus 592 ~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 671 (764)
-+|.++++. ...++++++++.++.|.+.+|.-.-. ++.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 378899875 45679999999999999999888721 11111233457899999999888764 1110
Q ss_pred ecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHHHHHHhhhhcc
Q 004268 672 LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYLKNFSQG 747 (764)
Q Consensus 672 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 747 (764)
.....+.|||... ...+.+.=|||||+++|..+-=..|= .+.+.++.++..+|..|...
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e--------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE--------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT--------------TEEECCCHHHHHHHHHHTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc--------------ccchhhCHHHHHHHHHHHhc
Confidence 1233566888753 34567788999999999998643332 23456788888888777654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.77 E-value=0.23 Score=52.33 Aligned_cols=31 Identities=26% Similarity=0.412 Sum_probs=26.0
Q ss_pred CcEEcCCCCCCeee------cCCCCEEEeeecccccc
Q 004268 633 SIVHRDISSNNILL------NSNLEAFVADFGLARLL 663 (764)
Q Consensus 633 ~iiH~Dlkp~NIll------~~~~~~kl~Dfg~~~~~ 663 (764)
.++|+|+.+.||++ +++..++++||..|...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 46899999999999 45678999999998653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.96 E-value=0.1 Score=34.36 Aligned_cols=26 Identities=12% Similarity=0.144 Sum_probs=10.7
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhhccC
Q 004268 448 IILAMVAFVFAILIFGILFVHRRKDK 473 (764)
Q Consensus 448 i~~~~v~~~~~~li~~~~~~~rrr~k 473 (764)
.+++.++++++++...+++++||+.+
T Consensus 15 gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 15 GVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred eehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 33333333334443444444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.19 Score=33.23 Aligned_cols=29 Identities=17% Similarity=0.228 Sum_probs=12.5
Q ss_pred eehhhhHHHHHHHHHHHHHHHHHhhhccC
Q 004268 445 LVTIILAMVAFVFAILIFGILFVHRRKDK 473 (764)
Q Consensus 445 ~~~i~~~~v~~~~~~li~~~~~~~rrr~k 473 (764)
++..+++.+++++++++.++++++||+.+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 33444444444444444444444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.67 E-value=0.39 Score=31.57 Aligned_cols=6 Identities=0% Similarity=0.512 Sum_probs=2.5
Q ss_pred ehhhhH
Q 004268 446 VTIILA 451 (764)
Q Consensus 446 ~~i~~~ 451 (764)
+.++++
T Consensus 15 a~~vVG 20 (44)
T 2jwa_A 15 ISAVVG 20 (44)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 334444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.89 E-value=1.1 Score=41.71 Aligned_cols=118 Identities=6% Similarity=0.133 Sum_probs=82.0
Q ss_pred CCCceeeEeeEEeeCCEEEEEEEecCCC-CHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCC
Q 004268 565 RHRNIVKLYGFCLHNKCMFLIYEYMERG-SLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNN 643 (764)
Q Consensus 565 ~hpniv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N 643 (764)
.||+++.. .+-.+.+.+.+.++.-+.+ ++.. ++ ..+....++++.+|+....+++ .=+|--++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence 57888866 5666667766666654422 3322 22 3677888999999998886666 44888999999
Q ss_pred eeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHH-HHHHHHHHHHhCCCCCCcccc
Q 004268 644 ILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVY-SFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 644 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw-slG~il~~lltg~~Pf~~~~~ 718 (764)
++++.++.+++.=.|....+. |.- .+ ..|.| .+=+++..++++++.|+..-.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-----------------P~~-----~~-ee~fL~qyKAliiall~~K~~Fe~l~~ 162 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-----------------PLP-----VS-EAEFLTRYKALVICAFNEKQSFDALVE 162 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-----------------CCC-----CC-HHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred EEEcCCCCEEEEEccCccCCC-----------------CCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence 999999999998777643332 221 11 12444 577899999999999986544
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.31 E-value=2.8 Score=39.18 Aligned_cols=118 Identities=13% Similarity=0.121 Sum_probs=81.5
Q ss_pred CCCceeeEeeEEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHH-HHHhcCCCCcEEcCCCCCC
Q 004268 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS-YLHYDCKPSIVHRDISSNN 643 (764)
Q Consensus 565 ~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~iiH~Dlkp~N 643 (764)
.||++ -..+-.+++.+.+.++.-+++.-...++ ..+....++++.+|+.... +++ .-+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence 57888 3444567777777777664443333333 3677888888888888766 555 56888999999
Q ss_pred eeecCCCCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHH-HHHHHHHHHHhCCCCCCcccc
Q 004268 644 ILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVY-SFGVVALEVLMGSHPTDLLSS 718 (764)
Q Consensus 644 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw-slG~il~~lltg~~Pf~~~~~ 718 (764)
++++.++.+++.=.|.-..+ +|.-.. ..|.| .+=+++..++.+++.|+..-.
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e~~------ee~fl~qyKali~all~~K~~Fe~l~~ 167 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-----------------PPDEWD------DERLLREVKATVLALTEGEYRFDEYLK 167 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-----------------SSCSCC------HHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred EEEeCCCcEEEEEcCCcccC-----------------CCCCCC------HHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 99999999999877764332 222211 22444 577888999999999886554
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=85.23 E-value=1.9 Score=34.83 Aligned_cols=17 Identities=6% Similarity=0.003 Sum_probs=6.7
Q ss_pred cCCccCcCCCCCCEEEc
Q 004268 106 SIPLEFGNLKDLDQLRL 122 (764)
Q Consensus 106 ~~~~~~~~l~~L~~L~L 122 (764)
+...+|.++.+|+.+.|
T Consensus 11 I~~~aF~~c~~L~~i~i 27 (100)
T 2lz0_A 11 MDKSLFAGNTVIREITV 27 (100)
T ss_dssp SCSCTTTTCTTCCCEEE
T ss_pred ecHHHhcCCCCCcEEEc
Confidence 33333444444444433
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=81.80 E-value=3.1 Score=33.51 Aligned_cols=48 Identities=17% Similarity=0.185 Sum_probs=30.0
Q ss_pred CcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 77 NRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 77 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
..++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.+.
T Consensus 6 ~~vt~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~aF~~C~~L~~i~~~~~ 53 (100)
T 2lz0_A 6 EPVVGMDKSLFAGNTVIREITVQPN-IGLLYDGMFSGCTALEKLILTGE 53 (100)
T ss_dssp CCCCSSCSCTTTTCTTCCCEEECTT-SSCCCTTSSTTCTTCCCEEECCS
T ss_pred CccCEecHHHhcCCCCCcEEEcCCc-hheEcHHHHhccCCccEEEEcCC
Confidence 3455555566777777777776654 33466666777777777766554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 764 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-33 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-16 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-10 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-08 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 2e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-59
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 10/208 (4%)
Query: 506 ATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI 564
+DF +G G G V++ SG ++A K +H +PA E ++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC 61
Query: 565 RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALS 624
IV YG + + + E+M+ GSL VL+ +A + + ++ L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLT 118
Query: 625 YLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
YL K I+HRD+ +NIL+NS E + DFG++ L +N VGT Y++PE
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPER 174
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D++S G+ +E+ +G +P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 9e-59
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 7/243 (2%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + Y IGTG YG + + S GK++ K+L E A + +E LL +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 62
Query: 567 RNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEAVE-LDWTKRVNIVKSMAHAL 623
NIV+ Y + N ++++ EY E G L V+ + + LD + ++ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 624 SYLHY--DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
H D +++HRD+ N+ L+ + DFGLAR+L+ D+S VGT Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQCNAYL 741
PE M+ EK D++S G + E+ P S + + + R+ + + L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242
Query: 742 KNF 744
Sbjct: 243 NEI 245
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 14/210 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ IG+G +G+VY+ + VA+K L+ + P L++F+ E +L + RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHV 64
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NI+ G+ + ++ ++ E SL+ L + + K ++I + A + YLH
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPELA 685
SI+HRD+ SNNI L+ +L + DFGLA + S + + G+ ++APE+
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 686 YTM---AVTEKCDVYSFGVVALEVLMGSHP 712
+ + DVY+FG+V E++ G P
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-57
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF I +G G +G+VY A+ S ++ALK L +++ E+ + E + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
NI++LYG+ ++LI EY G+++ L+ + D + + +A+ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H ++HRDI N+LL S E +ADFG + H SS RT + GT Y+ PE+
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
EK D++S GV+ E L+G P
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E + +G G +G V+ + VA+K L + ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY +++I EYME GSL L+ ++L K +++ +A ++++
Sbjct: 69 RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN-RTLVVGTYGYIAPELAY 686
+ + +HRD+ + NIL++ L +ADFGLARL+ + R + APE
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
T K DV+SFG++ E++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 3e-53
Identities = 65/245 (26%), Positives = 114/245 (46%), Gaps = 19/245 (7%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ F IG G +G+VY A+ + + ++VA+KK+ S + + E R L ++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H N ++ G L +L+ EY + + + L + + L+Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 130
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH +++HRD+ + NILL+ + DFG A ++ P +S VGT ++APE+
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183
Query: 686 YTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQ---CNA 739
M K DV+S G+ +E+ P ++++S+ I+QN LQ +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNESPALQSGHWSE 241
Query: 740 YLKNF 744
Y +NF
Sbjct: 242 YFRNF 246
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-53
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ + IG G G+VY A +++G+ VA+++++ + + E E ++ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
+ NIV L ++++ EY+ GSL V+ D + + + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEF 131
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH ++HRDI S+NILL + + DFG + P+ S R+ +VGT ++APE+
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
A K D++S G++A+E++ G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 7e-53
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 9/208 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
EDF +G G + +V A+ L++ + A+K L + + + E ++S++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
VKLY ++ ++ Y + G L +R D T + AL YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYL 124
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPEL 684
H I+HRD+ NILLN ++ + DFG A++L P+S VGT Y++PEL
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D+++ G + +++ G P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-53
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ IG+G +G V+ + VA+K + E E F EA ++ ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LYG CL + L++E+ME G L LR + + + +
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MA 115
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYGYIAPELAY 686
Y + ++HRD+++ N L+ N V+DFG+ R + D + + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K DV+SFGV+ EV
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-53
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 13/229 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+D +GTG +G V + VA+K + E + F EA+++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LYG C + +F+I EYM G L LR + + + K + A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL-VVGTYGYIAPELAY 686
+HRD+++ N L+N V+DFGL+R + D ++ + PE+
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 687 TMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRKISQNPRLD 734
+ K D+++FGV+ E+ +G P + + +S + I+Q RL
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGLRLY 221
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 12/211 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
ED+ + +G G YG V A + + VA+K + + E+ + E + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+VK YG +L EY G LF + D + + + + YL
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYIAPEL 684
H I HRDI N+LL+ ++DFGLA + ++ R L + GT Y+APEL
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 685 AYTMAV-TEKCDVYSFGVVALEVLMGSHPTD 714
E DV+S G+V +L G P D
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 9e-52
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ + I +G G +G VY+AQ + L A K + EE LE + E +L+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCD 67
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H NIVKL + ++++ E+ G++ V+ L ++ + K AL+Y
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 125
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
LH I+HRD+ + NIL + + +ADFG++ R +GT ++APE+
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 686 YTMA-----VTEKCDVYSFGVVALEVLMGSHP 712
K DV+S G+ +E+ P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-51
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E ++ +G G +G V+ + VA+K L E+F EA+++ ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+V+LY ++++ EYM +GSL L+ + L + V++ +A ++Y+
Sbjct: 73 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD-SSNRTLVVGTYGYIAPELAY 686
VHRD+ + NIL+ NL VADFGLARL+ + + R + APE A
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
T K DV+SFG++ E+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-51
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ + IG G +G V G VA+K + T + +F EA +++Q+RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60
Query: 568 NIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G + K ++++ EYM +GSL LR+ +V L + + A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+ VHRD+++ N+L++ + A V+DFGL + SS + + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K DV+SFG++ E+
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-51
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 516 IGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYG 574
IG G + +VY+ + VA +L + + + + F+ EA +L ++H NIV+ Y
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 575 FCL----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC 630
KC+ L+ E M G+L L+ + + + + L +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH-TR 131
Query: 631 KPSIVHRDISSNNILLNS-NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMA 689
P I+HRD+ +NI + + D GLA L + V+GT ++APE+ Y
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAPEM-YEEK 188
Query: 690 VTEKCDVYSFGVVALEVLMGSHP 712
E DVY+FG+ LE+ +P
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP 211
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 2e-50
Identities = 80/267 (29%), Positives = 122/267 (45%), Gaps = 30/267 (11%)
Query: 499 TFEEMIEATEDFH---------IKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSET 545
TFE+ EA +F I+ IG G +G V L VA+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 546 EEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAV 605
E+ F +EA ++ Q H N++ L G + + +I E+ME GSL LR +
Sbjct: 68 EK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-- 123
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+ + V +++ +A + YL VHRD+++ NIL+NSNL V+DFGL+R L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 666 DSSNRTLV-----VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSL 719
D+S+ T + APE T DV+S+G+V EV+ G P ++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238
Query: 720 SSSSGRKISQNPRLD--LQCNAYLKNF 744
+ I Q+ RL + C + L
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALHQL 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 20/254 (7%)
Query: 501 EEMIEATEDFHI-KYCIGTGGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQT 556
+++ ++ I +G G +GSV + VA+K L + E A E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58
Query: 557 EARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIV 616
EA+++ Q+ + IV+L G C + + L+ E G L L E E+ + ++
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115
Query: 617 KSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN---RTLV 673
++ + YL + VHRD+++ N+LL + A ++DFGL++ L D S R+
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 674 VGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVL-MGSHPTDLLSSLSSSSGRKISQNPR 732
+ APE + + DV+S+GV E L G P + I Q R
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--AFIEQGKR 230
Query: 733 LDL--QCNAYLKNF 744
++ +C L
Sbjct: 231 MECPPECPPELYAL 244
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 516 IGTGGYGSVYRAQL---SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKL 572
+G+G +G+V + K VA+K L ++E +PA + EA ++ Q+ + IV++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
G C M L+ E E G L L+ + + + +V ++ + YL
Sbjct: 74 IGICEAESWM-LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN---RTLVVGTYGYIAPELAYTMA 689
+ VHRD+++ N+LL + A ++DFGL++ L D + +T + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 690 VTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGRKISQNPRLDL 735
+ K DV+SFGV+ E G P + + + + R+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--AMLEKGERMGC 231
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 3e-49
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + I +GTG +G V+R ++G A K + + E+ + E + +S +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 82
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+V L+ + M +IYE+M G LF + + E ++ + V ++ + L ++
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 627 HYDCKPSIVHRDISSNNILLNS--NLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
H + + VH D+ NI+ + + E + DFGL L P S + GT + APE+
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEV 196
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
A V D++S GV++ +L G P
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-49
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 8/207 (3%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIR 565
EDF + +G G +G V+ A+ + + A+K L + +E E R+LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H + ++ + +F + EY+ G L ++ + D ++ + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELA 685
L IV+RD+ +NILL+ + +ADFG+ + + GT YIAPE+
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
D +SFGV+ E+L+G P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 7e-49
Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 34/242 (14%)
Query: 500 FEEMIEATEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLES 553
+ + IG G +G V++A+ +VA+K L + +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62
Query: 554 FQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN------------- 600
FQ EA L+++ + NIVKL G C K M L++EYM G L LR+
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 601 --------DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEA 652
L +++ I + +A ++YL VHRD+++ N L+ N+
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 179
Query: 653 FVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGS 710
+ADFGL+R ++ + ++ PE + T + DV+++GVV E+
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 711 HP 712
Sbjct: 240 LQ 241
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 9e-49
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
D +K+ +G G YG VY VA+K L E +E F EA ++ +I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKH 72
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
N+V+L G C ++I E+M G+L L + E+ + + ++ A+ YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLVVGTYGYIAPELA 685
K + +HRD+++ N L+ N VADFGL+RL+ D+ + APE
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ K DV++FGV+ E+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS 215
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 1e-48
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + I +G+G +G V+R ++G++ K ++ + + + E +++Q+ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
++ L+ M LI E++ G LF + E ++ + +N ++ L ++
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHM 143
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVVGTYGYIAPEL 684
H + SIVH DI NI+ + + V DFGLA L+PD + T + APE+
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEI 199
Query: 685 AYTMAVTEKCDVYSFGVVALEVLMGSHP 712
V D+++ GV+ +L G P
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 29/251 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
+G G +G V A + VA+K L S E+ +E ++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 562 SQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN---------------DVEAV 605
S + H NIV L G C +I EY G L LR + + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
LD ++ +A +++L + +HRD+++ NILL + DFGLAR +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 666 DSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS 723
DS+ + ++APE + T + DV+S+G+ E+ + S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 724 GRKISQNPRLD 734
+ I + R+
Sbjct: 258 YKMIKEGFRML 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-47
Identities = 58/257 (22%), Positives = 105/257 (40%), Gaps = 34/257 (13%)
Query: 508 EDFHIKYCIGTGGYGSVYRA------QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
E+ +G+G +G V A + VA+K L E+ +E +++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 94
Query: 562 SQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------------- 600
+Q+ H NIV L G C + ++LI+EY G L LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 601 DVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660
+ + L + + +A + +L S VHRD+++ N+L+ + DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 661 RLLHPDSSNRTL--VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSS 718
R + DS+ ++APE + T K DV+S+G++ E+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 719 LSSSSGRKISQNPRLDL 735
+ ++ + I ++D
Sbjct: 272 VDANFYKLIQNGFKMDQ 288
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 13/212 (6%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
+D + +G G +G V R + + VA+K L +P ++ F E +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
+ HRN+++LYG M ++ E GSL LR L R +A +
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN---RTLVVGTYGYI 680
YL +HRD+++ N+LL + + DFGL R L + + + + +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
APE T + D + FGV E+
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 168 bits (427), Expect = 2e-47
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+DF I +GTG +G V+ + +G+ A+K L + +E E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
I++++G + +F+I +Y+E G LF +LR A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
Y I++RD+ NILL+ N + DFG A+ + + GT YIAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
T + D +SFG++ E+L G P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (423), Expect = 3e-47
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
++ + + +G GG V+ A+ L + VA+K L +P+F F+ EA+ + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 566 HRNIVKLYGFCLH----NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
H IV +Y +++ EY++ +L ++ + + + + + +A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEV---IAD 119
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTYG 678
A L++ + I+HRD+ NI++++ V DFG+AR + ++ T V+GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y++PE A +V + DVYS G V EVL G P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
E E + I +G G +G V+R SS K K + T++ + E +L+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
RHRNI+ L+ + + +I+E++ +F + A EL+ + V+ V + AL
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEAL 115
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFV--ADFGLARLLHPDSSNRTLVVGTYGYIA 681
+LH +I H DI NI+ + + + +FG AR L P + R + Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYA 171
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE+ V+ D++S G + +L G +P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 28/224 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
++ IG G +G V+R + G+ VA+K E + E +RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS----WFREAEIYQTVMLRHE 57
Query: 568 NIVKLYGFCLHN----KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
NI+ + ++L+ +Y E GSLF L + + + S A L
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGL 113
Query: 624 SYLHYDC-----KPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN----RTLVV 674
++LH + KP+I HRD+ S NIL+ N +AD GLA + V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 675 GTYGYIAPELAYTMA------VTEKCDVYSFGVVALEVLMGSHP 712
GT Y+APE+ ++ D+Y+ G+V E+
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 6e-47
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 507 TEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR 565
+ + + +GTG + V A+ + KLVA+K + + E S + E +L +I+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK 65
Query: 566 HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
H NIV L ++LI + + G LF + E ++ + A+ Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKY 122
Query: 626 LHYDCKPSIVHRDISSNNILL---NSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAP 682
LH IVHRD+ N+L + + + ++DFGL+++ P S T GT GY+AP
Sbjct: 123 LHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 178
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E+ ++ D +S GV+A +L G P
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 59/245 (24%), Positives = 104/245 (42%), Gaps = 24/245 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKL---VALKKLHRSETEEPAFLESFQTEARLLSQI 564
D + IG G +G V +A++ L A+K++ +++ F E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67
Query: 565 -RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------DVEAVELDWT 610
H NI+ L G C H ++L EY G+L LR + A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 611 KRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670
+ ++ +A + Y + +HRD+++ NIL+ N A +ADFGL+R +
Sbjct: 128 QLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 183
Query: 671 TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQN 730
T+ ++A E T DV+S+GV+ E++ + + K+ Q
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-EKLPQG 242
Query: 731 PRLDL 735
RL+
Sbjct: 243 YRLEK 247
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 8e-46
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 18/245 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
E + CIG G +G V++ S VA+K ++ E F EA + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
H +IVKL G +++I E G L L+ + LD + ++ AL
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 121
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR-TLVVGTYGYIAP 682
+YL VHRDI++ N+L++SN + DFGL+R + + + + ++AP
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 683 ELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSSGRKISQNPRLDL--QCNA 739
E T DV+ FGV E+LM G P + + +I RL + C
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIENGERLPMPPNCPP 236
Query: 740 YLKNF 744
L +
Sbjct: 237 TLYSL 241
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 68/213 (31%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSG-----KLVALKKLHRSETEEPAFLESFQTEARLLS 562
+ IG G +G VY+ L + VA+K L TE+ F EA ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMG 64
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
Q H NI++L G K M +I EYME G+L LR + E + V +++ +A
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAG 122
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSN---RTLVVGTYGY 679
+ Y + VHRD+++ NIL+NSNL V+DFGL+R+L D + +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
APE T DV+SFG+V EV+
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 16/211 (7%)
Query: 511 HIKYCIGTGGYGSVYRAQLSSGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
H IG G +G VY L A+K L+R + F TE ++ H
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 87
Query: 567 RNIVKLYGFCLHNK-CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSY 625
N++ L G CL ++ ++ YM+ G L E + +A +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM-- 143
Query: 626 LHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS----SNRTLVVGTYGYIA 681
+ VHRD+++ N +L+ VADFGLAR ++ N+T ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 682 PELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
E T T K DV+SFGV+ E++ P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 3e-44
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHR------SETEEPAFLESFQTEARL 560
E++ K +G G V R + K A+K + S E E+ E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 561 LSQIR-HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSM 619
L ++ H NI++L N FL+++ M++G LF L V L + I++++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 620 AHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+ LH K +IVHRD+ NILL+ ++ + DFG + L P R V GT Y
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 175
Query: 680 IAPELAYTMAV------TEKCDVYSFGVVALEVLMGSHP 712
+APE+ ++ D++S GV+ +L GS P
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 15/213 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRS---ETEEPAFLESFQTEARLLSQ 563
+ + +G+G + V + + S+G A K + + + E + E +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
I+H N++ L+ + + LI E + G LF L + + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQIL 123
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSN----LEAFVADFGLARLLHPDSSNRTLVVGTYGY 679
+ ++Y I H D+ NI+L + DFGLA + + + GT +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182
Query: 680 IAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+APE+ + + D++S GV+ +L G+ P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-44
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 7/206 (3%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
DF +G G +G V + ++G+ A+K L + + TE+R+L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+ L + + + EY G LF L + E A +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAEIVSAL 118
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
Y +V+RDI N++L+ + + DFGL + D + GT Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
D + GVV E++ G P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (399), Expect = 5e-44
Identities = 68/260 (26%), Positives = 112/260 (43%), Gaps = 14/260 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
E +H IG G YG VY+AQ + G+ ALKK+ R E E+ + E +L +++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 568 NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
NIVKLY K + L++E++++ + + L+ + L+ +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVT---AKSFLLQLLNGIA 114
Query: 628 YDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LAY 686
Y ++HRD+ N+L+N E +ADFGLAR T + T Y AP+ L
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP------TDLLSSLSSSSGRKISQNPRLDLQCNAY 740
+ + D++S G + E++ G+ D L + G S+N + Y
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 741 LKNFSQGNHRWENLLFKKFP 760
NF+ K
Sbjct: 235 DPNFTVYEPLPWESFLKGLD 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 2e-43
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 13/233 (5%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTE---ARLLSQ 563
DF + IG GG+G VY + +GK+ A+K L + + E L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 564 IRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHAL 623
IV + + I + M G L L E D + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---RFYAAEIILGL 120
Query: 624 SYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE 683
++H +V+RD+ NILL+ + ++D GLA + + VGT+GY+APE
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPE 175
Query: 684 -LAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDL 735
L +A D +S G + ++L G P + +++ ++L
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
E+F IG G YG VY+A+ +G++VALKK+ R +TE + E LL ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
NIVKL ++L++E++ + + + + + L K + L L
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPE-LA 685
+ ++HRD+ N+L+N+ +ADFGLAR T V T Y APE L
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 686 YTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ D++S G + E++
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-42
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 20/220 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
E + +G G +G VY VA+K ++ + + F EA ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 562 SQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLR-------NDVEAVELDWTKRVN 614
+ ++V+L G + +I E M RG L LR N+ +K +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 615 IVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR--TL 672
+ +A ++YL VHRD+++ N ++ + + DFG+ R ++ R
Sbjct: 138 MAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 673 VVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ +++PE T DV+SFGVV E+ +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 516 IGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEE--PAFLESFQTEARLLSQIRHRNIVKL 572
+G G + +VY+A+ ++ ++VA+KK+ E + E +LL ++ H NI+ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 573 YGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP 632
H + L++++ME + N + I M L L Y +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH------IKAYMLMTLQGLEYLHQH 119
Query: 633 SIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-T 691
I+HRD+ NN+LL+ N +ADFGLA+ + T V T Y APEL + +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 692 EKCDVYSFGVVALEVLMGSHP 712
D+++ G + E+L+
Sbjct: 180 VGVDMWAVGCILAELLLRVPF 200
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 49/212 (23%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKL----VALKKLHRSETEEPAFLESFQTEARLLS 562
+F +G+G +G+VY+ + G+ VA+K+L + + + + EA +++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66
Query: 563 QIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+ + ++ +L G CL + + LI + M G L +R + + +N +A
Sbjct: 67 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 123
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL--VVGTYGYI 680
++YL +VHRD+++ N+L+ + + DFGLA+LL + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
A E T + DV+S+GV E++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL--------SSGKLVALKKLHRSETEEPAFLESFQTEAR 559
+ + +G G +G V A+ + VA+K L TE+ L +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 560 LLSQI-RHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRN-------------DVEAV 605
++ I +H+NI+ L G C + +++I EY +G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 606 ELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665
+L V+ +A + Y +HRD+++ N+L+ + +ADFGLAR +H
Sbjct: 131 QLSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 666 DSSNRTLVV--GTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ ++APE + T + DV+SFGV+ E+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-41
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 10/216 (4%)
Query: 502 EMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARL 560
++ + + IG G YG V A + VA+KK+ E + + + E ++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKI 59
Query: 561 LSQIRHRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
L + RH NI+ + + Y+ + L ++ L + +
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL---VVGTY 677
L Y+H +++HRD+ +N+LLN+ + + DFGLAR+ PD + V T
Sbjct: 120 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 678 GYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHP 712
Y APE+ T+ D++S G + E+L
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 60/266 (22%), Positives = 99/266 (37%), Gaps = 24/266 (9%)
Query: 509 DFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHR 567
+ IG G +G VY+A+L SG+LVA+KK+ + + E +++ ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73
Query: 568 NIVKLYGFCLH------NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
NIV+L F + L+ +Y+ L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAF-VADFGLARLLHPDSSNRTLVVGTYGYI 680
+L+Y+H I HRDI N+LL+ + + DFG A+ L N + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 681 APELAYTMAVTEKCDVYSFGVVALEVLMGSHP------TDLLSSLSSSSGRKISQNPRLD 734
+ T DV+S G V E+L+G D L + G + R
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 735 LQCNAYLKNFSQGNHRWENLLFKKFP 760
K H W + + P
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTP 276
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (370), Expect = 6e-40
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 9/207 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ + IG G YG+V++A+ + ++VALK++ R + ++ S E LL +++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+NIV+L+ +K + L++E+ ++ + + + L L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
+ +++HRD+ N+L+N N E +A+FGLAR + V T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 687 -TMAVTEKCDVYSFGVVALEVLMGSHP 712
+ D++S G + E+ P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 1e-39
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 10/206 (4%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ F +GTG +G V + SG A+K L + + + +E E R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 RNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYL 626
+VKL N ++++ EY+ G +F LR + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 627 HYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAY 686
H +++RD+ N+L++ V DFG A+ + + GT +APE+
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL 211
Query: 687 TMAVTEKCDVYSFGVVALEVLMGSHP 712
+ + D ++ GV+ E+ G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 506 ATEDFHIKYCIGTGGYGSVYRAQ--LSSGKLVALKKLHRSETEEPAFLESFQ--TEARLL 561
A + + IG G YG V++A+ + G+ VALK++ EE L + + R L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 562 SQIRHRNIVKLYGFCL-----HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIV 616
H N+V+L+ C + L++E++++ + V + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 122
Query: 617 KSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGT 676
+ L +LH +VHRD+ NIL+ S+ + +ADFGLAR+ + + VV T
Sbjct: 123 FQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178
Query: 677 YGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y APE+ + D++S G + E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 56/251 (22%), Positives = 102/251 (40%), Gaps = 28/251 (11%)
Query: 508 EDFHIKYCIGTGGYGSVYRA------QLSSGKLVALKKLHRSETEEPAFLESFQTEARLL 561
+ + +G G +G V A + ++ + VA+K L T + +E ++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70
Query: 562 SQIRHR-NIVKLYGFCLH-NKCMFLIYEYMERGSLFCVLRN-------------DVEAVE 606
I H N+V L G C + +I E+ + G+L LR+ D+
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 607 LDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666
L + +A + +L +HRD+++ NILL+ + DFGLAR ++ D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 667 SSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG 724
+ ++APE + T + DV+SFGV+ E+ +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 725 RKISQNPRLDL 735
R++ + R+
Sbjct: 248 RRLKEGTRMRA 258
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-39
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 18/249 (7%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQL----SSGKLVALKKLHRSE-TEEPAFLESFQTEARLLS 562
E+F + +GTG YG V+ + +GKL A+K L ++ ++ E +TE ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 563 QIRHR-NIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAH 621
IR +V L+ + LI +Y+ G LF L E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 622 ALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRT-LVVGTYGYI 680
+ L + K I++RDI NILL+SN + DFGL++ D + R GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 681 APELAYTM--AVTEKCDVYSFGVVALEVLMGSHP---TDLLSSLSSSSGRKISQNPRLDL 735
AP++ + D +S GV+ E+L G+ P +S + S R + P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 736 QCNAYLKNF 744
+ +A K+
Sbjct: 258 EMSALAKDL 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 508 EDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH 566
+ IG G +G V++A+ +G+ VALKK+ E E+ F + E ++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLLKH 68
Query: 567 RNIVKLYGFCL--------HNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
N+V L C ++L++++ E + V+ L KRV
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV----- 122
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS----NRTLVV 674
M L+ L+Y + I+HRD+ + N+L+ + +ADFGLAR + T V
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 675 GTYGYIAPE-LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
T Y PE L D++ G + E+ S
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 15/212 (7%)
Query: 509 DFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLES---FQTEARLLSQI 564
+ + +G+GG+GSVY +S VA+K + + + L + E LL ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 565 R--HRNIVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHA 622
+++L + LI E E E L + + A
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEA 122
Query: 623 LSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPDSSNRTLVVGTYGYIA 681
+ + ++HRDI NIL++ N E + DFG LL + T GT Y
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSP 177
Query: 682 PE-LAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
PE + Y V+S G++ +++ G P
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 2e-38
Identities = 37/249 (14%), Positives = 86/249 (34%), Gaps = 23/249 (9%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ + IG+G +G +Y +++G+ VA+K E+++ ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63
Query: 569 IVKLYGFCLH-NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
+ +C ++ E + + + + M + Y+H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120
Query: 628 YDCKPSIVHRDISSNNILLNS---NLEAFVADFGLARLLHPDSSN-------RTLVVGTY 677
+ +HRD+ +N L+ ++ DFGLA+ ++ + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQC 737
Y + + + + D+ S G V + +GS P L + + + ++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 738 NAYLKNFSQ 746
K +
Sbjct: 238 EVLCKGYPS 246
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 23/215 (10%)
Query: 508 EDFHI-KYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI- 564
+D+ + +G G G V + + + ALK L + E L +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRAS 62
Query: 565 RHRNIVKLYGFC----LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMA 620
+ +IV++ KC+ ++ E ++ G LF +++ + + I+KS+
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIG 121
Query: 621 HALSYLHYDCKPSIVHRDISSNNILLNSNLE---AFVADFGLARLLHPDSSNRTLVVGTY 677
A+ YLH +I HRD+ N+L S + DFG A+ +S T T
Sbjct: 122 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTP 177
Query: 678 GYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
Y+APE+ + CD++S GV+ +L G P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (345), Expect = 1e-36
Identities = 39/219 (17%), Positives = 75/219 (34%), Gaps = 25/219 (11%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ + IG G +G ++ L + + VA+K R + E R +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 61
Query: 569 -IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLH 627
I +Y F L+ + + + + K M + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH 118
Query: 628 YDCKPSIVHRDISSNNILLNSNL-----EAFVADFGLARLLHPDSSN-------RTLVVG 675
+ S+V+RDI +N L+ +V DFG+ + + + + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 676 TYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTD 714
T Y++ + + D+ + G V + L GS P
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 136 bits (343), Expect = 6e-36
Identities = 42/229 (18%), Positives = 90/229 (39%), Gaps = 25/229 (10%)
Query: 490 SIWNYDG-RITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEE 547
W+Y+ + + +D+ + +G G Y V+ A +++ + V +K L + ++
Sbjct: 20 EYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK 75
Query: 548 PAFLESFQTEARLLSQIR-HRNIVKLYGFCLH--NKCMFLIYEYMERGSLFCVLRNDVEA 604
+ E ++L +R NI+ L ++ L++E++ + +
Sbjct: 76 ------IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---- 125
Query: 605 VELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFGLARLL 663
L + + AL Y H I+HRD+ +N++++ + + + D+GLA
Sbjct: 126 --LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
HP V Y L D++S G + ++ P
Sbjct: 181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 25/279 (8%)
Query: 496 GRITFEEMIEATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESF 554
G TF + + + IG+G G V A + VA+KKL R + +
Sbjct: 9 GDSTFTVL----KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRA 63
Query: 555 QTEARLLSQIRHRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVELD 608
E L+ + H+NI+ L K + +L+ E M+ + D
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------D 117
Query: 609 WTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668
+ ++ M + +LH I+HRD+ +NI++ S+ + DFGLAR S
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSF 173
Query: 669 NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP---TDLLSSLSSSSGR 725
T V T Y APE+ M E D++S G + E++ D + + +
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 726 KISQNPRLDLQCNAYLKNFSQGNHRWENLLFKKFPYQNL 764
+ P + ++N+ + ++ L F K +L
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)
Query: 499 TFEEMIEATEDFHIKY----CIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLES 553
+E+ + + Y +G+G YG+V A +G VA+KKL+R + F +
Sbjct: 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKR 63
Query: 554 FQTEARLLSQIRHRNIVKLYGFCLHNKCM------FLIYEYMERGSLFCVLRNDVEAVEL 607
E RLL +RH N++ L ++ + +L+ +M + +L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-----KL 118
Query: 608 DWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667
+ +V M L Y+H I+HRD+ N+ +N + E + DFGLAR DS
Sbjct: 119 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS 173
Query: 668 SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
VV + + M T+ D++S G + E++ G
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 16/214 (7%)
Query: 505 EATEDFHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQ 563
E E + +G+G YGSV A +G VA+KKL R + + E RLL
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73
Query: 564 IRHRNIVKLYGFC-----LHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKS 618
++H N++ L L + ++ L +++ +L ++
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQ 129
Query: 619 MAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTLVVGTYG 678
+ L Y+H I+HRD+ +N+ +N + E + DFGLAR H D V +
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWY 184
Query: 679 YIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP 712
+ M + D++S G + E+L G
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 111 bits (278), Expect = 1e-27
Identities = 63/294 (21%), Positives = 121/294 (41%), Gaps = 15/294 (5%)
Query: 51 SHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
S L ++P ++ +LDL N++T + +L++L L L NN ++ P
Sbjct: 18 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 111 FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFL 170
F L L++L L N+L L L L + + ++ + + + + L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGT 133
Query: 171 DNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPST 230
+ SG + +L+ + + + T G +L LHL+GN +T ++
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAAS 190
Query: 231 IGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSL 290
+ LN L +L LS N + ++ N +L L L++N+L +P + + KY+ + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL 249
Query: 291 NGNILIG------PIPPTIGYLTNLTYLNLGYNRLS-SSIPPELMNCSQLLNLV 337
+ N + P + + ++L N + I P C + V
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 7e-26
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 15/289 (5%)
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
+P + D L LQ NK+ + NL NL L L N++S P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225
+ L+L N L L +L K+ V + M ++ L N +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285
+ L + ++ + IP G +L L L N+++ + + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 286 ASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSG 345
A L L+ N + ++ +L L+L N+L +P L + + + L +N++S
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISA 256
Query: 346 ------SIPSEIGNLIFFRQLDLSRNFINGT--IPSQLGKIPNISAVDL 386
P + + L N + PS + +AV L
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.6 bits (244), Expect = 4e-23
Identities = 63/291 (21%), Positives = 116/291 (39%), Gaps = 19/291 (6%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93
++P ++ L L +N +T + L L L L N+++ P L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDL--SLNQL 151
L LS N L L K L +LR+ N++ + S L + ++L + +
Sbjct: 82 ERLYLSKNQLKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 152 SGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMK 211
SG +K L + + + +++ IP L L L L NK+ + +
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQL 271
NL +L L+ N+++ ++ L ELHL++N+L +P + + + + L +N +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254
Query: 272 SGL------LPREVGNLKYLASLSLNGN-ILIGPIPP-TIGYLTNLTYLNL 314
S + P + +SL N + I P T + + L
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.0 bits (227), Expect = 7e-21
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 15/273 (5%)
Query: 2 DNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPS 61
+N T + +F NL T + +S P L KLE+L LS N L
Sbjct: 40 NNKITE--IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121
L L+V + ++ ++ + + + +++L + +G F +K L +R
Sbjct: 98 MPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
+ + + G +LT L L N+++ + L NL L L N +S
Sbjct: 157 IADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 213
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG------SIPSTIGYLN 235
+L + L L L NKLV V + + K + ++L+ NN++ P
Sbjct: 214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 272
Query: 236 LLDELHLSHNRL-DGPIPP-TIGNLTNLIALDL 266
+ L N + I P T + A+ L
Sbjct: 273 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 8e-21
Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 32/283 (11%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+P + + LDL N+++ + NLKNL +L L NN +S P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 191 TLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP 250
L L N+L K ++ L + S+ + + + +++ L + + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 251 IPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLT 310
+ L + ++ ++ + G +LT
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQ---------------------------GLPPSLT 174
Query: 311 YLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGT 370
L+L N+++ L + L L LS NS+S + N R+L L+ N +
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-K 233
Query: 371 IPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+P L I V L NN+S I ++ P + +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTKKASYS 275
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 24/105 (22%), Positives = 43/105 (40%), Gaps = 3/105 (2%)
Query: 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFI 367
+L + L +P +L + LL+L +N ++ + NL L L N I
Sbjct: 11 HLRVVQCSDLGLEK-VPKDLPPDTALLDL--QNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 368 NGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL 412
+ P + + + LSKN L + + + +L V EN +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (282), Expect = 1e-27
Identities = 45/278 (16%), Positives = 102/278 (36%), Gaps = 35/278 (12%)
Query: 510 FHIKYCIGTGGYGSVYRAQ-LSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN 568
+ + +G G + +V+ A+ + + VA+K + + + E+ + E +LL ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 70
Query: 569 IVKLYGFCLHN---------------KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRV 613
K ++ + +++E + L + + + + L + K+
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129
Query: 614 NIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN-LEAFVADFGLARLLHPDSSNRT- 671
I K + L Y+H + I+H DI N+L+ + +A L + +
Sbjct: 130 -ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 672 -LVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------ 724
+ T Y +PE+ D++S + E++ G + S +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 725 --RKISQNPRLDLQCNAYLKNFSQGNHRWENLLFKKFP 760
+ + P L+ Y + F N+ KF
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 103 bits (258), Expect = 2e-24
Identities = 82/361 (22%), Positives = 142/361 (39%), Gaps = 33/361 (9%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
L ++ L + + L+ L ++ S N+LT P + +L L+D+ ++NN
Sbjct: 43 LDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 98
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIP------------SSIGNLTNLTYLDLSLN 149
+ PL L + ++I +++ L+ L
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 150 QLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLY-HLNQLATLCLGYNKLVGPVTKEVG 208
G ++ L NL +L + + ++ L L +L N++ +G
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT--PLG 216
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
+ NLD L LNGN L T+ L L +L L++N++ P + LT L L L +
Sbjct: 217 ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM 328
NQ+S + P L+ N I L NLTYL L +N +S P +
Sbjct: 273 NQISNISPLAGLTALTNLELNENQL----EDISPISNLKNLTYLTLYFNNISDISP--VS 326
Query: 329 NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
+ ++L L ++N +S S + NL L N I+ P L + I+ + L+
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
Query: 389 N 389
Sbjct: 383 Q 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 4e-22
Identities = 76/380 (20%), Positives = 140/380 (36%), Gaps = 74/380 (19%)
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+L + + L + ++ +L + L+ + + + L NLT ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL---------------------- 186
NQL+ P + NL L + ++NN ++ P
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 187 --------NQLATLCLGYNKLVGPVTKEVGNMKNLDRL-------HLNGNNLTGSIPSTI 231
N ++ + + +L L L+ ++ S S +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 232 GYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291
L L+ L ++N++ P I TNL L L+ NQL + +L L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 292 GNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP--------------------PELMNCS 331
N + P + LT LT L LG N++S+ P + N
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 332 QLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNL 391
L L L N++S P + +L ++L + N + + S L + NI+ + N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQI 363
Query: 392 SGVIP-ASVRRIPKLIVSEN 410
S + P A++ RI +L +++
Sbjct: 364 SDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.1 bits (235), Expect = 2e-21
Identities = 82/342 (23%), Positives = 131/342 (38%), Gaps = 31/342 (9%)
Query: 37 SEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
+ L+ L ++ S+N LT P + L++L + ++ N++ P + L L
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 97 NLSNNILNGSIPL------------EFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYL 144
+ + ++ L L G + + L NLT L
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 145 DLSLNQLS-GRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203
+ + + L NL+SL NN +S P + L L L N+L
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI- 234
Query: 204 TKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIA 263
+ ++ NL L L N ++ P + L L EL L N++ P + LT L
Sbjct: 235 -GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 289
Query: 264 LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSI 323
L+L+ NQL + NLK L L+L N + P + LT L L N++S
Sbjct: 290 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-- 343
Query: 324 PPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRN 365
L N + + L HN +S P + NL QL L+
Sbjct: 344 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 3e-14
Identities = 70/357 (19%), Positives = 115/357 (32%), Gaps = 68/357 (19%)
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
L + + L + + + +L +T L + V L NL + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 173 NHLSGPIP----STLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228
N L+ P + L + L + N ++ ++
Sbjct: 76 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 229 STIGYLNLLDELH-------------------------------LSHNRLDGPIPPTIGN 257
N + ++ L + +
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 258 LTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYN 317
LTNL +L ++NQ+S + P L L LSLNGN L T+ LTNLT L+L N
Sbjct: 196 LTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 318 RLSSSIPPELMNCSQLLNLVLSHNSLSGSIP--------------------SEIGNLIFF 357
++S+ P L ++L L L N +S P S I NL
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 358 RQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP-ASVRRIPKLIVSENNLE 413
L L N I+ P + + + + + N +S V A++ I L N +
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 4e-10
Identities = 17/88 (19%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
+ NL ++ +S S + +L+KL++L ++N ++ S + L+ + L
Sbjct: 302 PISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
+N+++ P + +L + L L++
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (235), Expect = 3e-22
Identities = 63/264 (23%), Positives = 95/264 (35%), Gaps = 7/264 (2%)
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+P I + L N++S +NL L+L +N L+ + L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 191 TLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
L L N + V + L LHL+ L P L L L+L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 250 PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNL 309
T +L NL L L N++S + R L L L L+ N + P L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 310 TYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFING 369
L L N LS+ L L L L+ N + + ++ S + +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 370 TIPSQLGKIPNISAVDLSKNNLSG 393
++P +L L+ N+L G
Sbjct: 263 SLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (233), Expect = 6e-22
Identities = 62/263 (23%), Positives = 92/263 (34%), Gaps = 31/263 (11%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNR----------------- 78
P I A +++ L N ++ + A L +L L N
Sbjct: 27 PVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ 84
Query: 79 --------LTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGL 130
L P+ L L L+L L P F L L L LQ N L L
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144
Query: 131 IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLA 190
+ +L NLT+L L N++S + L +L L L N ++ P L +L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 191 TLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGP 250
TL L N L T+ + ++ L L LN N + L + S + +
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCS 263
Query: 251 IPPTIGNLTNLIALDLSSNQLSG 273
+P L L++N L G
Sbjct: 264 LPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (231), Expect = 1e-21
Identities = 63/282 (22%), Positives = 100/282 (35%), Gaps = 8/282 (2%)
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
+ + L ++P+ ++ L GN++ + +S NLT L L
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI-PSTLYHLNQLATLCLGYNKLVGPVTKEV 207
N L+ L L+ L L +N + P+T + L +L TL L L
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 208 GNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLS 267
+ L L+L N L T L L L L NR+ L +L L L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 268 SNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPEL 327
N+++ + P +L L +L L N L + L L YL L N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245
Query: 328 MNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFING 369
+ + L S + + S+P + L+ N + G
Sbjct: 246 L-WAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (225), Expect = 8e-21
Identities = 59/273 (21%), Positives = 95/273 (34%), Gaps = 5/273 (1%)
Query: 142 TYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG 201
L +P + + +FL N +S ++ L L L N L
Sbjct: 14 VTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 202 PVTKEVGNMKNLDRLHLNGNNLTGSI-PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
+ L++L L+ N S+ P+T L L LHL L P L
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L L L N L L +L L L L+GN + L +L L L NR++
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 321 SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPN 380
P + +L+ L L N+LS + L + L L+ N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249
Query: 381 ISAVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ S + + +P + ++ N+L+
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 5e-14
Identities = 47/236 (19%), Positives = 75/236 (31%), Gaps = 28/236 (11%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
L P+ L +L L L L P L+ L+ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPS 133
L N L L +L L L N ++ F L LD+L L N++ + P
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ +L L L L N LS + + L+ L+ L L++N +
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA------------ 243
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
L + + + + S+P + +L L+ N L G
Sbjct: 244 -------------RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 39/175 (22%), Positives = 51/175 (29%), Gaps = 4/175 (2%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSE 62
+ EL F L + L L L L L N ++
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 63 IGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRL 122
L L L L NR+ P L L+ L L N L+ L+ L LRL
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 123 QGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177
N + L S +++ LPQ L L N L G
Sbjct: 233 NDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 93.7 bits (231), Expect = 2e-21
Identities = 70/271 (25%), Positives = 111/271 (40%), Gaps = 9/271 (3%)
Query: 37 SEIGALSKLEKLVLSHNSLTGR--IPSEIGALSRLKVLDLSYN-RLTGTIPSEIGSLRDL 93
++ L LS +L IPS + L L L + L G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSG 153
L +++ ++G+IP +K L L N L G +P SI +L NL + N++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 154 RLPQEVGNLKNLKS-LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKN 212
+P G+ L + + + N L+G IP T +LN +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML--EGDASVLFGSDK 221
Query: 213 LDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS 272
+ N +G L+ L L +NR+ G +P + L L +L++S N L
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 273 GLLPREVGNLKYLASLSLNGNILI--GPIPP 301
G +P + GNL+ + N + P+P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 91.7 bits (226), Expect = 8e-21
Identities = 74/275 (26%), Positives = 108/275 (39%), Gaps = 9/275 (3%)
Query: 61 SEIGALSRLKVLDLSYNRLTG--TIPSEIGSLRDLLDLNLSNNI-LNGSIPLEFGNLKDL 117
R+ LDLS L IPS + +L L L + L G IP L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 118 DQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177
L + + G IP + + L LD S N LSG LP + +L NL + D N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 178 PIPSTLYHLNQLAT-LCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNL 236
IP + ++L T + + N+L G + N+ + N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN- 222
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI 296
+ +G NL LDL +N++ G LP+ + LK+L SL+++ N L
Sbjct: 223 -TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 297 GPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCS 331
G IP G L N+ P L C+
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.8 bits (221), Expect = 4e-20
Identities = 62/268 (23%), Positives = 110/268 (41%), Gaps = 7/268 (2%)
Query: 128 DGLIPSSIGNLTNLTYLDLSLNQLSGR--LPQEVGNLKNLKSLFLDNNH-LSGPIPSTLY 184
G++ + + LDLS L +P + NL L L++ + L GPIP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 185 HLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244
L QL L + + + G + + +K L L + N L+G++P +I L L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 245 NRLDGPIPPTIGNLTNLIA-LDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTI 303
NR+ G IP + G+ + L + +S N+L+G +P NL + ++ +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVL 216
Query: 304 GYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLS 363
T + ++ L L L +N + G++P + L F L++S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 364 RNFINGTIPSQLGKIPNISAVDLSKNNL 391
N + G IP G + + N
Sbjct: 277 FNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.8 bits (208), Expect = 2e-18
Identities = 68/272 (25%), Positives = 104/272 (38%), Gaps = 5/272 (1%)
Query: 80 TGTIPSEIGSLRDLLDLNLSNNILNG--SIPLEFGNLKDLDQLRLQGN-KLDGLIPSSIG 136
G + + +L+LS L IP NL L+ L + G L G IP +I
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY 196
LT L YL ++ +SG +P + +K L +L N LSG +P ++ L L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 197 NKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256
N++ G + G+ L N L + LS N L+G G
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
+ N + +VG K L L L N + G +P + L L LN+ +
Sbjct: 219 SDKN-TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIP 348
N L IP + N + ++N P
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 19/71 (26%), Positives = 28/71 (39%), Gaps = 1/71 (1%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
NL + + G +P + L L L +S N+L G IP + G L R V
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297
Query: 74 LSYNRLTGTIP 84
+ N+ P
Sbjct: 298 YANNKCLCGSP 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.2 bits (223), Expect = 2e-21
Identities = 26/164 (15%), Positives = 55/164 (33%), Gaps = 17/164 (10%)
Query: 516 IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAF-------LESFQTEARLLSQIRHRN 568
+G G +V+ +K T F A ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 569 IVKLYGFCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHY 628
+ KL G + +Y + E ++ L + E + ++ + ++ ++
Sbjct: 68 LQKLQGLAVPK-----VYAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 629 DCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNRTL 672
IVH D+S N+L+ S ++ DF + + + L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (189), Expect = 3e-16
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 7/208 (3%)
Query: 86 EIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLD 145
E+ + L++N L ++P + KD L L N L +++ T LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 146 LSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205
L + Q G L L +L L +N L L L L + +N+L
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALD 265
+ + L L+L GN L P + L++L L++N L + L NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 266 LSSNQLSGLLPREVGNLKYLASLSLNGN 293
L N L +P+ L L+GN
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 51/211 (24%), Positives = 78/211 (36%), Gaps = 7/211 (3%)
Query: 38 EIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLN 97
E+ ++ ++ +LT +P ++ +L LS N L + + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ 157
L + G L L L L N+L L D+S N+L+
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 158 EVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLH 217
+ L L+ L+L N L P L +L L L N L + ++NLD L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 218 LNGNNLTGSIPSTIGYLNLLDELHLSHNRLD 248
L N+L +IP +LL L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 49/210 (23%), Positives = 70/210 (33%), Gaps = 7/210 (3%)
Query: 134 SIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLC 193
+ + + ++ L+ LP ++ K+ L L N L +TL +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 194 LGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253
L + + G + L L L+ N L L +S NRL
Sbjct: 62 LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
+ L L L L N+L L P + L LSL N L + L NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 314 LGYNRLSSSIPPELMNCSQLLNLVLSHNSL 343
L N +IP L L N
Sbjct: 179 LQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (147), Expect = 8e-11
Identities = 47/209 (22%), Positives = 72/209 (34%), Gaps = 29/209 (13%)
Query: 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALD 265
EV + + ++ + NLT ++P + LHLS N L T+ T L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 266 LSSNQLSGLLPREVGNLKYLASLSLNGNI-----------------------LIGPIPPT 302
L +L+ + G L L +L L+ N L
Sbjct: 62 LDRAELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 303 IGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDL 362
+ L L L L N L + P L +L L L++N+L+ + L L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNL 391
N + TIP + L N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 5e-09
Identities = 48/188 (25%), Positives = 69/188 (36%), Gaps = 6/188 (3%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
P ++ L LS N L + + +RL L+L LT +L
Sbjct: 26 PPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP---VLG 80
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL 155
++ S+PL L L L + N+L L ++ L L L L N+L
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140
Query: 156 PQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR 215
P + L+ L L NN+L+ L L L TL L N L + K L
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199
Query: 216 LHLNGNNL 223
L+GN
Sbjct: 200 AFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 39/190 (20%), Positives = 57/190 (30%), Gaps = 27/190 (14%)
Query: 10 LSQLNFTCFP-----NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIG 64
+ N T P + + LL + + ++L +L L LT
Sbjct: 17 CDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76
Query: 65 ALSRLKVLDLSYN---------------------RLTGTIPSEIGSLRDLLDLNLSNNIL 103
+ L + RLT + L +L +L L N L
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 104 NGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLK 163
P L++L L N L L + L NL L L N L +P+
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 164 NLKSLFLDNN 173
L FL N
Sbjct: 196 LLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 26/93 (27%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 9 ELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSR 68
L L + G L P + KLEKL L++N+LT + L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
L L L N L TIP L L N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 42/279 (15%), Positives = 80/279 (28%), Gaps = 16/279 (5%)
Query: 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN-ILNG 105
L L+ +L + + + + + + + R + ++LSN+ I
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
++ L L L+G +L I +++ +NL L+LS +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGN---- 221
+ L+ + + + + L G + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 222 -----NLTGSIPSTIGYLNLLDELHLSH-NRLDGPIPPTIGNLTNLIALDLSSNQLSGLL 275
L LN L L LS + +G + L L + G L
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNL 314
L L +N + PTIG N +
Sbjct: 242 QLLKEALP---HLQINCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 39/282 (13%), Positives = 81/282 (28%), Gaps = 37/282 (13%)
Query: 142 TYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG 201
LDL+ L + + + + + + + P+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF------------------ 43
Query: 202 PVTKEVGNMKNLDRLHLNGNNLTG-SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTN 260
+ + + L+ + + ++ + + L L L RL PI T+ +N
Sbjct: 44 -------SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
Query: 261 LIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLS 320
L+ L+LS + LN + + + LS
Sbjct: 97 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 156
Query: 321 SSIPPELMNCSQLLNLVLSHN---------SLSGSIPSEIGNLIFFRQLDLSR-NFINGT 370
+ L + L E L + + L LSR I
Sbjct: 157 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216
Query: 371 IPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNL 412
+LG+IP + + + G + +P L ++ ++
Sbjct: 217 TLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHF 258
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 39/283 (13%), Positives = 89/283 (31%), Gaps = 24/283 (8%)
Query: 3 NNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGR-IPS 61
N +L ++ FR + + + E + +++ + LS++ + +
Sbjct: 10 KNLHPDVTGRL---LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHG 65
Query: 62 EIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121
+ S+L+ L L RL+ I + + +L+ LNLS L+
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT---------- 115
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
+ L ++ + T + + NL + ++ +
Sbjct: 116 -LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNG-NNLTGSIPSTIGYLNLLDEL 240
L +E + L L L+ ++ +G + L L
Sbjct: 175 PNLVHLD----LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK 283
+ DG + L + L ++ + + + +GN K
Sbjct: 231 QVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKK 270
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 58.1 bits (139), Expect = 4e-10
Identities = 41/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 82 TIPSEIG------SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSI 135
T+P+ I + + + NL + ++ L +DQ+ + + + I
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 136 GNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLG 195
L N+T L L+ N+L+ L NLK+L + + +
Sbjct: 65 QYLPNVTKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119
Query: 196 YNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255
+ + + V + N L LS +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPL 174
Query: 256 GNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
LT L L LS N +S L R + LK L L L
Sbjct: 175 AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 1e-07
Identities = 38/215 (17%), Positives = 63/215 (29%), Gaps = 22/215 (10%)
Query: 131 IPSSIG------NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLY 184
+P+ I +L ++ + Q L ++ + +N+ + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 185 HLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSH 244
+L + L L NKL +K L L G + S
Sbjct: 66 YLPNVTKLFLNGNKLTD--------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117
Query: 245 NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIG 304
+ I G + L + L L +LSL N + +P +
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175
Query: 305 YLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLS 339
LT L L L N +S L L L L
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 1e-06
Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 22/216 (10%)
Query: 59 IPSEIG------ALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFG 112
+P+ I A + +L +T + L + + +N+ + ++
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ-- 65
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
L ++ +L L GNKL + NL NL +L L N++ + L
Sbjct: 66 YLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK----SLSL 119
Query: 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
H + L HL QL +L LG NK+ + L N ++ +P +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTL--SLEDNQISDIVP--LA 175
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
L L L+LS N + + L NL L+L S
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 5e-06
Identities = 32/186 (17%), Positives = 67/186 (36%), Gaps = 14/186 (7%)
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
+ +L ++T ++ T LN +D++ +++ + I L N+ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM 328
N+L+ + K LA+L G + + + + I
Sbjct: 78 NKLTDI--------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 329 NCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSK 388
L + + + + L L L N I+ +P L + + + LSK
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 389 NNLSGV 394
N++S +
Sbjct: 188 NHISDL 193
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 39/194 (20%), Positives = 66/194 (34%), Gaps = 24/194 (12%)
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
+ L + VT+ + ++D++ N +++ I YL + +L L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGY 305
+L P + NL NL L L N++ L + SL NG I +
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 306 LTNLTYLNLGYNRLSSSI----------------PPELMNCSQLLNLVLSHNSLSGSIPS 349
+ N + S L ++L NL LS N +S
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LR 194
Query: 350 EIGNLIFFRQLDLS 363
+ L L+L
Sbjct: 195 ALAGLKNLDVLELF 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.1 bits (132), Expect = 8e-10
Identities = 32/126 (25%), Positives = 50/126 (39%), Gaps = 9/126 (7%)
Query: 48 LVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSI 107
L L+H LT + + L + LDLS+NRL P+ + +LR L L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALEN 57
Query: 108 PLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLSLNQLSGR---LPQEVGNLK 163
NL L +L L N+L + + L L+L N L + L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 164 NLKSLF 169
++ S+
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 4e-09
Identities = 32/129 (24%), Positives = 53/129 (41%), Gaps = 12/129 (9%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
+VL L++ L T+ + L + L+LS+N L P L+ L+ L+ N L+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 130 LIPSSIGNLTNLTYLDLSLNQL-SGRLPQEVGNLKNLKSLFLDNNHLSGP------IPST 182
+ + NL L L L N+L Q + + L L L N L +
Sbjct: 58 V--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 183 LYHLNQLAT 191
L ++ + T
Sbjct: 116 LPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 33/126 (26%), Positives = 45/126 (35%), Gaps = 6/126 (4%)
Query: 216 LHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLL 275
LHL +LT + + L L+ L LSHNRL PP + L L L S N L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59
Query: 276 PREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSS--SIPPELMNCSQL 333
L N + + L LNL N L I L
Sbjct: 60 GVANLPRLQELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 334 LNLVLS 339
++ +L+
Sbjct: 119 VSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 6e-08
Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
L L L L + L +T+LDLS N+L P + L+ L+ L + +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57
Query: 180 PSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYL 234
+ +L +L L L N+L + + + L L+L GN+L L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERL 112
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 24/110 (21%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTG 225
+ L L + L+ + L L + L L +N+L + ++ L+ L ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLE--VLQASDNAL 55
Query: 226 SIPSTIGYLNLLDELHLSHNRL-DGPIPPTIGNLTNLIALDLSSNQLSGL 274
+ L L EL L +NRL + + L+ L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 28/112 (25%), Positives = 43/112 (38%), Gaps = 5/112 (4%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLD 95
+ L + L LSHN L P+ + AL L+VL S N L L
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELL 71
Query: 96 LNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL---DGLIPSSIGNLTNLTYL 144
L +N + + + L L LQGN L +G+ L +++ +
Sbjct: 72 LC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 23/120 (19%), Positives = 41/120 (34%), Gaps = 27/120 (22%)
Query: 311 YLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPS--------------------- 349
L+L + L+ L + +L LSHN L P+
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 350 EIGNLIFFRQLDLSRNFINGT-IPSQLGKIPNISAVDLSKNNLS---GVIPASVRRIPKL 405
+ NL ++L L N + + L P + ++L N+L G+ +P +
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 3e-09
Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 9/104 (8%)
Query: 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLD 73
F+ L + S + S LE+L +S+N L +P+ RL+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLI 310
Query: 74 LSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDL 117
S+N L +P +L+ L++ N L P +++DL
Sbjct: 311 ASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 3e-08
Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 10/93 (10%)
Query: 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIP 252
N + +L+ L+++ N L +P+ L L S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP 320
Query: 253 PTIGNLTNLIALDLSSNQLSGL--LPREVGNLK 283
NL L + N L +P V +L+
Sbjct: 321 ELPQNLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 10/93 (10%)
Query: 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLP 156
N + I L++L + NKL +P+ L L S N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVP 320
Query: 157 QEVGNLKNLKSLFLDNNHLSG--PIPSTLYHLN 187
+ +NLK L ++ N L IP ++ L
Sbjct: 321 EL---PQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 5e-07
Identities = 25/97 (25%), Positives = 38/97 (39%), Gaps = 10/97 (10%)
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLP 276
N + I S L+EL++S+N+L +P L L S N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHLAE-VP 320
Query: 277 REVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLN 313
NLK L + N L P + +L +N
Sbjct: 321 ELPQNLKQ---LHVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 9/93 (9%)
Query: 241 HLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIP 300
N I +L L++S+N+L LP L+ L + N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFN-HLAEVP 320
Query: 301 PTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333
NL L++ YN L P + L
Sbjct: 321 ELPQ---NLKQLHVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 3e-06
Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 16/104 (15%)
Query: 313 NLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIP 372
N S+ I L L +S+N L +P+ L +L S N + +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP 320
Query: 373 SQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
N+ + + N L P + S +L + +
Sbjct: 321 ELPQ---NLKQLHVEYNPLRE--------FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 10/93 (10%)
Query: 146 LSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205
LN S + +L+ L + NN L +P+ +L L +N L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHL----AE 318
Query: 206 EVGNMKNLDRLHLNGNNLTG--SIPSTIGYLNL 236
+NL +LH+ N L IP ++ L +
Sbjct: 319 VPELPQNLKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 19/67 (28%), Positives = 30/67 (44%), Gaps = 5/67 (7%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNI 102
+ +L L++ L+ +P L+ L S N LT +P SL+ LL N +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 103 LNGSIPL 109
L+ PL
Sbjct: 93 LSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 211 KNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
+ L LN L+ S+P +L L S N L +P +L +L+ + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 271 LSGLLP 276
LS L P
Sbjct: 93 LSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 5/48 (10%)
Query: 237 LDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284
EL L++ L +P +L +L S N L+ LP +LK
Sbjct: 40 AHELELNNLGLSS-LPELPPHLESL---VASCNSLTE-LPELPQSLKS 82
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 8e-09
Identities = 38/228 (16%), Positives = 72/228 (31%), Gaps = 18/228 (7%)
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
L + ++ + + + + +L +T L ++ + V L NL L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
N ++ P L K V + + + S +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
L L + + L G + + NL L +L +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 293 NILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSH 340
N + P + L NL ++L N++S P L N S L + L++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 34/227 (14%), Positives = 71/227 (31%), Gaps = 18/227 (7%)
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY 196
L N + + ++ + Q +L + +L ++ + +LN L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 197 NKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256
N++ + L N +I L + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
L + + + L+GL + ++ + L+ LT L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----------DLTPLANLSKLTTLKADD 182
Query: 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLS 363
N++S P L + L+ + L +N +S P + N + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 35 MPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLL 94
+ + LSKL L N ++ P + +L L + L N+++ P + + +L
Sbjct: 165 DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLF 220
Query: 95 DLNLSN 100
+ L+N
Sbjct: 221 IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 40/202 (19%), Positives = 64/202 (31%), Gaps = 20/202 (9%)
Query: 209 NMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268
+ N ++ +N+T ++ T L+ + L + + L NLI L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY------------ 316
NQ++ L P + LS N + I T
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 317 --NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQ 374
+ I LS + S + + NL L N I+ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 375 LGKIPNISAVDLSKNNLSGVIP 396
L +PN+ V L N +S V P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 17/91 (18%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 260 NLIALDLSSNQLSGL-LPREVGNLKYLASLSLNGNIL----IGPIPPTIGYLTNLTYLNL 314
++ +LD+ +LS + L+ + L+ L I + L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 315 GYNRLSSSIPPELMNCSQLLNLVLSHNSLSG 345
N L ++ Q + + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 3e-07
Identities = 18/99 (18%), Positives = 31/99 (31%), Gaps = 5/99 (5%)
Query: 92 DLLDLNLSNNILNGSIPLE-FGNLKDLDQLRLQGNKLDG----LIPSSIGNLTNLTYLDL 146
D+ L++ L+ + E L+ +RL L I S++ L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 147 SLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYH 185
N+L V S + L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 8e-07
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 5/84 (5%)
Query: 45 LEKLVLSHNSLT-GRIPSEIGALSRLKVLDLSYNRLTG----TIPSEIGSLRDLLDLNLS 99
++ L + L+ R + L + +V+ L LT I S + L +LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 100 NNILNGSIPLEFGNLKDLDQLRLQ 123
+N L ++Q
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 15/91 (16%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 308 NLTYLNLGYNRLSSSIPPELM-NCSQLLNLVLSHNSLSG----SIPSEIGNLIFFRQLDL 362
++ L++ LS + EL+ Q + L L+ I S + +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 363 SRNFINGTIPSQLGKIPNISAVDLSKNNLSG 393
N + + + + + K +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 14/84 (16%), Positives = 26/84 (30%), Gaps = 5/84 (5%)
Query: 212 NLDRLHLNGNNLTGS-IPSTIGYLNLLDELHLSHNRLDG----PIPPTIGNLTNLIALDL 266
++ L + L+ + + L + L L I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 267 SSNQLSGLLPREVGNLKYLASLSL 290
SN+L + V S +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 16/91 (17%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 20 NLVTFRIWGTLLSGRMPSEI-GALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDL 74
++ + I LS +E+ L + + + L LT I S + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 75 SYNRLTGTIPSEIGSLRDLLDLNLSNNILNG 105
N L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 9/81 (11%)
Query: 307 TNLTYLNLGYNRLS----SSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIF-----F 357
+ L L L +S SS+ L+ L L LS+N L + ++ +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 358 RQLDLSRNFINGTIPSQLGKI 378
QL L + + + +L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 7e-06
Identities = 14/84 (16%), Positives = 26/84 (30%), Gaps = 5/84 (5%)
Query: 116 DLDQLRLQGNKL-DGLIPSSIGNLTNLTYLDLSLNQLSGR----LPQEVGNLKNLKSLFL 170
D+ L +Q +L D + L + L L+ + + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 171 DNNHLSGPIPSTLYHLNQLATLCL 194
+N L + Q + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 8e-06
Identities = 16/87 (18%), Positives = 29/87 (33%), Gaps = 9/87 (10%)
Query: 111 FGNLKDLDQLRLQGNKLDGL----IPSSIGNLTNLTYLDLSLNQLSGRLPQEVG-----N 161
L L L + + +++ +L LDLS N L ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQ 188
L+ L L + + S + L L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 209 NMKNLDRLHLNGNNLTG----SIPSTIGYLNLLDELHLSHNRLDGPIPPTIG-----NLT 259
L L L +++ S+ +T+ + L EL LS+N L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 260 NLIALDLSSNQLSGLLPREVGNLK 283
L L L S + + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 9/82 (10%)
Query: 43 SKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTGTIPSEIG-SLRD----L 93
S L L L+ ++ + + + A L+ LDLS N L ++ S+R L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 94 LDLNLSNNILNGSIPLEFGNLK 115
L L + + + L+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 31/115 (26%)
Query: 67 SRLKVLDLSYNRLTGT----IPSEIGSLRDLLDLNLSNNILNGSIPLEFGN-LKDLDQLR 121
S L+VL L+ ++ + + + + + L +L+LSNN L + L+ ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ----- 423
Query: 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176
L L L S + L++L D L
Sbjct: 424 ---------------PGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 189 LATLCLGYNKLV-GPVTKEVGNMKNLDRLHLNGNNLTG----SIPSTIGYLNLLDELHLS 243
+ +L + +L + + ++ + L+ LT I S + L EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 244 HNRLDGPIPPTIG-----NLTNLIALDLSSNQ 270
N L + + L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 16/83 (19%), Positives = 26/83 (31%), Gaps = 9/83 (10%)
Query: 281 NLKYLASLSLNGNIL----IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELM-----NCS 331
L L L + + T+ +L L+L N L + +L+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 332 QLLNLVLSHNSLSGSIPSEIGNL 354
L LVL S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 327 LMNCSQLLNLVLSHNSLSG----SIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKI---- 378
S L L L+ +S S+ + + R+LDLS N + QL +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 379 -PNISAVDLSKNNLSGVIPASVRRIPK 404
+ + L S + ++ + K
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 9/89 (10%)
Query: 12 QLNFTCFPNLVTFRIWGTLLSGR----MPSEIGALSKLEKLVLSHNSLTGRIPSEIGA-- 65
Q L + +S + + + A L +L LS+N L ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 66 ---LSRLKVLDLSYNRLTGTIPSEIGSLR 91
L+ L L + + + +L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 18/105 (17%), Positives = 31/105 (29%), Gaps = 23/105 (21%)
Query: 235 NLLDELHLSHNRLDG----PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSL 290
++L L L+ + + T+ +L LDLS+N L ++ S+
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-----SVRQ 423
Query: 291 NGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLN 335
G L L L S + L +
Sbjct: 424 PG--------------CLLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.8 bits (122), Expect = 8e-08
Identities = 34/228 (14%), Positives = 70/228 (30%), Gaps = 7/228 (3%)
Query: 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDG 129
+V +++T IPS++ R+ ++L L F DL+++ + N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 130 LIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS----GPIPSTLYH 185
+I + + + + + +L ++ +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 186 LNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHN 245
L + N VG L LN N + L + +N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 246 RLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGN 293
L+ + + LD+S ++ L + NLK L + S
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 37/224 (16%), Positives = 67/224 (29%), Gaps = 7/224 (3%)
Query: 51 SHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLE 110
+ +T IPS++ L +L DL + +S N + I +
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 111 FGNLKDLDQLRLQG--NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168
+ N L + P + NL NL YL +S + + L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 169 FLDN--NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGS 226
+ + N + S + + L L N + + + + NNL
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 227 IPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQ 270
+ L +S R+ + NL L A + +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 6e-06
Identities = 35/234 (14%), Positives = 70/234 (29%), Gaps = 10/234 (4%)
Query: 120 LRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179
Q +K+ IPS + N L L +L +L+ + + N + I
Sbjct: 13 FLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 180 PSTLYHLNQLATLCLGY--NKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLL 237
+ ++ N L+ + N+ NL L ++ + +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 238 DELHLSH--NRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNIL 295
L + N +G + L L+ N + + + + N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 296 IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPS 349
+ L++ R+ S L N +L S +L +P+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL--RARSTYNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 11/58 (18%), Positives = 16/58 (27%), Gaps = 13/58 (22%)
Query: 111 FGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168
F L + ++ L + NL L NLK L +L
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-------------NLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 9e-04
Identities = 34/246 (13%), Positives = 60/246 (24%), Gaps = 17/246 (6%)
Query: 140 NLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL--NQLATLCLGYN 197
+ ++++ +P ++ +N L L + +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 198 KLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGN 257
V K + NNL P L L L +S+ + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 258 LTNLIALDLSS--NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLG 315
+ LD+ N + VG L LN N +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 316 YNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQL 375
N L S + L +S + + NL R L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST----------YNL 235
Query: 376 GKIPNI 381
K+P +
Sbjct: 236 KKLPTL 241
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 8e-08
Identities = 43/199 (21%), Positives = 74/199 (37%), Gaps = 16/199 (8%)
Query: 90 LRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLN 149
L + + L + ++ +L + L+ + + + L NLT ++ S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 150 QLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGN 209
QL+ LK+L + L T G +T
Sbjct: 73 QLTDI--------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 210 MKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSN 269
+ L ++ T S S + L L +L+ S N++ P + NLT L LD+SSN
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 270 QLSGLLPREVGNLKYLASL 288
++S + + L L SL
Sbjct: 183 KVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 39/200 (19%), Positives = 63/200 (31%), Gaps = 16/200 (8%)
Query: 113 NLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDN 172
L + + L + + + +L +T L + V L NL + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 173 NHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIG 232
N L+ L L + L+ I
Sbjct: 72 NQLTDI--------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 233 YLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNG 292
NL + L + + LT+L L+ SSNQ++ L P + NL L L ++
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 293 NILIGPIPPTIGYLTNLTYL 312
N + + LTNL L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 1e-04
Identities = 31/200 (15%), Positives = 60/200 (30%), Gaps = 16/200 (8%)
Query: 137 NLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGY 196
L L ++ + Q +L + +L D + + +LN L +
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 197 NKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256
N+L + ++ N I NL ++ D +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIA---DITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316
NL L + + +S L +S + + LT L L++
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD-------LKPLANLTTLERLDISS 181
Query: 317 NRLSSSIPPELMNCSQLLNL 336
N++S L + L +L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 39/200 (19%), Positives = 68/200 (34%), Gaps = 16/200 (8%)
Query: 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSN 100
AL++ K VL ++T + L ++ L + + L +L +N SN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 101 NILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160
N L PL+ + + I L+L +
Sbjct: 72 NQLTDITPLKN------LTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125
Query: 161 NLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNG 220
NL NL L L +N +S + Q + P + N+ L+RL ++
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP----LANLTTLERLDISS 181
Query: 221 NNLTGSIPSTIGYLNLLDEL 240
N ++ S + L L+ L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 8e-08
Identities = 49/333 (14%), Positives = 100/333 (30%), Gaps = 33/333 (9%)
Query: 115 KDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGR----LPQEVGNLKNLKSLFL 170
K L + + + + ++ + LS N + L + + + K+L+
Sbjct: 8 KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 171 DNNH---LSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227
+ + IP L L Q C + + + L+ + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLK---- 283
L ++ + + N L ++ N+L +E
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 284 --YLASLSLNGNILIGPIPPTIGYLTNLTYL-------NLGYNRLSSSIPPELMNCSQLL 334
+ + NG G + L L N + SS++ L + L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 335 NLVLSHNSLSGSIPSEIGNLIFF------RQLDLSRNFINGTIPSQL-----GKIPNISA 383
L L+ LS + + + + L L N I L K+P++
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 384 VDLSKNNLSGVIPASVRRIPKLIVSENNLELEN 416
++L+ N S V I ++ + EL+
Sbjct: 307 LELNGNRFSE-EDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 49/326 (15%), Positives = 88/326 (26%), Gaps = 34/326 (10%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG----SIPLEFGNLKDLDQLRLQG 124
LK+ ++ ++ + + + ++ LS N + + + KDL+
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 125 N---KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPS 181
++ IP ++ L L+ + + FL + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT----GSIPSTIGYLNLL 237
L A + V K+ N L + N L T LL
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLS---------GLLPREVGNLKYLASL 288
+ + N + + +L L L + + L L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 289 SLNGNILIGPIPPTIG------YLTNLTYLNLGYNRLSSSIPPELM-----NCSQLLNLV 337
LN +L + L L L YN + L LL L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 338 LSHNSLS--GSIPSEIGNLIFFRQLD 361
L+ N S + EI + R
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 41/305 (13%), Positives = 87/305 (28%), Gaps = 32/305 (10%)
Query: 36 PSEIGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYN---RLTGTIPSEIG 88
+ + ++++VLS N++ + I + L++ + S R+ IP +
Sbjct: 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR 83
Query: 89 SLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSL 148
L L + + S ++ L + + L ++
Sbjct: 84 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 143
Query: 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVG 208
+ ++ N L+S+ N L Q L + + E
Sbjct: 144 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 203
Query: 209 NMKNLDRL-------------HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTI 255
L+ L + + + ++ + L EL L+ L +
Sbjct: 204 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 263
Query: 256 GN------LTNLIALDLSSNQLSG-----LLPREVGNLKYLASLSLNGNILIGPIPPTIG 304
+ L L L N++ L + L L LNGN +
Sbjct: 264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN-RFSEEDDVVD 322
Query: 305 YLTNL 309
+ +
Sbjct: 323 EIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 10/66 (15%), Positives = 23/66 (34%), Gaps = 6/66 (9%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGA-----LSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96
L+ L L +N + + + L L+L+ NR + + +R++
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFST 330
Query: 97 NLSNNI 102
+
Sbjct: 331 RGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 12/87 (13%)
Query: 50 LSHNSLTGRIPSEIG------ALSRLKVLDLSYNRLTGTIPSEIGS-----LRDLLDLNL 98
L+ L+ R + + L+ L L YN + + + + DLL L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 99 SNNILNGSIPLEFGNLKDLDQLRLQGN 125
+ N ++++ R +G
Sbjct: 310 NGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 6/67 (8%), Positives = 18/67 (26%), Gaps = 8/67 (11%)
Query: 285 LASLSLNGNIL----IGPIPPTIGYLTNLTYLNLGYNRLS----SSIPPELMNCSQLLNL 336
+ SL + + + + ++ + L N + + + + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 337 VLSHNSL 343
S
Sbjct: 65 EFSDIFT 71
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (112), Expect = 8e-07
Identities = 36/154 (23%), Positives = 56/154 (36%), Gaps = 6/154 (3%)
Query: 106 SIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNL 165
+ L D Q L L + L+ + ++ L N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67
Query: 166 KSLFLDNNHLSG--PIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNL 223
SL L NN L + S + L L L N+L + L+ L L+GN+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 224 TGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIG 256
+ + Y++ + E RLDG +PP I
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 33/164 (20%), Positives = 50/164 (30%), Gaps = 7/164 (4%)
Query: 145 DLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVT 204
+L Q+ +L + + LD L L N L +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATL-R 58
Query: 205 KEVGNMKNLDRLHLNGNNLTG--SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLI 262
N+ L L+L+ N L + S + L L+LS N L L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 263 ALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIG-PIPPTIGY 305
L L N LS + + + L G +PP I +
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIAF 162
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 2e-06
Identities = 28/127 (22%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLD 128
+ LDL R ++ + + LN +++ ++ + N+ +L L L N+L
Sbjct: 24 QQALDLKGLR----SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 129 GL--IPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL 186
L + S + NL L+LS N+L + L+ L+LD N LS ++
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138
Query: 187 NQLATLC 193
+ +
Sbjct: 139 SAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 3e-06
Identities = 29/137 (21%), Positives = 50/137 (36%), Gaps = 5/137 (3%)
Query: 226 SIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYL 285
+ + + L L P + + L+ S+ + L N+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 286 ASLSLNGNIL--IGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSL 343
SL+L+ N L + + + NL LNL N L S + + +L L L NSL
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 344 SGSIPSEIGNLIFFRQL 360
S + + + R+
Sbjct: 128 SDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 6e-05
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 3/123 (2%)
Query: 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGT--IPSEIGSLR 91
R ++ A + L + + + L L+LS NRL + S +
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQL 151
+L LNLS N L L+ L++L L GN L ++ + L +L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 152 SGR 154
G
Sbjct: 152 DGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 28/151 (18%), Positives = 53/151 (35%), Gaps = 6/151 (3%)
Query: 265 DLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIP 324
+L Q+ L + + +L+ L P + LN + +++++
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLR 58
Query: 325 PELMNCSQLLNLVLSHNSLSG--SIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNIS 382
N +LL+L LS+N L + S + + L+LS N + K +
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 383 AVDLSKNNLSGVIPASVRRIPKLIVSENNLE 413
+ L N+LS I + L
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLL 149
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 7/123 (5%)
Query: 14 NFTCFPNLVTFRIWGTLLSGR-----MPSEIGALSKLEKLVLSHNSLTGR--IPSEIGAL 66
P+LV I L + + +L L LS+N L + S +
Sbjct: 31 GLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKA 90
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
LK+L+LS N L + L +L L N L+ + + + + + + +
Sbjct: 91 PNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
Query: 127 LDG 129
LDG
Sbjct: 151 LDG 153
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 2e-06
Identities = 45/200 (22%), Positives = 68/200 (34%), Gaps = 32/200 (16%)
Query: 50 LSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNNILNGSIP 108
+ L IP +I L L+ N L + G L L+ L L N L G P
Sbjct: 15 CTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71
Query: 109 LEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSL 168
F + +L+L NK+ + L L L+L NQ+S +P +L +L SL
Sbjct: 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 169 FLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228
L +N + + L + LNG P
Sbjct: 132 NLASNPFNCNCHLA-------------------------WFAEWLRKKSLNGGAARCGAP 166
Query: 229 STIGYLNLLDELHLSHNRLD 248
S + + + D L H+
Sbjct: 167 SKVRDVQIKD---LPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 7e-06
Identities = 42/188 (22%), Positives = 71/188 (37%), Gaps = 8/188 (4%)
Query: 166 KSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV-GNMKNLDRLHLNGNNLT 224
++ L IP + L L N+L + + G + +L +L L N LT
Sbjct: 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 225 GSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKY 284
G P+ + + EL L N++ L L L+L NQ+S ++P +L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 285 LASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344
L SL+L N + L +L P ++ + Q+ + L H+
Sbjct: 128 LTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV-QIKD--LPHSEFK 183
Query: 345 GSIPSEIG 352
S + G
Sbjct: 184 CSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 6e-05
Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 4/160 (2%)
Query: 1 MDNNFTGAELSQLNFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIP 60
+++N G S F P+LV + L+G P+ S +++L L N +
Sbjct: 36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISN 95
Query: 61 SEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120
L +LK L+L N+++ +P L L LNL++N N + L + + L +
Sbjct: 96 KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKK 154
Query: 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVG 160
L G PS + ++ DL ++ G
Sbjct: 155 SLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 4e-06
Identities = 32/153 (20%), Positives = 61/153 (39%), Gaps = 10/153 (6%)
Query: 98 LSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQ 157
L+ ++ + ++ N +L L+G K+ I + L +D S N++ R
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLD 57
Query: 158 EVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG-PVTKEVGNMKNLDRL 216
L+ LK+L ++NN + L L L L N LV + ++K+L L
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 217 HLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG 249
+ N +T + + + ++ LD
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVR----VLDF 146
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 27/131 (20%), Positives = 47/131 (35%), Gaps = 7/131 (5%)
Query: 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNN 101
+ +L L + I + L + +D S N + LR L L ++NN
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGL-IPSSIGNLTNLTYLDLS---LNQLSGRLPQ 157
+ L DL +L L N L L + +L +LTYL + +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 158 EVGNLKNLKSL 168
+ + ++ L
Sbjct: 134 VIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 4e-05
Identities = 28/147 (19%), Positives = 46/147 (31%), Gaps = 8/147 (5%)
Query: 222 NLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGN 281
L + EL L ++ I L A+D S N++ L
Sbjct: 6 ELIEQAAQYTNAVRDR-ELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--L 61
Query: 282 LKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341
L+ L +L +N N + L +LT L L N L + + + L +
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121
Query: 342 S----LSGSIPSEIGNLIFFRQLDLSR 364
+ I + R LD +
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 3e-05
Identities = 23/153 (15%), Positives = 49/153 (32%), Gaps = 4/153 (2%)
Query: 253 PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPP-TIGYLTNLTY 311
P L + + + + L L + + + + L L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 312 LNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTI 371
L + + L P +L L LS N+L S+ + + ++L LS N ++ +
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119
Query: 372 PSQ-LGKIPNISAVDLSKNNLSGVIPASVRRIP 403
+ L + + + L + +P
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 6e-04
Identities = 20/163 (12%), Positives = 36/163 (22%), Gaps = 24/163 (14%)
Query: 67 SRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126
L + + + +L +L + N
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQ-----------------------QH 43
Query: 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHL 186
L L + L L L + + L P L L L N L T+ L
Sbjct: 44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL 103
Query: 187 NQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPS 229
+ + G + + + + L
Sbjct: 104 SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 8e-04
Identities = 19/148 (12%), Positives = 40/148 (27%), Gaps = 2/148 (1%)
Query: 43 SKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEI-GSLRDLLDLNLSNN 101
L + + + L L + + + L +L +L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 102 ILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGN 161
L P F L +L L N L+ L ++ L+ + + +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 162 LKNLKSLFLDNNHLSGPIPSTLYHLNQL 189
+ + L L H+
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 22/145 (15%), Positives = 43/145 (29%), Gaps = 4/145 (2%)
Query: 212 NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP-TIGNLTNLIALDLSSNQ 270
L + + L EL++ + + + + L L L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 271 LSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE-LMN 329
L + P L+ L+L+ N L + +L L L N L S L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 330 CSQLLNLVLSHNSLSGSIPSEIGNL 354
+ + L + ++
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 27/173 (15%), Positives = 53/173 (30%), Gaps = 22/173 (12%)
Query: 110 EFGNLKDLDQLRLQGNKLDGLIP------SSIGNLTNLTYLDLSLNQLSGRLPQEVGNLK 163
F K + + +L G+IP +++ L +L LS N + ++ +L
Sbjct: 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSLS 67
Query: 164 NLKSL-FLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNN 222
+++L L L + + ++ + N
Sbjct: 68 GMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKI 127
Query: 223 LTGSIPSTIGYLNLLDELHLSHNRLDGPIPPT----------IGNLTNLIALD 265
+ L+ L++L L+ N L + L NL LD
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 764 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.55 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.69 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.67 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.02 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.63 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.58 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.28 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.98 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=388.26 Aligned_cols=236 Identities=30% Similarity=0.487 Sum_probs=203.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+++ +++.||+|++.+....+....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 367999999999999999999875 7899999998754333333347788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|.....
T Consensus 85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999973 346899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 742 (764)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.. .......+..++.++.++++
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 236 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 236 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 2345568999999999999999999999999999999999999999876653221 22333345567899999999
Q ss_pred hhhccchh
Q 004268 743 NFSQGNHR 750 (764)
Q Consensus 743 ~~l~~~~~ 750 (764)
+|++.++.
T Consensus 237 ~~L~~dp~ 244 (263)
T d2j4za1 237 RLLKHNPS 244 (263)
T ss_dssp HHTCSSGG
T ss_pred HHccCCHh
Confidence 99998833
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=393.46 Aligned_cols=236 Identities=23% Similarity=0.369 Sum_probs=200.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|++. +|+.||||++.+.........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999864 79999999987543222223477899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++. ....+++..++.++.|++.||+||| ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987 3456899999999999999999999 899999999999999999999999999999876533
Q ss_pred C--CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHH
Q 004268 667 S--SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 667 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 741 (764)
. ......+||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+.+..+. ........+..++..+.+++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 2 223446799999999999999999999999999999999999999987655322 12223334556899999999
Q ss_pred hhhhccch
Q 004268 742 KNFSQGNH 749 (764)
Q Consensus 742 ~~~l~~~~ 749 (764)
++||+.++
T Consensus 242 ~~~L~~dP 249 (288)
T d1uu3a_ 242 EKLLVLDA 249 (288)
T ss_dssp HTTSCSSG
T ss_pred HHHccCCH
Confidence 99999883
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=388.42 Aligned_cols=231 Identities=26% Similarity=0.424 Sum_probs=202.6
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|++ .+|+.||+|++....... .+.+.+|++++++++||||+++++++.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 5799999999999999999985 479999999987655443 367899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.. ..+++.+++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 99999999998863 35899999999999999999999 899999999999999999999999999999987665
Q ss_pred CCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------CCcCCCCCCCcHHHHHH
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS------GRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 740 (764)
.......+||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+.+..+... ......++.++..+.++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 555566789999999999999999999999999999999999999998766532211 11233345578899999
Q ss_pred Hhhhhccc
Q 004268 741 LKNFSQGN 748 (764)
Q Consensus 741 ~~~~l~~~ 748 (764)
+++||+.+
T Consensus 250 i~~~L~~d 257 (293)
T d1yhwa1 250 LNRCLDMD 257 (293)
T ss_dssp HHHHTCSS
T ss_pred HHHHccCC
Confidence 99999988
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=385.59 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=201.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+++ +|+.||+|++......+ ..+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 468999999999999999999865 79999999997654332 236789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++. ....+++..++.++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999986 3446999999999999999999999 89999999999999999999999999999987643
Q ss_pred CC--CCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCCCCCcHH
Q 004268 666 DS--SNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQNPRLDLQ 736 (764)
Q Consensus 666 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~ 736 (764)
.. ......+||+.|+|||++.+..+ +.++||||+||++|+|+||++||......... ........+.++..
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 235 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHH
Confidence 32 22345689999999999988876 57899999999999999999999865543211 11222223457889
Q ss_pred HHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 737 CNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+.+++++|++.++.-| .....+.||
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 9999999999883322 334444454
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=383.32 Aligned_cols=254 Identities=27% Similarity=0.414 Sum_probs=196.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee--CCEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH--NKCMF 583 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 583 (764)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++...... +...+.+.+|++++++++||||+++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 467999999999999999999865 7999999999876544 3345778999999999999999999999865 45689
Q ss_pred EEEEecCCCCHHHHHhcCc-cccccCHHHHHHHHHHHHHHHHHHHhcC--CCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 584 LIYEYMERGSLFCVLRNDV-EAVELDWTKRVNIVKSMAHALSYLHYDC--KPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
+||||+++|+|.+++.+.. ....+++..++.++.||+.||+|||... ..+|+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999999986432 3456999999999999999999999321 124999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
+.............||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+..+.. .......+..++.+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~ 241 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 98765555555678999999999999999999999999999999999999999876653321 11222334567899
Q ss_pred HHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 737 CNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
+.+++++||+.++.-| .....+.||
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 9999999999884443 555566665
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=391.29 Aligned_cols=236 Identities=23% Similarity=0.310 Sum_probs=206.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++.+.........+.+.+|++++++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999864 8999999999754332222347788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||+|.+++.+ ...+++..++.++.||+.||+||| ++||+||||||+|||++++|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999873 446899999999999999999999 99999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccc---cccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLS---SSSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 742 (764)
........+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+..+ .........+..++..+.++++
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 5555566789999999999999999999999999999999999999998776532 2222334456678999999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+||+.+
T Consensus 238 ~~L~~d 243 (337)
T d1o6la_ 238 GLLKKD 243 (337)
T ss_dssp HHTCSS
T ss_pred hhccCC
Confidence 999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=384.19 Aligned_cols=233 Identities=27% Similarity=0.404 Sum_probs=197.8
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
+.|++.+.||+|+||+||+|++. +|+.||+|++....... .+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 56999999999999999999865 79999999987654332 367889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++.+. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999999987642 345899999999999999999999 899999999999999999999999999999765433
Q ss_pred CCCceecccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCCcH
Q 004268 667 SSNRTLVVGTYGYIAPELAY-----TMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRLDL 735 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~ 735 (764)
........||+.|+|||++. +..|+.++||||+||++|+|+||++||.+.+..+.... .....++.++.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence 22233467999999999984 45689999999999999999999999987765433211 12233455788
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
++.+++++||+.+
T Consensus 244 ~~~~li~~~L~~d 256 (288)
T d2jfla1 244 NFKDFLKKCLEKN 256 (288)
T ss_dssp HHHHHHHHHSCSS
T ss_pred HHHHHHHHHccCC
Confidence 9999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-46 Score=381.90 Aligned_cols=235 Identities=24% Similarity=0.380 Sum_probs=184.5
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|+++ +|+.||+|++........ .+.+.+|++++++++||||+++++++.+++..|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3577999999999999999999865 789999999976554332 3678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~ 661 (764)
||||++||+|.+++.. ...+++..+..++.||+.||+||| ++||+||||||+||++. +++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999999973 456999999999999999999999 89999999999999995 57899999999998
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccCCcCCCCCCCc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS-------SSGRKISQNPRLD 734 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~ 734 (764)
..... ......+||+.|+|||++.+..|++++||||+||++|+|++|++||.+....+. .........+.++
T Consensus 159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred EccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 76433 233456899999999999999999999999999999999999999987654221 1111222345688
Q ss_pred HHHHHHHhhhhccch
Q 004268 735 LQCNAYLKNFSQGNH 749 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~ 749 (764)
..+.+++++|++.++
T Consensus 238 ~~~~~li~~~L~~dP 252 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDP 252 (307)
T ss_dssp HHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHccCCH
Confidence 999999999999883
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-46 Score=386.25 Aligned_cols=233 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999864 7999999998754332223347889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||++||++..++.. ...+++..++.++.||+.||+||| ++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999999873 445788899999999999999999 99999999999999999999999999999987643
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 742 (764)
. ....+||+.|+|||++.+..|+.++||||+||++|+|+||+.||.+.+..+.. .......++.++..+.++++
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 233 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 233 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2 33468999999999999999999999999999999999999999876653221 22334456778999999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+|++.+
T Consensus 234 ~~L~~d 239 (316)
T d1fota_ 234 RLITRD 239 (316)
T ss_dssp HHTCSC
T ss_pred HHhhhC
Confidence 999887
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=378.08 Aligned_cols=232 Identities=25% Similarity=0.355 Sum_probs=199.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.+.|+..+.||+|+||+||+|++. +|+.||||++...........+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 356999999999999999999864 7889999999877766666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
||||++|++..++. ....+++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999977765 3346899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCCceeccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----CCcCCCCCCCcHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYT---MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-----GRKISQNPRLDLQC 737 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-----~~~~~~~~~~~~~~ 737 (764)
. ....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+....+... ..........+..+
T Consensus 168 ~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (309)
T ss_dssp B----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHH
T ss_pred C----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2 34579999999999864 458999999999999999999999998766533211 11222344578899
Q ss_pred HHHHhhhhccc
Q 004268 738 NAYLKNFSQGN 748 (764)
Q Consensus 738 ~~~~~~~l~~~ 748 (764)
.++++.||+.+
T Consensus 244 ~~li~~~L~~d 254 (309)
T d1u5ra_ 244 RNFVDSCLQKI 254 (309)
T ss_dssp HHHHHHHTCSS
T ss_pred HHHHHHHCcCC
Confidence 99999999988
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-45 Score=379.69 Aligned_cols=234 Identities=23% Similarity=0.345 Sum_probs=201.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999864 7999999998765422 246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~~~~~ 663 (764)
|||++||+|.+++.. ....+++.+++.|+.||+.||+||| ++||+||||||+|||++ .++.+||+|||+|...
T Consensus 105 mE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999999988764 3346899999999999999999999 89999999999999998 6789999999999887
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~ 736 (764)
... .......||+.|+|||++.+..++.++||||+||++|+|+||++||.+.+..+... .......+.++.+
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred CCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 643 33455689999999999999999999999999999999999999998766533211 1122234568999
Q ss_pred HHHHHhhhhccch
Q 004268 737 CNAYLKNFSQGNH 749 (764)
Q Consensus 737 ~~~~~~~~l~~~~ 749 (764)
+.+++++||+.++
T Consensus 259 ~~~li~~~L~~dp 271 (352)
T d1koba_ 259 AKDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHHTTSCSSG
T ss_pred HHHHHHHHccCCh
Confidence 9999999999883
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=365.06 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=195.7
Q ss_pred CCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee----CCEEEE
Q 004268 510 FHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH----NKCMFL 584 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~l 584 (764)
|++.+.||+|+||+||+|.+. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+ +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 367778999999999999865 78899999987655433 335789999999999999999999999865 456899
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCC--cEEcCCCCCCeeec-CCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPS--IVHRDISSNNILLN-SNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfg~~~ 661 (764)
||||+++|+|.+++.+ ...+++..++.++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999999973 346899999999999999999999 777 99999999999997 57899999999997
Q ss_pred ccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC------CcCCCCCCCcH
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG------RKISQNPRLDL 735 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~ 735 (764)
.... ......+||+.|+|||++.+ .++.++||||+||++|||++|+.||.+......... .........++
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred eccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 6432 33455789999999999876 599999999999999999999999986544221111 11112234577
Q ss_pred HHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 736 QCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
++.+++++|++.++.-| .....+.||
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 89999999999884443 444445554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=385.29 Aligned_cols=201 Identities=27% Similarity=0.385 Sum_probs=178.5
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +|+.||+|++....... ..+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 578999999999999999999865 78999999997654332 347889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCC-CcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKP-SIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
|||+++|+|.+++.+ ...+++..++.++.|++.||+||| ++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999974 346899999999999999999999 64 89999999999999999999999999998764
Q ss_pred CCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 665 PDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 665 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
.. .....+||+.|+|||++.+..|++++||||+||++|||++|+.||.+.+
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2234689999999999999999999999999999999999999997643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.7e-45 Score=379.49 Aligned_cols=234 Identities=24% Similarity=0.366 Sum_probs=200.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 578999999999999999999864 799999999975432 2347789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec--CCCCEEEeeecccccc
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN--SNLEAFVADFGLARLL 663 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfg~~~~~ 663 (764)
|||++||+|.+++.. ....+++..++.++.||+.||+||| ++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999999864 2346999999999999999999999 89999999999999996 4688999999999877
Q ss_pred CCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC-------CcCCCCCCCcHH
Q 004268 664 HPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------RKISQNPRLDLQ 736 (764)
Q Consensus 664 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------~~~~~~~~~~~~ 736 (764)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.... ......+.++..
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 543 334457899999999999999999999999999999999999999987654322111 111223457889
Q ss_pred HHHHHhhhhccch
Q 004268 737 CNAYLKNFSQGNH 749 (764)
Q Consensus 737 ~~~~~~~~l~~~~ 749 (764)
+.+++++|+..++
T Consensus 256 ~~~li~~~L~~dP 268 (350)
T d1koaa2 256 GKDFIRKLLLADP 268 (350)
T ss_dssp HHHHHHHHCCSSG
T ss_pred HHHHHHHHccCCh
Confidence 9999999999883
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=370.93 Aligned_cols=235 Identities=21% Similarity=0.319 Sum_probs=199.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc---HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE---PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|+++ +|+.||||++.+..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999864 79999999987544322 11247889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC----CEEEeeec
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL----EAFVADFG 658 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfg 658 (764)
|+|||||++|+|.+++.. ...+++..++.++.|++.||+||| ++||+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999974 346999999999999999999999 89999999999999998776 59999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---CCc----CCCCC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---GRK----ISQNP 731 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---~~~----~~~~~ 731 (764)
+|....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+... ... ....+
T Consensus 163 ~a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 163 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TCEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 998775433 3344678999999999999999999999999999999999999998766532211 111 11235
Q ss_pred CCcHHHHHHHhhhhccc
Q 004268 732 RLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~ 748 (764)
.++..+.+++++||+.+
T Consensus 242 ~~s~~~~~li~~~L~~d 258 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKD 258 (293)
T ss_dssp TSCHHHHHHHHTTSCSS
T ss_pred CCCHHHHHHHHHHccCC
Confidence 67889999999999988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-45 Score=382.70 Aligned_cols=233 Identities=22% Similarity=0.335 Sum_probs=202.7
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 585 (764)
.++|++++.||+|+||+||+|+++ +|+.||||++.+.........+.+.+|+++++.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999865 7999999998654332223346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+.+|++..++.+ ...+++..++.++.||+.||.||| ++|||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999873 346899999999999999999999 89999999999999999999999999999987653
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccc---ccCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS---SSGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 742 (764)
. .....||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.... ........++.++..+.++++
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 2 3346899999999999999999999999999999999999999987665322 222334455678999999999
Q ss_pred hhhccc
Q 004268 743 NFSQGN 748 (764)
Q Consensus 743 ~~l~~~ 748 (764)
+||+.+
T Consensus 271 ~~L~~d 276 (350)
T d1rdqe_ 271 NLLQVD 276 (350)
T ss_dssp HHSCSC
T ss_pred HHhhhC
Confidence 999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=375.73 Aligned_cols=239 Identities=23% Similarity=0.371 Sum_probs=202.6
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHH-hcCCCceeeEeeEEeeCCEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLS-QIRHRNIVKLYGFCLHNKCMFLI 585 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv 585 (764)
++|.+.+.||+|+||+||+|+++ +|+.||||++.+.........+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999865 79999999997533222222355667777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++. ....+++..++.++.||+.||+||| ++||+||||||+|||+++++.+||+|||.++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997 3446899999999999999999999 89999999999999999999999999999987765
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---cCCcCCCCCCCcHHHHHHHh
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS---SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 742 (764)
.........||+.|+|||++.+..|++++||||+||++|+|+||+.||.+.+..... .......+..++..+.++++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 555566678999999999999999999999999999999999999999876653321 22223334557999999999
Q ss_pred hhhccchhhH
Q 004268 743 NFSQGNHRWE 752 (764)
Q Consensus 743 ~~l~~~~~~~ 752 (764)
+|++.++..|
T Consensus 236 ~~L~~dP~~R 245 (320)
T d1xjda_ 236 KLFVREPEKR 245 (320)
T ss_dssp HHSCSSGGGS
T ss_pred HhcccCCCCC
Confidence 9999884444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=372.39 Aligned_cols=239 Identities=26% Similarity=0.388 Sum_probs=200.0
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.++ +++.||||++...... .+++.+|++++++++||||+++++++.+++..++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3578999999999999999999865 6889999999765543 3678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccC
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLH 664 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 664 (764)
||||+++|+|.+++... ....+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999754 3456899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCCC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC-Cccccccc----ccCCcCCCCCCCcHHHH
Q 004268 665 PDSSN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPT-DLLSSLSS----SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 665 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf-~~~~~~~~----~~~~~~~~~~~~~~~~~ 738 (764)
..... .....|++.|+|||++.+..|+.++||||+||++|||++|..|| .+.+.... ........++..+..+.
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 246 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHH
Confidence 43322 22345789999999999999999999999999999999976665 43332211 11223344556789999
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++++||+.++.-|
T Consensus 247 ~li~~cl~~dP~~R 260 (287)
T d1opja_ 247 ELMRACWQWNPSDR 260 (287)
T ss_dssp HHHHHHTCSSGGGS
T ss_pred HHHHHHcCCCHhHC
Confidence 99999999885444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=363.76 Aligned_cols=236 Identities=25% Similarity=0.396 Sum_probs=190.0
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
++|++.+.||+|+||+||+|++.+++.||||++....... +++.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 5789999999999999999999888899999997655442 678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||+|+......
T Consensus 81 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999998743 345889999999999999999999 8999999999999999999999999999998765433
Q ss_pred CC-ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHHH
Q 004268 668 SN-RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 741 (764)
.. .....||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..+.. .......+...+..+.+++
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 22 233578999999999999999999999999999999999 56667655432221 1223333445688999999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
++||+.++.-|
T Consensus 236 ~~cl~~~p~~R 246 (263)
T d1sm2a_ 236 NHCWKERPEDR 246 (263)
T ss_dssp HHHTCSSGGGS
T ss_pred HHHccCCHhHC
Confidence 99999885544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=363.53 Aligned_cols=237 Identities=25% Similarity=0.423 Sum_probs=191.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|+++ ..||||++....... ...+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 478999999999999999999864 369999997654433 345789999999999999999999998755 4589999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++... ...+++..+..++.||++||+||| ++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999743 345899999999999999999999 899999999999999999999999999999876432
Q ss_pred C--CCceecccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-----cC----CcCCCCCC
Q 004268 667 S--SNRTLVVGTYGYIAPELAYTM---AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-----SG----RKISQNPR 732 (764)
Q Consensus 667 ~--~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-----~~----~~~~~~~~ 732 (764)
. .......||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..... .. ......+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2 223446799999999998653 5789999999999999999999999876543211 11 11123445
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
.+..+.+++.+||+.++.-|
T Consensus 238 ~~~~l~~li~~cl~~dp~~R 257 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDER 257 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGS
T ss_pred chHHHHHHHHHHcCCCHhHC
Confidence 67899999999999884443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.4e-44 Score=360.72 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=205.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc------HHHHHHHHHHHHHHHhcC-CCceeeEeeEEee
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE------PAFLESFQTEARLLSQIR-HRNIVKLYGFCLH 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 578 (764)
.++|++.+.||+|+||+||+|+.. +|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999864 78999999987655332 233457889999999997 9999999999999
Q ss_pred CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeec
Q 004268 579 NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFG 658 (764)
Q Consensus 579 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg 658 (764)
++..|+||||+++|+|.++++. ...+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999973 446999999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCCceeccccccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CC
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYT------MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GR 725 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~ 725 (764)
.++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+...... ..
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 998876433 3445689999999998863 346889999999999999999999999876532211 11
Q ss_pred cCCCCCCCcHHHHHHHhhhhccchhhH--HHhhhcCCC
Q 004268 726 KISQNPRLDLQCNAYLKNFSQGNHRWE--NLLFKKFPY 761 (764)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~p~ 761 (764)
.....+.+++++.+++++|++.++..| .......||
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 122233578999999999999884443 333444444
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=357.81 Aligned_cols=236 Identities=24% Similarity=0.417 Sum_probs=202.8
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
++|++.+.||+|+||+||+|++++++.||||+++...... +.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 6789999999999999999999888899999998765543 678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|++..++.. ....+++..+.+++.|+++||+||| ++||+||||||+||++++++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999999764 3446888999999999999999999 8999999999999999999999999999998765433
Q ss_pred C-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc----CCcCCCCCCCcHHHHHHH
Q 004268 668 S-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSSS----GRKISQNPRLDLQCNAYL 741 (764)
Q Consensus 668 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 741 (764)
. ......||+.|+|||++.+..++.++||||+||++|||+| |+.||++.+..+... ......+...+....+++
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence 2 2234578999999999999999999999999999999998 899999876543221 223334445678899999
Q ss_pred hhhhccchhhH
Q 004268 742 KNFSQGNHRWE 752 (764)
Q Consensus 742 ~~~l~~~~~~~ 752 (764)
++||+.++.-|
T Consensus 235 ~~cl~~dP~~R 245 (258)
T d1k2pa_ 235 YSCWHEKADER 245 (258)
T ss_dssp HHTTCSSGGGS
T ss_pred HHHccCCHhHC
Confidence 99998875554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-44 Score=377.40 Aligned_cols=238 Identities=22% Similarity=0.286 Sum_probs=195.2
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHH---HHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQ---TEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|++. +|+.||+|++.+...........+. .|+++++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999865 7999999998643322111112333 446666777899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+||||++||+|.+++.+ ...+++..++.++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999974 446889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------ccCCcCCCCCCCcH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS------SSGRKISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~ 735 (764)
.... .....+||+.|+|||++.+ ..|+.++||||+||++|+|+||+.||.+...... ........+..++.
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 6543 2344689999999999864 5689999999999999999999999986544221 12223333456899
Q ss_pred HHHHHHhhhhccchhhH
Q 004268 736 QCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~ 752 (764)
.+.+++++||+.++.-|
T Consensus 235 ~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp HHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcccCHHHh
Confidence 99999999999884443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.2e-44 Score=362.59 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=197.6
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----E
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----C 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 581 (764)
.++|++.+.||+|+||+||+|++ .+|+.||+|++......++...+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999986 479999999998877766676788999999999999999999999987643 4
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.|+||||++|++|.+++. ....+++.+++.++.||+.||+||| ++||+||||||+||+++.++.++++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence 899999999999999887 3446899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCC---CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------CCcCCCCC
Q 004268 662 LLHPDS---SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------GRKISQNP 731 (764)
Q Consensus 662 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------~~~~~~~~ 731 (764)
...... ......+||+.|+|||++.+..+++++||||+||++|+|+||++||.+.+..+... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 654322 22344679999999999999999999999999999999999999998766532211 11123346
Q ss_pred CCcHHHHHHHhhhhccchhhH
Q 004268 732 RLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 732 ~~~~~~~~~~~~~l~~~~~~~ 752 (764)
.+|..+.+++++|++.++.-|
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R 260 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENR 260 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCHHHHHHHHHHccCCHhHC
Confidence 688999999999999884443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-44 Score=367.03 Aligned_cols=239 Identities=29% Similarity=0.436 Sum_probs=189.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC---EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK---LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|+++ +++ .||||.+...... ...+.+.+|++++++++||||+++++++.+++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 367888999999999999999865 333 5889988654433 3457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++|+|.+++... ...+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999999988742 346899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCCc-----eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCC
Q 004268 663 LHPDSSNR-----TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPR 732 (764)
Q Consensus 663 ~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~ 732 (764)
........ ....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+.. .......+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 65432211 22457899999999999999999999999999999998 89999877653221 2233444556
Q ss_pred CcHHHHHHHhhhhccchhhH
Q 004268 733 LDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 733 ~~~~~~~~~~~~l~~~~~~~ 752 (764)
.+..+.+++++||+.++.-|
T Consensus 258 ~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTS
T ss_pred chHHHHHHHHHHcCCCHhHC
Confidence 78899999999999874433
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=361.43 Aligned_cols=237 Identities=25% Similarity=0.430 Sum_probs=196.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|.+++++.||||++...... .+.+.+|++++++++||||+++++++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 4689999999999999999999988889999999765443 2678999999999999999999998765 4578999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|+|.+++... ....+++..+..++.||++||+||| ++||+||||||+||++++++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999987643 3345899999999999999999999 889999999999999999999999999999877543
Q ss_pred CC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCccccccc----ccCCcCCCCCCCcHHHHHH
Q 004268 667 SS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGS-HPTDLLSSLSS----SSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~-~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 740 (764)
.. ......|++.|+|||++.+..++.++|||||||++|||+||. +||......+. ........+...+..+.++
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 22 223356889999999999999999999999999999999954 55554443221 1223334455678899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++||+.++.-|
T Consensus 243 i~~cl~~~P~~R 254 (272)
T d1qpca_ 243 MRLCWKERPEDR 254 (272)
T ss_dssp HHHHTCSSGGGS
T ss_pred HHHHcCCCHhHC
Confidence 999999885444
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=361.01 Aligned_cols=237 Identities=25% Similarity=0.391 Sum_probs=197.3
Q ss_pred hcCCccee-eeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEE
Q 004268 508 EDFHIKYC-IGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 508 ~~y~~~~~-ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 583 (764)
++|.+.+. ||+|+||+||+|.++ ++..||||++..... ....+++.+|++++++++||||+++++++.++ ..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 56777774 999999999999754 355799999976543 34457899999999999999999999998754 578
Q ss_pred EEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccccc
Q 004268 584 LIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLL 663 (764)
Q Consensus 584 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 663 (764)
+||||+++|+|.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+..
T Consensus 85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999999864 2346899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc----ccCCcCCCCCCCcH
Q 004268 664 HPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS----SSGRKISQNPRLDL 735 (764)
Q Consensus 664 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~----~~~~~~~~~~~~~~ 735 (764)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+. ........++..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 543321 223468899999999999999999999999999999998 9999987765322 12233445566889
Q ss_pred HHHHHHhhhhccchhhH
Q 004268 736 QCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~~~ 752 (764)
.+.+++++||+.++.-|
T Consensus 240 ~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HHHHHHHHTTCSSGGGS
T ss_pred HHHHHHHHHcCCCHhHC
Confidence 99999999999885444
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=366.60 Aligned_cols=233 Identities=24% Similarity=0.339 Sum_probs=198.6
Q ss_pred HhhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEE
Q 004268 506 ATEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 506 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 584 (764)
..++|++.+.||+|+||+||+|.++ +|+.||+|++...... ...+.+|++++++++||||+++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999865 7889999999765422 3568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC--CCCEEEeeeccccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS--NLEAFVADFGLARL 662 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfg~~~~ 662 (764)
|||||+||+|.+++... ...+++.+++.++.||+.||+||| ++||+||||||+|||++. ...+||+|||.++.
T Consensus 79 vmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999742 336899999999999999999999 899999999999999984 45899999999987
Q ss_pred cCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC---Cc----CCCCCCCcH
Q 004268 663 LHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG---RK----ISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~---~~----~~~~~~~~~ 735 (764)
.... .......+++.|+|||...+..|+.++||||+||++|+|++|++||.+.+..+.... .. ....+.++.
T Consensus 154 ~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred cccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 6533 334456889999999999999999999999999999999999999987665322111 11 112246788
Q ss_pred HHHHHHhhhhccc
Q 004268 736 QCNAYLKNFSQGN 748 (764)
Q Consensus 736 ~~~~~~~~~l~~~ 748 (764)
.+.+++++|++.+
T Consensus 233 ~~~~li~~~L~~d 245 (321)
T d1tkia_ 233 EAMDFVDRLLVKE 245 (321)
T ss_dssp HHHHHHHTTSCSS
T ss_pred HHHHHHHHHccCC
Confidence 9999999999988
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=365.96 Aligned_cols=241 Identities=27% Similarity=0.395 Sum_probs=197.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CC-----CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SG-----KLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||+||+|++. .+ ..||+|.+....... ....+.+|+.+++++ +||||+++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH--HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 468999999999999999999754 22 269999987554332 236788999999998 899999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCcc--------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVE--------------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 639 (764)
+..|+||||+++|+|.++++.... ...+++..+..++.||+.||+||| ++|||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence 999999999999999999975421 234889999999999999999999 899999999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLL 716 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~ 716 (764)
||+||+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 223567999999999999999999999999999999998 89999876
Q ss_pred ccccc-----ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 717 SSLSS-----SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 717 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
..... ........++..+..+.+++++||+.++.-|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 54321 1122334455678899999999999885554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=356.73 Aligned_cols=231 Identities=24% Similarity=0.381 Sum_probs=189.1
Q ss_pred eeeeecCceeEEEEEEC---CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEecC
Q 004268 514 YCIGTGGYGSVYRAQLS---SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEYME 590 (764)
Q Consensus 514 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 590 (764)
+.||+|+||+||+|.++ +++.||||++..... ++...+++.+|++++++++||||+++++++.++ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999754 356899999976543 334457899999999999999999999998654 5789999999
Q ss_pred CCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCCCc
Q 004268 591 RGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSSNR 670 (764)
Q Consensus 591 ~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 670 (764)
+|+|.++++. ...+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.........
T Consensus 91 ~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999973 346899999999999999999999 8999999999999999999999999999998765433222
Q ss_pred ---eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHHHh
Q 004268 671 ---TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAYLK 742 (764)
Q Consensus 671 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 742 (764)
....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.. .......++..+..+.++++
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 23468999999999999999999999999999999998 89999987653321 22333445567889999999
Q ss_pred hhhccchhhH
Q 004268 743 NFSQGNHRWE 752 (764)
Q Consensus 743 ~~l~~~~~~~ 752 (764)
+||+.++.-|
T Consensus 245 ~cl~~dp~~R 254 (277)
T d1xbba_ 245 LCWTYDVENR 254 (277)
T ss_dssp HHTCSSTTTS
T ss_pred HHcCCCHhHC
Confidence 9998874433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=359.86 Aligned_cols=235 Identities=25% Similarity=0.357 Sum_probs=191.4
Q ss_pred hcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|.+ .+|+.||+|++...... +...+++.+|++++++++||||+++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 5899999999999999999986 57999999999654322 222467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+.++ +..++... ....+++..++.++.||+.||+||| ++|||||||||+|||++.++.+||+|||.|+.....
T Consensus 81 e~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 999865 44444322 3446899999999999999999999 899999999999999999999999999999887665
Q ss_pred CCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccc-----------------------
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS----------------------- 722 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~----------------------- 722 (764)
........||+.|+|||++....+ +.++||||+||++|+|++|+.||.+.+..+..
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 555566789999999998777664 78999999999999999999999765421100
Q ss_pred ---------cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 ---------SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ---------~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+.++.++.+++++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 270 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCC
Confidence 00000113456788999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=353.93 Aligned_cols=235 Identities=26% Similarity=0.437 Sum_probs=191.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
.++|++.+.||+|+||+||+|.+++++.||||++....... +.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 46899999999999999999999888899999997655432 678999999999999999999999865 4578999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
||+++|++..++... ....+++.++..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 91 Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999988643 2345899999999999999999999 889999999999999999999999999999876433
Q ss_pred C-CCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC-CCcccccc----cccCCcCCCCCCCcHHHHHH
Q 004268 667 S-SNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP-TDLLSSLS----SSSGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 667 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P-f~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 740 (764)
. .......||+.|+|||++.+..++.++||||+||++|||++|..| |......+ .........++..+..+.++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 2 223345789999999999999999999999999999999996555 44443321 11223445566788999999
Q ss_pred Hhhhhccchh
Q 004268 741 LKNFSQGNHR 750 (764)
Q Consensus 741 ~~~~l~~~~~ 750 (764)
+++||+.++.
T Consensus 247 i~~cl~~dP~ 256 (285)
T d1fmka3 247 MCQCWRKEPE 256 (285)
T ss_dssp HHHHTCSSGG
T ss_pred HHHHcccCHh
Confidence 9999998833
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=360.56 Aligned_cols=229 Identities=24% Similarity=0.373 Sum_probs=189.8
Q ss_pred hhcCCcce-eeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEee----C
Q 004268 507 TEDFHIKY-CIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLH----N 579 (764)
Q Consensus 507 ~~~y~~~~-~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~----~ 579 (764)
.++|.+.+ .||+|+||+||+|++ .+++.||||++... +.+.+|++++.++ +||||+++++++.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57898875 599999999999986 57999999998642 5677899987665 89999999999876 4
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC---CCCEEEee
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS---NLEAFVAD 656 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 656 (764)
..+|+|||||+||+|.+++... ....+++.+++.|+.||+.||+||| ++||+||||||+||+++. .+.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence 6699999999999999999753 2346999999999999999999999 899999999999999985 56799999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cCCcCCCC
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------SGRKISQN 730 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------~~~~~~~~ 730 (764)
||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||++||.+.+..... ........
T Consensus 158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 99998765433 334568999999999999999999999999999999999999999876543221 11111111
Q ss_pred -----CCCcHHHHHHHhhhhccc
Q 004268 731 -----PRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 731 -----~~~~~~~~~~~~~~l~~~ 748 (764)
+.++..+.+++++|++.+
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~d 259 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTE 259 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSS
T ss_pred CCcccccCCHHHHHHHHHHccCC
Confidence 236788999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=354.95 Aligned_cols=235 Identities=21% Similarity=0.293 Sum_probs=195.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcH---HHHHHHHHHHHHHHhcC--CCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEP---AFLESFQTEARLLSQIR--HRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++........ ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999864 799999999875432211 11134668999999996 899999999999999
Q ss_pred EEEEEEEecCC-CCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-CCCEEEeeec
Q 004268 581 CMFLIYEYMER-GSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-NLEAFVADFG 658 (764)
Q Consensus 581 ~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg 658 (764)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||+||| ++||+||||||+||+++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence 99999999986 578888763 446899999999999999999999 899999999999999985 5799999999
Q ss_pred cccccCCCCCCceecccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccccCCcCCCCCCCcHHH
Q 004268 659 LARLLHPDSSNRTLVVGTYGYIAPELAYTMAV-TEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGRKISQNPRLDLQC 737 (764)
Q Consensus 659 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 737 (764)
+|+.... .......||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...... .......++.++.++
T Consensus 157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IRGQVFFRQRVSSEC 231 (273)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HHCCCCCSSCCCHHH
T ss_pred cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH---hhcccCCCCCCCHHH
Confidence 9986543 23345689999999999988776 56789999999999999999999875532 223344566789999
Q ss_pred HHHHhhhhccchhhH
Q 004268 738 NAYLKNFSQGNHRWE 752 (764)
Q Consensus 738 ~~~~~~~l~~~~~~~ 752 (764)
.+++++|++.++.-|
T Consensus 232 ~~li~~~L~~dp~~R 246 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDR 246 (273)
T ss_dssp HHHHHHHTCSSGGGS
T ss_pred HHHHHHHccCCHhHC
Confidence 999999999884433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=360.72 Aligned_cols=231 Identities=24% Similarity=0.300 Sum_probs=186.7
Q ss_pred cceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCc--HHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEEe
Q 004268 512 IKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEE--PAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYEY 588 (764)
Q Consensus 512 ~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 588 (764)
.++.||+|+||+||+|+++ +|+.||||++....... ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999864 79999999987654322 12235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCCC
Q 004268 589 MERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDSS 668 (764)
Q Consensus 589 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 668 (764)
++++++..+.. ....+++..++.++.||+.||+||| ++||+||||||+||+++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887776654 3456888999999999999999999 89999999999999999999999999999988765555
Q ss_pred CceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------------------CC
Q 004268 669 NRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS----------------------GR 725 (764)
Q Consensus 669 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~----------------------~~ 725 (764)
.....+||+.|+|||++.+. .|+.++||||+||++|||+||++||.+.+..+... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 55567899999999988654 57999999999999999999999997654321100 00
Q ss_pred cCC---------CCCCCcHHHHHHHhhhhccc
Q 004268 726 KIS---------QNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 726 ~~~---------~~~~~~~~~~~~~~~~l~~~ 748 (764)
... ..+..+..+.+++++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~d 267 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCC
Confidence 000 12356788999999999988
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=350.51 Aligned_cols=237 Identities=31% Similarity=0.402 Sum_probs=187.6
Q ss_pred hcCCcceeeeecCceeEEEEEECCC-----CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSG-----KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
++|+..+.||+|+||+||+|.++.. ..||||++...... .....+.+|++++++++||||+++++++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 5688899999999999999976532 36999998755433 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+.++++.+++.. ....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988764 3346899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC-CCccccccc----ccCCcCCCCCCCc
Q 004268 663 LHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHP-TDLLSSLSS----SSGRKISQNPRLD 734 (764)
Q Consensus 663 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~P-f~~~~~~~~----~~~~~~~~~~~~~ 734 (764)
....... .....||+.|+|||++.+..++.++|||||||++|||++|..| |......+. ........+...+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence 6433221 2234678999999999999999999999999999999996555 544333211 1222334455578
Q ss_pred HHHHHHHhhhhccchhh
Q 004268 735 LQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 735 ~~~~~~~~~~l~~~~~~ 751 (764)
..+.++++.||+.++.-
T Consensus 240 ~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERAR 256 (283)
T ss_dssp HHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHCcCCHhH
Confidence 89999999999887433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=349.12 Aligned_cols=240 Identities=24% Similarity=0.364 Sum_probs=189.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC--CC--CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS--SG--KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|+.. ++ ..||||++.......+...+.+.+|++++++++||||+++++++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 367999999999999999999753 23 36899999876665666678899999999999999999999999764 57
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++||||+++|++.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988764 3346899999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCCC---ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc-----cCCcCCCCCCC
Q 004268 663 LHPDSSN---RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS-----SGRKISQNPRL 733 (764)
Q Consensus 663 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~-----~~~~~~~~~~~ 733 (764)
....... .....|+..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.. ........+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccc
Confidence 7544332 223457889999999999999999999999999999998 89999877654321 12233345567
Q ss_pred cHHHHHHHhhhhccchhhH
Q 004268 734 DLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~~ 752 (764)
+..+.+++++||+.++.-|
T Consensus 241 ~~~l~~li~~cl~~dp~~R 259 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDR 259 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGS
T ss_pred cHHHHHHHHHHcCCChhHC
Confidence 8899999999999885554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=348.47 Aligned_cols=238 Identities=26% Similarity=0.380 Sum_probs=188.7
Q ss_pred hhcCCcceeeeecCceeEEEEEECC----CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS----GKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.+.. +..||+|.+..... ....+.+.+|++++++++||||+++++++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 4689999999999999999997642 34688998865443 3445789999999999999999999999864 568
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
|+||||+++|++.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||++++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999998764 3346899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCC-CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHH
Q 004268 663 LHPDSS-NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQ 736 (764)
Q Consensus 663 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~ 736 (764)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.. .......++.++..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 653322 2334567899999999999999999999999999999998 89999887664332 22334456678899
Q ss_pred HHHHHhhhhccchhhH
Q 004268 737 CNAYLKNFSQGNHRWE 752 (764)
Q Consensus 737 ~~~~~~~~l~~~~~~~ 752 (764)
+.+++++||+.++.-|
T Consensus 238 ~~~li~~cl~~dp~~R 253 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRR 253 (273)
T ss_dssp HHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHcCCCHhHC
Confidence 9999999999885544
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=344.84 Aligned_cols=233 Identities=26% Similarity=0.404 Sum_probs=189.2
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CCEEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NKCMFLI 585 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv 585 (764)
.++|++.+.||+|+||.||+|+++ |+.||||+++.... .+.+.+|++++++++||||+++++++.+ .+.+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 467899999999999999999986 88999999975442 2678999999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCC
Q 004268 586 YEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHP 665 (764)
Q Consensus 586 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 665 (764)
|||+++|+|.+++... ....+++..+..|+.||+.||+||| +++|+||||||+||+++.++.+|++|||.++....
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999743 2335899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcHHHHHH
Q 004268 666 DSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDLQCNAY 740 (764)
Q Consensus 666 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 740 (764)
. .....++..|+|||++.+..+++++|||||||++|||+| |++||......+.. .......++..+....++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 2 233467899999999999999999999999999999998 79999876653322 223344455578899999
Q ss_pred HhhhhccchhhH
Q 004268 741 LKNFSQGNHRWE 752 (764)
Q Consensus 741 ~~~~l~~~~~~~ 752 (764)
+++||+.++.-|
T Consensus 233 i~~cl~~dP~~R 244 (262)
T d1byga_ 233 MKNCWHLDAAMR 244 (262)
T ss_dssp HHHHTCSSGGGS
T ss_pred HHHHcccCHhHC
Confidence 999999874444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.3e-42 Score=349.91 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=198.2
Q ss_pred hcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIYE 587 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 587 (764)
++|++.+.||+|+||+||+|++++|+.||||++...... +...+++.+|+.++++++||||+++++++.+++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 689999999999999999999999999999999765432 2224788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
++.++.+..+.+ ....+++..++.++.||+.||+||| ++|||||||||+|||++.++.+|++|||.|.......
T Consensus 81 ~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 999877776665 3456999999999999999999999 8899999999999999999999999999998876655
Q ss_pred CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc------------------------
Q 004268 668 SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS------------------------ 722 (764)
Q Consensus 668 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~------------------------ 722 (764)
.......+++.|+|||.+.+. .+++++||||+||++|||++|+.||.+.+..+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 555566789999999998765 5689999999999999999999999765321100
Q ss_pred --------cCCcCCCCCCCcHHHHHHHhhhhccchh--hHHHhhhcCCC
Q 004268 723 --------SGRKISQNPRLDLQCNAYLKNFSQGNHR--WENLLFKKFPY 761 (764)
Q Consensus 723 --------~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~p~ 761 (764)
........+.++..+.+++++|++.++. +-..+..+.||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0000112345678899999999998833 33444555555
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=352.05 Aligned_cols=235 Identities=24% Similarity=0.419 Sum_probs=190.5
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCC----EEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGK----LVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 582 (764)
.+|++.+.||+|+||+||+|.+. +|+ .||+|++....... ..+.+.+|++++++++||||+++++++.++. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C--THHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 46999999999999999999764 454 58889886544332 2478999999999999999999999998754 6
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
++++|++.+++|.+++.. ....+++..+..++.||+.||+||| ++||+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 778899999999988864 3456899999999999999999999 88999999999999999999999999999988
Q ss_pred cCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc----cCCcCCCCCCCcH
Q 004268 663 LHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSSS----SGRKISQNPRLDL 735 (764)
Q Consensus 663 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~~----~~~~~~~~~~~~~ 735 (764)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |++||++.+..+.. .......++..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 240 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCH
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 7543332 233468999999999999999999999999999999998 89999876653321 1233344566788
Q ss_pred HHHHHHhhhhccchh
Q 004268 736 QCNAYLKNFSQGNHR 750 (764)
Q Consensus 736 ~~~~~~~~~l~~~~~ 750 (764)
.+.+++++||+.++.
T Consensus 241 ~~~~li~~cl~~dP~ 255 (317)
T d1xkka_ 241 DVYMIMVKCWMIDAD 255 (317)
T ss_dssp HHHHHHHHHTCSSGG
T ss_pred HHHHHHHHhCCCChh
Confidence 999999999998843
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=346.45 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=199.0
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|+++ +++.||||++..... ....+++.+|++++++++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 568999999999999999999754 457899999875443 334578999999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc---------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCC
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV---------------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDI 639 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl 639 (764)
..+++|||+++|+|.+++.... ....+++..+..++.|++.||+||| +++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence 9999999999999999986421 1224788999999999999999999 899999999
Q ss_pred CCCCeeecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCcc
Q 004268 640 SSNNILLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGS-HPTDLL 716 (764)
Q Consensus 640 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~-~Pf~~~ 716 (764)
||+||+++.++.+||+|||+|+....... ..+...+++.|+|||.+.+..|+.++|||||||++|||++|. +||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999999999987643322 223457889999999999999999999999999999999985 688877
Q ss_pred ccccccc----CCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 717 SSLSSSS----GRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 717 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
...+... ......+..++..+.+++..||+.++.-|
T Consensus 247 ~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 247 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHC
Confidence 6543221 12223344678899999999999885554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=345.66 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=186.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||+||+|.+. +++.||||++...... ...+.+.+|.+++.++ +||||+++++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 478999999999999999999753 3468999998754433 2346778888888877 689999999987654
Q ss_pred -CEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCee
Q 004268 580 -KCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNIL 645 (764)
Q Consensus 580 -~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl 645 (764)
...++||||+++|+|.++++.... ...+++..+..++.||+.||+||| ++||+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence 468999999999999999975321 234889999999999999999999 899999999999999
Q ss_pred ecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCccccccc-
Q 004268 646 LNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSS- 721 (764)
Q Consensus 646 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~- 721 (764)
+++++.+||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||+|| .+||.+......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987643332 23345799999999999999999999999999999999986 568876654221
Q ss_pred ----ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 722 ----SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 722 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
........+...+..+.+++++||+.++.-|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1ywna1 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHC
Confidence 1122333445578899999999998875444
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=343.76 Aligned_cols=239 Identities=25% Similarity=0.399 Sum_probs=194.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCC--EEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeCCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGK--LVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHNKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 582 (764)
.++|++.+.||+|+||+||+|.++ +|. .||||++......+ ..+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH--HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 478999999999999999999765 454 47788875443332 246789999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhcC-------------ccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCC
Q 004268 583 FLIYEYMERGSLFCVLRND-------------VEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSN 649 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~ 649 (764)
++||||+++|+|.++++.. .....+++..+..++.||+.||.|+| ++||+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCC
Confidence 9999999999999999753 13456899999999999999999999 8999999999999999999
Q ss_pred CCEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCccccccc----ccC
Q 004268 650 LEAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGS-HPTDLLSSLSS----SSG 724 (764)
Q Consensus 650 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~-~Pf~~~~~~~~----~~~ 724 (764)
+.+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..+. ...
T Consensus 164 ~~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GCEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999976543222 23456899999999999999999999999999999999965 67876654332 222
Q ss_pred CcCCCCCCCcHHHHHHHhhhhccchhh
Q 004268 725 RKISQNPRLDLQCNAYLKNFSQGNHRW 751 (764)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~l~~~~~~ 751 (764)
.....+..++..+.+++++||+.++.-
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~ 269 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYE 269 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhH
Confidence 334445667899999999999988433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-41 Score=344.93 Aligned_cols=235 Identities=25% Similarity=0.331 Sum_probs=186.9
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-C-CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc---CCCceeeEeeEEee---
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-S-GKLVALKKLHRSETEEPAFLESFQTEARLLSQI---RHRNIVKLYGFCLH--- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~--- 578 (764)
.++|++.+.||+|+||+||+|++. + ++.||||++........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 579999999999999999999863 4 56799999865432211 113455778777766 79999999999853
Q ss_pred --CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEee
Q 004268 579 --NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVAD 656 (764)
Q Consensus 579 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 656 (764)
....+++||+++++.+...... ....+++..++.++.|++.||+||| ++||+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence 3468999999998776554442 3456899999999999999999999 89999999999999999999999999
Q ss_pred eccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------------
Q 004268 657 FGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------------- 722 (764)
Q Consensus 657 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------------- 722 (764)
||.+...... .......||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+..+..
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9998765322 2334568999999999999999999999999999999999999999865431100
Q ss_pred ----------------cCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 723 ----------------SGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 723 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
........+.++..+.+++++|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC
Confidence 00011123456788999999999988
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=339.61 Aligned_cols=241 Identities=24% Similarity=0.377 Sum_probs=196.4
Q ss_pred hhcCCcceeeeecCceeEEEEEECC--------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEe
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSS--------GKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCL 577 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~ 577 (764)
.++|++.+.||+|+||.||+|+... +..||||++..... ......+.+|...+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 5789999999999999999997431 24799999976543 33357788999999888 8999999999999
Q ss_pred eCCEEEEEEEecCCCCHHHHHhcCcc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 578 HNKCMFLIYEYMERGSLFCVLRNDVE-------------AVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 578 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+++..++||||+++|+|.+++..... ...+++..+..++.||+.||+||| ++|||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence 99999999999999999999975432 235899999999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCC--CceecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSS--NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
|++.++.+||+|||.++....... ......+++.|+|||.+.+..|+.++|||||||++|||++ |++||.+......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999987654322 2233578999999999999999999999999999999998 7999987665322
Q ss_pred ----ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 722 ----SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 722 ----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
........+..++..+.+++.+|++.++..|
T Consensus 247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1fgka_ 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281 (299)
T ss_dssp HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHC
Confidence 1223344455678899999999999886555
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=339.62 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=199.7
Q ss_pred hhcCCcceeeeecCceeEEEEEE------CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhc-CCCceeeEeeEEeeC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL------SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQI-RHRNIVKLYGFCLHN 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 579 (764)
.++|++.+.||+|+||.||+|++ .+++.||||++...... .....+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 47899999999999999999975 24678999999765433 3346789999999999 699999999999999
Q ss_pred CEEEEEEEecCCCCHHHHHhcCc---------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCe
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDV---------------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNI 644 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI 644 (764)
+..++||||+++|+|.+++++.. ....+++..+..++.||+.|++||| ++|++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 99999999999999999997532 2235889999999999999999999 89999999999999
Q ss_pred eecCCCCEEEeeeccccccCCCCCCc--eecccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 004268 645 LLNSNLEAFVADFGLARLLHPDSSNR--TLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLM-GSHPTDLLSSLSS 721 (764)
Q Consensus 645 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~llt-g~~Pf~~~~~~~~ 721 (764)
+++.++.+|++|||.++......... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765433322 33578999999999999999999999999999999998 6666766554322
Q ss_pred -----ccCCcCCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 722 -----SSGRKISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 722 -----~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
........+...+..+.++++.||+.++.-|
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 292 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 1122333345578899999999999885544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=346.16 Aligned_cols=230 Identities=26% Similarity=0.330 Sum_probs=185.3
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC------C
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN------K 580 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~ 580 (764)
-+|+..+.||+|+||+||+|++. +|+.||||++...... ..+|++++++++||||+++++++... .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 36899999999999999999865 7999999999765432 24799999999999999999998543 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeecc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGL 659 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~ 659 (764)
++|+||||++++.+..+.........+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccc
Confidence 58999999987654444332224557999999999999999999999 99999999999999999765 899999999
Q ss_pred ccccCCCCCCceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS--------------- 723 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~--------------- 723 (764)
+....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|++||...+..+...
T Consensus 170 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 170 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 98765433 2344689999999998765 478999999999999999999999997654311100
Q ss_pred -----------------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 -----------------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 -----------------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+..+.++.+++++|++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 290 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCC
Confidence 0011224557889999999999988
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=333.41 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=203.0
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCCEEEEEE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNKCMFLIY 586 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 586 (764)
++|++.+.||+|+||+||+|++. +++.||||+++.... .....+++.+|+.+++.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 58999999999999999999864 789999999976543 3344678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCC
Q 004268 587 EYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPD 666 (764)
Q Consensus 587 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 666 (764)
+++.++++..+++ ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||.|+.....
T Consensus 81 ~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eeccccccccccc---cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888876 3456889999999999999999999 899999999999999999999999999999987665
Q ss_pred CCCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCcccccc-------------------------
Q 004268 667 SSNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPTDLLSSLS------------------------- 720 (764)
Q Consensus 667 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf~~~~~~~------------------------- 720 (764)
........+++.|+|||++.+.. ++.++||||+||++|||++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 55555567889999999987765 6899999999999999999999963221100
Q ss_pred --------cccCCcCCCCCCCcHHHHHHHhhhhccc--hhhHHHhhhcCCC
Q 004268 721 --------SSSGRKISQNPRLDLQCNAYLKNFSQGN--HRWENLLFKKFPY 761 (764)
Q Consensus 721 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~p~ 761 (764)
..........+.++..+.+++++|++.+ .||-..+..+.||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 0111222234556889999999999987 3333444444444
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=334.54 Aligned_cols=233 Identities=26% Similarity=0.376 Sum_probs=187.6
Q ss_pred ceeeeecCceeEEEEEECCC----CEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-CCEEEEEEE
Q 004268 513 KYCIGTGGYGSVYRAQLSSG----KLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH-NKCMFLIYE 587 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 587 (764)
.+.||+|+||+||+|.+..+ ..||||++.... .....+++.+|++++++++||||+++++++.+ ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 56899999999999986432 258999986533 34446889999999999999999999999875 568999999
Q ss_pred ecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccccccCCCC
Q 004268 588 YMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLARLLHPDS 667 (764)
Q Consensus 588 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 667 (764)
|+++|+|.+++... ....++..+..++.|++.||.|+| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998753 345678889999999999999999 8999999999999999999999999999998764332
Q ss_pred C----CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccccc-cc----ccCCcCCCCCCCcHHHH
Q 004268 668 S----NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSL-SS----SSGRKISQNPRLDLQCN 738 (764)
Q Consensus 668 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~-~~----~~~~~~~~~~~~~~~~~ 738 (764)
. ......||+.|+|||.+.+..++.++||||||+++|||+||..||...... +. ........++..+..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 2 122356899999999999999999999999999999999987777543321 11 11223334455678999
Q ss_pred HHHhhhhccchhhH
Q 004268 739 AYLKNFSQGNHRWE 752 (764)
Q Consensus 739 ~~~~~~l~~~~~~~ 752 (764)
+++.+||+.++.-|
T Consensus 265 ~li~~cl~~dP~~R 278 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMR 278 (311)
T ss_dssp HHHHHHTCSSGGGS
T ss_pred HHHHHHcCCCHhHC
Confidence 99999999884443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=342.61 Aligned_cols=240 Identities=27% Similarity=0.382 Sum_probs=196.3
Q ss_pred hhcCCcceeeeecCceeEEEEEEC----CCCEEEEEEccCCCCC-cHHHHHHHHHHHHHHHhcCC-CceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS----SGKLVALKKLHRSETE-EPAFLESFQTEARLLSQIRH-RNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.+.... +....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 477999999999999999999742 5889999998654321 11123567899999999976 89999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.|++|+| ++||+||||||+||+++.++.+||+|||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999973 345788899999999999999999 899999999999999999999999999999
Q ss_pred cccCCCC-CCceecccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cCCcCCCC
Q 004268 661 RLLHPDS-SNRTLVVGTYGYIAPELAYTM--AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSS-------SGRKISQN 730 (764)
Q Consensus 661 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~-------~~~~~~~~ 730 (764)
+...... .......|++.|+|||.+.+. .++.++||||+||++|+|+||+.||.+....... .......+
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 8764322 223456799999999998765 4678999999999999999999999876543321 11222334
Q ss_pred CCCcHHHHHHHhhhhccchhhH
Q 004268 731 PRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 731 ~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
...+..+.+++++|++.++.-|
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R 278 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKR 278 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGS
T ss_pred ccCCHHHHHHHHHHcccCHHHc
Confidence 5678999999999999884443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-40 Score=342.35 Aligned_cols=233 Identities=24% Similarity=0.321 Sum_probs=186.1
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----E
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----C 581 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~ 581 (764)
..+|++++.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|++++++++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 46899999999999999999975 589999999997544 3344578899999999999999999999987653 2
Q ss_pred EEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecccc
Q 004268 582 MFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLAR 661 (764)
Q Consensus 582 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~ 661 (764)
.+++++++.+|+|.+++... .+++..++.++.|++.||+||| ++|||||||||+|||++.++.+||+|||+|.
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 34455667789999999642 5899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCC---Cceeccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------------
Q 004268 662 LLHPDSS---NRTLVVGTYGYIAPELAYT-MAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS-------------- 723 (764)
Q Consensus 662 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~-------------- 723 (764)
....... .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 6543221 2344678999999999854 467889999999999999999999997654211000
Q ss_pred --------------------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 --------------------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 --------------------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+.++..+.+++.+|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 282 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCC
Confidence 0001124567788999999999988
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-40 Score=336.51 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=200.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC------CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS------SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 580 (764)
.++|++.+.||+|+||+||+|.+. ++..||||++..... ......+.+|++++++++||||+++++++...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 578999999999999999999753 357899999975443 333467899999999999999999999999999
Q ss_pred EEEEEEEecCCCCHHHHHhcCc-------cccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEE
Q 004268 581 CMFLIYEYMERGSLFCVLRNDV-------EAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAF 653 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k 653 (764)
..++||||+++|+|.+++.... ....+++..+..++.|+++||.||| +++|+||||||+|||+++++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999886421 2234688999999999999999999 88999999999999999999999
Q ss_pred EeeeccccccCCCCCC--ceecccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCcccccccc----cCCc
Q 004268 654 VADFGLARLLHPDSSN--RTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMG-SHPTDLLSSLSSS----SGRK 726 (764)
Q Consensus 654 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg-~~Pf~~~~~~~~~----~~~~ 726 (764)
|+|||+|+........ .....+++.|+|||.+.+..++.++||||||+++|||+|| ++||.+.+..+.. ....
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999876433222 2234689999999999999999999999999999999998 5888876653221 2223
Q ss_pred CCCCCCCcHHHHHHHhhhhccchhhH
Q 004268 727 ISQNPRLDLQCNAYLKNFSQGNHRWE 752 (764)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~l~~~~~~~ 752 (764)
...++..+..+.+++..||+.++.-|
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~R 279 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMR 279 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCcccchHHHHHHHHHHcCCChhHC
Confidence 34455678899999999999885444
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=341.05 Aligned_cols=230 Identities=26% Similarity=0.351 Sum_probs=186.1
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC-----
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----- 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 580 (764)
.++|++++.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|++++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999864 799999999976543 3445678899999999999999999999997654
Q ss_pred -EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 581 -CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 581 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
.+|+||||+ +.++..+.+. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+|++|||.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence 479999999 5678777653 35999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc-----------------
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSS----------------- 721 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~----------------- 721 (764)
|+..... .+...||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9876432 3456799999999998765 568999999999999999999999976543111
Q ss_pred -----------------ccCCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 722 -----------------SSGRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 722 -----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.........+..+..+.+++++|++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 288 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCC
Confidence 011111223556889999999999988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=333.66 Aligned_cols=202 Identities=28% Similarity=0.416 Sum_probs=164.6
Q ss_pred hhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeCC----EE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHNK----CM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 582 (764)
.++|.+.+.||+|+||+||+|++. |+.||||++...... ....+.|+..+++++||||+++++++.+.+ .+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 467889999999999999999874 899999998643211 122234555556789999999999997653 68
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhc-----CCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYD-----CKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
|+||||+++|+|.+++++. .+++..+..++.|++.||+|+|.. +++||+||||||+|||+++++.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999999743 488999999999999999999932 1369999999999999999999999999
Q ss_pred ccccccCCCCC----CceecccccccccccccccCC------CCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDSS----NRTLVVGTYGYIAPELAYTMA------VTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99987754332 223467999999999987653 5678999999999999999999886543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-39 Score=332.75 Aligned_cols=232 Identities=19% Similarity=0.246 Sum_probs=190.6
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCC-CceeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRH-RNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++...... +.+.+|++.++.++| +|++.+++++.++...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 368999999999999999999865 7899999998665433 456789999999965 899999999999999999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecC-----CCCEEEeeecc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNS-----NLEAFVADFGL 659 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfg~ 659 (764)
||||+ +++|.+++... ...+++..+..++.|++.||+||| ++||+||||||+||+++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence 99999 57999888642 345899999999999999999999 999999999999999974 57899999999
Q ss_pred ccccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccC--------
Q 004268 660 ARLLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSG-------- 724 (764)
Q Consensus 660 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~-------- 724 (764)
|+....... .....+||+.|+|||++.+..+++++||||+||++|||+||+.||.+.........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 987643221 22346799999999999999999999999999999999999999986554321110
Q ss_pred ---CcCCCCCCCcHHHHHHHhhhhccch
Q 004268 725 ---RKISQNPRLDLQCNAYLKNFSQGNH 749 (764)
Q Consensus 725 ---~~~~~~~~~~~~~~~~~~~~l~~~~ 749 (764)
......+.+|.++.++++.|+..++
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred CCCChHHhcCCCCHHHHHHHHHHhcCCc
Confidence 0011134577888889988887663
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=337.10 Aligned_cols=204 Identities=25% Similarity=0.401 Sum_probs=169.4
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee-------
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------- 578 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------- 578 (764)
.++|++.+.||+|+||+||+|++ ++|+.||||++......+ ...+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 58999999999999999999986 489999999986654332 223678899999999999999999998855
Q ss_pred -CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeee
Q 004268 579 -NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADF 657 (764)
Q Consensus 579 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df 657 (764)
.+..|+||||++++.+..... ....+++..++.++.|++.||+||| ++||+||||||+||+++.++.+|++||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence 345899999998876665543 3456889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----CCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 658 GLARLLHPDS----SNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 658 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
|++....... ......+||+.|+|||++.+. .+++++||||+||++|||++|+.||.+.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 9997765322 122335799999999998765 68999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-39 Score=332.91 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=168.4
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEee--CCEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLH--NKCM 582 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~ 582 (764)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... .+++.+|++++++++ ||||+++++++.. ....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 36899999999999999999986 479999999986533 267889999999995 9999999999874 3569
Q ss_pred EEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC-CEEEeeecccc
Q 004268 583 FLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL-EAFVADFGLAR 661 (764)
Q Consensus 583 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfg~~~ 661 (764)
++||||+++++|..+.+ .+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||.|+
T Consensus 108 ~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccce
Confidence 99999999999876643 4899999999999999999999 99999999999999998655 69999999998
Q ss_pred ccCCCCCCceecccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 662 LLHPDSSNRTLVVGTYGYIAPELAYTM-AVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 662 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
...... .....++|+.|+|||.+.+. .++.++||||+||++|+|++|+.||...
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 765433 33456789999999998765 4799999999999999999999999654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-39 Score=331.48 Aligned_cols=233 Identities=17% Similarity=0.262 Sum_probs=185.5
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc-eeeEeeEEeeCCEEEE
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN-IVKLYGFCLHNKCMFL 584 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~l 584 (764)
.++|++.+.||+|+||+||+|++ .+|+.||||++...... +++.+|+++++.++|++ |+.+.+++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 36799999999999999999986 47899999998765443 45778999999997665 5666677788889999
Q ss_pred EEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeec---CCCCEEEeeecccc
Q 004268 585 IYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLN---SNLEAFVADFGLAR 661 (764)
Q Consensus 585 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfg~~~ 661 (764)
||||+. +++...+.. ....+++..+..++.|++.||+||| ++||+||||||+||+++ .+..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999995 466665543 3446899999999999999999999 89999999999999986 35579999999998
Q ss_pred ccCCCCC-------CceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccCC---------
Q 004268 662 LLHPDSS-------NRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSSGR--------- 725 (764)
Q Consensus 662 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~~~--------- 725 (764)
....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 8754322 123457999999999999999999999999999999999999999876543222111
Q ss_pred --cCCCCCCCcHHHHHHHhhhhccchh
Q 004268 726 --KISQNPRLDLQCNAYLKNFSQGNHR 750 (764)
Q Consensus 726 --~~~~~~~~~~~~~~~~~~~l~~~~~ 750 (764)
.....+.+|.++.++++.|++.++.
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~ 261 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFD 261 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTT
T ss_pred CChhHhccCCCHHHHHHHHHHccCChh
Confidence 0112346788899999999987733
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=330.89 Aligned_cols=200 Identities=27% Similarity=0.338 Sum_probs=163.4
Q ss_pred hhcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEee------C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLH------N 579 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 579 (764)
.++|++.+.||+|+||+||+|++. +|+.||||++...... ....+++.+|+.++++++||||+++++++.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 378999999999999999999865 7999999999776543 4445678999999999999999999999864 3
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeecc
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGL 659 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~ 659 (764)
...|+||||+.++.+ +.+. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 679999999987544 4443 24789999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 004268 660 ARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLLS 717 (764)
Q Consensus 660 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~~ 717 (764)
++..... ......++|+.|+|||++.+..+++++||||+||++|+|++|++||.+.+
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 8765433 33445678999999999999999999999999999999999999997554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-38 Score=330.52 Aligned_cols=231 Identities=23% Similarity=0.286 Sum_probs=185.8
Q ss_pred hhcCCcceeeeecCceeEEEEEE-CCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCceeeEeeEEeeC-----C
Q 004268 507 TEDFHIKYCIGTGGYGSVYRAQL-SSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNIVKLYGFCLHN-----K 580 (764)
Q Consensus 507 ~~~y~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~ 580 (764)
.++|++.+.||+|+||+||+|++ .+|+.||||++...... ....+++.+|++++++++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 47899999999999999999986 47999999999865443 33456788999999999999999999998643 3
Q ss_pred EEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEEeeeccc
Q 004268 581 CMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFVADFGLA 660 (764)
Q Consensus 581 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~ 660 (764)
..+++|+++.+|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence 34667778889999999863 35999999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCCceecccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCccccccccc----------------
Q 004268 661 RLLHPDSSNRTLVVGTYGYIAPELAYTMA-VTEKCDVYSFGVVALEVLMGSHPTDLLSSLSSSS---------------- 723 (764)
Q Consensus 661 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~~lltg~~Pf~~~~~~~~~~---------------- 723 (764)
..... ......|++.|+|||+..+.. ++.++||||+||++|+|++|++||.+.+......
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76432 234467899999999877664 5889999999999999999999997654311000
Q ss_pred ------------------CCcCCCCCCCcHHHHHHHhhhhccc
Q 004268 724 ------------------GRKISQNPRLDLQCNAYLKNFSQGN 748 (764)
Q Consensus 724 ------------------~~~~~~~~~~~~~~~~~~~~~l~~~ 748 (764)
.......+.++..+.+++++|++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 288 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCC
Confidence 0000012456888999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-33 Score=297.17 Aligned_cols=200 Identities=21% Similarity=0.298 Sum_probs=161.7
Q ss_pred hcCCcceeeeecCceeEEEEEEC-CCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-----------CCceeeEeeE
Q 004268 508 EDFHIKYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-----------HRNIVKLYGF 575 (764)
Q Consensus 508 ~~y~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~ 575 (764)
++|++++.||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+++++.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999864 79999999997542 23467788999888875 5789999988
Q ss_pred Eee--CCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCC---
Q 004268 576 CLH--NKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNL--- 650 (764)
Q Consensus 576 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~--- 650 (764)
+.. ....+++++++..+..............+++..++.++.||+.|++|||. ..||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 764 45677777777665444333333355678999999999999999999993 27999999999999998654
Q ss_pred ---CEEEeeeccccccCCCCCCceecccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 004268 651 ---EAFVADFGLARLLHPDSSNRTLVVGTYGYIAPELAYTMAVTEKCDVYSFGVVALEVLMGSHPTDLL 716 (764)
Q Consensus 651 ---~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~~lltg~~Pf~~~ 716 (764)
.++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3899999999765432 23457999999999999999999999999999999999999999754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=8.2e-30 Score=271.91 Aligned_cols=323 Identities=29% Similarity=0.421 Sum_probs=213.4
Q ss_pred CCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEE
Q 004268 41 ALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQL 120 (764)
Q Consensus 41 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 120 (764)
.+.+|++|++++|.|+++ +.+..+++|++|+|++|+|++.. .++++++|++|++++|++.++. .++++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccc
Confidence 344555555555555532 23555555555555555555322 2555555555555555555332 24555555555
Q ss_pred EccCCcCcccCCccccCCCCcCEEecccCcccccC-------------------CccccCCCCCCeeecccCCCCCCCCC
Q 004268 121 RLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRL-------------------PQEVGNLKNLKSLFLDNNHLSGPIPS 181 (764)
Q Consensus 121 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-------------------~~~~~~l~~L~~L~L~~n~i~~~~~~ 181 (764)
++++|.++++. .......+..+....|.+.... ...+...+.........|... ...
T Consensus 116 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 191 (384)
T d2omza2 116 TLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DIS 191 (384)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CCG
T ss_pred ccccccccccc--cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--ccc
Confidence 55555555432 2223344444444444443221 122333444445555555443 345
Q ss_pred ccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCC
Q 004268 182 TLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNL 261 (764)
Q Consensus 182 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 261 (764)
.+..+++++.+++++|.++.+.+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+++.. .+..+++|
T Consensus 192 ~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L 265 (384)
T d2omza2 192 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKL 265 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred ccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccC
Confidence 56778888888888888886543 45667888888888888753 35777888888888888888553 37778888
Q ss_pred CeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecccc
Q 004268 262 IALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHN 341 (764)
Q Consensus 262 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N 341 (764)
+.|++++|++.+.. .+..++.++.+++++|.+.+. ..+..+++++.|++++|++++.. .+..+++|++|++++|
T Consensus 266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANN 339 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSS
T ss_pred CEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCC
Confidence 88888888887543 477888888888888888753 34777888888888888888542 3778888888888888
Q ss_pred ccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCC
Q 004268 342 SLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKN 389 (764)
Q Consensus 342 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 389 (764)
+|++ ++ .+.++++|+.|+|++|+|++..| +.++++|+.|++++|
T Consensus 340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 340 KVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8884 34 57888888888888888886654 788888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.2e-29 Score=268.60 Aligned_cols=337 Identities=29% Similarity=0.399 Sum_probs=269.8
Q ss_pred EEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcC
Q 004268 48 LVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127 (764)
Q Consensus 48 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 127 (764)
..++.+.+++.+. ...+.+|++|++++|.|+.. +.++.+++|++|+|++|+|+++. .|+++++|++|++++|++
T Consensus 27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i 100 (384)
T d2omza2 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI 100 (384)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence 3566777775443 35677899999999999854 46888999999999999999764 389999999999999999
Q ss_pred cccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCC-------------------CccccCCC
Q 004268 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIP-------------------STLYHLNQ 188 (764)
Q Consensus 128 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-------------------~~~~~l~~ 188 (764)
.++. .+.++++|+.|++++|.+++..+ ......+..+....|.+..... ..+.....
T Consensus 101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (384)
T d2omza2 101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT 176 (384)
T ss_dssp CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT
T ss_pred cccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 9764 48899999999999999986543 4455677777777666542211 22333334
Q ss_pred ccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccC
Q 004268 189 LATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSS 268 (764)
Q Consensus 189 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 268 (764)
........|... ....+..+++++.+++++|.+++..+ +...++|++|++++|.+++. ..+..+++|+.|++++
T Consensus 177 ~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~ 250 (384)
T d2omza2 177 LERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250 (384)
T ss_dssp CCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred cccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhcccc
Confidence 444455555443 23456778999999999999997654 56678999999999999854 4688999999999999
Q ss_pred CcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCc
Q 004268 269 NQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIP 348 (764)
Q Consensus 269 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 348 (764)
|.+++.. .+..+++|+.|++++|++.+.. .+..++.++.+.+++|++++. ..+..+++++.|++++|++++..
T Consensus 251 n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~- 323 (384)
T d2omza2 251 NQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS- 323 (384)
T ss_dssp SCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG-
T ss_pred CccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc-
Confidence 9998654 4888999999999999998653 477889999999999999853 46889999999999999999653
Q ss_pred hhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccC-CccccCccccccCC
Q 004268 349 SEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP-ASVRRIPKLIVSEN 410 (764)
Q Consensus 349 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~~~~~~~~~n 410 (764)
.+..+++|++|+|++|+|++. + .+.++++|+.|++++|++++..| ..+++++.+++++|
T Consensus 324 -~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 -PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred -ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 388999999999999999853 3 68999999999999999998765 34567788888876
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=8.7e-28 Score=247.04 Aligned_cols=283 Identities=22% Similarity=0.270 Sum_probs=167.0
Q ss_pred ccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCC
Q 004268 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93 (764)
Q Consensus 14 ~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 93 (764)
+|.|-...++++.++.+++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|.+|..+++|
T Consensus 5 p~~c~c~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L 81 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81 (305)
T ss_dssp CTTCEEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCCCEecCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence 3444456677777777776 5566553 467777777777776666677777777777777777776667777777777
Q ss_pred CEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCccc--ccCCccccCCCCCCeeecc
Q 004268 94 LDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS--GRLPQEVGNLKNLKSLFLD 171 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~ 171 (764)
++|++++|+++.+.... ...|+.|++.+|.+..+.+..+.....++.++...|... ...+..|.++++|+.++++
T Consensus 82 ~~L~l~~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~ 158 (305)
T d1xkua_ 82 ERLYLSKNQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158 (305)
T ss_dssp CEEECCSSCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CEecccCCccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccc
Confidence 77777777777543322 346677777777777666666666666777776666543 2234455566666666666
Q ss_pred cCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC
Q 004268 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251 (764)
Q Consensus 172 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 251 (764)
+|.++.+... .+++ |++|++++|..+...+..|..++.++.|++++|.+.+..
T Consensus 159 ~n~l~~l~~~---~~~~------------------------L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 159 DTNITTIPQG---LPPS------------------------LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp SSCCCSCCSS---CCTT------------------------CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred cCCccccCcc---cCCc------------------------cCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 6665533221 1234 444555555544444445555555555555555555554
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCC------CCCCCccceEEccCCcCc--cCC
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPT------IGYLTNLTYLNLGYNRLS--SSI 323 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------~~~l~~L~~L~ls~N~l~--~~~ 323 (764)
+..+.++++|+.|+|++|.|+. .|.+|..+++|+.|+|++|+|+.+.... ...+++|+.|+|++|.++ ...
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred cccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 5555555555555555555553 2344555555555555555554433222 234556666677666654 234
Q ss_pred Chhhhcc
Q 004268 324 PPELMNC 330 (764)
Q Consensus 324 ~~~~~~l 330 (764)
|..|..+
T Consensus 291 ~~~f~~~ 297 (305)
T d1xkua_ 291 PSTFRCV 297 (305)
T ss_dssp GGGGTTC
T ss_pred HhHhccc
Confidence 4444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.3e-27 Score=245.67 Aligned_cols=245 Identities=26% Similarity=0.322 Sum_probs=138.0
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
..+.+|-+++.++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.+.+|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566777777777 4455553 567777777777776666677777777777777777777767777777777777777
Q ss_pred cCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCccccccc
Q 004268 148 LNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSI 227 (764)
Q Consensus 148 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 227 (764)
+|+++.+.... ...++.|.+..|.+..+....+.....+..++...|.... ....
T Consensus 88 ~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~----------------------~~~~ 142 (305)
T d1xkua_ 88 KNQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS----------------------SGIE 142 (305)
T ss_dssp SSCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG----------------------GGBC
T ss_pred CCccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccc----------------------cCCC
Confidence 77776543322 2456666666666655444444444444444444443221 1122
Q ss_pred CccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCC
Q 004268 228 PSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLT 307 (764)
Q Consensus 228 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 307 (764)
+..+..+++|+.+++++|.+... +..+ +++|+.|++++|.+....+..|.+++.++.|++++|.+.+..+..+..++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 23344445555555555555422 2221 34555555555555544455555555555555555555554455555555
Q ss_pred ccceEEccCCcCccCCChhhhcccccceeeccccccc
Q 004268 308 NLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLS 344 (764)
Q Consensus 308 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 344 (764)
+|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 5555555555555 33445555555555555555555
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1e-28 Score=255.03 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=152.4
Q ss_pred CCCEEEccCCcCccc--CCccccCCCCcCEEeccc-CcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEE
Q 004268 116 DLDQLRLQGNKLDGL--IPSSIGNLTNLTYLDLSL-NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATL 192 (764)
Q Consensus 116 ~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 192 (764)
+++.|+|++|.+.+. +|..+.++++|++|+|++ |++.+..|..|.++++|++|+|++|++.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~---------------- 114 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS---------------- 114 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE----------------
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccc----------------
Confidence 455555555555542 344555555555555554 4444444444555555555555555444
Q ss_pred EecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCC-CeEEccCCcc
Q 004268 193 CLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNL-IALDLSSNQL 271 (764)
Q Consensus 193 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l 271 (764)
.+.+..+..+..|+.+++++|.+....|..+..++.|+.+++++|.+.+..|..+..+..+ +.+++++|++
T Consensus 115 --------~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l 186 (313)
T d1ogqa_ 115 --------GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp --------EECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred --------ccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence 4444445555555555555555555555566666666666666666665556555555554 6666666666
Q ss_pred cCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhc
Q 004268 272 SGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEI 351 (764)
Q Consensus 272 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 351 (764)
++..+..+..+.. ..+++++|...+..|..+..+++|+.|++++|.+++. +..+..+++|+.|+|++|++++.+|..+
T Consensus 187 ~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~-~~~~~~~~~L~~L~Ls~N~l~g~iP~~l 264 (313)
T d1ogqa_ 187 TGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGL 264 (313)
T ss_dssp EEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB-GGGCCCCTTCCEEECCSSCCEECCCGGG
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccccccccccccc-ccccccccccccccCccCeecccCChHH
Confidence 6666666655543 3566666666666666666677777777777777643 3456666777777777777777777777
Q ss_pred ccccccceeecccccccCCCCCCCCCCCccceecCCCCc
Q 004268 352 GNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNN 390 (764)
Q Consensus 352 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 390 (764)
.++++|+.|||++|+|++.+|. +.++.+|+.+++++|+
T Consensus 265 ~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 265 TQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred hCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 7777777777777777766663 4667777777777776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1.1e-28 Score=254.81 Aligned_cols=249 Identities=33% Similarity=0.461 Sum_probs=173.4
Q ss_pred CCCCEEecCCCcccc--cCCccCcCCCCCCEEEccC-CcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCe
Q 004268 91 RDLLDLNLSNNILNG--SIPLEFGNLKDLDQLRLQG-NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKS 167 (764)
Q Consensus 91 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 167 (764)
.+++.|+|++|.+++ ..|..++++++|++|+|++ |.+.+..|..|.++++|++|+|++|++.++.+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468999999999986 3678999999999999997 8898888999999999999999999999999999999999999
Q ss_pred eecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCcccc-ceeeccCcccccccCccccCCCCCCEEEccCCc
Q 004268 168 LFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNL-DRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNR 246 (764)
Q Consensus 168 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 246 (764)
++++.|.+....+..+..++.++.+++++|.+....+..+..+..+ +.+++++|++++..+.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~----------------- 192 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP----------------- 192 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCG-----------------
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccc-----------------
Confidence 9999998887777777777777777666666654444444444433 4455555555544444
Q ss_pred ccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChh
Q 004268 247 LDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPE 326 (764)
Q Consensus 247 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~ 326 (764)
.+..+.. ..+++++|...+..+..+..+++|+.+++++|.+.+.++ .+..+++|+.|+|++|++++.+|..
T Consensus 193 -------~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~ 263 (313)
T d1ogqa_ 193 -------TFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp -------GGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGG
T ss_pred -------ccccccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChH
Confidence 4443322 245555555555555555555555555555555543322 3555566666666666666666666
Q ss_pred hhcccccceeeccccccccCCchhcccccccceeeccccc
Q 004268 327 LMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNF 366 (764)
Q Consensus 327 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 366 (764)
|.++++|++|+|++|+|+|.+|. +.++.+|+.+++++|+
T Consensus 264 l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 264 LTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred HhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 66666666666666666666653 4566666666676665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.6e-27 Score=238.02 Aligned_cols=254 Identities=24% Similarity=0.218 Sum_probs=143.1
Q ss_pred EEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeec-ccC
Q 004268 95 DLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFL-DNN 173 (764)
Q Consensus 95 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-~~n 173 (764)
.++.+++.++.+ |..+. +++++|+|++|+|+.+++.+|.++++|++|++++|++..+.+..+.++..++.+.. ..|
T Consensus 15 ~v~c~~~~L~~i-P~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQAV-PVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCSSC-CTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCCcc-CCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 345555555532 32222 34566666666666555555666666666666666665555555555555555543 233
Q ss_pred CCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCc
Q 004268 174 HLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPP 253 (764)
Q Consensus 174 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 253 (764)
.++. +.+..|.++++|++|++++|.+....+..+...++|+.+++++|.++.+.+.
T Consensus 92 ~~~~------------------------l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~ 147 (284)
T d1ozna_ 92 QLRS------------------------VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147 (284)
T ss_dssp TCCC------------------------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cccc------------------------ccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh
Confidence 3433 3344445555555555555555544444555555566666666666655555
Q ss_pred CCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccc
Q 004268 254 TIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQL 333 (764)
Q Consensus 254 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 333 (764)
.|..+++|+.|++++|++..+.+..|.++++|+.+++++|++.+..|..|..+++|++|++++|++++..+..|..+++|
T Consensus 148 ~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L 227 (284)
T d1ozna_ 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccccc
Confidence 66666666666666666666666666666666666666666666666666666667777777777666555666666667
Q ss_pred ceeeccccccccCCchhcccccccceeecccccccCCCCCCCC
Q 004268 334 LNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLG 376 (764)
Q Consensus 334 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 376 (764)
++|+|++|++...-+ ...-...++.+....+++.+..|..+.
T Consensus 228 ~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 228 QYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp CEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred CEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHc
Confidence 777777776663211 111122344444455555544444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-26 Score=234.77 Aligned_cols=224 Identities=27% Similarity=0.302 Sum_probs=178.7
Q ss_pred CEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc-c
Q 004268 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS-L 148 (764)
Q Consensus 70 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~ 148 (764)
..++.++++++ .+|..+. +++++|+|++|.|+.+.+.+|.++++|++|++++|++..+.+..+.++..++.++.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 45788888888 5666554 679999999999998888999999999999999999999999999999999999764 6
Q ss_pred CcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccC
Q 004268 149 NQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIP 228 (764)
Q Consensus 149 n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 228 (764)
|.++.+.+..|.++++|++|++++|.+..+....+....+|+.+++++|+++.+....|..+++|+.|++++|+++.+.+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 78888889999999999999999999987777777788888888888888887777777777777777777777776666
Q ss_pred ccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCcccc
Q 004268 229 STIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILI 296 (764)
Q Consensus 229 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 296 (764)
..|..+++|+.+++++|++.++.|..|..+++|++|++++|.+.++.+..|.++++|+.|++++|.+.
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 66677777777777777776666666666677777777777766666666666666666666666554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1e-23 Score=211.12 Aligned_cols=176 Identities=31% Similarity=0.246 Sum_probs=79.1
Q ss_pred CCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecc
Q 004268 92 DLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLD 171 (764)
Q Consensus 92 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 171 (764)
+|++|+|++|.|+++.+.+|.++++|++|+|++|+|+.+. .++.+++|++|+|++|+++. .+..+.++++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccccccccccc-ccccccccccccccccc
Confidence 3444444444444333344444444444444444444331 22334444444444444442 23334444444444444
Q ss_pred cCCCCCCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCC
Q 004268 172 NNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPI 251 (764)
Q Consensus 172 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 251 (764)
+|.+..+....+..+.+++.|++++|.+..+.+..+..+++|+.|++++|+++++.+..|..+++|++|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence 44444443334444444444444444444444444444444555555555544444444444555555555555554 33
Q ss_pred CcCCcCCCCCCeEEccCCcc
Q 004268 252 PPTIGNLTNLIALDLSSNQL 271 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l 271 (764)
|..+..+++|+.|+|++|++
T Consensus 188 p~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCB
T ss_pred ChhHCCCCCCCEEEecCCCC
Confidence 33444455555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-23 Score=210.56 Aligned_cols=199 Identities=28% Similarity=0.226 Sum_probs=117.1
Q ss_pred CCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEec
Q 004268 19 PNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNL 98 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 98 (764)
..+.+.++++++++ .+|+.+. +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+.. + .+..+++|++|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccc
Confidence 34455566666665 3455443 3566666666666655555666666666666666666632 2 3455666666666
Q ss_pred CCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCC
Q 004268 99 SNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGP 178 (764)
Q Consensus 99 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~ 178 (764)
++|+++ ..+..+.++++|+.|++++|.+..+.+..+..+.++++|++++|.++.+.+..+..+++|+.|++++|+++++
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred cccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence 666665 3344556666666666666666666556666666666666666666655555566666666666666666655
Q ss_pred CCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccc
Q 004268 179 IPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 179 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~ 224 (764)
.+..|..+++|++|+|++|+|+.++.+ +..+++|+.|+|++|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~~lp~~-~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLYTIPKG-FFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTT-TTTTCCCSEEECCSCCBC
T ss_pred CccccccccccceeecccCCCcccChh-HCCCCCCCEEEecCCCCC
Confidence 555555566666666666665544332 334555555555555543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.89 E-value=7.4e-21 Score=199.16 Aligned_cols=312 Identities=28% Similarity=0.288 Sum_probs=136.2
Q ss_pred CeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecC
Q 004268 20 NLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 20 ~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 99 (764)
+++.|+|++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++. ++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 3555566655554 34432 345555555555555 334322 345555555555552 2211 1235555555
Q ss_pred CCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCC
Q 004268 100 NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPI 179 (764)
Q Consensus 100 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~ 179 (764)
+|.+..+ | .++.+++|++|++++|.+..... ....+..+.+.++... ....+..++.++.|.++.|.+....
T Consensus 107 ~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~ 178 (353)
T d1jl5a_ 107 NNQLEKL-P-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLP 178 (353)
T ss_dssp SSCCSSC-C-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCC
T ss_pred ccccccc-c-chhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceecccccccccccc
Confidence 5555533 2 23445555555555555543211 1234444544444443 2233444555555555555443221
Q ss_pred CCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCC
Q 004268 180 PSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLT 259 (764)
Q Consensus 180 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 259 (764)
. .....+.+..+.+.+..+ + .+..++.|+.+++++|..... + ....
T Consensus 179 ~----~~~~~~~l~~~~~~~~~~-------------------------~-~~~~l~~L~~l~l~~n~~~~~-~---~~~~ 224 (353)
T d1jl5a_ 179 D----LPLSLESIVAGNNILEEL-------------------------P-ELQNLPFLTTIYADNNLLKTL-P---DLPP 224 (353)
T ss_dssp C----CCTTCCEEECCSSCCSSC-------------------------C-CCTTCTTCCEEECCSSCCSSC-C---SCCT
T ss_pred c----cccccccccccccccccc-------------------------c-ccccccccccccccccccccc-c---cccc
Confidence 1 111223333333333321 1 133344455555555444421 1 1223
Q ss_pred CCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecc
Q 004268 260 NLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLS 339 (764)
Q Consensus 260 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls 339 (764)
++..+.+.+|.+... + .....+...++..+.+.+.. .........++..|.+... ...+++|++|+|+
T Consensus 225 ~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls 292 (353)
T d1jl5a_ 225 SLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSL----CDLPPSLEELNVS 292 (353)
T ss_dssp TCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEES----CCCTTCCEEECCSSCCSEE----CCCCTTCCEEECC
T ss_pred ccccccccccccccc-c---cccccccccccccccccccc----cccchhcccccccCccccc----cccCCCCCEEECC
Confidence 444555555544321 1 11233444444443332110 0012334445555554421 1223455666666
Q ss_pred ccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccCCccccCcccc
Q 004268 340 HNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIPASVRRIPKLI 406 (764)
Q Consensus 340 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~ 406 (764)
+|+|+ .+|. .+++|+.|+|++|+|+ .+|.. +++|+.|++++|+++. +|..+..++.+.
T Consensus 293 ~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~~~~L~~L~ 350 (353)
T d1jl5a_ 293 NNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIPESVEDLR 350 (353)
T ss_dssp SSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCCCTTCCEEE
T ss_pred CCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCccccccCeeE
Confidence 66655 3332 2345556666666665 33332 3456666666666653 344444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.88 E-value=1.3e-20 Score=197.17 Aligned_cols=282 Identities=25% Similarity=0.258 Sum_probs=179.2
Q ss_pred cCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEE
Q 004268 17 CFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDL 96 (764)
Q Consensus 17 ~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 96 (764)
.+|+|++|++++|+++ .+|+. +.+|+.|++++|+++.+ +. +. +.|++|++++|.+.. +|. ++.+++|++|
T Consensus 56 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~-lp--~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L 125 (353)
T d1jl5a_ 56 LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SD-LP--PLLEYLGVSNNQLEK-LPE-LQNSSFLKII 125 (353)
T ss_dssp CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CS-CC--TTCCEEECCSSCCSS-CCC-CTTCTTCCEE
T ss_pred CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hh-hc--ccccccccccccccc-ccc-hhhhccceee
Confidence 3478999999999998 66765 46899999999999843 32 22 469999999999984 553 6889999999
Q ss_pred ecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCC
Q 004268 97 NLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLS 176 (764)
Q Consensus 97 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~ 176 (764)
++++|.+..... ....+..+.+..+.... ...+..++.++.|++++|....... .....+.+....+.+.
T Consensus 126 ~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~ 195 (353)
T d1jl5a_ 126 DVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILE 195 (353)
T ss_dssp ECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCS
T ss_pred cccccccccccc----ccccccchhhccccccc--cccccccccceeccccccccccccc----cccccccccccccccc
Confidence 999999984332 34678888888877753 3568889999999999999874422 2234567777777665
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCc
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIG 256 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 256 (764)
.. ..+..++.|+.+++++|...... ....++..+.+..+.+... + .....+...++..+.+.+...
T Consensus 196 ~~--~~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~~~~~~~~~~~~-~---~~~~~l~~~~~~~~~~~~l~~---- 261 (353)
T d1jl5a_ 196 EL--PELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVRDNYLTDL-P---ELPQSLTFLDVSENIFSGLSE---- 261 (353)
T ss_dssp SC--CCCTTCTTCCEEECCSSCCSSCC----SCCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSEESC----
T ss_pred cc--ccccccccccccccccccccccc----ccccccccccccccccccc-c---ccccccccccccccccccccc----
Confidence 33 23567888999999888766432 2345677777777766532 1 123455556655554442210
Q ss_pred CCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhccccccee
Q 004268 257 NLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNL 336 (764)
Q Consensus 257 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L 336 (764)
-.......++..|.+.+. ...+++|++|++++|++.. +|. .+++|+.|+|++|+|+ .+|.. +.+|++|
T Consensus 262 l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L 329 (353)
T d1jl5a_ 262 LPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQL 329 (353)
T ss_dssp CCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEE
T ss_pred ccchhcccccccCccccc----cccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEE
Confidence 012344555555555422 2234455555555555542 222 2345555555555555 23321 2344444
Q ss_pred eccccccc
Q 004268 337 VLSHNSLS 344 (764)
Q Consensus 337 ~ls~N~l~ 344 (764)
++++|+|+
T Consensus 330 ~L~~N~L~ 337 (353)
T d1jl5a_ 330 HVEYNPLR 337 (353)
T ss_dssp ECCSSCCS
T ss_pred ECcCCcCC
Confidence 44444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=4.7e-23 Score=194.92 Aligned_cols=167 Identities=15% Similarity=0.184 Sum_probs=122.1
Q ss_pred CCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCC---------------cHHHHHHHHHHHHHHHhcCCCceeeEee
Q 004268 510 FHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETE---------------EPAFLESFQTEARLLSQIRHRNIVKLYG 574 (764)
Q Consensus 510 y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpniv~~~~ 574 (764)
+.+.+.||+|+||+||+|...+|+.||||++...... .........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999888999999987532211 0112344567889999999999998886
Q ss_pred EEeeCCEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcCCCCcEEcCCCCCCeeecCCCCEEE
Q 004268 575 FCLHNKCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDCKPSIVHRDISSNNILLNSNLEAFV 654 (764)
Q Consensus 575 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl 654 (764)
+.. .+++|||+++..+. .++...+..++.|++.|++||| ++||+||||||+|||++++ .++|
T Consensus 82 ~~~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EET----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEE
T ss_pred ecC----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEE
Confidence 632 26999999875432 2344456679999999999999 8999999999999999965 5899
Q ss_pred eeeccccccCCCCCCceeccccccccccc-----ccccCCCCccchHHHHHHH
Q 004268 655 ADFGLARLLHPDSSNRTLVVGTYGYIAPE-----LAYTMAVTEKCDVYSFGVV 702 (764)
Q Consensus 655 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~DiwslG~i 702 (764)
+|||.|.....+... .|.... .+....|+.++|+||+.--
T Consensus 144 iDFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999765432211 111110 0123567889999997543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.7e-20 Score=184.96 Aligned_cols=219 Identities=19% Similarity=0.181 Sum_probs=96.4
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccc-cCCccCcCCCCCCEEEccC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNG-SIPLEFGNLKDLDQLRLQG 124 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~ 124 (764)
+.++.+++.++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.. +.+.+|.+++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34555555554 2332222 245555555555554333445555555555555554432 2333444445555544432
Q ss_pred -CcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCc
Q 004268 125 -NKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPV 203 (764)
Q Consensus 125 -n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~ 203 (764)
|.+....+..|.++++|++|++++|.+....+. ..+..+..+..+..+++.+..+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEEC
T ss_pred cccccccccccccccccccccccchhhhcccccc-----------------------ccccccccccccccccccccccc
Confidence 344444444444444444444444444322111 11222333334444444444444
Q ss_pred ccccCCcc-ccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccCCCCccccCC
Q 004268 204 TKEVGNMK-NLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSGLLPREVGNL 282 (764)
Q Consensus 204 ~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 282 (764)
...|.+++ .++.|++++|+++.+.+..+....-++.+++++|.++.+.+..|.++++|++|+|++|+|+.+.+..|.++
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l 224 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 224 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred ccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence 44444332 44555555555554333333222212222344455554444445555555555555555554444444444
Q ss_pred CCCCeEec
Q 004268 283 KYLASLSL 290 (764)
Q Consensus 283 ~~L~~L~l 290 (764)
++|+.|++
T Consensus 225 ~~L~~l~~ 232 (242)
T d1xwdc1 225 KKLRARST 232 (242)
T ss_dssp CEEESSSE
T ss_pred cccccCcC
Confidence 44444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.9e-20 Score=184.69 Aligned_cols=212 Identities=14% Similarity=0.084 Sum_probs=154.2
Q ss_pred eeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCccc-CCcccCCCCCCCEEecC
Q 004268 21 LVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGT-IPSEIGSLRDLLDLNLS 99 (764)
Q Consensus 21 l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~ 99 (764)
.+++++++++++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+... .+.+|..++++++|.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 468899999988 7777664 5899999999999988888899999999999999998754 45689999999999986
Q ss_pred -CCcccccCCccCcCCCCCCEEEccCCcCcccCCcc-ccCCCCcCEEecccCcccccCCccccCCC-CCCeeecccCCCC
Q 004268 100 -NNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSS-IGNLTNLTYLDLSLNQLSGRLPQEVGNLK-NLKSLFLDNNHLS 176 (764)
Q Consensus 100 -~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~ 176 (764)
.|.+....+..|.++++|++|++++|.+....+.. +..+..|..+..+++.+..+.+..|.+++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 47888888899999999999999999998654432 44566677777788888878778887764 6777888888877
Q ss_pred CCCCCccccCCCccEEEecCccCcCCcccccCCccccceeeccCcccccccCccccCCC
Q 004268 177 GPIPSTLYHLNQLATLCLGYNKLVGPVTKEVGNMKNLDRLHLNGNNLTGSIPSTIGYLN 235 (764)
Q Consensus 177 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 235 (764)
.+....+.....++.+++++|+++.++...|.++++|++|++++|+++.+.+..|..++
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 225 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK 225 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCC
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCc
Confidence 65554443322223334455555555555555555555555555555543333333333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=6.9e-20 Score=178.39 Aligned_cols=202 Identities=26% Similarity=0.414 Sum_probs=100.0
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCc
Q 004268 47 KLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNK 126 (764)
Q Consensus 47 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 126 (764)
.++++.+++++.. .+..+.+|+.|++++|.|+.. +.+..+++|++|+|++|.++++.+ |.++++|+.+++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3455555555432 244555666666666666532 235666666666666666654332 5566666666666666
Q ss_pred CcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCcccc
Q 004268 127 LDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKE 206 (764)
Q Consensus 127 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 206 (764)
++.+ ..+.++++|+.+++++|...+. ..+...+.++.+.++.+.+... ..+..+++|+.|++++|.+.... .
T Consensus 97 ~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 97 LKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp CSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--G
T ss_pred cccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--h
Confidence 6543 3455566666666666655432 2344555555555555555422 22444445555555555444221 2
Q ss_pred cCCccccceeeccCcccccccCccccCCCCCCEEEccCCcccCCCCcCCcCCCCCCeEEc
Q 004268 207 VGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDGPIPPTIGNLTNLIALDL 266 (764)
Q Consensus 207 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 266 (764)
+..+++|++|+|++|+++++. .+..+++|++|+|++|+++++. .++++++|+.|++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~l 224 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTL 224 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEE
T ss_pred hcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEe
Confidence 344444444444444444321 1334444444444444444321 1334444444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.4e-19 Score=176.18 Aligned_cols=57 Identities=28% Similarity=0.377 Sum_probs=24.2
Q ss_pred ccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeecc
Q 004268 279 VGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLS 339 (764)
Q Consensus 279 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls 339 (764)
+.++++|+.|++++|++++. ..++.+++|++|+|++|++++. + .+.++++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 33444444444444444332 1234444444444444444422 1 24444455555444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.4e-22 Score=217.61 Aligned_cols=379 Identities=20% Similarity=0.142 Sum_probs=234.6
Q ss_pred CCeeEEEeCCCCccccC-CccccCCCCCcEEEcCCCcCccc----CCccccCCCCCCEEEccCCcCccc----CCcccCC
Q 004268 19 PNLVTFRIWGTLLSGRM-PSEIGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTGT----IPSEIGS 89 (764)
Q Consensus 19 ~~l~~L~l~~~~~~~~~-~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~ 89 (764)
++|+.|||+++++++.. .+-+..+++++.|+|++|.++.. +...+..+++|++|||++|+|+.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 57899999999987632 34466778889999999988742 345567888999999999988632 2233332
Q ss_pred -CCCCCEEecCCCccccc----CCccCcCCCCCCEEEccCCcCcccCCcccc-----CCCCcCEEecccCcccccC----
Q 004268 90 -LRDLLDLNLSNNILNGS----IPLEFGNLKDLDQLRLQGNKLDGLIPSSIG-----NLTNLTYLDLSLNQLSGRL---- 155 (764)
Q Consensus 90 -l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~~---- 155 (764)
..+|++|+|++|.++.. .+.++..+++|++|+|++|.++......+. .......+......+....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 34799999999998743 244677888999999999988743222221 1223344444444332111
Q ss_pred CccccCCCCCCeeecccCCCCCCCC----Ccc-ccCCCccEEEecCccCcCCcc----cccCCccccceeeccCccccc-
Q 004268 156 PQEVGNLKNLKSLFLDNNHLSGPIP----STL-YHLNQLATLCLGYNKLVGPVT----KEVGNMKNLDRLHLNGNNLTG- 225 (764)
Q Consensus 156 ~~~~~~l~~L~~L~L~~n~i~~~~~----~~~-~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~l~~- 225 (764)
...+.....++.+.++.+.+..... ..+ ........+++..+.+..... ..+...+.++.+++.+|.+..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 1223445677778777776542100 011 122345667777776653321 223455777888888877642
Q ss_pred ----ccCccccCCCCCCEEEccCCcccCCC----CcCCcCCCCCCeEEccCCcccCCCCccc-----cCCCCCCeEeccC
Q 004268 226 ----SIPSTIGYLNLLDELHLSHNRLDGPI----PPTIGNLTNLIALDLSSNQLSGLLPREV-----GNLKYLASLSLNG 292 (764)
Q Consensus 226 ----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l~~ 292 (764)
...........++.|++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 12233445667888888888775321 1234456788888888888763322221 2345788888888
Q ss_pred ccccCCCCC----CCCCCCccceEEccCCcCccCC----Chhhh-cccccceeeccccccccC----Cchhcccccccce
Q 004268 293 NILIGPIPP----TIGYLTNLTYLNLGYNRLSSSI----PPELM-NCSQLLNLVLSHNSLSGS----IPSEIGNLIFFRQ 359 (764)
Q Consensus 293 n~l~~~~~~----~~~~l~~L~~L~ls~N~l~~~~----~~~~~-~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~ 359 (764)
|.+...... .+...++|++|+|++|++++.. +..+. ..+.|++|+|++|.|++. +...+..+++|++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 877643222 2334567888888888886421 22222 356688888888888753 3344566688888
Q ss_pred eecccccccCCCC----CCCC-CCCccceecCCCCccccccCC
Q 004268 360 LDLSRNFINGTIP----SQLG-KIPNISAVDLSKNNLSGVIPA 397 (764)
Q Consensus 360 L~l~~N~l~~~~~----~~~~-~l~~L~~l~l~~N~l~~~~~~ 397 (764)
|||++|+|+.... ..+. ....|+.|++++|.+......
T Consensus 402 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~ 444 (460)
T d1z7xw1 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444 (460)
T ss_dssp EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHH
Confidence 8888888864222 1222 234688899999888754443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=8.1e-20 Score=172.50 Aligned_cols=174 Identities=23% Similarity=0.266 Sum_probs=102.8
Q ss_pred cceeeccCcccccccCccccCCCCCCEEEccCCcccC-CCCcCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEecc
Q 004268 213 LDRLHLNGNNLTGSIPSTIGYLNLLDELHLSHNRLDG-PIPPTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLN 291 (764)
Q Consensus 213 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 291 (764)
.+.++.++++++.+ |..+ .+++++|+|++|+|+. ..+..|.++++|+.|+|++|.+..+.+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~~i-P~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEI-PRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSSC-CSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCcc-CCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 34566777776643 3332 2456677777777754 344556666677777777777666666666666667777777
Q ss_pred CccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCC
Q 004268 292 GNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTI 371 (764)
Q Consensus 292 ~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 371 (764)
+|+|..+.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|++..... ...-...++.+.+..|.+++..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCC
Confidence 777666666666666667777777777666666666666666666666666653221 1111223445555555555444
Q ss_pred CCCCCCCCccceecCCCCcccc
Q 004268 372 PSQLGKIPNISAVDLSKNNLSG 393 (764)
Q Consensus 372 ~~~~~~l~~L~~l~l~~N~l~~ 393 (764)
|..+. .++.++++.|.++|
T Consensus 166 p~~l~---~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 166 PSKVR---DVQIKDLPHSEFKC 184 (192)
T ss_dssp STTTT---TSBGGGSCTTTCCC
T ss_pred Chhhc---CCEeeecCHhhCcC
Confidence 44332 33445555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1e-22 Score=221.72 Aligned_cols=369 Identities=21% Similarity=0.170 Sum_probs=252.0
Q ss_pred CCcEEEcCCCcCcccC-CccccCCCCCCEEEccCCcCcc----cCCcccCCCCCCCEEecCCCcccccC----CccCc-C
Q 004268 44 KLEKLVLSHNSLTGRI-PSEIGALSRLKVLDLSYNRLTG----TIPSEIGSLRDLLDLNLSNNILNGSI----PLEFG-N 113 (764)
Q Consensus 44 ~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~-~ 113 (764)
+|+.||+++|++++.. ...++.++++++|+|++|.|+. .++.++..+++|++|+|++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999998542 3446778999999999999983 34566788999999999999997422 22332 3
Q ss_pred CCCCCEEEccCCcCccc----CCccccCCCCcCEEecccCcccccCCcccc-----CCCCCCeeecccCCCCCCC----C
Q 004268 114 LKDLDQLRLQGNKLDGL----IPSSIGNLTNLTYLDLSLNQLSGRLPQEVG-----NLKNLKSLFLDNNHLSGPI----P 180 (764)
Q Consensus 114 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~i~~~~----~ 180 (764)
..+|++|+|++|+++.. .+.++..+++|++|+|++|.+.......+. .......+......+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35899999999999754 245677899999999999998754322221 2223344444444332110 1
Q ss_pred CccccCCCccEEEecCccCcCCcccc-----cCCccccceeeccCcccccc----cCccccCCCCCCEEEccCCcccCC-
Q 004268 181 STLYHLNQLATLCLGYNKLVGPVTKE-----VGNMKNLDRLHLNGNNLTGS----IPSTIGYLNLLDELHLSHNRLDGP- 250 (764)
Q Consensus 181 ~~~~~l~~L~~L~l~~n~i~~~~~~~-----~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~- 250 (764)
..+.....++.++++++.+....... .........+.+..+.+... ....+...+.++.++++.|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 22445678899999988765321111 12224566788887766532 122345678899999999987532
Q ss_pred ----CCcCCcCCCCCCeEEccCCcccCCC----CccccCCCCCCeEeccCccccCCCCCC-----CCCCCccceEEccCC
Q 004268 251 ----IPPTIGNLTNLIALDLSSNQLSGLL----PREVGNLKYLASLSLNGNILIGPIPPT-----IGYLTNLTYLNLGYN 317 (764)
Q Consensus 251 ----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~-----~~~l~~L~~L~ls~N 317 (764)
..........++.|++++|.+.... ...+...+.++.+++++|.+.+..... ......|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2234455679999999999986432 234567889999999999986421111 123468999999999
Q ss_pred cCccCCChh----hhcccccceeeccccccccCCc----hhcc-cccccceeecccccccCC----CCCCCCCCCcccee
Q 004268 318 RLSSSIPPE----LMNCSQLLNLVLSHNSLSGSIP----SEIG-NLIFFRQLDLSRNFINGT----IPSQLGKIPNISAV 384 (764)
Q Consensus 318 ~l~~~~~~~----~~~l~~L~~L~ls~N~l~~~~~----~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l 384 (764)
.++...... +....+|++|+|++|++++... ..+. ....|++|+|++|+|++. +...+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 998543333 3456689999999999975432 2332 456799999999999742 34456677999999
Q ss_pred cCCCCccccccCC--------ccccCccccccCCCC
Q 004268 385 DLSKNNLSGVIPA--------SVRRIPKLIVSENNL 412 (764)
Q Consensus 385 ~l~~N~l~~~~~~--------~~~~~~~~~~~~n~~ 412 (764)
|+++|+++..-.. .-..++.+.+.+|.+
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 9999999842211 122567777776665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=2.6e-19 Score=168.94 Aligned_cols=174 Identities=21% Similarity=0.222 Sum_probs=119.4
Q ss_pred CEEEccCCcccCCCCcCCcCCCCCCeEEccCCcccC-CCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccC
Q 004268 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSNQLSG-LLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316 (764)
Q Consensus 238 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 316 (764)
+.+++++++++. +|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+....+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 467777777773 444443 567777777777754 4456677777777777777777777777777777777777777
Q ss_pred CcCccCCChhhhcccccceeeccccccccCCchhcccccccceeecccccccCCCCCCCCCCCccceecCCCCccccccC
Q 004268 317 NRLSSSIPPELMNCSQLLNLVLSHNSLSGSIPSEIGNLIFFRQLDLSRNFINGTIPSQLGKIPNISAVDLSKNNLSGVIP 396 (764)
Q Consensus 317 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 396 (764)
|+|+.+.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++.+.....+ -...++.+.+..|.+++..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCC
Confidence 77776666777777777777777777776667777777777777777777764332111 11235566677777777777
Q ss_pred CccccCccccccCCCCCCC
Q 004268 397 ASVRRIPKLIVSENNLELE 415 (764)
Q Consensus 397 ~~~~~~~~~~~~~n~~~~~ 415 (764)
..++.++-++++.|.+.|.
T Consensus 167 ~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 167 SKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TTTTTSBGGGSCTTTCCCC
T ss_pred hhhcCCEeeecCHhhCcCC
Confidence 7777777777777776553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.4e-18 Score=165.00 Aligned_cols=176 Identities=24% Similarity=0.339 Sum_probs=88.9
Q ss_pred EEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcc
Q 004268 24 FRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNIL 103 (764)
Q Consensus 24 L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 103 (764)
+.+..+.+++.++ ...+.++++|++++|.++.+ +.+..+++|++|+|++|++++.. .++++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCcc--cccCCccccccccccccc
Confidence 3444454443322 23445556666666666532 23555566666666666655322 255556666666666655
Q ss_pred cccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCcc
Q 004268 104 NGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTL 183 (764)
Q Consensus 104 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 183 (764)
..+. .+.++++|+.|++++|.+..+ ..+..+++|+.|++++|++..+ ..+..+++|+.|++.+|+++++. .+
T Consensus 97 ~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l 168 (199)
T d2omxa2 97 ADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PL 168 (199)
T ss_dssp CCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred cccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cc
Confidence 5322 255555566666655555543 2355555555555555555432 23555555555555555555332 24
Q ss_pred ccCCCccEEEecCccCcCCcccccCCccccce
Q 004268 184 YHLNQLATLCLGYNKLVGPVTKEVGNMKNLDR 215 (764)
Q Consensus 184 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 215 (764)
.++++|++|++++|+++++. .++.+++|++
T Consensus 169 ~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~ 198 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSDIS--VLAKLTNLES 198 (199)
T ss_dssp TTCTTCCEEECCSSCCCCCG--GGGGCTTCSE
T ss_pred cCCCCCCEEECCCCCCCCCc--cccCCCCCCc
Confidence 44555555555555544332 2344444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.2e-18 Score=166.89 Aligned_cols=163 Identities=26% Similarity=0.367 Sum_probs=72.3
Q ss_pred CCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEE
Q 004268 42 LSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLR 121 (764)
Q Consensus 42 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 121 (764)
+.+|++|++++|.+++.. .+..+++|++|+|++|+|++.. .++.+++|++|++++|+++.+. .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--cccccccccccc
Confidence 344555555555554321 2444555555555555554321 2344555555555555554321 244455555555
Q ss_pred ccCCcCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcC
Q 004268 122 LQGNKLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVG 201 (764)
Q Consensus 122 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~ 201 (764)
+++|.+..+ ..+.++++|+.+++++|.+++. ..+..+++|+.+++++|+++++. .+.++++|++|+|++|++++
T Consensus 119 l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred ccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence 555544432 2344444555555555544421 23344444444444444444321 13444444444444444433
Q ss_pred CcccccCCccccceeec
Q 004268 202 PVTKEVGNMKNLDRLHL 218 (764)
Q Consensus 202 ~~~~~~~~l~~L~~L~L 218 (764)
+. .+.++++|++|+|
T Consensus 193 l~--~l~~l~~L~~L~L 207 (210)
T d1h6ta2 193 LR--ALAGLKNLDVLEL 207 (210)
T ss_dssp CG--GGTTCTTCSEEEE
T ss_pred Ch--hhcCCCCCCEEEc
Confidence 21 2334444444443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.8e-18 Score=162.79 Aligned_cols=179 Identities=28% Similarity=0.400 Sum_probs=110.7
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
..+.++++.+++..+ ...+.++++|++++|.|+.. +.++.+++|++|+|++|+++++.+ |+++++|++|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence 344566677665433 34566777788888777743 346677777777777777775433 677777777777777
Q ss_pred cCcccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccc
Q 004268 126 KLDGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTK 205 (764)
Q Consensus 126 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 205 (764)
.+..+. .+.++++|+.|++++|.+... ..+.++++|+.|++++|++..+ ..+..+++|+.|++++|+++.+.
T Consensus 95 ~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~-- 166 (199)
T d2omxa2 95 QIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK-- 166 (199)
T ss_dssp CCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--
T ss_pred cccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--
Confidence 776542 466777777777777776643 3466667777777777766532 24556666666666666665432
Q ss_pred ccCCccccceeeccCcccccccCccccCCCCCCEE
Q 004268 206 EVGNMKNLDRLHLNGNNLTGSIPSTIGYLNLLDEL 240 (764)
Q Consensus 206 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 240 (764)
.+.++++|++|++++|+++++ ..+..+++|++|
T Consensus 167 ~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 167 PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 255555555555555555532 134445555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=2.9e-18 Score=164.08 Aligned_cols=163 Identities=28% Similarity=0.365 Sum_probs=87.6
Q ss_pred EEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcC
Q 004268 48 LVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKL 127 (764)
Q Consensus 48 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 127 (764)
.+++++.+++..+. ..+.+|+.|++++|.|+... .+..+++|++|+|++|.++++. .++.+++|++|++++|++
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 34555555543331 23456666777776666332 3556666666666666666433 245666666666666666
Q ss_pred cccCCccccCCCCcCEEecccCcccccCCccccCCCCCCeeecccCCCCCCCCCccccCCCccEEEecCccCcCCccccc
Q 004268 128 DGLIPSSIGNLTNLTYLDLSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSGPIPSTLYHLNQLATLCLGYNKLVGPVTKEV 207 (764)
Q Consensus 128 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~ 207 (764)
+++. .+.++++|+.|++++|.+..+ ..+.++++++.++++.|.+++. ..+..+++|+.+++++|+++.+. .+
T Consensus 103 ~~l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 103 KDLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CCGG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cccc--ccccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cc
Confidence 6542 456666666666666665532 3455566666666666655432 23444455555555555444322 24
Q ss_pred CCccccceeeccCcccc
Q 004268 208 GNMKNLDRLHLNGNNLT 224 (764)
Q Consensus 208 ~~l~~L~~L~L~~n~l~ 224 (764)
..+++|++|+|++|+++
T Consensus 175 ~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp TTCTTCCEEECCSSCCC
T ss_pred cCCCCCCEEECCCCCCC
Confidence 44444444444444444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.8e-16 Score=143.78 Aligned_cols=110 Identities=24% Similarity=0.190 Sum_probs=50.4
Q ss_pred cCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCE
Q 004268 40 GALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQ 119 (764)
Q Consensus 40 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 119 (764)
.++.++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+.. +.|..+++|++|+|++|.++.+.+..+..+++|++
T Consensus 15 ~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 3444445555555555422 33334444555555555555432 22444445555555555554444434444445555
Q ss_pred EEccCCcCcccCC-ccccCCCCcCEEecccCccc
Q 004268 120 LRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 120 L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 152 (764)
|++++|+++.+.. ..+..+++|++|++++|+++
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ceeccccccccccccccccccccchhhcCCCccc
Confidence 5555554443321 23444444555555554444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.8e-16 Score=141.66 Aligned_cols=131 Identities=21% Similarity=0.189 Sum_probs=112.6
Q ss_pred ccccCCCeeEEEeCCCCccccCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCC
Q 004268 14 NFTCFPNLVTFRIWGTLLSGRMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDL 93 (764)
Q Consensus 14 ~~~~~~~l~~L~l~~~~~~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 93 (764)
.|.++..+++|+|++|+|+ .++..+..+++|+.|+|++|+|+.+ +.|..+++|++|++++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence 4788899999999999998 4577778899999999999999965 358999999999999999997767777889999
Q ss_pred CEEecCCCcccccCC-ccCcCCCCCCEEEccCCcCcccCC---ccccCCCCcCEEecc
Q 004268 94 LDLNLSNNILNGSIP-LEFGNLKDLDQLRLQGNKLDGLIP---SSIGNLTNLTYLDLS 147 (764)
Q Consensus 94 ~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~ 147 (764)
++|+|++|+++.+.. ..+..+++|++|++++|.++.... ..+..+++|+.||-+
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~~ 147 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTE
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCCC
Confidence 999999999986543 568899999999999999986542 357788999988743
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.2e-15 Score=129.59 Aligned_cols=102 Identities=32% Similarity=0.376 Sum_probs=62.3
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCC
Q 004268 46 EKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGN 125 (764)
Q Consensus 46 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 125 (764)
++|+|++|+++.. + .+..+++|++|++++|+|+ .+|..|..+++|++|++++|.|+++ + .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 3566666666633 2 3666666666666666666 3455566666666666666666643 2 3566666666666666
Q ss_pred cCcccCC-ccccCCCCcCEEecccCccc
Q 004268 126 KLDGLIP-SSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 126 ~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 152 (764)
+++.+.. ..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6665432 44566666666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=3.1e-16 Score=157.35 Aligned_cols=58 Identities=22% Similarity=0.291 Sum_probs=24.7
Q ss_pred CCCCEEEccCCcCccc-CCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccC
Q 004268 67 SRLKVLDLSYNRLTGT-IPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQG 124 (764)
Q Consensus 67 ~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 124 (764)
.+|++|||++|.++.. ....+..+++|++|+|++|.++......+..+++|++|++++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3444444444444321 122334444444444444444433333344444444444444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=2.3e-16 Score=158.32 Aligned_cols=79 Identities=22% Similarity=0.249 Sum_probs=39.1
Q ss_pred CCEEEccCCcCcccCCcccCCCCCCCEEecCCCccccc-CCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecc
Q 004268 69 LKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGS-IPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLS 147 (764)
Q Consensus 69 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 147 (764)
+..+.++.+.+.... .......+|++|+|++|.++.. ....+.++++|++|+|++|.+.......+..+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 345555555444222 2222334566666666655422 12234555566666666655554444445555555555555
Q ss_pred c
Q 004268 148 L 148 (764)
Q Consensus 148 ~ 148 (764)
+
T Consensus 104 ~ 104 (284)
T d2astb2 104 G 104 (284)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.56 E-value=6.1e-15 Score=126.79 Aligned_cols=103 Identities=29% Similarity=0.355 Sum_probs=74.1
Q ss_pred CEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccC
Q 004268 70 KVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLN 149 (764)
Q Consensus 70 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 149 (764)
|+|+|++|+|+. ++ .+..+++|++|+|++|.|+. .|..|+.+++|++|++++|+|+++ +.+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc--CccccccccCeEECCCC
Confidence 567888888873 33 47777788888888888874 355677778888888888888765 24777778888888888
Q ss_pred cccccCC-ccccCCCCCCeeecccCCCCC
Q 004268 150 QLSGRLP-QEVGNLKNLKSLFLDNNHLSG 177 (764)
Q Consensus 150 ~l~~~~~-~~~~~l~~L~~L~L~~n~i~~ 177 (764)
+++.+.. ..+..+++|+.|++++|.++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 7775542 456777777777777777753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=1.3e-16 Score=165.55 Aligned_cols=136 Identities=21% Similarity=0.182 Sum_probs=71.0
Q ss_pred CCCCCeeecccCCCCCCC----CCccccCCCccEEEecCccCcCC-----cccccCCccccceeeccCcccccc----cC
Q 004268 162 LKNLKSLFLDNNHLSGPI----PSTLYHLNQLATLCLGYNKLVGP-----VTKEVGNMKNLDRLHLNGNNLTGS----IP 228 (764)
Q Consensus 162 l~~L~~L~L~~n~i~~~~----~~~~~~l~~L~~L~l~~n~i~~~-----~~~~~~~l~~L~~L~L~~n~l~~~----~~ 228 (764)
.+.|+.+++++|.++... ...+...+.|++|+|++|.+... ....+..+++|+.|+|++|.++.. ..
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 344555555555543211 11233445555555555555421 122344556666666666665432 22
Q ss_pred ccccCCCCCCEEEccCCcccCCCCc----CCc--CCCCCCeEEccCCcccCCC----Cccc-cCCCCCCeEeccCccccC
Q 004268 229 STIGYLNLLDELHLSHNRLDGPIPP----TIG--NLTNLIALDLSSNQLSGLL----PREV-GNLKYLASLSLNGNILIG 297 (764)
Q Consensus 229 ~~~~~l~~L~~L~L~~n~l~~~~~~----~~~--~l~~L~~L~L~~n~l~~~~----~~~~-~~l~~L~~L~l~~n~l~~ 297 (764)
..+...++|++|+|++|.|++.... .+. ..+.|+.|++++|.|+... ...+ .++++|+.|+|++|++..
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 3445566677777777766543221 122 2356777777777775322 1222 245677778887777753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.55 E-value=2.5e-16 Score=163.38 Aligned_cols=136 Identities=21% Similarity=0.226 Sum_probs=93.1
Q ss_pred cCCCccEEEecCccCcCCccc----ccCCccccceeeccCcccccc-----cCccccCCCCCCEEEccCCcccCC----C
Q 004268 185 HLNQLATLCLGYNKLVGPVTK----EVGNMKNLDRLHLNGNNLTGS-----IPSTIGYLNLLDELHLSHNRLDGP----I 251 (764)
Q Consensus 185 ~l~~L~~L~l~~n~i~~~~~~----~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~L~~n~l~~~----~ 251 (764)
..+.|+.|++++|.+...... .+...+.|++|+|++|.++.. ....+...++|+.|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 456788888888887643322 245567888899988887642 234466778889999988887633 2
Q ss_pred CcCCcCCCCCCeEEccCCcccCCCCcc----cc--CCCCCCeEeccCccccCCC----CCCC-CCCCccceEEccCCcCc
Q 004268 252 PPTIGNLTNLIALDLSSNQLSGLLPRE----VG--NLKYLASLSLNGNILIGPI----PPTI-GYLTNLTYLNLGYNRLS 320 (764)
Q Consensus 252 ~~~~~~l~~L~~L~L~~n~l~~~~~~~----~~--~l~~L~~L~l~~n~l~~~~----~~~~-~~l~~L~~L~ls~N~l~ 320 (764)
...+..+++|+.|+|++|.|++..... +. ..+.|++|++++|.|.... ...+ ...++|++|+|++|++.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 345667888899999999887542222 22 2467888999998875421 1122 24678889999998887
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.5e-13 Score=123.37 Aligned_cols=106 Identities=22% Similarity=0.177 Sum_probs=66.1
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCC-cCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEcc
Q 004268 45 LEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYN-RLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQ 123 (764)
Q Consensus 45 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 123 (764)
.+.++++++.+. ..|..+.++++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 345666666665 34555666666666666544 3665555666666666666666666666666666666666666666
Q ss_pred CCcCcccCCccccCCCCcCEEecccCccc
Q 004268 124 GNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 124 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
+|+|+.+.++.|..+ +|+.|+|++|++.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 666666655555544 4666666666664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=4.4e-16 Score=146.48 Aligned_cols=114 Identities=23% Similarity=0.280 Sum_probs=59.2
Q ss_pred cCCccccCCCCCcEEEcCCCcCcccCCccccCCCCCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcC
Q 004268 34 RMPSEIGALSKLEKLVLSHNSLTGRIPSEIGALSRLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGN 113 (764)
Q Consensus 34 ~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 113 (764)
.++.++..+++|++|+|++|+|+.+ + .|..+++|++|+|++|+|+ .++..+..+++|++|++++|.++.+ ..+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 3444555566666666666666533 2 3555556666666666555 2333333344555555555555533 22445
Q ss_pred CCCCCEEEccCCcCcccCC-ccccCCCCcCEEecccCccc
Q 004268 114 LKDLDQLRLQGNKLDGLIP-SSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 114 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 152 (764)
+++|+.|++++|+++.+.. ..+..+++|+.|+|++|++.
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 5555555555555554321 23455555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=2.8e-13 Score=121.54 Aligned_cols=105 Identities=25% Similarity=0.230 Sum_probs=55.9
Q ss_pred CEEEccCCcccCCCCcCCcCCCCCCeEEccCC-cccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccC
Q 004268 238 DELHLSHNRLDGPIPPTIGNLTNLIALDLSSN-QLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGY 316 (764)
Q Consensus 238 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 316 (764)
+.++++++.+. ..|..+..+++|+.|++++| .++.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34455555554 23444555555566665444 35555555555555666666666665555555555566666666666
Q ss_pred CcCccCCChhhhcccccceeeccccccc
Q 004268 317 NRLSSSIPPELMNCSQLLNLVLSHNSLS 344 (764)
Q Consensus 317 N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 344 (764)
|+|+...+..|. ..+|+.|+|++|++.
T Consensus 90 N~l~~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred CCCcccChhhhc-cccccccccCCCccc
Confidence 666533333332 234666666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=3e-15 Score=140.72 Aligned_cols=113 Identities=21% Similarity=0.237 Sum_probs=64.6
Q ss_pred cCCcCCCCCCeEEccCCcccCCCCccccCCCCCCeEeccCccccCCCCCCCCCCCccceEEccCCcCccCCChhhhcccc
Q 004268 253 PTIGNLTNLIALDLSSNQLSGLLPREVGNLKYLASLSLNGNILIGPIPPTIGYLTNLTYLNLGYNRLSSSIPPELMNCSQ 332 (764)
Q Consensus 253 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 332 (764)
..+..+++|++|+|++|+|+.+ ..+.++++|+.|++++|.|+.+ +..+..+++|+.|++++|+|+.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCCc--ccccCCccccChhhcccccccc-ccccccccccccccccccccccc--cccccccc
Confidence 3455566666666666666543 2355666666666666666532 33333345566666666666632 34566666
Q ss_pred cceeeccccccccCCc-hhcccccccceeecccccccCC
Q 004268 333 LLNLVLSHNSLSGSIP-SEIGNLIFFRQLDLSRNFINGT 370 (764)
Q Consensus 333 L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~ 370 (764)
|+.|++++|+|++... ..+..+++|+.|+|++|++...
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 6666666666663321 3456666666666666666533
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.69 E-value=3.2e-10 Score=102.00 Aligned_cols=66 Identities=32% Similarity=0.210 Sum_probs=29.0
Q ss_pred cCCCCCCCEEecCCCcccccC--CccCcCCCCCCEEEccCCcCcccCCccccCCCCcCEEecccCccc
Q 004268 87 IGSLRDLLDLNLSNNILNGSI--PLEFGNLKDLDQLRLQGNKLDGLIPSSIGNLTNLTYLDLSLNQLS 152 (764)
Q Consensus 87 ~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 152 (764)
+..+++|++|+|++|+|+.+. +..+..+++|+.|+|++|.|+.+.+-.+.+..+|+.|++++|++.
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 334455555555555554332 122334444555555555554443322223334444445554444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=4.7e-10 Score=100.86 Aligned_cols=105 Identities=27% Similarity=0.258 Sum_probs=63.0
Q ss_pred CCCEEEccCCcCcccCCcccCCCCCCCEEecCCCcccccCCccCcCCCCCCEEEccCCcCcccC--CccccCCCCcCEEe
Q 004268 68 RLKVLDLSYNRLTGTIPSEIGSLRDLLDLNLSNNILNGSIPLEFGNLKDLDQLRLQGNKLDGLI--PSSIGNLTNLTYLD 145 (764)
Q Consensus 68 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~ 145 (764)
..+.|++++.+.. ..+..+..+..|++.++... ..+..+.++++|++|+|++|+|+.+. +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666554432 22344444455555554443 33445556777888888888777653 24456677777777
Q ss_pred cccCcccccCCccccCCCCCCeeecccCCCCC
Q 004268 146 LSLNQLSGRLPQEVGNLKNLKSLFLDNNHLSG 177 (764)
Q Consensus 146 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~ 177 (764)
|++|.|+.+.+-.+.+..+|+.|++++|.++.
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 77777776544344445567777777777764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.57 E-value=1.6e-07 Score=91.62 Aligned_cols=150 Identities=13% Similarity=0.104 Sum_probs=103.9
Q ss_pred HHHHHHhhcCCcceeeeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeC
Q 004268 501 EEMIEATEDFHIKYCIGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHN 579 (764)
Q Consensus 501 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~ 579 (764)
.++....+.|+.++..+.++.+.||+... +++.+++|+......... ..+.+|...++.+. +--+++++.+..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 45666778888877766566678999865 466788888765433221 35678888888874 44478888888888
Q ss_pred CEEEEEEEecCCCCHHHHHhcCccccccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 004268 580 KCMFLIYEYMERGSLFCVLRNDVEAVELDWTKRVNIVKSMAHALSYLHYDC----------------------------- 630 (764)
Q Consensus 580 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------- 630 (764)
+..++||++++|.++....... .....++.++++.+..||...
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 9999999999998876543211 111223445555555555210
Q ss_pred ---------------------------CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 631 ---------------------------KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 631 ---------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=1.3e-06 Score=84.48 Aligned_cols=74 Identities=15% Similarity=0.100 Sum_probs=55.2
Q ss_pred eeeecCc-eeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC--CCceeeEeeEEeeCCEEEEEEEecCC
Q 004268 515 CIGTGGY-GSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIR--HRNIVKLYGFCLHNKCMFLIYEYMER 591 (764)
Q Consensus 515 ~ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~ 591 (764)
.+..|.. +.||+....++..+++|....... ..+..|.+.++.+. .-.+++++.+..+++..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 3445554 689999888788899998765443 34667888888773 33478888888888889999999988
Q ss_pred CCH
Q 004268 592 GSL 594 (764)
Q Consensus 592 ~~L 594 (764)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.02 E-value=9.2e-07 Score=79.14 Aligned_cols=86 Identities=9% Similarity=0.128 Sum_probs=37.9
Q ss_pred CCCCcEEEcCCC-cCccc----CCccccCCCCCCEEEccCCcCcc----cCCcccCCCCCCCEEecCCCcccccC----C
Q 004268 42 LSKLEKLVLSHN-SLTGR----IPSEIGALSRLKVLDLSYNRLTG----TIPSEIGSLRDLLDLNLSNNILNGSI----P 108 (764)
Q Consensus 42 l~~L~~L~Ls~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~----~ 108 (764)
.+.|++|+|+++ .++.. +...+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.++... .
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 345555555542 34321 22233444555555555555542 12233334455555555555554211 1
Q ss_pred ccCcCCCCCCEEEccCCcC
Q 004268 109 LEFGNLKDLDQLRLQGNKL 127 (764)
Q Consensus 109 ~~~~~l~~L~~L~L~~n~l 127 (764)
.++...+.|++|+|++|.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2234444455555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.92 E-value=1.3e-06 Score=78.19 Aligned_cols=111 Identities=14% Similarity=0.106 Sum_probs=80.7
Q ss_pred ccCCCeeEEEeCCC-Ccccc----CCccccCCCCCcEEEcCCCcCccc----CCccccCCCCCCEEEccCCcCccc----
Q 004268 16 TCFPNLVTFRIWGT-LLSGR----MPSEIGALSKLEKLVLSHNSLTGR----IPSEIGALSRLKVLDLSYNRLTGT---- 82 (764)
Q Consensus 16 ~~~~~l~~L~l~~~-~~~~~----~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~---- 82 (764)
++.|+|++|+|+++ .++.. +...+...+.|++|+|++|.+++. +...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34689999999985 45432 334577888999999999999843 334455679999999999999843
Q ss_pred CCcccCCCCCCCEEecCCCcccccC-------CccCcCCCCCCEEEccCCc
Q 004268 83 IPSEIGSLRDLLDLNLSNNILNGSI-------PLEFGNLKDLDQLRLQGNK 126 (764)
Q Consensus 83 ~~~~~~~l~~L~~L~L~~n~l~~~~-------~~~~~~l~~L~~L~L~~n~ 126 (764)
+..++...+.|++|+|++|.+..+. ...+...+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3457888899999999999766332 2233445667777666553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.63 E-value=4.4e-05 Score=78.33 Aligned_cols=79 Identities=13% Similarity=0.133 Sum_probs=49.7
Q ss_pred ceeeeecCceeEEEEEEC-CCCEEEEEEccCCC----CCcHHHHHHHHHHHHHHHhc-CC--CceeeEeeEEeeCCEEEE
Q 004268 513 KYCIGTGGYGSVYRAQLS-SGKLVALKKLHRSE----TEEPAFLESFQTEARLLSQI-RH--RNIVKLYGFCLHNKCMFL 584 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~~E~~~l~~l-~h--pniv~~~~~~~~~~~~~l 584 (764)
.+.||.|....||++... +++.|++|...... ...+....+...|.+.++.+ .+ ..+++++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 456899999999999755 47789999654311 00001124456788888777 23 4577777654 344578
Q ss_pred EEEecCCCC
Q 004268 585 IYEYMERGS 593 (764)
Q Consensus 585 v~e~~~~~~ 593 (764)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.58 E-value=2.9e-06 Score=75.87 Aligned_cols=41 Identities=15% Similarity=0.201 Sum_probs=17.7
Q ss_pred cCCCCCCEEEccCCcCccc----CCcccCCCCCCCEEecCCCccc
Q 004268 64 GALSRLKVLDLSYNRLTGT----IPSEIGSLRDLLDLNLSNNILN 104 (764)
Q Consensus 64 ~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~ 104 (764)
...++|++|+|++|.++.. +...+...+.|+.|++++|.++
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3444455555555544321 1223333444444444444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.49 E-value=4.3e-06 Score=74.70 Aligned_cols=64 Identities=9% Similarity=0.101 Sum_probs=30.0
Q ss_pred CCCCCCEEEccC-CcCcc----cCCcccCCCCCCCEEecCCCcccccCC----ccCcCCCCCCEEEccCCcCc
Q 004268 65 ALSRLKVLDLSY-NRLTG----TIPSEIGSLRDLLDLNLSNNILNGSIP----LEFGNLKDLDQLRLQGNKLD 128 (764)
Q Consensus 65 ~l~~L~~L~L~~-n~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~ 128 (764)
+.+.|++|+|++ +.|+. .+..++..+++|++|+|++|.++.... ..+...+.|+.|++++|.+.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 445555555554 33431 122344455556666666655542211 12333455555555555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00032 Score=69.73 Aligned_cols=136 Identities=15% Similarity=0.151 Sum_probs=79.9
Q ss_pred ceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCce--eeEe-----eEEeeCCEEEEEEEecCCCC
Q 004268 521 YGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRNI--VKLY-----GFCLHNKCMFLIYEYMERGS 593 (764)
Q Consensus 521 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~~~-----~~~~~~~~~~lv~e~~~~~~ 593 (764)
--.||++...+|+.|++|+........ +++..|.+.+..|....+ +... ..+...+..+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 358999998889999999987654432 667788888888742221 1111 13345677899999998743
Q ss_pred HH-----HH------H-------hcCc--cccc-------------------cCHH---HHHHHHHHHHHHHHHHH-hcC
Q 004268 594 LF-----CV------L-------RNDV--EAVE-------------------LDWT---KRVNIVKSMAHALSYLH-YDC 630 (764)
Q Consensus 594 L~-----~~------l-------~~~~--~~~~-------------------l~~~---~~~~i~~qi~~aL~~LH-~~~ 630 (764)
+. .+ + .... .... ++.. .....+.++...+...- ...
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 31 00 0 0000 0001 1111 11222333333333221 122
Q ss_pred CCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 631 KPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 631 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
..++||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4689999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.28 E-value=0.001 Score=65.68 Aligned_cols=159 Identities=13% Similarity=0.083 Sum_probs=88.2
Q ss_pred cCHHHHHHHhhcCCccee-----eeecCceeEEEEEECCCCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcCCCc--ee
Q 004268 498 ITFEEMIEATEDFHIKYC-----IGTGGYGSVYRAQLSSGKLVALKKLHRSETEEPAFLESFQTEARLLSQIRHRN--IV 570 (764)
Q Consensus 498 ~~~~~~~~~~~~y~~~~~-----ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv 570 (764)
++.+++.....+|.+.+. |..|.--+.|+....+|+ +++|++...... +.+..|.+++..+...+ ++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence 566788888889987544 345666788999877554 899988654322 44556777777773221 22
Q ss_pred eEee------EEeeCCEEEEEEEecCCCCHHH-----------HH---h---cCc---------------------cccc
Q 004268 571 KLYG------FCLHNKCMFLIYEYMERGSLFC-----------VL---R---NDV---------------------EAVE 606 (764)
Q Consensus 571 ~~~~------~~~~~~~~~lv~e~~~~~~L~~-----------~l---~---~~~---------------------~~~~ 606 (764)
..+. +.......+.++.+..+..... .+ + ... ....
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 2111 2233455667777776643310 00 0 000 0000
Q ss_pred cCHHHHHHHHHHHHHHHHHHHh-cCCCCcEEcCCCCCCeeecCCCCEEEeeeccccc
Q 004268 607 LDWTKRVNIVKSMAHALSYLHY-DCKPSIVHRDISSNNILLNSNLEAFVADFGLARL 662 (764)
Q Consensus 607 l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 662 (764)
.........+..+...+...+. ....|+||+|+.+.||+++++...-++||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111112222333333333331 2367899999999999999887778999998854
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.98 E-value=0.0013 Score=67.00 Aligned_cols=73 Identities=21% Similarity=0.218 Sum_probs=50.3
Q ss_pred ceeeeecCceeEEEEEECC--------CCEEEEEEccCCCCCcHHHHHHHHHHHHHHHhcC-CCceeeEeeEEeeCCEEE
Q 004268 513 KYCIGTGGYGSVYRAQLSS--------GKLVALKKLHRSETEEPAFLESFQTEARLLSQIR-HRNIVKLYGFCLHNKCMF 583 (764)
Q Consensus 513 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 583 (764)
++.|+.|-.-.+|++...+ .+.|++++.-... .. ....+|.++++.+. +.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE---SHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3568888889999997643 3568888765322 11 34558899988884 5455688887753 5
Q ss_pred EEEEecCCCCH
Q 004268 584 LIYEYMERGSL 594 (764)
Q Consensus 584 lv~e~~~~~~L 594 (764)
+|+||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987544
|